Citrus Sinensis ID: 016233
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 393 | 2.2.26 [Sep-21-2011] | |||||||
| Q38868 | 541 | Calcium-dependent protein | yes | no | 0.951 | 0.691 | 0.747 | 1e-167 | |
| P28582 | 532 | Calcium-dependent protein | N/A | no | 0.944 | 0.697 | 0.748 | 1e-166 | |
| P53683 | 533 | Calcium-dependent protein | yes | no | 0.936 | 0.690 | 0.759 | 1e-165 | |
| Q9C6P3 | 521 | Calcium-dependent protein | no | no | 0.778 | 0.587 | 0.869 | 1e-163 | |
| P49101 | 513 | Calcium-dependent protein | N/A | no | 0.862 | 0.660 | 0.792 | 1e-162 | |
| Q9ZSA2 | 531 | Calcium-dependent protein | no | no | 0.844 | 0.625 | 0.776 | 1e-159 | |
| O49717 | 554 | Calcium-dependent protein | no | no | 0.875 | 0.620 | 0.721 | 1e-150 | |
| Q1PFH8 | 551 | Calcium-dependent protein | no | no | 0.867 | 0.618 | 0.712 | 1e-146 | |
| Q9FMP5 | 528 | Calcium-dependent protein | no | no | 0.921 | 0.685 | 0.629 | 1e-142 | |
| Q3E9C0 | 523 | Calcium-dependent protein | no | no | 0.900 | 0.676 | 0.624 | 1e-140 |
| >sp|Q38868|CDPK9_ARATH Calcium-dependent protein kinase 9 OS=Arabidopsis thaliana GN=CPK9 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 588 bits (1515), Expect = e-167, Method: Compositional matrix adjust.
Identities = 287/384 (74%), Positives = 323/384 (84%), Gaps = 10/384 (2%)
Query: 1 MGGCLTKSKD-PKPRHYAHGYRSSPNTVAKAPAPA---QQQAHHRPEKPGPTPAAAPVSG 56
MG C K+ KP+ + RS V P+ Q + +PEKPG + P
Sbjct: 1 MGNCFAKNHGLMKPQQNGNTTRSVEVGVTNQDPPSYTPQARTTQQPEKPGSVNSQPPPWR 60
Query: 57 LKQAV----PRPDT--NTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACK 110
A P+ T N+IL +EDVKL Y+ GKELGRGQFGVTYLCTENSTG+++ACK
Sbjct: 61 AAAAAPGLSPKTTTKSNSILENAFEDVKLFYTLGKELGRGQFGVTYLCTENSTGKKYACK 120
Query: 111 SISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDR 170
SISK+KLVTK DKDD++REIQIMQHLSGQPNIVEFKGAYED+++V++VMELCAGGELFDR
Sbjct: 121 SISKKKLVTKADKDDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDR 180
Query: 171 IIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230
IIAKGHY+ERAAAS+CR IVNVV ICHFMGV+HRDLKPENFLLSSKDE AL+KATDFGLS
Sbjct: 181 IIAKGHYTERAAASVCRQIVNVVKICHFMGVLHRDLKPENFLLSSKDEKALIKATDFGLS 240
Query: 231 VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIF 290
VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKE+DIWSAG+ILYILLSGVPPFWAETEKGIF
Sbjct: 241 VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEVDIWSAGIILYILLSGVPPFWAETEKGIF 300
Query: 291 DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
DAIL+G IDFES PWP+ISSSAKDLVRRMLT DPK+RI++A VL+HPW++EGGEASDKPI
Sbjct: 301 DAILEGHIDFESQPWPSISSSAKDLVRRMLTADPKRRISAADVLQHPWLREGGEASDKPI 360
Query: 351 DSAVLSRMKQFRAMNKLKKLALKV 374
DSAVLSRMKQFRAMNKLKKLALKV
Sbjct: 361 DSAVLSRMKQFRAMNKLKKLALKV 384
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P28582|CDPK_DAUCA Calcium-dependent protein kinase OS=Daucus carota PE=2 SV=2 | Back alignment and function description |
|---|
Score = 585 bits (1509), Expect = e-166, Method: Compositional matrix adjust.
Identities = 282/377 (74%), Positives = 322/377 (85%), Gaps = 6/377 (1%)
Query: 1 MGGCLTKSKDPKPRHYAHGYRSSP---NTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGL 57
MGGC +K + +GYRS+P +TV Q +P P S
Sbjct: 1 MGGCFSKKEYQAD---GNGYRSAPTAYHTVTDQSYEKSSQRSQPQAQPQPQVQQTGPSLK 57
Query: 58 KQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL 117
+ V RP++NTILGKP+ED++ Y+ GKELGRGQFG Y CTENS+G+ +ACKSI KRKL
Sbjct: 58 PRQVHRPESNTILGKPFEDIRGKYTLGKELGRGQFGCVYQCTENSSGQLYACKSILKRKL 117
Query: 118 VTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY 177
V+KNDK+DIKREIQI+QHLSGQPNIVEFKG +ED+QSVH+VMELCAGGELFDRIIA+GHY
Sbjct: 118 VSKNDKEDIKREIQILQHLSGQPNIVEFKGVFEDRQSVHLVMELCAGGELFDRIIAQGHY 177
Query: 178 SERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237
SERAAA+ICR IVNVVH+CHFMGVMHRDLKPENFLLSSKD++A+LKATDFGLSVFIEEGK
Sbjct: 178 SERAAATICRQIVNVVHVCHFMGVMHRDLKPENFLLSSKDKDAMLKATDFGLSVFIEEGK 237
Query: 238 VYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD 297
VYR+IVGSAYYVAPEVLRR YGKEIDIWSAGVILYILLSGVPPFWAE EKGIFDAIL+G
Sbjct: 238 VYRNIVGSAYYVAPEVLRRSYGKEIDIWSAGVILYILLSGVPPFWAENEKGIFDAILEGV 297
Query: 298 IDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSR 357
IDFES PWP++S+SAKDLVR+MLTQDP++RITSAQVL+HPW++EGGEASDKPIDSAVLSR
Sbjct: 298 IDFESEPWPSVSNSAKDLVRKMLTQDPRRRITSAQVLDHPWMREGGEASDKPIDSAVLSR 357
Query: 358 MKQFRAMNKLKKLALKV 374
MKQFRAMNKLK+LALKV
Sbjct: 358 MKQFRAMNKLKQLALKV 374
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P53683|CDPK2_ORYSJ Calcium-dependent protein kinase isoform 2 OS=Oryza sativa subsp. japonica GN=CPK2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 580 bits (1494), Expect = e-165, Method: Compositional matrix adjust.
Identities = 291/383 (75%), Positives = 331/383 (86%), Gaps = 15/383 (3%)
Query: 1 MGGCLTKSKDPKP-RHYAHGYRSSPNTVAKAPAPAQQQ-AHHRPEKPGP-----TPAA-- 51
MG C +++ P R A+GY S T PAQ +++ P+ P P TP+A
Sbjct: 1 MGSCCSRATSPDSGRGGANGYGYSHQT-----KPAQTTPSYNHPQPPPPAEVRYTPSAMN 55
Query: 52 APVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKS 111
PV A P+P +TILGKPY+DV+ YS GKELGRGQFGVTYLCTE ++G+Q+ACKS
Sbjct: 56 PPVVPPVVAPPKPTPDTILGKPYDDVRSVYSLGKELGRGQFGVTYLCTEIASGKQYACKS 115
Query: 112 ISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI 171
ISKRKLV+K DK+DI+REIQIMQHLSGQ NIVEF+GAYEDK +VHVVMELCAGGELFDRI
Sbjct: 116 ISKRKLVSKADKEDIRREIQIMQHLSGQQNIVEFRGAYEDKSNVHVVMELCAGGELFDRI 175
Query: 172 IAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231
IAKGHYSERAAA+ICR++VNVV+ICHFMGVMHRDLKPENFLL++K+ENA+LKATDFGLSV
Sbjct: 176 IAKGHYSERAAATICRAVVNVVNICHFMGVMHRDLKPENFLLATKEENAMLKATDFGLSV 235
Query: 232 FIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFD 291
FIEEGK+YRDIVGSAYYVAPEVLRR YGKEID+WSAGVILYILLSGVPPFWAETEKGIFD
Sbjct: 236 FIEEGKMYRDIVGSAYYVAPEVLRRNYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFD 295
Query: 292 AILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPID 351
AILQG+IDFES PWP+IS SAKDLVR+MLTQDPKKRITSAQVL+HPW+++ GEASDKPID
Sbjct: 296 AILQGEIDFESQPWPSISESAKDLVRKMLTQDPKKRITSAQVLQHPWLRD-GEASDKPID 354
Query: 352 SAVLSRMKQFRAMNKLKKLALKV 374
SAVLSRMKQFRAMNKLKK+ALKV
Sbjct: 355 SAVLSRMKQFRAMNKLKKMALKV 377
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C6P3|CDPKX_ARATH Calcium-dependent protein kinase 33 OS=Arabidopsis thaliana GN=CPK33 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 575 bits (1481), Expect = e-163, Method: Compositional matrix adjust.
Identities = 266/306 (86%), Positives = 297/306 (97%)
Query: 69 ILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR 128
IL KPYEDVKL Y+ KELGRGQFGVTYLCTE STG++FACKSISK+KLVTK DK+D++R
Sbjct: 61 ILEKPYEDVKLFYTLSKELGRGQFGVTYLCTEKSTGKRFACKSISKKKLVTKGDKEDMRR 120
Query: 129 EIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRS 188
EIQIMQHLSGQPNIVEFKGAYED+++V++VMELCAGGELFDRI+AKGHYSERAAAS+CR
Sbjct: 121 EIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDRILAKGHYSERAAASVCRQ 180
Query: 189 IVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYY 248
IVNVV+ICHFMGVMHRDLKPENFLLSSKDE AL+KATDFGLSVFIEEG+VY+DIVGSAYY
Sbjct: 181 IVNVVNICHFMGVMHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGRVYKDIVGSAYY 240
Query: 249 VAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308
VAPEVL+RRYGKEIDIWSAG+ILYILLSGVPPFWAETEKGIFDAIL+G+IDFES PWP+I
Sbjct: 241 VAPEVLKRRYGKEIDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGEIDFESQPWPSI 300
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLK 368
S+SAKDLVRRMLTQDPK+RI++A+VL+HPW++EGGEASDKPIDSAVLSRMKQFRAMNKLK
Sbjct: 301 SNSAKDLVRRMLTQDPKRRISAAEVLKHPWLREGGEASDKPIDSAVLSRMKQFRAMNKLK 360
Query: 369 KLALKV 374
KLALKV
Sbjct: 361 KLALKV 366
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P49101|CDPK2_MAIZE Calcium-dependent protein kinase 2 OS=Zea mays GN=CPK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 571 bits (1472), Expect = e-162, Method: Compositional matrix adjust.
Identities = 271/342 (79%), Positives = 305/342 (89%), Gaps = 3/342 (0%)
Query: 33 PAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQF 92
P QQ A R P+ + P+P +TILGK YEDV+ YSFGKELGRGQF
Sbjct: 20 PPQQAAEVRYT---PSATNSSAVPPVAVPPKPTADTILGKQYEDVRSVYSFGKELGRGQF 76
Query: 93 GVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152
GVTYLCTE ++GRQ+ACKSISKRKLV+K D++DI+REIQIMQHLSGQPNIVEF+GAYEDK
Sbjct: 77 GVTYLCTEIASGRQYACKSISKRKLVSKADREDIRREIQIMQHLSGQPNIVEFRGAYEDK 136
Query: 153 QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFL 212
+VHVVMELCAGGELFDRIIAKGHY+ERAAA+ICR++VNVV+ICHFMGVMHRDLKPENFL
Sbjct: 137 SNVHVVMELCAGGELFDRIIAKGHYTERAAATICRAVVNVVNICHFMGVMHRDLKPENFL 196
Query: 213 LSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILY 272
L++ +ENA+LKATDFGLSVFIEEGK+YRDIVGSAYYVAPEVLRR YGKEID+WSAGVILY
Sbjct: 197 LATMEENAMLKATDFGLSVFIEEGKMYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILY 256
Query: 273 ILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQ 332
ILLSGVPPFWAE EKGIFDAIL +IDFES PWP+IS SAKDLVR+MLT+DPKKR+TSAQ
Sbjct: 257 ILLSGVPPFWAEIEKGIFDAILHEEIDFESQPWPSISESAKDLVRKMLTRDPKKRLTSAQ 316
Query: 333 VLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKV 374
VL+H W++EGGEASDKPIDSAVLSRMKQFRAMNKLKK+ALKV
Sbjct: 317 VLQHQWLREGGEASDKPIDSAVLSRMKQFRAMNKLKKMALKV 358
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZSA2|CDPKL_ARATH Calcium-dependent protein kinase 21 OS=Arabidopsis thaliana GN=CPK21 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 561 bits (1445), Expect = e-159, Method: Compositional matrix adjust.
Identities = 267/344 (77%), Positives = 299/344 (86%), Gaps = 12/344 (3%)
Query: 39 HHRPEKPGPTPAAAPVSGLKQAVPRPDTN--------TILGKPYEDVKLHYSFGKELGRG 90
H +P+ P P P P+ Q + P +N TILGKP+ED++ YS GKELGRG
Sbjct: 33 HRKPQTPTPKPMTQPIH---QQISTPSSNPVSVRDPDTILGKPFEDIRKFYSLGKELGRG 89
Query: 91 QFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150
QFG+TY+C E TG +ACKSI KRKL++K DK+D+KREIQIMQ+LSGQPNIVE KGAYE
Sbjct: 90 QFGITYMCKEIGTGNTYACKSILKRKLISKQDKEDVKREIQIMQYLSGQPNIVEIKGAYE 149
Query: 151 DKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210
D+QS+H+VMELCAGGELFDRIIA+GHYSERAAA I RSIVNVV ICHFMGV+HRDLKPEN
Sbjct: 150 DRQSIHLVMELCAGGELFDRIIAQGHYSERAAAGIIRSIVNVVQICHFMGVVHRDLKPEN 209
Query: 211 FLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVI 270
FLLSSK+ENA+LKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR YGKEIDIWSAGVI
Sbjct: 210 FLLSSKEENAMLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRSYGKEIDIWSAGVI 269
Query: 271 LYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITS 330
LYILLSGVPPFWAE EKGIFD +++G+IDF S PWP+IS SAKDLVR+MLT+DPK+RIT+
Sbjct: 270 LYILLSGVPPFWAENEKGIFDEVIKGEIDFVSEPWPSISESAKDLVRKMLTKDPKRRITA 329
Query: 331 AQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKV 374
AQVLEHPWIK GGEA DKPIDSAVLSRMKQFRAMNKLKKLALKV
Sbjct: 330 AQVLEHPWIK-GGEAPDKPIDSAVLSRMKQFRAMNKLKKLALKV 372
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49717|CDPKF_ARATH Calcium-dependent protein kinase 15 OS=Arabidopsis thaliana GN=CPK15 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 533 bits (1373), Expect = e-150, Method: Compositional matrix adjust.
Identities = 256/355 (72%), Positives = 295/355 (83%), Gaps = 11/355 (3%)
Query: 29 KAPAP----AQQQAHHRPEKPGPTPAAAP-----VSGLKQAVPRPDTNTILGKPYEDVKL 79
K P+P Q HH ++ P LK V R +T TILGKP+E+++
Sbjct: 42 KPPSPQIPTTTQSNHHHQQESKPVNQQIEKKHVLTQPLKPIVFR-ETETILGKPFEEIRK 100
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y+ GKELGRGQFG+TY C ENSTG +ACKSI KRKL K D DD+KREIQIMQ+LSGQ
Sbjct: 101 LYTLGKELGRGQFGITYTCKENSTGNTYACKSILKRKLTRKQDIDDVKREIQIMQYLSGQ 160
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
NIVE KGAYED+QS+H+VMELC G ELFDRIIA+GHYSE+AAA + RS++NVV ICHFM
Sbjct: 161 ENIVEIKGAYEDRQSIHLVMELCGGSELFDRIIAQGHYSEKAAAGVIRSVLNVVQICHFM 220
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYG 259
GV+HRDLKPENFLL+S DENA+LKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR YG
Sbjct: 221 GVIHRDLKPENFLLASTDENAMLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRSYG 280
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRM 319
KEIDIWSAG+ILYILL GVPPFW+ETEKGIF+ I++G+IDF+S PWP+IS SAKDLVR++
Sbjct: 281 KEIDIWSAGIILYILLCGVPPFWSETEKGIFNEIIKGEIDFDSQPWPSISESAKDLVRKL 340
Query: 320 LTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKV 374
LT+DPK+RI++AQ LEHPWI+ GGEA DKPIDSAVLSRMKQFRAMNKLKKLALKV
Sbjct: 341 LTKDPKQRISAAQALEHPWIR-GGEAPDKPIDSAVLSRMKQFRAMNKLKKLALKV 394
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PFH8|CDPKJ_ARATH Calcium-dependent protein kinase 19 OS=Arabidopsis thaliana GN=CPK19 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 519 bits (1337), Expect = e-146, Method: Compositional matrix adjust.
Identities = 253/355 (71%), Positives = 292/355 (82%), Gaps = 14/355 (3%)
Query: 29 KAPAP-AQQQAHHRPEK-----PGPTPAAAPVSGLKQAV---PRPDTNTILGKPYEDVKL 79
+ PAP A+ Q +P K P P ++ KQ+ P P ILG+P+ED+K
Sbjct: 41 RQPAPRAKFQIVVQPHKLPLPLPQPQEKQKLINHQKQSTLQQPEP----ILGRPFEDIKE 96
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
YS G+ELGRGQFG+TY+CTE S+G+ FACKSI KRKL+ D++D++REIQIM +LSGQ
Sbjct: 97 KYSLGRELGRGQFGITYICTEISSGKNFACKSILKRKLIRTKDREDVRREIQIMHYLSGQ 156
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
PNIVE KGAYED+QSVH+VMELC GGELFD+I +GHYSE+AAA I RS+V VV ICHFM
Sbjct: 157 PNIVEIKGAYEDRQSVHLVMELCEGGELFDKITKRGHYSEKAAAEIIRSVVKVVQICHFM 216
Query: 200 GVMHRDLKPENFLLSSKDE-NALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRY 258
GV+HRDLKPENFLLSSKDE +++LKATDFG+SVFIEEGKVY DIVGSAYYVAPEVL+R Y
Sbjct: 217 GVIHRDLKPENFLLSSKDEASSMLKATDFGVSVFIEEGKVYEDIVGSAYYVAPEVLKRNY 276
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
GK IDIWSAGVILYILL G PPFWAET+KGIF+ IL+G+IDFES PWP+IS SAKDLVR
Sbjct: 277 GKAIDIWSAGVILYILLCGNPPFWAETDKGIFEEILRGEIDFESEPWPSISESAKDLVRN 336
Query: 319 MLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALK 373
ML DPKKR T+AQVLEHPWI+EGGEASDKPIDSAVLSRMKQ RAMNKLKKLA K
Sbjct: 337 MLKYDPKKRFTAAQVLEHPWIREGGEASDKPIDSAVLSRMKQLRAMNKLKKLAFK 391
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FMP5|CDPKH_ARATH Calcium-dependent protein kinase 17 OS=Arabidopsis thaliana GN=CPK17 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 505 bits (1301), Expect = e-142, Method: Compositional matrix adjust.
Identities = 238/378 (62%), Positives = 290/378 (76%), Gaps = 16/378 (4%)
Query: 1 MGGCLTKSKDPKPRHYAHGYRSSPNTVAKAPAPAQQ----QAHHRPEKPGPTPAAAPVSG 56
MG C + +D A +S + A + P + Q+ H P P P P+
Sbjct: 1 MGNCCSHGRDSADNGDALENGASASNAANSTGPTAEASVPQSKHAPPSPPPATKQGPIG- 59
Query: 57 LKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRK 116
+LG+P EDVK YS GKELGRGQFGVT+LCT+ +TG QFACK+I+KRK
Sbjct: 60 -----------PVLGRPMEDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRK 108
Query: 117 LVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH 176
LV K D +D++RE+QIM HL+GQPNIVE KGAYEDK SVH+VMELCAGGELFDRIIAKGH
Sbjct: 109 LVNKEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGH 168
Query: 177 YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236
YSERAAAS+ R+IV +VH CH MGV+HRDLKPENFLL +KDEN+ LKATDFGLSVF + G
Sbjct: 169 YSERAAASLLRTIVQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPG 228
Query: 237 KVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG 296
+V++DIVGSAYY+APEVL+R+YG E DIWS GV+LYILL GVPPFWAE+E GIF+AIL+G
Sbjct: 229 EVFKDIVGSAYYIAPEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRG 288
Query: 297 DIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLS 356
+DF S PWP+IS AKDLV++ML DPK+R+T+AQVL HPWIKE GEA D P+D+AV+S
Sbjct: 289 HVDFSSDPWPSISPQAKDLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMS 348
Query: 357 RMKQFRAMNKLKKLALKV 374
R+KQF+AMN KK+AL+V
Sbjct: 349 RLKQFKAMNNFKKVALRV 366
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3E9C0|CDPKY_ARATH Calcium-dependent protein kinase 34 OS=Arabidopsis thaliana GN=CPK34 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 497 bits (1280), Expect = e-140, Method: Compositional matrix adjust.
Identities = 238/381 (62%), Positives = 289/381 (75%), Gaps = 27/381 (7%)
Query: 1 MGGCLTKSKD-------PKPRHYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAP 53
MG C + +D P+P + G ++ +V + + H P P P P
Sbjct: 1 MGNCCSHGRDSDDNKEEPRPENGGGGVGAAEASV--------RASKHPPASPPPATKQGP 52
Query: 54 VSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS 113
+ +LG+P EDVK Y+ GKELGRGQFGVT+LCT+ +TG QFACK+I+
Sbjct: 53 IG------------PVLGRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFACKTIA 100
Query: 114 KRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA 173
KRKLV K D +D++RE+QIM HL+GQPNIVE KGAYEDK SVH+VMELCAGGELFDRIIA
Sbjct: 101 KRKLVNKEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIA 160
Query: 174 KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233
KGHYSERAAAS+ R+IV ++H CH MGV+HRDLKPENFLL SKDEN+ LKATDFGLSVF
Sbjct: 161 KGHYSERAAASLLRTIVQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFY 220
Query: 234 EEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI 293
+ G+V++DIVGSAYY+APEVLRR+YG E DIWS GV+LYILL GVPPFWAE+E GIF+AI
Sbjct: 221 KPGEVFKDIVGSAYYIAPEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAI 280
Query: 294 LQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSA 353
L G +DF S PWP IS AKDLVR+ML DPK+R+T+AQVL HPWIKE GEA D P+D+A
Sbjct: 281 LSGQVDFSSDPWPVISPQAKDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNA 340
Query: 354 VLSRMKQFRAMNKLKKLALKV 374
V+SR+KQF+AMN KK+AL+V
Sbjct: 341 VMSRLKQFKAMNNFKKVALRV 361
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 393 | ||||||
| 225460973 | 536 | PREDICTED: calcium-dependent protein kin | 0.944 | 0.692 | 0.812 | 1e-175 | |
| 255583607 | 533 | calcium-dependent protein kinase, putati | 0.928 | 0.684 | 0.793 | 1e-174 | |
| 449470453 | 519 | PREDICTED: calcium-dependent protein kin | 0.926 | 0.701 | 0.786 | 1e-168 | |
| 91992434 | 538 | calcium dependent protein kinase 3 [Medi | 0.931 | 0.680 | 0.776 | 1e-167 | |
| 356569794 | 551 | PREDICTED: calcium-dependent protein kin | 0.928 | 0.662 | 0.751 | 1e-167 | |
| 13561063 | 542 | protein kinase [Medicago sativa] | 0.931 | 0.675 | 0.768 | 1e-166 | |
| 351727903 | 538 | calmodulin-like domain protein kinase is | 0.857 | 0.626 | 0.838 | 1e-166 | |
| 297830722 | 541 | calmodulin-domain protein kinase 9 [Arab | 0.951 | 0.691 | 0.744 | 1e-166 | |
| 15231140 | 541 | calmodulin-domain protein kinase 9 [Arab | 0.951 | 0.691 | 0.747 | 1e-165 | |
| 2827773 | 532 | RecName: Full=Calcium-dependent protein | 0.944 | 0.697 | 0.748 | 1e-164 |
| >gi|225460973|ref|XP_002278179.1| PREDICTED: calcium-dependent protein kinase 9-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 620 bits (1599), Expect = e-175, Method: Compositional matrix adjust.
Identities = 312/384 (81%), Positives = 331/384 (86%), Gaps = 13/384 (3%)
Query: 1 MGGCLTKSKDPKPRHYAHGYRSSP------NTVAKAPAPAQQQAHHRPEKPGPT---PAA 51
MG CL+K K Y +GY S + + + PA QQ H PEK P P
Sbjct: 1 MGICLSKGKRGSEPAY-NGYGSGAVAGGVYDRIQERPAAVQQPPHQLPEKRVPAAQPPMK 59
Query: 52 APVSGLK-QAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACK 110
P L + V RPDT ILGK +EDVKLHY+ GKELGRGQFGVTYLCTENSTG Q+ACK
Sbjct: 60 PPTVALSPKPVHRPDT--ILGKSFEDVKLHYTIGKELGRGQFGVTYLCTENSTGLQYACK 117
Query: 111 SISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDR 170
SISKRKLVTKNDK+DI+REIQIMQ LSGQPNIVEFKGAYED+ SVH+VMELCAGGELFDR
Sbjct: 118 SISKRKLVTKNDKEDIRREIQIMQDLSGQPNIVEFKGAYEDRLSVHLVMELCAGGELFDR 177
Query: 171 IIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230
IIAKGHYSERAAASICR+IVNVVHICHFMGVMHRDLKPENFLLSSK ENALLKATDFGLS
Sbjct: 178 IIAKGHYSERAAASICRAIVNVVHICHFMGVMHRDLKPENFLLSSKGENALLKATDFGLS 237
Query: 231 VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIF 290
VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIF
Sbjct: 238 VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIF 297
Query: 291 DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
DAILQG IDFE++PWP+ISSSAKDLVR+MLTQDP+KRITSAQVLEHPWIKE GEASDKPI
Sbjct: 298 DAILQGHIDFETSPWPSISSSAKDLVRKMLTQDPQKRITSAQVLEHPWIKEDGEASDKPI 357
Query: 351 DSAVLSRMKQFRAMNKLKKLALKV 374
DSAVLSRMKQFRAMNKLKKLALKV
Sbjct: 358 DSAVLSRMKQFRAMNKLKKLALKV 381
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255583607|ref|XP_002532559.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223527714|gb|EEF29820.1| calcium-dependent protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 617 bits (1591), Expect = e-174, Method: Compositional matrix adjust.
Identities = 307/387 (79%), Positives = 329/387 (85%), Gaps = 22/387 (5%)
Query: 1 MGGCLTKSKDPKPRHY------AHGYRSSPNTVAKAPA------PAQQQAHHRPEKPG-P 47
MG CL+K K + HY H R +K+PA P+Q P KP P
Sbjct: 1 MGFCLSKEKRSQQHHYNGATGLQHQSREPVAYQSKSPAQPSYQFPSQTPGAQIPRKPVVP 60
Query: 48 TPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQF 107
P+ PV +PDT IL KPYEDVKLHY+ GKELGRGQFGVTYLCTE STG+ +
Sbjct: 61 APSPKPVH-------KPDT--ILEKPYEDVKLHYTIGKELGRGQFGVTYLCTEISTGKLY 111
Query: 108 ACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGEL 167
ACKSISKRKLVT+NDK+D+KREIQIMQHLSGQPNIVEFKGAYEDKQSVH+VMELCAGGEL
Sbjct: 112 ACKSISKRKLVTRNDKEDMKREIQIMQHLSGQPNIVEFKGAYEDKQSVHLVMELCAGGEL 171
Query: 168 FDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227
FDRIIAKGHYSE+ AASICRSIVNVVH CHFMGVMHRDLKPENFLLSSKD+NALLKATDF
Sbjct: 172 FDRIIAKGHYSEKEAASICRSIVNVVHACHFMGVMHRDLKPENFLLSSKDQNALLKATDF 231
Query: 228 GLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEK 287
GLSVFIEEGK YRDIVGSAYYVAPEVLRRRYGKE+DIWSAGV+LYILLSGVPPFWAE+EK
Sbjct: 232 GLSVFIEEGKTYRDIVGSAYYVAPEVLRRRYGKEMDIWSAGVMLYILLSGVPPFWAESEK 291
Query: 288 GIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASD 347
GIFDAILQGDIDFES PWPTISSSAKDLVRRMLTQDPKKRITS QVLEHPW+KEGG+ASD
Sbjct: 292 GIFDAILQGDIDFESPPWPTISSSAKDLVRRMLTQDPKKRITSTQVLEHPWLKEGGDASD 351
Query: 348 KPIDSAVLSRMKQFRAMNKLKKLALKV 374
KPIDSAVLSRMKQFRAMNKLKK+ALKV
Sbjct: 352 KPIDSAVLSRMKQFRAMNKLKKMALKV 378
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449470453|ref|XP_004152931.1| PREDICTED: calcium-dependent protein kinase-like [Cucumis sativus] gi|449532030|ref|XP_004172987.1| PREDICTED: calcium-dependent protein kinase-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 597 bits (1539), Expect = e-168, Method: Compositional matrix adjust.
Identities = 295/375 (78%), Positives = 320/375 (85%), Gaps = 11/375 (2%)
Query: 1 MGGCLTKSKDPKPRHYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQA 60
MG C +K K R Y H Y P KAPA Q H PE A P K
Sbjct: 1 MGICTSKGK--YSRQYDH-YEQQP----KAPA---QHTHRSPEYRQTAGGAKPSGPPKSP 50
Query: 61 VPRP-DTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT 119
P ++TILGKP EDVKLHY+ GKELGRGQFGVTYLCTENS+G+Q+ACKSI KRKLVT
Sbjct: 51 KHTPFRSDTILGKPLEDVKLHYTIGKELGRGQFGVTYLCTENSSGKQYACKSILKRKLVT 110
Query: 120 KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE 179
KNDK+DI+REI IMQHLSGQPNIVEFKGAYEDK SVH++MELCAGGELFDRIIAKGHYSE
Sbjct: 111 KNDKEDIRREIHIMQHLSGQPNIVEFKGAYEDKLSVHLIMELCAGGELFDRIIAKGHYSE 170
Query: 180 RAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239
+AAASICRSIVNVVHICHFMGVMHRDLKPENFLL+SK+E+A+LKATDFGLSVFIEEGKVY
Sbjct: 171 KAAASICRSIVNVVHICHFMGVMHRDLKPENFLLASKEEDAMLKATDFGLSVFIEEGKVY 230
Query: 240 RDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID 299
RDIVGSAYYVAPEVLRR+YGKEID+WSAGV+LYILLSGVPPFWAETEKGIFD+ILQG ID
Sbjct: 231 RDIVGSAYYVAPEVLRRKYGKEIDVWSAGVMLYILLSGVPPFWAETEKGIFDSILQGHID 290
Query: 300 FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMK 359
FES PWP IS SAKDLV+RMLTQDP RITSAQVLEHPW++EGGEASDKPIDSAV +R+K
Sbjct: 291 FESDPWPHISPSAKDLVKRMLTQDPANRITSAQVLEHPWMREGGEASDKPIDSAVFTRLK 350
Query: 360 QFRAMNKLKKLALKV 374
QFRAMNKLKKLALKV
Sbjct: 351 QFRAMNKLKKLALKV 365
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|91992434|gb|ABE72958.1| calcium dependent protein kinase 3 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 595 bits (1535), Expect = e-167, Method: Compositional matrix adjust.
Identities = 298/384 (77%), Positives = 321/384 (83%), Gaps = 18/384 (4%)
Query: 1 MGGCLTKSKDPKPRHYAHGYR----------SSPNTVAKAPAPAQQQAHHRPEKPGPTPA 50
MG L+K KD +P H GYR NT AP + Q P KP A
Sbjct: 1 MGCLLSKDKDSEPEHNNGGYRYGEHNHRNNHEQVNTSRTAPTSSYQP--QIPTKPSSISA 58
Query: 51 AAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACK 110
+P +KQ D+NTILGK EDVK Y+ GKELGRGQFGVT+LCTENSTG +ACK
Sbjct: 59 PSPKPLIKQ-----DSNTILGKGLEDVKQFYTLGKELGRGQFGVTFLCTENSTGLLYACK 113
Query: 111 SISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDR 170
SISKRKLV+K+D++DIKREIQIMQHLSGQPNIVEFKGAYED+ SVHVVMELCAGGELFDR
Sbjct: 114 SISKRKLVSKSDREDIKREIQIMQHLSGQPNIVEFKGAYEDRNSVHVVMELCAGGELFDR 173
Query: 171 IIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230
IIAKGHYSE+AAASICR IVNVV+ICHFMGVMHRDLKPENFLL+SKDENALLKATDFGL+
Sbjct: 174 IIAKGHYSEKAAASICRQIVNVVNICHFMGVMHRDLKPENFLLASKDENALLKATDFGLA 233
Query: 231 VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIF 290
VFIEEGKVYRDIVGSAYYVAPEVLRRR GKEIDIWSAGVILYILLSGVPPFWAETEKGIF
Sbjct: 234 VFIEEGKVYRDIVGSAYYVAPEVLRRRCGKEIDIWSAGVILYILLSGVPPFWAETEKGIF 293
Query: 291 DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
DAIL+G IDFES PWP IS SAKDLVR+ML Q+PKKRIT+AQVLEHPWIK+G ASDKPI
Sbjct: 294 DAILEGHIDFESEPWPKISDSAKDLVRKMLIQEPKKRITAAQVLEHPWIKDGN-ASDKPI 352
Query: 351 DSAVLSRMKQFRAMNKLKKLALKV 374
DSAVLSRMKQFRAMNKLKKLALKV
Sbjct: 353 DSAVLSRMKQFRAMNKLKKLALKV 376
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356569794|ref|XP_003553081.1| PREDICTED: calcium-dependent protein kinase 9-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 595 bits (1534), Expect = e-167, Method: Compositional matrix adjust.
Identities = 299/398 (75%), Positives = 327/398 (82%), Gaps = 33/398 (8%)
Query: 1 MGGCLTKSKDPKPRHYAHG-------YRSSPNTVAKAPAPAQQQAHHRPEK--------- 44
MG C++K +P+ Y HG ++ V ++ APA Q +H PEK
Sbjct: 1 MGCCVSKDSEPQHNGYRHGGTGGVHNQKTHEPLVNQSRAPANQ-PYHLPEKHAASTAQTV 59
Query: 45 --------PGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTY 96
GP + PV ++Q +TILGK +EDVK Y+ GKELGRGQFGVTY
Sbjct: 60 PQNMPWKPSGPALSPKPVVSVRQ-------DTILGKQFEDVKQFYTLGKELGRGQFGVTY 112
Query: 97 LCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156
LCTENSTG Q+ACKSISKRKLV K+DK+DIKREIQIMQHLSGQPNIVEFKGAYED+ SVH
Sbjct: 113 LCTENSTGLQYACKSISKRKLVKKSDKEDIKREIQIMQHLSGQPNIVEFKGAYEDRNSVH 172
Query: 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK 216
VVMELCAGGELFDRIIAKGHYSERAAASICR IVNVVHICHFMGVMHRDLKPENFLLSS+
Sbjct: 173 VVMELCAGGELFDRIIAKGHYSERAAASICRQIVNVVHICHFMGVMHRDLKPENFLLSSR 232
Query: 217 DENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLS 276
DE+ALLKATDFGLSVFIEEGK+YRDIVGSAYYVAPEVLRRR GKEIDIWSAGVILYILLS
Sbjct: 233 DESALLKATDFGLSVFIEEGKLYRDIVGSAYYVAPEVLRRRCGKEIDIWSAGVILYILLS 292
Query: 277 GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
GVPPFWAETEKGIFDAIL+G IDFES PWP IS++AKDLVR+ML QDPKKRITSAQVLEH
Sbjct: 293 GVPPFWAETEKGIFDAILEGHIDFESQPWPNISNNAKDLVRKMLIQDPKKRITSAQVLEH 352
Query: 337 PWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKV 374
PWIK+G ASD+PIDSAVLSRMKQFRAMNKLKKLALKV
Sbjct: 353 PWIKDGN-ASDRPIDSAVLSRMKQFRAMNKLKKLALKV 389
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|13561063|emb|CAA65500.1| protein kinase [Medicago sativa] | Back alignment and taxonomy information |
|---|
Score = 591 bits (1523), Expect = e-166, Method: Compositional matrix adjust.
Identities = 298/388 (76%), Positives = 320/388 (82%), Gaps = 22/388 (5%)
Query: 1 MGGCLTKSKDPKPRHYAHGYRSSP--------------NTVAKAPAPAQQQAHHRPEKPG 46
MG L+K KD + H GYR + NT AP + Q P KP
Sbjct: 1 MGCLLSKDKDSEQEHNNGGYRYAESSGMHNHRNNHEQVNTSRTAPTSSYQP--QIPTKPS 58
Query: 47 PTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQ 106
A +P +KQ DTNTILGK EDVK Y+ GKELGRGQFGVT+LCTENSTG
Sbjct: 59 SISAPSPKPLIKQ-----DTNTILGKGLEDVKQFYTLGKELGRGQFGVTFLCTENSTGLL 113
Query: 107 FACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGE 166
+ACKSISKRKLV+K+D++DIKREIQIMQHLSGQPNIVEFKGAYED+ SVHVVMELCAGGE
Sbjct: 114 YACKSISKRKLVSKSDREDIKREIQIMQHLSGQPNIVEFKGAYEDRNSVHVVMELCAGGE 173
Query: 167 LFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226
LFDRIIAKGHYSE+AAASICR IVNVV+ICHFMGVMHRDLKPENFLL+SKDENALLKATD
Sbjct: 174 LFDRIIAKGHYSEKAAASICRQIVNVVNICHFMGVMHRDLKPENFLLASKDENALLKATD 233
Query: 227 FGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETE 286
FGLSVFIEEG+VYRDIVGSAYYVAPEVLR R GKEIDIWSAGVILYILLSGVPPFWAETE
Sbjct: 234 FGLSVFIEEGRVYRDIVGSAYYVAPEVLRPRCGKEIDIWSAGVILYILLSGVPPFWAETE 293
Query: 287 KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346
KGIFDAIL+G IDFES PWP IS SAKDLVR+ML Q+PKKRIT+AQVLEHPWIK GG AS
Sbjct: 294 KGIFDAILEGHIDFESEPWPKISDSAKDLVRKMLIQEPKKRITAAQVLEHPWIK-GGNAS 352
Query: 347 DKPIDSAVLSRMKQFRAMNKLKKLALKV 374
DKPIDSAVLSRMKQFRAMNKLKKLALKV
Sbjct: 353 DKPIDSAVLSRMKQFRAMNKLKKLALKV 380
|
Source: Medicago sativa Species: Medicago sativa Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351727903|ref|NP_001235641.1| calmodulin-like domain protein kinase isoenzyme gamma [Glycine max] gi|2501766|gb|AAB80693.1| calmodulin-like domain protein kinase isoenzyme gamma [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 591 bits (1523), Expect = e-166, Method: Compositional matrix adjust.
Identities = 290/346 (83%), Positives = 309/346 (89%), Gaps = 9/346 (2%)
Query: 30 APAPAQQQAHHRPEKP-GPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELG 88
A + AQ + P KP GP + PV G++Q +TILGK +EDVK ++ GKELG
Sbjct: 39 AASTAQTVPQNMPWKPPGPALSPKPVVGVRQ-------DTILGKQFEDVKQFHTLGKELG 91
Query: 89 RGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148
RGQFGVTYLCTENSTG Q+ACKSISKRKL +K+DK+DIKREIQIMQHLSGQPNIVEFKGA
Sbjct: 92 RGQFGVTYLCTENSTGLQYACKSISKRKLASKSDKEDIKREIQIMQHLSGQPNIVEFKGA 151
Query: 149 YEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKP 208
YED+ SVHVVMELCAGGELFDRIIAKGHYSE+AAASICR IVNVVHICHFMGVMHRDLKP
Sbjct: 152 YEDRSSVHVVMELCAGGELFDRIIAKGHYSEKAAASICRQIVNVVHICHFMGVMHRDLKP 211
Query: 209 ENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAG 268
ENFLLSS+DENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR GKEIDIWSAG
Sbjct: 212 ENFLLSSRDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRCGKEIDIWSAG 271
Query: 269 VILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRI 328
VILYILLSGVPPFWAETEKGIFDAIL+G IDFES PWP IS SAKDLVR+ML QDPKKRI
Sbjct: 272 VILYILLSGVPPFWAETEKGIFDAILEGHIDFESQPWPNISDSAKDLVRKMLIQDPKKRI 331
Query: 329 TSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKV 374
TSAQVLEHPWIK+G ASDKPIDSAVLSRMKQFRAMNKLKKLALKV
Sbjct: 332 TSAQVLEHPWIKDGN-ASDKPIDSAVLSRMKQFRAMNKLKKLALKV 376
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297830722|ref|XP_002883243.1| calmodulin-domain protein kinase 9 [Arabidopsis lyrata subsp. lyrata] gi|297329083|gb|EFH59502.1| calmodulin-domain protein kinase 9 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 589 bits (1518), Expect = e-166, Method: Compositional matrix adjust.
Identities = 286/384 (74%), Positives = 322/384 (83%), Gaps = 10/384 (2%)
Query: 1 MGGCLTKSKD-PKPRHYAHGYRSSPNTVAKAPAPA---QQQAHHRPEKPGPTPAAAPVSG 56
MG C K+ KP+ H RS V P+ Q ++ +PEKPG + P
Sbjct: 1 MGNCFAKNHGLMKPQQNGHTTRSVEVGVTNQDPPSYTPQARSTQQPEKPGSVNSQPPPWR 60
Query: 57 LKQAV------PRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACK 110
A +N+IL +EDVKL Y+ GKELGRGQFGVTYLCTENSTG+++ACK
Sbjct: 61 AAAAAPGPSPKTTSKSNSILENAFEDVKLFYTLGKELGRGQFGVTYLCTENSTGKKYACK 120
Query: 111 SISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDR 170
SISK+KLVTK DKDD++REIQIMQHLSGQPNIVEFKGAYED+++V++VMELCAGGELFDR
Sbjct: 121 SISKKKLVTKADKDDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDR 180
Query: 171 IIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230
IIAKGHYSERAAAS+CR IVNVV ICHFMGV+HRDLKPENFLLSSKDE AL+KATDFGLS
Sbjct: 181 IIAKGHYSERAAASVCRQIVNVVKICHFMGVLHRDLKPENFLLSSKDEKALIKATDFGLS 240
Query: 231 VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIF 290
VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKE+DIWSAG+ILYILLSGVPPFWAETEKGIF
Sbjct: 241 VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEVDIWSAGIILYILLSGVPPFWAETEKGIF 300
Query: 291 DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
DAIL+G IDFES PWP+IS+SAKDLVRRMLT DPK+RI++A VL+HPW++EGGEASDKPI
Sbjct: 301 DAILEGHIDFESQPWPSISNSAKDLVRRMLTADPKRRISAADVLQHPWLREGGEASDKPI 360
Query: 351 DSAVLSRMKQFRAMNKLKKLALKV 374
DSAVLSRMKQFRAMNKLKKLALKV
Sbjct: 361 DSAVLSRMKQFRAMNKLKKLALKV 384
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15231140|ref|NP_188676.1| calmodulin-domain protein kinase 9 [Arabidopsis thaliana] gi|75319414|sp|Q38868.1|CDPK9_ARATH RecName: Full=Calcium-dependent protein kinase 9; AltName: Full=Calmodulin-domain protein kinase CDPK isoform 9 gi|1399265|gb|AAB03242.1| calmodulin-domain protein kinase CDPK isoform 9 [Arabidopsis thaliana] gi|9294561|dbj|BAB02824.1| calmodulin-domain protein kinase CDPK isoform 9 [Arabidopsis thaliana] gi|21539465|gb|AAM53285.1| calmodulin-domain protein kinase CDPK isoform 9 [Arabidopsis thaliana] gi|31711962|gb|AAP68337.1| At3g20410 [Arabidopsis thaliana] gi|332642854|gb|AEE76375.1| calmodulin-domain protein kinase 9 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1515), Expect = e-165, Method: Compositional matrix adjust.
Identities = 287/384 (74%), Positives = 323/384 (84%), Gaps = 10/384 (2%)
Query: 1 MGGCLTKSKD-PKPRHYAHGYRSSPNTVAKAPAPA---QQQAHHRPEKPGPTPAAAPVSG 56
MG C K+ KP+ + RS V P+ Q + +PEKPG + P
Sbjct: 1 MGNCFAKNHGLMKPQQNGNTTRSVEVGVTNQDPPSYTPQARTTQQPEKPGSVNSQPPPWR 60
Query: 57 LKQAV----PRPDT--NTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACK 110
A P+ T N+IL +EDVKL Y+ GKELGRGQFGVTYLCTENSTG+++ACK
Sbjct: 61 AAAAAPGLSPKTTTKSNSILENAFEDVKLFYTLGKELGRGQFGVTYLCTENSTGKKYACK 120
Query: 111 SISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDR 170
SISK+KLVTK DKDD++REIQIMQHLSGQPNIVEFKGAYED+++V++VMELCAGGELFDR
Sbjct: 121 SISKKKLVTKADKDDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDR 180
Query: 171 IIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230
IIAKGHY+ERAAAS+CR IVNVV ICHFMGV+HRDLKPENFLLSSKDE AL+KATDFGLS
Sbjct: 181 IIAKGHYTERAAASVCRQIVNVVKICHFMGVLHRDLKPENFLLSSKDEKALIKATDFGLS 240
Query: 231 VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIF 290
VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKE+DIWSAG+ILYILLSGVPPFWAETEKGIF
Sbjct: 241 VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEVDIWSAGIILYILLSGVPPFWAETEKGIF 300
Query: 291 DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
DAIL+G IDFES PWP+ISSSAKDLVRRMLT DPK+RI++A VL+HPW++EGGEASDKPI
Sbjct: 301 DAILEGHIDFESQPWPSISSSAKDLVRRMLTADPKRRISAADVLQHPWLREGGEASDKPI 360
Query: 351 DSAVLSRMKQFRAMNKLKKLALKV 374
DSAVLSRMKQFRAMNKLKKLALKV
Sbjct: 361 DSAVLSRMKQFRAMNKLKKLALKV 384
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|2827773|sp|P28582.2|CDPK_DAUCA RecName: Full=Calcium-dependent protein kinase; Short=CDPK gi|1765912|emb|CAA39936.1| calcium- dependent protein kinase [Daucus carota] | Back alignment and taxonomy information |
|---|
Score = 585 bits (1509), Expect = e-164, Method: Compositional matrix adjust.
Identities = 282/377 (74%), Positives = 322/377 (85%), Gaps = 6/377 (1%)
Query: 1 MGGCLTKSKDPKPRHYAHGYRSSP---NTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGL 57
MGGC +K + +GYRS+P +TV Q +P P S
Sbjct: 1 MGGCFSKKEYQAD---GNGYRSAPTAYHTVTDQSYEKSSQRSQPQAQPQPQVQQTGPSLK 57
Query: 58 KQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL 117
+ V RP++NTILGKP+ED++ Y+ GKELGRGQFG Y CTENS+G+ +ACKSI KRKL
Sbjct: 58 PRQVHRPESNTILGKPFEDIRGKYTLGKELGRGQFGCVYQCTENSSGQLYACKSILKRKL 117
Query: 118 VTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY 177
V+KNDK+DIKREIQI+QHLSGQPNIVEFKG +ED+QSVH+VMELCAGGELFDRIIA+GHY
Sbjct: 118 VSKNDKEDIKREIQILQHLSGQPNIVEFKGVFEDRQSVHLVMELCAGGELFDRIIAQGHY 177
Query: 178 SERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237
SERAAA+ICR IVNVVH+CHFMGVMHRDLKPENFLLSSKD++A+LKATDFGLSVFIEEGK
Sbjct: 178 SERAAATICRQIVNVVHVCHFMGVMHRDLKPENFLLSSKDKDAMLKATDFGLSVFIEEGK 237
Query: 238 VYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD 297
VYR+IVGSAYYVAPEVLRR YGKEIDIWSAGVILYILLSGVPPFWAE EKGIFDAIL+G
Sbjct: 238 VYRNIVGSAYYVAPEVLRRSYGKEIDIWSAGVILYILLSGVPPFWAENEKGIFDAILEGV 297
Query: 298 IDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSR 357
IDFES PWP++S+SAKDLVR+MLTQDP++RITSAQVL+HPW++EGGEASDKPIDSAVLSR
Sbjct: 298 IDFESEPWPSVSNSAKDLVRKMLTQDPRRRITSAQVLDHPWMREGGEASDKPIDSAVLSR 357
Query: 358 MKQFRAMNKLKKLALKV 374
MKQFRAMNKLK+LALKV
Sbjct: 358 MKQFRAMNKLKQLALKV 374
|
Source: Daucus carota Species: Daucus carota Genus: Daucus Family: Apiaceae Order: Apiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 393 | ||||||
| TAIR|locus:2092399 | 541 | CPK9 "calmodulin-domain protei | 0.944 | 0.685 | 0.749 | 1.6e-148 | |
| TAIR|locus:2015846 | 521 | CPK33 "calcium-dependent prote | 0.778 | 0.587 | 0.869 | 5.7e-146 | |
| TAIR|locus:2138897 | 531 | CPK21 "calcium-dependent prote | 0.852 | 0.630 | 0.780 | 8.6e-143 | |
| TAIR|locus:2036783 | 551 | CPK19 "calcium-dependent prote | 0.844 | 0.602 | 0.730 | 1.9e-131 | |
| TAIR|locus:2177023 | 528 | CPK17 "calcium-dependent prote | 0.834 | 0.621 | 0.699 | 6.8e-127 | |
| TAIR|locus:2150225 | 523 | CPK34 "AT5G19360" [Arabidopsis | 0.819 | 0.615 | 0.708 | 1.8e-126 | |
| TAIR|locus:2204340 | 561 | CPK29 "calcium-dependent prote | 0.913 | 0.639 | 0.644 | 2.9e-126 | |
| TAIR|locus:2128409 | 529 | CDPK6 "calcium-dependent prote | 0.926 | 0.688 | 0.626 | 4.1e-120 | |
| TAIR|locus:2075885 | 646 | CPK2 "calmodulin-domain protei | 0.786 | 0.478 | 0.650 | 6.9e-115 | |
| TAIR|locus:2175503 | 610 | CPK1 "calcium dependent protei | 0.849 | 0.547 | 0.625 | 3.5e-114 |
| TAIR|locus:2092399 CPK9 "calmodulin-domain protein kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1450 (515.5 bits), Expect = 1.6e-148, P = 1.6e-148
Identities = 290/387 (74%), Positives = 323/387 (83%)
Query: 1 MGGCLTKSKD-PKPRHYAHGYRSSPNTVXXX---XXXXXXXXHHRPEKPG-----PTP-- 49
MG C K+ KP+ + RS V +PEKPG P P
Sbjct: 1 MGNCFAKNHGLMKPQQNGNTTRSVEVGVTNQDPPSYTPQARTTQQPEKPGSVNSQPPPWR 60
Query: 50 AAAPVSGLKQAVPRPDT--NTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQF 107
AAA GL P+ T N+IL +EDVKL Y+ GKELGRGQFGVTYLCTENSTG+++
Sbjct: 61 AAAAAPGLS---PKTTTKSNSILENAFEDVKLFYTLGKELGRGQFGVTYLCTENSTGKKY 117
Query: 108 ACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGEL 167
ACKSISK+KLVTK DKDD++REIQIMQHLSGQPNIVEFKGAYED+++V++VMELCAGGEL
Sbjct: 118 ACKSISKKKLVTKADKDDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGEL 177
Query: 168 FDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227
FDRIIAKGHY+ERAAAS+CR IVNVV ICHFMGV+HRDLKPENFLLSSKDE AL+KATDF
Sbjct: 178 FDRIIAKGHYTERAAASVCRQIVNVVKICHFMGVLHRDLKPENFLLSSKDEKALIKATDF 237
Query: 228 GLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEK 287
GLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKE+DIWSAG+ILYILLSGVPPFWAETEK
Sbjct: 238 GLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEVDIWSAGIILYILLSGVPPFWAETEK 297
Query: 288 GIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASD 347
GIFDAIL+G IDFES PWP+ISSSAKDLVRRMLT DPK+RI++A VL+HPW++EGGEASD
Sbjct: 298 GIFDAILEGHIDFESQPWPSISSSAKDLVRRMLTADPKRRISAADVLQHPWLREGGEASD 357
Query: 348 KPIDSAVLSRMKQFRAMNKLKKLALKV 374
KPIDSAVLSRMKQFRAMNKLKKLALKV
Sbjct: 358 KPIDSAVLSRMKQFRAMNKLKKLALKV 384
|
|
| TAIR|locus:2015846 CPK33 "calcium-dependent protein kinase 33" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1426 (507.0 bits), Expect = 5.7e-146, P = 5.7e-146
Identities = 266/306 (86%), Positives = 297/306 (97%)
Query: 69 ILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR 128
IL KPYEDVKL Y+ KELGRGQFGVTYLCTE STG++FACKSISK+KLVTK DK+D++R
Sbjct: 61 ILEKPYEDVKLFYTLSKELGRGQFGVTYLCTEKSTGKRFACKSISKKKLVTKGDKEDMRR 120
Query: 129 EIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRS 188
EIQIMQHLSGQPNIVEFKGAYED+++V++VMELCAGGELFDRI+AKGHYSERAAAS+CR
Sbjct: 121 EIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDRILAKGHYSERAAASVCRQ 180
Query: 189 IVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYY 248
IVNVV+ICHFMGVMHRDLKPENFLLSSKDE AL+KATDFGLSVFIEEG+VY+DIVGSAYY
Sbjct: 181 IVNVVNICHFMGVMHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGRVYKDIVGSAYY 240
Query: 249 VAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308
VAPEVL+RRYGKEIDIWSAG+ILYILLSGVPPFWAETEKGIFDAIL+G+IDFES PWP+I
Sbjct: 241 VAPEVLKRRYGKEIDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGEIDFESQPWPSI 300
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLK 368
S+SAKDLVRRMLTQDPK+RI++A+VL+HPW++EGGEASDKPIDSAVLSRMKQFRAMNKLK
Sbjct: 301 SNSAKDLVRRMLTQDPKRRISAAEVLKHPWLREGGEASDKPIDSAVLSRMKQFRAMNKLK 360
Query: 369 KLALKV 374
KLALKV
Sbjct: 361 KLALKV 366
|
|
| TAIR|locus:2138897 CPK21 "calcium-dependent protein kinase 21" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1396 (496.5 bits), Expect = 8.6e-143, P = 8.6e-143
Identities = 266/341 (78%), Positives = 298/341 (87%)
Query: 39 HHRPEKPGPTPAAAPV-SGLKQAVPRP----DTNTILGKPYEDVKLHYSFGKELGRGQFG 93
H +P+ P P P P+ + P D +TILGKP+ED++ YS GKELGRGQFG
Sbjct: 33 HRKPQTPTPKPMTQPIHQQISTPSSNPVSVRDPDTILGKPFEDIRKFYSLGKELGRGQFG 92
Query: 94 VTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153
+TY+C E TG +ACKSI KRKL++K DK+D+KREIQIMQ+LSGQPNIVE KGAYED+Q
Sbjct: 93 ITYMCKEIGTGNTYACKSILKRKLISKQDKEDVKREIQIMQYLSGQPNIVEIKGAYEDRQ 152
Query: 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLL 213
S+H+VMELCAGGELFDRIIA+GHYSERAAA I RSIVNVV ICHFMGV+HRDLKPENFLL
Sbjct: 153 SIHLVMELCAGGELFDRIIAQGHYSERAAAGIIRSIVNVVQICHFMGVVHRDLKPENFLL 212
Query: 214 SSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYI 273
SSK+ENA+LKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR YGKEIDIWSAGVILYI
Sbjct: 213 SSKEENAMLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRSYGKEIDIWSAGVILYI 272
Query: 274 LLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQV 333
LLSGVPPFWAE EKGIFD +++G+IDF S PWP+IS SAKDLVR+MLT+DPK+RIT+AQV
Sbjct: 273 LLSGVPPFWAENEKGIFDEVIKGEIDFVSEPWPSISESAKDLVRKMLTKDPKRRITAAQV 332
Query: 334 LEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKV 374
LEHPWIK GGEA DKPIDSAVLSRMKQFRAMNKLKKLALKV
Sbjct: 333 LEHPWIK-GGEAPDKPIDSAVLSRMKQFRAMNKLKKLALKV 372
|
|
| TAIR|locus:2036783 CPK19 "calcium-dependent protein kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1289 (458.8 bits), Expect = 1.9e-131, P = 1.9e-131
Identities = 247/338 (73%), Positives = 287/338 (84%)
Query: 40 HRPEKPGPTPAAAP--VSGLKQA-VPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTY 96
H+ P P P ++ KQ+ + +P+ ILG+P+ED+K YS G+ELGRGQFG+TY
Sbjct: 56 HKLPLPLPQPQEKQKLINHQKQSTLQQPEP--ILGRPFEDIKEKYSLGRELGRGQFGITY 113
Query: 97 LCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156
+CTE S+G+ FACKSI KRKL+ D++D++REIQIM +LSGQPNIVE KGAYED+QSVH
Sbjct: 114 ICTEISSGKNFACKSILKRKLIRTKDREDVRREIQIMHYLSGQPNIVEIKGAYEDRQSVH 173
Query: 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK 216
+VMELC GGELFD+I +GHYSE+AAA I RS+V VV ICHFMGV+HRDLKPENFLLSSK
Sbjct: 174 LVMELCEGGELFDKITKRGHYSEKAAAEIIRSVVKVVQICHFMGVIHRDLKPENFLLSSK 233
Query: 217 DE-NALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILL 275
DE +++LKATDFG+SVFIEEGKVY DIVGSAYYVAPEVL+R YGK IDIWSAGVILYILL
Sbjct: 234 DEASSMLKATDFGVSVFIEEGKVYEDIVGSAYYVAPEVLKRNYGKAIDIWSAGVILYILL 293
Query: 276 SGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335
G PPFWAET+KGIF+ IL+G+IDFES PWP+IS SAKDLVR ML DPKKR T+AQVLE
Sbjct: 294 CGNPPFWAETDKGIFEEILRGEIDFESEPWPSISESAKDLVRNMLKYDPKKRFTAAQVLE 353
Query: 336 HPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALK 373
HPWI+EGGEASDKPIDSAVLSRMKQ RAMNKLKKLA K
Sbjct: 354 HPWIREGGEASDKPIDSAVLSRMKQLRAMNKLKKLAFK 391
|
|
| TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1246 (443.7 bits), Expect = 6.8e-127, P = 6.8e-127
Identities = 235/336 (69%), Positives = 279/336 (83%)
Query: 46 GPTPAAAPVSGLKQAVPRPDTNT-------ILGKPYEDVKLHYSFGKELGRGQFGVTYLC 98
GPT A A V K A P P T +LG+P EDVK YS GKELGRGQFGVT+LC
Sbjct: 32 GPT-AEASVPQSKHAPPSPPPATKQGPIGPVLGRPMEDVKASYSLGKELGRGQFGVTHLC 90
Query: 99 TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158
T+ +TG QFACK+I+KRKLV K D +D++RE+QIM HL+GQPNIVE KGAYEDK SVH+V
Sbjct: 91 TQKATGHQFACKTIAKRKLVNKEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLV 150
Query: 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE 218
MELCAGGELFDRIIAKGHYSERAAAS+ R+IV +VH CH MGV+HRDLKPENFLL +KDE
Sbjct: 151 MELCAGGELFDRIIAKGHYSERAAASLLRTIVQIVHTCHSMGVIHRDLKPENFLLLNKDE 210
Query: 219 NALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGV 278
N+ LKATDFGLSVF + G+V++DIVGSAYY+APEVL+R+YG E DIWS GV+LYILL GV
Sbjct: 211 NSPLKATDFGLSVFYKPGEVFKDIVGSAYYIAPEVLKRKYGPEADIWSIGVMLYILLCGV 270
Query: 279 PPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
PPFWAE+E GIF+AIL+G +DF S PWP+IS AKDLV++ML DPK+R+T+AQVL HPW
Sbjct: 271 PPFWAESENGIFNAILRGHVDFSSDPWPSISPQAKDLVKKMLNSDPKQRLTAAQVLNHPW 330
Query: 339 IKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKV 374
IKE GEA D P+D+AV+SR+KQF+AMN KK+AL+V
Sbjct: 331 IKEDGEAPDVPLDNAVMSRLKQFKAMNNFKKVALRV 366
|
|
| TAIR|locus:2150225 CPK34 "AT5G19360" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1242 (442.3 bits), Expect = 1.8e-126, P = 1.8e-126
Identities = 231/326 (70%), Positives = 273/326 (83%)
Query: 49 PAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFA 108
P A+P KQ P +LG+P EDVK Y+ GKELGRGQFGVT+LCT+ +TG QFA
Sbjct: 40 PPASPPPATKQGPIGP----VLGRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFA 95
Query: 109 CKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELF 168
CK+I+KRKLV K D +D++RE+QIM HL+GQPNIVE KGAYEDK SVH+VMELCAGGELF
Sbjct: 96 CKTIAKRKLVNKEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELF 155
Query: 169 DRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228
DRIIAKGHYSERAAAS+ R+IV ++H CH MGV+HRDLKPENFLL SKDEN+ LKATDFG
Sbjct: 156 DRIIAKGHYSERAAASLLRTIVQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFG 215
Query: 229 LSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG 288
LSVF + G+V++DIVGSAYY+APEVLRR+YG E DIWS GV+LYILL GVPPFWAE+E G
Sbjct: 216 LSVFYKPGEVFKDIVGSAYYIAPEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENG 275
Query: 289 IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDK 348
IF+AIL G +DF S PWP IS AKDLVR+ML DPK+R+T+AQVL HPWIKE GEA D
Sbjct: 276 IFNAILSGQVDFSSDPWPVISPQAKDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDV 335
Query: 349 PIDSAVLSRMKQFRAMNKLKKLALKV 374
P+D+AV+SR+KQF+AMN KK+AL+V
Sbjct: 336 PLDNAVMSRLKQFKAMNNFKKVALRV 361
|
|
| TAIR|locus:2204340 CPK29 "calcium-dependent protein kinase 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1240 (441.6 bits), Expect = 2.9e-126, P = 2.9e-126
Identities = 239/371 (64%), Positives = 290/371 (78%)
Query: 5 LTKSKDPKPRHYAHGYRSSPNTVXXXXXXXXXXXHHRPE-KPGPTPAAAPVSGLKQAVPR 63
++ S D P H+ Y+ P + +P+ KP P P + SG Q P
Sbjct: 45 ISSSSDSSPPHH---YQPLPKPTVSQGQTSNPTSNPQPKPKPAPPPPPSTSSG-SQIGP- 99
Query: 64 PDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK 123
IL +P D+ Y KELGRGQFG+TY CT+ S GR++ACKSISKRKL+ + D
Sbjct: 100 -----ILNRPMIDLSALYDLHKELGRGQFGITYKCTDKSNGREYACKSISKRKLIRRKDI 154
Query: 124 DDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAA 183
+D++RE+ I+QHL+GQPNIVEF+GAYEDK ++H+VMELC+GGELFDRII KG YSE+ AA
Sbjct: 155 EDVRREVMILQHLTGQPNIVEFRGAYEDKDNLHLVMELCSGGELFDRIIKKGSYSEKEAA 214
Query: 184 SICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243
+I R IVNVVH+CHFMGV+HRDLKPENFLL S +E++ +KATDFGLSVFIEEGKVYRDIV
Sbjct: 215 NIFRQIVNVVHVCHFMGVVHRDLKPENFLLVSNEEDSPIKATDFGLSVFIEEGKVYRDIV 274
Query: 244 GSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA 303
GSAYYVAPEVL R YGKEID+WSAGV+LYILLSGVPPFW ETEK IF+AIL+G +D E++
Sbjct: 275 GSAYYVAPEVLHRNYGKEIDVWSAGVMLYILLSGVPPFWGETEKTIFEAILEGKLDLETS 334
Query: 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRA 363
PWPTIS SAKDL+R+ML +DPKKRIT+A+ LEHPW+ + + SDKPI+SAVL RMKQFRA
Sbjct: 335 PWPTISESAKDLIRKMLIRDPKKRITAAEALEHPWMTDT-KISDKPINSAVLVRMKQFRA 393
Query: 364 MNKLKKLALKV 374
MNKLKKLALKV
Sbjct: 394 MNKLKKLALKV 404
|
|
| TAIR|locus:2128409 CDPK6 "calcium-dependent protein kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1182 (421.1 bits), Expect = 4.1e-120, P = 4.1e-120
Identities = 231/369 (62%), Positives = 272/369 (73%)
Query: 6 TKSKDPKPRHYAHGYRSSPNTVXXXXXXXXXXXHHRPEKPGPTPAAAPVSGLKQAVPRPD 65
+KS DP P + SS N V G + + G +
Sbjct: 8 SKSSDPPP---SSSSSSSGNVVHHVKPAGERRGSSGSGTVGSSGSGT--GGSRSTTSTQQ 62
Query: 66 TNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD 125
ILG+P E+V+ Y FG+ELGRGQFGVTYL T T +Q ACKSI R+LV K+D +D
Sbjct: 63 NGRILGRPMEEVRRTYEFGRELGRGQFGVTYLVTHKETKQQVACKSIPTRRLVHKDDIED 122
Query: 126 IKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASI 185
++RE+QIM HLSG NIV+ KGAYED+ SV+++MELC GGELFDRII+KG YSERAAA +
Sbjct: 123 VRREVQIMHHLSGHRNIVDLKGAYEDRHSVNLIMELCEGGELFDRIISKGLYSERAAADL 182
Query: 186 CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGS 245
CR +V VVH CH MGVMHRDLKPENFL SKDEN+ LKATDFGLSVF + G ++D+VGS
Sbjct: 183 CRQMVMVVHSCHSMGVMHRDLKPENFLFLSKDENSPLKATDFGLSVFFKPGDKFKDLVGS 242
Query: 246 AYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW 305
AYYVAPEVL+R YG E DIWSAGVILYILLSGVPPFW E E GIFDAILQG +DF + PW
Sbjct: 243 AYYVAPEVLKRNYGPEADIWSAGVILYILLSGVPPFWGENETGIFDAILQGQLDFSADPW 302
Query: 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMN 365
P +S AKDLVR+ML DPK R+T+A+VL HPWI+E GEASDKP+D+AVLSRMKQFRAMN
Sbjct: 303 PALSDGAKDLVRKMLKYDPKDRLTAAEVLNHPWIREDGEASDKPLDNAVLSRMKQFRAMN 362
Query: 366 KLKKLALKV 374
KLKK+ALKV
Sbjct: 363 KLKKMALKV 371
|
|
| TAIR|locus:2075885 CPK2 "calmodulin-domain protein kinase cdpk isoform 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1115 (397.6 bits), Expect = 6.9e-115, Sum P(2) = 6.9e-115
Identities = 201/309 (65%), Positives = 254/309 (82%)
Query: 66 TNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD 125
T ++L + E+ K YS G++LG+GQFG T+LC E TG ++ACKSISKRKL+T D +D
Sbjct: 171 TESVLQRKTENFKEFYSLGRKLGQGQFGTTFLCLEKGTGNEYACKSISKRKLLTDEDVED 230
Query: 126 IKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASI 185
++REIQIM HL+G PN++ KGAYED +VH+VMELC+GGELFDRII +GHY+ER AA +
Sbjct: 231 VRREIQIMHHLAGHPNVISIKGAYEDVVAVHLVMELCSGGELFDRIIQRGHYTERKAAEL 290
Query: 186 CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGS 245
R+IV V+ CH +GVMHRDLKPENFL S++E++LLK DFGLS+F + +V+ D+VGS
Sbjct: 291 ARTIVGVLEACHSLGVMHRDLKPENFLFVSREEDSLLKTIDFGLSMFFKPDEVFTDVVGS 350
Query: 246 AYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW 305
YYVAPEVLR+RYG E D+WSAGVI+YILLSGVPPFWAETE+GIF+ +L GD+DF S PW
Sbjct: 351 PYYVAPEVLRKRYGPESDVWSAGVIVYILLSGVPPFWAETEQGIFEQVLHGDLDFSSDPW 410
Query: 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMN 365
P+IS SAKDLVR+ML +DPK+R+T+ QVL HPW++ G A DKP+DSAVLSRMKQF AMN
Sbjct: 411 PSISESAKDLVRKMLVRDPKRRLTAHQVLCHPWVQIDGVAPDKPLDSAVLSRMKQFSAMN 470
Query: 366 KLKKLALKV 374
K KK+AL+V
Sbjct: 471 KFKKMALRV 479
|
|
| TAIR|locus:2175503 CPK1 "calcium dependent protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1126 (401.4 bits), Expect = 3.5e-114, P = 3.5e-114
Identities = 210/336 (62%), Positives = 262/336 (77%)
Query: 41 RPE-KPGPTPAAAPVSGLKQAVPRP-DTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLC 98
+PE KP P +K+ T ++L + E+ K YS G++LG+GQFG T+LC
Sbjct: 108 KPESKPDPPAKPKKPKHMKRVSSAGLRTESVLQRKTENFKEFYSLGRKLGQGQFGTTFLC 167
Query: 99 TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158
E +TG++FACKSI+KRKL+T D +D++REIQIM HL+G PN++ KGAYED +VH+V
Sbjct: 168 VEKTTGKEFACKSIAKRKLLTDEDVEDVRREIQIMHHLAGHPNVISIKGAYEDVVAVHLV 227
Query: 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE 218
ME CAGGELFDRII +GHY+ER AA + R+IV VV CH +GVMHRDLKPENFL SK E
Sbjct: 228 MECCAGGELFDRIIQRGHYTERKAAELTRTIVGVVEACHSLGVMHRDLKPENFLFVSKHE 287
Query: 219 NALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGV 278
++LLK DFGLS+F + V+ D+VGS YYVAPEVLR+RYG E D+WSAGVI+YILLSGV
Sbjct: 288 DSLLKTIDFGLSMFFKPDDVFTDVVGSPYYVAPEVLRKRYGPEADVWSAGVIVYILLSGV 347
Query: 279 PPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
PPFWAETE+GIF+ +L GD+DF S PWP+IS SAKDLVR+ML +DPKKR+T+ QVL HPW
Sbjct: 348 PPFWAETEQGIFEQVLHGDLDFSSDPWPSISESAKDLVRKMLVRDPKKRLTAHQVLCHPW 407
Query: 339 IKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKV 374
++ G A DKP+DSAVLSRMKQF AMNK KK+AL+V
Sbjct: 408 VQVDGVAPDKPLDSAVLSRMKQFSAMNKFKKMALRV 443
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P53683 | CDPK2_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7597 | 0.9363 | 0.6904 | yes | no |
| P49101 | CDPK2_MAIZE | 2, ., 7, ., 1, 1, ., 1 | 0.7923 | 0.8625 | 0.6608 | N/A | no |
| Q38868 | CDPK9_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7473 | 0.9516 | 0.6913 | yes | no |
| P28582 | CDPK_DAUCA | 2, ., 7, ., 1, 1, ., 1 | 0.7480 | 0.9440 | 0.6973 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 393 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-104 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-94 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-71 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-66 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-63 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-61 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-60 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-57 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-55 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-54 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-52 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-52 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-51 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-49 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-48 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-46 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-46 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-45 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-45 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-42 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-41 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-41 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-40 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-40 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-40 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-40 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-40 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-39 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-39 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-39 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-38 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-38 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-38 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-38 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-38 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-37 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-37 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-37 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-37 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-36 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-36 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-36 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-35 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-35 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-35 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-35 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-34 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-34 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-34 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-34 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-34 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-34 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-33 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-33 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-33 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-33 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-33 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-33 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-33 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-33 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-32 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-32 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-32 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-32 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-32 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-32 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-31 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-31 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-31 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-31 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-31 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-30 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-30 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-30 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-30 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-30 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-30 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-30 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-30 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-30 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-29 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-29 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-29 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-29 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-29 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-29 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-28 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-28 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-28 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-28 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-28 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-28 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-28 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-28 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-28 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-28 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-28 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-27 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-27 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-27 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-27 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-27 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-26 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-26 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-26 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-26 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-26 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-25 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-25 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-25 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-25 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-25 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-25 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-25 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-25 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-24 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-24 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-24 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-24 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-24 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-24 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-24 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-24 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-24 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-24 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-24 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-24 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-23 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-23 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-23 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-23 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-23 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-23 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-23 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-23 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-23 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-22 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-22 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-22 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-22 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-22 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-22 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-21 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-21 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-21 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-21 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-21 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-21 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-21 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-20 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-20 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-20 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-20 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-20 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-20 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-19 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-19 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-19 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-18 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-18 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-18 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-17 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-17 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-16 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-16 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-14 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-14 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-13 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-10 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-08 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-05 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 4e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.002 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 0.002 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.002 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.003 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.004 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 307 bits (790), Expect = e-104
Identities = 110/261 (42%), Positives = 158/261 (60%), Gaps = 9/261 (3%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y ++LG G FG YL + TG+ A K I K+K+ K D++ I REI+I++ L P
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKL-KHP 57
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
NIV +ED+ +++VME C GG+LFD + +G SE A R I++ + H G
Sbjct: 58 NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-YG 259
++HRDLKPEN LL DE+ +K DFGL+ ++ G+ VG+ Y+APEVL + YG
Sbjct: 118 IVHRDLKPENILL---DEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174
Query: 260 KEIDIWSAGVILYILLSGVPPFWA-ETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
K +DIWS GVILY LL+G PPF + +F I + F P IS AKDL+R+
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-PEWDISPEAKDLIRK 233
Query: 319 MLTQDPKKRITSAQVLEHPWI 339
+L +DP+KR+T+ + L+HP+
Sbjct: 234 LLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 283 bits (727), Expect = 1e-94
Identities = 105/265 (39%), Positives = 148/265 (55%), Gaps = 11/265 (4%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y ++LG G FG Y TG+ A K + KR +K D+ REI+I++ LS P
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLSH-P 58
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
NIV A+EDK +++VME C GG+LFD + G SE A I I+ + H G
Sbjct: 59 NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLR--RR 257
++HRDLKPEN LL +K DFGL+ ++ VG+ +Y+APEVL
Sbjct: 119 IIHRDLKPENILLDENGV---VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKG---IFDAILQGDIDFESAPWPTISSSAKD 314
YG ++D+WS GVILY LL+G PPF E + IL ++F+ W + S AKD
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWI 339
L+++ L +DP KR T+ ++L+HPW
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 224 bits (573), Expect = 1e-71
Identities = 93/257 (36%), Positives = 148/257 (57%), Gaps = 13/257 (5%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG+G FG L + TG+ +A K + K+K++ + + + E I+ ++ P IV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLH 59
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL 206
A++ ++ +++V+E GGELF + +G +SE A IV + H +G+++RDL
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119
Query: 207 KPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDI 264
KPEN LL D + +K TDFGL+ EG G+ Y+APEVL + YGK +D
Sbjct: 120 KPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDW 176
Query: 265 WSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDP 324
WS GV+LY +L+G PPF+AE K I++ IL+ + F P +S A+DL+ +L +DP
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF---P-EFLSPEARDLISGLLQKDP 232
Query: 325 KKRITSA---QVLEHPW 338
KR+ S ++ HP+
Sbjct: 233 TKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 4e-66
Identities = 91/255 (35%), Positives = 131/255 (51%), Gaps = 44/255 (17%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG G FG YL + TG++ A K I K + + +++ REI+I++ L+ PNIV+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNH-PNIVKLY 57
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRD 205
G +ED+ +++VME C GG L D + G SE I I+ + H G++HRD
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 206 LKPENFLLSSKDENALLKATDFGLSVFIEEGK-VYRDIVGSAYYVAPEVLRRR--YGKEI 262
LKPEN LL S + L DFGLS + K + + IVG+ Y+APEVL + Y ++
Sbjct: 118 LKPENILLDSDNGKVKL--ADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 263 DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322
DIWS GVILY L KDL+R+ML +
Sbjct: 176 DIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200
Query: 323 DPKKRITSAQVLEHP 337
DP+KR ++ ++LEH
Sbjct: 201 DPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 9e-63
Identities = 90/268 (33%), Positives = 139/268 (51%), Gaps = 19/268 (7%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+ +G +G +L + STG +A K I K ++ KN D + E I+ P +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQS-PYVVKLY 59
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL 206
+++ K+++++VME GG+L + G E A IV + H G++HRDL
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119
Query: 207 KPENFLLSSKDENALLKATDFGLSVFIEEGKVY---------RDIVGSAYYVAPEVLRRR 257
KP+N L+ D N LK TDFGLS + + IVG+ Y+APEV+ +
Sbjct: 120 KPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 258 -YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316
+ K +D WS G ILY L G+PPF ET + IF IL G I++ +S A DL+
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI 234
Query: 317 RRMLTQDPKKRITSA---QVLEHPWIKE 341
++L DP+KR+ + ++ HP+ K
Sbjct: 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 5e-61
Identities = 80/262 (30%), Positives = 141/262 (53%), Gaps = 16/262 (6%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K++G+G FG YL S G+ + K I + ++ +++D E++I++ L+ PNI++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-HPNIIK 63
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRI----IAKGHYSERAAASICRSIVNVVHICHFMG 200
+ ++E+K + +VME GG+L +I + E + + H
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR-Y 258
++HRD+KP+N L+S L+K DFG+S V + + +VG+ YY++PE+ + + Y
Sbjct: 124 ILHRDIKPQNIFLTSNG---LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPY 180
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI-SSSAKDLVR 317
+ DIWS G +LY L + PF E + IL+G P P+ SS ++LV
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP----PIPSQYSSELRNLVS 236
Query: 318 RMLTQDPKKRITSAQVLEHPWI 339
+L +DP++R + AQ+L+ P+I
Sbjct: 237 SLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 195 bits (499), Expect = 4e-60
Identities = 86/284 (30%), Positives = 138/284 (48%), Gaps = 33/284 (11%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ FGK +G G F L E T +++A K + KR+L+ + +K E +++ L+G P
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
I++ ++D+++++ V+E GEL I G E+ I+ + H G
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFG-------LSVFIEEGKVYRDI----------- 242
++HRDLKPEN LL D++ +K TDFG S +I
Sbjct: 123 IIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 243 ---VGSAYYVAPEVLRRRY-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI 298
VG+A YV+PE+L + GK D+W+ G I+Y +L+G PPF E F IL+ +
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239
Query: 299 DFESAPWPTISSSAKDLVRRMLTQDPKKRITS----AQVLEHPW 338
F P AKDL+ ++L DP+ R+ ++ HP+
Sbjct: 240 SFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 2e-57
Identities = 83/264 (31%), Positives = 135/264 (51%), Gaps = 16/264 (6%)
Query: 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIV 143
G+ LGRG FG YL + TG A KS+ + + ++REI+I+ L PNIV
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEEL-EALEREIRILSSLQ-HPNIV 62
Query: 144 EFKGAYEDKQSVH--VVMELCAGGELFDRIIAKGHYSERAAASICRSIVN-VVHICHFMG 200
+ G+ D++ + +E +GG L + G E R I+ + ++ H G
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL-HSNG 121
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR- 256
++HRD+K N L+ S +K DFG + + + + + G+ Y++APEV+R
Sbjct: 122 IVHRDIKGANILVDSDGV---VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 257 RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-ISSSAKDL 315
YG+ DIWS G + + +G PP W+E A+ + E P +S AKD
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPP-WSELGNP-MAALYKIGSSGEPPEIPEHLSEEAKDF 236
Query: 316 VRRMLTQDPKKRITSAQVLEHPWI 339
+R+ L +DPKKR T+ ++L+HP++
Sbjct: 237 LRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 7e-55
Identities = 87/267 (32%), Positives = 142/267 (53%), Gaps = 16/267 (5%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ F K LG G FG L +G+ +A K +SK K+V + + E +I+Q + P
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HP 61
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
+V G+++D ++++VME GGELF + G + E A +V + H +
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD 121
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-YG 259
+++RDLKPEN LL D + +K TDFG + ++ Y + G+ Y+APE++ + YG
Sbjct: 122 IVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR-TY-TLCGTPEYLAPEIILSKGYG 176
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRM 319
K +D W+ G+++Y +L+G PPF+ + I++ IL+G + F S S AKDL+R +
Sbjct: 177 KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKDLIRNL 232
Query: 320 LTQDPKKRI-----TSAQVLEHPWIKE 341
L D KR+ + HPW
Sbjct: 233 LQVDLTKRLGNLKNGVNDIKNHPWFAG 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 6e-54
Identities = 88/261 (33%), Positives = 144/261 (55%), Gaps = 16/261 (6%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG G FG L S R FA K + KR +V ++ I E +I++ + P IV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLY 59
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL 206
++DK+ ++++ME C GGEL+ + +G + E A +V H G+++RDL
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119
Query: 207 KPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV-LRRRYGKEIDIW 265
KPEN LL D N +K DFG + ++ G+ G+ YVAPE+ L + Y +D W
Sbjct: 120 KPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176
Query: 266 SAGVILYILLSGVPPFWAETEK--GIFDAILQGDIDFESAPWPT-ISSSAKDLVRRMLTQ 322
S G++LY LL+G PPF + E I++ IL+G+ E +P I +AKDL++++L +
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE---FPNYIDKAAKDLIKQLLRR 233
Query: 323 DPKKRITSAQ-----VLEHPW 338
+P++R+ + + + +H W
Sbjct: 234 NPEERLGNLKGGIKDIKKHKW 254
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 1e-52
Identities = 87/263 (33%), Positives = 139/263 (52%), Gaps = 14/263 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ +++G+G FG Y TG++ A K I KL +K K+ I EIQI++
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKCK-H 56
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICRSIVNVVHICHF 198
PNIV++ G+Y K + +VME C+GG L D + + +E A +C+ ++ + H
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-R 257
G++HRD+K N LL+S E +K DFGLS + + K +VG+ Y++APEV+
Sbjct: 117 NGIIHRDIKAANILLTSDGE---VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP 173
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI-LQGDIDFESAPWPTISS-SAKDL 315
Y + DIWS G+ L G PP+ +E A+ P S KD
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEKWSDEFKDF 230
Query: 316 VRRMLTQDPKKRITSAQVLEHPW 338
+++ L ++P+KR T+ Q+L+HP+
Sbjct: 231 LKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 2e-52
Identities = 89/260 (34%), Positives = 129/260 (49%), Gaps = 10/260 (3%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K + +G FG YL + STG FA K + K ++ KN ++K E IM P + +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++ K +++VME GG+ I G E A +V V H G++HR
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYG-KEID 263
D+KPEN L+ D+ LK TDFGLS G + VG+ Y+APE + K D
Sbjct: 122 DIKPENLLI---DQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDDKMSD 175
Query: 264 IWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQD 323
WS G +++ L G PPF AET +FD IL I++ S A DL+ R+L D
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235
Query: 324 PKKRITS---AQVLEHPWIK 340
P KR+ + ++ HP+ K
Sbjct: 236 PAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 174 bits (441), Expect = 9e-51
Identities = 91/298 (30%), Positives = 139/298 (46%), Gaps = 28/298 (9%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y ++LG G FG YL + + A K ++K+ + + REIQI+ L+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRI---IAKGHYSERAAASICRSIVNVVHIC 196
PNIV+ ++D+ S+++VME GG L D + KG SE A I I++ +
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV-------YRDIVGSAYYV 249
H G++HRD+KPEN LL +K DFGL+ + + VG+ Y+
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRV--VKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 250 APEVLR----RRYGKEIDIWSAGVILYILLSGVPPF----WAETEKGIFDAILQGDIDFE 301
APEVL DIWS G+ LY LL+G+PPF + IL+
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 302 SAPW-----PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAV 354
++P IS +A DL++++L +DPK R++S+ L H + D
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLK 293
|
Length = 384 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 9e-49
Identities = 89/286 (31%), Positives = 145/286 (50%), Gaps = 30/286 (10%)
Query: 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIM 133
D + Y +++G G G Y T+ +TG++ A K + + K +K+ I EI IM
Sbjct: 14 EGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIM 69
Query: 134 QHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY-SERAAASICRSIVNV 192
+ PNIV++ +Y + VVME GG L D I +E A +CR ++
Sbjct: 70 KDCK-HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQG 128
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAP 251
+ H V+HRD+K +N LLS +K DFG + + + K R+ +VG+ Y++AP
Sbjct: 129 LEYLHSQNVIHRDIKSDNILLSKDGS---VKLADFGFAAQLTKEKSKRNSVVGTPYWMAP 185
Query: 252 EVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAE---------TEKGIFDAILQGDIDFE 301
EV++R YG ++DIWS G++ + G PP+ E T KGI L+
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP--LK-----N 238
Query: 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASD 347
W S KD + + L +DP+KR ++ ++L+HP++K+ +
Sbjct: 239 PEKW---SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEE 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 6e-48
Identities = 86/266 (32%), Positives = 129/266 (48%), Gaps = 18/266 (6%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+Y G +GRG FGV Y TG A K IS K+ + I +EI ++++L
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLK-H 58
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
PNIV++ G+ E S+++++E G L I G + E A ++ + H
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSV-FIEEGKVYRDIVGSAYYVAPEVLRRRY 258
GV+HRD+K N L +KD K DFG++ + K +VG+ Y++APEV+
Sbjct: 119 GVIHRDIKAANILT-TKDGVV--KLADFGVATKLNDVSKDDASVVGTPYWMAPEVIE--- 172
Query: 259 GKEI----DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-ISSSAK 313
DIWS G + LL+G PP++ I+Q D P P IS K
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD----HPPLPEGISPELK 228
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWI 339
D + + +DP R T+ Q+L+HPWI
Sbjct: 229 DFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 3e-46
Identities = 82/268 (30%), Positives = 128/268 (47%), Gaps = 24/268 (8%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSI------SKRKLVTKNDKDDIKREIQIMQHLSG 138
K LG+G GV Y TG+ +A K I RK + RE++ +
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQ--------LLRELKTL-RSCE 57
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH- 197
P +V+ GA+ + + +V+E GG L D + G E A I R I+ + H
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLR- 255
++HRD+KP N L++SK E +K DFG+S +E + VG+ Y++PE ++
Sbjct: 118 KRHIIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG 174
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP--TISSSAK 313
Y DIWS G+ L G PF + F+ ++Q D P S +
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFE-LMQAICDGPPPSLPAEEFSPEFR 233
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWIKE 341
D + L +DPKKR ++A++L+HP+IK+
Sbjct: 234 DFISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 4e-46
Identities = 76/263 (28%), Positives = 132/263 (50%), Gaps = 8/263 (3%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
H+ + +G+G FG + + T + FA K ++K+K V K ++ E +I+Q L+
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-H 59
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P +V +++D++++++V++L GG+L + K +SE IV + H
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-Y 258
G++HRD+KP+N LL DE + TDF ++ + + G+ Y+APEVL R+ Y
Sbjct: 120 GIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY 176
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
+D WS GV Y L G P+ + D I + T S+ A D + +
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-DQIRAKQETADVLYPATWSTEAIDAINK 235
Query: 319 MLTQDPKKRI--TSAQVLEHPWI 339
+L +DP+KR+ + HP+
Sbjct: 236 LLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 2e-45
Identities = 84/296 (28%), Positives = 133/296 (44%), Gaps = 51/296 (17%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHL 136
Y ++LG G +GV Y + TG A K I +L N+++ I REI +++ L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI---RL--DNEEEGIPSTALREISLLKEL 55
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD--RIIAK--GHYSERAAASICRSIVNV 192
PNIV+ ++ +++V E C D + + K G S SI ++
Sbjct: 56 K-HPNIVKLLDVIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRG 110
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAP 251
+ CH ++HRDLKP+N L++ +LK DFGL+ F + Y V + +Y AP
Sbjct: 111 LAYCHSHRILHRDLKPQNILINRDG---VLKLADFGLARAFGIPLRTYTHEVVTLWYRAP 167
Query: 252 EVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAIL----------- 294
E+L + Y +DIWS G I +++G P F ++E IF IL
Sbjct: 168 EILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ-ILGTPTEESWPGV 226
Query: 295 ----QGDIDF---ESAPW----PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
F P + DL+ +ML +P KRI++ + L+HP+
Sbjct: 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 4e-45
Identities = 89/292 (30%), Positives = 146/292 (50%), Gaps = 37/292 (12%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ K +GRG FG +L + TG+ +A K + K ++ +N ++ E I+ + P
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD-ADSP 61
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
IV+ +++D++ +++VME GG+L + +I K + E A +V + H +G
Sbjct: 62 WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG 121
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK----------------------- 237
+HRD+KP+N L+ D + +K DFGL + + K
Sbjct: 122 FIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 238 ------VYRD-IVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGI 289
V + VG+ Y+APEVLR YG E D WS GVILY +L G PPF+++T +
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238
Query: 290 FDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSA-QVLEHPWIK 340
++ I+ P P +S A DL+ R+L DP+ R+ S ++ HP+ K
Sbjct: 239 YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 3e-42
Identities = 91/297 (30%), Positives = 134/297 (45%), Gaps = 47/297 (15%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHL 136
Y GK+LG G + V Y + TGR A K I + K KD I REI+++Q L
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGER--KEAKDGINFTALREIKLLQEL 59
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAG---GELFDRII--AKGHYSERAAASICRSIVN 191
PNI+ + K ++++V E + D+ I S +
Sbjct: 60 K-HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIK-----SYMLMTLR 113
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVA 250
+ H ++HRDLKP N L++S LK DFGL+ F + V + +Y A
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGV---LKLADFGLARSFGSPNRKMTHQVVTRWYRA 170
Query: 251 PEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAI----------- 293
PE+L R YG +D+WS G I LL VP +++ IF+A+
Sbjct: 171 PELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV 230
Query: 294 --LQGDIDFESAP-------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
L ++F+ P +P S A DL++R+LT +P KRIT+ Q LEHP+
Sbjct: 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 1e-41
Identities = 81/289 (28%), Positives = 127/289 (43%), Gaps = 37/289 (12%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y +G G G+ + + TG A K ++ R+L + REI+ +Q P
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQ-HP 59
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICRSIVNVVHICHFM 199
+V+ + +VME L + + + E S R ++ V H
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSV--FIEEGKVYRDIVGSAYYVAPEVL--R 255
G+MHRDLKP N L+S+ +LK DFGL+ EE ++Y V + +Y APE+L
Sbjct: 119 GIMHRDLKPANLLISADG---VLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAI---------------LQG 296
R+Y +D+W+ G I LL+G P F E + +F +
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235
Query: 297 DIDFESA---PW----PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
I F + P P S A DL++ +L DP KR+++A+ L HP+
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 85/271 (31%), Positives = 140/271 (51%), Gaps = 17/271 (6%)
Query: 78 KLH-YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL 136
KL + G+ LG G FG + TG +A K + KR+++ + +E I+ L
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHIC 196
S P IV +++D+ V+ ++E GGELF + G + A +V
Sbjct: 76 S-HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYL 134
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR 256
H +++RDLKPEN LL +K +K TDFG + + + + + + G+ Y+APEV++
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGH---VKVTDFGFAKKVPD-RTF-TLCGTPEYLAPEVIQS 189
Query: 257 R-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315
+ +GK +D W+ GV+LY ++G PPF+ +T I++ IL G + F + W A+DL
Sbjct: 190 KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDL 245
Query: 316 VRRMLTQDPKKRITS-----AQVLEHPWIKE 341
V+ +L D KR+ + A V HP+
Sbjct: 246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276
|
Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 1e-40
Identities = 76/266 (28%), Positives = 136/266 (51%), Gaps = 24/266 (9%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +G G FG +L + + +A K ++ +++ + + E ++++ +S P I+
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIR 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
D++ ++++ME GGELF + G +S IV + H +++R
Sbjct: 66 LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYR 125
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD----IVGSAYYVAPEVLRRR-YG 259
DLKPEN LL D+ +K TDFG + K RD + G+ Y+APEV++ + +
Sbjct: 126 DLKPENILL---DKEGHIKLTDFGFA------KKLRDRTWTLCGTPEYLAPEVIQSKGHN 176
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRM 319
K +D W+ G+++Y +L G PPF+ + GI++ IL G ++F + AKDL++++
Sbjct: 177 KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIKKL 232
Query: 320 LTQDPKKRI-----TSAQVLEHPWIK 340
L D +R+ + V H W K
Sbjct: 233 LVVDRTRRLGNMKNGADDVKNHRWFK 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-40
Identities = 84/278 (30%), Positives = 132/278 (47%), Gaps = 31/278 (11%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y + +G+G FG S G+ K I + K +K + E+ I++ L
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK-EKQQLVSEVNILRELK-H 58
Query: 140 PNIVEFKGAYEDK--QSVHVVMELCAGGELFDRIIAK-----GHYSERAAASICRSIVNV 192
PNIV + D+ Q++++VME C GG+L ++I K + E I ++
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDL-AQLIQKCKKERKYIEEEFIWRILTQLLLA 117
Query: 193 VHICHF-----MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG----KVYRDIV 243
++ CH V+HRDLKP N L D N +K DFGL+ + K Y V
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFGLAKILGHDSSFAKTY---V 171
Query: 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES 302
G+ YY++PE L Y ++ DIWS G ++Y L + PPF A + + I +G
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR--- 228
Query: 303 APWPTISSSA-KDLVRRMLTQDPKKRITSAQVLEHPWI 339
P SS ++++ ML DP KR ++ ++L+ P I
Sbjct: 229 -RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-40
Identities = 88/273 (32%), Positives = 144/273 (52%), Gaps = 29/273 (10%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIM---QHLSGQPN 141
++G G G+ + T+ STGRQ A K + RK + ++ + E+ IM QH PN
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQH----PN 77
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGV 201
IVE +Y + VVME GG L D I+ +E A++C +++ + H GV
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGV 136
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDIVGSAYYVAPEVLRRR-YG 259
+HRD+K ++ LL+S + +K +DFG + +E + +VG+ Y++APEV+ R YG
Sbjct: 137 IHRDIKSDSILLTS---DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYG 193
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT------ISSSAK 313
E+DIWS G+++ ++ G PP++ E LQ P +S +
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAMKRIRDNLPPKLKNLHKVSPRLR 246
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346
+ RML +DP +R T+A++L HP++ + G S
Sbjct: 247 SFLDRMLVRDPAQRATAAELLNHPFLAKAGPPS 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 8e-40
Identities = 83/286 (29%), Positives = 126/286 (44%), Gaps = 38/286 (13%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
++G G +GV Y + TG A K I K + ++ REI++++ L+ PNI++
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELN-HPNIIK 62
Query: 145 FKGAYEDKQSVHVVMELCAGG--ELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVM 202
+ K +++V E +L + E S ++ + CH G++
Sbjct: 63 LLDVFRHKGDLYLVFEFMDTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120
Query: 203 HRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVL--RRRYG 259
HRDLKPEN L+ + +LK DFGL+ F + Y V + +Y APE+L + Y
Sbjct: 121 HRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ--GDI------------------- 298
+DIWS G I LLS P F ++E I + G
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237
Query: 299 -DFESAPWPTI----SSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
P P + S A DL+ +ML DP KRIT+ Q L HP+
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 8e-40
Identities = 80/270 (29%), Positives = 133/270 (49%), Gaps = 24/270 (8%)
Query: 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIV 143
G ++G G FG Y TG A K I + K K+ I E+++++ L PN+V
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKE-IADEMKVLELLK-HPNLV 62
Query: 144 EFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMH 203
++ G ++ V++ ME C+GG L + + E ++ + H G++H
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 204 RDLKPENFLLSSKDENALLKATDFGLSVFIEE-----GKVYRDIVGSAYYVAPEVLRRR- 257
RD+KP N L D N ++K DFG +V ++ G+ + + G+ Y+APEV+
Sbjct: 123 RDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 258 ---YGKEIDIWSAGVILYILLSGVPPFWAE--TEKGIFDAILQGDIDFESAPWPT---IS 309
+G+ DIWS G ++ + +G P W+E E I + G P P +S
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIMFHVGAG----HKPPIPDSLQLS 234
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
KD + R L DPKKR T++++L+HP++
Sbjct: 235 PEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 90/294 (30%), Positives = 131/294 (44%), Gaps = 48/294 (16%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y K+LG G FG YL TG A K + K+K + + ++ RE++ ++ L+ P
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNL-REVKSLRKLNEHP 58
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHF 198
NIV+ K + + ++ V E G L+ + +SE SI I+ + H
Sbjct: 59 NIVKLKEVFRENDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR- 257
G HRDLKPEN L+S + ++K DFGL+ I Y D V + +Y APE+L R
Sbjct: 118 HGFFHRDLKPENLLVSGPE---VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRST 174
Query: 258 -YGKEIDIWSAGVILYILLSGVPPF-----------------------WAETEKGIFDAI 293
Y +DIW+ G I+ L + P F W E K
Sbjct: 175 SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK------ 228
Query: 294 LQGDIDF---------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
L + F P S A DL++ ML DPKKR T++Q L+HP+
Sbjct: 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-39
Identities = 78/269 (28%), Positives = 138/269 (51%), Gaps = 17/269 (6%)
Query: 85 KELGRGQFGVTYLC---TENSTGRQFACKSISKRKLVTK-NDKDDIKREIQIMQHLSGQP 140
+ LG G +G +L + G+ +A K + K +V K + + E Q+++ + P
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
+V A++ +H++++ GGELF + + H++E IV + H +G
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG 125
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR--DIVGSAYYVAPEVLRRR- 257
+++RD+K EN LL D + TDFGLS + R G+ Y+APEV+R
Sbjct: 126 IIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGS 182
Query: 258 --YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP-TISSSAKD 314
+ K +D WS GV+ + LL+G PF + E+ I + I P+P T+S+ A+D
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR-RILKSKPPFPKTMSAEARD 241
Query: 315 LVRRMLTQDPKKRI---TSAQVLEHPWIK 340
++++L +DPKKR+ + ++ HP+ +
Sbjct: 242 FIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 5e-39
Identities = 95/326 (29%), Positives = 141/326 (43%), Gaps = 78/326 (23%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKD--DIKREIQIMQHLS 137
Y K +G G +GV + TGR+ A K IS V + D I REI++++HL
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN---VFDDLIDAKRILREIKLLRHL- 56
Query: 138 GQPNIVEFK-----GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNV 192
NI+ + ED V++V EL +L ++I S + +
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTEL-METDL-HKVI----KSPQP--------LTD 102
Query: 193 VHICHFM-------------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239
HI +F+ V+HRDLKP N L+ + N LK DFGL+ ++ +
Sbjct: 103 DHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDPDEDE 159
Query: 240 RDI----VGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETE----KGI 289
+ V + +Y APE+L RY K IDIWS G I LL+ P F I
Sbjct: 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLI 219
Query: 290 FDAILQG-----DIDFES----------------APW----PTISSSAKDLVRRMLTQDP 324
+ + G D+ F + P P S A DL+ +ML DP
Sbjct: 220 VEVL--GTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDP 277
Query: 325 KKRITSAQVLEHPWIKEGGEASDKPI 350
KKRIT+ + L HP++ + + D+P+
Sbjct: 278 KKRITADEALAHPYLAQLHDPEDEPV 303
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 1e-38
Identities = 93/268 (34%), Positives = 146/268 (54%), Gaps = 21/268 (7%)
Query: 85 KELGRGQFGVTYLC---TENSTGRQFACKSISKRKLVTKNDKDD--IKREIQIMQHLSGQ 139
K LG+G +G + T TG+ FA K + K +V +N KD K E I++ +
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-RNQKDTAHTKAERNILEAVK-H 59
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P IV+ A++ +++++E +GGELF + +G + E A I + H
Sbjct: 60 PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLRRR- 257
G+++RDLKPEN LL D +K TDFGL I EG V G+ Y+APE+L R
Sbjct: 120 GIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG 176
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
+GK +D WS G ++Y +L+G PPF AE K D IL+G + + P P ++ A+DL++
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL---NLP-PYLTPEARDLLK 232
Query: 318 RMLTQDPKKRITS-----AQVLEHPWIK 340
++L ++P R+ + A+V HP+ +
Sbjct: 233 KLLKRNPSSRLGAGPGDAAEVQSHPFFR 260
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 1e-38
Identities = 81/266 (30%), Positives = 126/266 (47%), Gaps = 21/266 (7%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
++G+G +G +L + TG A K + K L N+ + E I+ + +V+
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKSEWLVKL 66
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRD 205
A++D + +++ ME GG+ + G SE A + V H +G +HRD
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRD 126
Query: 206 LKPENFLLSSKDENALLKATDFGLSV-FIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEID 263
LKPENFL+ + +K TDFGLS + +VGS Y+APEVLR + Y +D
Sbjct: 127 LKPENFLIDASGH---IKLTDFGLSKGIVTYAN---SVVGSPDYMAPEVLRGKGYDFTVD 180
Query: 264 IWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP-------TISSSAKDLV 316
WS G +LY L G PPF T ++ + E+ P +S A DL+
Sbjct: 181 YWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK---ETLQRPVYDDPRFNLSDEAWDLI 237
Query: 317 RRMLTQDPKKRITS-AQVLEHPWIKE 341
+++ DP +R S + HP+ KE
Sbjct: 238 TKLIN-DPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 1e-38
Identities = 86/298 (28%), Positives = 129/298 (43%), Gaps = 58/298 (19%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDI----KREIQIMQHLSGQP 140
++G G +G Y TG A K K+ +N+K+ REI+++Q L P
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALK-----KIRMENEKEGFPITAIREIKLLQKLR-HP 58
Query: 141 NIVEFKGAYEDKQ--SVHVVMELC----AGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
NIV K K S+++V E G L D + ++E + ++ +
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLEGLQ 114
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI--EEGKVYRDIVGSAYYVAPE 252
H G++HRD+K N L+++ LK DFGL+ Y + V + +Y PE
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGV---LKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171
Query: 253 VL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ--GDIDFESAPWPT- 307
+L RYG E+D+WS G IL L G P F TE + I + G E+ WP
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN--WPGV 229
Query: 308 --------------------------ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
I SA DL+ ++LT DPKKRI++ Q L+H +
Sbjct: 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 78/265 (29%), Positives = 130/265 (49%), Gaps = 31/265 (11%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG G +G Y TG+ A K + + D +I +EI I++ P IV++
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVP-----VEEDLQEIIKEISILKQ-CDSPYIVKYY 64
Query: 147 GAYEDKQSVHVVMELCAGGELFD--RIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
G+Y + +VME C G + D +I K +E A+I + + H +HR
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNKKIHR 123
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRR-RYGKEI 262
D+K N LL +E K DFG+S + + R+ ++G+ +++APEV++ Y +
Sbjct: 124 DIKAGNILL---NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKA 180
Query: 263 DIWSAGVILYILLSGVPPFWAETE--KGIFDAILQGDIDFESAPWPTISSSAK------D 314
DIWS G+ + G PP+ ++ + IF I P PT+S K D
Sbjct: 181 DIWSLGITAIEMAEGKPPY-SDIHPMRAIF-MIPN-------KPPPTLSDPEKWSPEFND 231
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWI 339
V++ L +DP++R ++ Q+L+HP+I
Sbjct: 232 FVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 87/290 (30%), Positives = 146/290 (50%), Gaps = 51/290 (17%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K + G +G YL T ++FA K I+K+ L+ +N + E I+ + P +V
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILT-FAENPFVVS 65
Query: 145 FKGAYEDKQSVHVVMELCAGGE---LFDRI------IAKGHYSERAAASICRSIVNVVHI 195
++E K+ + +VME GG+ L I +A+ +++E A +
Sbjct: 66 MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLA---------LEY 116
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS--------VFIEEGKVYRD------ 241
H G++HRDLKP+N L++S +K TDFGLS + EG + +D
Sbjct: 117 LHNYGIVHRDLKPDNLLITSMGH---IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 242 --IVGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI 298
+ G+ Y+APEV LR+ YGK +D W+ G+ILY L G PF+ +T + +F ++ DI
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI 233
Query: 299 DFESAPWP----TISSSAKDLVRRMLTQDPKKRI---TSAQVLEHPWIKE 341
+ WP + + A+DL+ R+L Q+P +R+ + +V +H +
Sbjct: 234 E-----WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 83/261 (31%), Positives = 138/261 (52%), Gaps = 15/261 (5%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG+G FG L E +TG+ +A K + K ++ K++ E +++Q+ + P +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPFLTA 59
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
K +++ + VME GGELF + + +SE A IV+ + H V++R
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 205 DLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEI 262
DLK EN +L D++ +K TDFGL I +G + G+ Y+APEVL YG+ +
Sbjct: 120 DLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 263 DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322
D W GV++Y ++ G PF+ + + +F+ IL +I F T+S AK L+ +L +
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 232
Query: 323 DPKKRITSAQ-----VLEHPW 338
DPK+R+ ++EH +
Sbjct: 233 DPKQRLGGGPEDAKEIMEHRF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 3e-37
Identities = 83/270 (30%), Positives = 139/270 (51%), Gaps = 27/270 (10%)
Query: 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV--TKNDKDDIKREIQIMQHLSGQPN 141
GK LG+G FG YLC + TGR+ A K + TK + + ++ EIQ++++L
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HER 65
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGV 201
IV++ G D +++ + ME GG + D++ A G +E R I+ V H +
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMI 125
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIE----EGKVYRDIVGSAYYVAPEVLR-R 256
+HRD+K N L +D +K DFG S ++ G + + G+ Y+++PEV+
Sbjct: 126 VHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 257 RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-------IS 309
YG++ D+WS G + +L+ PP WAE E AI F+ A PT +S
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPP-WAEFEA--MAAI------FKIATQPTNPQLPSHVS 233
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
A++ +RR ++ KKR ++ ++L H ++
Sbjct: 234 PDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 4e-37
Identities = 81/265 (30%), Positives = 139/265 (52%), Gaps = 17/265 (6%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDI--KREIQIMQHLSGQPNIVE 144
+G+G FG Y + T R +A K +SK+++V K + +R I + L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE-RAAASICRSIVNVVHICHFMGVMH 203
K +++ +++V + +GGELF + +G +SE RA I ++ + H+ H +++
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHL-HKYDIVY 119
Query: 204 RDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVL--RRRYGK 260
RDLKPEN LL D + DFGLS + + K G+ Y+APEVL + Y K
Sbjct: 120 RDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTK 176
Query: 261 EIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRML 320
+D WS GV+++ + G PF+AE + ++ I G + F P +S + V+ +L
Sbjct: 177 HVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF---PKNVLSDEGRQFVKGLL 233
Query: 321 TQDPKKRITS----AQVLEHPWIKE 341
++P+ R+ + ++ EHP+ +
Sbjct: 234 NRNPQHRLGAHRDAVELKEHPFFAD 258
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 6e-37
Identities = 80/269 (29%), Positives = 143/269 (53%), Gaps = 16/269 (5%)
Query: 85 KELGRGQFGVTYL---CTENSTGRQFACKSISKRKLVTK-NDKDDIKREIQIMQHLSGQP 140
K LG G +G +L T + TG+ +A K + K LV K + + E +++H+ P
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
+V A++ + +H++++ +GGE+F + + ++SE I+ + H +G
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG 125
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLS--VFIEEGKVYRDIVGSAYYVAPEVLRRR- 257
+++RD+K EN LL S+ L TDFGLS EE + G+ Y+APE++R +
Sbjct: 126 IVYRDIKLENILLDSEGHVVL---TDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG 182
Query: 258 -YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316
+GK +D WS G++++ LL+G PF E E+ + + + + I A+DL+
Sbjct: 183 GHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLL 242
Query: 317 RRMLTQDPKKRITSA-----QVLEHPWIK 340
++L +DPKKR+ + ++ EHP+ K
Sbjct: 243 HKLLRKDPKKRLGAGPQGASEIKEHPFFK 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 82/248 (33%), Positives = 130/248 (52%), Gaps = 12/248 (4%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ K +GRG FG L S+ + +A K +SK +++ ++D E IM H +
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH-ANSE 103
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
IV+ A++D + +++VME GG+L + +++ E+ A +V + H MG
Sbjct: 104 WIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIHSMG 162
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDI-VGSAYYVAPEVLRRR- 257
+HRD+KP+N LL D++ LK DFG + ++ G V D VG+ Y++PEVL+ +
Sbjct: 163 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 258 ----YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313
YG+E D WS GV LY +L G PF+A++ G + I+ IS AK
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAK 279
Query: 314 DLVRRMLT 321
DL+ LT
Sbjct: 280 DLICAFLT 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 3e-36
Identities = 75/275 (27%), Positives = 128/275 (46%), Gaps = 24/275 (8%)
Query: 80 HYSFGKELGRGQFGVTY--LCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS 137
Y + +G G V Y +C N + A K I K T D++++E+Q M
Sbjct: 2 DYELIEVIGVGATAVVYAAICLPN--NEKVAIKRIDLEKCQT--SVDELRKEVQAMS-QC 56
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFD---RIIAKGHYSERAAASICRSIVNVVH 194
PN+V++ ++ + +VM +GG L D +G E A++ + ++ +
Sbjct: 57 NHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLE 116
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-----KVYRDIVGSAYYV 249
H G +HRD+K N LL E+ +K DFG+S + +G KV + VG+ ++
Sbjct: 117 YLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173
Query: 250 APEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD---IDFESAP 304
APEV+ Y + DIWS G+ L +G P+ + LQ D ++ A
Sbjct: 174 APEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLE-TGAD 232
Query: 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
+ S S + ++ L +DP KR T+ ++L+H +
Sbjct: 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 7e-36
Identities = 83/268 (30%), Positives = 137/268 (51%), Gaps = 25/268 (9%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
ELG G GV TG+ A K+I R + + + I RE+ I+ P IV
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHK-CNSPYIVG 63
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRII--AKGHYSERAAASICRSIVN-VVHICHFMGV 201
F GA+ + + + ME GG L D+I+ +G ER I +++ + ++ +
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI 122
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI----VGSAYYVAPEVLR-R 256
+HRD+KP N L++S+ + +K DFG+S G++ + VG++ Y+APE ++
Sbjct: 123 IHRDVKPSNILVNSRGQ---IKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERIQGN 174
Query: 257 RYGKEIDIWSAGVILYILLSG-VP-PFWAETEKGIFDAILQGDIDFESAPWPT--ISSSA 312
Y + DIWS G+ L L +G P P + GIF+ +LQ ++ P+ S
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE-LLQYIVNEPPPRLPSGKFSPDF 233
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIK 340
+D V L +DP++R + ++LEHP+IK
Sbjct: 234 QDFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 1e-35
Identities = 86/276 (31%), Positives = 147/276 (53%), Gaps = 27/276 (9%)
Query: 85 KELGRGQFGVTYLCTENS---TGRQFACKSISKRKLVTKNDKDDIKR-EIQIMQHLSGQP 140
K LG G +G +L + S +G+ +A K + K +V K + R E Q+++H+ P
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
+V A++ +H++++ GGELF + + + E+ IV + H +G
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG 125
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR--DIVGSAYYVAPEVLR--- 255
+++RD+K EN LL D N + TDFGLS E +V R G+ Y+AP+++R
Sbjct: 126 IIYRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGD 182
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAILQGDIDFESAPWPT-ISS 310
+ K +D WS GV++Y LL+G PF + EK I IL+ + P+P +S+
Sbjct: 183 GGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-----PPYPQEMSA 237
Query: 311 SAKDLVRRMLTQDPKKRITSA-----QVLEHPWIKE 341
AKD+++R+L +DPKKR+ ++ +HP+ ++
Sbjct: 238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 1e-35
Identities = 81/266 (30%), Positives = 149/266 (56%), Gaps = 23/266 (8%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
++G G G+ + E +GRQ A K + RK + ++ + E+ IM+ Q N+VE
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQ-NVVEM 83
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRD 205
+Y + + V+ME GG L D I+++ +E A++C S++ + H GV+HRD
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRD 142
Query: 206 LKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR-DIVGSAYYVAPEVLRRR-YGKEID 263
+K ++ LL+ + +K +DFG I + R +VG+ Y++APEV+ R YG E+D
Sbjct: 143 IKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199
Query: 264 IWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK------DLVR 317
IWS G+++ ++ G PP+++++ +Q +P P + ++ K D +
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSP-------VQAMKRLRDSPPPKLKNAHKISPVLRDFLE 252
Query: 318 RMLTQDPKKRITSAQVLEHPWIKEGG 343
RMLT++P++R T+ ++L+HP++ + G
Sbjct: 253 RMLTREPQERATAQELLDHPFLLQTG 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 89/296 (30%), Positives = 141/296 (47%), Gaps = 49/296 (16%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR---EIQIMQHLSGQPN 141
K LG+G G +L TG+ FA K + K K + K +K +KR E +I+ L P
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDK-KEMIKRNK--VKRVLTEQEILATLD-HPF 62
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFD--RIIAKGHYSERAAASICRSIVNVVHICHFM 199
+ +++ + + +VM+ C GGELF + SE A ++ + H +
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL 122
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLS----------------------------- 230
G+++RDLKPEN LL E+ + +DF LS
Sbjct: 123 GIVYRDLKPENILLH---ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 231 VFIEE-GKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKG 288
F EE VG+ Y+APEV+ +G +D W+ G++LY +L G PF
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239
Query: 289 IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITS----AQVLEHPWIK 340
F IL+ ++ F P +SSSA+DL+R++L +DP KR+ S A++ +HP+ +
Sbjct: 240 TFSNILKKEVTF--PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 7e-35
Identities = 78/266 (29%), Positives = 135/266 (50%), Gaps = 15/266 (5%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
+ +G+G FG Y + T + A K I + +++ +DI++EIQ + P I +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCR-SPYITK 63
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+ G++ + ++ME C GG D ++ G E A I R ++ + H G +HR
Sbjct: 64 YYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHEEGKIHR 122
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRR-RYGKEI 262
D+K N LLS E +K DFG+S + R+ VG+ +++APEV+++ Y ++
Sbjct: 123 DIKAANILLS---EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKA 179
Query: 263 DIWSAGVILYILLSGVPPFWAETE--KGIFDAILQGDIDFESAPWPTISSSAKDLVRRML 320
DIWS G+ L G PP ++ + +F I + + S S KD V L
Sbjct: 180 DIWSLGITAIELAKGEPPL-SDLHPMRVLF-LIPKNNPP--SLEGNKFSKPFKDFVSLCL 235
Query: 321 TQDPKKRITSAQVLEHPWIKEGGEAS 346
+DPK+R ++ ++L+H +IK+ + S
Sbjct: 236 NKDPKERPSAKELLKHKFIKKAKKTS 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 1e-34
Identities = 82/268 (30%), Positives = 144/268 (53%), Gaps = 13/268 (4%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH 135
D K Y+ +++G+G G Y + +TG++ A K ++ L + K+ I EI +M+
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMRE 72
Query: 136 LSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI 195
PNIV + +Y + VVME AGG L D ++ + E A++CR + +
Sbjct: 73 NK-HPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 130
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVL 254
H V+HRD+K +N LL + +K TDFG I + R +VG+ Y++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 255 -RRRYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPWPTISSSA 312
R+ YG ++DIWS G++ ++ G PP+ E + ++ G + ++ +S+
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIF 245
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIK 340
+D + R L D +KR ++ ++L+HP++K
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 84/259 (32%), Positives = 139/259 (53%), Gaps = 15/259 (5%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG+G FG L E +TGR +A K + K ++ K++ E +++Q+ + P +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 59
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
K A++ + VME GGELF + + ++E A IV+ + H V++R
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 205 DLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEI 262
D+K EN +L D++ +K TDFGL I +G + G+ Y+APEVL YG+ +
Sbjct: 120 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 263 DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322
D W GV++Y ++ G PF+ + + +F+ IL +I F T+S AK L+ +L +
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 232
Query: 323 DPKKRI-----TSAQVLEH 336
DPK+R+ + +V+EH
Sbjct: 233 DPKQRLGGGPSDAKEVMEH 251
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 2e-34
Identities = 84/266 (31%), Positives = 139/266 (52%), Gaps = 20/266 (7%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG+G FG C +TG+ +ACK + K+++ + + E QI++ ++ Q +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ-FVVNLA 66
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGH---YSERA---AASICRSIVNVVHICHFMG 200
AYE K ++ +V+ + GG+L I G+ ERA AA I + ++ H
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL----HREN 122
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRYG 259
++RDLKPEN LL D+ ++ +D GL+V I EG+ R VG+ Y+APEVL +RY
Sbjct: 123 TVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYT 179
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRM 319
D W G ++Y ++ G PF EK + + + ++ E S AK + + +
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239
Query: 320 LTQDPKKRI-----TSAQVLEHPWIK 340
LT+DPK+R+ + +V HP+ +
Sbjct: 240 LTKDPKQRLGCQEEGAGEVKRHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 3e-34
Identities = 80/261 (30%), Positives = 132/261 (50%), Gaps = 12/261 (4%)
Query: 84 GKELGRGQFGVTYLCTENSTGRQFACK--SISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
G+ LG G FG Y G FA K S++ + +++EI ++ L PN
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPN 63
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGV 201
IV++ G ++ ++++ +EL GG L + G + E R I+ + H
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR--YG 259
+HRD+K N L+ D N ++K DFG++ + E + GS Y++APEV+ ++ YG
Sbjct: 124 VHRDIKGANILV---DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP-TISSSAKDLVRR 318
DIWS G + + +G PP W++ E A+ + E P P +S AKD + +
Sbjct: 181 LAADIWSLGCTVLEMATGKPP-WSQLEG--VAAVFKIGRSKELPPIPDHLSDEAKDFILK 237
Query: 319 MLTQDPKKRITSAQVLEHPWI 339
L +DP R T+A++LEHP++
Sbjct: 238 CLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-34
Identities = 84/296 (28%), Positives = 131/296 (44%), Gaps = 49/296 (16%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHL 136
Y +G G +GV C +TG A K K D +D+K RE+++++ L
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIK-----KFKESEDDEDVKKTALREVKVLRQL 57
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGG--ELFDRIIAKGHYSERAAASICRSIVNVVH 194
NIV K A+ K +++V E EL + + G A S ++ +
Sbjct: 58 R-HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIA 114
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK--VYRDIVGSAYYVAPE 252
CH ++HRD+KPEN L+S E+ +LK DFG + + D V + +Y APE
Sbjct: 115 YCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171
Query: 253 VL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETE--------KGIFDAILQGDIDFES 302
+L YGK +D+W+ G I+ LL G P F +++ K + F S
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231
Query: 303 AP------WPTI--------------SSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
P +P SS A D ++ L DPK+R+T ++L+HP+
Sbjct: 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 6e-34
Identities = 89/291 (30%), Positives = 151/291 (51%), Gaps = 14/291 (4%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH 135
D K Y+ +++G+G G + + +TG++ A K I+ +K + K+ I EI +M+
Sbjct: 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKE 72
Query: 136 LSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI 195
L PNIV F ++ + VVME AGG L D ++ + E A++CR + +
Sbjct: 73 LK-NPNIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEF 130
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVL 254
H V+HRD+K +N LL +K TDFG I + R +VG+ Y++APEV+
Sbjct: 131 LHANQVIHRDIKSDNVLLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 255 RRR-YGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPWPTISSSA 312
R+ YG ++DIWS G++ ++ G PP+ E + ++ G + ++ +S
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSPIF 245
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASD-KPIDSAVLSRMKQFR 362
+D + R L D +KR ++ ++L+HP++K S P+ A MK R
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPLILAAKEAMKSNR 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 77/268 (28%), Positives = 130/268 (48%), Gaps = 22/268 (8%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG+G FG L T +A K + K ++ +D + E +++ P + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
++ K + VME GG+L I G + E A IV + H G+++R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD----IVGSAYYVAPEVLR-RRYG 259
DLK +N LL D +K DFG+ +EG + G+ Y+APE+L + YG
Sbjct: 121 DLKLDNVLL---DSEGHIKIADFGMC---KEGILGGVTTSTFCGTPDYIAPEILSYQPYG 174
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-ISSSAKDLVRR 318
+D W+ GV+LY +L+G PF + E +F +IL+ ++ + P +S AK +++
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRY-----PRWLSKEAKSILKS 229
Query: 319 MLTQDPKKRITS-----AQVLEHPWIKE 341
LT++P+KR+ + HP+ +E
Sbjct: 230 FLTKNPEKRLGCLPTGEQDIKGHPFFRE 257
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 3e-33
Identities = 82/272 (30%), Positives = 139/272 (51%), Gaps = 21/272 (7%)
Query: 74 YEDVKLHYSFGKELGRGQFGVTYLCT-ENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
YED ++F + LG G FG L T +N A K K K++ + D + E +I
Sbjct: 29 YED----FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKI 84
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNV 192
+ +++ P V G+++D+ +++V+E GGE F + + IV +
Sbjct: 85 LNYIN-HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI 143
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPE 252
+ +++RDLKPEN LL D++ +K TDFG + ++ + Y + G+ Y+APE
Sbjct: 144 FEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDT-RTY-TLCGTPEYIAPE 198
Query: 253 VLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311
+L +GK D W+ G+ +Y +L G PPF+A I+ IL+G I F + ++
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNN 254
Query: 312 AKDLVRRMLTQDPKKRITSAQ-----VLEHPW 338
K L++++L+ D KR + + V EHPW
Sbjct: 255 CKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286
|
Length = 340 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 4e-33
Identities = 84/247 (34%), Positives = 134/247 (54%), Gaps = 11/247 (4%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG+G FG L E +TGR +A K + K +V K++ E +++Q+ S P +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 59
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMH 203
K +++ + VME GGELF + + +SE A IV+ + H V++
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 204 RDLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKE 261
RDLK EN +L D++ +K TDFGL I++G + G+ Y+APEVL YG+
Sbjct: 120 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 176
Query: 262 IDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321
+D W GV++Y ++ G PF+ + + +F+ IL +I F T+S AK L+ +L
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLSGLLK 232
Query: 322 QDPKKRI 328
+DPK+R+
Sbjct: 233 KDPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 4e-33
Identities = 83/279 (29%), Positives = 149/279 (53%), Gaps = 17/279 (6%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
++G G G+ + TE TG+Q A K + RK + ++ + E+ IM+ N+V+
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYH-HENVVDM 84
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRD 205
+Y + VVME GG L D I+ +E A++C S++ + H GV+HRD
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143
Query: 206 LKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDIVGSAYYVAPEVLRR-RYGKEID 263
+K ++ LL+S + +K +DFG + +E + +VG+ Y++APEV+ R YG E+D
Sbjct: 144 IKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200
Query: 264 IWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQD 323
IWS G+++ ++ G PP++ E I + ++ +SS + + ML ++
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-RDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259
Query: 324 PKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFR 362
P +R T+ ++L+HP++K G S ++ M+Q+R
Sbjct: 260 PSQRATAQELLQHPFLKLAGPP------SCIVPLMRQYR 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 4e-33
Identities = 78/246 (31%), Positives = 132/246 (53%), Gaps = 10/246 (4%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG+G FG L E ++G+ +A K + K ++ K++ E +++++ + P +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTS 59
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
K +++ K + VME GGELF + + +SE IV+ + H +++R
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119
Query: 205 DLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEI 262
DLK EN +L D++ +K TDFGL I + + G+ Y+APEVL YG+ +
Sbjct: 120 DLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 263 DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322
D W GV++Y ++ G PF+ + + +F+ IL DI F T+S+ AK L+ +L +
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLLIK 232
Query: 323 DPKKRI 328
DP KR+
Sbjct: 233 DPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-33
Identities = 81/279 (29%), Positives = 151/279 (54%), Gaps = 17/279 (6%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
++G G G+ + T S+G+ A K + RK + ++ + E+ IM+ + N+VE
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHE-NVVEM 82
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRD 205
+Y + VVME GG L D I+ +E A++C +++ + + H GV+HRD
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141
Query: 206 LKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDIVGSAYYVAPEVLRR-RYGKEID 263
+K ++ LL+ + +K +DFG + +E + +VG+ Y++APE++ R YG E+D
Sbjct: 142 IKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198
Query: 264 IWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQD 323
IWS G+++ ++ G PP++ E I + ++ + +S S K + R+L +D
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-RDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257
Query: 324 PKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFR 362
P +R T+A++L+HP++ + G S ++ M+Q R
Sbjct: 258 PAQRATAAELLKHPFLAKAGPP------SCIVPLMRQNR 290
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 7e-33
Identities = 82/272 (30%), Positives = 133/272 (48%), Gaps = 24/272 (8%)
Query: 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS 137
+ Y + +G G +G Y + +TG A K I KL +D + I++EI +++
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECR 58
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI-IAKGHYSERAAASICRSIVNVVHIC 196
PNIV + G+Y + + +VME C GG L D + +G SE A +CR + +
Sbjct: 59 -HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL 117
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVL- 254
H G +HRD+K N LL+ + +K DFG+S + R +G+ Y++APEV
Sbjct: 118 HETGKIHRDIKGANILLTEDGD---VKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 255 ---RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311
+ Y + DIW+ G+ L PP + + A+ I + P P +
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMF---DLHPMRALFL--ISKSNFPPPKLKDK 229
Query: 312 AK------DLVRRMLTQDPKKRITSAQVLEHP 337
K D +++ LT+DPKKR T+ ++L+HP
Sbjct: 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 9e-33
Identities = 80/263 (30%), Positives = 128/263 (48%), Gaps = 15/263 (5%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG+G FG L +GR +A K + K ++ +D + E +I+ P + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL 206
++ + VME GG+L I + E A I + + H G+++RDL
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122
Query: 207 KPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDI 264
K +N LL D K DFG+ I GK G+ Y+APE+L+ YG +D
Sbjct: 123 KLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179
Query: 265 WSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDP 324
W+ GV+LY +L G PF AE E +F+AIL ++ + + W +S A D+++ +T++P
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--W--LSQDAVDILKAFMTKNP 235
Query: 325 KKRITS------AQVLEHPWIKE 341
R+ S +L HP+ KE
Sbjct: 236 TMRLGSLTLGGEEAILRHPFFKE 258
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 79/286 (27%), Positives = 130/286 (45%), Gaps = 45/286 (15%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ + +G G +G Y TG+ A K + + ++++++IK E I++ S P
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYSNHP 63
Query: 141 NIVEFKGAYEDKQSVH--------VVMELCAGG---ELFDRIIAKGH-YSERAAASICRS 188
NI F GA+ + +VMELC GG +L + KG E A I R
Sbjct: 64 NIATFYGAF--IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 189 IVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAY 247
+ + H V+HRD+K +N LL+ +NA +K DFG+S ++ R+ +G+ Y
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY 178
Query: 248 YVAPEV------LRRRYGKEIDIWSAGVILYILLSGVPPFWAETE--KGIFDAILQGDID 299
++APEV Y D+WS G+ L G PP + + +F I +
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL-CDMHPMRALF-KIPRN--- 233
Query: 300 FESAPWPTISSSAK------DLVRRMLTQDPKKRITSAQVLEHPWI 339
P PT+ S D + L ++ ++R ++LEHP+I
Sbjct: 234 ----PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 75/259 (28%), Positives = 130/259 (50%), Gaps = 16/259 (6%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K+LG+G +G Y S + +A K + + ++ +++D EI+I+ ++ PNI+
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVN-HPNIIS 63
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGH-----YSERAAASICRSIVNVVHICHFM 199
+K A+ D + +VME G+L + I+K E+ I ++ + H
Sbjct: 64 YKEAFLDGNKLCIVMEYAPFGDLS-KAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ 122
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-Y 258
++HRDLK N LL + N L+K D G+S +++ I G+ +Y+APEV + R Y
Sbjct: 123 KILHRDLKSANILLVA---NDLVKIGDLGISKVLKKNMAKTQI-GTPHYMAPEVWKGRPY 178
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
+ DIWS G +LY + + PPF A + + + + +G + P P S ++ +R
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG--KYPPIP-PIYSQDLQNFIRS 235
Query: 319 MLTQDPKKRITSAQVLEHP 337
ML PK R ++L P
Sbjct: 236 MLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 80/262 (30%), Positives = 128/262 (48%), Gaps = 12/262 (4%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
HY + LG+G FG L K ++ +L K ++ D EI I+ L
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK-ERRDALNEIVILSLLQ-H 58
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRII--AKGHYSERAAASICRSIVNVVHICH 197
PNI+ + + D ++ + ME GG L+D+I+ + E IV+ V H
Sbjct: 59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLR- 255
G++HRD+K N L+ L+K DFG+S + E + +VG+ YY++PE+ +
Sbjct: 119 KAGILHRDIKTLNIFLTKAG---LIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG 175
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315
+Y + DIW+ G +LY LL+ F A + I+QG+ + + SS L
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELISL 232
Query: 316 VRRMLTQDPKKRITSAQVLEHP 337
V +L QDP+KR T+ +VL+ P
Sbjct: 233 VHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 79/262 (30%), Positives = 138/262 (52%), Gaps = 19/262 (7%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK-DDIKREIQIMQHL--SGQPNIV 143
+GRG +G Y TGR A K I+ L T +D DI+RE+ ++ L S PNI
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIIN---LDTPDDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 144 EFKGAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVM 202
++ G+Y + ++ME GG + R + K G +E+ + I R ++ + H +GV+
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVI 123
Query: 203 HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLR--RRYG 259
HRD+K N L+++ +K DFG++ + + R VG+ Y++APEV+ + Y
Sbjct: 124 HRDIKAANILVTNTGN---VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYD 180
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI-LQGDIDFESAPWPTISSSAKDLVRR 318
+ DIWS G+ +Y + +G PP+ ++ + F A+ L S ++ V
Sbjct: 181 TKADIWSLGITIYEMATGNPPY-SDVDA--FRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237
Query: 319 MLTQDPKKRITSAQVLEHPWIK 340
L ++PK+R+++ ++L+ WIK
Sbjct: 238 CLDEEPKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 5e-32
Identities = 81/268 (30%), Positives = 144/268 (53%), Gaps = 13/268 (4%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH 135
D K Y+ +++G+G G Y + +TG++ A K ++ L + K+ I EI +M+
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRE 72
Query: 136 LSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI 195
+ PNIV + +Y + VVME AGG L D ++ + E A++CR + +
Sbjct: 73 -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDF 130
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVL 254
H V+HRD+K +N LL + +K TDFG I + R +VG+ Y++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 255 RRR-YGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPWPTISSSA 312
R+ YG ++DIWS G++ ++ G PP+ E + ++ G + ++ +S+
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP--ERLSAVF 245
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIK 340
+D + R L D +R ++ ++L+HP++K
Sbjct: 246 RDFLNRCLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 6e-32
Identities = 85/269 (31%), Positives = 141/269 (52%), Gaps = 14/269 (5%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y K +GRG FG L S+ + +A K +SK +++ ++D E IM + P
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 103
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
+V+ A++D + +++VME GG+L + +++ E+ A +V + H MG
Sbjct: 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMG 162
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDI-VGSAYYVAPEVLRRR- 257
++HRD+KP+N LL D++ LK DFG + ++E G V D VG+ Y++PEVL+ +
Sbjct: 163 LIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 258 ----YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313
YG+E D WS GV L+ +L G PF+A++ G + I+ IS AK
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAK 279
Query: 314 DLVRRMLTQDPKK--RITSAQVLEHPWIK 340
+L+ LT + R ++ +HP+ K
Sbjct: 280 NLICAFLTDREVRLGRNGVEEIKQHPFFK 308
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 81/268 (30%), Positives = 143/268 (53%), Gaps = 13/268 (4%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH 135
D K Y+ +++G+G G Y + +TG++ A I + L + K+ I EI +M+
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELIINEILVMRE 73
Query: 136 LSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI 195
+ PNIV + +Y + VVME AGG L D ++ + E A++CR + +
Sbjct: 74 -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR-DIVGSAYYVAPEVL 254
H V+HRD+K +N LL + +K TDFG I + R +VG+ Y++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 255 RRR-YGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPWPTISSSA 312
R+ YG ++DIWS G++ ++ G PP+ E + ++ G + ++ +S+
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIF 246
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIK 340
+D + R L D +KR ++ ++L+H ++K
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-31
Identities = 76/248 (30%), Positives = 128/248 (51%), Gaps = 9/248 (3%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +G+G FG L + G+ +A K + K+ ++ K ++ I E ++ P +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++ ++ V++ GGELF + + + E A I + + H + +++R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 205 DLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEI 262
DLKPEN LL S+ L TDFGL IE K G+ Y+APEVLR++ Y + +
Sbjct: 121 DLKPENILLDSQGHVVL---TDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTV 177
Query: 263 DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322
D W G +LY +L G+PPF++ ++D IL + + P IS SA+ L+ +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQK 233
Query: 323 DPKKRITS 330
D KR+ +
Sbjct: 234 DRTKRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 82/267 (30%), Positives = 131/267 (49%), Gaps = 19/267 (7%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+GRG FG + E +TG +A K + K L+ + + E I+ +S P I + +
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILS-ISNSPWIPQLQ 67
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRD 205
A++DK ++++VME GG+L + + + E A +V +H H MG +HRD
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRD 127
Query: 206 LKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDI-VGSAYYVAPEVL-------RR 256
+KPEN L+ D +K DFG + + V + VG+ Y+APEVL +
Sbjct: 128 IKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKG 184
Query: 257 RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL--QGDIDFESAPWPTISSSAKD 314
YG E D WS GVI Y ++ G PF T ++ I+ Q + F P +SS D
Sbjct: 185 TYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED--PKVSSDFLD 242
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWIKE 341
L++ +L K+R+ + HP+ +
Sbjct: 243 LIQSLLC-GQKERLGYEGLCCHPFFSK 268
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 5e-31
Identities = 77/267 (28%), Positives = 134/267 (50%), Gaps = 25/267 (9%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--GQPNIVE 144
LGRG FG L TG +A K++ K ++ +++ + + E +I + + P +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
++ + V VME AGG+L I +SE A +V + H +++R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLM-MHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD----IVGSAYYVAPEVL-RRRYG 259
DLK +N LL D +K DFGL +EG + D G+ ++APEVL Y
Sbjct: 126 DLKLDNLLL---DTEGFVKIADFGLC---KEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP-TISSSAKDLVRR 318
+ +D W GV++Y +L G PF + E+ +FD+I+ ++ +P +S A ++RR
Sbjct: 180 RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-----RYPRFLSREAISIMRR 234
Query: 319 MLTQDPKKRITSAQ-----VLEHPWIK 340
+L ++P++R+ S + V + P+ +
Sbjct: 235 LLRRNPERRLGSGEKDAEDVKKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 6e-31
Identities = 89/270 (32%), Positives = 140/270 (51%), Gaps = 16/270 (5%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y K +GRG FG L ST + +A K +SK +++ ++D E IM + P
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 103
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
+V+ A++D + +++VME GG+L + +++ E+ A +V + H MG
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 162
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDI-VGSAYYVAPEVLRRR- 257
+HRD+KP+N LL D++ LK DFG + + +EG V D VG+ Y++PEVL+ +
Sbjct: 163 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 258 ----YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313
YG+E D WS GV LY +L G PF+A++ G + I+ IS AK
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 279
Query: 314 DLVRRMLTQDPKKRITSAQVLE---HPWIK 340
+L+ LT D + R+ V E H + K
Sbjct: 280 NLICAFLT-DREVRLGRNGVEEIKRHLFFK 308
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 74/267 (27%), Positives = 128/267 (47%), Gaps = 14/267 (5%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
++F LG+G FG L T +A K + K ++ +D + E +++ P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
+ + ++ ++ VME GG+L I G + E A I + H G
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPE-VLRRRY 258
+++RDLK +N +L D +K DFG+ I GK R G+ Y+APE + + Y
Sbjct: 122 IIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY 178
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
GK +D W+ GV+LY +L+G PPF E E +F +I++ ++ + + +S A + +
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS----LSKEAVSICKG 234
Query: 319 MLTQDPKKRITSA-----QVLEHPWIK 340
+LT+ P KR+ + EH + +
Sbjct: 235 LLTKHPAKRLGCGPTGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 82/275 (29%), Positives = 129/275 (46%), Gaps = 22/275 (8%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
ELG G FG Y TG A K I ++ ++ + +D EI I+ PNIV
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSECK-HPNIVGL 67
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICRSIVNVVHICHFMGVMHR 204
AY + + +++E C GG L ++ +E +CR ++ ++ H V+HR
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVL------RRR 257
DLK N LL+ + +K DFG+S + RD +G+ Y++APEV+
Sbjct: 128 DLKAGNILLTLDGD---VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP--WPTISSSAKDL 315
Y + DIWS G+ L L PP + IL+ + P W SSS D
Sbjct: 185 YDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKW---SSSFNDF 241
Query: 316 VRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
++ L +DP R T+A++L+HP++ + +K I
Sbjct: 242 LKSCLVKDPDDRPTAAELLKHPFVSDQS--DNKAI 274
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 82/304 (26%), Positives = 127/304 (41%), Gaps = 64/304 (21%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHL 136
Y E+G G +G Y + +TGR A K K+ ++ I REI +++ L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALK-----KVRVPLSEEGIPLSTLREIALLKQL 55
Query: 137 --SGQPNIVE----FKGAYEDKQ-SVHVVMELC----AGGELFDRIIAKGHYSERAAASI 185
PNIV G D++ + +V E A + G +
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLAT--YLSKCPKPG-LPPETIKDL 112
Query: 186 CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD---- 241
R ++ V H ++HRDLKP+N L++S + +K DFGL+ ++Y
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ---VKIADFGLA------RIYSFEMAL 163
Query: 242 --IVGSAYYVAPEVL-RRRYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAI- 293
+V + +Y APEVL + Y +D+WS G I L P F +E IFD I
Sbjct: 164 TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIG 223
Query: 294 -------------------LQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVL 334
F+S P I DL+++MLT +P KRI++ + L
Sbjct: 224 LPSEEEWPRNVSLPRSSFPSYTPRSFKS-FVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282
Query: 335 EHPW 338
+HP+
Sbjct: 283 QHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 76/258 (29%), Positives = 134/258 (51%), Gaps = 15/258 (5%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+G+G FG + T R +A K+I K +V++++ E ++ ++ P IV K
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLK 59
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE-RAAASICRSIVNVVHICHFMGVMHRD 205
+++ + +++V+ GGELF + +G + RA + + ++ H V++RD
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENL-HKFNVIYRD 118
Query: 206 LKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEID 263
LKPEN LL + AL DFGL + +++ G+ Y+APE+L Y K +D
Sbjct: 119 LKPENILLDYQGHIAL---CDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVD 175
Query: 264 IWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQD 323
W+ GV+LY +L+G+PPF+ E ++ ILQ + F AKDL+ +L++D
Sbjct: 176 WWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG----FDRDAKDLLIGLLSRD 231
Query: 324 PKKRITSA---QVLEHPW 338
P +R+ ++ HP+
Sbjct: 232 PTRRLGYNGAQEIKNHPF 249
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-30
Identities = 80/266 (30%), Positives = 137/266 (51%), Gaps = 20/266 (7%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG+G FG C +TG+ +ACK + K+++ + + E QI++ ++ +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLA 66
Query: 147 GAYEDKQSVHVVMELCAGGEL---FDRIIAKGHYSERA---AASICRSIVNVVHICHFMG 200
AYE K ++ +V+ L GG+L + G ERA AA I + ++ H
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL----HRER 122
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRYG 259
+++RDLKPEN LL D+ ++ +D GL+V I EG+ R VG+ Y+APEV++ RY
Sbjct: 123 IVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYT 179
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRM 319
D W G ++Y ++ G PF EK + + + + + S +A+ + R++
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL 239
Query: 320 LTQDPKKRI-----TSAQVLEHPWIK 340
LT+DP R+ + +V HP+ +
Sbjct: 240 LTKDPGFRLGCRGEGAEEVKAHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 76/266 (28%), Positives = 127/266 (47%), Gaps = 16/266 (6%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG+G FG L T +A K + K ++ +D D E +I+ + P +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
++ K + VME GG+L +I + E + + + H GV++R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 205 DLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEI 262
DLK +N LL D K DFG+ I G G+ Y+APE+L+ YG +
Sbjct: 121 DLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV 177
Query: 263 DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322
D W+ GV++Y +++G PPF A+ E +F++IL D+ + W +S A +++ +T+
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV--W--LSKEAVSILKAFMTK 233
Query: 323 DPKKRI-------TSAQVLEHPWIKE 341
+P KR+ + +HP+ KE
Sbjct: 234 NPNKRLGCVASQGGEDAIKQHPFFKE 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 80/302 (26%), Positives = 141/302 (46%), Gaps = 54/302 (17%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +GRG FG L + TG +A K + K +++ K ++ E I+ + P +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE-ADNPWVVK 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++D+ ++++ME GG++ ++ K ++E + + H +G +HR
Sbjct: 66 LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHR 125
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGS---------------- 245
D+KP+N LL D +K +DFGL +++ YR + +
Sbjct: 126 DIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 246 -------------AY-------YVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAE 284
AY Y+APEV L+ Y KE D WS GVI+Y +L G PPF ++
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSD 242
Query: 285 TEKGIFDAILQGDIDFESAPWPT---ISSSAKDLVRRMLTQDPKKRITSAQVLE---HPW 338
+ + I+ E+ +P +S AKDL++R+ + ++R+ + V E HP+
Sbjct: 243 NPQETYRKIINWK---ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298
Query: 339 IK 340
K
Sbjct: 299 FK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 7e-30
Identities = 79/304 (25%), Positives = 132/304 (43%), Gaps = 53/304 (17%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +G G FG L + T +A K++ K ++ +N +K E I+ + +V+
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE-ADNEWVVK 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++DK +++ VM+ GG++ +I G + E A + + H MG +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHR 125
Query: 205 DLKPENFLLSSKDENALLKATDFGL---------SVFIEEGKVYR--------------- 240
D+KP+N L+ D + +K TDFGL S + ++G +R
Sbjct: 126 DIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 241 --------------------DIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVP 279
+VG+ Y+APEVL R Y + D WS GVILY +L G P
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 280 PFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITS---AQVLEH 336
PF A+T ++ + +S A DL+ R+ + R+ ++ H
Sbjct: 243 PFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAH 301
Query: 337 PWIK 340
P+ K
Sbjct: 302 PFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-30
Identities = 80/274 (29%), Positives = 141/274 (51%), Gaps = 23/274 (8%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
HY + LG+G FG C +TG+ +ACK + K+++ + + E +I++ ++ +
Sbjct: 4 HY---RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY---SERA---AASICRSIVNVV 193
+V AYE K ++ +V+ + GG+L I G+ +RA AA +C + ++
Sbjct: 61 -FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL- 118
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV 253
+++RDLKPEN LL D+ ++ +D GL+V I EG+ R VG+ Y+APEV
Sbjct: 119 ---QRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEV 172
Query: 254 LR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312
+ +Y D W G ++Y ++ G PF E+ + + + + + S A
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDA 232
Query: 313 KDLVRRMLTQDPKKRI-----TSAQVLEHPWIKE 341
K + R +LT++PK+R+ +A V +HP K
Sbjct: 233 KSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 81/262 (30%), Positives = 134/262 (51%), Gaps = 12/262 (4%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG+G FG C +TG+ +ACK + K++L + + E +I++ +S IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLA 59
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMGVMHR 204
A+E K + +VM L GG+L I G + E A I+ + H +++R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEID 263
DLKPEN LL D++ ++ +D GL+V ++ GK + G+ Y+APEVL+ Y +D
Sbjct: 120 DLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVD 176
Query: 264 IWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQD 323
++ G LY +++G PF EK + + + ++ S AKDL +L +D
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236
Query: 324 PKKRI-----TSAQVLEHPWIK 340
P+KR+ ++ +V EHP K
Sbjct: 237 PEKRLGCRGGSADEVREHPLFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 72/246 (29%), Positives = 125/246 (50%), Gaps = 9/246 (3%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +G+G FG L + + +A K + K+ ++ K ++ I E ++ P +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++ ++ V++ GGELF + + + E A I + + H + +++R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 205 DLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEI 262
DLKPEN LL S+ L TDFGL IE G+ Y+APEVL ++ Y + +
Sbjct: 121 DLKPENILLDSQGHIVL---TDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTV 177
Query: 263 DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322
D W G +LY +L G+PPF++ ++D IL + + P I++SA+ L+ +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQK 233
Query: 323 DPKKRI 328
D KR+
Sbjct: 234 DRTKRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 78/263 (29%), Positives = 137/263 (52%), Gaps = 12/263 (4%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG+G FG C +TG+ +ACK + K+++ + + E QI++ ++ + +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR-FVVSLA 66
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMGVMHR 204
AYE K ++ +V+ L GG+L I G + E A I + H +++R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYR 126
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEID 263
DLKPEN LL D++ ++ +D GL+V + EG+ + VG+ Y+APEV++ RY D
Sbjct: 127 DLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 183
Query: 264 IWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQD 323
W+ G +LY +++G PF +K + + + + + S A+ L + +L +D
Sbjct: 184 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKD 243
Query: 324 PKKRI-----TSAQVLEHPWIKE 341
PK+R+ + +V EHP K+
Sbjct: 244 PKERLGCQGGGAREVKEHPLFKQ 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 86/275 (31%), Positives = 134/275 (48%), Gaps = 26/275 (9%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
ELG+G +G Y TG A K I R + ++ + I E+ I+ H + P IV+F
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEI--RLELDESKFNQIIMELDIL-HKAVSPYIVDF 64
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN-VVHICHFM----G 200
GA+ + +V++ ME G L D++ A G +E + R I VV F+
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR---- 256
++HRD+KP N L++ + +K DFG+S + +I G Y+APE ++
Sbjct: 124 IIHRDVKPTNVLVNGNGQ---VKLCDFGVSGNLVASLAKTNI-GCQSYMAPERIKSGGPN 179
Query: 257 ---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIF---DAILQGDIDFESAPWPTISS 310
Y + D+WS G+ + + G P+ ET IF AI+ GD + P S
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP--PTLP-SGYSD 236
Query: 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEA 345
A+D V + L + P +R T AQ+LEHPW+ + A
Sbjct: 237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 87/296 (29%), Positives = 139/296 (46%), Gaps = 45/296 (15%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +GRG FG L + TG +A K + K ++ K I+ E I+ G +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW-VVK 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++DK++++++ME GG++ ++ K SE A V + H +G +HR
Sbjct: 66 MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHR 125
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEG---KVYRDI------------------- 242
D+KP+N LL +K +K +DFGL +++ + YR++
Sbjct: 126 DIKPDNLLLDAKGH---VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 243 --------------VGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAETEK 287
VG+ Y+APEV ++ Y K D WS GVI+Y +L G PPF +ET +
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 288 GIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE---HPWIK 340
+ ++ P IS AKDL+ R T D + RI S V E HP+ +
Sbjct: 243 ETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFE 297
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 69/273 (25%), Positives = 125/273 (45%), Gaps = 37/273 (13%)
Query: 82 SFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS 137
+ GK+LG G FG Y T + + A K++ + ++ ++ RE +IM+ L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA--SEQQIEEFLREARIMRKLD 59
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY--SERAAASICRSIVNVVHI 195
PNIV+ G +++ + +VME GG+L D + S S + I
Sbjct: 60 -HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFA------LQI 112
Query: 196 C------HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA--Y 247
+HRDL N L+ EN ++K +DFGLS + + Y+ G
Sbjct: 113 ARGMEYLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR 169
Query: 248 YVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305
++APE L+ ++ + D+WS GV+L+ + + G P+ + + + + +G
Sbjct: 170 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRL------ 223
Query: 306 PTISSSAKDLVRRMLT---QDPKKRITSAQVLE 335
P + +L + ML +DP+ R T ++++E
Sbjct: 224 PKPPNCPPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 67/272 (24%), Positives = 122/272 (44%), Gaps = 36/272 (13%)
Query: 82 SFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS 137
+ GK+LG G FG Y + A K++ + ++ ++ RE +IM+ L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA--SEQQIEEFLREARIMRKLD 59
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY-SERAAASICRSIVNVVHIC 196
PN+V+ G +++ +++VME GG+L + S S + I
Sbjct: 60 -HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFA------LQIA 112
Query: 197 ------HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA--YY 248
+HRDL N L+ EN ++K +DFGLS + + YR G +
Sbjct: 113 RGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRW 169
Query: 249 VAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWP 306
+APE L+ ++ + D+WS GV+L+ + + G P+ + + + + + G P
Sbjct: 170 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYR------LP 223
Query: 307 TISSSAKDLVRRMLT---QDPKKRITSAQVLE 335
+ +L ML +DP+ R T ++++E
Sbjct: 224 QPPNCPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-29
Identities = 71/267 (26%), Positives = 143/267 (53%), Gaps = 20/267 (7%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y K++G G FG L G+Q+ K I+ K+ K ++++ ++E+ ++ ++ P
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMK-HP 59
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KG-HYSERAAAS----ICRSIVNVVH 194
NIV+++ ++E+ ++++VM+ C GG+L+ +I A +G + E IC ++ +V
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHV-- 117
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEV 253
H ++HRD+K +N L+ ++ +K DFG++ V ++ R +G+ YY++PE+
Sbjct: 118 --HDRKILHRDIKSQNIFLT---KDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI 172
Query: 254 LRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312
R Y + DIW+ G +LY + + F A K + I++G + S
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--SYPPVS-SHYSYDL 229
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWI 339
++LV ++ ++P+ R + +LE +I
Sbjct: 230 RNLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 78/270 (28%), Positives = 138/270 (51%), Gaps = 18/270 (6%)
Query: 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS--KRKLVTKNDKDDIKREIQIMQHL 136
+++ GK LG+G FG YLC + TGR+ A K + T + ++ EIQ++++L
Sbjct: 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 137 SGQPNIVEFKGAYEDK--QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
+ IV++ G D+ +++ + ME GG + D++ A G +E R I+ +
Sbjct: 62 QHE-RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS 120
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE----EGKVYRDIVGSAYYVA 250
H ++HRD+K N L +D +K DFG S ++ G R + G+ Y+++
Sbjct: 121 YLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 251 PEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-I 308
PEV+ YG++ D+WS G + +L+ PP WAE E AI + + P+ I
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPP-WAEYEA--MAAIFKIATQPTNPQLPSHI 234
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
S A+D + + + + R ++ ++L HP+
Sbjct: 235 SEHARDFLGCIFVE-ARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 86/279 (30%), Positives = 130/279 (46%), Gaps = 42/279 (15%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND--KDDIKREIQIMQHLSGQPNIVE 144
LG G G C +TG FA K+I N + I RE++I + P IV+
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTI----TTDPNPDLQKQILRELEINKSCK-SPYIVK 63
Query: 145 FKGAYEDKQS--VHVVMELCAGGELFDRIIAK-----GHYSERAAASICRSIVNVVHICH 197
+ GA+ D+ S + + ME C GG L D I K G E+ I S++ + H
Sbjct: 64 YYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLR- 255
++HRD+KP N LL+ K + +K DFG+S + + G+++Y+APE ++
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQ---VKLCDFGVSGELVN--SLAGTFTGTSFYMAPERIQG 177
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES----APWPTI--- 308
+ Y D+WS G+ L + PF E E + G I+ S P P +
Sbjct: 178 KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL------GPIELLSYIVNMPNPELKDE 231
Query: 309 -------SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
S KD +++ L +DP +R T +LEHPWIK
Sbjct: 232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 91/319 (28%), Positives = 144/319 (45%), Gaps = 46/319 (14%)
Query: 69 ILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR 128
I G +E + Y + +G G FG+ + TG+ A K I K K R
Sbjct: 1 IFGTVFE-ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKR-TYR 58
Query: 129 EIQIMQHLSGQPNIVE----FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAAS 184
E+++++HL + NI+ F ED ++ V EL G R++ ++
Sbjct: 59 ELKLLKHLRHE-NIISLSDIFISPLED---IYFVTELL--GTDLHRLLTSRPLEKQFIQY 112
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG 244
I+ + H GV+HRDLKP N L+ +EN LK DFGL+ I++ ++ V
Sbjct: 113 FLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLAR-IQDPQM-TGYVS 167
Query: 245 SAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL-------- 294
+ YY APE++ ++Y E+DIWSAG I +L G P F + F I
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227
Query: 295 --------QGDIDF-------ESAP----WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335
+ + F E P + SA DL+ +ML DP+KRI++A+ L
Sbjct: 228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287
Query: 336 HPWIKEGGEASDKPIDSAV 354
HP++ + +D+P+
Sbjct: 288 HPYLAPYHDPTDEPVAEEK 306
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 79/273 (28%), Positives = 137/273 (50%), Gaps = 24/273 (8%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSI--SKRKLVTKNDKDDIKREIQIMQHLS 137
++ GK LG+G FG YLC + TGR+ A K + T + + ++ EIQ++++L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 138 GQPNIVEFKGAYEDKQ--SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI 195
+ IV++ G D ++ + ME GG + D++ + G +E R I+ V
Sbjct: 63 HE-RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE----EGKVYRDIVGSAYYVAP 251
H ++HRD+K N L +D +K DFG S ++ G + + G+ Y+++P
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 252 EVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETE--KGIFDAILQGDIDFESAPW--P 306
EV+ YG++ DIWS G + +L+ PP WAE E IF Q + P P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPP-WAEFEAMAAIFKIATQ-----PTNPVLPP 232
Query: 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
+S +D ++R+ + K R ++ ++L H ++
Sbjct: 233 HVSDHCRDFLKRIFVE-AKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 70/248 (28%), Positives = 126/248 (50%), Gaps = 9/248 (3%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +G+G FG L S G +A K + K+ ++ K +++ I E ++ P +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++ + ++ V++ GGELF + + + E A + + + H + +++R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 205 DLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEI 262
DLKPEN LL S+ L TDFGL +E + G+ Y+APEVLR+ Y + +
Sbjct: 121 DLKPENILLDSQGHVVL---TDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTV 177
Query: 263 DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322
D W G +LY +L G+PPF++ ++D IL + + +A DL+ +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLHK 233
Query: 323 DPKKRITS 330
D ++R+ +
Sbjct: 234 DQRRRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 84/292 (28%), Positives = 126/292 (43%), Gaps = 48/292 (16%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLSGQPNI 142
+G G +G+ Y + ++G A K K+ N++D I REI ++ +L PNI
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALK-----KVRMDNERDGIPISSLREITLLLNLR-HPNI 68
Query: 143 VEFKGAYEDKQ--SVHVVMELCAG--GELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198
VE K K S+ +VME C L D + +SE + ++ + H
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYLHE 126
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVL--R 255
++HRDLK N LL+ K LK DFGL+ + K V + +Y APE+L
Sbjct: 127 NFIIHRDLKVSNLLLTDK---GCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGC 183
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ-------------------G 296
Y ID+W+ G IL LL+ P ++E D I+Q G
Sbjct: 184 TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243
Query: 297 DIDFESAPW-------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
P+ P +S + L+ +L DPKKR T+ + LE + KE
Sbjct: 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-28
Identities = 75/268 (27%), Positives = 129/268 (48%), Gaps = 19/268 (7%)
Query: 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIM 133
YE +++ +GRG FG+ +LC + + K I ++ TK+++ + E Q++
Sbjct: 2 YEKIRV-------VGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVL 53
Query: 134 QHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVN 191
+ LS PNI+E+ + + +++ +VME GG L + I + + E I+
Sbjct: 54 KLLS-HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILL 112
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAP 251
+H H ++HRDLK +N LL ++K DFG+S + +VG+ Y++P
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKH--KMVVKIGDFGISKILSSKSKAYTVVGTPCYISP 170
Query: 252 EVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-IS 309
E+ + Y ++ DIW+ G +LY L S F A + I+ G AP S
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF----APISDRYS 226
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEHP 337
+ L+ ML DP KR +Q++ P
Sbjct: 227 PDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-28
Identities = 87/275 (31%), Positives = 131/275 (47%), Gaps = 23/275 (8%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P ED +L + +G G +G Y +TG A K I KL D +++EI I
Sbjct: 7 PQEDFELI----QRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEI-I 58
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNV 192
M NIV + G+Y + + + ME C GG L D G SE A + R +
Sbjct: 59 MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQG 118
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR-DIVGSAYYVAP 251
++ H G MHRD+K N LL+ +N +K DFG+S I R +G+ Y++AP
Sbjct: 119 LYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAP 175
Query: 252 EV--LRRR--YGKEIDIWSAGVILYILLSGVPP-FWAETEKGIF---DAILQGDIDFESA 303
EV + R+ Y + DIW+ G+ L PP F + +F + Q +
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKM 235
Query: 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
W S+S V+ LT++PKKR T+ ++L+HP+
Sbjct: 236 KW---SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 73/263 (27%), Positives = 131/263 (49%), Gaps = 19/263 (7%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +G+G FG L G+ +A K + K+ ++ + ++ I E ++ P +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++ + ++ V++ GGELF + + + E A I + + H + +++R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV----GSAYYVAPEVLRRR-YG 259
DLKPEN LL S+ L TDFGL +EG D G+ Y+APEV+R++ Y
Sbjct: 121 DLKPENILLDSQGHVVL---TDFGLC---KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRM 319
+D W G +LY +L G+PPF+ ++D IL + P S +A ++ +
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEEL 230
Query: 320 LTQDPKKRITSA----QVLEHPW 338
L +D ++R+ + ++ EHP+
Sbjct: 231 LEKDRQRRLGAKEDFLEIQEHPF 253
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 77/269 (28%), Positives = 135/269 (50%), Gaps = 36/269 (13%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG+G FG +TG+ +ACK + K++L K+ + E +I++ ++ P IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLA 59
Query: 147 GAYEDKQSVHVVMELCAGGEL-------------FDRIIAKGHYSERAAASICRSIVNVV 193
A+E K + +VM L GG+L +R+I HYS + I +
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVI---HYSAQITCGI-------L 109
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV 253
H+ H M +++RD+KPEN LL D+ + +D GL+V +++GK G+ Y+APE+
Sbjct: 110 HL-HSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEI 165
Query: 254 LRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI----LQGDIDFESAPWPTI 308
L+ Y +D ++ G +Y +++G PF EK + + L+ ++ FE
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ---NF 222
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHP 337
+ +KD+ R L + P+ R+ S + + P
Sbjct: 223 TEESKDICRLFLAKKPEDRLGSREKNDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-28
Identities = 77/266 (28%), Positives = 129/266 (48%), Gaps = 22/266 (8%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG+G FG L T FA K++ K ++ +D + E +++ P +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
++ K+ + VME GG+L I + G + E A I+ + H G+++R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY-----YVAPEVLR-RRY 258
DLK +N LL D++ +K DFG+ + + + S + Y+APE+L+ ++Y
Sbjct: 121 DLKLDNVLL---DKDGHIKIADFGMC----KENMNGEGKASTFCGTPDYIAPEILKGQKY 173
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW--PTISSSAKDLV 316
+ +D WS GV+LY +L G PF E E +FD+IL P IS AKD +
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN------DRPHFPRWISKEAKDCL 227
Query: 317 RRMLTQDPKKRITSA-QVLEHPWIKE 341
++ +DP KR+ + +HP+ +
Sbjct: 228 SKLFERDPTKRLGVDGDIRQHPFFRG 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-28
Identities = 63/255 (24%), Positives = 122/255 (47%), Gaps = 12/255 (4%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+G+G FGV + + R +A K I K+ + ++++ E +++ L I+ +
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-EREEAIDEARVLAKLD-SSYIIRYY 65
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMGVMHR 204
++ DK +++VME G+L + E I+ + H ++HR
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHR 125
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY-RDIVGSAYYVAPEVLRRR-YGKEI 262
D+K N L + D +K D G++ + + + IVG+ YY++PE+ + Y ++
Sbjct: 126 DIKSLNLFLDAYDN---VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKS 182
Query: 263 DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322
D+W+ GV+LY +G PF A + + I++G S + S L+ + LT+
Sbjct: 183 DVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMY---SQQLAQLIDQCLTK 239
Query: 323 DPKKRITSAQVLEHP 337
D ++R + Q+L +P
Sbjct: 240 DYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 9e-28
Identities = 69/250 (27%), Positives = 125/250 (50%), Gaps = 9/250 (3%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
++F LG+G FG L T +A K + K ++ +D + E +++ P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
+ + ++ ++ VME GG+L I G + E A I + H G
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLRRR-Y 258
+++RDLK +N +L S+ +K DFG+ + +G R G+ Y+APE++ + Y
Sbjct: 122 IIYRDLKLDNVMLDSEGH---IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY 178
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
GK +D W+ GV+LY +L+G PPF E E +F +I++ ++ + ++S A + +
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKG 234
Query: 319 MLTQDPKKRI 328
++T+ P KR+
Sbjct: 235 LMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 88/312 (28%), Positives = 129/312 (41%), Gaps = 69/312 (22%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQH 135
+ ++G G +G Y + TG A K K+ N+K+ REI+I++
Sbjct: 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALK-----KVRLDNEKEGFPITAIREIKILRQ 62
Query: 136 LSGQPNIVEFKGAYEDKQSV------------------HVVMELCAGGELFDRIIAKGHY 177
L+ NIV K DKQ H +M L G + H+
Sbjct: 63 LN-HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV--------HF 113
Query: 178 SERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI--EE 235
SE S + ++ ++ CH +HRD+K N LL++K + +K DFGL+ EE
Sbjct: 114 SEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNSEE 170
Query: 236 GKVYRDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI 293
+ Y + V + +Y PE+L RYG ID+WS G IL L + P F A E + I
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230
Query: 294 LQGDIDFESAPWPT--------------------------ISSSAKDLVRRMLTQDPKKR 327
+ A WP I + A DL+ MLT DP KR
Sbjct: 231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKR 290
Query: 328 ITSAQVLEHPWI 339
T+ + L PW+
Sbjct: 291 CTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 69/276 (25%), Positives = 130/276 (47%), Gaps = 29/276 (10%)
Query: 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK-------REIQIMQHL 136
G+ +G+G +G YL +TG A K + + K EI+ ++ L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHIC 196
NIV++ G ++ + + +E GG + + G + E+ ++ +
Sbjct: 66 D-HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-----IVGSAYYVAP 251
H G++HRDLK +N L+ D + + K +DFG+S ++ +Y + + GS +++AP
Sbjct: 125 HSKGILHRDLKADNLLV---DADGICKISDFGISKKSDD--IYDNDQNMSMQGSVFWMAP 179
Query: 252 EVL---RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT- 307
EV+ + Y ++DIWS G ++ + +G P W++ E A+ + + P P
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEE--AIAAMFKLGNKRSAPPIPPD 236
Query: 308 ----ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
+S A D + T +P R T+ ++L+HP+I
Sbjct: 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 80/293 (27%), Positives = 127/293 (43%), Gaps = 47/293 (16%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK-----REIQIMQH 135
Y ++G G F TG+ +A K + K ++ REIQ ++
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCM-------KKHFKSLEQVNNLREIQALRR 53
Query: 136 LSGQPNIVEFKGAYEDKQ--SVHVVMELCAGGELFDRIIAKGHY-SERAAASICRSIVNV 192
LS PNI+ D++ + +V EL L++ I + E+ S ++
Sbjct: 54 LSPHPNILRLIEVLFDRKTGRLALVFEL-MDMNLYELIKGRKRPLPEKRVKSYMYQLLKS 112
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPE 252
+ H G+ HRD+KPEN L+ KD+ +LK DFG I Y + + + +Y APE
Sbjct: 113 LDHMHRNGIFHRDIKPENILI--KDD--ILKLADFGSCRGIYSKPPYTEYISTRWYRAPE 168
Query: 253 VLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFD-------AIL----- 294
L YG ++DIW+ G + + +LS P F E I D +L
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228
Query: 295 --QGDIDFESA-----PW--PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
+ +F S P S+ DL++++L DP +RIT+ Q L HP+
Sbjct: 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 6e-27
Identities = 75/270 (27%), Positives = 131/270 (48%), Gaps = 21/270 (7%)
Query: 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK------DDIKREIQIMQHLS 137
G +G G FG YL S+G A K + + + D + REI +++ L
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH 197
NIV++ G+ D +++ +E GG + + G + E + R I+ ++ H
Sbjct: 65 -HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-------GKVYRDIVGSAYYVA 250
G++HRD+K N L+ +K +K +DFG+S +E + GS +++A
Sbjct: 124 NRGIIHRDIKGANILVDNKGG---IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 251 PEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309
PEV+++ Y ++ DIWS G ++ +L+G PF T+ AI + + IS
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIFKIGENASPEIPSNIS 237
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
S A D + + D KR T+A++L+HP++
Sbjct: 238 SEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-27
Identities = 81/276 (29%), Positives = 140/276 (50%), Gaps = 30/276 (10%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSI--SKRKLVTKNDKDDIKREIQIMQHLS 137
++ GK LGRG FG YLC + TGR+ A K + T + + ++ EIQ++++L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 138 GQPNIVEFKGAYED--KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI 195
IV++ G D ++ + + +E GG + D++ A G +E R I+ V
Sbjct: 63 -HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE----EGKVYRDIVGSAYYVAP 251
H ++HRD+K N L +D +K DFG S I+ G + + G+ Y+++P
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 252 EVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT--- 307
EV+ YG++ D+WS + +L+ PP WAE E AI F+ A PT
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPP-WAEYEA--MAAI------FKIATQPTKPM 229
Query: 308 ----ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
+S + +D ++++ ++ K+R T+ +L HP++
Sbjct: 230 LPDGVSDACRDFLKQIFVEE-KRRPTAEFLLRHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 7e-27
Identities = 70/251 (27%), Positives = 129/251 (51%), Gaps = 11/251 (4%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
++F LG+G FG L T +A K + K ++ +D + E +++ LSG+P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-LSGKP 60
Query: 141 N-IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
+ + ++ ++ VME GG+L +I G + E A I + H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLRRR- 257
G+++RDLK +N +L S+ +K DFG+ + +G + G+ Y+APE++ +
Sbjct: 121 GIIYRDLKLDNVMLDSEGH---IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQP 177
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
YGK +D W+ GV+LY +L+G PF E E +F +I++ ++ + ++S A + +
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICK 233
Query: 318 RMLTQDPKKRI 328
++T+ P KR+
Sbjct: 234 GLMTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 7e-27
Identities = 86/320 (26%), Positives = 135/320 (42%), Gaps = 63/320 (19%)
Query: 80 HYSFGKELGRGQFGVTYLC----TENSTGRQFACKSISK---RKLVTKNDKDDIKREIQI 132
Y KELG+G +G+ +C E S A K I+ +K++ K RE+++
Sbjct: 1 RYELIKELGQGAYGI--VCSARNAETSEEETVAIKKITNVFSKKILAKR----ALRELKL 54
Query: 133 MQHLSGQPNIVE-------FKGAYEDKQSVHVVMELCAGGELFDRIIAKGH-YSERAAAS 184
++H G NI F G + + +++ EL +II G ++ S
Sbjct: 55 LRHFRGHKNITCLYDMDIVFPGNFNE---LYLYEELMEAD--LHQIIRSGQPLTDAHFQS 109
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD--- 241
I+ + H V+HRDLKP N L+++ E LK DFGL+ E
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE---LKICDFGLARGFSENPGENAGFM 166
Query: 242 --IVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ-- 295
V + +Y APE++ + Y K ID+WS G IL LL P F + + ILQ
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL 226
Query: 296 -----------------------GDIDFESAPW--PTISSSAKDLVRRMLTQDPKKRITS 330
+I + P + A DL+ ++L DP KRI+
Sbjct: 227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV 286
Query: 331 AQVLEHPWIKEGGEASDKPI 350
+ LEHP++ + D+P+
Sbjct: 287 EEALEHPYLAIWHDPDDEPV 306
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 83/292 (28%), Positives = 127/292 (43%), Gaps = 56/292 (19%)
Query: 90 GQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK------REIQIMQHLSGQPNIV 143
G +GV Y + TG A K + K +K+ REI I+ L PNIV
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKL-------KMEKEKEGFPITSLREINILLKLQ-HPNIV 67
Query: 144 EFK----GAYEDKQSVHVVMELCAGGELFDRI-IAKGHYSERAAASICRSIVNVVHICHF 198
K G+ DK +++VME +L + K + + + +++ V H
Sbjct: 68 TVKEVVVGSNLDK--IYMVME-YVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD 124
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVL--R 255
++HRDLK N LL+++ LK DFGL+ + K Y +V + +Y APE+L
Sbjct: 125 NWILHRDLKTSNLLLNNRGI---LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA 181
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ-------------------G 296
+ Y ID+WS G I LL+ P F ++E + I +
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241
Query: 297 DIDFESAP-------WPTISSSAK--DLVRRMLTQDPKKRITSAQVLEHPWI 339
F P +P +S S DL+ R+LT DP KRI++ L+HP+
Sbjct: 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 76/271 (28%), Positives = 125/271 (46%), Gaps = 41/271 (15%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +GRG FG L + TG +A K + K ++ K I+ E I+ + +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-ADSLWVVK 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++DK +++++ME GG++ ++ K +E V + H +G +HR
Sbjct: 66 MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHR 125
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEG---KVYRDI------------------- 242
D+KP+N LL SK +K +DFGL +++ + YR++
Sbjct: 126 DIKPDNLLLDSKGH---VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 243 --------------VGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAETEK 287
VG+ Y+APEV ++ Y K D WS GVI+Y +L G PPF +ET +
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 288 GIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
+ ++ P IS AKDL+ R
Sbjct: 243 ETYKKVMNWKETLIFPPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 76/262 (29%), Positives = 127/262 (48%), Gaps = 16/262 (6%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG+G FG L G FA K++ K ++ +D + E +++ P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
++ K+ + VME GG+L I KG + A IV + H G+++R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 205 DLKPENFLLSSKDENALLKATDFGL---SVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGK 260
DLK +N +L D + +K DFG+ +VF + G+ Y+APE+L+ +Y
Sbjct: 121 DLKLDNVML---DRDGHIKIADFGMCKENVFGDNRA--STFCGTPDYIAPEILQGLKYTF 175
Query: 261 EIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP-WPTISSSAKDLVRRM 319
+D WS GV+LY +L G PF + E +F++I D P W I+ +KD++ ++
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV---DTPHYPRW--ITKESKDILEKL 230
Query: 320 LTQDPKKRI-TSAQVLEHPWIK 340
+DP +R+ + HP+ K
Sbjct: 231 FERDPTRRLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-26
Identities = 67/269 (24%), Positives = 129/269 (47%), Gaps = 15/269 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD----IKREIQIMQH 135
+ G++LG G F Y + TG A K ++ + T +++++ +++EI++M
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVR-NTSSEQEEVVEALRKEIRLMAR 59
Query: 136 LSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI 195
L+ P+I+ GA + ++ +E AGG + + G + E + ++ +
Sbjct: 60 LN-HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSY 118
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-----GKVYRDIVGSAYYVA 250
H ++HRD+K N L+ S + L+ DFG + + G+ ++G+ ++A
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 251 PEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-I 308
PEVLR +YG+ D+WS G ++ + + PP+ AE I + + P +
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHP 337
S +D+ R L P+ R S ++L+HP
Sbjct: 237 SPGLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 5e-26
Identities = 78/263 (29%), Positives = 132/263 (50%), Gaps = 23/263 (8%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y+ + +G G FG L ++ +++A K I R + + +D ++E ++ + P
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI--RLPKSSSAVEDSRKEAVLLAKMK-HP 58
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRI-IAKGH-YSERAA----ASICRSIVNVVH 194
NIV FK ++E +++VME C GG+L +I + +G + E +C + V H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMC---LGVQH 115
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR-DIVGSAYYVAPEV 253
I H V+HRD+K +N L+ +N +K DFG + + Y VG+ YYV PE+
Sbjct: 116 I-HEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI 171
Query: 254 LRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-ISSS 311
Y + DIWS G ILY L + PF A + K + + QG P P+ S
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK----PLPSHYSYE 227
Query: 312 AKDLVRRMLTQDPKKRITSAQVL 334
+ L+++M ++P+ R ++ +L
Sbjct: 228 LRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 70/261 (26%), Positives = 130/261 (49%), Gaps = 12/261 (4%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG+G FG +L T + FA K++ K ++ +D + E +++ P +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
++ K+++ VME GG+L I + + A I+ + H G+++R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 205 DLKPENFLLSSKDENALLKATDFGL--SVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKE 261
DLK +N LL D + +K DFG+ + + K G+ Y+APE+L ++Y
Sbjct: 121 DLKLDNILL---DTDGHIKIADFGMCKENMLGDAKT-CTFCGTPDYIAPEILLGQKYNTS 176
Query: 262 IDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321
+D WS GV+LY +L G PF E+ +F +I + + W ++ AKD++ ++
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--W--LTREAKDILVKLFV 232
Query: 322 QDPKKRI-TSAQVLEHPWIKE 341
++P++R+ + +HP+ +E
Sbjct: 233 REPERRLGVKGDIRQHPFFRE 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 72/266 (27%), Positives = 130/266 (48%), Gaps = 20/266 (7%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ K++G+GQF V Y GR A K + +++ + D +EI +++ L P
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HP 62
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN-VVHIC--- 196
N++++ ++ + +++V+EL G+L R+I H+ ++ R+I V +C
Sbjct: 63 NVIKYLASFIENNELNIVLELADAGDL-SRMIK--HFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 197 ---HFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPE 252
H +MHRD+KP N +++ ++K D GL F + +VG+ YY++PE
Sbjct: 120 EHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 253 VLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEK--GIFDAILQGDIDFESAPWPTIS 309
+ Y + DIWS G +LY + + PF+ + + I + D+ P S
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYPPLPADHYS 234
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLE 335
+DLV R + DP+KR + VL+
Sbjct: 235 EELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-25
Identities = 80/265 (30%), Positives = 129/265 (48%), Gaps = 15/265 (5%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y K++G G FG YL S K I K+ K +K+ K+E+ ++ + P
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKMK-HP 59
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRI-IAKG-HYSERAAASICRSI-VNVVHICH 197
NIV F ++++ + +VME C GG+L RI +G +SE S I + + HI H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHI-H 118
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRR 256
++HRD+K +N LS A K DFG++ + ++ VG+ YY++PE+ +
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVA--KLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 257 R-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW-PTISSSAKD 314
R Y + DIWS G +LY L + PF + I QG AP P S +
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF----APISPNFSRDLRS 232
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWI 339
L+ ++ P+ R + +L+ P++
Sbjct: 233 LISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-25
Identities = 72/267 (26%), Positives = 128/267 (47%), Gaps = 16/267 (5%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL--VTKNDKDDIKREIQIMQHLSG 138
Y + LG+G FG YL + + K + + + + N+ +E Q++ L
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD- 60
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSER-AAASICRSIVNV---VH 194
P IV+F ++ ++ + ++ E C G +L ++ H + + +C + + VH
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-KVYRDIVGSAYYVAPEV 253
H ++HRDLK +N L +N LLK DFG+S + + G+ YY++PE
Sbjct: 121 YMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA 176
Query: 254 LRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312
L+ + Y + DIWS G ILY + F + + I++G S P T S
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT--PSLP-ETYSRQL 233
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWI 339
+++ ML +DP R ++A++L +P+I
Sbjct: 234 NSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 92/335 (27%), Positives = 138/335 (41%), Gaps = 88/335 (26%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS--------KRKLVTKNDKDDI 126
DV Y +G G +G+ T TG + A K IS +R L
Sbjct: 1 FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL--------- 51
Query: 127 KREIQIMQHLSGQPNIVEFK-----GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERA 181
REI+I++ + NI+ ++E V++V EL +L+ ++I H S
Sbjct: 52 -REIKILRRFKHE-NIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSND- 106
Query: 182 AASICRSIVNVVHICHFM-------------GVMHRDLKPENFLLSSKDENALLKATDFG 228
HI +F+ V+HRDLKP N LL++ N LK DFG
Sbjct: 107 ------------HIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT---NCDLKICDFG 151
Query: 229 LSVFIEEGKVYR----DIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFW 282
L+ + + + V + +Y APE++ + Y K IDIWS G IL +LS P F
Sbjct: 152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP 211
Query: 283 AETEKGIFDAILQ-----GDIDFES------------------APW----PTISSSAKDL 315
+ + IL D PW P A DL
Sbjct: 212 GKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDL 271
Query: 316 VRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
+ +MLT +P KRIT + L HP++++ + SD+P+
Sbjct: 272 LDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPV 306
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 72/250 (28%), Positives = 134/250 (53%), Gaps = 22/250 (8%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +GRG FG + +TG+ +A K ++K +++ + + + E ++ + + I
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW-ITN 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICR----SIVNVVHICHFMG 200
A++D+ ++++VM+ GG+L +++K + +R + R +V + H +G
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLT-LLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDI-VGSAYYVAPEVLRR-- 256
+HRD+KP+N LL D+N ++ DFG + + +G V ++ VG+ Y++PE+L+
Sbjct: 123 YVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 257 ----RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL--QGDIDFESAPWPTISS 310
RYG E D WS GV +Y +L G PF+AE+ + I+ + F +S
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV-TDVSE 238
Query: 311 SAKDLVRRML 320
AKDL+RR++
Sbjct: 239 EAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 71/267 (26%), Positives = 121/267 (45%), Gaps = 19/267 (7%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQF-ACKSISKRKLVTKNDK-------DDIKREIQI 132
Y+ + LG G FG Y + + G+ A K I+ DK DI E+ I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA----KGHYSERAAASICRS 188
++ PNIV + + + +++VM+L G L + + K ++E +I
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 189 IVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY 247
+V + H ++HRDL P N +L D+ + TDFGL+ + +VG+
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDK---VTITDFGLAKQKQPESKLTSVVGTIL 178
Query: 248 YVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP 306
Y PE+++ YG++ D+W+ G ILY + + PPF++ + I++ +E P
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA--VYEPLPEG 236
Query: 307 TISSSAKDLVRRMLTQDPKKRITSAQV 333
S D++ LT D + R QV
Sbjct: 237 MYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-25
Identities = 70/271 (25%), Positives = 129/271 (47%), Gaps = 25/271 (9%)
Query: 84 GKELGRGQFGVTYLCTENSTGRQFACKSI---SKRKLVTKNDKDDIKREIQIMQHLSGQP 140
G+ LG+G +G Y C + G+ A K + + L + + + ++ E+ +++ L
Sbjct: 5 GEVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HV 62
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
NIV++ G D ++ + ME GG + + G E + I++ V H
Sbjct: 63 NIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFG-------LSVFIEEGKVYRDIVGSAYYVAPEV 253
V+HRD+K N +L N ++K DFG + + + + + G+ Y++APEV
Sbjct: 123 VVHRDIKGNNVMLMP---NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 254 LRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI---- 308
+ YG++ DIWS G ++ + +G PP A ++ A+ I P +
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPP-LASMDR--LAAMFY--IGAHRGLMPRLPDSF 234
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
S++A D V LT+D +R ++ Q+L H ++
Sbjct: 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 73/266 (27%), Positives = 123/266 (46%), Gaps = 27/266 (10%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
+E+G G FG Y + T A K +S + DI +E++ +Q L PN +E
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIE 79
Query: 145 FKGAYEDKQSVHVVMELCAG--GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVM 202
+KG Y + + +VME C G ++ + + K E A+IC + + H +
Sbjct: 80 YKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSHERI 137
Query: 203 HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL----RRRY 258
HRD+K N LL+ E +K DFG + + + VG+ Y++APEV+ +Y
Sbjct: 138 HRDIKAGNILLT---EPGTVKLADFGSASLVSPANSF---VGTPYWMAPEVILAMDEGQY 191
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA-----K 313
++D+WS G+ L PP + I Q D PT+SS+ +
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS-------PTLSSNDWSDYFR 244
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWI 339
+ V L + P+ R +S ++L+H ++
Sbjct: 245 NFVDSCLQKIPQDRPSSEELLKHRFV 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 9e-25
Identities = 89/331 (26%), Positives = 139/331 (41%), Gaps = 82/331 (24%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH 135
DV Y + +G G +GV + +G++ A K I V K + RE++I++H
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-RELKILRH 60
Query: 136 LSGQPNIVE----FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN 191
NI+ + D + V+VVM+L +L I + +E
Sbjct: 61 FK-HDNIIAIRDILRPPGADFKDVYVVMDL-MESDLHHIIHSDQPLTEE----------- 107
Query: 192 VVHICHFM-------------GVMHRDLKPENFLLSSKDENALLKATDFG----LSVFIE 234
HI +F+ V+HRDLKP N L+ +E+ L+ DFG LS
Sbjct: 108 --HIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPT 162
Query: 235 EGKVY-RDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVI-------------------LY 272
E K + + V + +Y APE+L Y ID+WS G I L
Sbjct: 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK 222
Query: 273 ILLS--GVPPFWAETEKGIFDAI--------LQGDIDFESAPW----PTISSSAKDLVRR 318
++LS G P + + + I +Q + PW P S A DL+ +
Sbjct: 223 LILSVLGSPS------EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQ 276
Query: 319 MLTQDPKKRITSAQVLEHPWIKEGGEASDKP 349
ML DP++RIT Q L+HP++ + + D+P
Sbjct: 277 MLQFDPEERITVEQALQHPFLAQYHDPDDEP 307
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 82/298 (27%), Positives = 131/298 (43%), Gaps = 31/298 (10%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
E+G G FG Y T + T A K +S T DI +E++ +Q L PN +E+
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEY 86
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRD 205
KG Y + + +VME C G + K E A+I + + H ++HRD
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 146
Query: 206 LKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL----RRRYGKE 261
+K N LL+ E +K DFG + + VG+ Y++APEV+ +Y +
Sbjct: 147 IKAGNILLT---EPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEGQYDGK 200
Query: 262 IDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI-DFESAPWPTISSSAKDLVRRML 320
+D+WS G+ L PP + I Q D +S W + S + V L
Sbjct: 201 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW---TDSFRGFVDYCL 257
Query: 321 TQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAV--LSRMK---------QFRAMNKL 367
+ P++R SA++L H +++ D+P + + R K Q+R M K+
Sbjct: 258 QKIPQERPASAELLRHDFVRR-----DRPARVLIDLIQRTKDAVRELDNLQYRKMKKI 310
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 85/315 (26%), Positives = 134/315 (42%), Gaps = 57/315 (18%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG G FG L + T +A K++ K+ ++ +N +K E I+ + +V
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW-VVR 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++DK +++ VM+ GG++ +I G + E A + V H MG +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125
Query: 205 DLKPENFLLSSKDENALLKATDFGLSV---FIEEGKVYR--------------------- 240
D+KP+N L+ D + +K TDFGL + + K Y+
Sbjct: 126 DIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 241 ------------------------DIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILL 275
+VG+ Y+APEVL R Y + D WS GVILY +L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 276 SGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335
G PPF A+T ++ P +S A DL+ + L + P+ R+ E
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGADE 301
Query: 336 ---HPWIKEGGEASD 347
HP+ K +SD
Sbjct: 302 IKAHPFFKTIDFSSD 316
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 76/253 (30%), Positives = 128/253 (50%), Gaps = 16/253 (6%)
Query: 85 KELGRGQFGVTYLC---TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
K LG+G FG +L T G+ +A K + K L + D+ K E I+ + P
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR-DRVRTKMERDILAEV-NHPF 59
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGV 201
IV+ A++ + ++++++ GG+LF R+ + ++E + + H +G+
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLS--VFIEEGKVYRDIVGSAYYVAPEVLRRR-Y 258
++RDLKPEN LL DE +K TDFGLS E K Y G+ Y+APEV+ RR +
Sbjct: 120 IYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAY-SFCGTVEYMAPEVVNRRGH 175
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
+ D WS GV+++ +L+G PF + K IL+ + +S A+ L+R
Sbjct: 176 TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRA 231
Query: 319 MLTQDPKKRITSA 331
+ ++P R+ +
Sbjct: 232 LFKRNPANRLGAG 244
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 75/286 (26%), Positives = 131/286 (45%), Gaps = 43/286 (15%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLSGQPNI 142
+G G +G+ C TG+ A K K + D +K REI++++ L + N+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIK-----KFLESEDDKMVKKIAMREIRMLKQLRHE-NL 62
Query: 143 VEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVM 202
V + K+ +++V E L D E I+ + CH ++
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII 122
Query: 203 HRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDIVGSAYYVAPEVL--RRRYG 259
HRD+KPEN L+S ++ ++K DFG + + G+VY D V + +Y APE+L +YG
Sbjct: 123 HRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETE------------------KGIFD--AILQG--- 296
+ +DIW+ G ++ +L+G P F +++ + IF + G
Sbjct: 180 RAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239
Query: 297 ----DIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
+I+ +P +S DL ++ L DP R +S+Q+L H +
Sbjct: 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 74/256 (28%), Positives = 134/256 (52%), Gaps = 34/256 (13%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN-IV 143
K +GRG FG + + + FA K ++K +++ + + + E ++ ++G I
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL--VNGDNQWIT 64
Query: 144 EFKGAYEDKQSVHVVMELCAGGELF-------DRI---IAKGHYSERAAASICRSIVNVV 193
A++D+ ++++VM+ GG+L DR+ +A+ + +E A ++ V
Sbjct: 65 TLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIA------IDSV 118
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV-FIEEGKVYRDI-VGSAYYVAP 251
H H++ HRD+KP+N L+ D N ++ DFG + +E+G V + VG+ Y++P
Sbjct: 119 HQLHYV---HRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 172
Query: 252 EVL------RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE-SAP 304
E+L + +YG E D WS GV +Y +L G PF+AE+ + I+ F+ A
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQ 232
Query: 305 WPTISSSAKDLVRRML 320
+S AKDL+RR++
Sbjct: 233 VTDVSEDAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 89/310 (28%), Positives = 136/310 (43%), Gaps = 51/310 (16%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK--REIQIMQHLSG 138
Y K +GRG +G+ + T + A K I+ N D + REI++++HL
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN---AFDNRIDAKRTLREIKLLRHLDH 63
Query: 139 QPNIVEFKG--------AYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIV 190
+ N++ K A+ D V++V EL +L I + S+ ++
Sbjct: 64 E-NVIAIKDIMPPPHREAFND---VYIVYEL-MDTDLHQIIRSSQTLSDDHCQYFLYQLL 118
Query: 191 NVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYV 249
+ H V+HRDLKP N LL + N LK DFGL+ E+G + V + +Y
Sbjct: 119 RGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSEKGDFMTEYVVTRWYR 175
Query: 250 APEVLRR--RYGKEIDIWSAGVILYILLSGVPPF----WAETEKGIFDAI---LQGDIDF 300
APE+L Y ID+WS G I LL P F + K I + + + D+ F
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235
Query: 301 ----------ESAP----------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
S P +P + A DL+ +ML DP KRIT + L HP++
Sbjct: 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295
Query: 341 EGGEASDKPI 350
+ SD+P+
Sbjct: 296 SLHDPSDEPV 305
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 3e-24
Identities = 55/230 (23%), Positives = 108/230 (46%), Gaps = 25/230 (10%)
Query: 85 KELGRGQFGVTYLCT---ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
K+LG G FG Y ++ + A K++ + ++ ++ D +E ++M+ L G PN
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--SEEERKDFLKEARVMKKL-GHPN 57
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHIC----- 196
+V G +++ +++V+E GG+L D + S S+ +++
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKS-TLSLKDLLSFAIQIAK 116
Query: 197 -----HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV-- 249
+HRDL N L+ E+ ++K +DFGLS + + YR G +
Sbjct: 117 GMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173
Query: 250 -APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
APE L+ + + D+WS GV+L+ + + G P+ + + + + + +G
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG 223
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 84/289 (29%), Positives = 124/289 (42%), Gaps = 31/289 (10%)
Query: 68 TILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK 127
TI G+ Y E+G G G Y TG A K + R+ K + I
Sbjct: 4 TIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQM--RRTGNKEENKRIL 61
Query: 128 REIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMEL---CAGGELFDRIIAKGHYSERAAAS 184
++ ++ P IV+ G + V + MEL C +L RI +G E
Sbjct: 62 MDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLD-KLLKRI--QGPIPEDILGK 118
Query: 185 ICRSIVNVVHIC---HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD 241
+ +IV +H H GV+HRD+KP N LL D + +K DFG+S + + K
Sbjct: 119 MTVAIVKALHYLKEKH--GVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTR 173
Query: 242 IVGSAYYVAPEVL-----RRRYGKEIDIWSAGVILYILLSGVPPF-WAETEKGIFDAILQ 295
G A Y+APE + +Y D+WS G+ L L +G P+ +TE + ILQ
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ 233
Query: 296 GDIDFESAPWP----TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
E P S V LT+D +KR ++L+HP+I+
Sbjct: 234 -----EEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 6e-24
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 46/225 (20%)
Query: 83 FGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG 138
GK+LG G FG Y T T + A K++ ++ ++ ++++ E IM+ LS
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL--KEGASEEEREEFLEEASIMKKLS- 59
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHIC- 196
PNIV G + +++V E GG+L D + G + + + I
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMAL------QIAK 113
Query: 197 -----HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV-- 249
+HRDL N L+ EN ++K +DFGLS RDI YY
Sbjct: 114 GMEYLESKNFVHRDLAARNCLV---TENLVVKISDFGLS---------RDIYEDDYYRKR 161
Query: 250 ----------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFW 282
APE L+ ++ + D+WS GV+L+ + + G P+
Sbjct: 162 GGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYP 206
|
Length = 258 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 72/249 (28%), Positives = 131/249 (52%), Gaps = 20/249 (8%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +GRG FG + T R +A K ++K +++ + + + E ++ + Q I
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW-ITT 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICR----SIVNVVHICHFMG 200
A++D+ +++VM+ GG+L +++K + +R + R +V +H H +
Sbjct: 66 LHYAFQDENYLYLVMDYYVGGDLLT-LLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSV-FIEEGKVYRDI-VGSAYYVAPEVLRR-- 256
+HRD+KP+N LL D N ++ DFG + ++G V + VG+ Y++PE+L+
Sbjct: 123 YVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 257 ----RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-ISSS 311
+YG E D WS GV +Y +L G PF+AE+ + I+ + F+ T +S
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239
Query: 312 AKDLVRRML 320
AKDL++R++
Sbjct: 240 AKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 7e-24
Identities = 83/286 (29%), Positives = 130/286 (45%), Gaps = 44/286 (15%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND--KDDIKREIQIMQHLSGQPNIVE 144
+G G +GV C T A I K K +N+ K+ RE+++++ L Q NIVE
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVA---IKKFKDSEENEEVKETTLRELKMLRTLK-QENIVE 64
Query: 145 FKGAYEDKQSVHVVMELCAGG--ELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVM 202
K A+ + +++V E EL + + G E+ + I + ++ +H CH ++
Sbjct: 65 LKEAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYIYQ-LIKAIHWCHKNDIV 122
Query: 203 HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK--VYRDIVGSAYYVAPEVLR-RRYG 259
HRD+KPEN L+S D +LK DFG + + EG Y + V + +Y +PE+L YG
Sbjct: 123 HRDIKPENLLISHND---VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETE-------------------KGIFDAILQGDIDF 300
K +D+WS G IL L G P F E+E K + + F
Sbjct: 180 KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239
Query: 301 ESAPWPT---------ISSSAKDLVRRMLTQDPKKRITSAQVLEHP 337
+ P +S DL++ +L +P R + Q L HP
Sbjct: 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 8e-24
Identities = 75/268 (27%), Positives = 136/268 (50%), Gaps = 19/268 (7%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG+G FG C +TG+ +ACK ++K++L + + E +I+ + + IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSR-FIVSLA 59
Query: 147 GAYEDKQSVHVVMELCAGGELFDRII-----AKGHYSERAAASICRSIVNVVHICHFMGV 201
A++ K + +VM + GG+L I G RA + I + H+ H +
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL-HQRRI 118
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV-YRDIVGSAYYVAPEVLR-RRYG 259
++RDLKPEN LL D + ++ +D GL+V +++G+ + G+ ++APE+L+ Y
Sbjct: 119 IYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-ISSSAKDLVRR 318
+D ++ GV LY +++ PF A EK + + L+ I +S +P S ++K
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRILNDSVTYPDKFSPASKSFCEA 234
Query: 319 MLTQDPKKRI-----TSAQVLEHPWIKE 341
+L +DP+KR+ + HP ++
Sbjct: 235 LLAKDPEKRLGFRDGNCDGLRTHPLFRD 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 1e-23
Identities = 84/290 (28%), Positives = 135/290 (46%), Gaps = 44/290 (15%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKD--DIKREIQIMQHLSGQPNIV 143
ELG G FG Y TG A K I TK++++ D EI+I+ + P IV
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYMVEIEILATCN-HPYIV 72
Query: 144 EFKGAYEDKQSVHVVMELCAGGEL------FDRIIAKGHYSERAAASICRSIVNVVHICH 197
+ GA+ + +++E C GG + DR + +E ICR ++ + H
Sbjct: 73 KLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGL-----TEPQIQVICRQMLEALQYLH 127
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLR- 255
M ++HRDLK N LL+ + +K DFG+S + RD +G+ Y++APEV+
Sbjct: 128 SMKIIHRDLKAGNVLLTLDGD---IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMC 184
Query: 256 -----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310
Y + DIWS G+ L + PP + I + + P PT+S
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE------P-PTLSQ 237
Query: 311 SAK------DLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAV 354
+K D ++ L + P+ R ++AQ+LEHP++ S++P+ V
Sbjct: 238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS--VTSNRPLRELV 285
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 32/216 (14%)
Query: 80 HYSFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH 135
H F K+LG G FG LC ++TG Q A KS+ + + D +REI+I++
Sbjct: 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREIEILRT 62
Query: 136 LSGQPNIVEFKGAYED--KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVV 193
L NIV++KG E +S+ ++ME G L R + H R ++ R ++
Sbjct: 63 LD-HENIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRH---RDQINLKRLLLFSS 116
Query: 194 HIC------HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY------RD 241
IC +HRDL N L+ + L+K +DFGL+ + E K Y +
Sbjct: 117 QICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDYYYVKEPGE 173
Query: 242 IVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS 276
++ APE LR ++ D+WS GV LY L +
Sbjct: 174 S--PIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 80/314 (25%), Positives = 135/314 (42%), Gaps = 55/314 (17%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG G FG L + T +A K++ K+ ++ +N +K E I+ + +V+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW-VVK 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++DK +++ VM+ GG++ +I + E A + + H MG +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125
Query: 205 DLKPENFLLSSKDENALLKATDFGL---------SVFIEEGKVYR--------------- 240
D+KP+N L+ D + +K TDFGL S + ++G R
Sbjct: 126 DIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 241 ------------------------DIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILL 275
+VG+ Y+APEVL R+ Y + D WS GVIL+ +L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 276 SGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRML--TQDPKKRITSAQV 333
G PPF A T ++ + P +S A DL+ ++ ++ R + +
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302
Query: 334 LEHPWIKEGGEASD 347
HP+ E +SD
Sbjct: 303 KAHPFFSEVDFSSD 316
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 2e-23
Identities = 78/287 (27%), Positives = 131/287 (45%), Gaps = 45/287 (15%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLSGQPNI 142
+G G +GV + C TG+ A K K V D IK REI++++ L PN+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLKQLK-HPNL 62
Query: 143 VEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICRSIVNVVHICHFMGV 201
V + K+ +H+V E C + + + E I + V+ CH
Sbjct: 63 VNLIEVFRRKRKLHLVFEYC-DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIVGSAYYVAPEVL--RRRY 258
+HRD+KPEN L++ + + +K DFG + + G Y D V + +Y APE+L +Y
Sbjct: 122 IHRDVKPENILITKQGQ---IKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETE--------KGIFDAILQGDIDFES-------- 302
G +D+W+ G + LL+G P + +++ K + D I + F +
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238
Query: 303 -----------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
+ +P ISS A ++ L DP +R++ ++LEHP+
Sbjct: 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-23
Identities = 86/295 (29%), Positives = 123/295 (41%), Gaps = 53/295 (17%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLSGQPNI 142
+G G +G Y + +TG+ A K K + D++ I REI ++Q LS I
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALK-----KTRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 143 V-----EFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSER-----AAASICRSIVNV 192
V E K S+++V E +L + + G R S ++
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAP 251
V CH GVMHRDLKP+N L+ + LLK D GL F K Y + + +Y AP
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180
Query: 252 EVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAILQGDIDFESAP- 304
EVL Y +DIWS G I + P F ++E IF + G + P
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL--GTPTEQVWPG 238
Query: 305 ------W---------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
W P +S DL+++ML DP KRI++ L HP+
Sbjct: 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 4e-23
Identities = 78/288 (27%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLSGQP 140
+++G G +GV Y TG+ A K K+ +++++ + REI +++ L P
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMK-----KIRLESEEEGVPSTAIREISLLKELQ-HP 59
Query: 141 NIVEFKGAYEDKQSVHVVMEL--CAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198
NIV + + ++++ E + D + + S I+ + CH
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVL--R 255
V+HRDLKP+N L+ D ++K DFGL+ F +VY V + +Y APEVL
Sbjct: 120 RRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGS 176
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAILQGDID----FESAP--- 304
RY +DIWS G I + + P F ++E IF + D S P
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236
Query: 305 -----W---------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
W + DL+ +ML DP KRI++ + L HP+
Sbjct: 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 4e-23
Identities = 82/268 (30%), Positives = 125/268 (46%), Gaps = 25/268 (9%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y + +G G +G Y TG A K I KL +D I++EI +++
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECK-HC 66
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
NIV + G+Y ++ + + ME C GG L D G SE A +CR + + H G
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR-DIVGSAYYVAPEVLRRR-- 257
MHRD+K N LL+ +N +K DFG++ I R +G+ Y++APEV
Sbjct: 127 KMHRDIKGANILLT---DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 258 --YGKEIDIWSAGVILYILLSGVPP-FWAETEKGIFDAILQGDIDF------ESAPWPTI 308
Y + DIW+ G+ L PP F + +F L +F + W
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMSKSNFQPPKLKDKTKW--- 237
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVLEH 336
SS+ + V+ LT++PKKR T+ ++L H
Sbjct: 238 SSTFHNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 5e-23
Identities = 75/259 (28%), Positives = 129/259 (49%), Gaps = 20/259 (7%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+G+G FG Y +N T A K I + +++ +DI++EI ++ P I +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYITRYY 68
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL 206
G+Y + ++ME GG D ++ G E A+I R I+ + H +HRD+
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDI 127
Query: 207 KPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRRR-YGKEIDI 264
K N LLS E +K DFG++ + + ++ R+ VG+ +++APEV+++ Y + DI
Sbjct: 128 KAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADI 184
Query: 265 WSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI----SSSAKDLVRRML 320
WS G+ L G PP + I + ++P PT+ S K+ V L
Sbjct: 185 WSLGITAIELAKGEPPNSDLHPMRVLFLIPK------NSP-PTLEGQYSKPFKEFVEACL 237
Query: 321 TQDPKKRITSAQVLEHPWI 339
+DP+ R T+ ++L+H +I
Sbjct: 238 NKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 9e-23
Identities = 70/271 (25%), Positives = 123/271 (45%), Gaps = 24/271 (8%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+GRG + L T R +A K + K + D D ++ E + + S P +V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL 206
++ + + V+E GG+L + + E A I ++ H G+++RDL
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122
Query: 207 KPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDI 264
K +N LL S+ +K TD+G+ + G G+ Y+APE+LR YG +D
Sbjct: 123 KLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 265 WSAGVILYILLSGVPPF---------WAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315
W+ GV+++ +++G PF TE +F IL+ I ++S A +
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAASV 235
Query: 316 VRRMLTQDPKKRITS------AQVLEHPWIK 340
++ L +DPK+R+ A + HP+ +
Sbjct: 236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 9e-23
Identities = 78/269 (28%), Positives = 130/269 (48%), Gaps = 26/269 (9%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+G G +G Y TG+ A K + VT +++++IK+EI +++ S NI +
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHRNIATYY 69
Query: 147 GAYEDKQ------SVHVVMELCAGGELFDRII-AKGH-YSERAAASICRSIVNVVHICHF 198
GA+ K + +VME C G + D I KG+ E A ICR I+ + H
Sbjct: 70 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ 129
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLR-- 255
V+HRD+K +N LL+ ENA +K DFG+S ++ R+ +G+ Y++APEV+
Sbjct: 130 HKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 186
Query: 256 ----RRYGKEIDIWSAGVILYILLSGVPPFW-AETEKGIFDAILQGDIDFESAPWPTISS 310
Y + D+WS G+ + G PP + +F +S W S
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW---SK 243
Query: 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
+ + L ++ +R T+ Q+++HP+I
Sbjct: 244 KFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 1e-22
Identities = 91/319 (28%), Positives = 144/319 (45%), Gaps = 51/319 (15%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y K++G G+FG +L T F K+IS R L + +K + E+ +M+ L
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELK-HK 72
Query: 141 NIVEFKGAYEDK--QSVHVVMELCAGGELFDRIIAK-----GHYSERAAASICRSIVNVV 193
NIV + + +K Q ++++ME C G+L R I K G E A I R +++ +
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDL-SRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 194 HICHFMG-------VMHRDLKPENFLLSSK--------------DENALLKATDFGLSVF 232
CH + V+HRDLKP+N LS+ + + K DFGLS
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191
Query: 233 IEEGKVYRDIVGSAYYVAPEVL---RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGI 289
I + VG+ YY +PE+L + Y + D+W+ G I+Y L SG PF
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN--- 248
Query: 290 FDAILQGDIDFESAPWPTISSSAKD---LVRRMLTQDPKKRITSAQVLEHPWIK------ 340
F ++ + + P I +K+ L++ +L K+R ++ Q L + IK
Sbjct: 249 FSQLIS---ELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPPV 305
Query: 341 --EGGEASDKPIDSAVLSR 357
GG A AV++R
Sbjct: 306 GAAGGGAGVAAAPGAVVAR 324
|
Length = 1021 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-22
Identities = 79/269 (29%), Positives = 128/269 (47%), Gaps = 26/269 (9%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+G G +G Y TG+ A K + VT++++++IK EI +++ S NI +
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHRNIATYY 79
Query: 147 GAYEDKQ------SVHVVMELCAGGELFDRII-AKGH-YSERAAASICRSIVNVVHICHF 198
GA+ K + +VME C G + D + KG+ E A ICR I+ + H
Sbjct: 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA 139
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLR-- 255
V+HRD+K +N LL+ ENA +K DFG+S ++ R+ +G+ Y++APEV+
Sbjct: 140 HKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 196
Query: 256 ----RRYGKEIDIWSAGVILYILLSGVPPFW-AETEKGIFDAILQGDIDFESAPWPTISS 310
Y DIWS G+ + G PP + +F +S W S
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKW---SK 253
Query: 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
D + L ++ R ++ Q+L+HP+I
Sbjct: 254 KFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 2e-22
Identities = 66/265 (24%), Positives = 134/265 (50%), Gaps = 15/265 (5%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y F + +G+G +G L + G+Q+ K ++ R ++ ++ ++E Q++ L P
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN-ASRRERKAAEQEAQLLSQLK-HP 59
Query: 141 NIVEFKGAYEDKQS-VHVVMELCAGGELFDRII-AKGHY-SERAAASICRSIVNVVHICH 197
NIV ++ ++E + +++VM C GG+L+ ++ KG E I + H
Sbjct: 60 NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIVGSAYYVAPEVLRR 256
++HRDLK +N L+ + ++K D G++ +E + + ++G+ YY++PE+
Sbjct: 120 EKHILHRDLKTQNVFLTRTN---IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176
Query: 257 R-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-ISSSAKD 314
+ Y + D+W+ G +Y + + F A+ + I++G + P P S +
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL----PPMPKDYSPELGE 232
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWI 339
L+ ML++ P+KR + +L P+I
Sbjct: 233 LIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 85/318 (26%), Positives = 138/318 (43%), Gaps = 44/318 (13%)
Query: 69 ILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR 128
L K +V Y +G G +G + TGR+ A K +S R + R
Sbjct: 5 ELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYR 63
Query: 129 EIQIMQHLSGQPNIVEFKGAY------EDKQSVHVVMELCAGGELFDRIIAKGHYSERAA 182
E+++++H+ N++ + ED Q V++V L G +L + I+ S+
Sbjct: 64 ELRLLKHMD-HENVIGLLDVFTPASSLEDFQDVYLVTHL-MGADL-NNIVKCQKLSDDHI 120
Query: 183 ASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI 242
+ I+ + H G++HRDLKP N + +E+ LK DFGL+ ++
Sbjct: 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLARHTDDEMT--GY 175
Query: 243 VGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ----- 295
V + +Y APE++ Y + +DIWS G I+ LL+G F I+
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP 235
Query: 296 -----GDIDFESA-------P----------WPTISSSAKDLVRRMLTQDPKKRITSAQV 333
I ESA P + + A DL+ +ML DP KRIT+A+
Sbjct: 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA 295
Query: 334 LEHPWIKEGGEASDKPID 351
L HP++ E + D+P+
Sbjct: 296 LAHPYLAEYHDPEDEPVA 313
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-22
Identities = 71/261 (27%), Positives = 131/261 (50%), Gaps = 20/261 (7%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
+++G+G FG + +N T + A K I + +++ +DI++EI ++ P + +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTK 66
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+ G+Y + ++ME GG D ++ G E A+I R I+ + H +HR
Sbjct: 67 YYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHR 125
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRRR-YGKEI 262
D+K N LLS E+ +K DFG++ + + ++ R+ VG+ +++APEV+++ Y +
Sbjct: 126 DIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 263 DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI----SSSAKDLVRR 318
DIWS G+ L G PP + I + + PT+ S K+ V
Sbjct: 183 DIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------PTLEGNYSKPLKEFVEA 235
Query: 319 MLTQDPKKRITSAQVLEHPWI 339
L ++P R T+ ++L+H +I
Sbjct: 236 CLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 79/315 (25%), Positives = 122/315 (38%), Gaps = 69/315 (21%)
Query: 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK-----------REIQI 132
G LG G +G + TG+ A K + ++ KD RE++I
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNV 192
M + NI+ Y + +++VM++ A +L + K +E I I+N
Sbjct: 74 MNEIK-HENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNG 131
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-------VFIEEGKV------- 238
+++ H MHRDL P N ++SK K DFGL+ K
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGI---CKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 239 -YRDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ 295
V + +Y APE+L +Y +D+WS G I LL+G P F E E I Q
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE------IDQ 242
Query: 296 -GDIDF-----ESAPWPTI------------------------SSSAKDLVRRMLTQDPK 325
G I WP S A DL++ +L +P
Sbjct: 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPL 302
Query: 326 KRITSAQVLEHPWIK 340
+RI++ + L+H + K
Sbjct: 303 ERISAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 4e-22
Identities = 86/332 (25%), Positives = 129/332 (38%), Gaps = 92/332 (27%)
Query: 81 YSFGKELGRGQFGVTYLC--TENSTGRQFACKSISKRKLVTKNDKDDIK-------REIQ 131
Y +GRG +G Y G+++A K K DK+ REI
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF-------KGDKEQYTGISQSACREIA 54
Query: 132 IMQHLSGQPNIVEFKGAYEDK--QSVHVVMELCAGGELFD--RIIAKGHYSERAAASICR 187
+++ L N+V + + +SV+++ + D +II + + SI
Sbjct: 55 LLRELK-HENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIK--FHRQAKRVSIPP 107
Query: 188 SIV--------NVVHICHFMGVMHRDLKPENFLLSSK-DENALLKATDFGLS-------- 230
S+V N VH H V+HRDLKP N L+ + E ++K D GL+
Sbjct: 108 SMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167
Query: 231 VFIEEGKVYRDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEK- 287
+ V V + +Y APE+L R Y K IDIW+ G I LL+ P F K
Sbjct: 168 PLADLDPV----VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKI 223
Query: 288 ------------GIFDAI-------------------LQGDIDFESAP----------WP 306
IF+ + L D ++ P
Sbjct: 224 KKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHK 283
Query: 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
S DL+R++L DP KRIT+ + LEHP+
Sbjct: 284 KPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 5e-22
Identities = 79/316 (25%), Positives = 132/316 (41%), Gaps = 50/316 (15%)
Query: 42 PEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTEN 101
P + +++ S A K +++ +G G G Y
Sbjct: 48 PPPSSSSSSSSSSSASGSAPSAA-------KSLSELER----VNRIGSGAGGTVYKVIHR 96
Query: 102 STGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157
TGR +A K I N +D ++ REI+I++ ++ PN+V+ ++ + V
Sbjct: 97 PTGRLYALKVI------YGNHEDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQV 149
Query: 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217
++E GG L IA E+ A + R I++ + H ++HRD+KP N L++S
Sbjct: 150 LLEFMDGGSLEGTHIAD----EQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK 205
Query: 218 ENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRR-----RY-GKEIDIWSAGVI 270
+K DFG+S + + VG+ Y++PE + Y G DIWS GV
Sbjct: 206 N---VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVS 262
Query: 271 LYILLSGVPPF-------WAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQD 323
+ G PF WA + AI T S + + L ++
Sbjct: 263 ILEFYLGRFPFGVGRQGDWA----SLMCAICMSQ---PPEAPATASREFRHFISCCLQRE 315
Query: 324 PKKRITSAQVLEHPWI 339
P KR ++ Q+L+HP+I
Sbjct: 316 PAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 6e-22
Identities = 69/260 (26%), Positives = 117/260 (45%), Gaps = 15/260 (5%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
+E+G G FG Y + A K +S + DI +E++ +Q L PN ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQ 79
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
++G Y + + +VME C G + K E A++ + + H ++HR
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL----RRRYGK 260
D+K N LLS E L+K DFG + + + VG+ Y++APEV+ +Y
Sbjct: 140 DVKAGNILLS---EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDG 193
Query: 261 EIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID-FESAPWPTISSSAKDLVRRM 319
++D+WS G+ L PP + I Q + +S W S ++ V
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSC 250
Query: 320 LTQDPKKRITSAQVLEHPWI 339
L + P+ R TS +L+H ++
Sbjct: 251 LQKIPQDRPTSEVLLKHRFV 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 6e-22
Identities = 85/285 (29%), Positives = 126/285 (44%), Gaps = 55/285 (19%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSI---SKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
+LG G G TG A K + +K + + I RE+QIM P
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSV-----RKQILRELQIMHECR-SPY 64
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIV-------NVV 193
IV F GA+ ++ ++ + ME G L DRI K G I ++V NV
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI----VGSAYYV 249
I MHRD+KP N L++S+ + +K DFG+S G++ I VG++ Y+
Sbjct: 124 RI------MHRDIKPSNILVNSRGQ---IKLCDFGVS-----GELINSIADTFVGTSTYM 169
Query: 250 APEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEK--------GIFDAILQGDIDF 300
+PE ++ +Y + D+WS G+ + L G PF GI D + Q I
Sbjct: 170 SPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ--IVQ 227
Query: 301 ESAPWPTISSS-----AKDLVRRMLTQDPKKRITSAQVLE-HPWI 339
E P P + SS +D V L +DP +R T Q+ P+I
Sbjct: 228 E--PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 6e-22
Identities = 72/270 (26%), Positives = 122/270 (45%), Gaps = 15/270 (5%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
ED + ++ +E+G G FG Y + T A K +S + DI +E++ +Q
Sbjct: 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
+ PN +E+KG Y + + +VME C G + K E A+I + +
Sbjct: 81 RIK-HPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLA 139
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL 254
H ++HRD+K N LL+ E +K DFG + + VG+ Y++APEV+
Sbjct: 140 YLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASIASPANSF---VGTPYWMAPEVI 193
Query: 255 ----RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI-DFESAPWPTIS 309
+Y ++D+WS G+ L PP + I Q + +S W S
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW---S 250
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
++ V L + P+ R TS ++L+H ++
Sbjct: 251 DYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 7e-22
Identities = 69/259 (26%), Positives = 128/259 (49%), Gaps = 20/259 (7%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+G+G FG + +N T + A K I + +++ +DI++EI ++ P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYY 68
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL 206
G+Y + ++ME GG D ++ G + E A++ + I+ + H +HRD+
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDI 127
Query: 207 KPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRRR-YGKEIDI 264
K N LLS E +K DFG++ + + ++ R+ VG+ +++APEV+++ Y + DI
Sbjct: 128 KAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 184
Query: 265 WSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI----SSSAKDLVRRML 320
WS G+ L G PP + I + PT+ S K+ + L
Sbjct: 185 WSLGITAIELAKGEPPNSDMHPMRVLFLIPKN-------NPPTLTGEFSKPFKEFIDACL 237
Query: 321 TQDPKKRITSAQVLEHPWI 339
+DP R T+ ++L+H +I
Sbjct: 238 NKDPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 81/317 (25%), Positives = 130/317 (41%), Gaps = 64/317 (20%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----R 128
P+ D Y ++G+G FG + T + A K K++ +N+K+ R
Sbjct: 6 PFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALK-----KVLMENEKEGFPITALR 60
Query: 129 EIQIMQHLSGQPNIVEF--------KGAYEDKQSVHVVMELC----AGGELFDRIIAKGH 176
EI+I+Q L N+V K S ++V E C AG L K
Sbjct: 61 EIKILQLLK-HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAG--LLSNKNVK-- 115
Query: 177 YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VF--- 232
++ + + ++N ++ H ++HRD+K N L++ ++ +LK DFGL+ F
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLS 172
Query: 233 -IEEGKVYRDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGI 289
+ Y + V + +Y PE+L R YG ID+W AG I+ + + P TE+
Sbjct: 173 KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ 232
Query: 290 FDAILQ--GDIDFESAP-------------------------WPTISS-SAKDLVRRMLT 321
I Q G I E P P + A DL+ ++L
Sbjct: 233 LTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLV 292
Query: 322 QDPKKRITSAQVLEHPW 338
DP KRI + L H +
Sbjct: 293 LDPAKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 65/251 (25%), Positives = 115/251 (45%), Gaps = 16/251 (6%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+GRG + L + +A K + K + D D ++ E + + S P +V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL 206
++ + +V+E GG+L + + E A I ++ H G+++RDL
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122
Query: 207 KPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDI 264
K +N LL D + +K TD+G+ + G G+ Y+APE+LR YG +D
Sbjct: 123 KLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179
Query: 265 WSAGVILYILLSGVPPF-------WAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
W+ GV+++ +++G PF TE +F IL+ I +S A +++
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKASHVLK 235
Query: 318 RMLTQDPKKRI 328
L +DPK+R+
Sbjct: 236 GFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-21
Identities = 77/276 (27%), Positives = 131/276 (47%), Gaps = 25/276 (9%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
ELG G FG Y TG A K I + ++ + +D EI I+ PNIV+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCD-HPNIVKL 67
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMGVMH 203
A+ + ++ +++E CAGG + D ++ + +E +C+ + ++ H ++H
Sbjct: 68 LDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126
Query: 204 RDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLR------R 256
RDLK N L + + +K DFG+S RD +G+ Y++APEV+ R
Sbjct: 127 RDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 257 RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP--WPTISSSAKD 314
Y + D+WS G+ L + PP + I + + + P W SS KD
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---SSEFKD 240
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
+++ L ++ R T+ Q+L+HP++ S+KPI
Sbjct: 241 FLKKCLEKNVDARWTTTQLLQHPFVT---VNSNKPI 273
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 3e-21
Identities = 63/180 (35%), Positives = 93/180 (51%), Gaps = 12/180 (6%)
Query: 166 ELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225
E+ R + E A + ++ VH H ++HRD+K N LL S N L+K
Sbjct: 129 EIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS---NGLVKLG 185
Query: 226 DFGLSVFIE---EGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPF 281
DFG S V R G+ YYVAPE+ RR+ Y K+ D++S GV+LY LL+ PF
Sbjct: 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF 245
Query: 282 WAETEKGIFDAILQGDIDFESAPWP-TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
E + + L G D P P +IS +++V +L+ DPK+R +S+++L P K
Sbjct: 246 DGENMEEVMHKTLAGRYD----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICK 301
|
Length = 496 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 4e-21
Identities = 67/242 (27%), Positives = 102/242 (42%), Gaps = 36/242 (14%)
Query: 128 REIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGG--ELFDRIIAKGHYSERAAASI 185
REI +M+ L NIV + + +V E + D +G S
Sbjct: 47 REISLMKELK-HENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSF 105
Query: 186 CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL--SVFIEEGKVYRDIV 243
++ + CH V+HRDLKP+N L++ + E LK DFGL + I ++V
Sbjct: 106 TYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIPVNTFSNEVV 162
Query: 244 GSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIF------- 290
+ +Y AP+VL R Y IDIWS G I+ +++G P F IF
Sbjct: 163 -TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPT 221
Query: 291 DAILQG-------DIDFESAP-------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
++ G F P +P DL+ R+L +P+ RI++ L+H
Sbjct: 222 ESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281
Query: 337 PW 338
PW
Sbjct: 282 PW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 5e-21
Identities = 83/300 (27%), Positives = 134/300 (44%), Gaps = 47/300 (15%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK--REIQIMQHLSG 138
Y ++LG+G +G+ + + T A K I +N D + REI +Q L
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFD---AFRNATDAQRTFREIMFLQELGD 65
Query: 139 QPNIVEFKGAY--EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHIC 196
PNIV+ E+ + +++V E +L +I + I ++ +
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFE-YMETDL-HAVIRANILEDVHKRYIMYQLLKALKYI 123
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR------DIVGSAYYVA 250
H V+HRDLKP N LL+S +K DFGL+ + E + D V + +Y A
Sbjct: 124 HSGNVIHRDLKPSNILLNSD---CRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180
Query: 251 PEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG-------DID-- 299
PE+L RY K +D+WS G IL +L G P F + + I++ DI+
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240
Query: 300 --------FESAP----------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
+S P P S A DL++++L +P KR+T+ + LEHP++ +
Sbjct: 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 9e-21
Identities = 71/271 (26%), Positives = 122/271 (45%), Gaps = 24/271 (8%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+GRG + L T R +A K I K + D D ++ E + + S P +V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL 206
++ + + V+E +GG+L + + E A I ++ H G+++RDL
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122
Query: 207 KPENFLLSSKDENALLKATDFGL-SVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDI 264
K +N LL D +K TD+G+ I G G+ Y+APE+LR YG +D
Sbjct: 123 KLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 265 WSAGVILYILLSGVPPF---------WAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315
W+ GV+++ +++G PF TE +F IL+ I ++S A +
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKASSV 235
Query: 316 VRRMLTQDPKKRITS------AQVLEHPWIK 340
++ L +DPK+R+ + HP+ +
Sbjct: 236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 70/214 (32%), Positives = 107/214 (50%), Gaps = 28/214 (13%)
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIA--KGH--YSERAAASICRSIVNVVHICH 197
IV+ ++ + ++ME +GG+L +I K H + E + IV + H
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH 186
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV---------GSAYY 248
+MHRDLK N L ++K DFG S K Y D V G+ YY
Sbjct: 187 SRKMMHRDLKSANIFLMP---TGIIKLGDFGFS------KQYSDSVSLDVASSFCGTPYY 237
Query: 249 VAPEVL-RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT 307
+APE+ R+RY K+ D+WS GVILY LL+ PF +++ I +L G D P+P
Sbjct: 238 LAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD----PFPC 293
Query: 308 -ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
+SS K L+ +L+++P R T+ Q+L ++K
Sbjct: 294 PVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-20
Identities = 77/278 (27%), Positives = 129/278 (46%), Gaps = 40/278 (14%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+G+G +G Y T G A K + + ++I+ E I+Q L PN+V+F
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDP----ISDVDEEIEAEYNILQSLPNHPNVVKFY 85
Query: 147 GAY--EDKQS---VHVVMELCAGG---ELFDRIIAKGHYSERAAAS--ICRSIVNVVHIC 196
G + DK + +V+ELC GG EL ++ G + A S + +++ + H+
Sbjct: 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL- 144
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI-VGSAYYVAPEVLR 255
H ++HRD+K N LL+++ +K DFG+S + ++ R+ VG+ +++APEV+
Sbjct: 145 HNNRIIHRDVKGNNILLTTEGG---VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201
Query: 256 ------RRYGKEIDIWSAGVILYILLSGVPP-FWAETEKGIFDAILQGDIDFESAPWPTI 308
Y D+WS G+ L G PP F K +F P PT+
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF--------KIPRNPPPTL 253
Query: 309 SSSAK------DLVRRMLTQDPKKRITSAQVLEHPWIK 340
K + + L +D + R + +LEHP+IK
Sbjct: 254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 82/305 (26%), Positives = 128/305 (41%), Gaps = 69/305 (22%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND-KDDIKREIQIMQHLSGQPNIV 143
ELG G GV +G A K I L K ++ I RE++++ H P IV
Sbjct: 7 GELGAGNGGVVTKVLHRPSGLIMARKLI---HLEIKPAIRNQIIRELKVL-HECNSPYIV 62
Query: 144 EFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG--- 200
F GA+ + + ME GG L D+++ K A I +I+ + I G
Sbjct: 63 GFYGAFYSDGEISICMEHMDGGSL-DQVLKK-------AGRIPENILGKISIAVLRGLTY 114
Query: 201 ------VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI----VGSAYYVA 250
+MHRD+KP N L++S+ E +K DFG+S G++ + VG+ Y++
Sbjct: 115 LREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMS 166
Query: 251 PEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKG---IFDAILQGDID------- 299
PE L+ Y + DIWS G+ L + G P K +F +
Sbjct: 167 PERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226
Query: 300 -------------FE------SAPWPTI-----SSSAKDLVRRMLTQDPKKRITSAQVLE 335
FE + P P + S +D V + L ++PK+R ++ +
Sbjct: 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286
Query: 336 HPWIK 340
HP+IK
Sbjct: 287 HPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-20
Identities = 79/296 (26%), Positives = 134/296 (45%), Gaps = 40/296 (13%)
Query: 68 TILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK 127
TI+ + D + + +G+G +G + G + A K + + ++I+
Sbjct: 7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP----IHDIDEEIE 62
Query: 128 REIQIMQHLSGQPNIVEFKGAYEDKQSVH-----VVMELCAGGELFDRIIAKG------H 176
E I++ LS PN+V+F G Y K + +V+ELC GG + D + KG
Sbjct: 63 AEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTD--LVKGFLKRGER 120
Query: 177 YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236
E A I + + H +HRD+K N LL+++ +K DFG+S +
Sbjct: 121 MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG---VKLVDFGVSAQLTST 177
Query: 237 KVYRDI-VGSAYYVAPEV------LRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGI 289
++ R+ VG+ +++APEV L Y D+WS G+ L G PP A+
Sbjct: 178 RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL-ADLHP-- 234
Query: 290 FDAILQGDIDFESAPWPTI------SSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
++ P PT+ S+ D +R+ LT+D +KR T + +L+H +I
Sbjct: 235 ----MRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 77/317 (24%), Positives = 128/317 (40%), Gaps = 73/317 (23%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQH 135
Y +LG G FG Y + TGR A K K++ N+KD REI+I++
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKILKK 63
Query: 136 LSGQPNIVEF--------KGAYEDKQSVHVVM-----ELCAGGELFDRIIAKGHYSERAA 182
L PN+V + + SV++V +L G L + + +E
Sbjct: 64 LK-HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS--GLLENPSV---KLTESQI 117
Query: 183 ASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV---- 238
++ ++ H ++HRD+K N L+ D +LK DFGL+ +
Sbjct: 118 KCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFGLARPYDGPPPNPKG 174
Query: 239 --------YRDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETE-- 286
Y ++V + +Y PE+L RRY +DIW G + + + P +++
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID 234
Query: 287 --KGIFDAI----------------LQGDIDFESAPWPTISSSAK-------DLVRRMLT 321
IF +G F + P T+ DL+ ++L+
Sbjct: 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYP-RTLEERFGKLGPEGLDLLSKLLS 293
Query: 322 QDPKKRITSAQVLEHPW 338
DP KR+T++ LEHP+
Sbjct: 294 LDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 3e-20
Identities = 74/268 (27%), Positives = 125/268 (46%), Gaps = 22/268 (8%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ--PNIVE 144
+GRG FG Y C + TG+ +A K + K+++ K + E ++ +S P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
A+ + +++L GG+L + G +SE I+ + H V++R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEI 262
DLKP N LL DE+ ++ +D GL+ + K + VG+ Y+APEVL++ Y
Sbjct: 122 DLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSA 177
Query: 263 DIWSAGVILYILLSGVPPFWAETEKG---IFDAILQGDIDFESAPWP-TISSSAKDLVRR 318
D +S G +L+ LL G PF K I L ++ P + S + L+
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-----LPDSFSPELRSLLEG 232
Query: 319 MLTQDPKKRI-----TSAQVLEHPWIKE 341
+L +D +R+ + +V EHP+ +
Sbjct: 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRS 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 5e-20
Identities = 82/298 (27%), Positives = 126/298 (42%), Gaps = 68/298 (22%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD-------IKREIQIMQHLSGQ 139
+G G +GV Y + TG A K I + + +D I REI +++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-------RLETEDEGVPSTAI-REISLLKELN-H 57
Query: 140 PNIVEFKGAYEDKQSVHVV-----------MELCAGGELFDRIIAKGHYSERAAASICRS 188
PNIV + +++V M+ L +I Y + +
Sbjct: 58 PNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQ------LLQG 111
Query: 189 IVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAY 247
I CH V+HRDLKP+N L+ D LK DFGL+ F + Y V + +
Sbjct: 112 IA----YCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVPVRTYTHEVVTLW 164
Query: 248 YVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IF-------DAIL 294
Y APE+L R+Y +DIWS G I +++ P F ++E IF + +
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVW 224
Query: 295 QGDI---DFESA-P-W---------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
G D++ P W P + DL+ +ML DP KRI++ L+HP+
Sbjct: 225 PGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 6e-20
Identities = 67/251 (26%), Positives = 118/251 (47%), Gaps = 14/251 (5%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K++GRGQF Y T + A K + +++ + D +EI +++ L+ PN+++
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIK 66
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRII----AKGHYSERAAASICRSIVNVVHICHFMG 200
+ ++ + +++V+EL G+L I K ER + + V H
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDIVGSAYYVAPEVLRRR-Y 258
VMHRD+KP N +++ +K D GL F + +VG+ YY++PE + Y
Sbjct: 127 VMHRDIKPANVFITATGV---VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT--ISSSAKDLV 316
+ DIWS G +LY + + PF+ +K ++ Q + P PT S ++LV
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYG--DKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELV 241
Query: 317 RRMLTQDPKKR 327
+ DP +R
Sbjct: 242 SMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 8e-20
Identities = 69/259 (26%), Positives = 124/259 (47%), Gaps = 20/259 (7%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
++ K++GRGQF Y T G A K + L+ + D +EI +++ L+
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-H 61
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN-VVHIC-- 196
PN++++ ++ + +++V+EL G+L R+I H+ ++ +++ V +C
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDL-SRMIK--HFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 197 ----HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDIVGSAYYVAP 251
H VMHRD+KP N +++ ++K D GL F + +VG+ YY++P
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 252 EVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEK--GIFDAILQGDIDFESAPWPTI 308
E + Y + DIWS G +LY + + PF+ + + I Q D+ P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ--CDYPPLPSDHY 233
Query: 309 SSSAKDLVRRMLTQDPKKR 327
S + LV + DP+KR
Sbjct: 234 SEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 9e-20
Identities = 75/283 (26%), Positives = 122/283 (43%), Gaps = 34/283 (12%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
+++G G +GV Y TG A K I + T+ REI +++ L+ PNIV+
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN-HPNIVK 63
Query: 145 FKGAYEDKQSVHVVME-LCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMH 203
+ +++V E L + F S ++ + CH V+H
Sbjct: 64 LLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLH 123
Query: 204 RDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLR--RRYGK 260
RDLKP+N L+ + +K DFGL+ F + Y V + +Y APE+L + Y
Sbjct: 124 RDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180
Query: 261 EIDIWSAGVILYILLSGVPPFWAETEKG----IFDAILQGD----------IDFESA--P 304
+DIWS G I +++ F ++E IF + D D++ +
Sbjct: 181 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPK 240
Query: 305 W---------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
W P + +DL+ +ML DP KRI++ L HP+
Sbjct: 241 WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 90/304 (29%), Positives = 130/304 (42%), Gaps = 61/304 (20%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSI---------SKR-----KLVTKNDKDDIKREI 130
+ +G G FGV + T+ G++ A K + KR K++ D++ +
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 131 QIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIV 190
I+Q P+I F + ++VV EL +L I++ S I+
Sbjct: 66 DILQ----PPHIDPF-------EEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQIL 113
Query: 191 NVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE--EGKVYRDIVGSAYY 248
+ H G++HRD+KP N L++S N +LK DFGL+ E E K V + YY
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 249 VAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI--LQGDIDFE--- 301
APE+L R Y +DIWS G I LL F A++ D I L G E
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230
Query: 302 ------------SAPWP-------TISS----SAKDLVRRMLTQDPKKRITSAQVLEHPW 338
P T+SS A L+ RML DP KRI++A L HP+
Sbjct: 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290
Query: 339 IKEG 342
+ EG
Sbjct: 291 LDEG 294
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 71/264 (26%), Positives = 124/264 (46%), Gaps = 22/264 (8%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG+G +G+ Y + ST + A K I +R + EI + +L NIV++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLK-HRNIVQYL 71
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKG---HYSERAAASICRSIVNVVHICHFMGVMH 203
G+ + + ME GG L + +K +E+ + I+ + H ++H
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 204 RDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDIVGSAYYVAPEVL---RRRYG 259
RD+K +N L+++ + ++K +DFG S + G+ Y+APEV+ R YG
Sbjct: 132 RDIKGDNVLVNTY--SGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYG 189
Query: 260 KEIDIWSAGVILYILLSGVPPFW--AETEKGIFDAILQGDIDFESAP-WPT-ISSSAKDL 315
DIWS G + + +G PPF E + +F + F+ P P +S+ AK+
Sbjct: 190 APADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM-----FKIHPEIPESLSAEAKNF 244
Query: 316 VRRMLTQDPKKRITSAQVLEHPWI 339
+ R DP KR ++ +L+ P++
Sbjct: 245 ILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 5e-19
Identities = 77/267 (28%), Positives = 125/267 (46%), Gaps = 22/267 (8%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ---PNIV 143
+GRG FG Y C + TG+ +A K + K+++ K + E +IM L P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFIV 60
Query: 144 EFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMH 203
A+ + +++L GG+L + G +SE+ I+ + H V++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 204 RDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKE 261
RDLKP N LL DE+ ++ +D GL+ + K + VG+ Y+APEVL++ Y
Sbjct: 121 RDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSS 176
Query: 262 IDIWSAGVILYILLSGVPPFWAETEKG---IFDAILQGDIDFESAPWPTISSSAKDLVRR 318
D +S G +L+ LL G PF K I L +++ + S K L+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPD----SFSPELKSLLEG 232
Query: 319 MLTQDPKKRI-----TSAQVLEHPWIK 340
+L +D KR+ + +V EH + K
Sbjct: 233 LLQRDVSKRLGCLGRGAQEVKEHVFFK 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 7e-19
Identities = 81/335 (24%), Positives = 137/335 (40%), Gaps = 77/335 (22%)
Query: 70 LGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK-- 127
LG Y D++ LG G G+ + ++ ++ A K I D +K
Sbjct: 3 LGSRYMDLR-------PLGCGSNGLVFSAVDSDCDKRVAVKKIVLT------DPQSVKHA 49
Query: 128 -REIQIMQHLSGQPNIVE-----FKGAYEDKQSVHVVMEL---CAGGELFD----RIIAK 174
REI+I++ L NIV+ + + V + EL E + ++ +
Sbjct: 50 LREIKIIRRLD-HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ 108
Query: 175 GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234
G SE A ++ + H V+HRDLKP N +++ E+ +LK DFGL+ ++
Sbjct: 109 GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--EDLVLKIGDFGLARIVD 166
Query: 235 -----EGKVYRDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEK 287
+G + +V + +Y +P +L Y K ID+W+AG I +L+G P F E
Sbjct: 167 PHYSHKGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL 225
Query: 288 GIFDAILQGDIDFESAP--------------------------------WPTISSSAKDL 315
IL ES P P ++ A D
Sbjct: 226 EQMQLIL------ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDF 279
Query: 316 VRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
+ ++LT +P R+T+ + L HP++ D+P+
Sbjct: 280 LEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPV 314
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 83/303 (27%), Positives = 134/303 (44%), Gaps = 59/303 (19%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD------IKREIQIMQHLSG 138
+++G G +GV Y + T A K I + +++D REI +++ +
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKI-------RLEQEDEGVPSTAIREISLLKEMQ- 59
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY--------SERAAASICRSIV 190
NIV + ++ +++V E + + K H + R + I+
Sbjct: 60 HGNIVRLQDVVHSEKRLYLVFE-------YLDLDLKKHMDSSPDFAKNPRLIKTYLYQIL 112
Query: 191 NVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYV 249
+ CH V+HRDLKP+N LL + NA LK DFGL+ F + + V + +Y
Sbjct: 113 RGIAYCHSHRVLHRDLKPQN-LLIDRRTNA-LKLADFGLARAFGIPVRTFTHEVVTLWYR 170
Query: 250 APEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ------------ 295
APE+L R Y +DIWS G I +++ P F ++E I +
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230
Query: 296 --GDIDFESA--PW---------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342
D++SA W PT+ + DL+ +ML DP KRIT+ LEH + K+
Sbjct: 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290
Query: 343 GEA 345
G+A
Sbjct: 291 GDA 293
|
Length = 294 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 82/316 (25%), Positives = 131/316 (41%), Gaps = 61/316 (19%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN--DKDDIKREIQIMQHLSG 138
Y + +G+G +GV + TG + A K I+ V ++ D I REI++++ L
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIND---VFEHVSDATRILREIKLLRLLR- 57
Query: 139 QPNIVEFKG-----AYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVV 193
P+IVE K + + + ++VV EL +L I A + ++ +
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS--VFIEEGKV--YRDIVGSAYYV 249
H V HRDLKP+N L ++ + LK DFGL+ F + + D V + +Y
Sbjct: 117 KYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 250 APEV---LRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI--DFESAP 304
APE+ +Y IDIWS G I +L+G P F + + + Q D+ D P
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK------NVVHQLDLITDLLGTP 227
Query: 305 -------------------------------WPTISSSAKDLVRRMLTQDPKKRITSAQV 333
+P A L+ R+L DPK R T+ +
Sbjct: 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEA 287
Query: 334 LEHPWIKEGGEASDKP 349
L P+ K + +P
Sbjct: 288 LADPYFKGLAKVEREP 303
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 7e-18
Identities = 77/327 (23%), Positives = 144/327 (44%), Gaps = 57/327 (17%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +G+G FG L + TG+ +A K++ K ++ K+ +K E ++ S P +V
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-SDSPWVVS 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+++D Q ++++ME GG+L +I +SE V + H +G +HR
Sbjct: 66 LYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHR 125
Query: 205 DL-------------KPENFLLSS----KDENA----LLKATDFGLSVFIEEGKVYRDI- 242
D+ K +F LS+ + ++A LL+ + I
Sbjct: 126 DIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSIN 185
Query: 243 -----------------------VGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGV 278
VG+ Y+APE+ L++ YG+E D WS G I++ L G
Sbjct: 186 LTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGW 245
Query: 279 PPFWAETEKGIFDAILQGDIDFESAPWP---TISSSAKDLVRRMLTQDPKKRI---TSAQ 332
PPF +E + I+ E+ +P +S A+DL+RR++T + + R+ + +
Sbjct: 246 PPFCSENSHETYRKIINWR---ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301
Query: 333 VLEHPWIKEGGEASDKPIDSAVLSRMK 359
+ HP+ + + + I + + ++K
Sbjct: 302 IKSHPFFRGVDWDTIRQIRAPFIPQLK 328
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 66/264 (25%), Positives = 113/264 (42%), Gaps = 37/264 (14%)
Query: 90 GQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH--LSGQPNIVEFKG 147
G+FG + T + F K I K I+ M H + PN ++
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKII----------KAKNFNAIEPMVHQLMKDNPNFIKLYY 76
Query: 148 AYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLK 207
+ + ++M+ G+LFD + +G SE I R +V ++ H ++H D+K
Sbjct: 77 SVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIK 136
Query: 208 PENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWS 266
EN L + L D+GL I Y G+ Y +PE ++ Y D W+
Sbjct: 137 LENVLYDRAKDRIYL--CDYGLCKIIGTPSCYD---GTLDYFSPEKIKGHNYDVSFDWWA 191
Query: 267 AGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES---------APWPTISSSAKDLVR 317
GV+ Y LL+G PF + ++ ++D ES +S +A D V+
Sbjct: 192 VGVLTYELLTGKHPFKEDEDE---------ELDLESLLKRQQKKLPFIKNVSKNANDFVQ 242
Query: 318 RMLTQDPKKRITS-AQVLEHPWIK 340
ML + R+T+ ++++HP++K
Sbjct: 243 SMLKYNINYRLTNYNEIIKHPFLK 266
|
Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 75/270 (27%), Positives = 122/270 (45%), Gaps = 24/270 (8%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
E+GRG FG +G A K I R V + ++ + ++ ++ S P IV+F
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 146 KGAYEDKQSVHVVMELCAGG-ELFDRII---AKGHYSERAAASICRSIVNVV-HICHFMG 200
GA + + MEL + F + + K E I + V + ++ +
Sbjct: 69 YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK 128
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL--RRRY 258
++HRD+KP N LL D N +K DFG+S + + G Y+APE + R
Sbjct: 129 IIHRDVKPSNILL---DRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARD 185
Query: 259 GKEI--DIWSAGVILYILLSGVPPF--WAETEKGIFDAILQ---GDID-FESAPWPTISS 310
G ++ D+WS G+ LY + +G P+ W +FD + Q GD ++ S
Sbjct: 186 GYDVRSDVWSLGITLYEVATGKFPYPKW----NSVFDQLTQVVKGDPPILSNSEEREFSP 241
Query: 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
S + + L +D KR ++LEHP+IK
Sbjct: 242 SFVNFINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 7e-17
Identities = 73/292 (25%), Positives = 123/292 (42%), Gaps = 54/292 (18%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLSGQPN 141
++G G +G + T A K + +D + + REI +++ L N
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVR-----LDDDDEGVPSSALREICLLKELK-HKN 60
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAA--ASICRSIVNV----VHI 195
IV + + +V E C D+ + K S I +S + +
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYC------DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVL 254
CH V+HRDLKP+N L+ ++N LK DFGL+ F + Y V + +Y P+VL
Sbjct: 115 CHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL 171
Query: 255 --RRRYGKEIDIWSAGVILYILLSGVPPFWAETE-----KGIFDAI-------------L 294
+ Y ID+WSAG I L + P + + K IF + L
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231
Query: 295 QGDIDFESAP----W----PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
+ P P ++S+ +DL++ +L +P +RI++ + L+HP+
Sbjct: 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 8e-17
Identities = 59/222 (26%), Positives = 111/222 (50%), Gaps = 16/222 (7%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
+F KELG GQFGV +L + + A K+I++ + ++D E ++M LS P
Sbjct: 7 TFMKELGSGQFGVVHLGKWRAQ-IKVAIKAINEGAM----SEEDFIEEAKVMMKLS-HPK 60
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMG 200
+V+ G ++ +++V E G L + + + G S+ S+C+ + +
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---APEVLR-R 256
+HRDL N L+SS ++K +DFG++ ++ + + Y G+ + V PEV
Sbjct: 121 FIHRDLAARNCLVSST---GVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVFNFS 176
Query: 257 RYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQGD 297
+Y + D+WS GV+++ + G PF ++ + + I +G
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF 218
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 8e-17
Identities = 76/294 (25%), Positives = 124/294 (42%), Gaps = 52/294 (17%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLSG--Q 139
E+G G +G Y + +G A KS+ + ++D + RE+ +++ L
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVR-----VQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 140 PNIVEF----KGAYEDKQSV------HVVMELCAGGELFDRIIAKGHYSERAAASICRSI 189
PNIV + D+++ HV +L D++ G +E + R
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRT---YLDKVPPPGLPAETIK-DLMRQF 117
Query: 190 VNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV 249
+ + H ++HRDLKPEN L++S + +K DFGL+ +V + +Y
Sbjct: 118 LRGLDFLHANCIVHRDLKPENILVTSGGQ---VKLADFGLARIYSCQMALTPVVVTLWYR 174
Query: 250 APEV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAI-------LQGD 297
APEV L+ Y +D+WS G I + P F +E IFD I D
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234
Query: 298 IDFESAPW------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
+ + P I S L+ MLT +P KRI++ + L+HP+
Sbjct: 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 8e-17
Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 16/225 (7%)
Query: 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS 137
+F KELG GQFGV +L A K I + + +DD E ++M LS
Sbjct: 3 PSELTFLKELGSGQFGVVHLGKWRGK-IDVAIKMIREGAM----SEDDFIEEAKVMMKLS 57
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHIC 196
PN+V+ G ++ + +V E A G L + + KG +C + +
Sbjct: 58 -HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYL 116
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---APEV 253
G +HRDL N L+ E+ ++K +DFGL+ ++ + + Y G+ + V PEV
Sbjct: 117 ESNGFIHRDLAARNCLVG---EDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPEV 172
Query: 254 L-RRRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
R+ + D+WS GV+++ + S G P+ + + +++ G
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 55/183 (30%), Positives = 78/183 (42%), Gaps = 51/183 (27%)
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGL----SVFIEEGKVYRDIVGSAYYVAP 251
CH V+HRDLKP+N L+S + E LK DFGL SV K Y + V + +Y P
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSV---PSKTYSNEVVTLWYRPP 172
Query: 252 EVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES------A 303
+VL Y +D+W G I Y + +G P F G D Q F
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF-----PGSTDVEDQLHKIFRVLGTPTEE 227
Query: 304 PWPTISS----------------------------SAKDLVRRMLTQDPKKRITSAQVLE 335
WP +SS ++L + L +PKKRI++A+ ++
Sbjct: 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287
Query: 336 HPW 338
HP+
Sbjct: 288 HPY 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-16
Identities = 60/221 (27%), Positives = 109/221 (49%), Gaps = 16/221 (7%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
+ +E+G GQFG+ +L R+ A K+I + + ++D E Q+M LS P
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLEK-RKVAIKTIREGAM----SEEDFIEEAQVMMKLS-HPK 60
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMG 200
+V+ G ++ + +V E G L D + A +G +S+ +C + +
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---APEVLR-R 256
V+HRDL N L+ EN ++K +DFG++ F+ + + Y G+ + V +PEV
Sbjct: 121 VIHRDLAARNCLVG---ENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSFS 176
Query: 257 RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
+Y + D+WS GV+++ + S G P+ + + + I G
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG 217
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 71/266 (26%), Positives = 119/266 (44%), Gaps = 17/266 (6%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
ELGRG +GV TG A K I R V ++ + ++ I P V F
Sbjct: 8 ELGRGAYGVVDKMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDLDISMRSVDCPYTVTF 65
Query: 146 KGAYEDKQSVHVVMELCAGG--ELFDRIIAKG-HYSERAAASICRSIVNVVHICHF-MGV 201
GA + V + ME+ + + ++ KG E I SIV + H + V
Sbjct: 66 YGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV 125
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL-----RR 256
+HRD+KP N L+ + N +K DFG+S ++ + G Y+APE + ++
Sbjct: 126 IHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK 182
Query: 257 RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA-PWPTISSSAKDL 315
Y + D+WS G+ + L +G P+ ++ K F + Q + P S +D
Sbjct: 183 GYDVKSDVWSLGITMIELATGRFPY--DSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDF 240
Query: 316 VRRMLTQDPKKRITSAQVLEHPWIKE 341
V + L ++ K+R ++L+HP+ +
Sbjct: 241 VNKCLKKNYKERPNYPELLQHPFFEL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 5e-16
Identities = 70/317 (22%), Positives = 123/317 (38%), Gaps = 60/317 (18%)
Query: 82 SFGKELGRG--QFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR---EIQIMQHL 136
+G+ + +L T A K I+ + K+D+K EI + L
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKIN----LDSCSKEDLKLLQQEIITSRQL 56
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY----SERAAASICRSIVNV 192
PNI+ + ++ ++VV L A G D + K H+ E A A I + ++N
Sbjct: 57 Q-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNA 113
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA------ 246
+ H G +HR +K + LLS D +L + +S I+ GK R +
Sbjct: 114 LDYIHSKGFIHRSVKASHILLSG-DGKVVLSGLRYSVS-MIKHGKRQRVVHDFPKSSVKN 171
Query: 247 -YYVAPEVLR---RRYGKEIDIWSAGVILYILLSGVPPFWAETE---------KGIFDAI 293
+++PEVL+ + Y ++ DI+S G+ L +G PF + +G +
Sbjct: 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF-KDMPATQMLLEKVRGTVPCL 230
Query: 294 L--------QGDI--DFESAPWPTISSSAKDLVRRM------------LTQDPKKRITSA 331
L + + S P S R L +DP+ R +++
Sbjct: 231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSAS 290
Query: 332 QVLEHPWIKEGGEASDK 348
Q+L H + K+ +
Sbjct: 291 QLLNHSFFKQCKRRNTS 307
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 6e-16
Identities = 68/228 (29%), Positives = 117/228 (51%), Gaps = 15/228 (6%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
ELG G GV + + +G A K I + ++ I RE+Q++ H P IV F
Sbjct: 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVL-HECNSPYIVGF 68
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVN-VVHICHFMGVMH 203
GA+ + + ME GG L D+++ K G E+ + +++ + ++ +MH
Sbjct: 69 YGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMH 127
Query: 204 RDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRYGKEI 262
RD+KP N L++S+ E +K DFG+S + + + VG+ Y++PE L+ Y +
Sbjct: 128 RDVKPSNILVNSRGE---IKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQS 183
Query: 263 DIWSAGVILYILLSG---VPPFWAETEKGIFDAILQGD-IDFESAPWP 306
DIWS G+ L + G +PP A+ + +F ++GD + E++P P
Sbjct: 184 DIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRP 231
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 7e-16
Identities = 74/276 (26%), Positives = 106/276 (38%), Gaps = 48/276 (17%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCT---ENSTGRQFACKSISKRKLVTKNDKDDIKR--- 128
ED+ L G+ +G GQFG Y + A K KN R
Sbjct: 6 EDITL----GRCIGEGQFGDVYQGVYMSPENEKIAVAVK-------TCKNCTSPSVREKF 54
Query: 129 --EIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASI- 185
E IM+ P+IV+ G + V +VMEL GEL Y + S+
Sbjct: 55 LQEAYIMRQFD-HPHIVKLIGVITE-NPVWIVMELAPLGEL-------RSYLQVNKYSLD 105
Query: 186 -------CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238
+ + +HRD+ N L+SS D +K DFGLS ++E+
Sbjct: 106 LASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD---CVKLGDFGLSRYLEDESY 162
Query: 239 YRDIVGS--AYYVAPEVLR-RRYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAIL 294
Y+ G ++APE + RR+ D+W GV ++ IL+ GV PF + I
Sbjct: 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE 222
Query: 295 QGDIDFESAPWPTISSSA-KDLVRRMLTQDPKKRIT 329
G E P P L+ + DP KR
Sbjct: 223 NG----ERLPMPPNCPPTLYSLMTKCWAYDPSKRPR 254
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 80/289 (27%), Positives = 118/289 (40%), Gaps = 42/289 (14%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND--KDDIKREIQIMQHLS 137
Y + +G+G G YL + R+ A K I R+ +++N K RE +I L
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKI--REDLSENPLLKKRFLREAKIAADLI 60
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFD--------RIIAKGHY---SERAAASIC 186
P IV D V+ M G L ++K S A SI
Sbjct: 61 -HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 187 RSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE------------ 234
I + H GV+HRDLKP+N LL E +L D+G ++F +
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVIL---DWGAAIFKKLEEEDLLDIDVD 176
Query: 235 -EGKVYRD------IVGSAYYVAPEVLRRRYGKE-IDIWSAGVILYILLSGVPPFWAETE 286
Y IVG+ Y+APE L E DI++ GVILY +L+ P+ +
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236
Query: 287 KGI-FDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVL 334
+ I + ++ I E AP+ I + + L DP +R +S Q L
Sbjct: 237 RKISYRDVILSPI--EVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283
|
Length = 932 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 76/300 (25%), Positives = 127/300 (42%), Gaps = 53/300 (17%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +G G G+ + G A K +S R + RE+ +++ ++ NI+
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQNQTHAKRAYRELVLLKCVN-HKNIIS 84
Query: 145 FKGAY------EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198
+ E+ Q V++VMEL ++I ER + + + + + H+ H
Sbjct: 85 LLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGIKHL-HS 141
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV-LRRR 257
G++HRDLKP N ++ S + LK DFGL+ + V + YY APEV L
Sbjct: 142 AGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG 198
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ----GDIDFESAPWPTI----- 308
Y + +DIWS G I+ L+ G F ++ +++ +F + PT+
Sbjct: 199 YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVE 258
Query: 309 -----------------------------SSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
+S A+DL+ +ML DP KRI+ + L HP+I
Sbjct: 259 NRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
+++G+G FG Y + A K+ R + + K +E +I++ PNIV+
Sbjct: 1 EKIGKGNFGDVYKGVLKGNT-EVAVKTC--RSTLPPDLKRKFLQEAEILKQYD-HPNIVK 56
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRI-IAKGHYSERAAASICRSIVNVVHICHFMGVMH 203
G KQ +++VMEL GG L + K + + + + +H
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIH 116
Query: 204 RDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY------YVAPEVLRR- 256
RDL N L+ EN +LK +DFG+S EEG +Y V + APE L
Sbjct: 117 RDLAARNCLV---GENNVLKISDFGMSR-EEEGGIY--TVSDGLKQIPIKWTAPEALNYG 170
Query: 257 RYGKEIDIWSAGVILYILLS-GVPPF 281
RY E D+WS G++L+ S G P+
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPY 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 32/211 (15%)
Query: 85 KELGRGQFGVTYLC----TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
++LG G FG LC ++TG Q A KS+ N D+K+EI+I+++L +
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHE- 66
Query: 141 NIVEFKGAYEDK--QSVHVVMELCAGGELFDRIIAKGHYSERAAASI-CRSIVN-VVHIC 196
NIV++KG + + ++ME G L + Y R I + + V IC
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKE-------YLPRNKNKINLKQQLKYAVQIC 119
Query: 197 HFMGVM------HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR----DIVGSA 246
M + HRDL N L+ S+ + +K DFGL+ IE K Y D+
Sbjct: 120 KGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDKEYYTVKDDLDSPV 176
Query: 247 YYVAPEVL-RRRYGKEIDIWSAGVILYILLS 276
++ APE L + ++ D+WS GV LY LL+
Sbjct: 177 FWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 45/146 (30%), Positives = 75/146 (51%), Gaps = 4/146 (2%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K + RG FG YL + + + +A K + K ++ KN ++ E + LS P IV
Sbjct: 10 KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-LSKSPFIVH 68
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
+ + +V++VME GG++ + G++ E A + + H G++HR
Sbjct: 69 LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHR 128
Query: 205 DLKPENFLLSSKDENALLKATDFGLS 230
DLKP+N L+S++ +K TDFGLS
Sbjct: 129 DLKPDNMLISNEGH---IKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 74/258 (28%), Positives = 113/258 (43%), Gaps = 33/258 (12%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
+ +GRG FG + + A KS R+ + + K +E +I++ S PNIV
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSC--RETLPPDLKAKFLQEARILKQYS-HPNIVR 57
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKG---------HYSERAAASICRSIVNVVHI 195
G KQ +++VMEL GG+ + +G E AAA + + H
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGM--EYLESKH- 114
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG----SAYYVAP 251
+HRDL N L++ K+ +LK +DFG+S E+G VY G + AP
Sbjct: 115 -----CIHRDLAARNCLVTEKN---VLKISDFGMSREEEDG-VYASTGGMKQIPVKWTAP 165
Query: 252 EVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309
E L RY E D+WS G++L+ S G P+ + + +AI QG
Sbjct: 166 EALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG---VRLPCPELCP 222
Query: 310 SSAKDLVRRMLTQDPKKR 327
+ L+ R DP +R
Sbjct: 223 DAVYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 77/315 (24%), Positives = 130/315 (41%), Gaps = 42/315 (13%)
Query: 70 LGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKRE 129
L K +V Y +G G +G + TG + A K +S R + RE
Sbjct: 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRE 66
Query: 130 IQIMQHLS-----GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAAS 184
+++++H+ G ++ + E+ V++V L G +L + I+ ++
Sbjct: 67 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADL-NNIVKCQKLTDDHVQF 124
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG 244
+ I+ + H ++HRDLKP N + +E+ LK DFGL+ ++ V
Sbjct: 125 LIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMT--GYVA 179
Query: 245 SAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES 302
+ +Y APE++ Y + +DIWS G I+ LL+G F IL+ +
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239
Query: 303 APWPTISSS---------------------------AKDLVRRMLTQDPKKRITSAQVLE 335
ISS A DL+ +ML D KRIT+AQ L
Sbjct: 240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299
Query: 336 HPWIKEGGEASDKPI 350
H + + + D+P+
Sbjct: 300 HAYFAQYHDPDDEPV 314
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-15
Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 16/223 (7%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+F KELG GQFGV A K I + + +D+ E ++M LS
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSM----SEDEFIEEAKVMMKLS-H 58
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAA-ASICRSIVNVVHICHF 198
+V+ G ++ +++V E + G L + + G + + +C+ + +
Sbjct: 59 EKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES 118
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---APEVLR 255
+HRDL N L+ D+ +K +DFGLS ++ + + Y VGS + V PEVL
Sbjct: 119 KQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLL 174
Query: 256 R-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
++ + D+W+ GV+++ + S G P+ + + QG
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG 217
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 4e-15
Identities = 65/259 (25%), Positives = 112/259 (43%), Gaps = 19/259 (7%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKL-VTKNDKDDIKREIQIMQHLSGQPNIVEF 145
+G G+FG G++ +I K T+ + D E IM PNI+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNIIHL 70
Query: 146 KGAYEDKQSVHVVMELCAGGEL--FDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMH 203
+G + V ++ E G L F R G ++ + R I + M +H
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVH 129
Query: 204 RDLKPENFLLSSKDENALLKATDFGLSVFIEEGK---VYRDIVGSAY---YVAPEVLR-R 256
RDL N L++S N + K +DFGLS F+E+ Y +G + APE + R
Sbjct: 130 RDLAARNILVNS---NLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 257 RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315
++ D+WS G++++ ++S G P+W + + + +AI Q D+ P ++ L
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ---DYRLPPPMDCPTALHQL 243
Query: 316 VRRMLTQDPKKRITSAQVL 334
+ +D R Q++
Sbjct: 244 MLDCWQKDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 5e-15
Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 30/209 (14%)
Query: 85 KELGRGQFG-VTYLC---TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ LG G FG V+ C + TG A K++ KR+ +N K+EI I++ L +
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL-KRECGQQN-TSGWKKEINILKTLYHE- 66
Query: 141 NIVEFKGAYEDK--QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198
NIV++KG ++ + + ++ME G L D Y + ++ + ++ IC
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD-------YLPKHKLNLAQLLLFAQQICEG 119
Query: 199 MGVMH------RDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY----RDIVGSAYY 248
M +H RDL N LL D + L+K DFGL+ + EG Y D ++
Sbjct: 120 MAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 249 VAPEVLRR-RYGKEIDIWSAGVILYILLS 276
A E L+ ++ D+WS GV LY LL+
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 6e-15
Identities = 68/284 (23%), Positives = 127/284 (44%), Gaps = 21/284 (7%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG G G Y T R A K I +T + I E++I+ + P I+ F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEIL-YKCDSPYIIGFY 65
Query: 147 GAYEDKQSVHVVMELCAGGEL--FDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
GA+ + + + E GG L + +I E I ++V + + ++HR
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKI------PEHVLGRIAVAVVKGLTYLWSLKILHR 119
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPE-VLRRRYGKEID 263
D+KP N L++++ + +K DFG+S + + + VG+ Y+APE + +YG D
Sbjct: 120 DVKPSNMLVNTRGQ---VKLCDFGVSTQLVN-SIAKTYVGTNAYMAPERISGEQYGIHSD 175
Query: 264 IWSAGVILYILLSGVPPF-WAETEKGIFDAI--LQGDIDFESAPWPT--ISSSAKDLVRR 318
+WS G+ L G P+ + +G + LQ +D + P S + +
Sbjct: 176 VWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQ 235
Query: 319 MLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFR 362
+ + PK+R +++HP+I + + + + + V +++ R
Sbjct: 236 CMRKQPKERPAPENLMDHPFIVQYNDGNAEVVSMWVCRALEERR 279
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 6e-15
Identities = 72/271 (26%), Positives = 105/271 (38%), Gaps = 38/271 (14%)
Query: 85 KELGRGQFGVTYLCT-ENSTGR--QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
K+LG G FGV S G+ A K + KL + DD +E IM L N
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLD-HEN 57
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRI--IAKGHYSERAAASICRSIVNVVHICHFM 199
++ G + +V EL G L DR+ A GH+ I N +
Sbjct: 58 LIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---------- 249
+HRDL N LL+S D +K DFGL + + + +YV
Sbjct: 117 RFIHRDLAARNILLASDD---KVKIGDFGLMRALPQNE--------DHYVMEEHLKVPFA 165
Query: 250 --APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305
APE LR R + D+W GV L+ + + G P+ + I I D + E
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI---DKEGERLER 222
Query: 306 PTISSS-AKDLVRRMLTQDPKKRITSAQVLE 335
P +++ + +P R T A + E
Sbjct: 223 PEACPQDIYNVMLQCWAHNPADRPTFAALRE 253
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 80/300 (26%), Positives = 128/300 (42%), Gaps = 53/300 (17%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +G G G+ + R A K +S R + RE+ +M+ ++ NI+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVN-HKNIIS 80
Query: 145 FKGAY------EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198
+ E+ Q V++VMEL ++I ER + + + + + H+ H
Sbjct: 81 LLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 137
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV-LRRR 257
G++HRDLKP N ++ S + LK DFGL+ + V + YY APEV L
Sbjct: 138 AGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 258 YGKEIDIWSAGVIL------YILLSG-----------------VPPFWAETEKGIFDAI- 293
Y + +DIWS G I+ IL G P F + + + + +
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 294 -------LQGDIDFESAPWPTIS-------SSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
L F + +P S S A+DL+ +ML DP KRI+ + L+HP+I
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 75/313 (23%), Positives = 132/313 (42%), Gaps = 52/313 (16%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISK---RKLVTKNDKDDIKREIQI 132
+V Y K++G G +G + TG + A K + + +L K RE+++
Sbjct: 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR----AYRELRL 67
Query: 133 MQHLSGQPNIVEFKGAY------EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASIC 186
++H+ + N++ + + ++VM G +++ SE +
Sbjct: 68 LKHMKHE-NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLV 124
Query: 187 RSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA 246
++ + H G++HRDLKP N + +E+ LK DFGL+ + V +
Sbjct: 125 YQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLAR--QTDSEMTGYVVTR 179
Query: 247 YYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAE--------------TEKGIF 290
+Y APEV+ Y + +DIWS G I+ +L+G P F T F
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239
Query: 291 DAILQGD--------------IDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
LQ + DF S P + A +++ +ML D + RIT+A+ L H
Sbjct: 240 VQKLQSEDAKNYVKKLPRFRKKDFRSL-LPNANPLAVNVLEKMLVLDAESRITAAEALAH 298
Query: 337 PWIKEGGEASDKP 349
P+ +E + D+
Sbjct: 299 PYFEEFHDPEDET 311
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 52/180 (28%), Positives = 84/180 (46%), Gaps = 36/180 (20%)
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIVGSAYYVAPEVL 254
CH V+HRDLKP+N L++ + E LK DFGL+ K Y + V + +Y P++L
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYSNEVVTLWYRPPDIL 176
Query: 255 --RRRYGKEIDIWSAGVILYILLSGVPPFWAET--EKGIFDAILQGDIDFESAPWPTISS 310
Y +ID+W G I Y + +G P F T E+ F + G E+ WP I S
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEET--WPGILS 234
Query: 311 SAK--------------------------DLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344
+ + +L+ ++L + +KRI++ + ++HP+ GE
Sbjct: 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 77/314 (24%), Positives = 135/314 (42%), Gaps = 55/314 (17%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH 135
++ Y+ K++G G +G + TG + A K +S R ++ RE+ +++H
Sbjct: 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS-RPFQSEIFAKRAYRELTLLKH 70
Query: 136 L-----SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI----IAKGHYSERAAASIC 186
+ G ++ + ++ Q ++VM + + I SE +
Sbjct: 71 MQHENVIGLLDVFTSAVSGDEFQDFYLVMP-------YMQTDLQKIMGHPLSEDKVQYLV 123
Query: 187 RSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIVGS 245
++ + H G++HRDLKP N + +E+ LK DFGL+ + E Y V +
Sbjct: 124 YQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGLARHADAEMTGY---VVT 177
Query: 246 AYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ-----GDI 298
+Y APEV+ Y + +DIWS G I+ +L+G F + IL+ G
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP- 236
Query: 299 DF-------------ESAP----------WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335
+F +S P +P S A DL+ +ML D KR+T+ + LE
Sbjct: 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296
Query: 336 HPWIKEGGEASDKP 349
HP+ +A ++
Sbjct: 297 HPYFDSFRDADEET 310
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 29/214 (13%)
Query: 80 HYSFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH 135
H F ++LG+G FG LC +++TG A K K + T D +REI+I++
Sbjct: 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVK---KLQHSTAEHLRDFEREIEILKS 61
Query: 136 LSGQPNIVEFKG-AYE-DKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVV 193
L NIV++KG Y ++++ +VME G L D + + ER + ++
Sbjct: 62 LQHD-NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQ---KHRERLDHR--KLLLYAS 115
Query: 194 HICHFMGVM------HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV---- 243
IC M + HRDL N L+ S+ +K DFGL+ + + K Y +
Sbjct: 116 QICKGMEYLGSKRYVHRDLATRNILVESE---NRVKIGDFGLTKVLPQDKEYYKVREPGE 172
Query: 244 GSAYYVAPEVL-RRRYGKEIDIWSAGVILYILLS 276
++ APE L ++ D+WS GV+LY L +
Sbjct: 173 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 90/326 (27%), Positives = 140/326 (42%), Gaps = 72/326 (22%)
Query: 66 TNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD 125
T T+L K Y+++K +G G G+ + TG+ A K +S R
Sbjct: 11 TFTVL-KRYQNLKP-------IGSGAQGIVCAAYDTVTGQNVAIKKLS-RPFQNVTHAKR 61
Query: 126 IKREIQIMQHLSGQPNIVEFKGAY------EDKQSVHVVME-----LCAGGELFDRIIAK 174
RE+ +M+ L NI+ + E+ Q V++VME LC ++I
Sbjct: 62 AYRELVLMK-LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLC-------QVIQM 113
Query: 175 GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234
ER + + + + + H+ H G++HRDLKP N ++ S + LK DFGL+
Sbjct: 114 DLDHERMSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAG 169
Query: 235 EGKVYRDIVGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPF--------WAE- 284
+ V + YY APEV L Y + +DIWS G I+ ++ G F W +
Sbjct: 170 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKI 229
Query: 285 -----TEKGIFDAILQGDID--FESAP---------------WPTISSS--------AKD 314
T F + LQ + E+ P +P S S A+D
Sbjct: 230 IEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARD 289
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWIK 340
L+ +ML DP+KRI+ L+HP+I
Sbjct: 290 LLSKMLVIDPEKRISVDDALQHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 56/177 (31%), Positives = 78/177 (44%), Gaps = 42/177 (23%)
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGL----SVFIEEGKVYRDIVGSAYYVAP 251
CH ++HRDLKP+N L++ K E LK DFGL SV K Y + V + +Y P
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSV---PTKTYSNEVVTLWYRPP 172
Query: 252 EVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI--LQGDIDFESAPWPT 307
+VL Y ID+W G ILY + +G P F T K I L G E+ WP
Sbjct: 173 DVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET--WPG 230
Query: 308 ISSSAK--------------------------DLVRRMLTQDPKKRITSAQVLEHPW 338
I+S+ + DL+ +L + K RI++ L H +
Sbjct: 231 ITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 79/299 (26%), Positives = 131/299 (43%), Gaps = 51/299 (17%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ-----HLSGQ 139
K +G G G+ + R A K +S R + RE+ +M+ ++ G
Sbjct: 30 KPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
N+ + + E+ Q V++VMEL ++I ER + + + + + H+ H
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HSA 145
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV-LRRRY 258
G++HRDLKP N ++ S + LK DFGL+ + V + YY APEV L Y
Sbjct: 146 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 259 GKEIDIWSAGVILYILLSGVPPF--------WAETEKGI------FDAILQGDID--FES 302
+ +DIWS G I+ ++ G F W + + + F LQ + E+
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262
Query: 303 AP----------WPTI------------SSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
P +P + +S A+DL+ +ML D KRI+ + L+HP+I
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 5e-14
Identities = 38/101 (37%), Positives = 60/101 (59%), Gaps = 10/101 (9%)
Query: 242 IVGSAYYVAPEVL-RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF 300
I+G+ Y+APE+L + +G +D W+ GV L+ L+G+PPF ET + +F IL DI
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDI-- 597
Query: 301 ESAPWP----TISSSAKDLVRRMLTQDPKKRITSAQVLEHP 337
PWP +S +A++ + +LT DP KR ++ +HP
Sbjct: 598 ---PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 7e-14
Identities = 73/279 (26%), Positives = 109/279 (39%), Gaps = 58/279 (20%)
Query: 87 LGRGQFGVTYLCT-----ENSTGRQ-FACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
LG G FG Y T +G A K++ RK T +K + +E +M + + P
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNFN-HP 59
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAAS--------------IC 186
NIV+ G + +++MEL GG+L Y A IC
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLL-------SYLRDARVERFGPPLLTLKELLDIC 112
Query: 187 RSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA--LLKATDFGLSVFIEEGKVYRDIVG 244
+ M +HRDL N L+S K +A ++K DFGL+ RDI
Sbjct: 113 LDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDIYK 163
Query: 245 SAYY------------VAPEVLRR-RYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIF 290
S YY +APE L ++ + D+WS GV+++ IL G P+ A + +
Sbjct: 164 SDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223
Query: 291 DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT 329
+ G L+ QDP +R T
Sbjct: 224 QHVTAGG---RLQKPENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 7e-14
Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 14/221 (6%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKL-VTKNDKDDIKREIQIMQHLSGQPNIV 143
K +G G+FG G++ +I K T+ + D E IM PNI+
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD-HPNII 68
Query: 144 EFKGAYEDKQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGV 201
+G + V +V E G L D + K G ++ + R I + + MG
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY 127
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG--KVYRDIVGS--AYYVAPEVLR-R 256
+HRDL N L++S N + K +DFGLS +E+ Y G + APE + R
Sbjct: 128 VHRDLAARNILVNS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 257 RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
++ D+WS G++++ ++S G P+W + + + AI +G
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG 225
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
ELG G GV +G A K I + ++ I RE+Q++ H P IV F
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVL-HECNSPYIVGF 68
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG----- 200
GA+ + + ME GG L D+++ + A I I+ V I G
Sbjct: 69 YGAFYSDGEISICMEHMDGGSL-DQVL-------KEAKRIPEEILGKVSIAVLRGLAYLR 120
Query: 201 ----VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR- 255
+MHRD+KP N L++S+ E +K DFG+S + + + VG+ Y++PE L+
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQG 176
Query: 256 RRYGKEIDIWSAGVILYILLSG---VPPFWAETEKGIF 290
Y + DIWS G+ L L G +PP A+ + IF
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 63/245 (25%), Positives = 105/245 (42%), Gaps = 54/245 (22%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND---KDDIKRE 129
P V+ F +ELG G FG Y + + S++ + L + + + ++E
Sbjct: 3 PLSAVR----FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 130 IQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSI 189
++M L PNIV G +Q ++ E A G+L + ++ +S+ A S ++
Sbjct: 59 AELMSDLQ-HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 190 VN------VVHIC------------HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231
+ +HI H +HRDL N L+ E +K +DFGLS
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG---EGLTVKISDFGLS- 171
Query: 232 FIEEGKVYRDIVGSAYY------------VAPE-VLRRRYGKEIDIWSAGVILYILLS-G 277
RDI + YY + PE +L ++ E DIWS GV+L+ + S G
Sbjct: 172 --------RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYG 223
Query: 278 VPPFW 282
+ P++
Sbjct: 224 LQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 21/222 (9%)
Query: 127 KREIQIMQHLSGQPNIVEF--KGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAAS 184
+RE + L PNIV G + V E G L + + A G
Sbjct: 26 RRETALCARLY-HPNIVALLDSGEAPPGL-LFAVFEYVPGRTLREVLAADGALPAGETGR 83
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI---EEGKVYR- 240
+ +++ + H G++HRDLKP+N ++S K DFG+ + + V
Sbjct: 84 LMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATL 143
Query: 241 ----DIVGSAYYVAPEVLRRRYGKEI----DIWSAGVILYILLSGVPPFWAETEKGIFDA 292
+++G+ Y APE LR G+ + D+++ G+I L+G + I
Sbjct: 144 TRTTEVLGTPTYCAPEQLR---GEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQ 200
Query: 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVL 334
L +D PW ++R+ L +DP++R SA L
Sbjct: 201 QL-SPVDVSLPPW-IAGHPLGQVLRKALNKDPRQRAASAPAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 32/177 (18%)
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIVGSAYYVAPEVL 254
CH V+HRDLKP+N L++ + E LK DFGL+ K Y + V + +Y P+VL
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 176
Query: 255 --RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312
Y +ID+W G I + + SG P F T + I + WP ISS+
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236
Query: 313 K--------------------------DLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343
+ +L+ + L + KKRI++ + ++H + + G
Sbjct: 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 72/309 (23%), Positives = 120/309 (38%), Gaps = 68/309 (22%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y G +G G FGV Y T + A K + + D RE+ IM++L+
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ-------DPQYKNRELLIMKNLN-HI 119
Query: 141 NIVEFKGAY--------EDKQSVHVVMELCAGGELFDRIIAK--GHYSERAAA------- 183
NI+ K Y E ++VVME + + K HY+ A
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEF------IPQTVHKYMKHYARNNHALPLFLVK 173
Query: 184 ----SICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239
+CR++ + H + HRDLKP+N L+ LK DFG + + G+
Sbjct: 174 LYSYQLCRALAYI----HSKFICHRDLKPQNLLIDPNTHT--LKLCDFGSAKNLLAGQRS 227
Query: 240 RDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ-- 295
+ S +Y APE++ Y ID+WS G I+ ++ G P F ++ I+Q
Sbjct: 228 VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL 287
Query: 296 ----------GDIDFESAPWPTISS-------------SAKDLVRRMLTQDPKKRITSAQ 332
+ ++ +P + A + + + L +P KR+ +
Sbjct: 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIE 347
Query: 333 VLEHPWIKE 341
L P+ +
Sbjct: 348 ALADPFFDD 356
|
Length = 440 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 9e-13
Identities = 83/324 (25%), Positives = 128/324 (39%), Gaps = 82/324 (25%)
Query: 84 GKELGRGQFGVTYLC--TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
G ++GRG +G Y + +++A K I + REI +++ L PN
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMS-----ACREIALLRELK-HPN 59
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRI------IAKGHYSERA-----------AAS 184
++ + + V + LFD I K H + +A S
Sbjct: 60 VIALQKVFLSHSDRKVWL-------LFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKS 112
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFL-LSSKDENALLKATDFGLS-VFIEEGKVYRD- 241
+ I++ +H H V+HRDLKP N L + E +K D G + +F K D
Sbjct: 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 242 --IVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVP-------------PFWAE 284
+V + +Y APE+L R Y K IDIW+ G I LL+ P PF +
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHD 232
Query: 285 TEKGIFDAI-LQGDIDFES----APWPTISSSAKD------------------------- 314
IF + D D+E +PT+ +
Sbjct: 233 QLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFL 292
Query: 315 LVRRMLTQDPKKRITSAQVLEHPW 338
L++++LT DP KRITS Q L+ P+
Sbjct: 293 LLQKLLTMDPTKRITSEQALQDPY 316
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 43/214 (20%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR------EIQIM 133
G +G+G+FG L +K+ K KDD E +M
Sbjct: 7 ELKLGATIGKGEFGDVMLGD------------YRGQKVAVKCLKDDSTAAQAFLAEASVM 54
Query: 134 QHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVV 193
L PN+V+ G +++V E A G L D + ++G RA ++ + + +
Sbjct: 55 TTLR-HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG----RAVITLAQQLGFAL 109
Query: 194 HICHFM------GVMHRDLKPENFLLSSKDENALLKATDFGL----SVFIEEGKVYRDIV 243
+C M +HRDL N L+S E+ + K +DFGL S + GK+
Sbjct: 110 DVCEGMEYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLAKEASQGQDSGKL----- 161
Query: 244 GSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS 276
+ APE LR +++ + D+WS G++L+ + S
Sbjct: 162 -PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 72/314 (22%), Positives = 134/314 (42%), Gaps = 42/314 (13%)
Query: 70 LGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKRE 129
L K +V Y +G G +G + ++ A K +S R + RE
Sbjct: 6 LNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLS-RPFQSLIHARRTYRE 64
Query: 130 IQIMQHLS-----GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAAS 184
+++++H+ G ++ + E+ V++V L G +L + I+ S+
Sbjct: 65 LRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNL-MGADL-NNIVKCQKLSDEHVQF 122
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG 244
+ ++ + H G++HRDLKP N + +E+ L+ DFGL+ ++ V
Sbjct: 123 LIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGLARQADDEMT--GYVA 177
Query: 245 SAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPF----WAETEKGIFDAILQGDI 298
+ +Y APE++ Y + +DIWS G I+ LL G F + + K I + +
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237
Query: 299 DF-------------ESAP----------WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335
+ +S P + + A DL+ +ML D KRI++++ L
Sbjct: 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297
Query: 336 HPWIKEGGEASDKP 349
HP+ + + D+P
Sbjct: 298 HPYFSQYHDPEDEP 311
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 85/324 (26%), Positives = 127/324 (39%), Gaps = 82/324 (25%)
Query: 84 GKELGRGQFGVTYLCT--ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
G ++GRG +G Y + R +A K I + REI +++ L PN
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMS-----ACREIALLRELK-HPN 59
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRI------IAKGHYSERA-----------AAS 184
++ + + V + LFD I K H + +A S
Sbjct: 60 VISLQKVFLSHADRKVWL-------LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS 112
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFL-LSSKDENALLKATDFGLS-VFIEEGKVYRD- 241
+ I++ +H H V+HRDLKP N L + E +K D G + +F K D
Sbjct: 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 242 --IVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETE----------- 286
+V + +Y APE+L R Y K IDIW+ G I LL+ P F E
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 232
Query: 287 --KGIFDAI-LQGDIDFES-APWPTISSSAKD---------------------------- 314
IF+ + D D+E P S+ KD
Sbjct: 233 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFH 292
Query: 315 LVRRMLTQDPKKRITSAQVLEHPW 338
L++++LT DP KRITS Q ++ P+
Sbjct: 293 LLQKLLTMDPIKRITSEQAMQDPY 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 50/177 (28%), Positives = 69/177 (38%), Gaps = 41/177 (23%)
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIVGSAYYVAPEVL- 254
H ++HRDLKP+N L+S E LK DFGL+ + Y V + +Y P+VL
Sbjct: 120 HGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLL 176
Query: 255 -RRRYGKEIDIWSAGVILYILLSGVPPF-------------WA-------ETEKGIFDAI 293
Y +DIW AG I +L G P F W +T G+
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL- 235
Query: 294 LQGDIDFESAPWPTISS------------SAKDLVRRMLTQDPKKRITSAQVLEHPW 338
+ E A+DL +ML PK RI++ L HP+
Sbjct: 236 --PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 5e-12
Identities = 58/246 (23%), Positives = 102/246 (41%), Gaps = 48/246 (19%)
Query: 82 SFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL 136
+ + LG G FG Y ++ Q A K++ + ++ D+ D E IM
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESCSEQDESDFLMEALIMSKF 66
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGEL--FDRIIAKGHYSERAAASICRSIVNVVH 194
+ NIV G ++ +++EL AGG+L F R R ++ +++
Sbjct: 67 N-HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLR-----ENRPRPERPSSLTMKDLLF 120
Query: 195 I-------CHFM---GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG 244
C ++ +HRD+ N LL+ K + K DFG++ RDI
Sbjct: 121 CARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYR 171
Query: 245 SAYY------------VAPEV-LRRRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIF 290
++YY + PE L + + D+WS GV+L+ + S G P+ T + +
Sbjct: 172 ASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231
Query: 291 DAILQG 296
+ + G
Sbjct: 232 EFVTGG 237
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-12
Identities = 59/219 (26%), Positives = 89/219 (40%), Gaps = 31/219 (14%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD---IKREIQIMQHLSG 138
SFGK LG G FG T + A ++ + L + + E++IM HL
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN 97
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHIC 196
NIV GA + V+ E C G+L + + K + S + +
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV------- 249
+HRDL N LL+ ++K DFGL+ RDI+ + YV
Sbjct: 158 ASKNCIHRDLAARNVLLT---HGKIVKICDFGLA---------RDIMNDSNYVVKGNARL 205
Query: 250 -----APE-VLRRRYGKEIDIWSAGVILYILLS-GVPPF 281
APE + Y E D+WS G++L+ + S G P+
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 70/277 (25%), Positives = 117/277 (42%), Gaps = 55/277 (19%)
Query: 86 ELGRGQFGVTYL--CTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIV 143
ELG G FG +L C + ++ K +++ + D +RE +++ L Q +IV
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQ-HIV 70
Query: 144 EFKGAYEDKQSVHVVMELCAGGEL--FDR-------IIAKGHYSE----------RAAAS 184
F G + + + +V E G+L F R I+A G A+
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG 244
I +V + + HF+ HRDL N L+ + ++K DFG+S RDI
Sbjct: 131 IASGMVYLASL-HFV---HRDLATRNCLVG---QGLVVKIGDFGMS---------RDIYS 174
Query: 245 SAYY------------VAPE-VLRRRYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIF 290
+ YY + PE +L R++ E DIWS GV+L+ I G P++ +
Sbjct: 175 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234
Query: 291 DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKR 327
+ I QG E T +++ ++P++R
Sbjct: 235 ECITQGR---ELERPRTCPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 8e-12
Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 17/222 (7%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKL---VTKNDKDDIKREIQIMQHLSGQPN 141
K +G G+FG G++ ++ + L + + D E IM PN
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKK--EIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD-HPN 66
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFM 199
I+ +G + V ++ E G L D+ + + G ++ + R I + + M
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM 125
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG---SAYYVAPEVLR- 255
+HRDL N L++S N + K +DFGLS +E+ + G + APE +
Sbjct: 126 NYVHRDLAARNILVNS---NLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182
Query: 256 RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
R++ D+WS G++++ ++S G P+W + + + A+ G
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 9e-12
Identities = 67/287 (23%), Positives = 117/287 (40%), Gaps = 53/287 (18%)
Query: 83 FGKELGRGQFGVTYL--CTENSTGRQFACKSISKRKLVTKND-KDDIKREIQIMQHLSGQ 139
+ELG G FG +L C ++ K ND + D +RE +++ +
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QH 67
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAA--SICR--SIVNVVHI 195
NIV+F G + +V E G+L + + G + + S ++ ++ I
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 196 C-------------HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI 242
HF+ HRDL N L+ + ++K DFG+S RD+
Sbjct: 128 AVQIASGMVYLASQHFV---HRDLATRNCLVG---YDLVVKIGDFGMS---------RDV 172
Query: 243 VGSAYY------------VAPE-VLRRRYGKEIDIWSAGVILY-ILLSGVPPFWAETEKG 288
+ YY + PE ++ R++ E D+WS GV+L+ I G P++ + +
Sbjct: 173 YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232
Query: 289 IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335
+ + I QG T S D++ +DP++RI + E
Sbjct: 233 VIECITQG---RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 63/244 (25%), Positives = 108/244 (44%), Gaps = 31/244 (12%)
Query: 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIM 133
+ED+K F +G G FG G + ++ ++ND D E++++
Sbjct: 1 WEDIK----FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVL 56
Query: 134 QHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD-----RII------AKGHYSERAA 182
L PNI+ GA E++ +++ +E G L D R++ AK H +
Sbjct: 57 CKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTL 116
Query: 183 AS--ICRSIVNVVHICHFMG---VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237
S + + +V ++ +HRDL N L+ EN K DFGLS +
Sbjct: 117 TSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG---ENLASKIADFGLS---RGEE 170
Query: 238 VY-RDIVGS--AYYVAPEVLRRR-YGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDA 292
VY + +G ++A E L Y + D+WS GV+L+ ++S G P+ T +++
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK 230
Query: 293 ILQG 296
+ QG
Sbjct: 231 LPQG 234
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 14/226 (6%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL-VTKNDKDDIKREIQIMQHLSG 138
H + K +G G+FG + GR+ +I K T+ + D E IM S
Sbjct: 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHIC 196
NI+ +G + ++ E G L D+ + G +S + R I +
Sbjct: 66 H-NIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK--VYRDIVGSA--YYVAPE 252
M +HRDL N L++S N K +DFGLS +E+ Y G + APE
Sbjct: 124 SDMNYVHRDLAARNILVNS---NLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180
Query: 253 VLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
+ R++ D+WS G++++ ++S G P+W + + AI G
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 74/291 (25%), Positives = 125/291 (42%), Gaps = 47/291 (16%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK--REIQIMQHLSG--QPN 141
E+G G +G + + G +F ++ + ++ T + + RE+ +++HL PN
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 142 IVEF-------KGAYEDKQSV---HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN 191
+V + E K ++ HV +L D++ G +E + ++
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTE-TIKDMMFQLLR 121
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAP 251
+ H V+HRDLKP+N L++S + +K DFGL+ +V + +Y AP
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTLWYRAP 178
Query: 252 EV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAI-LQGDID------ 299
EV L+ Y +D+WS G I + P F ++ I D I L G+ D
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238
Query: 300 -----FESAPW-------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
F S I KDL+ + LT +P KRI++ L HP+
Sbjct: 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 38/213 (17%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--------G 138
LG+G FG + T K + K K+D+ +E++I + LS
Sbjct: 3 LGKGNFGEVFKGTLKD-----------KTPVAVKTCKEDLPQELKI-KFLSEARILKQYD 50
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198
PNIV+ G +Q +++VMEL GG+ + K E + + ++ +
Sbjct: 51 HPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAY 108
Query: 199 M---GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY-----RDIVGSAYYVA 250
+ +HRDL N L+ EN +LK +DFG+S E+ +Y + I + A
Sbjct: 109 LESKNCIHRDLAARNCLVG---ENNVLKISDFGMSR-QEDDGIYSSSGLKQI--PIKWTA 162
Query: 251 PEVLRR-RYGKEIDIWSAGVILYILLS-GVPPF 281
PE L RY E D+WS G++L+ S GV P+
Sbjct: 163 PEALNYGRYSSESDVWSYGILLWETFSLGVCPY 195
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 69/283 (24%), Positives = 114/283 (40%), Gaps = 42/283 (14%)
Query: 83 FGKELGRGQFGVTYLCTENS------------TGRQFACKSISKRKLVTKNDKDDIKREI 130
++LG GQFG +LC G+ R VTK ++D +EI
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 131 QIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAAS--ICRS 188
+IM L PNI+ G + ++ E G+L + + S A+ S
Sbjct: 69 KIMSRLK-NPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 189 IVNVVHIC----------HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238
I N++++ + +HRDL N L+ + +K DFG+S + G
Sbjct: 128 IANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV---GNHYTIKIADFGMSRNLYSGDY 184
Query: 239 YRDIVGSAY----YVAPE-VLRRRYGKEIDIWSAGVILY--ILLSGVPPFWAETEKGIFD 291
YR I G A ++A E +L ++ D+W+ GV L+ L P+ +++ + +
Sbjct: 185 YR-IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE 243
Query: 292 AI-----LQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT 329
QG + S P S L+ R ++D K R T
Sbjct: 244 NTGEFFRNQGRQIYLSQT-PLCPSPVFKLMMRCWSRDIKDRPT 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 4e-11
Identities = 54/217 (24%), Positives = 87/217 (40%), Gaps = 38/217 (17%)
Query: 85 KELGRGQFGVT---YLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
KELG G FG ++ + A K++ + + K + RE +M L P
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI--AAGKKEFLREASVMAQLD-HPC 57
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSI---VNVVHICHF 198
IV G + + + +VMEL G L + + + + + + HF
Sbjct: 58 IVRLIGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHF 116
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYY---------- 248
+ HRDL N LL ++ + K +DFG+S + GS YY
Sbjct: 117 V---HRDLAARNVLLVNRHQ---AKISDFGMS------RALG--AGSDYYRATTAGRWPL 162
Query: 249 --VAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPF 281
APE + ++ + D+WS GV L+ S G P+
Sbjct: 163 KWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-11
Identities = 65/246 (26%), Positives = 113/246 (45%), Gaps = 48/246 (19%)
Query: 85 KELGRGQFGVTYL--CTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNI 142
+ELG G FG +L C + ++ K + N + D RE +++ +L + +I
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE-HI 69
Query: 143 VEFKGAYEDKQSVHVVMELCAGGEL--FDR-------IIAKGH----YSERAAASICRSI 189
V+F G + + +V E G+L F R ++A+G+ ++ I + I
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 190 V-NVVHIC--HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA 246
+V++ HF+ HRDL N L+ EN L+K DFG+S RD+ +
Sbjct: 130 AAGMVYLASQHFV---HRDLATRNCLVG---ENLLVKIGDFGMS---------RDVYSTD 174
Query: 247 YY------------VAPE-VLRRRYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDA 292
YY + PE ++ R++ E D+WS GV+L+ I G P++ + + +
Sbjct: 175 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234
Query: 293 ILQGDI 298
I QG +
Sbjct: 235 ITQGRV 240
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 54/227 (23%), Positives = 92/227 (40%), Gaps = 45/227 (19%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYL-----CTENSTGRQFACKSISKRKLVTKNDKDDIK 127
P E + L +ELG+G FG+ Y + + A K++++ + ++ +
Sbjct: 4 PREKITL----IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFL 57
Query: 128 REIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE-------- 179
E +M+ + ++V G Q VVMEL A G+L + + E
Sbjct: 58 NEASVMKEFN-CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLG 114
Query: 180 --------RAAASICR--SIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229
+ AA I + + HRDL N +++ E+ +K DFG+
Sbjct: 115 PPTLQKFIQMAAEIADGMAYLAAKKFV------HRDLAARNCMVA---EDLTVKIGDFGM 165
Query: 230 SVFIEEGKVYRDIVGSAYYV---APEVLRR-RYGKEIDIWSAGVILY 272
+ I E YR V APE L+ + + D+WS GV+L+
Sbjct: 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 63/260 (24%), Positives = 117/260 (45%), Gaps = 37/260 (14%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ G+ +G G+FG TG++ A K+I + VT + + + H
Sbjct: 7 KLTLGEIIGEGEFGAVL--QGEYTGQKVAVKNI--KCDVTAQAFLEETAVMTKLHH---- 58
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
N+V G +++VMEL + G L + + +G RA S+ + + + + M
Sbjct: 59 KNLVRLLGVIL-HNGLYIVMELMSKGNLVNFLRTRG----RALVSVIQLLQFSLDVAEGM 113
Query: 200 ------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY----YV 249
++HRDL N L+S E+ + K +DFGL+ +V V ++ +
Sbjct: 114 EYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLA------RVGSMGVDNSKLPVKWT 164
Query: 250 APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307
APE L+ +++ + D+WS GV+L+ + S G P+ + K + + + +G + P
Sbjct: 165 APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG---YRMEPPEG 221
Query: 308 ISSSAKDLVRRMLTQDPKKR 327
+ L+ +PKKR
Sbjct: 222 CPADVYVLMTSCWETEPKKR 241
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 77 VKLHYSFGKELGRGQFGVTYLCTE--NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
V++ Y+ L G G ++CT+ + ++ K+++ K REI I++
Sbjct: 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILK 141
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMEL--CAGGELFDRIIAKGHYSERAAASICRSIVNV 192
+S I+ AY K +V +VM C +LF + G A +I R ++
Sbjct: 142 TIS-HRAIINLIHAYRWKSTVCMVMPKYKC---DLFTYVDRSGPLPLEQAITIQRRLLEA 197
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG----LSVFIEEGKVYRDIVGSAYY 248
+ H G++HRD+K EN L + ENA+L DFG L + + Y G+
Sbjct: 198 LAYLHGRGIIHRDVKTENIFL-DEPENAVLG--DFGAACKLDAHPDTPQCY-GWSGTLET 253
Query: 249 VAPEVLR-RRYGKEIDIWSAGVILY 272
+PE+L Y + DIWSAG++L+
Sbjct: 254 NSPELLALDPYCAKTDIWSAGLVLF 278
|
Length = 392 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 68/249 (27%), Positives = 109/249 (43%), Gaps = 51/249 (20%)
Query: 85 KELGRGQFGVTYL--CTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNI 142
+ELG G FG +L C S + ++ K T + D +RE +++ +L +I
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ-HEHI 69
Query: 143 VEFKGAYEDKQSVHVVMELCAGGELF--------DRII--------AKGHYSERAAASIC 186
V+F G D + +V E G+L D +I AKG I
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 187 RSIVN-VVHIC--HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243
I + +V++ HF+ HRDL N L+ + N L+K DFG+S RD+
Sbjct: 130 SQIASGMVYLASQHFV---HRDLATRNCLVGA---NLLVKIGDFGMS---------RDVY 174
Query: 244 GSAYY------------VAPE-VLRRRYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGI 289
+ YY + PE ++ R++ E D+WS GVIL+ I G P++ + +
Sbjct: 175 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234
Query: 290 FDAILQGDI 298
+ I QG +
Sbjct: 235 IECITQGRV 243
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 69/274 (25%), Positives = 115/274 (41%), Gaps = 32/274 (11%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNI 142
F +G G FG G + ++ +K+D D E++++ L PNI
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 143 VEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSER----AAASICRSIVNVVHICHF 198
+ GA E + +++ +E G L D + K E A A+ S ++ + HF
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 199 MG-------------VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY-RDIVG 244
+HRDL N L+ EN + K DFGLS +VY + +G
Sbjct: 130 AADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS---RGQEVYVKKTMG 183
Query: 245 S--AYYVAPEVLRRR-YGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDF 300
++A E L Y D+WS GV+L+ ++S G P+ T +++ + QG +
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---Y 240
Query: 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVL 334
DL+R+ + P +R + AQ+L
Sbjct: 241 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 180 RAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239
A I + I+ + H ++HRD+K EN ++ D+ + D G + F +
Sbjct: 157 DQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCI---GDLGAAQFPVVAPAF 213
Query: 240 RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS 276
+ G+ APEVL R +Y + DIWSAG++L+ +L+
Sbjct: 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 66/266 (24%), Positives = 122/266 (45%), Gaps = 29/266 (10%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P E ++L +LG+G FG ++ T N T + A K++ + + +E Q+
Sbjct: 4 PRESLRLEV----KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQV 54
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSER----AAASICRS 188
M+ L + + + A ++ +++V E + G L D + KG + +
Sbjct: 55 MKKLRHEKLVQLY--AVVSEEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQ 110
Query: 189 IVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY- 247
I + + M +HRDL+ N L+ EN + K DFGL+ IE+ + Y G+ +
Sbjct: 111 IASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE-YTARQGAKFP 166
Query: 248 --YVAPE-VLRRRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESA 303
+ APE L R+ + D+WS G++L L + G P+ + + D + +G +
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMP 223
Query: 304 PWPTISSSAKDLVRRMLTQDPKKRIT 329
P S DL+ + ++P++R T
Sbjct: 224 CPPECPESLHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 71/292 (24%), Positives = 115/292 (39%), Gaps = 58/292 (19%)
Query: 82 SFGKELGRGQFG----VTYLCTENSTGRQ-FACKSISKRKLVTKNDKD--DIKREIQIMQ 134
+ GK LG G FG + +N A K + +KD D+ E+++M+
Sbjct: 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD----DATEKDLSDLVSEMEMMK 70
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
+ NI+ G + ++VV+E A G L D + A+ E A+ R +
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 195 ICHFMG----------------VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238
+ +HRDL N L++ E+ ++K DFGL+
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLA-------- 179
Query: 239 YRDIVGSAYY------------VAPEVLRRR-YGKEIDIWSAGVILY--ILLSGVPPFWA 283
RDI YY +APE L R Y + D+WS GV+L+ L G P
Sbjct: 180 -RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238
Query: 284 ETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335
E+ +F + +G + + L+R + P +R T Q++E
Sbjct: 239 PVEE-LFKLLKEG---YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 6e-10
Identities = 61/274 (22%), Positives = 116/274 (42%), Gaps = 38/274 (13%)
Query: 85 KELGRGQFGVTYLC-----TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
LGRG+FG +L E K++ K K +N + + +RE+ + + LS
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLS-H 67
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGEL--FDRIIAKGHYSERAAASICRSIVNVVHICH 197
N+V G + + ++++E G+L F R + S V +C
Sbjct: 68 KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL---STKQKVALCT 124
Query: 198 FMG----------VMHRDLKPENFLLSSKDENALLKATDFGLS--VFIEEGKVYRDIVGS 245
+ +HRDL N L+SS+ E +K + LS V+ E R+ +
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVSSQRE---VKVSLLSLSKDVYNSEYYKLRNALIP 181
Query: 246 AYYVAPE-VLRRRYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQGDIDFESA 303
++APE V + + D+WS GV+++ + G PF+ +++ + + + G ++
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE---- 237
Query: 304 PWPTISSSAKDLVRRMLT---QDPKKRITSAQVL 334
P L + M +PK R + ++++
Sbjct: 238 -LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 66/277 (23%), Positives = 119/277 (42%), Gaps = 36/277 (12%)
Query: 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS 137
K +S + G G + C +N T K+ + T E I++ ++
Sbjct: 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTAT---------EAHILRAIN 141
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH 197
P+I++ KG + + +++ +L+ + AK + + +I RS++ + H
Sbjct: 142 -HPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLH 199
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF---IEEGKVYRDIVGSAYYVAPEVL 254
++HRD+K EN ++ + L DFG + F I K Y G+ APE+L
Sbjct: 200 ENRIIHRDIKAENIFINHPGDVCL---GDFGAACFPVDINANKYY-GWAGTIATNAPELL 255
Query: 255 RRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI-LQGDIDFESAPWPTISSSA 312
R YG +DIWSAG++L+ + + +F+ L GD D +
Sbjct: 256 ARDPYGPAVDIWSAGIVLFEMATC--------HDSLFEKDGLDGDCDSD--------RQI 299
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKP 349
K ++RR T + I + L+ +I ++S KP
Sbjct: 300 KLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKP 336
|
Length = 391 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 9e-10
Identities = 60/236 (25%), Positives = 100/236 (42%), Gaps = 45/236 (19%)
Query: 80 HYSFGKELGRGQFGVTYLCTENS--------------TGRQFACKSISKRKLVTKNDKDD 125
H F ++LG GQFG +LC + GR R KN ++D
Sbjct: 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARND 65
Query: 126 IKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASI 185
+E++I+ L PNI+ G D+ + ++ E G+L ++ ++ H ++
Sbjct: 66 FLKEVKILSRLK-DPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGN 123
Query: 186 C-------------RSIVNV-VHICHFM------GVMHRDLKPENFLLSSKDENALLKAT 225
S+++V + I M +HRDL N L+ EN +K
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG---ENLTIKIA 180
Query: 226 DFGLSVFIEEGKVYRDIVGSAY----YVAPE-VLRRRYGKEIDIWSAGVILYILLS 276
DFG+S + G YR I G A ++A E +L ++ D+W+ GV L+ +L
Sbjct: 181 DFGMSRNLYAGDYYR-IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 63/268 (23%), Positives = 110/268 (41%), Gaps = 30/268 (11%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+G G FG G + ++ +K+D D E++++ L PNI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 147 GAYEDKQSVHVVMELCAGGELFD-----RII------AKGH-----YSERAAASICRSIV 190
GA E + +++ +E G L D R++ A + S + +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 191 NVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY-RDIVGS--AY 247
+ +HRDL N L+ EN + K DFGLS +VY + +G
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS---RGQEVYVKKTMGRLPVR 176
Query: 248 YVAPEVLRRR-YGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305
++A E L Y D+WS GV+L+ ++S G P+ T +++ + QG +
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEKP 233
Query: 306 PTISSSAKDLVRRMLTQDPKKRITSAQV 333
DL+R+ + P +R + AQ+
Sbjct: 234 LNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 54/233 (23%), Positives = 95/233 (40%), Gaps = 47/233 (20%)
Query: 80 HYSFGKELGRGQFGVTYLC-TENSTG---------------RQFACKSISKRKLVTKNDK 123
+F ++LG GQFG +LC + A K + R + N +
Sbjct: 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL--RPDASDNAR 63
Query: 124 DDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGEL---FDRIIAKGHYSER 180
+D +E++I+ LS PNI G + ++ME G+L + +A+
Sbjct: 64 EDFLKEVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 181 AAASICRSIVNVVHIC----------HFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230
+ S+ S ++++ + +HRDL N L+ N +K DFG+S
Sbjct: 123 NSKSLSFS--TLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK---NYTIKIADFGMS 177
Query: 231 VFIEEGKVYRDIVGSAYYVAP-------EVLRRRYGKEIDIWSAGVILYILLS 276
+ YR + G A P VL ++ + D+W+ GV L+ +L+
Sbjct: 178 RNLYSSDYYR-VQGRA--PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK--DDIKREIQI 132
+++KL + GK G+FG L + G + A K I KND E +
Sbjct: 6 KELKLLQTIGK----GEFGDVML--GDYRGNKVAVKCI-------KNDATAQAFLAEASV 52
Query: 133 MQHLSGQPNIVEFKGA-YEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN 191
M L N+V+ G E+K +++V E A G L D + ++G R+ +
Sbjct: 53 MTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG----RSVLGGDCLLKF 107
Query: 192 VVHICHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG- 244
+ +C M +HRDL N L+S E+ + K +DFGL+ +E +D
Sbjct: 108 SLDVCEAMEYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKL 161
Query: 245 SAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS 276
+ APE LR +++ + D+WS G++L+ + S
Sbjct: 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 65/266 (24%), Positives = 121/266 (45%), Gaps = 29/266 (10%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P E ++L +LG+G FG ++ T N T + A K++ ++ + +E QI
Sbjct: 4 PRESLRLDV----KLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMM----PEAFLQEAQI 54
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKG---HYSERAAASICRSI 189
M+ L + + A ++ +++V E G L D + +G + + I
Sbjct: 55 MKKLRHDKLVPLY--AVVSEEPIYIVTEFMGKGSLLD-FLKEGDGKYLKLPQLVDMAAQI 111
Query: 190 VNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY-- 247
+ + M +HRDL+ N L+ +N + K DFGL+ IE+ + Y G+ +
Sbjct: 112 ADGMAYIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLIEDNE-YTARQGAKFPI 167
Query: 248 -YVAPE-VLRRRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAP 304
+ APE L R+ + D+WS G++L L++ G P+ + + + + +G P
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG----YRMP 223
Query: 305 WPT-ISSSAKDLVRRMLTQDPKKRIT 329
P S +L++ +DP +R T
Sbjct: 224 CPQGCPESLHELMKLCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 30/212 (14%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
ELG G FG +Q + K+ +D++ RE +IM L P IV
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD-NPYIVRM 60
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH--FMGV-- 201
G E +++ +VME+ +GG L + K + S NVV + H MG+
Sbjct: 61 IGVCE-AEALMLVMEMASGGPLNKFLSGK---KDEITVS------NVVELMHQVSMGMKY 110
Query: 202 ------MHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAY---YVAP 251
+HRDL N LL ++ K +DFGLS + Y+ + + AP
Sbjct: 111 LEGKNFVHRDLAARNVLLVNQH---YAKISDFGLSKALGADDSYYKARSAGKWPLKWYAP 167
Query: 252 E-VLRRRYGKEIDIWSAGVILYILLS-GVPPF 281
E + R++ D+WS G+ ++ S G P+
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 69/282 (24%), Positives = 118/282 (41%), Gaps = 60/282 (21%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P E +KL ++LG GQFG ++ T N T + A K++ + + +E QI
Sbjct: 4 PRESLKL----ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTM----SPEAFLQEAQI 54
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI-------------------IA 173
M+ L +V+ +++ +++V E + G L D + IA
Sbjct: 55 MKKLR-HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIA 113
Query: 174 KG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232
+G Y E +HRDL N L+ EN + K DFGL+
Sbjct: 114 EGMAYLES------------------RNYIHRDLAARNILVG---ENLVCKIADFGLARL 152
Query: 233 IEEGKVYRDIVGSAY---YVAPE-VLRRRYGKEIDIWSAGVILY-ILLSGVPPFWAETEK 287
IE+ Y G+ + + APE R+ + D+WS G++L I+ G P+ T +
Sbjct: 153 IED-DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR 211
Query: 288 GIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT 329
+ + + +G + P DL+ + +DP++R T
Sbjct: 212 EVLEQVERG---YRMPRPPNCPEELYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 8e-09
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 17/219 (7%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
++LG GQFG + N+T A K++ + D D E QIM+ L P +++
Sbjct: 12 RKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQ 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFD--RIIAKGHYSERAAASICRSIVNVVHICHFMGVM 202
++ +++V EL G L + + A + + + + +
Sbjct: 66 LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYI 125
Query: 203 HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY---YVAPEVLR-RRY 258
HRDL N L+ EN + K DFGL+ I+E +Y G+ + + APE R+
Sbjct: 126 HRDLAARNVLVG---ENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPEAALYNRF 181
Query: 259 GKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQG 296
+ D+WS G++L I+ G P+ T + + QG
Sbjct: 182 SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG 220
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 58/230 (25%), Positives = 97/230 (42%), Gaps = 45/230 (19%)
Query: 82 SFGKELGRGQFGVTYLC----TENSTGRQFACKSISK----------RKLVTKNDKDDIK 127
+F ++LG GQFG +LC E + F+ R+ KN ++D
Sbjct: 8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL 67
Query: 128 REIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICR 187
+EI+IM L PNI+ + ++ E G+L ++ +++ H + AA
Sbjct: 68 KEIKIMSRLK-DPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSR-HEPQEAAEKADV 124
Query: 188 SIVNVVHICHFMGV--------------MHRDLKPENFLLSSKDENALLKATDFGLSVFI 233
++ + FM +HRDL N L+ +N +K DFG+S +
Sbjct: 125 VTISYSTLI-FMATQIASGMKYLSSLNFVHRDLATRNCLVG---KNYTIKIADFGMSRNL 180
Query: 234 EEGKVYRDIVGSAYYVAP-------EVLRRRYGKEIDIWSAGVILYILLS 276
G YR I G A V P +L ++ D+W+ GV L+ +L+
Sbjct: 181 YSGDYYR-IQGRA--VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145
+LG GQ+G Y A K++ + + ++ +E +M+ + PN+V+
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIK-HPNLVQL 67
Query: 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAA-----ASICRSIVNVVHICHFMG 200
G + +++ E G L D + A A+ S + + +F+
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI- 126
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY---YVAPEVLR-R 256
HRDL N L+ EN L+K DFGLS + G Y G+ + + APE L
Sbjct: 127 --HRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYN 180
Query: 257 RYGKEIDIWSAGVILY-ILLSGVPPF 281
++ + D+W+ GV+L+ I G+ P+
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 47/182 (25%), Positives = 72/182 (39%), Gaps = 15/182 (8%)
Query: 97 LCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156
L + T + F K + K ++ I PN+V + SV
Sbjct: 11 LVMDTRTQQTFILKGLRKSSEYSRERLTIIPH---------CVPNMVCLHKYIVSEDSVF 61
Query: 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK 216
+V++ GG+L+ I + E +V + H G++ RDL P N LL
Sbjct: 62 LVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL--- 118
Query: 217 DENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKE-IDIWSAGVILYILL 275
D+ ++ T F +E+ + V Y APEV E D WS G IL+ LL
Sbjct: 119 DDRGHIQLTYFSRWSEVED-SCDGEAV-ENMYCAPEVGGISEETEACDWWSLGAILFELL 176
Query: 276 SG 277
+G
Sbjct: 177 TG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 52/226 (23%), Positives = 98/226 (43%), Gaps = 29/226 (12%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISK-----RKLVTKNDKDDIKREIQIMQHL 136
+ GK LG G FG + + ++++ + T+ D D+ E+++M+ +
Sbjct: 18 TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 77
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICR------SIV 190
NI+ GA ++V++E + G L + + A+ + I R +
Sbjct: 78 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137
Query: 191 NVVHICHFMG----------VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR 240
++V + + +HRDL N L++ EN ++K DFGL+ + Y+
Sbjct: 138 DLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNNIDYYK 194
Query: 241 DIVGS---AYYVAPEVL-RRRYGKEIDIWSAGVILY-ILLSGVPPF 281
++APE L R Y + D+WS GV+++ I G P+
Sbjct: 195 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 39/146 (26%), Positives = 65/146 (44%), Gaps = 29/146 (19%)
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPE--------- 252
+HRDL N L+ EN ++K DFGLS R+I + YY A E
Sbjct: 152 VHRDLATRNCLVG---ENMVVKIADFGLS---------RNIYSADYYKASENDAIPIRWM 199
Query: 253 ----VLRRRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307
+ RY E D+W+ GV+L+ + S G+ P++ + + + G++ S P
Sbjct: 200 PPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNV--LSCP-DN 256
Query: 308 ISSSAKDLVRRMLTQDPKKRITSAQV 333
+L+R ++ P R + A +
Sbjct: 257 CPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 55/234 (23%), Positives = 102/234 (43%), Gaps = 29/234 (12%)
Query: 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND---KD--DIKR 128
+E + + GK LG G FG + + K ++ + K+D KD D+
Sbjct: 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVS 66
Query: 129 EIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICR- 187
E+++M+ + NI+ GA ++V++E + G L + + A+ + C+
Sbjct: 67 EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 188 -----SIVNVVHICHFMG----------VMHRDLKPENFLLSSKDENALLKATDFGLSVF 232
+ ++V + + +HRDL N L++ E+ ++K DFGL+
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLARD 183
Query: 233 IEEGKVYRDIVGS---AYYVAPEVL-RRRYGKEIDIWSAGVILY-ILLSGVPPF 281
+ Y+ ++APE L R Y + D+WS GV+L+ I G P+
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 58/238 (24%), Positives = 104/238 (43%), Gaps = 34/238 (14%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKD---DIKREIQIMQHLSGQ 139
F +ELG FG Y G A + ++ + L N+ + ++E +M L
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHA-QLVAIKTLKDINNPQQWGEFQQEASLMAELH-H 66
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIV-------NV 192
PNIV G +Q V ++ E G+L + +I + +S+ +S V +
Sbjct: 67 PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 193 VHIC------------HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR 240
+HI HF +H+DL N L+ E +K +D GLS I YR
Sbjct: 127 LHIAIQIAAGMEYLSSHFF--VHKDLAARNILIG---EQLHVKISDLGLSREIYSADYYR 181
Query: 241 ---DIVGSAYYVAPE-VLRRRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAI 293
+ ++ PE ++ ++ + DIWS GV+L+ + S G+ P++ + + + + +
Sbjct: 182 VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 59/237 (24%), Positives = 106/237 (44%), Gaps = 33/237 (13%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P E +KL K+LG GQFG ++ N++ + A K++ + + E +
Sbjct: 4 PRESIKLV----KKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQA----FLEEANL 54
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNV 192
M+ L +V ++ ++++ E A G L D + + E + + I
Sbjct: 55 MKTLQ-HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD----EGGKVLLPKLIDFS 109
Query: 193 VHICHFMGVM------HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA 246
I M + HRDL+ N L+S E+ + K DFGL+ IE+ + Y G+
Sbjct: 110 AQIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAK 165
Query: 247 Y---YVAPEVLRRRYGK---EIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQG 296
+ + APE + +G + D+WS G++LY I+ G P+ + + A+ +G
Sbjct: 166 FPIKWTAPEAIN--FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG 220
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 60/267 (22%), Positives = 114/267 (42%), Gaps = 28/267 (10%)
Query: 81 YSFGKELGRGQFGV---TYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS 137
++ G+ LG+G+FG L +E+ + ++ A K + K + + +D ++ RE M+
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 138 GQPNIVEFKGAYEDKQSVH------VVMELCAGGELFDRIIAKGHYSERAAASICRSIVN 191
PN+++ G ++ V++ G+L ++ E + +
Sbjct: 60 -HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 192 VVHICHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGS 245
++ I M +HRDL N +L +EN + DFGLS I G YR S
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 246 AY---YVAPEVLRRR-YGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQGDIDF 300
++A E L Y D+W+ GV ++ I+ G P+ I++ +++G+
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN--- 232
Query: 301 ESAPWPTISSSAKDLVRRMLTQDPKKR 327
P +L+ + + +PK R
Sbjct: 233 RLKQPPDCLEDVYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 55/241 (22%), Positives = 100/241 (41%), Gaps = 31/241 (12%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISK------RKLVTKNDKDDIKREIQIMQHL 136
GK LG G FG + ++ + ++K + T+ D D+ E+++M+ +
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNR-VTKVAVKMLKSDATEKDLSDLISEMEMMKMI 80
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK----------------GHYSER 180
NI+ GA ++V++E + G L + + A+ S +
Sbjct: 81 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 181 AAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR 240
S + + +HRDL N L++ E+ ++K DFGL+ I Y+
Sbjct: 141 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYYK 197
Query: 241 DIVGS---AYYVAPEVLRRR-YGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQ 295
++APE L R Y + D+WS GV+L+ I G P+ + +F + +
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 257
Query: 296 G 296
G
Sbjct: 258 G 258
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 183 ASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE---EGKVY 239
++ R +++ + H G++HRD+K EN L++ ++ L DFG + F +
Sbjct: 263 TAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICL---GDFGAACFARGSWSTPFH 319
Query: 240 RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILY 272
I G+ APEVL Y +DIWSAG++++
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 53/238 (22%), Positives = 96/238 (40%), Gaps = 33/238 (13%)
Query: 74 YEDVKLHYSFGKELGRGQFGVTYLCTEN--STGRQFACKSISKRKLVTKNDKDDIKREIQ 131
+E + ++ ++LG G FG + E + A K + L+ + D ++E+Q
Sbjct: 1 WERPREEFTLERKLGSGYFGEVW---EGLWKNRVRVAIKILKSDDLL---KQQDFQKEVQ 54
Query: 132 IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY---SERAAASICRS 188
++ L +++ + V+++ EL G L + E +
Sbjct: 55 ALKRLR-HKHLISLFAVCSVGEPVYIITELMEKGSLL-------AFLRSPEGQVLPVASL 106
Query: 189 IVNVVHICHFMG------VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY--R 240
I + M +HRDL N L+ E+ + K DFGL+ I+E VY
Sbjct: 107 IDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKE-DVYLSS 162
Query: 241 DIVGSAYYVAPEVL-RRRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
D + APE + + D+WS G++LY + + G P+ ++D I G
Sbjct: 163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG 220
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 64/257 (24%), Positives = 117/257 (45%), Gaps = 31/257 (12%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K+LG GQFG ++ T N + A K++ + + E QIM+ L +V+
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTM----SPESFLEEAQIMKKLR-HDKLVQ 65
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRII-AKGHYSE-----RAAASICRSIVNVVHICHF 198
A ++ +++V E + G L D + +G + AA + + +
Sbjct: 66 LY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---- 120
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY---YVAPE-VL 254
M +HRDL+ N L+ + + K DFGL+ IE+ + Y G+ + + APE L
Sbjct: 121 MNYIHRDLRSANILVG---DGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL 176
Query: 255 RRRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS-SSA 312
R+ + D+WS G++L L++ G P+ + + + + +G P P S
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG----YRMPCPQDCPISL 232
Query: 313 KDLVRRMLTQDPKKRIT 329
+L+ + +DP++R T
Sbjct: 233 HELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 46/221 (20%)
Query: 87 LGRGQFGVTY---LCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIV 143
+G+G FG Y L + A KS+++ + + + +E IM+ S PN++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFS-HPNVL 59
Query: 144 EFKG-AYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVM 202
G + S VV+ G+L + I SE ++ I + + M +
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFI-----RSETHNPTVKDLIGFGLQVAKGMEYL 114
Query: 203 ------HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYY-------- 248
HRDL N +L DE+ +K DFGL+ RDI YY
Sbjct: 115 ASKKFVHRDLAARNCML---DESFTVKVADFGLA---------RDIYDKEYYSVHNHTGA 162
Query: 249 ------VAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPF 281
+A E L+ +++ + D+WS GV+L+ L++ G PP+
Sbjct: 163 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 63/279 (22%), Positives = 112/279 (40%), Gaps = 36/279 (12%)
Query: 82 SFGKELGRGQFGVTY---LCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG 138
GK LG G+FG L ++ + + A K++ K + T ++ ++ E M+
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD- 59
Query: 139 QPNIVEFKGA---YEDKQSVH---VVMELCAGGELFDRIIAKGHYSERAAAS-------I 185
PN+++ G Q + V++ G+L ++ YS +
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL----YSRLGGLPEKLPLQTL 115
Query: 186 CRSIVNVVHICHFMG---VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI 242
+ +V++ ++ +HRDL N +L E+ + DFGLS I G YR
Sbjct: 116 LKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKKIYSGDYYRQG 172
Query: 243 VGSAY---YVAPEVLRRR-YGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQGD 297
+ ++A E L R Y + D+W+ GV ++ I G P+ I+D + G+
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN 232
Query: 298 IDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
+ DL+ DPK R T ++ E
Sbjct: 233 RLKQPEDCL---DELYDLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 46/178 (25%), Positives = 70/178 (39%), Gaps = 45/178 (25%)
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIVGSAYYVAPEVL--RRR 257
++HRDLKP+N L+S E LK DFGL+ Y + V + +Y P+VL
Sbjct: 124 ILHRDLKPQNLLISDTGE---LKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF------ESAPWPTISS- 310
Y +D+W G I ++ GV F G+ D Q + F WP + S
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAF-----PGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235
Query: 311 ---------------------------SAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
A+DL ++L PK R+++ L H + +
Sbjct: 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 59/235 (25%), Positives = 98/235 (41%), Gaps = 24/235 (10%)
Query: 82 SFGKELGRGQFGVTY--LCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ GK LG G+FG ++ + + A K++ K + T+++ +D E M+
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFD-H 59
Query: 140 PNIVEFKGA------YEDKQSVHVVMELCAGGEL-----FDRIIAKGHY-SERAAASICR 187
PN++ G E S V++ G+L + R+ Y +
Sbjct: 60 PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119
Query: 188 SIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY 247
I + + +HRDL N +L +EN + DFGLS I G YR +
Sbjct: 120 DIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 248 ---YVAPEVLRRR-YGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQGD 297
++A E L R Y + D+WS GV ++ I G P+ I+D + QG+
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 55/246 (22%), Positives = 108/246 (43%), Gaps = 50/246 (20%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND---KDDIKREIQIMQHLSGQ 139
F +ELG +FG Y T ++++ + L K + +++ K E + L
Sbjct: 9 FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQ-H 67
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSI------VNVV 193
PNIV G +Q + ++ C+ +L + ++ + +S+ + +++ + V
Sbjct: 68 PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 194 HIC-------HFMG---VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243
HI F+ V+H+DL N L+ K L+V I + ++R++
Sbjct: 128 HIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK------------LNVKISDLGLFREVY 175
Query: 244 GSAYY------------VAPEVLRRRYGK---EIDIWSAGVILYILLS-GVPPFWAETEK 287
+ YY ++PE + YGK + DIWS GV+L+ + S G+ P+ + +
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIM--YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 233
Query: 288 GIFDAI 293
+ + I
Sbjct: 234 DVIEMI 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 44/163 (26%), Positives = 75/163 (46%), Gaps = 13/163 (7%)
Query: 154 SVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFL 212
+V +V +L G L D + K + + C I + + ++HRDL N L
Sbjct: 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVL 141
Query: 213 LSSKDENALLKATDFGLSVF--IEEGKVYRD--IVGSAYYVAPEVLRRRYGKEIDIWSAG 268
+ S + +K TDFGL+ I+E + + D V + +L RR+ + D+WS G
Sbjct: 142 VKSPNH---VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYG 198
Query: 269 VILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310
V ++ L++ G P+ + I D + +G E P P I +
Sbjct: 199 VTVWELMTFGAKPYDGIPAREIPDLLEKG----ERLPQPPICT 237
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P E +KL K+LG GQFG ++ N + A KS+ + + + E +
Sbjct: 4 PRETLKLV----KKLGAGQFGEVWMGYYNGH-TKVAIKSLKQGSM----SPEAFLAEANL 54
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNV 192
M+ L P +V A ++ ++++ E G L D + E +I + I
Sbjct: 55 MKQLQ-HPRLVRLY-AVVTQEPIYIITEYMENGSLVDFL----KTPEGIKLTINKLIDMA 108
Query: 193 VHICHFMGVM------HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA 246
I M + HRDL+ N L+S E K DFGL+ IE+ + Y G+
Sbjct: 109 AQIAEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNE-YTAREGAK 164
Query: 247 Y---YVAPEVLRRRYGK---EIDIWSAGVIL 271
+ + APE + YG + D+WS G++L
Sbjct: 165 FPIKWTAPEAI--NYGTFTIKSDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 52/225 (23%), Positives = 96/225 (42%), Gaps = 29/225 (12%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSIS-KRKLVTKN--DKD--DIKREIQIMQHLS 137
GK LG G FG + ++++ K++ N DKD D+ E+++M+ +
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG 75
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK----------------GHYSERA 181
NI+ G + ++V++E A G L + + A+ S +
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 182 AASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD 241
S + + +HRDL N L++ E+ ++K DFGL+ + + Y+
Sbjct: 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLARGVHDIDYYKK 192
Query: 242 IVGS---AYYVAPEVL-RRRYGKEIDIWSAGVILY-ILLSGVPPF 281
++APE L R Y + D+WS G++++ I G P+
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 9e-06
Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 6/96 (6%)
Query: 184 SICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI- 242
+I + ++ V H ++HRD+K EN L+ + L DFG ++ E+ + D
Sbjct: 271 AIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVL---GDFGTAMPFEKEREAFDYG 327
Query: 243 -VGSAYYVAPEVLRRRYGKEI-DIWSAGVILYILLS 276
VG+ +PE+L EI DIWS G+IL +LS
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 39/171 (22%), Positives = 68/171 (39%), Gaps = 22/171 (12%)
Query: 178 SERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237
+E ++C + +HR K N LL+ + LLK G F +
Sbjct: 15 NEEEIWAVCLQC------LGALRELHRQAKSGNILLT---WDGLLKL--DGSVAFKTPEQ 63
Query: 238 VYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQ 295
Y++APEV++ + Y ++ DI+S G+ LY L P+ E E I + +L
Sbjct: 64 ---SRPDP-YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN 119
Query: 296 GDIDFESAPWPTISS-----SAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
G + + S +D +R ++ P++R + L H
Sbjct: 120 GMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALF 170
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 64/288 (22%), Positives = 118/288 (40%), Gaps = 49/288 (17%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL---VTKNDKDDIKREIQIMQHLSGQ 139
GK LG G+FG T + +++ + L + ++ D+ E +++ ++
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN-H 62
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGEL--FDRIIAK-----------------GHYSER 180
P++++ GA + +++E G L F R K + ER
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 181 A---------AASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231
A A I R + + M ++HRDL N L++ E +K +DFGLS
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAE----MKLVHRDLAARNVLVA---EGRKMKISDFGLSR 175
Query: 232 FIEEGKVY----RDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLS-GVPPFWAET 285
+ E Y + + ++A E L Y + D+WS GV+L+ +++ G P+
Sbjct: 176 DVYEEDSYVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234
Query: 286 EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQV 333
+ +F+ + G + S +L+ Q+P KR T A +
Sbjct: 235 PERLFNLLKTG---YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 42/222 (18%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
+ RG+ G +Y G QF K I+ + ++ D+ + +QH PNIV+
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGK----LQH----PNIVKLI 749
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM---GVMH 203
G ++ +++ E G L + + + ER I I + H V+
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSE--VLRNLSWER-RRKIAIGIAKALRFLHCRCSPAVVV 806
Query: 204 RDLKPENFLLSSKDENAL------LKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR 257
+L PE ++ KDE L L TD FI S+ YVAPE R
Sbjct: 807 GNLSPEKIIIDGKDEPHLRLSLPGLLCTDT--KCFI-----------SSAYVAPET---R 850
Query: 258 YGKEI----DIWSAGVILYILLSGVPPFWAETEKGIFDAILQ 295
K+I DI+ G+IL LL+G P A+ E G+ +I++
Sbjct: 851 ETKDITEKSDIYGFGLILIELLTGKSP--ADAEFGVHGSIVE 890
|
Length = 968 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 33/94 (35%), Positives = 45/94 (47%), Gaps = 26/94 (27%)
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV------------ 249
+HRDL N LLS EN ++K DFGL+ RDI YV
Sbjct: 195 IHRDLAARNILLS---ENNVVKICDFGLA---------RDIYKDPDYVRKGDARLPLKWM 242
Query: 250 APE-VLRRRYGKEIDIWSAGVILYILLS-GVPPF 281
APE + + Y + D+WS GV+L+ + S G P+
Sbjct: 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 33/94 (35%), Positives = 45/94 (47%), Gaps = 26/94 (27%)
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV------------ 249
+HRDL N LLS EN ++K DFGL+ RDI YV
Sbjct: 196 IHRDLAARNILLS---ENNVVKICDFGLA---------RDIYKDPDYVRKGSARLPLKWM 243
Query: 250 APE-VLRRRYGKEIDIWSAGVILYILLS-GVPPF 281
APE + + Y + D+WS GV+L+ + S G P+
Sbjct: 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 34/94 (36%), Positives = 45/94 (47%), Gaps = 26/94 (27%)
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV------------ 249
+HRDL N LLS EN ++K DFGL+ RDI YV
Sbjct: 201 IHRDLAARNILLS---ENNVVKICDFGLA---------RDIYKDPDYVRKGDARLPLKWM 248
Query: 250 APE-VLRRRYGKEIDIWSAGVILYILLS-GVPPF 281
APE + R Y + D+WS GV+L+ + S G P+
Sbjct: 249 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 59/237 (24%), Positives = 107/237 (45%), Gaps = 34/237 (14%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P E +KL K+LG GQFG ++ T N + A K++ + + E +
Sbjct: 4 PRESLKLE----KKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLA----EANV 54
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNV 192
M+ L Q + + A K+ ++++ E A G L D + + E + + + I
Sbjct: 55 MKTL--QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFS 108
Query: 193 VHICHFMG------VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA 246
I M +HRDL+ N L+S+ + K DFGL+ IE+ + Y G+
Sbjct: 109 AQIAEGMAFIEQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIEDNE-YTAREGAK 164
Query: 247 Y---YVAPEVLRRRYGK---EIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
+ + APE + +G + D+WS G++L +++ G P+ + + A+ +G
Sbjct: 165 FPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 219
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 59/239 (24%), Positives = 98/239 (41%), Gaps = 23/239 (9%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK---DDIKREIQIMQHLSGQ 139
K LG G FG Y G + ++ + L + +I E +M +
Sbjct: 11 KIKVLGSGAFGTVYKGVWIPEGEK-VKIPVAIKVLREETSPKANKEILDEAYVMASV-DH 68
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASI---CRSIVNVVHIC 196
P++V G Q V ++ +L G L D + + H + + C I +
Sbjct: 69 PHVVRLLGICLSSQ-VQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWCVQIAKGMSYL 125
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-KVYRDIVGSA--YYVAPE- 252
++HRDL N L+ + +K TDFGL+ ++ K Y G ++A E
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 253 VLRRRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310
+L R Y + D+WS GV ++ L++ G P+ I D + +G E P P I +
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG----ERLPQPPICT 237
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 69/329 (20%), Positives = 131/329 (39%), Gaps = 71/329 (21%)
Query: 86 ELGRGQFGVT--YLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIV 143
E+GRG +T YL TG + I+ + T+ ++ E+ ++ H PNI+
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVR-ITDLENCTEEHLKALQNEV-VLSHFFRHPNIM 62
Query: 144 EFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSI----VNVVHICHFM 199
+ + V+ A G + K ++ E + ++ +I + ++ H
Sbjct: 63 TSWTVFTTGSWLWVISPFMAYGSA--NSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN 120
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFI------EEGKVYRDI----VGSAYYV 249
G +HR++K + L+S + L+ + GLS ++ KV D ++
Sbjct: 121 GYIHRNIKASHILIS---GDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWL 175
Query: 250 APEVLRRR---YGKEIDIWSAGVILYILLSGVPPF--------------------WAET- 285
+PE+LR+ Y + DI+S G+ L +G PF T
Sbjct: 176 SPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT 235
Query: 286 ---------------EKGIFDAILQGDI------DFESAPWP-TISSSAKDLVRRMLTQD 323
+ GI ++++ + + P T S + ++LV L QD
Sbjct: 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQD 295
Query: 324 PKKRITSAQVLEHPWIKEGGEASDKPIDS 352
P+KR +++ +L H + K+ E + I S
Sbjct: 296 PEKRPSASSLLSHAFFKQVKEQTQGSILS 324
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 18/160 (11%)
Query: 136 LSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY----SERAAASICRSIVN 191
L PNIV ++ + + VV A G D I H+ SE A A I + ++
Sbjct: 55 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT--HFMDGMSELAIAYILQGVLK 112
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG---KVYRDI----VG 244
+ H MG +HR +K + L+S D L LS+ I G +V D V
Sbjct: 113 ALDYIHHMGYVHRSVKASHILISV-DGKVYLSGLRSNLSM-INHGQRLRVVHDFPKYSVK 170
Query: 245 SAYYVAPEVLRRR---YGKEIDIWSAGVILYILLSGVPPF 281
+++PEVL++ Y + DI+S G+ L +G PF
Sbjct: 171 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 52/234 (22%), Positives = 103/234 (44%), Gaps = 26/234 (11%)
Query: 85 KELGRGQFGVTYL-----CTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ELG+G FG+ Y ++ + A K++++ + ++ + E +M+ +
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCH 69
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE----RAAASICRSIVNVVHI 195
++V G Q V+MEL G+L + + E +A S+ + I I
Sbjct: 70 -HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 196 CHFMGVM------HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR---DIVGSA 246
M + HRDL N +++ E+ +K DFG++ I E YR +
Sbjct: 129 ADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 247 YYVAPEVLRRR-YGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQGDI 298
+++PE L+ + D+WS GV+L+ I P+ + + + +++G +
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL 239
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 59/233 (25%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS-GQP--- 140
KE+G G FG L NS + ++V K + + Q M+ L QP
Sbjct: 1 KEIGNGWFGKVILGEVNS--------GYTPAQVVVKELRVSASVQEQ-MKFLEEAQPYRS 51
Query: 141 ----NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY-SERAAASI---------- 185
N+++ G + +VME C G+L KG+ S R A +
Sbjct: 52 LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDL------KGYLRSCRKAELMTPDPTTLQRM 105
Query: 186 -CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-------VFIEEGK 237
C + ++H+ H +H DL N LL++ + +K D+GLS ++ +
Sbjct: 106 ACEIALGLLHL-HKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKEDYYVTPDQ 161
Query: 238 VYRDIVGSAYYVAPEVLRRRYG--------KEIDIWSAGVILYILLS-GVPPF 281
++ + ++APE++ +G KE ++WS GV ++ L G P+
Sbjct: 162 LWVPL----RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 37/126 (29%), Positives = 55/126 (43%), Gaps = 17/126 (13%)
Query: 167 LFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKD-------- 217
L D I+ G +S R A I + H + +MH DLKPEN L+ + D
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTN 277
Query: 218 -----ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV-LRRRYGKEIDIWSAGVIL 271
+ ++ D G +E IV + +Y +PEV L + D+WS G I+
Sbjct: 278 RALPPDPCRVRICDLGGCC--DERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCII 335
Query: 272 YILLSG 277
Y L +G
Sbjct: 336 YELYTG 341
|
Length = 467 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 37/213 (17%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK------NDKDDIKREIQIMQHLSG 138
+ELG+G FG+ Y + + I K + T+ N+ ++ I+ + S
Sbjct: 12 RELGQGSFGMVY---------EGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 62
Query: 139 QP-----NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE----RAAASICRSI 189
++V G Q VVMEL A G+L + + +E R ++ I
Sbjct: 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 190 VNVVHICHFMGVM------HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR--- 240
I M + HRDL N +++ + +K DFG++ I E YR
Sbjct: 123 QMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 241 DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILY 272
+ ++APE L+ + D+WS GV+L+
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 5e-04
Identities = 28/98 (28%), Positives = 42/98 (42%), Gaps = 3/98 (3%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD---IKREIQIMQHLSGQ 139
FGK LG G FG T G++ ++ + L D+ + E++I+ HL
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY 177
NIV GA V V+ E C G+L + + K
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAET 139
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 34/162 (20%), Positives = 70/162 (43%), Gaps = 10/162 (6%)
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHF 198
NIV +G ++ +V E + G L D + K G + + + +
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE 125
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGS--AYYVAPEVLR- 255
MG +H+ L L++S + + K + F + +Y + G + APE ++
Sbjct: 126 MGYVHKGLAAHKVLVNS---DLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182
Query: 256 RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
+ D+WS G++++ ++S G P+W + + + A+ G
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 7e-04
Identities = 32/134 (23%), Positives = 65/134 (48%), Gaps = 9/134 (6%)
Query: 154 SVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFL 212
S+ +V +L G L D + + + + C I ++ ++HR+L N L
Sbjct: 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNIL 141
Query: 213 LSSKDENALLKATDFGLSVFI---EEGKVYRDIVGSAYYVAPE-VLRRRYGKEIDIWSAG 268
L S +++++ DFG++ + ++ Y + ++A E +L RY + D+WS G
Sbjct: 142 LKS---DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYG 198
Query: 269 VILYILLS-GVPPF 281
V ++ ++S G P+
Sbjct: 199 VTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 23/89 (25%), Positives = 42/89 (47%), Gaps = 4/89 (4%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL---VTKNDKDDIKREIQIMQHLSGQ 139
GK LGRG FG + + +C++++ + L T ++ + E++I+ H+
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHH 70
Query: 140 PNIVEFKGAYEDKQS-VHVVMELCAGGEL 167
N+V GA + V++E C G L
Sbjct: 71 LNVVNLLGACTKPGGPLMVIVEYCKFGNL 99
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 35/115 (30%), Positives = 59/115 (51%), Gaps = 12/115 (10%)
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIVGSA--YYVAPEVLR-R 256
++HRDL N L+ S + +K TDFGL+ +E + K Y G ++A E + R
Sbjct: 130 LVHRDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 257 RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310
++ + D+WS GV ++ L++ G P+ + I D + +G E P P I +
Sbjct: 187 KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG----ERLPQPPICT 237
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.002
Identities = 23/113 (20%), Positives = 43/113 (38%), Gaps = 20/113 (17%)
Query: 125 DIKREIQIMQHLSGQ----PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSER 180
D +RE+ I+Q L+ + P ++ E +++ME G L SE
Sbjct: 37 DREREVAILQLLARKGLPVPKVLAS---GESDGWSYLLMEWIEGETL-------DEVSEE 86
Query: 181 AAASICRSIVNVVHICH---FMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230
I + ++ H + + H DL P N L+ ++ D+ +
Sbjct: 87 EKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGII---DWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 42/151 (27%), Positives = 63/151 (41%), Gaps = 34/151 (22%)
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV------------ 249
+HRDL N LL+ + K DFGL+ RDI + YV
Sbjct: 236 IHRDLAARNILLT---HGRITKICDFGLA---------RDIRNDSNYVVKGNARLPVKWM 283
Query: 250 APE-VLRRRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFES---AP 304
APE + Y E D+WS G++L+ + S G P+ F +++ S AP
Sbjct: 284 APESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAP 343
Query: 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335
S D+++ DP KR T Q+++
Sbjct: 344 -----SEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 55/234 (23%), Positives = 93/234 (39%), Gaps = 17/234 (7%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISK--RKLVTKNDKDDIKREIQIMQHLSGQPNI 142
K LG G FG Y G + K R+ + +I E +M + P++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHV 71
Query: 143 VEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGV 201
G +V ++ +L G L D + K + + + C I ++ +
Sbjct: 72 CRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRL 130
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDIVGSA---YYVAPEVLRRR 257
+HRDL N L+ + +K TDFGL+ + + K Y G + +L R
Sbjct: 131 VHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRI 187
Query: 258 YGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310
Y + D+WS GV ++ L++ G P+ I + +G E P P I +
Sbjct: 188 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG----ERLPQPPICT 237
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 46/220 (20%), Positives = 86/220 (39%), Gaps = 48/220 (21%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKD--DIKREIQIMQHLS----- 137
E+G G FG L + +SK ++V K + ++ +Q +
Sbjct: 1 DEIGNGWFGKVLLGEAHR--------GMSKARVVVKELRASATPDEQLLFLQEVQPYREL 52
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY-SERAAASI----------- 185
PN+++ G + +V+E C G+L K + S R +
Sbjct: 53 NHPNVLQCLGQCIESIPYLLVLEFCPLGDL------KNYLRSNRGMVAQMAQKDVLQRMA 106
Query: 186 CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL--SVFIEEGKVYRD-I 242
C ++ + H +H DL N L++ + +K D+GL + E+ + +D
Sbjct: 107 CEVASGLLWL-HQADFIHSDLALRNCQLTA---DLSVKIGDYGLALEQYPEDYYITKDCH 162
Query: 243 VGSAYYVAPEVLRRRYG--------KEIDIWSAGVILYIL 274
++APE++ R K+ +IWS GV ++ L
Sbjct: 163 AVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 393 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.93 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.92 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.92 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.9 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.79 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.78 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.64 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.61 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.6 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.53 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.51 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.49 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.48 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.45 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.31 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.29 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.22 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.2 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.19 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.16 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.04 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.03 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.84 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.78 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.76 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.75 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.73 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.72 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.65 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.64 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.58 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.57 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.49 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.48 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.47 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.41 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.25 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.13 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.08 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.94 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.93 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.9 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.9 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.86 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.85 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.79 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.74 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.74 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.67 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.6 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.45 | |
| PLN02236 | 344 | choline kinase | 97.39 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.3 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.3 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.24 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.01 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.91 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.84 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.58 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.48 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.4 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.23 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.23 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.84 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.4 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.31 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.27 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 93.71 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.28 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-69 Score=482.31 Aligned_cols=269 Identities=40% Similarity=0.691 Sum_probs=249.3
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcc----cHHHHHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN----DKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
+.+.+.|.+.+.||+|+||.|-+|..+.||+.||||++++++..... ....+.+|++||++|+ |||||+++++|+
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKDFFE 246 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEeeeee
Confidence 34678899999999999999999999999999999999988764422 3445789999999996 999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 151 DKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 151 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
...+.||||||++||+|++++..++.+.+...+.+++|++.|+.|||++||+||||||+|||++.+.+...+||+|||+|
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 99999999999999999999999999999999999999999999999999999999999999998888899999999999
Q ss_pred ccccCCcceecccCcccccchHHHhhc----CCCcchHHHHHHHHHHHhhCCCCCCCCChHH-HHHHHHcCCCCCCCCCC
Q 016233 231 VFIEEGKVYRDIVGSAYYVAPEVLRRR----YGKEIDIWSAGVILYILLSGVPPFWAETEKG-IFDAILQGDIDFESAPW 305 (393)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~ 305 (393)
+...+...+.+.||||.|.|||++.+. +..++|+||+||+||.+|+|.+||.+..... ..+.|.++.+.|....|
T Consensus 327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 999988889999999999999999642 5669999999999999999999998876555 88999999999999999
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
..+|+++.+||.+||..||++|||++|+|+||||+....
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 999999999999999999999999999999999986543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-67 Score=443.93 Aligned_cols=300 Identities=39% Similarity=0.742 Sum_probs=279.9
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
.+.+.|.+-+.||+|.|+.||+|.+..||+.+|+|+++..++. ....+.+.+|++|.+.|+ |||||++.+.+.+.+..
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~-~~~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFH 85 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhc-cccHHHHHHHHHHHHhcC-CCcEeehhhhhccccee
Confidence 3567899999999999999999999999999999999887764 447899999999999997 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
|||+|++.|++|..-|...-.++|..+..+++||+++|.|||.+||||||+||+|+++.+++...-+||+|||+|..+.+
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 99999999999988777777899999999999999999999999999999999999999988889999999999999998
Q ss_pred CcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 236 GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
+......+|||.|||||+++. .|+..+|||+.|||||.||.|++||++.+...+++.|+++.++++.+.|+++++++++
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~ 245 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS 245 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence 777888999999999999975 6999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCCCCCCCCcCCHHHHHHHHHHHHhhHHHHHHHHHHHH
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVSLI 377 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (393)
||++||..||.+|+|+.|+|+|||+.+...........+.++.|++|.+.+|||.+.|..+..
T Consensus 246 LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavLtav~s 308 (355)
T KOG0033|consen 246 LIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTVIA 308 (355)
T ss_pred HHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHHHHHHh
Confidence 999999999999999999999999998766666666678899999999999999998875544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-63 Score=466.29 Aligned_cols=260 Identities=35% Similarity=0.620 Sum_probs=245.4
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.+|..++.||+|||+.||++++..+|+.||+|++.+..+......+.+.+||+|.++|+ |||||+++++|++.+++|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCceEEE
Confidence 57999999999999999999999999999999999988888888999999999999997 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-c
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-K 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~-~ 237 (393)
+|+|..++|..++++.+.++|.+++.+++||+.||.|||+++|+|||||..|+|+ +++..+||+|||||..+... .
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCccc
Confidence 9999999999999988999999999999999999999999999999999999999 67788999999999998754 6
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
...+.||||.|.|||++.. .++..+||||+||+||.||+|++||...+-.+++.+|....+.++. .+|.++++||
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI 249 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLI 249 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHH
Confidence 6788999999999999975 5999999999999999999999999999999999999999988876 6899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCCCCCC
Q 016233 317 RRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346 (393)
Q Consensus 317 ~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~ 346 (393)
.+||..||.+|||++++|.|+||+.+..+.
T Consensus 250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~ 279 (592)
T KOG0575|consen 250 RKLLRPNPSERPSLDEVLDHPFFKSGFTPA 279 (592)
T ss_pred HHHhcCCcccCCCHHHHhcCHhhhCCCcCC
Confidence 999999999999999999999997665443
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-59 Score=443.63 Aligned_cols=299 Identities=63% Similarity=1.052 Sum_probs=275.9
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
...+...|.+.+.||+|.||.||+|+++.+|+.+|+|++.+.........+.+.+|++||++|.+|||||.++++|++..
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 45567799999999999999999999999999999999998887666677899999999999988999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCC-CCcEEEeecCCccc
Q 016233 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE-NALLKATDFGLSVF 232 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~-~~~~kl~DFg~a~~ 232 (393)
.+++|||+|.||+|++++... .+++..+..+++|++.++.|||+.||+||||||+|+|+...+. +..+|++|||++..
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999999887 5999999999999999999999999999999999999987654 45899999999999
Q ss_pred ccCCcceecccCcccccchHHHh-hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 016233 233 IEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (393)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (393)
...+......+||+.|+|||++. ..|+..+||||+||++|.|++|.+||++.+......+|..+.+.|....|+.++..
T Consensus 189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 189 IKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred ccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 98877888999999999999998 57999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCCCCcCCHHHHHHHHHHHHhhHHHHHHHH
Q 016233 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALK 373 (393)
Q Consensus 312 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (393)
+++||.+||..||.+|+|+.++|+|||+.................+++++.+.+++++..++
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKKLALR 330 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999876666666666777777888888777776543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-59 Score=434.76 Aligned_cols=257 Identities=35% Similarity=0.650 Sum_probs=239.2
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.+|.+++.||+|+|++|++|+++.+++.||||++.++.+..+.....+.+|-.+|.+|.+||.|++|+-.|+|+..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 36999999999999999999999999999999999888777777788999999999998899999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~ 238 (393)
+||+++|+|+++|.+.+.|.+..++.++.||+.||+|||++|||||||||+|||+ +.++.+||.|||.|+.+.....
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCChhhc
Confidence 9999999999999999999999999999999999999999999999999999999 7888999999999998753221
Q ss_pred ------------e--ecccCcccccchHHHhhc-CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC
Q 016233 239 ------------Y--RDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA 303 (393)
Q Consensus 239 ------------~--~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 303 (393)
. .+.+||..|.+||+|... .++.+|||+||||+|+|+.|.+||.+.++.-++++|+...+.|+.
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~- 308 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE- 308 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC-
Confidence 1 457999999999999864 789999999999999999999999999999999999999988875
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
++++.++|||+++|..||.+|+|+++|.+||||...
T Consensus 309 ---~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 309 ---GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred ---CCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 578999999999999999999999999999999753
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-59 Score=445.37 Aligned_cols=257 Identities=39% Similarity=0.669 Sum_probs=242.3
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.-|++++.||.|+.|.|.+|++..||+.+|||+|.+...........+++||-||+.|. ||||+++|++|++..++|+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCceEEEE
Confidence 36999999999999999999999999999999999875556667888999999999997 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~ 238 (393)
+||++||.|++++..++.+++.+++++++||+.|+.|||..+|+||||||+|+|+ +....+||+|||+|..-.++..
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccCCcc
Confidence 9999999999999999999999999999999999999999999999999999999 5555599999999999888888
Q ss_pred eecccCcccccchHHHhhc--CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 239 YRDIVGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 239 ~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
..+.||+|+|.|||++++. -+.++||||+|||||.||||++||.+++...++.++.+|.+..+ .++|+++++||
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is~eaQdLL 243 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNISSEAQDLL 243 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCCHHHHHHH
Confidence 9999999999999999874 47899999999999999999999999999999999999998877 47999999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 317 RRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 317 ~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
.+||..||++|+|.+||++|||+....
T Consensus 244 r~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 244 RRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHhccCccccccHHHHhhCchhhcCC
Confidence 999999999999999999999998654
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-61 Score=410.12 Aligned_cols=305 Identities=34% Similarity=0.634 Sum_probs=262.7
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccC--Cc---ccHHHHHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV--TK---NDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
.+...|.-.+.||.|..++|.+|.++.+|+.+|+|++....-. .+ ...+.-.+|+.||+++.+||||+++.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3455788889999999999999999999999999998643211 11 124556789999999999999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 151 DKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 151 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
.+..+++|+|.|+.|.|+|+|.+.-.+++.+.+.|++||++|++|||.++||||||||+|||+ +++..+||+|||+|
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa 170 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFA 170 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEecccee
Confidence 999999999999999999999998889999999999999999999999999999999999999 77888999999999
Q ss_pred ccccCCcceecccCcccccchHHHh-------hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC
Q 016233 231 VFIEEGKVYRDIVGSAYYVAPEVLR-------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA 303 (393)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 303 (393)
..+..+......||||+|.|||.+. ..|+..+|+|++|||||.||.|.+|||.....-++..|++|++.|..+
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 9999999999999999999999874 248999999999999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCCCCcC----CHHHHHHHHHHHHhhHHHHHHHHHHHHHH
Q 016233 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI----DSAVLSRMKQFRAMNKLKKLALKVSLIKY 379 (393)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (393)
.|.++|...+|||.+||+.||.+|+|++|+|.||||.+........+ ....+..--.++++++++-+.+.+.+...
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP~~~~~~~k~qt~~~aRkrFk~ail~vra~~R 330 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSPVVEVELVKDQTSERARKRFKVAILTVRAFQR 330 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCCCcchhhhhhhhhHHhhhheeeeeehHHHHHH
Confidence 99999999999999999999999999999999999954322111111 12223333456677777777766666655
Q ss_pred HHHh
Q 016233 380 MLMY 383 (393)
Q Consensus 380 ~~~~ 383 (393)
+..+
T Consensus 331 ia~~ 334 (411)
T KOG0599|consen 331 IAKY 334 (411)
T ss_pred HHHH
Confidence 5443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-59 Score=419.20 Aligned_cols=257 Identities=35% Similarity=0.660 Sum_probs=238.0
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
+.|++++.||+|+||+||+++.+.|++.+|+|++++..............|..||.+++ ||.||+++..|++.+.+|+|
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCeEEEE
Confidence 47999999999999999999999999999999999988877778889999999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc-ccCCc
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF-IEEGK 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~-~~~~~ 237 (393)
+||+.||+|+..|.+.+.++|..++.++..|+.||.|||++|||||||||+|||+ |..+.++|+|||+++. ...+.
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhcccCCC
Confidence 9999999999999999999999999999999999999999999999999999999 7888899999999995 44455
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
...+.|||+.|||||++.+ .|+..+|.||||+++|+|++|.+||.+.+..+++++|.++....... .++.++++||
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~---~ls~~ardll 257 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG---YLSEEARDLL 257 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc---cCCHHHHHHH
Confidence 6677899999999999875 59999999999999999999999999999999999999988444332 3789999999
Q ss_pred HHhcccCCCCCC----CHHHHhcCccccCC
Q 016233 317 RRMLTQDPKKRI----TSAQVLEHPWIKEG 342 (393)
Q Consensus 317 ~~~L~~dp~~Rp----t~~e~l~h~~~~~~ 342 (393)
+++|+.||++|. +++++-+||||..-
T Consensus 258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred HHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 999999999995 78999999999754
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-59 Score=421.73 Aligned_cols=263 Identities=35% Similarity=0.638 Sum_probs=239.8
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
..+|.+.+.||+|+||+||+|+++.++..||||.|.+..+ .....+.+..|+.||+.|+ |||||.++++++.++.+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeEEE
Confidence 4579999999999999999999999999999999987765 4556788899999999997 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCC---CcEEEeecCCccccc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDEN---ALLKATDFGLSVFIE 234 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~---~~~kl~DFg~a~~~~ 234 (393)
|||||.||+|.++|...+.+++..++.++.||+.||++||+++||||||||+|||++..... ..+||+|||+|+.+.
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999999999999999999999999999999999999999999999999999865333 689999999999999
Q ss_pred CCcceecccCcccccchHHHh-hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 235 EGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
++....+.||++.|||||+++ .+|+-|+|+||+|+|+|+|++|+.||...+..+++..+.++....+... ..++..+.
T Consensus 167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~s~~~~ 245 (429)
T KOG0595|consen 167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-AELSNPLR 245 (429)
T ss_pred chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh-hhccCchh
Confidence 888889999999999999995 5799999999999999999999999999999999998888765544332 34667788
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
+|+...|..+|.+|.+..+-+.|+++....
T Consensus 246 ~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 246 ELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 999999999999999999999999987643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-58 Score=413.01 Aligned_cols=256 Identities=28% Similarity=0.439 Sum_probs=227.2
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC-eEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-SVHV 157 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-~~~l 157 (393)
.+.+.++.||+|..|+||+|+|+.|++.+|+|+|... .......++.+|+++++.++ |||||++|+.|.+++ .++|
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~-spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQ-SPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCC-CCCeeeEeEEEEeCCceEEe
Confidence 3566788999999999999999999999999999432 24556789999999999995 999999999999999 4999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~-~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+||||+||+|.+.+...++++|.....++.+++.||.|||+ ++||||||||+|||+ +..+.+||||||.++.+.+.
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhh
Confidence 99999999999999988999999999999999999999996 999999999999999 45666999999999988776
Q ss_pred cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCC-----ChHHHHHHHHcCCCCCCCCCCCCCCH
Q 016233 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAE-----TEKGIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
...+.+||..|||||.+.+ .|+.++||||||+.++|+.+|+.||... +..+++..|..+..+-... ..+|+
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~--~~fS~ 309 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE--GEFSP 309 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc--ccCCH
Confidence 5578899999999999987 5999999999999999999999999874 5667888888764332221 24899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
++++||..||++||.+|+|+.|+|+|||+++..
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 999999999999999999999999999998653
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-57 Score=428.31 Aligned_cols=259 Identities=41% Similarity=0.729 Sum_probs=236.4
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCc--ccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK--NDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
....+|.+++.||+|+||.|+.|.+..++..||+|++.++..... ...+.+.+|+.+++++..||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345689999999999999999999999999999998877533212 345677799999999977999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCC-CcEEEeecCCccc
Q 016233 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDEN-ALLKATDFGLSVF 232 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~-~~~kl~DFg~a~~ 232 (393)
.+|+|||||.||+|++++.+.+++.|.+++.+++||+.|++|||++||+||||||+|||++ .+ +.+||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld---~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD---GNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec---CCCCCEEEeccccccc
Confidence 9999999999999999999999999999999999999999999999999999999999994 44 7899999999998
Q ss_pred c-cCCcceecccCcccccchHHHhhc--C-CCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 016233 233 I-EEGKVYRDIVGSAYYVAPEVLRRR--Y-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (393)
Q Consensus 233 ~-~~~~~~~~~~gt~~y~aPE~l~~~--~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (393)
. .......+.+||+.|+|||++.+. | +.++||||+||+||.|++|..||.+.+...++..|..+.+.++.. +
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~----~ 246 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY----L 246 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC----c
Confidence 8 466778899999999999999863 4 689999999999999999999999999999999999998887754 4
Q ss_pred -CHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 309 -SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 309 -s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
|+++++||.+||..||.+|+|+.+++.||||+.
T Consensus 247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 247 LSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999999999999999999999997
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-57 Score=392.70 Aligned_cols=255 Identities=35% Similarity=0.645 Sum_probs=238.7
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
-++|++++.||.|+||.|.+++++.+|..+|+|++++.....-.+.+...+|.++|+.+. ||.++++++.+.+.+.+||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeEEE
Confidence 347899999999999999999999999999999999887766667778899999999997 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||||++||.|+.++++.+++++..++.++.||+.||+|||+++|++|||||||||+ |.++.+||+|||+|+.....
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecCc-
Confidence 99999999999999999999999999999999999999999999999999999999 78889999999999987654
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
..+.||||.|+|||++.. .|++.+|.|||||++|||+.|.+||.+.+..+++++|..++..|+. .++++++|||
T Consensus 198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kdLl 272 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKDLL 272 (355)
T ss_pred -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHHHH
Confidence 578899999999999875 5999999999999999999999999999999999999999999886 5899999999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCccccCC
Q 016233 317 RRMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (393)
Q Consensus 317 ~~~L~~dp~~Rp-----t~~e~l~h~~~~~~ 342 (393)
.++|+.|-.+|. ...++.+||||...
T Consensus 273 ~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 273 KKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred HHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 999999999993 56799999999854
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-58 Score=396.56 Aligned_cols=257 Identities=28% Similarity=0.535 Sum_probs=221.7
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|+.+.++|+|+||+||+|+++.||+.||||.+..+.. .+...+-..+||++|++|+ |+|+|.++++|.....++||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhcceeEEE
Confidence 368889999999999999999999999999999864431 2334556789999999997 99999999999999999999
Q ss_pred EeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc-CC
Q 016233 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EG 236 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~-~~ 236 (393)
+|||+. ++.+-|... ..++...+..++.|++.|+.|||++++|||||||+|||+ ..++.+||||||+|+.+. .+
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---ecCCcEEeccchhhHhhcCCc
Confidence 999966 666666553 458999999999999999999999999999999999999 567789999999999987 67
Q ss_pred cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC----------------
Q 016233 237 KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI---------------- 298 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~---------------- 298 (393)
..++.++.|.||+|||.+-+ +|++.+||||+||++.||++|.+.|.+.++-+.+..|...--
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 78889999999999998875 699999999999999999999999999988777665543110
Q ss_pred ---CCC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 299 ---DFE--------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 299 ---~~~--------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
.++ ...++.++..+.||+++||..||++|++.+++|.|+||..
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 111 1135678889999999999999999999999999999953
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-56 Score=414.64 Aligned_cols=260 Identities=32% Similarity=0.565 Sum_probs=236.1
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
.++|++++.||+|+||.||+|+.+.||..+|+|++++.......+.+-+..|-.||... ++|+||+++..|++..++||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeEE
Confidence 45799999999999999999999999999999999998877777888899999999996 59999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG- 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~- 236 (393)
||||++||++..+|.+.+.+++..++.++.+++.|++.||+.|+|||||||+|+|| |..+.+||+||||+..+...
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999 78888999999998643210
Q ss_pred -----------------------cc------------------------eecccCcccccchHHHhh-cCCCcchHHHHH
Q 016233 237 -----------------------KV------------------------YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAG 268 (393)
Q Consensus 237 -----------------------~~------------------------~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG 268 (393)
.. ....+|||.|||||++.+ .|+..+|.||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 00 013579999999999876 599999999999
Q ss_pred HHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCccccCC
Q 016233 269 VILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT---SAQVLEHPWIKEG 342 (393)
Q Consensus 269 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~e~l~h~~~~~~ 342 (393)
|||||||.|.+||.+.+..+++.+|.+....+..+.-..++++++|||.+||. ||++|.. ++||.+||||+..
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 99999999999999999999999999988666666556789999999999999 9999985 8999999999864
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-56 Score=388.94 Aligned_cols=267 Identities=39% Similarity=0.691 Sum_probs=240.5
Q ss_pred ccccceeecc-eecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe---
Q 016233 76 DVKLHYSFGK-ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--- 151 (393)
Q Consensus 76 ~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 151 (393)
.+.++|.+.. +||-|-.|.|..|.++.||+.+|+|++. +....++|+++.-..++|||||.++++|+.
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~--------Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL--------DSPKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh--------cCHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 3556787754 6999999999999999999999999874 335667889888888899999999999864
Q ss_pred -CCeEEEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecC
Q 016233 152 -KQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (393)
Q Consensus 152 -~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg 228 (393)
...+.+|||.++||+|+.++...+. |+|.++..|++||..|+.|||+.+|.||||||+|+|.+....+..+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 3567899999999999999998766 9999999999999999999999999999999999999988889999999999
Q ss_pred CcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh----HHHHHHHHcCCCCCCCC
Q 016233 229 LSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAILQGDIDFESA 303 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~----~~~~~~i~~~~~~~~~~ 303 (393)
+|+.........+.|-||+|.|||++.. +|+..+|+||+||++|.||+|.+||+.... ..+-..|..+.+.|+.+
T Consensus 210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p 289 (400)
T KOG0604|consen 210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP 289 (400)
T ss_pred cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence 9998887778889999999999999974 699999999999999999999999987653 45678899999999999
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCCCCcC
Q 016233 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350 (393)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~~~~ 350 (393)
.|..+|+.++|+|+++|..+|.+|.|++++++|||+.......+.++
T Consensus 290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl 336 (400)
T KOG0604|consen 290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPL 336 (400)
T ss_pred hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCc
Confidence 99999999999999999999999999999999999998766555554
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-55 Score=403.72 Aligned_cols=260 Identities=28% Similarity=0.474 Sum_probs=226.4
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC--CeE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QSV 155 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~ 155 (393)
.+.|+.+++||+|.||.||+|++..||+.||+|.+..... .........+||.||++|. ||||+++.+...+. ..+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~-HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLD-HPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcC-CCcccceeeEEEecCCceE
Confidence 3568899999999999999999999999999999987653 2345566789999999996 99999999988776 789
Q ss_pred EEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
|||+|||+. +|.-++... -.|++.++..+++||+.||+|||.+||+|||||.+|||| |.++.+||+|||||+++.
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeecc
Confidence 999999965 787766653 369999999999999999999999999999999999999 778889999999999776
Q ss_pred CCc--ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCC----
Q 016233 235 EGK--VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP---- 306 (393)
Q Consensus 235 ~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~---- 306 (393)
... .++..+-|.+|+|||.|.+ .|+..+|+||+||||.||++|++.|.+.++.+.+..|.+..-.+....|+
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 543 5778889999999999876 59999999999999999999999999999999998886644333333332
Q ss_pred ---------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 307 ---------------------TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 307 ---------------------~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
.++..+.+|+..||..||++|.||.++|+++||+...
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p 407 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEP 407 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCC
Confidence 3578899999999999999999999999999995543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-56 Score=409.44 Aligned_cols=261 Identities=32% Similarity=0.492 Sum_probs=227.3
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC-e
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-S 154 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-~ 154 (393)
.+.++|.++++||.|.||.||+|+.+.+|..||||.++++. ....+ -.-.||+..|++|..|||||++.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf-~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF-YSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh-ccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 45679999999999999999999999999999999987654 33322 233579999999977999999999998887 9
Q ss_pred EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
+|+|||||+ .+|+++++.. +.|++..++.|+.||+.||+|+|++|+.|||+||||||++ ....+||+|||+|+.+
T Consensus 85 L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~---~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 85 LYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS---GNDVIKIADFGLAREV 160 (538)
T ss_pred EeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec---ccceeEeccccccccc
Confidence 999999995 5999988765 4699999999999999999999999999999999999995 4667999999999999
Q ss_pred cCCcceecccCcccccchHHHh--hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC------------
Q 016233 234 EEGKVYRDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID------------ 299 (393)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~------------ 299 (393)
.....++.++.|.+|+|||+|. +.|+.+.|||++|||++|+.+-++.|.|.++.+.+.+|..---.
T Consensus 161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 9999999999999999999875 35999999999999999999999999999998888777542111
Q ss_pred -------CCCC-------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 300 -------FESA-------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 300 -------~~~~-------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
++.. ..++.+.++.++|.+||.+||++||||.|+|+||||+..
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 1111 134578999999999999999999999999999999864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-55 Score=409.56 Aligned_cols=254 Identities=32% Similarity=0.569 Sum_probs=234.6
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.+|.+.+.||+|+||.||+|+.+.|.+.||+|.+.+..- .+.+...+.+|++|++.|+ |||||.++++|+...++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceEEEE
Confidence 368899999999999999999999999999999987653 4557788999999999997 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc-
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~- 237 (393)
.|||.| +|+.+|...+.++|+.++.++.+++.||.|||+++|+|||+||.|||+ +.++.+|+||||+|+......
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~ 155 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS 155 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce
Confidence 999977 999999999999999999999999999999999999999999999999 788899999999999887654
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
..+..-|||.|||||++.+ .|+..+|+||||||+|||++|++||+.....++.+.|......++. .+|..+..|+
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----~~S~~f~nfl 231 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----TASSSFVNFL 231 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----cccHHHHHHH
Confidence 4556789999999999986 4999999999999999999999999999999999999987665554 7899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCC
Q 016233 317 RRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 317 ~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+.+|.+||.+|.|..+++.|||.+..
T Consensus 232 ~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 232 QGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHhhcChhhcccHHHHhcChHHhhh
Confidence 99999999999999999999998764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-54 Score=369.80 Aligned_cols=259 Identities=33% Similarity=0.515 Sum_probs=225.2
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.+|...++||+|.||.||+|++..||+.||||.|+...... .......+||+.|+.++ |+||+.++++|.+.+.+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~-h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELK-HPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHcc-CcchhhhhhhccCCCceEEE
Confidence 47888999999999999999999999999999998775432 33456778999999997 99999999999999999999
Q ss_pred EeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
+||++. +|...++.. ..++..++..++.+++.||+|||++.|+||||||+|+|+ +.++.+||+|||+|+.+....
T Consensus 80 fEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE---cCCCcEEeecccchhccCCCC
Confidence 999965 888888754 458999999999999999999999999999999999999 566779999999999987554
Q ss_pred ce-ecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCC---------
Q 016233 238 VY-RDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW--------- 305 (393)
Q Consensus 238 ~~-~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~--------- 305 (393)
.. ...+-|.+|+|||.+.+ .|+..+||||.|||+.||+.|.+.|.+.++-+.+..|.+.--+.....|
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 33 33478999999999865 5999999999999999999999999999998888888764444433333
Q ss_pred ---------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 306 ---------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 306 ---------------~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
+..+.++.||+.+||..||.+|+|+.|+|+|+||+...
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 34577889999999999999999999999999998753
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-56 Score=382.31 Aligned_cols=246 Identities=30% Similarity=0.537 Sum_probs=217.2
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeE-EEEeCCe-E
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG-AYEDKQS-V 155 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~-~~~~~~~-~ 155 (393)
...|++.++||+|+||.||++.+..+|..+|.|.+.-... +....+.+..|+.+|++|+ |||||++++ .|..++. +
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccchhh
Confidence 3479999999999999999999999999999999985443 4567788999999999996 999999998 4555544 9
Q ss_pred EEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH--cC--cEecCCCCCcEEeccCCCCCcEEEeec
Q 016233 156 HVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHF--MG--VMHRDLKPENFLLSSKDENALLKATDF 227 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~--~~--ivH~Dikp~Nill~~~~~~~~~kl~DF 227 (393)
+||||||++|+|...++. .+.++|..+|.++.|++.||..||. .. |+||||||.||++ +.++.+||+||
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDf 172 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDF 172 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeeccc
Confidence 999999999999988764 3569999999999999999999999 45 9999999999999 67788999999
Q ss_pred CCcccccCCcc-eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 016233 228 GLSVFIEEGKV-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW 305 (393)
Q Consensus 228 g~a~~~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (393)
|+++.+..... ..+.+|||.||+||.+.+ .|+.++||||+||++|||+.-.+||++.+..++-.+|.++.++.-+ -
T Consensus 173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p--~ 250 (375)
T KOG0591|consen 173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP--D 250 (375)
T ss_pred hhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc--H
Confidence 99999876553 457899999999999876 5999999999999999999999999999999999999999654222 1
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCH
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITS 330 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~ 330 (393)
..+|.++..||..|+..||+.||+.
T Consensus 251 ~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHhhhHHHHHHHHHccCCcccCCCc
Confidence 4689999999999999999999985
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-55 Score=391.49 Aligned_cols=260 Identities=39% Similarity=0.660 Sum_probs=244.4
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
......+|++.+.||+|.||.|-+|.+..+|+.||||.|++.++..++++-.+.+||+||..|+ ||||+.+|++|+..+
T Consensus 48 khnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyEVFENkd 126 (668)
T KOG0611|consen 48 KHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYEVFENKD 126 (668)
T ss_pred ccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhhhhcCCc
Confidence 3456779999999999999999999999999999999999999988888999999999999996 999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
.+.|||||..+|+|.|++.+.+.+++.+++.+++||+.|+.|||+++++|||||.+|||+ |.++.+||+|||++..+
T Consensus 127 KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLY 203 (668)
T ss_pred eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhhh
Confidence 999999999999999999999999999999999999999999999999999999999999 77888999999999999
Q ss_pred cCCcceecccCcccccchHHHhhc--CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 016233 234 EEGKVYRDIVGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (393)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (393)
...+...++||+|.|.+||++++. -++.+|-|||||+||.|..|..||.+.+...++..|.++.+..+. -+.+
T Consensus 204 ~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-----~PSd 278 (668)
T KOG0611|consen 204 ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-----TPSD 278 (668)
T ss_pred ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-----CCch
Confidence 999999999999999999999874 478999999999999999999999999999999999999876443 3578
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 312 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+.-||+.||..||++|.|++++-.|=|+.-+
T Consensus 279 A~gLIRwmLmVNP~RRATieDiAsHWWvNwg 309 (668)
T KOG0611|consen 279 ASGLIRWMLMVNPERRATIEDIASHWWVNWG 309 (668)
T ss_pred HHHHHHHHHhcCcccchhHHHHhhhheeecc
Confidence 9999999999999999999999999988643
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-53 Score=391.17 Aligned_cols=260 Identities=33% Similarity=0.615 Sum_probs=226.7
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCC-----------cccHHHHHHHHHHHHHccCCCCeeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT-----------KNDKDDIKREIQIMQHLSGQPNIVEF 145 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~~h~niv~~ 145 (393)
.-.+|++++.||+|.||.|.+|++..+++.||||++.+..... -...+.+.+||.||++|. |||||++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nVV~L 173 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNVVKL 173 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCeeEE
Confidence 4457999999999999999999999999999999998754321 123468899999999997 9999999
Q ss_pred eEEEEeC--CeEEEEEeccCCCChHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcE
Q 016233 146 KGAYEDK--QSVHVVMELCAGGELFDRIIAKGH-YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALL 222 (393)
Q Consensus 146 ~~~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~ 222 (393)
+++..+. +.+|||+|||..|.+.. .-..+. +++.+++.+++.++.||+|||.+|||||||||+|+|+ ++++.+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl---~~~g~V 249 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL---SSDGTV 249 (576)
T ss_pred EEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE---cCCCcE
Confidence 9999765 57999999999998854 333334 8999999999999999999999999999999999999 566889
Q ss_pred EEeecCCcccccC------CcceecccCcccccchHHHhh---c--CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHH
Q 016233 223 KATDFGLSVFIEE------GKVYRDIVGSAYYVAPEVLRR---R--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFD 291 (393)
Q Consensus 223 kl~DFg~a~~~~~------~~~~~~~~gt~~y~aPE~l~~---~--~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~ 291 (393)
||+|||.+..... ...+...+|||.|+|||.+.+ . .+.+.||||+||+||.|+.|..||.+....++++
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 9999999987632 223445789999999999865 2 4788999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 292 AILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 292 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
+|.+..+.|+.. +.+.++++|||.+||.+||++|++..++..|||.....
T Consensus 330 KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 330 KIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred HHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 999998887765 46889999999999999999999999999999998763
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-53 Score=404.06 Aligned_cols=257 Identities=30% Similarity=0.540 Sum_probs=238.5
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
-++|+++++||+|+||+|+++..+.+++.+|||++++..+....+.+....|.+|+....+||.++.++.+|+..+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 45799999999999999999999999999999999999988888999999999999999889999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc-CC
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EG 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~-~~ 236 (393)
||||+.||++. .+...+.|++..++.++..|+.||.|||++||||||||.+|||+ |..+.+||+|||+++..- .+
T Consensus 447 vmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 447 VMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccCCCC
Confidence 99999999954 34455789999999999999999999999999999999999999 778889999999998754 55
Q ss_pred cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
....+.||||.|||||++.+ .|+..+|.|||||+|||||.|..||.++++.++++.|...+..++. .+|.++.++
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea~~i 598 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEAIAI 598 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHHHHH
Confidence 67788999999999999986 5999999999999999999999999999999999999999887775 589999999
Q ss_pred HHHhcccCCCCCCCH-----HHHhcCccccCC
Q 016233 316 VRRMLTQDPKKRITS-----AQVLEHPWIKEG 342 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~-----~e~l~h~~~~~~ 342 (393)
++++|.+||++|..+ +++.+||||+..
T Consensus 599 l~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 599 MRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred HHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 999999999999865 789999999864
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-54 Score=384.02 Aligned_cols=269 Identities=31% Similarity=0.520 Sum_probs=229.5
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe----
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED---- 151 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~---- 151 (393)
.+..+|...+.||+|+||.|+.+.++.+|+.||||.+.. .+......++..+|+++|+.++ |+||+.+.+++..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPSRD 96 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhc-CCCcceEEeeccccccc
Confidence 455677778999999999999999999999999998853 2345566788999999999997 9999999998864
Q ss_pred -CCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 152 -KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 152 -~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
-+.+|+|+|+| +.+|...++....+++..++.++.||+.||+|+|+.+|+||||||.|+|+ +.++.+||||||+|
T Consensus 97 ~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 97 KFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICDFGLA 172 (359)
T ss_pred ccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEeccccce
Confidence 46799999999 56888888877779999999999999999999999999999999999999 56667999999999
Q ss_pred ccccC---CcceecccCcccccchHHHh--hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC--------
Q 016233 231 VFIEE---GKVYRDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD-------- 297 (393)
Q Consensus 231 ~~~~~---~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~-------- 297 (393)
+.... ....+.++.|.+|+|||++. ..|+...||||+||||.||++|++.|.+.+....+..|..-.
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 98864 44567889999999999875 369999999999999999999999999887766555554311
Q ss_pred ---------------CCCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCCCCcC
Q 016233 298 ---------------IDFESA----PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350 (393)
Q Consensus 298 ---------------~~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~~~~ 350 (393)
...+.. .+++.++.+.||+++||..||.+|+|++|+|+|||+.......+++.
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~ 324 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPV 324 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCC
Confidence 111111 25688999999999999999999999999999999998877776663
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-54 Score=379.40 Aligned_cols=263 Identities=36% Similarity=0.653 Sum_probs=238.2
Q ss_pred cccceee-cceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 77 VKLHYSF-GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 77 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
+.+-|++ .+.||+|+|+.|--|....+|.+||||+|.+. ....+.++.+|++++.++++|+||++++++|+++..+
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 4455666 45699999999999999999999999999765 3556889999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
|||||-+.||+|+.+|.+...|++.++..+.+.|+.||++||.+||.||||||+|||-...+.-..+|||||.+...+..
T Consensus 152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 99999999999999999999999999999999999999999999999999999999998878888899999998765532
Q ss_pred C--------cceecccCcccccchHHHh---h---cCCCcchHHHHHHHHHHHhhCCCCCCCCC---------------h
Q 016233 236 G--------KVYRDIVGSAYYVAPEVLR---R---RYGKEIDIWSAGVILYILLSGVPPFWAET---------------E 286 (393)
Q Consensus 236 ~--------~~~~~~~gt~~y~aPE~l~---~---~~~~~~DiwSlG~il~~lltg~~pf~~~~---------------~ 286 (393)
. ....+.+|+..|||||+.. + .|++++|.||||||||.||+|.+||.+.. .
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence 2 2345678999999999863 2 49999999999999999999999997643 3
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 287 KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 287 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+.+++.|..+.+.|+...|..+|.+++|+|..+|..|+.+|.++.++++|||+...
T Consensus 312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 57889999999999999999999999999999999999999999999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=388.15 Aligned_cols=258 Identities=34% Similarity=0.562 Sum_probs=216.6
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC--eEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ--SVH 156 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--~~~ 156 (393)
.+|..++.||+|+||.||++.+..+|...|||.+.... ....+.+.+|+.+|++|+ |||||++++...... .++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeE
Confidence 46888999999999999999999999999999987552 112677999999999998 999999999855444 699
Q ss_pred EEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 157 VVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
|+|||++||+|.+++.+.+ .++++.++.+.+||++||.|||++|||||||||+|||+... ++.+||+|||++.....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~--~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS--NGDVKLADFGLAKKLES 170 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC--CCeEEeccCcccccccc
Confidence 9999999999999999877 79999999999999999999999999999999999999431 57799999999987763
Q ss_pred ----CcceecccCcccccchHHHhhc--CCCcchHHHHHHHHHHHhhCCCCCCC-CChHHHHHHHHcCCCCCCCCCCCCC
Q 016233 236 ----GKVYRDIVGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWA-ETEKGIFDAILQGDIDFESAPWPTI 308 (393)
Q Consensus 236 ----~~~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~~lltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (393)
........||+.|||||++... ..+++|||||||++.||+||+.||.. ....+.+-.+......+ .....+
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P--~ip~~l 248 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP--EIPDSL 248 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC--CCCccc
Confidence 1223457899999999999843 23599999999999999999999987 33334344444433222 233469
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
|+++++||.+||..||++||||+++|+|||......
T Consensus 249 s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 249 SDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 999999999999999999999999999999976543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-53 Score=373.87 Aligned_cols=260 Identities=29% Similarity=0.417 Sum_probs=222.1
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe--CCeEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--KQSVH 156 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~~ 156 (393)
+.|+.+..|++|+||.||+|+++.|++.||+|.++.++.... ..-.-.+||.+|.+++ |||||.+-++... -+.+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G-FPItsLREIniLl~~~-H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG-FPITSLREINILLKAR-HPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC-CcchhHHHHHHHHhcC-CCCeeeeEEEEeccccceee
Confidence 468999999999999999999999999999999987653222 2334568999999997 9999999998754 45799
Q ss_pred EEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 157 VVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
||||||+. +|...+..-+ +|...+++.++.|++.|++|||.+.|+||||||+|+|+ ...+.+||+|||+|+.+..
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm---~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL---SHKGILKIADFGLAREYGS 229 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---ccCCcEEecccchhhhhcC
Confidence 99999965 8888777644 79999999999999999999999999999999999999 5677799999999999876
Q ss_pred C-cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCC------
Q 016233 236 G-KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP------ 306 (393)
Q Consensus 236 ~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~------ 306 (393)
. ..++..+-|.+|+|||.+.+ .|++..|+||+|||+.||+++++.|.+.++.+.+++|.+.--......|+
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 5 45677889999999999876 49999999999999999999999999999998888886532222222222
Q ss_pred ----------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 307 ----------------------TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 307 ----------------------~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
.+++...+|+..+|..||.+|.|++|+|+|.||.+...
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence 14588899999999999999999999999999998543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-54 Score=363.48 Aligned_cols=254 Identities=33% Similarity=0.663 Sum_probs=236.2
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++++.||+|-||.||+|+.++++-.||+|++.++.+.......++.+|++|-..|+ ||||+++|++|.+...+||+
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheeccceeEEE
Confidence 47999999999999999999999999999999999888777777889999999999997 99999999999999999999
Q ss_pred EeccCCCChHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 159 MELCAGGELFDRII--AKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 159 ~e~~~gg~L~~~l~--~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+||..+|+|+..|. ...++++..++.+++|++.||.|||.++|+||||||+|+|++ ..+.+||+|||.+.... .
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg---~~~~lkiAdfGwsV~~p-~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAP-S 176 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC---CCCCeeccCCCceeecC-C
Confidence 99999999999998 556799999999999999999999999999999999999995 45569999999998765 4
Q ss_pred cceecccCcccccchHHHhhc-CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 237 KVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
..-.+.|||..|.+||+.++. ++..+|+|++|++.||++.|.+||...+..+.+..|.+-++.++ +.++..+.|+
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is~~a~dl 252 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STISGGAADL 252 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccChhHHHH
Confidence 445788999999999999874 89999999999999999999999999999999999999888877 4799999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccC
Q 016233 316 VRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
|.+||..+|.+|.+..|++.|||+..
T Consensus 253 I~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHhccCccccccHHHHhhhHHHHh
Confidence 99999999999999999999999865
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-53 Score=398.90 Aligned_cols=257 Identities=33% Similarity=0.567 Sum_probs=224.9
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
+....|...++||+|+.|.||.|....+++.||||.+..+. ....+-+.+|+.+|+.++ |+|||.+++.|-..+.+
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---QPKKELLLNEILVMRDLH-HPNIVNFLDSYLVGDEL 345 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc---CCchhhhHHHHHHHHhcc-chHHHHHHHHhccccee
Confidence 34567999999999999999999999999999999997653 345678899999999997 99999999999888999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
|+||||++||+|.|.+.. ..++|.+++.|++.++.||+|||.+||+|||||.+|||+ +.++.+||+|||++..+..
T Consensus 346 WVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---TMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---ccCCcEEEeeeeeeecccc
Confidence 999999999999886654 469999999999999999999999999999999999999 4556699999999998876
Q ss_pred Cc-ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 236 GK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 236 ~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
.. .-.+.+|||+|||||++.. .|+++.||||||++++||+-|.+||...+....+..|.... ......+..+|++++
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng-~P~lk~~~klS~~~k 500 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPKLKNPEKLSPELK 500 (550)
T ss_pred ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC-CCCcCCccccCHHHH
Confidence 55 4467899999999999865 69999999999999999999999999777655555554332 223334467999999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
||+.+||..|+++|+++.|+|+||||+.
T Consensus 501 dFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 501 DFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 9999999999999999999999999954
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-52 Score=391.64 Aligned_cols=253 Identities=32% Similarity=0.626 Sum_probs=227.1
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.+|++.+.||+|+||.||+|.+..+++.||||++.+.........+.+.+|+.++++++ ||||+++++++.+++.+|+|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcCCEEEEE
Confidence 57999999999999999999999999999999997654433445677899999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~ 238 (393)
|||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCCCc-
Confidence 9999999999999988889999999999999999999999999999999999999 556779999999998765432
Q ss_pred eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 016233 239 YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (393)
Q Consensus 239 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (393)
...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+...++. .++..+++||.
T Consensus 173 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~ 247 (329)
T PTZ00263 173 -FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN----WFDGRARDLVK 247 (329)
T ss_pred -ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC----CCCHHHHHHHH
Confidence 34679999999999875 4889999999999999999999999998888888888887655442 47899999999
Q ss_pred HhcccCCCCCCC-----HHHHhcCccccC
Q 016233 318 RMLTQDPKKRIT-----SAQVLEHPWIKE 341 (393)
Q Consensus 318 ~~L~~dp~~Rpt-----~~e~l~h~~~~~ 341 (393)
+||..||.+|++ ++++++||||..
T Consensus 248 ~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 248 GLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 999999999997 799999999976
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=372.58 Aligned_cols=260 Identities=32% Similarity=0.566 Sum_probs=233.9
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.+|++++.||.|.-|+||+|..+.++..+|+|++.+..+.......+++.|-+||+.+. ||.++.+|..|+.++..|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhhheeeccceeEEE
Confidence 47899999999999999999999999999999999887776677788899999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC-
Q 016233 159 MELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE- 235 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~- 235 (393)
||||+||+|...++++ +.++++.++.++..++.||+|||-.|||+|||||+|||| .+++.|.|+||.|+.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCCC
Confidence 9999999999877664 569999999999999999999999999999999999999 6778899999998753210
Q ss_pred --------------------------------C-c-----------------------ceecccCcccccchHHHhhc-C
Q 016233 236 --------------------------------G-K-----------------------VYRDIVGSAYYVAPEVLRRR-Y 258 (393)
Q Consensus 236 --------------------------------~-~-----------------------~~~~~~gt~~y~aPE~l~~~-~ 258 (393)
. . .....+||-.|.|||++++. .
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 01135799999999999874 8
Q ss_pred CCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHHHh
Q 016233 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT----SAQVL 334 (393)
Q Consensus 259 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt----~~e~l 334 (393)
+.++|.|+|||++||||.|..||.+.+.++.+.+|......|+... .++..++|||+++|.+||.+|.. ++||.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 9999999999999999999999999999999999999988888763 78999999999999999999998 99999
Q ss_pred cCccccCCCC
Q 016233 335 EHPWIKEGGE 344 (393)
Q Consensus 335 ~h~~~~~~~~ 344 (393)
+||||+....
T Consensus 391 ~HpFF~gVnW 400 (459)
T KOG0610|consen 391 RHPFFEGVNW 400 (459)
T ss_pred cCccccCCCh
Confidence 9999986543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-52 Score=385.18 Aligned_cols=252 Identities=29% Similarity=0.570 Sum_probs=225.3
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+. ||||+++++++.+.+.+|+||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeEEEEE
Confidence 6899999999999999999999999999999997654333344567889999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcce
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~ 239 (393)
||+++|+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~--~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDR--T 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCC--c
Confidence 999999999999988889999999999999999999999999999999999999 45667999999999876543 2
Q ss_pred ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 016233 240 RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318 (393)
Q Consensus 240 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 318 (393)
...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+...++. .++..+++||++
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~ 231 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIKK 231 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCHHHHHHHHH
Confidence 34679999999999875 4889999999999999999999999998888888888887665543 468999999999
Q ss_pred hcccCCCCCCC-----HHHHhcCccccC
Q 016233 319 MLTQDPKKRIT-----SAQVLEHPWIKE 341 (393)
Q Consensus 319 ~L~~dp~~Rpt-----~~e~l~h~~~~~ 341 (393)
||..||.+|++ ++++++||||..
T Consensus 232 ~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 232 LLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HcCCCHHHccCCccCCHHHHhcCccccC
Confidence 99999999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=374.26 Aligned_cols=261 Identities=30% Similarity=0.467 Sum_probs=228.7
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
....|++.++||.|..++||+|++..++..||||+++.++.. .....+.+|+..|+.+. ||||++++..|..++.+|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~-HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLID-HPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcC-CCCcceEEEEEEecceeE
Confidence 345899999999999999999999999999999999877643 34899999999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 157 VVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+||.||.+|++++++... ..+.|..+..|+++++.||.|||++|.||||||+.|||| +.++.|||+|||.+..+.
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASLF 177 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeeec
Confidence 999999999999999874 349999999999999999999999999999999999999 677889999999877654
Q ss_pred CCc-----ceecccCcccccchHHHhh---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC-----
Q 016233 235 EGK-----VYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE----- 301 (393)
Q Consensus 235 ~~~-----~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~----- 301 (393)
... .+.+.+||++|||||++.. .|+.|+||||||++..||.+|..||......+++...+++.....
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~ 257 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGL 257 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccC
Confidence 321 1245689999999999753 599999999999999999999999999888887777777665422
Q ss_pred -CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 302 -SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 302 -~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
......++..++++|..||..||.+|||++++|+|+||+...
T Consensus 258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 222345678899999999999999999999999999998753
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=393.13 Aligned_cols=258 Identities=29% Similarity=0.494 Sum_probs=221.9
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..++ |+||+++++.+.+...+|+||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCeEEEEE
Confidence 6899999999999999999999999999999997654333445567889999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc--
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-- 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-- 237 (393)
|||+||+|.+++...+.+++.+++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCcccccccccc
Confidence 999999999999888899999999999999999999999999999999999999 556779999999987543211
Q ss_pred ----------------------------------ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCC
Q 016233 238 ----------------------------------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFW 282 (393)
Q Consensus 238 ----------------------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~ 282 (393)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 0124579999999999865 58999999999999999999999999
Q ss_pred CCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCC---CCCCHHHHhcCccccCC
Q 016233 283 AETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPK---KRITSAQVLEHPWIKEG 342 (393)
Q Consensus 283 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~---~Rpt~~e~l~h~~~~~~ 342 (393)
+.+..+.+..+.........+....+++++++||.+|+. +|. .||+++|+++||||...
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 988888888887654333333334588999999999875 454 45899999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-52 Score=389.17 Aligned_cols=250 Identities=33% Similarity=0.592 Sum_probs=221.3
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~g 164 (393)
+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.++++++ ||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999998654433445567788999999996 99999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc-CCcceeccc
Q 016233 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIV 243 (393)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~-~~~~~~~~~ 243 (393)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++... ........+
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCccccee
Confidence 9999999888889999999999999999999999999999999999999 556679999999987642 223344568
Q ss_pred CcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 016233 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (393)
Q Consensus 244 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (393)
||+.|+|||++.+ .++.++|||||||++|+|++|..||...+.......+..+...++ ..+++++.+||.+||..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAGLLKK 232 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence 9999999999875 589999999999999999999999999888888888877765554 35789999999999999
Q ss_pred CCCCCC-----CHHHHhcCccccCC
Q 016233 323 DPKKRI-----TSAQVLEHPWIKEG 342 (393)
Q Consensus 323 dp~~Rp-----t~~e~l~h~~~~~~ 342 (393)
||++|| ++.++++||||...
T Consensus 233 dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-51 Score=379.26 Aligned_cols=259 Identities=29% Similarity=0.494 Sum_probs=217.7
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
.|++.+.||+|+||.||+|.+..+|+.||+|.+.+...........+.+|+.+++.+. |+||+++++++.+++.+++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccCCeEEEEE
Confidence 3788899999999999999999999999999987654433334556788999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 160 ELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCC
Confidence 999999998877643 358999999999999999999999999999999999999 556679999999998776555
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+..............++.++.+||
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 5556789999999999865 589999999999999999999999987654332222222111112222346899999999
Q ss_pred HHhcccCCCCCCC-----HHHHhcCccccCC
Q 016233 317 RRMLTQDPKKRIT-----SAQVLEHPWIKEG 342 (393)
Q Consensus 317 ~~~L~~dp~~Rpt-----~~e~l~h~~~~~~ 342 (393)
++||..||++||+ ++++++||||...
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 9999999999997 8999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-51 Score=392.31 Aligned_cols=258 Identities=28% Similarity=0.554 Sum_probs=224.4
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++ ||||+++++++.+.+.+|+||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeEEEEE
Confidence 6999999999999999999999999999999997654333344567889999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc--
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-- 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-- 237 (393)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++..+....
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceeccccccc
Confidence 999999999999888889999999999999999999999999999999999999 566779999999987543211
Q ss_pred -------------------------------------ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCC
Q 016233 238 -------------------------------------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVP 279 (393)
Q Consensus 238 -------------------------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~ 279 (393)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0112469999999999865 58999999999999999999999
Q ss_pred CCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCccccCC
Q 016233 280 PFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT---SAQVLEHPWIKEG 342 (393)
Q Consensus 280 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~e~l~h~~~~~~ 342 (393)
||.+.+..+.+..+......+..+....+++++.+||.+||. +|.+|++ ++++|+||||+..
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 999988888877777655444433344679999999999996 9999998 9999999999754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-51 Score=386.72 Aligned_cols=257 Identities=30% Similarity=0.498 Sum_probs=225.8
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++ ||||+++++++.+.+.+|+||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEEEEE
Confidence 6999999999999999999999999999999998654433345667889999999997 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcce
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~ 239 (393)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~--~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVT--YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCccccc--cc
Confidence 999999999999888889999999999999999999999999999999999999 5566799999999986544 23
Q ss_pred ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCC----CCCCHHHHH
Q 016233 240 RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW----PTISSSAKD 314 (393)
Q Consensus 240 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~s~~~~~ 314 (393)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+.+..+......+..+.+ ..+++++.+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~ 235 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence 45679999999999875 5899999999999999999999999988887777777654433322222 257899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
||.+||..+|++||+++++++||||...
T Consensus 236 li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 236 LITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 9999999999999999999999999853
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-51 Score=391.37 Aligned_cols=259 Identities=29% Similarity=0.482 Sum_probs=221.1
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
.|++++.||+|+||+||+|.+..+++.||||++.+...........+.+|+.+++.++ ||||+++++++.+.+.+|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEEEEE
Confidence 5889999999999999999999999999999998755444455677899999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc--
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-- 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-- 237 (393)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCccccccccc
Confidence 999999999999888889999999999999999999999999999999999999 556679999999975431100
Q ss_pred ----------------------------------------------ceecccCcccccchHHHhh-cCCCcchHHHHHHH
Q 016233 238 ----------------------------------------------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVI 270 (393)
Q Consensus 238 ----------------------------------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~i 270 (393)
.....+||+.|+|||++.+ .++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 0123579999999999865 58999999999999
Q ss_pred HHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc--CCCCCCCHHHHhcCccccCC
Q 016233 271 LYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ--DPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 271 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~--dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+|+|++|..||...+..+....+.........+.+..+++++.+||.+||.. ++..|++++++++||||...
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 9999999999998887766666665443344444456899999999996654 45559999999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-51 Score=364.05 Aligned_cols=259 Identities=29% Similarity=0.467 Sum_probs=222.3
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCC-eeEEeEEEEeCC----
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN-IVEFKGAYEDKQ---- 153 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-iv~~~~~~~~~~---- 153 (393)
..|..+++||+|+||+||+|+++.+|+.||+|.+...... +.......+|+.+|+.|+ |+| ||.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhC-CCcceEEEEeeeeecccccc
Confidence 4688888999999999999999999999999999765421 234566789999999997 999 999999998877
Q ss_pred --eEEEEEeccCCCChHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeec
Q 016233 154 --SVHVVMELCAGGELFDRIIAKG----HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (393)
Q Consensus 154 --~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DF 227 (393)
.+++|+||++. +|..++.... .++...++.+++||+.||+|||+++|+||||||+|||| +..+.+||+||
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaDF 164 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLKLADF 164 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEeeecc
Confidence 89999999954 8999998755 47778999999999999999999999999999999999 45778999999
Q ss_pred CCccccc-CCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 016233 228 GLSVFIE-EGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP 304 (393)
Q Consensus 228 g~a~~~~-~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (393)
|+|+... +...+...++|.+|+|||++.+ .|+...||||+|||++||++++..|.+.++.+.+..|-+---......
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 9999876 4455777889999999999875 499999999999999999999999999999888877765333322222
Q ss_pred CC--------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 305 WP--------------------------TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 305 ~~--------------------------~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
|+ ..+++..+++.+||+.+|.+|.|++.+|.||||....
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 22 2345899999999999999999999999999998754
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-53 Score=384.94 Aligned_cols=275 Identities=28% Similarity=0.483 Sum_probs=234.2
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
...|+..+.||+|+||.||+|.+..+++.||+|++..+. .....+++++|+.+|..++ ++||.++|+.|-.+..+++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~Lwi 88 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKLWI 88 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcC-cchHHhhhhheeecccHHH
Confidence 346888899999999999999999999999999998664 4556789999999999997 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
+||||.||++.+.+...+.+.+.++..++++++.||.|||.++.+|||||+.|||+. ..+.+||+|||.+..+....
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeeeeechh
Confidence 999999999999998877779999999999999999999999999999999999995 44779999999999887654
Q ss_pred ce-ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 238 VY-RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 238 ~~-~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
.. .+.+|||.|||||++.. .|+.++||||||++++||++|.+||........+..|-+...+ ..-..+|+.+++|
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP---~L~~~~S~~~kEF 242 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPP---RLDGDFSPPFKEF 242 (467)
T ss_pred hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCC---ccccccCHHHHHH
Confidence 33 67899999999999986 6999999999999999999999999877764444334333221 1123678999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCCCCCCCCcCCHHHHHHHHHHHHh
Q 016233 316 VRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAM 364 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (393)
|..||.+||+.||+|.++|+|+|++.. .........+.+.++++.+
T Consensus 243 V~~CL~k~P~~RpsA~~LLKh~FIk~a---~k~s~L~~~i~r~~~~~~~ 288 (467)
T KOG0201|consen 243 VEACLDKNPEFRPSAKELLKHKFIKRA---KKTSELKELIDRYKRWRVK 288 (467)
T ss_pred HHHHhhcCcccCcCHHHHhhhHHHHhc---CCchHHHHHHHHHHHHhhc
Confidence 999999999999999999999999872 2222334556666666554
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-51 Score=385.18 Aligned_cols=255 Identities=30% Similarity=0.579 Sum_probs=225.7
Q ss_pred ccceeecceecccCCeEEEEEEECCCC-cEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTG-RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+.+.........+.+.+|+.+++.++ ||||+++++++.+.+.+|
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCEEE
Confidence 457999999999999999999977655 689999997654433445677889999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+||||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeecCCC
Confidence 999999999999999988889999999999999999999999999999999999999 55677999999999876432
Q ss_pred cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+..+...++ ..+++.+.++
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l 258 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFLDNNCKHL 258 (340)
T ss_pred --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHH
Confidence 245689999999999875 489999999999999999999999999888888888888766544 3578999999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCccccCC
Q 016233 316 VRRMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (393)
Q Consensus 316 i~~~L~~dp~~Rp-----t~~e~l~h~~~~~~ 342 (393)
|++||..||++|+ |++++++||||...
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999995 89999999999753
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-51 Score=380.76 Aligned_cols=248 Identities=30% Similarity=0.569 Sum_probs=219.6
Q ss_pred ecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCCCC
Q 016233 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGE 166 (393)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~gg~ 166 (393)
||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++++++ ||||+++++++.+.+.+|+||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 799999999999999999999999997654434445677889999999996 9999999999999999999999999999
Q ss_pred hHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC-CcceecccCc
Q 016233 167 LFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDIVGS 245 (393)
Q Consensus 167 L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~-~~~~~~~~gt 245 (393)
|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .......+||
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCccccccCC
Confidence 99999888889999999999999999999999999999999999999 5567799999999986432 2233456799
Q ss_pred ccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCC
Q 016233 246 AYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDP 324 (393)
Q Consensus 246 ~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp 324 (393)
+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......++ ..+++++.+||.+||..||
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp 232 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSRDP 232 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcCCCH
Confidence 99999999875 489999999999999999999999999888888888877655544 3588999999999999999
Q ss_pred CCCC---CHHHHhcCccccCC
Q 016233 325 KKRI---TSAQVLEHPWIKEG 342 (393)
Q Consensus 325 ~~Rp---t~~e~l~h~~~~~~ 342 (393)
++|| ++.++|+||||...
T Consensus 233 ~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 233 TRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHcCCCCCHHHHHcCCCcCCC
Confidence 9997 57999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-51 Score=391.76 Aligned_cols=257 Identities=29% Similarity=0.533 Sum_probs=220.1
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.+. ||||+++++++.+.+.+|+||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCeeEEEE
Confidence 6899999999999999999999999999999987654333445677889999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc--
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-- 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-- 237 (393)
||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeeccccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999 556779999999986332100
Q ss_pred ----------------------------------------------ceecccCcccccchHHHhh-cCCCcchHHHHHHH
Q 016233 238 ----------------------------------------------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVI 270 (393)
Q Consensus 238 ----------------------------------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~i 270 (393)
.....+||+.|+|||++.+ .++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0012469999999999865 58999999999999
Q ss_pred HHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCccccC
Q 016233 271 LYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKR---ITSAQVLEHPWIKE 341 (393)
Q Consensus 271 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R---pt~~e~l~h~~~~~ 341 (393)
+|+|++|..||.+.+..+.+..+.........+....++.++.+||.+||. +|.+| +|+.++++||||..
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999999888877777777644333333334688999999999997 77765 59999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-51 Score=390.85 Aligned_cols=258 Identities=31% Similarity=0.525 Sum_probs=223.1
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+. ||||+++++.+.+.+.+|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEeCCEEEEEE
Confidence 5899999999999999999999999999999997654333445667889999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC---
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG--- 236 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~--- 236 (393)
|||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCccccccccc
Confidence 999999999999888889999999999999999999999999999999999999 56678999999997532100
Q ss_pred ---------------------------------------------cceecccCcccccchHHHhh-cCCCcchHHHHHHH
Q 016233 237 ---------------------------------------------KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVI 270 (393)
Q Consensus 237 ---------------------------------------------~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~i 270 (393)
......+||+.|+|||++.+ .++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 00123479999999999865 58999999999999
Q ss_pred HHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCccccCC
Q 016233 271 LYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT---SAQVLEHPWIKEG 342 (393)
Q Consensus 271 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~e~l~h~~~~~~ 342 (393)
+|+|++|..||.+.+..+....+.........+....+++++.++|.+|+ .||++|++ ++++++||||+..
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 99999999999988877777777765555555555678999999999986 59999997 9999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=379.35 Aligned_cols=262 Identities=35% Similarity=0.617 Sum_probs=240.5
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
.+..-|.+.+.||+|-|++|.+|+|.-||..||||+|.+.++ .......+..|++.|+.++ |||||++|++...+..+
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl-D~~st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DTLSTGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQTKL 92 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc-chhhhhHHHHHHHHHHHhc-CcCeeeeeehhcccceE
Confidence 355679999999999999999999999999999999998775 3345677889999999998 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
|||+|+-++|+|+|+|.+. ..+.|+.++.+++||+.|+.|||+..+|||||||+|+.+- ..-+.+||.|||++-.+.
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccccccCC
Confidence 9999999999999999765 4699999999999999999999999999999999999885 456789999999999999
Q ss_pred CCcceecccCcccccchHHHhhc-C-CCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 016233 235 EGKVYRDIVGSAYYVAPEVLRRR-Y-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (393)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~l~~~-~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (393)
.+....+.||+..|.|||++.+. | .+++||||||||||.|.+|++||...+..+.+..|+..++..+. .+|.++
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----hvS~eC 246 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----HVSKEC 246 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----hhhHHH
Confidence 99999999999999999998763 5 57899999999999999999999999999999999999888765 589999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccCCCCC
Q 016233 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEA 345 (393)
Q Consensus 313 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 345 (393)
+|||..||..||.+|.+.++|..|+|++.....
T Consensus 247 rdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 247 RDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred HHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 999999999999999999999999999876543
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-50 Score=382.16 Aligned_cols=255 Identities=26% Similarity=0.416 Sum_probs=208.1
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
...|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+++++.++ |+||+++++++.+.+.+++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCeEEE
Confidence 346888999999999999999999999999999986432 2334567889999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||||+++++|.+. ....+..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+....
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceeccccc
Confidence 9999999998643 246778889999999999999999999999999999999 556779999999998765332
Q ss_pred -ceecccCcccccchHHHhh------cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 016233 238 -VYRDIVGSAYYVAPEVLRR------RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 238 -~~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
......||..|+|||++.. ..+.++|||||||++|+|++|+.||......+....+..............++.
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR 302 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence 2345679999999998742 245689999999999999999999974433222211111111112222346789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
++.+||.+||..||++|||+.|+|+||||...
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 99999999999999999999999999999875
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-51 Score=390.85 Aligned_cols=257 Identities=30% Similarity=0.512 Sum_probs=221.9
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
.|++++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+|+.+. |+||+++++.+.+++.+|+||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEEEEEE
Confidence 6999999999999999999999999999999987544333344567889999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC---
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG--- 236 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~--- 236 (393)
|||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCccccccccc
Confidence 999999999999888889999999999999999999999999999999999999 55667999999997532100
Q ss_pred -----------------------------------------cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHH
Q 016233 237 -----------------------------------------KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYIL 274 (393)
Q Consensus 237 -----------------------------------------~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~l 274 (393)
......+||+.|+|||++.+ .++.++|||||||++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 00123579999999999875 589999999999999999
Q ss_pred hhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCccccC
Q 016233 275 LSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRI---TSAQVLEHPWIKE 341 (393)
Q Consensus 275 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---t~~e~l~h~~~~~ 341 (393)
++|..||.+.+..+....+...........+..+++++.++|.+|+ .+|.+|+ |+.++++||||..
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 9999999988877776666655444444445678999999999987 5999999 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=381.52 Aligned_cols=249 Identities=31% Similarity=0.583 Sum_probs=219.9
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~g 164 (393)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+. ||||+++++++..++.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999998654444445677889999999996 99999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC-Ccceeccc
Q 016233 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDIV 243 (393)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~-~~~~~~~~ 243 (393)
|+|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .......+
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccccccccc
Confidence 9999999888889999999999999999999999999999999999999 5566799999999876432 22334567
Q ss_pred CcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 016233 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (393)
Q Consensus 244 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (393)
||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+....+......++ ..+++++.+||.+||..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSGLLIK 232 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCCHHHHHHHHHHcCC
Confidence 9999999999865 589999999999999999999999998888777777776655544 35789999999999999
Q ss_pred CCCCCC-----CHHHHhcCccccC
Q 016233 323 DPKKRI-----TSAQVLEHPWIKE 341 (393)
Q Consensus 323 dp~~Rp-----t~~e~l~h~~~~~ 341 (393)
||++|+ ++.++++||||..
T Consensus 233 dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999997 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=379.56 Aligned_cols=251 Identities=31% Similarity=0.563 Sum_probs=221.1
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~g 164 (393)
+.||+|+||.||+|.++.+++.||||++.+...........+..|..++..+.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654333445667788999998876799999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc-CCcceeccc
Q 016233 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIV 243 (393)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~-~~~~~~~~~ 243 (393)
|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... .........
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999 556679999999987643 223334567
Q ss_pred CcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 016233 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (393)
Q Consensus 244 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (393)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+...++ ..++.++.+||.+||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~ 233 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLSQDAVDILKAFMTK 233 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccc
Confidence 9999999999875 589999999999999999999999999998888888887765543 24789999999999999
Q ss_pred CCCCCCCH------HHHhcCccccCC
Q 016233 323 DPKKRITS------AQVLEHPWIKEG 342 (393)
Q Consensus 323 dp~~Rpt~------~e~l~h~~~~~~ 342 (393)
||++|+++ +++++||||...
T Consensus 234 dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 234 NPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 99999998 999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-51 Score=386.31 Aligned_cols=258 Identities=34% Similarity=0.627 Sum_probs=226.7
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|.+.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.++..+. ||||+++++++.+++.+|+||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeEEEEE
Confidence 6999999999999999999999999999999998655434455677889999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc--
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-- 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-- 237 (393)
||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccCcc
Confidence 999999999999888889999999999999999999999999999999999999 556779999999998765432
Q ss_pred ----------------------------ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHH
Q 016233 238 ----------------------------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKG 288 (393)
Q Consensus 238 ----------------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 288 (393)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 2234579999999999875 58999999999999999999999999988877
Q ss_pred HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCccccCC
Q 016233 289 IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT-SAQVLEHPWIKEG 342 (393)
Q Consensus 289 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-~~e~l~h~~~~~~ 342 (393)
....+......+..+....+++++.+||.+||. ||.+|++ ++++|+||||...
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 777777733333333334589999999999997 9999999 9999999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-50 Score=378.17 Aligned_cols=255 Identities=29% Similarity=0.547 Sum_probs=224.6
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||+|.+..+++.||||++.+.........+.+..|+.++..+.+|++|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 48899999999999999999999999999999986544344456778889999999975667999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc-CCcc
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKV 238 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~-~~~~ 238 (393)
||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCCc
Confidence 999999999999888889999999999999999999999999999999999999 556679999999987532 2233
Q ss_pred eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 016233 239 YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (393)
Q Consensus 239 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (393)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......++ ..++.++.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~ 233 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICK 233 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence 445689999999999875 489999999999999999999999999888888888887665544 357899999999
Q ss_pred HhcccCCCCCCCH-----HHHhcCccccC
Q 016233 318 RMLTQDPKKRITS-----AQVLEHPWIKE 341 (393)
Q Consensus 318 ~~L~~dp~~Rpt~-----~e~l~h~~~~~ 341 (393)
+||..||.+|++. +++++||||..
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 234 GLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999987 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=386.03 Aligned_cols=260 Identities=32% Similarity=0.521 Sum_probs=226.1
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
..+|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+.+|+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCEEEE
Confidence 457999999999999999999999999999999997644333344566788999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 121 v~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccCCC
Confidence 9999999999988765 468999999999999999999999999999999999999 566789999999998765432
Q ss_pred --ceecccCcccccchHHHhh-----cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 016233 238 --VYRDIVGSAYYVAPEVLRR-----RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 238 --~~~~~~gt~~y~aPE~l~~-----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+.........+....+|.
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISK 276 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCH
Confidence 2235679999999999853 378899999999999999999999999988888888877654444444456899
Q ss_pred HHHHHHHHhcccCCCC--CCCHHHHhcCccccCC
Q 016233 311 SAKDLVRRMLTQDPKK--RITSAQVLEHPWIKEG 342 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~--Rpt~~e~l~h~~~~~~ 342 (393)
++.+||.+||..+|++ |+|++++++||||+..
T Consensus 277 ~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 277 QAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 9999999999999988 9999999999999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-50 Score=372.09 Aligned_cols=254 Identities=26% Similarity=0.410 Sum_probs=212.5
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.+|.+.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++ ||||+++++++.+.+..++|
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc--cCCcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEEEE
Confidence 36999999999999999999999999999999986543 2233456789999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-
Q 016233 159 MELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG- 236 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~- 236 (393)
|||+++ +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCC
Confidence 999975 8988887644 47899999999999999999999999999999999999 55667999999999765432
Q ss_pred cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC------------
Q 016233 237 KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES------------ 302 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~------------ 302 (393)
.......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+.+..+.........
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 22344678999999998864 4899999999999999999999999888776665554332111000
Q ss_pred --------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 303 --------------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 303 --------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
...+.++.++.+||.+||..||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0123568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=384.90 Aligned_cols=261 Identities=31% Similarity=0.532 Sum_probs=224.3
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
...+|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+. ||||+++++++.+++.+|
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEE
Confidence 4568999999999999999999999999999999997644333344566889999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+||||++||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||+ +..+.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceecccC
Confidence 999999999999988654 68999999999999999999999999999999999999 56677999999999876543
Q ss_pred cc--eecccCcccccchHHHhh-----cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 237 KV--YRDIVGSAYYVAPEVLRR-----RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 237 ~~--~~~~~gt~~y~aPE~l~~-----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
.. ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+......+..+....++
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 275 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS 275 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence 22 235679999999999864 27889999999999999999999999988888888887655444434445689
Q ss_pred HHHHHHHHHhcccCCCC--CCCHHHHhcCccccCC
Q 016233 310 SSAKDLVRRMLTQDPKK--RITSAQVLEHPWIKEG 342 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~--Rpt~~e~l~h~~~~~~ 342 (393)
..++++|.+||..++.+ |+|++++++||||+..
T Consensus 276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 99999999999866554 8999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=379.99 Aligned_cols=250 Identities=33% Similarity=0.591 Sum_probs=220.0
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~g 164 (393)
+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++ ||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeCCCC
Confidence 46999999999999999999999999997654333445567788999999996 99999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC-Ccceeccc
Q 016233 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDIV 243 (393)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~-~~~~~~~~ 243 (393)
|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999 5566799999999876422 22334567
Q ss_pred CcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 016233 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (393)
Q Consensus 244 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (393)
||+.|+|||++.+ .++.++|||||||++|+|++|..||...+.......+......++ ..+++++.+||.+||..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKK 232 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccC
Confidence 9999999999864 589999999999999999999999998888888887776665544 35789999999999999
Q ss_pred CCCCCC-----CHHHHhcCccccCC
Q 016233 323 DPKKRI-----TSAQVLEHPWIKEG 342 (393)
Q Consensus 323 dp~~Rp-----t~~e~l~h~~~~~~ 342 (393)
||++|+ ++.++++|+||...
T Consensus 233 dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 999998 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=377.44 Aligned_cols=250 Identities=30% Similarity=0.547 Sum_probs=220.9
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~g 164 (393)
+.||+|+||.||+|.+..+++.||||++.+...........+..|..++..+.+||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999997654434445667788999998876799999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC-Ccceeccc
Q 016233 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDIV 243 (393)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~-~~~~~~~~ 243 (393)
|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCccccccc
Confidence 9999999888889999999999999999999999999999999999999 5567799999999876432 22334567
Q ss_pred CcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 016233 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (393)
Q Consensus 244 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (393)
||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+.+..+..+...++. .++.++.+||.+||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV----WLSKEAVSILKAFMTK 233 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhcc
Confidence 9999999999875 5899999999999999999999999999988888888887655442 4789999999999999
Q ss_pred CCCCCC-------CHHHHhcCccccC
Q 016233 323 DPKKRI-------TSAQVLEHPWIKE 341 (393)
Q Consensus 323 dp~~Rp-------t~~e~l~h~~~~~ 341 (393)
||++|+ +++++++||||..
T Consensus 234 dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 999999 9999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-50 Score=375.76 Aligned_cols=256 Identities=27% Similarity=0.510 Sum_probs=225.2
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+.+|++|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 48899999999999999999999999999999986544334445667788889888877899999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC-Ccc
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKV 238 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~-~~~ 238 (393)
||+++|+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCCc
Confidence 999999999999888889999999999999999999999999999999999999 5567799999999976432 223
Q ss_pred eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 016233 239 YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (393)
Q Consensus 239 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (393)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......++ ..++.++.+|+.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~ 233 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAICK 233 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CcCCHHHHHHHH
Confidence 345689999999999875 589999999999999999999999999988888888887766544 357899999999
Q ss_pred HhcccCCCCCCCH-----HHHhcCccccCC
Q 016233 318 RMLTQDPKKRITS-----AQVLEHPWIKEG 342 (393)
Q Consensus 318 ~~L~~dp~~Rpt~-----~e~l~h~~~~~~ 342 (393)
+||..||++|++. .++++||||...
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 234 GLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred HHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999984 899999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-50 Score=384.12 Aligned_cols=258 Identities=31% Similarity=0.540 Sum_probs=222.1
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
.|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..+. ||||+++++.+.+.+.+|+||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEEE
Confidence 6899999999999999999999999999999997654334445677889999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc--
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-- 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-- 237 (393)
||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||+ +.++.++|+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCccccccccc
Confidence 999999999999888889999999999999999999999999999999999999 556779999999987543211
Q ss_pred ----------------------------------ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCC
Q 016233 238 ----------------------------------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFW 282 (393)
Q Consensus 238 ----------------------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~ 282 (393)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 0123579999999999865 58999999999999999999999999
Q ss_pred CCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCccccCC
Q 016233 283 AETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRI---TSAQVLEHPWIKEG 342 (393)
Q Consensus 283 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---t~~e~l~h~~~~~~ 342 (393)
+.+..+.+..+.........+....+++++++||.+|+ .||.+|+ +++++++||||...
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence 98888888877764433322223357899999999987 4999998 47999999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-50 Score=380.14 Aligned_cols=258 Identities=31% Similarity=0.503 Sum_probs=224.2
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+. |+||+++++++.+.+.+|+||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCeEEEEE
Confidence 6899999999999999999999999999999998654433445667889999999986 999999999999999999999
Q ss_pred eccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc
Q 016233 160 ELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (393)
Q Consensus 160 e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~ 238 (393)
||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCCc
Confidence 999999999999876 679999999999999999999999999999999999999 5667799999999987654332
Q ss_pred --eecccCcccccchHHHh-------hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 239 --YRDIVGSAYYVAPEVLR-------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 239 --~~~~~gt~~y~aPE~l~-------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||...+....+..+.........+..+.++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVS 237 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCC
Confidence 23357999999999985 247889999999999999999999999888877777777654333333335689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+++.+||.+||. ||++|||++++++||||...
T Consensus 238 ~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 238 SDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred HHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 999999999998 99999999999999999753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-50 Score=373.65 Aligned_cols=247 Identities=29% Similarity=0.449 Sum_probs=212.7
Q ss_pred ceeecceecccCCeEEEEEEECCCCcE-EEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC-eEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQ-FACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-SVHV 157 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-~~~l 157 (393)
...+.+.||+|+||+||+|.++ |.. ||+|++......... .+.|.+|+.+|.+|+ |||||+++|++.+.. .++|
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLR-HPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCceEE
Confidence 4556667999999999999988 556 999999765543333 779999999999997 999999999999887 7999
Q ss_pred EEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcC-cEecCCCCCcEEeccCCCCC-cEEEeecCCcccc
Q 016233 158 VMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMG-VMHRDLKPENFLLSSKDENA-LLKATDFGLSVFI 233 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qll~~l~~lH~~~-ivH~Dikp~Nill~~~~~~~-~~kl~DFg~a~~~ 233 (393)
||||+++|+|.+++.. .+.++...+..++.||+.||+|||+++ ||||||||+|||+ +... ++||+|||+++..
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLSREK 194 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCccceee
Confidence 9999999999999987 578999999999999999999999999 9999999999999 5564 8999999999887
Q ss_pred cCC-cceecccCcccccchHHHhh---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 234 EEG-KVYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 234 ~~~-~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
... .......||+.|||||++++ .|+.++||||||++||||+||..||.+....+....+..+......+ ..++
T Consensus 195 ~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p--~~~~ 272 (362)
T KOG0192|consen 195 VISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP--KECP 272 (362)
T ss_pred ccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--ccCC
Confidence 654 33444789999999999985 39999999999999999999999999988766666665443333222 2388
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+.+..|+.+||..||++||++.+++.
T Consensus 273 ~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 273 PHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 99999999999999999999998874
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-50 Score=369.11 Aligned_cols=255 Identities=29% Similarity=0.473 Sum_probs=212.1
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||+|+++.+++.||+|++..... .....+.+.+|+.+++.++ ||||+++++++..++.+++||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCC-CccccchhhhEecCCEEEEEE
Confidence 69999999999999999999999999999999975432 2334567889999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc--
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-- 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-- 237 (393)
||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCcccccccccc
Confidence 999987776554445679999999999999999999999999999999999999 556679999999998765332
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC------------------
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI------------------ 298 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~------------------ 298 (393)
......||+.|+|||++.+ .++.++|||||||++|+|++|++||.+.+..+....+.....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 2334679999999999865 589999999999999999999999988765544333322110
Q ss_pred -CCCC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 299 -DFES---------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 299 -~~~~---------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
.++. ..+..+|.++.+||++||..||++|||++++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000 0112368889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-50 Score=376.22 Aligned_cols=250 Identities=28% Similarity=0.517 Sum_probs=214.0
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~g 164 (393)
+.||+|+||.||+|.+..+++.||||++++...........+.+|..+++.+.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999998755444445667889999999997799999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc-cCCcceeccc
Q 016233 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDIV 243 (393)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~-~~~~~~~~~~ 243 (393)
|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.. .........+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCCcccccc
Confidence 9999999888899999999999999999999999999999999999999 55667999999998753 2233345578
Q ss_pred CcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCC---------hHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET---------EKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 244 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.... .......+......++ ..++.++.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~ 233 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAS 233 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCCHHHH
Confidence 9999999999875 58999999999999999999999996321 1223444555544433 35789999
Q ss_pred HHHHHhcccCCCCCCC------HHHHhcCccccC
Q 016233 314 DLVRRMLTQDPKKRIT------SAQVLEHPWIKE 341 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt------~~e~l~h~~~~~ 341 (393)
++|.+||..||.+|+| ++++++||||..
T Consensus 234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9999999999999997 789999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=373.43 Aligned_cols=251 Identities=28% Similarity=0.510 Sum_probs=217.7
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~g 164 (393)
+.||+|+||.||+|.++.+|+.||+|++.+...........+..|..++..+.+||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999999999999999997654333344566778888888765699999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC-Ccceeccc
Q 016233 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDIV 243 (393)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~-~~~~~~~~ 243 (393)
|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..... .......+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCceeccC
Confidence 9999999888889999999999999999999999999999999999999 5566799999999875322 22344578
Q ss_pred CcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 016233 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (393)
Q Consensus 244 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (393)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+......++ ..++.++++||.+||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~ 233 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP----RWITKESKDILEKLFER 233 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHccC
Confidence 9999999999875 589999999999999999999999999888888887776654433 24789999999999999
Q ss_pred CCCCCCCH-HHHhcCccccCC
Q 016233 323 DPKKRITS-AQVLEHPWIKEG 342 (393)
Q Consensus 323 dp~~Rpt~-~e~l~h~~~~~~ 342 (393)
||++|+++ +++++||||...
T Consensus 234 dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 234 DPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred CHHHcCCChHHHHcCCCcCCC
Confidence 99999998 588899999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-50 Score=378.16 Aligned_cols=249 Identities=33% Similarity=0.600 Sum_probs=219.3
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~g 164 (393)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+++++.+. ||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999998654434445567788999999996 99999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc-CCcceecc
Q 016233 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDI 242 (393)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~-~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~-~~~~~~~~ 242 (393)
|+|.+++...+.+++..++.++.||+.||.|||+ +||+||||||+|||+ +.++.+||+|||++.... ........
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcccccc
Confidence 9999999888889999999999999999999997 799999999999999 556679999999987543 23333456
Q ss_pred cCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 016233 243 VGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321 (393)
Q Consensus 243 ~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 321 (393)
.||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+......++ ..+++++.+||.+||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~ 232 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLSGLLK 232 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhh
Confidence 79999999999865 589999999999999999999999998888777777776665544 3578999999999999
Q ss_pred cCCCCCC-----CHHHHhcCccccC
Q 016233 322 QDPKKRI-----TSAQVLEHPWIKE 341 (393)
Q Consensus 322 ~dp~~Rp-----t~~e~l~h~~~~~ 341 (393)
.||++|+ ++.++++||||..
T Consensus 233 ~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 9999997 9999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=372.43 Aligned_cols=251 Identities=31% Similarity=0.543 Sum_probs=217.0
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~g 164 (393)
+.||+|+||.||+|.+..+++.||||+++..........+.+..|..++..+.+||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654333444566677888887765699999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-cceeccc
Q 016233 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-KVYRDIV 243 (393)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~-~~~~~~~ 243 (393)
|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...... ......+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999 55667999999999864332 2334567
Q ss_pred CcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 016233 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (393)
Q Consensus 244 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (393)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......++ ..++.++.+||.+||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSKLFER 233 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence 9999999999875 589999999999999999999999999888888887776544333 35789999999999999
Q ss_pred CCCCCCCHH-HHhcCccccCC
Q 016233 323 DPKKRITSA-QVLEHPWIKEG 342 (393)
Q Consensus 323 dp~~Rpt~~-e~l~h~~~~~~ 342 (393)
||++||++. ++++||||...
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 234 DPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred CHHHcCCChHHHHcCcccCCC
Confidence 999999874 88899999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-50 Score=382.37 Aligned_cols=258 Identities=30% Similarity=0.462 Sum_probs=217.9
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCC-----CCeeEEeEEEEe
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ-----PNIVEFKGAYED 151 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-----~niv~~~~~~~~ 151 (393)
+..+|.+.+.||+|+||.|.+|.+..|++.||||+++... ....+...|+.||..|+.| -|||+++++|..
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 4458999999999999999999999999999999997543 3466777899999999733 389999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 152 KQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
.+++|||+|++ .-+|.++|+.++ .++...++.+++||+.||.+||+.||||+||||||||+...+. ..|||+|||.
T Consensus 260 r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r-~~vKVIDFGS 337 (586)
T KOG0667|consen 260 RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKR-SRIKVIDFGS 337 (586)
T ss_pred ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCc-CceeEEeccc
Confidence 99999999999 559999998764 4889999999999999999999999999999999999976544 3899999999
Q ss_pred cccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC----------
Q 016233 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI---------- 298 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~---------- 298 (393)
|......- .+++-+..|+|||++.+ .|+.+.||||||||++||++|.+.|.+.++.+++..|.+-.-
T Consensus 338 Sc~~~q~v--ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 338 SCFESQRV--YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred ccccCCcc--eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 99865443 37888999999998765 799999999999999999999999999999888777643000
Q ss_pred ----C-CCC--------------------------------CCCC------------CCCHHHHHHHHHhcccCCCCCCC
Q 016233 299 ----D-FES--------------------------------APWP------------TISSSAKDLVRRMLTQDPKKRIT 329 (393)
Q Consensus 299 ----~-~~~--------------------------------~~~~------------~~s~~~~~li~~~L~~dp~~Rpt 329 (393)
. |.. ...+ .-...+.|||++||.+||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 0 000 0001 11245799999999999999999
Q ss_pred HHHHhcCccccCC
Q 016233 330 SAQVLEHPWIKEG 342 (393)
Q Consensus 330 ~~e~l~h~~~~~~ 342 (393)
+.++|+||||...
T Consensus 496 p~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 496 PAQALNHPFLTGT 508 (586)
T ss_pred HHHHhcCcccccc
Confidence 9999999999853
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=374.89 Aligned_cols=259 Identities=30% Similarity=0.469 Sum_probs=211.7
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC-----Ce
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK-----QS 154 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-----~~ 154 (393)
+|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++ ||||+++++++... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCce
Confidence 58999999999999999999999999999999864321 2234457889999999996 99999999987543 35
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+|+||||| +++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 79 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccccccc
Confidence 89999999 46899999888889999999999999999999999999999999999999 566779999999998653
Q ss_pred CCc----ceecccCcccccchHHHhh---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH-------------
Q 016233 235 EGK----VYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL------------- 294 (393)
Q Consensus 235 ~~~----~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~------------- 294 (393)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|++||.+.+....+..+.
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 1234679999999999864 58899999999999999999999998766433322111
Q ss_pred --------------cCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 295 --------------QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 295 --------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
..........++.+++++.++|.+||..||++|||++|+|+||||+....
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 11111111224567889999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=373.19 Aligned_cols=251 Identities=30% Similarity=0.550 Sum_probs=220.7
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~g 164 (393)
+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.+.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999998654434445667788999999886799999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC-Ccceeccc
Q 016233 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDIV 243 (393)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~-~~~~~~~~ 243 (393)
|+|.+++...+.+++.++..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..... .......+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCccccee
Confidence 9999999888889999999999999999999999999999999999999 5566799999999875322 22334467
Q ss_pred CcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 016233 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (393)
Q Consensus 244 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (393)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++ ..++.++.+||++||..
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~ 233 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKSILKSFLTK 233 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHccC
Confidence 9999999999875 589999999999999999999999998888888888877665443 35789999999999999
Q ss_pred CCCCCCCH-----HHHhcCccccCC
Q 016233 323 DPKKRITS-----AQVLEHPWIKEG 342 (393)
Q Consensus 323 dp~~Rpt~-----~e~l~h~~~~~~ 342 (393)
||++|||+ .++++||||...
T Consensus 234 dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999999 999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=361.98 Aligned_cols=258 Identities=28% Similarity=0.493 Sum_probs=218.0
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC---
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ--- 153 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--- 153 (393)
..-.|.-.+++|+|+||.||+|....+++.||||.+-.+ .+.-.+|+.+|+.+. |||||++.-+|....
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d-------~r~knrEl~im~~l~-HpNIV~L~~~f~~~~~~d 93 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD-------KRYKNRELQIMRKLD-HPNIVRLLYFFSSSTESD 93 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCC-------CCcCcHHHHHHHhcC-CcCeeeEEEEEEecCCCc
Confidence 455789999999999999999999999999999987433 223457999999996 999999998885432
Q ss_pred --eEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeec
Q 016233 154 --SVHVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (393)
Q Consensus 154 --~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DF 227 (393)
...+||||++. +|.+.++. +..++.-.++-+..||++||.|||+.||+||||||.|+|++ .+.+.+|||||
T Consensus 94 ~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicDF 170 (364)
T KOG0658|consen 94 EVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICDF 170 (364)
T ss_pred hhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEeccC
Confidence 34689999965 89888874 46788899999999999999999999999999999999996 34578999999
Q ss_pred CCcccccCCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---------
Q 016233 228 GLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG--------- 296 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~--------- 296 (393)
|.|+.+..+....++..|..|+|||.+-+ .|+.+.||||.||++.||+-|.+.|.+.+..+++..|.+-
T Consensus 171 GSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 171 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred CcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99999988888888899999999998865 5999999999999999999999999999887776665431
Q ss_pred --------C---CCCCCCC-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCC
Q 016233 297 --------D---IDFESAP-----WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEA 345 (393)
Q Consensus 297 --------~---~~~~~~~-----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 345 (393)
. ..+.... ....++++.+|+.++|..+|.+|.++.|+|.||||.+....
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 0 1111112 23578999999999999999999999999999999875443
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=387.53 Aligned_cols=261 Identities=24% Similarity=0.336 Sum_probs=207.4
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHcc-----CCCCeeEEeEEE
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS-----GQPNIVEFKGAY 149 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~~~~~~ 149 (393)
+....+|++.+.||+|+||.||+|.+..+++.||||+++.. .........|+.+++.+. +|.+|+++++++
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 33457899999999999999999999999999999998642 123345667888887775 244689999988
Q ss_pred EeC-CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCCCCCcEEeccCCC---------
Q 016233 150 EDK-QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDE--------- 218 (393)
Q Consensus 150 ~~~-~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~-~~ivH~Dikp~Nill~~~~~--------- 218 (393)
... ..+++|||++ |++|.+++.+.+.+++..++.++.||+.||+|||+ .|||||||||+|||++.++.
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 765 5789999998 77999999888889999999999999999999998 59999999999999964331
Q ss_pred ----CCcEEEeecCCcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHH
Q 016233 219 ----NALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI 293 (393)
Q Consensus 219 ----~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 293 (393)
...+||+|||++..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+.+..+.+..+
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred cCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 23599999998864332 2345789999999999875 5999999999999999999999999887765544433
Q ss_pred HcCCCCCCC---------------------------C---------CC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 294 LQGDIDFES---------------------------A---------PW--PTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 294 ~~~~~~~~~---------------------------~---------~~--~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
......++. . .+ ...++.+.|||.+||.+||++|||++|+|+
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 221110000 0 00 001456789999999999999999999999
Q ss_pred CccccCC
Q 016233 336 HPWIKEG 342 (393)
Q Consensus 336 h~~~~~~ 342 (393)
||||...
T Consensus 438 Hp~~~~~ 444 (467)
T PTZ00284 438 HPYVLKY 444 (467)
T ss_pred Ccccccc
Confidence 9999874
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=369.46 Aligned_cols=257 Identities=24% Similarity=0.402 Sum_probs=208.7
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.+. ||||+++++++.++...++|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCC-CCCcCeEEEEEecCCeEEEE
Confidence 579999999999999999999999999999999865432 223456778999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-
Q 016233 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG- 236 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~- 236 (393)
|||+. ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCCC
Confidence 99995 5787777654 568999999999999999999999999999999999999 55667999999998764322
Q ss_pred cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCCC--------------
Q 016233 237 KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDID-------------- 299 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~-------------- 299 (393)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... .+.+..+......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 23345678999999999864 478899999999999999999999987543 2233222110000
Q ss_pred CCCCC------------C--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 300 FESAP------------W--PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 300 ~~~~~------------~--~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+.... | ...++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00000 0 1245789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-50 Score=376.96 Aligned_cols=256 Identities=30% Similarity=0.571 Sum_probs=215.1
Q ss_pred ceeecceecccCCeEEEEEEEC---CCCcEEEEEEeecCccC-CcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 80 HYSFGKELGRGQFGVTYLCTEN---STGRQFACKSISKRKLV-TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
+|++++.||+|+||.||+|.+. .+++.||+|++.+.... .....+.+.+|+.+++.+.+|+||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4889999999999999998864 57899999999754321 2233566788999999997799999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
++||||++||+|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCccccc
Confidence 9999999999999999888889999999999999999999999999999999999999 4566799999999986533
Q ss_pred Cc--ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCC----hHHHHHHHHcCCCCCCCCCCCC
Q 016233 236 GK--VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAET----EKGIFDAILQGDIDFESAPWPT 307 (393)
Q Consensus 236 ~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~ 307 (393)
.. .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.... .......+......+ ...
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~~ 233 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF----PSF 233 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCC----CCC
Confidence 22 2234679999999999875 37889999999999999999999996432 233334444433322 245
Q ss_pred CCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCC
Q 016233 308 ISSSAKDLVRRMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (393)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rp-----t~~e~l~h~~~~~~ 342 (393)
+++.+.+||.+||..||++|| +++++++||||+..
T Consensus 234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 889999999999999999999 88899999999753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=372.55 Aligned_cols=252 Identities=29% Similarity=0.553 Sum_probs=218.2
Q ss_pred eeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHH---HccCCCCeeEEeEEEEeCCeEEE
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ---HLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~---~l~~h~niv~~~~~~~~~~~~~l 157 (393)
|++.+.||+|+||.||+|.+..+++.||||++.+.........+.+.+|++++. .+ +||||+++++++.+.+.+|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEcCCEEEE
Confidence 678999999999999999999999999999997654333344567777877664 45 49999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC-C
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-G 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~-~ 236 (393)
||||++|++|..++.. +.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..... .
T Consensus 80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCC
Confidence 9999999999887754 579999999999999999999999999999999999999 5566799999999875432 2
Q ss_pred cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+...++ ..++..+.+|
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l 231 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSREAISI 231 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence 23345689999999999875 589999999999999999999999999888888888877765543 3578999999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCccccC
Q 016233 316 VRRMLTQDPKKRI-----TSAQVLEHPWIKE 341 (393)
Q Consensus 316 i~~~L~~dp~~Rp-----t~~e~l~h~~~~~ 341 (393)
|.+||..||++|| ++.++++||||..
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 9999999999999 7999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=378.72 Aligned_cols=261 Identities=31% Similarity=0.505 Sum_probs=223.6
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
...+|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++ ||||+++++++.+++.+|
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEEE
Confidence 3468999999999999999999999999999999997544333334566788999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEcCcC
Confidence 99999999999988765 468999999999999999999999999999999999999 45667999999999876543
Q ss_pred c--ceecccCcccccchHHHhh-----cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 237 K--VYRDIVGSAYYVAPEVLRR-----RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 237 ~--~~~~~~gt~~y~aPE~l~~-----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
. .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+......+..+....++
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence 2 2235679999999999864 27889999999999999999999999998888888888765444444456789
Q ss_pred HHHHHHHHHhcccCCCC--CCCHHHHhcCccccCC
Q 016233 310 SSAKDLVRRMLTQDPKK--RITSAQVLEHPWIKEG 342 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~--Rpt~~e~l~h~~~~~~ 342 (393)
.++++||.+||..++.+ |++++++++|+||+..
T Consensus 276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 99999999999844443 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=374.20 Aligned_cols=261 Identities=36% Similarity=0.659 Sum_probs=237.2
Q ss_pred cccceee--cceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 77 VKLHYSF--GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 77 ~~~~y~~--~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
+..-|++ .+.||+|.||+||-|.++.+|+.||||+|.+..+.. ....++++|+.||+.+. ||.||.+.-.|+..+.
T Consensus 560 ~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~-HPGiV~le~M~ET~er 637 (888)
T KOG4236|consen 560 ISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLH-HPGIVNLECMFETPER 637 (888)
T ss_pred HHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcC-CCCeeEEEEeecCCce
Confidence 3344554 568999999999999999999999999999887744 45588999999999996 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 155 VHVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
+|+|||-+.| +.++.|.. .+++++.....++.||+.||.|||-++|+|+||||+|||+.+.+....+||||||+|+.
T Consensus 638 vFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 638 VFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred EEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence 9999999955 66666643 57899999999999999999999999999999999999999888888999999999999
Q ss_pred ccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 016233 233 IEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (393)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (393)
+.+...-.+.+|||.|.|||+++. .|...-|+||+|||+|--|+|..||... +++-+.|.+..+.++..+|..++++
T Consensus 717 IgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~ 794 (888)
T KOG4236|consen 717 IGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPE 794 (888)
T ss_pred cchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHH
Confidence 998877788999999999999986 5999999999999999999999999644 4567889999999999999999999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 312 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+.|||..+|+..-.+|.|.+..|.|||++..
T Consensus 795 AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 795 AIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 9999999999999999999999999999875
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=370.80 Aligned_cols=256 Identities=27% Similarity=0.523 Sum_probs=223.9
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||+|.++.+|+.||+|++.+...........+..|+.+++.+.+|++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 37788999999999999999999999999999986543334455677889999999876788999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-cc
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-KV 238 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~-~~ 238 (393)
||++||+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...... ..
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCCcc
Confidence 999999999999888889999999999999999999999999999999999999 55667999999998764322 22
Q ss_pred eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 016233 239 YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (393)
Q Consensus 239 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (393)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+......++ ..++.++.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~ 233 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICK 233 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHH
Confidence 345679999999999875 589999999999999999999999999888888888887665544 357899999999
Q ss_pred HhcccCCCCCCC-----HHHHhcCccccCC
Q 016233 318 RMLTQDPKKRIT-----SAQVLEHPWIKEG 342 (393)
Q Consensus 318 ~~L~~dp~~Rpt-----~~e~l~h~~~~~~ 342 (393)
+||..||.+|++ .+++++||||...
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 234 GLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 999999999997 4789999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=364.42 Aligned_cols=258 Identities=30% Similarity=0.515 Sum_probs=217.5
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
.|++.+.||+|+||.||++.+..+++.||||.+.............+.+|+.+++.++ ||||+++++++..++.+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecCCCeEEEEE
Confidence 4888999999999999999999999999999997654333333456778999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 160 ELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||+.||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ ++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCC
Confidence 999999999887653 358999999999999999999999999999999999999 556779999999998765554
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
......|++.|+|||++.+ .++.++||||+||++|+|++|..||.+.........+..............++..+.+||
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 4455689999999999864 588999999999999999999999987665443333322211112222345889999999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCccccC
Q 016233 317 RRMLTQDPKKRI-----TSAQVLEHPWIKE 341 (393)
Q Consensus 317 ~~~L~~dp~~Rp-----t~~e~l~h~~~~~ 341 (393)
.+||..||++|| +++++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-49 Score=371.77 Aligned_cols=251 Identities=28% Similarity=0.509 Sum_probs=213.4
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~g 164 (393)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++.++.+||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999998764434445567888999998886799999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc-CCcceeccc
Q 016233 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIV 243 (393)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~-~~~~~~~~~ 243 (393)
|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999 556679999999987643 223334568
Q ss_pred CcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCC---------ChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAE---------TEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 244 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
||+.|+|||++.+ .++.++|||||||++|+|++|..||... ........+......++ ..++..+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~ 233 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAA 233 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCCHHHH
Confidence 9999999999875 4889999999999999999999999521 12223444555544433 35789999
Q ss_pred HHHHHhcccCCCCCCC------HHHHhcCccccCC
Q 016233 314 DLVRRMLTQDPKKRIT------SAQVLEHPWIKEG 342 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt------~~e~l~h~~~~~~ 342 (393)
+||.+||..||++|+| ++++++||||...
T Consensus 234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 9999999999999998 5799999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=368.86 Aligned_cols=251 Identities=27% Similarity=0.491 Sum_probs=216.8
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~g 164 (393)
+.||+|+||.||+|.+..+++.||||++................|..++..+.+||||+++++++.+.+.+++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999997654333344566777888888765699999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC-Ccceeccc
Q 016233 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDIV 243 (393)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~-~~~~~~~~ 243 (393)
|+|.+++.....+++.++..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++..... ........
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCceeeec
Confidence 9999999887889999999999999999999999999999999999999 4566799999999875422 22334567
Q ss_pred CcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 016233 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (393)
Q Consensus 244 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (393)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......++ ..++.++.+||.+||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~ 233 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKDILVKLFVR 233 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHhcc
Confidence 9999999999875 589999999999999999999999998888877777766544332 24789999999999999
Q ss_pred CCCCCCCHH-HHhcCccccCC
Q 016233 323 DPKKRITSA-QVLEHPWIKEG 342 (393)
Q Consensus 323 dp~~Rpt~~-e~l~h~~~~~~ 342 (393)
||++||++. ++++||||...
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 234 EPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred CHhhcCCChHHHHcCcccCCC
Confidence 999999996 89999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=370.58 Aligned_cols=250 Identities=35% Similarity=0.629 Sum_probs=217.3
Q ss_pred ceecccCCeEEEEEEEC---CCCcEEEEEEeecCccC-CcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEe
Q 016233 85 KELGRGQFGVTYLCTEN---STGRQFACKSISKRKLV-TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 160 (393)
+.||+|+||.||+|.+. .+++.||+|++.+.... .......+.+|+.+++.++ ||||+++++++..++.+|+|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEEe
Confidence 67999999999999864 57889999999764321 2233456788999999996 9999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC-Ccce
Q 016233 161 LCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVY 239 (393)
Q Consensus 161 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~-~~~~ 239 (393)
|++|++|.+++...+.+.+..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCCcc
Confidence 99999999999888889999999999999999999999999999999999999 5567799999999875432 2233
Q ss_pred ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 016233 240 RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318 (393)
Q Consensus 240 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 318 (393)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||...+....+..+..+...++ +.+++++.+||.+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~ 233 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLLKK 233 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence 45679999999999865 488999999999999999999999999888888888887765443 3578999999999
Q ss_pred hcccCCCCCC-----CHHHHhcCccccCC
Q 016233 319 MLTQDPKKRI-----TSAQVLEHPWIKEG 342 (393)
Q Consensus 319 ~L~~dp~~Rp-----t~~e~l~h~~~~~~ 342 (393)
||..||++|| +++++++||||...
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999 89999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=361.98 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=209.2
Q ss_pred ceeecceecccCCeEEEEEEECC-CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHcc--CCCCeeEEeEEEE-----e
Q 016233 80 HYSFGKELGRGQFGVTYLCTENS-TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--GQPNIVEFKGAYE-----D 151 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~-----~ 151 (393)
+|++.+.||+|+||.||+|.+.. +++.||+|.+..... .......+.+|+.+++.+. +||||+++++++. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 79999999999999999999864 468899999875432 2223445667888887764 4999999999875 3
Q ss_pred CCeEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 152 KQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
...+++||||+. ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEccccc
Confidence 456899999996 5898888653 358999999999999999999999999999999999999 4566799999999
Q ss_pred cccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC-----
Q 016233 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA----- 303 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~----- 303 (393)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred eEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 987665544456679999999999864 58999999999999999999999999888777766665422111100
Q ss_pred ------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 304 ------------------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 304 ------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
..+.+++.+.+||.+||+.||++|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 113578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=368.81 Aligned_cols=260 Identities=28% Similarity=0.507 Sum_probs=219.4
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.+++.++ |+||+++++++.+++.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEecCCeEEEE
Confidence 36999999999999999999999999999999997643333345567889999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 159 MELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
|||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCC
Confidence 999999999999976 4579999999999999999999999999999999999999 556679999999987665433
Q ss_pred ce--ecccCcccccchHHHh------hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC-CCCCCC
Q 016233 238 VY--RDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES-APWPTI 308 (393)
Q Consensus 238 ~~--~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~ 308 (393)
.. ...+||+.|+|||++. +.++.++|||||||++|+|++|..||.+.+..+.+..+......+.. .....+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence 22 2346999999999986 23788999999999999999999999988877777777654332221 223458
Q ss_pred CHHHHHHHHHhcccCCCC--CCCHHHHhcCccccCC
Q 016233 309 SSSAKDLVRRMLTQDPKK--RITSAQVLEHPWIKEG 342 (393)
Q Consensus 309 s~~~~~li~~~L~~dp~~--Rpt~~e~l~h~~~~~~ 342 (393)
+.++++||++||..++++ |++++++++||||...
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 999999999999765544 8899999999999753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=374.61 Aligned_cols=250 Identities=31% Similarity=0.558 Sum_probs=216.1
Q ss_pred ecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHcc--CCCCeeEEeEEEEeCCeEEEEEeccCC
Q 016233 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--GQPNIVEFKGAYEDKQSVHVVMELCAG 164 (393)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~~~~~lv~e~~~g 164 (393)
||+|+||.||+|.+..+++.||||++.+..............|..++..+. +||||+++++++.+.+.+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999997654333334445566777777654 699999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC-Ccceeccc
Q 016233 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDIV 243 (393)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~-~~~~~~~~ 243 (393)
|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .......+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 9999999888889999999999999999999999999999999999999 5566799999999876432 23334568
Q ss_pred CcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 016233 244 GSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321 (393)
Q Consensus 244 gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 321 (393)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+...++. ..+++++.+||++||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~~L~ 234 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGLLN 234 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcC
Confidence 9999999999864 3789999999999999999999999998888888888877665543 2478999999999999
Q ss_pred cCCCCCC----CHHHHhcCccccCC
Q 016233 322 QDPKKRI----TSAQVLEHPWIKEG 342 (393)
Q Consensus 322 ~dp~~Rp----t~~e~l~h~~~~~~ 342 (393)
.||++|| +++++++||||...
T Consensus 235 ~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 235 RNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCHHHCCCCCCCHHHHhcCccccCC
Confidence 9999998 79999999999753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-49 Score=370.31 Aligned_cols=249 Identities=30% Similarity=0.589 Sum_probs=214.6
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHH-HHHHccCCCCeeEEeEEEEeCCeEEEEEeccC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQ-IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCA 163 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 163 (393)
+.||+|+||.||+|.+..+|+.||||++.+...........+..|.. +++.++ ||||+++++++.+.+.+|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 46999999999999999999999999997654333333445555655 456775 9999999999999999999999999
Q ss_pred CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC-Ccceecc
Q 016233 164 GGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDI 242 (393)
Q Consensus 164 gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~-~~~~~~~ 242 (393)
||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .......
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCCccccc
Confidence 99999999888889999999999999999999999999999999999999 5566799999999875432 2233456
Q ss_pred cCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 016233 243 VGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321 (393)
Q Consensus 243 ~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 321 (393)
+||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+.+..+........ +.++..+.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~ 232 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQ 232 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhh
Confidence 79999999999875 589999999999999999999999999888888888877654433 4579999999999999
Q ss_pred cCCCCCCCH----HHHhcCccccC
Q 016233 322 QDPKKRITS----AQVLEHPWIKE 341 (393)
Q Consensus 322 ~dp~~Rpt~----~e~l~h~~~~~ 341 (393)
.||.+||++ .++++||||..
T Consensus 233 ~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 233 KDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred cCHHhCCCCCCCHHHHHcCCCcCC
Confidence 999999998 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=367.33 Aligned_cols=258 Identities=25% Similarity=0.381 Sum_probs=216.5
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
.++|++.+.||+|+||.||++.+..++..+|+|++.... .......+.+|+++++.++ ||||+++++++.+++.+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEE
Confidence 468999999999999999999999999999999986532 2334567899999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~-~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
||||++|++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCccccccccc
Confidence 999999999999998888899999999999999999999986 69999999999999 45567999999999866433
Q ss_pred cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC-----------------
Q 016233 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI----------------- 298 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~----------------- 298 (393)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+....+.....
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 2345679999999999875 489999999999999999999999976655443322211000
Q ss_pred ---------------------------CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 299 ---------------------------DFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 299 ---------------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
..+......+++++++||.+||..||++|||+.++|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 00011112468899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=360.54 Aligned_cols=252 Identities=28% Similarity=0.482 Sum_probs=208.0
Q ss_pred ecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCCCC
Q 016233 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGE 166 (393)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~gg~ 166 (393)
||+|+||+||+|.+..+++.||||.+.+.........+.+..|+.+++.++ |+||+++.+++..++.+++||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 799999999999999999999999987654333334566788999999996 9999999999999999999999999999
Q ss_pred hHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc-ceec
Q 016233 167 LFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-VYRD 241 (393)
Q Consensus 167 L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-~~~~ 241 (393)
|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++....... ....
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCccccc
Confidence 9887743 3468999999999999999999999999999999999999 556679999999998765432 2334
Q ss_pred ccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhc
Q 016233 242 IVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRML 320 (393)
Q Consensus 242 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 320 (393)
..||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+..............++..+.+++.+||
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence 679999999999875 5889999999999999999999999765432222222221111122222458899999999999
Q ss_pred ccCCCCCC-----CHHHHhcCccccCC
Q 016233 321 TQDPKKRI-----TSAQVLEHPWIKEG 342 (393)
Q Consensus 321 ~~dp~~Rp-----t~~e~l~h~~~~~~ 342 (393)
+.||++|| |++++++||||+..
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 99999999 88999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=367.34 Aligned_cols=251 Identities=26% Similarity=0.489 Sum_probs=213.7
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~g 164 (393)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++.++.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999998765444445667889999999997799999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc-CCcceeccc
Q 016233 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIV 243 (393)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~-~~~~~~~~~ 243 (393)
|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCCceeccc
Confidence 9999999888889999999999999999999999999999999999999 556679999999987532 233345678
Q ss_pred CcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCC-------hHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET-------EKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 244 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.... .......+......++ ..++..+.++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~l 233 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSVKASHV 233 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence 9999999999865 58999999999999999999999995321 2233444444433332 3578999999
Q ss_pred HHHhcccCCCCCCC------HHHHhcCccccCC
Q 016233 316 VRRMLTQDPKKRIT------SAQVLEHPWIKEG 342 (393)
Q Consensus 316 i~~~L~~dp~~Rpt------~~e~l~h~~~~~~ 342 (393)
|.+||..||++|++ ++++++||||...
T Consensus 234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 99999999999998 5799999999763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=374.15 Aligned_cols=253 Identities=22% Similarity=0.398 Sum_probs=207.2
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
..+|++++.||+|+||.||+|.+..+++.||+|... ...+.+|++++++|+ ||||++++++|......++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAIN-HPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCC-CCCCCCEeEEEEECCeeEE
Confidence 457999999999999999999999999999999642 234678999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG- 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~- 236 (393)
|+|++. ++|.+++.....+++.++..++.||+.||.|||++||+||||||+|||+ +..+.+||+|||++......
T Consensus 161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCccccccccc
Confidence 999994 6899988888889999999999999999999999999999999999999 45667999999999754322
Q ss_pred -cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCC-------hHHHHHHHHcC-----------
Q 016233 237 -KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET-------EKGIFDAILQG----------- 296 (393)
Q Consensus 237 -~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~-------~~~~~~~i~~~----------- 296 (393)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ....+..+...
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 23345689999999999865 58999999999999999999998876432 11111111110
Q ss_pred ---------------CCC--CCCCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 297 ---------------DID--FESAPW---PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 297 ---------------~~~--~~~~~~---~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
... .....| ..++.++.+||.+||+.||++|||++|+|+||||+....
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 384 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD 384 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence 000 001111 135678999999999999999999999999999987543
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=368.90 Aligned_cols=257 Identities=36% Similarity=0.618 Sum_probs=237.3
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
...|.+.+.||+|.|+.|.+|++..|+..||||+|++..... ..+..+.+|+++|+.|. |||||+++.+.+....+|+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~-HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLN-HPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcC-CcceeeeeeeeeecceeEE
Confidence 347999999999999999999999999999999998876543 34455899999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||||+.+|.+++++.+.++..+..++.++.|++.|++|||+++|||||||++|||+ +.+..+||+|||++..+..+.
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeecccc
Confidence 99999999999999999999999999999999999999999999999999999999 677779999999999999888
Q ss_pred ceecccCcccccchHHHhhc--CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
...+.||++.|.|||++.+. .++.+|+||+|+++|.|+.|.+||.+.+..+.-...+.+++..+. .++.++.++
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~dce~l 285 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCDCEDL 285 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeechhHHH
Confidence 89999999999999999864 589999999999999999999999999988888888888776654 378999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 316 VRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
|+++|..+|.+|++.+++..|.|.....
T Consensus 286 Lrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred HHHhhccCccccCCHHHhhhhcccchhh
Confidence 9999999999999999999999987553
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=368.99 Aligned_cols=255 Identities=30% Similarity=0.533 Sum_probs=231.0
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe-EEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS-VHV 157 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~-~~l 157 (393)
++|.+++.+|+|+||.+++++++.+++.+++|.|..... +........+|+.+++++. |||||.+.+.|..++. ++|
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~-t~~~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKL-TEPERRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEecccc-CchhhHHHHHHHHHHHhcc-CCCeeeeccchhcCCceEEE
Confidence 479999999999999999999999999999999987664 3445557889999999997 9999999999988887 999
Q ss_pred EEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 158 VMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
||+||+||+|.+.|.+.+ .++++.+..++.|++.|+.|||+++|+|||||+.|||++ .+..|||+|||+|+.+..
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt---k~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT---KDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc---ccCceeecchhhhhhcCC
Confidence 999999999999997654 589999999999999999999999999999999999995 455589999999999987
Q ss_pred Cc-ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 236 GK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 236 ~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
.. ...+.+||+.||.||++.+ .|+.|+|||||||++|||++-+++|.+.+...+..+|.++...... ...+.+++
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys~el~ 235 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYSSELR 235 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---ccccHHHH
Confidence 76 6678899999999999987 5999999999999999999999999999999999999998754333 35789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
.+|..||..+|+.||++.++|.+|.+..
T Consensus 236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 236 SLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 9999999999999999999999988763
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=381.46 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=207.7
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC-----
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK----- 152 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~----- 152 (393)
..+|++++.||+|+||.||+|.+..+++.||||.+... .....+|+.+|+.++ ||||++++++|...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-------~~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-------PQYKNRELLIMKNLN-HINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-------cchHHHHHHHHHhcC-CCCCcceeeeEeecccccC
Confidence 45799999999999999999999999999999988532 123457999999996 99999999876432
Q ss_pred ---CeEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEe
Q 016233 153 ---QSVHVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225 (393)
Q Consensus 153 ---~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~ 225 (393)
..+++||||+++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. ....+||+
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~--~~~~vkL~ 213 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP--NTHTLKLC 213 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC--CCCceeee
Confidence 257799999975 67666642 456999999999999999999999999999999999999952 23469999
Q ss_pred ecCCcccccCCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC------
Q 016233 226 DFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD------ 297 (393)
Q Consensus 226 DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~------ 297 (393)
|||+++.+..........||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+.+..
T Consensus 214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9999998766555556789999999998754 58999999999999999999999999887665555443311
Q ss_pred -----------CCCCCCC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 298 -----------IDFESAP--------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 298 -----------~~~~~~~--------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
..++... ....++++.+||.+||..||.+|||+.|+|+||||...
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 1111100 12367899999999999999999999999999999753
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=367.50 Aligned_cols=249 Identities=28% Similarity=0.566 Sum_probs=214.4
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHH-HHHccCCCCeeEEeEEEEeCCeEEEEEeccC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI-MQHLSGQPNIVEFKGAYEDKQSVHVVMELCA 163 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 163 (393)
+.||+|+||.||+|.+..+|+.||+|++.+...........+..|..+ ++.++ ||||+++++++...+.+|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC-CCCCccEEEEEecCCEEEEEEcCCC
Confidence 469999999999999999999999999976543333344555666654 56675 9999999999999999999999999
Q ss_pred CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC-Ccceecc
Q 016233 164 GGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDI 242 (393)
Q Consensus 164 gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~-~~~~~~~ 242 (393)
||+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..... .......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCCcccc
Confidence 99999999888889999999999999999999999999999999999999 5566799999999875432 2333456
Q ss_pred cCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 016233 243 VGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321 (393)
Q Consensus 243 ~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 321 (393)
+||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+.+..+........ +.++..+.++|.+||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE 232 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHHHHhc
Confidence 79999999999875 589999999999999999999999999888888888877654433 3578999999999999
Q ss_pred cCCCCCCCH----HHHhcCccccC
Q 016233 322 QDPKKRITS----AQVLEHPWIKE 341 (393)
Q Consensus 322 ~dp~~Rpt~----~e~l~h~~~~~ 341 (393)
.||.+||++ .++++||||..
T Consensus 233 ~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 233 KDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCHHhcCCCCCCHHHHhcCCCcCC
Confidence 999999987 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=365.72 Aligned_cols=258 Identities=27% Similarity=0.497 Sum_probs=219.5
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||++.++.+++.+|+|++.+...........+.+|+.++..+. |+||+++++++.+.+.+|+||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCEEEEEE
Confidence 6899999999999999999999999999999987543323334556788999999986 999999999999999999999
Q ss_pred eccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc
Q 016233 160 ELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (393)
Q Consensus 160 e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~ 238 (393)
||+++|+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCCc
Confidence 99999999999977 4678999999999999999999999999999999999999 5566799999999976543322
Q ss_pred --eecccCcccccchHHHh------hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC-CCCCCCC
Q 016233 239 --YRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES-APWPTIS 309 (393)
Q Consensus 239 --~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s 309 (393)
....+||+.|+|||++. +.++.++|||||||++|+|++|..||...+..+.+..+......+.. .....++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s 237 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVS 237 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCC
Confidence 23457999999999985 24789999999999999999999999998888888888765433322 2234689
Q ss_pred HHHHHHHHHhcccCCCC--CCCHHHHhcCccccC
Q 016233 310 SSAKDLVRRMLTQDPKK--RITSAQVLEHPWIKE 341 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~--Rpt~~e~l~h~~~~~ 341 (393)
+++++||.+||..++++ |++++++++||||..
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 238 EDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 99999999999765554 789999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-49 Score=367.48 Aligned_cols=249 Identities=30% Similarity=0.540 Sum_probs=217.1
Q ss_pred ceecccCCeEEEEEEE---CCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEec
Q 016233 85 KELGRGQFGVTYLCTE---NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMEL 161 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~ 161 (393)
+.||+|+||.||++.+ ..+|+.||+|++.+... .......+.+|++++++++ ||||+++++++.+++.+|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEcC
Confidence 5799999999999886 46789999999976432 1223456778999999996 99999999999999999999999
Q ss_pred cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-ccee
Q 016233 162 CAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-KVYR 240 (393)
Q Consensus 162 ~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~-~~~~ 240 (393)
+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...... ....
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~ 156 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAY 156 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCcee
Confidence 9999999999888889999999999999999999999999999999999999 55667999999999865443 2344
Q ss_pred cccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHh
Q 016233 241 DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRM 319 (393)
Q Consensus 241 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 319 (393)
...||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+.+..+......++ ..+++++.+||++|
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~ 232 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLRAL 232 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHH
Confidence 5689999999999875 588999999999999999999999999888888888877665543 35789999999999
Q ss_pred cccCCCCCCC-----HHHHhcCccccCC
Q 016233 320 LTQDPKKRIT-----SAQVLEHPWIKEG 342 (393)
Q Consensus 320 L~~dp~~Rpt-----~~e~l~h~~~~~~ 342 (393)
|+.||++||| .+++++||||...
T Consensus 233 l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 233 FKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred hhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 9999999999 6779999999753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-48 Score=357.06 Aligned_cols=255 Identities=27% Similarity=0.438 Sum_probs=208.6
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHcc--CCCCeeEEeEEEEe-----C
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--GQPNIVEFKGAYED-----K 152 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~-----~ 152 (393)
+|++.+.||+|+||.||+|.++.+++.||+|.+..... .......+.+|+.+++.+. +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 58999999999999999999999999999999875432 2223345667888887764 49999999998864 3
Q ss_pred CeEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 153 QSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
..+++||||+.+ +|.+++... ..+++.+++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLA 155 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCcc
Confidence 458999999975 888888663 348999999999999999999999999999999999999 45667999999999
Q ss_pred ccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC----------
Q 016233 231 VFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID---------- 299 (393)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~---------- 299 (393)
.............||..|+|||++.+ .++.++|||||||++|+|++|.+||.+....+.+..+......
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 87765444455678999999998864 5899999999999999999999999887766555554321100
Q ss_pred ------CC-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 300 ------FE-------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 300 ------~~-------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
+. ....+.++..+.+||.+||..||++|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 01124578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=365.51 Aligned_cols=259 Identities=26% Similarity=0.486 Sum_probs=220.1
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.++..+. |+||+++++++.+.+..|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEE
Confidence 37999999999999999999999999999999997543323334556788999999986 99999999999999999999
Q ss_pred EeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 159 MELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
|||+.||+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCC
Confidence 999999999999987 4679999999999999999999999999999999999999 556679999999998765433
Q ss_pred ce--ecccCcccccchHHHhh------cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC-CCCCCCC
Q 016233 238 VY--RDIVGSAYYVAPEVLRR------RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE-SAPWPTI 308 (393)
Q Consensus 238 ~~--~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~ 308 (393)
.. ...+||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+.+..+......+. ...+..+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence 22 23579999999999863 478899999999999999999999998888777777776543332 2223567
Q ss_pred CHHHHHHHHHhcccCCCC--CCCHHHHhcCccccC
Q 016233 309 SSSAKDLVRRMLTQDPKK--RITSAQVLEHPWIKE 341 (393)
Q Consensus 309 s~~~~~li~~~L~~dp~~--Rpt~~e~l~h~~~~~ 341 (393)
++++.+||.+||..++++ |++++++++|+||..
T Consensus 237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999999999876654 579999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=365.79 Aligned_cols=249 Identities=29% Similarity=0.561 Sum_probs=212.8
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHH-HHHHccCCCCeeEEeEEEEeCCeEEEEEeccC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQ-IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCA 163 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 163 (393)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|.. +++.+. ||||+++++++...+.+|+||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC-CCCCCceeEEEEcCCeEEEEEeCCC
Confidence 46999999999999999999999999997643322223344444544 467775 9999999999999999999999999
Q ss_pred CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC-Ccceecc
Q 016233 164 GGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDI 242 (393)
Q Consensus 164 gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~-~~~~~~~ 242 (393)
||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .......
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCCCcccc
Confidence 99999999888889999999999999999999999999999999999999 4566799999999976432 2234456
Q ss_pred cCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 016233 243 VGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321 (393)
Q Consensus 243 ~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 321 (393)
+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......+ .+.++..+.++|.+||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL----KPNITNSARHLLEGLLQ 232 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCC----CCCCCHHHHHHHHHHcc
Confidence 79999999999875 48899999999999999999999999988888888877654433 24689999999999999
Q ss_pred cCCCCCCCHH----HHhcCccccC
Q 016233 322 QDPKKRITSA----QVLEHPWIKE 341 (393)
Q Consensus 322 ~dp~~Rpt~~----e~l~h~~~~~ 341 (393)
.||.+|+++. ++++|+||..
T Consensus 233 ~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 233 KDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred cCHHHCCCCCCCHHHHhcCcccCC
Confidence 9999999876 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=357.10 Aligned_cols=255 Identities=30% Similarity=0.547 Sum_probs=213.8
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
.|++.+.||+|+||.||+|.+..+++.||||.+.............+.+|+.++++++ |+||+.+++.+.+.+.+++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCEEEEEE
Confidence 3778889999999999999999999999999987654433333456778999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 160 ELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||+.|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +..+.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCCc
Confidence 999999999888653 358999999999999999999999999999999999999 556679999999998765544
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChH---HHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEK---GIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
......||..|+|||++.+ .++.++||||+||++|+|++|..||...... +....+... ........+++++.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 233 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---VQEEYSEKFSPDAR 233 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh---hhhhcCccCCHHHH
Confidence 4455689999999999865 5899999999999999999999999865432 122222111 11122346789999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHhcCccccC
Q 016233 314 DLVRRMLTQDPKKRIT-----SAQVLEHPWIKE 341 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt-----~~e~l~h~~~~~ 341 (393)
+|+.+||+.||++||| ++|+++||||.+
T Consensus 234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999999 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=364.27 Aligned_cols=249 Identities=29% Similarity=0.557 Sum_probs=213.1
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHH-HHHHccCCCCeeEEeEEEEeCCeEEEEEeccC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQ-IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCA 163 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 163 (393)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|.. +++.++ ||||+++++++.+.+.+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999999999999999997654323333445555654 577785 9999999999999999999999999
Q ss_pred CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC-Ccceecc
Q 016233 164 GGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GKVYRDI 242 (393)
Q Consensus 164 gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~-~~~~~~~ 242 (393)
|++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..... .......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCccccc
Confidence 99999999888889999999999999999999999999999999999999 5566799999999875322 2233456
Q ss_pred cCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 016233 243 VGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321 (393)
Q Consensus 243 ~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 321 (393)
+||+.|+|||++.+ .++.++|||||||++|+|++|..||...+....+..+......++ +..+..+.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~ 232 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLH 232 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHcc
Confidence 79999999999875 589999999999999999999999999888888888877654433 3578899999999999
Q ss_pred cCCCCCCCH----HHHhcCccccC
Q 016233 322 QDPKKRITS----AQVLEHPWIKE 341 (393)
Q Consensus 322 ~dp~~Rpt~----~e~l~h~~~~~ 341 (393)
.||.+|+++ .++++|+||..
T Consensus 233 ~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 233 KDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred CCHhhcCCCCCCHHHHhCCCCcCC
Confidence 999999976 49999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-48 Score=359.49 Aligned_cols=258 Identities=26% Similarity=0.419 Sum_probs=213.4
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.+|.+.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.++++++ ||||+++++++..++..++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCC-CCCcceEEEEEeeCCeEEEE
Confidence 479999999999999999999999999999999875432 233456778999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
|||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +..+.+||+|||++.......
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPT 158 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCc
Confidence 999975 888877654 358899999999999999999999999999999999999 456679999999997654322
Q ss_pred -ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-----------------
Q 016233 238 -VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD----------------- 297 (393)
Q Consensus 238 -~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~----------------- 297 (393)
......+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 2334578999999998864 47899999999999999999999998877655544443211
Q ss_pred --CCCCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 298 --IDFES-------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 298 --~~~~~-------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
..++. ...+.++.++.+||.+||..||.+|||++|+|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00110 11235788999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=346.51 Aligned_cols=257 Identities=33% Similarity=0.607 Sum_probs=237.5
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
-.+|.++++||+|.||.|.+|+.+.+++.+|+|+++++.+.......--..|-++|+..+ ||.+..+-..|+..+.+|+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCceEEE
Confidence 346899999999999999999999999999999999887766666666778999999997 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc-ccCC
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF-IEEG 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~-~~~~ 236 (393)
||||..||.|+-+|.+.+.+++..++.+...|+.||.|||+++||+||||.+|+|+ |.++.+||.|||+++. +..+
T Consensus 246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhccccc
Confidence 99999999999999988899999999999999999999999999999999999999 7788899999999986 4556
Q ss_pred cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
....+.||||.|.|||++.. .|+..+|.|.+||+||||++|++||+..+...+++.|+...+.|+. .++++++.|
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~eAktL 398 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSPEAKTL 398 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCHHHHHH
Confidence 67789999999999999976 5999999999999999999999999999999999999999998886 589999999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCccccCC
Q 016233 316 VRRMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (393)
Q Consensus 316 i~~~L~~dp~~Rp-----t~~e~l~h~~~~~~ 342 (393)
+..+|.+||.+|. .+.|+.+|+||...
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 9999999999997 57899999999753
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=353.48 Aligned_cols=259 Identities=31% Similarity=0.525 Sum_probs=218.7
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
.|+..+.||+|+||+||+|.+..+++.+|+|.+.............+.+|+.+++.++ |+||+.+++.+..++..++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCEEEEEE
Confidence 3778889999999999999999999999999987654433334556788999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 160 ELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.+..++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCCC
Confidence 999999998888653 359999999999999999999999999999999999999 455679999999997765444
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
......|+..|+|||.+.+ .++.++|+|||||++|+|++|..||.+.........+..............++.++.+|+
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 4455689999999999864 589999999999999999999999987765544444433222222233356889999999
Q ss_pred HHhcccCCCCCCC-----HHHHhcCccccCC
Q 016233 317 RRMLTQDPKKRIT-----SAQVLEHPWIKEG 342 (393)
Q Consensus 317 ~~~L~~dp~~Rpt-----~~e~l~h~~~~~~ 342 (393)
.+||..||++||| +.++++|+||...
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999 8899999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=352.57 Aligned_cols=248 Identities=29% Similarity=0.529 Sum_probs=208.5
Q ss_pred ecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCCCC
Q 016233 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGE 166 (393)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~gg~ 166 (393)
||+|+||.||++.++.+|+.||+|.+.............+..|++++++++ ||||++++++++++..+++||||++|++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999999999999999997654433333455667999999996 9999999999999999999999999999
Q ss_pred hHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcceecccC
Q 016233 167 LFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG 244 (393)
Q Consensus 167 L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~g 244 (393)
|.+++.... .+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++.............|
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAG 156 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCceeeccCC
Confidence 988876543 48889999999999999999999999999999999999 5566799999999987766555556679
Q ss_pred cccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh----HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHh
Q 016233 245 SAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAILQGDIDFESAPWPTISSSAKDLVRRM 319 (393)
Q Consensus 245 t~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 319 (393)
++.|+|||++.+ .++.++|||||||++|+|++|..||..... .+....+......+. ...+++++.+||.+|
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~ 233 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE---HQNFTEESKDICRLF 233 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc---cccCCHHHHHHHHHH
Confidence 999999999864 589999999999999999999999976433 223333333333222 246899999999999
Q ss_pred cccCCCCCCCH----HHHhcCccccC
Q 016233 320 LTQDPKKRITS----AQVLEHPWIKE 341 (393)
Q Consensus 320 L~~dp~~Rpt~----~e~l~h~~~~~ 341 (393)
|..||++||++ ++++.|+||+.
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcC
Confidence 99999999999 67889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=360.29 Aligned_cols=251 Identities=25% Similarity=0.426 Sum_probs=218.5
Q ss_pred cccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 71 GKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 71 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
...++.-+..+++++.||+|.||.||.|..+. ...||+|.++... ...+.+.+|+++|++|+ |+|||++++++.
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~----m~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS----MSPEAFLREAQIMKKLR-HEKLVKLYGVCT 271 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc----cChhHHHHHHHHHHhCc-ccCeEEEEEEEe
Confidence 44566666778899999999999999999884 2489999997543 34577889999999997 999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecC
Q 016233 151 DKQSVHVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (393)
Q Consensus 151 ~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg 228 (393)
.++.+||||||++.|+|.++|.. ...+...+...++.||++|++||+++++|||||...|||| +++..+||+|||
T Consensus 272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFG 348 (468)
T KOG0197|consen 272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFG 348 (468)
T ss_pred cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccc
Confidence 98899999999999999999987 4568999999999999999999999999999999999999 677789999999
Q ss_pred CcccccCCcceecccCc---ccccchHHHh-hcCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCC
Q 016233 229 LSVFIEEGKVYRDIVGS---AYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESA 303 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~gt---~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 303 (393)
+|+...++ .+....|. ..|.|||.++ +.++.++|||||||+||||+| |+.||.+.+..+.++.+.+|..-..
T Consensus 349 LAr~~~d~-~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~-- 425 (468)
T KOG0197|consen 349 LARLIGDD-EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR-- 425 (468)
T ss_pred cccccCCC-ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC--
Confidence 99955443 33333333 3699999987 569999999999999999998 9999999999999999999865433
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 016233 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVL 334 (393)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l 334 (393)
...+|+++.+++..||..+|++|||++.+.
T Consensus 426 -P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 426 -PEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred -CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 357999999999999999999999998654
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=364.46 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=208.6
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC---
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ--- 153 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--- 153 (393)
+..+|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++ ||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCCcc
Confidence 4568999999999999999999999999999999986543 23344567789999999996 999999999986543
Q ss_pred ---eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 154 ---SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 154 ---~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
.+|+||||+.+ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~a 170 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA 170 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEecCCCc
Confidence 57999999965 5666554 358899999999999999999999999999999999999 55677999999999
Q ss_pred ccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc--------------
Q 016233 231 VFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ-------------- 295 (393)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~-------------- 295 (393)
.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 171 RTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred cccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 87654444455689999999999875 589999999999999999999999987665433322211
Q ss_pred --------CCCCCCC----------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 296 --------GDIDFES----------------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 296 --------~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
....+.. ......++++++||.+||..||++|||+.|+|+||||..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 1111100 001124678999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=359.52 Aligned_cols=256 Identities=26% Similarity=0.407 Sum_probs=213.9
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
.++|++.+.||+|+||.||+|.+..++..+|+|++.... .......+.+|+++++.++ ||||+++++++.+++.+++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCEEEE
Confidence 468999999999999999999999999999999886532 2234567899999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~-~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
||||+.|++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhhh
Confidence 999999999999998888899999999999999999999985 79999999999999 45567999999999765432
Q ss_pred cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH---------------------
Q 016233 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL--------------------- 294 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~--------------------- 294 (393)
......||..|+|||++.+ .++.++|||||||++|+|++|..||......+....+.
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 2234579999999999875 48899999999999999999999997655433322110
Q ss_pred -----------------------cCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 295 -----------------------QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 295 -----------------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.... +......++.++++||.+||..||++|||++|+++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCC--ccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000 000011357889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=373.07 Aligned_cols=254 Identities=28% Similarity=0.442 Sum_probs=219.5
Q ss_pred ccceeecceecccCCeEEEEEEECCC-CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENST-GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
...|.+.+.||+|+||.||+|.+..+ ++.||+|.+... .......+.+|+.+|+.++ |||||++++++...+.+|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEECCEEE
Confidence 34599999999999999999998887 788999976432 2334556788999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 157 VVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
|||||++||+|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||+ +..+.+||+|||++..
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~ 218 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQ 218 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCcee
Confidence 99999999999987754 3468999999999999999999999999999999999999 5566799999999987
Q ss_pred ccCCc---ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 016233 233 IEEGK---VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (393)
Q Consensus 233 ~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (393)
..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+..... ...+
T Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~ 295 (478)
T PTZ00267 219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF---PCPV 295 (478)
T ss_pred cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---CccC
Confidence 65432 2345679999999999875 589999999999999999999999998888888888877655322 2357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
+.++.+||.+||..||++|||++++|.|+|++.
T Consensus 296 s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 899999999999999999999999999999864
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=374.46 Aligned_cols=257 Identities=31% Similarity=0.500 Sum_probs=220.6
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC---
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ--- 153 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--- 153 (393)
...+|.+.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.++..+. |+||+++++.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCC-CCcEEEeecceecccccC
Confidence 34699999999999999999999999999999999976543 3345667889999999996 999999988765332
Q ss_pred -----eEEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEE
Q 016233 154 -----SVHVVMELCAGGELFDRIIAK----GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKA 224 (393)
Q Consensus 154 -----~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl 224 (393)
.+++||||+++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEE
Confidence 378999999999999988653 468999999999999999999999999999999999999 45667999
Q ss_pred eecCCcccccCC---cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC
Q 016233 225 TDFGLSVFIEEG---KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF 300 (393)
Q Consensus 225 ~DFg~a~~~~~~---~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 300 (393)
+|||+++..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~ 264 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 999999865432 22345679999999999875 58999999999999999999999999988888888877765432
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 301 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
. .+.+++++.+|+.+||..||++|||+.++++|||++.
T Consensus 265 ~---~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 265 L---PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred C---CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 2 2468899999999999999999999999999999864
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-48 Score=350.05 Aligned_cols=254 Identities=37% Similarity=0.682 Sum_probs=213.3
Q ss_pred eeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEe
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 160 (393)
|++++.||+|+||+||++.+..+++.||+|++...... ........+|+.++++++ ||||+++++++.+....++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-EEEREENIREIKILRRLR-HPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-HHHHHHHHHHHHHHHHHT-BTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc-ccccchhhhhhhcccccc-cccccccccccccccccccccc
Confidence 88999999999999999999999999999999865421 112233456999999995 9999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc-cCCcce
Q 016233 161 LCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVY 239 (393)
Q Consensus 161 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~-~~~~~~ 239 (393)
|+.+++|.+++...+.+++.++..++.||+.||.+||++||+|+||||+||++ +.++.++|+|||.+... ......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~~~ 155 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNENF 155 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTSEB
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence 99999999999878899999999999999999999999999999999999999 56777999999999863 333445
Q ss_pred ecccCcccccchHHHh--hcCCCcchHHHHHHHHHHHhhCCCCCCCCC---hHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 240 RDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAET---EKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 240 ~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
....+|..|+|||++. ..++.++||||||+++|+|++|..||.... ....+..................+..+.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 5678999999999987 458999999999999999999999998873 33333333332222222211223489999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccc
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
+|.+||..||++|||+.++++||||
T Consensus 236 li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=361.96 Aligned_cols=257 Identities=27% Similarity=0.420 Sum_probs=211.0
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC----
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK---- 152 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---- 152 (393)
+..+|++.+.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++ ||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcC-CCCccccceeeccccccc
Confidence 4568999999999999999999999999999999986532 22334567889999999996 99999999987543
Q ss_pred --CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 153 --QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 153 --~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
..+|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a 173 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA 173 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCCCc
Confidence 357999999965 67776643 58899999999999999999999999999999999999 55667999999999
Q ss_pred ccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC----------
Q 016233 231 VFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID---------- 299 (393)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~---------- 299 (393)
.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 87665544456689999999999875 5899999999999999999999999887766555554321110
Q ss_pred ------------CC----------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 300 ------------FE----------------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 300 ------------~~----------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
+. .......+..+++||.+||..||++|||+.++|+||||..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 00 0001123567899999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=362.47 Aligned_cols=259 Identities=27% Similarity=0.419 Sum_probs=210.0
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC---
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--- 152 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 152 (393)
.+.++|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++ ||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhC-CCchhceeeeeeccccc
Confidence 355789999999999999999999999999999999865432 2334567788999999996 99999999988643
Q ss_pred ---CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 153 ---QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 153 ---~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
..+|+||||+++ +|.+.+.. .+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~Dfg~ 165 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 165 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEeeCcc
Confidence 357999999965 66666643 58899999999999999999999999999999999999 5566799999999
Q ss_pred cccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC------------
Q 016233 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG------------ 296 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~------------ 296 (393)
++............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 987665544556789999999999875 5899999999999999999999999877654433322111
Q ss_pred ----------CCCC----------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 297 ----------DIDF----------------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 297 ----------~~~~----------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
...+ ........+.++++||.+||..||++|||+.|+|+||||...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0000 000112245778999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=365.04 Aligned_cols=256 Identities=29% Similarity=0.431 Sum_probs=212.7
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC-----e
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-----S 154 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-----~ 154 (393)
.|++++.||+|+||.||+|.+..+++.||||.+.... ........+.+|+.+++.++ |+||+++++++...+ .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccce
Confidence 3778899999999999999999999999999886432 12234567889999999996 999999999998776 7
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
.|+||||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeecc
Confidence 899999995 5888888877889999999999999999999999999999999999999 556789999999998654
Q ss_pred CCc--ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC--------------
Q 016233 235 EGK--VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG-------------- 296 (393)
Q Consensus 235 ~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~-------------- 296 (393)
... ......+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 322 2334568999999999865 3789999999999999999999999887766555444321
Q ss_pred ---------CCCCCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 297 ---------DIDFES-----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 297 ---------~~~~~~-----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
....+. ......++++.+||.+||..||++|||+.|+|+||||..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 111110 112346889999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-47 Score=351.28 Aligned_cols=259 Identities=25% Similarity=0.420 Sum_probs=213.9
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|.+.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++ ||||+++++++...+.+++|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccc--ccCchhHHHHHHHHHHhcC-CCCcceEEEEEecCCeEEEE
Confidence 47999999999999999999999999999999986543 2233456778999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
|||+. ++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++.......
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT 158 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCCC
Confidence 99996 5888887653 468999999999999999999999999999999999999 456679999999997654322
Q ss_pred -ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC---------------
Q 016233 238 -VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID--------------- 299 (393)
Q Consensus 238 -~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~--------------- 299 (393)
......+++.|+|||++.+ .++.++|||||||++|+|++|.+||...+..+.+..+......
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 2334567899999998864 3788999999999999999999999887765555443321110
Q ss_pred ----CCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 300 ----FES-------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 300 ----~~~-------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
++. ...+.+++.+++||.+||..||.+|||++|+|+||||....+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 000 012357889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-48 Score=329.94 Aligned_cols=258 Identities=28% Similarity=0.419 Sum_probs=220.9
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
..+++..||+|+.|+|++++.+.+|...|||.+.+.. ...+..++...+.++....++|+||+.+++|..+..++|.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 3456778999999999999999999999999997654 34566778888888877767899999999999999999999
Q ss_pred eccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 160 ELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~-~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
|.|.. .+..++.. .+.++|..+-.+...++.||.||.+ +||+|||+||+|||+ |+.+.+|+||||++..+.+..
T Consensus 171 elMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeeccc
Confidence 99843 34333333 4679999999999999999999986 689999999999999 788889999999999998888
Q ss_pred ceecccCcccccchHHHh----hcCCCcchHHHHHHHHHHHhhCCCCCCC-CChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 016233 238 VYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWA-ETEKGIFDAILQGDIDFESAPWPTISSSA 312 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (393)
......|-+.|||||.+. ..|+.++||||||++++||.||..||.+ .++.+.+.++.+...+ .-+.-..+|+++
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP-~L~~~~gFSp~F 325 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPP-LLPGHMGFSPDF 325 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCC-CCCcccCcCHHH
Confidence 878889999999999885 2489999999999999999999999987 4577888888885542 222223489999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 313 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
++|+..||++|+.+||...++|+|||+.....
T Consensus 326 ~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 326 QSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET 357 (391)
T ss_pred HHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence 99999999999999999999999999987644
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-47 Score=385.06 Aligned_cols=264 Identities=31% Similarity=0.513 Sum_probs=218.3
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe--
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED-- 151 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-- 151 (393)
.+....+|.+++.||+|+||.||+|.+..++..||+|++..... .......+..|+.+++.|. |||||+++++|.+
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELK-HKNIVRYIDRFLNKA 85 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEecC
Confidence 34455689999999999999999999999999999999875543 2334667889999999997 9999999998854
Q ss_pred CCeEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc-------CcEecCCCCCcEEeccC----
Q 016233 152 KQSVHVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFM-------GVMHRDLKPENFLLSSK---- 216 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~~-------~ivH~Dikp~Nill~~~---- 216 (393)
...+||||||+++|+|.++|.. ...+++..++.|+.||+.||.|||+. +||||||||+||||...
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 4579999999999999998865 25699999999999999999999985 49999999999999642
Q ss_pred ----------CCCCcEEEeecCCcccccCCcceecccCcccccchHHHhh---cCCCcchHHHHHHHHHHHhhCCCCCCC
Q 016233 217 ----------DENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWA 283 (393)
Q Consensus 217 ----------~~~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~ 283 (393)
+....+||+|||++..+..........||+.|+|||++.+ .++.++||||||||||+|++|..||..
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 2234689999999987755444456689999999999853 378999999999999999999999986
Q ss_pred CChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 284 ETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 284 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
......+........ .......+.++.+||..||..+|.+|||+.++|.|+|+...
T Consensus 246 ~~~~~qli~~lk~~p---~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 246 ANNFSQLISELKRGP---DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCcHHHHHHHHhcCC---CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 654433333332222 22234578999999999999999999999999999999744
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=347.46 Aligned_cols=253 Identities=34% Similarity=0.665 Sum_probs=223.9
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+++++++. ||||+++++++.+.+.+++||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEEEEE
Confidence 6999999999999999999999999999999997654433445677889999999997 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcce
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~ 239 (393)
||+++++|.+++.....+++..+..++.||+.||.|||++||+|+||+|+||++ +.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~--~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR--T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC--C
Confidence 999999999999888889999999999999999999999999999999999999 55667999999999876544 3
Q ss_pred ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 016233 240 RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318 (393)
Q Consensus 240 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 318 (393)
....|++.|+|||.+.+ .++.++||||||+++|+|++|..||...+..+....+..+...++ ..++..++++|.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~ 231 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFFSPDAKDLIRN 231 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC----ccCCHHHHHHHHH
Confidence 44578999999998764 478899999999999999999999988877777777776655443 2468999999999
Q ss_pred hcccCCCCCC-----CHHHHhcCccccCC
Q 016233 319 MLTQDPKKRI-----TSAQVLEHPWIKEG 342 (393)
Q Consensus 319 ~L~~dp~~Rp-----t~~e~l~h~~~~~~ 342 (393)
||..||.+|+ +++++++||||...
T Consensus 232 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 232 LLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HccCCHHHccCcccCCHHHHHcCcccccC
Confidence 9999999999 99999999999753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=342.02 Aligned_cols=254 Identities=28% Similarity=0.509 Sum_probs=216.0
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCC--cccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT--KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
.|.+.+.||+|++|.||.|.+..+++.+|+|.+....... ......+.+|+.+++++. ||||+++++++.+++.+++
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRDDETLSI 81 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEccCCeEEE
Confidence 6889999999999999999999999999999987543221 123457889999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
|+||++|++|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||++ +.++.++|+|||++.......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceeccccc
Confidence 99999999999999888889999999999999999999999999999999999999 455679999999997654322
Q ss_pred c----eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 016233 238 V----YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (393)
Q Consensus 238 ~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (393)
. .....|+..|+|||++.+ .++.++||||||+++|+|++|+.||...........+....... .....++..+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 236 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP--QLPSHVSPDA 236 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCC--CCCccCCHHH
Confidence 1 133568889999999875 48899999999999999999999998776655555544433222 1224678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 313 KDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 313 ~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
.++|.+||..||++|||+.++++|+||
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 237 RNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-47 Score=353.71 Aligned_cols=249 Identities=29% Similarity=0.465 Sum_probs=194.1
Q ss_pred cceecccCCeEEEEEEEC--CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe--CCeEEEEE
Q 016233 84 GKELGRGQFGVTYLCTEN--STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--KQSVHVVM 159 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~~lv~ 159 (393)
+++||+|+||.||+|.++ .+++.||+|.+.... ....+.+|+.++++++ ||||+++++++.. +..+++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEE
Confidence 468999999999999976 467899999886432 2345778999999996 9999999998854 45789999
Q ss_pred eccCCCChHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccC-CCCCcEEEeecCC
Q 016233 160 ELCAGGELFDRIIAK---------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK-DENALLKATDFGL 229 (393)
Q Consensus 160 e~~~gg~L~~~l~~~---------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~-~~~~~~kl~DFg~ 229 (393)
||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||+|||+
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 9995 5888777532 248899999999999999999999999999999999999543 3456899999999
Q ss_pred cccccCCc----ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChH---------HHHHHHH
Q 016233 230 SVFIEEGK----VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEK---------GIFDAIL 294 (393)
Q Consensus 230 a~~~~~~~----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---------~~~~~i~ 294 (393)
+....... ......||+.|+|||++.+ .++.++||||+||++|+|++|.+||...... ..+..+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 98764322 2345678999999998864 4899999999999999999999999654321 1111111
Q ss_pred cCCCC--------------------------CC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 295 QGDID--------------------------FE--------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 295 ~~~~~--------------------------~~--------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
..... +. .......+..+.+||.+||+.||++|||++|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 10000 00 00011235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=356.14 Aligned_cols=252 Identities=24% Similarity=0.353 Sum_probs=202.5
Q ss_pred ccccceeecceecccCCeEEEEEEE-----CCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTE-----NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
...++|++++.||+|+||.||+|.+ ..+++.||+|++.... .......+.+|+.+++.+.+||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 3456899999999999999999985 2445789999986432 22345678899999999956999999999887
Q ss_pred eC-CeEEEEEeccCCCChHHHHHHc-------------------------------------------------------
Q 016233 151 DK-QSVHVVMELCAGGELFDRIIAK------------------------------------------------------- 174 (393)
Q Consensus 151 ~~-~~~~lv~e~~~gg~L~~~l~~~------------------------------------------------------- 174 (393)
.. +.+++||||+++|+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 54 4689999999999999988652
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc---eecccC
Q 016233 175 -------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV---YRDIVG 244 (393)
Q Consensus 175 -------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~---~~~~~g 244 (393)
..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....... .....+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcchhcccCCCC
Confidence 236778889999999999999999999999999999999 4566799999999986543221 123346
Q ss_pred cccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHH-HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 016233 245 SAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKG-IFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321 (393)
Q Consensus 245 t~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 321 (393)
++.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+ ....+..+... . ....+++++.+|+.+||.
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~l~~li~~cl~ 315 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-R--APENATPEIYRIMLACWQ 315 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-C--CCCCCCHHHHHHHHHHcc
Confidence 678999998865 58999999999999999997 999998765433 33334433221 1 124678999999999999
Q ss_pred cCCCCCCCHHHHhc
Q 016233 322 QDPKKRITSAQVLE 335 (393)
Q Consensus 322 ~dp~~Rpt~~e~l~ 335 (393)
.||++|||+.++++
T Consensus 316 ~dp~~RPs~~el~~ 329 (338)
T cd05102 316 GDPKERPTFSALVE 329 (338)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=357.97 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=207.0
Q ss_pred cccccceeecceecccCCeEEEEEEEC--CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTEN--STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
..+..+|.+++.||+|+||.||+|... .+++.||+|.+... ....+|+.+|+.++ ||||+++++++...
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~-h~~iv~~~~~~~~~ 158 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTIS-HRAIINLIHAYRWK 158 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcC-CCCccceeeeEeeC
Confidence 345668999999999999999999864 35678999987532 23468999999996 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 153 QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
+.+++|||++. ++|.+++.....+++.++..++.||+.||.|||++||+||||||+|||+ +..+.++|+|||++..
T Consensus 159 ~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACK 234 (392)
T ss_pred CEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCccccc
Confidence 99999999995 6888988777889999999999999999999999999999999999999 5566799999999976
Q ss_pred ccCCc---ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh---HHHHHHHHcC----CCCCC
Q 016233 233 IEEGK---VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE---KGIFDAILQG----DIDFE 301 (393)
Q Consensus 233 ~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~---~~~~~~i~~~----~~~~~ 301 (393)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ...+..+.+. ...++
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 65432 1234679999999999875 589999999999999999999999976542 1222222110 00000
Q ss_pred C-----------------------CC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 302 S-----------------------AP---WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 302 ~-----------------------~~---~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
. +. ...++.++.+||.+||..||++|||+.|+|+||||.+.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0 00 01356789999999999999999999999999999864
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=343.05 Aligned_cols=254 Identities=26% Similarity=0.475 Sum_probs=219.1
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.-|.++++||+|+||.||+|.|+.+|+.+|||.+.. +.+++++.+|+.|++++. .|++|++|+.|-....+|||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-----~sDLQEIIKEISIMQQC~-S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-----DTDLQEIIKEISIMQQCK-SKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-----cchHHHHHHHHHHHHHcC-CchhhhhhhhhccCCceEee
Confidence 458899999999999999999999999999998864 457899999999999996 99999999999888899999
Q ss_pred EeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 159 MELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||||..|++.|.++. ++.+++.++..+++..+.||+|||...-+|||||..|||+ +..+..||+|||.|..+.+..
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhhH
Confidence 999999999998875 4679999999999999999999999999999999999999 566789999999999887654
Q ss_pred c-eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-CCCCCCCCCCCCHHHHH
Q 016233 238 V-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD-IDFESAPWPTISSSAKD 314 (393)
Q Consensus 238 ~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~~ 314 (393)
. -.++.|||.|||||++.. .|+.++||||||++..||.-|++||.+-.....+-.|-..- ..|. .....|.++-|
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~--KPE~WS~~F~D 261 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFK--KPEEWSSEFND 261 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCC--ChHhhhhHHHH
Confidence 3 346789999999999986 59999999999999999999999997765543332222211 1111 11235789999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
||++||.++|++|-|+.++++|||++...
T Consensus 262 Fi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 262 FIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred HHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 99999999999999999999999998643
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=358.55 Aligned_cols=259 Identities=24% Similarity=0.418 Sum_probs=211.1
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC---
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--- 152 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 152 (393)
.+.++|++++.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++ ||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcC-CCchhhhhhhhcccccc
Confidence 355789999999999999999999999999999999865321 2233456778999999996 99999999987543
Q ss_pred ---CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 153 ---QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 153 ---~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
..+|+++|++ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~ 164 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGL 164 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcCCcc
Confidence 4578999998 778877664 4579999999999999999999999999999999999999 5566799999999
Q ss_pred cccccCCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC--------
Q 016233 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID-------- 299 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~-------- 299 (393)
+...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 165 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 165 ARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred ceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 9876442 345679999999999865 4889999999999999999999999877655444433221100
Q ss_pred ---------------CCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 300 ---------------FES----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 300 ---------------~~~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
.+. ..+...++.+.+||.+||..||++|||+.|+|+||||....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 000 01234577899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=347.77 Aligned_cols=255 Identities=26% Similarity=0.429 Sum_probs=204.0
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
..|+++++||+||.+.||++.... .+.||+|.+.... ........+.+|+.+|.+|++|.+||++++|-..++.+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 469999999999999999998654 4566666554322 24556788999999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCC-CHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 159 MELCAGGELFDRIIAKGHY-SERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~-~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
|||= ..+|..+|.+.... ....++.++.|+|.++.++|++||||.||||.|+|+. .+.+||+|||+|..+....
T Consensus 439 mE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV----kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV----KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred eecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE----eeeEEeeeechhcccCccc
Confidence 9985 55898888776543 3358899999999999999999999999999999994 5679999999999886543
Q ss_pred ---ceecccCcccccchHHHhh------------cCCCcchHHHHHHHHHHHhhCCCCCCCCC-hHHHHHHHHcCCCCCC
Q 016233 238 ---VYRDIVGSAYYVAPEVLRR------------RYGKEIDIWSAGVILYILLSGVPPFWAET-EKGIFDAILQGDIDFE 301 (393)
Q Consensus 238 ---~~~~~~gt~~y~aPE~l~~------------~~~~~~DiwSlG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~ 301 (393)
...+.+||..||+||.+.. +.++++||||||||||+|+.|++||..-. ...-+..|......++
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ie 593 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIE 593 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccc
Confidence 2346799999999998741 15789999999999999999999995432 2223334443322222
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 302 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
.+..+. ..++.++++.||+.||++|||+.++|+|||++.
T Consensus 594 fp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 594 FPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 211111 234999999999999999999999999999975
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=385.09 Aligned_cols=259 Identities=30% Similarity=0.513 Sum_probs=230.1
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
.++|.++++||+|+||.|.+++++.|++.||+|++++-..........|..|-.+|-.-. .+-|+.++-.|.+++++|+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHhcCccceEE
Confidence 468999999999999999999999999999999998744433345567788888888764 8999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||||++||+|..++.+..++++..++.++..|+.||+-||+.|+|||||||+|||+ |..|.+||+|||.+..+....
T Consensus 153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcCCCC
Confidence 99999999999999988899999999999999999999999999999999999999 788889999999998876433
Q ss_pred c--eecccCcccccchHHHh------hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC--CCCCCCCCCCC
Q 016233 238 V--YRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG--DIDFESAPWPT 307 (393)
Q Consensus 238 ~--~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~ 307 (393)
. ....+|||.|.+||+|. +.|++.+|.||+||++|||+.|..||+.++-.+.+.+|++- .+.|| .-..
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP--~~~~ 307 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP--DETD 307 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC--cccc
Confidence 2 34568999999999985 35999999999999999999999999999999999999987 45555 3346
Q ss_pred CCHHHHHHHHHhcccCCCCCCC---HHHHhcCccccCCC
Q 016233 308 ISSSAKDLVRRMLTQDPKKRIT---SAQVLEHPWIKEGG 343 (393)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rpt---~~e~l~h~~~~~~~ 343 (393)
+|.++++||.++++ +|+.|.. ++++.+||||....
T Consensus 308 VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 308 VSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred cCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence 99999999999986 7889988 99999999997643
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=341.97 Aligned_cols=256 Identities=28% Similarity=0.520 Sum_probs=213.6
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++++. |+||+++++++.....+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEEEEE
Confidence 379999999999999999999999999999999865432 2233456789999999997 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc-
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~- 237 (393)
|||+++++|..++.....+++..+..++.||+.+|.|||++||+||||||+||++ +.++.++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCcc
Confidence 9999998887777666679999999999999999999999999999999999999 455679999999998765543
Q ss_pred ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC-----------------
Q 016233 238 VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI----------------- 298 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~----------------- 298 (393)
......++..|+|||.+.+ .++.++||||||+++|+|++|..||.+.+..+....+.....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 3334568899999998864 478899999999999999999999987765544433321100
Q ss_pred --CCCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 299 --DFES--------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 299 --~~~~--------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
..+. ..++.++..+.+||.+||..||++|||+.|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000 1134578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=340.65 Aligned_cols=254 Identities=29% Similarity=0.474 Sum_probs=213.9
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
..+|.+.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.++ ||||+++++.+...+.+|+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCK-HSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEE
Confidence 457999999999999999999999999999999986542 233456788999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||||+++++|.+++...+.+++.+++.++.|++.||.|||++||+|+||||+||++ +..+.++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCcc
Confidence 99999999999999888889999999999999999999999999999999999999 456679999999987654322
Q ss_pred -ceecccCcccccchHHHh----hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC-CCCCCCHH
Q 016233 238 -VYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA-PWPTISSS 311 (393)
Q Consensus 238 -~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~ 311 (393)
......|+..|+|||++. +.++.++|+|||||++|+|++|..||...................+.. ....++..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 223457999999999873 348889999999999999999999997665544443333333222211 11246789
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcc
Q 016233 312 AKDLVRRMLTQDPKKRITSAQVLEHPW 338 (393)
Q Consensus 312 ~~~li~~~L~~dp~~Rpt~~e~l~h~~ 338 (393)
+.++|.+||..||++|||++++++|||
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=348.10 Aligned_cols=257 Identities=32% Similarity=0.613 Sum_probs=221.4
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+++++.+. |+||+++++.+.+.+..|+||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEEEEEE
Confidence 6999999999999999999999999999999998765433345677899999999997 999999999999999999999
Q ss_pred eccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 160 ELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||+.|++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhcccccc
Confidence 999999999988754 468999999999999999999999999999999999999 456679999999987543211
Q ss_pred ------------------------------ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh
Q 016233 238 ------------------------------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE 286 (393)
Q Consensus 238 ------------------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 286 (393)
......||..|+|||++.+ .++.++||||||+++|+|++|..||.+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 0113468899999999865 488899999999999999999999998887
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHHHhcCccccCC
Q 016233 287 KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT----SAQVLEHPWIKEG 342 (393)
Q Consensus 287 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt----~~e~l~h~~~~~~ 342 (393)
...+..+......++.. ..++..+.++|.+||..||++||| ++++|+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 238 DETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 77777776655444332 237899999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-46 Score=345.09 Aligned_cols=258 Identities=30% Similarity=0.545 Sum_probs=221.4
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++ ||||+++++.+..++.+++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCCEEEEEE
Confidence 6889999999999999999999999999999987654333344567889999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc--
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-- 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-- 237 (393)
||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++ +..+.++|+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcCccc
Confidence 999999999999888889999999999999999999999999999999999999 556679999999986421100
Q ss_pred --------------ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC
Q 016233 238 --------------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES 302 (393)
Q Consensus 238 --------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 302 (393)
......|+..|+|||.+.+ .++.++|+|||||++|+|++|..||.+.+..+.+..+..+....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 0112467889999998754 5899999999999999999999999988887777777766554444
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCccccCC
Q 016233 303 APWPTISSSAKDLVRRMLTQDPKKRIT---SAQVLEHPWIKEG 342 (393)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~e~l~h~~~~~~ 342 (393)
... .++.++.+||.+||..||++||+ +.++|+||||...
T Consensus 238 ~~~-~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 238 GDE-ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred ccc-cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 332 57899999999999999999998 7899999999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=344.80 Aligned_cols=256 Identities=27% Similarity=0.404 Sum_probs=212.8
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|++++++++ ||||+++++++.+++.+++||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECN-SPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCEEEEEe
Confidence 6899999999999999999999999999999886432 2234566889999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~-~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~ 238 (393)
||++|++|.+++...+.+++..+..++.|++.||.|||+ .+++||||||+|||+ +.++.+||+|||++...... .
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~-~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-M 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCccccccc-c
Confidence 999999999999888889999999999999999999997 599999999999999 45567999999998765432 2
Q ss_pred eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC-----------------
Q 016233 239 YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF----------------- 300 (393)
Q Consensus 239 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~----------------- 300 (393)
.....|+..|+|||.+.+ .++.++|||||||++|+|++|..||...+.......+.......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 245678999999999865 48899999999999999999999997655433222221110000
Q ss_pred -----------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 301 -----------------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 301 -----------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+......++.++.+|+.+||..||++|||+.++++||||...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 011112367889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-47 Score=354.68 Aligned_cols=258 Identities=22% Similarity=0.370 Sum_probs=222.2
Q ss_pred cccccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEE
Q 016233 69 ILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (393)
Q Consensus 69 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 148 (393)
.....|+.......+++.||+|.||+||+|.+-. .||||+++.... +....+.|++|+.++++-+ |.||+-+.|+
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTR-H~NIlLFMG~ 456 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTR-HENILLFMGA 456 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcc-hhhheeeehh
Confidence 3346777777888999999999999999999874 699999988765 4458899999999999997 9999999999
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeec
Q 016233 149 YEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (393)
Q Consensus 149 ~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DF 227 (393)
+..+.. .||+.||+|-+|+.+|.- ..+|.....+.|++||+.|+.|||.++|||||||..||++ .++..|||+||
T Consensus 457 ~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDF 532 (678)
T KOG0193|consen 457 CMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDF 532 (678)
T ss_pred hcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecc
Confidence 999887 999999999999998864 3468888999999999999999999999999999999999 56688999999
Q ss_pred CCcccc---cCCcceecccCcccccchHHHhh----cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC
Q 016233 228 GLSVFI---EEGKVYRDIVGSAYYVAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF 300 (393)
Q Consensus 228 g~a~~~---~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 300 (393)
|++..- .....+....|...|||||+++. .|++.+||||||+++|||+||..||......+++-.+-+|....
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~p 612 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMP 612 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCc
Confidence 998753 33445566778999999999974 49999999999999999999999999777777777777774433
Q ss_pred CC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 301 ES-APWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 301 ~~-~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.. ....+.+.++++|+..||.+++++||++.++|.
T Consensus 613 d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 613 DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 22 233567789999999999999999999999987
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=340.79 Aligned_cols=254 Identities=29% Similarity=0.461 Sum_probs=208.2
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+.+++++. ||||+++++++.+++.+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEEEEE
Confidence 48899999999999999999999999999999865432 2334567889999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 160 ELCAGGELFDRIIAK---GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 160 e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCC
Confidence 9997 5888877643 458999999999999999999999999999999999999 45667999999998765432
Q ss_pred c-ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC---------------
Q 016233 237 K-VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI--------------- 298 (393)
Q Consensus 237 ~-~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~--------------- 298 (393)
. ......+++.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+.....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 2 2233467899999998864 378899999999999999999999987665433322211100
Q ss_pred ----------CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 299 ----------DFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 299 ----------~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
......+..+++++.+||.+||..||++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00011134578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=338.98 Aligned_cols=255 Identities=29% Similarity=0.498 Sum_probs=218.7
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++.+.||.|++|.||+|.+..+++.||+|.+.... .......+.+|+.+++.++ |+||+++++++.++..+++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeEEEE
Confidence 36889999999999999999999999999999986543 2334567889999999997 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-c
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-K 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~-~ 237 (393)
+||+++++|.+++... .+++..++.++.|++.||.|||+++++|+||+|+||++ +.++.++|+|||++...... .
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeeccccc
Confidence 9999999999988765 78999999999999999999999999999999999999 55667999999999877644 2
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
......|++.|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+...... ......++.++.+++
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l 231 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPP--SLEGNKFSKPFKDFV 231 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCC--CCcccccCHHHHHHH
Confidence 3345578899999999875 4899999999999999999999999877665555555544221 111122788999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCC
Q 016233 317 RRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 317 ~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.+||..||++|||++++++||||...
T Consensus 232 ~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 232 SLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred HHHhhCChhhCcCHHHHhhChhhcCC
Confidence 99999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=353.62 Aligned_cols=249 Identities=22% Similarity=0.370 Sum_probs=200.0
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
..|++++.||+|+||.||+|.+..+++.||+|+.... ....|+.++++++ ||||+++++++...+..++|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVN-HPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCC-CCCCcChhheEEeCCeeEEE
Confidence 4699999999999999999999999999999975322 2346999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 159 MELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||++. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +..+.+||+|||++.......
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccCc
Confidence 99995 588888765 4569999999999999999999999999999999999999 556679999999998654444
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCC-Ch---------HHHHHHHHcC-CC---CCC-
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAE-TE---------KGIFDAILQG-DI---DFE- 301 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~-~~---------~~~~~~i~~~-~~---~~~- 301 (393)
......||+.|+|||++.+ .++.++|||||||++|+|+++..++... .. ...+..+... .. .++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 4456679999999998865 5899999999999999999865554322 11 0111111110 00 000
Q ss_pred -------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 302 -------------------------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 302 -------------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
......++.++.+||.+||+.||++|||+.|+|+||||++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0011245778889999999999999999999999999975
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=335.85 Aligned_cols=255 Identities=27% Similarity=0.470 Sum_probs=217.2
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++++.||.|+||+||+|.+..++..+|+|++..... ......+.+|+.+++.++ |+||+++++.+...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc--chHHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEEEEE
Confidence 369999999999999999999998999999999865432 225678899999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 159 MELCAGGELFDRIIAK---GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
||+++|++|.+++... ..+++..++.++.|++.||.|||++||+||||+|+||++ ++++.++|+|||++.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHHhcc
Confidence 9999999999998764 458999999999999999999999999999999999999 4556799999999887654
Q ss_pred Ccce-----ecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC--CCC
Q 016233 236 GKVY-----RDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA--PWP 306 (393)
Q Consensus 236 ~~~~-----~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~--~~~ 306 (393)
.... ....|+..|+|||++.. .++.++|+|||||++|+|++|..||...+..+.+..+.......... .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence 3222 33468999999998864 48899999999999999999999998777666565555543221111 124
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
.+++.+.+|+.+||..||++|||++++++||||
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 678999999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=337.53 Aligned_cols=255 Identities=28% Similarity=0.478 Sum_probs=212.5
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC---
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--- 152 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 152 (393)
+....|++.+.||+|+||.||+|.+..+++.||+|.+... ......+.+|+.+++++.+|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC----CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 3456799999999999999999999999999999998643 234567889999999996699999999998753
Q ss_pred ---CeEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeec
Q 016233 153 ---QSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (393)
Q Consensus 153 ---~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DF 227 (393)
..+|+||||+.+++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||++ +.++.++|+||
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Df 155 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDF 155 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccC
Confidence 4689999999999999988763 358999999999999999999999999999999999999 45667999999
Q ss_pred CCcccccCC-cceecccCcccccchHHHh------hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC
Q 016233 228 GLSVFIEEG-KVYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF 300 (393)
Q Consensus 228 g~a~~~~~~-~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 300 (393)
|++...... .......|++.|+|||++. ..++.++|||||||++|+|++|..||...........+.... .
T Consensus 156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~ 233 (272)
T cd06637 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--A 233 (272)
T ss_pred CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--C
Confidence 999865432 2233467899999999884 247889999999999999999999997766544444333321 2
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 301 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
.......++.++.+|+.+||..||.+|||+.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 234 PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 222234578999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=343.93 Aligned_cols=254 Identities=26% Similarity=0.476 Sum_probs=207.1
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.++++++ ||||+++++++.+.+.+++|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceEEEE
Confidence 58899999999999999999999999999999875432 2233456778999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-c
Q 016233 160 ELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-K 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~-~ 237 (393)
||++ ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||++...... .
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 79 EYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCCC
Confidence 9996 478887765 4679999999999999999999999999999999999999 45567999999999865432 2
Q ss_pred ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCC-CCChHHHHHHHHcCCC--------------C-
Q 016233 238 VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFW-AETEKGIFDAILQGDI--------------D- 299 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~-~~~~~~~~~~i~~~~~--------------~- 299 (393)
......+++.|+|||++.+ .++.++|||||||++|+|++|..||. +.+..+.+..+..... .
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 2334567899999998865 37899999999999999999988864 3443344333321100 0
Q ss_pred --CC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 300 --FE--------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 300 --~~--------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
++ ....+.+++++.+||.+||..||.+|||++++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00 01123578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=360.02 Aligned_cols=255 Identities=21% Similarity=0.470 Sum_probs=223.1
Q ss_pred eecceecccCCeEEEEEEECCCCcEEEEEEeecCcc-CCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe--EEEE
Q 016233 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL-VTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS--VHVV 158 (393)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~--~~lv 158 (393)
++..+||+|+|-+||+|.|..+|..||.-.++.+++ .....++++..|+.+|+.|+ |||||++|++|.+... +.+|
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCceeeee
Confidence 556789999999999999999999999766554433 23445689999999999997 9999999999987655 8899
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--cEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~--ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+|++..|+|..|+++.+.+....++.|++|||.||.|||++. |+|||||.+||+|+ +..+.|||+|+|||......
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHHhhcc
Confidence 999999999999999999999999999999999999999986 99999999999997 66788999999999987765
Q ss_pred cceecccCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCCCCC-CChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 237 KVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWA-ETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
.. ...+|||.|||||++...|+..+||||||++|.||.|+..||.. .+..++++++..|..+-.... --.+++++|
T Consensus 200 ~a-ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k--V~dPevr~f 276 (632)
T KOG0584|consen 200 HA-KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK--VKDPEVREF 276 (632)
T ss_pred cc-ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc--cCCHHHHHH
Confidence 44 44899999999999999999999999999999999999999965 556788899988865422221 126899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 316 VRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
|.+||.. .++|+|+.|+|+||||....
T Consensus 277 IekCl~~-~~~R~sa~eLL~d~Ff~~d~ 303 (632)
T KOG0584|consen 277 IEKCLAT-KSERLSAKELLKDPFFDEDG 303 (632)
T ss_pred HHHHhcC-chhccCHHHHhhChhhcccc
Confidence 9999999 99999999999999998763
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=337.71 Aligned_cols=254 Identities=29% Similarity=0.466 Sum_probs=211.9
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
..+|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++ ||||+++++++...+.+++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECK-HCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEEEE
Confidence 457999999999999999999999999999999986432 234556889999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeecccc
Confidence 99999999999999887889999999999999999999999999999999999999 456679999999998764322
Q ss_pred -ceecccCcccccchHHHh----hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC-CCCCCCHH
Q 016233 238 -VYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA-PWPTISSS 311 (393)
Q Consensus 238 -~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~ 311 (393)
......|+..|+|||.+. ..++.++||||+||++|+|++|..||......+....+.......+.. ....++..
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence 223457889999999874 237789999999999999999999997655433333332222222111 11346889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcc
Q 016233 312 AKDLVRRMLTQDPKKRITSAQVLEHPW 338 (393)
Q Consensus 312 ~~~li~~~L~~dp~~Rpt~~e~l~h~~ 338 (393)
+.+||++||..||++|||++++|+|+|
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=336.06 Aligned_cols=252 Identities=35% Similarity=0.546 Sum_probs=214.5
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~g 164 (393)
+.||+|+||.||+|.+..+++.||+|.+.+...........+..|..++....+|+||+++++++..++.+|+|+||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999999999999999987543322223344556666555544699999999999999999999999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcceecccC
Q 016233 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG 244 (393)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~g 244 (393)
++|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||++ +..+.++|+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc---cccCCC
Confidence 9999999887889999999999999999999999999999999999999 4566799999999876543 234568
Q ss_pred cccccchHHHhhc-CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccC
Q 016233 245 SAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQD 323 (393)
Q Consensus 245 t~~y~aPE~l~~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 323 (393)
+..|+|||.+.+. ++.++||||||+++|+|++|..||...+....+..+..+...++......+++++.++|.+||..|
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 8999999998654 789999999999999999999999988887777777777666555555578999999999999999
Q ss_pred CCCCCC---HHHHhcCccccCC
Q 016233 324 PKKRIT---SAQVLEHPWIKEG 342 (393)
Q Consensus 324 p~~Rpt---~~e~l~h~~~~~~ 342 (393)
|++||+ ++|+|.||||...
T Consensus 236 p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 236 PAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred HHHccCCCcHHHHHcChHhhcC
Confidence 999995 5799999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=356.30 Aligned_cols=250 Identities=22% Similarity=0.378 Sum_probs=203.6
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
...|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+++|++|+ |+|||++++++...+..++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLS-HPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEE
Confidence 457999999999999999999999999999999532 223568999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 158 VMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
|||++. ++|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+++.....
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARGS 313 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceecccc
Confidence 999995 6888888664 469999999999999999999999999999999999999 45667999999999865432
Q ss_pred c---ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCC--------hHHHHHHHHcCCCC-----
Q 016233 237 K---VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET--------EKGIFDAILQGDID----- 299 (393)
Q Consensus 237 ~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~--------~~~~~~~i~~~~~~----- 299 (393)
. ......||+.|+|||++.+ .++.++|||||||+||||++|..|+.... ..++...+......
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 2 1224579999999999875 48999999999999999999887654321 22333333322211
Q ss_pred ----------------------CCCCCCC---CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 300 ----------------------FESAPWP---TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 300 ----------------------~~~~~~~---~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
+....|. .++.++.+||.+||..||.+|||++|+|+||||+.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0111122 45678999999999999999999999999999974
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=340.01 Aligned_cols=259 Identities=31% Similarity=0.521 Sum_probs=217.4
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
.+...+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.+. |+||+++++.+.....
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~~~~ 91 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENK-NPNIVNYLDSYLVGDE 91 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC---cchHHHHHHHHHHHHhCC-CCCEeeEEEEEEeCCE
Confidence 344568999999999999999999999999999999987543 224567889999999996 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
.++||||++|++|.+++.. ..+++.++..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++....
T Consensus 92 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred EEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchhcc
Confidence 9999999999999998754 468999999999999999999999999999999999999 456679999999988654
Q ss_pred CCc-ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 016233 235 EGK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (393)
Q Consensus 235 ~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (393)
... ......|++.|+|||.+.+ .++.++|||||||++|+|++|..||...........+..... ........++..+
T Consensus 168 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 246 (296)
T cd06654 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIF 246 (296)
T ss_pred ccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCC-CCCCCccccCHHH
Confidence 332 2234578999999998865 478999999999999999999999987765444333332221 1112234578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 313 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.+||.+||..||++|||+.++++||||...
T Consensus 247 ~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 999999999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=332.29 Aligned_cols=252 Identities=25% Similarity=0.468 Sum_probs=218.7
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
.|.+.+.||+|++|.||+|.+..+++.|++|.+..... .......+.+|+.+++.++ ||||+++++++.+.+..++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEEEEE
Confidence 47888999999999999999999999999999875433 2345677889999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 160 ELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||++|++|.+++... ..+++..++.++.|++.||.|||++||+|+||||+||+++ .++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~---~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe---CCCCEEEcccccceeccCcc
Confidence 999999999998764 5689999999999999999999999999999999999994 55679999999998765433
Q ss_pred c-eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 238 V-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 238 ~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
. .....|++.|+|||++.+ .++.++|+|||||++|+|++|..||...+.......+..+...... ..++..+.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS---QMYSQQLAQL 232 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHH
Confidence 2 234578999999999865 4889999999999999999999999888877777777665443221 2578999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccc
Q 016233 316 VRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
|.+||+.+|++||++.++++|||+
T Consensus 233 i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 233 IDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=339.83 Aligned_cols=252 Identities=32% Similarity=0.537 Sum_probs=211.8
Q ss_pred ecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCCCC
Q 016233 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGE 166 (393)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~gg~ 166 (393)
||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.++ ||||++++++++..+.+|+||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 699999999999999999999999997654433344566778999999997 9999999999999999999999999999
Q ss_pred hHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcceecccC
Q 016233 167 LFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG 244 (393)
Q Consensus 167 L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~g 244 (393)
|.+++.... .+++..+..++.|++.||.|||++|++||||+|+||++ +.++.++|+|||++.............+
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAG 156 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCccccccC
Confidence 999987765 69999999999999999999999999999999999999 5566799999999987655444455678
Q ss_pred cccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccC
Q 016233 245 SAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQD 323 (393)
Q Consensus 245 t~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 323 (393)
+..|+|||.+.+ .++.++|||||||++|+|++|..||...........+..............+++.+.++|.+||..|
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 899999998864 4888999999999999999999999776542222233332222233333457899999999999999
Q ss_pred CCCCC-----CHHHHhcCccccCC
Q 016233 324 PKKRI-----TSAQVLEHPWIKEG 342 (393)
Q Consensus 324 p~~Rp-----t~~e~l~h~~~~~~ 342 (393)
|++|| ++.++++||||...
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhcC
Confidence 99999 88999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=335.32 Aligned_cols=253 Identities=29% Similarity=0.513 Sum_probs=214.1
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCc------ccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK------NDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
+|.+.+.||+|++|.||+|.+..+++.+|+|.+........ ...+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC
Confidence 47888999999999999999999999999998865432211 12356889999999996 999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
..++||||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||++ +.++.++|+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKKL 156 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCccc
Confidence 999999999999999999888889999999999999999999999999999999999999 55667999999999876
Q ss_pred cCCc-------ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 016233 234 EEGK-------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW 305 (393)
Q Consensus 234 ~~~~-------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (393)
.... ......|+..|+|||.+.+ .++.++|+|||||++|+|++|..||...+....+..+..... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~ 233 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS---PEIP 233 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC---CcCC
Confidence 5221 1123468899999998865 588899999999999999999999987766555555444321 1122
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
..++..+.++|++||+.||.+||++.++++||||
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 3578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=361.58 Aligned_cols=251 Identities=26% Similarity=0.460 Sum_probs=217.7
Q ss_pred eecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCCC
Q 016233 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGG 165 (393)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~gg 165 (393)
+||+|.||+||.|++..|....|||.|..+. ....+-+..||.+.++|+ |.|||+++|.+..++++-|.||.++||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 5999999999999999999999999997653 345667889999999997 999999999999999999999999999
Q ss_pred ChHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc-ceec
Q 016233 166 ELFDRIIAK-GHY--SERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-VYRD 241 (393)
Q Consensus 166 ~L~~~l~~~-~~~--~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-~~~~ 241 (393)
+|.++|... +++ .|..+..+.+||++||.|||++.|||||||-+|+|++ .-.+.+||+|||.++.+..-+ ...+
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCccccc
Confidence 999998764 666 7888999999999999999999999999999999996 456789999999999876544 3456
Q ss_pred ccCcccccchHHHhh---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 016233 242 IVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318 (393)
Q Consensus 242 ~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 318 (393)
..||..|||||++.. .|++.+|||||||++.||.||++||........ ....-|.++..++....+|.+++.||.+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-AMFkVGmyKvHP~iPeelsaeak~Filr 814 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-AMFKVGMYKVHPPIPEELSAEAKNFILR 814 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-hhhhhcceecCCCCcHHHHHHHHHHHHH
Confidence 889999999999963 499999999999999999999999976554322 2234455554444446789999999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCCC
Q 016233 319 MLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 319 ~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
|+..||.+||++.++|++||++...
T Consensus 815 cFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 815 CFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred HcCCCcccCccHHHhccCcccccCC
Confidence 9999999999999999999998763
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=363.05 Aligned_cols=259 Identities=26% Similarity=0.473 Sum_probs=223.8
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
..++.|.|+..||.|+||.||+|..+.++-..|.|+|... +...++++.-||.||..+. ||+||++++.|-.++.+
T Consensus 29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~Cd-HP~ivkLl~ayy~enkL 104 (1187)
T KOG0579|consen 29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECD-HPVIVKLLSAYYFENKL 104 (1187)
T ss_pred CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccCce
Confidence 4567899999999999999999999999999999998543 4567888999999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+|+.|||.||-+...+..- ..+++.++..+++|++.||.|||+++|||||||..|||++- ++.++|+|||.+....
T Consensus 105 wiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tl---dGdirLADFGVSAKn~ 181 (1187)
T KOG0579|consen 105 WILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTL---DGDIRLADFGVSAKNK 181 (1187)
T ss_pred EEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEe---cCcEeeecccccccch
Confidence 9999999999988877764 56999999999999999999999999999999999999964 4559999999886543
Q ss_pred CC-cceecccCcccccchHHHh------hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 016233 235 EG-KVYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (393)
Q Consensus 235 ~~-~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (393)
.. ..-.+++|||+|||||+.. ..|+.++||||||++|.+|..+.+|....+....+-+|.....+-. .....
T Consensus 182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTL-lqPS~ 260 (1187)
T KOG0579|consen 182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-LQPSH 260 (1187)
T ss_pred hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcc-cCcch
Confidence 32 2345789999999999863 3599999999999999999999999988888877777766544321 12244
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.+..+.||+.+||.+||+.||+++++|+||||+..
T Consensus 261 Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 261 WSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred hhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 67899999999999999999999999999999864
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=366.51 Aligned_cols=260 Identities=31% Similarity=0.495 Sum_probs=217.6
Q ss_pred CccccccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEe
Q 016233 67 NTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146 (393)
Q Consensus 67 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~ 146 (393)
....|..+..-..++++.+.|.+|||+.||+|.+...|..||+|.+-.. .+..++.+.+|+.+|+.|++|+|||.++
T Consensus 25 ~~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yi 101 (738)
T KOG1989|consen 25 NYFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYI 101 (738)
T ss_pred cCCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEe
Confidence 4455666666777899999999999999999999998899999987543 4667889999999999999999999999
Q ss_pred E-EEEe---C---CeEEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcC--cEecCCCCCcEEecc
Q 016233 147 G-AYED---K---QSVHVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSS 215 (393)
Q Consensus 147 ~-~~~~---~---~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qll~~l~~lH~~~--ivH~Dikp~Nill~~ 215 (393)
+ .... + -.++|.||||.||.|.|++.. ...|++.++.+|+.|+++|+.+||... |||||||-|||||+
T Consensus 102 dss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls- 180 (738)
T KOG1989|consen 102 DSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS- 180 (738)
T ss_pred ccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc-
Confidence 9 3321 1 247899999999999999974 356999999999999999999999998 99999999999994
Q ss_pred CCCCCcEEEeecCCcccccCCc-cee---------cccCcccccchHHHh---h-cCCCcchHHHHHHHHHHHhhCCCCC
Q 016233 216 KDENALLKATDFGLSVFIEEGK-VYR---------DIVGSAYYVAPEVLR---R-RYGKEIDIWSAGVILYILLSGVPPF 281 (393)
Q Consensus 216 ~~~~~~~kl~DFg~a~~~~~~~-~~~---------~~~gt~~y~aPE~l~---~-~~~~~~DiwSlG~il~~lltg~~pf 281 (393)
.++.+||||||.|....... ... ...-|+.|+|||++. + ..+.|+|||+|||+||-|+....||
T Consensus 181 --~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PF 258 (738)
T KOG1989|consen 181 --ADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPF 258 (738)
T ss_pred --CCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCc
Confidence 55679999999987532211 000 123589999999874 3 4899999999999999999999999
Q ss_pred CCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 016233 282 WAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338 (393)
Q Consensus 282 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~ 338 (393)
..... -.|+.+.+.|+.. +.++..+++||..||+.||++||++.+++.+-+
T Consensus 259 e~sg~----laIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 259 EESGK----LAILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred CcCcc----eeEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 77644 3577787777664 689999999999999999999999999987543
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=331.92 Aligned_cols=252 Identities=25% Similarity=0.534 Sum_probs=214.9
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe-CCeEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED-KQSVHVV 158 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~~~~lv 158 (393)
.|++.+.||+|++|.||.+.+..+++.||+|.+..... .....+.+.+|++++++++ |+|++++++.+.. +..+|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEEEEE
Confidence 48999999999999999999999999999999865432 2334567889999999996 9999999998864 4568999
Q ss_pred EeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 159 MELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
|||+++++|.+++... ..+++.+++.++.|++.+|.+||++||+||||||+||++ +.++.++|+|||++......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEeccc
Confidence 9999999999988763 358999999999999999999999999999999999999 55677999999999876432
Q ss_pred c-ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 237 K-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 237 ~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
. ......|++.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+..+.... ....+++++.+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 232 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSPELGE 232 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHHHHH
Confidence 2 2334578999999998865 48889999999999999999999998877766666666654322 22457899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccc
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
||.+||..||++|||+.++++||||
T Consensus 233 li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 233 LIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=339.01 Aligned_cols=241 Identities=20% Similarity=0.229 Sum_probs=206.4
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe----CCeEEEEEe
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED----KQSVHVVME 160 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----~~~~~lv~e 160 (393)
..||+|++|.||+|.. +|+.||||.+...........+.+.+|+.+|++++ ||||+++++++.+ ...+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEEE
Confidence 4689999999999997 58999999987643322223567889999999997 9999999999876 357899999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcce
Q 016233 161 LCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239 (393)
Q Consensus 161 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~-~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~ 239 (393)
|++||+|.+++.+...+++.....++.|++.||.|||+ .+++||||||+|||+ +.++.+||+|||++.......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc--
Confidence 99999999999888889999999999999999999998 499999999999999 556789999999998654432
Q ss_pred ecccCcccccchHHHhh---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 240 RDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 240 ~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
....||..|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......+..+ ..+++++.+|+
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li 255 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIV 255 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHH
Confidence 34578999999999864 58999999999999999999999999888888888776554443322 25789999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 016233 317 RRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 317 ~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+||+.||++|||+.++++
T Consensus 256 ~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 256 EACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHhcCCcccCcCHHHHHH
Confidence 9999999999999999986
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=341.78 Aligned_cols=262 Identities=31% Similarity=0.475 Sum_probs=216.4
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCC--cccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT--KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
+|++.+.||+|+||.||+|.+..+++.||||.+....... ......+.+|+.+++.++ |+||+++++++.+.+..++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCEEEE
Confidence 5888999999999999999999999999999997654321 223455778999999997 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 158 VMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++......
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeeccCC
Confidence 99999 889999987765 79999999999999999999999999999999999999 45667999999999876543
Q ss_pred c-ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC-----------
Q 016233 237 K-VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES----------- 302 (393)
Q Consensus 237 ~-~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~----------- 302 (393)
. ......+++.|+|||.+.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+.........
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 2 2334467889999998854 4788999999999999999998888877765555544322100000
Q ss_pred -------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCC
Q 016233 303 -------------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346 (393)
Q Consensus 303 -------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~ 346 (393)
..+...+..+.+||.+||..||++|||+.++|+|+||.+.....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 01234578899999999999999999999999999999865433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=338.14 Aligned_cols=257 Identities=30% Similarity=0.476 Sum_probs=218.8
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
.++|++.+.||.|+||.||+|.+..++..+|+|.+... .....+.+.+|+.++++++ ||||+++++++..+..+|+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCeEEE
Confidence 45799999999999999999999989999999998643 2345567889999999997 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 158 VMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
||||+++++|.+++... ..+++.+++.++.|++.+|.|||++||+|+||||+||++ +.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhccc
Confidence 99999999999988764 469999999999999999999999999999999999999 55677999999998765432
Q ss_pred c-ceecccCcccccchHHHhh------cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 237 K-VYRDIVGSAYYVAPEVLRR------RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 237 ~-~~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
. ......|++.|+|||.+.. .++.++|+||||+++|+|++|..||...+..+.+..+..+..... .....++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 235 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-DQPSKWS 235 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc-CCcccCC
Confidence 2 2234578999999998742 367799999999999999999999988777666666655433211 1123578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.++.++|.+||..||++||+++++|+||||...
T Consensus 236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=346.43 Aligned_cols=255 Identities=22% Similarity=0.335 Sum_probs=204.7
Q ss_pred ecceeccc--CCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEe
Q 016233 83 FGKELGRG--QFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (393)
Q Consensus 83 ~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 160 (393)
++++||+| +|++||++.++.+|+.||+|.+..... .......+.+|+.+++.++ ||||+++++++..++..++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCEEEEEEe
Confidence 56789999 788999999999999999999865432 2234567888999999996 9999999999999999999999
Q ss_pred ccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc-
Q 016233 161 LCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (393)
Q Consensus 161 ~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~- 237 (393)
|+++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++ .++.++++||+.+.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~---~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe---cCCcEEEcccchhhccccccc
Confidence 99999999988653 4589999999999999999999999999999999999994 55679999998654432111
Q ss_pred -------ceecccCcccccchHHHhh---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC------
Q 016233 238 -------VYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE------ 301 (393)
Q Consensus 238 -------~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~------ 301 (393)
......++..|+|||++.+ .++.++|||||||++|+|++|..||..............+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 0112356778999999864 488999999999999999999999986654443333332221100
Q ss_pred ------------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 302 ------------------------------------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 302 ------------------------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
......+++++.+||.+||..||++|||++++|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 00112356789999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=336.96 Aligned_cols=252 Identities=30% Similarity=0.521 Sum_probs=218.1
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||.|+||.||+|.+..+++.||+|++.+...........+.+|++++++++ ||||+++++.+.+.+..++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhcCCCeEEEEE
Confidence 4889999999999999999999999999999998655444445778999999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcce
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~ 239 (393)
||+.|++|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||++.........
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCccc
Confidence 999999999999887789999999999999999999999999999999999999 45667999999999877655444
Q ss_pred ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh---HHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 240 RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE---KGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 240 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
....|+..|+|||.+.. .++.++|+||||+++|+|++|..||...+. ............ .....++..+.++
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 232 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADV----LYPATWSTEAIDA 232 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccc----cCcccCcHHHHHH
Confidence 55678999999999865 479999999999999999999999987764 333222222222 2224578999999
Q ss_pred HHHhcccCCCCCCCH--HHHhcCccc
Q 016233 316 VRRMLTQDPKKRITS--AQVLEHPWI 339 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~--~e~l~h~~~ 339 (393)
|.+||..||.+||++ .|+++||||
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHccCChhHcCCccHHHHhcCCCC
Confidence 999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=333.92 Aligned_cols=250 Identities=34% Similarity=0.624 Sum_probs=215.6
Q ss_pred ecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCCCC
Q 016233 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGE 166 (393)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~gg~ 166 (393)
||.|++|.||+|.+..+++.+|+|++.+...........+.+|+.+++.++ ||||+++++.+.+++.+++|+||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 699999999999999999999999998665444445678999999999996 9999999999999999999999999999
Q ss_pred hHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcceecccCcc
Q 016233 167 LFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA 246 (393)
Q Consensus 167 L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~gt~ 246 (393)
|.+++.+...+++..+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||++.............|++
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccccCCc
Confidence 99999887789999999999999999999999999999999999999 456679999999998876544334567899
Q ss_pred cccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCC--hHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccC
Q 016233 247 YYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET--EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQD 323 (393)
Q Consensus 247 ~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 323 (393)
.|+|||.+.+ .++.++|+||||+++|+|++|..||.... ..+.+..+..+......+ ...++++.++|.+||..|
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP--NYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC--cccCHHHHHHHHHHccCC
Confidence 9999998764 58899999999999999999999998776 555666666322222211 234889999999999999
Q ss_pred CCCCCC-----HHHHhcCccccCC
Q 016233 324 PKKRIT-----SAQVLEHPWIKEG 342 (393)
Q Consensus 324 p~~Rpt-----~~e~l~h~~~~~~ 342 (393)
|++||+ ++|+++||||+..
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhCC
Confidence 999999 9999999999853
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=331.35 Aligned_cols=253 Identities=28% Similarity=0.489 Sum_probs=219.3
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||+|.+..+++.+|+|.+..... .......+.+|+.+++.++ ||||+++++.+...+..++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEEEEE
Confidence 58899999999999999999999999999999976543 2334678899999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 160 ELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||++|++|.+++... ..+++..+..++.|++.+|.|||++||+|+||+|+||+++. .+..++|+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~--~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK--HKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEccCCCceecCCCc
Confidence 999999999999764 34899999999999999999999999999999999999953 34568999999998876554
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
......|+..|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+....... ....++.++.+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li 233 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP---ISDRYSPDLRQLI 233 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC---CCCCcCHHHHHHH
Confidence 4455678999999999875 47889999999999999999999998877766666666543321 1235789999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccc
Q 016233 317 RRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 317 ~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
.+||..||++|||+.++++||||
T Consensus 234 ~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 234 LSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=338.75 Aligned_cols=259 Identities=32% Similarity=0.545 Sum_probs=219.4
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
....+|++.+.||.|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++ ||||+++++++...+.+
T Consensus 16 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELK-NPNIVNFLDSFLVGDEL 91 (296)
T ss_pred CCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcC-CCceeeeeeeEecCceE
Confidence 34467999999999999999999999999999999986532 234567889999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
++|+||+.+++|.+++.. ..+++.++..++.|++.||.|||++|++||||||+||++ +.++.++|+|||++.....
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhccc
Confidence 999999999999987764 468999999999999999999999999999999999999 4566799999999887654
Q ss_pred Ccc-eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 236 GKV-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 236 ~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
... .....|+..|+|||.+.+ .++.++|||||||++|+|++|..||...+.......+...... .......+++.+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 246 (296)
T cd06655 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSPIFR 246 (296)
T ss_pred ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCc-ccCCcccCCHHHH
Confidence 332 234578899999998865 4889999999999999999999999887765554444433221 1222346889999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
+||.+||..||++|||+.++++||||....
T Consensus 247 ~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 247 DFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 999999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=329.46 Aligned_cols=252 Identities=31% Similarity=0.539 Sum_probs=220.6
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||.|+||.||.+.+..+++.+++|.+..... .......+.+|+.++++++ |+||+++++++.+.+.+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCC-CCCeeEEEeEEecCCeEEEEE
Confidence 58999999999999999999999999999999875443 2344567889999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 160 ELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||+++++|.+++... ..+++.++..++.|++.+|.|||+.|++|+||+|+||++ +.++.+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE---eCCCCEEECcCcceEEccccc
Confidence 999999999998764 458999999999999999999999999999999999999 455679999999998764433
Q ss_pred -ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 238 -VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 238 -~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
......|++.|+|||.+.+ .++.++||||||+++|+|++|..||......+....+..+...... ..++.++.++
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV---SVYSSELISL 232 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHH
Confidence 2345678999999998865 4788999999999999999999999988888888777776554322 4678999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccc
Q 016233 316 VRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
|.+||..||++||++.++|+|+|+
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=336.11 Aligned_cols=250 Identities=25% Similarity=0.427 Sum_probs=208.3
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+++++++. ||||+++++++..++..++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCD-SPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEECCEEEEEE
Confidence 5788899999999999999999999999999986542 2334567889999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcce
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~ 239 (393)
||+++++|..+ ..+++..+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||++...... ..
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~-~~ 150 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNS-IA 150 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceecccc-cc
Confidence 99999998643 357899999999999999999999999999999999999 55677999999999866433 23
Q ss_pred ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh-------HHHHHHHHcCCCCCCCCCCCCCCHH
Q 016233 240 RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE-------KGIFDAILQGDIDFESAPWPTISSS 311 (393)
Q Consensus 240 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (393)
....||..|+|||++.+ .++.++|+|||||++|+|++|..||..... ......+..... .......++++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 228 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--PVLPVGQFSEK 228 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--CCCCCCcCCHH
Confidence 44679999999998865 589999999999999999999999965321 122222222211 11223457889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 312 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+.+||.+||..||++||+++++++||||...
T Consensus 229 ~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 229 FVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 9999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=333.20 Aligned_cols=254 Identities=26% Similarity=0.465 Sum_probs=211.8
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccC---CcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV---TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
+|++.+.||+|+||.||+|.+. +++.+|+|.+...... .......+.+|+.++++++ |+||+++++++.+.+.++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCCeEE
Confidence 4788999999999999999864 7889999988654221 1223456889999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC-
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE- 235 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~- 235 (393)
+|+||++|++|.+++.+...+++..++.++.|++.||+|||+.||+|+||+|+||++ +.++.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhhc
Confidence 999999999999999887889999999999999999999999999999999999999 4566799999999876532
Q ss_pred ------CcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 016233 236 ------GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (393)
Q Consensus 236 ------~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (393)
........|+..|+|||.+.+ .++.++|||||||++|+|++|..||...+.......+.......+ .....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 234 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP-RLPDSF 234 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCC-CCCCCC
Confidence 112234568999999999875 478999999999999999999999987665544444433322211 122457
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
+.++.++|++||..||++|||+.++|+||||
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=339.11 Aligned_cols=258 Identities=28% Similarity=0.408 Sum_probs=213.8
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++++. |+||+++++.+..++.+++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAV-SPYIVDFYGAFFIEGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcC-CCcHHhhhhheecCCeEEEE
Confidence 36889999999999999999999999999999886432 2334567889999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 159 MELCAGGELFDRIIAK---GHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qll~~l~~lH~-~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
|||++|++|..++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++ .++.++|+|||++....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN---GNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC---CCCCEEEeecCCccccc
Confidence 9999999998887663 378999999999999999999997 5999999999999994 46679999999997654
Q ss_pred CCcceecccCcccccchHHHhh-------cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 016233 235 EGKVYRDIVGSAYYVAPEVLRR-------RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (393)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (393)
.. ......|++.|+|||.+.+ .++.++|||||||++|+|++|..||...........+............+.
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd06622 155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG 233 (286)
T ss_pred CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence 32 2234568889999998753 257899999999999999999999976655444433322111112223345
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
++.++.+||.+||..||++||+++++++||||....
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 899999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=345.65 Aligned_cols=256 Identities=34% Similarity=0.570 Sum_probs=227.9
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
..|+.-++||+||||.||-|+.+.||+.+|+|.+.+..+..........+|-.||++++ .+.||.+-..|+..+.+++|
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCceEEE
Confidence 35788889999999999999999999999999998777666666677889999999996 89999999999999999999
Q ss_pred EeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 159 MELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
|..|.||+|.-+|.+.+ .|++..++.++.+|+.||++||+.+||+|||||+|||+ |+.+.++|+|.|+|..+..+
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEecCCC
Confidence 99999999988887765 79999999999999999999999999999999999999 78888999999999999999
Q ss_pred cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChH----HHHHHHHcCCCCCCCCCCCCCCHH
Q 016233 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEK----GIFDAILQGDIDFESAPWPTISSS 311 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~ 311 (393)
......+||.+|||||++.+ .|+...|.|||||++|+|+.|+.||....+. ++-..++.....++ ..+|++
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~----~kFS~e 416 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS----DKFSEE 416 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc----cccCHH
Confidence 98888999999999999975 5999999999999999999999999765543 33334444433333 578999
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHhcCccccCC
Q 016233 312 AKDLVRRMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (393)
Q Consensus 312 ~~~li~~~L~~dp~~Rp-----t~~e~l~h~~~~~~ 342 (393)
+++|.+.+|++||.+|. .++++.+||||+..
T Consensus 417 akslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 417 AKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred HHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 99999999999999997 56799999999864
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=335.67 Aligned_cols=256 Identities=27% Similarity=0.472 Sum_probs=216.1
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
+.|++.+.||+|+||.||+|.+..++..+++|.+... .......+.+|+.+++.+. ||||+++++++..++..++|
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCC-CCCeeeEEEEEeeCCEEEEE
Confidence 3578899999999999999999999999999998543 2334667888999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-
Q 016233 159 MELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG- 236 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~- 236 (393)
+||+++++|..++.. ...+++..+..++.|++.||.|||+.||+||||||+||++ +.++.+||+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEccccccccccccc
Confidence 999999999887765 4568999999999999999999999999999999999999 45567999999998765432
Q ss_pred cceecccCcccccchHHHh------hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 016233 237 KVYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
.......|+..|+|||++. ..++.++|||||||++|+|++|.+||...+..+....+....... ......++.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 236 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWSS 236 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-CCCccccCH
Confidence 2233457899999999873 236789999999999999999999998877666666655443221 112235789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
++.+||.+||..||++|||++++++||||...
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 99999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=337.85 Aligned_cols=258 Identities=29% Similarity=0.422 Sum_probs=209.4
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe----
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS---- 154 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~---- 154 (393)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+.+||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 369999999999999999999999999999998865432 223446788899999999768999999999887665
Q ss_pred -EEEEEeccCCCChHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecC
Q 016233 155 -VHVVMELCAGGELFDRIIAK-----GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (393)
Q Consensus 155 -~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg 228 (393)
.|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. .++.+||+|||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~--~~~~~kl~dfg 156 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK--QKGLLKIADLG 156 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec--CCCeEEEeecc
Confidence 8999999976 788887653 34799999999999999999999999999999999999953 25679999999
Q ss_pred CcccccCC-cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC---
Q 016233 229 LSVFIEEG-KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES--- 302 (393)
Q Consensus 229 ~a~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~--- 302 (393)
++...... .......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+.+..+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98865332 22233467889999998754 3789999999999999999999999887765544443321110000
Q ss_pred ---------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 016233 303 ---------------------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (393)
Q Consensus 303 ---------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 340 (393)
...+.++.++.+||.+||..||.+|||+.++|.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 01135789999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=336.10 Aligned_cols=261 Identities=26% Similarity=0.430 Sum_probs=212.2
Q ss_pred cccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 71 GKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 71 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
........++|++.+.||+|+||.||+|.+..+++.+|+|++... ......+.+|+.+++.+.+||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~----~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI----HDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc----cchHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 345556778999999999999999999999999999999987532 1234668889999999966999999999873
Q ss_pred -----eCCeEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCc
Q 016233 151 -----DKQSVHVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENAL 221 (393)
Q Consensus 151 -----~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~ 221 (393)
.++.+++||||++|++|.+++.. ...+++..++.++.|++.||.|||+++|+||||||+||+++ ..+.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC---CCCC
Confidence 44678999999999999987753 34688999999999999999999999999999999999994 4556
Q ss_pred EEEeecCCcccccCCc-ceecccCcccccchHHHh------hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH
Q 016233 222 LKATDFGLSVFIEEGK-VYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL 294 (393)
Q Consensus 222 ~kl~DFg~a~~~~~~~-~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 294 (393)
++|+|||++....... ......|++.|+|||++. ..++.++|||||||++|+|++|..||........+..+.
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 242 (286)
T cd06638 163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP 242 (286)
T ss_pred EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc
Confidence 9999999998764332 223456999999999874 237889999999999999999999998766544443333
Q ss_pred cCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 295 QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 295 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
.... ........++..+.+||.+||..||++|||+.|+++|+||
T Consensus 243 ~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 243 RNPP-PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ccCC-CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 2211 1111112357889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=337.68 Aligned_cols=258 Identities=28% Similarity=0.475 Sum_probs=217.0
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
..+.|+++++||.|+||.||+|.+..+++.+|+|.+... .......+.+|+.+++.+. |+||+++++.+..++.++
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCeEE
Confidence 346899999999999999999999999999999998643 2334677888999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 157 VVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
+||||++|++|..++.+ ...+++..+..++.|++.+|.|||++||+||||||+||++ +.++.++|+|||++.....
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceeccc
Confidence 99999999999887765 4568999999999999999999999999999999999999 4566799999999876433
Q ss_pred C-cceecccCcccccchHHHh------hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 016233 236 G-KVYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (393)
Q Consensus 236 ~-~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (393)
. .......+++.|+|||++. ..++.++|||||||++|+|++|..||...+..+.+..+...... .......+
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 241 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TLSQPSKW 241 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc-cCCCCccc
Confidence 2 2234457889999999874 23678999999999999999999999887766655555443321 11122457
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+.++.+||.+||..||++||+++++++||||...
T Consensus 242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 8899999999999999999999999999999754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=336.38 Aligned_cols=252 Identities=29% Similarity=0.453 Sum_probs=202.9
Q ss_pred eecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHc--cCCCCeeEEeEEEEeCCeEEEEEeccC
Q 016233 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL--SGQPNIVEFKGAYEDKQSVHVVMELCA 163 (393)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~~h~niv~~~~~~~~~~~~~lv~e~~~ 163 (393)
.||+|+||.||++.+..+++.+|+|.+.+.............+|..+++.+ .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999999765433222333344555444443 249999999999999999999999999
Q ss_pred CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcceeccc
Q 016233 164 GGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243 (393)
Q Consensus 164 gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~ 243 (393)
|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++....... .....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~-~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccC-ccCcC
Confidence 99999999888889999999999999999999999999999999999999 556679999999987654332 23457
Q ss_pred CcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 016233 244 GSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321 (393)
Q Consensus 244 gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 321 (393)
||+.|+|||.+.+ .++.++||||+||++|+|++|..||........ ..+..............++.++.++|.+||.
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 235 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence 9999999998853 478999999999999999999999975432211 1111111122222334688999999999999
Q ss_pred cCCCCCC-----CHHHHhcCccccCC
Q 016233 322 QDPKKRI-----TSAQVLEHPWIKEG 342 (393)
Q Consensus 322 ~dp~~Rp-----t~~e~l~h~~~~~~ 342 (393)
.||++|+ |++++++||||+..
T Consensus 236 ~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 236 RDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred CCHHHhcCCCCCCHHHHHhCccccCC
Confidence 9999999 69999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=339.97 Aligned_cols=262 Identities=29% Similarity=0.412 Sum_probs=214.2
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC--CeE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QSV 155 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~ 155 (393)
..+|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.++++++ |+||+++++++.+. +.+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLR-HPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCCeE
Confidence 35799999999999999999999999999999998754321 222345668999999997 99999999998765 568
Q ss_pred EEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
++||||+.+ +|.+++.. ...+++.+++.++.||+.||.|||++|++||||||+||++ +..+.+||+|||++....
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeeecC
Confidence 999999965 78887765 3568999999999999999999999999999999999999 456679999999998765
Q ss_pred CCc-ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC------------
Q 016233 235 EGK-VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID------------ 299 (393)
Q Consensus 235 ~~~-~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~------------ 299 (393)
... ......+++.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 432 2233456788999998864 4789999999999999999999999988877776665542111
Q ss_pred -------CCCC-------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCC
Q 016233 300 -------FESA-------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEA 345 (393)
Q Consensus 300 -------~~~~-------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 345 (393)
.... ....+++++.+||.+||..||++|||+.++|.||||......
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 1100 012358899999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=337.64 Aligned_cols=261 Identities=31% Similarity=0.524 Sum_probs=217.1
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
.+...+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++ |+||+++++++...+.
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~ 90 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENK-NPNIVNYLDSYLVGDE 90 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCE
Confidence 345578999999999999999999999999999999986533 234567889999999996 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
.++||||+++++|.+++.+ ..+++.++..++.|++.+|.|||+.||+||||||+|||+ +.++.++|+|||++....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred EEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceEcc
Confidence 9999999999999998754 468999999999999999999999999999999999999 556679999999988764
Q ss_pred CCcc-eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 016233 235 EGKV-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (393)
Q Consensus 235 ~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (393)
.... .....|++.|+|||.+.+ .++.++|+|||||++|+|++|..||...+.......+.... .........++..+
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 245 (297)
T cd06656 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSAVF 245 (297)
T ss_pred CCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCCCCCccccCHHH
Confidence 4322 234578999999998865 48899999999999999999999998765533322222211 11111224578899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 313 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
.+||.+||..||++|||++++++||||.....
T Consensus 246 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 246 RDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 99999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=337.96 Aligned_cols=255 Identities=29% Similarity=0.536 Sum_probs=213.7
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.++++++ ||||+++++++...+..++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeEEEe
Confidence 58999999999999999999999999999999876432 2334567889999999997 999999999999999999999
Q ss_pred eccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc-
Q 016233 160 ELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~- 237 (393)
||+ +++|.+++.. ...+++.+++.++.||+.+|.|||++||+|+||||+||++ +.++.++|+|||++.......
T Consensus 79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCC
Confidence 999 9999998865 3568999999999999999999999999999999999999 456679999999998765433
Q ss_pred -ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC----------------
Q 016233 238 -VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI---------------- 298 (393)
Q Consensus 238 -~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~---------------- 298 (393)
......|+..|+|||.+.+ .++.++||||+|+++|+|++|.+||.+.+..+.+..+.....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 2345678999999998754 368999999999999999999888887766555544432110
Q ss_pred ---CCCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 016233 299 ---DFES-------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (393)
Q Consensus 299 ---~~~~-------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 340 (393)
.+.. ..++..+..+.+||++||..||++|||++++|+||||.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0000 11235678999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=335.97 Aligned_cols=255 Identities=26% Similarity=0.470 Sum_probs=216.4
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
...|+..+.||.|+||.||+|.+..++..||+|++.... .......+.+|+.+++++. |+||+++++++.+++.+++
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEEE
Confidence 346888999999999999999999999999999987543 2334677889999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||||++|++|.+++.. +.+++.++..++.|++.||.|||+++++|+||+|+||+++ .++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~---~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 80 IMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc---CCCCEEEcccccceeccCCc
Confidence 9999999999998864 5789999999999999999999999999999999999994 55679999999997765433
Q ss_pred -ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 238 -VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 238 -~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
......++..|+|||.+.+ .++.++|+|||||++|+|++|..||...........+..... ......++..+.+|
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l 232 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP---PTLTGEFSKPFKEF 232 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCC---CCCchhhhHHHHHH
Confidence 2233468889999998865 488999999999999999999999987776655554433322 12223567889999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 316 VRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
|.+||..||++||+++++++|+||...
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 233 IDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred HHHHcccCcccCcCHHHHHhChHhhhc
Confidence 999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=331.53 Aligned_cols=254 Identities=28% Similarity=0.505 Sum_probs=209.6
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccC--CcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe--CCeE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV--TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--KQSV 155 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~ 155 (393)
.|++.+.||+|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.++ ||||+++++++.+ ...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCEE
Confidence 688999999999999999999999999999998654321 1223457889999999996 9999999998875 4678
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
++++||+++++|.+++...+.+++...+.++.|++.||.|||+++|+||||||+||++ +.+..++|+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCcccccc
Confidence 9999999999999999887789999999999999999999999999999999999999 4566799999999876543
Q ss_pred C----cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 016233 236 G----KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 236 ~----~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
. .......|+..|+|||.+.+ .++.++|||||||++|+|++|..||......+....+...... ......+++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN--PQLPSHISE 236 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC--CCCchhcCH
Confidence 1 12233568899999999865 4889999999999999999999999876655444443332211 111134678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 340 (393)
.+.++| +||..||++|||++|+++||||+
T Consensus 237 ~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 237 HARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 899999 57778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=330.35 Aligned_cols=254 Identities=30% Similarity=0.517 Sum_probs=216.6
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
.++|++.+.||.|+||.||+|.+..+++.+|+|++.... ......+.+|+.++++++ ||||+++++++.+.+.+|+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l 77 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECR-HPNIVAYFGSYLRRDKLWI 77 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCC-CCChhceEEEEEeCCEEEE
Confidence 357999999999999999999999999999999997543 235678899999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 158 VMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+|||+.+++|.+++... ..+++.+++.++.|++.||.|||++||+|+||+|+||++ +.++.++|+|||++......
T Consensus 78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhh
Confidence 99999999999988776 789999999999999999999999999999999999999 45667999999999876543
Q ss_pred c-ceecccCcccccchHHHhh----cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC-CCCCCCCH
Q 016233 237 K-VYRDIVGSAYYVAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES-APWPTISS 310 (393)
Q Consensus 237 ~-~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~ 310 (393)
. ......|+..|+|||.+.+ .++.++|+||||+++|+|++|..||...+.......+......... .....++.
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP 234 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhH
Confidence 2 2334578899999998753 4788999999999999999999999887766555555444322211 11234578
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLEHPW 338 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~ 338 (393)
++.+|+.+||..||.+|||+.+++.|+|
T Consensus 235 ~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 235 VFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 8999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=351.31 Aligned_cols=255 Identities=28% Similarity=0.487 Sum_probs=220.9
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
....|.=++.||.|+||.||-|++..+.+.||||.+....-.+...-.++..|++.|++|. |||+|.+-++|-.+...|
T Consensus 24 PEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~TaW 102 (948)
T KOG0577|consen 24 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHTAW 102 (948)
T ss_pred HHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccchHH
Confidence 3446777889999999999999999999999999987654334444567899999999997 999999999999999999
Q ss_pred EEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 157 VVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
||||||- |+-.|++.- .+++.+-++..|+.+.+.||.|||+++.||||||..|||+ .+.+.|||+|||.|....+
T Consensus 103 LVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL---se~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 103 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL---SEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---cCCCeeeeccccchhhcCc
Confidence 9999995 477776643 4679999999999999999999999999999999999999 5678899999999987665
Q ss_pred CcceecccCcccccchHHHh----hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC-CCCCCCCCCCH
Q 016233 236 GKVYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID-FESAPWPTISS 310 (393)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~s~ 310 (393)
. .+++|||+|||||++. |.|+-++||||||++..||.-.++|+...+....+.-|.++..+ .... ..|.
T Consensus 179 A---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~---eWS~ 252 (948)
T KOG0577|consen 179 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSN---EWSD 252 (948)
T ss_pred h---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCc---hhHH
Confidence 4 4679999999999873 67999999999999999999999999988877777777666543 3333 3478
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.++.||..||.+-|.+|||.+++|.|+|+...
T Consensus 253 ~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 253 YFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred HHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 89999999999999999999999999999763
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=333.01 Aligned_cols=258 Identities=25% Similarity=0.468 Sum_probs=211.7
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCC---cccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT---KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
+|+.++.||+|+||.||+|.+..+++.+|+|.+....... ......+.+|+.++++++ |+||+++++++.+.+.++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCCeEE
Confidence 4788899999999999999999999999999987543211 113567889999999997 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+|+||+.|++|.+++...+.+++..+..++.||+.||.|||++|++|+||+|+||+++. ....++|+|||++......
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~--~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEcccccccccccc
Confidence 99999999999999988888999999999999999999999999999999999999943 2346999999998876533
Q ss_pred c-----ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC-CCCCCCCCCCCCC
Q 016233 237 K-----VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG-DIDFESAPWPTIS 309 (393)
Q Consensus 237 ~-----~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~s 309 (393)
. ......|+..|+|||.+.+ .++.++||||+|+++|+|++|..||...........+... ...........++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 1 1123468899999998865 5889999999999999999999999754432222222111 1111122223578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 340 (393)
+++.+++.+||..||++|||+.++++||||.
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=342.02 Aligned_cols=249 Identities=29% Similarity=0.471 Sum_probs=192.5
Q ss_pred cceecccCCeEEEEEEECC--CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE--eCCeEEEEE
Q 016233 84 GKELGRGQFGVTYLCTENS--TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE--DKQSVHVVM 159 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~--~~~~~~lv~ 159 (393)
+.+||+|+||.||+|.+.. ++..||+|.+.... ....+.+|+.+++.++ ||||+++++++. .+..+++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEEE
Confidence 4679999999999999754 56899999886432 2346788999999996 999999999885 456789999
Q ss_pred eccCCCChHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccC-CCCCcEEEeecCC
Q 016233 160 ELCAGGELFDRIIAK---------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK-DENALLKATDFGL 229 (393)
Q Consensus 160 e~~~gg~L~~~l~~~---------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~-~~~~~~kl~DFg~ 229 (393)
||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..+ +..+.+||+|||+
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 80 DYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 9996 4777776421 247889999999999999999999999999999999999543 3456899999999
Q ss_pred cccccCCc----ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChH---------HHHHHHH
Q 016233 230 SVFIEEGK----VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEK---------GIFDAIL 294 (393)
Q Consensus 230 a~~~~~~~----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---------~~~~~i~ 294 (393)
++...... ......||+.|+|||++.+ .++.++|||||||++|+|+||.+||...... ..+..+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 98764332 2234578999999999864 4789999999999999999999999654321 1111111
Q ss_pred cCCC--------------C-------CC-------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 295 QGDI--------------D-------FE-------------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 295 ~~~~--------------~-------~~-------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
.... . +. .......+..+.+||.+||..||.+|||++|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 0 00 00011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=333.67 Aligned_cols=258 Identities=26% Similarity=0.423 Sum_probs=213.2
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC--
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK-- 152 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 152 (393)
....++|.+.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++++.+||||+++++++...
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 345678999999999999999999999999999999985431 23467788999999996699999999998653
Q ss_pred ---CeEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEe
Q 016233 153 ---QSVHVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225 (393)
Q Consensus 153 ---~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~ 225 (393)
+.+++||||++|++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+||++ +.++.+||+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEe
Confidence 368999999999999988753 3568999999999999999999999999999999999999 455669999
Q ss_pred ecCCcccccCCc-ceecccCcccccchHHHhh------cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC
Q 016233 226 DFGLSVFIEEGK-VYRDIVGSAYYVAPEVLRR------RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI 298 (393)
Q Consensus 226 DFg~a~~~~~~~-~~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~ 298 (393)
|||++....... ......|+..|+|||.+.. .++.++|||||||++|+|++|+.||......+.+..+.....
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~ 250 (291)
T cd06639 171 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP 250 (291)
T ss_pred ecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC
Confidence 999988765432 2234568899999998753 267899999999999999999999988776555555554422
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 016233 299 DFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (393)
Q Consensus 299 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 340 (393)
.. ......++..+.+||.+||..||++||++.++++||||+
T Consensus 251 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 251 PT-LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CC-CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 11 111234678899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=328.67 Aligned_cols=252 Identities=26% Similarity=0.552 Sum_probs=218.1
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||.+.+..+|+.||+|.+..... .......+.+|+.+++.++ ||||+++++++...+..++|+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEEEEE
Confidence 58999999999999999999999999999999875432 2334567899999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 160 ELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||+.+++|.+++.... .+++.++..++.|++.||.|||++|++|+||+|+||++ +.+..++|+|||++.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcch
Confidence 9999999999887643 57899999999999999999999999999999999999 455679999999998765432
Q ss_pred c-eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 238 V-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 238 ~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
. .....|++.|+|||++.+ .++.++|+|||||++|+|++|..||......+....+..+..... ...++.++.++
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 232 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV---SSHYSYDLRNL 232 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC---cccCCHHHHHH
Confidence 2 223568899999999865 478899999999999999999999988887777777776654322 23578999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccc
Q 016233 316 VRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
|.+||..+|++||++.++++||||
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=335.32 Aligned_cols=252 Identities=30% Similarity=0.509 Sum_probs=208.2
Q ss_pred eeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC--CeEEEE
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QSVHVV 158 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~~lv 158 (393)
|++.+.||+|+||.||+|.+..+++.||+|.+..... ........+|+.+++++.+|+||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--CchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6788999999999999999999999999998865321 122234457899999997799999999999987 889999
Q ss_pred EeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
|||+. ++|.+.+... ..+++.+++.++.|++.||.|||+.||+||||+|+||+++ . +.+||+|||++.......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEecccccccccCC
Confidence 99996 4888887763 5689999999999999999999999999999999999994 4 789999999998776555
Q ss_pred ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC------------------
Q 016233 238 VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD------------------ 297 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~------------------ 297 (393)
......++..|+|||.+.. .++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 5455678999999997643 47889999999999999999999998877655544443211
Q ss_pred CCCCCC-------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 298 IDFESA-------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 298 ~~~~~~-------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
..++.. ..+.++.++.+||.+||..||++|||++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 011110 013568999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=299.87 Aligned_cols=257 Identities=27% Similarity=0.485 Sum_probs=219.1
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|.-.++||+|.||+||+|++..+++.||+|.++.... .+.......+|+-+|+.|+ |.|||+++++...++.+-+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelk-hknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhh-hcceeehhhhhccCceeEEeH
Confidence 56677899999999999999999999999999976543 3344677889999999997 999999999999999999999
Q ss_pred eccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc-
Q 016233 160 ELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~- 237 (393)
|||.. +|..+... ++.+..+.++.++.|++.||.+||++++.|||+||.|+|+ +.++.+|++|||+++.+.-.-
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCceE
Confidence 99954 78777765 5679999999999999999999999999999999999999 677889999999999876442
Q ss_pred ceecccCcccccchHHHhhc--CCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCC--------
Q 016233 238 VYRDIVGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWP-------- 306 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-------- 306 (393)
.+...+-|.+|++|.++-+. |+...|+||-|||+.|+.. |.+.|.+.+..+.+..|...--......|+
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 34455779999999998763 9999999999999999985 888899998888887775533333333332
Q ss_pred -----------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 307 -----------------TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 307 -----------------~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.++...+|+++++|.-+|.+|++++++|+||||...
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 335567899999999999999999999999999753
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=331.46 Aligned_cols=256 Identities=25% Similarity=0.467 Sum_probs=213.5
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcc-------cHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN-------DKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
+|.+.+.||+|+||.||+|.+..+|+.+|+|.+......... ..+.+.+|+.+++.++ ||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEeccC
Confidence 688999999999999999999999999999988643211111 2346788999999996 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 153 QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
+.+++||||+.+++|.+++...+.+++..+..++.||+.||.|||++|++||||+|+||++ +.++.++|+|||++..
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISKK 157 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeecccccc
Confidence 9999999999999999999888889999999999999999999999999999999999999 5567799999999976
Q ss_pred ccCCc---ceecccCcccccchHHHhh---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC--CCCCCCCC
Q 016233 233 IEEGK---VYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG--DIDFESAP 304 (393)
Q Consensus 233 ~~~~~---~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~--~~~~~~~~ 304 (393)
..... ......|+..|+|||.+.. .++.++|+||||+++|++++|..||......+.+..+... ...++...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 54321 1233568899999998864 2788999999999999999999999766554444333322 22233333
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
...++.++.++|.+||..||++|||++++|+||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 45678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=349.79 Aligned_cols=253 Identities=23% Similarity=0.361 Sum_probs=205.3
Q ss_pred ccccceeecceecccCCeEEEEEEECCC-----CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENST-----GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
...++|++++.||+|+||.||+|++..+ +..||+|.+.... .......+.+|+.+++.+.+|+||+++++++.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 3456899999999999999999986544 3579999986543 22345678899999999955999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHHc--------------------------------------------------------
Q 016233 151 DKQSVHVVMELCAGGELFDRIIAK-------------------------------------------------------- 174 (393)
Q Consensus 151 ~~~~~~lv~e~~~gg~L~~~l~~~-------------------------------------------------------- 174 (393)
..+.+++|||||++|+|.+++...
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 999999999999999999988542
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcce-
Q 016233 175 --------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY- 239 (393)
Q Consensus 175 --------------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~- 239 (393)
..+++.+++.++.||+.||.|||++||+||||||+|||+ +.+..+||+|||++.........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCccee
Confidence 136788899999999999999999999999999999999 45667999999999865433221
Q ss_pred --ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 240 --RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 240 --~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
....++..|+|||++.+ .++.++|||||||++|+|++ |..||........+..+.......... ..+++++.++
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l 347 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP--DFAPPEIYSI 347 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCC--CCCCHHHHHH
Confidence 12235567999998764 58999999999999999997 999998766544444444433322222 3468999999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 016233 316 VRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~~e~l~ 335 (393)
|.+||+.||++|||+.++++
T Consensus 348 i~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 348 MKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=334.83 Aligned_cols=254 Identities=28% Similarity=0.459 Sum_probs=210.3
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE------
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE------ 150 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~------ 150 (393)
....|++.+.||.|+||.||+|.+..+++.+|+|++... ......+..|+.+++++.+|+||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 345799999999999999999999999999999998643 2345678889999999977999999999984
Q ss_pred eCCeEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecC
Q 016233 151 DKQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (393)
Q Consensus 151 ~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg 228 (393)
..+.+|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||++ +.++.++|+|||
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg 166 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFG 166 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCc
Confidence 346789999999999999988753 348888899999999999999999999999999999999 456679999999
Q ss_pred CcccccCC-cceecccCcccccchHHHh------hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC
Q 016233 229 LSVFIEEG-KVYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE 301 (393)
Q Consensus 229 ~a~~~~~~-~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 301 (393)
++...... .......|++.|+|||.+. ..++.++|||||||++|+|++|..||...........+.... ..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~ 244 (282)
T cd06636 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--PP 244 (282)
T ss_pred chhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC--CC
Confidence 98765432 2234467899999999874 247889999999999999999999997766544443333321 11
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 302 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
......++.++.+||.+||..||.+|||+.|+|+||||
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 22224578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=332.22 Aligned_cols=248 Identities=25% Similarity=0.439 Sum_probs=201.5
Q ss_pred cceeeccee--cccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 79 LHYSFGKEL--GRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 79 ~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
..|++.+.+ |+|+||.||++.++.+++.+|+|.+...... . .|+.....+.+||||+++++.+..++.++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~------~--~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN------A--IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc------h--hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 456776666 9999999999999999999999998654321 1 12333333336999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+||||+++++|.+++.....+++.+++.++.|++.||.|||+.|++||||||+||++..++ ..++|+|||++......
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK--DRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC--CeEEEecCccceecCCC
Confidence 9999999999999998877899999999999999999999999999999999999995322 27999999998866433
Q ss_pred cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHH-HHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGI-FDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
....|+..|+|||++.+ .++.++||||||+++|+|++|..||........ ...+.... ......++.+++.+.+
T Consensus 164 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 239 (267)
T PHA03390 164 ---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNAND 239 (267)
T ss_pred ---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHHH
Confidence 23468999999999865 588999999999999999999999986544322 11222111 2222334568999999
Q ss_pred HHHHhcccCCCCCCC-HHHHhcCcccc
Q 016233 315 LVRRMLTQDPKKRIT-SAQVLEHPWIK 340 (393)
Q Consensus 315 li~~~L~~dp~~Rpt-~~e~l~h~~~~ 340 (393)
||.+||+.||.+|++ ++++|+||||.
T Consensus 240 li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 240 FVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHhccChhhCCchHHHHhcCCccc
Confidence 999999999999996 59999999996
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=349.47 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=204.7
Q ss_pred ccccceeecceecccCCeEEEEEEE-----CCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTE-----NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
....+|++++.||+|+||.||+|.+ ..++..||||+++... .....+.+.+|+.+++.+.+||||+++++++.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 3456899999999999999999974 4567789999986433 22345678899999999955999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHHcC-------------------------------------------------------
Q 016233 151 DKQSVHVVMELCAGGELFDRIIAKG------------------------------------------------------- 175 (393)
Q Consensus 151 ~~~~~~lv~e~~~gg~L~~~l~~~~------------------------------------------------------- 175 (393)
+.+..++|||||+||+|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999999886532
Q ss_pred --------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 176 --------------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 176 --------------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
.+++..+..++.||+.||.|||++||+||||||+|||+ +.+..+||+|||++.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE---ECCCcEEEecCccceeccC
Confidence 36778889999999999999999999999999999999 4566799999999987644
Q ss_pred Ccce---ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHH-HHHHHHcCCCCCCCCCCCCCC
Q 016233 236 GKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKG-IFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 236 ~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s 309 (393)
.... ....++..|+|||++.+ .++.++|||||||++|+|++ |..||....... ....+..+. .... ....+
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~~ 343 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY-RMLS--PECAP 343 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc-cCCC--CCCCC
Confidence 3221 12334567999999865 58999999999999999998 899997765433 334444332 2221 23467
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
.++.+||.+||..||++|||+.++++.
T Consensus 344 ~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 344 SEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=338.24 Aligned_cols=255 Identities=27% Similarity=0.490 Sum_probs=211.9
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|+++++.++ ||||+++++++.+++..++|+
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED-DKMVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC-cchhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCeEEEEE
Confidence 68999999999999999999999999999998865432 2234567889999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-cc
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-KV 238 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~-~~ 238 (393)
||+++++|.++......+++.++..++.|++.||.|||+.||+|+||+|+||++ +.++.++|+|||++...... ..
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCccc
Confidence 999998888776666679999999999999999999999999999999999999 55667999999998876443 22
Q ss_pred eecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC-----------------
Q 016233 239 YRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID----------------- 299 (393)
Q Consensus 239 ~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~----------------- 299 (393)
.....++..|+|||++.+ .++.++||||||+++|+|++|.+||......+....+......
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 344568899999998864 3788999999999999999999999876654433332210000
Q ss_pred --CCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 300 --FES--------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 300 --~~~--------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
.+. ..++.++..+.+|+.+||..||++|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000 1134678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=328.76 Aligned_cols=254 Identities=28% Similarity=0.524 Sum_probs=210.2
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccC--CcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC--CeE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV--TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QSV 155 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~ 155 (393)
+|++.+.||+|+||.||.|.+..+++.||+|.+...... .......+.+|+.+++++. ||||+++++++.+. ..+
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPMERTL 81 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCCceE
Confidence 689999999999999999999999999999988643211 1223567889999999996 99999999998763 568
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
++||||++|++|.+++.....+++..+..++.|++.+|.|||+++|+|+||||+||++ +.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCcccccccc
Confidence 8999999999999999887789999999999999999999999999999999999999 4566799999999886542
Q ss_pred C----cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 016233 236 G----KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 236 ~----~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
. .......|+..|+|||++.+ .++.++|||||||++|+|++|..||........+..+...... ......++.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PVLPPHVSD 236 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCC--CCCchhhCH
Confidence 1 12234568999999998865 5889999999999999999999999876555444444332211 112235778
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 340 (393)
.+.++|.+||. +|++||+++++++|||+.
T Consensus 237 ~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 237 HCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 89999999994 999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=333.75 Aligned_cols=266 Identities=27% Similarity=0.432 Sum_probs=216.0
Q ss_pred ccccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCC-C----CeeE
Q 016233 70 LGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ-P----NIVE 144 (393)
Q Consensus 70 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~----niv~ 144 (393)
.....+.+..+|.+...+|+|.||.|-+|.+..++..||||+++.- ..-.+...-|+++|+++..+ | -+|+
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 3445566688999999999999999999999999999999998632 23355666799999999522 3 3888
Q ss_pred EeEEEEeCCeEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCC-----
Q 016233 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD----- 217 (393)
Q Consensus 145 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~----- 217 (393)
+.+||+..++.+||+|.+ |.++++++.+++ +++...++.+.+||+.++++||+.+++|-||||+|||+.+.+
T Consensus 156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred eehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEe
Confidence 999999999999999999 779999998764 588999999999999999999999999999999999996432
Q ss_pred ------------CCCcEEEeecCCcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCC
Q 016233 218 ------------ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAE 284 (393)
Q Consensus 218 ------------~~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~ 284 (393)
.+..|+|+|||.|....... ...+.|..|+|||++.+ .++.++||||+||||+|+.||...|+..
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 14568999999998765544 56788999999999876 7999999999999999999999999988
Q ss_pred ChHHHH---HHHHcCCC-------------CCCCCCCCC--------------------------CCHHHHHHHHHhccc
Q 016233 285 TEKGIF---DAILQGDI-------------DFESAPWPT--------------------------ISSSAKDLVRRMLTQ 322 (393)
Q Consensus 285 ~~~~~~---~~i~~~~~-------------~~~~~~~~~--------------------------~s~~~~~li~~~L~~ 322 (393)
...+.+ +.|+.... .-....|++ --.++.|||++||..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 766633 33322000 000111211 113478999999999
Q ss_pred CCCCCCCHHHHhcCccccCC
Q 016233 323 DPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 323 dp~~Rpt~~e~l~h~~~~~~ 342 (393)
||.+|+|+.|+|.||||+..
T Consensus 393 DP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 393 DPARRITLREALSHPFFARL 412 (415)
T ss_pred CccccccHHHHhcCHHhhcC
Confidence 99999999999999999864
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=327.97 Aligned_cols=251 Identities=27% Similarity=0.487 Sum_probs=213.3
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++.+.||+|+||.||+|.+..+++.+++|.+.... ..+.+.+|+.++++++ |+||+++++++.+...+|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCD-SPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCC-CCcEeeeeeeeecCCcEEEE
Confidence 57999999999999999999999989999999986432 2678999999999995 99999999999999999999
Q ss_pred EeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 159 MELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
+||+.+++|.+++.. ...+++..++.++.|++.||.|||+.+|+||||+|+||++ +.++.++|+|||++.......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcccCc
Confidence 999999999998875 4568999999999999999999999999999999999999 455679999999998765543
Q ss_pred -ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 238 -VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 238 -~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
......|+..|+|||++.+ .++.++||||||+++|+|++|..||...........+...... .......++.++.++
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-TLSDPEKWSPEFNDF 232 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC-CCCchhhcCHHHHHH
Confidence 2334568899999999865 4888999999999999999999999876655444333322111 111123467899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccc
Q 016233 316 VRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
|.+||..||++|||+.++|+||||
T Consensus 233 i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 233 VKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=350.83 Aligned_cols=247 Identities=37% Similarity=0.571 Sum_probs=216.9
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
+.+.|.+...+|.|+|+.|-.|.+..+++..++|++.++. .+..+|+.++....+||||+++.+.+.+..+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 5678999999999999999999999999999999997652 234567878888888999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+|||++.|+.+.+.+.....+. .++..|+.+|+.|+.|||++|||||||||+|||+. +..+.++|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCchh
Confidence 9999999999999998876666 88889999999999999999999999999999995 35667999999999987665
Q ss_pred cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
..+.+-|..|.|||++.. .|+..||+||||++||+||+|+.||...... ++...+..+.+. ..+|.++++
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS~~AKd 541 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVSDEAKD 541 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccCHHHHH
Confidence 455677899999999975 5999999999999999999999999865544 566666655444 468999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
||++||+.||.+|+++.+++.||||.+
T Consensus 542 Ll~~LL~~dP~~Rl~~~~i~~h~w~~~ 568 (612)
T KOG0603|consen 542 LLQQLLQVDPALRLGADEIGAHPWFLS 568 (612)
T ss_pred HHHHhccCChhhCcChhhhccCcchhc
Confidence 999999999999999999999999933
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=327.68 Aligned_cols=254 Identities=28% Similarity=0.509 Sum_probs=214.8
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++ |+||+++++.+.+.+.+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEEEEE
Confidence 589999999999999999999999999999998765432 346778999999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc-
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV- 238 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~- 238 (393)
||+++++|.+++.....+++..++.++.|++.||.|||++||+|+||+|+||++ +.++.+||+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCc
Confidence 999999999999887779999999999999999999999999999999999999 4566799999999987654322
Q ss_pred ----eecccCcccccchHHHhh-c---CCCcchHHHHHHHHHHHhhCCCCCCCCChHH-HHHHHHcCCCCCCCCCCCCCC
Q 016233 239 ----YRDIVGSAYYVAPEVLRR-R---YGKEIDIWSAGVILYILLSGVPPFWAETEKG-IFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 239 ----~~~~~gt~~y~aPE~l~~-~---~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s 309 (393)
.....++..|+|||.+.+ . ++.++||||||+++|+|++|..||....... ....+.. ......+.+..++
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLS 234 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcccccC
Confidence 123568889999999864 2 7889999999999999999999997653332 2223332 2222233344568
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
..+.+||.+||..||++|||+.+++.|||+
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 235 PEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=336.34 Aligned_cols=255 Identities=30% Similarity=0.445 Sum_probs=210.7
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC--CeEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QSVH 156 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~~ 156 (393)
+.|++.+.||+|+||.||+|.+..+++.+|+|.++..... ......+.+|+.++++++ ||||+++++++... +..|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcEE
Confidence 4699999999999999999999999999999999755432 233445678999999997 99999999998877 8999
Q ss_pred EEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 157 VVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
+||||+.+ +|.+++.... .+++.+++.++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++.....
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGS 158 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeeccC
Confidence 99999974 8988887643 58999999999999999999999999999999999999 5567799999999987655
Q ss_pred C-cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC-------------
Q 016233 236 G-KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID------------- 299 (393)
Q Consensus 236 ~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~------------- 299 (393)
. .......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||......+.+..+......
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 4 23344568899999998864 3688999999999999999999999887765555444321100
Q ss_pred -------------CCCCCCCC--CCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 300 -------------FESAPWPT--ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 300 -------------~~~~~~~~--~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
.....++. +++.+.+||++||..||++|||+.|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00011222 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=330.20 Aligned_cols=255 Identities=29% Similarity=0.466 Sum_probs=212.2
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC---
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ--- 153 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--- 153 (393)
..++|++.+.||+|++|.||+|.+..+++.+++|++.... ...+.+.+|+.+++++.+|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 3568999999999999999999999999999999986542 245678999999999966999999999997644
Q ss_pred ---eEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEee
Q 016233 154 ---SVHVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (393)
Q Consensus 154 ---~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~D 226 (393)
.+++||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||++ +.++.++|+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d 156 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVD 156 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEEECC
Confidence 48999999999999988765 3478999999999999999999999999999999999999 4566799999
Q ss_pred cCCcccccCCc-ceecccCcccccchHHHhh------cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC
Q 016233 227 FGLSVFIEEGK-VYRDIVGSAYYVAPEVLRR------RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID 299 (393)
Q Consensus 227 Fg~a~~~~~~~-~~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 299 (393)
||++....... ......|+..|+|||++.. .++.++|||||||++|+|++|..||...........+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (275)
T cd06608 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP 236 (275)
T ss_pred CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence 99987654322 2234568999999998742 3678899999999999999999999876655555555444221
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 300 FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 300 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
. ......++.++.+||.+||..||++|||+.++++|||+
T Consensus 237 ~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 237 T-LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred C-CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 1 11112367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=326.10 Aligned_cols=254 Identities=30% Similarity=0.490 Sum_probs=216.2
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccC--CcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV--TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
+|+..+.||+|+||.||+|.+..+++.|++|.+...... .......+.+|+.+++.++ |+||+++++++.+...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEecCCeEEE
Confidence 477889999999999999999989999999998654321 2234567889999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
|+||+++++|.+++.....+++..+..++.||+.||.|||+.||+|+||+|+||++ +.++.+||+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceeccccc
Confidence 99999999999999888789999999999999999999999999999999999999 456679999999998765544
Q ss_pred ceecccCcccccchHHHhh-c-CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-R-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
......|+..|+|||.+.. . ++.++|+||||+++|+|++|..||......+....+..... .......+++.+.+|
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l 234 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE--LPPIPDHLSDEAKDF 234 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc--CCCcCCCcCHHHHHH
Confidence 4456678999999998754 3 78999999999999999999999977665444444433111 112234678999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccc
Q 016233 316 VRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
+.+||..||++|||+.+++.|||+
T Consensus 235 i~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 235 ILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=332.77 Aligned_cols=254 Identities=28% Similarity=0.452 Sum_probs=204.4
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++.+.||+|++|.||+|.++.+++.||||.+..... ......+.+|+.+++.++ |+||+++++++.+.+..++|
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLK-HANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCC-CcceeeEEEEEecCCeEEEE
Confidence 479999999999999999999999999999999865431 223345678999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-
Q 016233 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG- 236 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~- 236 (393)
|||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVPS 157 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCCC
Confidence 999975 898888764 468999999999999999999999999999999999999 55667999999998764322
Q ss_pred cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCC-hHHHHHHHHcCCC---------------
Q 016233 237 KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAET-EKGIFDAILQGDI--------------- 298 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~--------------- 298 (393)
.......++..|+|||++.+ .++.++||||+|+++|+|++|..||.+.. ..+.+..+.....
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 12223457889999998864 47889999999999999999999997665 2222222211000
Q ss_pred ----CCC-------CCCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 299 ----DFE-------SAPWPTIS--SSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 299 ----~~~-------~~~~~~~s--~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
.+. ...++.++ .++.++|.+||..||++|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 00112344 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=330.52 Aligned_cols=256 Identities=29% Similarity=0.534 Sum_probs=215.1
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHcc--CCCCeeEEeEEEEeCCeEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--GQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~~~~~l 157 (393)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.+. .||||+++++++......++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4788899999999999999999999999999986532 2345667889999999995 49999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||||++|++|.+++.. +.+++..+..++.|++.+|.|||+.||+|+||+|+||+++ ..+.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT---NTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc---CCCCEEEccCCceeecCCCc
Confidence 9999999999988755 4789999999999999999999999999999999999994 46679999999998765433
Q ss_pred -ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 238 -VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 238 -~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
......|+..|+|||.+.+ .++.++|+|||||++|+|++|..||.+.........+... ..+......++.++.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLRE 233 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCCCCcccCCHHHHH
Confidence 2234578999999998864 3688999999999999999999999877655444333322 1122222247889999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
++.+||..||++|||+.+++.|+||++..
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 99999999999999999999999997754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=334.50 Aligned_cols=252 Identities=23% Similarity=0.366 Sum_probs=202.1
Q ss_pred ccceeecceecccCCeEEEEEEECC----------------CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCC
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENS----------------TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n 141 (393)
..+|++.++||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++.+++ |||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLK-DPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcC-CCC
Confidence 4589999999999999999998642 34579999886532 2334567899999999996 999
Q ss_pred eeEEeEEEEeCCeEEEEEeccCCCChHHHHHHcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcE
Q 016233 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKG-------------------HYSERAAASICRSIVNVVHICHFMGVM 202 (393)
Q Consensus 142 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-------------------~~~~~~~~~i~~qll~~l~~lH~~~iv 202 (393)
|+++++++.+.+..++||||+.+|+|.+++.... .+++..+..++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999886532 357788999999999999999999999
Q ss_pred ecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcce---ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh--
Q 016233 203 HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-- 276 (393)
Q Consensus 203 H~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-- 276 (393)
||||||+|||+ +.++.+||+|||++......... ....++..|+|||++.. .++.++||||||+++|+|++
T Consensus 161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred ccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 99999999999 45677999999999866443221 23345788999998764 68999999999999999986
Q ss_pred CCCCCCCCChHHHHHHHHc----CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 277 GVPPFWAETEKGIFDAILQ----GDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 277 g~~pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+..||...+..+.+..+.. ..........+.++..+.+|+.+||..||++|||+.++.+
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 6678877666555544322 1111111122457889999999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=332.43 Aligned_cols=259 Identities=27% Similarity=0.433 Sum_probs=211.2
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++.+.||+|++|.||+|.+..+|+.||+|.+..... .......+.+|++++++++ ||||+++++++.+.+.+|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCeEEEE
Confidence 469999999999999999999999999999998865432 2234567889999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 159 MELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
|||++ ++|.+++..... +++..++.++.||+.||+|||++||+||||+|+||+++. .+..+||+|||++......
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~--~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR--RTNALKLADFGLARAFGIP 156 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC--CCCEEEEcccccccccCCC
Confidence 99995 588887765433 578889999999999999999999999999999999953 3456899999999765332
Q ss_pred -cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC-----------
Q 016233 237 -KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES----------- 302 (393)
Q Consensus 237 -~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~----------- 302 (393)
.......|++.|+|||.+.+ .++.++|||||||++|+|++|..||...+..+.+.++.........
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 22334567899999998865 3788999999999999999999999887765555443321100000
Q ss_pred --------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 303 --------------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 303 --------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
...+.+++++.++|.+||+.||++||++.++++||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0124578899999999999999999999999999999864
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=336.66 Aligned_cols=262 Identities=30% Similarity=0.553 Sum_probs=218.2
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
...+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++ |+||+++++.+...+..
T Consensus 19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~ 94 (292)
T cd06658 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDEL 94 (292)
T ss_pred chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCC-CCcHHHHHHheecCCeE
Confidence 34556777788999999999999999999999999886432 334567889999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
++||||+++++|.+++.. ..+++.++..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++.....
T Consensus 95 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 95 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred EEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhccc
Confidence 999999999999887744 568999999999999999999999999999999999999 4556799999999876533
Q ss_pred Cc-ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 236 GK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 236 ~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
.. ......|+..|+|||.+.+ .++.++||||||+++|+|++|..||........+..+.... .........++..+.
T Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 249 (292)
T cd06658 171 EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL-PPRVKDSHKVSSVLR 249 (292)
T ss_pred ccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCccccccccCHHHH
Confidence 22 2234578999999998865 58899999999999999999999998877666555544322 111122235788999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccCCCCCC
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~ 346 (393)
+++.+||..||.+|||++++++||||.......
T Consensus 250 ~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 250 GFLDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 999999999999999999999999998654433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=328.36 Aligned_cols=249 Identities=16% Similarity=0.287 Sum_probs=208.7
Q ss_pred ccceeecceecccCCeEEEEEEEC---CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTEN---STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
..+|++.+.||+|+||.||+|.++ ..+..||+|.++... .......+.+|+.+++.++ ||||+++++++...+.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRGNT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEecCCC
Confidence 347999999999999999999865 446789999886532 2234567889999999996 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
.++||||+++|+|.+++... ..+++..++.++.||+.||+|||++|++||||||+||++ +.+..++++|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQED 157 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCcccccc
Confidence 99999999999999988764 578999999999999999999999999999999999999 55667999999987654
Q ss_pred cCCccee--cccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 234 EEGKVYR--DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 234 ~~~~~~~--~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
....... ...++..|+|||.+.+ .++.++|||||||++|++++ |..||+..+..+....+..+... .....++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~ 234 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL---PAPRNCP 234 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC---CCCCCCC
Confidence 3322222 2335678999998764 58999999999999999775 99999998888877777665332 2235688
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
..+.+++.+||..+|++|||++++++
T Consensus 235 ~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 235 NLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=331.91 Aligned_cols=258 Identities=26% Similarity=0.377 Sum_probs=215.1
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.+|++.+.||+|+||.||++.+..+++.||+|++.... .......+.+|+++++.++ ||||+++++++...+.+++|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCEEEEE
Confidence 57999999999999999999999999999999886432 2334678899999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~-~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
|||+++++|.+++...+.+++..+..++.+++.+|.|||+ .+++||||||+||++ +.++.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhh-
Confidence 9999999999998887889999999999999999999997 699999999999999 55667999999998765332
Q ss_pred ceecccCcccccchHHHh-hcCCCcchHHHHHHHHHHHhhCCCCCCCCChH-----------HHHHHHHcCCCCCCCCCC
Q 016233 238 VYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEK-----------GIFDAILQGDIDFESAPW 305 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-----------~~~~~i~~~~~~~~~~~~ 305 (393)
......|+..|+|||++. +.++.++|||||||++|+|++|..||...... +.+..+..... +....
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 235 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP--PRLPS 235 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC--CCCCc
Confidence 223457899999999875 46889999999999999999999999765431 22233332211 11112
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCC
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEA 345 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 345 (393)
..++.++.+||.+||..||++|||+.|+++|+||.+....
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~ 275 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRA 275 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 2377899999999999999999999999999999765433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=331.18 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=206.0
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||+|.+..+|+.||+|.+..... ......+..|+.++.+..+||||+++++++..++.+|+||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 68999999999999999999999999999999875432 2233455667776444446999999999999999999999
Q ss_pred eccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 160 ELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 160 e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~~-~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
||++ |+|.+++.. ...+++..++.++.|++.||.|||++ +++||||||+||++ +.++.+||+|||++....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecccccccc
Confidence 9996 577776654 24689999999999999999999997 99999999999999 556679999999998765
Q ss_pred CCcceecccCcccccchHHHhh-----cCCCcchHHHHHHHHHHHhhCCCCCCCCC-hHHHHHHHHcCCCCCCCCCCCCC
Q 016233 235 EGKVYRDIVGSAYYVAPEVLRR-----RYGKEIDIWSAGVILYILLSGVPPFWAET-EKGIFDAILQGDIDFESAPWPTI 308 (393)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~DiwSlG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~ 308 (393)
.........|+..|+|||.+.+ .++.++|+|||||++|+|++|..||.... ..+.+..+..+.. .......+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 233 (283)
T cd06617 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS--PQLPAEKF 233 (283)
T ss_pred cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC--CCCCcccc
Confidence 4433344578999999998753 36889999999999999999999996532 2233333333211 11112357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+.++.+||.+||..||++|||+.++++||||...
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 8999999999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=334.48 Aligned_cols=254 Identities=28% Similarity=0.453 Sum_probs=208.4
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||.|++|.||+|.+..+++.||||.+..... .......+.+|++++++++ ||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEEEEe
Confidence 48899999999999999999999999999998865432 2334467889999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 160 ELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||+. ++|.+++.. ...+++..+..++.|++.||+|||++|++||||+|+||++ +.++.+||+|||++.......
T Consensus 79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCc
Confidence 9995 588888765 3468999999999999999999999999999999999999 556679999999987654322
Q ss_pred -ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC---------------
Q 016233 238 -VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID--------------- 299 (393)
Q Consensus 238 -~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~--------------- 299 (393)
......+++.|+|||.+.+ .++.++|||||||++|+|+||..||...+..+....+.+....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 2234467889999998754 2688999999999999999999999877655444333221100
Q ss_pred ---CCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 300 ---FES-------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 300 ---~~~-------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
++. ...+.++++++++|.+||..||++|||++++|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 000 0123478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=326.46 Aligned_cols=252 Identities=32% Similarity=0.551 Sum_probs=216.4
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe--CCeEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--KQSVHV 157 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~~l 157 (393)
+|++.+.||.|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++ |+||+++++++.. ....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEEE
Confidence 48899999999999999999999999999999875433 3344667889999999997 9999999997753 456899
Q ss_pred EEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-----HcCcEecCCCCCcEEeccCCCCCcEEEeecC
Q 016233 158 VMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICH-----FMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH-----~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg 228 (393)
+|||+++++|.+++.. ...+++..++.++.||+.||.||| +.+|+|+||+|+||++ +.++.+||+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEeccc
Confidence 9999999999998865 357899999999999999999999 8999999999999999 456779999999
Q ss_pred CcccccCCcc-eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 016233 229 LSVFIEEGKV-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP 306 (393)
Q Consensus 229 ~a~~~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 306 (393)
++........ .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||...+.......+..+..... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~ 232 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI---PY 232 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCC---cc
Confidence 9988765443 345678999999999865 478899999999999999999999998877777777766543221 23
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
.++..+.+++.+||..+|++|||+.++++|||+
T Consensus 233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 578999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=330.05 Aligned_cols=248 Identities=29% Similarity=0.465 Sum_probs=202.3
Q ss_pred eecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHH---HHHccCCCCeeEEeEEEEeCCeEEEEEecc
Q 016233 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI---MQHLSGQPNIVEFKGAYEDKQSVHVVMELC 162 (393)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~---l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 162 (393)
.||+|+||.||+|.+..+++.||+|.+.+..............|..+ ++.. +||||+++++++.+.+.+++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCEEEEEEecC
Confidence 48999999999999999999999999976543322222333444443 3444 4999999999999999999999999
Q ss_pred CCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcceecc
Q 016233 163 AGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI 242 (393)
Q Consensus 163 ~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~~~ 242 (393)
.|++|.+++...+.+++..+..++.|++.||.|||+++|+||||||+||++ +.++.++|+|||++....... ....
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~~-~~~~ 155 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHAS 155 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCccC-CcCc
Confidence 999999999888889999999999999999999999999999999999999 456679999999987654332 2345
Q ss_pred cCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCC---hHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 016233 243 VGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAET---EKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (393)
Q Consensus 243 ~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (393)
.|+..|+|||++.+ .++.++||||+||++|+|++|..||.... .......+...... ....++.++.+++.
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~~li~ 231 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE----LPDSFSPELRSLLE 231 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC----CCCcCCHHHHHHHH
Confidence 79999999999863 48899999999999999999999998763 22222222222222 22356899999999
Q ss_pred HhcccCCCCCC-----CHHHHhcCccccCC
Q 016233 318 RMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (393)
Q Consensus 318 ~~L~~dp~~Rp-----t~~e~l~h~~~~~~ 342 (393)
+||..||.+|| ++.++++||||...
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 232 GLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred HHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 99999999999 99999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=341.35 Aligned_cols=264 Identities=32% Similarity=0.480 Sum_probs=210.1
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC----
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK---- 152 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---- 152 (393)
+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++ |+||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFES 79 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCcCchhheeecccccc
Confidence 3568999999999999999999999999999999985321 2234566788999999997 99999999886544
Q ss_pred -CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 153 -QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 153 -~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
...|+|+||+.+ +|.+.+. ...+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 80 ~~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~ 154 (336)
T cd07849 80 FNDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLAR 154 (336)
T ss_pred cceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECccccee
Confidence 358999999964 8877664 4579999999999999999999999999999999999999 556779999999987
Q ss_pred cccCCc----ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC--------
Q 016233 232 FIEEGK----VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD-------- 297 (393)
Q Consensus 232 ~~~~~~----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~-------- 297 (393)
...... ......||+.|+|||.+.+ .++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 654322 1233578999999998653 48899999999999999999999997765443332221100
Q ss_pred --------------CCC-CCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCCCC
Q 016233 298 --------------IDF-ESA----PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDK 348 (393)
Q Consensus 298 --------------~~~-~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~~ 348 (393)
... ... ..+.+++++.+||.+||..||++|||+.++++||||.........
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~ 304 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDE 304 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCc
Confidence 000 000 124568889999999999999999999999999999876544333
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=333.71 Aligned_cols=255 Identities=30% Similarity=0.529 Sum_probs=211.9
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+++++.+. |+||+++++++...+..++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEEEEEE
Confidence 69999999999999999999999999999998865432 2334578899999999997 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc--
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-- 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-- 237 (393)
||++++.+..++.....+++.+++.++.||+.||.|||++||+|+||+|+||++ +.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCccc
Confidence 999887776656556679999999999999999999999999999999999999 557779999999998765543
Q ss_pred ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC-----------------
Q 016233 238 VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI----------------- 298 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~----------------- 298 (393)
......++..|+|||++.+ .++.++||||||+++|+|++|.+||.+....+.+..+.....
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 3345678999999998764 478899999999999999999999987665544333221000
Q ss_pred --CCCCC--------CCC-CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 299 --DFESA--------PWP-TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 299 --~~~~~--------~~~-~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
.+... .++ .++.++.+||++||..||++|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00000 011 248899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=334.90 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=204.9
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC---
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ--- 153 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--- 153 (393)
.-++|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.++++++ ||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKATPY 87 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCC-CCCccceEEEEecccccc
Confidence 34579999999999999999999999999999999865432 2223445678999999996 999999999886543
Q ss_pred -----eEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeec
Q 016233 154 -----SVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (393)
Q Consensus 154 -----~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DF 227 (393)
..++||||+. ++|.+.+.... .+++.+++.++.||+.||.|||++|++|+||||+||++ +.++.+||+||
T Consensus 88 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~df 163 (310)
T cd07865 88 NRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADF 163 (310)
T ss_pred cCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEECcC
Confidence 4599999995 47877776543 68999999999999999999999999999999999999 55677999999
Q ss_pred CCcccccCCc-----ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC
Q 016233 228 GLSVFIEEGK-----VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF 300 (393)
Q Consensus 228 g~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 300 (393)
|++....... ......++..|+|||.+.+ .++.++||||||+++|+|++|..||.+.+.......+......+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9998664322 1224567889999998764 37889999999999999999999998776554443333211111
Q ss_pred CCCC----------------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 301 ESAP----------------------------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 301 ~~~~----------------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
+... ....+..+.+||.+||..||++|||++++|+||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0000 01135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=330.11 Aligned_cols=254 Identities=30% Similarity=0.472 Sum_probs=213.9
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||+|.+..+++.+|+|.+.... .......+.+|+++++++. ||||+++++.+...+.+++|+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEEEEEE
Confidence 5788899999999999999999999999999987643 2244567889999999997 999999999999999999999
Q ss_pred eccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 160 ELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~-~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||+.+++|.+++... ..+++..+..++.|++.+|.|||+ .|++|+||||+||++ +.++.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE---CCCCCEEEeecccchhhHHHH
Confidence 999999999998775 789999999999999999999999 999999999999999 456679999999987764332
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCC-----hHHHHHHHHcCCCCCCCCCCCCCCHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET-----EKGIFDAILQGDIDFESAPWPTISSS 311 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (393)
.. ...|+..|+|||.+.+ .++.++||||||+++|+|++|..||.... ..+....+...... ......++.+
T Consensus 156 ~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 232 (265)
T cd06605 156 AK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP--RLPSGKFSPD 232 (265)
T ss_pred hh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC--CCChhhcCHH
Confidence 22 2678999999998865 58899999999999999999999997542 23334444433211 1111127889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 312 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+.++|.+||..||++|||+.+++.||||+..
T Consensus 233 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 233 FQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 9999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=343.23 Aligned_cols=257 Identities=28% Similarity=0.440 Sum_probs=208.5
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC----
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK---- 152 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---- 152 (393)
+..+|++.+.||+|+||.||+|.+..+++.||||.+.+.. ........+.+|+.++++++ |+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCCcc
Confidence 4568999999999999999999999999999999886432 12334556778999999996 99999999988644
Q ss_pred --CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 153 --QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 153 --~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
...|+||||+. ++|.+.+... +++..+..++.|++.||+|||++||+||||||+||++ +.++.+||+|||++
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~~ 165 (353)
T cd07850 92 EFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA 165 (353)
T ss_pred ccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCccc
Confidence 35799999995 4888877543 8999999999999999999999999999999999999 55667999999999
Q ss_pred ccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC------------
Q 016233 231 VFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD------------ 297 (393)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~------------ 297 (393)
.............|++.|+|||.+.+ .++.++|||||||++|+|++|..||...+....+..+....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 166 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred eeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 87655444445678999999998865 58999999999999999999999998776544443332110
Q ss_pred ----------CCCC---------CCC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 298 ----------IDFE---------SAP--------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 298 ----------~~~~---------~~~--------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
.... ... ....++.+.+||.+||..||++|||+.|+|+||||..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 0000 000 1134667899999999999999999999999998863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=324.36 Aligned_cols=248 Identities=29% Similarity=0.519 Sum_probs=214.2
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||++.+..+++.+|+|.+.... .....+.+.+|+.+++.++ |+||+++++.+.+.+.+|+||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEE
Confidence 4889999999999999999999999999999986543 2335677889999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 160 ELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++.......
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeecccc
Confidence 999999999988653 358899999999999999999999999999999999999 556679999999998765432
Q ss_pred c-eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 238 V-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 238 ~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
. .....|++.|+|||++.+ .++.++|+||||+++|+|++|..||...+.......+..+...... ..++..+.+|
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l 231 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP---SHYSYELRSL 231 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC---cccCHHHHHH
Confidence 2 234578999999999865 4889999999999999999999999988877777777666543222 3578899999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 016233 316 VRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~~e~l~h 336 (393)
|.+||..||++|||+.+++.-
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=331.61 Aligned_cols=249 Identities=23% Similarity=0.362 Sum_probs=211.2
Q ss_pred cceeecceecccCCeEEEEEEECCCC-----cEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTG-----RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
.+|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++ ||||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKEQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCCC
Confidence 36889999999999999999976555 689999886432 2334567899999999996 999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCC
Q 016233 154 SVHVVMELCAGGELFDRIIAK----------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~ 217 (393)
..+++|||+++++|.+++... ..+++.++..++.|++.||.|||++||+||||||+||++ +
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---G 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---c
Confidence 999999999999999999764 457888999999999999999999999999999999999 4
Q ss_pred CCCcEEEeecCCcccccCCc---ceecccCcccccchHHHh-hcCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHH
Q 016233 218 ENALLKATDFGLSVFIEEGK---VYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDA 292 (393)
Q Consensus 218 ~~~~~kl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~ 292 (393)
.++.++|+|||++....... ......+++.|+|||.+. +.++.++|||||||++|+|++ |..||.+....+....
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 56679999999998654332 123345688999999875 468999999999999999998 9999999888888777
Q ss_pred HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 293 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
+..+..... ...++.++.+|+.+||+.||++|||+.+++++
T Consensus 239 i~~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 239 IRSRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHcCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 776543322 24688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=355.66 Aligned_cols=263 Identities=21% Similarity=0.301 Sum_probs=195.8
Q ss_pred cccccceeecceecccCCeEEEEEEECCCC-cEEEEEE--------------eecCccCCcccHHHHHHHHHHHHHccCC
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTG-RQFACKS--------------ISKRKLVTKNDKDDIKREIQIMQHLSGQ 139 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~--------------~~~~~~~~~~~~~~~~~E~~~l~~l~~h 139 (393)
..+..+|++++.||+|+||.||+|..+... ...++|. +.+...........+.+|+.+|++++ |
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-H 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-C
Confidence 345678999999999999999998765432 2222221 11111112223556889999999996 9
Q ss_pred CCeeEEeEEEEeCCeEEEEEeccCCCChHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEec
Q 016233 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK-----GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLS 214 (393)
Q Consensus 140 ~niv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~ 214 (393)
|||+++++++.+.+..|+|+|++. ++|.+++... ......+++.++.||+.||.|||++||+||||||+|||+
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl- 300 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL- 300 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE-
Confidence 999999999999999999999994 5777776542 224466788999999999999999999999999999999
Q ss_pred cCCCCCcEEEeecCCcccccCCcc--eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCC---hHH
Q 016233 215 SKDENALLKATDFGLSVFIEEGKV--YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET---EKG 288 (393)
Q Consensus 215 ~~~~~~~~kl~DFg~a~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~---~~~ 288 (393)
+.++.+||+|||++..+..... ....+||..|+|||++.+ .++.++|||||||++|+|++|..++.... ...
T Consensus 301 --~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 301 --NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred --CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 5566799999999987654332 234679999999999875 58999999999999999999886554322 112
Q ss_pred HHHHHHcC-C---CCCCCC------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 016233 289 IFDAILQG-D---IDFESA------------------------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (393)
Q Consensus 289 ~~~~i~~~-~---~~~~~~------------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 340 (393)
.+..+... . ..++.. ....++.++.++|.+||..||.+|||+.|+|+||||.
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~ 458 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS 458 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence 22221110 0 001000 0013567788999999999999999999999999997
Q ss_pred CC
Q 016233 341 EG 342 (393)
Q Consensus 341 ~~ 342 (393)
..
T Consensus 459 ~~ 460 (501)
T PHA03210 459 AE 460 (501)
T ss_pred cC
Confidence 64
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=322.83 Aligned_cols=265 Identities=30% Similarity=0.468 Sum_probs=211.6
Q ss_pred ccceeecceecccCCeEEEEEEECCCCc----EEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe-C
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGR----QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED-K 152 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~ 152 (393)
...|++...||+|.||.||+|..+.++- .+|||.++.++..+. .-....+|+.+++.|+ ||||+.+..+|-. +
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG-iS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG-ISMSACREIALLRELK-HPNVISLVKVFLSHD 100 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC-cCHHHHHHHHHHHHhc-CCcchhHHHHHhccC
Confidence 3479999999999999999997766543 789999876543222 3355678999999997 9999999998876 8
Q ss_pred CeEEEEEeccCCCChHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccC-CCCCcEEEee
Q 016233 153 QSVHVVMELCAGGELFDRIIA-----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK-DENALLKATD 226 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~-~~~~~~kl~D 226 (393)
..+++++||.+. +|+..|.- ...++...++.|+.||+.|+.|||++-|+||||||.|||+..+ .+.+.+||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 899999999965 88887753 2458999999999999999999999999999999999999644 2458999999
Q ss_pred cCCcccccCCc----ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCCh---------HHHHH
Q 016233 227 FGLSVFIEEGK----VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETE---------KGIFD 291 (393)
Q Consensus 227 Fg~a~~~~~~~----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~---------~~~~~ 291 (393)
||+++.+.+.- ....++-|.+|+|||.+.+ .|+++.|||++|||+.||||-.+.|.+... .+.++
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999886542 2345678999999999875 499999999999999999999998866432 13344
Q ss_pred HHHcCCCCCCCCCCC---------------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 016233 292 AILQGDIDFESAPWP---------------------------------TISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338 (393)
Q Consensus 292 ~i~~~~~~~~~~~~~---------------------------------~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~ 338 (393)
.|.+---......|+ .-++...+|+.+||+.||.+|+|++++|+|+|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 443322222222222 12556899999999999999999999999999
Q ss_pred ccCCCCC
Q 016233 339 IKEGGEA 345 (393)
Q Consensus 339 ~~~~~~~ 345 (393)
|.+....
T Consensus 340 F~~d~lp 346 (438)
T KOG0666|consen 340 FTEDPLP 346 (438)
T ss_pred cccCCCC
Confidence 9987443
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=339.83 Aligned_cols=262 Identities=30% Similarity=0.440 Sum_probs=212.9
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC----
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK---- 152 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---- 152 (393)
+..+|.+.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++ |+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHREA 80 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCccchHHheecccccc
Confidence 34589999999999999999999999999999999865322 2334556778999999996 99999999987644
Q ss_pred -CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 153 -QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 153 -~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
..+|+|+||+. ++|.+++...+.+++..+..++.|++.||.|||+++++||||||+||++ +.++.+||+|||++.
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLAR 156 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCcccc
Confidence 35899999995 6899988887889999999999999999999999999999999999999 455679999999998
Q ss_pred cccCC-cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-----------
Q 016233 232 FIEEG-KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD----------- 297 (393)
Q Consensus 232 ~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~----------- 297 (393)
..... .......|+..|+|||.+.. .++.++|||||||++|+|++|..||.+.+....+..+....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 76543 22344578899999998753 58899999999999999999999997765433332221100
Q ss_pred ------------CCCC----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 298 ------------IDFE----SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 298 ------------~~~~----~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
.... ...++.+++++.+||++||..||++|||++++|+||||.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 0000 1123468899999999999999999999999999999976433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=330.04 Aligned_cols=253 Identities=27% Similarity=0.472 Sum_probs=208.9
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||.|++|.||+|.+..+|+.||||.+..... ......+.+|+.+++.++ |+||+++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELK-HENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEEEEE
Confidence 48899999999999999999999999999999875432 234566778999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 160 ELCAGGELFDRIIAK---GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 160 e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
||+++ +|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIP 153 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCC
Confidence 99975 888887654 358999999999999999999999999999999999999 45667999999999765432
Q ss_pred -cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC-------------
Q 016233 237 -KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF------------- 300 (393)
Q Consensus 237 -~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~------------- 300 (393)
.......++..|+|||.+.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.+.....
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 12234567889999998754 36889999999999999999999998877655554443211000
Q ss_pred -----CC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 301 -----ES-------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 301 -----~~-------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
+. ...+.++..+.++|.+||+.||++|||++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 0012457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=326.84 Aligned_cols=252 Identities=27% Similarity=0.487 Sum_probs=210.2
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.+|++.+.||+|+||.||+|.+..+++.||||.+.............+.+|+.+++.++ ||||+++++++.+.+..++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeEEEE
Confidence 47999999999999999999999999999999887544334445567889999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 159 MELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+||+++++|.+++.. ...+++..+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccceecc
Confidence 999999999887753 3448899999999999999999999999999999999999 455679999999988765
Q ss_pred CCcc-eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh--HHHHHHHHcCCCCCCCCCCCCCCH
Q 016233 235 EGKV-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE--KGIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 235 ~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
.... .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||..... ......+.... ++......++.
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTEHYSE 235 (267)
T ss_pred chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--CCCCChhhcCH
Confidence 4321 234568899999998865 588899999999999999999999976542 34444444432 22222345778
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
.+.+++.+||..||++|||++++++.
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 99999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=331.45 Aligned_cols=253 Identities=33% Similarity=0.650 Sum_probs=221.2
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|.+.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++++.+|+||+++++++.+.+..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 68999999999999999999999999999999976554444456778899999999966999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc--
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-- 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-- 237 (393)
||+++++|.+++...+.+++..++.++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccCCcccc
Confidence 999999999999888889999999999999999999999999999999999999 455679999999988664322
Q ss_pred -------------------ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC
Q 016233 238 -------------------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD 297 (393)
Q Consensus 238 -------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 297 (393)
......|+..|+|||++.. .++.++||||||++++++++|..||...+....+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence 1123467899999998764 47889999999999999999999999888777777766554
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCccc
Q 016233 298 IDFESAPWPTISSSAKDLVRRMLTQDPKKRITS----AQVLEHPWI 339 (393)
Q Consensus 298 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~----~e~l~h~~~ 339 (393)
..++ ..+++.+.+||.+||..||++|||+ +++|+||||
T Consensus 239 ~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 YSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 4443 3568999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=333.09 Aligned_cols=257 Identities=28% Similarity=0.490 Sum_probs=214.5
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
+...+|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++ ||||+++++++.+.+..
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREHTA 90 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCCeE
Confidence 34567999999999999999999999999999999986543333334567889999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
++|+||+. |++.+.+.. ...+++..+..++.|++.||.|||+.||+||||+|+||++ +.++.++|+|||++....
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLVS 166 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcceecC
Confidence 99999996 577676654 4568999999999999999999999999999999999999 556679999999987654
Q ss_pred CCcceecccCcccccchHHHh----hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 016233 235 EGKVYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
.. ....|+..|+|||++. +.++.++||||||+++|+|++|..||...+.......+..... +......++.
T Consensus 167 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 241 (307)
T cd06607 167 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLSSNDWSD 241 (307)
T ss_pred CC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--CCCCchhhCH
Confidence 33 3456889999999873 3488899999999999999999999988776655544443321 1111234678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.+.++|.+||..||++||++.+++.||||...
T Consensus 242 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 242 YFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 99999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=332.36 Aligned_cols=257 Identities=26% Similarity=0.377 Sum_probs=207.6
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|...+.||+|+||.||++.+..+++.+|+|.+..... ......+.+|+.++.++.+|+||+++++++..++..+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 56778899999999999999999999999999875432 2345678899999999977999999999999999999999
Q ss_pred eccCCCChHHHH---H--HcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 160 ELCAGGELFDRI---I--AKGHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 160 e~~~gg~L~~~l---~--~~~~~~~~~~~~i~~qll~~l~~lH~~-~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
||+.+ ++.++. . ....+++..+..++.|++.||+|||+. +|+||||||+||++ +..+.++|+|||++...
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQL 158 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHHh
Confidence 99854 554432 2 235699999999999999999999974 99999999999999 45567999999999876
Q ss_pred cCCcceecccCcccccchHHHhh----cCCCcchHHHHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCC-CCCCCCCCCC
Q 016233 234 EEGKVYRDIVGSAYYVAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGD-IDFESAPWPT 307 (393)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~-~~~~~~~~~~ 307 (393)
..........|+..|+|||++.+ .++.++|||||||++|+|++|..||..... .+.+..+..+. .......+..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence 55444445578999999999864 488999999999999999999999976542 12222222222 1222222345
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
++.++.+||.+||..||++|||++++++||||...
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 88999999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=333.89 Aligned_cols=250 Identities=25% Similarity=0.357 Sum_probs=204.8
Q ss_pred cceeecceecccCCeEEEEEEECCCCcE--EEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQ--FACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
.+|++.+.||+|+||.||+|.+..++.. +|+|.+.. .........+.+|+.++.++.+|+||+++++++..++.+|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 3689999999999999999999887765 46665542 2233445678899999999955999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCC
Q 016233 157 VVMELCAGGELFDRIIAKG----------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA 220 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~ 220 (393)
+||||+++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||+ +.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCCC
Confidence 9999999999999987542 47889999999999999999999999999999999999 4566
Q ss_pred cEEEeecCCcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCC
Q 016233 221 LLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDI 298 (393)
Q Consensus 221 ~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~ 298 (393)
.+||+|||++.............++..|+|||.+.+ .++.++|||||||++|+|+| |..||...+..+....+..+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 241 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCc
Confidence 799999999864322111112234567999998865 47899999999999999998 9999988877777666654321
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 299 DFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 299 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
......+++++.+||.+||..||++||+++++|++
T Consensus 242 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 242 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11223578999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=327.49 Aligned_cols=256 Identities=31% Similarity=0.583 Sum_probs=216.9
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
..|...+.||+|++|.||++.+..+++.+++|.+... .....+.+.+|+.+++.+. ||||+++++++...+..++|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcC-CCChheEEEEEEcCCeEEEE
Confidence 3566667899999999999999999999999988543 2234566889999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc-
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~- 237 (393)
+||+.|++|.+++.. ..+++..+..++.|++.||.|||++||+||||+|+||++ +.++.++|+|||++.......
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 95 MEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCCc
Confidence 999999999998877 679999999999999999999999999999999999999 556779999999887654322
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
......|++.|+|||.+.+ .++.++|||||||++|+|++|..||...+.......+....... ......++..+.+|+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li 249 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPK-LKNLHKVSPRLRSFL 249 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCC-CcccccCCHHHHHHH
Confidence 2234568999999999865 48899999999999999999999998877766666666553221 112234789999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 317 RRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 317 ~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
.+||..||++|||+.++++||||....
T Consensus 250 ~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 250 DRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HHHcccChhhCcCHHHHccCcccccCC
Confidence 999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=327.69 Aligned_cols=254 Identities=26% Similarity=0.466 Sum_probs=215.1
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
+-|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++++. ||||+++++++..++.+++|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeEEEE
Confidence 45788899999999999999999999999999886432 2234567889999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc-
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~- 237 (393)
|||+++++|.+++.. ..+++..+..++.|++.++.|||++|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccchh
Confidence 999999999988754 568999999999999999999999999999999999999 455679999999987664432
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
......|+..|+|||.+.+ .++.++|+|||||++|+|++|..||...........+...... .....++.++.++|
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i 233 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPLKEFV 233 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCC---CCCcccCHHHHHHH
Confidence 2233568899999998865 4788999999999999999999999877666555555443221 11235789999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCC
Q 016233 317 RRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 317 ~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.+||..||++||++.++++||||.+.
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 234 EACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHccCChhhCcCHHHHHhCHHHhhh
Confidence 99999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=344.58 Aligned_cols=235 Identities=27% Similarity=0.480 Sum_probs=208.8
Q ss_pred cceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccC
Q 016233 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCA 163 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 163 (393)
++-||+|+.|.||+|+.. ++.||||.++ +.-+.+|+-|++|+ ||||+.+.++|...--+|||||||.
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~----------elkETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVR----------ELKETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHh----------hhhhhhHHHHHhcc-CcceeeEeeeecCCceeEEeeeccc
Confidence 556899999999999977 7899999764 22245788999997 9999999999999999999999999
Q ss_pred CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcceeccc
Q 016233 164 GGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243 (393)
Q Consensus 164 gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~ 243 (393)
.|.|...|+....++......|..+|+.|++|||.+.|||||||.-||||+.++ .|||+|||.++...+....-.++
T Consensus 196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d---~VKIsDFGTS~e~~~~STkMSFa 272 (904)
T KOG4721|consen 196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD---VVKISDFGTSKELSDKSTKMSFA 272 (904)
T ss_pred cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc---eEEeccccchHhhhhhhhhhhhh
Confidence 999999999999999999999999999999999999999999999999996544 59999999999887776667789
Q ss_pred CcccccchHHHhhc-CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 016233 244 GSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (393)
Q Consensus 244 gt~~y~aPE~l~~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (393)
||..|||||+++.+ .+.|+|||||||+|||||||..||.+.+...++.-+-.+.+..+.+ ..+++-++-||+.||.-
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvP--stcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVP--STCPDGFKLLLKQCWNS 350 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCc--ccCchHHHHHHHHHHhc
Confidence 99999999999864 8999999999999999999999998887776666555555544443 57889999999999999
Q ss_pred CCCCCCCHHHHhcC
Q 016233 323 DPKKRITSAQVLEH 336 (393)
Q Consensus 323 dp~~Rpt~~e~l~h 336 (393)
.|..||++.++|.|
T Consensus 351 KpRNRPSFrqil~H 364 (904)
T KOG4721|consen 351 KPRNRPSFRQILLH 364 (904)
T ss_pred CCCCCccHHHHHHH
Confidence 99999999999988
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=333.23 Aligned_cols=255 Identities=28% Similarity=0.464 Sum_probs=214.1
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
...|+..+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++++. ||||+++++++..++.+|+
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCceEE
Confidence 346888899999999999999999999999999886442 2234567899999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||||+++++|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||++. .++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 80 IMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe---CCCCEEEccccccccccCcc
Confidence 9999999999987754 5789999999999999999999999999999999999994 55679999999998765432
Q ss_pred c-eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 238 V-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 238 ~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
. .....|+..|+|||.+.+ .++.++|||||||++|+|++|..||...........+...... .....++.++.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l 232 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP---TLEGQYSKPFKEF 232 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC---CCCcccCHHHHHH
Confidence 2 223468899999999865 4888999999999999999999999766655544444333211 1113467899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 316 VRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
|.+||..+|++|||+.++++||||...
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 233 VEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 999999999999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=326.44 Aligned_cols=249 Identities=36% Similarity=0.629 Sum_probs=216.6
Q ss_pred ecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCCCC
Q 016233 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGE 166 (393)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~gg~ 166 (393)
||.|+||.||+|.+..+|+.+|+|.+.............+.+|+.++++++ ||||+++++.+...+..|+|+||+.+++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999999999999999997654433455678899999999997 9999999999999999999999999999
Q ss_pred hHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc---------
Q 016233 167 LFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK--------- 237 (393)
Q Consensus 167 L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~--------- 237 (393)
|.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccccccc
Confidence 99999887789999999999999999999999999999999999999 456679999999987654321
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
......++..|+|||.+.. .++.++||||||+++|+|++|..||......+....+..+...++.. ..++..+.+|+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i 234 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI 234 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHHHHHH
Confidence 2234568889999998764 48889999999999999999999999888888887777755544332 23589999999
Q ss_pred HHhcccCCCCCCCH---HHHhcCccccC
Q 016233 317 RRMLTQDPKKRITS---AQVLEHPWIKE 341 (393)
Q Consensus 317 ~~~L~~dp~~Rpt~---~e~l~h~~~~~ 341 (393)
.+||..+|++|||+ .++|+||||..
T Consensus 235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred HHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 99999999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=326.78 Aligned_cols=253 Identities=23% Similarity=0.359 Sum_probs=210.6
Q ss_pred ccceeecceecccCCeEEEEEEECC-----CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENS-----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
..+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++ |+||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFN-HQNIVRLIGVSFER 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccC
Confidence 4579999999999999999999987 77899999875432 2233456888999999996 99999999999998
Q ss_pred CeEEEEEeccCCCChHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEe
Q 016233 153 QSVHVVMELCAGGELFDRIIAKG-------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~~-------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~ 225 (393)
+..++||||+.|++|.+++...+ .+++..+..++.||+.||.|||+++++||||||+||+++..+....+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999999987653 48889999999999999999999999999999999999765555679999
Q ss_pred ecCCcccccCCcce---ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCC
Q 016233 226 DFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDF 300 (393)
Q Consensus 226 DFg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 300 (393)
|||++......... ....++..|+|||++.+ .++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~- 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL- 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-
Confidence 99999876432211 12233567999999864 59999999999999999997 99999988777766665543221
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 301 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
.....++..+.+++.+||..||++|||+.++++|
T Consensus 241 --~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 --DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1124578999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=323.45 Aligned_cols=253 Identities=28% Similarity=0.530 Sum_probs=216.1
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|.+.+.||+|+||.||+|.+..+|..+|+|.+..... .....+.+.+|+.+++.++ |+||+++++.+.+.+..++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEEEEE
Confidence 58899999999999999999999999999999876432 2234567889999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 160 ELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||+.+++|.+++.... .+++..+..++.|++.||.|||+++|+|+||||+||+++. ....+||+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK--NGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC--CCCeEEecccccchhccCCc
Confidence 9999999999887643 4789999999999999999999999999999999999953 22457999999998765433
Q ss_pred c-eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 238 V-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 238 ~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
. .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||...+..+....+........ .+.++.++.++
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 233 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPI---SPNFSRDLRSL 233 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCC---CCCCCHHHHHH
Confidence 2 233468999999998864 588999999999999999999999988777766666665543322 24578899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccc
Q 016233 316 VRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
|.+||..+|++|||+.++++||||
T Consensus 234 i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 234 ISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=324.64 Aligned_cols=253 Identities=30% Similarity=0.490 Sum_probs=217.8
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|++|.||+|.+..+++.|++|.+..... ......+.+|+.++++++ |+||+++++++...+.+++||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEEEEE
Confidence 68899999999999999999999999999999865432 134678999999999997 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~-~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~ 238 (393)
||+++++|.+++.....+++..+..++.|++.+|.|||+ .|++||||+|+||++ +.++.++|+|||++........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCCC
Confidence 999999999999887889999999999999999999999 999999999999999 5567799999999987654433
Q ss_pred e-ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCC---ChHHHHHHHHcCCCCCCCCCCCC-CCHHH
Q 016233 239 Y-RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAE---TEKGIFDAILQGDIDFESAPWPT-ISSSA 312 (393)
Q Consensus 239 ~-~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~-~s~~~ 312 (393)
. ....++..|+|||.+.+ .++.++|+||||+++|+|++|..||... ...+....+....... . ... ++..+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~l 232 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS--L-PAEEFSPEF 232 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC--C-CcccCCHHH
Confidence 2 24568899999998865 4788999999999999999999999776 3444455555332211 1 123 78999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 313 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
.++|.+||..+|++|||+.++++||||+.
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=339.97 Aligned_cols=263 Identities=27% Similarity=0.436 Sum_probs=214.0
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE----eCC
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE----DKQ 153 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~----~~~ 153 (393)
..+|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++ ||||+++++++. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCCc
Confidence 4689999999999999999999999999999999875432 2234567788999999997 999999999875 335
Q ss_pred eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
.+++||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEecccccceee
Confidence 7899999995 5898888777789999999999999999999999999999999999999 55677999999999765
Q ss_pred cCCc-----ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC----------
Q 016233 234 EEGK-----VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG---------- 296 (393)
Q Consensus 234 ~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~---------- 296 (393)
.... ......|+..|+|||.+.+ .++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 4322 1234578999999998754 4889999999999999999999999876654333222210
Q ss_pred -------------CCCCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCC
Q 016233 297 -------------DIDFESA----PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346 (393)
Q Consensus 297 -------------~~~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~ 346 (393)
....... .++.++.++.++|++||+.||++|||+++++.||||.......
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~ 304 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD 304 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence 0000111 1245789999999999999999999999999999997654443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=326.85 Aligned_cols=252 Identities=20% Similarity=0.345 Sum_probs=208.0
Q ss_pred ccccceeecceecccCCeEEEEEEECC-----CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENS-----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
....+|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++ ||||+++++++.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~ 79 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVS 79 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEc
Confidence 456789999999999999999998652 35689999875432 2234556889999999996 999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCC
Q 016233 151 DKQSVHVVMELCAGGELFDRIIAKG----------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA 220 (393)
Q Consensus 151 ~~~~~~lv~e~~~gg~L~~~l~~~~----------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~ 220 (393)
..+..++||||+++++|.+++.... .++...+..++.|++.||.|||+.|++||||||+||++ +.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~~ 156 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDF 156 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCCC
Confidence 9999999999999999999987532 25677889999999999999999999999999999999 4566
Q ss_pred cEEEeecCCcccccCCcce---ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHc
Q 016233 221 LLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQ 295 (393)
Q Consensus 221 ~~kl~DFg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~ 295 (393)
.++|+|||++......... ....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 7999999998765433221 12345778999999865 58999999999999999999 7899988887777776666
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 296 GDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 296 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
...... ...++..+.+++.+||..||++|||+.|++++
T Consensus 237 ~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 237 GGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 543221 13578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=331.84 Aligned_cols=256 Identities=30% Similarity=0.572 Sum_probs=216.6
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
..|.....||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.+. ||||+++++++..++..++|
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~iv 96 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HQNVVEMYKSYLVGEELWVL 96 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCC-CCchhhhhhheeeCCeEEEE
Confidence 34556678999999999999999999999999986542 234567889999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc-
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~- 237 (393)
+||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.++|+|||++.......
T Consensus 97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhcccccc
Confidence 999999999886644 578999999999999999999999999999999999999 556779999999987654332
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
......|+..|+|||++.+ .++.++|||||||++|+|++|..||...+..+.+..+..... .....+..++..+.++|
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i 251 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PKLKNAHKISPVLRDFL 251 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-CCccccCCCCHHHHHHH
Confidence 2234678999999999875 588999999999999999999999988776666665544322 22223456789999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 317 RRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 317 ~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
.+||..||++||+++++++||||.+..
T Consensus 252 ~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 252 ERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred HHHhcCCcccCcCHHHHhhChhhccCC
Confidence 999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=334.35 Aligned_cols=258 Identities=30% Similarity=0.484 Sum_probs=205.0
Q ss_pred ceeecceecccCCeEEEEEEECC--CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC--CeE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENS--TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QSV 155 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~ 155 (393)
+|++.+.||+|+||.||+|.+.. +++.||+|.+...........+.+.+|+.+++.++ ||||+++++++.+. ..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCceE
Confidence 48899999999999999999988 89999999997643223334567788999999996 99999999999988 889
Q ss_pred EEEEeccCCCChHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEecc-CCCCCcEEEeecCC
Q 016233 156 HVVMELCAGGELFDRIIAK-----GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSS-KDENALLKATDFGL 229 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~-~~~~~~~kl~DFg~ 229 (393)
++||||+++ +|.+.+... ..+++..++.++.||+.||.|||+++|+||||||+||+++. .+..+.+||+|||+
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999999965 677766432 25889999999999999999999999999999999999954 12277899999999
Q ss_pred cccccCCcc----eecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHH---------HHHHHH
Q 016233 230 SVFIEEGKV----YRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKG---------IFDAIL 294 (393)
Q Consensus 230 a~~~~~~~~----~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~---------~~~~i~ 294 (393)
+........ .....++..|+|||++.+ .++.++|||||||++|+|++|..||.+..... .+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 987643321 234568899999998764 47899999999999999999999997654321 111110
Q ss_pred cCC----------------C-----CCCCCCC------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 295 QGD----------------I-----DFESAPW------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 295 ~~~----------------~-----~~~~~~~------------~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
... . ......+ ...+..+.++|.+||..||++|||+.|+++||||
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 000 0 0000111 1467789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=362.18 Aligned_cols=253 Identities=28% Similarity=0.372 Sum_probs=205.4
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.+|++.++||+|+||.||+|.+..+|+.||+|++.............+.+|+++++.+. ||||+++++++.+.+..|+|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEEEEE
Confidence 47999999999999999999999999999999997543333334567899999999997 99999999999999999999
Q ss_pred EeccCCCChHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeec
Q 016233 159 MELCAGGELFDRIIAK-----------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~-----------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DF 227 (393)
|||++||+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||+ +.++.++|+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEec
Confidence 9999999999988642 234566788999999999999999999999999999999 55667999999
Q ss_pred CCcccccCCc-------------------ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChH
Q 016233 228 GLSVFIEEGK-------------------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEK 287 (393)
Q Consensus 228 g~a~~~~~~~-------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 287 (393)
|++....... .....+||+.|+|||++.+ .++.++|||||||++|+|+||..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9998662110 0113469999999999865 5899999999999999999999999876554
Q ss_pred HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 288 GIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 288 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
......... .......+..+++.+.+++.+||..||++|++..+.+.+
T Consensus 238 ki~~~~~i~-~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 238 KISYRDVIL-SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhhhcc-ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 333221111 111112345688999999999999999999987776654
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=329.89 Aligned_cols=253 Identities=28% Similarity=0.459 Sum_probs=208.8
Q ss_pred eeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEe
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 160 (393)
|++.+.||.|++|.||+|.+..+|..||+|++..... .......+.+|+.+++.++ ||||+++++++.+.+..|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEEEEe
Confidence 6778899999999999999999999999999875432 2233466788999999997 9999999999999999999999
Q ss_pred ccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-c
Q 016233 161 LCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-K 237 (393)
Q Consensus 161 ~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~-~ 237 (393)
|+. ++|.+++.... .+++..+..++.|++.||.|||+++++||||+|+||+++ .++.++|+|||++...... .
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFGVPVR 154 (283)
T ss_pred ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCcEEEeecccccccCCCcc
Confidence 995 68999887765 689999999999999999999999999999999999994 4667999999999765432 2
Q ss_pred ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC-----------------
Q 016233 238 VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI----------------- 298 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~----------------- 298 (393)
......++..|+|||++.+ .++.++||||||+++|+|++|..||...+....+..+.+...
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 2233467889999998754 368899999999999999999999987765444333322100
Q ss_pred --------CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 299 --------DFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 299 --------~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
.......+.++..+.++|.+||+.||++|||++++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00011234678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=328.02 Aligned_cols=249 Identities=23% Similarity=0.399 Sum_probs=210.9
Q ss_pred ccceeecceecccCCeEEEEEEECC-----CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENS-----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
..+|.+.+.||+|+||.||+|.+.. +++.||+|.+.... .....+.+.+|+++++.+. |+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQ-HENIVKFYGVCTEG 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcC-CCCchheeeEEecC
Confidence 3468999999999999999998753 46789999986432 2224578899999999996 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCC
Q 016233 153 QSVHVVMELCAGGELFDRIIAKG--------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE 218 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~~--------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~ 218 (393)
+..++||||+++++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||++ +.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~ 157 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GY 157 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cC
Confidence 99999999999999999997642 37888999999999999999999999999999999999 55
Q ss_pred CCcEEEeecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHH
Q 016233 219 NALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAI 293 (393)
Q Consensus 219 ~~~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i 293 (393)
++.+||+|||++........ .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||...+..+....+
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 67899999999976533221 123345788999998864 58999999999999999998 99999988888888888
Q ss_pred HcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 294 LQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 294 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
..+...... ..++..+.+++.+||..||++|||+.|+++
T Consensus 238 ~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 238 TQGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 766543322 357899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=341.92 Aligned_cols=255 Identities=22% Similarity=0.347 Sum_probs=206.4
Q ss_pred cccccccceeecceecccCCeEEEEEEECCC-----CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeE
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENST-----GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 147 (393)
.++...++|.+++.||+|+||.||+|.+... +..||||++.... .....+.+.+|+++++++..||||+++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 4555577899999999999999999987533 3479999986432 23345678999999999966999999999
Q ss_pred EEEeCCeEEEEEeccCCCChHHHHHHc-----------------------------------------------------
Q 016233 148 AYEDKQSVHVVMELCAGGELFDRIIAK----------------------------------------------------- 174 (393)
Q Consensus 148 ~~~~~~~~~lv~e~~~gg~L~~~l~~~----------------------------------------------------- 174 (393)
++.+.+.+|||||||++|+|.+++...
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 999999999999999999999888642
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcE
Q 016233 175 -------------------------------------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENF 211 (393)
Q Consensus 175 -------------------------------------------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Ni 211 (393)
..+++..+..++.||+.||.|||+++|+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 1367778899999999999999999999999999999
Q ss_pred EeccCCCCCcEEEeecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCCh
Q 016233 212 LLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETE 286 (393)
Q Consensus 212 ll~~~~~~~~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~ 286 (393)
|+ +.+..+||+|||++........ .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.....
T Consensus 269 ll---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 269 LL---AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred EE---eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 99 4566799999999986543322 123456788999998864 58999999999999999997 9999987654
Q ss_pred HH-HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 287 KG-IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 287 ~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.. ....+..+ .... ....++.++.+++.+||..||++|||+.++.+
T Consensus 346 ~~~~~~~~~~~-~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 346 DSTFYNKIKSG-YRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred hHHHHHHHhcC-CCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 33 33344433 2222 22467899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=329.43 Aligned_cols=256 Identities=30% Similarity=0.583 Sum_probs=213.4
Q ss_pred ceeecceecccCCeEEEEEEEC---CCCcEEEEEEeecCccC-CcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 80 HYSFGKELGRGQFGVTYLCTEN---STGRQFACKSISKRKLV-TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
.|++.+.||+|+||.||.|.+. .+|+.||+|++...... .....+.+.+|+.+++++.+|+||++++++++.++.+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999874 47899999998754321 2233567888999999997799999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
++||||+++++|.+++.....+++..+..++.|++.||.|||++|++||||+|+|||+ +.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceeccc
Confidence 9999999999999999888889999999999999999999999999999999999999 4567799999999987644
Q ss_pred Cc--ceecccCcccccchHHHhh---cCCCcchHHHHHHHHHHHhhCCCCCCCCCh----HHHHHHHHcCCCCCCCCCCC
Q 016233 236 GK--VYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAILQGDIDFESAPWP 306 (393)
Q Consensus 236 ~~--~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~ 306 (393)
.. ......|+..|+|||.+.+ .++.++||||||+++|+|++|..||..... .+....+......+ ..
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~ 233 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY----PQ 233 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC----Cc
Confidence 32 2234568999999998753 367899999999999999999999964332 33333333333222 23
Q ss_pred CCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCC
Q 016233 307 TISSSAKDLVRRMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (393)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rp-----t~~e~l~h~~~~~~ 342 (393)
.+++.+.+++.+||..||++|| ++++++.||||...
T Consensus 234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 5789999999999999999997 89999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=328.49 Aligned_cols=254 Identities=27% Similarity=0.414 Sum_probs=202.9
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.+|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++ |+||+++++++.+++..|+|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCeEEEE
Confidence 579999999999999999999999999999999865431 223446778999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 159 MELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
|||+. ++|.+++.. ...+++..+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||++.......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCCC
Confidence 99995 677776654 3467888999999999999999999999999999999999 456679999999987643321
Q ss_pred -ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHcCC--------------CC
Q 016233 238 -VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGD--------------ID 299 (393)
Q Consensus 238 -~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~--------------~~ 299 (393)
......+++.|+|||.+.+ .++.++|||||||++|+|++|..||.+.... +.+..+.... ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 2234567899999998764 4788999999999999999999999765432 2222221100 00
Q ss_pred CCC------------CCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 300 FES------------APWP--TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 300 ~~~------------~~~~--~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
+.. ..|. ..+..+.+++.+||..||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 000 0011 125789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=335.19 Aligned_cols=263 Identities=27% Similarity=0.412 Sum_probs=213.5
Q ss_pred cccceee-cceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcc-----------cHHHHHHHHHHHHHccCCCCeeE
Q 016233 77 VKLHYSF-GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN-----------DKDDIKREIQIMQHLSGQPNIVE 144 (393)
Q Consensus 77 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~~h~niv~ 144 (393)
+..+|.. .+.||+|+||.||+|.+..+++.||||.+......... ....+.+|+.+++.++ |+||++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~ 84 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIMG 84 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Ccceee
Confidence 4567864 57799999999999999999999999998654321100 1225778999999996 999999
Q ss_pred EeEEEEeCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEE
Q 016233 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKA 224 (393)
Q Consensus 145 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl 224 (393)
+++++...+..++||||+. |+|.+++.....+++..+..++.|++.||.|||++||+|+||+|+||++ +..+.++|
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~~~kl 160 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKGICKI 160 (335)
T ss_pred eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCCCEEE
Confidence 9999999999999999996 5899999887789999999999999999999999999999999999999 45667999
Q ss_pred eecCCcccccCC---------------cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChH
Q 016233 225 TDFGLSVFIEEG---------------KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEK 287 (393)
Q Consensus 225 ~DFg~a~~~~~~---------------~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 287 (393)
+|||++...... .......+++.|+|||.+.+ .++.++|||||||++|+|++|..||.+.+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999998765411 11223457889999998865 3788999999999999999999999888776
Q ss_pred HHHHHHHcCCCCCCCC------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 288 GIFDAILQGDIDFESA------------------------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 288 ~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
+.+..+.......... ..+..+.++.++|.+||..||++|||++++|.||||+...
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 6655543311100000 1134578899999999999999999999999999998654
Q ss_pred C
Q 016233 344 E 344 (393)
Q Consensus 344 ~ 344 (393)
.
T Consensus 321 ~ 321 (335)
T PTZ00024 321 L 321 (335)
T ss_pred C
Confidence 3
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=318.96 Aligned_cols=252 Identities=31% Similarity=0.593 Sum_probs=219.1
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||++.+..+++.||+|.+..... .......+.+|+++++.++ |+|++++++.+......++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEEEEE
Confidence 58899999999999999999999999999999875432 2345677889999999997 999999999999999999999
Q ss_pred eccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 160 ELCAGGELFDRIIAK----GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 160 e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceeeccc
Confidence 999999999988764 679999999999999999999999999999999999999 4566799999999987655
Q ss_pred Cc-ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 236 GK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 236 ~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
.. ......|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||......+....+......... ..++..+.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 232 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIP---SQYSSELR 232 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCC---CCCCHHHH
Confidence 43 2334578999999998765 4889999999999999999999999888777777766655432221 25789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
+++.+||..||++|||+.++|+||||
T Consensus 233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 233 NLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=320.36 Aligned_cols=254 Identities=28% Similarity=0.518 Sum_probs=211.8
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCcc--CCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC--Ce
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL--VTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QS 154 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~ 154 (393)
.+|++.+.||+|+||.||+|.+..+++.||+|.+..... ........+.+|+.++++++ |+||+++++++.+. +.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCE
Confidence 369999999999999999999999999999998854321 12234567889999999996 99999999998764 56
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+++|+||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||++ +.++.++|+|||++....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECccccccccc
Confidence 88999999999999999887789999999999999999999999999999999999999 456679999999998654
Q ss_pred CC----cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 235 EG----KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 235 ~~----~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
.. .......|+..|+|||.+.+ .++.++|+|||||++|+|++|..||......+....+..... .......++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~p~~~~ 235 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT--KPMLPDGVS 235 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCC--CCCCCcccC
Confidence 21 12234568999999998865 488999999999999999999999987765555544443221 122235688
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
+.+.++|.+||. +|.+|||+.+++.|||.
T Consensus 236 ~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 236 DACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=336.14 Aligned_cols=263 Identities=27% Similarity=0.424 Sum_probs=211.0
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC----
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK---- 152 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---- 152 (393)
+..+|.+.+.||.|+||.||+|.+..+|+.||+|.+.... ....+.+.+|+++++.++ ||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcC-CCcchhhHhhhccccccc
Confidence 3568999999999999999999999999999999986543 234567889999999996 99999999876543
Q ss_pred ----------CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcE
Q 016233 153 ----------QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALL 222 (393)
Q Consensus 153 ----------~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~ 222 (393)
...|+||||++ ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++. .+..+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~--~~~~~ 154 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--EDLVL 154 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC--CCceE
Confidence 35799999996 588877653 57999999999999999999999999999999999999953 34568
Q ss_pred EEeecCCcccccCCcc----eecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC
Q 016233 223 KATDFGLSVFIEEGKV----YRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG 296 (393)
Q Consensus 223 kl~DFg~a~~~~~~~~----~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 296 (393)
+|+|||++........ .....|+..|+|||.+.+ .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999976543211 123467889999998753 4788999999999999999999999877655544443321
Q ss_pred CC----------------------CCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCCC
Q 016233 297 DI----------------------DFES----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASD 347 (393)
Q Consensus 297 ~~----------------------~~~~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~ 347 (393)
.. .... ...+.++.++.+||.+||..||++|||+.++|+||||+......+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~ 311 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFD 311 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCcc
Confidence 10 0000 012357889999999999999999999999999999986544433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=325.21 Aligned_cols=251 Identities=27% Similarity=0.499 Sum_probs=209.7
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++.+.||+|+||.||+|.+..+++.+|||.+.............+.+|+.+++.+. |+||+++++++..++..+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEeCCeEEEE
Confidence 36889999999999999999999999999999887544333445567889999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 159 MELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
|||+.|++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||++ +.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccc
Confidence 999999999988763 3458999999999999999999999999999999999999 456679999999988765
Q ss_pred CCc-ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh--HHHHHHHHcCCCCCCCCCCCCCCH
Q 016233 235 EGK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE--KGIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 235 ~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
... ......|+..|+|||.+.+ .++.++|+||||+++|+|++|..||.+... ......+.... ++...+..+++
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSE 235 (267)
T ss_pred cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC--CCCCCcccccH
Confidence 432 2234578999999999865 488899999999999999999999976543 23333443322 23333346889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+.++|.+||..||++|||+.++++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=322.55 Aligned_cols=249 Identities=27% Similarity=0.459 Sum_probs=203.2
Q ss_pred ecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEecc
Q 016233 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELC 162 (393)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 162 (393)
....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++ |+||+++++++..++..++|+||+
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEEEEecC
Confidence 3457999999999999999999999999886432 334567899999999996 999999999999999999999999
Q ss_pred CCCChHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc-c
Q 016233 163 AGGELFDRIIAK-GHY--SERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-V 238 (393)
Q Consensus 163 ~gg~L~~~l~~~-~~~--~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-~ 238 (393)
++++|.+++... ..+ ++..+..++.||+.||.|||++||+||||||+||+++. ....++|+|||++....... .
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~--~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT--YSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCeEEEecchhheecccCCCc
Confidence 999999988764 445 78889999999999999999999999999999999953 24579999999987654322 2
Q ss_pred eecccCcccccchHHHhh---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHH-HHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 239 YRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGI-FDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 239 ~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
.....|++.|+|||.+.+ .++.++||||||+++|+|++|..||........ ...+.. ..........+++++.+
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 243 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM--FKIHPEIPESLSAEAKN 243 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh--hccCCCCCcccCHHHHH
Confidence 234568999999998853 378899999999999999999999975433221 111111 11111122457889999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccc
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
|+.+||..+|++|||+.+++.||||
T Consensus 244 li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 244 FILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHcCCCchhCCCHHHHHhCCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=336.83 Aligned_cols=256 Identities=25% Similarity=0.358 Sum_probs=203.5
Q ss_pred ccccccceeecceecccCCeEEEEEEEC-----CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEE
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 148 (393)
|....++|++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++++.+|+||++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 3445678999999999999999999754 345789999886432 223345678899999999669999999998
Q ss_pred EEe-CCeEEEEEeccCCCChHHHHHHc-----------------------------------------------------
Q 016233 149 YED-KQSVHVVMELCAGGELFDRIIAK----------------------------------------------------- 174 (393)
Q Consensus 149 ~~~-~~~~~lv~e~~~gg~L~~~l~~~----------------------------------------------------- 174 (393)
+.. +..++++|||+++++|.+++...
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 754 45788999999999999988642
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc---eeccc
Q 016233 175 --------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV---YRDIV 243 (393)
Q Consensus 175 --------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~---~~~~~ 243 (393)
..+++..+..++.||+.||.|||++||+||||||+|||++ .++.++|+|||++..+..... .....
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---~~~~vkL~DfG~a~~~~~~~~~~~~~~~~ 236 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDAR 236 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---CCCcEEEeccccchhcccCcchhhccCCC
Confidence 2578889999999999999999999999999999999994 566799999999987643221 12345
Q ss_pred CcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcc
Q 016233 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321 (393)
Q Consensus 244 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 321 (393)
++..|+|||++.+ .++.++|||||||++|+|++ |..||.+....+.+............ ....++++.+++.+||+
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~cl~ 314 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA--PEYATPEIYSIMLDCWH 314 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC--CccCCHHHHHHHHHHcc
Confidence 6678999998764 58999999999999999998 99999875544433333322222211 13568899999999999
Q ss_pred cCCCCCCCHHHHhcC
Q 016233 322 QDPKKRITSAQVLEH 336 (393)
Q Consensus 322 ~dp~~Rpt~~e~l~h 336 (393)
.+|++||++.++++|
T Consensus 315 ~~p~~RPs~~ell~~ 329 (337)
T cd05054 315 NNPEDRPTFSELVEI 329 (337)
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=324.28 Aligned_cols=256 Identities=30% Similarity=0.465 Sum_probs=208.2
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC--CeEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QSVHV 157 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~~l 157 (393)
+|+..+.||.|++|.||+|.+..+++.+|+|.+.... .......+.+|++++++++ ||||+++++++.+. +.+++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeEEE
Confidence 6889999999999999999999999999999987543 2234677899999999996 99999999988643 47899
Q ss_pred EEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 158 VMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
||||++|++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||++ +....++|+|||++...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeeccccccc
Confidence 9999999999887653 3458899999999999999999999999999999999999 45567999999998765
Q ss_pred cCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCC-----ChHHHHHHHHcCCCCCCCCCC--
Q 016233 234 EEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAE-----TEKGIFDAILQGDIDFESAPW-- 305 (393)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~-- 305 (393)
.... .....++..|+|||.+.+ .++.++|||||||++|+|++|..||... ...+....+............
T Consensus 156 ~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd06621 156 VNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234 (287)
T ss_pred cccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence 4322 124567889999998865 5889999999999999999999999765 223344444432211111111
Q ss_pred -CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 306 -PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 306 -~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
...++.+.+||.+||..||++|||+.|++.||||+..
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 1246789999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=328.69 Aligned_cols=258 Identities=29% Similarity=0.547 Sum_probs=232.7
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
...|.++.+||+|+||.|.+|..+.|.+.+|||++++.-+....+.+--..|-++|.....-|.+++++.+|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 34688999999999999999999999999999999887665555566556688888777667899999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc-cCC
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEG 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~-~~~ 236 (393)
||||+.||+|--.+++.+++.|+.+..++..|+.||-+||++||++||||.+|||+ +..+.+||+|||+++.- -.+
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIFDG 504 (683)
T ss_pred EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeecccccccccCC
Confidence 99999999999999999999999999999999999999999999999999999999 67778999999999853 345
Q ss_pred cceecccCcccccchHHHh-hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 237 KVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
....+.||||.|+|||++. ..|+..+|.||+||+|||||.|.+||.+.++.+++..|......++. .+|.++.++
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkEAv~i 580 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKEAVAI 580 (683)
T ss_pred cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHHHHHH
Confidence 5667899999999999875 57999999999999999999999999999999999999998888775 589999999
Q ss_pred HHHhcccCCCCCCCH-----HHHhcCccccCC
Q 016233 316 VRRMLTQDPKKRITS-----AQVLEHPWIKEG 342 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~-----~e~l~h~~~~~~ 342 (393)
.+.+|.+.|.+|..+ .++-.||||+..
T Consensus 581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred HHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 999999999999865 588999999754
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=320.36 Aligned_cols=247 Identities=21% Similarity=0.363 Sum_probs=209.9
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
...|.+.+.||+|+||.||+|.+..+++.||+|.+... ......+.+|+++++.+. |+||+++++++..++.+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCCcEE
Confidence 44688999999999999999999999999999988643 234567889999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 158 VMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCcccccccc
Confidence 99999999999998764 358899999999999999999999999999999999999 5567799999999987654
Q ss_pred Cccee--cccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 016233 236 GKVYR--DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (393)
Q Consensus 236 ~~~~~--~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (393)
..... ...++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+.+..+....+..... ......++.+
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 233 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---MERPEGCPPK 233 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCCHH
Confidence 32211 2234567999998764 58899999999999999998 9999988877777777665421 1222467899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 016233 312 AKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 312 ~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+.++|.+||..||++|||+.++++
T Consensus 234 ~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 234 VYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHHccCCcccCCCHHHHHH
Confidence 999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=326.51 Aligned_cols=253 Identities=32% Similarity=0.507 Sum_probs=210.8
Q ss_pred eeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC--CeEEEE
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QSVHVV 158 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~~lv 158 (393)
|++.+.||+|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.+. |+|++++++++.+. +..++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEE
Confidence 678899999999999999999999999999997653 22334567889999999997 99999999999988 899999
Q ss_pred EeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
+||+++ +|.+++... ..+++..++.++.||+.||+|||++|++|+||+|+||++ ++++.++|+|||++.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCC
Confidence 999975 888887665 579999999999999999999999999999999999999 556779999999998765443
Q ss_pred --ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCC--------
Q 016233 238 --VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW-------- 305 (393)
Q Consensus 238 --~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 305 (393)
......++..|+|||.+.+ .++.++||||||+++|+|++|..||...+....+..+...........|
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 2334567889999997654 4789999999999999999999999887766655555432111111111
Q ss_pred ------------------CC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 306 ------------------PT-ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 306 ------------------~~-~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
.. ++..+.++|.+||..||++|||++++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 12 27889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=327.96 Aligned_cols=257 Identities=31% Similarity=0.531 Sum_probs=214.6
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
..+|.+.+.||+|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.++ ||||+++++++...+..|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENK-HPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcC-CCCeeehhheeeeCCcEEE
Confidence 468999999999999999999999899999999985432 234567889999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
|+||+++++|.+++.+ ..+++.++..++.|++.||.|||++|++|+||||+||++ +.++.++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceecccccc
Confidence 9999999999998765 368899999999999999999999999999999999999 455679999999887654332
Q ss_pred -ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 238 -VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 238 -~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
......|++.|+|||.+.+ .++.++|+||||+++|++++|..||...+....+..+..... .....+..++..+.++
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l 248 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFRDF 248 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCC-CCCCCccccCHHHHHH
Confidence 2234568899999998764 588999999999999999999999987665443333322211 1112234578899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 316 VRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
|.+||..||++||++.+++.|+||....
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 9999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=327.82 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=206.0
Q ss_pred cceeecceecccCCeEEEEEEECCCCc--EEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGR--QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
++|++.+.||+|+||.||+|.+..++. .+++|.++.. ......+.+.+|+.++.++.+||||+++++++...+.++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 479999999999999999999887765 4688877532 123345678899999999966999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCC
Q 016233 157 VVMELCAGGELFDRIIAKG----------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA 220 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~ 220 (393)
+||||+++++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||+ +.+.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCC
Confidence 9999999999999986532 47889999999999999999999999999999999999 4566
Q ss_pred cEEEeecCCcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCC
Q 016233 221 LLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDI 298 (393)
Q Consensus 221 ~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~ 298 (393)
.+||+|||++..............+..|+|||.+.. .++.++|||||||++|+|++ |..||.+....+....+..+..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~ 236 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence 799999999875332211111223457999998764 58999999999999999997 9999998888777777765432
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 299 DFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 299 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
. .....++..+.+||.+||..||.+|||++++++.
T Consensus 237 ~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 237 M---EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 1223578999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=324.73 Aligned_cols=258 Identities=23% Similarity=0.361 Sum_probs=210.5
Q ss_pred cccccceeecceecccCCeEEEEEEECC-----CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEE
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENS-----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 149 (393)
+...++|++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.+. ||||+++++++
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~ 78 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFT-CHHVVRLLGVV 78 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEE
Confidence 3456789999999999999999997652 35589999876432 2223456788999999996 99999999999
Q ss_pred EeCCeEEEEEeccCCCChHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCC
Q 016233 150 EDKQSVHVVMELCAGGELFDRIIAKG----------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDEN 219 (393)
Q Consensus 150 ~~~~~~~lv~e~~~gg~L~~~l~~~~----------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~ 219 (393)
.+.+..++||||+.+|+|.+++.... ..+...+..++.|++.||.|||++||+||||||+||++ +.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~ 155 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHD 155 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCC
Confidence 99999999999999999999997532 24567888999999999999999999999999999999 456
Q ss_pred CcEEEeecCCcccccCCcce---ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHH
Q 016233 220 ALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAIL 294 (393)
Q Consensus 220 ~~~kl~DFg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 294 (393)
+.++|+|||+++........ ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 67999999998865432211 12345678999998864 58999999999999999998 789998888777777666
Q ss_pred cCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc------CccccC
Q 016233 295 QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE------HPWIKE 341 (393)
Q Consensus 295 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~------h~~~~~ 341 (393)
.+..... ...+++.+.+++.+||..||++|||+.++++ ||||..
T Consensus 236 ~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 236 DGGYLDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred cCCCCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 5433211 1346789999999999999999999999986 888865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=325.06 Aligned_cols=248 Identities=24% Similarity=0.410 Sum_probs=209.1
Q ss_pred ccceeecceecccCCeEEEEEEEC-----CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
+..|.+.+.||+|+||.||++.+. .++..+|+|.+... .......+.+|+.++++++ ||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecC
Confidence 457999999999999999999863 34567999988542 2334567899999999996 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCC
Q 016233 153 QSVHVVMELCAGGELFDRIIAKG-------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDEN 219 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~~-------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~ 219 (393)
+.+++||||+++++|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||++ +.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccC
Confidence 99999999999999999987543 38999999999999999999999999999999999999 556
Q ss_pred CcEEEeecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHH
Q 016233 220 ALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAIL 294 (393)
Q Consensus 220 ~~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 294 (393)
+.++|+|||++........ .....++..|+|||++.+ .++.++|||||||++|+|++ |..||......+....+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 6799999999986543321 122345778999999875 58899999999999999998 999998888878888887
Q ss_pred cCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 295 QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 295 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+..... ...++.++.+|+.+||..||.+|||+.+++.
T Consensus 237 ~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 237 QGRVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 7654322 1357899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=335.54 Aligned_cols=263 Identities=28% Similarity=0.470 Sum_probs=215.7
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe-
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS- 154 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~- 154 (393)
.+.++|++.+.||+|++|.||+|.+..+++.||+|++..... .......+.+|+.+++.+. |+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPASSL 89 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhccccc
Confidence 456689999999999999999999999999999998864321 2234466778999999996 9999999998866554
Q ss_pred -----EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 155 -----VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 155 -----~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
.++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||++ +.++.++|+|||+
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~ 164 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGL 164 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEccccc
Confidence 89999999 6799887765 579999999999999999999999999999999999999 4566799999999
Q ss_pred cccccCCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC------
Q 016233 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE------ 301 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~------ 301 (393)
+...... .....++..|+|||.+.+ .++.++|||||||++|+|++|+.||.+....+.+..+........
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 165 ARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred ccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence 9876433 345578899999998864 478899999999999999999999988776655555443211100
Q ss_pred -----------------C----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCCC
Q 016233 302 -----------------S----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASD 347 (393)
Q Consensus 302 -----------------~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~ 347 (393)
. ..+..++..+.+||.+||..||++|||+.++++||||.+......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~ 309 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPED 309 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcc
Confidence 0 012346889999999999999999999999999999987654443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=358.92 Aligned_cols=149 Identities=28% Similarity=0.476 Sum_probs=136.4
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.+|.++++||+|+||.||+|.+..+++.||||++.............+..|+.+++.++ ||||+++++++...+.+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCEEEEE
Confidence 47999999999999999999999999999999997655444445678899999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
|||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence 9999999999999888889999999999999999999999999999999999999 456679999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=333.13 Aligned_cols=261 Identities=26% Similarity=0.419 Sum_probs=213.0
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
...+.++|++.+.||+|+||.||+|.+..++..||||.+.... ........+.+|+.+++.++ ||||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 87 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDL 87 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCccceeeeecCCc
Confidence 3446778999999999999999999999999999999986432 22233456889999999996 999999999987654
Q ss_pred ------eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeec
Q 016233 154 ------SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (393)
Q Consensus 154 ------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DF 227 (393)
.+++||||+ |++|.+++. ...+++..++.++.|++.||.|||++||+||||||+||++ +.++.++|+||
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill---~~~~~~kl~df 162 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDF 162 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeec
Confidence 468999999 778887765 4579999999999999999999999999999999999999 45667999999
Q ss_pred CCcccccCCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC-----
Q 016233 228 GLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF----- 300 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~----- 300 (393)
|++...... .....+++.|+|||.+.+ .++.++|+|||||++|+|++|..||.+.+....+..+.......
T Consensus 163 g~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 163 GLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred ccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 999865432 234567899999998864 47889999999999999999999998776554444333211100
Q ss_pred ------------------C----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 301 ------------------E----SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 301 ------------------~----~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
. ...++.+++++.++|.+||..||++|||+.+++.||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 0 011246788999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=317.92 Aligned_cols=245 Identities=24% Similarity=0.440 Sum_probs=207.5
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.+|++.+.||+|+||.||++..+. +..+|+|.+.... .....+.+|+.++++++ ||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA----MSEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC----ccHHHHHHHHHHHHHCC-CCCceeEEEEEccCCCEEEE
Confidence 358899999999999999998764 5689999875432 23567889999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 159 MELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
|||+++|+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCc
Confidence 999999999998875 3468999999999999999999999999999999999999 556679999999998654332
Q ss_pred cee--cccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 238 VYR--DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 238 ~~~--~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
... ...++..|+|||.+.+ .++.++||||||+++|+|++ |+.||...+..+.+..+..+...... ...+..+.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~ 231 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASMTVY 231 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCHHHH
Confidence 221 2234568999999864 58899999999999999999 99999988888888888776433222 24678899
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 016233 314 DLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+++.+||..||++|||++++++
T Consensus 232 ~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 232 EVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=315.92 Aligned_cols=252 Identities=32% Similarity=0.558 Sum_probs=217.4
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|++|.||++.+..+++.||+|.+..... .......+.+|+++++++. |+|++++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEE
Confidence 58899999999999999999999999999999976543 2245678999999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc-
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV- 238 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~- 238 (393)
||+++++|.+++.....+++..++.++.|++.+|.|||++||+||||+|+||+++ .++.++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC---CCCCEEEeccccceecCCCccc
Confidence 9999999999998888899999999999999999999999999999999999994 456799999999987654432
Q ss_pred eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 016233 239 YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (393)
Q Consensus 239 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (393)
.....|+..|+|||.+.+ .++.++||||+|+++|+|++|..||...........+...... .....++..+.+++.
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~ 232 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP---PLPEGISPELKDFLM 232 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCC---CCCCCCCHHHHHHHH
Confidence 234578999999998864 4788999999999999999999999877655555444433221 222467899999999
Q ss_pred HhcccCCCCCCCHHHHhcCccc
Q 016233 318 RMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 318 ~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
+||..+|++|||+++++.||||
T Consensus 233 ~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHhCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=314.31 Aligned_cols=251 Identities=32% Similarity=0.568 Sum_probs=213.8
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
.|++.+.||+|++|.||++.+..+++.+++|.+..... .....+.+|+++++.+. |+||+++++++..++..++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEEE
Confidence 37888999999999999999999999999999865432 35678899999999997 999999999999999999999
Q ss_pred eccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc
Q 016233 160 ELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (393)
Q Consensus 160 e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~ 238 (393)
||++|++|.+++... ..+++..+..++.|++.+|.+||++|++||||+|+||+++ .++.++|+|||.+........
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc---cCCeEEEeecccccccccccc
Confidence 999999999988775 5799999999999999999999999999999999999994 466799999999988765443
Q ss_pred eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 016233 239 YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (393)
Q Consensus 239 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (393)
.....|+..|+|||.+.+ .++.++|+||||+++|+|++|..||...+.......+....... ......++..+.++|.
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~ 232 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPG-LRNPEKWSDEFKDFLK 232 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCC-cCcccccCHHHHHHHH
Confidence 345678999999999865 47889999999999999999999998775554444444322111 1111224889999999
Q ss_pred HhcccCCCCCCCHHHHhcCcc
Q 016233 318 RMLTQDPKKRITSAQVLEHPW 338 (393)
Q Consensus 318 ~~L~~dp~~Rpt~~e~l~h~~ 338 (393)
+||..||++|||+.++|+|||
T Consensus 233 ~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHccCChhhCCCHHHHhcCCC
Confidence 999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=324.68 Aligned_cols=256 Identities=29% Similarity=0.469 Sum_probs=214.2
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
..+.|...+.||+|+||.||+|.+..+++.|++|.+.............+.+|+.+++.++ |||++++++++.+.+..|
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 97 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTAW 97 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEEE
Confidence 3445778889999999999999999999999999987654333344567889999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 157 VVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
+||||+. |++.+.+.. ...+++.++..++.||+.+|.|||++||+|+||+|+||++ +.++.+||+|||++.....
T Consensus 98 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 98 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSSP 173 (313)
T ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCcccCC
Confidence 9999995 577777755 4568999999999999999999999999999999999999 4556799999999865432
Q ss_pred CcceecccCcccccchHHHh----hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 016233 236 GKVYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (393)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (393)
.....|+..|+|||.+. +.++.++|||||||++|+|++|..||...+.......+...... ......++..
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 248 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--TLQSNEWTDS 248 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCccccCHH
Confidence 23457899999999873 34888999999999999999999999887766655555543322 2223456788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 312 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+.+|+.+||+.+|.+||++.+++.||||...
T Consensus 249 l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 249 FRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=315.82 Aligned_cols=253 Identities=31% Similarity=0.560 Sum_probs=215.3
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC--CeEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QSVHV 157 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~~l 157 (393)
+|++.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.+++++. |+||+++++.+.+. +.+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEE
Confidence 478889999999999999999999999999998754321 345678899999999997 99999999999988 89999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
|+||+++++|.+++.....+++..++.++.|++.+|.|||+.|++|+||+|+||+++ .++.++|+|||.+.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD---SDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEcccccEEeccccc
Confidence 999999999999998877899999999999999999999999999999999999994 46679999999998876554
Q ss_pred c---eecccCcccccchHHHhhc-CCCcchHHHHHHHHHHHhhCCCCCCCCC-hHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 016233 238 V---YRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAET-EKGIFDAILQGDIDFESAPWPTISSSA 312 (393)
Q Consensus 238 ~---~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (393)
. .....++..|+|||.+.+. ++.++||||||+++|+|++|..||.... .......+..... .......++..+
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 233 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGE--PPEIPEHLSEEA 233 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCC--CcCCCcccCHHH
Confidence 3 3456789999999988754 8899999999999999999999997765 2222233322111 111223568999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 313 KDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 313 ~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
.+||.+||..||++||++.++++||||
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=322.96 Aligned_cols=254 Identities=28% Similarity=0.456 Sum_probs=208.9
Q ss_pred eeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHcc--CCCCeeEEeEEEEeCCe----
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--GQPNIVEFKGAYEDKQS---- 154 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~~~---- 154 (393)
|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++++. +|+||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6788999999999999999998999999999975432 2223455667888887774 49999999999988776
Q ss_pred -EEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 155 -VHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 155 -~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
++++|||+.+ +|.+++.... .+++..++.++.|++.||.|||+.+++|+||+|+||++ +.++.++|+|||++.
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcce
Confidence 9999999965 8888887643 48999999999999999999999999999999999999 455779999999998
Q ss_pred cccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC-----CC----
Q 016233 232 FIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID-----FE---- 301 (393)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~-----~~---- 301 (393)
............++..|+|||++.+ .++.++|+|||||++|+|++|.+||.+.+..+.+..+...... ++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 7765544445568899999998865 5889999999999999999999999888776666655431110 00
Q ss_pred --------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 302 --------------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 302 --------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
....+.++..+.++|.+||..||++||+++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00112456788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=341.59 Aligned_cols=257 Identities=30% Similarity=0.536 Sum_probs=236.2
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+.+++..||-|+||.|=++..+.....+|+|++++..+....+.+-+..|-+||..++ .|.||++|-.|.++.++|++|
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhhhH
Confidence 4567788999999999999887666669999999888777777888999999999997 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcce
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY 239 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~ 239 (393)
|-|-||+|+..+...+.|.+..++.++..+++|++|||++|||+|||||+|+++ +.++.+||.|||+|+.+..+...
T Consensus 500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCCce
Confidence 999999999999999999999999999999999999999999999999999999 78889999999999999999999
Q ss_pred ecccCcccccchHHHh-hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 016233 240 RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318 (393)
Q Consensus 240 ~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 318 (393)
.+.||||.|.|||++. ...+..+|+||||+++||||+|.+||.+.+...++..|+.+.-.+..+ ..++..+.+||++
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~Lik~ 654 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATDLIKK 654 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHHHHHH
Confidence 9999999999999764 568999999999999999999999999999999999999986554443 4689999999999
Q ss_pred hcccCCCCCCC-----HHHHhcCccccCC
Q 016233 319 MLTQDPKKRIT-----SAQVLEHPWIKEG 342 (393)
Q Consensus 319 ~L~~dp~~Rpt-----~~e~l~h~~~~~~ 342 (393)
+...+|.+|.. +.++-.|.||..-
T Consensus 655 LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 655 LCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred HHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 99999999986 7899999999753
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=317.94 Aligned_cols=245 Identities=37% Similarity=0.697 Sum_probs=215.1
Q ss_pred ecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCCCC
Q 016233 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGE 166 (393)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~gg~ 166 (393)
||+|+||.||++.+..+++.+|+|++.+...........+.+|+.+++.+. |+||+++++.++.++.+++||||+.+++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999999899999999998765444445678899999999997 9999999999999999999999999999
Q ss_pred hHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-cceecccCc
Q 016233 167 LFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-KVYRDIVGS 245 (393)
Q Consensus 167 L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~-~~~~~~~gt 245 (393)
|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||++ +..+.++|+|||++...... .......|+
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCCcccCCcCC
Confidence 99999888789999999999999999999999999999999999999 45567999999999876543 233456789
Q ss_pred ccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCC
Q 016233 246 AYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDP 324 (393)
Q Consensus 246 ~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp 324 (393)
..|+|||.+.+ ..+.++|+||||+++|+|++|..||......+....+......++. .++..+.++|++||..||
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~~i~~~l~~~p 232 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE----FLSPEARDLISGLLQKDP 232 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHhcCCH
Confidence 99999998865 4788999999999999999999999887776777777665443332 458999999999999999
Q ss_pred CCCCCH---HHHhcCccc
Q 016233 325 KKRITS---AQVLEHPWI 339 (393)
Q Consensus 325 ~~Rpt~---~e~l~h~~~ 339 (393)
++|||+ +++++||||
T Consensus 233 ~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 233 TKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hhCCCcccHHHHHhCCCC
Confidence 999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=318.15 Aligned_cols=251 Identities=27% Similarity=0.513 Sum_probs=210.4
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++.+.||+|+||.||+|.+..+|+.||+|.++............+.+|+.+++++. |+||+++++++...+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeecCCeEEEE
Confidence 47999999999999999999999999999999987544434445678899999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 159 MELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||++ +.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeecc
Confidence 999999999988864 2458899999999999999999999999999999999999 456679999999987654
Q ss_pred CCc-ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh--HHHHHHHHcCCCCCCCCCCCCCCH
Q 016233 235 EGK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE--KGIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 235 ~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
... ......|++.|+|||.+.+ .++.++|+|||||++|+|++|..||..... .+..+.+..+.. .......++.
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 235 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY--PPLPADHYSE 235 (267)
T ss_pred CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC--CCCChhhcCH
Confidence 332 2234568999999998865 488999999999999999999999965532 234444444332 2222336788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+.++|.+||..+|++|||+.++++
T Consensus 236 ~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 236 ELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=322.20 Aligned_cols=257 Identities=33% Similarity=0.565 Sum_probs=219.1
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
+....|++.+.||+|++|.||+|.+..++..|++|++..... ..+.+.+|+.+++.++ |+||+++++.+...+..
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCK-HPNIVDYYDSYLVGDEL 90 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEECCEE
Confidence 456679999999999999999999998999999999864321 4677889999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
++|+||++|++|.+++.... .+++..+..++.|++.||.|||+.||+|+||+|+||++ +.++.++|+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhhhhc
Confidence 99999999999999998876 89999999999999999999999999999999999999 455679999999987654
Q ss_pred CCc-ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 016233 235 EGK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (393)
Q Consensus 235 ~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (393)
... ......++..|+|||.+.+ .++.++|+|||||++|+|++|..||...........+...... .......++..+
T Consensus 168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 246 (286)
T cd06614 168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWSPEF 246 (286)
T ss_pred cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCCHHH
Confidence 332 2234468889999998865 4889999999999999999999999877665555554443322 112223478999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 313 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
.+||.+||+.+|.+|||+.++++|+||..
T Consensus 247 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 247 KDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 99999999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=326.84 Aligned_cols=255 Identities=24% Similarity=0.370 Sum_probs=209.7
Q ss_pred ccccccceeecceecccCCeEEEEEEECC-------CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEe
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENS-------TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~ 146 (393)
++...++|.+++.||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+++.+.+||||++++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 34445789999999999999999998643 23579999886532 2334567888999999996699999999
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCc
Q 016233 147 GAYEDKQSVHVVMELCAGGELFDRIIAKG----------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210 (393)
Q Consensus 147 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~N 210 (393)
+++...+..|+||||+.+|+|.+++.... .++..++..++.|++.||+|||++|++||||||+|
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 99999999999999999999999997642 37888999999999999999999999999999999
Q ss_pred EEeccCCCCCcEEEeecCCcccccCCcce---ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCC
Q 016233 211 FLLSSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAET 285 (393)
Q Consensus 211 ill~~~~~~~~~kl~DFg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 285 (393)
|++ +.++.+||+|||++......... ....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+..
T Consensus 171 ill---~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 171 VLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred eEE---cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 999 45567999999998765432211 12234568999998865 48899999999999999998 899998877
Q ss_pred hHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 286 EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 286 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
..+....+...... .....++.++.+||.+||..+|++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 248 VEELFKLLKEGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHHcCCCC---CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 77777666654321 1224578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=335.14 Aligned_cols=262 Identities=32% Similarity=0.480 Sum_probs=218.9
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC-----e
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-----S 154 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-----~ 154 (393)
+|++.+.||+|++|.||+|.+..+++.||||.+.... ......+.+.+|+.+++.++ |+||+++++++.... .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccc
Confidence 5899999999999999999999999999999986532 12345577899999999996 999999999987765 7
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVD 154 (330)
T ss_pred eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeec
Confidence 899999996 5898888877789999999999999999999999999999999999999 455789999999998775
Q ss_pred CCc----ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC-----
Q 016233 235 EGK----VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA----- 303 (393)
Q Consensus 235 ~~~----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~----- 303 (393)
... ......++..|+|||++.+ .++.++|+||||+++|+|++|.+||.+.+..+.+..+..........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 543 2345578999999998764 47899999999999999999999998887766655554421111100
Q ss_pred ----------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCCC
Q 016233 304 ----------------------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASD 347 (393)
Q Consensus 304 ----------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~ 347 (393)
..+.++.++.+||.+||..||++|||++++++||||........
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~ 300 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED 300 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccccc
Confidence 12346889999999999999999999999999999986654433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=330.66 Aligned_cols=260 Identities=30% Similarity=0.432 Sum_probs=209.1
Q ss_pred ceeecceecccCCeEEEEEEECCC--CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe----CC
Q 016233 80 HYSFGKELGRGQFGVTYLCTENST--GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED----KQ 153 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----~~ 153 (393)
+|++.+.||+|+||.||+|.+..+ +..||+|.+.... ........+.+|+.+++++.+||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999999988 8999999886432 1222356678899999999779999999986432 25
Q ss_pred eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
.+++++||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGF 155 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceec
Confidence 6789999985 6899988887889999999999999999999999999999999999999 45667999999999865
Q ss_pred cCCc-----ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC---------
Q 016233 234 EEGK-----VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD--------- 297 (393)
Q Consensus 234 ~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~--------- 297 (393)
.... ......||+.|+|||.+.+ .++.++|||||||++|+|++|.+||...+....+..+....
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 4322 1234578999999998754 48899999999999999999999998765443333222110
Q ss_pred ----------------C--CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 298 ----------------I--DFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 298 ----------------~--~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
. ......++.++..+.+|+.+||..||++|||+.+++.||||.+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~ 300 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD 300 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence 0 0001123456889999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=325.35 Aligned_cols=263 Identities=28% Similarity=0.397 Sum_probs=213.0
Q ss_pred cccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
.+....+.|++.+.||+|+||.||+|.+..+++.||||.+..... ......+.+|+.++..+.+|+||+++++++.+.
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 344445689999999999999999999999999999999875432 223456677888777776799999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 153 QSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~-~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
...|+||||+. +++.+.+.. ...+++..+..++.|++.||.|||+ .||+||||+|+||++ +.++.+||+|||++
T Consensus 87 ~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~ 162 (296)
T cd06618 87 SDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGIS 162 (296)
T ss_pred CeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccc
Confidence 99999999985 467666654 4568999999999999999999997 699999999999999 55677999999999
Q ss_pred ccccCCcceecccCcccccchHHHhhc-----CCCcchHHHHHHHHHHHhhCCCCCCCCC-hHHHHHHHHcCCCCCCCCC
Q 016233 231 VFIEEGKVYRDIVGSAYYVAPEVLRRR-----YGKEIDIWSAGVILYILLSGVPPFWAET-EKGIFDAILQGDIDFESAP 304 (393)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~DiwSlG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~ 304 (393)
..+..........++..|+|||.+.+. ++.++||||||+++|+|++|+.||.... ..+.+..+....... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 241 (296)
T cd06618 163 GRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS-LPP 241 (296)
T ss_pred hhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCC-CCC
Confidence 876554444445688899999988532 7889999999999999999999997533 234444444433211 111
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
...++.++.+|+.+||..||++|||++++++|+||...
T Consensus 242 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 12478899999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=317.84 Aligned_cols=242 Identities=27% Similarity=0.403 Sum_probs=200.8
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~g 164 (393)
+.||+|+||.||+|.+..+++.+|+|.+.... .......+.+|+++++.++ ||||+++++++...+.+++||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcCCCCeEEEEeeccC
Confidence 46999999999999999999999999875432 2334567899999999996 99999999999999999999999999
Q ss_pred CChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCccee---
Q 016233 165 GELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR--- 240 (393)
Q Consensus 165 g~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~--- 240 (393)
++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++..........
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccccCC
Confidence 99999987644 58999999999999999999999999999999999999 455679999999988654322111
Q ss_pred cccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 016233 241 DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318 (393)
Q Consensus 241 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 318 (393)
...++..|+|||.+.+ .++.++|||||||++|+|++ |..||...........+...... .....++..+.+|+.+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~ 231 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL---PCPELCPDAVYRLMER 231 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---CCcccCCHHHHHHHHH
Confidence 1123456999998864 58899999999999999997 99999877766665555543221 2224578999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 016233 319 MLTQDPKKRITSAQVLE 335 (393)
Q Consensus 319 ~L~~dp~~Rpt~~e~l~ 335 (393)
||..||++|||+.++++
T Consensus 232 ~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 232 CWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=323.29 Aligned_cols=257 Identities=27% Similarity=0.460 Sum_probs=215.9
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
+....|...+.||+|+||.||++.+..++..+|+|.+.............+.+|+++++.++ |||++++++++.+++..
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 100 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHTA 100 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCeE
Confidence 34456889999999999999999999999999999987654333344567889999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
++||||+.| +|.+.+.. ...+++.++..++.|++.||.|||++||+||||+|+||++ +.++.++|+|||++....
T Consensus 101 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 101 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIAS 176 (317)
T ss_pred EEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCccccC
Confidence 999999965 77776654 4568999999999999999999999999999999999999 455679999999987654
Q ss_pred CCcceecccCcccccchHHHh----hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 016233 235 EGKVYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
.. ....|+..|+|||.+. +.++.++|||||||++|+|++|..||...........+........ ....+++
T Consensus 177 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 251 (317)
T cd06635 177 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL--QSNEWSD 251 (317)
T ss_pred Cc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC--CCccccH
Confidence 32 3456889999999873 3588899999999999999999999988776666666655433221 2235778
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.+.+||.+||..+|.+||++.++++|+|+...
T Consensus 252 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 252 YFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 99999999999999999999999999999654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=326.55 Aligned_cols=257 Identities=30% Similarity=0.486 Sum_probs=210.0
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC---
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ--- 153 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--- 153 (393)
..++|++.+.||+|+||.||+|.++.+|+.||+|.+..... .......+.+|+.++++++ ||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchhh
Confidence 35689999999999999999999999999999999875432 2334456788999999996 999999999887654
Q ss_pred -------eEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEe
Q 016233 154 -------SVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225 (393)
Q Consensus 154 -------~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~ 225 (393)
.+++|+||+++ ++.+.+... ..+++..++.++.|++.||.|||+.||+||||||+||++ ++++.+||+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~kl~ 158 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKLA 158 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEEeC
Confidence 79999999976 677766653 468999999999999999999999999999999999999 566779999
Q ss_pred ecCCcccccCCc--ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC
Q 016233 226 DFGLSVFIEEGK--VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE 301 (393)
Q Consensus 226 DFg~a~~~~~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 301 (393)
|||++....... ......++..|+|||.+.+ .++.++|||||||++|+|++|++||...+..+.+..+........
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999998765432 2233456788999998854 378899999999999999999999987766555544433211000
Q ss_pred --------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 302 --------------------------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 302 --------------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
...+..++..+.++|.+||..||++|||+++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 01233578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=317.41 Aligned_cols=247 Identities=21% Similarity=0.350 Sum_probs=208.5
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
..++|++.++||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++ |+||+++++++.+.+..+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCcE
Confidence 3568999999999999999999865 46789999875432 23578899999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 157 VVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+++++||||||+||++ +..+.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIE 154 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecC
Confidence 999999999999988753 468889999999999999999999999999999999999 556779999999998765
Q ss_pred CCcce--ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 016233 235 EGKVY--RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 235 ~~~~~--~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
..... ....++..|+|||.+.. .++.++|||||||++|+|++ |..||...........+..... . .....++.
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~ 231 (261)
T cd05072 155 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR-M--PRMENCPD 231 (261)
T ss_pred CCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-C--CCCCCCCH
Confidence 43221 22345678999998864 58889999999999999998 9999988877777777665532 2 22346789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
++.+++.+||..||++|||++++++
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 232 ELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=320.41 Aligned_cols=251 Identities=21% Similarity=0.323 Sum_probs=208.8
Q ss_pred ccccceeecceecccCCeEEEEEEECCC-----CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENST-----GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
...++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.+. |+||+++++++.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~ 79 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVS 79 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEc
Confidence 3456899999999999999999998644 3789999875432 2233456889999999996 999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCC
Q 016233 151 DKQSVHVVMELCAGGELFDRIIAKG----------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA 220 (393)
Q Consensus 151 ~~~~~~lv~e~~~gg~L~~~l~~~~----------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~ 220 (393)
.....++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||++ +.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~ 156 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDL 156 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCC
Confidence 9999999999999999999986532 36778899999999999999999999999999999999 5567
Q ss_pred cEEEeecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHc
Q 016233 221 LLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQ 295 (393)
Q Consensus 221 ~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~ 295 (393)
.+||+|||+++....... .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 799999999986644322 223456789999998864 58899999999999999998 9999988887777777764
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 296 GDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 296 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+..... ...++..+.++|.+||..+|++|||+.++++
T Consensus 237 ~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 237 GGHLDL---PENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCC---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 432111 1346899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=323.78 Aligned_cols=252 Identities=21% Similarity=0.321 Sum_probs=207.9
Q ss_pred ccceeecceecccCCeEEEEEEECCCC----------------cEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCC
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTG----------------RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n 141 (393)
..+|++++.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|++++++++ |||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLS-DPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcC-CCC
Confidence 457999999999999999999876544 568999886543 2345678889999999996 999
Q ss_pred eeEEeEEEEeCCeEEEEEeccCCCChHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCc
Q 016233 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKG-----------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210 (393)
Q Consensus 142 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-----------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~N 210 (393)
|+++++++..++..++||||+.+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999987755 68999999999999999999999999999999999
Q ss_pred EEeccCCCCCcEEEeecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh--CCCCCCCC
Q 016233 211 FLLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS--GVPPFWAE 284 (393)
Q Consensus 211 ill~~~~~~~~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt--g~~pf~~~ 284 (393)
|++ +..+.++|+|||++........ .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||...
T Consensus 161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 161 CLV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999 4557799999999986543321 223456778999998765 68999999999999999998 78898877
Q ss_pred ChHHHHHHHHcC----CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 285 TEKGIFDAILQG----DIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 285 ~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+..+.+..+... ...........++.++.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 766666655433 111111122356789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=321.92 Aligned_cols=249 Identities=21% Similarity=0.344 Sum_probs=206.7
Q ss_pred cceeecceecccCCeEEEEEEE----CCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 79 LHYSFGKELGRGQFGVTYLCTE----NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
..|++.+.||+|+||.||+|.. ..++..+|+|.+.... .......+.+|+.+++.++ ||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCc
Confidence 4688999999999999999985 3456789999886432 2334467889999999996 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCC
Q 016233 155 VHVVMELCAGGELFDRIIAK-----------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~-----------------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~ 217 (393)
.|+||||+.+++|.+++... ..+++.++..++.|++.||.|||++||+||||||+|||+ +
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---G 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---c
Confidence 99999999999999988532 237788899999999999999999999999999999999 4
Q ss_pred CCCcEEEeecCCcccccCCcc---eecccCcccccchHHHh-hcCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHH
Q 016233 218 ENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDA 292 (393)
Q Consensus 218 ~~~~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~ 292 (393)
....+||+|||++........ .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+.........
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 556799999999987643321 22344567899999886 458999999999999999998 9999988877666666
Q ss_pred HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 293 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
+...... .....+++.+.+++.+||+.||++||++.+++++
T Consensus 239 ~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VRKRQLL---PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHcCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 6654432 1234678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=316.70 Aligned_cols=251 Identities=28% Similarity=0.506 Sum_probs=217.1
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||++.+..+++.+|+|.+..... .......+.+|+.+++.++ |+||+++++++.+....++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEEEEe
Confidence 58899999999999999999999999999999875432 2334567788999999997 999999999999999999999
Q ss_pred eccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 160 ELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 160 e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++ ....+||+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccchhhhcc
Confidence 99999999998866 35689999999999999999999999999999999999995 456799999999987755
Q ss_pred CcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 236 GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
. ......|++.|+|||.+.+ .++.++|+||||+++|+|++|+.||...+..+....+..+...... ..++.++.+
T Consensus 156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 231 (256)
T cd08530 156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP---PIYSQDLQN 231 (256)
T ss_pred C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc---hhhCHHHHH
Confidence 4 3344678999999999865 4788999999999999999999999888877766666655443222 257889999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccc
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
++.+||..+|++|||+.++++||++
T Consensus 232 li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 232 FIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=324.07 Aligned_cols=254 Identities=25% Similarity=0.386 Sum_probs=207.4
Q ss_pred cccccceeecceecccCCeEEEEEEE-----CCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEE
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTE-----NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 149 (393)
....++|.+.+.||+|+||.||+|.+ ..++..+|+|.+.... .....+.+.+|+.+++++.+||||+++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 34456899999999999999999985 3345689999886432 2234567889999999995599999999999
Q ss_pred EeCCeEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeec
Q 016233 150 EDKQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (393)
Q Consensus 150 ~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DF 227 (393)
...+..++||||+.+|+|.+++.... .+++.++..++.|++.||.|||+++|+|+||||+|||+ +.+..++|+||
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~df 185 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDF 185 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCC
Confidence 99999999999999999999987643 38999999999999999999999999999999999999 45667999999
Q ss_pred CCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCC
Q 016233 228 GLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFES 302 (393)
Q Consensus 228 g~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 302 (393)
|++........ .....++..|+|||.+.+ .++.++||||+||++|+|++ |..||......+.+...........
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~- 264 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA- 264 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC-
Confidence 99986643321 112345778999998864 58899999999999999998 9999987765554444433322221
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.....++++.+|+.+||..+|++|||+.++++
T Consensus 265 -~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 265 -QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred -CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 22356899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=309.64 Aligned_cols=265 Identities=27% Similarity=0.453 Sum_probs=220.4
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE---
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE--- 150 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~--- 150 (393)
+.+....|.-..+||+|.||.||+|+++.+|+.||+|++-.+... ........+|+.+|+.|+ |+|++.+++.+.
T Consensus 12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK-eGfpitalreikiL~~lk-Henv~nliEic~tk~ 89 (376)
T KOG0669|consen 12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK-EGFPITALREIKILQLLK-HENVVNLIEICRTKA 89 (376)
T ss_pred ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc-cCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhcc
Confidence 344455788888999999999999999999999999976543221 223455678999999997 999999988763
Q ss_pred -----eCCeEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEE
Q 016233 151 -----DKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKA 224 (393)
Q Consensus 151 -----~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl 224 (393)
+...+|+||++|+. +|.-+|... -+++..++..++++++.||.|+|+..|+|||+|++|+|| +.++++||
T Consensus 90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilkl 165 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILKL 165 (376)
T ss_pred CCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEEe
Confidence 33469999999965 787777654 579999999999999999999999999999999999999 67788999
Q ss_pred eecCCcccccCC-----cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC
Q 016233 225 TDFGLSVFIEEG-----KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD 297 (393)
Q Consensus 225 ~DFg~a~~~~~~-----~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 297 (393)
+|||+++.+... ..++..+.|.+|++||.+.+ .|+++.|||.-||||.+|+||.+.|.+.++...+..|..-.
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc 245 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC 245 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh
Confidence 999999766432 23556678999999998865 59999999999999999999999999999998888876655
Q ss_pred CCCCCCCCCCC-------------------------------CHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 298 IDFESAPWPTI-------------------------------SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 298 ~~~~~~~~~~~-------------------------------s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
-.+....|+++ .+++.||+.++|..||.+|+++.++|+|.||.....
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 55555555542 347889999999999999999999999999987543
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=318.03 Aligned_cols=249 Identities=23% Similarity=0.384 Sum_probs=209.4
Q ss_pred cceeecceecccCCeEEEEEEECCC---CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENST---GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
.+|++.+.||+|+||.||+|.+..+ ...||||.+.... .......+.+|+.+++.++ ||||+++++++...+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCce
Confidence 4699999999999999999998654 4579999886432 2334567889999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
++||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhccc
Confidence 9999999999999998764 468999999999999999999999999999999999999 556679999999998875
Q ss_pred CC-ccee--cccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 235 EG-KVYR--DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 235 ~~-~~~~--~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
.. .... ...++..|+|||.+.+ .++.++||||||+++|+|++ |..||......+....+........ ...++
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 234 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP---PMDCP 234 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCC
Confidence 21 1112 2234578999998864 58999999999999999998 9999988887777777766532211 23578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
..+.+|+.+||+.||++||++.+++++
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=315.38 Aligned_cols=246 Identities=23% Similarity=0.382 Sum_probs=207.6
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.+|++.+.||+|+||.||.|.+.. +..+|+|.+.... .....+.+|+.+++++. ||||+++++++.....+++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS----MSEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc----ccHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCcEEE
Confidence 368999999999999999998764 4569999886432 23467889999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
|||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||++ +.++.+||+|||++.......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCc
Confidence 9999999999998764 468999999999999999999999999999999999999 456679999999988664432
Q ss_pred cee--cccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 238 VYR--DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 238 ~~~--~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
... ...++..|+|||.+.+ .++.++|||||||++|+|++ |..||......+....+.++...+.. ...+..+.
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASEKVY 231 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCHHHH
Confidence 211 2235567999999864 58899999999999999998 99999888777777777766443322 34688999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
+++.+||..||++|||+.+++.+
T Consensus 232 ~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 232 AIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHHHh
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=327.81 Aligned_cols=248 Identities=20% Similarity=0.309 Sum_probs=203.7
Q ss_pred cceeecceecccCCeEEEEEEECCCCcE----EEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQ----FACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
.+|++.+.||+|+||.||+|.+..++.. ||+|.+.... .....+.+.+|+.+++.+. ||||+++++++... .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~-~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC-C
Confidence 4699999999999999999998766654 8999885432 2334567889999999996 99999999998765 4
Q ss_pred EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
.++|+||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.+..+||+|||+++..
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEccccccccc
Confidence 68999999999999999874 458899999999999999999999999999999999999 45667999999999876
Q ss_pred cCCcce---ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 016233 234 EEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (393)
Q Consensus 234 ~~~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (393)
...... ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+....+....+..+ ..++. .+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~ 236 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQ--PPIC 236 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCC-CCCCC--CCCC
Confidence 543322 12234668999998864 58999999999999999997 99999887766554444433 22222 2357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 309 SSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
+.++.+++.+||..||++|||+.+++.+
T Consensus 237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 237 TIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=324.14 Aligned_cols=254 Identities=25% Similarity=0.382 Sum_probs=210.6
Q ss_pred cccccceeecceecccCCeEEEEEEECCC-----CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEE
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENST-----GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 149 (393)
+....+|++.+.||+|+||.||++.+... ...+|+|.+.... .......+.+|+.+++++.+|+||+++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34456899999999999999999997644 3789999886432 2234566889999999995599999999999
Q ss_pred EeCCeEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEe
Q 016233 150 EDKQSVHVVMELCAGGELFDRIIAK----------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLL 213 (393)
Q Consensus 150 ~~~~~~~lv~e~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill 213 (393)
..++.+++||||+.+|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 9999999999999999999998642 358889999999999999999999999999999999999
Q ss_pred ccCCCCCcEEEeecCCcccccCCcce---ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHH
Q 016233 214 SSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKG 288 (393)
Q Consensus 214 ~~~~~~~~~kl~DFg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~ 288 (393)
+.++.+||+|||++......... ....++..|+|||++.+ .++.++|||||||++|+|++ |..||.+....+
T Consensus 166 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 166 ---TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred ---cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 45667999999999876543221 12234567999998764 58999999999999999997 999999888777
Q ss_pred HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 289 IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 289 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
....+..+... . ....++..+.+|+.+||..||++|||+.+++++
T Consensus 243 ~~~~~~~~~~~-~--~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 243 LFKLLKEGYRM-E--KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHcCCcC-C--CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 77776655322 1 223578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=316.30 Aligned_cols=243 Identities=24% Similarity=0.410 Sum_probs=210.0
Q ss_pred ceecccCCeEEEEEEECCC---CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEec
Q 016233 85 KELGRGQFGVTYLCTENST---GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMEL 161 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~ 161 (393)
+.||+|+||.||+|.+... +..||+|.+..... ......+.+|+.+++.++ |+||+++++++.....+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEe
Confidence 4699999999999999866 89999999875432 224678899999999997 99999999999999999999999
Q ss_pred cCCCChHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 162 CAGGELFDRIIAK---------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 162 ~~gg~L~~~l~~~---------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
+++++|.+++... ..+++.+++.++.|++.||.|||++||+||||||+||++ +.++.++|+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccc
Confidence 9999999999875 679999999999999999999999999999999999999 5567799999999987
Q ss_pred ccCCc---ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 016233 233 IEEGK---VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (393)
Q Consensus 233 ~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (393)
..... ......++..|+|||.+.. .++.++||||||+++|+|++ |..||......+....+..+... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 231 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL---PKPEY 231 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCcc
Confidence 65432 2234567889999998865 58999999999999999999 69999988887787777764322 12245
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
++.++.+++.+||..||++|||+.+++++
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 68999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=323.28 Aligned_cols=256 Identities=29% Similarity=0.566 Sum_probs=214.5
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
.|....+||+|+||.||++.+..+++.||||.+... .......+.+|+.+++.+. |+||+++++++...+..++||
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEEEE
Confidence 444557899999999999999999999999987532 2234567889999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc-c
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-V 238 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-~ 238 (393)
||+++++|.+++. ...+++..++.++.|++.+|.|||++|++||||+|+||++ +.++.++|+|||++....... .
T Consensus 97 e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~~ 172 (292)
T cd06657 97 EFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPR 172 (292)
T ss_pred ecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceeccccccc
Confidence 9999999988664 4578999999999999999999999999999999999999 556679999999987654322 2
Q ss_pred eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 016233 239 YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (393)
Q Consensus 239 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (393)
.....|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.+....+....+...... .......++..+.+++.
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~ 251 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-KLKNLHKVSPSLKGFLD 251 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc-ccCCcccCCHHHHHHHH
Confidence 234578999999998764 5789999999999999999999999887766655555443221 12223467899999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 318 RMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 318 ~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
+||..||.+||++.++|+||||.....
T Consensus 252 ~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 252 RLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHhCCcccCcCHHHHhcChHHhccCC
Confidence 999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=324.51 Aligned_cols=254 Identities=23% Similarity=0.348 Sum_probs=209.1
Q ss_pred ccccccceeecceecccCCeEEEEEEECC-------CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEe
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENS-------TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~ 146 (393)
+....++|.+++.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++++.+||||++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 34456789999999999999999998642 34579999876432 2334567889999999996699999999
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCc
Q 016233 147 GAYEDKQSVHVVMELCAGGELFDRIIAK----------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210 (393)
Q Consensus 147 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~N 210 (393)
+++.+.+.+++||||+.+|+|.+++... ..+++.++..++.||+.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 9999999999999999999999998753 247888999999999999999999999999999999
Q ss_pred EEeccCCCCCcEEEeecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCC
Q 016233 211 FLLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAET 285 (393)
Q Consensus 211 ill~~~~~~~~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 285 (393)
||+ +.++.+||+|||+++....... .....++..|+|||++.+ .++.++|||||||++|+|++ |..||.+..
T Consensus 165 ill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 165 VLV---TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred EEE---cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 999 4556799999999987643221 112234567999998865 58899999999999999999 999998888
Q ss_pred hHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 286 EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 286 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
..+.+..+..+... .....++.++.++|.+||..||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 242 VEELFKLLREGHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 77777777665321 112467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=323.51 Aligned_cols=253 Identities=34% Similarity=0.520 Sum_probs=210.2
Q ss_pred eeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEe
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 160 (393)
|++.+.||+|++|.||+|....+++.||||.+..... ........+|+..++++.+|+||+++++++.+++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--SWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--chhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6788999999999999999999999999998865432 12233456799999999769999999999999999999999
Q ss_pred ccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc
Q 016233 161 LCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (393)
Q Consensus 161 ~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~ 238 (393)
|+ +|+|.+++.... .+++..+..++.|++.+|.|||++|++|+||+|+||++ +.++.++|+|||++........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCC
Confidence 99 789999887764 78999999999999999999999999999999999999 5567799999999987765555
Q ss_pred eecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC---------------
Q 016233 239 YRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE--------------- 301 (393)
Q Consensus 239 ~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~--------------- 301 (393)
.....|+..|+|||++.+ .++.++|+||||+++|+|++|.+||......+.+..+........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 556678999999998743 478999999999999999999999987766555444332110000
Q ss_pred -----------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 302 -----------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 302 -----------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
....+..+..+.+||++||..||++|||++|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00112346889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=330.65 Aligned_cols=254 Identities=22% Similarity=0.312 Sum_probs=201.5
Q ss_pred ceeccc--CCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEecc
Q 016233 85 KELGRG--QFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELC 162 (393)
Q Consensus 85 ~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 162 (393)
..||.| +||+||++.+..+|+.||+|++..... .....+.+.+|+.+++.++ ||||+++++++...+..++||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEEEecc
Confidence 456666 999999999999999999999875432 2234577889999999996 999999999999999999999999
Q ss_pred CCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc-e
Q 016233 163 AGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV-Y 239 (393)
Q Consensus 163 ~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~-~ 239 (393)
.+++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||++. ..+.++++||+.+........ .
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~---~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS---GDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe---CCCcEEEechHHHhhhhccCccc
Confidence 999999988764 3489999999999999999999999999999999999994 556799999986543321110 0
Q ss_pred -------ecccCcccccchHHHhh---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC--------
Q 016233 240 -------RDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE-------- 301 (393)
Q Consensus 240 -------~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~-------- 301 (393)
....++..|+|||++.+ .++.++|||||||++|+|++|..||...................+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 11234567999999864 378999999999999999999999987665544433332211000
Q ss_pred -----------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 302 -----------------------------------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 302 -----------------------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
......+++.+.+||.+||..||++|||+.++|+||||....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 001123567899999999999999999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=315.69 Aligned_cols=241 Identities=26% Similarity=0.348 Sum_probs=201.5
Q ss_pred eecccCCeEEEEEEE--CCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccC
Q 016233 86 ELGRGQFGVTYLCTE--NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCA 163 (393)
Q Consensus 86 ~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 163 (393)
+||+|+||.||+|.+ ..++..+|+|++.... ......+.+.+|+.+++.+. ||||+++++++.. +..++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLD-NPYIVRMIGICEA-ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcC-CCcEEEEecCC
Confidence 689999999999964 4568899999886442 22334677889999999996 9999999998864 46789999999
Q ss_pred CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcce----
Q 016233 164 GGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY---- 239 (393)
Q Consensus 164 gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~---- 239 (393)
+++|.+++.....+++..+..++.|++.||.|||++||+||||||.||++ +.+..+||+|||++.........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCeeeec
Confidence 99999999887889999999999999999999999999999999999999 45667999999999876543221
Q ss_pred ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 016233 240 RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (393)
Q Consensus 240 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (393)
....++..|+|||.+.. .++.++|||||||++|+|++ |..||.+....+....+..+... . ....+++++.+||.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~-~--~~~~~~~~l~~li~ 232 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM-E--CPQRCPPEMYDLMK 232 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC-C--CCCCCCHHHHHHHH
Confidence 12234578999998864 58889999999999999998 99999888887777777765431 1 12458899999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q 016233 318 RMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 318 ~~L~~dp~~Rpt~~e~l~ 335 (393)
+||..||++||+++++.+
T Consensus 233 ~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 233 LCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHhccCchhCcCHHHHHH
Confidence 999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=326.87 Aligned_cols=256 Identities=26% Similarity=0.420 Sum_probs=205.5
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC-----
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK----- 152 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~----- 152 (393)
.++|++.+.||+|+||.||+|.++.+++.+|+|.+..... .......+.+|+++++.++ ||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLK-HPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcC-CCCccchhhheeccccccc
Confidence 4689999999999999999999999999999999865432 2223346678999999996 99999999887443
Q ss_pred ---CeEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecC
Q 016233 153 ---QSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (393)
Q Consensus 153 ---~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg 228 (393)
..+++|+||+.+ +|...+.. ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg 160 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFG 160 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcCc
Confidence 357999999965 67666654 3479999999999999999999999999999999999999 556779999999
Q ss_pred CcccccCCcc------------eecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH
Q 016233 229 LSVFIEEGKV------------YRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL 294 (393)
Q Consensus 229 ~a~~~~~~~~------------~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 294 (393)
++........ .....|++.|+|||.+.+ .++.++|||||||++|+|++|++||.+.+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9986543221 123467889999998754 47899999999999999999999998877665554443
Q ss_pred cCCCCCCC--------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 295 QGDIDFES--------------------------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 295 ~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
........ ..+..+++.+.+||.+||..||++|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 21110000 0123455788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=322.09 Aligned_cols=248 Identities=20% Similarity=0.335 Sum_probs=208.1
Q ss_pred ceeecceecccCCeEEEEEEECCC-----CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 80 HYSFGKELGRGQFGVTYLCTENST-----GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
+|++.+.||+|+||.||+|.+..+ ++.||+|.+.... .....+.+.+|+.++..++ ||||+++++++...+.
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCCc
Confidence 588899999999999999987543 5789999986432 2223567889999999996 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCC
Q 016233 155 VHVVMELCAGGELFDRIIAK----------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE 218 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~ 218 (393)
.++++||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ ++
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---FD 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---cC
Confidence 99999999999999988532 247888899999999999999999999999999999999 45
Q ss_pred CCcEEEeecCCcccccCCcc---eecccCcccccchHHHh-hcCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHH
Q 016233 219 NALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAI 293 (393)
Q Consensus 219 ~~~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i 293 (393)
+..+||+|||+++....... .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||.+....+.+..+
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 56799999999886643322 12345678999999875 468999999999999999998 89999888888888888
Q ss_pred HcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 294 LQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 294 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
..+..... ...++..+.+|+.+||+.||++||++++++..
T Consensus 240 ~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 240 RNRQVLPC---PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HcCCcCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 77654322 24678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=324.47 Aligned_cols=256 Identities=27% Similarity=0.459 Sum_probs=213.6
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
....|...+.||+|+||.||+|++..+++.+|+|.+.............+.+|+++++.++ |+|++++++++...+..+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAW 91 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCeeE
Confidence 4456888899999999999999999999999999986543333334567788999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 157 VVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
+||||+. |++.+.+.. ...+++.++..++.|++.||.|||+++++||||+|+||++ +.++.++|+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccceeecC
Confidence 9999996 578776654 4568999999999999999999999999999999999999 4556799999999876543
Q ss_pred CcceecccCcccccchHHHh----hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 016233 236 GKVYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (393)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (393)
. ....|++.|+|||.+. +.++.++|||||||++|+|++|..||......+....+..+.... .....++..
T Consensus 168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 242 (308)
T cd06634 168 A---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--LQSGHWSEY 242 (308)
T ss_pred c---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCC--cCcccccHH
Confidence 3 3456889999999874 347889999999999999999999998776555555554443221 112357889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 312 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+.+||.+||..+|++||+++++++|||+...
T Consensus 243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 9999999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=315.50 Aligned_cols=247 Identities=23% Similarity=0.328 Sum_probs=207.8
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
....+|++.+.||+|++|.||+|.+.. ++.||+|.+.... ...+.+.+|+.++++++ ||||+++++++...+..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 76 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT----MDPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPI 76 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc----ccHHHHHHHHHHHHHCC-CCCccceeEEEecCCCe
Confidence 345679999999999999999999754 5789999986432 23567889999999997 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 156 HVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
++||||+.+++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVI 153 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEEc
Confidence 99999999999999987654 68999999999999999999999999999999999999 45667999999999876
Q ss_pred cCCcceeccc---CcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 016233 234 EEGKVYRDIV---GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (393)
Q Consensus 234 ~~~~~~~~~~---gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (393)
..... .... ++..|+|||.+.+ .++.++||||||+++|+|++ |..||.+.+....+..+..... .+ ....+
T Consensus 154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~ 229 (261)
T cd05068 154 KEDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR-MP--CPPGC 229 (261)
T ss_pred cCCcc-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CC--CCCcC
Confidence 53321 1222 2357999998764 58899999999999999999 9999988887777777665422 11 22457
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 309 SSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+..+.+++.+||..||++||++.++++
T Consensus 230 ~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 230 PKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=369.93 Aligned_cols=259 Identities=30% Similarity=0.496 Sum_probs=223.4
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
.+..+|.-+..||.|.||.||-|.+..+|...|+|-+.-.... ......+.+|+.++..+. |||+|+++++-.+++.+
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhcc-CccccccCceeecHHHH
Confidence 3556788899999999999999999999999999998765543 455678899999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
+|.||||+||+|.+.+...+...+...+.+..|++.|+.|||++|||||||||+||++ +.++.+|++|||.|..+..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccceeEecC
Confidence 9999999999999988887778888899999999999999999999999999999999 6677999999999988765
Q ss_pred Cc-----ceecccCcccccchHHHhh----cCCCcchHHHHHHHHHHHhhCCCCCCCCC-hHHHHHHHHcCCCCCCCCCC
Q 016233 236 GK-----VYRDIVGSAYYVAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAET-EKGIFDAILQGDIDFESAPW 305 (393)
Q Consensus 236 ~~-----~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~ 305 (393)
.. ......||+.|||||++.+ ....++|||||||++.||+||+.||...+ +-.++-.+..+..+..+
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P--- 1463 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP--- 1463 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc---
Confidence 32 3346789999999999864 35678999999999999999999997644 33455555555443222
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
..+|.+.+|||..||..||++|.++.|+|+|.|-+..
T Consensus 1464 ~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1464 ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 2489999999999999999999999999999987654
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=315.37 Aligned_cols=246 Identities=24% Similarity=0.369 Sum_probs=204.8
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
...+|++.++||+|+||.||+|.+..+ ..||+|.+.... ...+.+.+|+.+++.++ ||||+++++.+.. ...+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~----~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc----cCHHHHHHHHHHHHhCC-CCCcceEEEEECC-CCcE
Confidence 456899999999999999999998765 469999986432 23467899999999996 9999999998754 5579
Q ss_pred EEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 157 VVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+||++ +.++.++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIE 153 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceeecc
Confidence 999999999999999763 357899999999999999999999999999999999999 456679999999998765
Q ss_pred CCcc--eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 016233 235 EGKV--YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 235 ~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
.... .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+....+....+..+... .....++.
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 230 (262)
T cd05071 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPECPE 230 (262)
T ss_pred ccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC---CCccccCH
Confidence 4322 123346678999998754 58999999999999999999 89999888777777766554321 11245789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+.+++.+||+.||++|||++++++
T Consensus 231 ~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 231 SLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=335.17 Aligned_cols=258 Identities=23% Similarity=0.396 Sum_probs=216.8
Q ss_pred ccccccccceeecceecccCCeEEEEEEECCCCc---E-EEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeE
Q 016233 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGR---Q-FACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (393)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 147 (393)
..|+..+.+-.+.++||+|+||.||+|..+..+. . ||+|..+...........++.+|+++|+.++ |||||++||
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yG 228 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYG 228 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEE
Confidence 4455666677788999999999999999875432 3 8999887544345667888999999999996 999999999
Q ss_pred EEEeCCeEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEee
Q 016233 148 AYEDKQSVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (393)
Q Consensus 148 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~D 226 (393)
+...+..++||||+|.||+|.++|.+.+ .++..+...++.+.+.||+|||+++++||||-..|+|+ .....+||+|
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~---~~~~~vKISD 305 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY---SKKGVVKISD 305 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee---cCCCeEEeCc
Confidence 9999999999999999999999999877 49999999999999999999999999999999999999 4556689999
Q ss_pred cCCcccccCCcceecc-cCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCC
Q 016233 227 FGLSVFIEEGKVYRDI-VGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESA 303 (393)
Q Consensus 227 Fg~a~~~~~~~~~~~~-~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 303 (393)
||+++.-..-...... --...|+|||.+.. .|+.++|||||||++||+++ |..||.+....+....|....+..+.+
T Consensus 306 FGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~ 385 (474)
T KOG0194|consen 306 FGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP 385 (474)
T ss_pred cccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC
Confidence 9998865411111111 12357999999975 59999999999999999998 899999999999999995554443333
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
...+.++..++.+|+..||++|||+.++.+
T Consensus 386 --~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 386 --SKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred --CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 367889999999999999999999998865
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=322.57 Aligned_cols=254 Identities=23% Similarity=0.347 Sum_probs=210.4
Q ss_pred cccccceeecceecccCCeEEEEEEEC-------CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeE
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTEN-------STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 147 (393)
....++|.+.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.+.+||||+++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 344668999999999999999999753 234579999876432 23445778999999999956999999999
Q ss_pred EEEeCCeEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcE
Q 016233 148 AYEDKQSVHVVMELCAGGELFDRIIAK----------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENF 211 (393)
Q Consensus 148 ~~~~~~~~~lv~e~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Ni 211 (393)
++...+..++||||+.+|+|.+++... ..++...+..++.||+.||.|||++||+||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 999999999999999999999998763 2467788999999999999999999999999999999
Q ss_pred EeccCCCCCcEEEeecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCCh
Q 016233 212 LLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETE 286 (393)
Q Consensus 212 ll~~~~~~~~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~ 286 (393)
++ +.++.+||+|||++........ .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+.
T Consensus 169 li---~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 169 LV---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred EE---cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 99 4566799999999987654321 122345678999998865 48999999999999999998 8899988888
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 287 KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 287 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
.+....+..+.... ....++.++.+||.+||..+|++|||+.++++.
T Consensus 246 ~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 246 EELFKLLKEGHRMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 88777776554321 124678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=317.29 Aligned_cols=248 Identities=19% Similarity=0.335 Sum_probs=210.9
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
...+|++++.||+|+||.||+|.+.. ++.+|+|++.... ......+.+|+.+++.++ |+||+++++++.+.+..+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEPVY 78 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCC-CcchhheeeeEecCCCeE
Confidence 34579999999999999999999987 8899999986542 234567889999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 157 VVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||++ +.++.+||+|||++....
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIK 155 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhhcC
Confidence 999999999999998753 458999999999999999999999999999999999999 556679999999998764
Q ss_pred CCcc-eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 016233 235 EGKV-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (393)
Q Consensus 235 ~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (393)
.... .....++..|+|||.+.+ .++.++||||||+++|+|++ |..||...+..+.+..+..+.. . .....+++.
T Consensus 156 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~ 232 (261)
T cd05148 156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR-M--PCPAKCPQE 232 (261)
T ss_pred CccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc-C--CCCCCCCHH
Confidence 4321 123345678999998864 58899999999999999998 8999988887777777765422 1 222467899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 016233 312 AKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 312 ~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+.+++.+||..||++|||+.++++
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 233 IYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=317.18 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=204.4
Q ss_pred eeecceecccCCeEEEEEEECC---CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe---
Q 016233 81 YSFGKELGRGQFGVTYLCTENS---TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS--- 154 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~--- 154 (393)
|++++.||+|+||.||+|.+.. ++..||+|.+..... .......+.+|+.+++.++ ||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCcccc
Confidence 5788999999999999999765 347899999865332 2334567899999999996 9999999998765443
Q ss_pred ---EEEEEeccCCCChHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEe
Q 016233 155 ---VHVVMELCAGGELFDRIIAK------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225 (393)
Q Consensus 155 ---~~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~ 225 (393)
.++||||+++|+|..++... ..+++..+..++.|++.||.|||+++|+||||||+||++ +++..+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEEC
Confidence 79999999999999887542 358899999999999999999999999999999999999 556679999
Q ss_pred ecCCcccccCCcce---ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCC
Q 016233 226 DFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDF 300 (393)
Q Consensus 226 DFg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 300 (393)
|||+++........ ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+....+.++.+..+....
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK 235 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99999876543221 12235678999998864 58899999999999999999 999998888777777776654321
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 301 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
....++.++.+++.+||..||++|||+.+++++
T Consensus 236 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 236 ---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 124678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=329.63 Aligned_cols=262 Identities=26% Similarity=0.421 Sum_probs=210.8
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC-
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK- 152 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 152 (393)
...+.++|.+.+.||+|+||.||+|.+..+++.||+|.+.+... .....+.+.+|+.++++++ ||||+++++++...
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~ 89 (345)
T cd07877 12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 89 (345)
T ss_pred HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcC-CCcccceeeeeeecc
Confidence 34466799999999999999999999999999999999865321 2223466788999999996 99999999988643
Q ss_pred -----CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeec
Q 016233 153 -----QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (393)
Q Consensus 153 -----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DF 227 (393)
+..|++++++ |++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~df 164 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDF 164 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEecc
Confidence 3478888887 7788876654 469999999999999999999999999999999999999 45667999999
Q ss_pred CCcccccCCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC-------
Q 016233 228 GLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI------- 298 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~------- 298 (393)
|++..... ......|+..|+|||.+.+ .++.++|||||||++|+|++|..||...+....+..+.....
T Consensus 165 g~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T cd07877 165 GLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 242 (345)
T ss_pred cccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99886543 2344578999999998764 478899999999999999999999987665444433322110
Q ss_pred ----------------CCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 299 ----------------DFES----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 299 ----------------~~~~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
..+. ..+...++++.+||.+||..||.+|||+.++|+||||.+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred hhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 0000 012245788999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=317.57 Aligned_cols=248 Identities=24% Similarity=0.353 Sum_probs=203.1
Q ss_pred eeecceecccCCeEEEEEEECCCCc--EEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe------C
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGR--QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED------K 152 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~------~ 152 (393)
|.+++.||+|+||.||+|.+..++. .+|+|.++... ......+.+.+|+.+++.++ |+||+++++++.. .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccCC
Confidence 3577899999999999999887765 69999886542 23345677889999999996 9999999997642 2
Q ss_pred CeEEEEEeccCCCChHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEee
Q 016233 153 QSVHVVMELCAGGELFDRIIAK------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~D 226 (393)
...++||||+.+|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||+ +.+..+||+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECC
Confidence 3578999999999998887432 247899999999999999999999999999999999999 5566799999
Q ss_pred cCCcccccCCcce---ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCC
Q 016233 227 FGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFE 301 (393)
Q Consensus 227 Fg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 301 (393)
||++......... ....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.+....+....+..+....
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~- 234 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK- 234 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 9999876543221 12345678999998865 58999999999999999999 899998887777777777654321
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 302 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
..+.++..+.++|.+||+.||++|||+.+++++
T Consensus 235 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 --QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred --CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 124678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=321.31 Aligned_cols=253 Identities=33% Similarity=0.538 Sum_probs=210.6
Q ss_pred eeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEe
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 160 (393)
|++.+.||+|++|.||+|.+..+++.+++|.+..... .......+.+|+.++++++ |+||+++++++.+.+.+++|+|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEEEEe
Confidence 5678899999999999999999999999999875432 2234567889999999997 9999999999999999999999
Q ss_pred ccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc-c
Q 016233 161 LCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-V 238 (393)
Q Consensus 161 ~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-~ 238 (393)
|+++ +|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||++ +.++.++|+|||.+....... .
T Consensus 79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCccc
Confidence 9975 888877663 578999999999999999999999999999999999999 456679999999998765543 3
Q ss_pred eecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC-----------------
Q 016233 239 YRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID----------------- 299 (393)
Q Consensus 239 ~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~----------------- 299 (393)
.....++..|+|||.+.+ .++.++|+||||+++|+|++|+.||...+..+.+..+......
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 344568889999998764 4788999999999999999999999887765554443321100
Q ss_pred --CC-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 300 --FE-------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 300 --~~-------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
++ ...++.++.++.+||.+||..||.+||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 00 01123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=315.99 Aligned_cols=243 Identities=26% Similarity=0.361 Sum_probs=199.0
Q ss_pred ceecccCCeEEEEEEECCCCcE--EEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEecc
Q 016233 85 KELGRGQFGVTYLCTENSTGRQ--FACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELC 162 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 162 (393)
+.||+|+||.||+|.+..++.. +|+|.+... ......+.+.+|+.+++++.+||||+++++++...+.+++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 3689999999999999888764 577876532 123345678899999999966999999999999999999999999
Q ss_pred CCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEee
Q 016233 163 AGGELFDRIIAKG----------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (393)
Q Consensus 163 ~gg~L~~~l~~~~----------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~D 226 (393)
++|+|.+++.... .+++.++..++.|++.||+|||++|++||||||+||++ +.+..+||+|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECC
Confidence 9999999987543 37889999999999999999999999999999999999 5667799999
Q ss_pred cCCcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 016233 227 FGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAP 304 (393)
Q Consensus 227 Fg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (393)
||++..............+..|+|||++.. .++.++|||||||++|+|++ |..||.+.+..+....+..+.. ...
T Consensus 156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~---~~~ 232 (270)
T cd05047 156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR---LEK 232 (270)
T ss_pred CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC---CCC
Confidence 999864322111112233567999998864 58899999999999999997 9999988877777766655421 112
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
...++.++.+++.+||..||.+|||+.++++
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 2357889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=322.62 Aligned_cols=256 Identities=29% Similarity=0.538 Sum_probs=210.1
Q ss_pred ceeecceecccCCeEEEEEEEC---CCCcEEEEEEeecCccC-CcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 80 HYSFGKELGRGQFGVTYLCTEN---STGRQFACKSISKRKLV-TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
+|++.+.||+|+||.||++.+. .+++.||||++.+.... .......+.+|+.++.++.+||||+++++.+..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 46789999998754321 1223466789999999997799999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
++||||+.+++|.+++.....+++..+..++.|++.+|.|||+.|++||||+|+||++ +.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECcccccccc
Confidence 9999999999999999877789999999999999999999999999999999999999 4566799999999876543
Q ss_pred Ccc--eecccCcccccchHHHhhc---CCCcchHHHHHHHHHHHhhCCCCCCCCC----hHHHHHHHHcCCCCCCCCCCC
Q 016233 236 GKV--YRDIVGSAYYVAPEVLRRR---YGKEIDIWSAGVILYILLSGVPPFWAET----EKGIFDAILQGDIDFESAPWP 306 (393)
Q Consensus 236 ~~~--~~~~~gt~~y~aPE~l~~~---~~~~~DiwSlG~il~~lltg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~ 306 (393)
... .....|+..|+|||.+.+. .+.++||||||+++|+|++|..||.... ..+....+...... ...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~ 233 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP----FPK 233 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC----CCc
Confidence 322 1234689999999987643 6789999999999999999999996432 22333333333222 223
Q ss_pred CCCHHHHHHHHHhcccCCCCCCC---HHHHhcCccccCC
Q 016233 307 TISSSAKDLVRRMLTQDPKKRIT---SAQVLEHPWIKEG 342 (393)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rpt---~~e~l~h~~~~~~ 342 (393)
.++..+.++|.+||+.||++||| +.++|+||||+..
T Consensus 234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 57899999999999999999998 5677999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=319.65 Aligned_cols=247 Identities=23% Similarity=0.392 Sum_probs=207.1
Q ss_pred cceeecceecccCCeEEEEEEEC-----CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 79 LHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+... .......+.+|+.++++++ |+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCC
Confidence 46889999999999999999854 34567899987532 2233467889999999996 999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCC
Q 016233 154 SVHVVMELCAGGELFDRIIAKG----------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~ 217 (393)
..++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||++ +
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---G 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---c
Confidence 9999999999999999987542 37889999999999999999999999999999999999 5
Q ss_pred CCCcEEEeecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHH
Q 016233 218 ENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDA 292 (393)
Q Consensus 218 ~~~~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~ 292 (393)
.++.++|+|||++........ .....|+..|+|||.+.+ .++.++|||||||++|+|++ |..||......+..+.
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 566899999999976543321 123456788999998865 58899999999999999998 9999988887777777
Q ss_pred HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 293 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+..+..... ....+..+.+++.+||..||++|||+.++++
T Consensus 238 ~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 238 ITQGRVLER---PRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HhCCCCCCC---CccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 766544322 2346889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=313.26 Aligned_cols=245 Identities=24% Similarity=0.428 Sum_probs=205.4
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+|++.+.||+|+||.||+|.++ ++..+|+|++.... .....+.+|+.+++.++ ||||+++++++...+..++||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA----MSEDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC----CCHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCceEEEE
Confidence 5889999999999999999876 46789999886432 23456788999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc
Q 016233 160 ELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (393)
Q Consensus 160 e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~ 238 (393)
||++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++....+...
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceecccccc
Confidence 999999999998763 468999999999999999999999999999999999999 5566799999999986543322
Q ss_pred ee--cccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 239 YR--DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 239 ~~--~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
.. ...++..|+|||.+.+ .++.++||||||+++|+|++ |..||...+..+....+..+... .....++.++.+
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 232 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL---YRPKLAPTEVYT 232 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCCHHHHH
Confidence 11 1223457999998864 58899999999999999999 89999887777777776654321 122357899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcC
Q 016233 315 LVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h 336 (393)
++.+||..+|++|||+.++++.
T Consensus 233 li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 233 IMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=325.97 Aligned_cols=256 Identities=23% Similarity=0.368 Sum_probs=210.3
Q ss_pred cccccccceeecceecccCCeEEEEEEECCC-------CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEE
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENST-------GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~ 145 (393)
.++....+|++++.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++++.+||||+++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 3455567899999999999999999986432 2368999876432 233467788999999999569999999
Q ss_pred eEEEEeCCeEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCC
Q 016233 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKG----------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPE 209 (393)
Q Consensus 146 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~ 209 (393)
++++...+.+++||||+.+|+|.+++.... .++..++..++.|++.||.|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 999999999999999999999999987532 3677888999999999999999999999999999
Q ss_pred cEEeccCCCCCcEEEeecCCcccccCCcce---ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCC
Q 016233 210 NFLLSSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAE 284 (393)
Q Consensus 210 Nill~~~~~~~~~kl~DFg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~ 284 (393)
|||+ +.++.+||+|||+++........ ....++..|+|||++.+ .++.++|||||||++|+|++ |..||.+.
T Consensus 164 Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 164 NVLV---TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred eEEE---cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 9999 45567999999999876543221 22334567999998865 58899999999999999998 89999988
Q ss_pred ChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 285 TEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 285 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
+..+....+..+... .....++.++.+|+.+||..+|++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 241 PVEELFKLLKEGHRM---DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 877777777654322 1123578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=330.12 Aligned_cols=262 Identities=30% Similarity=0.476 Sum_probs=211.7
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC--C
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--Q 153 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~ 153 (393)
.+.++|++.+.||+|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++++.+||||+++++++... .
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 35678999999999999999999999999999999886432 12334456778999999994499999999988653 4
Q ss_pred eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
..|+||||+. ++|.+++... .+.+...+.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSL 157 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccchhcc
Confidence 6899999996 5898888665 78899999999999999999999999999999999999 56678999999999866
Q ss_pred cCCc------ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC--------
Q 016233 234 EEGK------VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD-------- 297 (393)
Q Consensus 234 ~~~~------~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~-------- 297 (393)
.... ......||..|+|||.+.+ .++.++||||||+++|+|++|+.||.+....+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 4322 2234578999999998743 47889999999999999999999998766544333322211
Q ss_pred -------------------CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 298 -------------------IDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 298 -------------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
........+.++.++.++|.+||..||++|||+.++++||||....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 1111122345789999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=329.26 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=201.4
Q ss_pred cccccceeecceecccCCeEEEEEEE-----CCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEE
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTE-----NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 149 (393)
+-..++|++++.||+|+||.||+|.+ ..+++.||||.++... .......+.+|+.++.++.+||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 33456899999999999999999984 3567899999986532 2233567889999999997699999999987
Q ss_pred Ee-CCeEEEEEeccCCCChHHHHHHcC-----------------------------------------------------
Q 016233 150 ED-KQSVHVVMELCAGGELFDRIIAKG----------------------------------------------------- 175 (393)
Q Consensus 150 ~~-~~~~~lv~e~~~gg~L~~~l~~~~----------------------------------------------------- 175 (393)
.. ...+++|||||++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 64 456899999999999999886431
Q ss_pred --------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc---
Q 016233 176 --------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV--- 238 (393)
Q Consensus 176 --------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~--- 238 (393)
.++...+..++.||+.||.|||++||+||||||+||++ +.+..+||+|||++........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~ 237 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVR 237 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcchhh
Confidence 35677888999999999999999999999999999999 4566799999999986533221
Q ss_pred eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHH-HHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 239 YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKG-IFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 239 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
.....++..|+|||.+.+ .++.++||||||+++|+|++ |..||....... ....+..+.. ...+ ..+++++.++
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~ 314 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAP--DYTTPEMYQT 314 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC-CCCC--CCCCHHHHHH
Confidence 112345678999998764 58999999999999999997 999997654333 3333333322 2222 2367899999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 016233 316 VRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~~e~l~h 336 (393)
+.+||..||++|||+.++++|
T Consensus 315 ~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 315 MLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=312.91 Aligned_cols=247 Identities=22% Similarity=0.352 Sum_probs=205.1
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
...++|++.+.||+|+||.||+|.+. ++..+|+|.+.... ...+.+.+|+.++++++ |+||+++++++.. +..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~----~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~~ 75 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGT----MSPESFLEEAQIMKKLR-HDKLVQLYAVVSE-EPI 75 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCC----CCHHHHHHHHHHHHhcC-CCceEEEEeEECC-CCc
Confidence 34568999999999999999999876 46679999886533 23467899999999996 9999999998854 568
Q ss_pred EEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 156 HVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ ++++.++|+|||++...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili---~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV---GDGLVCKIADFGLARLI 152 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---eCCceEEeCCceeeeec
Confidence 9999999999999988763 358999999999999999999999999999999999999 45667999999999876
Q ss_pred cCCcc--eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 234 EEGKV--YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 234 ~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
..... .....++..|+|||.+.+ .++.++||||||+++|+|++ |..||.+.+..+....+..+.. . ......+
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~ 229 (260)
T cd05070 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR-M--PCPQDCP 229 (260)
T ss_pred cCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C--CCCCcCC
Confidence 44321 112345567999998764 58899999999999999999 9999988887777777765422 1 2224578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
..+.+|+.+||..||++|||++++++
T Consensus 230 ~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 230 ISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHH
Confidence 99999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=319.98 Aligned_cols=253 Identities=30% Similarity=0.526 Sum_probs=211.4
Q ss_pred eeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEe
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 160 (393)
|++.+.||+|++|.||+|.+..+++.||+|.+.... ......+.+.+|+.+++.+. |+||+++++++.+.+.+++|+|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEEEec
Confidence 667889999999999999999999999999997653 22334567788999999996 9999999999999999999999
Q ss_pred ccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc-c
Q 016233 161 LCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-V 238 (393)
Q Consensus 161 ~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-~ 238 (393)
|+. ++|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||++ +.++.++|+|||++....... .
T Consensus 79 ~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 79 YCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred CcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCccc
Confidence 997 5899999876 579999999999999999999999999999999999999 556779999999998765432 3
Q ss_pred eecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC------------------C
Q 016233 239 YRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD------------------I 298 (393)
Q Consensus 239 ~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~------------------~ 298 (393)
.....++..|+|||.+.+ .++.++|||||||++|+|++|..||...+..+.+..+.... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 334556788999998754 58889999999999999999999998877655554443211 0
Q ss_pred CCC-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 299 DFE-------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 299 ~~~-------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
.++ ...++.++..+.++|.+||..||++||+++++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 000 01223467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=314.89 Aligned_cols=248 Identities=24% Similarity=0.420 Sum_probs=207.6
Q ss_pred cceeecceecccCCeEEEEEEECCCCc---EEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGR---QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
.+|++.+.||+|+||.||+|.+..++. .+|+|.+.... .......+.+|+.++++++ ||||+++++++..++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcc
Confidence 478999999999999999999865543 79999886432 2334567899999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
++||||+++++|.+++... ..+++.++..++.|++.||.|||++|++||||||+||++ +.+..++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCcccccc
Confidence 9999999999999998764 468999999999999999999999999999999999999 456679999999998765
Q ss_pred CCcce----ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 016233 235 EGKVY----RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (393)
Q Consensus 235 ~~~~~----~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (393)
..... ....++..|+|||.+.+ .++.++|+|||||++|++++ |..||......+....+..+.. .+ ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~ 234 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-LP--APMDC 234 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-CC--CCCCC
Confidence 43211 11223568999999874 58999999999999999886 9999988877777777766532 22 22457
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 309 SSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
++.+.+++.+||..+|++||++.++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=328.66 Aligned_cols=257 Identities=27% Similarity=0.450 Sum_probs=208.5
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC----
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK---- 152 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---- 152 (393)
+..+|.+.+.||+|+||.||+|.+..+|+.||||.+.+.. ........+.+|+.+++.+. ||||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVSGD 90 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcC-CCCccchhheecccccCC
Confidence 4568999999999999999999999999999999986542 22334556789999999996 99999999998754
Q ss_pred --CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 153 --QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 153 --~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
..+++|+||+.. +|..++ ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~ 164 (342)
T cd07879 91 EFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGLA 164 (342)
T ss_pred CCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCCCC
Confidence 346999999954 666544 3468999999999999999999999999999999999999 45667999999998
Q ss_pred ccccCCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC----------
Q 016233 231 VFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI---------- 298 (393)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~---------- 298 (393)
...... .....|+..|+|||.+.+ .++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 165 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 165 RHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred cCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 765332 234567899999998864 478899999999999999999999988775554444332100
Q ss_pred -------------CCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 299 -------------DFESA----PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 299 -------------~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
.++.. .++..+..+.+||.+||..||++|||++++|.||||....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00111 1245778899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=317.73 Aligned_cols=245 Identities=31% Similarity=0.500 Sum_probs=201.4
Q ss_pred eecceecccCCeEEEEEEEC----CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 82 SFGKELGRGQFGVTYLCTEN----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
++.+.||.|.||.||+|... ..+..|+||.+... ......+.+.+|++++++++ ||||+++++++...+..++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLR-HPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHS-BTTBE-EEEEEESSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccc-ccccccccccccccccccc
Confidence 46788999999999999988 45678999998532 23344788999999999995 9999999999998888999
Q ss_pred EEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 158 VMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
|+||+++|+|.++|... ..+++.+...++.||+.||.|||+++|+|+||+++||++ +.++.+||+|||++.....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccc
Confidence 99999999999999886 679999999999999999999999999999999999999 5567899999999987733
Q ss_pred Ccce---ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 016233 236 GKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 236 ~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
.... ....+...|+|||.+.. .++.++||||||+++|||++ |..||...+..+....+..+..... ...++.
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 232 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI---PDNCPK 232 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS---BTTSBH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccee---ccchhH
Confidence 2221 23446778999999875 48999999999999999999 7899998888888888866544222 235789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+.++|.+||..||++|||+.++++
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHh
Confidence 9999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=345.39 Aligned_cols=249 Identities=24% Similarity=0.463 Sum_probs=215.5
Q ss_pred cccceeecceecccCCeEEEEEEECC-----CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENS-----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 151 (393)
.+.+-.+.+.||+|+||.||+|.... ....||||.++... +.+...+|++|++++..|+ |||||+++|++..
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQ-HPNIVRLLGVCRE 560 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEcc
Confidence 34456778899999999999998542 34579999987543 4447889999999999997 9999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCC
Q 016233 152 KQSVHVVMELCAGGELFDRIIAKG--------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~~~--------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~ 217 (393)
++.+++|+|||..|||.++|.... .++..+...|+.||+.|+.||-++.+|||||-+.|+|| +
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---g 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---G 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---c
Confidence 999999999999999999997532 27788999999999999999999999999999999999 7
Q ss_pred CCCcEEEeecCCcccccCCcceecc---cCcccccchHHH-hhcCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHH
Q 016233 218 ENALLKATDFGLSVFIEEGKVYRDI---VGSAYYVAPEVL-RRRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDA 292 (393)
Q Consensus 218 ~~~~~kl~DFg~a~~~~~~~~~~~~---~gt~~y~aPE~l-~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~ 292 (393)
++..|||+|||+++.+=..+.++.. .-...|||||.+ .++|+.++||||+||+|||+++ |..||++.+..+.++.
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 8889999999999976554444322 123579999965 5789999999999999999997 9999999999999999
Q ss_pred HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 016233 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVL 334 (393)
Q Consensus 293 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l 334 (393)
|.++.. .+.+ .+++.++++|+..||+.+|.+||++.||-
T Consensus 718 i~~g~l-L~~P--e~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 718 IRAGQL-LSCP--ENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHcCCc-ccCC--CCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 999987 3333 57999999999999999999999999883
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=316.10 Aligned_cols=247 Identities=21% Similarity=0.314 Sum_probs=203.9
Q ss_pred cceeecceecccCCeEEEEEEECCCCc----EEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGR----QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
.+|++.+.||+|+||+||+|.+..+++ .||+|.+.... .......+.+|+.+++.+. |+||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVG-SPYVCRLLGICLTS-T 82 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcCC-C
Confidence 478999999999999999999877776 48999886432 2334567889999999996 99999999988754 5
Q ss_pred EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
.++++||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||+. .+..+||+|||+++..
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~---~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK---SPNHVKITDFGLARLL 159 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc---CCCcEEECCCCceeec
Confidence 78999999999999998764 5689999999999999999999999999999999999994 4556999999999876
Q ss_pred cCCcce---ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 016233 234 EEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (393)
Q Consensus 234 ~~~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (393)
...... ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||...........+..+.... ....+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 236 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLP---QPPIC 236 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC---CCccC
Confidence 533221 12234678999998764 58999999999999999998 999998776666665555543221 22467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 309 SSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+.++.+++.+||..||++||++.++++
T Consensus 237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 237 TIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=332.02 Aligned_cols=256 Identities=22% Similarity=0.338 Sum_probs=206.5
Q ss_pred ccccccceeecceecccCCeEEEEEEEC-----CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEE
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 148 (393)
++...++|.+++.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+|.++..||||++++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 4455668999999999999999999864 345789999996532 223345788999999999669999999999
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHHcC-----------------------------------------------------
Q 016233 149 YEDKQSVHVVMELCAGGELFDRIIAKG----------------------------------------------------- 175 (393)
Q Consensus 149 ~~~~~~~~lv~e~~~gg~L~~~l~~~~----------------------------------------------------- 175 (393)
+...+.+++|||||++|+|.+++...+
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999986532
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCc
Q 016233 176 ---------------------------------------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210 (393)
Q Consensus 176 ---------------------------------------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~N 210 (393)
.+++..+..++.||+.||.|||+.+|+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 25666788899999999999999999999999999
Q ss_pred EEeccCCCCCcEEEeecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCC
Q 016233 211 FLLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAET 285 (393)
Q Consensus 211 ill~~~~~~~~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 285 (393)
||+ +....+||+|||++........ .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||....
T Consensus 270 iLl---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 270 VLI---CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred EEE---eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999 4566799999999986533221 123457788999998864 58899999999999999998 899997765
Q ss_pred hHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 286 EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 286 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
..+............. ....++.++.+|+.+||..||.+||++.++++.
T Consensus 347 ~~~~~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 347 MNEQFYNAIKRGYRMA--KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred chHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5554444333322222 224578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=312.10 Aligned_cols=248 Identities=21% Similarity=0.330 Sum_probs=207.0
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
+...+.|+++++||+|+||.||+|... +++.||+|.+.... .....+.+|+.++++++ |+||+++++++.. +.
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~ 74 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS----MSPEAFLAEANLMKQLQ-HPRLVRLYAVVTQ-EP 74 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC----CcHHHHHHHHHHHHhcC-CcCeeeEEEEEcc-CC
Confidence 445678999999999999999999865 57889999886433 24567899999999996 9999999998754 56
Q ss_pred EEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 155 VHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
.++||||+.+++|.+++... ..+++.++..++.|++.||+|||+.|++||||||+||++ +.++.++|+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~ 151 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARL 151 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceee
Confidence 89999999999999988653 358899999999999999999999999999999999999 5566799999999987
Q ss_pred ccCCcc--eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 016233 233 IEEGKV--YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (393)
Q Consensus 233 ~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (393)
...... .....++..|+|||++.. .++.++||||||+++|+|++ |..||.+.+..+....+..+... ......
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~ 228 (260)
T cd05067 152 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM---PRPDNC 228 (260)
T ss_pred cCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC---CCCCCC
Confidence 653221 123345678999998864 58899999999999999999 99999888877777666554321 223457
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 309 SSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+.++.++|.+||..||++|||++++++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 229 PEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=311.58 Aligned_cols=241 Identities=23% Similarity=0.348 Sum_probs=201.5
Q ss_pred ceecccCCeEEEEEEECCCC---cEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEec
Q 016233 85 KELGRGQFGVTYLCTENSTG---RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMEL 161 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~ 161 (393)
++||+|+||.||+|.+..++ ..+|+|.+...... .....+.+|+.+++.+. |+||+++++++.. +.+++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLD-HPCIVRLIGVCKG-EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEcC-CceEEEEEe
Confidence 46999999999999876555 78999998754422 34567889999999996 9999999998764 468999999
Q ss_pred cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcce-e
Q 016233 162 CAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY-R 240 (393)
Q Consensus 162 ~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~-~ 240 (393)
+.+++|.+++.....+++..+..++.|++.+|.|||+++++||||||+|||+ +.++.+||+|||++......... .
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCcccc
Confidence 9999999999887789999999999999999999999999999999999999 45667999999999876443321 1
Q ss_pred ---cccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 241 ---DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 241 ---~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
...++..|+|||.+.+ .++.++|||||||++|+|++ |..||...+..+....+...... .....++..+.++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l 230 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL---PRPEECPQEIYSI 230 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC---CCCCCCCHHHHHH
Confidence 1123467999998864 58999999999999999998 99999888777777776655322 2234678999999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 016233 316 VRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~~e~l~ 335 (393)
|.+||..||++|||+.++++
T Consensus 231 i~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 231 MLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=317.26 Aligned_cols=248 Identities=22% Similarity=0.387 Sum_probs=206.7
Q ss_pred ccceeecceecccCCeEEEEEEEC-----CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
..+|.+.++||+|+||.||++... .++..+|+|.+... .......+.+|+++++.++ |+||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQ-HQHIVRFYGVCTEG 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCC-CCCCceEEEEEecC
Confidence 346888999999999999999743 35678999987543 2345678999999999996 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCC
Q 016233 153 QSVHVVMELCAGGELFDRIIAKG---------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~ 217 (393)
+..++||||+.+++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+ +
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---G 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---c
Confidence 99999999999999999987643 47889999999999999999999999999999999999 4
Q ss_pred CCCcEEEeecCCcccccCCcce---ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHH
Q 016233 218 ENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDA 292 (393)
Q Consensus 218 ~~~~~kl~DFg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~ 292 (393)
++..+||+|||++......... ....+++.|+|||.+.+ .++.++|||||||++|+|++ |.+||......+....
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 5667999999998765432211 12335678999998764 58999999999999999998 9999988777777777
Q ss_pred HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 293 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+..+.... ....+++.+.+||.+||+.||.+||+++++++
T Consensus 237 ~~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 76653321 12357899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=311.01 Aligned_cols=246 Identities=23% Similarity=0.356 Sum_probs=204.1
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
..++|.+.+.||+|++|.||+|.+..+ ..+|+|.+.... ...+.+.+|+++++.+. |+||+++++++.. +..+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~~~ 76 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT----MMPEAFLQEAQIMKKLR-HDKLVPLYAVVSE-EPIY 76 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC----ccHHHHHHHHHHHHhCC-CCCeeeEEEEEcC-CCcE
Confidence 346799999999999999999987755 469999875432 23467889999999996 9999999998864 5688
Q ss_pred EEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 157 VVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+||||+.+++|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||++ +.++.++|+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIE 153 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEcc
Confidence 999999999999998764 247899999999999999999999999999999999999 556779999999998664
Q ss_pred CCcc--eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 016233 235 EGKV--YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 235 ~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
.... .....++..|+|||.+.+ .++.++||||||+++|+|++ |..||.+....+....+..+.. ......++.
T Consensus 154 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 230 (260)
T cd05069 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR---MPCPQGCPE 230 (260)
T ss_pred CCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCcccCH
Confidence 3321 122345678999998764 58899999999999999999 9999998887777776665422 122346789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+.+++.+||..||++||+++++++
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 231 SLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=312.34 Aligned_cols=248 Identities=25% Similarity=0.405 Sum_probs=207.2
Q ss_pred cceeecceecccCCeEEEEEEECCCCc---EEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGR---QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
.+|+..+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+++++.++ |+||+++.+++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKPA 81 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCCc
Confidence 478889999999999999999876665 79999886432 2334567889999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
++||||+++++|.+++... +.+++.++..++.|++.||.|||+.|++||||||+||++ +.+..+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceecc
Confidence 9999999999999988764 578999999999999999999999999999999999999 456679999999998664
Q ss_pred CCcc--eec--ccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 016233 235 EGKV--YRD--IVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (393)
Q Consensus 235 ~~~~--~~~--~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (393)
.... ... ...+..|+|||.+.. .++.++|||||||++|+|++ |..||...+..+....+...... +....+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~~ 235 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL---PAPMDC 235 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCC---CCCCCC
Confidence 3221 111 123457999998864 58899999999999999997 99999988877777777654321 222357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 309 SSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+.++.+++.+||..||++||++.++++
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=310.37 Aligned_cols=246 Identities=26% Similarity=0.454 Sum_probs=209.7
Q ss_pred eeecceecccCCeEEEEEEECCCC----cEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTG----RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
+++.+.||.|+||.||+|.+..++ ..||+|.+.... .......+..|+.+++.+. |+||+++++++.+.+..+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLD-HPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCCeeE
Confidence 356789999999999999998766 899999985432 2225678899999999995 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 157 VVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
++|||+++++|.+++..... +++..+..++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||++....
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLY 154 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceecc
Confidence 99999999999999876544 9999999999999999999999999999999999999 556679999999998765
Q ss_pred CCcceec--ccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 016233 235 EGKVYRD--IVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 235 ~~~~~~~--~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
....... ..+++.|+|||.+.+ .++.++||||||+++|+|++ |..||...+.......+..+..... ...++.
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 231 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK---PENCPP 231 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCH
Confidence 5432222 336789999998854 58999999999999999998 8999988887777777776654322 234789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
++.+++.+||..||++|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 9999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=319.00 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=202.6
Q ss_pred ccceeecceecccCCeEEEEEEECCCC--------------cEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCee
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTG--------------RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIV 143 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~--------------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv 143 (393)
..+|++.+.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|++++++++ |+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~ 80 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLK-NPNII 80 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCcC
Confidence 458999999999999999999875432 358999886432 2334567899999999996 99999
Q ss_pred EEeEEEEeCCeEEEEEeccCCCChHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcE
Q 016233 144 EFKGAYEDKQSVHVVMELCAGGELFDRIIAKG------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENF 211 (393)
Q Consensus 144 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Ni 211 (393)
++++++...+..++||||+.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999886532 367888999999999999999999999999999999
Q ss_pred EeccCCCCCcEEEeecCCcccccCCcce---ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh--CCCCCCCCC
Q 016233 212 LLSSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS--GVPPFWAET 285 (393)
Q Consensus 212 ll~~~~~~~~~kl~DFg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt--g~~pf~~~~ 285 (393)
+++ .+..+||+|||++......... ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||...+
T Consensus 161 ll~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 161 LVG---NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EEc---CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 994 4567999999999765433221 22345678999998764 58999999999999999988 778888777
Q ss_pred hHHHHHHHHcC----CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 286 EKGIFDAILQG----DIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 286 ~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
..+.+..+... .........+.+++.+.+|+.+||..||++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 66655544321 111111223457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=317.06 Aligned_cols=247 Identities=23% Similarity=0.347 Sum_probs=203.2
Q ss_pred ceeecceecccCCeEEEEEEECC-----CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 80 HYSFGKELGRGQFGVTYLCTENS-----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.+. ||||+++++.+..++.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCC
Confidence 47889999999999999998753 23578888876432 2234567889999999996 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCc
Q 016233 155 VHVVMELCAGGELFDRIIAK------------------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~------------------------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~N 210 (393)
.++|+||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 99999999999999988642 236788899999999999999999999999999999
Q ss_pred EEeccCCCCCcEEEeecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCC
Q 016233 211 FLLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAET 285 (393)
Q Consensus 211 ill~~~~~~~~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 285 (393)
||+ ++++.+||+|||++........ .....++..|+|||.+.+ .++.++||||||+++|+|++ |..||.+..
T Consensus 158 ill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999 4566799999999986543221 122345678999998764 48899999999999999998 999998887
Q ss_pred hHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 286 EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 286 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
..+....+.... ... ....++.++.+|+.+||+.||++||++.++++
T Consensus 235 ~~~~~~~~~~~~-~~~--~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 235 PERLFNLLKTGY-RME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHHhCCC-CCC--CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 777666655442 221 22467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=313.59 Aligned_cols=247 Identities=23% Similarity=0.427 Sum_probs=206.8
Q ss_pred ceeecceecccCCeEEEEEEECCCCc---EEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGR---QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
.|++.+.||+|+||.||+|.+..+++ .||||.+.... .......+..|+.+++.+. ||||+++++++.+++.++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCceE
Confidence 58999999999999999999887665 59999886432 3344678899999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 157 VVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
+||||+++++|.+++... +.+++.+++.++.|++.||.|||++|++|+||||+||++ +.+..+||+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCcccccccc
Confidence 999999999999988763 568999999999999999999999999999999999999 5566799999999876543
Q ss_pred Ccce---eccc---CcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 016233 236 GKVY---RDIV---GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (393)
Q Consensus 236 ~~~~---~~~~---gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (393)
.... .... ++..|+|||.+.+ .++.++|||||||++|+|++ |..||+..+..+....+.... . ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~-~--~~~~~~ 235 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY-R--LPPPMD 235 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-c--CCCccc
Confidence 3211 1111 2357999998864 58999999999999999886 999999888777777775432 2 222346
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 308 ISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
++..+.+++.+||..+|++||++++++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 236 CPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=322.27 Aligned_cols=265 Identities=31% Similarity=0.489 Sum_probs=212.3
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe-CCe
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED-KQS 154 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~~ 154 (393)
.+.++|++.+.||.|+||.||+|.+..+++.||||.+.+... .......+.+|+.+++.++ ||||+++++++.. .+.
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLR-HENIISLSDIFISPLED 84 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecCCCc
Confidence 356789999999999999999999999999999998865432 2334567889999999996 9999999999865 567
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
.++|+||+ +++|.+++. ...+++..+..++.|++.||.|||++||+||||+|+||++ +.++.++|+|||++....
T Consensus 85 ~~lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 85 IYFVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQD 159 (328)
T ss_pred EEEEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccccccC
Confidence 89999999 568877665 3568899999999999999999999999999999999999 556779999999987653
Q ss_pred CCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC----------------
Q 016233 235 EGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG---------------- 296 (393)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~---------------- 296 (393)
.. .....++..|+|||.+.+ .++.++|||||||++|+|++|..||...........+.+.
T Consensus 160 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 160 PQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred CC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 32 234567889999998754 4889999999999999999999999776543222211110
Q ss_pred -----------CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCCCCc
Q 016233 297 -----------DIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKP 349 (393)
Q Consensus 297 -----------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~~~ 349 (393)
.........+.++..+.++|.+||..||++|||+++++.||||.........+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~ 301 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEP 301 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCcccc
Confidence 00000011245788999999999999999999999999999998765544333
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=310.54 Aligned_cols=240 Identities=25% Similarity=0.345 Sum_probs=198.0
Q ss_pred eecccCCeEEEEEEEC--CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccC
Q 016233 86 ELGRGQFGVTYLCTEN--STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCA 163 (393)
Q Consensus 86 ~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 163 (393)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++ ||||++++++++. ...++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~-~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLD-NPYIVRMIGVCEA-EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEcC-CCeEEEEEeCC
Confidence 4899999999999865 445679999886432 2334567899999999996 9999999998864 46899999999
Q ss_pred CCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcce-e-
Q 016233 164 GGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY-R- 240 (393)
Q Consensus 164 gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~-~- 240 (393)
+++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||++ +.+..+||+|||++......... .
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCccceec
Confidence 9999998875 4568999999999999999999999999999999999999 45667999999999865433221 1
Q ss_pred --cccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 241 --DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 241 --~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
...++..|+|||.+.. .++.++|||||||++|+|++ |..||......+....+..+.... ..+..++++.++|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li 231 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLD---CPAECPPEMYALM 231 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCCCCHHHHHHH
Confidence 1223568999998864 58899999999999999996 999999888777777776654321 2245789999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 016233 317 RRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 317 ~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+||..||++||++.++++
T Consensus 232 ~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 232 KDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=309.64 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=209.1
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
...++|++.+.||+|+||.||+|.+. .++.+|||.+.... .....+.+|+.++++++ |+||+++++++......
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT----MSPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEEPI 76 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc----cCHHHHHHHHHHHhhCC-CCCEeeeeeeeecCCce
Confidence 45678999999999999999999976 45789999886432 34577899999999997 99999999999998999
Q ss_pred EEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 156 HVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||++...
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLI 153 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECccccceec
Confidence 9999999999999998764 368999999999999999999999999999999999999 45677999999999876
Q ss_pred cCCcc--eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 234 EEGKV--YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 234 ~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
..... .....++..|+|||.+.+ .++.++||||||+++|+|++ |+.||.+.+....+..+..+... ......+
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~ 230 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM---PRPPNCP 230 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCC
Confidence 53211 112234568999998865 58889999999999999998 99999888877777777654321 1223468
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.++.+++.+||..||++||+++++++
T Consensus 231 ~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 231 EELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHH
Confidence 89999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=316.27 Aligned_cols=249 Identities=22% Similarity=0.365 Sum_probs=207.3
Q ss_pred ccceeecceecccCCeEEEEEEECC-----CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENS-----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
..+|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++++. ||||+++++++.++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-HPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcC-CCchheEEEEEcCC
Confidence 4579999999999999999998753 67899999886432 2234567889999999996 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHcC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCc
Q 016233 153 QSVHVVMELCAGGELFDRIIAKG----------------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~~----------------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~N 210 (393)
..+++||||+++++|.+++.... .+++.++..++.|++.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999987432 36788899999999999999999999999999999
Q ss_pred EEeccCCCCCcEEEeecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCC
Q 016233 211 FLLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAET 285 (393)
Q Consensus 211 ill~~~~~~~~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 285 (393)
|++ +.++.++|+|||++........ .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+..
T Consensus 161 il~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 161 CLV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred eEe---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999 5566799999999876543221 122334667999998764 58999999999999999997 889998888
Q ss_pred hHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 286 EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 286 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
..+....+..+..... ...++.++.+||.+||..||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 238 HEEVIYYVRDGNVLSC---PDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7777777766543211 1357899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=313.94 Aligned_cols=247 Identities=21% Similarity=0.314 Sum_probs=201.6
Q ss_pred cceeecceecccCCeEEEEEEECCCCcE----EEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQ----FACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
.+|++.+.||+|+||.||+|.+..+++. +++|.+.... .......+..|+.+++++. ||||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLD-HAYIVRLLGICPG-AS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCC-CCCcceEEEEECC-Cc
Confidence 4788999999999999999999877764 6667664221 2233467788888999996 9999999998764 45
Q ss_pred EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
.++++||+++|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+||++ +.+..+||+|||+++..
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLL 159 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceec
Confidence 78899999999999999764 568999999999999999999999999999999999999 55677999999999865
Q ss_pred cCCc---ceecccCcccccchHHHh-hcCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 016233 234 EEGK---VYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (393)
Q Consensus 234 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (393)
.... ......++..|+|||.+. +.++.++|||||||++|+|++ |..||.+.......+.+..+..... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 236 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ---PQIC 236 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---CCCC
Confidence 4322 122345677899999886 458999999999999999998 9999988776666555554433221 1246
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 309 SSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+.++.+++.+||..||++|||+.|+++
T Consensus 237 ~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 237 TIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=309.20 Aligned_cols=241 Identities=23% Similarity=0.369 Sum_probs=203.0
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEE-EeCCeEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY-EDKQSVHV 157 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~-~~~~~~~l 157 (393)
.+|++.+.||+|+||.||++... |..+|+|.+... ...+.+.+|+.++++++ |+||+++++++ ..++..++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCCceEE
Confidence 47899999999999999999865 788999987532 23567889999999996 99999999975 45567999
Q ss_pred EEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 158 VMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccc
Confidence 999999999999987643 37889999999999999999999999999999999999 5566799999999886543
Q ss_pred CcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 236 GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
.. ....++..|+|||++.+ .++.++|||||||++|+|++ |..||...+..+....+..+.. ....+.+++.+.
T Consensus 155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 229 (256)
T cd05082 155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPVVY 229 (256)
T ss_pred cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCCHHHH
Confidence 22 23345678999998875 48899999999999999997 9999988877777777665422 222356789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 016233 314 DLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+++.+||..||++|||+.++++
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=321.74 Aligned_cols=253 Identities=25% Similarity=0.347 Sum_probs=198.5
Q ss_pred ecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEecc
Q 016233 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELC 162 (393)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 162 (393)
+++.+|. +|.||.+++..+++.||+|++..... .......+.+|+.+++.++ |+||+++++++...+..+++|||+
T Consensus 6 i~~~~~~--~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~e~~ 81 (314)
T cd08216 6 IGKCFED--LMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVSPLM 81 (314)
T ss_pred hhHhhcC--CceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEEEecc
Confidence 3444444 45566667777899999999976432 3345678999999999997 999999999999999999999999
Q ss_pred CCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc--
Q 016233 163 AGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV-- 238 (393)
Q Consensus 163 ~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~-- 238 (393)
.+++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++ .++.+||+|||.+........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~---~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS---GDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe---cCCceEEecCccceeeccccccc
Confidence 999999988763 4588999999999999999999999999999999999994 456799999998875532211
Q ss_pred ------eecccCcccccchHHHhh---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC---------
Q 016233 239 ------YRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF--------- 300 (393)
Q Consensus 239 ------~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~--------- 300 (393)
.....++..|+|||++.. .++.++||||+||++|+|++|..||..............+....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhh
Confidence 123457788999999864 37899999999999999999999998765443322211111000
Q ss_pred ---------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 301 ---------------------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 301 ---------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.......++.++.+|+.+||..||++|||++++|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 000001235678999999999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=308.84 Aligned_cols=243 Identities=24% Similarity=0.387 Sum_probs=206.9
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
..+|++.+.||.|+||.||+|... |+.||+|.+.... .....+.+|+.+++.++ |+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS----TAAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccch----hHHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCCeEE
Confidence 347889999999999999999876 7899999986432 14678899999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 158 VMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEccccccccccc
Confidence 999999999999997765 68999999999999999999999999999999999999 5567799999999987643
Q ss_pred CcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 236 GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
... ...++..|+|||.+.. .++.++||||||+++|+|++ |..||...+..+....+..+.. . .....+++.+.
T Consensus 155 ~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~ 229 (256)
T cd05039 155 GQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR-M--EAPEGCPPEVY 229 (256)
T ss_pred ccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-C--CCccCCCHHHH
Confidence 222 3345567999998764 58889999999999999997 9999988877766666655422 1 11245789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 016233 314 DLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
++|.+||..+|++|||+.++++
T Consensus 230 ~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 230 KVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHhccChhhCcCHHHHHH
Confidence 9999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=312.98 Aligned_cols=252 Identities=27% Similarity=0.490 Sum_probs=209.6
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccC--CcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV--TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
+|.+.+.||+|+||.||++.+..++..+++|+++..... .......+.+|+.+++.++ ||||+++++++.+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCceEE
Confidence 589999999999999999999888777777776543221 1223445778999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 158 VMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
|+||+++++|.+++.. ...+++.+++.++.|++.||.|||++|++|+||+|+||+++. ..++|+|||++...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~----~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN----NLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec----CCEeecccCceeec
Confidence 9999999999888754 346899999999999999999999999999999999999942 35999999998776
Q ss_pred cCCc-ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 016233 234 EEGK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (393)
Q Consensus 234 ~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (393)
.... ......|++.|+|||.+.+ .++.++|+||||+++|+|++|..||...........+..+..... ...++.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 232 (260)
T cd08222 156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL---PETYSRQ 232 (260)
T ss_pred CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCC---cchhcHH
Confidence 4332 2334568899999998764 478899999999999999999999987776666666655432211 2357889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 312 AKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 312 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
+.++|.+||..||++||++.++++||||
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=301.15 Aligned_cols=252 Identities=26% Similarity=0.369 Sum_probs=205.7
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe----
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED---- 151 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~---- 151 (393)
.-..||++.+.||+|||+.||++....+++.||+|.+.... ..+.+...+|+...++++ |||+++++++...
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEKD 93 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhcc
Confidence 34569999999999999999999999999999999996543 456788899999999996 9999999887533
Q ss_pred -CCeEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC--cEecCCCCCcEEeccCCCCCcEEE
Q 016233 152 -KQSVHVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKDENALLKA 224 (393)
Q Consensus 152 -~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~~~--ivH~Dikp~Nill~~~~~~~~~kl 224 (393)
....||++.|...|+|.+.+.. ...+++.++..|+.+|++||++||+.. ++||||||.|||++ +.+.++|
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl 170 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLPVL 170 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCceEE
Confidence 3459999999999999998864 236999999999999999999999998 99999999999995 4567999
Q ss_pred eecCCcccccCC----c------ceecccCcccccchHHHhh----cCCCcchHHHHHHHHHHHhhCCCCCCCCCh--HH
Q 016233 225 TDFGLSVFIEEG----K------VYRDIVGSAYYVAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAETE--KG 288 (393)
Q Consensus 225 ~DFg~a~~~~~~----~------~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~~lltg~~pf~~~~~--~~ 288 (393)
.|||.+....-. . .......|..|+|||.+.- -.+.++|||||||+||.|+.|..||...-. ..
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS 250 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS 250 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence 999998754311 0 1112346889999999862 378999999999999999999999942211 11
Q ss_pred HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 289 IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 289 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
+.-++..+.+.++.. +.+|+.+.+||+.||+.||.+||++.+++.+
T Consensus 251 laLAv~n~q~s~P~~--~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 251 LALAVQNAQISIPNS--SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EEEeeeccccccCCC--CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 112344555555554 3489999999999999999999999999874
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=305.36 Aligned_cols=261 Identities=26% Similarity=0.487 Sum_probs=232.5
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
+..--..|+++++||+|+|+.|.++++++|.+.+|+|+++++.+....+..-++.|-.+..+.++||.+|-++.+|..+.
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 33344579999999999999999999999999999999999888888888889999999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc-
Q 016233 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF- 232 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~- 232 (393)
.+++|.||++||+|.-.+.+.++++++.++.+...|+.||+|||++||++||||.+|+|+ +..+.+||.|+|+++.
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~ 401 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEG 401 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcC
Confidence 999999999999998888889999999999999999999999999999999999999999 6677799999999986
Q ss_pred ccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCC--------CChHHHHHHHHcCCCCCCCC
Q 016233 233 IEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWA--------ETEKGIFDAILQGDIDFESA 303 (393)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~--------~~~~~~~~~i~~~~~~~~~~ 303 (393)
+.++....+.||||.|.|||++++ .|+..+|.|+|||+|+||+.|+.||.- .++.-+++.|+...+.++.
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr- 480 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR- 480 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc-
Confidence 456667788999999999999997 499999999999999999999999942 2233456667777766654
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCC------HHHHhcCccccC
Q 016233 304 PWPTISSSAKDLVRRMLTQDPKKRIT------SAQVLEHPWIKE 341 (393)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rpt------~~e~l~h~~~~~ 341 (393)
.+|-.+..+++..|.+||.+|.. +.++..|+||..
T Consensus 481 ---slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 481 ---SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred ---eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 46778889999999999999974 578999999974
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=313.07 Aligned_cols=250 Identities=21% Similarity=0.391 Sum_probs=209.7
Q ss_pred cceeecceecccCCeEEEEEEECC-----CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENS-----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
.+|++.+.||+|+||.||+|+.+. +.+.+++|.+.... .......+.+|++++++++ |+||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLS-HKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcC-CcceeeeEEEECCCC
Confidence 578999999999999999999754 34679999875432 1224567899999999996 999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEE
Q 016233 154 SVHVVMELCAGGELFDRIIAKG---------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKA 224 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl 224 (393)
..++||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||++ +..+.+++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEE
Confidence 9999999999999999997655 68999999999999999999999999999999999999 45567999
Q ss_pred eecCCcccccCCc--ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCC
Q 016233 225 TDFGLSVFIEEGK--VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDF 300 (393)
Q Consensus 225 ~DFg~a~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 300 (393)
+|||++....... ......++..|+|||.+.+ .++.++||||||+++|+|++ |..||........+..+..+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 9999987543222 2233456788999998764 57889999999999999998 889998777777777776665443
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 301 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
.. ...++..+.+++.+||..||++|||+.+++.+
T Consensus 239 ~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 239 PV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 32 24578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=314.16 Aligned_cols=248 Identities=25% Similarity=0.394 Sum_probs=195.8
Q ss_pred cce-eecceecccCCeEEEEEE----ECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC-
Q 016233 79 LHY-SFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK- 152 (393)
Q Consensus 79 ~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 152 (393)
++| ++.+.||+|+||+||++. ...++..||+|.+.... .......+.+|+.+++.++ ||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence 456 899999999999998865 34568899999986542 2234567889999999996 99999999987653
Q ss_pred -CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 153 -QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 153 -~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
..+++||||+++++|.+++... .+++.+++.++.|++.||.|||++||+||||||+||++ +.+..++|+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~ 155 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAK 155 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeeccccc
Confidence 4689999999999999988664 69999999999999999999999999999999999999 455679999999998
Q ss_pred cccCCcc----eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChH--HHH------------HH
Q 016233 232 FIEEGKV----YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEK--GIF------------DA 292 (393)
Q Consensus 232 ~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~--~~~------------~~ 292 (393)
....... .....++..|+|||.+.+ .++.++||||||+++|+|++|..||...... +.. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 7654322 112345667999998864 5899999999999999999999998643321 000 00
Q ss_pred HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 293 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
........ .....++.++.+++.+||..||++|||++++++
T Consensus 236 ~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 236 LLERGMRL--PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhcCCCC--CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 01111111 112357889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=308.84 Aligned_cols=242 Identities=26% Similarity=0.380 Sum_probs=202.7
Q ss_pred ceecccCCeEEEEEEECC-CC--cEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEec
Q 016233 85 KELGRGQFGVTYLCTENS-TG--RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMEL 161 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~ 161 (393)
+.||+|++|.||+|.+.. .+ ..||||.+...... ...+.+.+|+.++++++ ||||+++++++.. ...++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEe
Confidence 468999999999999865 33 36999998765432 45678899999999997 9999999999988 889999999
Q ss_pred cCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc-
Q 016233 162 CAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV- 238 (393)
Q Consensus 162 ~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~- 238 (393)
+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||++ +.++.+||+|||++..+.....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ecCCEEEeccccccccccccccc
Confidence 99999999997754 68999999999999999999999999999999999999 4557899999999987654221
Q ss_pred ---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 239 ---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 239 ---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
.....++..|+|||.+.+ .++.++|||||||++|+|++ |..||...+..+....+......... ...++..+.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 231 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER--PEACPQDIY 231 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCC--CccCCHHHH
Confidence 112457788999998875 58999999999999999998 99999888777777666643222221 235789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 016233 314 DLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+++.+||..+|++|||+.++++
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHH
Confidence 9999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=314.99 Aligned_cols=252 Identities=21% Similarity=0.346 Sum_probs=201.0
Q ss_pred ccceeecceecccCCeEEEEEEECC----------------CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCC
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENS----------------TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n 141 (393)
..+|++.+.||+|+||.||++.+.. ++..+|+|.+.... .......+.+|+.+++.++ |+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~-~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLK-DPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCC
Confidence 4579999999999999999986432 34579999886432 2334567899999999996 999
Q ss_pred eeEEeEEEEeCCeEEEEEeccCCCChHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCc
Q 016233 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKG-----------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210 (393)
Q Consensus 142 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-----------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~N 210 (393)
|+++++++...+..++||||+.+++|.+++.... .+++.++..++.|++.||.|||++||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999999887642 36677899999999999999999999999999999
Q ss_pred EEeccCCCCCcEEEeecCCcccccCCcce---ecccCcccccchHHHh-hcCCCcchHHHHHHHHHHHhh--CCCCCCCC
Q 016233 211 FLLSSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS--GVPPFWAE 284 (393)
Q Consensus 211 ill~~~~~~~~~kl~DFg~a~~~~~~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt--g~~pf~~~ 284 (393)
||+ +.++.++|+|||++..+...... ....++..|+|||... +.++.++|||||||++|+|++ |..||...
T Consensus 161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 161 CLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 999 45667999999999865433211 1233467899999765 468999999999999999998 78999877
Q ss_pred ChHHHHHHHHc----CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 285 TEKGIFDAILQ----GDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 285 ~~~~~~~~i~~----~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+..+.+..... .......+....+++.+.+|+.+||..||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 66555443321 0011111122357789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=305.98 Aligned_cols=245 Identities=26% Similarity=0.474 Sum_probs=206.4
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
.|++.+.||+|+||.||+|.+. .+..+|+|.+.... .....+.+|+++++++. ||||+++++++......++||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA----MSEEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC----CCHHHHHHHHHHHHhCC-CCCeeeEEEEEccCCceEEEE
Confidence 6889999999999999999876 46789999886432 23467889999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc
Q 016233 160 ELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (393)
Q Consensus 160 e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~ 238 (393)
||+.+++|.+++... +.+++..++.++.|++.+|.|||+++++||||||+||++ +.+..++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecccCcc
Confidence 999999999988764 468999999999999999999999999999999999999 4566799999999876543321
Q ss_pred --eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 239 --YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 239 --~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
.....++..|+|||.+.+ .++.++||||||+++|+|++ |..||......+....+..+...+.. ...+..+.+
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 232 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQSVYE 232 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCHHHHH
Confidence 112335568999998864 58889999999999999998 99999888877777777665332221 236899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcC
Q 016233 315 LVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h 336 (393)
|+.+||..+|++|||+.+++++
T Consensus 233 l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 233 LMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHcccChhhCCCHHHHHHh
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=310.12 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=205.8
Q ss_pred ccceeecceecccCCeEEEEEEECCC---CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENST---GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
..+|.+.+.||+|+||.||+|.+... ...||||.+.... .....+.+.+|+.+++.+. ||||+++++++.+. .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~-~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFD-HPHIVKLIGVITEN-P 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCchhceeEEEcCC-C
Confidence 45789999999999999999997644 3568999875432 2334567899999999996 99999999998764 5
Q ss_pred EEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 155 VHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++ ..+.++|+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS---SPDCVKLGDFGLSRYL 157 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe---cCCCeEEccCceeeec
Confidence 789999999999999997643 589999999999999999999999999999999999994 5567999999999876
Q ss_pred cCCccee--cccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 234 EEGKVYR--DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 234 ~~~~~~~--~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
....... ...++..|+|||.+.. .++.++||||||+++|+|++ |..||...+..+....+..+... .....++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~ 234 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---PMPPNCP 234 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCC
Confidence 5443222 2234567999998764 58899999999999999986 99999888877777777665432 2234678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
..+.++|.+||..+|++|||+.+++..
T Consensus 235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 235 PTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=318.65 Aligned_cols=260 Identities=25% Similarity=0.351 Sum_probs=205.1
Q ss_pred ccccccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeE
Q 016233 68 TILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (393)
Q Consensus 68 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 147 (393)
.+...+.......|.-...||+|+||.||+|.... |..||||.+...... . ..+|.+|+.++.+++ |||+|+++|
T Consensus 64 ~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~--~-~~eF~~Ei~~ls~l~-H~Nlv~LlG 138 (361)
T KOG1187|consen 64 SFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQ--G-EREFLNEVEILSRLR-HPNLVKLLG 138 (361)
T ss_pred eeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCc--c-hhHHHHHHHHHhcCC-CcCcccEEE
Confidence 34445555667789888999999999999999775 489999977543211 1 456999999999997 999999999
Q ss_pred EEEeCC-eEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC---cEecCCCCCcEEeccCCCCCc
Q 016233 148 AYEDKQ-SVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMG---VMHRDLKPENFLLSSKDENAL 221 (393)
Q Consensus 148 ~~~~~~-~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~---ivH~Dikp~Nill~~~~~~~~ 221 (393)
||.+.+ ..+||+||+++|+|.++|.... .++|....+|+..++.||+|||... |||||||++|||+ |++..
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~ 215 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFN 215 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCC
Confidence 999988 5999999999999999998755 7899999999999999999999854 9999999999999 78889
Q ss_pred EEEeecCCcccccC-Ccceecc-cCcccccchHHHh-hcCCCcchHHHHHHHHHHHhhCCCCCCCCC---hHHHHH----
Q 016233 222 LKATDFGLSVFIEE-GKVYRDI-VGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAET---EKGIFD---- 291 (393)
Q Consensus 222 ~kl~DFg~a~~~~~-~~~~~~~-~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~---~~~~~~---- 291 (393)
.||+|||+|+.... ....... .||.+|+|||.+. +..+.++|||||||+|.||+||+.+..... .....+
T Consensus 216 aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred EEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 99999999976654 3333333 8999999999886 579999999999999999999998876432 111222
Q ss_pred HHHcCCCC-CCCCCC--CCCC-----HHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 292 AILQGDID-FESAPW--PTIS-----SSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 292 ~i~~~~~~-~~~~~~--~~~s-----~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+..+... +..+.. ...+ ..+..+..+|+..+|.+||++.++++
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 22222111 111111 1222 23567889999999999999999754
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=304.67 Aligned_cols=241 Identities=25% Similarity=0.380 Sum_probs=200.0
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~g 164 (393)
+.||+|+||.||+|... ++..+|+|.+.... .......+.+|+.+++.+. ||||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYD-HPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEecCCccEEEEECCCC
Confidence 36999999999999865 68899999876432 2233456889999999996 99999999999999999999999999
Q ss_pred CChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcce--ec
Q 016233 165 GELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY--RD 241 (393)
Q Consensus 165 g~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~--~~ 241 (393)
++|.+++... ..+++..+..++.|++.+|.|||++|++||||||+||++ +.++.+||+|||++......... ..
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceeccccccccCCC
Confidence 9999988653 458899999999999999999999999999999999999 45667999999998765432211 12
Q ss_pred ccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHh
Q 016233 242 IVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRM 319 (393)
Q Consensus 242 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 319 (393)
..++..|+|||++.. .++.++||||||+++|++++ |..||...........+..+... .....++..+.+|+.+|
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~ 230 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM---SCPQKCPDDVYKVMQRC 230 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHH
Confidence 234567999998864 58889999999999999998 99999888777666666554221 22245789999999999
Q ss_pred cccCCCCCCCHHHHhc
Q 016233 320 LTQDPKKRITSAQVLE 335 (393)
Q Consensus 320 L~~dp~~Rpt~~e~l~ 335 (393)
|..+|++|||+.++++
T Consensus 231 l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 231 WDYKPENRPKFSELQK 246 (250)
T ss_pred cccCcccCCCHHHHHH
Confidence 9999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=309.59 Aligned_cols=248 Identities=22% Similarity=0.318 Sum_probs=206.3
Q ss_pred ccceeecceecccCCeEEEEEEECCCCc----EEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGR----QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
..+|++.+.||+|+||.||+|.++.+|+ .+|+|.+.... .......+.+|+.+++++. ||||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVD-HPHVVRLLGICLS-S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-C
Confidence 3579999999999999999999877665 58999876443 2334567889999999996 9999999999887 7
Q ss_pred eEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 154 SVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 158 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCccccc
Confidence 889999999999999998764 468999999999999999999999999999999999999 4556799999999987
Q ss_pred ccCCccee---cccCcccccchHHHh-hcCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 016233 233 IEEGKVYR---DIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (393)
Q Consensus 233 ~~~~~~~~---~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (393)
........ ...++..|+|||.+. ..++.++|+||||+++|++++ |..||.+....++...+..+... +. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~--~~~ 235 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL-PQ--PPI 235 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC-CC--CCC
Confidence 65432211 122356799999876 458899999999999999998 99999888877777777654322 11 134
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 308 ISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+..+.+++.+||..||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 6789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=328.13 Aligned_cols=257 Identities=30% Similarity=0.487 Sum_probs=221.9
Q ss_pred eeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEe
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 160 (393)
|..++.||-|+||.|.++....|...||.|.+.+.+....+...-++.|-.||.... .+-||+||-.|.+.+.+|+|||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEeccCCceEEEEe
Confidence 777889999999999999999999999999998887766667777889999999985 8999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC----
Q 016233 161 LCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG---- 236 (393)
Q Consensus 161 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~---- 236 (393)
|++||++-.+|.+-+.|.|..++.++..|..|+++.|+.|+|||||||+|||| |.++.|||.||||+.-+.-.
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceeccccc
Confidence 99999999999999999999999999999999999999999999999999999 77888999999998754210
Q ss_pred -----c----------------------------------ceecccCcccccchHHHh-hcCCCcchHHHHHHHHHHHhh
Q 016233 237 -----K----------------------------------VYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS 276 (393)
Q Consensus 237 -----~----------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt 276 (393)
. .....+||+.|+|||++. ..|+..||.||.|||||||+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 0 001357999999999986 469999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCccccCC
Q 016233 277 GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRI---TSAQVLEHPWIKEG 342 (393)
Q Consensus 277 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---t~~e~l~h~~~~~~ 342 (393)
|.+||.+.+.-+.-.++.+..-........++|+++.++|.++. -+++.|. .++++..||||+..
T Consensus 867 g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCcccccc
Confidence 99999988776665555554444444445679999999999986 4788887 45779999999853
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=310.35 Aligned_cols=249 Identities=18% Similarity=0.218 Sum_probs=205.9
Q ss_pred ccceeecceecccCCeEEEEEEECC----CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe-C
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENS----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED-K 152 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~ 152 (393)
.++|++.+.||+|+||.||+|.+.. ++..|++|.+.... .......+.+|+.+++.+. |+||+++++++.. .
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLS-HQNILPILHVCIEDG 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence 5689999999999999999999876 35789999875332 3345677889999999996 9999999998765 5
Q ss_pred CeEEEEEeccCCCChHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEE
Q 016233 153 QSVHVVMELCAGGELFDRIIAK--------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKA 224 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~--------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl 224 (393)
...++++||+.+++|.+++... ..+++..+..++.|++.||.|||+++++||||||+||++ +....+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE---cCCCcEEE
Confidence 6789999999999999988653 358899999999999999999999999999999999999 45577999
Q ss_pred eecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCC
Q 016233 225 TDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDID 299 (393)
Q Consensus 225 ~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~ 299 (393)
+|||+++.+..... .....++..|+|||.+.+ .++.++|||||||++|++++ |..||...+..+....+..+. .
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~ 237 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-R 237 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-C
Confidence 99999986543321 122345678999998865 48899999999999999999 999998877766666555542 2
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 300 FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 300 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+. ....+++++.+++.+||..||++|||+.++++
T Consensus 238 ~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 238 LA--QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CC--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22 22457899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=306.17 Aligned_cols=248 Identities=21% Similarity=0.336 Sum_probs=206.1
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
+...++|++.+.||+|+||.||++.+. .+..+|+|.+... ......+.+|+.+++.++ |+||+++++++.+ ..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~ 74 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-EP 74 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcC-CCCcceEEEEEcC-CC
Confidence 445678999999999999999999865 4567999987643 223567889999999996 9999999999887 77
Q ss_pred EEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 155 VHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
.+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||++ +..+.+||+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~ 151 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARV 151 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCcceee
Confidence 89999999999999998763 357888899999999999999999999999999999999 5567899999999987
Q ss_pred ccCCcc--eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 016233 233 IEEGKV--YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (393)
Q Consensus 233 ~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (393)
...... .....++..|+|||.+.. .++.++|+|||||++|++++ |..||.+.+.......+..+... ......
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~ 228 (260)
T cd05073 152 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---PRPENC 228 (260)
T ss_pred ccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC---CCcccC
Confidence 644321 122345677999998864 48889999999999999998 99999988777777666654321 223467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 309 SSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+.++.+++.+||..||++||++.++++
T Consensus 229 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 229 PEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=312.91 Aligned_cols=248 Identities=27% Similarity=0.426 Sum_probs=199.0
Q ss_pred ceeecceecccCCeEEEEEEE----CCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC--C
Q 016233 80 HYSFGKELGRGQFGVTYLCTE----NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--Q 153 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~ 153 (393)
.|++.+.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+++.+. ||||+++++++.+. .
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCC
Confidence 578999999999999999984 4578899999986432 2334567899999999996 99999999998775 5
Q ss_pred eEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 154 SVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
..++||||++|++|.+++.+. ..+++.++..++.|++.||+|||++||+||||||+||+++ .++.++|+|||++..
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~---~~~~~~l~dfg~~~~ 158 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKA 158 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc---CCCCEEECCCccccc
Confidence 789999999999999998664 3589999999999999999999999999999999999994 456799999999987
Q ss_pred ccCCcc----eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh---------------HHHHHH
Q 016233 233 IEEGKV----YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE---------------KGIFDA 292 (393)
Q Consensus 233 ~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~---------------~~~~~~ 292 (393)
+..... .....|+..|+|||++.+ .++.++|||||||++|+|+++..|+..... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 654322 123456778999998764 588999999999999999998776532211 111122
Q ss_pred HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 293 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
+..+. ....+..++..+.+|+.+||+.||++|||+.+++++
T Consensus 239 ~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 239 LEEGK---RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHcCc---cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 22221 112235688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=307.25 Aligned_cols=244 Identities=21% Similarity=0.317 Sum_probs=193.1
Q ss_pred ceecccCCeEEEEEEEC--CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEecc
Q 016233 85 KELGRGQFGVTYLCTEN--STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELC 162 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 162 (393)
+.||+|+||.||+|... .++..+|+|.+.... .......+.+|+.++++++ ||||+++++++.+...+++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEECC
Confidence 36999999999999864 355789999876432 2233457888999999996 999999999999999999999999
Q ss_pred CCCChHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 163 AGGELFDRIIAKG-----HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 163 ~gg~L~~~l~~~~-----~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
++|+|.+++.... ..++..+..++.|++.||.|||++|++||||||+||++ +....+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCcc
Confidence 9999999886532 35667788999999999999999999999999999999 456679999999997644332
Q ss_pred ce---ecccCcccccchHHHhh--------cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHH-HcCCCCCCCCC
Q 016233 238 VY---RDIVGSAYYVAPEVLRR--------RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAI-LQGDIDFESAP 304 (393)
Q Consensus 238 ~~---~~~~gt~~y~aPE~l~~--------~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i-~~~~~~~~~~~ 304 (393)
.. ....|+..|+|||++.+ .++.++||||||+++|+|++ |..||......+..... ......+..+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence 21 23457888999998853 25789999999999999996 99999876655544332 22223333222
Q ss_pred C-CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 305 W-PTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 305 ~-~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
. ...++.+.+++.+|+ .+|++|||+++++.
T Consensus 235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 2 246788999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=311.15 Aligned_cols=240 Identities=18% Similarity=0.277 Sum_probs=192.9
Q ss_pred ceecccCCeEEEEEEECCCCc-------EEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 85 KELGRGQFGVTYLCTENSTGR-------QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
+.||+|+||.||+|.+..++. .+|+|.+.... ....+.+.+|+.+++.+. ||||+++++++..+...++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEE
Confidence 469999999999999866544 48888775321 234567888999999996 9999999999999899999
Q ss_pred EEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCC-----CCcEEEeecCCcc
Q 016233 158 VMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE-----NALLKATDFGLSV 231 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~-----~~~~kl~DFg~a~ 231 (393)
||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++. ...++++|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999999987644 5899999999999999999999999999999999999965432 2348999999987
Q ss_pred cccCCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCC-CCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 016233 232 FIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGV-PPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (393)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (393)
..... ....++..|+|||++.+ .++.++|||||||++|+|++|. .||...+...... +......++. ..
T Consensus 157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~----~~ 228 (258)
T cd05078 157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPA----PK 228 (258)
T ss_pred ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCC----CC
Confidence 65432 23568889999999875 3788999999999999999985 6665544433322 2333232222 35
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 309 SSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
+.++.+||.+||+.||++|||++++++.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 6889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=307.00 Aligned_cols=252 Identities=27% Similarity=0.457 Sum_probs=209.6
Q ss_pred ceeecceecccCCeEEEEEEECC-CCcEEEEEEeecCcc-------CCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe
Q 016233 80 HYSFGKELGRGQFGVTYLCTENS-TGRQFACKSISKRKL-------VTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 151 (393)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.++.+.-+||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37889999999999999999987 688999998864321 1222345677899888764359999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCCCCCcEEeccCCCCCcEEEee
Q 016233 152 KQSVHVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATD 226 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~-~~ivH~Dikp~Nill~~~~~~~~~kl~D 226 (393)
++..++||||++|++|.+++.. ...+++..++.++.|++.+|.|||+ .+|+|+||+|+||++ +..+.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEec
Confidence 9999999999999999887743 3468999999999999999999996 789999999999999 4566799999
Q ss_pred cCCcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 016233 227 FGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW 305 (393)
Q Consensus 227 Fg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (393)
||++.............|+..|+|||.+.+ .++.++||||||+++|+|++|..||...........+........ ..
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~ 235 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL--PE 235 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--Cc
Confidence 999987665544456678999999998865 488999999999999999999999988777666666665544321 22
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
..+++++.++|.+||..||++||++.|+..+
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 3578999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=303.16 Aligned_cols=241 Identities=26% Similarity=0.387 Sum_probs=200.9
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~g 164 (393)
++||+|+||.||+|.+.. ++.||+|.+..... ......+.+|+++++++. |+||+++++++.+.+..++||||+.|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 469999999999999887 99999998865432 234567899999999996 99999999999999999999999999
Q ss_pred CChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcce---e
Q 016233 165 GELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY---R 240 (393)
Q Consensus 165 g~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~---~ 240 (393)
++|.+++... ..+++..+..++.|++.+|.|||+++++||||||+||++ +.++.++|+|||++......... .
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCcceeccc
Confidence 9999998663 468899999999999999999999999999999999999 45667999999999865432211 1
Q ss_pred cccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHH
Q 016233 241 DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318 (393)
Q Consensus 241 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 318 (393)
...++..|+|||.+.+ .++.++|+|||||++|+|++ |..||...........+.... .. .....++.++.+++.+
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~ 230 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RM--PAPQLCPEEIYRLMLQ 230 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CC--CCCccCCHHHHHHHHH
Confidence 1233567999998764 58899999999999999999 899998877666666655432 11 1224578999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 016233 319 MLTQDPKKRITSAQVLE 335 (393)
Q Consensus 319 ~L~~dp~~Rpt~~e~l~ 335 (393)
||..+|++|||+.|+++
T Consensus 231 ~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 231 CWAYDPENRPSFSEIYN 247 (251)
T ss_pred HhccChhhCcCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=333.03 Aligned_cols=246 Identities=29% Similarity=0.491 Sum_probs=200.0
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC------
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ------ 153 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~------ 153 (393)
.|...+.||+|+||.||+++++.||+.||||.++... .....+..-+|+++|++|+ |+|||+++++-+...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCcccc
Confidence 4667788999999999999999999999999987643 3456788899999999997 999999999876554
Q ss_pred eEEEEEeccCCCChHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccC-CCCCcEEEeecCC
Q 016233 154 SVHVVMELCAGGELFDRIIAK---GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK-DENALLKATDFGL 229 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~-~~~~~~kl~DFg~ 229 (393)
...+|||||.||+|...+.+. ..+++.+...++..+..||.|||++||+||||||.||++-.. +.....||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 457999999999999999753 459999999999999999999999999999999999998543 3567889999999
Q ss_pred cccccCCcceecccCcccccchHHHh--hcCCCcchHHHHHHHHHHHhhCCCCCCCCCh----HHHHHHHHcCCC-----
Q 016233 230 SVFIEEGKVYRDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAILQGDI----- 298 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~----~~~~~~i~~~~~----- 298 (393)
|+.+.++....+..||+.|.+||++. ..|+..+|.|||||++|++.||..||..... .++...+..+..
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence 99999999999999999999999987 4589999999999999999999999954322 223333222111
Q ss_pred ----------CCC--CCCCCCCCH----HHHHHHHHhcccCCCCCC
Q 016233 299 ----------DFE--SAPWPTISS----SAKDLVRRMLTQDPKKRI 328 (393)
Q Consensus 299 ----------~~~--~~~~~~~s~----~~~~li~~~L~~dp~~Rp 328 (393)
.+. .+....+++ .+-..+..+|..+|.+|.
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 100 000112222 345678889999999998
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=344.25 Aligned_cols=254 Identities=29% Similarity=0.495 Sum_probs=206.6
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe-------
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED------- 151 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~------- 151 (393)
..|+.++.||+||||.||+++++-+|+.||||.|.-.. +......+.+|+.+|.+|+ |||||+++..+.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLn-HpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLN-HPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcC-CcceeeeehhhhccCCcccc
Confidence 46788899999999999999999999999999997653 4456678999999999996 9999998754300
Q ss_pred --------------------------------------------------------------------------------
Q 016233 152 -------------------------------------------------------------------------------- 151 (393)
Q Consensus 152 -------------------------------------------------------------------------------- 151 (393)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CeEEEEEeccCCCChHHHHHHcCCC-CHHHHHHHHHHHHHHHHHHHH
Q 016233 152 ------------------------K--------QSVHVVMELCAGGELFDRIIAKGHY-SERAAASICRSIVNVVHICHF 198 (393)
Q Consensus 152 ------------------------~--------~~~~lv~e~~~gg~L~~~l~~~~~~-~~~~~~~i~~qll~~l~~lH~ 198 (393)
+ ..+||-||||+..+|.+++..+... ....+|+++++|++||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 2468899999887776666655443 478899999999999999999
Q ss_pred cCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc-------------------CCcceecccCcccccchHHHhh---
Q 016233 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-------------------EGKVYRDIVGSAYYVAPEVLRR--- 256 (393)
Q Consensus 199 ~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~l~~--- 256 (393)
+|||||||||.||++ +....|||+|||+|.... +....++.+||..|+|||++.+
T Consensus 716 ~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred CceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 999999999999999 456679999999998721 0113456789999999999863
Q ss_pred -cCCCcchHHHHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 016233 257 -RYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVL 334 (393)
Q Consensus 257 -~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l 334 (393)
.|+.|+|+|||||||+||+. ||....+ ..++.++..+.++++...+..--+.-..+|+.||+.||.+||||.|+|
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 49999999999999999995 5754443 356677777777666433444446678899999999999999999999
Q ss_pred cCccccC
Q 016233 335 EHPWIKE 341 (393)
Q Consensus 335 ~h~~~~~ 341 (393)
++.||..
T Consensus 870 ~s~llpp 876 (1351)
T KOG1035|consen 870 NSELLPP 876 (1351)
T ss_pred hccCCCc
Confidence 9999974
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=305.48 Aligned_cols=244 Identities=20% Similarity=0.315 Sum_probs=192.6
Q ss_pred ceecccCCeEEEEEEECC--CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEecc
Q 016233 85 KELGRGQFGVTYLCTENS--TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELC 162 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 162 (393)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++ |+||+++++.+.....+++||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIESIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCC-CCCcceEEEEECCCCceEEEEEeC
Confidence 369999999999996533 34578888765322 2334556788999999996 999999999999999999999999
Q ss_pred CCCChHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 163 AGGELFDRIIAKG-----HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 163 ~gg~L~~~l~~~~-----~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
++|+|.+++.... ..++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccch
Confidence 9999999987643 24677889999999999999999999999999999999 556679999999987543322
Q ss_pred c---eecccCcccccchHHHhh--------cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHc-CCCCCCCCC
Q 016233 238 V---YRDIVGSAYYVAPEVLRR--------RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQ-GDIDFESAP 304 (393)
Q Consensus 238 ~---~~~~~gt~~y~aPE~l~~--------~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~-~~~~~~~~~ 304 (393)
. .....++..|+|||++.. .++.++|||||||++|+|++ |..||......+.+..+.. .....+.+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence 1 123345678999998742 36789999999999999999 7889887776665555443 333333322
Q ss_pred -CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 305 -WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 305 -~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
...++..+.+++..|+ .||++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 2357888999999998 59999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=303.30 Aligned_cols=240 Identities=25% Similarity=0.396 Sum_probs=201.6
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.+|++.+.||+|+||.||++. .+++.||+|.+... .....+.+|+.+++.++ ||||+++++++..++ .++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~-~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD-----VTAQAFLEETAVMTKLH-HKNLVRLLGVILHNG-LYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc-----chHHHHHHHHHHHHhCC-CCCcCeEEEEEcCCC-cEEE
Confidence 469999999999999999986 46889999988532 23467889999999996 999999999987654 7999
Q ss_pred EeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 159 MELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
|||+.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceecccc
Confidence 99999999999987643 47899999999999999999999999999999999999 45667999999998764332
Q ss_pred cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
......+..|+|||.+.+ .++.++|+|||||++|+|++ |..||...+..+....+..+.. . .....++..+.+
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~ 228 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR-M--EPPEGCPADVYV 228 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC-C--CCCCcCCHHHHH
Confidence 123344568999998864 58899999999999999997 9999988887777776665422 1 123467899999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 016233 315 LVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~ 335 (393)
++.+||..+|++||+++++++
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=307.41 Aligned_cols=248 Identities=25% Similarity=0.426 Sum_probs=196.4
Q ss_pred cceeecceecccCCeEEEEEE----ECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe--C
Q 016233 79 LHYSFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--K 152 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~ 152 (393)
.+|++.+.||+|+||.||+|. +..+++.||+|.+... .......+.+|+++++.++ ||||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCC
Confidence 478999999999999999997 4567889999998643 2334567889999999996 9999999997643 4
Q ss_pred CeEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 153 QSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
..+++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCcccc
Confidence 5689999999999999998764 468999999999999999999999999999999999999 556679999999998
Q ss_pred cccCCcce----ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHH---------------HHH
Q 016233 232 FIEEGKVY----RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKG---------------IFD 291 (393)
Q Consensus 232 ~~~~~~~~----~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~---------------~~~ 291 (393)
........ ....++..|+|||.+.+ .++.++|||||||++|+|++|..++......- .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 76543221 11223456999998865 58899999999999999999887764332110 011
Q ss_pred HHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 292 AILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 292 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+......+ .....++.++.+||.+||..+|++|||+.++++
T Consensus 237 ~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 237 ELLKNNGRL--PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHhcCCcC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111111111 122457899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=290.00 Aligned_cols=254 Identities=27% Similarity=0.516 Sum_probs=211.5
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC--e
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ--S 154 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--~ 154 (393)
..++|++.+++|+|-|+.||.|.+..+++.++||+++.. ....+.+|+.||+.|++||||++++++..+.. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 356799999999999999999999999999999998643 46789999999999999999999999987764 5
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
..||+||+.+.+...+. ..++...++.++.+|+.||.|||+.||+|||+||.|++++. ....++|+|+|+|.+..
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh--~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYH 184 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech--hhceeeeeecchHhhcC
Confidence 78999999886654332 35888899999999999999999999999999999999964 34569999999999999
Q ss_pred CCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCC-CCChHHHHHHHHc-------------CCC
Q 016233 235 EGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFW-AETEKGIFDAILQ-------------GDI 298 (393)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~-~~~~~~~~~~i~~-------------~~~ 298 (393)
.+..+...+.+..|.-||.+-. .|+..-|+|||||+|..|+..+.||. +.+..+.+-+|.. -.+
T Consensus 185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 9988888899999999998864 58999999999999999999998885 4444433333211 000
Q ss_pred -----------CCCCCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 299 -----------DFESAPW---------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 299 -----------~~~~~~~---------~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
......| ..+++++.||+.++|..|-.+|+|+.|++.||||..
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 0111122 235799999999999999999999999999999964
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=304.06 Aligned_cols=228 Identities=25% Similarity=0.370 Sum_probs=188.1
Q ss_pred cCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCCCChHH
Q 016233 90 GQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD 169 (393)
Q Consensus 90 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~gg~L~~ 169 (393)
|.+|.||++.+..+++.||+|.+.... ...+|...+.... ||||+++++++.+.+.+++||||++||+|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 899999999999999999999986532 2233444444554 9999999999999999999999999999999
Q ss_pred HHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcceecccCccccc
Q 016233 170 RIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV 249 (393)
Q Consensus 170 ~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~ 249 (393)
++.....+++..+..++.|++.||.|||++||+||||||+||++ +.++.++++|||.+...... .....++..|+
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhccccc--cccCCcCcccc
Confidence 99887789999999999999999999999999999999999999 45667999999988765432 23445678899
Q ss_pred chHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 016233 250 APEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRI 328 (393)
Q Consensus 250 aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp 328 (393)
|||.+.+ .++.++|+||+|+++|+|++|..||...... + .....+.. ...+++.++++|.+||..||++|+
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-NTHTTLNI--PEWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-ccccccCC--cccCCHHHHHHHHHHccCCHHHhc
Confidence 9998864 5889999999999999999999887543221 0 00111111 134789999999999999999999
Q ss_pred CH-----HHHhcCccc
Q 016233 329 TS-----AQVLEHPWI 339 (393)
Q Consensus 329 t~-----~e~l~h~~~ 339 (393)
|+ +++++||||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 96 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=306.76 Aligned_cols=245 Identities=26% Similarity=0.411 Sum_probs=200.5
Q ss_pred ceecccCCeEEEEEEECCCC------cEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 85 KELGRGQFGVTYLCTENSTG------RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
+.||+|+||.||+|.+.... +.+|+|.+.... .......+.+|+.+++.++ ||||+++++++...+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEE
Confidence 36899999999999986544 689999875432 2234667889999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCC--CCCcEEEeecCC
Q 016233 159 MELCAGGELFDRIIAK-------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD--ENALLKATDFGL 229 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~-------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~--~~~~~kl~DFg~ 229 (393)
|||+++++|.+++... ..+++.++..++.|++.||.|||+++++|+||||+||+++.++ ....++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999998642 2378889999999999999999999999999999999996533 233799999999
Q ss_pred cccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 016233 230 SVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAP 304 (393)
Q Consensus 230 a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (393)
+........ .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||...+..+....+..+... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~ 234 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL---QK 234 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc---CC
Confidence 976543321 122345678999998864 58999999999999999998 99999887777666666543221 12
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
...++..+.+||.+||..+|.+||++.++++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2467899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=307.92 Aligned_cols=239 Identities=17% Similarity=0.198 Sum_probs=190.8
Q ss_pred eecccCCeEEEEEEECCC------------------------CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCC
Q 016233 86 ELGRGQFGVTYLCTENST------------------------GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141 (393)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n 141 (393)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++ |||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~-h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVS-HIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCC-CCC
Confidence 599999999999985322 2358888875432 223456788999999996 999
Q ss_pred eeEEeEEEEeCCeEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCC---
Q 016233 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD--- 217 (393)
Q Consensus 142 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~--- 217 (393)
|+++++++.+....++||||+++|+|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999888865 45789999999999999999999999999999999999996422
Q ss_pred -CCCcEEEeecCCcccccCCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHh-hCCCCCCCCChHHHHHHH
Q 016233 218 -ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILL-SGVPPFWAETEKGIFDAI 293 (393)
Q Consensus 218 -~~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~ll-tg~~pf~~~~~~~~~~~i 293 (393)
....+|++|||++...... ....++..|+|||.+.+ .++.++|||||||++|+|+ +|..||......+....+
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 234 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY 234 (274)
T ss_pred CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 2345899999988654322 23457888999998864 4889999999999999985 799999876655443322
Q ss_pred HcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 294 LQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 294 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
. ....++ ...++.+.++|.+||..+|++|||+.++|++
T Consensus 235 ~-~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 235 E-KKHRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred H-hccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2 222222 2245789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=302.88 Aligned_cols=242 Identities=23% Similarity=0.333 Sum_probs=193.9
Q ss_pred ceecccCCeEEEEEEECC---CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE-eCCeEEEEEe
Q 016233 85 KELGRGQFGVTYLCTENS---TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE-DKQSVHVVME 160 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~-~~~~~~lv~e 160 (393)
+.||+|+||.||+|.+.. .+..+|+|.+.... .......+.+|+.+++.++ ||||+++++++. .++..++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCC-CCCcceEEEEeecCCCCcEEEEe
Confidence 468999999999998653 34579999875321 2234567888999999996 999999999765 4566899999
Q ss_pred ccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc--
Q 016233 161 LCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-- 237 (393)
Q Consensus 161 ~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-- 237 (393)
|+.+++|.+++... ...++..+..++.|++.||.|||+.+|+||||||+|||+ +.++.+||+|||++.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCcce
Confidence 99999999998764 346778888999999999999999999999999999999 456679999999997654321
Q ss_pred ---ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 016233 238 ---VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (393)
Q Consensus 238 ---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (393)
......++..|+|||.+.+ .++.++|||||||++|+|++ |.+||...+..+....+..+..... ...+++.+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ---PEYCPDPL 231 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHH
Confidence 1123346778999998764 58899999999999999999 5677777776666666655432211 13468899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 016233 313 KDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 313 ~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+++.+||..+|++||++.++++
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=303.68 Aligned_cols=237 Identities=19% Similarity=0.236 Sum_probs=191.2
Q ss_pred ceecccCCeEEEEEEECCCC----------cEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 85 KELGRGQFGVTYLCTENSTG----------RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
+.||+|+||.||+|.+..++ ..+++|.+.... .....+.+|+.+++.++ ||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLS-HKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCC-CcchhheeeEEec-CC
Confidence 46999999999999998776 357888765332 12678889999999996 9999999999887 77
Q ss_pred EEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCC----CCCcEEEeecCC
Q 016233 155 VHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD----ENALLKATDFGL 229 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~----~~~~~kl~DFg~ 229 (393)
.++||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ ....+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 899999999999999998765 789999999999999999999999999999999999996433 223699999999
Q ss_pred cccccCCcceecccCcccccchHHHhh---cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 016233 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (393)
+..... .....++..|+|||++.+ .++.++|||||||++|+|++ |..||...+..+......... ..+.
T Consensus 155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~-~~~~--- 227 (259)
T cd05037 155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH-RLPM--- 227 (259)
T ss_pred cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC-CCCC---
Confidence 987544 223456788999999864 48899999999999999999 588886665433333322211 1111
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.....+.++|.+||..||++|||+.++++
T Consensus 228 -~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 228 -PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 12378999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=303.86 Aligned_cols=240 Identities=18% Similarity=0.235 Sum_probs=190.5
Q ss_pred ceecccCCeEEEEEEECCC------------CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 85 KELGRGQFGVTYLCTENST------------GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
+.||+|+||.||+|..... ...+++|.+.... ......+.+|+.+++.++ ||||+++++++..+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVS-HKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence 4689999999999985322 2358888775432 234457788999999996 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCC----CCcEEEeec
Q 016233 153 QSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE----NALLKATDF 227 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~----~~~~kl~DF 227 (393)
...++||||+++++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||+..++. ...++++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999998877653 56899999999999999999999999999999999999964321 124899999
Q ss_pred CCcccccCCcceecccCcccccchHHHh--hcCCCcchHHHHHHHHHHHh-hCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 016233 228 GLSVFIEEGKVYRDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILL-SGVPPFWAETEKGIFDAILQGDIDFESAP 304 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~ll-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (393)
|++...... ....|+..|+|||.+. ..++.++|||||||++|+|+ +|..||......+.. ..........
T Consensus 157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~--- 229 (262)
T cd05077 157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLV--- 229 (262)
T ss_pred CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCC---
Confidence 998765332 2346788999999885 34889999999999999998 588888765544332 2223222211
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
...++++.+||.+||..||++||++.+++++
T Consensus 230 -~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 230 -TPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 2346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=340.15 Aligned_cols=249 Identities=25% Similarity=0.439 Sum_probs=211.4
Q ss_pred ccceeecceecccCCeEEEEEEECCCCc-----EEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGR-----QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
...-++++.||+|.||.||.|....... .||+|.+++. .+.....+|.+|..+|+.+. |||||+++|++-+.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLDS 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCC-CcceeeEEEeecCC
Confidence 4567788999999999999999764333 3888887643 35667889999999999996 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEe
Q 016233 153 QSVHVVMELCAGGELFDRIIAK-------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~-------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~ 225 (393)
...+|++|||+||+|..+|++. ..++......++.||+.|++||+++++|||||...|+|+ +....+||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEEc
Confidence 9999999999999999999875 348889999999999999999999999999999999999 566889999
Q ss_pred ecCCcccccCCcceecc-cCc--ccccchHHHh-hcCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCC
Q 016233 226 DFGLSVFIEEGKVYRDI-VGS--AYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDF 300 (393)
Q Consensus 226 DFg~a~~~~~~~~~~~~-~gt--~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 300 (393)
|||+|+.+-....+... .+. ..|||||.+. +.|+.++|||||||++||++| |..||.+.+..+.+....++. ..
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL 923 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RL 923 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-cc
Confidence 99999965444433321 122 3699999987 569999999999999999998 999999999988888555544 22
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 301 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+ ....++..+.+++..||+.+|++||++..+++
T Consensus 924 ~--~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 924 D--PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred C--CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 2 22578999999999999999999999999987
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=309.51 Aligned_cols=248 Identities=21% Similarity=0.317 Sum_probs=201.3
Q ss_pred cceeecceecccCCeEEEEEEECCCCc----EEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGR----QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
.+|+..+.||+|+||.||+|.+..++. .+|+|.+.... .......+.+|+.+++.+. ||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~-~ 82 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMD-HPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcCC-C
Confidence 468889999999999999999887776 46888775432 1223446889999999996 99999999998754 4
Q ss_pred EEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 155 VHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
.++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLARLL 159 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEccccccccc
Confidence 679999999999999987643 58999999999999999999999999999999999999 44567999999999876
Q ss_pred cCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 016233 234 EEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (393)
Q Consensus 234 ~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (393)
..... .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+....+....+..+.. ++ ..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~ 236 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER-LP--QPPIC 236 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-CC--CCCCC
Confidence 53322 122345678999998864 58899999999999999997 9999987766555555444322 22 12456
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 309 SSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
+..+.+++.+||..||++||+++++++.
T Consensus 237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 237 TIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=308.34 Aligned_cols=249 Identities=15% Similarity=0.165 Sum_probs=187.4
Q ss_pred cccceeecceecccCCeEEEEEEECCC---CcEEEEEEeecCccCCcccH--------HHHHHHHHHHHHccCCCCeeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENST---GRQFACKSISKRKLVTKNDK--------DDIKREIQIMQHLSGQPNIVEF 145 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~~h~niv~~ 145 (393)
...+|++.+.||+|+||.||+|.+..+ +..+|+|+............ .....+...+..+. |+||+++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~-h~~i~~~ 88 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNID-HLGIPKY 88 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCC-CCCCCcE
Confidence 446899999999999999999999887 66778876432221100000 11122333445564 9999999
Q ss_pred eEEEEeCC----eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCc
Q 016233 146 KGAYEDKQ----SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENAL 221 (393)
Q Consensus 146 ~~~~~~~~----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~ 221 (393)
++++.... ..++++|++. .++.+.+......++..+..++.|++.||.|||+++|+||||||+|||+ +..+.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~~~~ 164 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DGNNR 164 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCc
Confidence 98765443 4578888874 4666666655567889999999999999999999999999999999999 45567
Q ss_pred EEEeecCCcccccCCc--------ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh-HH---
Q 016233 222 LKATDFGLSVFIEEGK--------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE-KG--- 288 (393)
Q Consensus 222 ~kl~DFg~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~--- 288 (393)
++|+|||+|+.+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ..
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 9999999998653211 1123469999999999875 489999999999999999999999987632 22
Q ss_pred -----HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 289 -----IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 289 -----~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+..+..+... .+..++++.++++.|+..+|++||+++++++
T Consensus 245 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 245 AAKCDFIKRLHEGKIK-----IKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HhHHHHHHHhhhhhhc-----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 22333333222 2456899999999999999999999999875
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=314.28 Aligned_cols=268 Identities=29% Similarity=0.452 Sum_probs=222.5
Q ss_pred ccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCccc----HHHHHHHHHHHHHccCCCCeeEEeE
Q 016233 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND----KDDIKREIQIMQHLSGQPNIVEFKG 147 (393)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~ 147 (393)
++...+.++|-++..||+|||+.||+|.+....+.||||+-...+...+.. ..-.-+|.+|.+.|. ||-||++|+
T Consensus 456 kDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKlYD 534 (775)
T KOG1151|consen 456 KDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKLYD 534 (775)
T ss_pred ccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeeeee
Confidence 344456789999999999999999999999999999999876544322111 233457999999996 999999999
Q ss_pred EEEe-CCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc--CcEecCCCCCcEEeccCCCCCcEEE
Q 016233 148 AYED-KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM--GVMHRDLKPENFLLSSKDENALLKA 224 (393)
Q Consensus 148 ~~~~-~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~--~ivH~Dikp~Nill~~~~~~~~~kl 224 (393)
+|.- .+.+|-|+|||+|.+|.-+|+..+.+++.+++.|+.||+.||.||.+. -|||-||||.|||+.+....+.+||
T Consensus 535 yfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 535 YFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred eeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEe
Confidence 9974 467889999999999999999999999999999999999999999986 4999999999999988778889999
Q ss_pred eecCCcccccCCc--------ceecccCcccccchHHHh-h----cCCCcchHHHHHHHHHHHhhCCCCCCCCCh-HHHH
Q 016233 225 TDFGLSVFIEEGK--------VYRDIVGSAYYVAPEVLR-R----RYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIF 290 (393)
Q Consensus 225 ~DFg~a~~~~~~~--------~~~~~~gt~~y~aPE~l~-~----~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~ 290 (393)
.|||+++.+.+.. ......||.||.+||.+- + ..+.++||||+|||+|.++.|+.||..... .+++
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdIL 694 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDIL 694 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHH
Confidence 9999999886542 223467999999999763 2 378899999999999999999999965433 3333
Q ss_pred HH---HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 291 DA---ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 291 ~~---i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.. +......|+.. +.++.++++||++||+.--++|....++-.||||...
T Consensus 695 qeNTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 695 QENTILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred hhhchhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 22 23344556554 5789999999999999999999999999999999753
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=328.49 Aligned_cols=259 Identities=28% Similarity=0.463 Sum_probs=221.1
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE-----
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE----- 150 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~----- 150 (393)
+..+.|.+.+.||.|.+|.||+++++.+++.+|+|+... .....++++.|.+||+.+.+|||++.++++|.
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~----~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP----TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC----CccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 345579999999999999999999999999999998754 33456788899999999999999999999885
Q ss_pred eCCeEEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecC
Q 016233 151 DKQSVHVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (393)
Q Consensus 151 ~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg 228 (393)
.++.+|||||||.||+..|+++. ..++.|..+..|++.++.||.+||++.++|||||-.|||++ .++.+||+|||
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT---~e~~VKLvDFG 168 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT---ENAEVKLVDFG 168 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe---ccCcEEEeeee
Confidence 34689999999999999998875 35689999999999999999999999999999999999995 56669999999
Q ss_pred CcccccCCc-ceecccCcccccchHHHhh------cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC
Q 016233 229 LSVFIEEGK-VYRDIVGSAYYVAPEVLRR------RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE 301 (393)
Q Consensus 229 ~a~~~~~~~-~~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 301 (393)
.+..++... .-.+.+|||.|||||++.. .|+..+|+||||++..||--|.+|+.+......+-.|-+.- ++.
T Consensus 169 vSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP-PPk 247 (953)
T KOG0587|consen 169 VSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-PPK 247 (953)
T ss_pred eeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC-Ccc
Confidence 999876543 2346789999999999742 37889999999999999999999998888766655554431 122
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 302 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
...|..-+.++.+||..||.+|-++||+..++|+|||+++.
T Consensus 248 Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 248 LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 22345668899999999999999999999999999999954
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=302.50 Aligned_cols=248 Identities=21% Similarity=0.368 Sum_probs=200.7
Q ss_pred eeecceecccCCeEEEEEEEC---CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC----
Q 016233 81 YSFGKELGRGQFGVTYLCTEN---STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ---- 153 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~---- 153 (393)
|++.+.||+|+||.||+|.+. .+++.||||++.... ......+.+.+|+++++.+. ||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence 677889999999999999864 457899999986543 23334667889999999996 999999999886432
Q ss_pred --eEEEEEeccCCCChHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEe
Q 016233 154 --SVHVVMELCAGGELFDRIIAK------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225 (393)
Q Consensus 154 --~~~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~ 225 (393)
..++++||+.+|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||++ +.+..+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEEC
Confidence 247889999999998877532 247889999999999999999999999999999999999 456679999
Q ss_pred ecCCcccccCCcce---ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCC
Q 016233 226 DFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDF 300 (393)
Q Consensus 226 DFg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 300 (393)
|||++......... ....+++.|++||.+.. .++.++|||||||++|+|++ |.+||.+.+..+....+.......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 99999876433211 22345678999998865 47889999999999999999 899998877777666666543221
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 301 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
. .+..+..+.+++.+||..+|++|||+.+++++
T Consensus 236 ~---~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 236 Q---PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred C---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 13577899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=297.90 Aligned_cols=260 Identities=23% Similarity=0.327 Sum_probs=216.1
Q ss_pred eeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEe
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 160 (393)
.+-+..||.|+||+|++-.++.+|+..|||.|..... ..+..++..|.....+-.++||||++||..-.++..||.||
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 3446679999999999999999999999999976542 45667888999888777789999999999888889999999
Q ss_pred ccCCCChHHHH-----HHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 161 LCAGGELFDRI-----IAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 161 ~~~gg~L~~~l-----~~~~~~~~~~~~~i~~qll~~l~~lH~-~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+|+- +|..+. ..+..++|+....|.--.+.||+||.. ..|||||+||+|||+ +..+.+||||||++..+.
T Consensus 144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHH
Confidence 9943 553322 235679999999999999999999986 689999999999999 677889999999999887
Q ss_pred CCcceecccCcccccchHHHh--h-cCCCcchHHHHHHHHHHHhhCCCCCCCCC-hHHHHHHHHcCCCCCCCCC--CCCC
Q 016233 235 EGKVYRDIVGSAYYVAPEVLR--R-RYGKEIDIWSAGVILYILLSGVPPFWAET-EKGIFDAILQGDIDFESAP--WPTI 308 (393)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~l~--~-~~~~~~DiwSlG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~--~~~~ 308 (393)
+.-..+.-.|-..|||||.+. + .|+.++||||||++|||+.||..||.+-+ ..+.+..+..+..+..... .-.+
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~ 299 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHY 299 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccccc
Confidence 766666678999999999885 2 49999999999999999999999997644 4456666677765543322 1247
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCC
Q 016233 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346 (393)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~ 346 (393)
+..+..||..||.+|-+.||...+++++||+..+....
T Consensus 300 s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~ 337 (361)
T KOG1006|consen 300 SFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEG 337 (361)
T ss_pred CHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcC
Confidence 89999999999999999999999999999998765433
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=308.72 Aligned_cols=252 Identities=25% Similarity=0.392 Sum_probs=209.2
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
.+....++++||+|.||.|.+|.-.. +..||||+++... ......+|.+|+++|.+|+ |||||.++++|..++.++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--TKNARNDFLKEIKILSRLK-HPNIVELLGVCVQDDPLC 611 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--chhHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCchH
Confidence 45677889999999999999998653 6899999987654 4456789999999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 157 VVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+|+||++.|+|.+++.+.. ...-.....|+.||+.|++||.+.++|||||.+.|+|+ +++.++||+|||+++.+-
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCcccccccc
Confidence 9999999999999998763 23445567799999999999999999999999999999 888999999999999765
Q ss_pred CCcceec---ccCcccccchHH-HhhcCCCcchHHHHHHHHHHHh--hCCCCCCCCChHHHHHHHHcCCCCCCC----CC
Q 016233 235 EGKVYRD---IVGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILL--SGVPPFWAETEKGIFDAILQGDIDFES----AP 304 (393)
Q Consensus 235 ~~~~~~~---~~gt~~y~aPE~-l~~~~~~~~DiwSlG~il~~ll--tg~~pf~~~~~~~~~~~i~~~~~~~~~----~~ 304 (393)
.+..+.. .+-...|||+|. +.+++++++|+|+||+++||++ +...||...+.++..++...-...... ..
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~ 768 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSR 768 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccC
Confidence 5544322 233468999995 5689999999999999999975 588999888887777765432221111 12
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+-++..+.+++.+||..|.++||+++++..
T Consensus 769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 769 PPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 2457889999999999999999999999843
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=299.91 Aligned_cols=243 Identities=19% Similarity=0.308 Sum_probs=191.0
Q ss_pred eecccCCeEEEEEEECCC--CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccC
Q 016233 86 ELGRGQFGVTYLCTENST--GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCA 163 (393)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 163 (393)
.||+|+||.||+|..... ...+++|.+.... .....+.+.+|+.+++.++ ||||+++++.+.+....|+||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccC-CcchhheEEEecCCCccEEEEecCC
Confidence 599999999999975432 3456677665432 2234578899999999996 9999999999999999999999999
Q ss_pred CCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc--
Q 016233 164 GGELFDRIIAK----GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-- 237 (393)
Q Consensus 164 gg~L~~~l~~~----~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-- 237 (393)
+|+|.+++.+. ...++..+..++.||+.||.|||+++|+||||||+|||+ +.++.++|+|||++.......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchhh
Confidence 99999998753 235667788999999999999999999999999999999 456679999999986432211
Q ss_pred -ceecccCcccccchHHHhh--------cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCC-CCCCCCC-C
Q 016233 238 -VYRDIVGSAYYVAPEVLRR--------RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGD-IDFESAP-W 305 (393)
Q Consensus 238 -~~~~~~gt~~y~aPE~l~~--------~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~-~ 305 (393)
......|+..|+|||++.. .++.++|||||||++|+|++ |..||......+.+..+..+. .....+. .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE 235 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence 1234568899999998742 25678999999999999997 577887777766666554432 2222221 2
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
..+++.+.+++..|| .+|++|||++++++
T Consensus 236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 236 LPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 347889999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=302.62 Aligned_cols=249 Identities=29% Similarity=0.464 Sum_probs=200.0
Q ss_pred cceeecceecccCCeEEEEEEEC----CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe--C
Q 016233 79 LHYSFGKELGRGQFGVTYLCTEN----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--K 152 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~ 152 (393)
..|++.+.||+|+||.||+|... .+++.+|||.+..... ......+.+|+++++.+. |+||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE--EQHRSDFEREIEILRTLD-HENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc--hHHHHHHHHHHHHHHhCC-CCChheEEeeeecCCC
Confidence 36788899999999999999864 3488999999865432 134678999999999996 9999999999877 5
Q ss_pred CeEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 153 QSVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
...++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||++.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~ 157 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAK 157 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEccccccc
Confidence 67899999999999999997654 58999999999999999999999999999999999999 455779999999998
Q ss_pred cccCCcce----ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHH--------------HHHH
Q 016233 232 FIEEGKVY----RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKG--------------IFDA 292 (393)
Q Consensus 232 ~~~~~~~~----~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~--------------~~~~ 292 (393)
........ ....++..|+|||.+.+ .++.++||||||+++|+|++|..||....... .+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 77533221 12244567999998764 58899999999999999999999986542211 1122
Q ss_pred HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 293 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
........+. ...++.++.+|+.+||..||++|||+.++++
T Consensus 238 ~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 238 LLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2222222221 2356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=313.51 Aligned_cols=258 Identities=26% Similarity=0.430 Sum_probs=215.6
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccC-----CCCeeEEeEEEE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG-----QPNIVEFKGAYE 150 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-----h~niv~~~~~~~ 150 (393)
.+..+|.+....|+|-|++|.+|.+...|..||||+|.... .....=..|++||++|.. .-|+++++..|.
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 34568888999999999999999999999999999997543 234445679999999962 348999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeec
Q 016233 151 DKQSVHVVMELCAGGELFDRIIAKGH---YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (393)
Q Consensus 151 ~~~~~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DF 227 (393)
..+++|||+|-+ ..+|.+.|++.+. +....++.++.||+.||..|-+.||+|.||||+|||++ ....++|||||
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDf 581 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILKLCDF 581 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceeeeccC
Confidence 999999999998 4589999987654 78889999999999999999999999999999999996 34568999999
Q ss_pred CCcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCC--
Q 016233 228 GLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP-- 304 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~-- 304 (393)
|.|....+. ..+.+..+..|.|||++.+ .|+...|+||+||+||||+||+..|.+.+.+.++...+..+-.|+...
T Consensus 582 GSA~~~~en-eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR 660 (752)
T KOG0670|consen 582 GSASFASEN-EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR 660 (752)
T ss_pred ccccccccc-cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence 999887654 3456667889999998876 699999999999999999999999999999888776554333332210
Q ss_pred -----------------------------------------------CCCCC-------HHHHHHHHHhcccCCCCCCCH
Q 016233 305 -----------------------------------------------WPTIS-------SSAKDLVRRMLTQDPKKRITS 330 (393)
Q Consensus 305 -----------------------------------------------~~~~s-------~~~~~li~~~L~~dp~~Rpt~ 330 (393)
.+.++ ..+++|+.+||..||++|.|.
T Consensus 661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~ 740 (752)
T KOG0670|consen 661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV 740 (752)
T ss_pred hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence 00111 347899999999999999999
Q ss_pred HHHhcCccccC
Q 016233 331 AQVLEHPWIKE 341 (393)
Q Consensus 331 ~e~l~h~~~~~ 341 (393)
.++|.||||+.
T Consensus 741 nqAL~HpFi~~ 751 (752)
T KOG0670|consen 741 NQALKHPFITE 751 (752)
T ss_pred HHHhcCCcccC
Confidence 99999999975
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=326.83 Aligned_cols=257 Identities=21% Similarity=0.319 Sum_probs=177.5
Q ss_pred cccceeecceecccCCeEEEEEEECCC----CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEE----
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENST----GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA---- 148 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~---- 148 (393)
..++|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ..+....| . ++... +.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e-~-l~~~~-~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNE-R-VRRAC-PNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHH-H-HHhhc-hhhHHHHHHhhhcc
Confidence 346899999999999999999999998 9999999875321 11111111 1 12211 2233322221
Q ss_pred --EEeCCeEEEEEeccCCCChHHHHHHcCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCcEecCC
Q 016233 149 --YEDKQSVHVVMELCAGGELFDRIIAKGH--------------------YSERAAASICRSIVNVVHICHFMGVMHRDL 206 (393)
Q Consensus 149 --~~~~~~~~lv~e~~~gg~L~~~l~~~~~--------------------~~~~~~~~i~~qll~~l~~lH~~~ivH~Di 206 (393)
...+..+++|+||+.+++|.+++..... ..+..+..++.||+.||.|||++||+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 2455679999999999999998865321 123446789999999999999999999999
Q ss_pred CCCcEEeccCCCCCcEEEeecCCcccccCCc--ceecccCcccccchHHHhh-----------------------cCCCc
Q 016233 207 KPENFLLSSKDENALLKATDFGLSVFIEEGK--VYRDIVGSAYYVAPEVLRR-----------------------RYGKE 261 (393)
Q Consensus 207 kp~Nill~~~~~~~~~kl~DFg~a~~~~~~~--~~~~~~gt~~y~aPE~l~~-----------------------~~~~~ 261 (393)
||+|||++. ..+.+||+|||+|+.+.... .....+||+.|+|||.+.. .++.+
T Consensus 282 KP~NILl~~--~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 282 KPQNIIFSE--GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CHHHEEEeC--CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 999999952 34579999999998654332 2345689999999997531 13346
Q ss_pred chHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC-------CC----------CCCCCCCHHHHHHHHHhcccCC
Q 016233 262 IDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF-------ES----------APWPTISSSAKDLVRRMLTQDP 324 (393)
Q Consensus 262 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~-------~~----------~~~~~~s~~~~~li~~~L~~dp 324 (393)
+|||||||+||+|+++..++... .......+....... .. ..+........+||.+||..||
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 79999999999999977664322 111111222111110 00 0011123346699999999999
Q ss_pred CCCCCHHHHhcCccccCCCC
Q 016233 325 KKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 325 ~~Rpt~~e~l~h~~~~~~~~ 344 (393)
++|||+.++|+||||.....
T Consensus 439 ~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 439 RQRISAKAALAHPYFDREGL 458 (566)
T ss_pred ccCCCHHHHhCCcCcCCCCc
Confidence 99999999999999986543
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=309.72 Aligned_cols=255 Identities=26% Similarity=0.442 Sum_probs=216.0
Q ss_pred cccccccccceeecceecccCCeEEEEEEECCC--C--cEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEe
Q 016233 71 GKPYEDVKLHYSFGKELGRGQFGVTYLCTENST--G--RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146 (393)
Q Consensus 71 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~ 146 (393)
+..++..+....+.+.||+|.||.||+|....- | -.||||.-+.. .+....+.|..|+.+|+.+. |||||+++
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d--~t~d~tekflqEa~iMrnfd-HphIikLI 457 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD--CTPDDTEKFLQEASIMRNFD-HPHIIKLI 457 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC--CChhhHHHHHHHHHHHHhCC-Ccchhhee
Confidence 344555566677788999999999999986432 3 35788876543 34566889999999999996 99999999
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEe
Q 016233 147 GAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225 (393)
Q Consensus 147 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~ 225 (393)
|++.+. ..|||||+++-|.|..+|..+ ..++......++.||+.||.|||+.++|||||...|||+. ....+||+
T Consensus 458 Gv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs---Sp~CVKLa 533 (974)
T KOG4257|consen 458 GVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS---SPQCVKLA 533 (974)
T ss_pred eeeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec---Ccceeeec
Confidence 999865 589999999999999999875 4688889999999999999999999999999999999995 44569999
Q ss_pred ecCCcccccCCcceecccCcc--cccchHHHh-hcCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCC
Q 016233 226 DFGLSVFIEEGKVYRDIVGSA--YYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFE 301 (393)
Q Consensus 226 DFg~a~~~~~~~~~~~~~gt~--~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 301 (393)
|||+++.+.+...+....|.. -|||||.++ .+++.++|||-|||++||++. |..||.+-...+.+-.|.+|...+-
T Consensus 534 DFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~ 613 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPC 613 (974)
T ss_pred ccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCC
Confidence 999999998877766555543 699999887 469999999999999999886 9999999988888888888765432
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 302 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+++++.+..|+.+||+.||.+||++.++..
T Consensus 614 ---P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 614 ---PPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred ---CCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 3579999999999999999999999987753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=294.93 Aligned_cols=264 Identities=27% Similarity=0.483 Sum_probs=199.4
Q ss_pred ccccc-cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCC-------CCeeEE
Q 016233 74 YEDVK-LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ-------PNIVEF 145 (393)
Q Consensus 74 ~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-------~niv~~ 145 (393)
.+.+. .+|.+.++||.|-|++||+|.|..+.+.||+|+++... .-.+....||++|++++.+ .+||+|
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 34455 79999999999999999999999999999999986432 2356677899999998732 379999
Q ss_pred eEEEEe----CCeEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCCCCCcEEeccCCC
Q 016233 146 KGAYED----KQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDE 218 (393)
Q Consensus 146 ~~~~~~----~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~-~~ivH~Dikp~Nill~~~~~ 218 (393)
++.|.. ..+++||+|++ |.+|+.+|... +.++...++.|++|||.||.|||. .||||-||||+|||+...+.
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~ 226 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEI 226 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecccc
Confidence 999964 45899999999 88999988764 459999999999999999999997 59999999999999854310
Q ss_pred --------------------------------------------------------------------------------
Q 016233 219 -------------------------------------------------------------------------------- 218 (393)
Q Consensus 219 -------------------------------------------------------------------------------- 218 (393)
T Consensus 227 ~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~ 306 (590)
T KOG1290|consen 227 DPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNE 306 (590)
T ss_pred chhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccc
Confidence
Q ss_pred -------------------------------C------------------------------------------------
Q 016233 219 -------------------------------N------------------------------------------------ 219 (393)
Q Consensus 219 -------------------------------~------------------------------------------------ 219 (393)
.
T Consensus 307 ~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~ 386 (590)
T KOG1290|consen 307 PRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPL 386 (590)
T ss_pred cCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCC
Confidence 0
Q ss_pred ----CcEEEeecCCcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCC------hHH
Q 016233 220 ----ALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET------EKG 288 (393)
Q Consensus 220 ----~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~------~~~ 288 (393)
..+||+|||-|..... .++.-+.|..|+|||++.+ .|+..+||||++|++|||.||...|...+ +++
T Consensus 387 ~~~di~vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDED 464 (590)
T KOG1290|consen 387 PECDIRVKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDED 464 (590)
T ss_pred CccceeEEEeeccchhhhhh--hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHH
Confidence 0134444444443221 2233456888999998765 69999999999999999999999985322 122
Q ss_pred HHHHHHc------------CCCC--CC-----------CCCCCC-------------CCHHHHHHHHHhcccCCCCCCCH
Q 016233 289 IFDAILQ------------GDID--FE-----------SAPWPT-------------ISSSAKDLVRRMLTQDPKKRITS 330 (393)
Q Consensus 289 ~~~~i~~------------~~~~--~~-----------~~~~~~-------------~s~~~~~li~~~L~~dp~~Rpt~ 330 (393)
.+..|.+ |+.. |. -..|+. -..++.+|+.-||+.+|++||||
T Consensus 465 HiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA 544 (590)
T KOG1290|consen 465 HIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTA 544 (590)
T ss_pred HHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccH
Confidence 3322221 1110 00 011221 13468899999999999999999
Q ss_pred HHHhcCccccCCCC
Q 016233 331 AQVLEHPWIKEGGE 344 (393)
Q Consensus 331 ~e~l~h~~~~~~~~ 344 (393)
.++|+|||+.....
T Consensus 545 ~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 545 AQCLKHPWLNPVAG 558 (590)
T ss_pred HHHhcCccccCCCC
Confidence 99999999986544
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=284.83 Aligned_cols=242 Identities=42% Similarity=0.750 Sum_probs=207.6
Q ss_pred CCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCCCChHHH
Q 016233 91 QFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDR 170 (393)
Q Consensus 91 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~gg~L~~~ 170 (393)
+||.||+|.+..+++.+|+|++...... .....+.+|++.+++++ |+||+++++++......++++||+.+++|.++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK--KKRERILREISILKKLK-HPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc--cHHHHHHHHHHHHHhCC-CCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 5899999999999999999998654321 11678999999999995 99999999999999999999999999999999
Q ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcceecccCcccccc
Q 016233 171 IIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVA 250 (393)
Q Consensus 171 l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~a 250 (393)
+.....++...++.++.+++.++.+||+.+|+|+||+|.||+++ .++.++|+|||.+.............++..|++
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 154 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD---EDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA 154 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC---CCCcEEEccccceeeeccccccccccCCcCCCC
Confidence 88766689999999999999999999999999999999999994 456799999999998766545556778999999
Q ss_pred hHHHh-hcCCCcchHHHHHHHHHHHhhCCCCCCC-CChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 016233 251 PEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWA-ETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRI 328 (393)
Q Consensus 251 PE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp 328 (393)
||.+. ..++.++||||||+++|+|++|..||.. .......+.+......... .+..++.++.+++.+||..||++||
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp 233 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-PEWKISPEAKDLIRKLLVKDPEKRL 233 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-ccccCCHHHHHHHHHHccCCchhcc
Confidence 99886 4588899999999999999999999987 5555555555554443322 1222789999999999999999999
Q ss_pred CHHHHhcCccc
Q 016233 329 TSAQVLEHPWI 339 (393)
Q Consensus 329 t~~e~l~h~~~ 339 (393)
++.++++||||
T Consensus 234 ~~~~~~~~~~~ 244 (244)
T smart00220 234 TAEEALQHPFF 244 (244)
T ss_pred CHHHHhhCCCC
Confidence 99999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=310.25 Aligned_cols=259 Identities=22% Similarity=0.323 Sum_probs=188.1
Q ss_pred cccceeecceecccCCeEEEEEEEC----------------CCCcEEEEEEeecCccCC-----------cccHHHHHHH
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTEN----------------STGRQFACKSISKRKLVT-----------KNDKDDIKRE 129 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~~~-----------~~~~~~~~~E 129 (393)
..++|++.++||+|+||+||+|.+. ..++.||||.+....... ....+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3568999999999999999999752 345689999986432100 0011223347
Q ss_pred HHHHHHccCCCC-----eeEEeEEEEe--------CCeEEEEEeccCCCChHHHHHHcC---------------------
Q 016233 130 IQIMQHLSGQPN-----IVEFKGAYED--------KQSVHVVMELCAGGELFDRIIAKG--------------------- 175 (393)
Q Consensus 130 ~~~l~~l~~h~n-----iv~~~~~~~~--------~~~~~lv~e~~~gg~L~~~l~~~~--------------------- 175 (393)
+.++.+++ |.+ ++++++++.. .+..+||+||+++++|.+++....
T Consensus 223 ~~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 223 AYMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 77777776 443 3667776643 356899999999999999886421
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcceecc--cCcccccc
Q 016233 176 ---HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI--VGSAYYVA 250 (393)
Q Consensus 176 ---~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~~~--~gt~~y~a 250 (393)
.+++..++.++.|++.+|.|||+++|+||||||+|||+ +.+..+||+|||++............ .+|+.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 23456788999999999999999999999999999999 45567999999999765443332222 34789999
Q ss_pred hHHHhhc---------------------CC--CcchHHHHHHHHHHHhhCCC-CCCCCCh-----------HHHHHHHHc
Q 016233 251 PEVLRRR---------------------YG--KEIDIWSAGVILYILLSGVP-PFWAETE-----------KGIFDAILQ 295 (393)
Q Consensus 251 PE~l~~~---------------------~~--~~~DiwSlG~il~~lltg~~-pf~~~~~-----------~~~~~~i~~ 295 (393)
||++... |+ .+.||||+||++|+|++|.. ||..... ...+..+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 9987421 12 24799999999999999986 6643211 111122223
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCC---CCCCCHHHHhcCccccC
Q 016233 296 GDIDFESAPWPTISSSAKDLVRRMLTQDP---KKRITSAQVLEHPWIKE 341 (393)
Q Consensus 296 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp---~~Rpt~~e~l~h~~~~~ 341 (393)
....+ ..+..+++.++||+.+||..+| .+|+|++|+|+||||..
T Consensus 459 ~~~~~--~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 459 QKYDF--SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cCCCc--ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 33333 3467789999999999999866 68999999999999964
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=290.79 Aligned_cols=255 Identities=26% Similarity=0.454 Sum_probs=207.9
Q ss_pred eecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC-----eEE
Q 016233 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-----SVH 156 (393)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-----~~~ 156 (393)
+-.+.||-|+||+||.+++..+|+.||+|.+..- +..-...+.+.+|+++|..++ |.|++..++...-.+ .+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHHHH
Confidence 3456799999999999999999999999987532 223334677889999999997 999999988775443 467
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+|+|++ ..+|...|.....++.+.++-++.||+.||+|||+.+|.||||||.|+|+ +.+..+||||||+++..+..
T Consensus 134 V~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccccchh
Confidence 889998 45888888888889999999999999999999999999999999999999 67889999999999986543
Q ss_pred c--ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc-----------------
Q 016233 237 K--VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ----------------- 295 (393)
Q Consensus 237 ~--~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~----------------- 295 (393)
. ..+..+-|.+|+|||++.+ .|+...||||+|||+.|||..+..|...+..+.++.|..
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 3 3444567899999999986 499999999999999999999999988877666655532
Q ss_pred ------CCCCCCCC-CC------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 296 ------GDIDFESA-PW------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 296 ------~~~~~~~~-~~------~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+....+.. .. ..-..+..+++.++|..||++|++.++++.|++..++
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 11111110 00 1223568899999999999999999999999998754
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=305.68 Aligned_cols=252 Identities=21% Similarity=0.384 Sum_probs=217.6
Q ss_pred ccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe
Q 016233 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (393)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 151 (393)
++|+--+.......+||-|.||.||.|.+++..-.||||.++.. ....++|..|+.+|+.++ |||+|+++++|..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeik-HpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTH 334 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhc-CccHHHHhhhhcc
Confidence 44555556677788999999999999999999999999998643 346889999999999997 9999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 152 KQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
+-.+|||+|||..|+|++||.+..+ ++.-....++.||..|++||..+++|||||-..|.|+ +++..+|++|||+
T Consensus 335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGL 411 (1157)
T KOG4278|consen 335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGL 411 (1157)
T ss_pred CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccch
Confidence 9999999999999999999987543 5666678899999999999999999999999999999 7888999999999
Q ss_pred cccccCCcceecccCc---ccccchHHHh-hcCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 016233 230 SVFIEEGKVYRDIVGS---AYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAP 304 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt---~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (393)
++.+..+. ++...|. .-|.|||-|. ..++.++|||+|||+|||+.| |-.||.+.+..+.+..+.++.. ...
T Consensus 412 sRlMtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR---M~~ 487 (1157)
T KOG4278|consen 412 SRLMTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR---MDG 487 (1157)
T ss_pred hhhhcCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc---ccC
Confidence 99887543 3444444 3699999775 569999999999999999997 9999999998888877776532 233
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
...+++.+.+|++.||+++|.+||+++|+-+
T Consensus 488 PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 488 PEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 3579999999999999999999999999854
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=308.96 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=214.1
Q ss_pred ccceeecceecccCCeEEEEEEECCCC---cEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTG---RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
....++.++||+|+||.|++|.+...+ ..||||.+..... .....+|.+|+.+|.+|+ |+|++++|++..+ ..
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l--~~~mddflrEas~M~~L~-H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL--NAIMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QP 184 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc--chhHHHHHHHHHHHHhcc-CcceeEEeeeecc-ch
Confidence 345677889999999999999987543 3689999876543 236789999999999997 9999999999987 56
Q ss_pred EEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 155 VHVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
..+|||++++|+|+++|.+ ...|.......++.||+.|+.||..+++|||||-..|+|+. ...+|||+|||+.+.
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla---sprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA---SPRTVKICDFGLMRA 261 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec---ccceeeeecccceec
Confidence 8899999999999999987 34578888999999999999999999999999999999995 455799999999999
Q ss_pred ccCCcceecccC----cccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 016233 233 IEEGKVYRDIVG----SAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWP 306 (393)
Q Consensus 233 ~~~~~~~~~~~g----t~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 306 (393)
+..........+ ...|+|||.++. .++.++|||++||++|||+| |..||.+....+++++|..+..- +.+ +
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erL-pRP--k 338 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERL-PRP--K 338 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccC-CCC--C
Confidence 876654443322 236999999985 69999999999999999998 89999999999999999865432 222 4
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 016233 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (393)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 340 (393)
.+++++++++..||+.+|.+|||+..|.+.-+..
T Consensus 339 ~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 339 YCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred CChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 6899999999999999999999999987654443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=313.16 Aligned_cols=247 Identities=25% Similarity=0.453 Sum_probs=218.0
Q ss_pred ceeecceecccCCeEEEEEEECCCCc---EEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGR---QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
...+.++||.|.||.|++|+.+..|+ .||||.++... ++....+|..|+.||-++. ||||++|.++......+.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFd-HPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCC-CCcEEEEEEEEecCceeE
Confidence 45788899999999999999987774 69999997653 5667889999999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 157 VVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
||.|||++|+|..+|+.+ ++|+.-+...+++-|+.|++||-+.|+|||||...|||+ +.+..+|++|||+++.+.+
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeeccc
Confidence 999999999999999764 679999999999999999999999999999999999999 7788999999999998865
Q ss_pred Cc--ceecccCc--ccccchHHHh-hcCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 236 GK--VYRDIVGS--AYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 236 ~~--~~~~~~gt--~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
+. .+++.-|. ..|.|||.+. .+++.++||||+|++|||.++ |..|||+.++.+.+..|.++..-+++ ..++
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP---mDCP 860 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP---MDCP 860 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC---CCCc
Confidence 43 23333333 4799999876 579999999999999999775 99999999999999999988543333 4789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
..+.+|+..||++|-.+||++.+++.
T Consensus 861 ~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 861 AALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred HHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 99999999999999999999999976
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=283.23 Aligned_cols=255 Identities=30% Similarity=0.482 Sum_probs=209.5
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC----
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK---- 152 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---- 152 (393)
+..+|.-+..+|.|.- .|..+-|.-++++||+|.+... +.......+..+|..++..+. |+||++++.+|.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhc-ccceeeeeeccCccccHH
Confidence 4458888899999988 7888899999999999988665 445566778889999999996 99999999999644
Q ss_pred --CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 153 --QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 153 --~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
...|+|||++. .+|...+. -.+.-..+..++.|++.|++|||+.||+||||||+||++ +..+.+||.|||+|
T Consensus 92 ~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 92 EFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFGLA 165 (369)
T ss_pred HHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccchhh
Confidence 35799999995 48877776 357788899999999999999999999999999999999 66778999999999
Q ss_pred ccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC------------
Q 016233 231 VFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD------------ 297 (393)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~------------ 297 (393)
+.....-..+.++.|..|.|||++-+ .|...+||||+||++.||++|+..|.+.+.-+.+.++...-
T Consensus 166 r~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 166 RTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 98766656677889999999998754 59999999999999999999999998876554443332100
Q ss_pred ---------------C----CCCCCCCC-------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 016233 298 ---------------I----DFESAPWP-------TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (393)
Q Consensus 298 ---------------~----~~~~~~~~-------~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 340 (393)
. .|+...|+ .-+..+++++.+||..||++|.+++++|+|||++
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 1 11111221 1235689999999999999999999999999996
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=312.04 Aligned_cols=250 Identities=33% Similarity=0.491 Sum_probs=201.0
Q ss_pred ceeecceecccCCe-EEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 80 HYSFGKELGRGQFG-VTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 80 ~y~~~~~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
-|.-.+.+|.|+.| .||+|... |+.||||.+-. .......+|+..|+.-..|||||++++.-.++...||.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa 581 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA 581 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC--CceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence 34556778999887 57999976 88999998742 23567789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccC--CCCCcEEEeecCCccc
Q 016233 159 MELCAGGELFDRIIAKGH----YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK--DENALLKATDFGLSVF 232 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~----~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~--~~~~~~kl~DFg~a~~ 232 (393)
.|.| ..+|.+++...+. ...-..+.++.|++.||++||+.+||||||||.||||... +....++|+|||+++.
T Consensus 582 lELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 582 LELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred ehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 9999 4599999876411 1113468899999999999999999999999999999764 3346789999999998
Q ss_pred ccCCcc----eecccCcccccchHHHhhc-CCCcchHHHHHHHHHHHhhC-CCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 016233 233 IEEGKV----YRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSG-VPPFWAETEKGIFDAILQGDIDFESAPWP 306 (393)
Q Consensus 233 ~~~~~~----~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 306 (393)
+..+.. ..+..||-+|+|||+++.. -+..+||+||||++|+.++| ..||.+.-.. -.+|+.+.........
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~- 737 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEP- 737 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeecc-
Confidence 876542 3456799999999999864 66789999999999999886 9999654432 2456666554332211
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
....++.|||.+||..||..||+|.++|.||||-.
T Consensus 738 ~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 738 LPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred CchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 11128999999999999999999999999999964
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=281.49 Aligned_cols=257 Identities=30% Similarity=0.470 Sum_probs=202.9
Q ss_pred cccccceeecceecccCCeEEEEEEECC---CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENS---TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 151 (393)
..+...|.++++||+|.|++||++.+.. .++.||+|.+.. ......+.+|+++|..+.++.||+++.+++..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~-----ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR-----TSSPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccc-----ccCchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 3455679999999999999999999887 788999998853 23567799999999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 152 KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
++.+.+||||++..+..++.. .++..+++.+++.++.||.++|.+|||||||||.|+|.+.. .+.-.|+|||+|.
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~--t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRR--TQRGVLVDFGLAQ 181 (418)
T ss_pred CCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccc--cCCceEEechhHH
Confidence 999999999999887777664 47789999999999999999999999999999999999754 4456789999997
Q ss_pred ccc-----------------C--C--------------c-c-----------eecccCcccccchHHHhh--cCCCcchH
Q 016233 232 FIE-----------------E--G--------------K-V-----------YRDIVGSAYYVAPEVLRR--RYGKEIDI 264 (393)
Q Consensus 232 ~~~-----------------~--~--------------~-~-----------~~~~~gt~~y~aPE~l~~--~~~~~~Di 264 (393)
... . + . . .....||++|+|||++.. .-++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 221 0 0 0 0 012469999999999864 46889999
Q ss_pred HHHHHHHHHHhhCCCCCCCCCh-HHHHHHH--------------HcCC-------------------CC-----------
Q 016233 265 WSAGVILYILLSGVPPFWAETE-KGIFDAI--------------LQGD-------------------ID----------- 299 (393)
Q Consensus 265 wSlG~il~~lltg~~pf~~~~~-~~~~~~i--------------~~~~-------------------~~----------- 299 (393)
||.|||+..++++..||..... ...+..| ..+. ..
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 9999999999999999954321 1111000 0011 00
Q ss_pred --CCCCCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 300 --FESAPWP-TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 300 --~~~~~~~-~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
.....|. ..+..+.||+.+||..||.+|+|++++|+||||..
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 0111111 24558999999999999999999999999999985
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=291.72 Aligned_cols=200 Identities=31% Similarity=0.535 Sum_probs=179.0
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccC-----CcccHHHHHHHHHHHHHcc--CCCCeeEEeEEEEeC
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV-----TKNDKDDIKREIQIMQHLS--GQPNIVEFKGAYEDK 152 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~ 152 (393)
.|...+.||+|+||.|++|.++.....|+||.|.+++.. ....+..+-.||+||..|+ .|+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 489999999999999999999999999999999876542 1223444667999999995 489999999999999
Q ss_pred CeEEEEEecc-CCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 153 QSVHVVMELC-AGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 153 ~~~~lv~e~~-~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
+++||+||-- +|.+|+++|..+..++|.++..|++|+..|+++||++||||||||-+|+.+ +.++.+||+|||.|.
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgsaa 718 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGSAA 718 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccchh
Confidence 9999999976 567999999999999999999999999999999999999999999999999 778899999999988
Q ss_pred cccCCcceecccCcccccchHHHhhc--CCCcchHHHHHHHHHHHhhCCCCCCC
Q 016233 232 FIEEGKVYRDIVGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWA 283 (393)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~~lltg~~pf~~ 283 (393)
...++ .+...+||..|.|||++++. .+..-|||+||++||.++...-||+.
T Consensus 719 ~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 YTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 76654 56788999999999999874 58899999999999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=298.51 Aligned_cols=259 Identities=28% Similarity=0.497 Sum_probs=221.8
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
+..++|.+...+|+|.||.||+++++.+++..|+|+++.. ......-++.|+-+++.++ |||||.+++.|-.+..+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~-h~nivay~gsylr~dkl 87 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRRDKL 87 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCC-CcChHHHHhhhhhhcCc
Confidence 3466899999999999999999999999999999999654 4556777889999999997 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
+++||||.||+|.+.-.-.+.+++.++..+++..+.+|+|||+.|=+|||||-.||+++ +.+.+|+.|||.+..+..
T Consensus 88 wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt---d~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT---DEGDVKLADFGVSAQITA 164 (829)
T ss_pred EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec---ccCceeecccCchhhhhh
Confidence 99999999999998777778999999999999999999999999999999999999995 455699999999887754
Q ss_pred Cc-ceecccCcccccchHHH----hhcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC-CCCCCC
Q 016233 236 GK-VYRDIVGSAYYVAPEVL----RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA-PWPTIS 309 (393)
Q Consensus 236 ~~-~~~~~~gt~~y~aPE~l----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s 309 (393)
.- ......||++|||||+. .+.|...+|||++|+...|+---.+|..+......+.......+..+.. .-..-+
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws 244 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS 244 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence 32 23567899999999975 2569999999999999999998888877766665555444444433322 122357
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
+.+-+|++.+|.++|++|||++.+|+|||...
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 88999999999999999999999999999875
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=299.91 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=213.2
Q ss_pred cccccccceeecceecccCCeEEEEEEEC----C---CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEE
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLCTEN----S---TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEF 145 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~ 145 (393)
.++..+.+..+.+.||+|.||.|++|.-. . ....||||..+... ...+.+.+..|+++|+.+..|+||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~--~~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA--SSSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc--CcHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 34445555677789999999999999743 1 14579999886543 336788999999999999999999999
Q ss_pred eEEEEeCCeEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCC
Q 016233 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKG----------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPE 209 (393)
Q Consensus 146 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~ 209 (393)
++++...+.+++|+||+..|+|.+++...+ .++..+...++.||+.|++||++..+|||||-..
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999998765 3888899999999999999999999999999999
Q ss_pred cEEeccCCCCCcEEEeecCCcccccCCcceec--ccCcc--cccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCC
Q 016233 210 NFLLSSKDENALLKATDFGLSVFIEEGKVYRD--IVGSA--YYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWA 283 (393)
Q Consensus 210 Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~~--~~gt~--~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~ 283 (393)
|||+ ..+..+||+|||+|+.......+.. ..|+. .|||||.+.. .|+.++||||+||+|||+++ |..||.+
T Consensus 448 NVLi---~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 448 NVLI---TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hEEe---cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 9999 5667899999999997665554432 22323 4999999886 59999999999999999998 8999988
Q ss_pred CC-hHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 284 ET-EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 284 ~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.. ..++++.+..|.....+ ..+++++.++++.||..+|++||++.++.+
T Consensus 525 ~~~~~~l~~~l~~G~r~~~P---~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 525 IPPTEELLEFLKEGNRMEQP---EHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCcHHHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 55 56667767776543222 357999999999999999999999999876
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=248.66 Aligned_cols=216 Identities=25% Similarity=0.360 Sum_probs=180.8
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
+...+...-+..||+|+||.|=+-++..+|...|+|.+...- ..+...++.+|+.+..+...+|.+|.+++.+-....
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 334445556788999999999999999999999999997653 345567788999998888789999999999999999
Q ss_pred EEEEEeccCCCChHHH----HHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 155 VHVVMELCAGGELFDR----IIAKGHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~----l~~~~~~~~~~~~~i~~qll~~l~~lH~~-~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
++|.||.++. +|..+ +...+.++|..+-+|+..++.||+|||++ .|+|||+||+|||+ +..+.+|+||||+
T Consensus 120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGI 195 (282)
T KOG0984|consen 120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGI 195 (282)
T ss_pred EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEccccc
Confidence 9999999954 66433 33456799999999999999999999985 89999999999999 6677899999999
Q ss_pred cccccCCcceecccCcccccchHHHhh-----cCCCcchHHHHHHHHHHHhhCCCCCCC-CChHHHHHHHHcC
Q 016233 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR-----RYGKEIDIWSAGVILYILLSGVPPFWA-ETEKGIFDAILQG 296 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~DiwSlG~il~~lltg~~pf~~-~~~~~~~~~i~~~ 296 (393)
+..+.+.-..+...|-..|||||.+.. .|+-++||||||++++||.+++.||.. .+..+++.++...
T Consensus 196 sG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 196 SGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred ceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 998877655555678899999998752 489999999999999999999999964 4566666666654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.87 Aligned_cols=240 Identities=23% Similarity=0.276 Sum_probs=183.2
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
..|...+.||+|+||.||+|.+..++..||||.+..... ....|++++++++ |||||++++++.+.+..|+|
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~-HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQ-HPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCC-CCCcceEEEEEEcCCCCEEE
Confidence 456677889999999999999999999999998853221 1234688999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH---FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH---~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
|||+++|+|.+++. .+++.....++.|++.||+||| +.+|+||||||+||+++ .....++. ||.+.....
T Consensus 762 ~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~---~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 762 HEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID---GKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC---CCCceEEE-ecccccccc
Confidence 99999999999885 4889999999999999999999 66999999999999994 34445554 665543322
Q ss_pred CcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh--HHHHHHHH---cC-C----CCCCC-C
Q 016233 236 GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE--KGIFDAIL---QG-D----IDFES-A 303 (393)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~--~~~~~~i~---~~-~----~~~~~-~ 303 (393)
. ....||+.|+|||++.+ .++.++|||||||++|||+||+.||..... ....+... .. . .+... .
T Consensus 835 ~---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 D---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred C---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 1 23468999999998865 599999999999999999999999854211 11111110 00 0 00000 0
Q ss_pred CC---CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 304 PW---PTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 304 ~~---~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
.. .....++.+++.+||..||++|||+.|+++.
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00 0112357789999999999999999999874
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=267.98 Aligned_cols=245 Identities=23% Similarity=0.369 Sum_probs=192.7
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHH--ccCCCCeeEEeEEEEeC--
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH--LSGQPNIVEFKGAYEDK-- 152 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~~h~niv~~~~~~~~~-- 152 (393)
+..+..+.+.||+|.||.||+|.++ |+.||||++.. .+...+.+|.+|.+. |+ |+||+.+++.-..+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~s------rdE~SWfrEtEIYqTvmLR-HENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSS------RDERSWFRETEIYQTVMLR-HENILGFIAADNKDNG 279 (513)
T ss_pred hhheeEEEEEecCccccceeecccc--CCceEEEEecc------cchhhhhhHHHHHHHHHhc-cchhhhhhhccccCCC
Confidence 4557889999999999999999988 89999999953 346778889988876 55 99999998865433
Q ss_pred --CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc--------CcEecCCCCCcEEeccCCCCCcE
Q 016233 153 --QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM--------GVMHRDLKPENFLLSSKDENALL 222 (393)
Q Consensus 153 --~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~--------~ivH~Dikp~Nill~~~~~~~~~ 222 (393)
..+|||.+|.+.|+|+|+|.. ..++.+...+++..++.||++||-. .|.|||||..|||+ ..++.+
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C 355 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTC 355 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcE
Confidence 268999999999999999988 5799999999999999999999952 49999999999999 567789
Q ss_pred EEeecCCcccccCCc-----ceecccCcccccchHHHhhcC-------CCcchHHHHHHHHHHHhhC----------CCC
Q 016233 223 KATDFGLSVFIEEGK-----VYRDIVGSAYYVAPEVLRRRY-------GKEIDIWSAGVILYILLSG----------VPP 280 (393)
Q Consensus 223 kl~DFg~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~-------~~~~DiwSlG~il~~lltg----------~~p 280 (393)
.|+|+|||....... .....+||..|||||++.+.. -..+||||||.++||+... .+|
T Consensus 356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 999999998765432 234578999999999997532 2469999999999999863 578
Q ss_pred CCCC-----ChHHHHHHHHcCCCCCC-CCCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHh
Q 016233 281 FWAE-----TEKGIFDAILQGDIDFE-SAPWPTIS--SSAKDLVRRMLTQDPKKRITSAQVL 334 (393)
Q Consensus 281 f~~~-----~~~~~~~~i~~~~~~~~-~~~~~~~s--~~~~~li~~~L~~dp~~Rpt~~e~l 334 (393)
|++. +.+++.+-+...+..+. +..|...+ ..+..+++.||..||.-|.|+-.+.
T Consensus 436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred cccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 8643 33444444443333332 23344322 2467889999999999999986654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=269.59 Aligned_cols=240 Identities=25% Similarity=0.361 Sum_probs=188.4
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHcc-CCCCeeEEeEEEEeCC----e
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS-GQPNIVEFKGAYEDKQ----S 154 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~~~~~~~~~~----~ 154 (393)
..++.+.||+|.||.||+|... ++.||||+++ ..+.+.+.+|-+|.+... .|+||+++++.-+... .
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred chhhHHHhhcCccceeehhhcc--CceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 4667889999999999999866 6999999985 346778888888877632 4999999998765444 7
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---------CcEecCCCCCcEEeccCCCCCcEEEe
Q 016233 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM---------GVMHRDLKPENFLLSSKDENALLKAT 225 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~---------~ivH~Dikp~Nill~~~~~~~~~kl~ 225 (393)
++||+||.+.|+|.++|..+ .+++....+++..+++||+|||+- .|+|||||..|||+ ..+.+..|+
T Consensus 283 ywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIa 358 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIA 358 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEee
Confidence 99999999999999999765 799999999999999999999962 59999999999999 567789999
Q ss_pred ecCCcccccCCc---ceecccCcccccchHHHhhcCC-------CcchHHHHHHHHHHHhhCCCCCC-------------
Q 016233 226 DFGLSVFIEEGK---VYRDIVGSAYYVAPEVLRRRYG-------KEIDIWSAGVILYILLSGVPPFW------------- 282 (393)
Q Consensus 226 DFg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~-------~~~DiwSlG~il~~lltg~~pf~------------- 282 (393)
|||+|..+..+. .....+||..|||||+|.+... .+.||||+|.+||||++....++
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 999999886543 2334789999999999976422 45899999999999998654332
Q ss_pred ----CCChHHHHHHHHcCCCCC-CCCCCCC--CCHHHHHHHHHhcccCCCCCCCHH
Q 016233 283 ----AETEKGIFDAILQGDIDF-ESAPWPT--ISSSAKDLVRRMLTQDPKKRITSA 331 (393)
Q Consensus 283 ----~~~~~~~~~~i~~~~~~~-~~~~~~~--~s~~~~~li~~~L~~dp~~Rpt~~ 331 (393)
..+..++...+.+.+..+ ....|.. --..+++.+..||..|++.|.|+.
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 112233334443333221 1222322 235689999999999999999995
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=254.77 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=205.6
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeE-EEEeCCe
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG-AYEDKQS 154 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~-~~~~~~~ 154 (393)
++.+.|.+.+.||+|.||.+-+|.|+.++..+++|.+++.. ....+|.+|...--.|..|.||+.-|+ .|+..+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 46678999999999999999999999999999999997643 357889999998888888999999776 5788889
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+++++||++.|+|..-+.. ..+-|.....++.|+++|++|+|++++||||||.+||||-..| ...+||||||+.+...
T Consensus 97 YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d-f~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD-FYRVKLCDFGLTRKVG 174 (378)
T ss_pred EEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC-ccEEEeeecccccccC
Confidence 9999999999999876654 4588889999999999999999999999999999999996544 3489999999987644
Q ss_pred CCcceecccCcccccchHHHh----hc--CCCcchHHHHHHHHHHHhhCCCCCCCCCh----HHHHHHHHcCCCCCCCCC
Q 016233 235 EGKVYRDIVGSAYYVAPEVLR----RR--YGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAILQGDIDFESAP 304 (393)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~l~----~~--~~~~~DiwSlG~il~~lltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~ 304 (393)
.. ....--+..|.+||++. +. ..+.+|||.||+++|.+|||++||+.... .-.+.+...+...-.+..
T Consensus 175 ~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~ 252 (378)
T KOG1345|consen 175 TT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK 252 (378)
T ss_pred ce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh
Confidence 32 22223456799999864 22 57889999999999999999999974322 122334444444444455
Q ss_pred CCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCccc
Q 016233 305 WPTISSSAKDLVRRMLTQDPKKR---ITSAQVLEHPWI 339 (393)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~R---pt~~e~l~h~~~ 339 (393)
+..+++.+..+.++-|..++++| -+++.-....|.
T Consensus 253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 66789999999999999999999 455444455554
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=278.41 Aligned_cols=245 Identities=23% Similarity=0.352 Sum_probs=205.7
Q ss_pred eeecceecccCCeEEEEEEECCCCc----EEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGR----QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
.+..++||+|+||+||+|.+--.|+ +||+|++.... ....-.++..|+-+|.+|. |||++++++++.... +-
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLD-HPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCC-CchHHHHhhhcccch-HH
Confidence 3446789999999999999855454 68999886443 4445678999999999996 999999999998765 78
Q ss_pred EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 157 VVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
||++|+++|+|.|+++.. ..+-......|+.||+.||.|||++++|||||-..|||+. ....+||.|||+++.+..
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk---sP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK---SPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec---CCCeEEEEecchhhccCc
Confidence 999999999999999864 5688899999999999999999999999999999999995 455699999999998765
Q ss_pred Cc-ceecccC--cccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 016233 236 GK-VYRDIVG--SAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 236 ~~-~~~~~~g--t~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
.. .+....| .+.|||-|.++. .|+.++||||+||++||++| |..|+.+....++-+.+..+.. .+. .+..+-
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-Lsq--PpiCti 927 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LSQ--PPICTI 927 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CCC--CCCccH
Confidence 43 2333333 346899998764 69999999999999999998 9999999998888888877765 332 257899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
++.-++.+||..|++.||+++++..
T Consensus 928 DVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHHHHH
Confidence 9999999999999999999988754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=240.80 Aligned_cols=211 Identities=44% Similarity=0.740 Sum_probs=184.7
Q ss_pred ecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCCCC
Q 016233 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGE 166 (393)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~gg~ 166 (393)
||+|++|.||++.+..+++.+++|++....... ....+.+|+.+++.+. |++|+++++++......++++|++.|++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 689999999999999889999999986543211 3578999999999997 8999999999999999999999999999
Q ss_pred hHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc-ceecccC
Q 016233 167 LFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-VYRDIVG 244 (393)
Q Consensus 167 L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-~~~~~~g 244 (393)
|.+++... ..++...++.++.+++.++.+||+.|++|+||+|.||+++.. ...++|+|||.+....... ......+
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD--NGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCC--CCcEEEecCCceEEccCCcchhhcccC
Confidence 99988765 478999999999999999999999999999999999999531 5679999999998765432 2334567
Q ss_pred cccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 016233 245 SAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (393)
Q Consensus 245 t~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (393)
...|++||.+.. .++.++|+|++|+++++| ..+.+++.+||..
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~~ 200 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhhC
Confidence 889999999875 678899999999999999 5789999999999
Q ss_pred CCCCCCCHHHHhcCc
Q 016233 323 DPKKRITSAQVLEHP 337 (393)
Q Consensus 323 dp~~Rpt~~e~l~h~ 337 (393)
||++||+++++++|+
T Consensus 201 ~p~~R~~~~~l~~~~ 215 (215)
T cd00180 201 DPEKRPSAKEILEHL 215 (215)
T ss_pred CcccCcCHHHHhhCC
Confidence 999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=241.13 Aligned_cols=211 Identities=43% Similarity=0.753 Sum_probs=181.5
Q ss_pred eeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEe
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 160 (393)
|++.+.||+|++|.||+|.+..+++.+|+|.+...... .....+.+|++.+++++ |+|++++++++......++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLK-HPNIVKLYGVFEDPEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCC-CCChhhheeeeecCCceEEEEe
Confidence 56788999999999999999988999999998754321 25678899999999996 9999999999999999999999
Q ss_pred ccCCCChHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc--
Q 016233 161 LCAGGELFDRIIAKGH-YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-- 237 (393)
Q Consensus 161 ~~~gg~L~~~l~~~~~-~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-- 237 (393)
++++++|.+++..... +++..+..++.+++.++.+||+++++|+||+|.||+++ ....++|+|||++.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~---~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG---MDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeeCceeeEecCcccc
Confidence 9999999999987666 89999999999999999999999999999999999994 45779999999998876543
Q ss_pred ceecccCcccccchHHHh-h-cCCCcchHHHHHHHHHHHhhCCCCCCC--CChHHHHHHHHcCC
Q 016233 238 VYRDIVGSAYYVAPEVLR-R-RYGKEIDIWSAGVILYILLSGVPPFWA--ETEKGIFDAILQGD 297 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~-~-~~~~~~DiwSlG~il~~lltg~~pf~~--~~~~~~~~~i~~~~ 297 (393)
......++..|++||.+. . .++.++|+|+||+++++|++|+.||.. .....+.+.+..+.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 334567888999999983 3 477799999999999999999999977 33345666666654
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=286.44 Aligned_cols=197 Identities=19% Similarity=0.229 Sum_probs=148.0
Q ss_pred CCeeEEeEEE-------EeCCeEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcE
Q 016233 140 PNIVEFKGAY-------EDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENF 211 (393)
Q Consensus 140 ~niv~~~~~~-------~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Ni 211 (393)
+||+++++++ .....++++|||+ +++|.++|.. ...+++.++..+++||+.||+|||++||+||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 5777777776 2334577888987 6699999965 34599999999999999999999999999999999999
Q ss_pred EeccC----------------CCCCcEEEeecCCcccccCCc-----------------ceecccCcccccchHHHhh-c
Q 016233 212 LLSSK----------------DENALLKATDFGLSVFIEEGK-----------------VYRDIVGSAYYVAPEVLRR-R 257 (393)
Q Consensus 212 ll~~~----------------~~~~~~kl~DFg~a~~~~~~~-----------------~~~~~~gt~~y~aPE~l~~-~ 257 (393)
||+.. +....+|++|||+++...... .....+||++|||||++.+ .
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 99531 234567888888886432100 0112468999999998765 5
Q ss_pred CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 016233 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHP 337 (393)
Q Consensus 258 ~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~ 337 (393)
|+.++|||||||+||||++|.+|+.... ..+..+...... . .+....+...+++.+||..||.+|||+.|+|+||
T Consensus 192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLP--P-QILLNWPKEASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcC--h-hhhhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence 9999999999999999999998875332 222222222111 1 1112245678999999999999999999999999
Q ss_pred cccCC
Q 016233 338 WIKEG 342 (393)
Q Consensus 338 ~~~~~ 342 (393)
||...
T Consensus 267 ~~~~~ 271 (793)
T PLN00181 267 FINEP 271 (793)
T ss_pred hhhhh
Confidence 99763
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=236.39 Aligned_cols=253 Identities=17% Similarity=0.211 Sum_probs=204.8
Q ss_pred ccccccceeecceecccCCeEEEEEEECCC-----CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEE
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENST-----GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 148 (393)
....+.++++...+-+|.||.||.|.+... .+.|-+|.++... ++.+...+..|.-++..+. |||+..+.++
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~s-H~nll~V~~V 355 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGAS-HPNLLSVLGV 355 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCc-CCCccceeEE
Confidence 334567889999999999999999976533 3456667665332 4456677888999999997 9999999987
Q ss_pred EE-eCCeEEEEEeccCCCChHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCC
Q 016233 149 YE-DKQSVHVVMELCAGGELFDRIIAK--------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDEN 219 (393)
Q Consensus 149 ~~-~~~~~~lv~e~~~gg~L~~~l~~~--------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~ 219 (393)
.. +....++++.+..-|+|..++... ..++..+...++.|+..|++|||++||||.||...|.+| ++.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhh
Confidence 64 445678889999889999988721 236777888999999999999999999999999999999 677
Q ss_pred CcEEEeecCCcccccCCcce---ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHH
Q 016233 220 ALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAIL 294 (393)
Q Consensus 220 ~~~kl~DFg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 294 (393)
..+||+|=.+++.+-+.... ..-.-...||+||.+.. .|+..+|+|||||+||||+| |+.|+..-+..++...++
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk 512 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK 512 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence 88999999999876544321 11112346999998865 69999999999999999998 999999999999988888
Q ss_pred cCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 295 QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 295 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.|..--. .-++++++..++.-||+.+|++||+++|+..
T Consensus 513 dGyRlaQ---P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 513 DGYRLAQ---PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ccceecC---CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 8754222 2478999999999999999999999998864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=216.16 Aligned_cols=251 Identities=20% Similarity=0.271 Sum_probs=206.1
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
.+..+|+++++||+|+||.+|+|....+|..||||+-.. .....++..|.++.+.|++...|..+..++.+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-----~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS-----KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecc-----cCCCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 345689999999999999999999999999999997543 224567888999999999888999999999999999
Q ss_pred EEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
.+|||++ |.+|.+++.- .+.++..++..++.|++.-++|+|.++++||||||+|+|++-......+.++|||+|+.+.
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999999 8899887753 4679999999999999999999999999999999999999776677789999999999775
Q ss_pred CCc--------ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCC---hHHHHHHHHcCCCCCCC
Q 016233 235 EGK--------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET---EKGIFDAILQGDIDFES 302 (393)
Q Consensus 235 ~~~--------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~---~~~~~~~i~~~~~~~~~ 302 (393)
+.. ......||..|.+=...-+ .-+...|+-|+|.+|..+..|..||++.. ..+-+++|.+.+...+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 432 2235689999998776543 46788999999999999999999998754 44566777766554332
Q ss_pred -CCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 016233 303 -APWPTISSSAKDLVRRMLTQDPKKRITSAQ 332 (393)
Q Consensus 303 -~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e 332 (393)
.....++.++.-.+.-|-..--++-|...-
T Consensus 246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~y 276 (341)
T KOG1163|consen 246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMY 276 (341)
T ss_pred HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHH
Confidence 234567888888888887766666676543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-29 Score=221.24 Aligned_cols=249 Identities=20% Similarity=0.314 Sum_probs=200.9
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
+.-+|+++++||+|+||.+|.|...-+++.||||.-++ .....++..|.+..+.|.+.++|..+|-+..+..+-.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-----kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccc-----cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 34589999999999999999999999999999997653 3356789999999999999999999999999998899
Q ss_pred EEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccC--CCCCcEEEeecCCcccc
Q 016233 157 VVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK--DENALLKATDFGLSVFI 233 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~--~~~~~~kl~DFg~a~~~ 233 (393)
||+|++ |.+|.|++.= .+.|+...+..++.|++.-++|+|++.+|.|||||+|+||+.. .....+.|+|||+|+.+
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 999999 8899887764 4579999999999999999999999999999999999999642 23457899999999988
Q ss_pred cCCcc--------eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCC---CChHHHHHHHHcCCCCCC
Q 016233 234 EEGKV--------YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWA---ETEKGIFDAILQGDIDFE 301 (393)
Q Consensus 234 ~~~~~--------~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~---~~~~~~~~~i~~~~~~~~ 301 (393)
.+... .....||..||+=....+ +-+.+.|+-|||-+++.+|.|.+||.+ .+..+-+++|-..+...+
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP 259 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence 66532 245789999999775444 478899999999999999999999986 455667777755443322
Q ss_pred C-CCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 016233 302 S-APWPTISSSAKDLVRRMLTQDPKKRITSA 331 (393)
Q Consensus 302 ~-~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ 331 (393)
. ....+++.++...+.-.-..+-++-|..+
T Consensus 260 i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 260 IEVLCEGFPEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred HHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence 1 22345666666666555555555566553
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=229.06 Aligned_cols=253 Identities=23% Similarity=0.289 Sum_probs=196.1
Q ss_pred ceeecceecccCCeEEEEEEECCCC-cEEEEEEeecCccCCcccHHHHHHHHHHHHHcc---CCCCeeEEeEEE-EeCCe
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTG-RQFACKSISKRKLVTKNDKDDIKREIQIMQHLS---GQPNIVEFKGAY-EDKQS 154 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---~h~niv~~~~~~-~~~~~ 154 (393)
+|.+.+.||+|+||.||.|.+..++ ..+|+|+...... .....+..|..++..+. +..++..+++.+ .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~---~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELG---SKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEeccc---CCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999998775 6789998764321 11226788999999986 246999999999 57888
Q ss_pred EEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCC--CCcEEEeecCCc
Q 016233 155 VHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE--NALLKATDFGLS 230 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~--~~~~kl~DFg~a 230 (393)
.|+||+.+ |.+|.++.... +.++..++..++.|++.+|++||+.|++||||||+|++++..+. ...+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 88999977543 57999999999999999999999999999999999999975432 257999999999
Q ss_pred c--cccCCc--------c-eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC
Q 016233 231 V--FIEEGK--------V-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI 298 (393)
Q Consensus 231 ~--~~~~~~--------~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~ 298 (393)
+ ...... . .....||..|+++.+..+ ..+.+.|+||++.++.+++.|..||.+.........+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8 321111 1 123459999999998876 589999999999999999999999976654322333222222
Q ss_pred CCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 299 DFESA-PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 299 ~~~~~-~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
..... .....+.++.++...+-..+...+|....+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 11111 223456778888888888899999998877553
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-28 Score=225.12 Aligned_cols=255 Identities=35% Similarity=0.581 Sum_probs=209.6
Q ss_pred eeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCC-CeeEEeEEEEeCCeEEEEE
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP-NIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~~~~~~~~~~~lv~ 159 (393)
|.+.+.||.|+||.||++.+. ..+++|.+.............+.+|+.++..+. |+ +|+++.+.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLN-HPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-CCcceeeEEEEEecCCEEEEEE
Confidence 778899999999999999988 789999997765433335778999999999997 55 8999999998888889999
Q ss_pred eccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCC-cEEEeecCCcccccC
Q 016233 160 ELCAGGELFDRIIAKG---HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA-LLKATDFGLSVFIEE 235 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~-~~kl~DFg~a~~~~~ 235 (393)
+++.++++.+++.... .+.+..+..++.|++.++.|+|+.+++||||||+||++. ... .++++|||++.....
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~---~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD---RDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---CCCCeEEEeccCcceecCC
Confidence 9999999997776654 799999999999999999999999999999999999994 444 699999999986554
Q ss_pred Cc-------ceecccCcccccchHHHhh----cCCCcchHHHHHHHHHHHhhCCCCCCCCCh----HHHHHHHHcCCCC-
Q 016233 236 GK-------VYRDIVGSAYYVAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAILQGDID- 299 (393)
Q Consensus 236 ~~-------~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~~lltg~~pf~~~~~----~~~~~~i~~~~~~- 299 (393)
.. ......||..|+|||.+.+ .+....|+||+|++++++++|..||..... ......+......
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence 33 3466789999999999865 588899999999999999999999877663 4555555544433
Q ss_pred CCCCCCCCC----CHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 300 FESAPWPTI----SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 300 ~~~~~~~~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
......... ...+.+++.+++..+|..|.+..+...++|....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 222211111 2579999999999999999999999988776543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=217.24 Aligned_cols=162 Identities=25% Similarity=0.349 Sum_probs=128.1
Q ss_pred CChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcceeccc
Q 016233 165 GELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243 (393)
Q Consensus 165 g~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~ 243 (393)
|+|.+++... ..+++.+++.++.|++.||.|||+++ ||+|||+ +.++.+|+ ||++....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc----CC
Confidence 6899999864 45999999999999999999999999 9999999 55667888 99988765432 36
Q ss_pred CcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCCCCCC---CCCCCCCH--HHHHHH
Q 016233 244 GSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFES---APWPTISS--SAKDLV 316 (393)
Q Consensus 244 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~---~~~~~~s~--~~~~li 316 (393)
||+.|||||++.+ .++.++|||||||++|+|++|..||..... ...+..+......... .....++. ++.++|
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 8999999999875 589999999999999999999999976543 2333333332222111 11122333 699999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccC
Q 016233 317 RRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 317 ~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
.+||..||++|||+.++++|+|+..
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHH
Confidence 9999999999999999999999863
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-31 Score=262.32 Aligned_cols=257 Identities=29% Similarity=0.475 Sum_probs=199.5
Q ss_pred eecceecccCCeEEEEEEECCCCcEEEEEEeecC---ccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKR---KLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.....+|.|++|.|+.+......+.++.|.+... ..........+..|+-+-..+. |+|++..+..+.+....+-+
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhhcccchhh
Confidence 4567899999999998888877777777765422 1111111122566777778886 99998887776666555566
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC--
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-- 236 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~-- 236 (393)
||||++ +|+.++...+.++..++-.+++||+.|++|+|..||.|||+|++|+++ ..++.+||+|||.+.....+
T Consensus 400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~---~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV---TENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE---ecCCceEEeecCcceeeccCcc
Confidence 999999 999999888889999999999999999999999999999999999999 56668999999999876433
Q ss_pred ---cceecccCcccccchHHHhh-cCC-CcchHHHHHHHHHHHhhCCCCCCCCChHHH--HHHHHcCC---CCCCCCCCC
Q 016233 237 ---KVYRDIVGSAYYVAPEVLRR-RYG-KEIDIWSAGVILYILLSGVPPFWAETEKGI--FDAILQGD---IDFESAPWP 306 (393)
Q Consensus 237 ---~~~~~~~gt~~y~aPE~l~~-~~~-~~~DiwSlG~il~~lltg~~pf~~~~~~~~--~~~i~~~~---~~~~~~~~~ 306 (393)
......+|+..|+|||++.+ .|. ...||||.|+++..|.+|+.||......+. ....-... ..-+...+.
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS 555 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence 23456789999999999875 465 468999999999999999999965443322 11111111 111223345
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
.++...+.+|.+||+.||.+|.|+++|++.+||++..
T Consensus 556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred hchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 6788999999999999999999999999999998753
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=229.49 Aligned_cols=177 Identities=19% Similarity=0.199 Sum_probs=134.3
Q ss_pred ccccccceeecceecccCCeEEEEEEECC-CCcEEEEEEeecCcc--CCcccHHHHHHHHHHHHHccCCCCeeE-EeEEE
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENS-TGRQFACKSISKRKL--VTKNDKDDIKREIQIMQHLSGQPNIVE-FKGAY 149 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~-~~~~~ 149 (393)
...+..+|.+.+.||+|+||+||+|.+.. +++.+|||.+..... ........+.+|+++|++|+ |+||+. ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~~- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLAT- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEEc-
Confidence 34456689999999999999999999886 677889998753211 12223567899999999997 999884 5442
Q ss_pred EeCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCC-CCCcEEeccCCCCCcEEEeecC
Q 016233 150 EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL-KPENFLLSSKDENALLKATDFG 228 (393)
Q Consensus 150 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Di-kp~Nill~~~~~~~~~kl~DFg 228 (393)
+..|+||||++|++|.. +. ... ...++.|++.+|.|||++||+|||| ||+|||+ +.++.+||+|||
T Consensus 91 ---~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ikLiDFG 157 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAAVIDFQ 157 (365)
T ss_pred ---CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEEEEECc
Confidence 45799999999999963 21 111 2568899999999999999999999 9999999 445579999999
Q ss_pred CcccccCCc---------ceecccCcccccchHHHhhc-------CCCcchHH
Q 016233 229 LSVFIEEGK---------VYRDIVGSAYYVAPEVLRRR-------YGKEIDIW 265 (393)
Q Consensus 229 ~a~~~~~~~---------~~~~~~gt~~y~aPE~l~~~-------~~~~~Diw 265 (393)
+|+.+.... ......+++.|+|||.+... .+..+|-|
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 999765432 12356788899999987421 34456766
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-29 Score=239.34 Aligned_cols=241 Identities=27% Similarity=0.488 Sum_probs=206.8
Q ss_pred eecccCCeEEEEEEE---CCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEecc
Q 016233 86 ELGRGQFGVTYLCTE---NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELC 162 (393)
Q Consensus 86 ~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 162 (393)
.+|+|+||.|+++.. ...|.-+|+|+..+......... ....|..++..+++||.+|++...++.+...++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 379999999997652 34577899998876554333222 45568888888888999999999999999999999999
Q ss_pred CCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcceecc
Q 016233 163 AGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI 242 (393)
Q Consensus 163 ~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~~~ 242 (393)
.||+|+..+.....+.+...+.+...++-+++++|+.+|+|||+|++||++ +..+.+++.|||+++..-..+..
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhhc---
Confidence 999999999888889999999999999999999999999999999999999 77788999999999987654433
Q ss_pred cCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 016233 243 VGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (393)
Q Consensus 243 ~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (393)
|||..|||||+++ .....+|.||+|+++|+|+||..||.. ++...|...+..++. .++..+++++..++..
T Consensus 154 cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~r 224 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFKR 224 (612)
T ss_pred ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHhh
Confidence 9999999999998 667889999999999999999999987 667777776666554 4678899999999999
Q ss_pred CCCCCCCH-----HHHhcCccccCC
Q 016233 323 DPKKRITS-----AQVLEHPWIKEG 342 (393)
Q Consensus 323 dp~~Rpt~-----~e~l~h~~~~~~ 342 (393)
+|.+|.-. .++++|+||...
T Consensus 225 ~p~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 225 NPENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred CHHHHhccCcchhHHHhccchheee
Confidence 99999855 799999999753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-26 Score=228.69 Aligned_cols=221 Identities=31% Similarity=0.591 Sum_probs=175.0
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
...|+.++.|..|+||.||.++|+.+.+++|+| +++..+. +++ |+... +.|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-------lRn---ilt~a-~npfvv-------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-------LRN---ILTFA-GNPFVV-------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-------hhc---ccccc-CCccee--------------
Confidence 346888999999999999999999999999995 4333221 011 33333 345544
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG- 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~- 236 (393)
|+-...++.-+.++... +.+++|||+.||+|||+||+|.+|+ .-+.+|+.|||+++..-..
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT---~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceee---ecccccccchhhhhhhhhhc
Confidence 44455555555555544 7889999999999999999999994 5677999999998753211
Q ss_pred -------------c--ceecccCcccccchHHHh-hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC
Q 016233 237 -------------K--VYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF 300 (393)
Q Consensus 237 -------------~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 300 (393)
. .-+..+|||.|.|||++. ..|++.+|.|++|+|+|+++-|+.||.+++.++++..+....+.+
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w 277 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 277 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence 0 123469999999999865 569999999999999999999999999999999999999988888
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCccccCCC
Q 016233 301 ESAPWPTISSSAKDLVRRMLTQDPKKRI---TSAQVLEHPWIKEGG 343 (393)
Q Consensus 301 ~~~~~~~~s~~~~~li~~~L~~dp~~Rp---t~~e~l~h~~~~~~~ 343 (393)
+... ..++++++++|.++|..+|..|. .+.++.+|+||+...
T Consensus 278 pE~d-ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD 322 (1205)
T KOG0606|consen 278 PEED-EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD 322 (1205)
T ss_pred cccC-cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence 7774 45789999999999999999995 566888999998643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=195.53 Aligned_cols=174 Identities=18% Similarity=0.162 Sum_probs=133.3
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHH------HHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD------IKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
+..+|++.+.||.|+||.||++.. ++..+|+|++.......+..... +.+|+..+.+|. |++|..+.+++.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~~~ 105 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDFYL 105 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEeee
Confidence 567999999999999999999655 47789999997554333322223 689999999996 999999998866
Q ss_pred eC--------CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcE
Q 016233 151 DK--------QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALL 222 (393)
Q Consensus 151 ~~--------~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~ 222 (393)
.. +..+|||||++|.+|.+.. .+++ ....+++.+|..||+.|++||||||+||++++ ++ +
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~---~g-i 173 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSK---NG-L 173 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeC---CC-E
Confidence 43 3578999999999997763 2333 34669999999999999999999999999953 44 9
Q ss_pred EEeecCCcccccCCcceecccCcccccchHHHhhcCCCcchHHHHHHHHHHHh
Q 016233 223 KATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILL 275 (393)
Q Consensus 223 kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~ll 275 (393)
+|+|||............. =++...|+.++|+||||+++..+.
T Consensus 174 ~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence 9999998876533221111 022345778999999999887655
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=191.74 Aligned_cols=144 Identities=19% Similarity=0.202 Sum_probs=111.6
Q ss_pred cceecccCCeEEEEEEECCCCcEEEEEEeecCccCCccc-----------------------HHHHHHHHHHHHHccCCC
Q 016233 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND-----------------------KDDIKREIQIMQHLSGQP 140 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-----------------------~~~~~~E~~~l~~l~~h~ 140 (393)
.+.||+|+||.||+|.+. +|+.||||+++......... .....+|++++.++. ++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HC
Confidence 467999999999999987 89999999997643211110 122345999999996 77
Q ss_pred CeeEEeEEEEeCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHcCcEecCCCCCcEEeccCCCC
Q 016233 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHIC-HFMGVMHRDLKPENFLLSSKDEN 219 (393)
Q Consensus 141 niv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~l-H~~~ivH~Dikp~Nill~~~~~~ 219 (393)
++.....+.... .+|||||++|+++...+.....+++..+..++.|++.+|.++ |+.||+||||||+|||++ .
T Consensus 80 ~v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~----~ 153 (190)
T cd05147 80 GIPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH----D 153 (190)
T ss_pred CCCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----C
Confidence 764433332222 389999999887766555567899999999999999999999 799999999999999995 2
Q ss_pred CcEEEeecCCcccccC
Q 016233 220 ALLKATDFGLSVFIEE 235 (393)
Q Consensus 220 ~~~kl~DFg~a~~~~~ 235 (393)
+.++|+|||+|.....
T Consensus 154 ~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 154 GKLYIIDVSQSVEHDH 169 (190)
T ss_pred CcEEEEEccccccCCC
Confidence 4699999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-25 Score=197.01 Aligned_cols=234 Identities=25% Similarity=0.379 Sum_probs=152.6
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccC---------CCCeeEEeEEE-
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG---------QPNIVEFKGAY- 149 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~---------h~niv~~~~~~- 149 (393)
....++.||.|+++.||.+++..||+.+|+|++...........+.+++|.-....+.+ |-.++..++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 56778899999999999999999999999999876654445567777777755544332 21233222222
Q ss_pred --------EeC---C-----eEEEEEeccCCCChHHHHH---HcCCCC--H-HHH-HHHHHHHHHHHHHHHHcCcEecCC
Q 016233 150 --------EDK---Q-----SVHVVMELCAGGELFDRII---AKGHYS--E-RAA-ASICRSIVNVVHICHFMGVMHRDL 206 (393)
Q Consensus 150 --------~~~---~-----~~~lv~e~~~gg~L~~~l~---~~~~~~--~-~~~-~~i~~qll~~l~~lH~~~ivH~Di 206 (393)
... + ..+++|.-+ -++|.+.+. ...... . ..+ ..+..|++..+++||..||+|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 111 1 236677777 447766543 322221 1 122 445589999999999999999999
Q ss_pred CCCcEEeccCCCCCcEEEeecCCcccccCCcceecccCcccccchHHHhh---------cCCCcchHHHHHHHHHHHhhC
Q 016233 207 KPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR---------RYGKEIDIWSAGVILYILLSG 277 (393)
Q Consensus 207 kp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~---------~~~~~~DiwSlG~il~~lltg 277 (393)
+|+|+++ +.++.+.|+||+....... .......+..|.+||.... .++.+.|.|+||+++|.|++|
T Consensus 172 ~~~nfll---~~~G~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLL---DQDGGVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE----TTS-EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEE---cCCCCEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999 6678899999987765443 2222455678999997643 278899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 016233 278 VPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKR 327 (393)
Q Consensus 278 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 327 (393)
..||........... .|. ...++++.+++||..+|..||.+|
T Consensus 247 ~lPf~~~~~~~~~~~------~f~--~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW------DFS--RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG------GGT--TSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc------cch--hcCCcCHHHHHHHHHHccCCcccC
Confidence 999976543211111 222 223789999999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=184.81 Aligned_cols=188 Identities=20% Similarity=0.261 Sum_probs=141.5
Q ss_pred ecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCc-ccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEec
Q 016233 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK-NDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMEL 161 (393)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~ 161 (393)
+...|++|+||+||.+.. .+.+++.+.+........ .....+.+|+++|++|.++++|++++++ +..+++|||
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 567899999999998775 477888776653321111 1123578999999999877899999886 346999999
Q ss_pred cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCC-CCCcEEeccCCCCCcEEEeecCCcccccCCcce-
Q 016233 162 CAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL-KPENFLLSSKDENALLKATDFGLSVFIEEGKVY- 239 (393)
Q Consensus 162 ~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Di-kp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~- 239 (393)
+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++ .++.++|+|||+|.........
T Consensus 80 I~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~---~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 80 LAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ---EDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc---CCCCEEEEECCCceecCCcchHH
Confidence 999988654321 1 2357889999999999999999999 79999994 4556999999999865433210
Q ss_pred -------------ecccCcccccchHHHh--hcCC-CcchHHHHHHHHHHHhhCCCCCCCCCh
Q 016233 240 -------------RDIVGSAYYVAPEVLR--RRYG-KEIDIWSAGVILYILLSGVPPFWAETE 286 (393)
Q Consensus 240 -------------~~~~gt~~y~aPE~l~--~~~~-~~~DiwSlG~il~~lltg~~pf~~~~~ 286 (393)
.-...++.|++|+.-+ ...+ ...+.++.|+-+|.++|+..+++++++
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0123688899998543 2333 567888999999999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-24 Score=184.00 Aligned_cols=145 Identities=17% Similarity=0.169 Sum_probs=113.9
Q ss_pred cceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcc------------------c-----HHHHHHHHHHHHHccCCC
Q 016233 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN------------------D-----KDDIKREIQIMQHLSGQP 140 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------------------~-----~~~~~~E~~~l~~l~~h~ 140 (393)
.+.||+|++|.||+|.+. +|+.||||+++........ . ...+.+|...+.++. ++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-EA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-hC
Confidence 568999999999999987 8999999999865211000 0 123467999999997 88
Q ss_pred CeeEEeEEEEeCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCCCCCcEEeccCCCC
Q 016233 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDEN 219 (393)
Q Consensus 141 niv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~-~~ivH~Dikp~Nill~~~~~~ 219 (393)
+|.....+.... .+|||||++|+++.........+++.++..++.|++.++.++|+ +||+||||||+||+++ +
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~----~ 153 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH----D 153 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE----C
Confidence 875444443332 48999999988665444445678889999999999999999999 9999999999999995 4
Q ss_pred CcEEEeecCCcccccCC
Q 016233 220 ALLKATDFGLSVFIEEG 236 (393)
Q Consensus 220 ~~~kl~DFg~a~~~~~~ 236 (393)
+.++|+|||++......
T Consensus 154 ~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 154 GKPYIIDVSQAVELDHP 170 (190)
T ss_pred CCEEEEEcccceecCCC
Confidence 56999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-25 Score=199.32 Aligned_cols=189 Identities=29% Similarity=0.424 Sum_probs=143.8
Q ss_pred CCCCeeEEeEEEEe---------------------------CCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHH
Q 016233 138 GQPNIVEFKGAYED---------------------------KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIV 190 (393)
Q Consensus 138 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll 190 (393)
.|||||++..+|.+ ...+|+||..+. .+|.+++..+ ..+....+.++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHH
Confidence 59999999887643 346899999884 4898888664 567778889999999
Q ss_pred HHHHHHHHcCcEecCCCCCcEEecc-CCCCCcEEEeecCCcccccCC-------cceecccCcccccchHHHhhcC----
Q 016233 191 NVVHICHFMGVMHRDLKPENFLLSS-KDENALLKATDFGLSVFIEEG-------KVYRDIVGSAYYVAPEVLRRRY---- 258 (393)
Q Consensus 191 ~~l~~lH~~~ivH~Dikp~Nill~~-~~~~~~~kl~DFg~a~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~---- 258 (393)
+|+.|||++||.|||+|.+|||+.- +|+...+.|+|||++-..+.. ......-|...-||||+.....
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 9999999999999999999999974 345567889999988654321 1223445788899999986322
Q ss_pred ---CCcchHHHHHHHHHHHhhCCCCCCCCChHHHHH-HHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 016233 259 ---GKEIDIWSAGVILYILLSGVPPFWAETEKGIFD-AILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSA 331 (393)
Q Consensus 259 ---~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ 331 (393)
-.++|.|+.|.+.||+++..-||++..+.-+-. ...+... ......+++.+++++..+|+.||.+|++..
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL---Palp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL---PALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC---CCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 248999999999999999999999855432111 1111111 112246889999999999999999999874
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=217.51 Aligned_cols=245 Identities=22% Similarity=0.337 Sum_probs=178.2
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCcc-CCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL-VTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.|...+.||++.|=.|.+|++.+ | .|+||++-+... .+-....+...|++ .... .+||++.+.-+.+.+..-|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~-~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALM-KAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhh-cCCcccchHHHHHhhHHHHHH
Confidence 67888999999999999999874 4 499999876542 22222333444555 3333 599999998888888888999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc--cCC
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI--EEG 236 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~--~~~ 236 (393)
-+|.. .+|+|++.....+..-+-+.|+.||+.||.-||+.||+|||||.+|||++ .-..+.|+||...+.. ..+
T Consensus 100 Rqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT---SWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 100 RQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT---SWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe---eechhhhhcccccCCccCCCC
Confidence 99994 59999998887788889999999999999999999999999999999995 3445889999876532 111
Q ss_pred c--c----eecccCcccccchHHHhh-----------c-CCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCC
Q 016233 237 K--V----YRDIVGSAYYVAPEVLRR-----------R-YGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGD 297 (393)
Q Consensus 237 ~--~----~~~~~gt~~y~aPE~l~~-----------~-~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~ 297 (393)
+ . +.+..--.+|.|||.+.. . .+++-||||+||+++||++ |.+||.- .+++. ...+.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---SQL~a-Yr~~~ 251 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---SQLLA-YRSGN 251 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---HHHHh-HhccC
Confidence 1 1 122223357999998742 1 4678999999999999987 7888831 11111 11111
Q ss_pred CCCCCCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 298 IDFESAPWPT-ISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 298 ~~~~~~~~~~-~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
...+...... -+..++.+|..|++.||++|.++++.|+.
T Consensus 252 ~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0000000000 12468999999999999999999999985
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.9e-23 Score=177.81 Aligned_cols=138 Identities=20% Similarity=0.251 Sum_probs=109.3
Q ss_pred cceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHcc----CCCCeeEEeEEEEeCC---eEE
Q 016233 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS----GQPNIVEFKGAYEDKQ---SVH 156 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv~~~~~~~~~~---~~~ 156 (393)
.+.||+|+||.||. +..++.. +||++.... ....+.+.+|+.+++.+. .||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46799999999995 7777666 699886542 234577999999999994 3799999999999874 434
Q ss_pred -EEEec--cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHH-HHHHHcCcEecCCCCCcEEeccCC-CCCcEEEeecCCc
Q 016233 157 -VVMEL--CAGGELFDRIIAKGHYSERAAASICRSIVNVV-HICHFMGVMHRDLKPENFLLSSKD-ENALLKATDFGLS 230 (393)
Q Consensus 157 -lv~e~--~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l-~~lH~~~ivH~Dikp~Nill~~~~-~~~~~kl~DFg~a 230 (393)
+|+|| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++..+ ....++|+||+-+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 5579999999663 56665 35678888777 999999999999999999997533 3457999995444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=205.72 Aligned_cols=195 Identities=24% Similarity=0.383 Sum_probs=159.2
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHcc--CCCCeeEEeEEEEeCCe
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--GQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~~~ 154 (393)
-...|.|.+.||+|+||.||+|.+.. |+.||+|+-+.... -+|.--.+++.+|+ --+.|..+...+...+.
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~------WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP------WEFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc------eeeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 34579999999999999999999887 99999997643321 11111223333432 12466667777777778
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEecc----CCCCCcEEEeecCCc
Q 016233 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSS----KDENALLKATDFGLS 230 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~----~~~~~~~kl~DFg~a 230 (393)
-+||+||.+.|+|.+++...+.+++..+..+..|++..++.||..+|||+||||+|+||.. +.+..-++|+|||.+
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 8999999999999999998888999999999999999999999999999999999999952 234567999999998
Q ss_pred ccc---cCCcceecccCcccccchHHHhhc-CCCcchHHHHHHHHHHHhhCC
Q 016233 231 VFI---EEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGV 278 (393)
Q Consensus 231 ~~~---~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~~lltg~ 278 (393)
..+ .++..+...++|-.+-.+|+..+. |+..+|.|.|..+++.||.|+
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 754 345567788899999999999874 999999999999999999994
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-22 Score=175.07 Aligned_cols=240 Identities=19% Similarity=0.265 Sum_probs=187.4
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
...+..+|.+.-.|..|+|++. |..+++|++..+.. +.....+|..|.-.|+.+. ||||+.+++.+.....+.++.
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~-t~risrdfneefp~lrifs-hpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREV-TARISRDFNEEFPALRIFS-HPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhc-chhhcchhhhhCcceeeec-CCchhhhhhhccCCCCceEee
Confidence 3556778899999999999988 56788888876654 3344567888999999986 999999999999999999999
Q ss_pred eccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcC--cEecCCCCCcEEeccCCCCCcEEE--eecCCcccc
Q 016233 160 ELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKDENALLKA--TDFGLSVFI 233 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qll~~l~~lH~~~--ivH~Dikp~Nill~~~~~~~~~kl--~DFg~a~~~ 233 (393)
.|++.|+|+..+..... ....++.+++.+++.|+.|||+.. |.---|....+++ |++.+.+| +|--++..
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfsfq- 342 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSFQ- 342 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceeeee-
Confidence 99999999999987543 667889999999999999999975 4444578888999 55554443 33322221
Q ss_pred cCCcceecccCcccccchHHHhhc----CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 234 EEGKVYRDIVGSAYYVAPEVLRRR----YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
.....-+|.||+||.+... .-..+|+|||.+++|||.|...||.+-...+.-.+|.-....... .+.++
T Consensus 343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~i--ppgis 415 (448)
T KOG0195|consen 343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHI--PPGIS 415 (448)
T ss_pred -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccC--CCCcc
Confidence 1223457899999998643 345799999999999999999999888777665555433332222 26799
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHh
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVL 334 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l 334 (393)
..+..|+.-|+..||.+||.+..++
T Consensus 416 ~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 416 RHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHHHhcCCCCcCCCcceeh
Confidence 9999999999999999999987654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.8e-22 Score=176.35 Aligned_cols=147 Identities=19% Similarity=0.189 Sum_probs=115.1
Q ss_pred ceeecceecccCCeEEEEEE-ECCCCcEEEEEEeecCccCCc-----------------c----cHHHHHHHHHHHHHcc
Q 016233 80 HYSFGKELGRGQFGVTYLCT-ENSTGRQFACKSISKRKLVTK-----------------N----DKDDIKREIQIMQHLS 137 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~~~-----------------~----~~~~~~~E~~~l~~l~ 137 (393)
-|.+.+.||+|+||.||+|. +..+|+.||||++........ . ....+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999999 777899999999975432100 0 1134678999999996
Q ss_pred CCC--CeeEEeEEEEeCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC-cEecCCCCCcEEec
Q 016233 138 GQP--NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG-VMHRDLKPENFLLS 214 (393)
Q Consensus 138 ~h~--niv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~-ivH~Dikp~Nill~ 214 (393)
+. .+++++++ . ..++||||+.|++|.........+...++..++.|++.+|.+||++| |+||||||+||+++
T Consensus 109 -~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 109 -EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred -hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 42 34444443 2 34899999999888765544455677778899999999999999999 99999999999995
Q ss_pred cCCCCCcEEEeecCCcccccC
Q 016233 215 SKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 215 ~~~~~~~~kl~DFg~a~~~~~ 235 (393)
.+.++|+|||.+.....
T Consensus 184 ----~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 184 ----DGKVVIIDVSQSVELDH 200 (237)
T ss_pred ----CCCEEEEEChhhhccCC
Confidence 45699999999886543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.9e-24 Score=210.70 Aligned_cols=258 Identities=28% Similarity=0.487 Sum_probs=209.7
Q ss_pred ceeecceecccCCeEEEEEEECC-CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENS-TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.|.+.+.||+|+|+.|-.+.... +...+|.|.+.... ........+..|..+-+.+.+|.|++.+++...+.+..+++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 57777789999999999887643 34567777665433 23344556667888888887799999999999999999999
Q ss_pred EeccCCCChHHHH-HHcC-CCCHHHHHHHHHHHHHHHHHHH-HcCcEecCCCCCcEEeccCCCCC-cEEEeecCCccccc
Q 016233 159 MELCAGGELFDRI-IAKG-HYSERAAASICRSIVNVVHICH-FMGVMHRDLKPENFLLSSKDENA-LLKATDFGLSVFIE 234 (393)
Q Consensus 159 ~e~~~gg~L~~~l-~~~~-~~~~~~~~~i~~qll~~l~~lH-~~~ivH~Dikp~Nill~~~~~~~-~~kl~DFg~a~~~~ 234 (393)
++|..|+++++.+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++ ..+ .+++.|||+|..+.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~---~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD---ESGSALKIADFGLATAYR 176 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc---cCCCcccCCCchhhcccc
Confidence 9999999999888 4444 6778889999999999999999 99999999999999994 444 79999999998876
Q ss_pred C-Cc---ceecccC-cccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHH-HHHHHHcCCCCCCCCCCC
Q 016233 235 E-GK---VYRDIVG-SAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKG-IFDAILQGDIDFESAPWP 306 (393)
Q Consensus 235 ~-~~---~~~~~~g-t~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 306 (393)
. .. .....+| ++.|+|||...+ ...+..|+||+|+++.-+++|..|+....... .+.........+....|.
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN 256 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence 5 22 3345678 999999998766 46788999999999999999999997654432 112222333344566788
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
.++....+++.++|..+|..|.+.+++-.++|+..
T Consensus 257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 257 SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cCChhhhhcccccccCCchhccccccccccccccc
Confidence 99999999999999999999999999999999987
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-22 Score=185.57 Aligned_cols=175 Identities=27% Similarity=0.437 Sum_probs=136.5
Q ss_pred CeEEEEEeccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 153 QSVHVVMELCAGGELFDRIIAKG---HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
.++||.|++|.-.+|.++|.... ..+......++.|+..+++| ++.+|||+||.||++.. +..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~---d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSD---DDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccccc---chhhhhhhhhh
Confidence 46899999999999999997543 35667788999999999999 99999999999999954 44699999999
Q ss_pred cccccCCc-------ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCC
Q 016233 230 SVFIEEGK-------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDF 300 (393)
Q Consensus 230 a~~~~~~~-------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 300 (393)
........ ..+..+||.+||+||.+++ .|+.++||||||+||+|++. -...|. ....+..+..+.++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g~ip- 478 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDGIIP- 478 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcCCCC-
Confidence 88776544 4456789999999999986 59999999999999999998 333331 12234445555443
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 301 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
...+.+. ++-.+|+..||...|.+||++.+.--|.|.
T Consensus 479 -~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 479 -PEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred -hHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 1222222 456789999999999999988777777664
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.6e-20 Score=162.02 Aligned_cols=137 Identities=26% Similarity=0.339 Sum_probs=112.4
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCc-----ccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK-----NDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
+.||+|++|.||+|.+ .|..+++|+......... .....+.+|+.++..+. |++|+....++.+.+..++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCEEEE
Confidence 5799999999999987 578899997653322111 12345778999999997 888887777777777889999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
||++|++|.+.+.... . ....++.+++.+|.++|+.|++|||++|.|||+. .+.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence 9999999998876532 2 7889999999999999999999999999999995 45689999999875
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.5e-20 Score=174.89 Aligned_cols=198 Identities=28% Similarity=0.374 Sum_probs=157.0
Q ss_pred HHccCCCCeeEEeEEEEeCCeEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCc-EecCCCCCcE
Q 016233 134 QHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGV-MHRDLKPENF 211 (393)
Q Consensus 134 ~~l~~h~niv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~i-vH~Dikp~Ni 211 (393)
+.+. |.|+.++++.+.+....++|-+||..|+|.|.+.. .-.++..-...++++|+.||.|+|.-.| .|+.++..|.
T Consensus 2 ~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred cccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4565 99999999999999999999999999999999877 3457777888999999999999999766 9999999999
Q ss_pred EeccCCCCCcEEEeecCCcccccCC---cceecccCcccccchHHHhhc--------CCCcchHHHHHHHHHHHhhCCCC
Q 016233 212 LLSSKDENALLKATDFGLSVFIEEG---KVYRDIVGSAYYVAPEVLRRR--------YGKEIDIWSAGVILYILLSGVPP 280 (393)
Q Consensus 212 ll~~~~~~~~~kl~DFg~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~--------~~~~~DiwSlG~il~~lltg~~p 280 (393)
++ +....+||.|||+....... .......-...|.|||.+++. .+.+.||||+|++++|+++...|
T Consensus 81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99 78889999999998776421 111112234579999999753 46779999999999999999999
Q ss_pred CCCCC----hHHHHHHHHc-CCCCCCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 281 FWAET----EKGIFDAILQ-GDIDFESAPW--PTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 281 f~~~~----~~~~~~~i~~-~~~~~~~~~~--~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
|.... ..+++..+.. +...+.+..+ ..+.+++..++..||..+|++||+++++-.
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 97522 2345556665 3222222222 145668999999999999999999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=158.37 Aligned_cols=141 Identities=20% Similarity=0.247 Sum_probs=108.6
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCc-------------------ccHHHHHHHHHHHHHccCCC
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK-------------------NDKDDIKREIQIMQHLSGQP 140 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~~h~ 140 (393)
.|.+.+.||+|+||.||+|... +|+.||||++........ .......+|+.++..+. ++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 93 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-EE 93 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH-Hc
Confidence 4888899999999999999875 799999998765321000 01223677999999986 66
Q ss_pred --CeeEEeEEEEeCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCC
Q 016233 141 --NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE 218 (393)
Q Consensus 141 --niv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~ 218 (393)
.++..++. ...++||||++|++|.+... ......++.+++.++.++|+.||+||||||+||++ +.
T Consensus 94 ~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~ 160 (198)
T cd05144 94 GFPVPKPIDW----NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DD 160 (198)
T ss_pred CCCCCceeec----CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cC
Confidence 34444432 34589999999998865432 14567889999999999999999999999999999 45
Q ss_pred CCcEEEeecCCcccccC
Q 016233 219 NALLKATDFGLSVFIEE 235 (393)
Q Consensus 219 ~~~~kl~DFg~a~~~~~ 235 (393)
++.++|+|||++.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 66799999999976554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=156.98 Aligned_cols=134 Identities=21% Similarity=0.278 Sum_probs=105.5
Q ss_pred eecccCCeEEEEEEECCCCcEEEEEEeecCccCCc-----ccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEe
Q 016233 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK-----NDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (393)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 160 (393)
.||+|+||.||+|.. ++..+++|.......... .....+.+|+++++.+. |+++.....++...+..++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEEEEE
Confidence 389999999999984 578999998654322111 12356778999999997 7765554445556666789999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 161 LCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 161 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
|++|++|.+.+..... .++.+++.+|.+||+.|++|+|++|+||+++ .+.++++|||++...
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYS 139 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcCC
Confidence 9999999887754321 8899999999999999999999999999995 456999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.7e-19 Score=176.06 Aligned_cols=140 Identities=19% Similarity=0.230 Sum_probs=111.2
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCC-----cccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT-----KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
..|...+.||+|+||.||+|.+.. ..+++|......... ....+.+.+|+++++.++ |++|+....++.+..
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYDVDPE 409 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEEEeCC
Confidence 355678899999999999998753 445555432221111 112356889999999997 999988877777777
Q ss_pred eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
..++||||++|++|.+++. ....++.+++.+|.+||++||+||||||+|||+. +..++|+|||+++..
T Consensus 410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~----~~~~~liDFGla~~~ 477 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR----DDRLYLIDFGLGKYS 477 (535)
T ss_pred CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE----CCcEEEEeCcccccC
Confidence 7899999999999998775 3577899999999999999999999999999992 345899999999764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.4e-19 Score=151.82 Aligned_cols=142 Identities=18% Similarity=0.236 Sum_probs=100.8
Q ss_pred cceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHH---------------------HHHHHHHHHHccCC-CC
Q 016233 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD---------------------IKREIQIMQHLSGQ-PN 141 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~~h-~n 141 (393)
++.||+|+||.||+|.+. +++.||||++............. ...|...+..+.++ -.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 567999999999999987 79999999987543211111111 14577777777522 23
Q ss_pred eeEEeEEEEeCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCCCCCcEEeccCCCCC
Q 016233 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENA 220 (393)
Q Consensus 142 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~-~~ivH~Dikp~Nill~~~~~~~ 220 (393)
+.+.+++ ...++||||++|+.+.......... ..++..++.+++.++.++|. +||+||||||+||+++ ++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~----~~ 151 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD----DG 151 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE----CC
Confidence 4455443 2358999999985443211111111 16788999999999999999 9999999999999995 55
Q ss_pred cEEEeecCCcccccC
Q 016233 221 LLKATDFGLSVFIEE 235 (393)
Q Consensus 221 ~~kl~DFg~a~~~~~ 235 (393)
.++|+|||.+.....
T Consensus 152 ~~~liDfg~a~~~~~ 166 (187)
T cd05119 152 KVYIIDVPQAVEIDH 166 (187)
T ss_pred cEEEEECcccccccC
Confidence 699999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=166.81 Aligned_cols=259 Identities=22% Similarity=0.262 Sum_probs=201.9
Q ss_pred ccccceeecceecc--cCCeEEEEEEE--CCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe
Q 016233 76 DVKLHYSFGKELGR--GQFGVTYLCTE--NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (393)
Q Consensus 76 ~~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 151 (393)
.+...+.+...+|. |.+|.||.+.. ..++..+|+|.-+.. .........=.+|+...+.+..|+|.++.+..++.
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCccccc
Confidence 34567788889999 99999999998 888999999973221 12223333445678888888889999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHcCC-CCHHHHHHHHHHHHH----HHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEee
Q 016233 152 KQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICRSIVN----VVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~i~~qll~----~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~D 226 (393)
.+..|+-+|+| +.+|..+...... +++..++..+.+... ||.++|..+++|-|+||.||++..+. ...+++|
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~--~s~~~~d 266 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW--TSCKLTD 266 (524)
T ss_pred CCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc--ceeecCC
Confidence 99999999999 5788887776554 888999999999999 99999999999999999999995331 6789999
Q ss_pred cCCcccccCCcce------ecccCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC
Q 016233 227 FGLSVFIEEGKVY------RDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF 300 (393)
Q Consensus 227 Fg~a~~~~~~~~~------~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 300 (393)
||+...+.++... ....|...|++||.+++-++...||+++|.+..+-.+|..++...-.. .+..+.++. .
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~~~r~~~--i 343 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS-SWSQLRQGY--I 343 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC-Ccccccccc--C
Confidence 9999887765421 233677889999999999999999999999999888876665332110 111111111 2
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 301 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
+.......+.++...+..|+..+|..|++++.+++|+++..
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 22333456677778999999999999999999999999874
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.74 E-value=5e-17 Score=145.35 Aligned_cols=138 Identities=19% Similarity=0.268 Sum_probs=103.6
Q ss_pred ceec-ccCCeEEEEEEECCCCcEEEEEEeecCcc----------CCcccHHHHHHHHHHHHHccCCCCe--eEEeEEEEe
Q 016233 85 KELG-RGQFGVTYLCTENSTGRQFACKSISKRKL----------VTKNDKDDIKREIQIMQHLSGQPNI--VEFKGAYED 151 (393)
Q Consensus 85 ~~lg-~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~ni--v~~~~~~~~ 151 (393)
..|| .||.|+||.+... +..++||.+.+... ........+.+|++++.+|. |++| +..+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeeee
Confidence 4577 7888899988765 78999998864321 01123466888999999997 7774 667766433
Q ss_pred C-Ce---EEEEEeccCC-CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEee
Q 016233 152 K-QS---VHVVMELCAG-GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (393)
Q Consensus 152 ~-~~---~~lv~e~~~g-g~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~D 226 (393)
. .. .++|||+++| .+|.+++.. ..+++. .+.||+.+|.+||++||+||||||+|||++. ++.++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~---~~~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDP---DGKFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcC---CCCEEEEE
Confidence 2 22 2599999997 688877654 345554 3678999999999999999999999999953 44699999
Q ss_pred cCCcccc
Q 016233 227 FGLSVFI 233 (393)
Q Consensus 227 Fg~a~~~ 233 (393)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9988763
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.5e-17 Score=134.01 Aligned_cols=133 Identities=23% Similarity=0.293 Sum_probs=110.9
Q ss_pred ecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCC-CCeeEEeEEEEeCCeEEEEEec
Q 016233 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ-PNIVEFKGAYEDKQSVHVVMEL 161 (393)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~~~~~~~~lv~e~ 161 (393)
+.+.||+|.++.||++.... ..+++|.+..... ...+.+|+.+++.+.++ .++++++.++...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 35679999999999999764 7899998754321 56788999999999733 6899999998888889999999
Q ss_pred cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 162 CAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM---GVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 162 ~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~---~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
+.|+.+..+ +......++.+++.+|.++|.. +++|+|++|+||+++ ....++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEecccccC
Confidence 998877543 5566778899999999999984 799999999999995 356799999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.2e-18 Score=170.45 Aligned_cols=259 Identities=28% Similarity=0.446 Sum_probs=204.3
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
.+.+.+-+-+|+++.++.+.-..+|...++|+............+.+..+-.++-.-. +|-++...-.+......+||+
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~-~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR-SPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred cceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCC-CCceecccCCCCCCCCcchhh
Confidence 4556667888999999988888888777777665443333334444444544444332 577776655566677889999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC----
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE---- 235 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~---- 235 (393)
+|+.|++|...+...+..+.+.++..+..+..+++|||...+.|||++|.|++. ...+..++.|||......-
T Consensus 884 ~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred HHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCccccccccccccCc
Confidence 999999999999888888888899999999999999999999999999999999 5666789999984332110
Q ss_pred --C--------------------------cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh
Q 016233 236 --G--------------------------KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE 286 (393)
Q Consensus 236 --~--------------------------~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 286 (393)
. .......||+.|.+||.+.+ ..+..+|.|++|+++++.++|.+||.....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 0 01123579999999998765 588899999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH---HHhcCccccCCC
Q 016233 287 KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSA---QVLEHPWIKEGG 343 (393)
Q Consensus 287 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~---e~l~h~~~~~~~ 343 (393)
.+.+++|..+...++... ...+.++++++.++|..+|.+|..+. ++-.|+||+...
T Consensus 1041 q~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred hhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence 999999998877665543 34688999999999999999999988 888999998653
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=5e-16 Score=152.38 Aligned_cols=157 Identities=22% Similarity=0.284 Sum_probs=100.0
Q ss_pred cccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccC--------------------Cc----------
Q 016233 71 GKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV--------------------TK---------- 120 (393)
Q Consensus 71 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------------~~---------- 120 (393)
|.+.+.+-..|+. +.||+|++|+||+|+.+.+|+.||||+.+..... ..
T Consensus 112 G~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v 190 (537)
T PRK04750 112 GGPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVV 190 (537)
T ss_pred CCCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHH
Confidence 3444444455666 7899999999999999988999999998754100 00
Q ss_pred -ccHHH------HHHHHHHHHHcc---CCCCeeEEeEEEE-eCCeEEEEEeccCCCChHHH--HHHcC----CCCHHHHH
Q 016233 121 -NDKDD------IKREIQIMQHLS---GQPNIVEFKGAYE-DKQSVHVVMELCAGGELFDR--IIAKG----HYSERAAA 183 (393)
Q Consensus 121 -~~~~~------~~~E~~~l~~l~---~h~niv~~~~~~~-~~~~~~lv~e~~~gg~L~~~--l~~~~----~~~~~~~~ 183 (393)
...+. +.+|+..+.++. .+.+.+.+-.+|. .....+|||||++|+.+.+. +...+ .+.+..+.
T Consensus 191 ~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~ 270 (537)
T PRK04750 191 AEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVE 270 (537)
T ss_pred HHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHH
Confidence 01112 334444444443 1222233223222 23456899999999999764 33332 24444455
Q ss_pred HHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCC-CCCcEEEeecCCcccccC
Q 016233 184 SICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD-ENALLKATDFGLSVFIEE 235 (393)
Q Consensus 184 ~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~-~~~~~kl~DFg~a~~~~~ 235 (393)
.++.|++ ..|++|+|+||.||+++.++ ..+.++++|||+...++.
T Consensus 271 ~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 271 VFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 5555554 59999999999999996432 234799999999987654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.1e-14 Score=138.15 Aligned_cols=143 Identities=18% Similarity=0.219 Sum_probs=95.9
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCC-------------------c----cc--------------HHHHH
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT-------------------K----ND--------------KDDIK 127 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------------------~----~~--------------~~~~~ 127 (393)
+.||.|++|+||+|+.+ +|+.||||+.+..-... . .. .-++.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999975 68999999975431000 0 00 00244
Q ss_pred HHHHHHHHcc----CCCCeeEEeEEEEeCCeEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHH-HHHHHHHcCc
Q 016233 128 REIQIMQHLS----GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVN-VVHICHFMGV 201 (393)
Q Consensus 128 ~E~~~l~~l~----~h~niv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~-~l~~lH~~~i 201 (393)
+|++.+.++. ++++|.-..-+.+.....+|||||++|++|.+..... .... ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 5665555553 3444332222222234568999999999998766432 1222 2345556655 4678999999
Q ss_pred EecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 202 vH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+|+|+||.||++ +.++.++++|||++..+.
T Consensus 279 ~H~D~hPgNilv---~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFV---LKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEE---CCCCcEEEEeCCCeeECC
Confidence 999999999999 445679999999987764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.3e-14 Score=122.82 Aligned_cols=144 Identities=13% Similarity=0.120 Sum_probs=104.9
Q ss_pred cceecccCCeEEEEEEECC------CCcEEEEEEeecCcc--C--------C---------cccHHHHH----HHHHHHH
Q 016233 84 GKELGRGQFGVTYLCTENS------TGRQFACKSISKRKL--V--------T---------KNDKDDIK----REIQIMQ 134 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~--~--------~---------~~~~~~~~----~E~~~l~ 134 (393)
...||.|--+.||.|.... .+..+|||+++.... . . ......+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3569999999999998653 357999999864321 0 0 11123333 8999999
Q ss_pred HccCC-CCeeEEeEEEEeCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHcCcEecCCCCCcEE
Q 016233 135 HLSGQ-PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHIC-HFMGVMHRDLKPENFL 212 (393)
Q Consensus 135 ~l~~h-~niv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~l-H~~~ivH~Dikp~Nil 212 (393)
++... -++++.+++ ..-+|||||+.++.+.....+...+++.++..+..+++.+|..| |+.||||+||++.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 98732 467777765 34589999997654433223333466667788899999999998 8999999999999999
Q ss_pred eccCCCCCcEEEeecCCcccccC
Q 016233 213 LSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 213 l~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
+. .+.+.|+|||.+.....
T Consensus 158 ~~----~~~v~iIDF~qav~~~h 176 (197)
T cd05146 158 WH----DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred EE----CCcEEEEECCCceeCCC
Confidence 95 23589999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.5e-14 Score=119.20 Aligned_cols=128 Identities=16% Similarity=0.161 Sum_probs=95.6
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~g 164 (393)
+.|+.|.++.||++... ++.|++|+..... .....+.+|+.+++.+.+...+++++.+... ..++||||++|
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i~G 75 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGT----ELLINRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFIEG 75 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCc----ccccCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEecCC
Confidence 56899999999999865 7899999875332 1233567899999998633334556655432 34799999999
Q ss_pred CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCc-----EecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGV-----MHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~i-----vH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
.++.+. ......++.+++.+|..||+.++ +|+|++|.||+++ ...++++|||.+..
T Consensus 76 ~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM 136 (170)
T ss_pred Cccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence 887643 11123567899999999999885 9999999999995 33589999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.5e-14 Score=138.89 Aligned_cols=251 Identities=18% Similarity=0.211 Sum_probs=184.3
Q ss_pred ccceeecceecccCCeEEEEEEEC-CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTEN-STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
..+|.++..||.|.|+.|+.+... .++..|++|-+...... ......-..|+-+...+.-|.+++.++..+......|
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~-~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT-FASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccc-hHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 346788999999999999987755 67889999977654322 2222223456666667767889999888777777778
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+-.|||+++++...+.-...+.+...+.+..|++.++.++|+..++|+|+||+||++..++ +..++.|||++..+.-.
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTRLAFS 420 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhcccccccccccee
Confidence 9999999999877775555688889999999999999999999999999999999997543 67889999998753211
Q ss_pred cceecccCccccc-chHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 237 KVYRDIVGSAYYV-APEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 237 ~~~~~~~gt~~y~-aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
.....+.-.+. ..|++.. .+..++|++|||.-+++.++|...-+.... ...|..+... ..+....++.
T Consensus 421 --~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~~p----~~~~~~~~~q 491 (524)
T KOG0601|consen 421 --SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGDTP----NLPGLKLQLQ 491 (524)
T ss_pred --cccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeeccccc----CCCchHHhhh
Confidence 11122333444 3565544 378899999999999999998654332221 1223333221 1134457889
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccc
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEHPWIK 340 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h~~~~ 340 (393)
.+.+.++..|+..|+.+.++..|.=|.
T Consensus 492 ~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 492 VLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhcCCccccchhhhhhcccchhh
Confidence 999999999999999999998887553
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.4e-13 Score=110.58 Aligned_cols=148 Identities=20% Similarity=0.201 Sum_probs=113.0
Q ss_pred ecceecccCCeEEEEEEECCCCcEEEEEEeecCccCC-----cccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT-----KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
....|-+|+-+.|+++.+. |+.+.||.=....... .-...+..+|+++|.++. --.|.--.-++.+...-.|
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCCCeE
Confidence 4567889999999999866 8888888533222211 223456778999999986 4466555556777777789
Q ss_pred EEeccCC-CChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 158 VMELCAG-GELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 158 v~e~~~g-g~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
+|||++| .++.+++.... .........++++|-+.+.-||.++|+|+||.++||++.+++....+.++|||++..-
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9999987 46777776642 2333334789999999999999999999999999999998888888899999998753
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.7e-14 Score=125.59 Aligned_cols=236 Identities=16% Similarity=0.219 Sum_probs=155.3
Q ss_pred EEEEEEECCCCcEEEEEEeecCccCCcc-cHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC-----eEEEEEeccCCCCh
Q 016233 94 VTYLCTENSTGRQFACKSISKRKLVTKN-DKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-----SVHVVMELCAGGEL 167 (393)
Q Consensus 94 ~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-----~~~lv~e~~~gg~L 167 (393)
.||++.+...|.+|..-.+......... ..+....-..-|-.+. |.|||+++.|+.+.. ...++.||++.|++
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~ 159 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL 159 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence 4677777777776654433221111111 1122222233344554 899999999986543 47889999999999
Q ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC--cEecCCCCCcEEeccCCCCCcEEEeecCCccc---ccCC--
Q 016233 168 FDRIIAK----GHYSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKDENALLKATDFGLSVF---IEEG-- 236 (393)
Q Consensus 168 ~~~l~~~----~~~~~~~~~~i~~qll~~l~~lH~~~--ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~---~~~~-- 236 (393)
..+|++- ..+......+|+.||+.||.|||+.. |+|+++..+-|++ ..++.+|+.--..... ....
T Consensus 160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifi---q~ngLIkig~~ap~s~h~s~~~~~~ 236 (458)
T KOG1266|consen 160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFI---QHNGLIKIGSVAPDSTHPSVNSTRE 236 (458)
T ss_pred HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheee---cCCceEEecccCccccchhhhhhhH
Confidence 9998753 34788889999999999999999975 9999999999999 5677787642211110 0000
Q ss_pred cceecccCcccccchHHHh-hcCCCcchHHHHHHHHHHHhhCCCCC-CCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 237 KVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPF-WAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
.......|-++|.|||.=. ...+-.+|||++|.+..+|..|..-- ...+..+.-..+.+-.+... ...-++
T Consensus 237 ~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~ 309 (458)
T KOG1266|consen 237 AEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRG 309 (458)
T ss_pred hhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-------CccccC
Confidence 1112234678899998532 34667899999999999998876542 22221111122222211111 223467
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccc
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWIK 340 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~~ 340 (393)
++.+||.-.|..||++.++|-||.+-
T Consensus 310 ~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 310 SITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred cCcccccCCCCCCcchhhhhcCceee
Confidence 89999999999999999999999754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.9e-12 Score=124.50 Aligned_cols=231 Identities=15% Similarity=0.180 Sum_probs=155.5
Q ss_pred ceeecceecccCCeEEE-EEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 80 HYSFGKELGRGQFGVTY-LCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~-~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
-|++ +..+-++.+ +| .|..+.++.+|.|..++.+. ....+.+.+-++-|+.++ ||||+++++.++.++.+|||
T Consensus 14 pY~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylv 87 (690)
T KOG1243|consen 14 PYDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLV 87 (690)
T ss_pred Cccc-ccccCCCcc-cccccceeccCCceEEEEEeCCC---chhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEE
Confidence 3555 444445554 44 57778889999999887543 234566788899999998 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH-FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH-~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
+|-+. .|..++.+. ....+..-+.||+.||.+|| +.+++|++|.-..|++ +..+..||++|.++.......
T Consensus 88 TErV~--Pl~~~lk~l---~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~ 159 (690)
T KOG1243|consen 88 TERVR--PLETVLKEL---GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFN 159 (690)
T ss_pred eeccc--cHHHHHHHh---HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCC
Confidence 99984 455566553 36778888999999999998 5789999999999999 566679999999876543322
Q ss_pred c-eecccCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 238 V-YRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 238 ~-~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
. .....---.|..|+.+.. -....|.|-|||++++++.|..+ ...... .. ..++.....+.
T Consensus 160 ~~~~~~~~~~s~~~P~~~~~-s~~s~D~~~Lg~li~el~ng~~~--~~~~~~-----~~----------~~ipk~~~~~~ 221 (690)
T KOG1243|consen 160 APAKSLYLIESFDDPEEIDP-SEWSIDSWGLGCLIEELFNGSLL--TKTDLS-----NT----------GKIPKALIELY 221 (690)
T ss_pred cccccchhhhcccChhhcCc-cccchhhhhHHHHHHHHhCcccC--cchhhh-----cc----------CccchhHHHHH
Confidence 1 000011112455553321 11346999999999999999322 111110 00 12334455555
Q ss_pred HHhcccCCCCCCCHHHH-----hcCccccCC
Q 016233 317 RRMLTQDPKKRITSAQV-----LEHPWIKEG 342 (393)
Q Consensus 317 ~~~L~~dp~~Rpt~~e~-----l~h~~~~~~ 342 (393)
.+-+--.+..||..... +-|.||+..
T Consensus 222 ~k~~~~~~~~r~n~~~~~~~~~~~~gff~n~ 252 (690)
T KOG1243|consen 222 CKKLGATELKRPNKLRFILECRLLGGFFRND 252 (690)
T ss_pred HHHhccccccccchhhHHHHHHhccccccch
Confidence 55555566666654322 238888753
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.5e-12 Score=108.03 Aligned_cols=135 Identities=22% Similarity=0.279 Sum_probs=99.3
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcc-----cHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN-----DKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
..+++|+-+.+|.+... |..+++|.=.++....+. ....-.+|++++.++. --.|..-+-+..+.+...|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCEEEE
Confidence 35789999999998664 556777754333222221 2345678999999986 445554444555566678999
Q ss_pred eccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 160 ELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 160 e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
||++|..|.+.+... ...+++.+-.-+.-||..||+|+||.++||+++.. .+.++|||++..-
T Consensus 79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~----~i~~IDfGLg~~s 141 (204)
T COG3642 79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG----RIYFIDFGLGEFS 141 (204)
T ss_pred EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC----cEEEEECCccccc
Confidence 999998888887664 25677788888899999999999999999999532 2889999999854
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.6e-11 Score=108.60 Aligned_cols=143 Identities=24% Similarity=0.405 Sum_probs=102.8
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCC-CCeeEEeEEEEeC---CeEEEEEe
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ-PNIVEFKGAYEDK---QSVHVVME 160 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~~~~---~~~~lv~e 160 (393)
+.||.|.++.||++.... |+.+++|+...... ......+.+|+++++.+..+ .++++++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~--~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGAL--LPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCccc--CcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 568999999999998753 68999998754321 12355788999999999732 3467777776553 36789999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 016233 161 LCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF------------------------------------------ 198 (393)
Q Consensus 161 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~------------------------------------------ 198 (393)
|++|.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999887664421 345666666667777777666663
Q ss_pred --------------cCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 199 --------------MGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 199 --------------~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
..++|+|++|.||+++.+ ....+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence 236999999999999542 145688999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.9e-10 Score=108.89 Aligned_cols=211 Identities=17% Similarity=0.233 Sum_probs=156.4
Q ss_pred CeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE----eCCeEEEEEeccCC-CC
Q 016233 92 FGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE----DKQSVHVVMELCAG-GE 166 (393)
Q Consensus 92 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~----~~~~~~lv~e~~~g-g~ 166 (393)
-.+.|+|....+|..|++|.++..+... ....-.-+++++++. |+|||++.++|. .+..+++|++|+++ ++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~---~nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQS---TNKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccC---cccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 3578999999999999999985443322 222234577899996 999999999886 45679999999976 56
Q ss_pred hHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 167 LFDRIIA---------------KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 167 L~~~l~~---------------~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
|.++... ....+|..+|.++.||..||.++|+.|+.-+-|.|.+||+ .+...++|...|+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv---~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV---TGKMRIRISGCGIMD 441 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe---eCcceEEEeccccee
Confidence 7665422 1236789999999999999999999999999999999999 445578888888776
Q ss_pred cccCCcceecccCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCCCCCCChH-H-HHHHHHcCCCCCCCCCCCCCC
Q 016233 232 FIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEK-G-IFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~-~~~~i~~~~~~~~~~~~~~~s 309 (393)
.+.... + |.+. --.+-|.=-||.+++.|.||..--+..+.. + .++.|. ..+|
T Consensus 442 vl~~d~------~-------~~le--~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~yS 495 (655)
T KOG3741|consen 442 VLQEDP------T-------EPLE--SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TTYS 495 (655)
T ss_pred eecCCC------C-------cchh--HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hhhh
Confidence 655433 0 1111 123569999999999999996543222211 1 122222 3578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
.+++++|.-+...++++ -+..+++.+
T Consensus 496 ~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 496 TDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 99999999999999987 788888875
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.4e-10 Score=103.93 Aligned_cols=238 Identities=16% Similarity=0.190 Sum_probs=156.7
Q ss_pred ecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEE------EEeC-CeE
Q 016233 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA------YEDK-QSV 155 (393)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~------~~~~-~~~ 155 (393)
.++.||+|+.+.+|-.-.- + -.+.|++..... ....+ -+..|.....||-+-.=+.| .-+. ..+
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Ppp---a~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPP---AAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecchh--h-chhheeecCCCc---hHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 4667999999999965422 2 234587764321 11111 22233333345533321111 1122 236
Q ss_pred EEEEeccCCCCh-HHHHH------HcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecC
Q 016233 156 HVVMELCAGGEL-FDRII------AKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (393)
Q Consensus 156 ~lv~e~~~gg~L-~~~l~------~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg 228 (393)
.+.|..+.|..- ..++. ......++...++.+.|+.+...||+.|.+-+|+.++|+|++ +...+.|+|=.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEccc
Confidence 788888877532 22221 122366788999999999999999999999999999999995 55668888876
Q ss_pred CcccccCCcceecccCcccccchHHHh-h-----cCCCcchHHHHHHHHHHHhhC-CCCCCCCCh----HHHHH-HHHcC
Q 016233 229 LSVFIEEGKVYRDIVGSAYYVAPEVLR-R-----RYGKEIDIWSAGVILYILLSG-VPPFWAETE----KGIFD-AILQG 296 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~gt~~y~aPE~l~-~-----~~~~~~DiwSlG~il~~lltg-~~pf~~~~~----~~~~~-~i~~~ 296 (393)
......++..+.+.+|.+.|.+||.-+ . .-+...|.|.||+++|++|.| +.||.+... ..-++ .|..+
T Consensus 163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 555556667778899999999999754 2 245679999999999999987 999965311 01111 23222
Q ss_pred CC------------CCCCCCCCCCCHHHHHHHHHhcccC--CCCCCCHHH
Q 016233 297 DI------------DFESAPWPTISSSAKDLVRRMLTQD--PKKRITSAQ 332 (393)
Q Consensus 297 ~~------------~~~~~~~~~~s~~~~~li~~~L~~d--p~~Rpt~~e 332 (393)
.+ .....+|.-+++++..|..+|+... +.-|||++.
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 22 2223456678999999999999763 567999864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.5e-10 Score=100.68 Aligned_cols=137 Identities=18% Similarity=0.139 Sum_probs=95.4
Q ss_pred eEEEEEEECCCCcEEEEEEeecCccC----C----cccHHHHHHHHHHHHHccCCCCe--eEEeEEEEe-----CCeEEE
Q 016233 93 GVTYLCTENSTGRQFACKSISKRKLV----T----KNDKDDIKREIQIMQHLSGQPNI--VEFKGAYED-----KQSVHV 157 (393)
Q Consensus 93 g~V~~~~~~~~~~~vavK~~~~~~~~----~----~~~~~~~~~E~~~l~~l~~h~ni--v~~~~~~~~-----~~~~~l 157 (393)
..|+++.. .|+.|.||........ . ......+.+|.+.+.+|. .-+| +..+.+++. ...-+|
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEE
Confidence 34556554 3778999966332200 0 011124778999888885 3233 334445443 234689
Q ss_pred EEeccCCC-ChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccC----CCCCcEEEeecCCc
Q 016233 158 VMELCAGG-ELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK----DENALLKATDFGLS 230 (393)
Q Consensus 158 v~e~~~gg-~L~~~l~~--~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~----~~~~~~kl~DFg~a 230 (393)
|+|++++. +|.+++.. ...........++.++...+.-||++||+|+|+++.|||+..+ ++...+.++||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99999886 78887754 3446677888999999999999999999999999999999642 33567999999988
Q ss_pred cc
Q 016233 231 VF 232 (393)
Q Consensus 231 ~~ 232 (393)
..
T Consensus 193 ~~ 194 (268)
T PRK15123 193 QI 194 (268)
T ss_pred cc
Confidence 53
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.2e-11 Score=120.66 Aligned_cols=150 Identities=19% Similarity=0.287 Sum_probs=110.7
Q ss_pred HHHHHHHHH-cCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCccee----------cccCcccccchHHHhh-c
Q 016233 190 VNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR----------DIVGSAYYVAPEVLRR-R 257 (393)
Q Consensus 190 l~~l~~lH~-~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~----------~~~gt~~y~aPE~l~~-~ 257 (393)
..|+.|+|+ .++||++|.|++|.+ +.++..||+.|+++.....+..+. ...-...|.|||.+.+ .
T Consensus 109 ~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 109 ADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred cchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 399999997 589999999999999 677789999999987765522211 1123457999998865 4
Q ss_pred CCCcchHHHHHHHHHHHh-hCCCCCCCCChHHHHHHHHcCCCCCCCCC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 258 YGKEIDIWSAGVILYILL-SGVPPFWAETEKGIFDAILQGDIDFESAP-WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 258 ~~~~~DiwSlG~il~~ll-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+.++|++|+||++|.+. .|+.-+........ .............. -.++++++++-+.++|..|+.-||++.+++.
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-YSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcch-hhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 788999999999999999 56666654432221 11222111111111 1468999999999999999999999999999
Q ss_pred CccccCCC
Q 016233 336 HPWIKEGG 343 (393)
Q Consensus 336 h~~~~~~~ 343 (393)
-+||....
T Consensus 265 ~~ff~D~~ 272 (700)
T KOG2137|consen 265 IPFFSDPG 272 (700)
T ss_pred ccccCCch
Confidence 99998653
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.2e-10 Score=97.93 Aligned_cols=131 Identities=19% Similarity=0.205 Sum_probs=83.2
Q ss_pred EEEEEEECCCCcEEEEEEeecCccC------------C-----------cccHHHHHHHHHHHHHccCC-CCeeEEeEEE
Q 016233 94 VTYLCTENSTGRQFACKSISKRKLV------------T-----------KNDKDDIKREIQIMQHLSGQ-PNIVEFKGAY 149 (393)
Q Consensus 94 ~V~~~~~~~~~~~vavK~~~~~~~~------------~-----------~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~ 149 (393)
.||.|... .|..+|+|+....... . ........+|.+.|.++... -++++.+++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48998875 4779999997642110 0 01134567899999999733 2577777553
Q ss_pred EeCCeEEEEEeccC--CCChHHHHHHcCCCCHHHHHHHHHHHHHHHHH-HHHcCcEecCCCCCcEEeccCCCCCcEEEee
Q 016233 150 EDKQSVHVVMELCA--GGELFDRIIAKGHYSERAAASICRSIVNVVHI-CHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (393)
Q Consensus 150 ~~~~~~~lv~e~~~--gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~-lH~~~ivH~Dikp~Nill~~~~~~~~~kl~D 226 (393)
. .+|||||++ |..+.. +... .++......++.+++..+.. +|+.||+|+||.+.||+++. + .+.|+|
T Consensus 80 --~--~~ivME~I~~~G~~~~~-l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~---~-~~~iID 149 (188)
T PF01163_consen 80 --R--NVIVMEYIGEDGVPLPR-LKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDD---G-KVYIID 149 (188)
T ss_dssp --T--TEEEEE--EETTEEGGC-HHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEET---T-CEEE--
T ss_pred --C--CEEEEEecCCCccchhh-HHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeec---c-eEEEEe
Confidence 2 369999998 555533 4332 22245677888888885555 68999999999999999953 2 599999
Q ss_pred cCCcccccC
Q 016233 227 FGLSVFIEE 235 (393)
Q Consensus 227 Fg~a~~~~~ 235 (393)
||.+.....
T Consensus 150 f~qav~~~~ 158 (188)
T PF01163_consen 150 FGQAVDSSH 158 (188)
T ss_dssp GTTEEETTS
T ss_pred cCcceecCC
Confidence 998876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=5.4e-09 Score=91.50 Aligned_cols=111 Identities=21% Similarity=0.261 Sum_probs=87.0
Q ss_pred cHHHHHHHHHHHHHccCCC--CeeEEeEEEEeC----CeEEEEEeccCCC-ChHHHHHHcCCCCHHHHHHHHHHHHHHHH
Q 016233 122 DKDDIKREIQIMQHLSGQP--NIVEFKGAYEDK----QSVHVVMELCAGG-ELFDRIIAKGHYSERAAASICRSIVNVVH 194 (393)
Q Consensus 122 ~~~~~~~E~~~l~~l~~h~--niv~~~~~~~~~----~~~~lv~e~~~gg-~L~~~l~~~~~~~~~~~~~i~~qll~~l~ 194 (393)
......+|...+..|. .- .+++.+.+.+.. ...+||+|+++|. +|.+++......+......++.++...+.
T Consensus 54 ~~~ra~~E~~~~~~L~-~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLR-EAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIA 132 (206)
T ss_pred cchHHHHHHHHHHHHH-HcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHH
Confidence 4556788888888775 22 344555555542 2458999999884 78888877555777888999999999999
Q ss_pred HHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 195 ~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
-||++||+|+|+++.|||+..++....+.++||+-+...
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999999976665568999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.3e-09 Score=94.48 Aligned_cols=141 Identities=23% Similarity=0.276 Sum_probs=104.9
Q ss_pred eeecceecccCCeEEEEEEECCCCcEEEEEEeecCcc-----------------CC--cccHHHHHHHHHHHHHccCC-C
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL-----------------VT--KNDKDDIKREIQIMQHLSGQ-P 140 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------------~~--~~~~~~~~~E~~~l~~l~~h-~ 140 (393)
+.++..||-|--|.||.|.+. .|.++|||+-+.... .+ .......++|.++|++|... -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 567889999999999999987 589999997432110 01 11234567899999999633 3
Q ss_pred CeeEEeEEEEeCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCC
Q 016233 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA 220 (393)
Q Consensus 141 niv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~ 220 (393)
.|++.+++ +.-.+|||+++|-.|... ++....+..++..|+.-+..+-..||||+|+.+-||+++ +++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~---~dg 239 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT---EDG 239 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe---cCC
Confidence 67777665 455799999999777542 224566777788888887777799999999999999994 555
Q ss_pred cEEEeecCCccccc
Q 016233 221 LLKATDFGLSVFIE 234 (393)
Q Consensus 221 ~~kl~DFg~a~~~~ 234 (393)
.+.++||--+....
T Consensus 240 ~~~vIDwPQ~v~~~ 253 (304)
T COG0478 240 DIVVIDWPQAVPIS 253 (304)
T ss_pred CEEEEeCcccccCC
Confidence 69999997666543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=9.7e-08 Score=82.29 Aligned_cols=142 Identities=15% Similarity=0.138 Sum_probs=100.8
Q ss_pred ecccCCeEEEEEEECCCCcEEEEEEeecCccCC---cccHHHHHHHHHHHHHccCC-CCeeEEeEEEE---e--CCeEEE
Q 016233 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVT---KNDKDDIKREIQIMQHLSGQ-PNIVEFKGAYE---D--KQSVHV 157 (393)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~~---~--~~~~~l 157 (393)
-|+||.+.|+..... |+.+-+|.-......+ +.....+.+|+..|++|... -.+++.. ++. . .-.-+|
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 356899999987655 4578888754211111 34677899999999998621 1244444 222 1 123578
Q ss_pred EEeccCC-CChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 158 VMELCAG-GELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 158 v~e~~~g-g~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
|+|-+.| -+|.+++.+. .+.++.....++.++...+.-||+.|+.|+|+.+.||++...+ ...++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccch
Confidence 9997754 5787777553 3457777789999999999999999999999999999996433 34599999987654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.2e-08 Score=96.21 Aligned_cols=144 Identities=18% Similarity=0.206 Sum_probs=91.6
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCcc--------------------CCc---cc--------HH------HHH
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKL--------------------VTK---ND--------KD------DIK 127 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------------~~~---~~--------~~------~~~ 127 (393)
+.|+.++-|+||+|+.+. |+.||||+.+..-. ... -. .+ ++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 579999999999999775 99999999754211 000 00 01 133
Q ss_pred HHHHHHHHcc----CCCCeeEEeEEEEeCCeEEEEEeccCCCChHHHH--HHcCCCCHHHHHHHHHHHHHH-HHHHHHcC
Q 016233 128 REIQIMQHLS----GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI--IAKGHYSERAAASICRSIVNV-VHICHFMG 200 (393)
Q Consensus 128 ~E~~~l~~l~----~h~niv~~~~~~~~~~~~~lv~e~~~gg~L~~~l--~~~~~~~~~~~~~i~~qll~~-l~~lH~~~ 200 (393)
+|+..+.+++ +.++|.--.-+++-.+.-.|+|||++|-.+.+.. .. ..++...+. ..++.+ +..+-..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia---~~~~~~f~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELA---ELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHH---HHHHHHHHHHHHhcC
Confidence 4555554443 3454433333444445568999999998887763 33 334433222 222221 23333489
Q ss_pred cEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 201 ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
++|.|.+|.||++. .++.+-+.|||+...+.+.
T Consensus 286 ffHaDpHpGNi~v~---~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 286 FFHADPHPGNILVR---SDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ccccCCCccceEEe---cCCcEEEEcCcceecCCHH
Confidence 99999999999994 5567899999999877543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=5.5e-10 Score=108.26 Aligned_cols=241 Identities=17% Similarity=0.197 Sum_probs=167.8
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCC-eeEEeEEEEeCCeEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN-IVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-iv~~~~~~~~~~~~~lv 158 (393)
-|.....+++|+++.+++.+...+...+ .+++... ....-++++|.+++ ||| .+..++-++.+...+++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n-~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVN-NPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHcc-CCCCcccccccCCcccccchh
Confidence 3555667899999999998876654444 6655321 44556889999996 999 77778888888899999
Q ss_pred EeccCCC-ChH-HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 159 MELCAGG-ELF-DRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 159 ~e~~~gg-~L~-~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
++++.++ +.. ......-.+.+.+...+++.-+.+++++|+..=+|+| ||+.++ ...+..||+....+...
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~----~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE----EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc----cccccccccCCcccCcc
Confidence 9999887 222 1111112344455566777778899999998778999 888743 45788999999888776
Q ss_pred cceecccCcccccchHHHh-hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC--CCCCC-CCCCCCCHHH
Q 016233 237 KVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD--IDFES-APWPTISSSA 312 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~--~~~~~-~~~~~~s~~~ 312 (393)
.......+|+.++|||+.. +.+....|.|++|+-..++--|.+|-..... ....+-.+. ..... ..|... .-
T Consensus 385 ~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~p~s~~L~~~~aw~~~--~~ 460 (829)
T KOG0576|consen 385 MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNGPNSPMLTDKSAWSPV--FH 460 (829)
T ss_pred cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCCCCccccchhhhcCcc--cc
Confidence 6567788999999999765 4688999999999877777777776533110 000000000 00000 112111 11
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 313 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.++...|+..-|..|+....++-|.+|...
T Consensus 461 ~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 461 RDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred cCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 258889999999999999999999998753
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.2e-07 Score=77.20 Aligned_cols=129 Identities=22% Similarity=0.284 Sum_probs=91.9
Q ss_pred cceeecceecccCC-eEEEEEEECCCCcEEEEEEeecCccCCc------------------ccHHHHHHHHHHHHHcc--
Q 016233 79 LHYSFGKELGRGQF-GVTYLCTENSTGRQFACKSISKRKLVTK------------------NDKDDIKREIQIMQHLS-- 137 (393)
Q Consensus 79 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~~~E~~~l~~l~-- 137 (393)
..++.++.||.|.- |.||++... |+.+|+|++..-..... .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 57899999999999 999999866 88999999432111000 11235778888877776
Q ss_pred CCCCe--eEEeEEEEeC------------------CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 016233 138 GQPNI--VEFKGAYEDK------------------QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH 197 (393)
Q Consensus 138 ~h~ni--v~~~~~~~~~------------------~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH 197 (393)
++.++ |++++|..-. -...||.||.+... .++. .-+.++++-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 34456 8999987321 12467888876643 1222 33567777888899
Q ss_pred HcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 198 ~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
+.||+-+|+++.|..= -+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~~--------G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYRG--------GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCccccccC--------CEEEecccC
Confidence 9999999999999863 478999965
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.2e-07 Score=80.43 Aligned_cols=141 Identities=21% Similarity=0.196 Sum_probs=88.5
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccH------HHHHHHHHHHHHcc--CCCCeeEEeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK------DDIKREIQIMQHLS--GQPNIVEFKGAY 149 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~------~~~~~E~~~l~~l~--~h~niv~~~~~~ 149 (393)
..+|.+.+.+-......|.+.. -.|+.+++|.........+... ....+++..+.++. +-..+..++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4567777777777666666655 3478999997654321111111 11234455444443 122333322222
Q ss_pred -----EeCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEE
Q 016233 150 -----EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKA 224 (393)
Q Consensus 150 -----~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl 224 (393)
.-....++||||++|..|.+... +.+ .+...+..++.-+|+.|++|+|..|.|++++. ..+++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~----~~i~i 175 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN----NGIRI 175 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC----CcEEE
Confidence 22245678999999988866431 233 34466778899999999999999999999962 23899
Q ss_pred eecCCccc
Q 016233 225 TDFGLSVF 232 (393)
Q Consensus 225 ~DFg~a~~ 232 (393)
+||+..+.
T Consensus 176 ID~~~k~~ 183 (229)
T PF06176_consen 176 IDTQGKRM 183 (229)
T ss_pred EECccccc
Confidence 99986653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.72 E-value=3e-07 Score=81.54 Aligned_cols=73 Identities=22% Similarity=0.250 Sum_probs=55.9
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCC-CeeEEeEEEEeCCeEEEEEeccC
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP-NIVEFKGAYEDKQSVHVVMELCA 163 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~~~~~~~~~~~lv~e~~~ 163 (393)
..||+|..+.||+. .+..+++|..... .....+.+|.++++.+.... .+.+.+++.++.+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~-----~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPG-----FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCC-----CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 46899999999984 2557888977532 23456789999999986332 35788888888888899999999
Q ss_pred CCC
Q 016233 164 GGE 166 (393)
Q Consensus 164 gg~ 166 (393)
|.+
T Consensus 78 G~~ 80 (226)
T TIGR02172 78 GKR 80 (226)
T ss_pred Ccc
Confidence 863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.4e-07 Score=76.73 Aligned_cols=134 Identities=23% Similarity=0.279 Sum_probs=94.4
Q ss_pred eeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEe
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 160 (393)
-++.+.||+|.+|.||+|.+. |..+|+|+-. .+.....++.|+++|..+.+----.+++.+.++ ++.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr-----~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRR-----RDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEec-----CCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhh
Confidence 345678999999999999977 6799999653 344678899999999999754445567666543 45699
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCC-CC-cEEeccCCCCCcEEEeecCCcccccCC
Q 016233 161 LCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLK-PE-NFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 161 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dik-p~-Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
|+.|-.|.+.-... . +.-+..+++.---|-..||-|..|. |. ||+++ ...+.|+||.-|+....+
T Consensus 93 ~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~----~~~~~iIDFd~At~k~~p 159 (201)
T COG2112 93 YIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN----DRDVYIIDFDSATFKKKP 159 (201)
T ss_pred hhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEec----CCcEEEEEccchhhccCC
Confidence 99998886543211 1 2333445555445677899999987 44 55552 225889999999854443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.4e-07 Score=97.63 Aligned_cols=206 Identities=17% Similarity=0.216 Sum_probs=144.6
Q ss_pred HHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE----EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Q 016233 123 KDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH----VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198 (393)
Q Consensus 123 ~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~----lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~ 198 (393)
....+.|+..+..+. |+|++.++.|.-...... +..|+|...++...+...+..+....+.+..+++.||.|+|+
T Consensus 226 i~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 344556777888887 999999998875543332 445889999999999888899999999999999999999999
Q ss_pred cCcEecCCCCCcEEeccCCCCCcEEEe--ecCCcccccCCcceecccCcccccchHHHhhc---CCCcchHHHHHHHHHH
Q 016233 199 MGVMHRDLKPENFLLSSKDENALLKAT--DFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR---YGKEIDIWSAGVILYI 273 (393)
Q Consensus 199 ~~ivH~Dikp~Nill~~~~~~~~~kl~--DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~DiwSlG~il~~ 273 (393)
....|.-+...-..-...+..+.+.+. ||+.+.............-+..+.++|..... .....|+|.+|..+..
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 855554443332111112344455555 88888777665554455556678888877544 3344699999999999
Q ss_pred HhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 274 LLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 274 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+..|..+-... .....++. ........+++.+|+.-++++|+++.+++.|+|.+..
T Consensus 385 ~~~~~~i~~~~---~~~~~~l~----------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 385 LSQGEDISEKS---AVPVSLLD----------VLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhcCcccccc---cchhhhhc----------cccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 98876542111 01111111 0111268899999999999999999999999998643
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.58 E-value=6.9e-07 Score=80.40 Aligned_cols=75 Identities=15% Similarity=0.155 Sum_probs=55.2
Q ss_pred ecccCC-eEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCCC
Q 016233 87 LGRGQF-GVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGG 165 (393)
Q Consensus 87 lg~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~gg 165 (393)
|..|.. +.||++... +..+.+|+..... ...+.+|+++++.+..+--+++++++....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 445555 789998754 4688888764321 3457789999999976656778888887777789999999997
Q ss_pred ChHH
Q 016233 166 ELFD 169 (393)
Q Consensus 166 ~L~~ 169 (393)
++..
T Consensus 78 ~l~~ 81 (244)
T cd05150 78 PAAA 81 (244)
T ss_pred cHhH
Confidence 7653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.57 E-value=7.4e-07 Score=78.01 Aligned_cols=142 Identities=17% Similarity=0.171 Sum_probs=94.9
Q ss_pred eecccCCeEEEEEEECCCCcEEEEEEeecCccCC----------------cccHH-----HHHHHHHHHHHcc-CCCCee
Q 016233 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT----------------KNDKD-----DIKREIQIMQHLS-GQPNIV 143 (393)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------------~~~~~-----~~~~E~~~l~~l~-~h~niv 143 (393)
.|..|--+.||+|.. .++..+|+|++......- ..... -..+|..-|+++. .+-.++
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 566777779999885 458899999987543210 01111 1356888888875 123455
Q ss_pred EEeEEEEeCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCCCCCcEEeccCCCCCcE
Q 016233 144 EFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALL 222 (393)
Q Consensus 144 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~-~~ivH~Dikp~Nill~~~~~~~~~ 222 (393)
+-+.+.. ..|||||+.....-.-..+.-.+...++..+..+++..+.-|-. .++||+||..=|||+. .+.+
T Consensus 134 ~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~----~~~p 205 (268)
T COG1718 134 EPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH----DGEP 205 (268)
T ss_pred CceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE----CCeE
Confidence 5555543 36999999543111111111234444788889999999988776 9999999999999994 4558
Q ss_pred EEeecCCcccccCC
Q 016233 223 KATDFGLSVFIEEG 236 (393)
Q Consensus 223 kl~DFg~a~~~~~~ 236 (393)
.|+|||-|.....+
T Consensus 206 ~iID~~QaV~~~hp 219 (268)
T COG1718 206 YIIDVSQAVTIDHP 219 (268)
T ss_pred EEEECccccccCCC
Confidence 89999998876543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.49 E-value=6.8e-06 Score=70.93 Aligned_cols=137 Identities=20% Similarity=0.269 Sum_probs=96.5
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCcc-------------CCcccHHHHHHHHHHHHHcc-----CCCCeeEEe
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKL-------------VTKNDKDDIKREIQIMQHLS-----GQPNIVEFK 146 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~~~E~~~l~~l~-----~h~niv~~~ 146 (393)
..||+|+.-.||. |.. .....||+...... .......+..+|+.....+. .+.+|.+++
T Consensus 7 ~~i~~G~~R~cy~--HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEE--CCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 4699999999995 443 34567898865540 11223566777777766663 367899999
Q ss_pred EEEEeCCeEEEEEeccCC------CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCC
Q 016233 147 GAYEDKQSVHVVMELCAG------GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA 220 (393)
Q Consensus 147 ~~~~~~~~~~lv~e~~~g------g~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~ 220 (393)
|+.+.+....+|+|.+.+ .+|.+++.+ +.+++ . +...+-+-..||-+++|+.+|++|.||++...++..
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999999999998743 257777743 34655 3 334444556788899999999999999998665555
Q ss_pred -cEEEee-cCC
Q 016233 221 -LLKATD-FGL 229 (393)
Q Consensus 221 -~~kl~D-Fg~ 229 (393)
.+.|+| ||-
T Consensus 159 ~~lvlIDG~G~ 169 (199)
T PF10707_consen 159 FRLVLIDGLGE 169 (199)
T ss_pred eEEEEEeCCCC
Confidence 677777 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.5e-06 Score=75.84 Aligned_cols=79 Identities=16% Similarity=0.189 Sum_probs=57.1
Q ss_pred cceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCC-CCeeEEeEEEE---eCCeEEEEE
Q 016233 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ-PNIVEFKGAYE---DKQSVHVVM 159 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~~---~~~~~~lv~ 159 (393)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.|..+ ..+.+++.+.. .....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 3578999999999999775 59999986422 3467788999999998733 23567776443 334578999
Q ss_pred eccCCCChHH
Q 016233 160 ELCAGGELFD 169 (393)
Q Consensus 160 e~~~gg~L~~ 169 (393)
++++|..+..
T Consensus 75 ~~i~g~~~~~ 84 (239)
T PF01636_consen 75 EYIPGRPLDD 84 (239)
T ss_dssp EEESSEEHHH
T ss_pred EEeccccccc
Confidence 9999987766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.3e-06 Score=90.27 Aligned_cols=81 Identities=20% Similarity=0.340 Sum_probs=58.0
Q ss_pred cceecccCCeEEEEEEECCCC--cEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCe--eEEeEEEEeC---CeEE
Q 016233 84 GKELGRGQFGVTYLCTENSTG--RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNI--VEFKGAYEDK---QSVH 156 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni--v~~~~~~~~~---~~~~ 156 (393)
.+.|+.|.++.+|+......+ ..+++|+...... ......+.+|+++|+.|..|.+| ++++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~--~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL--LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc--CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 466899999999998765432 4678886643321 12345788999999999645554 7788877664 4678
Q ss_pred EEEeccCCCC
Q 016233 157 VVMELCAGGE 166 (393)
Q Consensus 157 lv~e~~~gg~ 166 (393)
+||||++|..
T Consensus 121 lVME~v~G~~ 130 (822)
T PLN02876 121 YIMEYLEGRI 130 (822)
T ss_pred EEEEecCCcc
Confidence 9999998864
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.7e-06 Score=84.76 Aligned_cols=144 Identities=15% Similarity=0.177 Sum_probs=90.2
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccC--------------------C--------cccHH------HHHHHH
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLV--------------------T--------KNDKD------DIKREI 130 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------------~--------~~~~~------~~~~E~ 130 (393)
+.||.-+.|+|++|+.+. |+.||||+-+..-.. . +.-.+ ++.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 569999999999999886 999999985432110 0 00011 123344
Q ss_pred HHHHHcc---CCCC------eeEEeEEEEeCCeEEEEEeccCCCChHH--HHHHcCCCCHHHHHHHHHHHHHH-HHHHHH
Q 016233 131 QIMQHLS---GQPN------IVEFKGAYEDKQSVHVVMELCAGGELFD--RIIAKGHYSERAAASICRSIVNV-VHICHF 198 (393)
Q Consensus 131 ~~l~~l~---~h~n------iv~~~~~~~~~~~~~lv~e~~~gg~L~~--~l~~~~~~~~~~~~~i~~qll~~-l~~lH~ 198 (393)
+-..+++ .|-+ |++++-.+. ....|+||||+|..+.| .|.+. .++...+. ..+.++ ++-+=.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~---~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKR-GISPHDIL---NKLVEAYLEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHc-CCCHHHHH---HHHHHHHHHHHHh
Confidence 3333322 1333 445544333 34689999999987654 44443 45555333 333332 222345
Q ss_pred cCcEecCCCCCcEEeccC-CCCCcEEEeecCCcccccC
Q 016233 199 MGVMHRDLKPENFLLSSK-DENALLKATDFGLSVFIEE 235 (393)
Q Consensus 199 ~~ivH~Dikp~Nill~~~-~~~~~~kl~DFg~a~~~~~ 235 (393)
.|++|+|-+|.||++.++ ..+..+.+-|||+...+..
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 789999999999999754 3566789999999987754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.25 E-value=6.9e-06 Score=73.45 Aligned_cols=73 Identities=15% Similarity=0.155 Sum_probs=47.1
Q ss_pred ceecccCCe-EEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCC--CCeeEEeEEEEeC---CeEEEE
Q 016233 85 KELGRGQFG-VTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ--PNIVEFKGAYEDK---QSVHVV 158 (393)
Q Consensus 85 ~~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~---~~~~lv 158 (393)
+.|+.|+.. .||+. +..+++|+.... .....+.+|.++++.|..+ -.+.++++..... ...++|
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 457766666 58975 235778865421 2345789999999998633 1345555544332 235889
Q ss_pred EeccCCCCh
Q 016233 159 MELCAGGEL 167 (393)
Q Consensus 159 ~e~~~gg~L 167 (393)
|++++|.++
T Consensus 73 ~~~i~G~~l 81 (235)
T cd05155 73 YRWLEGETA 81 (235)
T ss_pred EEeecCCCC
Confidence 999999665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.13 E-value=6.4e-05 Score=71.90 Aligned_cols=80 Identities=13% Similarity=0.140 Sum_probs=56.2
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCcc---CC-cccHHHHHHHHHHHHHccCC--CCeeEEeEEEEeCCeEEEE
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKL---VT-KNDKDDIKREIQIMQHLSGQ--PNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~-~~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~~~~~lv 158 (393)
+.||.|.+..||++.....++.++||.-..... .. ....++...|.+.|+.+..+ .++++++.+- .+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence 569999999999999864446899997532110 01 23466778889988887533 4678887773 3556899
Q ss_pred EeccCCCC
Q 016233 159 MELCAGGE 166 (393)
Q Consensus 159 ~e~~~gg~ 166 (393)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998744
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.08 E-value=4.2e-05 Score=68.32 Aligned_cols=75 Identities=15% Similarity=0.191 Sum_probs=50.1
Q ss_pred ceecccCCeEEEEEEECC-CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccC
Q 016233 85 KELGRGQFGVTYLCTENS-TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCA 163 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 163 (393)
+.|..|-...+|++.... .++.|++|+..... . ..-...+|+.+++.+..+.-.++++.... + .+||||++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~---~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~ 75 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT---E-LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIP 75 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCc---c-ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeC
Confidence 567888888999987543 35789999765321 1 11234579999999864444556655443 2 47999999
Q ss_pred CCCh
Q 016233 164 GGEL 167 (393)
Q Consensus 164 gg~L 167 (393)
|.++
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 8765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.94 E-value=3.2e-06 Score=89.87 Aligned_cols=204 Identities=16% Similarity=0.064 Sum_probs=136.7
Q ss_pred HHHHHHHHHHccCCCCeeEEeEEEEeC--CeEEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc
Q 016233 126 IKREIQIMQHLSGQPNIVEFKGAYEDK--QSVHVVMELCAGGELFDRIIAK----GHYSERAAASICRSIVNVVHICHFM 199 (393)
Q Consensus 126 ~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qll~~l~~lH~~ 199 (393)
...|..-++... |+++.....-.... ...+.+++|+.+|.+++.|.+. ....+.-+.....+.+.+..-+|+.
T Consensus 1276 ll~e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 334444455565 88888776655432 3468899999999999988653 2233344444445547777777764
Q ss_pred C-----cEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-cceecccCcccccchHHHhh-cCCCcchHHHHHHHHH
Q 016233 200 G-----VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILY 272 (393)
Q Consensus 200 ~-----ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ 272 (393)
. .+|+++|+-|.+| ..+..+|+.++|+.+..... .......+++.|++|++.+. .++.++|+|..|+.+|
T Consensus 1355 tnlg~T~v~~~Lkf~lpmI---Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMI---VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred ccCCccchhhhhhhhccce---ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 2 7899999999999 56677999999999943332 23345678899999999876 5788899999999999
Q ss_pred HHhhCCCCCCCCChHHHHHHHHcCCCC----CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 016233 273 ILLSGVPPFWAETEKGIFDAILQGDID----FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (393)
Q Consensus 273 ~lltg~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 340 (393)
....|..+|. ...+.+.++... +.... ..|.++-.....+|-+.-..||.-...+.-+.|.
T Consensus 1432 ~rs~~n~~fi-----~flq~~Lkgiidn~tf~sIe~--l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1432 LRSDGNAYFI-----FFLQPALKGIIDNHTFFSIEK--LKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHhcccHHHH-----HHHHHHHcCcccccccccccc--cCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 9999988873 333333333221 11111 1233444445555556666788888888766654
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.93 E-value=9.1e-05 Score=68.56 Aligned_cols=145 Identities=19% Similarity=0.211 Sum_probs=99.9
Q ss_pred ecceecccCCeEEEEEEECCCCcEEEEEEeecCcc-------------------CCcccH----HHHHHHHHHHHHccCC
Q 016233 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL-------------------VTKNDK----DDIKREIQIMQHLSGQ 139 (393)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------------~~~~~~----~~~~~E~~~l~~l~~h 139 (393)
+...|..|--+.||.|.. .+|..+|||+++.+-+ +..+.+ --.+.|++-|+++. .
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~-~ 225 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN-N 225 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH-h
Confidence 445677888889999884 4688899999864322 111111 22467899999986 4
Q ss_pred CCeeEEeEEEEeCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHcCcEecCCCCCcEEeccCCC
Q 016233 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHIC-HFMGVMHRDLKPENFLLSSKDE 218 (393)
Q Consensus 140 ~niv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~l-H~~~ivH~Dikp~Nill~~~~~ 218 (393)
..|.----+.-. .-.|||+|+.+.....-..+...++...+..+-.|++..+.-| |..++||.||.-=|+|+ .
T Consensus 226 aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly----h 299 (520)
T KOG2270|consen 226 AGIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY----H 299 (520)
T ss_pred cCCCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE----E
Confidence 454432222222 2369999996443333333445688888999999998888776 45789999999999999 3
Q ss_pred CCcEEEeecCCcccccC
Q 016233 219 NALLKATDFGLSVFIEE 235 (393)
Q Consensus 219 ~~~~kl~DFg~a~~~~~ 235 (393)
.+.+.|+|.+-+.....
T Consensus 300 dG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEHDH 316 (520)
T ss_pred CCEEEEEEccccccCCC
Confidence 56789999998876543
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00013 Score=67.49 Aligned_cols=138 Identities=16% Similarity=0.202 Sum_probs=82.1
Q ss_pred cceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCC-CeeEEeE------EEEeCCeEE
Q 016233 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP-NIVEFKG------AYEDKQSVH 156 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~~------~~~~~~~~~ 156 (393)
.+.|..|....+|+.... +..+++|+... .....+..|++++..|..+- .+++++. +....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 445777887899987643 45789998743 23456778898888886321 2455443 223455678
Q ss_pred EEEeccCCCChHH--------------HHHHc-CCCCH--------H----HHH--------HHHHHHHHHHHHHHH---
Q 016233 157 VVMELCAGGELFD--------------RIIAK-GHYSE--------R----AAA--------SICRSIVNVVHICHF--- 198 (393)
Q Consensus 157 lv~e~~~gg~L~~--------------~l~~~-~~~~~--------~----~~~--------~i~~qll~~l~~lH~--- 198 (393)
+|++|++|..+.. .+... ..+.. . ... .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999865421 01110 00000 0 000 011112233444443
Q ss_pred ----cCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 199 ----MGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 199 ----~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
.+++|+|+.|.||+++ ++..+.|+||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFD---GDELSGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEe---CCceEEEeehhhhcC
Confidence 4699999999999994 445568999987653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.90 E-value=7.9e-05 Score=67.52 Aligned_cols=134 Identities=19% Similarity=0.146 Sum_probs=76.0
Q ss_pred eecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCCC
Q 016233 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGG 165 (393)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~gg 165 (393)
.+..|-.+.+|+.. .+++.+++|...... ....-...+|..+++.+..+.-..+++.... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~---~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVC---KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccc---ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 35567888999887 346788898754321 1111135779999999874422344444432 26899999986
Q ss_pred ChHH--------------HHHH---cC----CCCH-HHHHHHHHHH---------HHHHHHHHH--------cCcEecCC
Q 016233 166 ELFD--------------RIIA---KG----HYSE-RAAASICRSI---------VNVVHICHF--------MGVMHRDL 206 (393)
Q Consensus 166 ~L~~--------------~l~~---~~----~~~~-~~~~~i~~ql---------l~~l~~lH~--------~~ivH~Di 206 (393)
.+.. .+.+ .. .+.. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 5431 1111 10 1111 1122222222 111222211 24899999
Q ss_pred CCCcEEeccCCCCCcEEEeecCCccc
Q 016233 207 KPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 207 kp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
.|.||+++. ++ +.|+||+.+..
T Consensus 154 ~~~Nil~~~---~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTP---QG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeC---CC-CEEEeccccCc
Confidence 999999953 23 68999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.86 E-value=5.4e-05 Score=65.00 Aligned_cols=101 Identities=18% Similarity=0.223 Sum_probs=79.7
Q ss_pred HHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCCCChHH---HHHHcCCCCHHHHHHHHHHHHHHHHHHHH---cC
Q 016233 127 KREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD---RIIAKGHYSERAAASICRSIVNVVHICHF---MG 200 (393)
Q Consensus 127 ~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~gg~L~~---~l~~~~~~~~~~~~~i~~qll~~l~~lH~---~~ 200 (393)
..|.-+++.+.+.+++++++|++- .++|.||...+++.. .+......++.....|+.++++.+++++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458889999986689999999983 367899998776542 12222346889999999999999999987 44
Q ss_pred cEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 201 ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+.-.|++++|+-++ +++.+|++|...+....
T Consensus 83 ~~lcDv~~~nfgv~---~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVN---DDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEe---CCCcEEEEechhcchhH
Confidence 88899999999994 55669999998776543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.85 E-value=1.9e-05 Score=71.84 Aligned_cols=141 Identities=17% Similarity=0.186 Sum_probs=98.5
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCc-----------------cCCcccH--HHHHHHHHHHHHccCCC
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRK-----------------LVTKNDK--DDIKREIQIMQHLSGQP 140 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------------~~~~~~~--~~~~~E~~~l~~l~~h~ 140 (393)
-|.+++.||-|--+.||.+.+. .|++.++|+-.... ..++..+ -...+|...|+.|..|-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4678999999999999999876 47888888632111 0112222 23457899999986443
Q ss_pred -CeeEEeEEEEeCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCC
Q 016233 141 -NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDEN 219 (393)
Q Consensus 141 -niv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~ 219 (393)
-+++.+++ +.-++|||++.|-.|...- ....+..+...+..-+.-|-++|+||+|..-=||++. +.
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~---dd 238 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK---DD 238 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeee------ecCChHHHHHHHHHHHHHHHHcCceecccchheeEEe---cC
Confidence 34455544 3468999999998775421 1223456666777777888999999999999999995 45
Q ss_pred CcEEEeecCCccccc
Q 016233 220 ALLKATDFGLSVFIE 234 (393)
Q Consensus 220 ~~~kl~DFg~a~~~~ 234 (393)
..++++||--.....
T Consensus 239 ~~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 239 DKIVVIDFPQMVSTS 253 (465)
T ss_pred CCEEEeechHhhccC
Confidence 569999997655443
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.79 E-value=5.9e-05 Score=72.51 Aligned_cols=166 Identities=21% Similarity=0.211 Sum_probs=107.3
Q ss_pred HHHHHHHHHHHHHccCCCCeeEEeEEEEeC-CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 016233 123 KDDIKREIQIMQHLSGQPNIVEFKGAYEDK-QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGV 201 (393)
Q Consensus 123 ~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~i 201 (393)
..++.--..+++.+. |+|...++++-... ....+|+|++ +.+|.+.+.... +...... .+|+
T Consensus 26 s~~ilgr~~~lktl~-~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~ 88 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQ-HDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGV 88 (725)
T ss_pred HHHHhhhhHHHHhhc-CccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------cccc
Confidence 345666788899997 99999999987643 3578899999 669998876543 2211111 2222
Q ss_pred EecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcceecccCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCCC
Q 016233 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPF 281 (393)
Q Consensus 202 vH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf 281 (393)
.|- || ++++| -++. .. ... .++++||||+|.++.++.-|...+
T Consensus 89 ~~~-----~~----------~~~td-~~~t---~~---~~~---------------~~pKsdVwsl~~i~~el~L~~~l~ 131 (725)
T KOG1093|consen 89 LHL-----NI----------IYITD-HFLT---KY---PSP---------------IGPKSDVWSLGFIILELYLGISLE 131 (725)
T ss_pred cee-----hh----------hhccc-cccc---cC---CCC---------------CCcchhhhhHHHHHHHHHHhhHHH
Confidence 222 22 22233 0000 00 111 124999999999999999998888
Q ss_pred CCCChHHHHHHHHcCCCCCCCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 282 WAETEKGIFDAILQGDIDFESA--------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 282 ~~~~~~~~~~~i~~~~~~~~~~--------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
......+....+..-....... ..-.++....++..+|+-..|..||...++.+++.|.+.
T Consensus 132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 7666665555554322110000 001245667899999999999999999999999999865
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00026 Score=65.84 Aligned_cols=76 Identities=14% Similarity=0.164 Sum_probs=50.2
Q ss_pred ceecccCCeEEEEEEECC------CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 85 KELGRGQFGVTYLCTENS------TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
+.|..|-...||++.... +++.+++|+..... .......+|.++++.+..+--..+++.++.. .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence 456677777899887543 25789999864321 1234567899999988744334556665542 368
Q ss_pred EeccCCCChH
Q 016233 159 MELCAGGELF 168 (393)
Q Consensus 159 ~e~~~gg~L~ 168 (393)
+||++|..+.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 9999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00057 Score=64.12 Aligned_cols=78 Identities=15% Similarity=0.113 Sum_probs=50.9
Q ss_pred eecccCCeEEEEEEECCCCcEEEEEEeecCcc----CCcccHHHHHHHHHHHHHccCC-C-CeeEEeEEEEeCCeEEEEE
Q 016233 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKL----VTKNDKDDIKREIQIMQHLSGQ-P-NIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~E~~~l~~l~~h-~-niv~~~~~~~~~~~~~lv~ 159 (393)
.||.|....||++.+...++.++||.-..-.- .-+...++..-|...|+..... | .+++++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 58999999999999764446899997532111 1133456666788888876532 3 45565444 344556899
Q ss_pred eccCCC
Q 016233 160 ELCAGG 165 (393)
Q Consensus 160 e~~~gg 165 (393)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00071 Score=63.07 Aligned_cols=138 Identities=17% Similarity=0.210 Sum_probs=79.8
Q ss_pred cceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCC-CCeeEEeEE------EEeCCeEE
Q 016233 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ-PNIVEFKGA------YEDKQSVH 156 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~~------~~~~~~~~ 156 (393)
.+.++.|....+|++... +..+++|+..... ....+..|++++..|..+ -.+++++.. ....+..+
T Consensus 27 i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD--VGRYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ccccCCccccceEEEEeC--CCcEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 455777877899987643 4468889765321 244566788888887522 124444432 12345678
Q ss_pred EEEeccCCCChH-----------HH---HHHc-CCC--------CHHHHH---------------HHHHHHHHHHHHHHH
Q 016233 157 VVMELCAGGELF-----------DR---IIAK-GHY--------SERAAA---------------SICRSIVNVVHICHF 198 (393)
Q Consensus 157 lv~e~~~gg~L~-----------~~---l~~~-~~~--------~~~~~~---------------~i~~qll~~l~~lH~ 198 (393)
+++||++|.++. .. +... ..+ ...... .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999885431 11 1110 011 000000 001122334555532
Q ss_pred -------cCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 199 -------MGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 199 -------~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
.+++|+|+.+.||+++ .+....|+||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFD---GDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEE---CCceEEEeeccccc
Confidence 5799999999999995 34456899999775
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0019 Score=60.51 Aligned_cols=74 Identities=15% Similarity=0.168 Sum_probs=45.8
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCC-CCeeEEeE------EEEeCCeEEE
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ-PNIVEFKG------AYEDKQSVHV 157 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~------~~~~~~~~~l 157 (393)
+.|+.|....+|..... +..+++|++. . ...+.+..|+.+++.|..+ -.+++++. +....+..++
T Consensus 28 ~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~-----~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~ 99 (319)
T PRK05231 28 KGIAEGIENSNFFLTTT--QGEYVLTLFE-R-----LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAA 99 (319)
T ss_pred chhccccccceEEEEeC--CCcEEEEEec-c-----CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEE
Confidence 45677777889988754 3478999875 1 1234555567777776421 12334332 2233566789
Q ss_pred EEeccCCCC
Q 016233 158 VMELCAGGE 166 (393)
Q Consensus 158 v~e~~~gg~ 166 (393)
++||++|..
T Consensus 100 l~~~l~G~~ 108 (319)
T PRK05231 100 IVTFLEGKW 108 (319)
T ss_pred EEEecCCCC
Confidence 999999864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0012 Score=61.08 Aligned_cols=104 Identities=8% Similarity=-0.002 Sum_probs=74.7
Q ss_pred cceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCC--CCeeEEeEEEEe---CCeEEEE
Q 016233 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ--PNIVEFKGAYED---KQSVHVV 158 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~---~~~~~lv 158 (393)
.+.||.|..+.||+.... +..+.+|..+. ......+..|...|+.|..+ -.++++++++.. .+..+||
T Consensus 19 ~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~-----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 19 VECISEQPYAALWALYDS--QGNPMPLMARS-----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred eeecCCccceeEEEEEcC--CCCEEEEEecc-----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 456999999999998643 23577787432 11346889999999999754 368888887754 3668999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~ 199 (393)
||+++|+++.+. .........+..+++.+|.-||+.
T Consensus 92 mE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 92 LERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred EeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 999999887651 123444566777788888888864
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0023 Score=60.60 Aligned_cols=139 Identities=13% Similarity=0.137 Sum_probs=80.4
Q ss_pred cceecccCCeEEEEEEECC----CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 84 GKELGRGQFGVTYLCTENS----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
++.|-.|-...+|++.... .++.|++|+..... .... ...+|..+++.+..+.--.++++.+... .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 3456568888999987432 34689999775431 2222 2367999999987544445666666432 589
Q ss_pred eccCCCChHHH--------------HH---HcC----C-CC-HHHHHHHHHHH-----------------HHHHHHHH--
Q 016233 160 ELCAGGELFDR--------------II---AKG----H-YS-ERAAASICRSI-----------------VNVVHICH-- 197 (393)
Q Consensus 160 e~~~gg~L~~~--------------l~---~~~----~-~~-~~~~~~i~~ql-----------------l~~l~~lH-- 197 (393)
||++|.++... +. ... . .. ...+..+..++ ...+..|.
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99987665311 11 100 0 11 12222222211 11122221
Q ss_pred ------HcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 198 ------FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 198 ------~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
...++|+|+++.|||+.. .+..+.++||..+..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~--~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDE--ETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeC--CCCcEEEEeehhccc
Confidence 225899999999999953 235699999988763
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0027 Score=60.43 Aligned_cols=80 Identities=18% Similarity=0.163 Sum_probs=53.2
Q ss_pred cceecccCCeEEEEEEECCCCcEEEEEEeecCc-c--CCcccHHHHHHHHHHHHHccCC-C-CeeEEeEEEEeCCeEEEE
Q 016233 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRK-L--VTKNDKDDIKREIQIMQHLSGQ-P-NIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~--~~~~~~~~~~~E~~~l~~l~~h-~-niv~~~~~~~~~~~~~lv 158 (393)
.+.||.|.-..||++.+...++.|+||.-..-. . .-....++..-|.++|+.+... | .+++++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 467899999999999985445789999743211 1 1134567777788888876532 3 46666544 34455789
Q ss_pred EeccCCC
Q 016233 159 MELCAGG 165 (393)
Q Consensus 159 ~e~~~gg 165 (393)
||+++..
T Consensus 112 MEdL~~~ 118 (409)
T PRK12396 112 MEDLSDH 118 (409)
T ss_pred HHhCccc
Confidence 9998653
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0024 Score=58.48 Aligned_cols=31 Identities=19% Similarity=0.346 Sum_probs=24.5
Q ss_pred CcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 200 ~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
.++|+|++|.|||++.+ ....-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~--~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDED--ARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCC--CCEEEEECcHhccc
Confidence 48999999999999531 34467999998765
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0035 Score=59.03 Aligned_cols=76 Identities=12% Similarity=0.133 Sum_probs=47.3
Q ss_pred cceecccCCeEEEEEEECCC---CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEe
Q 016233 84 GKELGRGQFGVTYLCTENST---GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 160 (393)
++.|..|-...+|++..... +..|++|+..... . ..-.-.+|..+++.+..+.--+++++++. .+ +|.+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~ 90 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---D-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQS 90 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc---C-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeeh
Confidence 34565577888998875432 3478999775321 1 22233578899999874433356666653 22 5899
Q ss_pred ccCCCCh
Q 016233 161 LCAGGEL 167 (393)
Q Consensus 161 ~~~gg~L 167 (393)
|++|.+|
T Consensus 91 fi~g~~l 97 (330)
T PLN02421 91 FINARTL 97 (330)
T ss_pred hhcCCCC
Confidence 9987654
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0073 Score=55.96 Aligned_cols=144 Identities=17% Similarity=0.202 Sum_probs=80.4
Q ss_pred cceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCC-CCeeEEeEEEEeCC--eEEEEEe
Q 016233 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ-PNIVEFKGAYEDKQ--SVHVVME 160 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~~~~~--~~~lv~e 160 (393)
.+.+-.|-.-.+|...+. ++.++++ .+. ............+|..+++.+... --+...++++.++. ..|.||+
T Consensus 30 v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred eeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 333433433455555544 7788888 332 112234566778899999998521 13334555555544 6799999
Q ss_pred ccCCCCh------------------HHHHHHc--------------CCCCHHHHHHHHHHH--------------HHHHH
Q 016233 161 LCAGGEL------------------FDRIIAK--------------GHYSERAAASICRSI--------------VNVVH 194 (393)
Q Consensus 161 ~~~gg~L------------------~~~l~~~--------------~~~~~~~~~~i~~ql--------------l~~l~ 194 (393)
|++|..+ .+.|..- +.+...+...+..+. ..-..
T Consensus 106 ~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~ 185 (321)
T COG3173 106 WVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK 185 (321)
T ss_pred EecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence 9988322 1111110 001111222222222 12245
Q ss_pred HHHHc--------CcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 195 ICHFM--------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 195 ~lH~~--------~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+++.+ .++|+|+.+.||++... ..+-|.||+++..-.
T Consensus 186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~---~~~gVlDwe~~~lGD 230 (321)
T COG3173 186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPG---RPTGVLDWELATLGD 230 (321)
T ss_pred HHHhcCCCcCCCceeeeCCcccCCEEEeCC---CeeEEEeccccccCC
Confidence 55443 48999999999999543 338889999987543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.025 Score=52.68 Aligned_cols=65 Identities=17% Similarity=0.143 Sum_probs=39.3
Q ss_pred EEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCC-CCeeEEeEE------EEeCCeEEEEEeccCCCC
Q 016233 94 VTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ-PNIVEFKGA------YEDKQSVHVVMELCAGGE 166 (393)
Q Consensus 94 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~~------~~~~~~~~lv~e~~~gg~ 166 (393)
.||++... +..+++|.+.. ....+..|+.++..|..+ -.+++++.. ...++..++|+||++|.+
T Consensus 11 ~v~~v~t~--~g~~~LK~~~~-------~~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~ 81 (313)
T TIGR02906 11 NVYKVETD--SGNKCLKKINY-------PPERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGRE 81 (313)
T ss_pred cEEEEEeC--CCCeEEEEcCC-------CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcC
Confidence 48887643 34688998742 124456677777777522 133444332 234567899999999854
Q ss_pred h
Q 016233 167 L 167 (393)
Q Consensus 167 L 167 (393)
+
T Consensus 82 ~ 82 (313)
T TIGR02906 82 C 82 (313)
T ss_pred C
Confidence 3
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.012 Score=56.50 Aligned_cols=77 Identities=17% Similarity=0.122 Sum_probs=48.2
Q ss_pred ecceecccCCeEEEEEEECCC-CcE-----EEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 83 FGKELGRGQFGVTYLCTENST-GRQ-----FACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~-~~~-----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
..+.|..|-...+|++..... +.. |.++.... .....-.-.+|+.+++.|..+..-.++++.+.. +
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----F 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence 345666688899999875432 222 44443211 111122335689999999866566677777753 5
Q ss_pred EEEeccCCCCh
Q 016233 157 VVMELCAGGEL 167 (393)
Q Consensus 157 lv~e~~~gg~L 167 (393)
+|.||++|.+|
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 89999998765
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.0074 Score=52.86 Aligned_cols=55 Identities=15% Similarity=0.090 Sum_probs=34.1
Q ss_pred CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCCCC
Q 016233 104 GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGE 166 (393)
Q Consensus 104 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~gg~ 166 (393)
++.|+||+.... ....-....|..+++.+..+-.-+++++++.+. +|.||++|.+
T Consensus 2 ~~~~~~Ri~g~~----t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~ 56 (211)
T PF01633_consen 2 PEKYLVRIPGEG----TENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRT 56 (211)
T ss_dssp TSEEEEEEEESC----GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE
T ss_pred CCEEEEEeCCCC----cccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccc
Confidence 467888887543 223456678999999887554556677765432 5779987654
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.015 Score=53.38 Aligned_cols=74 Identities=15% Similarity=0.204 Sum_probs=49.0
Q ss_pred cceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHcc--CCCCeeEEeEEEEeCCeEEEEEec
Q 016233 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--GQPNIVEFKGAYEDKQSVHVVMEL 161 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~~~~~lv~e~ 161 (393)
.+.++.|....+|+.. .+++.+.||+-. ......+..|+.-|+.|. .--.+++++.+....+.-||||||
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~------~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNS------ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEE------GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecC------hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence 4568889999999877 668899999764 223467888999888884 234688899998877777999999
Q ss_pred cCCC
Q 016233 162 CAGG 165 (393)
Q Consensus 162 ~~gg 165 (393)
++.+
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 9876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.14 Score=48.07 Aligned_cols=71 Identities=15% Similarity=0.132 Sum_probs=44.1
Q ss_pred CCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCC-CeeEEe---E--EEEeCCeEEEEEeccCC
Q 016233 91 QFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP-NIVEFK---G--AYEDKQSVHVVMELCAG 164 (393)
Q Consensus 91 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~---~--~~~~~~~~~lv~e~~~g 164 (393)
.-..||+.... ++..+++|+..... .....+..|+..+..|..+. .++... + ....++..+.|+++++|
T Consensus 37 ~eN~vy~v~~~-~~~~~vlKv~r~~~----~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 37 YENRVYQFGDE-DGRRVVAKFYRPER----WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred ccceEEEEecC-CCCEEEEEEcCccc----CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 44578987643 46689999874321 24677888998888876321 122211 1 22335677889999987
Q ss_pred CC
Q 016233 165 GE 166 (393)
Q Consensus 165 g~ 166 (393)
..
T Consensus 112 ~~ 113 (325)
T PRK11768 112 RA 113 (325)
T ss_pred CC
Confidence 53
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.017 Score=54.61 Aligned_cols=60 Identities=20% Similarity=0.206 Sum_probs=41.5
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHH-HHHHcCcEecCCCCCcEEecc
Q 016233 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH-ICHFMGVMHRDLKPENFLLSS 215 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~-~lH~~~ivH~Dikp~Nill~~ 215 (393)
..|+-+|..|.++..++... ..++.....++.-...|+- .+--.+++|.|+.|.||++..
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 45677888888887776543 3455455555555555543 344578999999999999964
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.098 Score=48.72 Aligned_cols=30 Identities=27% Similarity=0.308 Sum_probs=25.1
Q ss_pred CcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 200 ~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
+++|+|+.+.|||+ ++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLY---DETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEE---cCCCCEEEEEhhhccc
Confidence 79999999999999 4455688899987764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.14 Score=55.47 Aligned_cols=141 Identities=15% Similarity=0.230 Sum_probs=76.4
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCC-CC--eeEEeE--------EEEe-C
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ-PN--IVEFKG--------AYED-K 152 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~n--iv~~~~--------~~~~-~ 152 (393)
+.|+ |..-.+|+... .+|..+++|+.+... ....+..|..+|..|..+ +. +.+++- .... +
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~-----~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~ 103 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSE-----PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPD 103 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCcc-----chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCC
Confidence 3464 34577888764 357789999986431 334555566777666432 22 223221 1121 2
Q ss_pred C--eEEEEEeccCCCChHHH-----------------HHH----c------CCCCH-----------------HHHHHHH
Q 016233 153 Q--SVHVVMELCAGGELFDR-----------------IIA----K------GHYSE-----------------RAAASIC 186 (393)
Q Consensus 153 ~--~~~lv~e~~~gg~L~~~-----------------l~~----~------~~~~~-----------------~~~~~i~ 186 (393)
+ ..+-+++|++|..+.+. +.. . ..+.+ ...+.++
T Consensus 104 G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l 183 (1013)
T PRK06148 104 GEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALV 183 (1013)
T ss_pred CceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHH
Confidence 2 46778999999766430 110 0 00001 1112223
Q ss_pred HHHHHHHHH-----HH--HcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 187 RSIVNVVHI-----CH--FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 187 ~qll~~l~~-----lH--~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
.+++....- +. ..++||+|+.+.|||++.++.....-|+|||-+..
T Consensus 184 ~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 184 ERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 333332221 11 15799999999999996543223455999998764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.092 Score=49.18 Aligned_cols=103 Identities=17% Similarity=0.195 Sum_probs=66.4
Q ss_pred CCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 152 KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~-~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
..+.|++|++- |+.+. .+. .-...++..++++.+..+.-+..+ ..-|||+...|||| + .+.+.|+||-++
T Consensus 298 ~~y~yl~~kdh-gt~is-~ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI---d-~GnvtLIDfkls 368 (488)
T COG5072 298 TLYLYLHFKDH-GTPIS-IIK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI---D-EGNVTLIDFKLS 368 (488)
T ss_pred ceEEEEEEecC-Cceee-eee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee---e-cCceEEEEeeee
Confidence 34677888876 55553 222 235667888889888887777654 68999999999999 4 667999999999
Q ss_pred ccccCCcceecccCcccccchHHHhhcCCCcchHHHH
Q 016233 231 VFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSA 267 (393)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSl 267 (393)
+.-..+.. +-....--|-.+.|.-+..-+||-+
T Consensus 369 Rl~~~q~~----isy~rldhp~lF~G~dd~QFeIYrl 401 (488)
T COG5072 369 RLSYSQGI----ISYNRLDHPDLFNGVDDYQFEIYRL 401 (488)
T ss_pred ecccCCce----eeccccCchhhhcCccceeeeHHHH
Confidence 84322211 1111222344444444555666654
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.16 Score=49.71 Aligned_cols=77 Identities=10% Similarity=0.068 Sum_probs=47.9
Q ss_pred ecceecccCCeEEEEEEECCC--------CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 83 FGKELGRGQFGVTYLCTENST--------GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
-++.|..|-.-.+|++..... ++.|.+++.-... . ..-.-..|..+++.+..+--=.++++.+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e-~lIdR~~E~~v~~~ls~~gi~P~l~~~f~---- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---D-ELYNPISEFEVYKTMSKYRIAPQLLNTFS---- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---c-ceeCHHHHHHHHHHHHHCCCCCceEEEeC----
Confidence 445677788888999875422 5689999874321 1 12234568888888863322335666553
Q ss_pred EEEEEeccCCCCh
Q 016233 155 VHVVMELCAGGEL 167 (393)
Q Consensus 155 ~~lv~e~~~gg~L 167 (393)
-+.|.||++|.+|
T Consensus 181 gg~I~efi~g~~l 193 (442)
T PTZ00296 181 GGRIEEWLYGDPL 193 (442)
T ss_pred CCEEEEeeCCccC
Confidence 2467899988643
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.11 Score=45.34 Aligned_cols=116 Identities=14% Similarity=0.139 Sum_probs=72.8
Q ss_pred cCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCCCChHH
Q 016233 90 GQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD 169 (393)
Q Consensus 90 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~gg~L~~ 169 (393)
|+.++.-.+..+- .+..+|.+...... -....+.++.+++.+.. .|+++..- +.-.+.+++|+|-.....
T Consensus 73 ~gNsTl~~~kt~i--G~L~lKKi~slp~~--~~~~~y~nky~v~Armh---GilrL~ND--n~~~yGvIlE~Cy~~~i~- 142 (308)
T PF07387_consen 73 NGNSTLLIGKTKI--GPLFLKKIRSLPCC--INDALYFNKYRVFARMH---GILRLKND--NNYKYGVILERCYKIKIN- 142 (308)
T ss_pred CCceEEEEecccc--chhhhhhccCCCcc--cchhhhhhhhhHHHHhh---heeEeecC--CCceeEEEEeeccCcccc-
Confidence 3444444443332 34556666433322 13455678899999984 88888732 344578999999443211
Q ss_pred HHHHcCCCCHHHHHHHHHHHHHHHHHHHH--cCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 170 RIIAKGHYSERAAASICRSIVNVVHICHF--MGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 170 ~l~~~~~~~~~~~~~i~~qll~~l~~lH~--~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
+ ..++.-=+.+|.-.|+ .+.+|+|-.|+||+- |..+.+||.|=+..
T Consensus 143 --------~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~---D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 143 --------F----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMC---DKFGYLKLVDPVCL 190 (308)
T ss_pred --------h----hHHHHHhHHHHHHhhccCCCeecCCCChhheee---cCCCCEEecChhhh
Confidence 0 1111112456677784 469999999999999 77888999998754
|
The function of this family is unknown. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=93.71 E-value=0.64 Score=44.80 Aligned_cols=84 Identities=14% Similarity=0.097 Sum_probs=55.1
Q ss_pred cceecccCCeEEEEEEECCCCcEEEEEEeecCccCCc----ccHHHHHHHHHHHHHccCC--CCeeEEeEEEEeCCeEEE
Q 016233 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK----NDKDDIKREIQIMQHLSGQ--PNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~~~~~l 157 (393)
.+.||.|....||+..+. +..++||.-........ ....+-..|++.|+.+... .++++++.+.++. .++
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEE
Confidence 457899999999998864 45799997652211111 2344555567777776422 4788888887744 578
Q ss_pred EEeccCCC--ChHHHH
Q 016233 158 VMELCAGG--ELFDRI 171 (393)
Q Consensus 158 v~e~~~gg--~L~~~l 171 (393)
+||+++++ .+.+.+
T Consensus 113 vME~L~~~~~ilr~~L 128 (418)
T PLN02756 113 GMRYLEPPHIILRKGL 128 (418)
T ss_pred EEeecCCcceehhhhh
Confidence 89999873 344444
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.28 E-value=1.3 Score=39.03 Aligned_cols=73 Identities=12% Similarity=0.179 Sum_probs=48.1
Q ss_pred ecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHcc--CCCCeeEEeEEEEeCCeEEEEEeccCC
Q 016233 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--GQPNIVEFKGAYEDKQSVHVVMELCAG 164 (393)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~~~~~lv~e~~~g 164 (393)
+.-|.--..|...+. ..++-||.=. ......+..|+.-|+.+. +.-++.+++.+..+.++.|+||||++-
T Consensus 24 v~gG~inea~~v~dg--~~~~FvK~n~------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~ 95 (286)
T COG3001 24 VSGGDINEAWRLRDG--TDPFFVKCNQ------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT 95 (286)
T ss_pred cCCccccceeEeecC--CcceEEEecc------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence 433433344444332 3578888532 234567778887777665 234688899999999999999999987
Q ss_pred CCh
Q 016233 165 GEL 167 (393)
Q Consensus 165 g~L 167 (393)
+.+
T Consensus 96 ~~~ 98 (286)
T COG3001 96 GPL 98 (286)
T ss_pred CCC
Confidence 544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 393 | ||||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-64 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-64 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-64 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-63 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-63 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-62 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-61 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-60 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-60 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-60 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-60 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-59 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-59 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-59 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-59 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-59 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-59 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-59 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-59 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-58 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-58 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-58 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-57 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-57 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-57 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-55 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-55 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-55 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-55 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-54 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-54 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-54 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-53 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-53 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-53 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-53 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-53 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-53 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-53 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-53 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-53 | ||
| 2jam_B | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-53 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-53 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-53 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-52 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-52 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-52 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-52 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-52 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-49 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-49 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-49 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-48 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-47 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-47 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-47 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-47 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-47 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-47 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-47 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-46 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-46 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-46 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-46 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-46 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-46 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-46 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-46 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-46 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-43 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-43 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-43 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-42 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-42 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-42 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-42 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-42 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-42 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-41 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-40 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-40 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-40 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-40 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-40 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-40 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-40 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-40 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-40 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-40 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-40 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-40 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-40 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-40 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-39 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-39 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-39 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-39 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-38 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-38 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-38 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-38 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-38 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-38 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-38 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-37 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-37 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-37 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-37 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-37 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-37 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-37 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-37 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-37 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-37 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-37 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-37 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-37 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-37 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-37 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-37 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-37 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-37 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-37 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-37 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-37 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-37 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-37 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-37 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-37 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-37 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-37 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-37 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-36 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-36 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-36 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-36 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-36 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-36 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-36 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-36 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-36 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-36 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-36 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-36 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-36 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-36 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-36 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 9e-36 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-36 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-35 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-35 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-35 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-34 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-34 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-34 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-34 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-34 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-34 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-34 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-34 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-34 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-34 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-34 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-34 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-34 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-34 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-34 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-34 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-34 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-34 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-34 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-34 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-34 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-34 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-33 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-33 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-33 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-33 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-33 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-33 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-33 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-33 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-33 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-33 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-33 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-33 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-33 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-33 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-33 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-33 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-33 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-33 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-33 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-33 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-32 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-32 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-32 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-32 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-32 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-32 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-32 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-32 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-32 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-32 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-32 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-32 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-32 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-32 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-32 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-32 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-32 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-32 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-32 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-32 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-32 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-32 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-32 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-32 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-32 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-32 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-32 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-32 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-32 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-32 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-32 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-32 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-32 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-32 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-32 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-32 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-32 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-31 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-31 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-31 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-31 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-31 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-31 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-31 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-31 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-31 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-31 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-31 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-31 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-31 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-31 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-31 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-31 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-31 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-30 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-30 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-30 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-30 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-30 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-30 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-30 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-30 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-30 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-30 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-30 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-30 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-29 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-29 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-29 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-29 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-28 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-28 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-28 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-28 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-28 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-28 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-28 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-28 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-28 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-28 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-28 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-28 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-28 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-28 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-28 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-28 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-28 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-28 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-28 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-28 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-28 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-28 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-28 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-28 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-28 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-28 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-28 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-28 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-28 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-28 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-28 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-27 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-27 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-27 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-27 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-27 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-27 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-25 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-25 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-25 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-25 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-25 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-25 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-25 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-25 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-25 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-25 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-24 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-24 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-24 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-24 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-24 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-24 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-23 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-23 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-23 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-23 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-23 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-23 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-23 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-23 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-23 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-23 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-23 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-23 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-23 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-23 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-23 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-23 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-23 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-23 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-23 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-23 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-23 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-23 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-23 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-23 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-22 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-22 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-22 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-22 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-22 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-22 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-22 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-22 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-22 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-22 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-22 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-22 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-22 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-22 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-22 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 9e-22 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-21 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-21 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-21 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-21 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-21 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-21 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-21 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-21 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-21 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-20 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-20 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-20 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-20 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-20 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-20 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-20 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-20 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-20 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-20 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-20 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-20 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-20 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-20 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-20 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-20 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-20 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-20 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-20 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-20 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-20 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-20 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-20 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-20 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-20 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-20 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-20 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-20 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-19 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-19 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-18 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-18 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-18 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-18 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-18 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-18 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-17 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-17 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-17 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-17 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-17 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-17 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-17 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-17 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-17 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-17 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-17 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-17 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-17 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-17 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-16 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-16 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-16 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-16 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-16 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-16 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-16 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-16 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-16 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-16 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-16 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-16 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-16 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-16 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-16 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-16 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-16 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-16 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-16 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-16 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-16 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-16 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-16 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-16 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-16 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-16 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-16 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-16 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-16 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-16 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-16 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-16 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-16 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-16 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-16 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-15 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-15 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-15 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-15 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-15 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-15 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-15 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-15 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-15 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-15 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-15 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-15 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-15 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-15 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-15 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-15 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-15 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-15 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-15 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-15 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-15 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-15 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-15 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 6e-15 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-15 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-15 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-15 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-15 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-15 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-15 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-15 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-15 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-15 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-15 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-15 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-15 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-15 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-15 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-14 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-14 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-14 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-14 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-14 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 5e-14 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-14 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-14 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-14 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-14 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-14 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 8e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-13 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-13 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-13 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-12 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 6e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-11 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-11 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-11 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-11 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-11 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-11 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-11 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-11 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 5e-11 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 5e-11 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-11 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-11 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-11 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-11 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 7e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-11 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 7e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-11 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 7e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-10 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-09 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 6e-09 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 6e-09 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 6e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-08 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 3e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-08 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 3e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-08 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-08 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-08 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 3e-07 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-07 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-07 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 4e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-07 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-07 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-06 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-06 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-06 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-05 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-05 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-05 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-05 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-05 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 4e-05 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-05 |
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 542 bits (1398), Expect = 0.0
Identities = 118/337 (35%), Positives = 181/337 (53%), Gaps = 8/337 (2%)
Query: 46 GPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGR 105
GP A+ + + +Y +ELG+G F V C +TG
Sbjct: 1 GPHMASMTGGQ-----QMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGL 55
Query: 106 QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGG 165
+FA K I+ +KL + D ++RE +I + L PNIV + +++ ++V +L GG
Sbjct: 56 EFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGG 113
Query: 166 ELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225
ELF+ I+A+ YSE A+ + I+ + CH G++HR+LKPEN LL+SK + A +K
Sbjct: 114 ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 173
Query: 226 DFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAE 284
DFGL++ + + + + G+ Y++PEVL++ Y K +DIW+ GVILYILL G PPFW E
Sbjct: 174 DFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233
Query: 285 TEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344
+ ++ I G D+ S W T++ AK L+ MLT +PKKRIT+ Q L+ PWI
Sbjct: 234 DQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 293
Query: 345 ASDKPIDSAVLSRMKQFRAMNKLKKLALKVSLIKYML 381
+ + +K+F A KLK L + L
Sbjct: 294 VASAIHRQDTVDCLKKFNARRKLKGAILTTMIATRNL 330
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 536 bits (1384), Expect = 0.0
Identities = 120/309 (38%), Positives = 179/309 (57%), Gaps = 4/309 (1%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
Y +ELG+G F V C + G+++A I+ +KL + D ++RE +I +
Sbjct: 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICR 65
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
L PNIV + ++ +++ +L GGELF+ I+A+ +YSE A+ + I+ V
Sbjct: 66 LLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL 124
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIVGSAYYVAPEV 253
CH MGV+HR+LKPEN LL+SK + A +K DFGL++ +E E + + G+ Y++PEV
Sbjct: 125 HCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184
Query: 254 LRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312
LR+ YGK +D+W+ GVILYILL G PPFW E + ++ I G DF S W T++ A
Sbjct: 185 LRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLAL 372
KDL+ +MLT +P KRIT+A+ L+HPWI + + +K+F A KLK L
Sbjct: 245 KDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAIL 304
Query: 373 KVSLIKYML 381
V L
Sbjct: 305 TVMLATRNF 313
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 537 bits (1385), Expect = 0.0
Identities = 127/325 (39%), Positives = 184/325 (56%), Gaps = 6/325 (1%)
Query: 53 PVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSI 112
P S + P + Y + LG+G FG LC + TG++ A K I
Sbjct: 2 PGSMMDHLHATPGM--FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI 59
Query: 113 SKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRII 172
SKR++ K DK+ + RE+Q+++ L PNI++ +EDK ++V E+ GGELFD II
Sbjct: 60 SKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII 118
Query: 173 AKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232
++ +SE AA I R +++ + H ++HRDLKPEN LL SK ++A ++ DFGLS
Sbjct: 119 SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178
Query: 233 IEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDA 292
E K +D +G+AYY+APEVL Y ++ D+WS GVILYILLSG PPF E I
Sbjct: 179 FEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKK 238
Query: 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK---EGGEASDKP 349
+ +G FE W +S SAKDL+R+MLT P RI++ L+H WI+ + + D P
Sbjct: 239 VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 298
Query: 350 IDSAVLSRMKQFRAMNKLKKLALKV 374
+ ++QF+ KL + AL
Sbjct: 299 SLDNAILNIRQFQGTQKLAQAALLY 323
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 529 bits (1364), Expect = 0.0
Identities = 124/352 (35%), Positives = 187/352 (53%), Gaps = 13/352 (3%)
Query: 31 PAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRG 90
+ + + + A+ G VP I G + + + ELGRG
Sbjct: 8 SSGVDLGTENLYFQSMSSVTASAAPGTASLVPD---YWIDGSNRDALSDFFEVESELGRG 64
Query: 91 QFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150
+ Y C + T + +A K + K DK ++ EI ++ LS PNI++ K +E
Sbjct: 65 ATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFE 118
Query: 151 DKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210
+ +V+EL GGELFDRI+ KG+YSER AA + I+ V H G++HRDLKPEN
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPEN 178
Query: 211 FLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGV 269
L ++ +A LK DFGLS +E + + + G+ Y APE+LR YG E+D+WS G+
Sbjct: 179 LLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238
Query: 270 ILYILLSGVPPFWAET-EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRI 328
I YILL G PF+ E ++ +F IL + F S W +S +AKDLVR+++ DPKKR+
Sbjct: 239 ITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRL 298
Query: 329 TSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVSLIKYM 380
T+ Q L+HPW+ G+A++ ++++F A KLK V +
Sbjct: 299 TTFQALQHPWVT--GKAANFVHMDTAQKKLQEFNARRKLKAAVKAVVASSRL 348
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 534 bits (1377), Expect = 0.0
Identities = 126/304 (41%), Positives = 178/304 (58%), Gaps = 6/304 (1%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
Y+ LG+G FG C + T +++A K I+K K D I RE+++++
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLK 76
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
L PNI++ ED S ++V EL GGELFD II + +SE AA I + + + +
Sbjct: 77 KLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL 254
H ++HRDLKPEN LL SK+++ +K DFGLS ++ +D +G+AYY+APEVL
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 255 RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314
R Y ++ D+WSAGVILYILLSG PPF+ + E I + G F+ W TIS AKD
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWIK----EGGEASDKPIDSAVLSRMKQFRAMNKLKKL 370
L+R+MLT P RIT+ Q LEHPWI+ E SD P + ++ ++QF+A KL +
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQA 315
Query: 371 ALKV 374
AL
Sbjct: 316 ALLY 319
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 534 bits (1377), Expect = 0.0
Identities = 113/349 (32%), Positives = 177/349 (50%), Gaps = 21/349 (6%)
Query: 39 HHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLC 98
HH G + + K + Y ++LG G +G LC
Sbjct: 3 HHHHHSSGRENLYFQGIAINP-------GMYVRKKEGKIGESYFKVRKLGSGAYGEVLLC 55
Query: 99 TENSTGRQFACKSISKRKLVT----------KNDKDDIKREIQIMQHLSGQPNIVEFKGA 148
E + + A K I K + + ++I EI +++ L PNI++
Sbjct: 56 KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNIIKLFDV 114
Query: 149 YEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKP 208
+EDK+ ++V E GGELF++II + + E AA+I + I++ + H ++HRD+KP
Sbjct: 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKP 174
Query: 209 ENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAG 268
EN LL +K+ +K DFGLS F + RD +G+AYY+APEVL+++Y ++ D+WS G
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCG 234
Query: 269 VILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRI 328
VI+YILL G PPF + ++ I + +G F+ W IS AK+L++ MLT D KR
Sbjct: 235 VIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC 294
Query: 329 TSAQVLEHPWIKEG---GEASDKPIDSAVLSRMKQFRAMNKLKKLALKV 374
T+ + L WIK+ SD+ LS M++F KL + A+
Sbjct: 295 TAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILF 343
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 526 bits (1358), Expect = 0.0
Identities = 115/322 (35%), Positives = 168/322 (52%), Gaps = 12/322 (3%)
Query: 63 RPDTNTILGKPYEDVKL--HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK 120
IL +DV Y + +G+G F V C TG+QFA K + K +
Sbjct: 6 SGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSS 65
Query: 121 N--DKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH-- 176
+D+KRE I L P+IVE Y +++V E G +L I+ +
Sbjct: 66 PGLSTEDLKREASICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAG 124
Query: 177 --YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV-FI 233
YSE A+ R I+ + CH ++HRD+KP LL+SK+ +A +K FG+++
Sbjct: 125 FVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184
Query: 234 EEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDA 292
E G V VG+ +++APEV++R YGK +D+W GVIL+ILLSG PF+ E+ +F+
Sbjct: 185 ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEG 243
Query: 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDS 352
I++G W IS SAKDLVRRML DP +RIT + L HPW+KE + K
Sbjct: 244 IIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLP 303
Query: 353 AVLSRMKQFRAMNKLKKLALKV 374
+ ++++F A KLK L
Sbjct: 304 ETVEQLRKFNARRKLKGAVLAA 325
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 528 bits (1362), Expect = 0.0
Identities = 120/340 (35%), Positives = 188/340 (55%), Gaps = 11/340 (3%)
Query: 39 HHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLC 98
HH L+ + + Y K+LG G +G LC
Sbjct: 2 HHHHHHSSGRENLYFQGDLQ-----ATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLC 56
Query: 99 TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158
+ T + A K I K + + + + E+ +++ L PNI++ +EDK++ ++V
Sbjct: 57 RDKVTHVERAIKIIRKTSV-STSSNSKLLEEVAVLKLLD-HPNIMKLYDFFEDKRNYYLV 114
Query: 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE 218
ME GGELFD II + ++E AA I + +++ V H ++HRDLKPEN LL SK++
Sbjct: 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEK 174
Query: 219 NALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGV 278
+AL+K DFGLS E K ++ +G+AYY+APEVLR++Y ++ D+WS GVIL+ILL+G
Sbjct: 175 DALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGY 234
Query: 279 PPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
PPF +T++ I + +G F+S W +S AKDL+++ML D ++RI++ Q LEHPW
Sbjct: 235 PPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294
Query: 339 IKEGGEAS----DKPIDSAVLSRMKQFRAMNKLKKLALKV 374
IKE + P + + M++F+ KL + AL
Sbjct: 295 IKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLY 334
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 517 bits (1335), Expect = 0.0
Identities = 90/338 (26%), Positives = 160/338 (47%), Gaps = 20/338 (5%)
Query: 39 HHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSF-GKELGRGQFGVTYL 97
HH T + + E+ Y KELGRG+F V
Sbjct: 2 HHHHHHSSGVDLG--------------TENLYFQSMENFNNFYILTSKELGRGKFAVVRQ 47
Query: 98 CTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157
C STG+++A K + KR+ ++ + +I EI +++ P ++ YE+ + +
Sbjct: 48 CISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106
Query: 158 VMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSS 215
++E AGGE+F + + SE + + I+ V+ H ++H DLKP+N LLSS
Sbjct: 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSS 166
Query: 216 KDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYIL 274
+K DFG+S I R+I+G+ Y+APE+L D+W+ G+I Y+L
Sbjct: 167 IYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYML 226
Query: 275 LSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVL 334
L+ PF E + + I Q ++D+ + ++S A D ++ +L ++P+KR T+ L
Sbjct: 227 LTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICL 286
Query: 335 EHPWIKEGG-EASDKPIDSAVLSRMKQFRAMNKLKKLA 371
H W+++ E P +++ S+ + + K +
Sbjct: 287 SHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSEDKTS 324
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 509 bits (1313), Expect = 0.0
Identities = 116/305 (38%), Positives = 170/305 (55%), Gaps = 13/305 (4%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN---DKDDIKREIQ 131
E+V +Y G+ELG GQF V C E STG Q+A K I KR+ + ++DI+RE+
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 132 IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN 191
I++ + PN++ YE+K V +++EL AGGELFD + K +E A + I+N
Sbjct: 67 ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKD-ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVA 250
V+ H + + H DLKPEN +L ++ +K DFGL+ I+ G +++I G+ +VA
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 251 PEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309
PE++ G E D+WS GVI YILLSG PF +T++ + + +FE + S
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKK 369
+ AKD +RR+L +DPKKR+T L+HPWIK LSR M K KK
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT-------QQALSRKASAVNMEKFKK 298
Query: 370 LALKV 374
A +
Sbjct: 299 FAARK 303
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 507 bits (1308), Expect = 0.0
Identities = 113/280 (40%), Positives = 165/280 (58%), Gaps = 4/280 (1%)
Query: 71 GKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREI 130
G D+ +Y+ +GRG +G + + T + A K I K + D D K+EI
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEI 57
Query: 131 QIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIV 190
+IM+ L PNI+ +ED +++VMELC GGELF+R++ K + E AA I + ++
Sbjct: 58 EIMKSLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL 116
Query: 191 NVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVA 250
+ V CH + V HRDLKPENFL + ++ LK DFGL+ + GK+ R VG+ YYV+
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 251 PEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310
P+VL YG E D WSAGV++Y+LL G PPF A T+ + I +G F W +S
Sbjct: 177 PQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236
Query: 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
A+ L+RR+LT+ PK+RITS Q LEH W ++ +S + +
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 503 bits (1298), Expect = e-180
Identities = 81/302 (26%), Positives = 157/302 (51%), Gaps = 12/302 (3%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
+++ Y ++LGRG+FG+ + C E S+ + + K + + D+ +K+EI I+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILN 56
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVV 193
NI+ ++E + + ++ E +G ++F+RI +ER S + +
Sbjct: 57 IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV 253
H + H D++PEN + ++ ++ +K +FG + ++ G +R + + Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 254 LRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312
+ D+WS G ++Y+LLSG+ PF AET + I + I+ + F+ + IS A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLAL 372
D V R+L ++ K R+T+++ L+HPW+K+ + + + V+ +K R + L K L
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQ----KIERVSTKVIRTLKHRRYYHTLIKKDL 290
Query: 373 KV 374
+
Sbjct: 291 NM 292
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 506 bits (1305), Expect = e-180
Identities = 110/384 (28%), Positives = 173/384 (45%), Gaps = 22/384 (5%)
Query: 22 SSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPD-TNTILGKPYEDVKLH 80
+S P PA P P P A P Q P+ + + K + +
Sbjct: 4 NSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDY 63
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ LG G G T +FA K + +RE+++ S P
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCP 115
Query: 141 NIVEFKGAYED----KQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVH 194
+IV YE+ ++ + +VME GGELF RI +G ++ER A+ I +SI +
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL 254
H + + HRD+KPEN L +SK NA+LK TDFG + + YYVAPEVL
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 235
Query: 255 RRR-YGKEIDIWSAGVILYILLSGVPPFWAE----TEKGIFDAILQGDIDFESAPWPTIS 309
Y K D+WS GVI+YILL G PPF++ G+ I G +F + W +S
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKK 369
K L+R +L +P +R+T + + HPWI + + P+ ++ + + + R + ++
Sbjct: 296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEE 355
Query: 370 LALKVSLIKYMLMYQHVNCKAALD 393
+ + + Y+ + K D
Sbjct: 356 MTSAL--ATMRVDYEQIKIKKIED 377
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 499 bits (1287), Expect = e-179
Identities = 108/322 (33%), Positives = 164/322 (50%), Gaps = 25/322 (7%)
Query: 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQ 131
P+ K LG G F + C + + FA K ISKR + ++EI
Sbjct: 4 SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEIT 57
Query: 132 IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN 191
++ G PNIV+ + D+ +VMEL GGELF+RI K H+SE A+ I R +V+
Sbjct: 58 ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS 117
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDIVGSAYYVA 250
V H +GV+HRDLKPEN L + +++N +K DFG + + + + + +Y A
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAA 177
Query: 251 PEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEK-------GIFDAILQGDIDFES 302
PE+L + Y + D+WS GVILY +LSG PF + I I +GD FE
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237
Query: 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI---------DSA 353
W +S AKDL++ +LT DP KR+ + + + W+++G + S P+ +A
Sbjct: 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAA 297
Query: 354 VLSRMK-QFRAMNKLKKLALKV 374
V + +K F A NK K+ +
Sbjct: 298 VHTCVKATFHAFNKYKREGFCL 319
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 497 bits (1281), Expect = e-177
Identities = 106/328 (32%), Positives = 159/328 (48%), Gaps = 19/328 (5%)
Query: 59 QAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV 118
Q V L + Y +++G G + V C +T +FA K I K K
Sbjct: 2 QTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR- 60
Query: 119 TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYS 178
D EI+I+ PNI+ K Y+D + V+VV EL GGEL D+I+ + +S
Sbjct: 61 ------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFS 114
Query: 179 ERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA-LLKATDFGLSVFIE-EG 236
ER A+++ +I V H GV+HRDLKP N L + N ++ DFG + + E
Sbjct: 115 EREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 237 KVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWA---ETEKGIFDA 292
+ +A +VAPEVL R+ Y DIWS GV+LY +L+G PF +T + I
Sbjct: 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR 234
Query: 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDS 352
I G W ++S +AKDLV +ML DP +R+T+A VL HPWI + ++
Sbjct: 235 IGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNR 294
Query: 353 AVLSRMKQ------FRAMNKLKKLALKV 374
+ + + A+N+ + L+
Sbjct: 295 QDAPHLVKGAMAATYSALNRNQSPVLEP 322
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 495 bits (1277), Expect = e-177
Identities = 106/313 (33%), Positives = 168/313 (53%), Gaps = 8/313 (2%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN---DKDDIKREIQ 131
+ V+ Y G+ELG GQF + C E STG ++A K I KR+ +++I+RE+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 132 IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN 191
I++ + N++ YE++ V +++EL +GGELFD + K SE A S + I++
Sbjct: 68 ILRQVLH-HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDEN-ALLKATDFGLSVFIEEGKVYRDIVGSAYYVA 250
V+ H + H DLKPEN +L K+ +K DFGL+ IE+G +++I G+ +VA
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 251 PEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309
PE++ G E D+WS GVI YILLSG PF +T++ I DF+ + S
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG--GEASDKPIDSAVLSRMKQFRAMNKL 367
AKD +R++L ++ +KR+T + L HPWI +A + L ++ +
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRW 306
Query: 368 KKLALKVSLIKYM 380
K VSL ++
Sbjct: 307 KLSFSIVSLCNHL 319
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 494 bits (1273), Expect = e-177
Identities = 115/267 (43%), Positives = 161/267 (60%), Gaps = 2/267 (0%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
Y+ LG+G FG C + T +++A K I+K K D I RE+++++
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLK 76
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
L PNI++ ED S ++V EL GGELFD II + +SE AA I + + + +
Sbjct: 77 KLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL 254
H ++HRDLKPEN LL SK+++ +K DFGLS ++ +D +G+AYY+APEVL
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 255 RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314
R Y ++ D+WSAGVILYILLSG PPF+ + E I + G F+ W TIS AKD
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWIKE 341
L+R+MLT P RIT+ Q LEHPWI++
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 493 bits (1272), Expect = e-177
Identities = 110/283 (38%), Positives = 165/283 (58%), Gaps = 6/283 (2%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN---DKDDIKREIQI 132
V+ HY G+ELG GQF + C + TG+++A K I KR+L + +++I+RE+ I
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNV 192
++ + PNI+ +E+K V +++EL +GGELFD + K +E A + I++
Sbjct: 62 LREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 193 VHICHFMGVMHRDLKPENFLLSSKD-ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAP 251
VH H + H DLKPEN +L K+ N +K DFG++ IE G +++I G+ +VAP
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180
Query: 252 EVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310
E++ G E D+WS GVI YILLSG PF ET++ I + DF+ + S
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240
Query: 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSA 353
AKD +RR+L +DPK+R+T AQ LEH WIK + + DS
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDSG 283
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 492 bits (1270), Expect = e-177
Identities = 107/275 (38%), Positives = 163/275 (59%), Gaps = 3/275 (1%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
+Y +ELG+G F V C +TG +FA K I+ +KL + D ++RE +I +
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICR 60
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
L PNIV + +++ ++V +L GGELF+ I+A+ YSE A+ + I+ +
Sbjct: 61 KLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 119
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL 254
CH G++HR+LKPEN LL+SK + A +K DFGL++ + + + + G+ Y++PEVL
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 255 RRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313
++ Y K +DIW+ GVILYILL G PPFW E + ++ I G D+ S W T++ AK
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDK 348
L+ MLT +PKKRIT+ Q L+ PWI +
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWICNRERVASA 274
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 495 bits (1276), Expect = e-176
Identities = 104/352 (29%), Positives = 166/352 (47%), Gaps = 21/352 (5%)
Query: 7 KSKDPKPRHYAHGYRSSPNTVAKAPA------PAQQQAHHRPEKPGPTPAAAPVSGLKQA 60
+ + R + +A P+Q K L
Sbjct: 16 NKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQ 75
Query: 61 VPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK 120
P+ ++ Y +GRG V C +TG +FA K +
Sbjct: 76 SMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLS 135
Query: 121 ND-----KDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKG 175
+ ++ +RE I++ ++G P+I+ +YE + +V +L GELFD + K
Sbjct: 136 PEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV 195
Query: 176 HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235
SE+ SI RS++ V H ++HRDLKPEN LL D+N ++ +DFG S +E
Sbjct: 196 ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFSCHLEP 252
Query: 236 GKVYRDIVGSAYYVAPEVLR-------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKG 288
G+ R++ G+ Y+APE+L+ YGKE+D+W+ GVIL+ LL+G PPFW +
Sbjct: 253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL 312
Query: 289 IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
+ I++G F S W SS+ KDL+ R+L DP+ R+T+ Q L+HP+ +
Sbjct: 313 MLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 491 bits (1266), Expect = e-175
Identities = 109/318 (34%), Positives = 169/318 (53%), Gaps = 8/318 (2%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN---DKDDIKREIQ 131
+ V+ Y G+ELG GQF + C E STG ++A K I KR+ +++I+RE+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 132 IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN 191
I++ + PNI+ YE++ V +++EL +GGELFD + K SE A S + I++
Sbjct: 68 ILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKD-ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVA 250
V+ H + H DLKPEN +L K+ +K DFGL+ IE+G +++I G+ +VA
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 251 PEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309
PE++ G E D+WS GVI YILLSG PF +T++ I DF+ + S
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG--EASDKPIDSAVLSRMKQFRAMNKL 367
AKD +R++L ++ +KR+T + L HPWI +A + L K+ +
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRW 306
Query: 368 KKLALKVSLIKYMLMYQH 385
K VSL ++
Sbjct: 307 KLSFSIVSLCNHLTRSLM 324
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 482 bits (1243), Expect = e-173
Identities = 89/272 (32%), Positives = 155/272 (56%), Gaps = 8/272 (2%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
+ + F ++LG G FG +L E S+G + K+I+K + ++ + I+ EI++++
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLK 75
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK----GHYSERAAASICRSIV 190
L PNI++ +ED ++++VME C GGEL +RI++ SE A + + ++
Sbjct: 76 SLD-HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134
Query: 191 NVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVA 250
N + H V+H+DLKPEN L ++ +K DFGL+ + + + G+A Y+A
Sbjct: 135 NALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMA 194
Query: 251 PEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310
PEV +R + DIWSAGV++Y LL+G PF + + + + ++ P ++
Sbjct: 195 PEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP-LTP 253
Query: 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342
A DL+++MLT+DP++R ++AQVL H W K+
Sbjct: 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 482 bits (1242), Expect = e-172
Identities = 96/288 (33%), Positives = 151/288 (52%), Gaps = 16/288 (5%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT------KNDKDDIKR 128
+Y + LGRG V C T +++A K I + + ++ +
Sbjct: 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 129 EIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRS 188
E+ I++ +SG PNI++ K YE +V +L GELFD + K SE+ I R+
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 189 IVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYY 248
++ V+ H + ++HRDLKPEN LL D++ +K TDFG S ++ G+ R++ G+ Y
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 189
Query: 249 VAPEVLR-------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE 301
+APE++ YGKE+D+WS GVI+Y LL+G PPFW + + I+ G+ F
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 249
Query: 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKP 349
S W S + KDLV R L P+KR T+ + L HP+ ++ +
Sbjct: 250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRH 297
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 474 bits (1222), Expect = e-169
Identities = 104/314 (33%), Positives = 163/314 (51%), Gaps = 18/314 (5%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK-----NDKDDIKRE 129
+ ++ Y K LG G G L E T ++ A K ISKRK + +++ E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 130 IQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSI 189
I+I++ L+ P I++ K ++ + ++V+EL GGELFD+++ E +
Sbjct: 66 IEILKKLN-HPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 190 VNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV 249
+ V H G++HRDLKPEN LLSS++E+ L+K TDFG S + E + R + G+ Y+
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183
Query: 250 APEVL----RRRYGKEIDIWSAGVILYILLSGVPPFWAE-TEKGIFDAILQGDIDFESAP 304
APEVL Y + +D WS GVIL+I LSG PPF T+ + D I G +F
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243
Query: 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAM 364
W +S A DLV+++L DPK R T+ + L HPW++ D+ + + +
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ------DEDMKRKFQDLLSEENES 297
Query: 365 NKLKKLALKVSLIK 378
L ++ + S +
Sbjct: 298 TALPQVLAQPSTSR 311
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 473 bits (1219), Expect = e-168
Identities = 94/309 (30%), Positives = 154/309 (49%), Gaps = 36/309 (11%)
Query: 80 HYSFGKE-LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG 138
Y ++ LG G C T +++A K I K+ + + + RE++++ G
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQG 69
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198
N++E +E++ ++V E GG + I + H++E A+ + + + + + H
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI--------VGSAYYVA 250
G+ HRDLKPEN L ++ + +K DF L I+ I GSA Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 251 PEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAE---------------TEKGI 289
PEV+ Y K D+WS GVILYILLSG PPF + +
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 290 FDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKP 349
F++I +G +F W IS +AKDL+ ++L +D K+R+++AQVL+HPW++ G A +
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ--GCAPENT 307
Query: 350 IDSA-VLSR 357
+ + VL R
Sbjct: 308 LPTPMVLQR 316
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 471 bits (1215), Expect = e-167
Identities = 100/366 (27%), Positives = 167/366 (45%), Gaps = 32/366 (8%)
Query: 36 QQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPY----EDVKLHYSFGKELGRGQ 91
HH P + +P V +Y +ELG G
Sbjct: 4 SHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGA 63
Query: 92 FGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151
FGV + C E +TGR F K I+ + DK +K EI IM L P ++ A+ED
Sbjct: 64 FGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLH-HPKLINLHDAFED 119
Query: 152 KQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210
K + +++E +GGELFDRI A+ + SE + R + H ++H D+KPEN
Sbjct: 120 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 179
Query: 211 FLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGV 269
+ +K +++ K DFGL+ + ++ + +A + APE++ R G D+W+ GV
Sbjct: 180 IMCETKKASSV-KIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGV 238
Query: 270 ILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT 329
+ Y+LLSG+ PF E + + + D +F+ + ++S AKD ++ +L ++P+KR+T
Sbjct: 239 LGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT 298
Query: 330 SAQVLEHPWIKEGGEASDKPIDSAVLS---------------------RMKQFRAMNKLK 368
LEHPW+K I S+ + R+ F ++ K +
Sbjct: 299 VHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHR 358
Query: 369 KLALKV 374
++
Sbjct: 359 PQEYQI 364
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 467 bits (1205), Expect = e-166
Identities = 107/313 (34%), Positives = 155/313 (49%), Gaps = 24/313 (7%)
Query: 75 EDVKLHYSFGKE-LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIM 133
V Y K+ LG G G C TG++ A K + ++E+
Sbjct: 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHH 75
Query: 134 QHLSGQPNIVEFKGAYED----KQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICR 187
SG P+IV YE+ K+ + ++ME GGELF RI +G ++ER AA I R
Sbjct: 76 WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135
Query: 188 SIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY 247
I + H + HRD+KPEN L +SK+++A+LK TDFG + + + + Y
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ-TPCYTPY 194
Query: 248 YVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEK----GIFDAILQGDIDFES 302
YVAPEVL Y K D+WS GVI+YILL G PPF++ T + G+ I G F +
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN 254
Query: 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSA-VLSRMKQF 361
W +S AK L+R +L DP +R+T Q + HPWI + P+ +A VL K
Sbjct: 255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDH 314
Query: 362 RAMNKLKKLALKV 374
+++K+
Sbjct: 315 --WDEVKEEMTSA 325
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 469 bits (1208), Expect = e-166
Identities = 100/370 (27%), Positives = 172/370 (46%), Gaps = 15/370 (4%)
Query: 6 TKSKDPKPRHYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPD 65
+++ + + + A P + + ++ A P P
Sbjct: 14 LGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPF 73
Query: 66 TNTILGKPYEDVKLHYSFGK--ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK 123
+ I+ V Y+ K LG G+FG + C E +TG + A K I R + DK
Sbjct: 74 DHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDK 130
Query: 124 DDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH-YSERAA 182
+++K EI +M L N+++ A+E K + +VME GGELFDRII + + +E
Sbjct: 131 EEVKNEISVMNQLD-HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 189
Query: 183 ASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI 242
+ I + H M ++H DLKPEN L ++D + K DFGL+ + + +
Sbjct: 190 ILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVN 248
Query: 243 VGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE 301
G+ ++APEV+ D+WS GVI Y+LLSG+ PF + + + IL D E
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE 308
Query: 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQF 361
+ IS AK+ + ++L ++ RI++++ L+HPW+ D + S + ++ K+
Sbjct: 309 DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS------DHKLHSRLSAQKKKN 362
Query: 362 RAMNKLKKLA 371
R + +
Sbjct: 363 RGSDAQDFVT 372
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 475 bits (1224), Expect = e-165
Identities = 105/352 (29%), Positives = 161/352 (45%), Gaps = 11/352 (3%)
Query: 29 KAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELG 88
+ G ++ + + + ++ V HY +ELG
Sbjct: 107 RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELG 166
Query: 89 RGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148
G FGV + TE +TG FA K + +DK+ +++EIQ M L P +V A
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLR-HPTLVNLHDA 222
Query: 149 YEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLK 207
+ED + ++ E +GGELF+++ + SE A R + + H +H DLK
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 282
Query: 208 PENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWS 266
PEN + ++K N L K DFGL+ ++ + + G+A + APEV + G D+WS
Sbjct: 283 PENIMFTTKRSNEL-KLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWS 341
Query: 267 AGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKK 326
GV+ YILLSG+ PF E + + D + + + + IS KD +R++L DP
Sbjct: 342 VGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNT 401
Query: 327 RITSAQVLEHPWIKEG-GEASDKPIDSAVLSRMKQFRAMNKLKKLALKVSLI 377
R+T Q LEHPW+ G D I S SR + R K K A L
Sbjct: 402 RMTIHQALEHPWLTPGNAPGRDSQIPS---SRYTKIRDSIKTKYDAWPEPLP 450
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 459 bits (1184), Expect = e-163
Identities = 91/313 (29%), Positives = 143/313 (45%), Gaps = 39/313 (12%)
Query: 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQ 131
K + + + LG G G T +FA K + +RE++
Sbjct: 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVE 62
Query: 132 IMQHLSGQPNIVEFKGAYED----KQSVHVVMELCAGGELFDRIIAKGH--YSERAAASI 185
+ S P+IV YE+ ++ + +VME GGELF RI +G ++ER A+ I
Sbjct: 63 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 186 CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGS 245
+SI + H + + HRD+KPEN L +SK NA+LK TDFG
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------- 166
Query: 246 AYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAE----TEKGIFDAILQGDIDFE 301
A E +Y K D+WS GVI+YILL G PPF++ G+ I G +F
Sbjct: 167 ----AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222
Query: 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQF 361
+ W +S K L+R +L +P +R+T + + HPWI + + P+ ++ + + +
Sbjct: 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 282
Query: 362 RAMNKLKKLALKV 374
R +K+
Sbjct: 283 R-WEDVKEEMTSA 294
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 444 bits (1143), Expect = e-155
Identities = 100/279 (35%), Positives = 153/279 (54%), Gaps = 12/279 (4%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK-----NDKDDIKRE 129
+ ++ Y K LG G G L E T ++ A + ISKRK + +++ E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 130 IQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSI 189
I+I++ L+ P I++ K ++ + ++V+EL GGELFD+++ E +
Sbjct: 191 IEILKKLN-HPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 190 VNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV 249
+ V H G++HRDLKPEN LLSS++E+ L+K TDFG S + E + R + G+ Y+
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308
Query: 250 APEVL----RRRYGKEIDIWSAGVILYILLSGVPPFWAE-TEKGIFDAILQGDIDFESAP 304
APEVL Y + +D WS GVIL+I LSG PPF T+ + D I G +F
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368
Query: 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343
W +S A DLV+++L DPK R T+ + L HPW+++
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 435 bits (1121), Expect = e-153
Identities = 96/330 (29%), Positives = 152/330 (46%), Gaps = 52/330 (15%)
Query: 69 ILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL--VTKNDKDDI 126
G +++ Y +G+G +GV + EN T A K ++K K+ + D + I
Sbjct: 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 127 KREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH---------- 176
K E+++M+ L PNI YED+Q + +VMELC GG L D++
Sbjct: 76 KTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDV 134
Query: 177 ------------------------------YSERAAASICRSIVNVVHICHFMGVMHRDL 206
E+ ++I R I + +H H G+ HRD+
Sbjct: 135 VKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDI 194
Query: 207 KPENFLLSSKDENALLKATDFGLSVFIE-----EGKVYRDIVGSAYYVAPEVLR---RRY 258
KPENFL S+ +++ +K DFGLS E G+ Y+VAPEVL Y
Sbjct: 195 KPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
G + D WSAGV+L++LL G PF + +L + FE+ + +S A+DL+
Sbjct: 254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSN 313
Query: 319 MLTQDPKKRITSAQVLEHPWIKEGGEASDK 348
+L ++ +R + + L+HPWI + + K
Sbjct: 314 LLNRNVDERFDAMRALQHPWISQFSDKIYK 343
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 329 bits (846), Expect = e-110
Identities = 70/304 (23%), Positives = 131/304 (43%), Gaps = 23/304 (7%)
Query: 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS 137
K+ + LG G G T + R A K I RE+Q+++
Sbjct: 23 KISFCPKDVLGHGAEG-TIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESD 75
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICRSIVNVVHIC 196
PN++ + +D+Q ++ +ELC L + + K + ++ + + +
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKA--TDFGLSVFIEEGKVY----RDIVGSAYYVA 250
H + ++HRDLKP N L+S + + +KA +DFGL + G+ + G+ ++A
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 251 PEVLR----RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305
PE+L +DI+SAG + Y ++S G PF ++ + +D P
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH-PE 253
Query: 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMN 365
A++L+ +M+ DP+KR ++ VL+HP+ V R+++
Sbjct: 254 KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW--SLEKQLQFFQDVSDRIEKESLDG 311
Query: 366 KLKK 369
+ K
Sbjct: 312 PIVK 315
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 319 bits (818), Expect = e-106
Identities = 81/337 (24%), Positives = 139/337 (41%), Gaps = 46/337 (13%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
+ +K K LG G G + GR A K + D EI+++
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC------DIALMEIKLLT 63
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERA-------AASICR 187
PN++ + + + +++ +ELC L D + +K E S+ R
Sbjct: 64 ESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 188 SIVNVVHICHFMGVMHRDLKPENFLLSSKD----------ENALLKATDFGLSVFIEEGK 237
I + V H + ++HRDLKP+N L+S+ EN + +DFGL ++ G+
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 238 VY-----RDIVGSAYYVAPEVLR--------RRYGKEIDIWSAGVILYILLS-GVPPFWA 283
+ G++ + APE+L RR + IDI+S G + Y +LS G PF
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 284 --ETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
E I I D + + ++ + A DL+ +M+ DP KR T+ +VL HP
Sbjct: 243 KYSRESNIIRGIFSLD-EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301
Query: 342 GGEASDKPIDSA----VLSRMKQFRAMNKLKKLALKV 374
+ + + + + +R + K + V
Sbjct: 302 KSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFV 338
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 4e-95
Identities = 97/325 (29%), Positives = 149/325 (45%), Gaps = 21/325 (6%)
Query: 31 PAPAQQQAHHRPEKPGP-TPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGR 89
PAPA P P PAAAP + + +P + + Y G+ LG+
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPA---KEIPEVLVDPRSRRRYV-------RGRFLGK 51
Query: 90 GQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149
G F + ++ T FA K + K L+ + ++ + EI I + L+ ++V F G +
Sbjct: 52 GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFF 110
Query: 150 EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPE 209
ED V VV+ELC L + + +E A R IV H V+HRDLK
Sbjct: 111 EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG 170
Query: 210 NFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRRR-YGKEIDIWSA 267
N L +E+ +K DFGL+ +E + + G+ Y+APEVL ++ + E+D+WS
Sbjct: 171 NLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSI 227
Query: 268 GVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKR 327
G I+Y LL G PPF K + I + + P I+ A L+++ML DP R
Sbjct: 228 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI---P-KHINPVAASLIQKMLQTDPTAR 283
Query: 328 ITSAQVLEHPWIKEGGEASDKPIDS 352
T ++L + G + PI
Sbjct: 284 PTINELLNDEFFTSGYIPARLPITC 308
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 2e-93
Identities = 83/265 (31%), Positives = 129/265 (48%), Gaps = 10/265 (3%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y G+ LG+G F + ++ T FA K + K L+ + ++ + EI I + L+
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-H 74
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
++V F G +ED V VV+ELC L + + +E A R IV H
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRRR- 257
V+HRDLK N L +E+ +K DFGL+ +E + + G+ Y+APEVL ++
Sbjct: 135 RVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 191
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
+ E+D+WS G I+Y LL G PPF K + I + + P I+ A L++
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI---P-KHINPVAASLIQ 247
Query: 318 RMLTQDPKKRITSAQVLEHPWIKEG 342
+ML DP R T ++L + G
Sbjct: 248 KMLQTDPTARPTINELLNDEFFTSG 272
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 1e-91
Identities = 84/264 (31%), Positives = 136/264 (51%), Gaps = 12/264 (4%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ G+ LG+G+FG YL E + A K + K +L + ++RE++I HL P
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
NI+ G + D V++++E G ++ + + E+ A+ + N + CH
Sbjct: 70 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRRR-Y 258
V+HRD+KPEN LL LK DFG SV + R + G+ Y+ PE++ R +
Sbjct: 130 VIHRDIKPENLLL---GSAGELKIADFGWSVHAPSSR--RTDLCGTLDYLPPEMIEGRMH 184
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
+++D+WS GV+ Y L G PPF A T + + I + + F P ++ A+DL+ R
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF---P-DFVTEGARDLISR 240
Query: 319 MLTQDPKKRITSAQVLEHPWIKEG 342
+L +P +R +VLEHPWI
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITAN 264
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 2e-91
Identities = 63/299 (21%), Positives = 113/299 (37%), Gaps = 43/299 (14%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ LG+G + TG FA K + D RE ++++ L+
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HK 67
Query: 141 NIVEFKGAYEDKQSVHV--VMELCAGGELFDRIIAKGH---YSERAAASICRSIVNVVHI 195
NIV+ E+ + H +ME C G L+ + + E + R +V ++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 196 CHFMGVMHRDLKPENFLLS-SKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL 254
G++HR++KP N + +D ++ K TDFG + +E+ + + + G+ Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 255 RRR---------YGKEIDIWSAGVILYILLSGVPPFWA----ETEKGIFDAILQG----- 296
R YG +D+WS GV Y +G PF K + I+ G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 297 ------------DIDFESAPWPTISSSAKDLV----RRMLTQDPKKRITSAQVLEHPWI 339
D + ++S + L+ +L D +K Q
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 2e-91
Identities = 79/266 (29%), Positives = 131/266 (49%), Gaps = 11/266 (4%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ G LG+G F Y TG + A K I K+ + ++ E++I L
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-H 70
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY-SERAAASICRSIVNVVHICHF 198
P+I+E +ED V++V+E+C GE+ + + SE A I+ + H
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRRR 257
G++HRDL N LL N +K DFGL+ ++ + G+ Y++PE+ R
Sbjct: 131 HGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 258 -YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316
+G E D+WS G + Y LL G PPF +T K + ++ D + P +S AKDL+
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM---P-SFLSIEAKDLI 243
Query: 317 RRMLTQDPKKRITSAQVLEHPWIKEG 342
++L ++P R++ + VL+HP++
Sbjct: 244 HQLLRRNPADRLSLSSVLDHPFMSRN 269
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 5e-91
Identities = 85/278 (30%), Positives = 147/278 (52%), Gaps = 10/278 (3%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ G+ LG+G+FG YL E A K + K +L + + ++REI+I HL P
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HP 74
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
NI+ + D++ +++++E GEL+ + G + E+ +A+ + + +H CH
Sbjct: 75 NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 134
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-YG 259
V+HRD+KPEN L+ LK DFG SV + R + G+ Y+ PE++ + +
Sbjct: 135 VIHRDIKPENLLM---GYKGELKIADFGWSVHAPSLRR-RTMCGTLDYLPPEMIEGKTHD 190
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRM 319
+++D+W AGV+ Y L G+PPF + + I+ D+ F P P +S +KDL+ ++
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF---P-PFLSDGSKDLISKL 246
Query: 320 LTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSR 357
L P +R+ V+EHPW+K P+ + S+
Sbjct: 247 LRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQSK 284
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 3e-90
Identities = 67/295 (22%), Positives = 117/295 (39%), Gaps = 41/295 (13%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ LG+G FG R +A K I T+ I E+ ++ L+
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLN-HQ 62
Query: 141 NIVEFKGAYEDKQSVHV-------------VMELCAGGELFDRIIAKGHYSER-AAASIC 186
+V + A+ ++++ ME C G L+D I ++ +R +
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 187 RSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI---- 242
R I+ + H G++HRDLKP N + DE+ +K DFGL+ + +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 243 -----------VGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKGI 289
+G+A YVA EVL Y ++ID++S G+I + ++ P I
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNI 237
Query: 290 FDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344
+ I+F K ++R ++ DP KR + +L W+ +
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 9e-90
Identities = 45/359 (12%), Positives = 97/359 (27%), Gaps = 44/359 (12%)
Query: 34 AQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFG 93
+++ + AA V + V + T + + + L G
Sbjct: 17 REEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRS 76
Query: 94 VTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL----------------- 136
V +L + FA K + ++++ + + L
Sbjct: 77 VVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP 136
Query: 137 ------SGQPNIVEFKGAYEDK--QSVHVVMELCAG------GELFDRIIAKGHYSERAA 182
QP + +D + ++M + L + +G A
Sbjct: 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILAL 196
Query: 183 ASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI 242
+ ++ + G++H P+N + + L D + G
Sbjct: 197 HILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVSALW--KVGTRGPAS 251
Query: 243 VGSAYYVAPEVLRRR---YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL----- 294
Y E L + ++ W G+ +Y + PF T
Sbjct: 252 SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRV 311
Query: 295 QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSA 353
G + K L+ R L D ++R+ + +E P + + +
Sbjct: 312 PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLSTG 370
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 6e-88
Identities = 73/319 (22%), Positives = 134/319 (42%), Gaps = 32/319 (10%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
YS K++G G + N + +A K ++ + D + EI + L
Sbjct: 10 IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 67
Query: 140 -PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198
I+ Q +++VME C +L + K S ++++ VH H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK--VYRD-IVGSAYYVAPEVL- 254
G++H DLKP NFL+ + +LK DFG++ ++ V +D VG+ Y+ PE +
Sbjct: 127 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 255 -----------RRRYGKEIDIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGDIDFES 302
+ + + D+WS G ILY + G PF + AI+ + + E
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242
Query: 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSA------VLS 356
+D+++ L +DPK+RI+ ++L HP+++ ++ VL
Sbjct: 243 --PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLG 300
Query: 357 RMKQFRAMNKLKKLALKVS 375
++ + N + K A +
Sbjct: 301 QLVGLNSPNSILKAAKTLY 319
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 2e-87
Identities = 72/354 (20%), Positives = 140/354 (39%), Gaps = 52/354 (14%)
Query: 53 PVSGLKQAVPRPDTNTILGKPYEDVKLH---YSFGKELGRGQFGVTYLCTENSTGRQFAC 109
P+ +K + L K ++ + Y + L +G+F LC + + +A
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYAL 59
Query: 110 KSISKRKLV--------------TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155
K K L K+ DD K E+QI+ + + +G + V
Sbjct: 60 KKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEYCLTCEGIITNYDEV 118
Query: 156 HVVMELCAGGELFDRIIAKGH--------YSERAAASICRSIVNVVHICH-FMGVMHRDL 206
+++ E + + I +S++N H + HRD+
Sbjct: 119 YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178
Query: 207 KPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR---YGKEID 263
KP N L+ D+N +K +DFG S ++ + K+ + G+ ++ PE G ++D
Sbjct: 179 KPSNILM---DKNGRVKLSDFGESEYMVDKKI-KGSRGTYEFMPPEFFSNESSYNGAKVD 234
Query: 264 IWSAGVILYILLSGVPPFWAE-TEKGIFDAILQGDIDF---------------ESAPWPT 307
IWS G+ LY++ V PF + + +F+ I +I++ +
Sbjct: 235 IWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNF 294
Query: 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQF 361
+S+ D ++ L ++P +RITS L+H W+ + + + + K+
Sbjct: 295 LSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYKKRKKL 348
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 2e-87
Identities = 78/378 (20%), Positives = 152/378 (40%), Gaps = 40/378 (10%)
Query: 18 HGYRSSPNTVAKAPAPAQQQAHHRPEKP-GPTPAAAPVSGLKQAVPRPDTNTILGKPYED 76
H + + + + ++ A + E+ +P K + + ++ G+ Y
Sbjct: 1 HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYS- 59
Query: 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL 136
K++G G + N + +A K ++ + D + EI + L
Sbjct: 60 ------ILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKL 111
Query: 137 SGQ-PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI 195
I+ Q +++VME C +L + K S ++++ VH
Sbjct: 112 QQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK--VYRD-IVGSAYYVAPE 252
H G++H DLKP NFL+ + +LK DFG++ ++ V +D VG+ Y+ PE
Sbjct: 171 IHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 253 VL------------RRRYGKEIDIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGDID 299
+ + + + D+WS G ILY + G PF + AI+ + +
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286
Query: 300 FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSA------ 353
E +D+++ L +DPK+RI+ ++L HP+++ ++
Sbjct: 287 IEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKY 344
Query: 354 VLSRMKQFRAMNKLKKLA 371
VL ++ + N + K A
Sbjct: 345 VLGQLVGLNSPNSILKAA 362
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 6e-87
Identities = 81/276 (29%), Positives = 134/276 (48%), Gaps = 14/276 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ + LG G +G L T A K + ++ V + ++IK+EI I + L+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-H 64
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
N+V+F G + ++ +E C+GGELFDRI E A ++ V H +
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI---VGSAYYVAPEVLRR 256
G+ HRD+KPEN LL DE LK +DFGL+ R + G+ YVAPE+L+R
Sbjct: 125 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 257 R-Y-GKEIDIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGDIDFESAPWPTISSSAK 313
R + + +D+WS G++L +L+G P+ ++ + + PW I S+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPL 239
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKP 349
L+ ++L ++P RIT + + W + + K
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 275
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 7e-87
Identities = 70/333 (21%), Positives = 131/333 (39%), Gaps = 40/333 (12%)
Query: 39 HHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLC 98
HH + + ++ G+ Y K++G G +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQ-------SMSVKGRIYS-------ILKQIGSGGSSKVFQV 47
Query: 99 TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ-PNIVEFKGAYEDKQSVHV 157
N + +A K ++ + D + EI + L I+ Q +++
Sbjct: 48 L-NEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105
Query: 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217
VME C +L + K S ++++ VH H G++H DLKP NFL+
Sbjct: 106 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--- 161
Query: 218 ENALLKATDFGLSVFIEEGK--VYRD-IVGSAYYVAPEVL------------RRRYGKEI 262
+ +LK DFG++ ++ V +D VG+ Y+ PE + + + +
Sbjct: 162 -DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 220
Query: 263 DIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGDIDFESAPWPTISSSAKDLVRRMLT 321
D+WS G ILY + G PF + AI+ + + E +D+++ L
Sbjct: 221 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF--PDIPEKDLQDVLKCCLK 278
Query: 322 QDPKKRITSAQVLEHPWIKEGGEASDKPIDSAV 354
+DPK+RI+ ++L HP+++ ++
Sbjct: 279 RDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 311
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 1e-86
Identities = 101/265 (38%), Positives = 135/265 (50%), Gaps = 10/265 (3%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
HY G LG G FG + TG + A K ++++K+ + + IKREIQ ++
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-H 70
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P+I++ +VME +GGELFD I G E A + + I++ V CH
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-Y 258
V+HRDLKPEN LL D + K DFGLS + +G+ R GS Y APEV+ R Y
Sbjct: 131 MVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 259 -GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
G E+DIWS GVILY LL G PF E +F I G F + ++ S L+
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEY--LNRSVATLLM 243
Query: 318 RMLTQDPKKRITSAQVLEHPWIKEG 342
ML DP KR T + EH W K+
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFKQD 268
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 5e-86
Identities = 100/307 (32%), Positives = 155/307 (50%), Gaps = 21/307 (6%)
Query: 67 NTILGKPYEDVKL-HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD 125
N+I E + +Y K +G+G F L TGR+ A K I K +L
Sbjct: 2 NSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQK 60
Query: 126 IKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASI 185
+ RE++IM+ L+ PNIV+ E +++++++ME +GGE+FD ++A G E+ A S
Sbjct: 61 LFREVRIMKILN-HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK 119
Query: 186 CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGS 245
R IV+ V CH ++HRDLK EN LL D + +K DFG S G G+
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGA 176
Query: 246 AYYVAPEVLRRR-Y-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA 303
Y APE+ + + Y G E+D+WS GVILY L+SG PF + K + + +L+G +
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KYRIP 234
Query: 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG---------GEASDKPIDSAV 354
+ +S+ ++L++R L +P KR T Q+++ WI G E D
Sbjct: 235 FY--MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKR 292
Query: 355 LSRMKQF 361
+ M
Sbjct: 293 IDIMVGM 299
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 6e-86
Identities = 63/298 (21%), Positives = 114/298 (38%), Gaps = 43/298 (14%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ LG+G + TG FA K + + D RE ++++ L+
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV--QMREFEVLKKLN-HK 67
Query: 141 NIVEFKGAYEDKQSVHV--VMELCAGGELFDRIIAKGH---YSERAAASICRSIVNVVHI 195
NIV+ E+ + H +ME C G L+ + + E + R +V ++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 196 CHFMGVMHRDLKPENFLLS-SKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL 254
G++HR++KP N + +D ++ K TDFG + +E+ + + + G+ Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 255 RRR---------YGKEIDIWSAGVILYILLSGVPPFWA----ETEKGIFDAILQG----- 296
R YG +D+WS GV Y +G PF K + I+ G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 297 ------------DIDFESAPWPTISSSAKDLV----RRMLTQDPKKRITSAQVLEHPW 338
D + ++S + L+ +L D +K Q
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 8e-86
Identities = 53/377 (14%), Positives = 105/377 (27%), Gaps = 63/377 (16%)
Query: 13 PRHYAHG----YRSSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNT 68
H++ G Y P V + + +AA S + ++
Sbjct: 4 HHHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAAD-SLVSTSLWNTGQPF 62
Query: 69 ILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR 128
+ + G LG+ T+ TG F + N +K
Sbjct: 63 RVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKE 122
Query: 129 EIQIMQHL------------------------SGQPNIVEFKGAYEDKQ--SVHVVMELC 162
E+ ++ L + ++ + D S +
Sbjct: 123 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 182
Query: 163 A------GGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK 216
G L A + ++ ++ H G++H L+P + +L
Sbjct: 183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL--- 239
Query: 217 DENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR------------YGKEIDI 264
D+ + T F V S + PE+ RR D
Sbjct: 240 DQRGGVFLTGFEHLV---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDA 296
Query: 265 WSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDP 324
W+ G+++Y + P + G + I + + I + L+ L
Sbjct: 297 WALGLVIYWIWCADLPITKDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRYPK 348
Query: 325 KKRITSAQVLEHPWIKE 341
+ R+ Q +E P ++
Sbjct: 349 EDRLLPLQAMETPEYEQ 365
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 9e-86
Identities = 83/323 (25%), Positives = 135/323 (41%), Gaps = 25/323 (7%)
Query: 34 AQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFG 93
+ HH P + T GK E ++ Y G LG G FG
Sbjct: 3 SSHHHHHHSSGLVPRGSHMA-----PCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG 57
Query: 94 VTYLCTENSTGRQFACKSISKRKLVTKNDKDD---IKREIQIMQHLS-GQPNIVEFKGAY 149
Y S A K + K ++ + + + E+ +++ +S G ++ +
Sbjct: 58 SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117
Query: 150 EDKQSVHVVMELCAG-GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKP 208
E S +++E +LFD I +G E A S ++ V CH GV+HRD+K
Sbjct: 118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKD 177
Query: 209 ENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRY-GKEIDIWS 266
EN L+ LK DFG +++ Y D G+ Y PE +R RY G+ +WS
Sbjct: 178 ENILIDLNRGE--LKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWS 234
Query: 267 AGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKK 326
G++LY ++ G PF + E I++G + F +SS + L+R L P
Sbjct: 235 LGILLYDMVCGDIPFEHDEE------IIRGQVFF---R-QRVSSECQHLIRWCLALRPSD 284
Query: 327 RITSAQVLEHPWIKEGGEASDKP 349
R T ++ HPW+++ +
Sbjct: 285 RPTFEEIQNHPWMQDVLLPQETA 307
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 2e-85
Identities = 84/305 (27%), Positives = 139/305 (45%), Gaps = 14/305 (4%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ + LG G +G L T A K + ++ V + IK+EI I + L+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLN-H 64
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
N+V+F G + ++ +E C+GGELFDRI E A ++ V H +
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI---VGSAYYVAPEVLRR 256
G+ HRD+KPEN LL DE LK +DFGL+ R + G+ YVAPE+L+R
Sbjct: 125 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 257 R-Y-GKEIDIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGDIDFESAPWPTISSSAK 313
R + + +D+WS G++L +L+G P+ ++ + + PW I S+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPL 239
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALK 373
L+ ++L ++P RIT + + W + + K + +K + L
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLD 299
Query: 374 VSLIK 378
S +
Sbjct: 300 FSPVN 304
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 3e-85
Identities = 91/269 (33%), Positives = 126/269 (46%), Gaps = 14/269 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y F K++G G FGV L + T A K I + + +N ++REI + L
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLR-H 75
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
PNIV FK + ++ME +GGEL++RI G +SE A + +++ V CH M
Sbjct: 76 PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM 135
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-Y 258
+ HRDLK EN LL LK DFG S + VG+ Y+APEVL R+ Y
Sbjct: 136 QICHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEY 194
Query: 259 -GKEIDIWSAGVILYILLSGVPPFWAETEKGIF----DAILQGDIDFESAPWPTISSSAK 313
GK D+WS GV LY++L G PF E + IL IS
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR--ISPECC 252
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEG 342
L+ R+ DP RI+ ++ H W +
Sbjct: 253 HLISRIFVADPATRISIPEIKTHSWFLKN 281
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 5e-85
Identities = 93/291 (31%), Positives = 146/291 (50%), Gaps = 19/291 (6%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y + LG G FG L T T ++ A K IS++ L + ++REI ++ L
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-H 68
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P+I++ + +V+E AGGELFD I+ K +E + I+ + CH
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-Y 258
++HRDLKPEN LL D+N +K DFGLS + +G + GS Y APEV+ + Y
Sbjct: 128 KIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY 184
Query: 259 -GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
G E+D+WS G++LY++L G PF E +F + + + +S A+ L+R
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC--VYVMPDF--LSPGAQSLIR 240
Query: 318 RMLTQDPKKRITSAQVLEHPWIKEGGEASDKP--------IDSAVLSRMKQ 360
RM+ DP +RIT ++ PW +P DS ++S++ +
Sbjct: 241 RMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGE 291
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 2e-84
Identities = 102/292 (34%), Positives = 146/292 (50%), Gaps = 19/292 (6%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
HY G LG G FG + TG + A K ++++K+ + + I+REIQ ++
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-H 75
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P+I++ + +VME +GGELFD I G E+ + + + I++ V CH
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-Y 258
V+HRDLKPEN LL D + K DFGLS + +G+ R GS Y APEV+ R Y
Sbjct: 136 MVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 192
Query: 259 -GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
G E+DIWS+GVILY LL G PF + +F I G F + + ++ S L++
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQY--LNPSVISLLK 248
Query: 318 RMLTQDPKKRITSAQVLEHPWIKEGG---------EASDKPIDSAVLSRMKQ 360
ML DP KR T + EH W K+ S ID L + +
Sbjct: 249 HMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCE 300
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 8e-84
Identities = 77/309 (24%), Positives = 127/309 (41%), Gaps = 23/309 (7%)
Query: 50 AAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFAC 109
P+ G A P T GK E + Y G LG+G FG + + Q A
Sbjct: 3 LTKPLQG-PPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAI 61
Query: 110 KSISKRKLVTKNDKDD---IKREIQIMQHLSGQ---PNIVEFKGAYEDKQSVHVVMEL-C 162
K I + +++ + D E+ ++ + P ++ +E ++ +V+E
Sbjct: 62 KVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPL 121
Query: 163 AGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALL 222
+LFD I KG E + +V + CH GV+HRD+K EN L+ +
Sbjct: 122 PAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC--A 179
Query: 223 KATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRY-GKEIDIWSAGVILYILLSGVPP 280
K DFG + + Y D G+ Y PE + +Y +WS G++LY ++ G P
Sbjct: 180 KLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
Query: 281 FWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
F E ++ I +A + +S L+RR L P R + ++L PW++
Sbjct: 239 F--ERDQEILEA------ELHFPAH--VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288
Query: 341 EGGEASDKP 349
E
Sbjct: 289 TPAEDVPLN 297
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 2e-82
Identities = 76/281 (27%), Positives = 129/281 (45%), Gaps = 22/281 (7%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD-----IKREIQIMQ 134
YS LG G FG + + ++ K I K K++ +D + EI I+
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMEL-CAGGELFDRIIAKGHYSERAAASICRSIVNVV 193
+ NI++ +E++ +VME +G +LF I E A+ I R +V+ V
Sbjct: 85 RVE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV 253
++HRD+K EN ++ E+ +K DFG + ++E GK++ G+ Y APEV
Sbjct: 144 GYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200
Query: 254 LRRR-Y-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311
L Y G E+++WS GV LY L+ PF + ++ I P+ +S
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHP---PYL-VSKE 250
Query: 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDS 352
LV +L P++R T +++ PW+ + +D +
Sbjct: 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEE 291
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 3e-81
Identities = 78/291 (26%), Positives = 137/291 (47%), Gaps = 37/291 (12%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV--------------------- 118
Y+ E+G+G +GV L + +A K +SK+KL+
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 119 --TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--KQSVHVVMELCAGGELFDRIIAK 174
+ + + +EI I++ L PN+V+ +D + +++V EL G + + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTL 131
Query: 175 GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFI 233
SE A + ++ + H+ ++HRD+KP N L+ E+ +K DFG+S F
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV---GEDGHIKIADFGVSNEFK 188
Query: 234 EEGKVYRDIVGSAYYVAPEVL---RRRY-GKEIDIWSAGVILYILLSGVPPFWAETEKGI 289
+ + VG+ ++APE L R+ + GK +D+W+ GV LY + G PF E +
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248
Query: 290 FDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
I ++F P I+ KDL+ RML ++P+ RI ++ HPW+
Sbjct: 249 HSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 3e-80
Identities = 62/293 (21%), Positives = 120/293 (40%), Gaps = 33/293 (11%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ + LG G FG TG Q A K + + +++ EIQIM+ L+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLN-H 71
Query: 140 PNIVEFKGAYEDKQSVH------VVMELCAGGELFDRIIAKGH---YSERAAASICRSIV 190
PN+V + + Q + + ME C GG+L + + E ++ I
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 191 NVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVA 250
+ + H ++HRDLKPEN +L + + K D G + +++G++ + VG+ Y+A
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 251 PEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309
PE+L ++ Y +D WS G + + ++G PF + + ++ + + ++
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251
Query: 310 SS--------------------AKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342
+ + ++ ML ++R T Q +
Sbjct: 252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 2e-79
Identities = 71/330 (21%), Positives = 114/330 (34%), Gaps = 24/330 (7%)
Query: 14 RHYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKP 73
H+ H T Q R G G + P
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQ----- 57
Query: 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIM 133
+ LG G +G + GR +A K S D+ E+
Sbjct: 58 ------SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK-RSMSPFRGPKDRARKLAEVGSH 110
Query: 134 QHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY-SERAAASICRSIVNV 192
+ + P V + A+E+ +++ ELC G L A G E R +
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLA 169
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPE 252
+ H G++H D+KP N L K DFGL V + G Y+APE
Sbjct: 170 LAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE 226
Query: 253 VLRRRYGKEIDIWSAGVILYILLSGVP-PFWAETEKGIFDAILQGDIDFESAPWPTISSS 311
+L+ YG D++S G+ + + + P E + + L + +SS
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF------TAGLSSE 280
Query: 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
+ ++ ML DPK R T+ +L P +++
Sbjct: 281 LRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 4e-77
Identities = 76/276 (27%), Positives = 126/276 (45%), Gaps = 23/276 (8%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y +G G +G S G+ K + + T+ +K + E+ +++ L
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-H 64
Query: 140 PNIVEFKGAYEDKQS--VHVVMELCAGGELFDRII----AKGHYSERAAASICRSIVNVV 193
PNIV + D+ + +++VME C GG+L I + + E + + +
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 194 HICH-----FMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAY 247
CH V+HRDLKP N L D +K DFGL+ + + + VG+ Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKTFVGTPY 181
Query: 248 YVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP 306
Y++PE + R Y ++ DIWS G +LY L + +PPF A ++K + I +G P
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR----RIP 237
Query: 307 TI-SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
S +++ RML R + ++LE+P I E
Sbjct: 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 1e-75
Identities = 78/303 (25%), Positives = 142/303 (46%), Gaps = 21/303 (6%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV-TKNDKDDIKREIQIMQHLSG 138
Y G LG G +G ++ T + A K + K+KL N + ++K+EIQ+++ L
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR- 64
Query: 139 QPNIVEFKG--AYEDKQSVHVVMELCAGG--ELFDRIIAKGHYSERAAASICRSIVNVVH 194
N+++ E+KQ +++VME C G E+ D + + + A +++ +
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGLE 123
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE---EGKVYRDIVGSAYYVAP 251
H G++H+D+KP N LL LK + G++ + R GS + P
Sbjct: 124 YLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 252 EVLR--RRY-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308
E+ + G ++DIWSAGV LY + +G+ PF + +F+ I +G +
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS--YAIPGD--C 236
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMK-QFRAMNKL 367
DL++ ML +P KR + Q+ +H W ++ ++ P+ K ++R+M +
Sbjct: 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVV 296
Query: 368 KKL 370
L
Sbjct: 297 PYL 299
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 4e-75
Identities = 68/267 (25%), Positives = 133/267 (49%), Gaps = 14/267 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y +++G G FG L GRQ+ K I+ ++ + ++++ +RE+ ++ ++
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMK-H 82
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICH 197
PNIV+++ ++E+ S+++VM+ C GG+LF RI A + E I + H
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRR 256
++HRD+K +N L ++ ++ DFG++ + +G+ YY++PE+
Sbjct: 143 DRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199
Query: 257 R-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-ISSSAKD 314
+ Y + DIW+ G +LY L + F A + K + I+ G P S +
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP----PVSLHYSYDLRS 255
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWIKE 341
LV ++ ++P+ R + +LE +I +
Sbjct: 256 LVSQLFKRNPRDRPSVNSILEKGFIAK 282
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 8e-69
Identities = 71/301 (23%), Positives = 125/301 (41%), Gaps = 17/301 (5%)
Query: 49 PAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFA 108
+ Q P+ +G ++ K++GRGQF Y G A
Sbjct: 5 SQGMQGPPVPQFQPQKALRPDMGYNTLA---NFRIEKKIGRGQFSEVYRAACLLDGVPVA 61
Query: 109 CKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELF 168
K + L+ + D +EI +++ L+ PN++++ ++ + +++V+EL G+L
Sbjct: 62 LKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELADAGDLS 120
Query: 169 DRI----IAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKA 224
I K ER + + + H VMHRD+KP N +++ ++K
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG---VVKL 177
Query: 225 TDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFW 282
D GL F + +VG+ YY++PE + Y + DIWS G +LY + + PF+
Sbjct: 178 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 237
Query: 283 AETE--KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
+ + I Q D+ P S + LV + DP+KR V +
Sbjct: 238 GDKMNLYSLCKKIEQC--DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295
Query: 341 E 341
Sbjct: 296 H 296
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 6e-68
Identities = 52/385 (13%), Positives = 108/385 (28%), Gaps = 71/385 (18%)
Query: 7 KSKDPKPRHYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGPTPA----AAPVSGLKQAVP 62
+ Y G+R ++ + P+ T + +A S + ++
Sbjct: 6 HHSSGRENLYFQGFRG----TDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLW 61
Query: 63 RPDTN----TILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV 118
+ LG+ G LG+ T+ TG F +
Sbjct: 62 NTGQPFRVESELGERP----RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP 117
Query: 119 TKNDKDDIKREIQIMQHL------------------------SGQPNIVEFKGAYEDK-- 152
N +K E+ ++ L + ++ + D
Sbjct: 118 PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWV 177
Query: 153 QSVHVVMELCAG------GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL 206
S + L A + ++ ++ H G++H L
Sbjct: 178 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237
Query: 207 KPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY----YVAPEVLRRR----- 257
+P + +L D+ + T F V +G +G + A +L
Sbjct: 238 RPVDIVL---DQRGGVFLTGFEHLV--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPT 292
Query: 258 -YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316
D W+ G+ +Y + P + G + I + + I + L+
Sbjct: 293 LMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKN--------IPQPVRALL 344
Query: 317 RRMLTQDPKKRITSAQVLEHPWIKE 341
L + R+ Q +E P ++
Sbjct: 345 EGFLRYPKEDRLLPLQAMETPEYEQ 369
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 8e-68
Identities = 58/280 (20%), Positives = 111/280 (39%), Gaps = 38/280 (13%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ + +G G FG + G+ + K + + + +RE++ + L
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY-------NNEKAEREVKALAKLD-HV 64
Query: 141 NIVEFKGAYED----------------KQSVHVVMELCAGGELFDRIIAK--GHYSERAA 182
NIV + G ++ + + + ME C G L I + + A
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 183 ASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI 242
+ I V H +++RDLKP N L + +K DFGL ++
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFL---VDTKQVKIGDFGLVTSLKNDGKRTRS 181
Query: 243 VGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE 301
G+ Y++PE + + YGKE+D+++ G+IL LL F + G I
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA--FETSKFFTDLRDGIIS-- 237
Query: 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
K L++++L++ P+ R ++++L + +
Sbjct: 238 ----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 4e-67
Identities = 62/302 (20%), Positives = 104/302 (34%), Gaps = 32/302 (10%)
Query: 64 PDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK 123
+ G HY F ++LG G F L G +A K I + + D+
Sbjct: 14 RENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDR 70
Query: 124 DDIKREIQIMQHLSGQPNIVEFKGAYEDKQS----VHVVMELCAGGELFDRI----IAKG 175
++ +RE + + PNI+ ++ +++ G L++ I
Sbjct: 71 EEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN 129
Query: 176 HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235
+E + I + H G HRDLKP N LL + + D G
Sbjct: 130 FLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ---PVLMDLGSMNQACI 186
Query: 236 GKVYRD----------IVGSAYYVAPEVL----RRRYGKEIDIWSAGVILYILLSGVPPF 281
+ Y APE+ + D+WS G +LY ++ G P+
Sbjct: 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246
Query: 282 WAETEKG-IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
+KG +Q + P SS+ L+ M+T DP +R +L
Sbjct: 247 DMVFQKGDSVALAVQNQLSIP--QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304
Query: 341 EG 342
+
Sbjct: 305 QP 306
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 2e-65
Identities = 96/307 (31%), Positives = 144/307 (46%), Gaps = 24/307 (7%)
Query: 45 PGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTG 104
G P +G Q P ED + FGK LG G F L E +T
Sbjct: 2 DGTAAEPRPGAGSLQHAQPPPQPRKKR--PED----FKFGKILGEGSFSTVVLARELATS 55
Query: 105 RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164
R++A K + KR ++ +N + RE +M L P V+ ++D + ++ +
Sbjct: 56 REYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKN 114
Query: 165 GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKA 224
GEL I G + E IV+ + H G++HRDLKPEN LL +E+ ++
Sbjct: 115 GELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQI 171
Query: 225 TDFGLS-VFIEEGKVYRD--IVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPP 280
TDFG + V E K R VG+A YV+PE+L + K D+W+ G I+Y L++G+PP
Sbjct: 172 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
Query: 281 FWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITS------AQVL 334
F A E IF I++ + DF P A+DLV ++L D KR+ +
Sbjct: 232 FRAGNEYLIFQKIIKLEYDF---P-EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 287
Query: 335 EHPWIKE 341
HP+ +
Sbjct: 288 AHPFFES 294
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 3e-65
Identities = 77/309 (24%), Positives = 122/309 (39%), Gaps = 43/309 (13%)
Query: 60 AVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT 119
D + +G+ E +L + L G F Y + +GR++A K + +
Sbjct: 9 GASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--- 65
Query: 120 KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS--------VHVVMELCAGGELFDRI 171
+ I +E+ M+ LSG PNIV+F A + ++ ELC G+L + +
Sbjct: 66 EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFL 124
Query: 172 I---AKGHYSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKDENALLKATD 226
++G S I V H ++HRDLK EN LL +K D
Sbjct: 125 KKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCD 181
Query: 227 FGLSVFIEEGKVYRDI-------------VGSAYYVAPEVL----RRRYGKEIDIWSAGV 269
FG + I Y + Y PE++ G++ DIW+ G
Sbjct: 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGC 241
Query: 270 ILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT 329
ILY+L PF E G I+ G P T + L+R ML +P++R++
Sbjct: 242 ILYLLCFRQHPF----EDGAKLRIVNGKYSI--PPHDTQYTVFHSLIRAMLQVNPEERLS 295
Query: 330 SAQVLEHPW 338
A+V+
Sbjct: 296 IAEVVHQLQ 304
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 6e-63
Identities = 64/292 (21%), Positives = 114/292 (39%), Gaps = 42/292 (14%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ + LGRG FGV + +A K I + ++ + RE++ + L P
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HP 63
Query: 141 NIVEFKGAYEDKQS------------VHVVMELCAGGELFDRIIAKGHYS---ERAAASI 185
IV + A+ +K + +++ M+LC L D + + I
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 186 CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-------------VF 232
I V H G+MHRDLKP N + ++K DFGL
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 233 IEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKG-IF 290
+ + VG+ Y++PE + Y ++DI+S G+IL+ LL PF + E+
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237
Query: 291 DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342
+ + +V+ ML+ P +R + ++E+ ++
Sbjct: 238 TDVRNLKF---PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 4e-61
Identities = 57/288 (19%), Positives = 113/288 (39%), Gaps = 34/288 (11%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ +++G G+FG + C + G +A K SK+ L D+ + RE+ L
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIK-RSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRI----IAKGHYSERAAASICRSIVNVVHI 195
++V + A+ + + + E C GG L D I ++ E + + +
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 196 CHFMGVMHRDLKPENFLLSSK----------------DENALLKATDFGLSVFIEEGKVY 239
H M ++H D+KP N +S + K D G I +V
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 190
Query: 240 RDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD 297
G + ++A EVL+ + + DI++ + + P + + I QG
Sbjct: 191 ---EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQGR 244
Query: 298 IDFESAPWP-TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344
+ P +S +L++ M+ DP++R ++ +++H +
Sbjct: 245 LP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-58
Identities = 81/271 (29%), Positives = 137/271 (50%), Gaps = 24/271 (8%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ K LG G FG L +G +A K + K+K+V + E +I+Q ++ P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FP 101
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
+V+ + +++D ++++VME AGGE+F + G +SE A IV H +
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV----GSAYYVAPEVLRR 256
+++RDLKPEN L+ D+ ++ TDFG + K + G+ +APE++
Sbjct: 162 LIYRDLKPENLLI---DQQGYIQVTDFGFA------KRVKGRTWTLCGTPEALAPEIILS 212
Query: 257 R-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315
+ Y K +D W+ GV++Y + +G PPF+A+ I++ I+ G + F P SS KDL
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF---P-SHFSSDLKDL 268
Query: 316 VRRMLTQDPKKRITSAQ-----VLEHPWIKE 341
+R +L D KR + + + H W
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-57
Identities = 74/277 (26%), Positives = 138/277 (49%), Gaps = 19/277 (6%)
Query: 75 EDVKL-HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIM 133
EDV H+ + +G+G FG + +N T + +A K ++K+K V +N+ ++ +E+QIM
Sbjct: 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIM 69
Query: 134 QHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE-RAAASICRSIVNV 192
Q L P +V +++D++ + +V++L GG+L + H+ E IC ++ +
Sbjct: 70 QGLE-HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMAL 128
Query: 193 VHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPE 252
++ ++HRD+KP+N LL DE+ + TDF ++ + + G+ Y+APE
Sbjct: 129 DYL-QNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPE 184
Query: 253 VLRRR----YGKEIDIWSAGVILYILLSGVPPFW---AETEKGIFDAILQGDIDFESAPW 305
+ R Y +D WS GV Y LL G P+ + + K I + + P
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY---P- 240
Query: 306 PTISSSAKDLVRRMLTQDPKKRITSAQ-VLEHPWIKE 341
S L++++L +P +R + V P++ +
Sbjct: 241 SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 1e-56
Identities = 83/267 (31%), Positives = 135/267 (50%), Gaps = 16/267 (5%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +GRG FG L ST + +A K +SK +++ ++D E IM + P +V+
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQ 133
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
A++D + +++VME GG+L +++ E+ A +V + H MG +HR
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHR 192
Query: 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD--IVGSAYYVAPEVLRR-----R 257
D+KP+N LL D++ LK DFG + + + + R VG+ Y++PEVL+
Sbjct: 193 DVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 249
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
YG+E D WS GV LY +L G PF+A++ G + I+ IS AK+L+
Sbjct: 250 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 309
Query: 318 RMLTQDPKKRITS---AQVLEHPWIKE 341
LT D + R+ ++ H + K
Sbjct: 310 AFLT-DREVRLGRNGVEEIKRHLFFKN 335
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 5e-56
Identities = 83/275 (30%), Positives = 137/275 (49%), Gaps = 32/275 (11%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ + LG G FG +L GR +A K + K +V + E ++ ++ P
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HP 66
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE-RA---AASICRSIVNVVHIC 196
I+ G ++D Q + ++M+ GGELF + + A AA +C ++ ++
Sbjct: 67 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE---YL- 122
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV----GSAYYVAPE 252
H +++RDLKPEN LL D+N +K TDFG + K D+ G+ Y+APE
Sbjct: 123 HSKDIIYRDLKPENILL---DKNGHIKITDFGFA------KYVPDVTYTLCGTPDYIAPE 173
Query: 253 VLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311
V+ + Y K ID WS G+++Y +L+G PF+ ++ IL ++ F P P +
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF---P-PFFNED 229
Query: 312 AKDLVRRMLTQDPKKRI-----TSAQVLEHPWIKE 341
KDL+ R++T+D +R+ + V HPW KE
Sbjct: 230 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-54
Identities = 75/273 (27%), Positives = 127/273 (46%), Gaps = 28/273 (10%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ--PNI 142
+ +GRG FG Y C + TG+ +A K + K+++ K + E ++ +S P I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 143 VEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE-RA---AASICRSIVNVVHICHF 198
V A+ + +++L GG+L + G +SE AA I + H+ H
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL---EHM-HN 310
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-- 256
V++RDLKP N LL DE+ ++ +D GL+ + K + VG+ Y+APEVL++
Sbjct: 311 RFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGV 366
Query: 257 RYGKEIDIWSAGVILYILLSGVPPFWAETEKG---IFDAILQGDIDFESAPWPTISSSAK 313
Y D +S G +L+ LL G PF K I L ++ + S +
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELR 422
Query: 314 DLVRRMLTQDPKKRI-----TSAQVLEHPWIKE 341
L+ +L +D +R+ + +V E P+ +
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 6e-54
Identities = 73/270 (27%), Positives = 130/270 (48%), Gaps = 18/270 (6%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +GRG FG + + + FA K ++K +++ + + + E ++ + I
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITT 138
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRII-AKGHYSERAAASICRSIVNVVHICHFMGVMH 203
A++D ++++VM+ GG+L + + E A +V + H + +H
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH 198
Query: 204 RDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRD-IVGSAYYVAPEVL------R 255
RD+KP+N L+ D N ++ DFG +E+G V VG+ Y++PE+L +
Sbjct: 199 RDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-ISSSAKD 314
RYG E D WS GV +Y +L G PF+AE+ + I+ F+ T +S +AKD
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKD 315
Query: 315 LVRRMLTQDPKKRITS---AQVLEHPWIKE 341
L+RR++ + R+ +HP+
Sbjct: 316 LIRRLIC-SREHRLGQNGIEDFKKHPFFSG 344
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 9e-54
Identities = 61/267 (22%), Positives = 122/267 (45%), Gaps = 16/267 (5%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNI 142
F E+GRG F Y + T + A + RKL TK+++ K E ++++ L PNI
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNI 87
Query: 143 VEFKGAYED----KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198
V F ++E K+ + +V EL G L + + S CR I+ + H
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 199 MG--VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR 256
++HRDLK +N ++ +K D GL+ + ++G+ ++APE+
Sbjct: 148 RTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLATLKRASFA-KAVIGTPEFMAPEMYEE 204
Query: 257 RYGKEIDIWSAGVILYILLSGVPPFWAETE--KGIFDAILQGDIDFESAPWPTISSSAKD 314
+Y + +D+++ G+ + + + P ++E + I+ + G ++ K+
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYP-YSECQNAAQIYRRVTSGVK--PASFDKVAIPEVKE 261
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWIKE 341
++ + Q+ +R + +L H + +E
Sbjct: 262 IIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-53
Identities = 50/295 (16%), Positives = 103/295 (34%), Gaps = 39/295 (13%)
Query: 72 KPYEDVKL---HYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDK 123
KP + +L LG G F Y T + ++F K +
Sbjct: 55 KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEF 111
Query: 124 DDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY-----S 178
+ ++ ++ Q ++F A+ + +V EL + G L + I +
Sbjct: 112 YIGTQLMERLKPSM-QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMP 170
Query: 179 ERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK--------DENALLKATDFGLS 230
+ S ++ ++ H ++H D+KP+NF+L + D +A L D G S
Sbjct: 171 QGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
Query: 231 V---FIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWA-ET 285
+ +G ++ ++ + E+L + + +ID + +Y +L G E
Sbjct: 231 IDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290
Query: 286 EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
+ + + + + W + ML + S +L K
Sbjct: 291 GECKPEGLFRRLPHLD--MW-------NEFFHVMLNIPDCHHLPSLDLLRQKLKK 336
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-53
Identities = 65/325 (20%), Positives = 119/325 (36%), Gaps = 19/325 (5%)
Query: 23 SPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYS 82
S + + A P + + V + + Y + +
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNI 142
+GRG FG + + TG Q A K + + E+ LS P I
Sbjct: 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL--------EVFRVEELVACAGLS-SPRI 112
Query: 143 VEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVM 202
V GA + V++ MEL GG L I G E A + + H ++
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRIL 172
Query: 203 HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR------DIVGSAYYVAPEVLRR 256
H D+K +N LLSS + DFG ++ ++ + + I G+ ++APEV+
Sbjct: 173 HGDVKADNVLLSSD--GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 257 R-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315
+ ++DIWS+ ++ +L+G P+ + I P P+ +
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP-PSCAPLTAQA 289
Query: 316 VRRMLTQDPKKRITSAQVLEHPWIK 340
++ L ++P R ++ ++
Sbjct: 290 IQEGLRKEPVHRASAMELRRKVGKA 314
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-53
Identities = 67/269 (24%), Positives = 121/269 (44%), Gaps = 20/269 (7%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K +GRG F + TG+ +A K ++K ++ + + + E ++ + + I +
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQ 125
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMH 203
A++D+ +++VME GG+L + G A IV + H +G +H
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVH 185
Query: 204 RDLKPENFLLSSKDENALLKATDFGLSV-FIEEGKVYRD-IVGSAYYVAPEVLRR----- 256
RD+KP+N LL D ++ DFG + +G V VG+ Y++PE+L+
Sbjct: 186 RDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP 242
Query: 257 ---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT-ISSSA 312
YG E D W+ GV Y + G PF+A++ + I+ + A
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEA 302
Query: 313 KDLVRRMLTQDPKKRITSAQVLE---HPW 338
+D ++R+L P+ R+ + HP+
Sbjct: 303 RDFIQRLLC-PPETRLGRGGAGDFRTHPF 330
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 3e-53
Identities = 70/258 (27%), Positives = 126/258 (48%), Gaps = 10/258 (3%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146
LG+G FG +L T + FA K++ K ++ +D + E +++ P +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDL 206
++ K+++ VME GG+L I + + A I+ + H G+++RDL
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDL 144
Query: 207 KPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDI 264
K +N LL D++ +K DFG+ + G+ Y+APE+L + Y +D
Sbjct: 145 KLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDW 201
Query: 265 WSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDP 324
WS GV+LY +L G PF + E+ +F +I + + P + AKDL+ ++ ++P
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY---P-RWLEKEAKDLLVKLFVREP 257
Query: 325 KKRITSAQ-VLEHPWIKE 341
+KR+ + +HP +E
Sbjct: 258 EKRLGVRGDIRQHPLFRE 275
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 7e-53
Identities = 78/270 (28%), Positives = 128/270 (47%), Gaps = 15/270 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
++ F + LG+G FG L TG +A K + K ++ +D + E +I+
Sbjct: 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P + + ++ + VME GG+L I + E A I++ + H
Sbjct: 84 PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK 143
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR- 257
G+++RDLK +N LL D K DFG+ I G G+ Y+APE+L+
Sbjct: 144 GIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML 200
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
YG +D W+ GV+LY +L G PF AE E +F+AIL ++ + P + A +++
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY---P-TWLHEDATGILK 256
Query: 318 RMLTQDPKKRITS------AQVLEHPWIKE 341
+T++P R+ S +L HP+ KE
Sbjct: 257 SFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-52
Identities = 70/269 (26%), Positives = 128/269 (47%), Gaps = 14/269 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
++F LG+G FG L T +A K + K ++ +D + E +++
Sbjct: 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P + + ++ ++ VME GG+L I G + E A I +
Sbjct: 81 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR- 257
G+++RDLK +N +L D +K DFG+ I +G + G+ Y+APE++ +
Sbjct: 141 GIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP 197
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
YGK +D W+ GV+LY +L+G PF E E +F +I++ ++ + P ++S A + +
Sbjct: 198 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-KSMSKEAVAICK 253
Query: 318 RMLTQDPKKRITSAQ-----VLEHPWIKE 341
++T+ P KR+ + EH + +
Sbjct: 254 GLMTKHPGKRLGCGPEGERDIKEHAFFRY 282
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 5e-52
Identities = 82/322 (25%), Positives = 151/322 (46%), Gaps = 32/322 (9%)
Query: 39 HHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGK-----PYEDVKLHYSFGKELGRGQFG 93
HH L D +L ++G G G
Sbjct: 2 HHHHHHSSGV--DLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTG 59
Query: 94 VTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153
+ L E +GRQ A K + L + ++ + E+ IM+ N+VE +Y +
Sbjct: 60 IVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGE 115
Query: 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLL 213
+ V+ME GG L D I+++ +E A++C +++ + H GV+HRD+K ++ LL
Sbjct: 116 ELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL 174
Query: 214 SSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRRR-YGKEIDIWSAGVIL 271
+ + +K +DFG I + R +VG+ Y++APEV+ R Y E+DIWS G+++
Sbjct: 175 T---LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMV 231
Query: 272 YILLSGVPPFWAETE-KGIFDAILQGDIDFESAPWPTI------SSSAKDLVRRMLTQDP 324
++ G PP+++++ + + + +P P + S +D + RML +DP
Sbjct: 232 IEMVDGEPPYFSDSPVQAMK-RL-------RDSPPPKLKNSHKVSPVLRDFLERMLVRDP 283
Query: 325 KKRITSAQVLEHPWIKEGGEAS 346
++R T+ ++L+HP++ + G
Sbjct: 284 QERATAQELLDHPFLLQTGLPE 305
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 5e-52
Identities = 92/319 (28%), Positives = 153/319 (47%), Gaps = 23/319 (7%)
Query: 32 APAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKL-HYSFGKELGRG 90
A Q +K + L KP V + + + K LG+G
Sbjct: 100 TTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKG 159
Query: 91 QFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150
FG L E +TGR +A K + K +V K++ E +++Q+ S P + K +++
Sbjct: 160 TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALKYSFQ 218
Query: 151 DKQSVHVVMELCAGGELFDRIIAKGHYSE-RA---AASICRSIVNVVHICHFMGVMHRDL 206
+ VME GGELF + + +SE RA A I ++ ++ V++RDL
Sbjct: 219 THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD---YLHSEKNVVYRDL 275
Query: 207 KPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDI 264
K EN +L D++ +K TDFGL I++G + G+ Y+APEVL YG+ +D
Sbjct: 276 KLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 332
Query: 265 WSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDP 324
W GV++Y ++ G PF+ + + +F+ IL +I F P T+ AK L+ +L +DP
Sbjct: 333 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF---P-RTLGPEAKSLLSGLLKKDP 388
Query: 325 KKRITSAQ-----VLEHPW 338
K+R+ +++H +
Sbjct: 389 KQRLGGGSEDAKEIMQHRF 407
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-51
Identities = 82/289 (28%), Positives = 146/289 (50%), Gaps = 31/289 (10%)
Query: 72 KPYEDVKL---HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR 128
K E + + + LG+G FG C +TG+ +ACK + K+++ + +
Sbjct: 174 KWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN 233
Query: 129 EIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI--IAKGHYSE-RA---A 182
E QI++ ++ +V AYE K ++ +V+ L GG+L I + + + E RA A
Sbjct: 234 EKQILEKVN-SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 183 ASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI 242
A IC + ++ H +++RDLKPEN LL D++ ++ +D GL+V + EG+ +
Sbjct: 293 AEICCGLEDL----HRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGR 345
Query: 243 VGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAILQGD 297
VG+ Y+APEV++ RY D W+ G +LY +++G PF +K + + +
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP 405
Query: 298 IDFESAPWPTISSSAKDLVRRMLTQDPKKRITS-----AQVLEHPWIKE 341
++ S A+ L ++L +DP +R+ +V EHP K+
Sbjct: 406 EEYS----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 3e-51
Identities = 85/261 (32%), Positives = 138/261 (52%), Gaps = 15/261 (5%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
K LG+G FG L E +TGR +A K + K ++ K++ E +++Q+ P +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTA 69
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHR 204
K A++ + VME GGELF + + ++E A IV+ + H V++R
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 205 DLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEI 262
D+K EN +L D++ +K TDFGL I +G + G+ Y+APEVL YG+ +
Sbjct: 130 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186
Query: 263 DIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322
D W GV++Y ++ G PF+ + + +F+ IL +I F P T+S AK L+ +L +
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF---P-RTLSPEAKSLLAGLLKK 242
Query: 323 DPKKRITSAQ-----VLEHPW 338
DPK+R+ V+EH +
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRF 263
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-51
Identities = 76/292 (26%), Positives = 134/292 (45%), Gaps = 34/292 (11%)
Query: 72 KPYEDVKL---HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR 128
K E + + + LGRG FG + C +TG+ +ACK ++K++L +
Sbjct: 175 KWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV 234
Query: 129 EIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYS-----ERA-- 181
E +I+ + IV A+E K + +VM + GG++ I + RA
Sbjct: 235 EKKILAKVH-SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 182 -AASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV-FIEEGKVY 239
A I + H+ H +++RDLKPEN LL D++ ++ +D GL+V
Sbjct: 294 YTAQIVSGL---EHL-HQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKT 346
Query: 240 RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAIL 294
+ G+ ++APE+L Y +D ++ GV LY +++ PF A EK + +L
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL 406
Query: 295 QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITS-----AQVLEHPWIKE 341
+ + + P S ++KD +L +DP+KR+ + HP ++
Sbjct: 407 EQAVTY---P-DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-51
Identities = 76/339 (22%), Positives = 141/339 (41%), Gaps = 17/339 (5%)
Query: 10 DPKPRHYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTI 69
K G + + ++ AP + + D N
Sbjct: 275 WFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGN 334
Query: 70 LGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKRE 129
+ ++F LG+G FG L T +A K + K ++ +D + E
Sbjct: 335 RDRMKLT---DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE 391
Query: 130 IQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSI 189
+++ P + + ++ ++ VME GG+L I G + E A I
Sbjct: 392 KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 451
Query: 190 VNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYY 248
+ G+++RDLK +N +L D +K DFG+ I +G + G+ Y
Sbjct: 452 AIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDY 508
Query: 249 VAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT 307
+APE++ + YGK +D W+ GV+LY +L+G PF E E +F +I++ ++ + P +
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-KS 564
Query: 308 ISSSAKDLVRRMLTQDPKKRITSAQ-----VLEHPWIKE 341
+S A + + ++T+ P KR+ + EH + +
Sbjct: 565 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 5e-51
Identities = 81/303 (26%), Positives = 142/303 (46%), Gaps = 24/303 (7%)
Query: 49 PAAAPVSGLKQAVPRPDTNTILGKPYEDVKL---HYSFGKELGRGQFGVTYLCTENSTGR 105
P + A P + I P + + F K +G+G FG L +
Sbjct: 5 PQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEV 64
Query: 106 QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGG 165
+A K + K+ ++ K ++ I E ++ P +V +++ ++ V++ GG
Sbjct: 65 FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 124
Query: 166 ELFDRIIAKGHYSE-RA---AASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENAL 221
ELF + + + E RA AA I ++ ++ H + +++RDLKPEN LL D
Sbjct: 125 ELFYHLQRERCFLEPRARFYAAEIASAL---GYL-HSLNIVYRDLKPENILL---DSQGH 177
Query: 222 LKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVP 279
+ TDFGL IE G+ Y+APEVL ++ Y + +D W G +LY +L G+P
Sbjct: 178 IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
Query: 280 PFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITS----AQVLE 335
PF++ ++D IL + P I++SA+ L+ +L +D KR+ + ++
Sbjct: 238 PFYSRNTAEMYDNILNKPLQL---K-PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKS 293
Query: 336 HPW 338
H +
Sbjct: 294 HVF 296
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 7e-51
Identities = 82/279 (29%), Positives = 141/279 (50%), Gaps = 21/279 (7%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
D K Y+ +++G+G G Y + +TG++ A + + L + K+ I EI +M+
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMR 72
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
PNIV + +Y + VVME AGG L D ++ + E A++CR + +
Sbjct: 73 ENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALE 130
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEV 253
H V+HRD+K +N LL + +K TDFG I + R +VG+ Y++APEV
Sbjct: 131 FLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 254 LRRR-YGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAP----WPT 307
+ R+ YG ++DIWS G++ ++ G PP+ E + ++ I P
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGTPELQNPEK 241
Query: 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346
+S+ +D + R L D +KR ++ ++L+H ++K S
Sbjct: 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS 280
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 9e-51
Identities = 81/265 (30%), Positives = 139/265 (52%), Gaps = 19/265 (7%)
Query: 85 KELGRGQFGVTYLC---TENSTGRQFACKSISKRKLVTK-NDKDDIKREIQIMQHLSGQP 140
+ LG+G +G + T +TG+ FA K + K +V D K E I++ + P
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HP 81
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
IV+ A++ +++++E +GGELF ++ +G + E A I + H G
Sbjct: 82 FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR-Y 258
+++RDLKPEN +L + +K TDFGL I +G V G+ Y+APE+L R +
Sbjct: 142 IIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH 198
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
+ +D WS G ++Y +L+G PPF E K D IL+ ++ P P ++ A+DL+++
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL---P-PYLTQEARDLLKK 254
Query: 319 MLTQDPKKRITS-----AQVLEHPW 338
+L ++ R+ + +V HP+
Sbjct: 255 LLKRNAASRLGAGPGDAGEVQAHPF 279
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-50
Identities = 66/272 (24%), Positives = 122/272 (44%), Gaps = 22/272 (8%)
Query: 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIV 143
LG+G +G+ Y + S + A K I + EI + +HL NIV
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHLK-HKNIV 82
Query: 144 EFKGAYEDKQSVHVVMELCAGGELFDRIIAKG---HYSERAAASICRSIVNVVHICHFMG 200
++ G++ + + + ME GG L + +K +E+ + I+ + H
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEVLRRR-- 257
++HRD+K +N L+++ + +LK +DFG S + + G+ Y+APE++ +
Sbjct: 143 IVHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 258 -YGKEIDIWSAGVILYILLSGVPPFWAETEKG---IFDAILQGDIDFESAPWP-TISSSA 312
YGK DIWS G + + +G PP + E + +F + P ++S+ A
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPP-FYELGEPQAAMF-KVGMFK---VHPEIPESMSAEA 255
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344
K + + DP KR + +L ++K +
Sbjct: 256 KAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-50
Identities = 74/327 (22%), Positives = 132/327 (40%), Gaps = 27/327 (8%)
Query: 35 QQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKL---HYSFGKELGRGQ 91
HH + P + + L + + +GRG
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGS 64
Query: 92 FGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151
+ L T R +A + + K + D D ++ E + + S P +V ++
Sbjct: 65 YAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT 124
Query: 152 KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENF 211
+ + V+E GG+L + + E A I ++ H G+++RDLK +N
Sbjct: 125 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 184
Query: 212 LLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGV 269
LL D +K TD+G+ + G G+ Y+APE+LR YG +D W+ GV
Sbjct: 185 LL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 241
Query: 270 ILYILLSGVPPFW---------AETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRML 320
+++ +++G PF TE +F IL+ I P ++S A +++ L
Sbjct: 242 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P-RSLSVKAASVLKSFL 297
Query: 321 TQDPKKRITS------AQVLEHPWIKE 341
+DPK+R+ A + HP+ +
Sbjct: 298 NKDPKERLGCHPQTGFADIQGHPFFRN 324
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-50
Identities = 71/279 (25%), Positives = 125/279 (44%), Gaps = 24/279 (8%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ + +GRG + L T R +A K + K + D D ++ E + + S
Sbjct: 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P +V ++ + + V+E GG+L + + E A I ++ H
Sbjct: 70 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 129
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR- 257
G+++RDLK +N LL D +K TD+G+ + G G+ Y+APE+LR
Sbjct: 130 GIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 186
Query: 258 YGKEIDIWSAGVILYILLSGVPPFW---------AETEKGIFDAILQGDIDFESAPWPTI 308
YG +D W+ GV+++ +++G PF TE +F IL+ I P ++
Sbjct: 187 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P-RSL 242
Query: 309 SSSAKDLVRRMLTQDPKKRITS------AQVLEHPWIKE 341
S A +++ L +DPK+R+ A + HP+ +
Sbjct: 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 3e-50
Identities = 76/268 (28%), Positives = 136/268 (50%), Gaps = 27/268 (10%)
Query: 85 KELGRGQFGVTYLC---TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
K LG+G FG +L + + + +A K + K L ++ K E I+ ++ P
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVN-HPF 87
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE-RA---AASICRSIVNVVHICH 197
IV+ A++ + ++++++ GG+LF R+ + ++E A + + + H+ H
Sbjct: 88 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL---ALALDHL-H 143
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRR 256
+G+++RDLKPEN LL DE +K TDFGLS I+ K G+ Y+APEV+ R
Sbjct: 144 SLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 257 R-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315
R + + D WS GV+++ +L+G PF + K IL+ + P +S A+ L
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM---P-QFLSPEAQSL 256
Query: 316 VRRMLTQDPKKRITSAQ-----VLEHPW 338
+R + ++P R+ + + H +
Sbjct: 257 LRMLFKRNPANRLGAGPDGVEEIKRHSF 284
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-49
Identities = 79/317 (24%), Positives = 132/317 (41%), Gaps = 28/317 (8%)
Query: 63 RPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND 122
+ TI G+ Y+ E+G G G + TG A K + R+ K +
Sbjct: 9 QTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEE 66
Query: 123 KDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAA 182
I ++ ++ P IV+ G + V + MEL + +G ER
Sbjct: 67 NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERIL 126
Query: 183 ASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD 241
+ +IV ++ GV+HRD+KP N LL + + +K DFG+S + + K
Sbjct: 127 GKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDFGISGRLVDDKAKDR 183
Query: 242 IVGSAYYVAPEVLRRR------YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ 295
G A Y+APE + Y D+WS G+ L L +G P+ + K F+ + +
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVLTK 241
Query: 296 GDIDFESAPWPTI----SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPID 351
+ E P S + V+ LT+D +KR ++LEH +IK +D
Sbjct: 242 --VLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK---RYETLEVD 296
Query: 352 SA-----VLSRMKQFRA 363
A V+++ + R+
Sbjct: 297 VASWFKDVMAKTESPRS 313
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-49
Identities = 79/299 (26%), Positives = 148/299 (49%), Gaps = 24/299 (8%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
D + ++ +++G+G FG + +N T + A K I + +++ +DI++EI ++
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLS 75
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
P + ++ G+Y + ++ME GG D ++ G E A+I R I+ +
Sbjct: 76 QCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLD 133
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPEV 253
H +HRD+K N LLS E+ +K DFG++ + + ++ R+ VG+ +++APEV
Sbjct: 134 YLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 190
Query: 254 LRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPWPTI--- 308
+++ Y + DIWS G+ L G PP K +F I + + P PT+
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-LIPK------NNP-PTLEGN 242
Query: 309 -SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNK 366
S K+ V L ++P R T+ ++L+H +I A + ++ R K+++A
Sbjct: 243 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR--NAKKTSYLTELIDRYKRWKAEQS 299
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 9e-49
Identities = 90/335 (26%), Positives = 160/335 (47%), Gaps = 34/335 (10%)
Query: 27 VAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKL-HYSFGK 85
+A +++ G + V L E V + ++ K
Sbjct: 1 MAHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK 60
Query: 86 ELGRGQFGVTYLC---TENSTGRQFACKSISKRKLVTK-NDKDDIKREIQIMQHLSGQPN 141
LG G +G +L + + TG+ +A K + K +V K + + E Q+++H+ P
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE-RA---AASICRSIVNVVHICH 197
+V A++ + +H++++ GGELF + + ++E I ++ H+ H
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE---HL-H 176
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLS--VFIEEGKVYRDIVGSAYYVAPEVLR 255
+G+++RD+K EN LL D N + TDFGLS +E + D G+ Y+AP+++R
Sbjct: 177 KLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 233
Query: 256 RR---YGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAILQGDIDFESAPWPTI 308
+ K +D WS GV++Y LL+G PF + EK I IL+ + + P +
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY---P-QEM 289
Query: 309 SSSAKDLVRRMLTQDPKKRITS-----AQVLEHPW 338
S+ AKDL++R+L +DPKKR+ ++ EH +
Sbjct: 290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-48
Identities = 77/322 (23%), Positives = 131/322 (40%), Gaps = 22/322 (6%)
Query: 37 QAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKP-------YEDVKLHYSFGKELGR 89
HH + PT G +P L P +D + +S +E+G
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGH 64
Query: 90 GQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149
G FG Y + A K +S + DI +E++ +Q L PN ++++G Y
Sbjct: 65 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCY 123
Query: 150 EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPE 209
+ + +VME C G + K E A++ + + H ++HRD+K
Sbjct: 124 LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAG 183
Query: 210 NFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL----RRRYGKEIDIW 265
N LLS E L+K DFG + + VG+ Y++APEV+ +Y ++D+W
Sbjct: 184 NILLS---EPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVW 237
Query: 266 SAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDP 324
S G+ L PP + ++ +S W S ++ V L + P
Sbjct: 238 SLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSCLQKIP 294
Query: 325 KKRITSAQVLEHPWIKEGGEAS 346
+ R TS +L+H ++ +
Sbjct: 295 QDRPTSEVLLKHRFVLRERPPT 316
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 8e-48
Identities = 78/307 (25%), Positives = 137/307 (44%), Gaps = 29/307 (9%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
D + + +G G +G Y TG+ A K + VT +++++IK+EI +++
Sbjct: 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLK 75
Query: 135 HLSGQPNIVEFKGAYEDKQSVH------VVMELCAGGELFD--RIIAKGHYSERAAASIC 186
S NI + GA+ K +VME C G + D + E A IC
Sbjct: 76 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 135
Query: 187 RSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGS 245
R I+ + H V+HRD+K +N LL+ ENA +K DFG+S ++ R+ +G+
Sbjct: 136 REILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGT 192
Query: 246 AYYVAPEVLRRR------YGKEIDIWSAGVILYILLSGVPPFWAETE--KGIFDAILQGD 297
Y++APEV+ Y + D+WS G+ + G PP + + +F
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL-CDMHPMRALFLIPRNPA 251
Query: 298 IDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASD-KPIDSAVLS 356
+S W S + + L ++ +R + Q+++HP+I++ + +
Sbjct: 252 PRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHID 308
Query: 357 RMKQFRA 363
R K+ R
Sbjct: 309 RTKKKRG 315
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-47
Identities = 73/287 (25%), Positives = 125/287 (43%), Gaps = 30/287 (10%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
D + ELG G FG Y TG A K I ++ + +D EI+I+
Sbjct: 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILA 71
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI-IAKGHYSERAAASICRSIVNVV 193
P IV+ GAY + +++E C GG + + +E +CR ++ +
Sbjct: 72 TCD-HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEAL 130
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPE 252
+ H ++HRDLK N L++ ++ DFG+S + RD +G+ Y++APE
Sbjct: 131 NFLHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187
Query: 253 VLRRR------YGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPW 305
V+ Y + DIWS G+ L + PP + + I + +
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL-KIAK-------SDP 239
Query: 306 PTI------SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346
PT+ S +D ++ L ++P+ R ++AQ+LEHP++
Sbjct: 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-47
Identities = 75/283 (26%), Positives = 135/283 (47%), Gaps = 29/283 (10%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
+ + + ++LG G +G Y TG+ A K + ++D +I +EI IMQ
Sbjct: 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-----VESDLQEIIKEISIMQ 79
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI-IAKGHYSERAAASICRSIVNVV 193
P++V++ G+Y + +VME C G + D I + +E A+I +S + +
Sbjct: 80 QCD-SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGL 138
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGSAYYVAPE 252
HFM +HRD+K N LL+ K DFG++ + + R+ ++G+ +++APE
Sbjct: 139 EYLHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE 195
Query: 253 VLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAI-------LQGDIDFESA 303
V++ Y DIWS G+ + G PP+ + IF I + +
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-MIPTNPPPTFRKPELW--- 251
Query: 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346
S + D V++ L + P++R T+ Q+L+HP+++ S
Sbjct: 252 -----SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-46
Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 28/292 (9%)
Query: 71 GKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREI 130
P+ + Y + +G G V + A K I+ K + D++ +EI
Sbjct: 7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEI 64
Query: 131 QIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI--------IAKGHYSERAA 182
Q M PNIV + ++ K + +VM+L +GG + D I G E
Sbjct: 65 QAMSQCH-HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 183 ASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD- 241
A+I R ++ + H G +HRD+K N LL E+ ++ DFG+S F+ G
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITRN 180
Query: 242 -----IVGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL 294
VG+ ++APEV+ + Y + DIWS G+ L +G P+ + L
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL 240
Query: 295 QGD------IDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
Q D + S + ++ L +DP+KR T+A++L H + +
Sbjct: 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 9e-46
Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 28/283 (9%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
E+GRG +G +G+ A K I R V + ++ + ++ ++ S P IV+
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ 85
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAK------GHYSERAAASICRSIVN-VVHICH 197
F GA + + MEL + FD+ E I + V + H+
Sbjct: 86 FYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL--- 254
+ ++HRD+KP N LL +K DFG+S + + G Y+APE +
Sbjct: 144 NLKIIHRDIKPSNILLDRSGN---IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 255 --RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDA---ILQGDI-DFESAPWPTI 308
R+ Y D+WS G+ LY L +G P+ +FD +++GD ++
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFPY--PKWNSVFDQLTQVVKGDPPQLSNSEEREF 258
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPID 351
S S + V LT+D KR ++L+HP+I ++ ++
Sbjct: 259 SPSFINFVNLCLTKDESKRPKYKELLKHPFIL---MYEERAVE 298
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 5e-45
Identities = 71/282 (25%), Positives = 121/282 (42%), Gaps = 30/282 (10%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
ELGRG +GV +G+ A K I R V ++ + ++ I P V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVT 70
Query: 145 FKGAYEDKQSVHVVMELCAGG--ELFDRIIAK-GHYSERAAASICRSIVNVVHICHF-MG 200
F GA + V + MEL + + ++I K E I SIV + H +
Sbjct: 71 FYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR----- 255
V+HRD+KP N L+++ + +K DFG+S ++ + G Y+APE +
Sbjct: 131 VIHRDVKPSNVLINALGQ---VKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP------WPTIS 309
+ Y + DIWS G+ + L P+ ++ F + Q + E +P + S
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPY--DSWGTPFQQLKQ--VVEEPSPQLPADKF---S 240
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPID 351
+ D + L ++ K+R T ++++HP+ K D
Sbjct: 241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFT---LHESKGTD 279
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-45
Identities = 82/305 (26%), Positives = 129/305 (42%), Gaps = 47/305 (15%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHL 136
Y ++G G +GV + C TG+ A K K + D IK REI++++ L
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLKQL 59
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAG--GELFDRIIAKGHYSERAAASICRSIVNVVH 194
PN+V + K+ +H+V E C DR + E SI + V+
Sbjct: 60 K-HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVN 116
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEV 253
CH +HRD+KPEN L++ +K DFG + + Y D V + +Y +PE+
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSV---IKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173
Query: 254 L--RRRYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAI-------------L 294
L +YG +D+W+ G + LLSGVP + +++ I +
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233
Query: 295 QGDIDFESAPW----------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344
Q + P IS A L++ L DP +R+T Q+L HP+ + E
Sbjct: 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293
Query: 345 ASDKP 349
D
Sbjct: 294 IEDLA 298
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 8e-45
Identities = 96/393 (24%), Positives = 161/393 (40%), Gaps = 79/393 (20%)
Query: 46 GPTPAAAPVSGLKQAVPRPDTNTI-----LGKPYEDVKLHYSFGKELGRGQFGVTYLCTE 100
T + AP++G+K I GK E ++ Y+ K +G G FGV +
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKL 61
Query: 101 NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK------GAYEDKQS 154
+ + A K + DK RE+QIM+ + PN+V+ K G +D+
Sbjct: 62 VESD-EVAIKKV-------LQDKRFKNRELQIMRIVK-HPNVVDLKAFFYSNGDKKDEVF 112
Query: 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI-------------CHFMGV 201
+++V+E E R HY++ + + ++ I H +G+
Sbjct: 113 LNLVLEYV--PETVYRASR--HYAKL------KQTMPMLLIKLYMYQLLRSLAYIHSIGI 162
Query: 202 MHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL--RRRYG 259
HRD+KP+N LL + +LK DFG + + G+ + S YY APE++ Y
Sbjct: 163 CHRDIKPQNLLLDP--PSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYT 220
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAIL----QGDIDFESA-------- 303
IDIWS G ++ L+ G P F E+ I +L + I +
Sbjct: 221 TNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK-VLGTPSREQIKTMNPNYMEHKFP 279
Query: 304 -----PW-----PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSA 353
P+ P A DL+ R+L P R+T+ + L HP+ E + +
Sbjct: 280 QIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGR 339
Query: 354 VLSRMKQFRAMNKLKKLALKVSLIKYMLMYQHV 386
L + + ++L+++ LI L+ QH
Sbjct: 340 ELPPLFNW----TKEELSVRPDLIS-RLVPQHA 367
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-43
Identities = 74/304 (24%), Positives = 125/304 (41%), Gaps = 49/304 (16%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHL 136
Y +G G +G+ C TGR A K K + +D +K REI++++ L
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLLKQL 81
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAG--GELFDRIIAKGHYSERAAASICRSIVNVVH 194
N+V + K+ ++V E + + + I+N +
Sbjct: 82 R-HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIG 138
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEV 253
CH ++HRD+KPEN L+S +K DFG + G+VY D V + +Y APE+
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGV---VKLCDFGFARTLAAPGEVYDDEVATRWYRAPEL 195
Query: 254 L--RRRYGKEIDIWSAGVILYILLSGVPPFWAETE------------------------- 286
L +YGK +D+W+ G ++ + G P F +++
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255
Query: 287 ---KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343
G+ ++ E +P +S DL ++ L DP KR A++L H + + G
Sbjct: 256 PVFAGVRLPEIKEREPLERR-YPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314
Query: 344 EASD 347
A
Sbjct: 315 FAER 318
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 2e-43
Identities = 56/261 (21%), Positives = 101/261 (38%), Gaps = 28/261 (10%)
Query: 98 CTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157
+ + + L + + D +I+ M S N V K +++
Sbjct: 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS-TKNTVGQLQPSSPKVYLYI 138
Query: 158 VMELCAGGELFDRIIAKGHYSER---AAASICRSIVNVVHICHFMGVMHRDLKPENFLLS 214
M+LC L D + + +R I I V H G+MHRDLKP N +
Sbjct: 139 QMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT 198
Query: 215 SKDENALLKATDFGLSVFIEEGKVYRDI-------------VGSAYYVAPEVLR-RRYGK 260
D +K DFGL +++ + + + VG+ Y++PE + Y
Sbjct: 199 MDDV---VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSH 255
Query: 261 EIDIWSAGVILYILLSGVPPFWAETEKG-IFDAILQGDIDFESAPWPTISSSAKDLVRRM 319
++DI+S G+IL+ LL F + E+ I + + +V+ M
Sbjct: 256 KVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKF---PLLFTQKYPQEHMMVQDM 309
Query: 320 LTQDPKKRITSAQVLEHPWIK 340
L+ P +R + ++E+ +
Sbjct: 310 LSPSPTERPEATDIIENAIFE 330
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-43
Identities = 76/329 (23%), Positives = 125/329 (37%), Gaps = 52/329 (15%)
Query: 65 DTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKD 124
T K E + ELG G GV + + +G A K I + ++
Sbjct: 19 AFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRN 76
Query: 125 DIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAAS 184
I RE+Q++ H P IV F GA+ + + ME GG L + G E+
Sbjct: 77 QIIRELQVL-HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 135
Query: 185 ICRSIVNVVHICHFMG-VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243
+ +++ + +MHRD+KP N L++S+ E +K DFG+S + + V
Sbjct: 136 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFV 191
Query: 244 GSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL-------- 294
G+ Y++PE L+ Y + DIWS G+ L + G P K +
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251
Query: 295 ------------QGDIDFESAPWPTI--------------------SSSAKDLVRRMLTQ 322
+S P I S +D V + L +
Sbjct: 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 311
Query: 323 DPKKRITSAQVLEHPWIKEGGEASDKPID 351
+P +R Q++ H +IK + + +D
Sbjct: 312 NPAERADLKQLMVHAFIK---RSDAEEVD 337
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 9e-43
Identities = 89/372 (23%), Positives = 141/372 (37%), Gaps = 67/372 (18%)
Query: 31 PAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGK-PYEDVKLHYSFGKELGR 89
P +P + + VS K G+ P ++ Y+ K +G
Sbjct: 5 PRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGN 64
Query: 90 GQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK--- 146
G FGV Y +G A K + DK RE+QIM+ L NIV +
Sbjct: 65 GSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD-HCNIVRLRYFF 116
Query: 147 ---GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM---- 199
G +D+ +++V++ E R+ HYS + + V+++ +M
Sbjct: 117 YSSGEKKDEVYLNLVLDYV--PETVYRVAR--HYSRA------KQTLPVIYVKLYMYQLF 166
Query: 200 ---------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVA 250
G+ HRD+KP+N LL + A+LK DFG + + G+ + S YY A
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 224
Query: 251 PEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ-------GDIDFE 301
PE++ Y ID+WSAG +L LL G P F ++ I++ I
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284
Query: 302 SA-------------PW-----PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343
+ PW P A L R+L P R+T + H + E
Sbjct: 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344
Query: 344 EASDKPIDSAVL 355
+ + K +
Sbjct: 345 DPNVKLPNGRDT 356
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-42
Identities = 55/353 (15%), Positives = 117/353 (33%), Gaps = 63/353 (17%)
Query: 74 YEDVKLHYSFGKELGRGQ--FGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQ 131
+ Y +G+G L TG + I+ + ++ E+
Sbjct: 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA-CSNEMVTFLQGELH 78
Query: 132 IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD--RIIAKGHYSERAAASICRSI 189
+ + + PNIV ++ + + VV A G D +E A A I + +
Sbjct: 79 VSKLFN-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGV 137
Query: 190 VNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR--------D 241
+ + H MG +HR +K + L+S + + + ++ + +
Sbjct: 138 LKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194
Query: 242 IVGSAYYVAPEVLRRR---YGKEIDIWSAGVILYILLSGVPPF----------------- 281
V +++PEVL++ Y + DI+S G+ L +G PF
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254
Query: 282 -------------------WAETEKGIFDAILQGDIDFESAPWPTI------SSSAKDLV 316
+ G+ D++ + P+ S V
Sbjct: 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFV 314
Query: 317 RRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKK 369
+ L ++P R +++ +L H + K+ + + + +L + +
Sbjct: 315 EQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPE-LLRPVTPITNFEGSQS 366
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-42
Identities = 85/339 (25%), Positives = 133/339 (39%), Gaps = 51/339 (15%)
Query: 38 AHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYL 97
AHH G A G P +I Y ++ +LG G +G Y
Sbjct: 2 AHHHHHHMGTLEAQTQGPGSMSVSAAPSATSI--DRYR--RI-----TKLGEGTYGEVYK 52
Query: 98 CTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLSGQPNIVEFKGAYEDKQ 153
+ T A K I +L +++++ + RE+ +++ L NI+E K
Sbjct: 53 AIDTVTNETVAIKRI---RL--EHEEEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNH 106
Query: 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLL 213
+H++ E +L + S R S ++N V+ CH +HRDLKP+N LL
Sbjct: 107 RLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLL 165
Query: 214 SSKD--ENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVL--RRRYGKEIDIWSAG 268
S D E +LK DFGL+ F + + + + +Y PE+L R Y +DIWS
Sbjct: 166 SVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIA 225
Query: 269 VILYILLSGVPPFWAETEKG----IFDAI----------------------LQGDIDFES 302
I +L P F ++E IF+ + +
Sbjct: 226 CIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKR 285
Query: 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
+ DL+ ML DP KRI++ LEHP+
Sbjct: 286 VLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-40
Identities = 79/322 (24%), Positives = 132/322 (40%), Gaps = 60/322 (18%)
Query: 65 DTNTILGKPYEDVKLH---------YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKR 115
D NT + Y D + H Y ++LGRG++ + + + K +
Sbjct: 13 DVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL--- 69
Query: 116 KLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS---VHVVMELCAGGELFDRII 172
K V K IKREI+I+++L G PNI+ +D S V + F ++
Sbjct: 70 KPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV--NNTDFKQLY 124
Query: 173 AKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232
++ I+ + CH MG+MHRD+KP N ++ E+ L+ D+GL+ F
Sbjct: 125 QT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEF 180
Query: 233 IEEGKVYRDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWA------- 283
G+ Y V S Y+ PE+L + Y +D+WS G +L ++ PF+
Sbjct: 181 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 240
Query: 284 ----------ETEKGIFDAI-LQGDIDFESA-------PW---------PTISSSAKDLV 316
E D ++ D F W +S A D +
Sbjct: 241 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 300
Query: 317 RRMLTQDPKKRITSAQVLEHPW 338
++L D + R+T+ + +EHP+
Sbjct: 301 DKLLRYDHQSRLTAREAMEHPY 322
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-40
Identities = 69/307 (22%), Positives = 113/307 (36%), Gaps = 56/307 (18%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD------IKREIQIMQHLSGQP 140
LG G + Y +TG A K + K D ++ I REI +M+ L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV-------KLDSEEGTPSTAI-REISLMKELK-HE 63
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGG-----ELFDRIIAKGHYSERAAASICRSIVNVVHI 195
NIV + + +V E + ++ +
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVL 254
CH ++HRDLKP+N L++ + + LK DFGL+ F + V + +Y AP+VL
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVL 180
Query: 255 --RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IF-------DAILQGDID-- 299
R Y IDIWS G IL +++G P F ++ IF +++
Sbjct: 181 MGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240
Query: 300 -----------------FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342
+ + + D + +L +P R+++ Q L HPW E
Sbjct: 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300
Query: 343 GEASDKP 349
+
Sbjct: 301 YHHASMG 307
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 9e-40
Identities = 88/297 (29%), Positives = 133/297 (44%), Gaps = 50/297 (16%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHL 136
Y +++G G +GV Y N+ G FA K I +L + + + I REI I++ L
Sbjct: 4 YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKI---RL--EKEDEGIPSTTIREISILKEL 57
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAG--GELFDRIIAKGHYSERAAASICRSIVNVVH 194
NIV+ K+ + +V E +L D +G A S ++N +
Sbjct: 58 K-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIA 114
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEV 253
CH V+HRDLKP+N L++ + E LK DFGL+ F + Y + + +Y AP+V
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171
Query: 254 L--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAILQG----DI--DFE 301
L ++Y IDIWS G I +++G P F +E IF + G +
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL--GTPNSKNWPNVT 229
Query: 302 SAPW-----------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
P + S DL+ +ML DP +RIT+ Q LEH + KE
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-39
Identities = 76/294 (25%), Positives = 119/294 (40%), Gaps = 41/294 (13%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHL 136
Y LG GQF Y + +T + A K I + KD I REI+++Q L
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKI--KLGHRSEAKDGINRTALREIKLLQEL 69
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAG--GELFDRIIAKGHYSERAAASICRSIVNVVH 194
S PNI+ A+ K ++ +V + + + + + +
Sbjct: 70 S-HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLE 126
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEV 253
H ++HRDLKP N LL LK DFGL+ F + Y V + +Y APE+
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183
Query: 254 L--RRRYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAI-------------L 294
L R YG +D+W+ G IL LL VP +++ IF+ + L
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243
Query: 295 QGDIDFESAP-------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
+ F+S P + DL++ + +P RIT+ Q L+ +
Sbjct: 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 1e-39
Identities = 72/290 (24%), Positives = 121/290 (41%), Gaps = 46/290 (15%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLSGQPNI 142
+G G +G + T A K + +L +D + + REI +++ L NI
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRV---RL--DDDDEGVPSSALREICLLKELK-HKNI 63
Query: 143 VEFKGAYEDKQSVHVVMELCAG--GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
V + + +V E C + FD G S ++ + CH
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVL--RRR 257
V+HRDLKP+N L++ E LK +FGL+ F + Y V + +Y P+VL +
Sbjct: 122 VLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 258 YGKEIDIWSAGVILYILLS-GVPPFWAETEKG----IFDAI-------------LQGDID 299
Y ID+WSAG I L + G P F IF + L
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 300 FESAP--------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
+ P P ++++ +DL++ +L +P +RI++ + L+HP+ +
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-39
Identities = 71/321 (22%), Positives = 125/321 (38%), Gaps = 66/321 (20%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD------IKREIQIMQ 134
Y +LG G + Y T A K I + + ++ I RE+ +++
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAI-REVSLLK 55
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELC---------AGGELFDRIIAKGHYSERAAASI 185
L NIV ++S+ +V E G + + K
Sbjct: 56 DLK-HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVK---------LF 105
Query: 186 CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVG 244
++ + CH V+HRDLKP+N L++ + E LK DFGL+ K Y + V
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEVV 162
Query: 245 SAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAI----- 293
+ +Y P++L Y +ID+W G I Y + +G P F T + IF +
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTE 222
Query: 294 --------LQG--DIDFESAP-------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
+ ++ P + S DL+ ++L + + RI++ ++H
Sbjct: 223 ETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282
Query: 337 PWIKEGGEASDK-PIDSAVLS 356
P+ GE K P +++ +
Sbjct: 283 PFFLSLGERIHKLPDTTSIFA 303
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-39
Identities = 68/277 (24%), Positives = 124/277 (44%), Gaps = 38/277 (13%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
Y++++ + +GRG FGV + A K ++ +++++ E++
Sbjct: 6 DYKEIE----VEEVVGRGAFGVVCKAKWR--AKDVAIK-----QIESESERKAFIVELRQ 54
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKG---HYSERAAASICRSI 189
+ ++ PNIV+ GA V +VME GG L++ + +Y+ A S C
Sbjct: 55 LSRVN-HPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 111
Query: 190 ---VNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA 246
V +H ++HRDLKP N LL + LK DFG + I+ GSA
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV--LKICDFGTACDIQTHMTNN--KGSA 167
Query: 247 YYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFW--AETEKGIFDAILQGDIDFESA 303
++APEV Y ++ D++S G+IL+ +++ PF I A+ G
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT------ 221
Query: 304 PWPTISSSA----KDLVRRMLTQDPKKRITSAQVLEH 336
P + + + L+ R ++DP +R + ++++
Sbjct: 222 -RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 80/298 (26%), Positives = 125/298 (41%), Gaps = 51/298 (17%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHL 136
Y +++G G +GV Y +S GR A K I +L + + I REI +++ L
Sbjct: 23 YQKLEKVGEGTYGVVYKAK-DSQGRIVALKRI---RL--DAEDEGIPSTAIREISLLKEL 76
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAG--GELFDRIIAKGHYSERAAASICRSIVNVVH 194
PNIV ++ + +V E ++ D K + ++ V
Sbjct: 77 H-HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN--KTGLQDSQIKIYLYQLLRGVA 133
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEV 253
CH ++HRDLKP+N L++S LK DFGL+ F + Y V + +Y AP+V
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGA---LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190
Query: 254 L--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAILQG----DI--DFE 301
L ++Y +DIWS G I +++G P F T+ IF + G +
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL--GTPNPREWPQVQ 248
Query: 302 SAPW------------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
P P DL+ ML DP KRI++ + HP+ K+
Sbjct: 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 69/281 (24%), Positives = 121/281 (43%), Gaps = 31/281 (11%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK----DDIKR 128
+++ + K++G+G FG+ + A KS+ + + + +R
Sbjct: 17 ADNEIE----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 129 EIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICR 187
E+ IM +L+ PNIV+ G +VME G+L+ R++ K H +
Sbjct: 73 EVFIMSNLN-HPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLML 129
Query: 188 SI---VNVVHICHFMGVMHRDLKPENFLLSSKDENA--LLKATDFGLSVFIEEGKVYRDI 242
I + + + ++HRDL+ N L S DENA K DFGLS + +
Sbjct: 130 DIALGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGL 186
Query: 243 VGSAYYVAPEVLRRR---YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID 299
+G+ ++APE + Y ++ D +S +ILY +L+G PF E I
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF---DEYSYGKIKFINMIR 243
Query: 300 FESAPWPTISSSA----KDLVRRMLTQDPKKRITSAQVLEH 336
E PTI ++++ + DPKKR + +++
Sbjct: 244 EEGLR-PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-37
Identities = 75/303 (24%), Positives = 118/303 (38%), Gaps = 53/303 (17%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK-------REIQIM 133
Y E+G G +G Y + +G A KS+ ++ N RE+ ++
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RV--PNGGGGGGGLPISTVREVALL 65
Query: 134 QHLSGQ--PNIVEFK-----GAYEDKQSVHVVMELCAG--GELFDRIIAKGHYSERAAAS 184
+ L PN+V + + V +V E D+ G
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKD 124
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG 244
+ R + + H ++HRDLKPEN L++S +K DFGL+ +V
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT---VKLADFGLARIYSYQMALTPVVV 181
Query: 245 SAYYVAPEVL-RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAILQG--- 296
+ +Y APEVL + Y +D+WS G I + P F +E IFD I G
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI--GLPP 239
Query: 297 -DI--DFESAPW---------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338
D S P P + S L+ MLT +P KRI++ + L+H +
Sbjct: 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
Query: 339 IKE 341
+ +
Sbjct: 300 LHK 302
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-36
Identities = 71/319 (22%), Positives = 126/319 (39%), Gaps = 50/319 (15%)
Query: 39 HHRPEKPGPTPAAAPVSGLKQAVPRPDTN-TILGKPYEDVKLHYSFGKELGRGQFGVTYL 97
HH P L + I P+ D+ +++G G FG +
Sbjct: 3 HHHHHHPMSDYDIPTTENLYFQGAMDGDDMDI---PWCDLN----IKEKIGAGSFGTVHR 55
Query: 98 CTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157
+ G A K + ++ ++ RE+ IM+ L PNIV F GA ++ +
Sbjct: 56 AEWH--GSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPPNLSI 111
Query: 158 VMELCAGGELFDRII---AKGHYSERAAASICRSI---VNVVHICHFMGVMHRDLKPENF 211
V E + G L+ + A+ ER S+ + +N +H + ++HR+LK N
Sbjct: 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP-IVHRNLKSPNL 170
Query: 212 LLSSKDENALLKATDFGLSVFIEEGKVYR-DIVGSAYYVAPEVLR-RRYGKEIDIWSAGV 269
L+ D+ +K DFGLS + G+ ++APEVLR ++ D++S GV
Sbjct: 171 LV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGV 227
Query: 270 ILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW--------PTISSSA----KDLVR 317
IL+ L + P+ G+++ I + ++
Sbjct: 228 ILWELATLQQPW--------------GNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273
Query: 318 RMLTQDPKKRITSAQVLEH 336
T +P KR + A +++
Sbjct: 274 GCWTNEPWKRPSFATIMDL 292
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 78/339 (23%), Positives = 127/339 (37%), Gaps = 73/339 (21%)
Query: 68 TILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK 127
+ + + G+G FG L E STG A K + D
Sbjct: 12 AAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-------IQDPRFRN 64
Query: 128 REIQIMQHLSGQ--PNIVEFK-----GAYEDKQSV--HVVMELCAGGELFDRIIAKGHYS 178
RE+QIMQ L+ PNIV+ + D++ + +VVME + R +Y
Sbjct: 65 RELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV--PDTLHRCCR--NYY 120
Query: 179 ERAAASICRSIVNVVHICHFM---------------GVMHRDLKPENFLLSSKDENALLK 223
R + + I F+ V HRD+KP N L++ + LK
Sbjct: 121 RR------QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE--ADGTLK 172
Query: 224 ATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPF 281
DFG + + + + S YY APE++ + Y +DIWS G I ++ G P F
Sbjct: 173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232
Query: 282 WAETEKGIFDAILQ--G-----DIDF-------------ESAPW--------PTISSSAK 313
+ G I++ G + + PW + A
Sbjct: 233 RGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAY 292
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDS 352
DL+ +L P++R+ + L HP+ E + + K ++
Sbjct: 293 DLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNN 331
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-35
Identities = 68/313 (21%), Positives = 126/313 (40%), Gaps = 55/313 (17%)
Query: 81 YSFGKELGRGQFGVTYLCTE-NSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQH 135
Y E+G G +G + + + GR A K + ++ + ++ + RE+ +++H
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRV---RV--QTGEEGMPLSTIREVAVLRH 67
Query: 136 LSGQ--PNIVEFK-----GAYEDKQSVHVVMELCAG--GELFDRIIAKGHYSERAAASIC 186
L PN+V + + + +V E D++ + +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMM 126
Query: 187 RSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA 246
++ + H V+HRDLKP+N L++S + +K DFGL+ +V +
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTL 183
Query: 247 YYVAPEVL-RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAILQG----D 297
+Y APEVL + Y +D+WS G I + P F ++ I D I G +
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI--GLPGEE 241
Query: 298 I--DFESAPW---------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340
+ P I KDL+ + LT +P KRI++ L HP+ +
Sbjct: 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301
Query: 341 EGGEASDKPIDSA 353
+ ++ ++
Sbjct: 302 D----LERCKENL 310
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 81/346 (23%), Positives = 132/346 (38%), Gaps = 104/346 (30%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS-------KRKLVTKNDKDDIKR 128
D+ Y K LG G G+ + +N ++ A K I K L R
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL----------R 57
Query: 129 EIQIMQHLSGQPNIVE--------------FKGAYEDKQSVHVVMELCAGGELFDRIIAK 174
EI+I++ L NIV+ G+ + SV++V E +L ++ +
Sbjct: 58 EIKIIRRLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-METDL-ANVLEQ 114
Query: 175 GHYSERAAASICRSIVNVVHICHFM-------------GVMHRDLKPENFLLSSKDENAL 221
G E H FM V+HRDLKP N +++ E+ +
Sbjct: 115 GPLLE-------------EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLV 159
Query: 222 LKATDFGLSVFIEEGKVYRDI----VGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILL 275
LK DFGL+ ++ ++ + + +Y +P +L Y K ID+W+AG I +L
Sbjct: 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219
Query: 276 SGVPPFWAETEKG---------IFDAI---LQGDIDF---------ESAPW--------- 305
+G F G I ++I + D +
Sbjct: 220 TGKTLF-----AGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQL 274
Query: 306 -PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
P IS A D + ++LT P R+T+ + L HP++ D+PI
Sbjct: 275 LPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEPI 320
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-35
Identities = 91/334 (27%), Positives = 135/334 (40%), Gaps = 88/334 (26%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS--------KRKLVTKNDKDDIK 127
DV Y+ +G G +G+ +N + A K IS +R L
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL---------- 73
Query: 128 REIQIMQHLSGQPNIVEFK-----GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAA 182
REI+I+ NI+ E + V++V +L +L +++ H S
Sbjct: 74 REIKILLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDL-METDL-YKLLKTQHLSN--- 127
Query: 183 ASICRSIVNVVHICHFM-------------GVMHRDLKPENFLLSSKDENALLKATDFGL 229
HIC+F+ V+HRDLKP N LL + LK DFGL
Sbjct: 128 ----------DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGL 174
Query: 230 SVFIEEGKVYRDI----VGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWA 283
+ + + V + +Y APE++ + Y K IDIWS G IL +LS P F
Sbjct: 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234
Query: 284 ETEKGIFDAIL-------QGDIDF----------ESAPW----------PTISSSAKDLV 316
+ + IL Q D++ S P P S A DL+
Sbjct: 235 KHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLL 294
Query: 317 RRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
+MLT +P KRI Q L HP++++ + SD+PI
Sbjct: 295 DKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 328
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 54/226 (23%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
D+ G+ LG+G FG T TG K + + + + +E+++
Sbjct: 8 RPSDLIH----GEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKV 60
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI-IAKGHYSERAAASICRSIVN 191
M+ L PN+++F G + ++ + E GG L I Y S + I +
Sbjct: 61 MRCLE-HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD---------- 241
+ H M ++HRDL N L+ EN + DFGL+ + + K +
Sbjct: 120 GMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 242 -----IVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPF 281
+VG+ Y++APE++ R Y +++D++S G++L ++ V
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-34
Identities = 74/308 (24%), Positives = 122/308 (39%), Gaps = 68/308 (22%)
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLSGQPNI 142
+G+G FG + TG++ A K K++ +N+K+ REI+I+Q L N+
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQLLK-HENV 78
Query: 143 VEFKG--------AYEDKQSVHVVMELC----AGGELFDRIIAKGHYSERAAASICRSIV 190
V K S+++V + C AG L + ++ + + ++
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKFTLSEIKRVMQMLL 134
Query: 191 NVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI-----EEGKVYRDIVGS 245
N ++ H ++HRD+K N L++ LK DFGL+ + Y + V +
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAFSLAKNSQPNRYTNRVVT 191
Query: 246 AYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAILQGDI- 298
+Y PE+L R YG ID+W AG I+ + + P TE+ I L G I
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ--LCGSIT 249
Query: 299 -----------DFESA--------------PWPTISSSAKDLVRRMLTQDPKKRITSAQV 333
+E A DL+ ++L DP +RI S
Sbjct: 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 309
Query: 334 LEHPWIKE 341
L H +
Sbjct: 310 LNHDFFWS 317
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-34
Identities = 74/390 (18%), Positives = 137/390 (35%), Gaps = 89/390 (22%)
Query: 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSI---SKRKLVTKNDKDDIKREI 130
E YS GK LG G FG+ + +G++FA K + + K RE+
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN----------REL 51
Query: 131 QIMQHLSGQPNIVEFKGAY---EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICR 187
IM+ L NI++ + D++ H+
Sbjct: 52 DIMKVLD-HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQN 110
Query: 188 SIVNVV-------------------------HICHFM-------------GVMHRDLKPE 209
+NV+ I ++ G+ HRD+KP+
Sbjct: 111 KYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQ 170
Query: 210 NFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL--RRRYGKEIDIWSA 267
N L++S ++ LK DFG + + + + S +Y APE++ Y ID+WS
Sbjct: 171 NLLVNS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSI 228
Query: 268 GVILYILLSGVPPFWAETEKGIFDAILQ-------GDIDF-------------ESAPWPT 307
G + L+ G P F ET I+Q + ++ W
Sbjct: 229 GCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRK 288
Query: 308 I-----SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFR 362
I S A DL+ ++L +P RI + + HP+ + + + + +
Sbjct: 289 ILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQ 348
Query: 363 AMNKL-----KKLALKVSLIKYMLMYQHVN 387
+ +L +L++ + ++ ++ +
Sbjct: 349 NIPQLFNFSPYELSIIPGNVLNRILPKNFS 378
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-34
Identities = 72/331 (21%), Positives = 124/331 (37%), Gaps = 74/331 (22%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN-----DKDDIK--- 127
++ Y+ + + G +G +S G A K + + D K
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 128 REIQIMQHLSGQPNIVEFK-----GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAA 182
REI+++ H PNI+ + +++V EL +L ++I
Sbjct: 78 REIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTEL-MRTDL-AQVIHDQ------- 127
Query: 183 ASICRSIVNVVHICHFM-------------GVMHRDLKPENFLLSSKDENALLKATDFGL 229
R +++ HI +FM GV+HRDL P N LL +N + DF L
Sbjct: 128 ----RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNL 180
Query: 230 SVFIEEGKVYRDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEK 287
+ V +Y APE++ + + K +D+WSAG ++ + + F T
Sbjct: 181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240
Query: 288 GIFDAILQ----------GDIDFESA--------------PW----PTISSSAKDLVRRM 319
+ I++ SA W PT A DL+ +M
Sbjct: 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKM 300
Query: 320 LTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
L +P++RI++ Q L HP+ + + D
Sbjct: 301 LEFNPQRRISTEQALRHPYFESLFDPLDLTE 331
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-34
Identities = 69/323 (21%), Positives = 118/323 (36%), Gaps = 89/323 (27%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS---------KRKLVTKNDKDDI 126
++ Y +G G +G + +G + A K +S KR
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--------- 71
Query: 127 KREIQIMQHLSGQPNIVEFK------GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSER 180
RE+ +++H+ N++ + + ++VM +L +I+
Sbjct: 72 -RELLLLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPF-MQTDL-QKIM-------- 119
Query: 181 AAASICRSIVNVVHICHFM-------------GVMHRDLKPENFLLSSKDENALLKATDF 227
+ I + + GV+HRDLKP N + +E+ LK DF
Sbjct: 120 ------GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDF 170
Query: 228 GLSVFIEEGKVYRDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAET 285
GL+ + V + +Y APEV+ Y + +DIWS G I+ +L+G F +
Sbjct: 171 GLARHADAEMT--GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228
Query: 286 EKGIFDAILQ-------GDIDF----------------ESAPW----PTISSSAKDLVRR 318
IL+ + + P S A DL+ +
Sbjct: 229 YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEK 288
Query: 319 MLTQDPKKRITSAQVLEHPWIKE 341
ML D KR+T+AQ L HP+ +
Sbjct: 289 MLELDVDKRLTAAQALTHPFFEP 311
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL-VTKNDKDDIKREIQ 131
+ ++ + +G G FG Y G + A K+ +++++E +
Sbjct: 5 DFAELT----LEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAK 58
Query: 132 IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSI-- 189
+ L PNI+ +G + ++ +VME GG L +++ + I
Sbjct: 59 LFAMLK-HPNIIALRGVCLKEPNLCLVMEFARGGPLNR-VLSGKRIPPDILVNWAVQIAR 116
Query: 190 -VNVVHICHFMGVMHRDLKPENFLLSSKDE-----NALLKATDFGLSVFIEEGKVYRDIV 243
+N +H + ++HRDLK N L+ K E N +LK TDFGL+
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAA 175
Query: 244 GSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPF 281
G+ ++APEV+R + K D+WS GV+L+ LL+G PF
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 87/338 (25%), Positives = 128/338 (37%), Gaps = 106/338 (31%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS--------KRKLVTKNDKDDIK 127
++ + LG G +GV T TG A K I R L
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL---------- 57
Query: 128 REIQIMQHLSGQPNIVEFK-----GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAA 182
REI+I++H NI+ ++E+ V+++ EL +L R+I+ S+
Sbjct: 58 REIKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQEL-MQTDL-HRVISTQMLSD--- 111
Query: 183 ASICRSIVNVVHICHFM-------------GVMHRDLKPENFLLSSKDENALLKATDFGL 229
HI +F+ V+HRDLKP N L+ + N LK DFGL
Sbjct: 112 ----------DHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGL 158
Query: 230 SVFIEEGKVYRDIVGSA-----------YYVAPEVL--RRRYGKEIDIWSAGVILYILLS 276
+ I+E +Y APEV+ +Y + +D+WS G IL L
Sbjct: 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218
Query: 277 GVPPFWAETEKG---------IFDAI----LQGDIDF---ESA-------------PW-- 305
P F G IF I D+ A P
Sbjct: 219 RRPIF-----PGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEK 273
Query: 306 --PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
P ++ DL++RML DP KRIT+ + LEHP+++
Sbjct: 274 MFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 74/319 (23%), Positives = 127/319 (39%), Gaps = 62/319 (19%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS---------KRKLVTKNDKDDI 126
+V Y +G G +G + TG + A K +S KR
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--------- 76
Query: 127 KREIQIMQHLSGQPNIVEFK------GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSER 180
RE+++++H+ N++ + E+ V++V L G +L + I+ ++
Sbjct: 77 -RELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADL-NNIVKCQKLTDD 132
Query: 181 AAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR 240
+ I+ + H ++HRDLKP N + +E+ LK DFGL+ +
Sbjct: 133 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTADEMT-- 187
Query: 241 DIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ--- 295
V + +Y APE++ Y + +DIWS G I+ LL+G F IL+
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247
Query: 296 ----GDIDF----------ESAPW----------PTISSSAKDLVRRMLTQDPKKRITSA 331
+ +S + A DL+ +ML D KRIT+A
Sbjct: 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 307
Query: 332 QVLEHPWIKEGGEASDKPI 350
Q L H + + + D+P+
Sbjct: 308 QALAHAYFAQYHDPDDEPV 326
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-33
Identities = 74/324 (22%), Positives = 116/324 (35%), Gaps = 76/324 (23%)
Query: 84 GKELGRGQFGVTY--LCTENSTGRQFACKSISKRKLVTKNDKDDIK----REIQIMQHLS 137
G ++GRG +G Y + + +A K + + I REI +++ L
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALK---------QIEGTGISMSACREIALLRELK 76
Query: 138 GQPNIVEFKGAYEDKQ--SVHVVME--------LCAGGELFDRIIAKGHYSERAAASICR 187
PN++ + + V ++ + + S+
Sbjct: 77 -HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 188 SIVNVVHICHFMGVMHRDLKPENFLLSSK-DENALLKATDFGLS-VFIEEGKVYRDIVGS 245
I++ +H H V+HRDLKP N L+ + E +K D G + +F K D+
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 246 A---YYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD--- 297
+Y APE+L R Y K IDIW+ G I LL+ P F E D
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255
Query: 298 -I-------------DFESAPW--------------------------PTISSSAKDLVR 317
I D + P S A L++
Sbjct: 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQ 315
Query: 318 RMLTQDPKKRITSAQVLEHPWIKE 341
++LT DP KRITS Q ++ P+ E
Sbjct: 316 KLLTMDPIKRITSEQAMQDPYFLE 339
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-33
Identities = 59/284 (20%), Positives = 112/284 (39%), Gaps = 38/284 (13%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P+E ++ G+ +G+G+FG Y + A + I + ++ KRE+
Sbjct: 31 PFEQLE----IGELIGKGRFGQVYHGRWHGE---VAIRLI-DIERDNEDQLKAFKREVMA 82
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI-IAKGHYSERAAASICRSIVN 191
+ N+V F GA + ++ LC G L+ + AK I + IV
Sbjct: 83 YRQTR-HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVK 141
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS------VFIEEGKVYRDIVGS 245
+ H G++H+DLK +N +N + TDFGL R G
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGW 197
Query: 246 AYYVAPEVLRRR----------YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ 295
++APE++R+ + K D+++ G I Y L + PF + + I +
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT 257
Query: 296 G---DIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
G ++ + D++ + ++R T ++++
Sbjct: 258 GMKPNL-----SQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-33
Identities = 66/326 (20%), Positives = 116/326 (35%), Gaps = 78/326 (23%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK---REIQIMQHLS---- 137
++LG G F +L + A K + + DK + EI+++Q ++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMK-------IVRGDKVYTEAAEDEIKLLQRVNDADN 77
Query: 138 ------GQPNIVEFKGA--YEDKQSVHV--VMELCAGGELFDRIIAKGH--YSERAAASI 185
G +I++ ++ VHV V E+ G L I H I
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQI 136
Query: 186 CRSIVNVVHICH-FMGVMHRDLKPENFLLSSKDENAL---LKATDFGLSVFIEEGKVYRD 241
+ ++ + H G++H D+KPEN L+ D +K D G + + +E
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-HYTNS 195
Query: 242 IVGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG------------ 288
I + Y +PEV L +G DIWS +++ L++G F +
Sbjct: 196 IQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254
Query: 289 -------------------IFDAILQGDIDFESAPWPTISSSAK-------------DLV 316
F++ + WP + D +
Sbjct: 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314
Query: 317 RRMLTQDPKKRITSAQVLEHPWIKEG 342
ML DP+KR + ++ HPW+K+
Sbjct: 315 SPMLQLDPRKRADAGGLVNHPWLKDT 340
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-33
Identities = 68/332 (20%), Positives = 124/332 (37%), Gaps = 88/332 (26%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS---------KRKLVTKNDKDDI 126
+V+ Y + +G G +G + TG + A K + KR
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY--------- 72
Query: 127 KREIQIMQHLSGQPNIVEFK------GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSER 180
RE+++++H+ N++ +D ++VM G +L +++ E
Sbjct: 73 -RELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPF-MGTDL-GKLMKHEKLGE- 127
Query: 181 AAASICRSIVNVVHICHFM-------------GVMHRDLKPENFLLSSKDENALLKATDF 227
I + G++HRDLKP N + +E+ LK DF
Sbjct: 128 ------------DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDF 172
Query: 228 GLSVFIEEGKVYRDIVGSAYYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPFWAET 285
GL+ + V + +Y APEV+ RY + +DIWS G I+ +++G F
Sbjct: 173 GLARQADSEMT--GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230
Query: 286 EKGIFDAILQ-------GDIDF----------------ESAPW----PTISSSAKDLVRR 318
I++ + E + S A +L+ +
Sbjct: 231 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK 290
Query: 319 MLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
ML D ++R+T+ + L HP+ + + D+P
Sbjct: 291 MLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ 322
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-33
Identities = 71/305 (23%), Positives = 117/305 (38%), Gaps = 31/305 (10%)
Query: 37 QAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTY 96
+HH P T G Y + +GRG G Y
Sbjct: 3 SSHHHHHHSSG---LVPRGSHMDGTAESREGTQFG--------PYRLRRLVGRGGMGDVY 51
Query: 97 LCTENSTGRQFACKSISKRKLVTKNDKDDIKR---EIQIMQHLSGQPNIVEFKGAYEDKQ 153
+ R A K + L +D R E + L +P++V E
Sbjct: 52 EAEDTVRERIVALK-LMSETLS--SDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDG 107
Query: 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLL 213
++V M L G +L + +G + A +I R I + + H G HRD+KPEN L+
Sbjct: 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV 167
Query: 214 SSKDENALLKATDFGLSVFIEEGKVYR--DIVGSAYYVAPEVLRRRYGKEI----DIWSA 267
S+ D DFG++ + K+ + + VG+ YY+APE DI++
Sbjct: 168 SADDF---AYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS---ESHATYRADIYAL 221
Query: 268 GVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKR 327
+LY L+G PP+ + + A + I S P I + ++ R + ++P+ R
Sbjct: 222 TCVLYECLTGSPPYQGDQL-SVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDR 280
Query: 328 ITSAQ 332
+
Sbjct: 281 YVTCG 285
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 76/320 (23%), Positives = 120/320 (37%), Gaps = 71/320 (22%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS---------KRKLVTKNDKDDI 126
V Y K +G G G+ + R A K +S KR
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--------- 109
Query: 127 KREIQIMQHLSGQPNIVEFK------GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSER 180
RE+ +M+ + NI+ E+ Q V++VMEL L ++I +
Sbjct: 110 -RELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANL-CQVI-QMELDHE 164
Query: 181 AAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR 240
+ + ++ + H G++HRDLKP N ++ + LK DFGL+ +
Sbjct: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMT 221
Query: 241 DIVGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPF------------------ 281
V + YY APEV L Y + +DIWS G I+ ++ F
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281
Query: 282 -WAETEKGI------------------FDAILQGDIDF-ESAPWPTISSSAKDLVRRMLT 321
E K + F + + +S +S A+DL+ +ML
Sbjct: 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 341
Query: 322 QDPKKRITSAQVLEHPWIKE 341
DP KRI+ L+HP+I
Sbjct: 342 IDPAKRISVDDALQHPYINV 361
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 4e-32
Identities = 71/266 (26%), Positives = 116/266 (43%), Gaps = 24/266 (9%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR---EIQIMQHLS 137
Y +LG G YL + + A K ++ +KR E+ LS
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPR--EKEETLKRFEREVHNSSQLS 69
Query: 138 GQPNIVEFKGAY---EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
NIV E+ ++VME G L + I + G S A + I++ +
Sbjct: 70 -HQNIV---SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD--IVGSAYYVAPE 252
H M ++HRD+KP+N L+ D N LK DFG++ + E + + ++G+ Y +PE
Sbjct: 126 HAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 253 VLRRRY-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI--LQGDIDFESAPW-PTI 308
+ + DI+S G++LY +L G PPF ET I AI +Q + + I
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHIQDSVPNVTTDVRKDI 240
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVL 334
S +++ R +D R + Q +
Sbjct: 241 PQSLSNVILRATEKDKANRYKTIQEM 266
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-32
Identities = 79/320 (24%), Positives = 125/320 (39%), Gaps = 71/320 (22%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS---------KRKLVTKNDKDDI 126
V Y K +G G G+ + R A K +S KR
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--------- 72
Query: 127 KREIQIMQHLSGQPNIVEFK------GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSER 180
RE+ +M+ + NI+ + E+ Q V++VMEL L ++I ER
Sbjct: 73 -RELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANL-CQVIQMELDHER 128
Query: 181 AAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR 240
+ + + + + H+ H G++HRDLKP N ++ + LK DFGL+ +
Sbjct: 129 MSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMT 184
Query: 241 DIVGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPF------------------ 281
V + YY APEV L Y + +DIWS G I+ ++ G F
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 244
Query: 282 -WAETEKGI------------------FDAILQG-DIDFESAPWPTISSSAKDLVRRMLT 321
E K + F+ + +S +S A+DL+ +ML
Sbjct: 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 304
Query: 322 QDPKKRITSAQVLEHPWIKE 341
D KRI+ + L+HP+I
Sbjct: 305 IDASKRISVDEALQHPYINV 324
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 43/287 (14%), Positives = 96/287 (33%), Gaps = 53/287 (18%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
++ + F +L G + G K + R + D E
Sbjct: 8 DFKQLN----FLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPR 60
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVH--VVMELCAGGELFDRIIAKGHY--SERAAASICRS 188
++ S PN++ GA + + H ++ G L++ + ++ + A
Sbjct: 61 LRIFS-HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALD 119
Query: 189 I---VNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGS 245
+ + +H + + L + ++ DE+ + + + + + +
Sbjct: 120 MARGMAFLHTLEPL-IPRHALNSRSVMI---DEDMTARISMADVKFSFQSPGR----MYA 171
Query: 246 AYYVAPEVLRRR----YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE 301
+VAPE L+++ + D+WS V+L+ L++ PF D+
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF--------------ADLSNM 217
Query: 302 SAPW------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
P IS L++ + +DP KR ++
Sbjct: 218 EIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 80/376 (21%), Positives = 129/376 (34%), Gaps = 129/376 (34%)
Query: 71 GKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS---------KRKLVTKN 121
G+ V Y K+LG+G +G+ + + TG A K I +R
Sbjct: 1 GRVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF---- 56
Query: 122 DKDDIKREIQIMQHLSGQPNIVEFKGAY--EDKQSVHVVMELCAGGELFDRIIAKGHYSE 179
REI I+ LSG NIV ++ + V++V + +L +I
Sbjct: 57 ------REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY-METDL-HAVIRANILEP 108
Query: 180 RAAASICRSIVNVVHICHFM-------------GVMHRDLKPENFLLSSKDENALLKATD 226
VH + + G++HRD+KP N LL + +K D
Sbjct: 109 -------------VHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVAD 152
Query: 227 FGLSVFIEEGKVYRDIVGSA----------------------YYVAPEVL--RRRYGKEI 262
FGLS + + + + +Y APE+L +Y K I
Sbjct: 153 FGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI 212
Query: 263 DIWSAGVILYILLSGVPPFWAETEKG---------IFDAI---LQGDIDF---------- 300
D+WS G IL +L G P F G I I D++
Sbjct: 213 DMWSLGCILGEILCGKPIF-----PGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMI 267
Query: 301 --------------------------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVL 334
+ P + A DL+ ++L +P KRI++ L
Sbjct: 268 ESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDAL 327
Query: 335 EHPWIKEGGEASDKPI 350
+HP++ +++P
Sbjct: 328 KHPFVSIFHNPNEEPN 343
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 58/274 (21%), Positives = 111/274 (40%), Gaps = 23/274 (8%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P + + G+ +G G FG Y + A K + T K E+ +
Sbjct: 22 PDGQITV----GQRIGSGSFGTVYKGKWHGD---VAVKML-NVTAPTPQQLQAFKNEVGV 73
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI-IAKGHYSERAAASICRSIVN 191
++ NI+ F G + +V + C G L+ + ++ + + I R
Sbjct: 74 LRKTR-HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS---VFIEEGKVYRDIVGSAYY 248
+ H ++HRDLK N L E+ +K DFGL+ + + GS +
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
Query: 249 VAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAETEKG-IFDAILQGDIDFESA 303
+APEV+R Y + D+++ G++LY L++G P+ + I + + +G + + +
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS 248
Query: 304 PWP-TISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
K L+ L + +R + ++L
Sbjct: 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 70/340 (20%), Positives = 113/340 (33%), Gaps = 80/340 (23%)
Query: 87 LGRGQFGVTYLCTENSTGRQF-ACKSISKRKLVTKNDK---DDIKREIQIMQHL-----S 137
LG G FG C +++ G+ A K + +N + + EI +++ +
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALK-------IIRNVGKYREAARLEINVLKKIKEKDKE 79
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY---SERAAASICRSIVNVVH 194
+ V + + + EL G F+ + + ++ + + + +
Sbjct: 80 NKFLCVLMSDWFNFHGHMCIAFELL-GKNTFE-FLKENNFQPYPLPHVRHMAYQLCHALR 137
Query: 195 ICHFMGVMHRDLKPENFLLSSKD----------------ENALLKATDFGLSVFIEEGKV 238
H + H DLKPEN L + + +N ++ DFG + F E
Sbjct: 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE-HH 196
Query: 239 YRDIVGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAETE----------K 287
IV + +Y PEV L + + D+WS G IL+ G F
Sbjct: 197 TT-IVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKIL 255
Query: 288 GIFD------AILQGDIDFESAPWPTISSSAK------------------------DLVR 317
G Q W SS + DL+R
Sbjct: 256 GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR 315
Query: 318 RMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSR 357
RML DP +RIT A+ L HP+ S SR
Sbjct: 316 RMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPSR 355
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-30
Identities = 68/268 (25%), Positives = 114/268 (42%), Gaps = 23/268 (8%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKR---EIQIMQHLS 137
Y G+ LG G +L + R A K + + L D R E Q L+
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLA--RDPSFYLRFRREAQNAAALN 70
Query: 138 GQPNIVEF--KGAYEDKQSVHV--VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVV 193
P IV G E VME G L D + +G + + A + +
Sbjct: 71 -HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY----RDIVGSAYYV 249
+ H G++HRD+KP N ++S +K DFG++ I + ++G+A Y+
Sbjct: 130 NFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 250 APEVLRRRY-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI--LQGDIDFESAPWP 306
+PE R D++S G +LY +L+G PPF ++ + A ++ D SA
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHVREDPIPPSARHE 244
Query: 307 TISSSAKDLVRRMLTQDPKKRITSAQVL 334
+S+ +V + L ++P+ R +A +
Sbjct: 245 GLSADLDAVVLKALAKNPENRYQTAAEM 272
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 67/334 (20%), Positives = 114/334 (34%), Gaps = 84/334 (25%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK---DDIKREIQIMQHLS 137
+ +++G G FG LC + +A K V +N K K E I++ +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVK-------VVRNIKKYTRSAKIEADILKKIQ 89
Query: 138 GQP----NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVN 191
NIV++ G + + ++ E G L++ I + + C I+
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILK 148
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKD----------------------ENALLKATDFGL 229
++ M + H DLKPEN LL ++ +K DFG
Sbjct: 149 ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 230 SVFIEEGKVYRDIVGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAETE-- 286
+ F + I + Y APEV L + D+WS G +L L +G F
Sbjct: 209 ATFKSD-YHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHME 266
Query: 287 --------KGIFDA--ILQG---------DIDFESAPWPTISSSAK-------------- 313
+ + + D WP +SS
Sbjct: 267 HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326
Query: 314 -------DLVRRMLTQDPKKRITSAQVLEHPWIK 340
D + +L DP R + A++L+H +++
Sbjct: 327 IKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 71/313 (22%), Positives = 113/313 (36%), Gaps = 44/313 (14%)
Query: 31 PAPAQQQAHHRPEKPGPTPAAAPVSG-LKQAVPRPDTNTILGKPYEDVKLHYSFGKELGR 89
+ E G + P G +P+ + I+ YE +
Sbjct: 38 WNCGRPVGRSDSETKGASEGWCPYCGSPYSFLPQLNPGDIVAGQYE-------VKGCIAH 90
Query: 90 GQFGVTYLCT-ENSTGRQFACKSISKRKLVTKNDKDDIKR---EIQIMQHLSGQPNIVE- 144
G G YL N GR K LV D + E Q + + P+IV+
Sbjct: 91 GGLGWIYLALDRNVNGRPVVLKG-----LVHSGDAEAQAMAMAERQFLAEVV-HPSIVQI 144
Query: 145 --FKGAYEDKQSVHV---VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
F + D+ V VME G L A + I+ + H +
Sbjct: 145 FNF-VEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSYLHSI 201
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYG 259
G+++ DLKPEN +L+ +++ LK D G I + + G+ + APE++R
Sbjct: 202 GLVYNDLKPENIMLT-EEQ---LKLIDLGAVSRINS---FGYLYGTPGFQAPEIVRTGPT 254
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRM 319
DI++ G L L +P G+ E P S L+RR
Sbjct: 255 VATDIYTVGRTLAALTLDLPTRNGRYVDGL----------PEDDPVLKTYDSYGRLLRRA 304
Query: 320 LTQDPKKRITSAQ 332
+ DP++R T+A+
Sbjct: 305 IDPDPRQRFTTAE 317
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 59/300 (19%), Positives = 107/300 (35%), Gaps = 63/300 (21%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ-----HLS 137
+ +G+G++G + + G A K S R D+ RE ++ H
Sbjct: 12 LLECVGKGRYGEVWRGSWQ--GENVAVKIFSSR------DEKSWFRETELYNTVMLRH-- 61
Query: 138 GQPNIVEFKGAYEDKQSVH----VVMELCAGGELFDRIIAKGHYSERAAASICRSIVN-- 191
NI+ F + + ++ G L+D + + I SI +
Sbjct: 62 --ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTLDTVSCLRIVLSIASGL 118
Query: 192 ------VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI--- 242
+ + HRDLK +N L+ +N D GL+V + D+
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 243 --VGSAYYVAPEVLR-------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGI-FDA 292
VG+ Y+APEVL K +DIW+ G++L+ + + + F
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235
Query: 293 ILQGDIDFESAPW--------PTISSSA---------KDLVRRMLTQDPKKRITSAQVLE 335
++ D FE P I + L++ Q+P R+T+ ++ +
Sbjct: 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-29
Identities = 76/328 (23%), Positives = 115/328 (35%), Gaps = 78/328 (23%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQF-ACKSISKRKLVTKNDK---DDIKREIQIMQHL 136
Y LG G FG C ++ G + A K + KN + + EIQ+++HL
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVK-------IVKNVDRYCEAARSEIQVLEHL 68
Query: 137 -----SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSI 189
+ V+ +E + +V EL G +D I G + + I
Sbjct: 69 NTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQI 127
Query: 190 VNVVHICHFMGVMHRDLKPENFLLSSKD----------------ENALLKATDFGLSVFI 233
V+ H + H DLKPEN L D N +K DFG + +
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187
Query: 234 EEGKVYRDIVGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAETE------ 286
+E +V + +Y APEV L + + D+WS G IL G F
Sbjct: 188 DE-HHST-LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245
Query: 287 ----KGIFD------AILQGDIDFESAPWPTISSSAK----------------------- 313
G + + W SS+ +
Sbjct: 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL 305
Query: 314 -DLVRRMLTQDPKKRITSAQVLEHPWIK 340
DL+++ML DP KRIT + L+HP+
Sbjct: 306 FDLIQKMLEYDPAKRITLREALKHPFFD 333
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 76/343 (22%), Positives = 125/343 (36%), Gaps = 86/343 (25%)
Query: 67 NTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK--- 123
+ + YE +K+ +G+G FG ++ + A K + +N+K
Sbjct: 92 HDHVAYRYEVLKV-------IGKGSFGQVVKAYDHKVHQHVALK-------MVRNEKRFH 137
Query: 124 DDIKREIQIMQHLS-----GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY- 177
EI+I++HL N++ + + + + EL L++ +I K +
Sbjct: 138 RQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYE-LIKKNKFQ 195
Query: 178 --SERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235
S SI+ + H ++H DLKPEN LL + + + K DFG S + +
Sbjct: 196 GFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGI-KVIDFGSSCYEHQ 254
Query: 236 GKVYRDIVGSAYYVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAETE-------- 286
+VY I S +Y APEV L RYG ID+WS G IL LL+G P E E
Sbjct: 255 -RVYTYIQ-SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMI 312
Query: 287 --KGIFDAIL-----QGDIDFESAP------------WPTISSSAKDLVRRMLTQDPKK- 326
G+ L + S + + + ++ +
Sbjct: 313 ELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESRE 372
Query: 327 ---------------------------RITSAQVLEHPWIKEG 342
R+T Q L HPW++
Sbjct: 373 WGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR 415
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 63/328 (19%), Positives = 113/328 (34%), Gaps = 71/328 (21%)
Query: 55 SGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISK 114
SG +P TI + L + +G+G+FG + G + A K S
Sbjct: 26 SGSGSGLPLLVQRTIA----RTIVL----QESIGKGRFGEVWRGKWR--GEEVAVKIFSS 75
Query: 115 RKLVTKNDKDDIKREIQI-----MQHLSGQPNIVEFKGAYEDKQSVH----VVMELCAGG 165
R ++ RE +I ++H NI+ F A +V + G
Sbjct: 76 R------EERSWFREAEIYQTVMLRH----ENILGFIAADNKDNGTWTQLWLVSDYHEHG 125
Query: 166 ELFDRIIAKGHYSERAAASICRSIVN--------VVHICHFMGVMHRDLKPENFLLSSKD 217
LFD + + + + S + +V + HRDLK +N L+
Sbjct: 126 SLFD-YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---K 181
Query: 218 ENALLKATDFGLSVFIEEGKVYRDI-----VGSAYYVAPEVLR-------RRYGKEIDIW 265
+N D GL+V + DI VG+ Y+APEVL K DI+
Sbjct: 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY 241
Query: 266 SAGVILYILLSGVPPFWAETEKGI-FDAILQGDIDFESAPW--------PTISSSA---- 312
+ G++ + + + + + ++ D E P I +
Sbjct: 242 AMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCE 301
Query: 313 -----KDLVRRMLTQDPKKRITSAQVLE 335
++R + R+T+ ++ +
Sbjct: 302 ALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 79/383 (20%), Positives = 129/383 (33%), Gaps = 137/383 (35%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS---------KRKLVTKNDKDDI 126
V +Y +GRG +G YL + +T + A K ++ KR L
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--------- 73
Query: 127 KREIQIMQHLSGQPNIVEFK-----GAYEDKQSVHVVMELCAGGELFDRIIAKGHY-SER 180
REI I+ L I+ +++V+E+ A +L ++ + +E
Sbjct: 74 -REITILNRLK-SDYIIRLYDLIIPDDLLKFDELYIVLEI-ADSDL-KKLFKTPIFLTE- 128
Query: 181 AAASICRSIVNVVHICHFM-------------GVMHRDLKPENFLLSSKDENALLKATDF 227
HI + G++HRDLKP N LL +++ +K DF
Sbjct: 129 ------------EHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDF 173
Query: 228 GLSVFIEEGKVYRDIVGSA-----------------------YYVAPEVL--RRRYGKEI 262
GL+ I K + +Y APE++ + Y K I
Sbjct: 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI 233
Query: 263 DIWSAGVILYILLSGVPPFWAETEKG--------------------------------IF 290
DIWS G I LL+ + + IF
Sbjct: 234 DIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIF 293
Query: 291 DAI---LQGDIDF----------------ESAPW----PTISSSAKDLVRRMLTQDPKKR 327
+ I + D+ + P+IS +L+ ML +P KR
Sbjct: 294 NIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKR 353
Query: 328 ITSAQVLEHPWIKEGGEASDKPI 350
IT Q L+HP++K+ + +
Sbjct: 354 ITIDQALDHPYLKDVRKKKLENF 376
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 84/427 (19%), Positives = 145/427 (33%), Gaps = 126/427 (29%)
Query: 27 VAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKE 86
A+ Q ++ G S ++PRP ++ + YE
Sbjct: 8 AAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRH-------L 60
Query: 87 LGRGQFGVTYLCTENSTGRQFACKSIS---------KRKLVTKNDKDDIKREIQIMQHLS 137
+G G +G + R A K I KR L REI I+ L+
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL----------REIAILNRLN 110
Query: 138 GQPNIVEFK-----GAYEDKQSVHVVMELCAGGELFDRIIAKGHY-SERAAASICRSIVN 191
++V+ E ++VV+E+ A + ++ Y +E ++ +++
Sbjct: 111 -HDHVVKVLDIVIPKDVEKFDELYVVLEI-ADSDF-KKLFRTPVYLTELHIKTLLYNLLV 167
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA----- 246
V H G++HRDLKP N L+ +++ +K DFGL+ ++ + + +
Sbjct: 168 GVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 247 -----------------------YYVAPEVL--RRRYGKEIDIWSAGVILYILLSGVPPF 281
+Y APE++ + Y + ID+WS G I LL+ +
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284
Query: 282 WAETEKG-----------------------------------IFDAI---LQGDIDF--- 300
A IF+ + + DI+
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344
Query: 301 -------------ESAPWPTI----SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343
E S+ A L++RML +P KRIT + L HP+ KE
Sbjct: 345 EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404
Query: 344 EASDKPI 350
A +
Sbjct: 405 IAEVETN 411
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 65/321 (20%), Positives = 122/321 (38%), Gaps = 33/321 (10%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK---DDIKREIQIMQHL 136
Y +G+G FG + A K + KN K + + E+++++ +
Sbjct: 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK-------IIKNKKAFLNQAQIEVRLLELM 107
Query: 137 S-----GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSI 189
+ + IV K + + + +V E+ L+D + S + +
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQM 166
Query: 190 VNVVHICHF--MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY 247
+ + ++H DLKPEN LL + +A+ K DFG S + + ++Y+ I S +
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILLCNPKRSAI-KIVDFGSSCQLGQ-RIYQYIQ-SRF 223
Query: 248 YVAPEV-LRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI--LQGDIDFESAP 304
Y +PEV L Y ID+WS G IL + +G P F E + I + G P
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP-----P 278
Query: 305 WPTI--SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFR 362
+ + A+ ++ + T E+ + +++ +
Sbjct: 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGE 338
Query: 363 AMNKLKKLALKVSLIKYMLMY 383
+ + + LI ML Y
Sbjct: 339 SGHTVADYLKFKDLILRMLDY 359
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 9e-07
Identities = 14/29 (48%), Positives = 18/29 (62%)
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
KDL+ RML DPK RI L+H + K+
Sbjct: 350 KDLILRMLDYDPKTRIQPYYALQHSFFKK 378
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 56/300 (18%), Positives = 105/300 (35%), Gaps = 63/300 (21%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI-----MQHLS 137
K++G+G++G ++ G + A K ++ RE +I M+H
Sbjct: 41 MVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLMRH-- 90
Query: 138 GQPNIVEFKGAYEDKQSVH----VVMELCAGGELFDRIIAKGHYSERAAASICRSIVN-- 191
NI+ F A ++ + G L+D + ++ + S V+
Sbjct: 91 --ENILGFIAADIKGTGSWTQLYLITDYHENGSLYD-YLKSTTLDAKSMLKLAYSSVSGL 147
Query: 192 ------VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI--- 242
+ + HRDLK +N L+ +N D GL+V DI
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 243 --VGSAYYVAPEVL-------RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGI-FDA 292
VG+ Y+ PEVL + D++S G+IL+ + E + +
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264
Query: 293 ILQGDIDFESAPW--------PTISSSA---------KDLVRRMLTQDPKKRITSAQVLE 335
++ D +E P+ + L+ +P R+T+ +V +
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 5e-24
Identities = 43/299 (14%), Positives = 73/299 (24%), Gaps = 46/299 (15%)
Query: 38 AHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYL 97
A +P +A P V I Y G +
Sbjct: 2 AFDALREPDRESSAPP-----DDVQLVPGARIANGRYR-------LLIFHGGVPPLQFWQ 49
Query: 98 CTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157
+ + RQ A + + ++ + + + + +P + + V
Sbjct: 50 ALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGGLV 108
Query: 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217
V E GG L + +A S A +S+ H GV P +S
Sbjct: 109 VAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS--- 163
Query: 218 ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSG 277
+G V + + + DI G LY LL
Sbjct: 164 ----------------IDGDVV---LAYPATMPDANPQD------DIRGIGASLYALLVN 198
Query: 278 VPPFWAETEKGIFDAILQGDIDFESAPW---PTISSSAKDLVRRMLTQDPKKRITSAQV 333
P + + P I + R + D R S +
Sbjct: 199 RWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 65/321 (20%), Positives = 112/321 (34%), Gaps = 66/321 (20%)
Query: 65 DTNTILGKPYEDVKL---HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN 121
++ + E++ + RG+FG + A K +
Sbjct: 7 HHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ------ 58
Query: 122 DKDDIKREIQI-----MQHLSGQPNIVEFKGAYEDKQSVHV----VMELCAGGELFDRII 172
DK + E ++ M+H NI++F GA + SV V + G L D +
Sbjct: 59 DKQSWQNEYEVYSLPGMKH----ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSD-FL 113
Query: 173 AKGHYSERAAASICRSI----------VNVVHICHFMGVMHRDLKPENFLLSSKDENALL 222
S I ++ + + H + HRD+K +N LL N
Sbjct: 114 KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTA 170
Query: 223 KATDFGLSVFIEEGKVYRDI---VGSAYYVAPEVLR------RRYGKEIDIWSAGVILYI 273
DFGL++ E GK D VG+ Y+APEVL R ID+++ G++L+
Sbjct: 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE 230
Query: 274 LLSGVPPFWAETEKGI--FDAILQGDIDFES---------------APWPTISSSAK--D 314
L S ++ + F+ + E W + A +
Sbjct: 231 LASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCE 290
Query: 315 LVRRMLTQDPKKRITSAQVLE 335
+ D + R+++ V E
Sbjct: 291 TIEECWDHDAEARLSAGCVGE 311
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 55/265 (20%), Positives = 104/265 (39%), Gaps = 33/265 (12%)
Query: 50 AAAPVSGLKQAVPRPDTNTILGKPYEDVKL-----HYSFGKELGRGQFGVTYLCTENSTG 104
A ++ L P+ + TI G K + +LG GQ+G Y
Sbjct: 186 ADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS 245
Query: 105 RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAG 164
A K++ + + ++ +E +M+ + PN+V+ G + +++ E
Sbjct: 246 LTVAVKTLKE----DTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTY 300
Query: 165 GELFD--RIIAKGHYSERAAASICRSIVNVVHIC------HFMGVMHRDLKPENFLLSSK 216
G L D R + S + I +HR+L N L+
Sbjct: 301 GNLLDYLRECNRQEVSAVVLLYMAT------QISSAMEYLEKKNFIHRNLAARNCLVG-- 352
Query: 217 DENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---APEVLR-RRYGKEIDIWSAGVILY 272
EN L+K DFGLS + Y G+ + + APE L ++ + D+W+ GV+L+
Sbjct: 353 -ENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLW 410
Query: 273 ILLS-GVPPFWAETEKGIFDAILQG 296
+ + G+ P+ +++ + +
Sbjct: 411 EIATYGMSPYPGIDLSQVYELLEKD 435
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 30/237 (12%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
+ED+ L G+++GRG FG + + A KS R+ + + K +E +I
Sbjct: 112 NHEDLVL----GEQIGRGNFGEVFSGRLRADNTLVAVKSC--RETLPPDLKAKFLQEARI 165
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY--SERAAASICRSIV 190
++ S PNIV G KQ +++VMEL GG+ + +E A + +
Sbjct: 166 LKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLT-------FLRTEGARLRVKTLLQ 217
Query: 191 NVVHIC------HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG 244
V +HRDL N L++ E +LK +DFG+S +G
Sbjct: 218 MVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGL 274
Query: 245 SAYYV---APEVLR-RRYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQG 296
V APE L RY E D+WS G++L+ G P+ + + + + +G
Sbjct: 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG 331
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-21
Identities = 65/263 (24%), Positives = 102/263 (38%), Gaps = 51/263 (19%)
Query: 39 HHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLC 98
HH + PT G + T +K ++LG+G FG +C
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSAFEDRDPTQF--EERHLKF----LQQLGKGNFGSVEMC 60
Query: 99 T----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA--YEDK 152
+++TG A K + + T+ D +REI+I++ L NIV++KG +
Sbjct: 61 RYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGR 116
Query: 153 QSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFM------GVMHRD 205
+++ ++ME G L D + K IC M +HRD
Sbjct: 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QICKGMEYLGTKRYIHRD 170
Query: 206 LKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV-----------APEVL 254
L N L+ +K DFGL+ + + K Y Y V APE L
Sbjct: 171 LATRNILVE---NENRVKIGDFGLTKVLPQDKEY-------YKVKEPGESPIFWYAPESL 220
Query: 255 R-RRYGKEIDIWSAGVILYILLS 276
++ D+WS GV+LY L +
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT 243
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 2e-21
Identities = 62/370 (16%), Positives = 115/370 (31%), Gaps = 120/370 (32%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS-- 137
Y ++LG G F +L + + A K + K ++ + EI++++ +
Sbjct: 38 RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKS---AEHYTETALDEIRLLKSVRNS 93
Query: 138 -----GQPNIV------EFKGAYEDKQSVHV--VMELCAGGELFDRIIAKGH--YSERAA 182
+ +V + G H+ V E+ G L II +
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVN----GTHICMVFEV-LGHHLLKWIIKSNYQGLPLPCV 148
Query: 183 ASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKD------------------------ 217
I + ++ + H ++H D+KPEN LLS +
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 218 ----------------------ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV-L 254
E +K D G + ++ + + + + + Y + EV +
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLI 266
Query: 255 RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFD---------AIL----------- 294
Y DIWS + + L +G F + + +L
Sbjct: 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAG 326
Query: 295 ---------QGDIDFESAPWPTISSS---------------AKDLVRRMLTQDPKKRITS 330
+GD+ + P D + ML P+KR T+
Sbjct: 327 KYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATA 386
Query: 331 AQVLEHPWIK 340
A+ L HPW+
Sbjct: 387 AECLRHPWLN 396
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-21
Identities = 50/228 (21%), Positives = 94/228 (41%), Gaps = 28/228 (12%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
+ +LG GQ+G Y A K++ + + ++ +E +M+ + PN
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIK-HPN 70
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFD--RIIAKGHYSERAAASICRSIVNVVHICHFM 199
+V+ G + +++ E G L D R + S + I M
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT------QISSAM 124
Query: 200 ------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---A 250
+HRDL N L+ EN L+K DFGLS + Y G+ + + A
Sbjct: 125 EYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTA 180
Query: 251 PEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
PE L ++ + D+W+ GV+L+ + + G+ P+ +++ + +
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 228
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 73/327 (22%), Positives = 119/327 (36%), Gaps = 63/327 (19%)
Query: 7 KSKDPKPRHYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDT 66
+ P R SS + + P + R TP A VS + +P
Sbjct: 21 TKRIPLRRQVTVSAESSSSMNSNTPL---VRITTRLSSTADTPMLAGVSEYE--LPEDPK 75
Query: 67 NTILGKPYEDVKLHYSFGKELGRGQFGVTYLCT-------ENSTGRQFACKSISKRKLVT 119
P + + L GK LG G FG + + A K + + T
Sbjct: 76 WEF---PRDKLTL----GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDAT 126
Query: 120 KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSE 179
+ D D+ E+++M+ + NI+ GA ++V++E + G L + + A+
Sbjct: 127 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 186
Query: 180 RAAASICRSIVNVVHICHFMGVM----------------HRDLKPENFLLSSKDENALLK 223
+ I R + + HRDL N L++ EN ++K
Sbjct: 187 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMK 243
Query: 224 ATDFGLSVFIEEGKVYRDIVGSAYYV------------APEVLR-RRYGKEIDIWSAGVI 270
DFGL+ RDI YY APE L R Y + D+WS GV+
Sbjct: 244 IADFGLA---------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 294
Query: 271 LY-ILLSGVPPFWAETEKGIFDAILQG 296
++ I G P+ + +F + +G
Sbjct: 295 MWEIFTLGGSPYPGIPVEELFKLLKEG 321
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-21
Identities = 52/236 (22%), Positives = 86/236 (36%), Gaps = 54/236 (22%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIK 127
P + GK LG G FG T ++ A K + + +++ +
Sbjct: 21 PRNRLSF----GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALM 74
Query: 128 REIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD--------RIIAKGHYSE 179
E++++ +L NIV GA V+ E C G+L + I +K +
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 180 RAAASICRSIVNVVHICH----------FMGVMHRDLKPENFLLSSKDENALLKATDFGL 229
+ + +++ + +HRDL N LL+ + K DFGL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGL 191
Query: 230 SVFIEEGKVYRDIVGSAYYV------------APEVLR-RRYGKEIDIWSAGVILY 272
+ RDI + YV APE + Y E D+WS G+ L+
Sbjct: 192 A---------RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 7e-21
Identities = 58/313 (18%), Positives = 106/313 (33%), Gaps = 76/313 (24%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI-----MQHL 136
+ +GRG++G Y + + R A K S ++ + E I M+H
Sbjct: 16 KLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFA------NRQNFINEKNIYRVPLMEH- 66
Query: 137 SGQPNIVEFKGAYEDKQSVH------VVMELCAGGELFDRIIAKGHYSERAAASICRSIV 190
NI F +++ + +VME G L ++ ++ + S+
Sbjct: 67 ---DNIARFIVG-DERVTADGRMEYLLVMEYYPNGSLXK-YLSLHTSDWVSSCRLAHSVT 121
Query: 191 N---------VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD 241
+ + HRDL N L+ + +DFGLS+ + ++ R
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 242 ---------IVGSAYYVAPEVLR--------RRYGKEIDIWSAGVILYILLSGV------ 278
VG+ Y+APEVL K++D+++ G+I + +
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 279 -------PPFWAETEKGIFDAILQGDIDFE------SAPWPTISSSA---KDLVRRMLTQ 322
F E +Q + E W S + K+ + Q
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298
Query: 323 DPKKRITSAQVLE 335
D + R+T+ E
Sbjct: 299 DAEARLTAQXAEE 311
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 7e-21
Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 17/225 (7%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQF----ACKSISKRKLVTKNDKDDIKREIQIMQHLS 137
K LG G FG Y G + A K + R+ + +I E +M +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD 75
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHIC 196
P++ G +V ++ +L G L D + K + + + C I ++
Sbjct: 76 -NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---APEV 253
++HRDL N L+ + +K TDFGL+ + + G + A E
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 254 LR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
+ R Y + D+WS GV ++ L++ G P+ I + +G
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 48/243 (19%), Positives = 95/243 (39%), Gaps = 44/243 (18%)
Query: 83 FGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS 137
+ELG+G FG+ Y ++ + A K++ + + ++ + E +M+
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEF- 85
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH 197
++V G Q V+MEL G+L + + S+ ++ +
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 198 ----------FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAY 247
+HRDL N +++ E+ +K DFG++ RDI + Y
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------RDIYETDY 193
Query: 248 YV------------APEVLR-RRYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAI 293
Y +PE L+ + D+WS GV+L+ I P+ + + + +
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253
Query: 294 LQG 296
++G
Sbjct: 254 MEG 256
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 56/232 (24%), Positives = 91/232 (39%), Gaps = 50/232 (21%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIK 127
P +++ GK LG G FG T + + A K + + ++K+ +
Sbjct: 44 PRNNLQF----GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALM 97
Query: 128 REIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD----RIIAKGHYSERAAA 183
E++IM HL NIV GA V V+ E C G+L + + A A
Sbjct: 98 SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 184 SICRSIVNVVHICH----------FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233
+ S +++H +HRD+ N LL+ + K DFGL+
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLA--- 211
Query: 234 EEGKVYRDIVGSAYYV------------APEVLR-RRYGKEIDIWSAGVILY 272
RDI+ + Y+ APE + Y + D+WS G++L+
Sbjct: 212 ------RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 257
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 55/244 (22%), Positives = 97/244 (39%), Gaps = 29/244 (11%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCT---ENSTGRQFACKSISKRKLVTKNDKDDIKRE 129
P + L G+ LG+G+FG E+ + + A K + K ++ +D ++ RE
Sbjct: 21 PEQQFTL----GRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLRE 75
Query: 130 IQIMQHLSGQPNIVEFKGA------YEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAA 183
M+ P++ + G V++ G+L ++A
Sbjct: 76 AACMKEFD-HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 184 SICRSIVNVVHICHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237
+ + +V I M +HRDL N +L+ E+ + DFGLS I G
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLSRKIYSGD 191
Query: 238 VYRDIVGSAYYV---APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDA 292
YR S V A E L Y D+W+ GV ++ +++ G P+ I++
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251
Query: 293 ILQG 296
++ G
Sbjct: 252 LIGG 255
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 70/306 (22%), Positives = 110/306 (35%), Gaps = 41/306 (13%)
Query: 11 PKPRHYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTIL 70
P + +T+ + P+KP P P V P D +
Sbjct: 271 PAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVF----ESPFSDPEELK 326
Query: 71 GKPYEDVKLHYSFGK-ELGRGQFGVTY---LCTENSTGRQFACKSISKRKLVTKNDKDDI 126
K + + ELG G FG A K + ++ K D +++
Sbjct: 327 DKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQ-IDVAIKVL--KQGTEKADTEEM 383
Query: 127 KREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASIC 186
RE QIM L P IV G + +++ +VME+ GG L ++ K
Sbjct: 384 MREAQIMHQLD-NPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEI-------- 433
Query: 187 RSIVNVVHICH----------FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236
+ NV + H +HR+L N LL ++ K +DFGLS +
Sbjct: 434 -PVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH---YAKISDFGLSKALGAD 489
Query: 237 K-VYRDIVGSAYYV---APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIF 290
Y + + APE + R++ D+WS GV ++ LS G P+ +
Sbjct: 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 549
Query: 291 DAILQG 296
I QG
Sbjct: 550 AFIEQG 555
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-20
Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 45/219 (20%)
Query: 83 FGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG 138
F ++LG+G FG +C +++TG A K + + T+ D +REI+I++ L
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQ- 69
Query: 139 QPNIVEFKGA--YEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHI 195
NIV++KG ++++ ++ME G L D + K I
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QI 123
Query: 196 CHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV 249
C M +HRDL N L+ +K DFGL+ + + K + + V
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEF-------FKV 173
Query: 250 -----------APEVLR-RRYGKEIDIWSAGVILYILLS 276
APE L ++ D+WS GV+LY L +
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-20
Identities = 56/243 (23%), Positives = 98/243 (40%), Gaps = 28/243 (11%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCT---ENSTGRQFACKSISKRKLVTKNDKDDIKRE 129
+ L GK LG G+FG E+ T + A K++ K ++ + ++ E
Sbjct: 32 DRNLLIL----GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSE 86
Query: 130 IQIMQHLSGQPNIVEFKGAYEDKQSVH-----VVMELCAGGELFDRIIAKGHYSERAAAS 184
M+ S PN++ G + S V++ G+L ++ +
Sbjct: 87 AACMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 185 ICRSIVNVVHICHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238
+ + +V I M +HRDL N +L ++ + DFGLS I G
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR---DDMTVCVADFGLSKKIYSGDY 202
Query: 239 YRDIVGSAYYV---APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAI 293
YR + V A E L R Y + D+W+ GV ++ + + G+ P+ ++D +
Sbjct: 203 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262
Query: 294 LQG 296
L G
Sbjct: 263 LHG 265
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 56/316 (17%), Positives = 111/316 (35%), Gaps = 50/316 (15%)
Query: 15 HYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPY 74
+Y H + + Q + P + + P+
Sbjct: 3 YYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLR-TSTIMTDYNPNYCFAGKTSS 61
Query: 75 EDVKLHY-----SFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKD 124
+ + LG G FG Y + + Q A K++ ++ ++ D+
Sbjct: 62 ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDEL 119
Query: 125 DIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAAS 184
D E I+ + NIV G +++EL AGG+L + + ++
Sbjct: 120 DFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 178
Query: 185 ICRSIVNVVHICH----------FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234
++++++H+ +HRD+ N LL+ + K DFG++
Sbjct: 179 ---AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---- 231
Query: 235 EGKVYRDIVGSAYYV------------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPP 280
RDI + YY PE + + D WS GV+L+ + S G P
Sbjct: 232 -----RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
Query: 281 FWAETEKGIFDAILQG 296
+ +++ + + + + G
Sbjct: 287 YPSKSNQEVLEFVTSG 302
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-20
Identities = 41/252 (16%), Positives = 74/252 (29%), Gaps = 51/252 (20%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSIS---KR-KLVTKNDKDDIKR 128
ED+ + LG+G F + G K +N +
Sbjct: 6 RNEDLIF----NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 129 EIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRS 188
+M LS ++V G +V E G L Y ++ I +
Sbjct: 62 AASMMSKLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDT-------YLKKNKNCI--N 111
Query: 189 IVNVVHICH----------FMGVMHRDLKPENFLLSSKD-----ENALLKATDFGLSVFI 233
I+ + + ++H ++ +N LL ++ +K +D G+S
Sbjct: 112 ILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS--- 168
Query: 234 EEGKVYRDIVGSAYY------VAPEVL--RRRYGKEIDIWSAGVILYILLS-GVPPFWAE 284
++ V PE + + D WS G L+ + S G P A
Sbjct: 169 ------ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222
Query: 285 TEKGIFDAILQG 296
+
Sbjct: 223 DSQRKLQFYEDR 234
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-20
Identities = 51/244 (20%), Positives = 98/244 (40%), Gaps = 44/244 (18%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQF-----ACKSISKRKLVTKNDKDDIKREIQIMQHL 136
+ + LG G FG Y + A K++ ++ ++ D+ D E I+
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKF 90
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHIC 196
+ NIV G ++MEL AGG+L + + ++ ++++++H+
Sbjct: 91 N-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSL---AMLDLLHVA 146
Query: 197 H----------FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSA 246
+HRD+ N LL+ + K DFG++ RDI ++
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---------RDIYRAS 197
Query: 247 YYV------------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDA 292
YY PE + + D WS GV+L+ + S G P+ +++ + + +
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 257
Query: 293 ILQG 296
+ G
Sbjct: 258 VTSG 261
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-20
Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 44/218 (20%)
Query: 83 FGKELGRGQFGVTYLC----TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG 138
++LG G FG L T + TG A K++ + + K+EI I++ L
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADAGPQHRSGWKQEIDILRTLY- 91
Query: 139 QPNIVEFKGA--YEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHIC 196
+I+++KG S+ +VME G L D Y R + + + ++ IC
Sbjct: 92 HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD-------YLPRHSIGLAQLLLFAQQIC 144
Query: 197 HFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV- 249
M +HRDL N LL + L+K DFGL+ + EG Y Y V
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEY-------YRVR 194
Query: 250 ----------APEVLR-RRYGKEIDIWSAGVILYILLS 276
APE L+ ++ D+WS GV LY LL+
Sbjct: 195 EDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 8e-20
Identities = 65/242 (26%), Positives = 98/242 (40%), Gaps = 47/242 (19%)
Query: 60 AVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKR 115
+ +P T P K ++LG G FG LC ++TG Q A KS+ +
Sbjct: 5 SEKKPATEV---DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--K 59
Query: 116 KLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA--YEDKQSVHVVMELCAGGELFDRIIA 173
N D+K+EI+I+++L NIV++KG + + ++ME G L + +
Sbjct: 60 PESGGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK 118
Query: 174 -KGHYSERAAASICRSIVNVVHIC------HFMGVMHRDLKPENFLLSSKDENALLKATD 226
K + + IC +HRDL N L+ +K D
Sbjct: 119 NKNKINLKQQLKYAV------QICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGD 169
Query: 227 FGLSVFIEEGKVYRDIVGSAYYV-----------APEVLR-RRYGKEIDIWSAGVILYIL 274
FGL+ IE K Y Y V APE L ++ D+WS GV L+ L
Sbjct: 170 FGLTKAIETDKEY-------YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222
Query: 275 LS 276
L+
Sbjct: 223 LT 224
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 8e-20
Identities = 63/247 (25%), Positives = 94/247 (38%), Gaps = 49/247 (19%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTY---LCTENSTGRQFACKSISKRKLVTKNDKDDIKRE 129
EDV L + LG G FG Y A K+ +K T ++K+ E
Sbjct: 10 AREDVVL----NRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSE 63
Query: 130 IQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRS 188
IM++L P+IV+ G E ++ ++MEL GEL + K
Sbjct: 64 AVIMKNLD-HPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL- 120
Query: 189 IVNVVHICHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI 242
IC M +HRD+ N L++ +K DFGLS R I
Sbjct: 121 -----QICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLS---------RYI 163
Query: 243 VGSAYYV-----------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGI 289
YY +PE + RR+ D+W V ++ +LS G PF+ K +
Sbjct: 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV 223
Query: 290 FDAILQG 296
+ +G
Sbjct: 224 IGVLEKG 230
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 89.7 bits (222), Expect = 9e-20
Identities = 61/244 (25%), Positives = 96/244 (39%), Gaps = 43/244 (17%)
Query: 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL 136
V + G+++G G FG YL T T + A K + K + E +I + L
Sbjct: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKIYRIL 59
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAG---GELFDRIIAKGHYSERAAASICRSIVNVV 193
G I + + +VM+L G +LF+ S + + ++N V
Sbjct: 60 QGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRV 116
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD------------ 241
H +HRD+KP+NFL+ + DFGL+ K YRD
Sbjct: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA------KKYRDTSTHQHIPYREN 170
Query: 242 --IVGSAYYVAPEVLRRRYGKEI----DIWSAGVILYILLSGVPPFW----AETEKGIFD 291
+ G+A Y + + G E D+ S G +L L G P W A T+K ++
Sbjct: 171 KNLTGTARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQKYE 226
Query: 292 AILQ 295
I +
Sbjct: 227 KISE 230
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 60/243 (24%), Positives = 100/243 (41%), Gaps = 41/243 (16%)
Query: 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL 136
V Y G+++G G FG YL T+ + G + A K K + E +I + +
Sbjct: 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMM 61
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD-RIIAKGHYSERAAASICRSIVNVVHI 195
G I + + +VMEL G L D +S + + +++ +
Sbjct: 62 QGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-------------- 241
H +HRD+KP+NFL+ + L+ DFGL+ K YRD
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA------KKYRDARTHQHIPYRENKN 174
Query: 242 IVGSAYYVAPEVLRRRYGKEI----DIWSAG-VILYILLSGVPPFW----AETEKGIFDA 292
+ G+A Y + + G E D+ S G V++Y L +P W A T++ ++
Sbjct: 175 LTGTARYAS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLP--WQGLKAATKRQKYER 229
Query: 293 ILQ 295
I +
Sbjct: 230 ISE 232
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-19
Identities = 60/227 (26%), Positives = 107/227 (47%), Gaps = 28/227 (12%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
+F +E+G GQFG+ +L + + A K+I + ++D E ++M LS P
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIRE----GAMSEEDFIEEAEVMMKLS-HPK 64
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFM- 199
+V+ G ++ + +V E G L D + +G ++ +C +C M
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCL------DVCEGMA 118
Query: 200 -----GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---AP 251
V+HRDL N L+ EN ++K +DFG++ F+ + Y G+ + V +P
Sbjct: 119 YLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASP 174
Query: 252 EVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
EV RY + D+WS GV+++ + S G P+ + + + I G
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 57/238 (23%), Positives = 90/238 (37%), Gaps = 29/238 (12%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQF--ACKSISKRKLVTKNDKDDIKREI 130
+ + L KELG G FG A K + K + KD++ E
Sbjct: 14 DRKLLTL---EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEA 69
Query: 131 QIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIV 190
+MQ L P IV G E +S +VME+ G L + H ++ +
Sbjct: 70 NVMQQLD-NPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH--- 124
Query: 191 NVVHICHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-VYRDIV 243
+ M +HRDL N LL K +DFGLS + + Y+
Sbjct: 125 ---QVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQT 178
Query: 244 GSAYYV---APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
+ V APE + ++ + D+WS GV+++ S G P+ + + +G
Sbjct: 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 18/227 (7%)
Query: 82 SFGKELGRGQFGVTY---LCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG 138
F + +GRG FG Y L + A KS+ ++ + E IM+ S
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFS- 84
Query: 139 QPNIVEFKGA-YEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHIC 196
PN++ G + S VV+ G+L + I + + + + +
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV-----AP 251
+HRDL N +L E +K DFGL+ + + + Y + + A
Sbjct: 145 ASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 252 EVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
E L+ +++ + D+WS GV+L+ L++ G PP+ I +LQG
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 67/294 (22%), Positives = 109/294 (37%), Gaps = 60/294 (20%)
Query: 40 HRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCT 99
H P A VS + +P P + + L GK LG G FG +
Sbjct: 5 HHHHHHSQDPMLAGVSEYE--LPEDPKWEF---PRDKLTL----GKPLGEGAFGQVVMAE 55
Query: 100 ENSTGRQF-------ACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152
+ A K + + T+ D D+ E+++M+ + NI+ GA
Sbjct: 56 AVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113
Query: 153 QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-------------- 198
++V++E + G L + + A+ + I R +
Sbjct: 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 173
Query: 199 --MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV------- 249
+HRDL N L++ EN ++K DFGL+ RDI YY
Sbjct: 174 ASQKCIHRDLAARNVLVT---ENNVMKIADFGLA---------RDINNIDYYKKTTNGRL 221
Query: 250 -----APEVLR-RRYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQG 296
APE L R Y + D+WS GV+++ I G P+ + +F + +G
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 64/302 (21%), Positives = 108/302 (35%), Gaps = 65/302 (21%)
Query: 38 AHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDV------KLHYSFGKELGRGQ 91
HH + PT + + P + +L GK LG G
Sbjct: 30 HHHHHDYDIPT------TENLYFQGMLAGVSEYELPEDPRWELPRDRL--VLGKPLGEGA 81
Query: 92 FGVTYLCT-------ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
FG L + + + A K + + T+ D D+ E+++M+ + NI+
Sbjct: 82 FGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKMIGKHKNIIN 139
Query: 145 FKGAYEDKQSVHVVMELCAGGELFD---RIIAKGHYSERAAASICRSIVNVVHICHF--- 198
GA ++V++E + G L + G + ++ +
Sbjct: 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ 199
Query: 199 ----------MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYY 248
+HRDL N L++ E+ ++K DFGL+ RDI YY
Sbjct: 200 VARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLA---------RDIHHIDYY 247
Query: 249 V------------APEVLR-RRYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAIL 294
APE L R Y + D+WS GV+L+ I G P+ + +F +
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 307
Query: 295 QG 296
+G
Sbjct: 308 EG 309
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 43/245 (17%)
Query: 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL 136
V +HY G+ +G G FGV + T +Q A K ++D ++ E + + L
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLL 62
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD-RIIAKGHYSERAAASICRSIVNVVHI 195
+G I ++ +V++L G L D + +S + A + ++ V
Sbjct: 63 AGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 196 CHFMGVMHRDLKPENFLL---SSKDENALLKATDFGLSVFIEEGKVYRD----------- 241
H +++RD+KP+NFL+ +SK+ N ++ DFG+ K YRD
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNAN-MIYVVDFGMV------KFYRDPVTKQHIPYRE 174
Query: 242 ---IVGSAYYVAPEVLRRRYGKEI----DIWSAGVILYILLSGVPPFW----AETEKGIF 290
+ G+A Y++ + G+E D+ + G + L G P W A T K +
Sbjct: 175 KKNLSGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP-WQGLKAATNKQKY 230
Query: 291 DAILQ 295
+ I +
Sbjct: 231 ERIGE 235
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 61/242 (25%), Positives = 93/242 (38%), Gaps = 46/242 (19%)
Query: 83 FGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG 138
+ +LG+G FG LC ++TG A K + + + + D +REIQI++ L
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQILKALH- 82
Query: 139 QPNIVEFKG--AYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHI 195
IV+++G +QS+ +VME G L D + + I
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS------QI 136
Query: 196 CHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV 249
C M +HRDL N L+ A +K DFGL+ + K Y Y V
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAKLLPLDKDY-------YVV 186
Query: 250 -----------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
APE L + ++ D+WS GV+LY L + E +
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD 246
Query: 297 DI 298
Sbjct: 247 VP 248
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 54/241 (22%), Positives = 93/241 (38%), Gaps = 59/241 (24%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIK 127
P E+++ GK LG G FG T + Q A K + ++ ++++ +
Sbjct: 43 PRENLEF----GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML--KEKADSSEREALM 96
Query: 128 REIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGEL----------FDRIIAKGHY 177
E+++M L NIV GA ++++ E C G+L F +
Sbjct: 97 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 178 SERAAASICRSIVNVVHICHF-------------MGVMHRDLKPENFLLSSKDENALLKA 224
+R +++ + F +HRDL N L++ ++K
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKI 213
Query: 225 TDFGLSVFIEEGKVYRDIVGSAYYV------------APEVLR-RRYGKEIDIWSAGVIL 271
DFGL+ RDI+ + YV APE L Y + D+WS G++L
Sbjct: 214 CDFGLA---------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264
Query: 272 Y 272
+
Sbjct: 265 W 265
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 3e-19
Identities = 66/328 (20%), Positives = 114/328 (34%), Gaps = 68/328 (20%)
Query: 2 GGCLTKSKDPK--PRHYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQ 59
G C + + + ++ K +Q T A +
Sbjct: 316 GYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEI----- 370
Query: 60 AVPRPDTNTILGK-----PYEDVKLHYSFGKELGRGQFGVTY---LCTENSTGRQFACKS 111
+ DT T+ E ++L G+ +G GQFG + + + A K+
Sbjct: 371 -IDEEDTYTMPSTRDYEIQRERIEL----GRCIGEGQFGDVHQGIYMSPENPAMAVAIKT 425
Query: 112 ISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI 171
+ + + ++ +E M+ P+IV+ G + V ++MELC GEL +
Sbjct: 426 C--KNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFL 481
Query: 172 IAKGHYSERAAASICRSIVNVVHICH----------FMGVMHRDLKPENFLLSSKDENAL 221
+ + +++ + +HRD+ N L+S N
Sbjct: 482 QVRKFSL---------DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDC 529
Query: 222 LKATDFGLSVFIEEGKVYRDIVGSAYYV-----------APEVLR-RRYGKEIDIWSAGV 269
+K DFGLS R + S YY APE + RR+ D+W GV
Sbjct: 530 VKLGDFGLS---------RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 580
Query: 270 ILYILLS-GVPPFWAETEKGIFDAILQG 296
++ +L GV PF + I G
Sbjct: 581 CMWEILMHGVKPFQGVKNNDVIGRIENG 608
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-19
Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 17/225 (7%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQF----ACKSISKRKLVTKNDKDDIKREIQIMQHLS 137
K LG G FG Y G + A K + R+ + +I E +M +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD 75
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHIC 196
P++ G +V ++ +L G L D + K + + + C I ++
Sbjct: 76 -NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---APEV 253
++HRDL N L+ + +K TDFGL+ + + G + A E
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 254 LR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
+ R Y + D+WS GV ++ L++ G P+ I + +G
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-19
Identities = 57/235 (24%), Positives = 98/235 (41%), Gaps = 44/235 (18%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
+F KELG GQFGV A K I + +D+ E ++M +LS
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKE----GSMSEDEFIEEAKVMMNLS-HEK 80
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFM- 199
+V+ G ++ + ++ E A G L + + + + + +C+ +C M
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK------DVCEAME 134
Query: 200 -----GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV----- 249
+HRDL N L++ + ++K +DFGLS R ++ Y
Sbjct: 135 YLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLS---------RYVLDDEYTSSVGSK 182
Query: 250 ------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
PEVL ++ + DIW+ GV+++ + S G P+ T + I QG
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-19
Identities = 62/256 (24%), Positives = 98/256 (38%), Gaps = 53/256 (20%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQF--ACKSISKRKLVTKNDKDDIKREI 130
+ D+K +G G FG G + A K + ++ +K+D D E+
Sbjct: 23 DWNDIKF----QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGEL 76
Query: 131 QIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD---RIIAKGHYSERAAASICR 187
+++ L PNI+ GA E + +++ +E G L D + A A+
Sbjct: 77 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 188 SIVNVVHICHF-------------MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234
S ++ + HF +HRDL N L+ EN + K DFGLS
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS---- 189
Query: 235 EGKVYRDIVGSAYYV------------APEVLR-RRYGKEIDIWSAGVILY-ILLSGVPP 280
R YV A E L Y D+WS GV+L+ I+ G P
Sbjct: 190 -----RG---QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
Query: 281 FWAETEKGIFDAILQG 296
+ T +++ + QG
Sbjct: 242 YCGMTCAELYEKLPQG 257
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-19
Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 46/236 (19%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
+ KELG GQFGV L A K I + +D+ +E Q M LS P
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKE----GSMSEDEFFQEAQTMMKLS-HPK 64
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY--SERAAASICRSIVNVVHICHFM 199
+V+F G + +++V E + G L + Y S + + +C M
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLN-------YLRSHGKGLEPSQLLEMCYDVCEGM 117
Query: 200 ------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---- 249
+HRDL N L+ + +K +DFG++ R ++ Y
Sbjct: 118 AFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMT---------RYVLDDQYVSSVGT 165
Query: 250 -------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
APEV +Y + D+W+ G++++ + S G P+ T + + QG
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG 221
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-19
Identities = 59/249 (23%), Positives = 99/249 (39%), Gaps = 50/249 (20%)
Query: 82 SFGKELGRGQFGVTYLCT-ENSTGRQF----ACKSISKRKLVTKNDKDDIKREIQIMQHL 136
ELG G FG +L N Q A K++ K +++ + D +RE +++ L
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTML 100
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD-----RIIAKGHYSERAAASICRSIVN 191
+IV F G + + + +V E G+L AK A +
Sbjct: 101 Q-HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 192 VVHICH----------FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD 241
++ + + +HRDL N L+ + ++K DFG+S RD
Sbjct: 160 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGLVVKIGDFGMS---------RD 207
Query: 242 IVGSAYYV------------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEK 287
I + YY PE + R++ E D+WS GV+L+ + + G P++ +
Sbjct: 208 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 267
Query: 288 GIFDAILQG 296
D I QG
Sbjct: 268 EAIDCITQG 276
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-19
Identities = 44/230 (19%), Positives = 80/230 (34%), Gaps = 29/230 (12%)
Query: 83 FGKELGRGQFGVTYLCTENSTGRQF----ACKSISKRKLVTKNDKDDIKREIQIMQHLSG 138
K LG G FG + G K I + + + + L
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAIGSLD- 73
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICH 197
+IV G S+ +V + G L D + +G + + I
Sbjct: 74 HAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIAK 126
Query: 198 FM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV-- 249
M G++HR+L N LL + ++ DFG++ + + +
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 250 -APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
A E + +Y + D+WS GV ++ L++ G P+ + D + +G
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG 233
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-19
Identities = 60/235 (25%), Positives = 95/235 (40%), Gaps = 53/235 (22%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIK 127
P + +KL GK LGRG FG + +T R A K + ++ T ++ +
Sbjct: 25 PRDRLKL----GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALM 78
Query: 128 REIQIMQHLSGQPNIVEFKGA-YEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASIC 186
E++I+ H+ N+V GA + + V++E C G L + +K + +
Sbjct: 79 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 138
Query: 187 RSIVNVVHICHF----------------MGVMHRDLKPENFLLSSKDENALLKATDFGLS 230
+ + + H +HRDL N LLS E ++K DFGL+
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA 195
Query: 231 VFIEEGKVYRDIVGSAYYV------------APEVLR-RRYGKEIDIWSAGVILY 272
RDI YV APE + R Y + D+WS GV+L+
Sbjct: 196 ---------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 241
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 9e-19
Identities = 64/306 (20%), Positives = 109/306 (35%), Gaps = 63/306 (20%)
Query: 14 RHYAHGYRSSPNTVAKAPAPAQQQAHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKP 73
H++ G R + K P P H E+PG + +
Sbjct: 5 HHHSSG-RENLYFQGKLPEPQFYAEPHTYEEPG-----RAGRSFTREIEA---------- 48
Query: 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQF---ACKSISKRKLVTKNDKDDIKREI 130
+ + K +G G G G++ A K++ + T+ + D E
Sbjct: 49 -SRIHI----EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEA 101
Query: 131 QIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSI 189
IM PNI+ +G + +V E G L + G ++ + R
Sbjct: 102 SIMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR-- 158
Query: 190 VNVVHICHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243
+ M G +HRDL N L+ N + K +DFGLS +E+
Sbjct: 159 ----GVGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLEDDPDA---- 207
Query: 244 GSAYYV-----------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIF 290
Y APE + R + D+WS GV+++ +L+ G P+W T + +
Sbjct: 208 ---AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI 264
Query: 291 DAILQG 296
++ +G
Sbjct: 265 SSVEEG 270
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-19
Identities = 50/250 (20%), Positives = 97/250 (38%), Gaps = 50/250 (20%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQF-----ACKSISKRKLVTKNDKDDIKREIQIMQHL 136
F +ELG +FG Y A K++ + +++ + E + L
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEAMLRARL 69
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICR------SIV 190
PN+V G Q + ++ C+ G+L + ++ + +S+ + R
Sbjct: 70 Q-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 191 NVVHICH----------FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR 240
+ VH+ V+H+DL N L+ + +K +D GL R
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLF---------R 176
Query: 241 DIVGSAYYV------------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETE 286
++ + YY APE + ++ + DIWS GV+L+ + S G+ P+ +
Sbjct: 177 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 236
Query: 287 KGIFDAILQG 296
+ + + I
Sbjct: 237 QDVVEMIRNR 246
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 59/276 (21%), Positives = 104/276 (37%), Gaps = 45/276 (16%)
Query: 39 HHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGK-----PYEDVKLHYSFGKELGRGQFG 93
H++ G L K P E +KL K+LG GQFG
Sbjct: 153 HYKKGNDGLC------QKLSVPCMSSKPQKPWEKDAWEIPRESLKL----EKKLGAGQFG 202
Query: 94 VTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153
++ T N + A K++ + E +M+ L +V+ K+
Sbjct: 203 EVWMATYNKHTK-VAVKTMKP----GSMSVEAFLAEANVMKTLQ-HDKLVKLHAVVT-KE 255
Query: 154 SVHVVMELCAGGELFD--RIIAKGHYSERAAASICRSIVNVVHICHFM------GVMHRD 205
++++ E A G L D + I M +HRD
Sbjct: 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA------QIAEGMAFIEQRNYIHRD 309
Query: 206 LKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---APEVLR-RRYGKE 261
L+ N L+S + + K DFGL+ IE+ + Y G+ + + APE + + +
Sbjct: 310 LRAANILVS---ASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 262 IDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
D+WS G++L +++ G P+ + + A+ +G
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 401
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 61/264 (23%), Positives = 93/264 (35%), Gaps = 43/264 (16%)
Query: 46 GPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTY---LCTENS 102
G P+ L + +D++L ++LG G FGV +
Sbjct: 1 GSAGEG-PLQSLTCLIGE-----------KDLRL----LEKLGDGSFGVVRRGEWDAPSG 44
Query: 103 TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELC 162
A K + L DD RE+ M L N++ G + +V EL
Sbjct: 45 KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVL-TPPMKMVTELA 102
Query: 163 AGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFM------GVMHRDLKPENFLLSS 215
G L DR+ +GH+ + + M +HRDL N LL++
Sbjct: 103 PLGSLLDRLRKHQGHFLLGTLSRYAV------QVAEGMGYLESKRFIHRDLAARNLLLAT 156
Query: 216 KDENALLKATDFGLSVFIEEG-KVYRDIVGSAYYV---APEVLR-RRYGKEIDIWSAGVI 270
+D L+K DFGL + + Y APE L+ R + D W GV
Sbjct: 157 RD---LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 213
Query: 271 LYILLS-GVPPFWAETEKGIFDAI 293
L+ + + G P+ I I
Sbjct: 214 LWEMFTYGQEPWIGLNGSQILHKI 237
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 62/283 (21%), Positives = 103/283 (36%), Gaps = 58/283 (20%)
Query: 38 AHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDV----KLHYSFGKELGRGQFG 93
H+ + G + L + T + Y + +G+G+FG
Sbjct: 154 EHYTTDADGL------CTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFG 207
Query: 94 VTYLCTENSTGRQFACKSISKRKLVTKND--KDDIKREIQIMQHLSGQPNIVEFKGA-YE 150
L G + A K I KND E +M L N+V+ G E
Sbjct: 208 DVMLGDYR--GNKVAVKCI-------KNDATAQAFLAEASVMTQLR-HSNLVQLLGVIVE 257
Query: 151 DKQSVHVVMELCAGGELFD--RIIAKGHYSERAAASICRSIVNVVHICHFM------GVM 202
+K +++V E A G L D R + +C M +
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL------DVCEAMEYLEGNNFV 311
Query: 203 HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV-------APEVLR 255
HRDL N L+S E+ + K +DFGL+ ++ + APE LR
Sbjct: 312 HRDLAARNVLVS---EDNVAKVSDFGLT---------KEASSTQDTGKLPVKWTAPEALR 359
Query: 256 -RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
+++ + D+WS G++L+ + S G P+ K + + +G
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 402
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 63/285 (22%), Positives = 103/285 (36%), Gaps = 52/285 (18%)
Query: 39 HHRPEKPGPTPAAAPVSGLKQAVP----RPDTNTILGKPYEDVKLHYSFGKELGRGQFGV 94
HH + PT G + P T I V K +G G+FG
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSDPNQAVLKFTTEI---HPSCVTR----QKVIGAGEFGE 59
Query: 95 ----TYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150
+ A K++ + T+ + D E IM S NI+ +G
Sbjct: 60 VYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVIS 116
Query: 151 DKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFM------GVMH 203
+ + ++ E G L + G +S + R I M +H
Sbjct: 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR------GIAAGMKYLANMNYVH 170
Query: 204 RDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV----------APEV 253
RDL N L++ N + K +DFGLS +E D + Y APE
Sbjct: 171 RDLAARNILVN---SNLVCKVSDFGLSRVLE------DDPEATYTTSGGKIPIRWTAPEA 221
Query: 254 LR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
+ R++ D+WS G++++ +++ G P+W + + AI G
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 266
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-18
Identities = 58/247 (23%), Positives = 94/247 (38%), Gaps = 49/247 (19%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTY---LCTENSTGRQFACKSISKRKLVTKNDKDDIKRE 129
E ++L G+ +G GQFG + + + A K+ + + + ++ +E
Sbjct: 13 QRERIEL----GRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQE 66
Query: 130 IQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRS 188
M+ P+IV+ G + V ++MELC GEL + K +
Sbjct: 67 ALTMRQFD-HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY- 123
Query: 189 IVNVVHICHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI 242
+ + +HRD+ N L+S N +K DFGLS R +
Sbjct: 124 -----QLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS---------RYM 166
Query: 243 VGSAYYV-----------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGI 289
S YY APE + RR+ D+W GV ++ +L GV PF +
Sbjct: 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 226
Query: 290 FDAILQG 296
I G
Sbjct: 227 IGRIENG 233
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-18
Identities = 62/250 (24%), Positives = 101/250 (40%), Gaps = 51/250 (20%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQF-----ACKSISKRKLVTKNDKDDIKREIQIMQHL 136
+ELG G FG +L + A K++ K T + D +RE +++ +L
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNL 74
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICR------SIV 190
+IV+F G D + +V E G+L + A G + R +
Sbjct: 75 Q-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133
Query: 191 NVVHICH----------FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR 240
++HI +HRDL N L+ N L+K DFG+S R
Sbjct: 134 QMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMS---------R 181
Query: 241 DIVGSAYYV------------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETE 286
D+ + YY PE + R++ E D+WS GVIL+ + + G P++ +
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241
Query: 287 KGIFDAILQG 296
+ + I QG
Sbjct: 242 TEVIECITQG 251
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 40/222 (18%), Positives = 72/222 (32%), Gaps = 36/222 (16%)
Query: 38 AHHRPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYL 97
HH G + P + + GK++G G FG+ YL
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMPFPEGKVLDDM------EGNQWVLGKKIGSGGFGLIYL 55
Query: 98 CTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNI--------------- 142
+ + A + V + + E++ Q ++ + I
Sbjct: 56 AFPTNKPEKDARHVVK----VEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111
Query: 143 -VEFKGAYEDKQSVH--VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
G E K + +VME G +L G + + + +++V+ H
Sbjct: 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN 170
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD 241
+H D+K N LL K+ + + D+GLS Y
Sbjct: 171 EYVHGDIKAANLLLGYKNPD-QVYLADYGLS------YRYCP 205
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-18
Identities = 60/252 (23%), Positives = 101/252 (40%), Gaps = 52/252 (20%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQF---ACKSISKRKLVTKNDKDDIKRE 129
P+E V H + +G+G FGV Y + A KS+ ++ + RE
Sbjct: 17 PHERVVTH--SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLRE 72
Query: 130 IQIMQHLSGQPNIVEFKGAYEDKQSVH-VVMELCAGGELFDRIIAKGHY--SERAAASIC 186
+M+ L+ PN++ G + + V++ G+L + S + ++
Sbjct: 73 GLLMRGLN-HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQ-------FIRSPQRNPTVK 124
Query: 187 RSIVNVVHICHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR 240
I + + M +HRDL N +L E+ +K DFGL+ R
Sbjct: 125 DLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLA---------R 172
Query: 241 DIVGSAYYV--------------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAE 284
DI+ YY A E L+ R+ + D+WS GV+L+ LL+ G PP+
Sbjct: 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI 232
Query: 285 TEKGIFDAILQG 296
+ + QG
Sbjct: 233 DPFDLTHFLAQG 244
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 6e-18
Identities = 54/231 (23%), Positives = 95/231 (41%), Gaps = 28/231 (12%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQF---ACKSISKRKLVTKNDKDDIKREIQIMQHLSG 138
S K +G G+FG ++ A K++ + T+ + D E IM
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFD- 104
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICH 197
PNI+ +G + V +V E G L + ++ + R I
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR------GIAS 158
Query: 198 FM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-VYRDIVGSAYYV- 249
M G +HRDL N L++ N + K +DFGL +E+ G +
Sbjct: 159 GMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 250 --APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
+PE + R++ D+WS G++L+ ++S G P+W + + + A+ +G
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 7e-18
Identities = 56/236 (23%), Positives = 93/236 (39%), Gaps = 36/236 (15%)
Query: 82 SFGKELGRGQFGVTY---LCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG 138
F + +GRG FG Y L + A KS+ ++ + E IM+ S
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFS- 148
Query: 139 QPNIVEFKGA-YEDKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHIC 196
PN++ G + S VV+ G+L + I + + + + +
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV------- 249
+HRDL N +L DE +K DFGL+ RD+ +
Sbjct: 209 ASKKFVHRDLAARNCML---DEKFTVKVADFGLA---------RDMYDKEFDSVHNKTGA 256
Query: 250 -------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
A E L+ +++ + D+WS GV+L+ L++ G PP+ I +LQG
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 312
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-18
Identities = 48/236 (20%), Positives = 86/236 (36%), Gaps = 46/236 (19%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN 141
+ LG GQFG ++ N + A KS+ + D E +M+ L
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQ----GSMSPDAFLAEANLMKQLQ-HQR 69
Query: 142 IVEFKGAYEDKQSVHVVMELCAGGELFD--RIIAKGHYSERAAASICRSIVNVVHICHFM 199
+V ++ ++++ E G L D + + + + I M
Sbjct: 70 LVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA------QIAEGM 122
Query: 200 ------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---- 249
+HRDL+ N L+S + K DFGL+ R I + Y
Sbjct: 123 AFIEERNYIHRDLRAANILVS---DTLSCKIADFGLA---------RLIEDNEYTAREGA 170
Query: 250 -------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
APE + + + D+WS G++L +++ G P+ T + + +G
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 57/256 (22%), Positives = 99/256 (38%), Gaps = 46/256 (17%)
Query: 62 PRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN 121
+P T + +E + +LG+G FG ++ T N T R A K++
Sbjct: 167 SKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKP----GTM 221
Query: 122 DKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERA 181
+ +E Q+M+ L +V+ ++ +++V E + G L D + + R
Sbjct: 222 SPEAFLQEAQVMKKLR-HEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRL 279
Query: 182 AA--SICRSIVNVVHICHFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233
+ I M +HRDL+ N L+ EN + K DFGL+
Sbjct: 280 PQLVDMAA------QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLA--- 327
Query: 234 EEGKVYRDIVGSAYYV-----------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPP 280
R I + Y APE R+ + D+WS G++L L + G P
Sbjct: 328 ------RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381
Query: 281 FWAETEKGIFDAILQG 296
+ + + D + +G
Sbjct: 382 YPGMVNREVLDQVERG 397
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 61/229 (26%), Positives = 93/229 (40%), Gaps = 34/229 (14%)
Query: 86 ELGRGQFGVTYLCTENSTGRQF--ACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIV 143
ELG G FG +Q A K + ++ K D +++ RE QIM L P IV
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLD-NPYIV 73
Query: 144 EFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH------ 197
G + +++ +VME+ GG L ++ K + NV + H
Sbjct: 74 RLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEI---------PVSNVAELLHQVSMGM 123
Query: 198 ----FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-VYRDIVGSAYYV--- 249
+HRDL N LL ++ K +DFGLS + Y + +
Sbjct: 124 KYLEEKNFVHRDLAARNVLLVNRH---YAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180
Query: 250 APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
APE + R++ D+WS GV ++ LS G P+ + I QG
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 229
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-17
Identities = 9/41 (21%), Positives = 16/41 (39%)
Query: 334 LEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKV 374
+ H G + VL K + + K +KLA+ +
Sbjct: 1 MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTI 41
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 55/267 (20%), Positives = 103/267 (38%), Gaps = 62/267 (23%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIK 127
P +++ L GK LG G+FG T + A K + ++ + ++ D+
Sbjct: 21 PRKNLVL----GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML--KENASPSELRDLL 74
Query: 128 REIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGEL-----------FDRIIAKGH 176
E +++ + P++++ GA + +++E G L + + G
Sbjct: 75 SEFNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 177 YSERAAASICRSIVNVVHICHF-------------MGVMHRDLKPENFLLSSKDENALLK 223
+ + + + + F M ++HRDL N L++ E +K
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMK 190
Query: 224 ATDFGLSVFIEEGKVYRDIVGSAYYV------------APEVLR-RRYGKEIDIWSAGVI 270
+DFGLS RD+ YV A E L Y + D+WS GV+
Sbjct: 191 ISDFGLS---------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 241
Query: 271 LY-ILLSGVPPFWAETEKGIFDAILQG 296
L+ I+ G P+ + +F+ + G
Sbjct: 242 LWEIVTLGGNPYPGIPPERLFNLLKTG 268
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 52/258 (20%), Positives = 94/258 (36%), Gaps = 58/258 (22%)
Query: 82 SFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL 136
+ +++G G FG + A K + ++ + + + D +RE +M
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEF 107
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGEL-----------FDRIIAKGHYSERAAASI 185
PNIV+ G + + ++ E A G+L + + +S
Sbjct: 108 D-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 186 CRSIVNVVHICHF-------------MGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232
++ +HRDL N L+ EN ++K DFGLS
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLS-- 221
Query: 233 IEEGKVYRDIVGSAYYV------------APEVLR-RRYGKEIDIWSAGVILYILLS-GV 278
R+I + YY PE + RY E D+W+ GV+L+ + S G+
Sbjct: 222 -------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274
Query: 279 PPFWAETEKGIFDAILQG 296
P++ + + + G
Sbjct: 275 QPYYGMAHEEVIYYVRDG 292
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-17
Identities = 57/235 (24%), Positives = 93/235 (39%), Gaps = 48/235 (20%)
Query: 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND--KDDIKREIQIMQHLSGQ 139
+ +G+G+FG L G + A K I KND E +M L
Sbjct: 24 KLLQTIGKGEFGDVMLGDYR--GNKVAVKCI-------KNDATAQAFLAEASVMTQLR-H 73
Query: 140 PNIVEFKGA-YEDKQSVHVVMELCAGGELFD--RIIAKGHYSERAAASICRSIVNVVHIC 196
N+V+ G E+K +++V E A G L D R + +C
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL------DVC 127
Query: 197 HFM------GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV- 249
M +HRDL N L+S E+ + K +DFGL+ ++ +
Sbjct: 128 EAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLT---------KEASSTQDTGK 175
Query: 250 ------APEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
APE LR +++ + D+WS G++L+ + S G P+ K + + +G
Sbjct: 176 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 230
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 61/282 (21%), Positives = 104/282 (36%), Gaps = 54/282 (19%)
Query: 38 AHHRPEKPGPTPAAAPVSGLKQAVPR--PDTNTILGKPYEDVKLHYSFGKELGRGQFGVT 95
A++ G L P P T + +E + +LG+G FG
Sbjct: 230 AYYSKHADGLC------HRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEV 283
Query: 96 YLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155
++ T N T R A K++ + +E Q+M+ L +V+ ++ +
Sbjct: 284 WMGTWNGTTR-VAIKTLKP----GTMSPEAFLQEAQVMKKLR-HEKLVQLYAVV-SEEPI 336
Query: 156 HVVMELCAGGELFDRIIAKGHYSERAAA--SICRSIVNVVHICHFM------GVMHRDLK 207
++V E + G L D + + R + I M +HRDL+
Sbjct: 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA------QIASGMAYVERMNYVHRDLR 390
Query: 208 PENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV-----------APEVLR- 255
N L+ EN + K DFGL+ R I + Y APE
Sbjct: 391 AANILVG---ENLVCKVADFGLA---------RLIEDNEYTARQGAKFPIKWTAPEAALY 438
Query: 256 RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
R+ + D+WS G++L L + G P+ + + D + +G
Sbjct: 439 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 55/245 (22%), Positives = 95/245 (38%), Gaps = 43/245 (17%)
Query: 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL 136
V ++ GK++G G FG L T A K + K + + E + + L
Sbjct: 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMK----SRAPQLHLEYRFYKQL 61
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFD-RIIAKGHYSERAAASICRSIVNVVHI 195
I + + +V+EL G L D + +S + I +++ +
Sbjct: 62 GSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEY 120
Query: 196 CHFMGVMHRDLKPENFLL---SSKDENALLKATDFGLSVFIEEGKVYRD----------- 241
H +++RD+KPENFL+ +K + ++ DF L+ K Y D
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQ-VIHIIDFALA------KEYIDPETKKHIPYRE 173
Query: 242 ---IVGSAYYVAPEVLRRRYGKEI----DIWSAGVILYILLSGVPPFW----AETEKGIF 290
+ G+A Y++ + GKE D+ + G + L G P W A+T K +
Sbjct: 174 HKSLTGTARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLP-WQGLKADTLKERY 229
Query: 291 DAILQ 295
I
Sbjct: 230 QKIGD 234
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-16
Identities = 12/44 (27%), Positives = 20/44 (45%), Gaps = 1/44 (2%)
Query: 332 QVLEHPWIKE-GGEASDKPIDSAVLSRMKQFRAMNKLKKLALKV 374
H +E + S +L +K F+ N+LKK+AL +
Sbjct: 3 HHHHHSSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTI 46
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 33/222 (14%), Positives = 76/222 (34%), Gaps = 39/222 (17%)
Query: 41 RPEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTE 100
R + ++ L + + T + + G +G+G FG YL +
Sbjct: 3 RVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAA------AWKVGLPIGQGGFGCIYLA-D 55
Query: 101 NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNI----------------VE 144
++ + K V +D + E++ Q + I
Sbjct: 56 MNSSESVGSDAPCVVK-VEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114
Query: 145 FKGAYEDKQSVH--VVMELCAG---GELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
G ++ + ++M+ G ++++ +S + + I++++ H
Sbjct: 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEH 171
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD 241
+H D+K N LL+ K+ + + D+GL+ Y
Sbjct: 172 EYVHGDIKASNLLLNYKNPD-QVYLVDYGLA------YRYCP 206
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 35/227 (15%), Positives = 71/227 (31%), Gaps = 35/227 (15%)
Query: 35 QQQAHHR--PEKPGPTPAAAPVSGLKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQF 92
HH + ++ +A+P T T+L + R
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMTTSLEALP---TGTVLTDK---SGRQWKLKSFQTRDNQ 55
Query: 93 GVTYLCTENSTGRQFACKSISK--RKLVTKNDKDDI----------KREIQIMQHLSGQP 140
G+ Y ST + K KL K+ + ++ + L P
Sbjct: 56 GILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115
Query: 141 NI----VEFKGAYEDKQSVHVVMELCAGGELFD--RIIAKGHYSERAAASICRSIVNVVH 194
+ G ++DK +V+ G L + K SER+ + +++ +
Sbjct: 116 LLAIPTCMGFGVHQDKYRF-LVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALE 173
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD 241
H +H ++ EN + +D++ + +G + Y
Sbjct: 174 FLHENEYVHGNVTAENIFVDPEDQS-QVTLAGYGFA------FRYCP 213
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 35/154 (22%), Positives = 63/154 (40%), Gaps = 16/154 (10%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIK 127
P + +KL GK LGRG FG + +T R A K + ++ T ++ +
Sbjct: 20 PRDRLKL----GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALM 73
Query: 128 REIQIMQHLSGQPNIVEFKGAY-EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASIC 186
E++I+ H+ N+V GA + + V++E C G L + +K +
Sbjct: 74 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN----EFVPYK 129
Query: 187 RSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA 220
++G + DLK ++S +A
Sbjct: 130 TKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSA 163
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 30/87 (34%), Positives = 42/87 (48%), Gaps = 8/87 (9%)
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYV---APEVLR 255
+HRDL N LLS E ++K DFGL+ I + Y + + APE +
Sbjct: 212 RKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 268
Query: 256 -RRYGKEIDIWSAGVILY-ILLSGVPP 280
R Y + D+WS GV+L+ I G P
Sbjct: 269 DRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 9e-10
Identities = 8/27 (29%), Positives = 14/27 (51%)
Query: 348 KPIDSAVLSRMKQFRAMNKLKKLALKV 374
K + L MK+F++ KL + A+
Sbjct: 2 KHALTGALGNMKKFQSSQKLAQAAMLF 28
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 2e-08
Identities = 37/243 (15%), Positives = 64/243 (26%), Gaps = 60/243 (24%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK-----DDIKREIQIMQH 135
+++G G FG + + A K I+ N ++I EI I +
Sbjct: 22 LQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE 79
Query: 136 LSGQ--------PNIVEFKGAY------------------------------EDKQSVHV 157
LS + + + +
Sbjct: 80 LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139
Query: 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSS- 215
V+E GG +++ K S A SI + + + + HRDL N LL
Sbjct: 140 VLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT 198
Query: 216 -------KDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVA-----PEVLRRRYGKEID 263
GL V I + + R ++ + D
Sbjct: 199 SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFD 258
Query: 264 IWS 266
I+
Sbjct: 259 IYR 261
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 3e-08
Identities = 37/130 (28%), Positives = 54/130 (41%), Gaps = 26/130 (20%)
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGK--VYRDIVGSAYYVAPEV 253
H ++HRD+K N LL DEN + K TDFG+S E + + + G+ Y+ PE
Sbjct: 156 HTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEY 212
Query: 254 LRRRYGKE-IDIWSAGVILYILLSGVPPF-------------WAET--EKGIFDAI---- 293
+ E D++S GV+L+ +L WA G + I
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN 272
Query: 294 LQGDIDFESA 303
L I ES
Sbjct: 273 LADKIRPESL 282
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 9e-08
Identities = 41/160 (25%), Positives = 65/160 (40%), Gaps = 37/160 (23%)
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGK--VYRDIVGSAYYVAPEVLRRR 257
+HRD+K N LL DE K +DFGL+ + + + IVG+ Y+APE LR
Sbjct: 154 HIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE 210
Query: 258 YGKEIDIWSAGVILYILLSGVPPF-----------WAE---TEKGIFDAILQGDIDFESA 303
+ DI+S GV+L +++G+P E E+ + ID
Sbjct: 211 ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY----ID---- 262
Query: 304 PWPTISSSAKDLVRRM-------LTQDPKKRITSAQVLEH 336
++ + V M L + KR +V +
Sbjct: 263 --KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-07
Identities = 5/25 (20%), Positives = 13/25 (52%)
Query: 350 IDSAVLSRMKQFRAMNKLKKLALKV 374
I VL+ MK + + ++ + + +
Sbjct: 2 ISPNVLNNMKSYMKHSNIRNIIINI 26
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 33/127 (25%), Positives = 53/127 (41%), Gaps = 27/127 (21%)
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK--VYRDIVGSAYYVAPEVLRRRY 258
++HRD+K N LL DE DFGL+ ++ V + G+ ++APE L
Sbjct: 155 IIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 211
Query: 259 GKE-IDIWSAGVILYILLSGVPPF---------------WAET--EKG----IFDAILQG 296
E D++ GV+L L++G F W + ++ + D LQG
Sbjct: 212 SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG 271
Query: 297 DIDFESA 303
+ E
Sbjct: 272 NYKDEEV 278
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 9e-06
Identities = 8/71 (11%), Positives = 20/71 (28%), Gaps = 4/71 (5%)
Query: 305 WPTISSSAKDLVRRMLTQDPK--KRITSAQVLEHPWIK--EGGEASDKPIDSAVLSRMKQ 360
I+ ++ ++ D K + + E A + + S +
Sbjct: 43 EAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLASLLKDLEDD 102
Query: 361 FRAMNKLKKLA 371
N+L+
Sbjct: 103 ASGYNRLRPSK 113
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A Length = 220 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 3/39 (7%), Positives = 12/39 (30%)
Query: 336 HPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKV 374
P + + +PI + + ++ ++
Sbjct: 2 QPPVANFCLWNLQPIQGSWMGAACIYQMPPSVRNTWWFP 40
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} Length = 204 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 4e-04
Identities = 7/33 (21%), Positives = 10/33 (30%), Gaps = 3/33 (9%)
Query: 343 GEASDKPIDSAVLSRMKQFRAMNKLKKLALKVS 375
G P+ S + M KL+ L
Sbjct: 3 GLVPRGPLGSHMD---AVDATMEKLRAQCLSRG 32
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 4e-04
Identities = 68/440 (15%), Positives = 121/440 (27%), Gaps = 148/440 (33%)
Query: 57 LKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGV----------TY------LCTE 100
K + + + + I+ F L + + V Y + TE
Sbjct: 42 PKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTE 101
Query: 101 NSTGRQFACKSISKR-KLVTKND---KDDIKRE---IQIMQHLSGQPNIVEFKGAYEDKQ 153
I +R +L N K ++ R +++ Q L E +
Sbjct: 102 QRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQAL------------LELRP 149
Query: 154 SVHVV---MELCAG-GE--LFDRIIAKGHYSERAAASICRSIVNVVHICHFMGV----MH 203
+ +V+ + G G+ + A +C S V + +
Sbjct: 150 AKNVLIDGV---LGSGKTWV--------------ALDVCLS--YKVQCKMDFKIFWLNLK 190
Query: 204 RDLKPENFL-----LSSKDENALLKATDFGLSVF--IEEGKVY-RDIVGSAYYVAPE--- 252
PE L L + + +D ++ I + R ++ S Y
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY--ENCLL 248
Query: 253 VLRRRYGKEIDIWSAGVILY------ILL-------------------SGVPPFWAETE- 286
VL ++ +A ILL S T
Sbjct: 249 VLL-------NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD 301
Query: 287 --KGIFDAILQGDIDFESAP------WP----TISSSAKDLVRR-----MLTQDPKKRI- 328
K + L D + P P I+ S +D + + D I
Sbjct: 302 EVKSLLLKYL--DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII 359
Query: 329 -TSAQVLEHPWIKEGGEA-----SDKPIDSAVLSRM-------KQFRAMNKLKKLAL--- 372
+S VLE ++ + I + +LS + +NKL K +L
Sbjct: 360 ESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEK 419
Query: 373 --KVSLIKYMLMYQHVNCKA 390
K S I +Y + K
Sbjct: 420 QPKESTISIPSIYLELKVKL 439
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 393 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.97 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.54 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.3 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.29 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.06 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.88 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.86 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.62 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.61 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.46 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.44 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.3 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.16 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.1 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.82 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.8 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.74 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.7 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.69 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.65 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.55 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.46 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.45 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.37 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.22 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.22 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.74 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.18 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 91.26 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 87.6 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-69 Score=498.63 Aligned_cols=256 Identities=33% Similarity=0.578 Sum_probs=234.4
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|++|+ |||||+++++|++++.+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEEE
Confidence 36999999999999999999999999999999998765544556788999999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC--
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-- 236 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~-- 236 (393)
||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.+...
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCCCC
Confidence 9999999999999999999999999999999999999999999999999999999 56678999999999987533
Q ss_pred -cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 237 -KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 237 -~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
....+.+||+.|||||++.+ .|+.++|||||||++|+|+||.+||.+.+..+++.+|.++.+.++ ..+|+++++
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~d 263 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKARD 263 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTCCHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----cccCHHHHH
Confidence 23456799999999999986 499999999999999999999999999999999999999887765 358999999
Q ss_pred HHHHhcccCCCCCCCHHH------HhcCccccCC
Q 016233 315 LVRRMLTQDPKKRITSAQ------VLEHPWIKEG 342 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e------~l~h~~~~~~ 342 (393)
||.+||..||++|||++| +++||||+.-
T Consensus 264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 999999999999999988 5899999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-69 Score=505.54 Aligned_cols=258 Identities=29% Similarity=0.555 Sum_probs=231.5
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
....|+++++||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|+.|+ |||||+++++|.+++.+|
T Consensus 72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~ 147 (346)
T 4fih_A 72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELW 147 (346)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch---hHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence 45679999999999999999999999999999999976542 34567889999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
||||||+||+|.+++.+ +.+++.+++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.+...
T Consensus 148 ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp EEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSS
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCCC
Confidence 99999999999998865 579999999999999999999999999999999999999 55677999999999987544
Q ss_pred -cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 237 -KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 237 -~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
....+.+||+.|||||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..|..... .....+..+|+++++
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~d 302 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKG 302 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHHHHH
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHHHHH
Confidence 34567899999999999975 599999999999999999999999999999888888876532 333445679999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
||.+||..||++|||++|+|+||||++..
T Consensus 303 li~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 303 FLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999999999998754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-68 Score=483.77 Aligned_cols=254 Identities=36% Similarity=0.641 Sum_probs=215.6
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++++.||+|+||+||+|.++.+|+.||||++.+...........+.+|+++|++++ |||||++++++++++.+|||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEEE
Confidence 47999999999999999999999999999999998776555566788999999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~ 238 (393)
|||| +|+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.......
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC--------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecCCCCc
Confidence 9999 78999999999999999999999999999999999999999999999999 5567799999999998777666
Q ss_pred eecccCcccccchHHHhhc--CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 239 YRDIVGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 239 ~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
..+.+||+.|||||++.+. ++.++|||||||++|+|+||+.||.+.+..+++..+..+...++ ..+|+++++||
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li 243 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGAAGLI 243 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence 6778999999999999764 46899999999999999999999999999999999998876654 35899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccC
Q 016233 317 RRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 317 ~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
.+||+.||++|||++|+|+||||+.
T Consensus 244 ~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 244 KRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHccCChhHCcCHHHHHcCccccc
Confidence 9999999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-68 Score=506.16 Aligned_cols=259 Identities=29% Similarity=0.563 Sum_probs=232.4
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
+....|+++++||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+|+.|+ |||||+++++|.+++.+
T Consensus 148 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~ 223 (423)
T 4fie_A 148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDEL 223 (423)
T ss_dssp CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT---CSSGGGHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred ChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHhCC-CCCCCceEEEEEECCEE
Confidence 44578999999999999999999999999999999997653 334567899999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
|||||||+||+|.+++.. +.+++.+++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.+..
T Consensus 224 ~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 224 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp EEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECCS
T ss_pred EEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECCC
Confidence 999999999999998764 579999999999999999999999999999999999999 5567799999999998754
Q ss_pred C-cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 236 G-KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 236 ~-~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
. ....+.+||+.|||||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..|..... .....+..+|++++
T Consensus 300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~ 378 (423)
T 4fie_A 300 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLK 378 (423)
T ss_dssp SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSCHHHH
T ss_pred CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCCHHHH
Confidence 4 34567899999999999976 599999999999999999999999999999888888877533 33445678999999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
+||.+||..||++|||++|+|+||||++..
T Consensus 379 dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 379 GFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 999999999999999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-67 Score=493.41 Aligned_cols=256 Identities=27% Similarity=0.546 Sum_probs=225.3
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+++|++|+ |||||+++++|++++.+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEEE
Confidence 589999999999999999999999999999999987654 3445778999999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 159 MELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
||||+||+|.++|...+ .+++.+++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.+...
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCC
Confidence 99999999999997643 47899999999999999999999999999999999999 55677999999999987543
Q ss_pred c-ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 237 K-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 237 ~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
. .....+||+.|||||++.+ .|+.++|||||||+||+|+||+.||.+.+..+++.++..+.+.. .+..+|+++++
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---~~~~~s~~~~~ 255 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP---VSLHYSYDLRS 255 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CCTTSCHHHHH
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---CCccCCHHHHH
Confidence 3 3346789999999999986 49999999999999999999999999999999999999886542 34578999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
||.+||+.||++|||++|+|+||||++.
T Consensus 256 li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 256 LVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 9999999999999999999999999764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-66 Score=472.98 Aligned_cols=254 Identities=24% Similarity=0.449 Sum_probs=220.6
Q ss_pred eeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe----CCeEE
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED----KQSVH 156 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----~~~~~ 156 (393)
|++.++||+|+||+||+|.+..+++.||+|++..... .....+.+.+|+++|++|+ |||||+++++|++ ++.+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCcEEE
Confidence 4788899999999999999999999999999976543 3445678999999999996 9999999999875 35689
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--cEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~--ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++| ||||||||+|||++. .++.+||+|||+|+...
T Consensus 106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~--~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS--TTSCEEECCTTGGGGCC
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC--CCCCEEEEeCcCCEeCC
Confidence 99999999999999999899999999999999999999999998 999999999999952 35679999999998654
Q ss_pred CCcceecccCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 235 EGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
. ....+.+||+.|||||++.+.|+.++|||||||+||+|+||..||.+... ..++..+..+... ......++++++
T Consensus 184 ~-~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~ 260 (290)
T 3fpq_A 184 A-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIPEVK 260 (290)
T ss_dssp T-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGCCCHHHH
T ss_pred C-CccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC--CCCCccCCHHHH
Confidence 3 34567899999999999998999999999999999999999999987554 4455555554332 222345789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
+||.+||..||++|||++|+|+||||++
T Consensus 261 ~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 261 EIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHccCChhHCcCHHHHhcCccccC
Confidence 9999999999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-66 Score=478.03 Aligned_cols=255 Identities=28% Similarity=0.505 Sum_probs=222.0
Q ss_pred cceeecceecccCCeEEEEEEEC---CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTEN---STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
++|++++.||+|+||+||+|++. .+++.||||++++.... ......+.+|+++|++|+ |||||++++++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK-VRDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEE-EEECC------CCCCCCC-CTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcC-hHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence 47999999999999999999984 46889999999865432 233456888999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
|||||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC---
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceeccC
Confidence 9999999999999999999999999999999999999999999999999999999999 5667799999999987543
Q ss_pred -CcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 236 -GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 236 -~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
.....+.+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+.+..+++..|.++...++ ..+|++++
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 254 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQ 254 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CcCCHHHH
Confidence 334456899999999999976 599999999999999999999999999999999999998876654 46899999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHhcCccccCC
Q 016233 314 DLVRRMLTQDPKKRIT-----SAQVLEHPWIKEG 342 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt-----~~e~l~h~~~~~~ 342 (393)
+||.+||+.||++||| ++|+++||||+..
T Consensus 255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 9999999999999998 4799999999753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-65 Score=475.95 Aligned_cols=254 Identities=25% Similarity=0.351 Sum_probs=221.8
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
...|++.++||+|+||.||+|+++.+|+.||||+++.+.. ..+|+.+|+.|+ |||||++++++.+++.+||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~-HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLS-SPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCC-CCCCCcEEEEEEECCEEEE
Confidence 3468999999999999999999999999999999976532 136999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCC-cEEEeecCCcccccCC
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA-LLKATDFGLSVFIEEG 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~-~~kl~DFg~a~~~~~~ 236 (393)
|||||+||+|.++|.+.+.+++.+++.++.||+.||+|||++|||||||||+|||++ .++ .+||+|||+|+.+...
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS---SDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC---TTSCCEEECCCTTCEEC---
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe---CCCCEEEEeeCCCCeEccCC
Confidence 999999999999999989999999999999999999999999999999999999995 343 5999999999977543
Q ss_pred cc------eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 237 KV------YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 237 ~~------~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
.. ....+||+.|||||++.+ .|+.++|||||||++|+|+||.+||.+.+..+++..|......+. ..++.+|
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s 283 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIPPSCA 283 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSCTTSC
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcCccCC
Confidence 21 223589999999999976 499999999999999999999999998887777888877654332 2346799
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHH-------------hcCccccCCCC
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQV-------------LEHPWIKEGGE 344 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~-------------l~h~~~~~~~~ 344 (393)
+++.+||.+||+.||++|||+.|+ |+|||+.+...
T Consensus 284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 999999999999999999999997 67999987543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-64 Score=480.57 Aligned_cols=262 Identities=27% Similarity=0.409 Sum_probs=225.1
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe-----
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED----- 151 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----- 151 (393)
+.++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+++|+.|+ |||||++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSCTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcC-CCCcceEeeeeecccccc
Confidence 45689999999999999999999999999999999975432 3344567889999999996 9999999998764
Q ss_pred -CCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 152 -KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 152 -~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
.+.+|||||||+ |+|.+++...+.+++.+++.+++||+.||.|||++|||||||||+|||+ +.++.+||+|||+|
T Consensus 130 ~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla 205 (398)
T 4b99_A 130 EFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMA 205 (398)
T ss_dssp TCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred cCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeeccee
Confidence 367999999995 6899999888899999999999999999999999999999999999999 56677999999999
Q ss_pred ccccCC-----cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC
Q 016233 231 VFIEEG-----KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA 303 (393)
Q Consensus 231 ~~~~~~-----~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 303 (393)
+.+... ....+.+||+.|||||++.+ .|+.++||||+||++|+|++|.+||.+.+..+.+..|......+...
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 876432 23456799999999999865 47999999999999999999999999999988888876533222211
Q ss_pred ---------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 304 ---------------------------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 304 ---------------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
.++.+++++.|||.+||..||++|||++|+|+||||++...
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 13467999999999999999999999999999999987543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-61 Score=457.42 Aligned_cols=256 Identities=27% Similarity=0.460 Sum_probs=211.8
Q ss_pred ccccceeecceecccCCeEEEEEEEC---CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTEN---STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
.+.++|+++++||+|+||+||+|+++ .+++.||+|.+... .....+.+|+++|+.+.+|||||+++++|++.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 45678999999999999999999875 46789999988543 24567889999999997799999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 153 QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
+.+|||||||+||+|.+++ +.+++.+++.+++||+.||+|||++||+||||||+|||++. +.+.+||+|||+|+.
T Consensus 93 ~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~--~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR--RLKKYALVDFGLAQG 167 (361)
T ss_dssp TEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCTTCEE
T ss_pred CEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC--CCCeEEECcCCCCcc
Confidence 9999999999999999988 36999999999999999999999999999999999999953 336799999999976
Q ss_pred ccCCc-----------------------------ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCC
Q 016233 233 IEEGK-----------------------------VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPF 281 (393)
Q Consensus 233 ~~~~~-----------------------------~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf 281 (393)
..+.. ...+.+||+.|||||++.+ .|+.++||||+||++|+|++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 53321 2234689999999999865 4899999999999999999999999
Q ss_pred CCCC-hHHHHHHHHc--------------------------------------CC------------CCCCCCCCCCCCH
Q 016233 282 WAET-EKGIFDAILQ--------------------------------------GD------------IDFESAPWPTISS 310 (393)
Q Consensus 282 ~~~~-~~~~~~~i~~--------------------------------------~~------------~~~~~~~~~~~s~ 310 (393)
...+ +.+.+..|.. .. .......|..+|+
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 6543 3344333321 00 0011234677899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
+++|||.+||..||++|+|++|+|+||||++
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999999986
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-61 Score=485.04 Aligned_cols=264 Identities=35% Similarity=0.636 Sum_probs=242.7
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
.+-++|++++.||+|+||.||+|.++.+|+.||+|++.... ....+.+.+|+++|+.|+ |||||+++++|++++.+
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 229 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEM 229 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSSEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEE
Confidence 34568999999999999999999999999999999997543 335677899999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
|||||||+||+|+++|.. .+.+++.+++.+++||+.||.|||++||+||||||+|||++.+ ..+.+||+|||+|+.+.
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~-~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCSSCEECC
T ss_pred EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC-CCCCEEEeeccceeEcc
Confidence 999999999999999864 4579999999999999999999999999999999999999643 34679999999999988
Q ss_pred CCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 235 EGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
........+||+.|||||++.+ .|+.++|||||||+||+|++|.+||.+.+..+.+..|......++...|..+|++++
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 388 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 8777788899999999999976 499999999999999999999999999999999999999998888888899999999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
+||.+||..||++|||++|+|+||||+....
T Consensus 389 dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 389 DFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 9999999999999999999999999987644
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-61 Score=447.63 Aligned_cols=252 Identities=25% Similarity=0.456 Sum_probs=200.8
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC-----
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ----- 153 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~----- 153 (393)
.+|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+++|++|+ |||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC-----
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCccccc
Confidence 36999999999999999999999999999999997543 3345678899999999996 999999999987554
Q ss_pred -------eEEEEEeccCCCChHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEE
Q 016233 154 -------SVHVVMELCAGGELFDRIIAKGH---YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLK 223 (393)
Q Consensus 154 -------~~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~k 223 (393)
.+|||||||+||+|.+++..... ..+..++.++.||+.||+|||++||+||||||+|||+ +.++.+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vK 158 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVK 158 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEE
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEE
Confidence 37999999999999999987654 3456689999999999999999999999999999999 5566799
Q ss_pred EeecCCcccccCCcc-------------eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChH-H
Q 016233 224 ATDFGLSVFIEEGKV-------------YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEK-G 288 (393)
Q Consensus 224 l~DFg~a~~~~~~~~-------------~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~ 288 (393)
|+|||+|+.+..... ..+.+||+.|||||++.+ .|+.++|||||||++|||++ ||...... .
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~ 235 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR 235 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence 999999987754321 234689999999999986 59999999999999999996 78654322 2
Q ss_pred HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 289 IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 289 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.+..+.....+ +.+...++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus 236 ~~~~~~~~~~p---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 236 TLTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHHTTCCC---HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHHHhcCCCC---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 33444443321 1223456788999999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-60 Score=438.14 Aligned_cols=255 Identities=22% Similarity=0.371 Sum_probs=209.5
Q ss_pred cccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
.|+...++++++++||+|+||+||+|++.. .||||+++... ......+.|.+|+.+|++|+ |||||++++++.+
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~- 103 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK- 103 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-
Confidence 455666789999999999999999998653 69999986543 23445678999999999996 9999999998765
Q ss_pred CeEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 153 QSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
+.+|||||||+||+|.++|... ..+++.++..|+.||+.||+|||+++||||||||+|||+ +.++.+||+|||+|+
T Consensus 104 ~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~ 180 (307)
T 3omv_A 104 DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLAT 180 (307)
T ss_dssp SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCB
T ss_pred CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCce
Confidence 5689999999999999999764 579999999999999999999999999999999999999 567789999999998
Q ss_pred cccCC---cceecccCcccccchHHHhh----cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHH-HcCCCCCC-C
Q 016233 232 FIEEG---KVYRDIVGSAYYVAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI-LQGDIDFE-S 302 (393)
Q Consensus 232 ~~~~~---~~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i-~~~~~~~~-~ 302 (393)
..... ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+.+....+..+ ..+..... .
T Consensus 181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 260 (307)
T 3omv_A 181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLS 260 (307)
T ss_dssp C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCST
T ss_pred ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcc
Confidence 76432 23456789999999999863 4889999999999999999999999887665555444 44332222 2
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
..+..+++++.+||.+||+.||++|||+.|++++
T Consensus 261 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 261 KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 3456789999999999999999999999987643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-60 Score=436.89 Aligned_cols=251 Identities=23% Similarity=0.401 Sum_probs=216.7
Q ss_pred ccceeecceecccCCeEEEEEEEC-----CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
+.+|.+.+.||+|+||.||+|.+. .++..||||+++.. .....+++.+|+++|++|+ |||||++++++.+.
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeC
Confidence 468999999999999999999875 35789999999643 3445678999999999996 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCC
Q 016233 153 QSVHVVMELCAGGELFDRIIAK-------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDEN 219 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~-------------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~ 219 (393)
+.+|||||||+||+|.++|... ..+++.++..++.||+.||.|||+++||||||||+|||+ +.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CCC
Confidence 9999999999999999999764 359999999999999999999999999999999999999 566
Q ss_pred CcEEEeecCCcccccCCcce---ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHH
Q 016233 220 ALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAIL 294 (393)
Q Consensus 220 ~~~kl~DFg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 294 (393)
+.+||+|||+|+........ ....||+.|||||++.+ .|+.++|||||||+||||+| |+.||.+.+..+++..+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 78999999999876544322 23469999999999875 59999999999999999998 999999999999999998
Q ss_pred cCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 016233 295 QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (393)
Q Consensus 295 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 340 (393)
.+.... ....+|+++.+|+.+||+.||++|||+++++ +|++
T Consensus 245 ~~~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 245 QGRVLQ---RPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp HTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred cCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 876432 2246899999999999999999999999994 4554
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-59 Score=444.87 Aligned_cols=303 Identities=38% Similarity=0.704 Sum_probs=270.4
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
...+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEES 101 (362)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCC
Confidence 34567789999999999999999999999999999999976543 3345677899999999996 999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
..|+||||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++...
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999999999999988888999999999999999999999999999999999999976666678999999999987
Q ss_pred cCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 016233 234 EEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (393)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (393)
.........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+...++...|..+++++
T Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (362)
T 2bdw_A 182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 261 (362)
T ss_dssp TTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred cCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 76666667889999999999876 59999999999999999999999999999999999999999888888888999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccCCCCCCCCcCCHHHHHHHHHHHHhhHHHHHHHHHHHHH
Q 016233 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVSLIK 378 (393)
Q Consensus 313 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (393)
.+||.+||..||++|||++++|+||||..................++.|...++++...+..++..
T Consensus 262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 327 (362)
T 2bdw_A 262 KSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMIAT 327 (362)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999865433333445667788999999999998887765543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-60 Score=471.77 Aligned_cols=254 Identities=28% Similarity=0.477 Sum_probs=221.3
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHH---HHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKRE---IQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E---~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+| +.+++.++ |||||+++++|++.+.+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~-HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEECSSEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCC-CCCEeEEEEEEEECCEE
Confidence 579999999999999999999999999999999987654333344445555 45555564 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
|||||||+||+|.++|.+.+.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.+..
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSS
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeeecCC
Confidence 9999999999999999999999999999999999999999999999999999999999 6677899999999988765
Q ss_pred CcceecccCcccccchHHHh-h-cCCCcchHHHHHHHHHHHhhCCCCCCCCC---hHHHHHHHHcCCCCCCCCCCCCCCH
Q 016233 236 GKVYRDIVGSAYYVAPEVLR-R-RYGKEIDIWSAGVILYILLSGVPPFWAET---EKGIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~l~-~-~~~~~~DiwSlG~il~~lltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
.. ..+.+||+.|||||++. + .|+.++|||||||++|+|++|.+||.+.+ ..++...+......++ ..+|+
T Consensus 345 ~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p----~~~S~ 419 (689)
T 3v5w_A 345 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSP 419 (689)
T ss_dssp CC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----TTSCH
T ss_pred CC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----ccCCH
Confidence 43 45679999999999995 3 59999999999999999999999997643 3455666766655543 46899
Q ss_pred HHHHHHHHhcccCCCCCCC-----HHHHhcCccccC
Q 016233 311 SAKDLVRRMLTQDPKKRIT-----SAQVLEHPWIKE 341 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt-----~~e~l~h~~~~~ 341 (393)
++++||.+||..||.+|++ ++|+++||||+.
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 9999999999999999998 799999999975
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-59 Score=437.98 Aligned_cols=249 Identities=22% Similarity=0.368 Sum_probs=210.1
Q ss_pred ccceeecceecccCCeEEEEEEEC-----CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
..+|.+.++||+|+||.||+|.+. .+++.||||+++.. .....+.|.+|+++|++|+ |||||++++++.+.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQ-HQHIVRFFGVCTEG 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC
Confidence 457889999999999999999865 46889999999643 3445678999999999996 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCC
Q 016233 153 QSVHVVMELCAGGELFDRIIAK---------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~---------------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~ 217 (393)
+.+|||||||++|+|.+++... +.+++.++..++.||+.||.|||+++||||||||+|||+ +
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---G 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---E
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---C
Confidence 9999999999999999998753 358999999999999999999999999999999999999 5
Q ss_pred CCCcEEEeecCCcccccCCc---ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHH
Q 016233 218 ENALLKATDFGLSVFIEEGK---VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDA 292 (393)
Q Consensus 218 ~~~~~kl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~ 292 (393)
.+..+||+|||+|+...... .....+||+.|||||++.+ .|+.++|||||||+||||+| |+.||.+.+..+.+..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 67789999999998765432 2235679999999999876 59999999999999999999 9999999999899888
Q ss_pred HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 293 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
+..+... .....+++++.+|+.+||+.||++|||+.|++++
T Consensus 273 i~~g~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 273 ITQGREL---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHTCCC---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHcCCCC---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 8876432 1224689999999999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-59 Score=451.84 Aligned_cols=296 Identities=40% Similarity=0.730 Sum_probs=262.9
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
..+.++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ 84 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLK-HPNIVRLHDSISEEGH 84 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEECSSE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEECCE
Confidence 3456789999999999999999999999999999999986543 2334667899999999996 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
.|+|||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+..++.+||+|||++....
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999999999999999998899999999999999999999999999999999999999766567889999999998765
Q ss_pred CCc-ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 016233 235 EGK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (393)
Q Consensus 235 ~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (393)
... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+..+...++...|+.+++++
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 433 3456789999999999976 59999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccCCCCCCCCcCCHHHHHHHHHHHHhhHHHHHHH
Q 016233 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLAL 372 (393)
Q Consensus 313 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (393)
.+||.+||..||++|||++|+|+||||+..............+..+++|...+++++..+
T Consensus 245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~~~ 304 (444)
T 3soa_A 245 KDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAIL 304 (444)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTTCS
T ss_pred HHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999865433334445677888999999998877543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-59 Score=431.66 Aligned_cols=250 Identities=19% Similarity=0.327 Sum_probs=216.5
Q ss_pred ccceeecceecccCCeEEEEEEEC-----CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
...+++.++||+|+||+||+|... .+++.||||+++... .....+.|.+|+.++++|+ |||||++++++.++
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKD 101 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEEC
Confidence 346889999999999999999863 467899999986542 3445688999999999996 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccC
Q 016233 153 QSVHVVMELCAGGELFDRIIAK----------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK 216 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~ 216 (393)
+.++||||||++|+|.++|... ..+++.++..++.||+.||.|||+++||||||||+|||+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl--- 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--- 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE---
Confidence 9999999999999999999653 358999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCCcccccCCc---ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHH
Q 016233 217 DENALLKATDFGLSVFIEEGK---VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFD 291 (393)
Q Consensus 217 ~~~~~~kl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~ 291 (393)
++++.+||+|||+|+...... .....+||+.|||||++.+ .|+.++|||||||+||||+| |..||.+.+..+++.
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 566789999999998764432 2345689999999999875 69999999999999999998 899999999999999
Q ss_pred HHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 292 AILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 292 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
.+..+.... ....+++++.+|+.+||+.||++|||+.|++++
T Consensus 259 ~i~~~~~~~---~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNRQVLP---CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 888775432 234689999999999999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-58 Score=454.23 Aligned_cols=305 Identities=41% Similarity=0.684 Sum_probs=274.7
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
...+.++|++.+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.++++++ ||||+++++++.+.+
T Consensus 21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDKG 99 (484)
T ss_dssp CCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSS
T ss_pred CCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence 3456779999999999999999999999999999999998766555566788999999999996 999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
.+|+|||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+...+..+.+||+|||++...
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999999999998889999999999999999999999999999999999999976666778999999999988
Q ss_pred cCCcceecccCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 234 EEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
.........+||+.|+|||++.+.++.++|||||||++|+|++|.+||.+.+..+.+..+..+...+..+.|..++++++
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 259 (484)
T 3nyv_A 180 EASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 259 (484)
T ss_dssp CCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred ccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence 77666667789999999999998999999999999999999999999999999999999999998888888889999999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccCCCC---CCCCcCCHHHHHHHHHHHHhhHHHHHHHHHHHHHH
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGGE---ASDKPIDSAVLSRMKQFRAMNKLKKLALKVSLIKY 379 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (393)
+||.+||..||.+|||++|+|+||||+.... ....+.....+.++++|...+++++..+..+....
T Consensus 260 ~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~ 328 (484)
T 3nyv_A 260 DLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKL 328 (484)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhcc
Confidence 9999999999999999999999999976432 22334456778889999999999988777665443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-58 Score=454.30 Aligned_cols=307 Identities=38% Similarity=0.674 Sum_probs=267.2
Q ss_pred cccccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEE
Q 016233 69 ILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (393)
Q Consensus 69 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 148 (393)
+.......+..+|++++.||+|+||.||+|.+..++..||||++.+... .......+.+|+.+++.++ ||||++++++
T Consensus 27 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~ 104 (494)
T 3lij_A 27 FITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV-STSSNSKLLEEVAVLKLLD-HPNIMKLYDF 104 (494)
T ss_dssp GCCCCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCC-CTTBCCEEEE
T ss_pred eeecCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHhCC-CCCCCeEEEE
Confidence 3334455677899999999999999999999999999999999986543 2334678899999999996 9999999999
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecC
Q 016233 149 YEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (393)
Q Consensus 149 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg 228 (393)
+.+.+.+|+|||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||
T Consensus 105 ~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG 184 (494)
T 3lij_A 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFG 184 (494)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECC
Confidence 99999999999999999999999988899999999999999999999999999999999999999776667789999999
Q ss_pred CcccccCCcceecccCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 016233 229 LSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (393)
++............+||+.|+|||++.+.++.++|||||||++|+|++|..||.+.+..+.+..+..+...+....|..+
T Consensus 185 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (494)
T 3lij_A 185 LSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV 264 (494)
T ss_dssp TCEECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTS
T ss_pred CCeECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccC
Confidence 99988776666778899999999999888999999999999999999999999999999999999999999888889999
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCC----CCCCcCCHHHHHHHHHHHHhhHHHHHHHHHHHH
Q 016233 309 SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE----ASDKPIDSAVLSRMKQFRAMNKLKKLALKVSLI 377 (393)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (393)
++.+++||.+||..||.+|||++++|+||||+.... ....+.....+.++++|...+++++..+...+.
T Consensus 265 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~ 337 (494)
T 3lij_A 265 SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMAS 337 (494)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHH
Confidence 999999999999999999999999999999975321 122333456678899999999999887766554
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-58 Score=438.53 Aligned_cols=303 Identities=36% Similarity=0.602 Sum_probs=248.2
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCc---ccHHHHHHHHHHHHHccCCCCeeEEeEEEEe
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK---NDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 151 (393)
..+.++|++++.||+|+||.||+|.++.+|+.||+|++.+...... ...+.+.+|+.+|+.+. ||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~ 86 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYEN 86 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEEC
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEEe
Confidence 4567789999999999999999999999999999999987643221 24678999999999997 9999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCC-CCcEEEeecCCc
Q 016233 152 KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE-NALLKATDFGLS 230 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~-~~~~kl~DFg~a 230 (393)
.+.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+..++. ...+||+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999999988888999999999999999999999999999999999999964331 237999999999
Q ss_pred ccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 231 VFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+...++...|..++
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 246 (361)
T 2yab_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246 (361)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence 98877666677889999999999876 59999999999999999999999999999999999999998888777778899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCCC--CcCCHHHHHHHHHHHHhhHHHHHHHHHHHHH
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASD--KPIDSAVLSRMKQFRAMNKLKKLALKVSLIK 378 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (393)
+++++||.+||..||++|||++|+|+||||+....... .......+.+++++...++++.....+.+..
T Consensus 247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (361)
T 2yab_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVSLCN 317 (361)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSHHHHHHHHTCBCCHHHHHHHTC---------------
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCchhhhhhcccchhhHHHHHHHHHHhHHHHHHHHHHHHH
Confidence 99999999999999999999999999999985321000 0000111345555656666666554444433
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-57 Score=453.07 Aligned_cols=305 Identities=36% Similarity=0.618 Sum_probs=265.3
Q ss_pred ccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCC----------cccHHHHHHHHHHHHHccCCCC
Q 016233 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT----------KNDKDDIKREIQIMQHLSGQPN 141 (393)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~~h~n 141 (393)
.....+..+|++++.||+|+||.||+|.+..+++.||||++.+..... ....+.+.+|+.++++++ |||
T Consensus 29 ~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn 107 (504)
T 3q5i_A 29 KKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPN 107 (504)
T ss_dssp EECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTT
T ss_pred ccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCC
Confidence 344567789999999999999999999999999999999998654321 134678899999999996 999
Q ss_pred eeEEeEEEEeCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCc
Q 016233 142 IVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENAL 221 (393)
Q Consensus 142 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~ 221 (393)
|+++++++.+.+.+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++....
T Consensus 108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999999999999998889999999999999999999999999999999999999976555567
Q ss_pred EEEeecCCcccccCCcceecccCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC
Q 016233 222 LKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE 301 (393)
Q Consensus 222 ~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 301 (393)
+||+|||++............+||+.|+|||++.+.++.++|||||||++|+|++|..||.+.+..+.+..+..+...+.
T Consensus 188 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267 (504)
T ss_dssp EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred EEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99999999998877666677889999999999998899999999999999999999999999999999999999988888
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCCCC---cCCHHHHHHHHHHHHhhHHHHHHHHHHHH
Q 016233 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDK---PIDSAVLSRMKQFRAMNKLKKLALKVSLI 377 (393)
Q Consensus 302 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (393)
...|..+++++++||.+||..||.+|||++|+|+||||+........ ......+.++++|...+++++..+.+...
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~i~~ 346 (504)
T 3q5i_A 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGS 346 (504)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHHHHH
T ss_pred ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhc
Confidence 77788999999999999999999999999999999999875433221 12244567888888888898887766553
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-58 Score=452.15 Aligned_cols=302 Identities=41% Similarity=0.704 Sum_probs=267.5
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
.+.++|++++.||+|+||.||+|.+..+++.||||++.+... .......+.+|+.++++++ ||||+++++++.+.+.+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSSF 96 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcCCEE
Confidence 456799999999999999999999999999999999975432 2335678899999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
|+|||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999999999999888999999999999999999999999999999999999997766677899999999998776
Q ss_pred CcceecccCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 236 GKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
.......+||+.|+|||++.+.++.++|||||||++|+|++|..||.+.+..+.+..+..+...+..+.|..+|+++++|
T Consensus 177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 177 NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp C----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred CCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 66667788999999999999889999999999999999999999999999999999999999888888888999999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCCCCCCCC----cCCHHHHHHHHHHHHhhHHHHHHHHHHHHHH
Q 016233 316 VRRMLTQDPKKRITSAQVLEHPWIKEGGEASDK----PIDSAVLSRMKQFRAMNKLKKLALKVSLIKY 379 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (393)
|.+||..||.+|||+.++|+||||+........ +.....+.++++|...+++++..+.+++...
T Consensus 257 i~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l 324 (486)
T 3mwu_A 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKL 324 (486)
T ss_dssp HHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999999999999999875433321 1224456788999999999998887766543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-58 Score=435.68 Aligned_cols=257 Identities=23% Similarity=0.353 Sum_probs=216.0
Q ss_pred ccccccccceeecceecccCCeEEEEEEECCC-----CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEe
Q 016233 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENST-----GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146 (393)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~ 146 (393)
.+|+...++|++++.||+|+||.||+|.+..+ ++.||||.+.... .....+.+.+|+++|+++.+|||||+++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 34667788999999999999999999997654 3679999986543 3345677999999999998679999999
Q ss_pred EEEEeC-CeEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCC
Q 016233 147 GAYEDK-QSVHVVMELCAGGELFDRIIAK----------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPE 209 (393)
Q Consensus 147 ~~~~~~-~~~~lv~e~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~ 209 (393)
+++.+. +.++||||||++|+|.++|... ..+++.++..++.||+.||+|||+++||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 998664 5689999999999999999753 24889999999999999999999999999999999
Q ss_pred cEEeccCCCCCcEEEeecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCC
Q 016233 210 NFLLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAE 284 (393)
Q Consensus 210 Nill~~~~~~~~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~ 284 (393)
|||+ +.++.+||+|||+|+.+..... ....+||+.|||||++.+ .|+.++|||||||+||||+| |..||.+.
T Consensus 215 NILl---~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 215 NILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp GEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ceee---CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 9999 5567799999999987654332 234679999999999875 59999999999999999998 99999886
Q ss_pred ChH-HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 285 TEK-GIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 285 ~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
+.. .+...+..+.. +. ....+++++.+|+.+||+.||++|||+.|+++|
T Consensus 292 ~~~~~~~~~i~~g~~-~~--~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 292 KIDEEFCRRLKEGTR-MR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CCSHHHHHHHHHTCC-CC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCC-CC--CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 644 44555555532 22 224689999999999999999999999999987
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-58 Score=433.06 Aligned_cols=302 Identities=36% Similarity=0.625 Sum_probs=248.4
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccC--CcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV--TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
.+.++|++.+.||+|+||.||+|.++.+++.||||++...... .....+.+.+|+.+++.++ ||||+++++++.+++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSSDG 99 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence 4567899999999999999999999999999999999754321 1224678999999999996 999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 154 SVHVVMELCAGGELFDRIIAK----GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
.+|+|||||+|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||+
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999998887653 2489999999999999999999999999999999999997666667799999999
Q ss_pred cccccCCcc-eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 016233 230 SVFIEEGKV-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (393)
Q Consensus 230 a~~~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (393)
+........ ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. ..+.+..+..+...+....|..
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTT
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccccc
Confidence 987765432 345689999999999875 5899999999999999999999999875 4566777887777766666778
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCCCCcCCHHHHHHHHHHHHhhHHHHHHHHHHHHHH
Q 016233 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVSLIKY 379 (393)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (393)
+++++.+||.+||..||++|||+.++|+||||+.................++.|...++++...+.......
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 330 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAVSSHK 330 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCCHHHHHHHHHHHHHHC-------------
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccchHHHHHHHHHHHHHHHHHHHHHHHHHhh
Confidence 999999999999999999999999999999998654323333345667888999999998888776655443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-57 Score=425.96 Aligned_cols=297 Identities=39% Similarity=0.685 Sum_probs=242.4
Q ss_pred cccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
..+.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.++++++ ||||+++++++.+.
T Consensus 47 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 120 (349)
T 2w4o_A 47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFETP 120 (349)
T ss_dssp BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCC-CTTBCCEEEEEECS
T ss_pred ccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCC-CCCCcceeeeEecC
Confidence 34556788999999999999999999999999999999997532 3466889999999996 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 153 QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
+.+++||||++|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++..
T Consensus 121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 121 TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred CeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 99999999999999999998888899999999999999999999999999999999999997655578899999999988
Q ss_pred ccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHH-HHHHHHcCCCCCCCCCCCCCCH
Q 016233 233 IEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKG-IFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
..........+||+.|+|||++.+ .++.++|||||||++|+|++|..||......+ .+..+......+....+..++.
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred cCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 766555566789999999999876 58999999999999999999999998766544 6777888877777777788999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCCCCcCCHHHHHHHHHHHHhhHHHHHHHHHHHH
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVSLI 377 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (393)
++.+||.+||..||++|||+.++|+||||...... ..........+++|...+++++....+.+.
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN--FVHMDTAQKKLQEFNARRKLKAAVKAVVAS 345 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC--CSCCHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc--hhhhcchHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999865432 223456677899999999999887766554
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-56 Score=418.08 Aligned_cols=258 Identities=36% Similarity=0.628 Sum_probs=234.6
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
...+|++.+.||+|+||.||+|.+..+|+.||||++.+... .....+.+.+|+++++.++ ||||+++++++.+.+.+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEE
Confidence 34589999999999999999999999999999999976543 3445677889999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSSS
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecCCC
Confidence 999999999999999988899999999999999999999999999999999999999 56677999999999987766
Q ss_pred cceecccCcccccchHHHhhc-C-CCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 237 KVYRDIVGSAYYVAPEVLRRR-Y-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~~-~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
......+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.+..+....+..+...++. .+++++.+
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~ 243 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCEN 243 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHH
T ss_pred CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHH
Confidence 666778999999999998764 4 57899999999999999999999999999999999888766543 47899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
||.+||..||.+|||++|+|+||||....
T Consensus 244 li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 244 LLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999999999998653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-57 Score=434.41 Aligned_cols=262 Identities=36% Similarity=0.640 Sum_probs=220.3
Q ss_pred ccccceeec-ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe---
Q 016233 76 DVKLHYSFG-KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--- 151 (393)
Q Consensus 76 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 151 (393)
.+.++|.+. +.||+|+||.||+|.+..+++.||||++.. ...+.+|+.++.++.+||||++++++|..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--------chhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 344567776 789999999999999999999999999853 24577899998776679999999999876
Q ss_pred -CCeEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecC
Q 016233 152 -KQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (393)
Q Consensus 152 -~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg 228 (393)
.+.+|||||||+||+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 567999999999999999998643 59999999999999999999999999999999999999765557889999999
Q ss_pred CcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChH----HHHHHHHcCCCCCCCC
Q 016233 229 LSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEK----GIFDAILQGDIDFESA 303 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~----~~~~~i~~~~~~~~~~ 303 (393)
+++...........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... .....+..+...++..
T Consensus 210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 289 (400)
T 1nxk_A 210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289 (400)
T ss_dssp TCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred cccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence 9998766555667889999999999865 5999999999999999999999999876532 2556777788888888
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCC
Q 016233 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEA 345 (393)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 345 (393)
.|..+++++.+||.+||..||++|||++++|+||||......
T Consensus 290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 331 (400)
T 1nxk_A 290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331 (400)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTS
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCC
Confidence 888999999999999999999999999999999999875443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-57 Score=421.55 Aligned_cols=263 Identities=29% Similarity=0.590 Sum_probs=238.9
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
.+.++|++++.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++ ||||+++++++.+.+.+
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~ 76 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIAR-HRNILHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCC-CCCCCeEeEEEecCCEE
Confidence 3567899999999999999999999999999999998643 234567889999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
++|||||+||+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.+ .++.+||+|||++....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECC
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCeECC
Confidence 9999999999999999765 369999999999999999999999999999999999999642 25679999999999887
Q ss_pred CCcceecccCcccccchHHHhhc-CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 235 EGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
.........||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+.+..+..+...+....|+.++.++.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T 1tki_A 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence 77666778899999999998764 79999999999999999999999999999999999999988887777788999999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
+||.+||..||++|||+.|+|+||||++...
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred HHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence 9999999999999999999999999987543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-56 Score=421.29 Aligned_cols=258 Identities=29% Similarity=0.537 Sum_probs=228.0
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|..+++.+.+||||+++++++.+.+.+|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 35799999999999999999999999999999999865433444567788999999998679999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc-CC
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EG 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~-~~ 236 (393)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++... ..
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC--
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeecccCC
Confidence 99999999999999988899999999999999999999999999999999999999 566779999999998643 23
Q ss_pred cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++..+..+...++. .+++++.+|
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~l 254 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATGI 254 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHH
Confidence 34456789999999999875 5999999999999999999999999999999999999998776653 488999999
Q ss_pred HHHhcccCCCCCCCH------HHHhcCccccCC
Q 016233 316 VRRMLTQDPKKRITS------AQVLEHPWIKEG 342 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~------~e~l~h~~~~~~ 342 (393)
|.+||..||.+||++ +++++||||+..
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 999999999999999 899999999753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-55 Score=413.48 Aligned_cols=267 Identities=40% Similarity=0.711 Sum_probs=239.4
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCc---ccHHHHHHHHHHHHHccCCCCeeEEeEEEEe
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK---NDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 151 (393)
+.+.++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++ ||||+++++++.+
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYEN 85 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence 4566789999999999999999999999999999999986543221 24678999999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCC-CCCcEEEeecCCc
Q 016233 152 KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD-ENALLKATDFGLS 230 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~-~~~~~kl~DFg~a 230 (393)
.+.+++||||++|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999999998888899999999999999999999999999999999999996433 2337999999999
Q ss_pred ccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 231 VFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......+....+..++
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence 98766656667789999999999875 58999999999999999999999999999888888888877777666667889
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
..+.+||.+||..||++|||++++|+||||+..
T Consensus 246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 999999999999999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-55 Score=412.99 Aligned_cols=255 Identities=33% Similarity=0.594 Sum_probs=230.6
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.+|++++.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+.+|+|
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCEEEEE
Confidence 57999999999999999999999999999999997654333445678899999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc-CCc
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGK 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~-~~~ 237 (393)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++... ...
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhcccCCC
Confidence 9999999999999988899999999999999999999999999999999999999 566789999999998643 334
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+......++. .+++++.+||
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li 236 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLL 236 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Confidence 4566789999999999875 5899999999999999999999999999988888888887766543 5899999999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCccccC
Q 016233 317 RRMLTQDPKKRI-----TSAQVLEHPWIKE 341 (393)
Q Consensus 317 ~~~L~~dp~~Rp-----t~~e~l~h~~~~~ 341 (393)
.+||..||++|| +++|+++||||..
T Consensus 237 ~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 999999999999 9999999999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-55 Score=402.46 Aligned_cols=265 Identities=42% Similarity=0.761 Sum_probs=243.0
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
...+.++|++.+.||+|+||.||+|.+..++..+|+|.+.... ....+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 79 (277)
T 3f3z_A 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF---VEDVDRFKQEIEIMKSLD-HPNIIRLYETFEDNT 79 (277)
T ss_dssp --CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred hhhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc---cchHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence 3456789999999999999999999999999999999997643 234678999999999996 999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
..++||||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||++..++.++.+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 80 DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 99999999999999999998889999999999999999999999999999999999999976667778999999999887
Q ss_pred cCCcceecccCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 234 EEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
..........||+.|+|||++.+.++.++||||||+++|+|++|..||...+..+....+..+...++...+..+++.+.
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T 3f3z_A 160 KPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE 239 (277)
T ss_dssp CTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred cCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence 76666677789999999999988899999999999999999999999999999899999998888777766678999999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+||.+||..||++|||+.++|+||||++.
T Consensus 240 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 240 SLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999999999999764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=399.02 Aligned_cols=267 Identities=40% Similarity=0.771 Sum_probs=244.7
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+.+..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFH 80 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcCCEE
Confidence 356799999999999999999999999999999999976543 3445677889999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
++||||++|++|.+.+.....+++..++.++.|++.||.|||++||+||||||+||+++.++....+||+|||++.....
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999999999999999888999999999999999999999999999999999999997766667799999999988776
Q ss_pred CcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 236 GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+..+...++...+..+++++.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240 (284)
T ss_dssp SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence 666667789999999999876 4899999999999999999999999999999999999999888888888899999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
||.+||..||++|||++|+|+||||.....
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 241 LIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 999999999999999999999999987543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-55 Score=411.60 Aligned_cols=261 Identities=38% Similarity=0.645 Sum_probs=232.7
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
.+.++|++.+.||+|+||.||+|.++.+|+.||||++.+... ...+|++++.++.+||||+++++++.+.+.+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 466789999999999999999999999999999999976432 2346888998886699999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCC-CCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD-ENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~-~~~~~kl~DFg~a~~~~ 234 (393)
|+|||||+||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||+..++ ....+||+|||++....
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999999999999888899999999999999999999999999999999999986433 33569999999998765
Q ss_pred CC-cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCC---CChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 235 EG-KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWA---ETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 235 ~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~---~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
.. ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..+++..+..+...+....|..++
T Consensus 172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 251 (342)
T 2qr7_A 172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251 (342)
T ss_dssp CTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSC
T ss_pred CCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCC
Confidence 43 33456789999999999876 488999999999999999999999986 45677888899999888888888999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
+++.+||.+||..||++|||++++|+||||....
T Consensus 252 ~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence 9999999999999999999999999999997643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-55 Score=417.10 Aligned_cols=258 Identities=27% Similarity=0.505 Sum_probs=225.8
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
..+|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|..+++++.+||||+++++++.+.+.+|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 35799999999999999999999999999999999876655555566788999999988669999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc-cCC
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEG 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~-~~~ 236 (393)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.. ...
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeecccCC
Confidence 99999999999999988899999999999999999999999999999999999999 56678999999999863 344
Q ss_pred cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCC---------ChHHHHHHHHcCCCCCCCCCCC
Q 016233 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAE---------TEKGIFDAILQGDIDFESAPWP 306 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~ 306 (393)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||... ........+......++.
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~---- 283 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR---- 283 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT----
T ss_pred CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC----
Confidence 45567899999999999876 5899999999999999999999999642 233456677777665543
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCH------HHHhcCccccCC
Q 016233 307 TISSSAKDLVRRMLTQDPKKRITS------AQVLEHPWIKEG 342 (393)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rpt~------~e~l~h~~~~~~ 342 (393)
.+++++.+||++||..||.+||++ +|+++||||+..
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 589999999999999999999995 799999999753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-55 Score=408.26 Aligned_cols=269 Identities=38% Similarity=0.680 Sum_probs=216.8
Q ss_pred cccceeec---ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 77 VKLHYSFG---KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 77 ~~~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
+..+|++. +.||+|+||.||+|.+..+++.||||++.+. ....+.+|+.+++.+.+||||+++++++.+.+
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 34567775 7899999999999999999999999998643 35678899999999978999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
..|+||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 99999999999999999999889999999999999999999999999999999999999976665668999999999866
Q ss_pred cCC-cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCC-------hHHHHHHHHcCCCCCCCCC
Q 016233 234 EEG-KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET-------EKGIFDAILQGDIDFESAP 304 (393)
Q Consensus 234 ~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~ 304 (393)
... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+..+..+...+....
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239 (325)
T ss_dssp CC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred CCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence 543 33456789999999999875 58999999999999999999999997643 3567788888888777777
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCCCCcCC
Q 016233 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPID 351 (393)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~~~~~ 351 (393)
|..+++++.+||.+||..||++|||++++++||||+........+..
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~~~~ 286 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLM 286 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCSCCS
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCCCCC
Confidence 77899999999999999999999999999999999987655554443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=416.39 Aligned_cols=264 Identities=34% Similarity=0.629 Sum_probs=238.1
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+|+.++ ||||+++++++.+.+.+
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEM 123 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeCCEE
Confidence 45678999999999999999999999999999999997542 234567899999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
++||||++||+|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++.+ ..+.+||+|||++....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC-CCCceEEEecccceecC
Confidence 99999999999999887543 69999999999999999999999999999999999999532 34579999999999887
Q ss_pred CCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 235 EGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......+....+..+++++.
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 6666667789999999999875 489999999999999999999999999998889999998888888878888999999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
+||.+||..||++|||+.++|+||||+....
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 9999999999999999999999999987543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-55 Score=411.66 Aligned_cols=258 Identities=27% Similarity=0.475 Sum_probs=231.0
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
..+|++.+.||+|+||.||+|+++.+|+.||||++.+...........+..|..+++.+.+||||+++++++.+.+.+|+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 35799999999999999999999999999999999865433334567788999999987569999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC-C
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-G 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~-~ 236 (393)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.... .
T Consensus 96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhcccCC
Confidence 99999999999999988899999999999999999999999999999999999999 5567899999999986432 2
Q ss_pred cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++..+..+...++ ..+++++.+|
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l 248 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDL 248 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC----cccCHHHHHH
Confidence 34456789999999999876 589999999999999999999999999999999999988766554 3589999999
Q ss_pred HHHhcccCCCCCCCHH-HHhcCccccCC
Q 016233 316 VRRMLTQDPKKRITSA-QVLEHPWIKEG 342 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~~-e~l~h~~~~~~ 342 (393)
|.+||..||++||++. ++++||||+..
T Consensus 249 i~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 9999999999999998 99999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=404.41 Aligned_cols=254 Identities=30% Similarity=0.605 Sum_probs=230.2
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.+|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.+|+|
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEeCCEEEEE
Confidence 57999999999999999999999999999999997654333345678889999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~ 238 (393)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC--
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCCc--
Confidence 9999999999999988899999999999999999999999999999999999999 56678999999999876542
Q ss_pred eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 016233 239 YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (393)
Q Consensus 239 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (393)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......++ +.+++++.+||.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~ 235 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS 235 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHH
Confidence 345789999999999875 589999999999999999999999999998889999988876654 358899999999
Q ss_pred HhcccCCCCCC-----CHHHHhcCccccCC
Q 016233 318 RMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (393)
Q Consensus 318 ~~L~~dp~~Rp-----t~~e~l~h~~~~~~ 342 (393)
+||..||++|| +++++++||||+..
T Consensus 236 ~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 236 RLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 99999999999 99999999999753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-54 Score=395.88 Aligned_cols=262 Identities=34% Similarity=0.624 Sum_probs=226.5
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
.+.++|.+.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+.+|++++++++ ||||+++++++.+.+..
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCC-CchHHhHHHheecCCeE
Confidence 35678999999999999999999999999999999997654 3345788999999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 156 HVVMELCAGGELFDRIIAK----GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++...+..+.+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999999999988643 679999999999999999999999999999999999999766666789999999998
Q ss_pred cccCCcceecccCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 016233 232 FIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (393)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (393)
............||+.|+|||++.+.++.++||||||+++|+|++|..||.+.+..+....+......+... ...++++
T Consensus 176 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 254 (285)
T 3is5_A 176 LFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPLTPQ 254 (285)
T ss_dssp C----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHH
T ss_pred ecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-cCcCCHH
Confidence 876665566778999999999998889999999999999999999999999988887777776655544332 2347899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 312 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
+.+||.+||..||++|||++|+|+||||++
T Consensus 255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999999999999999999999999985
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-54 Score=406.09 Aligned_cols=258 Identities=27% Similarity=0.504 Sum_probs=227.0
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
..+|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++++.+||||+++++++.+.+.+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 35799999999999999999999999999999999876654555567788999999998569999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc-CC
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EG 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~-~~ 236 (393)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++... ..
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccccccCCC
Confidence 99999999999999988899999999999999999999999999999999999999 566789999999998643 33
Q ss_pred cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCC---------CChHHHHHHHHcCCCCCCCCCCC
Q 016233 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWA---------ETEKGIFDAILQGDIDFESAPWP 306 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~---------~~~~~~~~~i~~~~~~~~~~~~~ 306 (393)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .........+......++ .
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~ 240 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----R 240 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC----T
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC----C
Confidence 34566789999999999876 589999999999999999999999975 233455666777665554 3
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCH------HHHhcCccccCC
Q 016233 307 TISSSAKDLVRRMLTQDPKKRITS------AQVLEHPWIKEG 342 (393)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rpt~------~e~l~h~~~~~~ 342 (393)
.++.++.+||.+||..||.+||++ +++++||||...
T Consensus 241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 589999999999999999999995 899999999753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=410.61 Aligned_cols=257 Identities=26% Similarity=0.511 Sum_probs=231.2
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
..+|++++.||+|+||.||+|.++.+++.||||++.+.........+.+.+|..++..+.+||||+++++++.+.+.+|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 35799999999999999999999999999999999865433344567788999999988669999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc-CC
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EG 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~-~~ 236 (393)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++... ..
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCcccccccCC
Confidence 99999999999999988899999999999999999999999999999999999999 566789999999998643 33
Q ss_pred cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++..+......++ ..+++++.+|
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l 251 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAI 251 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence 34556789999999999875 589999999999999999999999999999999999998876655 3589999999
Q ss_pred HHHhcccCCCCCCC-----HHHHhcCccccC
Q 016233 316 VRRMLTQDPKKRIT-----SAQVLEHPWIKE 341 (393)
Q Consensus 316 i~~~L~~dp~~Rpt-----~~e~l~h~~~~~ 341 (393)
|.+||..||.+||+ ++++++||||+.
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 99999999999995 699999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=414.79 Aligned_cols=260 Identities=34% Similarity=0.612 Sum_probs=228.1
Q ss_pred cccceee--cceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 77 VKLHYSF--GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 77 ~~~~y~~--~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
....|.+ .+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~ 160 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLD-HANLIQLYDAFESKND 160 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCE
Confidence 3344555 678999999999999999999999999997543 235678899999999996 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
+++||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+.. +..+.+||+|||++...
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEEC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceec
Confidence 99999999999999988764 46999999999999999999999999999999999999954 23467999999999988
Q ss_pred cCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 016233 234 EEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (393)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (393)
.........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......+....+..+++++
T Consensus 240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp CTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred CCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 76666667789999999999875 58899999999999999999999999999999999999888877777778899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 313 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
.+||.+||..||.+|||++|+|+||||..
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 99999999999999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-55 Score=420.27 Aligned_cols=261 Identities=31% Similarity=0.514 Sum_probs=229.6
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+.+|
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEE
Confidence 3468999999999999999999999999999999997643322334456789999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+|||||+||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeeccC
Confidence 99999999999998865 579999999999999999999999999999999999999 56678999999999877654
Q ss_pred cc--eecccCcccccchHHHhhc-----CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 237 KV--YRDIVGSAYYVAPEVLRRR-----YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 237 ~~--~~~~~gt~~y~aPE~l~~~-----~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
.. ....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+.+..|......+..+.+..++
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 301 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence 32 3467899999999998642 7889999999999999999999999999999999988765444444456799
Q ss_pred HHHHHHHHHhcccCCCC--CCCHHHHhcCccccCC
Q 016233 310 SSAKDLVRRMLTQDPKK--RITSAQVLEHPWIKEG 342 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~--Rpt~~e~l~h~~~~~~ 342 (393)
+++++||.+||..+|.+ |++++|+++||||+..
T Consensus 302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 99999999999999988 9999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-54 Score=407.67 Aligned_cols=254 Identities=31% Similarity=0.579 Sum_probs=231.0
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
..+|++++.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.+|+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEEEE
Confidence 358999999999999999999999999999999997654433445678899999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC-
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceeccCC-
Confidence 99999999999999988899999999999999999999999999999999999999 56678999999999876543
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+...++ ..+++++.+||
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li 269 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLL 269 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHHH
T ss_pred -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence 345689999999999875 589999999999999999999999999999999999998876654 35899999999
Q ss_pred HHhcccCCCCCCC-----HHHHhcCccccC
Q 016233 317 RRMLTQDPKKRIT-----SAQVLEHPWIKE 341 (393)
Q Consensus 317 ~~~L~~dp~~Rpt-----~~e~l~h~~~~~ 341 (393)
.+||..||.+||+ ++++++||||..
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 9999999999998 999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-54 Score=410.77 Aligned_cols=257 Identities=28% Similarity=0.539 Sum_probs=220.1
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHH-HHHccCCCCeeEEeEEEEeCCeEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI-MQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
..+|++++.||+|+||.||+|+++.+++.||||++.+...........+.+|..+ ++.++ ||||+++++++.+.+.+|
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~-hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCC-CTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEeCCEEE
Confidence 3579999999999999999999999999999999987765444455667778777 45564 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc-C
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-E 235 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~-~ 235 (393)
+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++... .
T Consensus 116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGGBCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCccccccccC
Confidence 999999999999999988899999999999999999999999999999999999999 566789999999998643 3
Q ss_pred CcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 236 GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
.......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++..+......++ +.++.++.+
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ 268 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARH 268 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCHHHHH
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHHH
Confidence 334556789999999999876 489999999999999999999999999999999999988766554 468999999
Q ss_pred HHHHhcccCCCCCCCH----HHHhcCccccCC
Q 016233 315 LVRRMLTQDPKKRITS----AQVLEHPWIKEG 342 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~----~e~l~h~~~~~~ 342 (393)
||.+||..||.+||++ +++++||||+..
T Consensus 269 li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 269 LLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred HHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 9999999999999997 699999999753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-54 Score=400.01 Aligned_cols=264 Identities=33% Similarity=0.611 Sum_probs=224.7
Q ss_pred ccccceeec-ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 76 DVKLHYSFG-KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 76 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
.+.++|++. +.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++++.+||||+++++++.+.+.
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 356689995 78999999999999999999999999997542 34567899999999996569999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+|+||||++|++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999999999988899999999999999999999999999999999999999765555569999999998654
Q ss_pred CC--------cceecccCcccccchHHHh------hcCCCcchHHHHHHHHHHHhhCCCCCCCCC---------------
Q 016233 235 EG--------KVYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAET--------------- 285 (393)
Q Consensus 235 ~~--------~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~--------------- 285 (393)
.. ......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 22 1223456999999999986 348999999999999999999999998754
Q ss_pred hHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 286 EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 286 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.......+..+...++...+..+++++.+||.+||..||++|||++|+|+||||+..
T Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 244667777777776665566789999999999999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=394.86 Aligned_cols=258 Identities=31% Similarity=0.530 Sum_probs=224.4
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
....+|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++ ||||+++++++...+.+
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENK-NPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHHHHhcCC-CCCCCeEeEEEEECCEE
Confidence 45678999999999999999999999999999999997543 234677899999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
++||||++||+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred EEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCceecCC
Confidence 9999999999999988664 69999999999999999999999999999999999999 5566799999999987654
Q ss_pred Cc-ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 236 GK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 236 ~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+...... .......+++.+.
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 247 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFR 247 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSCGGGSCHHHH
T ss_pred cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCCccccCHHHH
Confidence 33 3345689999999999875 5899999999999999999999999988877666555443221 1122346899999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+||.+||..||++|||++|+|+||||+..
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 99999999999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=413.44 Aligned_cols=256 Identities=34% Similarity=0.598 Sum_probs=224.2
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
..+|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++ ||||+++++++.+.+.+++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEE
Confidence 458999999999999999999999999999999997654333344568899999999997 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||||+ +|+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTTTTSB
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccceeccCCc
Confidence 99999 78999999988899999999999999999999999999999999999999 566779999999999887776
Q ss_pred ceecccCcccccchHHHhhc--CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
.....+||+.|+|||++.+. .+.++|||||||++|+|++|..||.+.........+..+...+ ...+++++.+|
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~l 238 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVM----PDFLSPGAQSL 238 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCC----CTTSCHHHHHH
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC----cccCCHHHHHH
Confidence 66778999999999998754 3789999999999999999999998766544433333332222 23579999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 316 VRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
|.+||..||.+|||++|+++||||+..
T Consensus 239 i~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 239 IRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHcCCChhHCcCHHHHHhChhhccC
Confidence 999999999999999999999999764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-54 Score=402.21 Aligned_cols=267 Identities=37% Similarity=0.670 Sum_probs=237.4
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCc---ccHHHHHHHHHHHHHccCCCCeeEEeEEEEe
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK---NDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 151 (393)
..+.++|++++.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.+. ||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYEN 86 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEec
Confidence 3456789999999999999999999999999999999986543221 24678999999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCC-CCcEEEeecCCc
Q 016233 152 KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE-NALLKATDFGLS 230 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~-~~~~kl~DFg~a 230 (393)
.+.+++||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++. ...+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999999988888999999999999999999999999999999999999954321 126999999999
Q ss_pred ccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 231 VFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......++...+..++
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence 98776655667789999999999875 58999999999999999999999999999888888888877766555556789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
..+.+||.+||..||++|||++|+|+||||...
T Consensus 247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp HHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 999999999999999999999999999999753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-54 Score=400.91 Aligned_cols=247 Identities=21% Similarity=0.286 Sum_probs=191.9
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC----
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ---- 153 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~---- 153 (393)
..+|.+.++||+|+||+||+|++. |+.||||++.... ......+.|+..+.+++ |||||++++++.+++
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE----ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc----hhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCCCce
Confidence 346999999999999999999974 8999999986432 12223345666667786 999999999997654
Q ss_pred eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc--------CcEecCCCCCcEEeccCCCCCcEEEe
Q 016233 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM--------GVMHRDLKPENFLLSSKDENALLKAT 225 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~--------~ivH~Dikp~Nill~~~~~~~~~kl~ 225 (393)
.+|||||||+||+|.+++.. ..++++.+..++.|++.||.|||++ +||||||||+|||+ +.++.+||+
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~ 150 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA 150 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEEC
T ss_pred EEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEE
Confidence 58999999999999999875 4699999999999999999999987 99999999999999 667789999
Q ss_pred ecCCcccccCCcc-----eecccCcccccchHHHhh-------cCCCcchHHHHHHHHHHHhhCCCCCCCC---------
Q 016233 226 DFGLSVFIEEGKV-----YRDIVGSAYYVAPEVLRR-------RYGKEIDIWSAGVILYILLSGVPPFWAE--------- 284 (393)
Q Consensus 226 DFg~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~-------~~~~~~DiwSlG~il~~lltg~~pf~~~--------- 284 (393)
|||+|+....... ....+||+.|||||++.+ .|+.++|||||||+||||+||.+||...
T Consensus 151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~ 230 (303)
T 3hmm_A 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence 9999987754432 224589999999999864 3677899999999999999997765321
Q ss_pred ------ChHHHHHHHHcCCCCCCCCC-CC--CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 285 ------TEKGIFDAILQGDIDFESAP-WP--TISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 285 ------~~~~~~~~i~~~~~~~~~~~-~~--~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
...+....+.........+. +. ..+..+.+|+.+||..||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 12333444444433222111 11 12356889999999999999999999976
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=401.40 Aligned_cols=274 Identities=30% Similarity=0.561 Sum_probs=239.5
Q ss_pred cccccccccccceeec-ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeE
Q 016233 69 ILGKPYEDVKLHYSFG-KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (393)
Q Consensus 69 ~~~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 147 (393)
+.....+.+..+|.+. +.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.+.+||||+++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 3445567788899998 889999999999999999999999999976542 34456789999999999987899999999
Q ss_pred EEEeCCeEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEe
Q 016233 148 AYEDKQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225 (393)
Q Consensus 148 ~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~ 225 (393)
++.+.+.+++||||+.||+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.....+.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEe
Confidence 999999999999999999999988543 579999999999999999999999999999999999999654446789999
Q ss_pred ecCCcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 016233 226 DFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP 304 (393)
Q Consensus 226 DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (393)
|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......+....
T Consensus 177 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 256 (327)
T 3lm5_A 177 DFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET 256 (327)
T ss_dssp CGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred eCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchh
Confidence 9999998776655667789999999999875 589999999999999999999999999999888888888888888888
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
+..+++.+.+||.+||..||++|||++++|+||||+...
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 888999999999999999999999999999999998653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=419.72 Aligned_cols=263 Identities=26% Similarity=0.473 Sum_probs=227.6
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
...++|+++++||+|+||.||+|+++.+++.||+|++.+...........+.+|+.++..++ ||||+++++++.+.+.+
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDDNNL 149 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCEE
Confidence 34578999999999999999999999999999999997643322233445888999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
|+|||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhcc
Confidence 999999999999999987 4689999999999999999999999999999999999999 566789999999998765
Q ss_pred CCcc--eecccCcccccchHHHh------hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC-CCC
Q 016233 235 EGKV--YRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES-APW 305 (393)
Q Consensus 235 ~~~~--~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~ 305 (393)
.... ....+||+.|+|||++. +.|+.++|||||||++|+|++|..||.+.+..+.+..+......+.. ..+
T Consensus 227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 306 (437)
T 4aw2_A 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV 306 (437)
T ss_dssp TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSC
T ss_pred cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccc
Confidence 4433 23468999999999986 24899999999999999999999999999998888888764322222 223
Q ss_pred CCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCccccCC
Q 016233 306 PTISSSAKDLVRRMLTQDPKK--RITSAQVLEHPWIKEG 342 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~--Rpt~~e~l~h~~~~~~ 342 (393)
..+++++++||++||..+|++ |++++|+++||||+..
T Consensus 307 ~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 568999999999999999888 9999999999999753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=407.91 Aligned_cols=256 Identities=27% Similarity=0.525 Sum_probs=228.4
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
.++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+|+.++ ||||+++++++.+.+.+|+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCEEEE
Confidence 468999999999999999999999999999999997655434456778899999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 93 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp EECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTTC
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeeccCCC
Confidence 99999999999999988889999999999999999999999999999999999999 566789999999999887766
Q ss_pred ceecccCcccccchHHHhh----cCCCcchHHHHHHHHHHHhhCCCCCCCC---ChHHHHHHHHcCCCCCCCCCCCCCCH
Q 016233 238 VYRDIVGSAYYVAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAE---TEKGIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~~lltg~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
.....+||+.|+|||++.. .++.++|||||||++|+|++|..||... ...+.+..+......++ ..+++
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~~~s~ 245 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWSQ 245 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----TTSCH
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----CcCCH
Confidence 6778899999999999853 4889999999999999999999999753 34455666666555444 35789
Q ss_pred HHHHHHHHhcccCCCCCCC-HHHHhcCccccC
Q 016233 311 SAKDLVRRMLTQDPKKRIT-SAQVLEHPWIKE 341 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt-~~e~l~h~~~~~ 341 (393)
++.+||.+||..||++||+ ++++++||||..
T Consensus 246 ~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 246 EMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred HHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 9999999999999999998 899999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=404.12 Aligned_cols=263 Identities=37% Similarity=0.713 Sum_probs=235.9
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCC-----cccHHHHHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT-----KNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
.+..+|++.+.||+|+||.||+|.+..+|+.||||++....... ....+.+.+|+.+++++.+||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 45578999999999999999999999999999999987543211 1124567899999999956999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 151 DKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 151 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
..+..|+||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFS 247 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecCcc
Confidence 999999999999999999999888889999999999999999999999999999999999999 55677999999999
Q ss_pred ccccCCcceecccCcccccchHHHhh-------cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC
Q 016233 231 VFIEEGKVYRDIVGSAYYVAPEVLRR-------RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA 303 (393)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 303 (393)
..+.........+||+.|+|||++.+ .++.++|||||||++|+|++|..||........+..+..+...+...
T Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 327 (365)
T 2y7j_A 248 CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP 327 (365)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHH
T ss_pred cccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 98876666677889999999999863 37889999999999999999999999988888888888888777766
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
.|..++..+.+||.+||..||++|||++++|+||||++
T Consensus 328 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 67789999999999999999999999999999999963
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-53 Score=393.21 Aligned_cols=264 Identities=25% Similarity=0.385 Sum_probs=218.6
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccC--CcccHHHHHHHHHHHHHcc--CCCCeeEEeEEEEe
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV--TKNDKDDIKREIQIMQHLS--GQPNIVEFKGAYED 151 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~ 151 (393)
.+..+|++++.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++.+. +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3456899999999999999999999999999999998754321 1223456778888887775 49999999999987
Q ss_pred CC-----eEEEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEE
Q 016233 152 KQ-----SVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKA 224 (393)
Q Consensus 152 ~~-----~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl 224 (393)
.. .+++||||+. ++|.+++..... +++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCEEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEE
Confidence 65 5899999996 599999887654 9999999999999999999999999999999999999 55667999
Q ss_pred eecCCcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC
Q 016233 225 TDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA 303 (393)
Q Consensus 225 ~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 303 (393)
+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.......+..
T Consensus 162 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp CSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 99999988776666667889999999999864 59999999999999999999999999998888777765432221111
Q ss_pred C-----------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 304 P-----------------------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 304 ~-----------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
. .+.+++++.+||.+||..||++|||++|+|+||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 1 235789999999999999999999999999999998643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-53 Score=390.72 Aligned_cols=258 Identities=25% Similarity=0.443 Sum_probs=216.1
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.++++++ ||||+++++++.+++.+++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEEEEE
Confidence 479999999999999999999999999999999976542 3344577889999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-
Q 016233 159 MELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG- 236 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~- 236 (393)
|||+++ ++.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCC
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCcc
Confidence 999976 56555554 5789999999999999999999999999999999999999 55667999999999876533
Q ss_pred cceecccCcccccchHHHhh-c-CCCcchHHHHHHHHHHHhhCCCCC-CCCChHHHHHHHHcCCCCCCC-----------
Q 016233 237 KVYRDIVGSAYYVAPEVLRR-R-YGKEIDIWSAGVILYILLSGVPPF-WAETEKGIFDAILQGDIDFES----------- 302 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~-~-~~~~~DiwSlG~il~~lltg~~pf-~~~~~~~~~~~i~~~~~~~~~----------- 302 (393)
.......||+.|+|||++.+ . ++.++|||||||++|+|++|..|| .+.+..+.+..+.........
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 33455689999999999865 3 799999999999999999888775 555555565555432111111
Q ss_pred --------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 303 --------------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 303 --------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
...+.+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 1123578999999999999999999999999999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-53 Score=401.06 Aligned_cols=257 Identities=34% Similarity=0.556 Sum_probs=210.0
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
.++|++++.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.+++.++ ||||+++++++.+.+.+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA----AIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST----TSCHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc----cccHHHHHHHHHHHhCC-CCCCCcEEEEEeeCCEEEE
Confidence 458999999999999999999999999999999997543 23467889999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+ ....+||+|||+++......
T Consensus 94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~-~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS-SSCCEEECCCCCC-------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCceEEEeecCccccccccC
Confidence 99999999999999888899999999999999999999999999999999999999532 23359999999998655544
Q ss_pred ceecccCcccccchHHHhh-cCCC-cchHHHHHHHHHHHhhCCCCCCCCCh----HHHHHHHHcCCCCCCCCCCCCCCHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGK-EIDIWSAGVILYILLSGVPPFWAETE----KGIFDAILQGDIDFESAPWPTISSS 311 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~-~~DiwSlG~il~~lltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (393)
.....+||+.|+|||++.+ .+.. ++|||||||++|+|++|..||.+... ...+..+......++. ...++++
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~ 250 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD--DIRISPE 250 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT--TSCCCHH
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC--cCCCCHH
Confidence 5556789999999999865 3544 48999999999999999999987543 4455556655544433 3468999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 312 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+.+||.+||..||++|||++|+|+||||...
T Consensus 251 ~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 251 CCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 9999999999999999999999999999654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-54 Score=419.85 Aligned_cols=258 Identities=37% Similarity=0.623 Sum_probs=233.1
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
...+|.+++.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++ ||||+++++++.+.+.+|
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence 3458999999999999999999999999999999997654333345678999999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEECCTT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhhcccc
Confidence 999999999999999888889999999999999999999999999999999999999 55667999999999987766
Q ss_pred cceecccCcccccchHHHhhc--CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 237 KVYRDIVGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
......+||+.|+|||++.+. .+.++|||||||++|+|++|..||.+.+....+..+..+....+ ..+++++.+
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~ 245 (476)
T 2y94_A 170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLNPSVIS 245 (476)
T ss_dssp CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCCHHHHH
T ss_pred ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCCHHHHH
Confidence 666778999999999999764 47899999999999999999999999988888888888765443 357899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
||.+||..||++|||++++++||||+..
T Consensus 246 Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 246 LLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 9999999999999999999999999764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-53 Score=393.37 Aligned_cols=263 Identities=40% Similarity=0.740 Sum_probs=235.1
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
.+..+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++ ||||+++++++.+.+.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKIK-HENIVTLEDIYESTTHY 81 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHhCC-CCCeeehhhhcccCCEE
Confidence 45678999999999999999999999999999999997543 223467889999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++...+.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999999999999998888999999999999999999999999999999999999996656677899999999976543
Q ss_pred CcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 236 GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+....+..+...+....+..+++++.+
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 240 (304)
T 2jam_A 162 G-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD 240 (304)
T ss_dssp B-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred C-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence 2 2345679999999999865 4899999999999999999999999999998899999998888877777889999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
||.+||..||++|||++++|+||||....
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 241 FICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 99999999999999999999999998653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=391.44 Aligned_cols=265 Identities=43% Similarity=0.756 Sum_probs=241.4
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
.+..+|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.++++++ ||||+++++++.+.+.+
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcc-CCCccEEEEEEeCCCeE
Confidence 456789999999999999999999999999999999976543 3345778999999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
++||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+||+++.++....+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 99999999999999998888999999999999999999999999999999999999997666667899999999987766
Q ss_pred CcceecccCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 236 GKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
........||+.|+|||++.+.++.++||||||+++|+|++|..||.+.+..+....+..+...+....+..+++++.+|
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (287)
T 2wei_A 177 NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (287)
T ss_dssp CSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred CCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence 55555667899999999998889999999999999999999999999999888888898888777766677899999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 316 VRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
|.+||..||++|||++++|+||||++.
T Consensus 257 i~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 257 IRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 999999999999999999999999753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=415.81 Aligned_cols=258 Identities=32% Similarity=0.574 Sum_probs=220.4
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
...+|++++.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++ ||||+++++++.+.+.+|
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETTEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCCEEE
Confidence 3468999999999999999999999999999999998654444455667889999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc-
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE- 234 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~-~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~- 234 (393)
+||||++||+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||+ +.++.+||+|||+++...
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTTCC
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceeccC
Confidence 999999999999999988899999999999999999999998 999999999999999 556679999999998643
Q ss_pred CCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 235 EGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+......++ ..+++++.
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~ 377 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEAK 377 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHH
Confidence 3334556789999999999875 599999999999999999999999999999888888888776654 35899999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHhcCccccCC
Q 016233 314 DLVRRMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (393)
Q Consensus 314 ~li~~~L~~dp~~Rp-----t~~e~l~h~~~~~~ 342 (393)
+||.+||..||.+|| |++|+|+||||...
T Consensus 378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 999999999999999 99999999999853
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=411.71 Aligned_cols=262 Identities=25% Similarity=0.446 Sum_probs=225.1
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
...++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|..++..+. ||||+++++++.+.+.+
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDENYL 136 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeCCEE
Confidence 34568999999999999999999999999999999997643322334456788999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheecc
Confidence 99999999999999998754 79999999999999999999999999999999999999 566789999999998775
Q ss_pred CCcce--ecccCcccccchHHHh--------hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC-
Q 016233 235 EGKVY--RDIVGSAYYVAPEVLR--------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA- 303 (393)
Q Consensus 235 ~~~~~--~~~~gt~~y~aPE~l~--------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~- 303 (393)
..... ...+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.+..+.+..+......+..+
T Consensus 214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 293 (412)
T 2vd5_A 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL 293 (412)
T ss_dssp TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-
T ss_pred CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc
Confidence 54332 3468999999999986 248999999999999999999999999999888888887643222111
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCccccCC
Q 016233 304 PWPTISSSAKDLVRRMLTQDPKKR---ITSAQVLEHPWIKEG 342 (393)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~R---pt~~e~l~h~~~~~~ 342 (393)
....+|+++++||++||. +|.+| ++++|+++||||+..
T Consensus 294 ~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 294 VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp ---CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 124689999999999999 99998 599999999999754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=395.94 Aligned_cols=260 Identities=32% Similarity=0.511 Sum_probs=232.1
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
...+|.+++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+. ||||+++++++.+.+.+|
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeEE
Confidence 3568999999999999999999999999999999998765544556778899999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCceecccC
Confidence 999999999999999888889999999999999999999999999999999999999 55667999999999876532
Q ss_pred -cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 237 -KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 237 -~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+.+..+......++ ..+++.+.+
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 270 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAAS 270 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHH
T ss_pred cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHHH
Confidence 33445679999999999875 488999999999999999999999999888888888877765543 357899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
||.+||..||++|||++++|+||||.....
T Consensus 271 li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 271 LIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred HHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 999999999999999999999999987543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=399.58 Aligned_cols=264 Identities=28% Similarity=0.458 Sum_probs=214.4
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
..++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.++++++ ||||+++++++.+.+.++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCC-CTTBCCEEEEEEETTEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcC-CCCcceEEEEEecCCEEE
Confidence 34589999999999999999999999999999999975432 2334566789999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccC--CCCCcEEEeecCCccccc
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK--DENALLKATDFGLSVFIE 234 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~--~~~~~~kl~DFg~a~~~~ 234 (393)
+||||++| +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+ +....+||+|||++....
T Consensus 110 lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 99999974 999999988889999999999999999999999999999999999999643 245569999999998765
Q ss_pred CC-cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCC-----
Q 016233 235 EG-KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP----- 306 (393)
Q Consensus 235 ~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----- 306 (393)
.. .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+...........|+
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence 33 23445678999999999875 38999999999999999999999999988877776665422111111111
Q ss_pred ---------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 307 ---------------------TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 307 ---------------------~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
.+++++.+||.+||..||++|||++|+|+||||+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 1678999999999999999999999999999998643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-53 Score=393.64 Aligned_cols=261 Identities=27% Similarity=0.457 Sum_probs=215.3
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
+.+.++|++++.||+|+||.||+|.+. +|+.||+|++..... .......+.+|+.++++++ ||||+++++++.+.+.
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELH-HPNIVSLIDVIHSERC 93 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCC-CTTBCCEEEEECCSSC
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcC-CCCEeeeeeEEccCCE
Confidence 446679999999999999999999986 489999999965432 3334577889999999996 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
+++||||+++ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAF 169 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEET
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCceec
Confidence 9999999975 888877664 459999999999999999999999999999999999999 45667999999999876
Q ss_pred cCC-cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC-------
Q 016233 234 EEG-KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA------- 303 (393)
Q Consensus 234 ~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~------- 303 (393)
... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..........
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 170 GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp TSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred CCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 533 33445689999999999865 48999999999999999999999998877666655554311111111
Q ss_pred -------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 304 -------------------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 304 -------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
..+.+++++.+||.+||..||++|||++|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 123578899999999999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=388.52 Aligned_cols=264 Identities=36% Similarity=0.687 Sum_probs=236.9
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCC------cccHHHHHHHHHHHHHccCCCCeeEEeEEE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT------KNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 149 (393)
.+..+|++.+.||+|+||.||+|.+..+|+.||||++....... ....+.+.+|+.+++++.+||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 35668999999999999999999999999999999997543211 122456789999999997799999999999
Q ss_pred EeCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 150 EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 150 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
.+.+..++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~ 170 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF 170 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEecccc
Confidence 9999999999999999999999988889999999999999999999999999999999999999 5566799999999
Q ss_pred cccccCCcceecccCcccccchHHHhh-------cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC
Q 016233 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR-------RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES 302 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 302 (393)
+.............||+.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+..+...+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 988776666667789999999998852 3788999999999999999999999999888888888888888777
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
..+..++..+.+||.+||..||++|||++++|+||||++.
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 7777899999999999999999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=393.44 Aligned_cols=257 Identities=30% Similarity=0.564 Sum_probs=217.0
Q ss_pred ccceeecceecccCCeEEEEEEEC---CCCcEEEEEEeecCccC-CcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTEN---STGRQFACKSISKRKLV-TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
..+|++.+.||+|+||.||+|.+. .+++.||+|++.+.... .......+.+|+.+++.++ ||||+++++++.+.+
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTGG 94 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcCC
Confidence 458999999999999999999985 68999999999765432 2234566788999999996 999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKES 171 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSCC---
T ss_pred EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCccccc
Confidence 999999999999999999988899999999999999999999999999999999999999 55677999999999864
Q ss_pred cC-CcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 016233 234 EE-GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (393)
Q Consensus 234 ~~-~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (393)
.. .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......++ +.++++
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~ 247 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQE 247 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TTSCHH
T ss_pred ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHH
Confidence 33 233456789999999999865 589999999999999999999999999998888888888766554 357899
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHhcCccccCC
Q 016233 312 AKDLVRRMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (393)
Q Consensus 312 ~~~li~~~L~~dp~~Rp-----t~~e~l~h~~~~~~ 342 (393)
+.+||.+||..||.+|| +++++++||||+..
T Consensus 248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 99999999999999999 88999999999753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-53 Score=396.83 Aligned_cols=258 Identities=30% Similarity=0.551 Sum_probs=218.3
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
+.++|++++.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++ ||||+++++++.+.+..|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeEE
Confidence 45689999999999999999999999999999999975432 223467889999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+||||++||+|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeeccceeccC
Confidence 999999999999999877789999999999999999999999999999999999999 55667999999999876433
Q ss_pred c---ceecccCcccccchHHHhhc--CCCcchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHcCCCCCCCCCCCCCCH
Q 016233 237 K---VYRDIVGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 237 ~---~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
. .....+||+.|+|||++.+. ++.++|||||||++|+|++|..||...... ..+......... ...+..+++
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNPWKKIDS 236 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--STTGGGSCH
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--CCccccCCH
Confidence 2 23456899999999998753 477899999999999999999999876543 333333333222 233567899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.+.+||.+||..||++|||++|+|+||||...
T Consensus 237 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 237 APLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 99999999999999999999999999999764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=416.27 Aligned_cols=261 Identities=27% Similarity=0.393 Sum_probs=200.0
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe-----
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED----- 151 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----- 151 (393)
+.++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|+.++ ||||+++++++..
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTTT
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCCccc
Confidence 4568999999999999999999999999999999986532 23445678899999999996 9999999999843
Q ss_pred CCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 152 KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
.+.+|+||||+ +++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 129 FDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLAR 204 (458)
T ss_dssp CCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCB
T ss_pred CceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccccch
Confidence 35799999998 57999999888889999999999999999999999999999999999999 566789999999998
Q ss_pred cccCCc----------------------------ceecccCcccccchHHHh--hcCCCcchHHHHHHHHHHHhh-----
Q 016233 232 FIEEGK----------------------------VYRDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLS----- 276 (393)
Q Consensus 232 ~~~~~~----------------------------~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~llt----- 276 (393)
...... .....+||++|+|||++. ..|+.++|||||||++|+|++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 764221 234568999999999863 359999999999999999999
Q ss_pred ------CCCCCCCCCh--------------------HHHHHHHHc-----------------------CC----CCCCCC
Q 016233 277 ------GVPPFWAETE--------------------KGIFDAILQ-----------------------GD----IDFESA 303 (393)
Q Consensus 277 ------g~~pf~~~~~--------------------~~~~~~i~~-----------------------~~----~~~~~~ 303 (393)
|.++|.+.+. .+.+..+.. .. ......
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 7777766431 112221111 00 000112
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
.++.+++++.+||.+||..||++|||++|+|+||||+...
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 2456799999999999999999999999999999998653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-53 Score=388.40 Aligned_cols=257 Identities=32% Similarity=0.473 Sum_probs=213.6
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++++.||+|+||.||+|.+ .+|+.||+|++..... .......+.+|+.+++.++ ||||+++++++.+.+.+++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeEEEE
Confidence 4799999999999999999998 6789999999975432 2334577889999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-
Q 016233 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG- 236 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~- 236 (393)
|||+++ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC--
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCccc
Confidence 999975 898888764 679999999999999999999999999999999999999 55667999999999876532
Q ss_pred cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC------------
Q 016233 237 KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES------------ 302 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~------------ 302 (393)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 23345679999999999864 4899999999999999999999999988877766665431110000
Q ss_pred -------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 303 -------------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 303 -------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.....+++++.+||.+||..||++|||++|+|+||||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0124578999999999999999999999999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-54 Score=414.95 Aligned_cols=264 Identities=38% Similarity=0.678 Sum_probs=221.3
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCc-----ccHHHHHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK-----NDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
.+.++|.+.+.||+|+||.||+|.+..+++.||||++.+...... .....+.+|+.+|++++ ||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~ 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFD 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCCEEEE
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence 356789999999999999999999999999999999986543221 12235789999999996 999999999986
Q ss_pred eCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 151 DKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 151 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
. +.+|+||||+++|+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++..+....+||+|||++
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred c-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 5 458999999999999999988888999999999999999999999999999999999999987666778999999999
Q ss_pred ccccCCcceecccCcccccchHHHh----hcCCCcchHHHHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCCCCCCCCC
Q 016233 231 VFIEEGKVYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPW 305 (393)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~ 305 (393)
............+||+.|+|||++. ..++.++|||||||++|+|++|..||..... ......+..+...+....|
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 9877666666788999999999874 3478899999999999999999999976543 3455667777776666666
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
..+++.+.+||.+||..||++|||++|+|+||||+.
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 789999999999999999999999999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=392.78 Aligned_cols=259 Identities=25% Similarity=0.423 Sum_probs=207.9
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.+|++++.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.++++++ ||||+++++++.+++.+++|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELK-HENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCeEEEE
Confidence 47999999999999999999999999999999997543 2334577889999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 159 MELCAGGELFDRIIAK------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
|||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARA 157 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCEE
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCcccee
Confidence 99997 5999988764 358999999999999999999999999999999999999 5566799999999987
Q ss_pred ccCC-cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC------
Q 016233 233 IEEG-KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA------ 303 (393)
Q Consensus 233 ~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~------ 303 (393)
.... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..........
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 6533 33455689999999999865 48999999999999999999999999988877776664321110000
Q ss_pred ------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 304 ------------------------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 304 ------------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
....++.++.+||.+||..||++|||++|+|+||||.+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 11257889999999999999999999999999999987543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=385.73 Aligned_cols=265 Identities=41% Similarity=0.734 Sum_probs=231.0
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCc---ccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK---NDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
+.++|++++.||+|+||.||+|.+..+++.||+|++........ ...+.+.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFENKT 81 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheecCCC
Confidence 35689999999999999999999999999999999986543222 24678999999999997 999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCC-CCCcEEEeecCCccc
Q 016233 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD-ENALLKATDFGLSVF 232 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~-~~~~~kl~DFg~a~~ 232 (393)
..++||||+++++|.+++.....+++.+++.++.||+.||.|||++||+||||||+||+++.++ ....+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999999999999998888899999999999999999999999999999999999996433 233799999999988
Q ss_pred ccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 016233 233 IEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (393)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (393)
...........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+.+..+......+....+..++..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241 (283)
T ss_dssp CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence 766555566789999999999875 5899999999999999999999999999988888888877766655555678999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 312 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+.+||.+||..||++|||+.++|+||||+..
T Consensus 242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 9999999999999999999999999999753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-53 Score=406.77 Aligned_cols=261 Identities=30% Similarity=0.472 Sum_probs=210.2
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC--
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-- 153 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-- 153 (393)
.+..+|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.+.+||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 34568999999999999999999999999999999986432 234456778899999999977999999999997554
Q ss_pred eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
.+|+|||||+ ++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRSF 159 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEES
T ss_pred EEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCcccccc
Confidence 7999999997 588887765 579999999999999999999999999999999999999 56677999999999865
Q ss_pred cC----------------------CcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHH
Q 016233 234 EE----------------------GKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGI 289 (393)
Q Consensus 234 ~~----------------------~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 289 (393)
.. .......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 32 112345689999999999865 589999999999999999999999999888777
Q ss_pred HHHHHcCCCCCC------------------------------C-------------CCCCCCCHHHHHHHHHhcccCCCC
Q 016233 290 FDAILQGDIDFE------------------------------S-------------APWPTISSSAKDLVRRMLTQDPKK 326 (393)
Q Consensus 290 ~~~i~~~~~~~~------------------------------~-------------~~~~~~s~~~~~li~~~L~~dp~~ 326 (393)
+..+........ . .....+++++.+||.+||..||++
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 766643110000 0 012267899999999999999999
Q ss_pred CCCHHHHhcCccccCC
Q 016233 327 RITSAQVLEHPWIKEG 342 (393)
Q Consensus 327 Rpt~~e~l~h~~~~~~ 342 (393)
|||++|+|+||||+..
T Consensus 320 R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 320 RISANDALKHPFVSIF 335 (388)
T ss_dssp SCCHHHHTTSTTTTTT
T ss_pred CCCHHHHhCCHHHHHh
Confidence 9999999999999754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-53 Score=390.13 Aligned_cols=257 Identities=30% Similarity=0.585 Sum_probs=217.6
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCC-----------------------cccHHHHHHHHHHHH
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT-----------------------KNDKDDIKREIQIMQ 134 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~ 134 (393)
..+|++.+.||+|+||.||+|.+..+++.||||++....... ....+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 358999999999999999999999999999999997654211 112456889999999
Q ss_pred HccCCCCeeEEeEEEEe--CCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEE
Q 016233 135 HLSGQPNIVEFKGAYED--KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFL 212 (393)
Q Consensus 135 ~l~~h~niv~~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nil 212 (393)
+++ ||||+++++++.+ .+.+|+||||+++++|.+++ ....+++.+++.++.||+.||.|||++||+||||||+|||
T Consensus 92 ~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 92 KLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp TCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred hCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 996 9999999999987 56899999999999998754 3457999999999999999999999999999999999999
Q ss_pred eccCCCCCcEEEeecCCcccccCCc-ceecccCcccccchHHHhhc----CCCcchHHHHHHHHHHHhhCCCCCCCCChH
Q 016233 213 LSSKDENALLKATDFGLSVFIEEGK-VYRDIVGSAYYVAPEVLRRR----YGKEIDIWSAGVILYILLSGVPPFWAETEK 287 (393)
Q Consensus 213 l~~~~~~~~~kl~DFg~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~----~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 287 (393)
+ +.++.+||+|||++....... ......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....
T Consensus 170 ~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 170 V---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp E---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred E---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 9 556679999999998765443 34456899999999998653 367899999999999999999999998887
Q ss_pred HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 288 GIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 288 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
.....+......++. .+.+++++.+||.+||..||++|||+.|+|+||||++
T Consensus 247 ~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 247 CLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 777777776655443 3578999999999999999999999999999999963
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=400.94 Aligned_cols=263 Identities=21% Similarity=0.321 Sum_probs=218.2
Q ss_pred ccccceeecceeccc--CCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 76 DVKLHYSFGKELGRG--QFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
....+|++++.||+| +||.||+|.+..+|+.||||++..... .......+.+|+.+++.++ ||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADN 99 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEECC
Confidence 345689999999999 999999999999999999999976543 3445677889999999996 999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 154 SVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
.+|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccce
Confidence 999999999999999999875 679999999999999999999999999999999999999 556689999999987
Q ss_pred cccCCc--------ceecccCcccccchHHHhh---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC
Q 016233 232 FIEEGK--------VYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF 300 (393)
Q Consensus 232 ~~~~~~--------~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 300 (393)
...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 256 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence 543221 1123479999999999875 48999999999999999999999998766555444333222110
Q ss_pred ------------------------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 016233 301 ------------------------------------------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338 (393)
Q Consensus 301 ------------------------------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~ 338 (393)
....+..+++++.+||.+||..||++|||++|+|+|||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 01123457899999999999999999999999999999
Q ss_pred ccCCC
Q 016233 339 IKEGG 343 (393)
Q Consensus 339 ~~~~~ 343 (393)
|+...
T Consensus 337 f~~~~ 341 (389)
T 3gni_B 337 FKQIK 341 (389)
T ss_dssp GGGC-
T ss_pred HHHHh
Confidence 98654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=400.34 Aligned_cols=270 Identities=34% Similarity=0.608 Sum_probs=230.6
Q ss_pred ccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccC--CcccHHHHHHHHHHHHHccCCCCeeEEeEEE
Q 016233 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV--TKNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149 (393)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 149 (393)
.....+..+|++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+.+|+.++++++ ||||+++++++
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~ 97 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVY 97 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhh
Confidence 34456778999999999999999999999999999999999764321 2345678999999999996 99999999999
Q ss_pred EeCCeEEEEEeccCCCChHHHHHH----------------------------------------cCCCCHHHHHHHHHHH
Q 016233 150 EDKQSVHVVMELCAGGELFDRIIA----------------------------------------KGHYSERAAASICRSI 189 (393)
Q Consensus 150 ~~~~~~~lv~e~~~gg~L~~~l~~----------------------------------------~~~~~~~~~~~i~~ql 189 (393)
.+.+..++||||++||+|.+++.. ...+++..++.++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 999999999999999999998741 0113577889999999
Q ss_pred HHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc-----ceecccCcccccchHHHh---hcCCCc
Q 016233 190 VNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-----VYRDIVGSAYYVAPEVLR---RRYGKE 261 (393)
Q Consensus 190 l~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-----~~~~~~gt~~y~aPE~l~---~~~~~~ 261 (393)
+.||.|||++||+||||||+|||++.+ ....+||+|||++..+.... ......||+.|+|||++. ..++.+
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESCS-SSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHHHCCccccCCChhhEEEecC-CCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999999999999999999999542 23379999999998764321 234567999999999986 358899
Q ss_pred chHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 262 IDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 262 ~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
+|||||||++|+|++|..||.+.+..+....+......+....+..+++++.+||.+||..||++|||+.++|+||||++
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~ 336 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence 99999999999999999999999998888999888887777777778999999999999999999999999999999987
Q ss_pred CC
Q 016233 342 GG 343 (393)
Q Consensus 342 ~~ 343 (393)
..
T Consensus 337 ~~ 338 (345)
T 3hko_A 337 FS 338 (345)
T ss_dssp TS
T ss_pred Ch
Confidence 53
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=428.45 Aligned_cols=258 Identities=26% Similarity=0.504 Sum_probs=233.8
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
..+|++++.||+|+||.||+|.++.+++.||||++.+.........+.+..|..++..+.+||||+++++++.+.+.+||
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 45799999999999999999999999999999999865433344567788999999998779999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc-CC
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EG 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~-~~ 236 (393)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++... ..
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECCCTT
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeeccccCC
Confidence 99999999999999998899999999999999999999999999999999999999 566789999999998643 33
Q ss_pred cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+++..|......++. .+++++.+|
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l 572 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAI 572 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSCHHHHHH
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHH
Confidence 44567789999999999875 5999999999999999999999999999999999999998776653 589999999
Q ss_pred HHHhcccCCCCCCCH-----HHHhcCccccCC
Q 016233 316 VRRMLTQDPKKRITS-----AQVLEHPWIKEG 342 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~-----~e~l~h~~~~~~ 342 (393)
|.+||..||++|+++ +|+++||||+..
T Consensus 573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred HHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 999999999999998 999999999753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=384.46 Aligned_cols=258 Identities=32% Similarity=0.610 Sum_probs=226.3
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
.++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.++++++ ||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCCEEEE
Confidence 458999999999999999999999999999999997654333345677899999999997 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~~~- 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSS- 162 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC----
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccCCcc-
Confidence 99999999999999988899999999999999999999999999999999999999 55667999999998655433
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||...+..+....+......++ ..+++.+.+||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li 238 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLI 238 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHH
T ss_pred cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC----CcCCHHHHHHH
Confidence 2345689999999999876 478999999999999999999999999998888888887766544 35789999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 317 RRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 317 ~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
.+||..||++|||+.|+|+||||+....
T Consensus 239 ~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 239 SRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp HHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred HHHhccChhhCCCHHHHhhCccccCCcc
Confidence 9999999999999999999999986543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-53 Score=420.99 Aligned_cols=257 Identities=30% Similarity=0.549 Sum_probs=227.2
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
...+|++.+.||+|+||.||+|.++.+|+.||||++.+...........+.+|+.+|+.++ ||||+++++++.+.+.+|
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeCCEEE
Confidence 3467999999999999999999999999999999997654433445677889999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 157 VVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+||||++||+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEecccceecc
Confidence 99999999999999876543 9999999999999999999999999999999999999 566789999999999887
Q ss_pred CCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCC----hHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 235 EGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET----EKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..++...+......++ ..++
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~~~s 413 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFS 413 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----TTSC
T ss_pred cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----ccCC
Confidence 6666677899999999999876 58999999999999999999999998753 3455566665544433 4689
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHhcCccccC
Q 016233 310 SSAKDLVRRMLTQDPKKRI-----TSAQVLEHPWIKE 341 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rp-----t~~e~l~h~~~~~ 341 (393)
+++++||.+||..||.+|| +++|+++||||+.
T Consensus 414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 9999999999999999999 8999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=395.55 Aligned_cols=264 Identities=38% Similarity=0.684 Sum_probs=224.4
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccC-----CcccHHHHHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV-----TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
.+.++|++.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++.+. ||||+++++++.
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 85 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEeeEEc
Confidence 4567899999999999999999999999999999999765321 1123345889999999996 999999999998
Q ss_pred eCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 151 DKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 151 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
.++ +|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 765 8999999999999999988888999999999999999999999999999999999999976666667999999999
Q ss_pred ccccCCcceecccCcccccchHHHh----hcCCCcchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHcCCCCCCCCCC
Q 016233 231 VFIEEGKVYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGDIDFESAPW 305 (393)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 305 (393)
.............||+.|+|||++. ..++.++|||||||++|+|++|..||...... .....+..+...+....+
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T 2ycf_A 165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244 (322)
T ss_dssp EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence 8876655555678999999999974 35889999999999999999999999765433 345556666655544445
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
..+++.+.+||.+||..||++|||++++|+||||..
T Consensus 245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 678999999999999999999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=399.36 Aligned_cols=261 Identities=26% Similarity=0.409 Sum_probs=212.2
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++ ||||+++++++.+.+.+++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEEEEE
Confidence 479999999999999999999999999999999864431 112223457999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-
Q 016233 159 MELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG- 236 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~- 236 (393)
|||++ |+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC----
T ss_pred ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCc
Confidence 99997 58988887754 59999999999999999999999999999999999999 55667999999999865432
Q ss_pred cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCC----------
Q 016233 237 KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP---------- 304 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~---------- 304 (393)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+...........
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 23445678999999999865 489999999999999999999999999888877766654222221111
Q ss_pred ----------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCC
Q 016233 305 ----------------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346 (393)
Q Consensus 305 ----------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~ 346 (393)
++.+++++.+||.+||..||++|||++|+|+||||.......
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 292 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI 292 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence 235789999999999999999999999999999998765433
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-53 Score=412.46 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=210.5
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC---
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--- 152 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 152 (393)
.+..+|++++.||+|+||.||+|.+..+++.||||++.+.. ........+.+|+.+|+.++ ||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTL 136 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCST
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCCcc
Confidence 34578999999999999999999999999999999997542 23445678889999999996 99999999999654
Q ss_pred ---CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 153 ---QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 153 ---~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
..+|+||||+++ +|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 137 ~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 137 EEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 210 (464)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCC
T ss_pred ccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEe
Confidence 467999999976 5666654 359999999999999999999999999999999999999 5667799999999
Q ss_pred cccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC---------
Q 016233 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID--------- 299 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~--------- 299 (393)
++...........+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp C-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred eeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 998776666677899999999999876 5999999999999999999999999998877776665432111
Q ss_pred -------------CCCCCC----CC------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 300 -------------FESAPW----PT------------ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 300 -------------~~~~~~----~~------------~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+....+ +. .++++.+||.+||..||++|||++|+|+||||...
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 011000 00 15679999999999999999999999999999853
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-52 Score=386.75 Aligned_cols=260 Identities=29% Similarity=0.531 Sum_probs=216.2
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.++++++ ||||+++++++.+.+..++|
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCC-CCCccchhheeecCCeEEEE
Confidence 57999999999999999999999999999999986543 22334567889999999997 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-c
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-K 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~-~ 237 (393)
|||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++...... .
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC----
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCccc
Confidence 9999999999888877889999999999999999999999999999999999999 55678999999999876533 2
Q ss_pred ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC------------------
Q 016233 238 VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD------------------ 297 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~------------------ 297 (393)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 3455689999999999865 48999999999999999999999999888766655443210
Q ss_pred -CCCCCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 298 -IDFESA--------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 298 -~~~~~~--------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
...+.. .++.+++++.+||.+||..||++|||++|+|+||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 001110 1256889999999999999999999999999999998753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=380.43 Aligned_cols=262 Identities=31% Similarity=0.509 Sum_probs=232.7
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
...+|.+++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+. ||||+++++++.+.+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCEEE
Confidence 4568999999999999999999999999999999998765444556778899999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+||||+++++|.+++.....+++.+++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCceecccC
Confidence 999999999999999888899999999999999999999999999999999999999 55667999999999876532
Q ss_pred -cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 237 -KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 237 -~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+......++ ..+++.+.+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 244 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAAS 244 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHH
T ss_pred ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc----cccCHHHHH
Confidence 23445679999999999875 488999999999999999999999999888888888777665443 357899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCCCCCC
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~ 346 (393)
||.+||..||++|||++++++||||.......
T Consensus 245 li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 245 LIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 99999999999999999999999998765433
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-52 Score=392.57 Aligned_cols=262 Identities=26% Similarity=0.420 Sum_probs=221.3
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe-----
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED----- 151 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----- 151 (393)
...+|++++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++ ||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKASPY 92 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhcc-CCCcccHhheeecccccc
Confidence 34689999999999999999999999999999999876543 3334567889999999997 9999999999877
Q ss_pred ---CCeEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeec
Q 016233 152 ---KQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (393)
Q Consensus 152 ---~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DF 227 (393)
.+.+++||||+++ +|.+.+... ..+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Df 168 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADF 168 (351)
T ss_dssp ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCC
T ss_pred ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEccc
Confidence 4568999999975 777777653 579999999999999999999999999999999999999 55667999999
Q ss_pred CCcccccC-----CcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC
Q 016233 228 GLSVFIEE-----GKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF 300 (393)
Q Consensus 228 g~a~~~~~-----~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 300 (393)
|++..... ........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+......+
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99987642 223345689999999999865 48999999999999999999999999998887777766544444
Q ss_pred CCCCCCCC----------------------------CHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 301 ESAPWPTI----------------------------SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 301 ~~~~~~~~----------------------------s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
....|+.. ++++.+||.+||..||++|||++|+|+||||.....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 43333332 678999999999999999999999999999987544
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-52 Score=397.17 Aligned_cols=257 Identities=26% Similarity=0.452 Sum_probs=216.8
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccC-CCCeeEEeEEEEeCCeEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG-QPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~~~~~~~~~~~~~ 156 (393)
..+|++++.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.+|+.|.+ ||||+++++++...+.+|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 3569999999999999999999875 89999999976542 34456788999999999974 699999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+||| +.+++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||+. ++.+||+|||++..+...
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----SSCEEECCCSSSCCC---
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----CCeEEEEecCccccccCC
Confidence 9999 56889999999888899999999999999999999999999999999999993 356999999999876543
Q ss_pred c---ceecccCcccccchHHHhh------------cCCCcchHHHHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCCCC
Q 016233 237 K---VYRDIVGSAYYVAPEVLRR------------RYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDF 300 (393)
Q Consensus 237 ~---~~~~~~gt~~y~aPE~l~~------------~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~ 300 (393)
. .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+..+......+
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 287 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence 2 2345689999999999864 588899999999999999999999987543 34556666554443
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 301 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
..+ ...+.++.+||.+||..||++|||+.|+|+||||+...
T Consensus 288 ~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 288 EFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 333 23578999999999999999999999999999998643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-52 Score=380.47 Aligned_cols=258 Identities=32% Similarity=0.644 Sum_probs=229.1
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
.++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++ ||||+++++++.+.+..++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCCEEEE
Confidence 357999999999999999999999999999999997654323334678899999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECSSS-
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccCccc-
Confidence 99999999999999988899999999999999999999999999999999999999 45667999999999765443
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+......++ +.++.++.+||
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li 243 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDLI 243 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHH
T ss_pred ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHHHHHH
Confidence 2345679999999999876 489999999999999999999999999888888888877665543 35789999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 317 RRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 317 ~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
.+||..||++|||++++++||||+....
T Consensus 244 ~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 244 SKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp HHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred HHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 9999999999999999999999986543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-52 Score=386.16 Aligned_cols=257 Identities=24% Similarity=0.342 Sum_probs=212.8
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
+.+..+|++.++||+|+||+||+|.+..+|+.||||++..... ..........|+..+..+.+||||+++++++.+.+.
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~ 131 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence 4456789999999999999999999999999999998865432 233444556677776666569999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 155 VHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
+++||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTCEEC
T ss_pred EEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceeeeec
Confidence 99999999 679988887654 59999999999999999999999999999999999999 45667999999999887
Q ss_pred cCCcceecccCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 234 EEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
..........||+.|+|||++.+.++.++|||||||++|+|++|..||.+.. ....+..+.. +......+++++.
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~l~ 282 (311)
T 3p1a_A 208 GTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYL--PPEFTAGLSSELR 282 (311)
T ss_dssp C------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCC--CHHHHTTSCHHHH
T ss_pred ccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCC--CcccccCCCHHHH
Confidence 6665556678999999999998899999999999999999999987776543 2334444322 1122346899999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
+||.+||..||++|||++|+|+||||++
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 283 SVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 9999999999999999999999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-52 Score=394.80 Aligned_cols=264 Identities=23% Similarity=0.389 Sum_probs=221.9
Q ss_pred ccccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHcc----CCCCeeEE
Q 016233 70 LGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS----GQPNIVEF 145 (393)
Q Consensus 70 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv~~ 145 (393)
...+...+..+|++++.||+|+||.||+|.+..+++.||||++... ......+..|+.+++.+. +||||+++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 3445566778999999999999999999999999999999998632 334567788999999996 49999999
Q ss_pred eEEEEeCCeEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccC-------
Q 016233 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK------- 216 (393)
Q Consensus 146 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~------- 216 (393)
++++...+.+++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccccc
Confidence 99999999999999999 999999998754 49999999999999999999999999999999999999531
Q ss_pred ---------------CCCCcEEEeecCCcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCC
Q 016233 217 ---------------DENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPP 280 (393)
Q Consensus 217 ---------------~~~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~p 280 (393)
.....+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence 12567999999999865432 345689999999999875 599999999999999999999999
Q ss_pred CCCCChHHHHHHHHcCCCCCCCC---------------------CCC---------------------CCCHHHHHHHHH
Q 016233 281 FWAETEKGIFDAILQGDIDFESA---------------------PWP---------------------TISSSAKDLVRR 318 (393)
Q Consensus 281 f~~~~~~~~~~~i~~~~~~~~~~---------------------~~~---------------------~~s~~~~~li~~ 318 (393)
|...+..+.+..+......++.. .|+ ..++.+.+||.+
T Consensus 259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 338 (360)
T 3llt_A 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS 338 (360)
T ss_dssp CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence 99888777666654432221100 011 123678899999
Q ss_pred hcccCCCCCCCHHHHhcCcccc
Q 016233 319 MLTQDPKKRITSAQVLEHPWIK 340 (393)
Q Consensus 319 ~L~~dp~~Rpt~~e~l~h~~~~ 340 (393)
||+.||++|||++|+|+||||+
T Consensus 339 ~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 339 ILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HCCSSGGGSCCHHHHTTSGGGC
T ss_pred HhcCChhhCCCHHHHhcCcccC
Confidence 9999999999999999999995
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-52 Score=393.93 Aligned_cols=259 Identities=24% Similarity=0.423 Sum_probs=214.7
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC--
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-- 153 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-- 153 (393)
.+..+|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++ ||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~ 99 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETL 99 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSST
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCCcc
Confidence 45678999999999999999999999999999999986532 23344677889999999997 999999999997653
Q ss_pred ----eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 154 ----SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 154 ----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 100 DDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGL 174 (367)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred ccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEEeeec
Confidence 469999999 8899988765 579999999999999999999999999999999999999 5567799999999
Q ss_pred cccccCCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC-------
Q 016233 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF------- 300 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~------- 300 (393)
++..... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 175 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 175 ARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp CEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 9876532 456789999999998865 58999999999999999999999999988777666654311110
Q ss_pred ----------------C----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 301 ----------------E----SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 301 ----------------~----~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
. ...++.+++++.+||.+||..||++|||++++|+||||....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 0 112356799999999999999999999999999999998654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-53 Score=393.43 Aligned_cols=263 Identities=24% Similarity=0.377 Sum_probs=221.9
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC-
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ- 153 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 153 (393)
..+.++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.++++++ ||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETP 86 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEEEET
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeeccCC
Confidence 346679999999999999999999999999999999997655444445677899999999996 999999999987654
Q ss_pred ---eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 154 ---SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 154 ---~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
..|+||||++|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~a 163 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIA 163 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTSCEEECCCSCC
T ss_pred CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc---CCCCEEEeeccCc
Confidence 3499999999999999999888999999999999999999999999999999999999994 4567999999999
Q ss_pred ccccCCc----ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 016233 231 VFIEEGK----VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW 305 (393)
Q Consensus 231 ~~~~~~~----~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (393)
....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+...........+
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc
Confidence 8765432 2234579999999999876 5899999999999999999999999998888777777666555444445
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
..+++++.+||.+||+.||++||++.++|.|+|+..
T Consensus 244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 678999999999999999999999999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-52 Score=379.36 Aligned_cols=258 Identities=39% Similarity=0.629 Sum_probs=220.6
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
...+|++++.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++ ||||+++++++.+.+..+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 87 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTPTDFF 87 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCeEE
Confidence 4568999999999999999999999999999999997654333345678899999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGCCCC-
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecccccccCCC
Confidence 999999999999999988899999999999999999999999999999999999999 55667999999999887665
Q ss_pred cceecccCcccccchHHHhhc-C-CCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 237 KVYRDIVGSAYYVAPEVLRRR-Y-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~~-~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
.......||+.|+|||++.+. + +.++||||||+++|+|++|..||...........+..+...++ ..++..+.+
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~ 240 (276)
T 2h6d_A 165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRSVAT 240 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCHHHHH
Confidence 555567899999999998764 3 5799999999999999999999999888888888877655443 357899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+|.+||..||++|||++++++||||++.
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHccCChhhCCCHHHHHhChhhccC
Confidence 9999999999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=409.27 Aligned_cols=256 Identities=28% Similarity=0.512 Sum_probs=225.2
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
.++|.+.+.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.++++++ ||||+++++++.+.+.+|+
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCCEEEE
Confidence 468999999999999999999999999999999997654433345678899999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 158 VMELCAGGELFDRIIAK----GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecceeeec
Confidence 99999999999998764 369999999999999999999999999999999999999 56678999999999887
Q ss_pred cCCcc-eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCC----hHHHHHHHHcCCCCCCCCCCCC
Q 016233 234 EEGKV-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET----EKGIFDAILQGDIDFESAPWPT 307 (393)
Q Consensus 234 ~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~ 307 (393)
..... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.. ..++...+......++ ..
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----~~ 415 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DK 415 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----TT
T ss_pred cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----cc
Confidence 65433 344689999999999876 58999999999999999999999998753 4566777777665544 46
Q ss_pred CCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccccC
Q 016233 308 ISSSAKDLVRRMLTQDPKKRIT-----SAQVLEHPWIKE 341 (393)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rpt-----~~e~l~h~~~~~ 341 (393)
+++++.+||.+||..||++||+ ++++++||||+.
T Consensus 416 ~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 8999999999999999999996 589999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=398.79 Aligned_cols=262 Identities=29% Similarity=0.454 Sum_probs=210.6
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC---
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--- 152 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 152 (393)
.+.++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|+.++ ||||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCCCC
Confidence 45678999999999999999999999999999999996532 23445678899999999996 99999999999776
Q ss_pred --CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 153 --QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 153 --~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
+.+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 101 ~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DFGla 176 (432)
T 3n9x_A 101 KFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLA 176 (432)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred cCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccCCCc
Confidence 57999999995 5999999888889999999999999999999999999999999999999 56677999999999
Q ss_pred ccccCCc-----------------------ceecccCcccccchHHHh--hcCCCcchHHHHHHHHHHHhhC--------
Q 016233 231 VFIEEGK-----------------------VYRDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSG-------- 277 (393)
Q Consensus 231 ~~~~~~~-----------------------~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg-------- 277 (393)
+...... .....+||++|+|||++. ..++.++|||||||++|+|++|
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~ 256 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence 8765432 235678999999999863 3599999999999999999984
Q ss_pred ---CCCCCCCCh-----------------HHHHHHHH------------------------cCCCCCCC---CCCCCCCH
Q 016233 278 ---VPPFWAETE-----------------KGIFDAIL------------------------QGDIDFES---APWPTISS 310 (393)
Q Consensus 278 ---~~pf~~~~~-----------------~~~~~~i~------------------------~~~~~~~~---~~~~~~s~ 310 (393)
.++|.+.+. .+.+..+. ........ ..++.+++
T Consensus 257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 336 (432)
T 3n9x_A 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD 336 (432)
T ss_dssp GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence 444444321 11111111 11100000 11356899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
++.+||.+||..||++|||++|+|+||||+...
T Consensus 337 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 337 DGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 999999999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=382.00 Aligned_cols=256 Identities=29% Similarity=0.562 Sum_probs=223.1
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
..|+..+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++.++ ||||+++++++...+..++|
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVL 120 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEE
Confidence 45888889999999999999999999999999997543 345678899999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc-
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~- 237 (393)
|||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 121 ~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 121 MEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp ECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC
T ss_pred EecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCcc
Confidence 999999999987754 579999999999999999999999999999999999999 556679999999998765432
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+....+....... ......+++.+.+||
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li 275 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-LKNSHKVSPVLRDFL 275 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-CTTGGGSCHHHHHHH
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-cCccccCCHHHHHHH
Confidence 3345689999999999875 48999999999999999999999999988877777776653321 122345789999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 317 RRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 317 ~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
.+||..||++|||++++|+||||.+..
T Consensus 276 ~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 276 ERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HHHccCChhhCcCHHHHhcChhhccCC
Confidence 999999999999999999999998643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-52 Score=391.10 Aligned_cols=253 Identities=30% Similarity=0.537 Sum_probs=219.2
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCc-----ccHHHHHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK-----NDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
.+..+|++.+.||+|+||.||+|.+..+++.||||++........ .....+.+|+.++++++ ||||+++++++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~ 99 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIFE 99 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence 456789999999999999999999999999999999987643221 13446778999999996 999999999999
Q ss_pred eCCeEEEEEeccCCC-ChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 151 DKQSVHVVMELCAGG-ELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 151 ~~~~~~lv~e~~~gg-~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
+.+.+++||||+.+| +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGS 176 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTT
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEeeccc
Confidence 999999999999766 999999888889999999999999999999999999999999999999 5567799999999
Q ss_pred cccccCCcceecccCcccccchHHHhhc-C-CCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 016233 230 SVFIEEGKVYRDIVGSAYYVAPEVLRRR-Y-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (393)
+............+||+.|+|||++.+. + +.++|||||||++|+|++|..||..... ...... .....
T Consensus 177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~----~~~~~ 246 (335)
T 3dls_A 177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAI----HPPYL 246 (335)
T ss_dssp CEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCC----CCSSC
T ss_pred ceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhcc----CCCcc
Confidence 9988776666678899999999998754 3 7889999999999999999999975322 111111 12235
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+++++.+||.+||..||++|||++++|+||||+..
T Consensus 247 ~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 79999999999999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=387.94 Aligned_cols=257 Identities=27% Similarity=0.463 Sum_probs=222.3
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
....+|++.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.++++++ ||||+++++++.+.+..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 129 (348)
T 1u5q_A 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTA 129 (348)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCeE
Confidence 34567999999999999999999999999999999997654333344567899999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
++||||+. |+|.+.+.. ...+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 130 ~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 130 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSS
T ss_pred EEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEeeccCceecC
Confidence 99999997 578887754 5679999999999999999999999999999999999999 456789999999998765
Q ss_pred CCcceecccCcccccchHHHh----hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 016233 235 EGKVYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
.. ....||+.|+|||++. +.++.++|||||||++|+|++|..||.+.+....+..+..+.... .....+++
T Consensus 206 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 280 (348)
T 1u5q_A 206 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--LQSGHWSE 280 (348)
T ss_dssp SB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--CCCTTSCH
T ss_pred CC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--CCCCCCCH
Confidence 32 3568999999999984 358999999999999999999999999888777776666654322 22246789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.+.+||.+||..||++|||++++|+||||...
T Consensus 281 ~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 99999999999999999999999999999764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=384.40 Aligned_cols=254 Identities=27% Similarity=0.495 Sum_probs=213.8
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe--CCeE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--KQSV 155 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~ 155 (393)
.++|++++.||+|+||.||+|.+..+++.||||++.. .....+.+|+.+++++.+||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS------CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc------cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 4689999999999999999999999999999999853 2457889999999999779999999999988 6779
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
++||||+.+++|.+++. .+++.+++.++.||+.||.|||++||+||||||+|||++. +...+||+|||++.....
T Consensus 109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCCTTCEECCT
T ss_pred EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC--CCCEEEEEeCCCceEcCC
Confidence 99999999999988764 4899999999999999999999999999999999999953 233799999999998776
Q ss_pred CcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCC-hHHHHHH-------------HHcCCCC
Q 016233 236 GKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAET-EKGIFDA-------------ILQGDID 299 (393)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~-~~~~~~~-------------i~~~~~~ 299 (393)
........||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ..+.+.. +......
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 666667789999999999865 48999999999999999999999996443 2222221 1111111
Q ss_pred C--------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 300 F--------------------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 300 ~--------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
. .......+++++.+||.+||..||++|||++|+|+||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 1 111122378999999999999999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=378.31 Aligned_cols=257 Identities=30% Similarity=0.556 Sum_probs=199.1
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
-.+|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++ ||||+++++++.+.+..++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCeEEE
Confidence 357999999999999999999999999999999997554323334678899999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 158 VMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEECC--
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeeccCC
Confidence 99999999999998865 569999999999999999999999999999999999999 55667999999999876532
Q ss_pred -cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 237 -KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 237 -~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+.+..+....... ...++.++.+
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 241 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM----PSFLSIEAKD 241 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCC----CTTSCHHHHH
T ss_pred CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCC----ccccCHHHHH
Confidence 22335679999999998865 58899999999999999999999998776655554443333222 2357899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
||.+||..||++|||++++|+||||...
T Consensus 242 li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 242 LIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 9999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=378.02 Aligned_cols=262 Identities=26% Similarity=0.395 Sum_probs=220.9
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
..+..+|++++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEEDDC 85 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEECSSE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeeeeCCe
Confidence 345679999999999999999999999999999999997655444455678999999999996 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSSSTTC-
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCCccccc
Confidence 99999999999999999988899999999999999999999999999999999999999 556679999999998765
Q ss_pred CCc--ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC-CCCCCCCCCH
Q 016233 235 EGK--VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF-ESAPWPTISS 310 (393)
Q Consensus 235 ~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~s~ 310 (393)
... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+............... .....+.+++
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence 432 2334679999999999876 48899999999999999999999999888776655555543322 1223457899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 340 (393)
.+.++|.+||..||.+||+..+.+.+.|..
T Consensus 243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 243 SLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 999999999999999999777777777654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=375.64 Aligned_cols=257 Identities=23% Similarity=0.439 Sum_probs=219.8
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe----CC
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED----KQ 153 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----~~ 153 (393)
...|++.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++ ||||+++++++.. ..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccCCCc
Confidence 4469999999999999999999999999999999976543 3445678899999999996 9999999999875 45
Q ss_pred eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--cEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~--ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
.+++||||+++++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ +.++.+||+|||++.
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCcc
Confidence 68999999999999999998889999999999999999999999999 99999999999995 245679999999997
Q ss_pred cccCCcceecccCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHcCCCCCCCCCCCCCCH
Q 016233 232 FIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
..... ......||+.|+|||++.+.++.++|||||||++|+|++|..||...... .....+..+... .......++
T Consensus 181 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 257 (290)
T 1t4h_A 181 LKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIP 257 (290)
T ss_dssp GCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGCCCH
T ss_pred ccccc-ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc--cccCCCCCH
Confidence 65443 33456799999999999888999999999999999999999999875544 444444443222 112235678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
++.+||.+||..||++|||++++|+||||++
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 9999999999999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=386.55 Aligned_cols=260 Identities=27% Similarity=0.464 Sum_probs=216.4
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
.-++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++ ||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecCCEEE
Confidence 3458999999999999999999999999999999986543 23334566889999999997 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceeecCC
Confidence 999999999998887777789999999999999999999999999999999999999 55668999999999876543
Q ss_pred -cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC----------------
Q 016233 237 -KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD---------------- 297 (393)
Q Consensus 237 -~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~---------------- 297 (393)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 33455689999999999875 48999999999999999999999999888766555443210
Q ss_pred ---CCCCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 298 ---IDFES--------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 298 ---~~~~~--------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
...+. ..++.+++++.+||.+||..||++|||++|+|+||||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 00000 012467899999999999999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=388.44 Aligned_cols=262 Identities=27% Similarity=0.396 Sum_probs=214.2
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCC--cccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT--KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
...+|++++.||+|+||.||+|.+..+|+.||||++....... ......+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSN 86 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEeeCCc
Confidence 4568999999999999999999999999999999987543211 112346789999999996 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
.++||||+++ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccceec
Confidence 9999999976 888877654 358999999999999999999999999999999999999 55667999999999876
Q ss_pred cCC-cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCC------
Q 016233 234 EEG-KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP------ 304 (393)
Q Consensus 234 ~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~------ 304 (393)
... ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+...........
T Consensus 163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 543 33455789999999999864 388999999999999999999999999888777776654221111111
Q ss_pred ------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 305 ------------------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 305 ------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
+..+++++.+||.+||..||++|||++|+|+||||....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 145678999999999999999999999999999998654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=372.03 Aligned_cols=256 Identities=21% Similarity=0.345 Sum_probs=215.4
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
+..+|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.++..+.+||||+++++++.+.+.++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 45689999999999999999999999999999999976532 23456778899999999955999999999999999999
Q ss_pred EEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCC---------------
Q 016233 157 VVMELCAGGELFDRIIAK----GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD--------------- 217 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~--------------- 217 (393)
+||||++|++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999999999764 6799999999999999999999999999999999999996443
Q ss_pred -CCCcEEEeecCCcccccCCcceecccCcccccchHHHhhc--CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH
Q 016233 218 -ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL 294 (393)
Q Consensus 218 -~~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 294 (393)
....+||+|||++....... ...||+.|+|||++.+. ++.++|||||||++|+|++|.+++.... ....+.
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~ 241 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIR 241 (289)
T ss_dssp --CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHH
T ss_pred CCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHH
Confidence 45579999999998765432 34699999999998764 5579999999999999999998875443 344555
Q ss_pred cCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 295 QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 295 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.+.... ....+++++.+||.+||..||++|||+.++|+||||...
T Consensus 242 ~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 242 QGRLPR---IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp TTCCCC---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred cCCCCC---CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 544322 224689999999999999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-51 Score=393.79 Aligned_cols=255 Identities=28% Similarity=0.455 Sum_probs=211.0
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC----
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK---- 152 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---- 152 (393)
...+|++.+.||+|+||.||+|.+..+|+.||||++.... ....+|+++|+.++ ||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCC-CTTBCCEEEEEEEEETTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcC-CCCccceeeEEeccCCCC
Confidence 4558999999999999999999999999999999986532 12347999999996 99999999988432
Q ss_pred --CeEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEee
Q 016233 153 --QSVHVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (393)
Q Consensus 153 --~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~D 226 (393)
.++++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++. +...+||+|
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~--~~~~~kl~D 200 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCD 200 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET--TTTEEEECC
T ss_pred cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC--CCCeEEecc
Confidence 247799999975 66655542 467999999999999999999999999999999999999953 345689999
Q ss_pred cCCcccccCCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC--------
Q 016233 227 FGLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG-------- 296 (393)
Q Consensus 227 Fg~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~-------- 296 (393)
||+++...........+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 201 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 201 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred chhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999998766555567789999999999864 5899999999999999999999999998876666555431
Q ss_pred ---------CCCCCC---CC-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 297 ---------DIDFES---AP-----WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 297 ---------~~~~~~---~~-----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.+.++. .. .+.+++++.+||.+||..||++|||+.|+|+||||...
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 111111 01 13568999999999999999999999999999999754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=390.35 Aligned_cols=258 Identities=26% Similarity=0.417 Sum_probs=206.6
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC--
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-- 153 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-- 153 (393)
.+..+|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++ ||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCCST
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcC-CCCccceEEeecccccc
Confidence 34578999999999999999999999999999999997543 23345677889999999996 999999999997665
Q ss_pred ----eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 154 ----SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 154 ----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
.+|+||||+++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 100 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 100 EEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 173 (371)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC
T ss_pred ccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEeec
Confidence 78999999965 7888775 469999999999999999999999999999999999999 5566799999999
Q ss_pred cccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC------
Q 016233 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES------ 302 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~------ 302 (393)
+............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 174 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 987765555566789999999999876 5899999999999999999999999998887777776653221100
Q ss_pred -----------CCC--------------C-------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 303 -----------APW--------------P-------TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 303 -----------~~~--------------~-------~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
..+ + ..+.++.+||.+||..||++|||++|+|+||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 000 0 01567999999999999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-51 Score=394.85 Aligned_cols=263 Identities=28% Similarity=0.439 Sum_probs=217.3
Q ss_pred ccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHcc-----CCCCeeEEe
Q 016233 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS-----GQPNIVEFK 146 (393)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~~~ 146 (393)
.+.+.+..+|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++ +|+||++++
T Consensus 90 ~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 90 VPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp CTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred cCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 34456677999999999999999999999999999999998642 234567888999999884 477999999
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEE
Q 016233 147 GAYEDKQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKA 224 (393)
Q Consensus 147 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl 224 (393)
+++...+.+++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||
T Consensus 166 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~-~~~vkL 243 (429)
T 3kvw_A 166 ENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG-RSGIKV 243 (429)
T ss_dssp EEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTT-SCCEEE
T ss_pred eecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCC-CcceEE
Confidence 99999999999999995 69999888754 499999999999999999999999999999999999995322 123999
Q ss_pred eecCCcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC--
Q 016233 225 TDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE-- 301 (393)
Q Consensus 225 ~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~-- 301 (393)
+|||++..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+.......+
T Consensus 244 ~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~ 321 (429)
T 3kvw_A 244 IDFGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK 321 (429)
T ss_dssp CCCTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred eecccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 99999976543 2345789999999999876 599999999999999999999999999888776665543100000
Q ss_pred ------------------------------------------------CCC-----CCCCCHHHHHHHHHhcccCCCCCC
Q 016233 302 ------------------------------------------------SAP-----WPTISSSAKDLVRRMLTQDPKKRI 328 (393)
Q Consensus 302 ------------------------------------------------~~~-----~~~~s~~~~~li~~~L~~dp~~Rp 328 (393)
... ....++++.+||.+||..||++||
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp 401 (429)
T 3kvw_A 322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401 (429)
T ss_dssp HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence 000 012478899999999999999999
Q ss_pred CHHHHhcCccccCC
Q 016233 329 TSAQVLEHPWIKEG 342 (393)
Q Consensus 329 t~~e~l~h~~~~~~ 342 (393)
|++|+|+||||+..
T Consensus 402 ta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 402 TPGQALRHPWLRRR 415 (429)
T ss_dssp CHHHHHTSTTTC--
T ss_pred CHHHHhCChhhccC
Confidence 99999999999875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=371.83 Aligned_cols=276 Identities=25% Similarity=0.457 Sum_probs=233.5
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
....|++++.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.+. ||||+++++++.+.+.++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 96 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLW 96 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEE
Confidence 45679999999999999999999999999999999976542 345788999999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 97 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp EEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECBTT
T ss_pred EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceecCcc
Confidence 99999999999998754 579999999999999999999999999999999999999 55667999999999876544
Q ss_pred c-ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 237 K-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 237 ~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
. ......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+...... .....++..+.+
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~ 249 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPLKE 249 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---CCCSSCCHHHHH
T ss_pred ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC---CCccccCHHHHH
Confidence 3 2345679999999999875 5889999999999999999999999988877777666655432 223468899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCCCCCCCCcCCHHHHHHHHHHHHh
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAM 364 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (393)
||.+||..||++|||+.++++||||....... ......+.+++++...
T Consensus 250 li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 297 (303)
T 3a7i_A 250 FVEACLNKEPSFRPTAKELLKHKFILRNAKKT--SYLTELIDRYKRWKAE 297 (303)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTCHHHHHHCCCG--GGGHHHHHHHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHhhChhhhcCCCcc--HHHHHHHHHHHHhhhh
Confidence 99999999999999999999999997643322 2234555555555443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=381.47 Aligned_cols=259 Identities=25% Similarity=0.438 Sum_probs=212.7
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCC-CCeeEEeEEEEeCCe
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ-PNIVEFKGAYEDKQS 154 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~~~~~~ 154 (393)
....+|++++.||+|+||.||+|.+. +++.||||++..... .......+.+|+.+|+.+.+| |||+++++++.+++.
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 34568999999999999999999985 589999999976542 334557889999999999732 999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+++||| +.+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC-
T ss_pred EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeecccccccC
Confidence 999999 45889999999988999999999999999999999999999999999999994 3569999999998765
Q ss_pred CCc---ceecccCcccccchHHHh------------hcCCCcchHHHHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCC
Q 016233 235 EGK---VYRDIVGSAYYVAPEVLR------------RRYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDI 298 (393)
Q Consensus 235 ~~~---~~~~~~gt~~y~aPE~l~------------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~ 298 (393)
... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||..... ...+..+.....
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence 432 223568999999999985 3478899999999999999999999987543 334444444333
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 299 DFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 299 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
.... ....+.++.+||.+||..||++|||+.|+|+||||+...
T Consensus 239 ~~~~--~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 239 EIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp CCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred ccCC--cccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 2222 234678999999999999999999999999999998643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=390.67 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=212.5
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe----
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED---- 151 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~---- 151 (393)
....+|++++.||+|+||.||+|.+..+|+.||||++..... ...+|+.+++.++ ||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLD-HVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCC-CTTBCCEEEEEEEC---
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcC-CCCccchhheeeecCcc
Confidence 345689999999999999999999999999999999865421 2237999999996 9999999999843
Q ss_pred ----------------------------------CCeEEEEEeccCCCChHHHHH----HcCCCCHHHHHHHHHHHHHHH
Q 016233 152 ----------------------------------KQSVHVVMELCAGGELFDRII----AKGHYSERAAASICRSIVNVV 193 (393)
Q Consensus 152 ----------------------------------~~~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~i~~qll~~l 193 (393)
...+++||||++| +|.+.+. ....+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 3458999999974 7766664 346799999999999999999
Q ss_pred HHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcceecccCcccccchHHHhh--cCCCcchHHHHHHHH
Q 016233 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVIL 271 (393)
Q Consensus 194 ~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il 271 (393)
.|||++||+||||||+|||++. .++.+||+|||++.............||+.|+|||++.+ .++.++|||||||++
T Consensus 155 ~~LH~~gi~H~Dikp~Nil~~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 155 GFIHSLGICHRDIKPQNLLVNS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHHTTTEECSCCCGGGEEEET--TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHHCcCccCccCHHHEEEcC--CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9999999999999999999952 456799999999998776666667789999999998865 489999999999999
Q ss_pred HHHhhCCCCCCCCChHHHHHHHHcC-----------------CCCCCC---C-----CCCCCCHHHHHHHHHhcccCCCC
Q 016233 272 YILLSGVPPFWAETEKGIFDAILQG-----------------DIDFES---A-----PWPTISSSAKDLVRRMLTQDPKK 326 (393)
Q Consensus 272 ~~lltg~~pf~~~~~~~~~~~i~~~-----------------~~~~~~---~-----~~~~~s~~~~~li~~~L~~dp~~ 326 (393)
|+|++|..||.+.+..+.+..+... ...++. . ....+++++.+||.+||..||++
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999998887776665431 111111 0 11347889999999999999999
Q ss_pred CCCHHHHhcCccccCC
Q 016233 327 RITSAQVLEHPWIKEG 342 (393)
Q Consensus 327 Rpt~~e~l~h~~~~~~ 342 (393)
|||+.|+|+||||+..
T Consensus 313 R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 313 RINPYEAMAHPFFDHL 328 (383)
T ss_dssp SCCHHHHHTSGGGHHH
T ss_pred CCCHHHHhcCHHHHHH
Confidence 9999999999999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=389.82 Aligned_cols=258 Identities=31% Similarity=0.567 Sum_probs=218.4
Q ss_pred ccceeecceecccCCeEEEEEEEC---CCCcEEEEEEeecCccC-CcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTEN---STGRQFACKSISKRKLV-TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
..+|++.+.||+|+||.||+|.+. .+++.||||++...... .....+.+.+|+.+++.+.+||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 368999999999999999999984 58999999998654321 12334567789999999977999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
.+++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEEC
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCeec
Confidence 999999999999999999988899999999999999999999999999999999999999 56678999999999865
Q ss_pred cCC--cceecccCcccccchHHHhh---cCCCcchHHHHHHHHHHHhhCCCCCCCCC----hHHHHHHHHcCCCCCCCCC
Q 016233 234 EEG--KVYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAET----EKGIFDAILQGDIDFESAP 304 (393)
Q Consensus 234 ~~~--~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~----~~~~~~~i~~~~~~~~~~~ 304 (393)
... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ...+...+......++
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 286 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--- 286 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC---
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC---
Confidence 432 22345689999999999874 37899999999999999999999997543 3344555555443332
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccCC
Q 016233 305 WPTISSSAKDLVRRMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (393)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rp-----t~~e~l~h~~~~~~ 342 (393)
..++..+.+||.+||..||++|| |++++++||||...
T Consensus 287 -~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 287 -QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred -cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 46889999999999999999999 99999999999853
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=376.17 Aligned_cols=260 Identities=27% Similarity=0.470 Sum_probs=217.0
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe--
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED-- 151 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-- 151 (393)
......+|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++++.+||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3445678999999999999999999999999999999987532 3457889999999999669999999999977
Q ss_pred ----CCeEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEe
Q 016233 152 ----KQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225 (393)
Q Consensus 152 ----~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~ 225 (393)
.+.+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~ 171 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLV 171 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEEC
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEEe
Confidence 56899999999999999999764 469999999999999999999999999999999999999 556679999
Q ss_pred ecCCcccccCCc-ceecccCcccccchHHHh------hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC
Q 016233 226 DFGLSVFIEEGK-VYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI 298 (393)
Q Consensus 226 DFg~a~~~~~~~-~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~ 298 (393)
|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.........+.....
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 251 (326)
T 2x7f_A 172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 251 (326)
T ss_dssp CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc
Confidence 999998765432 234567999999999985 3488999999999999999999999988887766666655433
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 299 DFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 299 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
. ......++..+.+||.+||..||.+|||++++++||||...
T Consensus 252 ~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 252 P--RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp C--CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred c--cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 2 22235678999999999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-51 Score=380.86 Aligned_cols=260 Identities=22% Similarity=0.390 Sum_probs=216.6
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC--
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-- 153 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-- 153 (393)
....+|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|++++++++ ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTR 82 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCcceEEEEeecCCCc
Confidence 456789999999999999999999999999999999975432 334677889999999997 999999999998765
Q ss_pred eEEEEEeccCCCChHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEec-cCCCCCcEEEeecCC
Q 016233 154 SVHVVMELCAGGELFDRIIAKGH---YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLS-SKDENALLKATDFGL 229 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~-~~~~~~~~kl~DFg~ 229 (393)
..++||||++|++|.+++..... +++.+++.++.||+.||.|||++||+||||||+|||+. .++....+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 78999999999999999976433 99999999999999999999999999999999999983 234556799999999
Q ss_pred cccccCCcceecccCcccccchHHHh---------hcCCCcchHHHHHHHHHHHhhCCCCCCCCC----hHHHHHHHHcC
Q 016233 230 SVFIEEGKVYRDIVGSAYYVAPEVLR---------RRYGKEIDIWSAGVILYILLSGVPPFWAET----EKGIFDAILQG 296 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~~~DiwSlG~il~~lltg~~pf~~~~----~~~~~~~i~~~ 296 (393)
+.............||+.|+|||++. ..++.++|||||||++|+|++|..||.... ..+.+..+..+
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 99887766666778999999999985 358899999999999999999999996432 23455555543
Q ss_pred CCCC-------------------C--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 016233 297 DIDF-------------------E--SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338 (393)
Q Consensus 297 ~~~~-------------------~--~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~ 338 (393)
.... + ......++..+.+||.+||+.||++|||++|+|+||-
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 3210 0 0111234567899999999999999999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=383.71 Aligned_cols=253 Identities=24% Similarity=0.429 Sum_probs=207.5
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC----
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ---- 153 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~---- 153 (393)
..+|++++.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.++++++ ||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSCHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccchh
Confidence 458999999999999999999999999999999997543 3445678999999999996 999999999986543
Q ss_pred -----------------------------------------------------eEEEEEeccCCCChHHHHHHcCC---C
Q 016233 154 -----------------------------------------------------SVHVVMELCAGGELFDRIIAKGH---Y 177 (393)
Q Consensus 154 -----------------------------------------------------~~~lv~e~~~gg~L~~~l~~~~~---~ 177 (393)
.+++|||||+|++|.+++..... .
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 38999999999999999987543 5
Q ss_pred CHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc-------------ceecccC
Q 016233 178 SERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-------------VYRDIVG 244 (393)
Q Consensus 178 ~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-------------~~~~~~g 244 (393)
.+..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....... ......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 566789999999999999999999999999999999 556679999999998775432 2234579
Q ss_pred cccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccC
Q 016233 245 SAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQD 323 (393)
Q Consensus 245 t~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 323 (393)
|+.|+|||++.+ .++.++|||||||++|+|++|..|+.. .......+...... ..+...++++.+||.+||..|
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~ 313 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFP---LLFTQKYPQEHMMVQDMLSPS 313 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCC---HHHHHHCHHHHHHHHHHHCSS
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCC---cccccCChhHHHHHHHHccCC
Confidence 999999999875 589999999999999999999777521 12233333333221 112345788999999999999
Q ss_pred CCCCCCHHHHhcCccccC
Q 016233 324 PKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 324 p~~Rpt~~e~l~h~~~~~ 341 (393)
|++|||++|+|+||||++
T Consensus 314 p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 314 PTERPEATDIIENAIFEN 331 (332)
T ss_dssp GGGSCCHHHHHHSTTCCC
T ss_pred CCcCCCHHHHhhchhhhc
Confidence 999999999999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=390.95 Aligned_cols=261 Identities=26% Similarity=0.421 Sum_probs=202.8
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC--
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK-- 152 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 152 (393)
..+..+|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++ ||||+++++++...
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARS 102 (367)
T ss_dssp EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSS
T ss_pred cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCCc
Confidence 345679999999999999999999999999999999986532 23345677889999999997 99999999998654
Q ss_pred ----CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecC
Q 016233 153 ----QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (393)
Q Consensus 153 ----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg 228 (393)
..+|+|+|++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 103 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~DFG 177 (367)
T 2fst_X 103 LEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFG 177 (367)
T ss_dssp GGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC--
T ss_pred cccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEeecc
Confidence 5689999999 7899887765 579999999999999999999999999999999999999 556779999999
Q ss_pred CcccccCCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC--------
Q 016233 229 LSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI-------- 298 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~-------- 298 (393)
+++..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 178 ~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 178 LARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred cccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99875432 345689999999999865 589999999999999999999999999887776665543111
Q ss_pred ---------------CCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 299 ---------------DFESA----PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 299 ---------------~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
..+.. .++.+++++.+||.+||..||++|||++++|+||||.....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 00111 12457899999999999999999999999999999987543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=370.66 Aligned_cols=258 Identities=30% Similarity=0.551 Sum_probs=220.9
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
+.++|++++.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++ ||||+++++++.+.+..+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCCEEE
Confidence 34689999999999999999999999999999999975442 345678899999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCccccCCC
Confidence 999999999999988777789999999999999999999999999999999999999 45667999999999876433
Q ss_pred c---ceecccCcccccchHHHhhc--CCCcchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHcCCCCCCCCCCCCCCH
Q 016233 237 K---VYRDIVGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 237 ~---~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
. ......||+.|+|||++.+. ++.++||||||+++|+|++|..||...... ..+..+...... ...+..+++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNPWKKIDS 236 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--STTGGGSCH
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--cCchhhcCH
Confidence 2 23456799999999998653 477899999999999999999999876543 333444443222 223457899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.+.+||.+||..||++|||++++++||||+..
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 237 APLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 99999999999999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=398.24 Aligned_cols=253 Identities=17% Similarity=0.198 Sum_probs=206.5
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHcc--CCCCeeEEe-----
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--GQPNIVEFK----- 146 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~----- 146 (393)
+.....+|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+. +|||||+++
T Consensus 68 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~ 147 (377)
T 3byv_A 68 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147 (377)
T ss_dssp SSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred cCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence 3444678999999999999999999999999999999998665445556788999995555443 499999998
Q ss_pred --EEEEeCCe-----------------EEEEEeccCCCChHHHHHHcCCCCH-------HHHHHHHHHHHHHHHHHHHcC
Q 016233 147 --GAYEDKQS-----------------VHVVMELCAGGELFDRIIAKGHYSE-------RAAASICRSIVNVVHICHFMG 200 (393)
Q Consensus 147 --~~~~~~~~-----------------~~lv~e~~~gg~L~~~l~~~~~~~~-------~~~~~i~~qll~~l~~lH~~~ 200 (393)
+++++.+. .|+||||+ +|+|.+++...+.+++ ..++.++.||+.||.|||++|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 226 (377)
T 3byv_A 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 226 (377)
T ss_dssp CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 77776643 89999999 6799999987655665 778889999999999999999
Q ss_pred cEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcceecccCcccccchHHHhh------------cCCCcchHHHHH
Q 016233 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR------------RYGKEIDIWSAG 268 (393)
Q Consensus 201 ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~------------~~~~~~DiwSlG 268 (393)
|+||||||+|||+ +.++.+||+|||+++.... .....+| +.|+|||++.+ .++.++||||||
T Consensus 227 ivHrDikp~NIll---~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 227 LVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp EECSCCCGGGEEE---CTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred eecCCCCHHHEEE---cCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 9999999999999 4556799999999986433 4456678 99999999864 489999999999
Q ss_pred HHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 269 VILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 269 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
|++|+|++|..||.+.+.......+. ..+..+++++.+||.+||..||++|||+.++|+||||+.
T Consensus 301 ~il~elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHHHSSCCC------CCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHHHCCCCCcccccccchhhhh--------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 99999999999997665433222222 123578999999999999999999999999999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=384.77 Aligned_cols=260 Identities=30% Similarity=0.437 Sum_probs=217.6
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC---
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--- 152 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 152 (393)
.+..+|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|++++++++ ||||+++++++...
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIE 100 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTT
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCCcc
Confidence 34568999999999999999999999999999999986432 3334577889999999996 99999999999765
Q ss_pred --CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 153 --QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 153 --~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
...|+||||+. |+|.+++.. ..+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 101 ~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 101 QMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA 175 (364)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred ccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeCcce
Confidence 46899999996 589888765 579999999999999999999999999999999999999 55667999999999
Q ss_pred ccccCCcc----eecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC----
Q 016233 231 VFIEEGKV----YRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF---- 300 (393)
Q Consensus 231 ~~~~~~~~----~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~---- 300 (393)
........ ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 87654322 245689999999998753 38999999999999999999999999887766665554211000
Q ss_pred -------------------CCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 301 -------------------ESA----PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 301 -------------------~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
... .++.+++++.+||.+||..||++|||++|+|+||||++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 000 1246789999999999999999999999999999998753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=393.70 Aligned_cols=262 Identities=28% Similarity=0.471 Sum_probs=198.7
Q ss_pred cccccceee-cceecccCCeEEEEEEEC--CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe
Q 016233 75 EDVKLHYSF-GKELGRGQFGVTYLCTEN--STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (393)
Q Consensus 75 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 151 (393)
..+.+.|.+ +++||+|+||.||+|.++ .+++.||||++.... ....+.+|+.+|+.|+ ||||+++++++..
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 89 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-----ISMSACREIALLRELK-HPNVISLQKVFLS 89 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-----CCHHHHHHHHHHHHCC-CTTBCCCCEEEEE
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-----CCHHHHHHHHHHHhcC-CCCeeeEeeEEec
Confidence 345667887 558999999999999976 578999999986432 3457889999999997 9999999999954
Q ss_pred --CCeEEEEEeccCCCChHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccC-CCC
Q 016233 152 --KQSVHVVMELCAGGELFDRIIAK---------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK-DEN 219 (393)
Q Consensus 152 --~~~~~lv~e~~~gg~L~~~l~~~---------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~-~~~ 219 (393)
...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..+ +..
T Consensus 90 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 90 HADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp TTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred CCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence 678999999996 5888877532 149999999999999999999999999999999999999644 456
Q ss_pred CcEEEeecCCcccccCC----cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChH------
Q 016233 220 ALLKATDFGLSVFIEEG----KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEK------ 287 (393)
Q Consensus 220 ~~~kl~DFg~a~~~~~~----~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~------ 287 (393)
+.+||+|||++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+....
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 78999999999876543 23345689999999999875 3899999999999999999999999765542
Q ss_pred ---HHHHHHHcCCCCCCCCCCC----------------------------------CCCHHHHHHHHHhcccCCCCCCCH
Q 016233 288 ---GIFDAILQGDIDFESAPWP----------------------------------TISSSAKDLVRRMLTQDPKKRITS 330 (393)
Q Consensus 288 ---~~~~~i~~~~~~~~~~~~~----------------------------------~~s~~~~~li~~~L~~dp~~Rpt~ 330 (393)
+.+..+...........|. ..++.+.+||.+||..||.+|||+
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 3333333221111122221 127789999999999999999999
Q ss_pred HHHhcCccccCCC
Q 016233 331 AQVLEHPWIKEGG 343 (393)
Q Consensus 331 ~e~l~h~~~~~~~ 343 (393)
+|+|+||||.+..
T Consensus 329 ~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 329 EQAMQDPYFLEDP 341 (405)
T ss_dssp HHHHTSGGGTSSS
T ss_pred HHHhcChhhccCC
Confidence 9999999998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=383.47 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=218.7
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++ ||||+++++++.+++.+
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEETTEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEEECCEE
Confidence 34678999999999999999999999999999999997642 3445678899999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~-~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
++||||++|++|.+++...+.+++..+..++.|++.||.|||++ ||+||||||+|||+ +.++.+||+|||++....
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHH
T ss_pred EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCCCcccc
Confidence 99999999999999999888999999999999999999999996 99999999999999 456679999999997654
Q ss_pred CCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHH---------------------
Q 016233 235 EGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDA--------------------- 292 (393)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~--------------------- 292 (393)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+....
T Consensus 184 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 184 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp HH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred cc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 32 2345689999999999876 489999999999999999999999987665443221
Q ss_pred ---------------------HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 293 ---------------------ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 293 ---------------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+..... +......++.++.+||.+||..||++|||++|+|+||||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 222211 111223478999999999999999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=379.89 Aligned_cols=264 Identities=39% Similarity=0.686 Sum_probs=194.1
Q ss_pred cccceeecc-eecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHH-HHHccCCCCeeEEeEEEEe---
Q 016233 77 VKLHYSFGK-ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI-MQHLSGQPNIVEFKGAYED--- 151 (393)
Q Consensus 77 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~h~niv~~~~~~~~--- 151 (393)
+.++|.+.+ .||+|+||.||+|.+..+|+.||||++... ....+|+.. ++.+ +||||+++++++..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~e~~~~~~~~-~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQAS-GGPHIVCILDVYENMHH 96 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--------HHHHHHHHHHHHHT-TSTTBCCEEEEEEEEET
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--------HHHHHHHHHHHHhc-CCCChHHHHHHHhhccC
Confidence 556899965 699999999999999999999999998542 223334444 4445 59999999999876
Q ss_pred -CCeEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecC
Q 016233 152 -KQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (393)
Q Consensus 152 -~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg 228 (393)
...+++||||++||+|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++.++....+||+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 456899999999999999998753 69999999999999999999999999999999999999876667789999999
Q ss_pred CcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHH----HHHHHcCCCCCCCC
Q 016233 229 LSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGI----FDAILQGDIDFESA 303 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~----~~~i~~~~~~~~~~ 303 (393)
++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||........ ...+......++..
T Consensus 177 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3fhr_A 177 FAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255 (336)
T ss_dssp TCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred cceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence 99876533 3345688999999999864 588899999999999999999999977665433 33444555566666
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCCCCcC
Q 016233 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350 (393)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~~~~ 350 (393)
.+..+++++.+||.+||..||++|||++|+|+||||++.......+.
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~ 302 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 302 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCCBC
T ss_pred hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCCcc
Confidence 77889999999999999999999999999999999987654444333
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=388.62 Aligned_cols=258 Identities=28% Similarity=0.451 Sum_probs=211.2
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
.+....+|++.+.||+|+||.||+|.+..+++ +|+|.+..... ...+|+.+++.++ ||||+++++++...+
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~-h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVK-HPNVVDLKAFFYSNG 105 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEEES
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCC-CCCcceEEEEEEecC
Confidence 34456789999999999999999999987765 88887754321 1236999999996 999999999985443
Q ss_pred ------eEEEEEeccCCCChHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEE
Q 016233 154 ------SVHVVMELCAGGELFDRII----AKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLK 223 (393)
Q Consensus 154 ------~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~k 223 (393)
.+++||||++++ +.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++. .++.+|
T Consensus 106 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~--~~~~~k 182 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP--PSGVLK 182 (394)
T ss_dssp SSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEE
T ss_pred CCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC--CCCcEE
Confidence 388999999774 433333 2467999999999999999999999999999999999999952 566899
Q ss_pred EeecCCcccccCCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC----
Q 016233 224 ATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD---- 297 (393)
Q Consensus 224 l~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~---- 297 (393)
|+|||+++............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 183 L~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 183 LIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262 (394)
T ss_dssp ECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred EeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999999998766666667889999999999865 48999999999999999999999999988776666554310
Q ss_pred -------------CCCCCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 298 -------------IDFESA--------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 298 -------------~~~~~~--------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
..++.. ..+.+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 111110 1234789999999999999999999999999999998653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=383.51 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=217.1
Q ss_pred cccccceeecceecccCCeEEEEEEEC-------CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeE
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTEN-------STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 147 (393)
+...++|++++.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+++.+.+||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 344678999999999999999999974 345679999986542 23456789999999999955999999999
Q ss_pred EEEeCCeEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcE
Q 016233 148 AYEDKQSVHVVMELCAGGELFDRIIAKG----------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENF 211 (393)
Q Consensus 148 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Ni 211 (393)
++.+.+.+|+||||++||+|.+++.... .+++.++..++.||+.||.|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 9999999999999999999999998653 478999999999999999999999999999999999
Q ss_pred EeccCCCCCcEEEeecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCCh
Q 016233 212 LLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETE 286 (393)
Q Consensus 212 ll~~~~~~~~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~ 286 (393)
|+ +.++.+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+...
T Consensus 235 ll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 235 LV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp EE---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred EE---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99 5567799999999987654322 233467889999998875 58999999999999999999 9999999888
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 287 KGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 287 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
.+.+..+..+.... ....++.++.+||.+||..||++|||+.|++++
T Consensus 312 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 312 EELFKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGHHHHHHTTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88887777664321 224688999999999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=370.74 Aligned_cols=259 Identities=25% Similarity=0.314 Sum_probs=198.8
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
...++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.++...++.+. ||||+++++++.+.+..
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~-h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVD-CPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSSE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCC-CCeEEEEeeeeeccCCE
Confidence 345689999999999999999999999999999999865421 1222333444444566665 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 156 HVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~~-~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
++||||++| +|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+||++ +.++.+||+|||++
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGIS 157 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC---
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCCc
Confidence 999999975 88776653 46799999999999999999999998 99999999999999 55667999999999
Q ss_pred ccccCCcceecccCcccccchHHHh-----hcCCCcchHHHHHHHHHHHhhCCCCCCCC-ChHHHHHHHHcCCCCCCCCC
Q 016233 231 VFIEEGKVYRDIVGSAYYVAPEVLR-----RRYGKEIDIWSAGVILYILLSGVPPFWAE-TEKGIFDAILQGDIDFESAP 304 (393)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~DiwSlG~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~ 304 (393)
.............||+.|+|||++. ..++.++|||||||++|+|++|..||... .....+......... ...
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~ 235 (290)
T 3fme_A 158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP--QLP 235 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC--CCC
T ss_pred ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC--Ccc
Confidence 8876655555668999999999972 34888999999999999999999999763 333344443333221 222
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
...+++++.+||.+||..||++|||++|+++||||+..
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 34689999999999999999999999999999999854
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=384.05 Aligned_cols=264 Identities=26% Similarity=0.383 Sum_probs=218.0
Q ss_pred cccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCC-----eeEE
Q 016233 71 GKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN-----IVEF 145 (393)
Q Consensus 71 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-----iv~~ 145 (393)
....+.+..+|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+..|++ |+++
T Consensus 46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence 344556678999999999999999999999999999999998643 2345677889999998875664 9999
Q ss_pred eEEEEeCCeEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HcCcEecCCCCCcEEeccCCCCCc
Q 016233 146 KGAYEDKQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICH--FMGVMHRDLKPENFLLSSKDENAL 221 (393)
Q Consensus 146 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH--~~~ivH~Dikp~Nill~~~~~~~~ 221 (393)
++++...+.+++||||+. ++|.+++... ..+++..++.++.||+.||.||| +.||+||||||+|||++. +..+.
T Consensus 122 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~ 199 (382)
T 2vx3_A 122 KRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSA 199 (382)
T ss_dssp EEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCC
T ss_pred eeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCc
Confidence 999999999999999996 5999998875 45999999999999999999999 579999999999999954 23567
Q ss_pred EEEeecCCcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC
Q 016233 222 LKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF 300 (393)
Q Consensus 222 ~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 300 (393)
+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 200 ~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 277 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277 (382)
T ss_dssp EEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred EEEEeccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999999999876532 346789999999999876 58999999999999999999999999988877776665421100
Q ss_pred C------------------CCCC-----------------CC-------------------------CCHHHHHHHHHhc
Q 016233 301 E------------------SAPW-----------------PT-------------------------ISSSAKDLVRRML 320 (393)
Q Consensus 301 ~------------------~~~~-----------------~~-------------------------~s~~~~~li~~~L 320 (393)
+ ...| .. .++++.+||.+||
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 357 (382)
T 2vx3_A 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRML 357 (382)
T ss_dssp CHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHT
T ss_pred CHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhc
Confidence 0 0000 00 0137899999999
Q ss_pred ccCCCCCCCHHHHhcCccccCC
Q 016233 321 TQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 321 ~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
..||++|||++|+|+||||+..
T Consensus 358 ~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 358 DYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp CSCTTTSCCHHHHTTSGGGCC-
T ss_pred CCChhhCCCHHHHhcCcccccC
Confidence 9999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=371.66 Aligned_cols=263 Identities=25% Similarity=0.392 Sum_probs=211.8
Q ss_pred ccccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEE
Q 016233 70 LGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149 (393)
Q Consensus 70 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 149 (393)
.+..++....+|++.+.||+|+||.||+|.+. |+.||||++..... .....+.+.+|+.++++++ ||||+++++++
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~ 103 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPNIVLFMGAV 103 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence 34455566779999999999999999999874 88999999875542 3344567899999999997 99999999999
Q ss_pred EeCCeEEEEEeccCCCChHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHcC--cEecCCCCCcEEeccCCCCCcEEE
Q 016233 150 EDKQSVHVVMELCAGGELFDRIIAKGH---YSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKDENALLKA 224 (393)
Q Consensus 150 ~~~~~~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~i~~qll~~l~~lH~~~--ivH~Dikp~Nill~~~~~~~~~kl 224 (393)
.+.+.+++||||+++|+|.+++...+. +++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL 180 (309)
T 3p86_A 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKV 180 (309)
T ss_dssp CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEE
T ss_pred EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEE
Confidence 999999999999999999999976543 999999999999999999999999 9999999999999 55678999
Q ss_pred eecCCcccccCCc-ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC
Q 016233 225 TDFGLSVFIEEGK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES 302 (393)
Q Consensus 225 ~DFg~a~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 302 (393)
+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.........
T Consensus 181 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 260 (309)
T 3p86_A 181 CDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI 260 (309)
T ss_dssp CCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCC
T ss_pred CCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 9999998654432 2345689999999999876 4899999999999999999999999998888777776544333222
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CccccC
Q 016233 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLE--HPWIKE 341 (393)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~--h~~~~~ 341 (393)
...+++++.+||.+||..||++|||++++++ +++++.
T Consensus 261 --~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 261 --PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred --CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 2468999999999999999999999999987 455543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=389.80 Aligned_cols=258 Identities=15% Similarity=0.192 Sum_probs=198.2
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHcc-CCCCeeEEe-------EEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS-GQPNIVEFK-------GAY 149 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~~~-------~~~ 149 (393)
...|++++.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.|+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 446999999999999999999999999999999998765434455677888866666664 499988855 555
Q ss_pred EeC-----------------CeEEEEEeccCCCChHHHHHHc-CCCCHHHH------HHHHHHHHHHHHHHHHcCcEecC
Q 016233 150 EDK-----------------QSVHVVMELCAGGELFDRIIAK-GHYSERAA------ASICRSIVNVVHICHFMGVMHRD 205 (393)
Q Consensus 150 ~~~-----------------~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~------~~i~~qll~~l~~lH~~~ivH~D 205 (393)
... ..+||||||++ |+|.+++... ..+.+... ..++.||+.||+|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 443 33899999998 8999999864 33444444 57779999999999999999999
Q ss_pred CCCCcEEeccCCCCCcEEEeecCCcccccCCcceecccCcccccchHHHhh---cCCCcchHHHHHHHHHHHhhCCCCCC
Q 016233 206 LKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFW 282 (393)
Q Consensus 206 ikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~ 282 (393)
|||+|||+ +.++.+||+|||+++..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 220 ikp~NIll---~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 220 FTPDNLFI---MPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp CSGGGEEE---CTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CCHHHEEE---CCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999 55667999999999876432 225567799999999874 58999999999999999999999998
Q ss_pred CCChHHH--HHH---HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 283 AETEKGI--FDA---ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 283 ~~~~~~~--~~~---i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
+...... +.. .......+....++.+++.+.+||.+||..||++|||++++|+||||++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 7643210 000 1111223333344678999999999999999999999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=373.00 Aligned_cols=262 Identities=24% Similarity=0.381 Sum_probs=218.7
Q ss_pred cccceeecceecccCCeEEEEEEEC-CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHcc--CCCCeeEEeEEEE---
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTEN-STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--GQPNIVEFKGAYE--- 150 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~--- 150 (393)
...+|++.+.||+|+||.||+|.+. .+|+.||+|++..... .......+.+|+.+++.+. +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcc-cccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4568999999999999999999995 6789999999975432 2223345667888887773 4999999999987
Q ss_pred --eCCeEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEee
Q 016233 151 --DKQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (393)
Q Consensus 151 --~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~D 226 (393)
....+++||||+. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEEec
Confidence 5567999999997 59999988753 49999999999999999999999999999999999999 5566799999
Q ss_pred cCCcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC-----
Q 016233 227 FGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF----- 300 (393)
Q Consensus 227 Fg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~----- 300 (393)
||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence 999987765555566789999999999865 58999999999999999999999999988877776665311000
Q ss_pred ------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 301 ------------------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 301 ------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
....+..++..+.+||.+||..||++|||+.++|+||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 0112356889999999999999999999999999999998653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=382.49 Aligned_cols=259 Identities=20% Similarity=0.291 Sum_probs=222.0
Q ss_pred ccccceeecceecccCCeEEEEEE-----ECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
....+|++++.||+|+||.||+|. +..+++.||||++.... .......+.+|+.++++++ ||||+++++++.
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~ 144 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFN-HQNIVRCIGVSL 144 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCC-CCCCCeEEEEEe
Confidence 446789999999999999999999 45678899999986432 3445667889999999996 999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEE
Q 016233 151 DKQSVHVVMELCAGGELFDRIIAKG-------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLK 223 (393)
Q Consensus 151 ~~~~~~lv~e~~~gg~L~~~l~~~~-------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~k 223 (393)
+.+..++||||++||+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++.++....+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999999998753 489999999999999999999999999999999999997666667899
Q ss_pred EeecCCcccccCC---cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCC
Q 016233 224 ATDFGLSVFIEEG---KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDI 298 (393)
Q Consensus 224 l~DFg~a~~~~~~---~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~ 298 (393)
|+|||+++..... .......||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+.+..+..+..
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999999865322 22344678999999998865 58999999999999999998 9999999998888888887653
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 016233 299 DFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (393)
Q Consensus 299 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 340 (393)
... ...++..+.+||.+||+.||++|||+.+++++.++.
T Consensus 305 ~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 305 MDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 322 246789999999999999999999999999988764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=370.98 Aligned_cols=258 Identities=28% Similarity=0.498 Sum_probs=219.3
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccC-CcccHHHHHHHHHHHHHccCCCCeeEEeEEE--EeCC
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV-TKNDKDDIKREIQIMQHLSGQPNIVEFKGAY--EDKQ 153 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~--~~~~ 153 (393)
+..+|++++.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+++.++ ||||+++++++ .+.+
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC---
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCC
Confidence 346899999999999999999999999999999999754321 1234678999999999996 99999999998 4556
Q ss_pred eEEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 154 SVHVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
..++||||++++ |.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAE 157 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeecccccc
Confidence 899999999876 7777765 3569999999999999999999999999999999999999 456679999999998
Q ss_pred cccC---CcceecccCcccccchHHHhhc---CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 016233 232 FIEE---GKVYRDIVGSAYYVAPEVLRRR---YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW 305 (393)
Q Consensus 232 ~~~~---~~~~~~~~gt~~y~aPE~l~~~---~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (393)
.... ........||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..+....+..+...++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---- 233 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP---- 233 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC----
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC----
Confidence 7643 2233456799999999998752 47799999999999999999999999988888888888765543
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
..+++.+.+||.+||..||++|||++++++||||+...
T Consensus 234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 35789999999999999999999999999999998653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=369.22 Aligned_cols=259 Identities=27% Similarity=0.474 Sum_probs=218.0
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
+...+|++++.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++ ||||+++++++.+.+.+
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 91 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATCD-HPYIVKLLGAYYHDGKL 91 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC-CE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC---CHHHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeCCeE
Confidence 4567899999999999999999999999999999998654 2345778899999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCcccc
Confidence 999999999999998876 4679999999999999999999999999999999999999 556679999999876432
Q ss_pred CC-cceecccCcccccchHHHh------hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 016233 235 EG-KVYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (393)
Q Consensus 235 ~~-~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (393)
.. .......||+.|+|||++. ..++.++||||||+++|+|++|..||...+.......+........ .....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 247 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LTPSK 247 (302)
T ss_dssp HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSGGG
T ss_pred ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CCccc
Confidence 21 1223467999999999873 3478899999999999999999999998887777776666543221 12245
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
++..+.+||.+||..||++|||++++++||||...
T Consensus 248 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 248 WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred cCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 78999999999999999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=367.69 Aligned_cols=258 Identities=28% Similarity=0.490 Sum_probs=216.4
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
....+|++.+.||+|+||.||+|.+..+|+.||||++... .....+.+|+.+++.+. ||||+++++++...+.+
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-----SDLQEIIKEISIMQQCD-SPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-----SCCHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-----HHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEE
Confidence 3456899999999999999999999999999999999753 24577899999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECB
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchhhh
Confidence 999999999999999874 5679999999999999999999999999999999999999 455679999999998765
Q ss_pred CCc-ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 016233 235 EGK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (393)
Q Consensus 235 ~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (393)
... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+...... .......++..+
T Consensus 177 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 255 (314)
T 3com_A 177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-TFRKPELWSDNF 255 (314)
T ss_dssp TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSSGGGSCHHH
T ss_pred hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-ccCCcccCCHHH
Confidence 432 2345679999999999875 5899999999999999999999999888776665555444221 111223478999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 313 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
.+||.+||..||.+|||+.++|+||||....
T Consensus 256 ~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 256 TDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred HHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 9999999999999999999999999998643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-51 Score=384.27 Aligned_cols=260 Identities=26% Similarity=0.482 Sum_probs=223.9
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccH--------------HHHHHHHHHHHHccCCCC
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK--------------DDIKREIQIMQHLSGQPN 141 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~--------------~~~~~E~~~l~~l~~h~n 141 (393)
....+|++++.||+|+||.||+|.+ +++.||||++........... +.+.+|+.++++++ |||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ 104 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEY 104 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-CTT
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-CCC
Confidence 3456899999999999999999998 799999999976543222211 88999999999996 999
Q ss_pred eeEEeEEEEeCCeEEEEEeccCCCChHHH------HHH--cCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCCCCCcEE
Q 016233 142 IVEFKGAYEDKQSVHVVMELCAGGELFDR------IIA--KGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFL 212 (393)
Q Consensus 142 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~------l~~--~~~~~~~~~~~i~~qll~~l~~lH~-~~ivH~Dikp~Nil 212 (393)
|+++++++.+.+.+++||||+++++|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+||+
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999999999999999999999999987 655 5679999999999999999999999 99999999999999
Q ss_pred eccCCCCCcEEEeecCCcccccCCcceecccCcccccchHHHhhc--CCC-cchHHHHHHHHHHHhhCCCCCCCCCh-HH
Q 016233 213 LSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR--YGK-EIDIWSAGVILYILLSGVPPFWAETE-KG 288 (393)
Q Consensus 213 l~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~-~~DiwSlG~il~~lltg~~pf~~~~~-~~ 288 (393)
+ +.++.+||+|||++...... ......||+.|+|||++.+. ++. ++|||||||++|+|++|..||..... .+
T Consensus 185 ~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 185 M---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp E---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred E---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 9 55667999999999876544 44567899999999998754 445 89999999999999999999988776 77
Q ss_pred HHHHHHcCCCCCCCCC---------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 289 IFDAILQGDIDFESAP---------------WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 289 ~~~~i~~~~~~~~~~~---------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
....+..+...++... ...++.++.+||.+||..||.+|||++|+|+||||+..
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 7788877766554321 14689999999999999999999999999999999863
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=365.46 Aligned_cols=257 Identities=29% Similarity=0.503 Sum_probs=221.0
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE--eCCeE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE--DKQSV 155 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~--~~~~~ 155 (393)
..+|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.++++++ ||||+++++++. ..+.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCceE
Confidence 3589999999999999999999999999999999976543 3345678899999999996 999999999874 46789
Q ss_pred EEEEeccCCCChHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC-----cEecCCCCCcEEeccCCCCCcEEEee
Q 016233 156 HVVMELCAGGELFDRIIAK----GHYSERAAASICRSIVNVVHICHFMG-----VMHRDLKPENFLLSSKDENALLKATD 226 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qll~~l~~lH~~~-----ivH~Dikp~Nill~~~~~~~~~kl~D 226 (393)
++||||++|++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||++ +.++.+||+|
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~d 159 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGD 159 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEECC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEec
Confidence 9999999999999998753 24999999999999999999999999 9999999999999 5566799999
Q ss_pred cCCcccccCCcc-eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 016233 227 FGLSVFIEEGKV-YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP 304 (393)
Q Consensus 227 Fg~a~~~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (393)
||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...+..+....+..+.....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--- 236 (279)
T 2w5a_A 160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI--- 236 (279)
T ss_dssp CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---
T ss_pred CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC---
Confidence 999987654322 234579999999999875 588999999999999999999999999888888888877755322
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
...++.++.+||.+||..||++|||++++|+|+|+...
T Consensus 237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 23678999999999999999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=372.71 Aligned_cols=264 Identities=29% Similarity=0.480 Sum_probs=199.0
Q ss_pred cccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
++.....+|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.++++++ ||||+++++++...
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVK 85 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCC-CTTBCCEEEEEESS
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcC-CCCEeeEEEEEeec
Confidence 344556789999999999999999999999999999998865432 234567889999999996 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEE
Q 016233 153 QSVHVVMELCAGGELFDRIIA--------KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKA 224 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~--------~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl 224 (393)
+..++||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl 162 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQI 162 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEE
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEE
Confidence 999999999999999998874 3459999999999999999999999999999999999999 55667999
Q ss_pred eecCCcccccCCc------ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC
Q 016233 225 TDFGLSVFIEEGK------VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG 296 (393)
Q Consensus 225 ~DFg~a~~~~~~~------~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 296 (393)
+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...............
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 242 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc
Confidence 9999987664322 2234579999999999864 5899999999999999999999999887766655555443
Q ss_pred CCCCC------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 297 DIDFE------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 297 ~~~~~------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
..... ...+..++.++.+||.+||..||.+|||+.++++||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 32211 12235688999999999999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=372.70 Aligned_cols=263 Identities=27% Similarity=0.433 Sum_probs=217.2
Q ss_pred ccccccccceeecceecccCCeEEEEEEE-CCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCC------CeeE
Q 016233 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTE-NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP------NIVE 144 (393)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~------niv~ 144 (393)
...+.+..+|++.+.||+|+||.||+|.+ ..+++.||||++... ....+.+.+|+.+++.+. |+ +|++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~-~~~~~~~~~i~~ 81 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLN-TTDPNSTFRCVQ 81 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHH-HHCTTCTTCBCC
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhh-hcCCCCceeeEe
Confidence 34455677999999999999999999998 567899999998642 234677889999999986 54 5999
Q ss_pred EeEEEEeCCeEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCC----
Q 016233 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE---- 218 (393)
Q Consensus 145 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~---- 218 (393)
+++++.+.+.+++||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++..+.
T Consensus 82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence 999999999999999999 889999998765 6899999999999999999999999999999999999964321
Q ss_pred ------------CCcEEEeecCCcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCC
Q 016233 219 ------------NALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET 285 (393)
Q Consensus 219 ------------~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~ 285 (393)
++.+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...+
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred CCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 557999999999875432 345689999999999875 58999999999999999999999999888
Q ss_pred hHHHHHHHHcCCCCCCC----------------CCC------------------------CCCCHHHHHHHHHhcccCCC
Q 016233 286 EKGIFDAILQGDIDFES----------------APW------------------------PTISSSAKDLVRRMLTQDPK 325 (393)
Q Consensus 286 ~~~~~~~i~~~~~~~~~----------------~~~------------------------~~~s~~~~~li~~~L~~dp~ 325 (393)
..+....+......++. ..| ...++++.+||.+||..||.
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 76655444321111100 011 12346789999999999999
Q ss_pred CCCCHHHHhcCccccCC
Q 016233 326 KRITSAQVLEHPWIKEG 342 (393)
Q Consensus 326 ~Rpt~~e~l~h~~~~~~ 342 (393)
+|||++|+|+||||+..
T Consensus 319 ~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 319 KRITLREALKHPFFDLL 335 (339)
T ss_dssp TSCCHHHHTTSGGGGGG
T ss_pred cccCHHHHhcCHHHHHH
Confidence 99999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=373.52 Aligned_cols=260 Identities=30% Similarity=0.458 Sum_probs=215.2
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC---
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--- 152 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 152 (393)
.+..+|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.++++++ ||||+++++++...
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFK-HENIITIFNIQRPDSFE 84 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCST
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCc-CCCcCCeeeeecccccC
Confidence 45678999999999999999999999999999999986432 3334567889999999996 99999999988654
Q ss_pred --CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 153 --QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 153 --~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
...++||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 85 ~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 85 NFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLA 159 (353)
T ss_dssp TCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred ccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEecccc
Confidence 67999999996 589887765 579999999999999999999999999999999999999 55667999999999
Q ss_pred ccccCCc-----------ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC
Q 016233 231 VFIEEGK-----------VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD 297 (393)
Q Consensus 231 ~~~~~~~-----------~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 297 (393)
....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 8764321 1223578999999998753 58899999999999999999999999888766554443210
Q ss_pred C------------------------CCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 298 I------------------------DFES----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 298 ~------------------------~~~~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
. ..+. ..++.+++++.+||.+||..||++|||++++|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 0 0000 01246889999999999999999999999999999998654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=371.22 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=215.0
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCc---EEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGR---QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
....+|++.+.||+|+||.||+|.+..+++ .||||++.... .....+.+.+|+.+++.++ ||||+++++++.+.
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRG 122 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECGG
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeC
Confidence 345689999999999999999999986655 49999986532 3445678999999999996 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 153 QSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
+..++||||++||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSR 199 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSCE
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCccc
Confidence 9999999999999999998754 579999999999999999999999999999999999999 566789999999998
Q ss_pred cccCCc----ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 016233 232 FIEEGK----VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (393)
Q Consensus 232 ~~~~~~----~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (393)
...... ......+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+.... ..
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~ 276 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP---AP 276 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---CC
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC---CC
Confidence 765432 1223456788999999875 58999999999999999999 999999999888888887763322 22
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
..+++.+.+||.+||..||++|||+.++++
T Consensus 277 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 468999999999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=380.27 Aligned_cols=257 Identities=27% Similarity=0.437 Sum_probs=213.1
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
.+..+|.+.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++ ||||+++++++...+..
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 116 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSL 116 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSS
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcC-CCCchhhhhheeccCCc
Confidence 45679999999999999999999999999999999997543 23344678889999999997 99999999999877654
Q ss_pred ------EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 156 ------HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 156 ------~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
++||||+. ++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 117 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 117 RNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGL 190 (371)
T ss_dssp TTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSTTC
T ss_pred ccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEEecCc
Confidence 99999996 58877663 459999999999999999999999999999999999999 5566799999999
Q ss_pred cccccCCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC--------
Q 016233 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID-------- 299 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~-------- 299 (393)
+...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 191 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 191 ARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp C----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 9865432 345689999999999875 5899999999999999999999999988877666655431100
Q ss_pred ---------------CCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 300 ---------------FES----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 300 ---------------~~~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
... ..++.+++++.+||.+||..||++|||++|+|+||||+..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 000 0124678999999999999999999999999999999854
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-50 Score=373.02 Aligned_cols=263 Identities=28% Similarity=0.413 Sum_probs=213.1
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE----
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE---- 150 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~---- 150 (393)
..+..+|++++.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++++++ ||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 82 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLD-HDNIVKVFEILGPSGS 82 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTSC
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcC-CCCeeEEEEecccccc
Confidence 34567999999999999999999999999999999998643 2345678899999999996 999999999873
Q ss_pred ----------eCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCC
Q 016233 151 ----------DKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA 220 (393)
Q Consensus 151 ----------~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~ 220 (393)
+.+..++||||++ |+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++. .+.
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~ 158 (320)
T 2i6l_A 83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDL 158 (320)
T ss_dssp BCCC----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET--TTT
T ss_pred ccccccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CCC
Confidence 4468899999997 59988775 467999999999999999999999999999999999999952 346
Q ss_pred cEEEeecCCcccccCC----cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH
Q 016233 221 LLKATDFGLSVFIEEG----KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL 294 (393)
Q Consensus 221 ~~kl~DFg~a~~~~~~----~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 294 (393)
.+||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 7999999999876432 12344568999999998753 58999999999999999999999999888777666655
Q ss_pred cCCCCC----------------------CC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCC
Q 016233 295 QGDIDF----------------------ES----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEA 345 (393)
Q Consensus 295 ~~~~~~----------------------~~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 345 (393)
...... +. ..++.++.++.+||.+||..||++|||++++|+||||+....+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 432110 00 1124689999999999999999999999999999999875443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=377.15 Aligned_cols=260 Identities=25% Similarity=0.350 Sum_probs=203.8
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe--
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS-- 154 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~-- 154 (393)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+|++.++.++ ||||+++++++...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP----RFRNRELQIMQDLAVLH-HPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCT----TCCCHHHHHHHHHHHHC-CTTBCCEEEEEEEECSSC
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc----cccHHHHHHHHHHHhcC-CCCcccHHHhhhcccccc
Confidence 3458999999999999999999999999999999986532 23345667888888886 9999999999865433
Q ss_pred -----EEEEEeccCCCChHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH--HcCcEecCCCCCcEEeccCCCCCcEE
Q 016233 155 -----VHVVMELCAGGELFDRII----AKGHYSERAAASICRSIVNVVHICH--FMGVMHRDLKPENFLLSSKDENALLK 223 (393)
Q Consensus 155 -----~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~i~~qll~~l~~lH--~~~ivH~Dikp~Nill~~~~~~~~~k 223 (393)
+++||||+++ +|.+.+. ....+++..++.++.|++.||.||| ++||+||||||+|||++. .++.+|
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~--~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE--ADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET--TTTEEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC--CCCcEE
Confidence 8899999976 5444443 4567899999999999999999999 999999999999999952 256899
Q ss_pred EeecCCcccccCCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC-
Q 016233 224 ATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF- 300 (393)
Q Consensus 224 l~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~- 300 (393)
|+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+.+.....
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 999999998876666667789999999999854 38999999999999999999999999988877766664311000
Q ss_pred -------------------CC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 301 -------------------ES--------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 301 -------------------~~--------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
.. ......++++.+||.+||+.||++|||+.|+|+||||++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 00 011225688999999999999999999999999999986543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-50 Score=378.85 Aligned_cols=257 Identities=24% Similarity=0.371 Sum_probs=213.8
Q ss_pred ccccccccceeecceecccCCeEEEEEE-----ECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEe
Q 016233 72 KPYEDVKLHYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146 (393)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~ 146 (393)
..++...++|++++.||+|+||.||+|. +..+++.||||++.... .....+.+.+|+.+++++.+||||++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 4556677899999999999999999999 56677999999996542 3344567899999999997699999999
Q ss_pred EEEEeCC-eEEEEEeccCCCChHHHHHHcCC-------------------------------------------------
Q 016233 147 GAYEDKQ-SVHVVMELCAGGELFDRIIAKGH------------------------------------------------- 176 (393)
Q Consensus 147 ~~~~~~~-~~~lv~e~~~gg~L~~~l~~~~~------------------------------------------------- 176 (393)
+++.+.+ .+++|||||+||+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998765 48999999999999999976533
Q ss_pred -----------------CCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc--
Q 016233 177 -----------------YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-- 237 (393)
Q Consensus 177 -----------------~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-- 237 (393)
+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccc
Confidence 8999999999999999999999999999999999999 455679999999998764432
Q ss_pred -ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHH-HHHHcCCCCCCCCCCCCCCHHHH
Q 016233 238 -VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIF-DAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 238 -~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
......||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+.+ ..+..+.. .. ....+++++.
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~l~ 326 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MR--APDYTTPEMY 326 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC-CC--CCTTCCHHHH
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC-CC--CCCCCCHHHH
Confidence 2234578999999998865 58999999999999999998 99999887654444 33443322 22 2245889999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
++|.+||..||++|||++++++|
T Consensus 327 ~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 327 QTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCCCHHHHHHH
Confidence 99999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=376.63 Aligned_cols=264 Identities=24% Similarity=0.379 Sum_probs=208.4
Q ss_pred cccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCC--------cccHHHHHHHHHHHHHccCCCCeeE
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT--------KNDKDDIKREIQIMQHLSGQPNIVE 144 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~~~E~~~l~~l~~h~niv~ 144 (393)
+...+..+|++++.||+|+||.||+|.+.. |+.||||++....... ....+.+.+|+.++++++ ||||++
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~ 93 (362)
T 3pg1_A 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILG 93 (362)
T ss_dssp HHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCC
T ss_pred HHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCccc
Confidence 344567899999999999999999999865 9999999986543211 112378899999999996 999999
Q ss_pred EeEEEEe-----CCeEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCC
Q 016233 145 FKGAYED-----KQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE 218 (393)
Q Consensus 145 ~~~~~~~-----~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~ 218 (393)
+++++.. ...+|+||||+. |+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~ 169 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---AD 169 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CT
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---cC
Confidence 9999843 347899999997 5888877654 369999999999999999999999999999999999999 55
Q ss_pred CCcEEEeecCCcccccCCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC
Q 016233 219 NALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG 296 (393)
Q Consensus 219 ~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 296 (393)
++.+||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 249 (362)
T 3pg1_A 170 NNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV 249 (362)
T ss_dssp TCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 66799999999987666555566789999999999864 5899999999999999999999999998877666655431
Q ss_pred C------------------------CCCCCCC----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 297 D------------------------IDFESAP----WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 297 ~------------------------~~~~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
. ...+... .+.+++.+.+||.+||..||++|||++|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 250 VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred cCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 1 1111111 24568899999999999999999999999999999865
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=365.10 Aligned_cols=267 Identities=24% Similarity=0.420 Sum_probs=215.5
Q ss_pred ccccccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccC-CCCeeEEe
Q 016233 68 TILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG-QPNIVEFK 146 (393)
Q Consensus 68 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~~~ 146 (393)
.+..........+|++++.||+|+||.||+|.+. +++.||||++..... .......+.+|+.+++++.+ ||||++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEE
Confidence 3334445556678999999999999999999986 489999999976542 33456788999999999974 69999999
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEee
Q 016233 147 GAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (393)
Q Consensus 147 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~D 226 (393)
+++.+.+.+++||| +.+++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|
T Consensus 95 ~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~D 169 (313)
T 3cek_A 95 DYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLID 169 (313)
T ss_dssp EEEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECC
T ss_pred EEeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEee
Confidence 99999999999999 55889999999888999999999999999999999999999999999999994 25799999
Q ss_pred cCCcccccCCcc---eecccCcccccchHHHhh------------cCCCcchHHHHHHHHHHHhhCCCCCCCCCh-HHHH
Q 016233 227 FGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR------------RYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIF 290 (393)
Q Consensus 227 Fg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~------------~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~ 290 (393)
||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH
Confidence 999987654321 234579999999999864 578899999999999999999999976543 3344
Q ss_pred HHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 291 DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 291 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
..+......... ....+.++.+||.+||..||++|||++++|+||||+...
T Consensus 250 ~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 250 HAIIDPNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp HHHHCTTSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred HHHHhcccccCC--cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 445444332222 234688999999999999999999999999999998643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=370.78 Aligned_cols=258 Identities=29% Similarity=0.543 Sum_probs=217.2
Q ss_pred ccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCc---ccHHHHHHHHHHHHHcc-CCCCeeEEeE
Q 016233 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK---NDKDDIKREIQIMQHLS-GQPNIVEFKG 147 (393)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~-~h~niv~~~~ 147 (393)
...+.+..+|++++.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+++++. +|+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 3445567799999999999999999999999999999999976543221 12345678999999997 3699999999
Q ss_pred EEEeCCeEEEEEeccCC-CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEee
Q 016233 148 AYEDKQSVHVVMELCAG-GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (393)
Q Consensus 148 ~~~~~~~~~lv~e~~~g-g~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~D 226 (393)
++...+..++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ..+.+||+|
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~~kL~D 193 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLID 193 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECC
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC--CCCCEEEee
Confidence 99999999999999976 899999998889999999999999999999999999999999999999952 456799999
Q ss_pred cCCcccccCCcceecccCcccccchHHHhhc--CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 016233 227 FGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP 304 (393)
Q Consensus 227 Fg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (393)
||++...... ......||+.|+|||++.+. ++.++|||||||++|+|++|..||.... .+......+.
T Consensus 194 fg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~--- 263 (320)
T 3a99_A 194 FGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR--- 263 (320)
T ss_dssp CTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS---
T ss_pred Cccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc---
Confidence 9999877543 33456799999999998753 4678999999999999999999996532 2233333222
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
..+++++.+||.+||..||++|||++++++||||+..
T Consensus 264 -~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 264 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp -SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 4689999999999999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=383.15 Aligned_cols=261 Identities=22% Similarity=0.388 Sum_probs=209.1
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHcc-------CCCCeeEEe
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS-------GQPNIVEFK 146 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-------~h~niv~~~ 146 (393)
.+.+..+|++.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.++ +|+||++++
T Consensus 32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 345567999999999999999999999999999999998643 334677889999999986 278899999
Q ss_pred EEEE----eCCeEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCCCCCcEEeccCC--
Q 016233 147 GAYE----DKQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSKD-- 217 (393)
Q Consensus 147 ~~~~----~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~-~ivH~Dikp~Nill~~~~-- 217 (393)
+++. +...+++||||+ +++|.+.+... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHH
T ss_pred cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchh
Confidence 9987 556899999999 66777777654 4699999999999999999999998 999999999999996432
Q ss_pred --------------------------------------------CCCcEEEeecCCcccccCCcceecccCcccccchHH
Q 016233 218 --------------------------------------------ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV 253 (393)
Q Consensus 218 --------------------------------------------~~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~ 253 (393)
....+||+|||++...... ....+||+.|+|||+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChh
Confidence 1137999999999876543 345689999999999
Q ss_pred Hhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh------HHHHHHHHc------------CCCC------------CCC
Q 016233 254 LRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE------KGIFDAILQ------------GDID------------FES 302 (393)
Q Consensus 254 l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~------~~~~~~i~~------------~~~~------------~~~ 302 (393)
+.+ .++.++|||||||++|+|++|..||...+. ...+..+.. +... ...
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 876 499999999999999999999999976542 222222211 0000 000
Q ss_pred -C-------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 303 -A-------------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 303 -~-------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
. .....++.+.+||.+||..||++|||++|+|+||||+.
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0 00123467889999999999999999999999999963
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=372.07 Aligned_cols=264 Identities=25% Similarity=0.400 Sum_probs=216.5
Q ss_pred cccccccccceeecceecccCCeEEEEEEECCCC-cEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCC------ee
Q 016233 71 GKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTG-RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN------IV 143 (393)
Q Consensus 71 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n------iv 143 (393)
....+.+..+|++.+.||+|+||.||+|.+..++ +.||+|++... ....+.+.+|+.+++.+. |++ ++
T Consensus 11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~ 85 (355)
T 2eu9_A 11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIK-EKDKENKFLCV 85 (355)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHH-HHCTTSCSCBC
T ss_pred cccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHh-hcCCCCceeEE
Confidence 3445566789999999999999999999998877 68999998642 234677889999999996 554 99
Q ss_pred EEeEEEEeCCeEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccC-----
Q 016233 144 EFKGAYEDKQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK----- 216 (393)
Q Consensus 144 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~----- 216 (393)
.+++++...+.+++||||+ +++|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||+...
T Consensus 86 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 86 LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEE
T ss_pred EeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccc
Confidence 9999999999999999999 667878777653 69999999999999999999999999999999999999543
Q ss_pred -----------CCCCcEEEeecCCcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCC
Q 016233 217 -----------DENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAE 284 (393)
Q Consensus 217 -----------~~~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~ 284 (393)
+....+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 24677999999999865433 345689999999999865 5899999999999999999999999988
Q ss_pred ChHHHHHHHHcCCCCCCC----------------CCC------------------------CCCCHHHHHHHHHhcccCC
Q 016233 285 TEKGIFDAILQGDIDFES----------------APW------------------------PTISSSAKDLVRRMLTQDP 324 (393)
Q Consensus 285 ~~~~~~~~i~~~~~~~~~----------------~~~------------------------~~~s~~~~~li~~~L~~dp 324 (393)
+..+.+..+......++. ..| ...+.++.+||.+||..||
T Consensus 243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 776655444322111110 001 1124578899999999999
Q ss_pred CCCCCHHHHhcCccccCC
Q 016233 325 KKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 325 ~~Rpt~~e~l~h~~~~~~ 342 (393)
++|||++|+|+||||+..
T Consensus 323 ~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 323 AQRITLAEALLHPFFAGL 340 (355)
T ss_dssp TTSCCHHHHTTSGGGGGC
T ss_pred hhCcCHHHHhcChhhcCC
Confidence 999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=364.37 Aligned_cols=254 Identities=26% Similarity=0.479 Sum_probs=211.0
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe-----
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED----- 151 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----- 151 (393)
+..+|++++.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.++ ||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchh
Confidence 356899999999999999999999999999999998642 234677899999999996 9999999998865
Q ss_pred --------CCeEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcE
Q 016233 152 --------KQSVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALL 222 (393)
Q Consensus 152 --------~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~ 222 (393)
.+.+|+||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~ 155 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNV 155 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCE
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCE
Confidence 457899999999999999998643 57889999999999999999999999999999999999 556679
Q ss_pred EEeecCCcccccCC---------------cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCC-C
Q 016233 223 KATDFGLSVFIEEG---------------KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWA-E 284 (393)
Q Consensus 223 kl~DFg~a~~~~~~---------------~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~-~ 284 (393)
||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++ ||.. .
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~ 232 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM 232 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence 99999999866422 12345679999999999874 48999999999999999998 5543 2
Q ss_pred ChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 285 TEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 285 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
...+....+......++.......++.+.+||.+||..||.+|||++++++||||..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 334556666666666666555677889999999999999999999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=368.83 Aligned_cols=262 Identities=21% Similarity=0.349 Sum_probs=199.9
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCCc---EEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGR---QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
......+|++++.||+|+||.||+|.+..++. .||||++..... .....+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 95 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFD-HPHVAKLVGVSL 95 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCC-CTTBCCCCEEEE
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCC-CCceehhhceee
Confidence 33456689999999999999999999887765 899999875432 3345678999999999996 999999999998
Q ss_pred eCCeE------EEEEeccCCCChHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCC
Q 016233 151 DKQSV------HVVMELCAGGELFDRIIAKG------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE 218 (393)
Q Consensus 151 ~~~~~------~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~ 218 (393)
..... ++||||+.+|+|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||+ +.
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~ 172 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AE 172 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cC
Confidence 77655 99999999999999986543 59999999999999999999999999999999999999 55
Q ss_pred CCcEEEeecCCcccccCCcce---ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHH
Q 016233 219 NALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAI 293 (393)
Q Consensus 219 ~~~~kl~DFg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i 293 (393)
++.+||+|||++......... ....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~ 252 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 678999999999876543322 23457789999999876 48999999999999999999 99999998888888887
Q ss_pred HcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-------HHHHhcCccccCCC
Q 016233 294 LQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRIT-------SAQVLEHPWIKEGG 343 (393)
Q Consensus 294 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-------~~e~l~h~~~~~~~ 343 (393)
..+..... .+.+++++.+||.+||..||++||| ++++++|+|+....
T Consensus 253 ~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 253 IGGNRLKQ---PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp HTTCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred hcCCCCCC---CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 76653222 2468899999999999999999999 77888999998643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=371.91 Aligned_cols=257 Identities=27% Similarity=0.436 Sum_probs=212.3
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe-
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS- 154 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~- 154 (393)
.+..+|.+.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++ ||||+++++++...+.
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 98 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSL 98 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSG
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCcccHhheEeccccc
Confidence 34578999999999999999999999999999999986543 23334677889999999996 9999999999987654
Q ss_pred -----EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 155 -----VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 155 -----~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
+|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 99 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 99 RNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGL 172 (353)
T ss_dssp GGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTC
T ss_pred ccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEeeccc
Confidence 499999996 58877663 359999999999999999999999999999999999999 5566799999999
Q ss_pred cccccCCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC----------
Q 016233 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD---------- 297 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~---------- 297 (393)
+...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 173 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 173 ARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred ccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 9875432 345689999999999865 58999999999999999999999999888766655543310
Q ss_pred -----------------CCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 298 -----------------IDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 298 -----------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.......++.+++++.+||.+||..||++|||++++|+||||...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 000112235679999999999999999999999999999999754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=372.93 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=219.6
Q ss_pred ccccccceeecceecccCCeEEEEEEECCC-------CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEe
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENST-------GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~ 146 (393)
++...++|.+++.||+|+||.||+|.+..+ +..||||++.... .......+.+|+++++++.+||||++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 455677999999999999999999997543 3579999986542 3445678899999999995599999999
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCc
Q 016233 147 GAYEDKQSVHVVMELCAGGELFDRIIAKG----------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210 (393)
Q Consensus 147 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~N 210 (393)
+++.+.+..++||||+++|+|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 99999999999999999999999998754 48999999999999999999999999999999999
Q ss_pred EEeccCCCCCcEEEeecCCcccccCCc---ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCC
Q 016233 211 FLLSSKDENALLKATDFGLSVFIEEGK---VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAET 285 (393)
Q Consensus 211 ill~~~~~~~~~kl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 285 (393)
||+ +.++.+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+..
T Consensus 222 Ill---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 222 VLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp EEE---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEE---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999 556679999999998765432 2334567889999999875 48999999999999999999 999999998
Q ss_pred hHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 286 EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 286 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
..+....+..+..... ...+++++.+||.+||..||++|||+.+++++
T Consensus 299 ~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 299 VEELFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8888888777643222 24689999999999999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=360.09 Aligned_cols=254 Identities=26% Similarity=0.444 Sum_probs=207.8
Q ss_pred eeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEe
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 160 (393)
|.....||+|+||.||+|.+..+++.||||.+.... ....+.+.+|+.+++.++ ||||+++++++.+.+..++|||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEEEEEE
Confidence 344458999999999999999999999999997542 344678899999999996 9999999999999999999999
Q ss_pred ccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 161 LCAGGELFDRIIAKG---HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 161 ~~~gg~L~~~l~~~~---~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
|+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++. .++.+||+|||++.......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT--YSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTCCEEECCTTTCEESCC--
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC--CCCCEEEeecccccccCCCC
Confidence 999999999987652 4678899999999999999999999999999999999953 25679999999998765432
Q ss_pred -ceecccCcccccchHHHhhc---CCCcchHHHHHHHHHHHhhCCCCCCCCChHHH-HHHHHcCCCCCCCCCCCCCCHHH
Q 016233 238 -VYRDIVGSAYYVAPEVLRRR---YGKEIDIWSAGVILYILLSGVPPFWAETEKGI-FDAILQGDIDFESAPWPTISSSA 312 (393)
Q Consensus 238 -~~~~~~gt~~y~aPE~l~~~---~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~ 312 (393)
......||+.|+|||++.+. ++.++||||||+++|+|++|..||........ ....... .........+++++
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 255 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF--KVHPEIPESMSAEA 255 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH--CCCCCCCTTSCHHH
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc--cccccccccCCHHH
Confidence 23456799999999998642 78999999999999999999999976543321 1111111 11122235689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 313 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.+||.+||..||++|||++++|+||||+..
T Consensus 256 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 256 KAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp HHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred HHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 999999999999999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=353.05 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=216.6
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
....+|++.+.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.++++++ ||||+++++++.+.+..
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS----MSEDEFFQEAQTMMKLS-HPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT----BCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSE
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC----CcHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCce
Confidence 34678999999999999999999877 46789999996543 24577899999999997 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
++||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVL 155 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEECC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceecc
Confidence 99999999999999998754 49999999999999999999999999999999999999 556779999999998765
Q ss_pred CCcce--ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCH
Q 016233 235 EGKVY--RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310 (393)
Q Consensus 235 ~~~~~--~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 310 (393)
..... ....||+.|+|||++.+ .++.++||||||+++|+|++ |..||......+....+..+...... ..+++
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 232 (268)
T 3sxs_A 156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLASD 232 (268)
T ss_dssp TTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSCH
T ss_pred hhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcChH
Confidence 54322 23456778999999876 58999999999999999999 99999998888888887776543332 35789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 311 SAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 311 ~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
.+.+||.+||..||++|||+.+++++
T Consensus 233 ~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 233 TIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=370.41 Aligned_cols=252 Identities=18% Similarity=0.218 Sum_probs=208.0
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
+..+|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.|.+||||+++++++.+.+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-----chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 4568999999999999999999999999999999987542 23457899999999955999999999999999999
Q ss_pred EEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCC--CCcEEEeecCCcccc
Q 016233 157 VVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE--NALLKATDFGLSVFI 233 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~--~~~~kl~DFg~a~~~ 233 (393)
+||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ...+||+|||++...
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 9999999886 467999999999999999999999999999999999999953321 123999999999876
Q ss_pred cCCcc--------eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCC---hHHHHHHHHcCCCCCC
Q 016233 234 EEGKV--------YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET---EKGIFDAILQGDIDFE 301 (393)
Q Consensus 234 ~~~~~--------~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~---~~~~~~~i~~~~~~~~ 301 (393)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+ ..+.+..+.......+
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 54322 245689999999999876 48999999999999999999999998743 3344455543332222
Q ss_pred CCC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 302 SAP-WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 302 ~~~-~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
... ...++ ++.+||..||..||.+||+++++++
T Consensus 241 ~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 111 12244 9999999999999999999998875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=357.00 Aligned_cols=250 Identities=23% Similarity=0.383 Sum_probs=213.9
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
.....+|++++.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS----MSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRP 93 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC----CCHHHHHHHHHHHhcCC-CCCEeeEEEEEecCCC
Confidence 444568999999999999999999877 57789999997543 24577899999999997 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 155 VHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
+++||||+++++|.+++.. ...+++.+++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGGB
T ss_pred eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEccccccccc
Confidence 9999999999999999976 4679999999999999999999999999999999999999 55667999999999876
Q ss_pred cCCcc--eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 234 EEGKV--YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 234 ~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
..... .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||...+..+....+..+...... ..++
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 247 (283)
T 3gen_A 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLAS 247 (283)
T ss_dssp CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTCC
T ss_pred cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC---CcCC
Confidence 44321 223457788999999874 58999999999999999998 99999998888888888776433322 4578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
+.+.+||.+||..||++|||+.++++|
T Consensus 248 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 248 EKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999999999985
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=354.25 Aligned_cols=250 Identities=24% Similarity=0.412 Sum_probs=216.0
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
.....+|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAP 79 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc----cCHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCc
Confidence 334568999999999999999999987 47789999997543 24577999999999997 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
.++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFV 156 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGB
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEeccccccccc
Confidence 99999999999999998654 458999999999999999999999999999999999999 45567999999999876
Q ss_pred cCCc--ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 234 EEGK--VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 234 ~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++ |..||......+....+..+..... ...++
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 233 (269)
T 4hcu_A 157 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAS 233 (269)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSC
T ss_pred cccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC---CCcCC
Confidence 4432 2233457788999999874 58999999999999999999 9999999998888888877643322 24578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
+.+.+||.+||..||++|||+.++++|
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 234 THVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=367.46 Aligned_cols=257 Identities=28% Similarity=0.544 Sum_probs=205.9
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCc---ccHHHHHHHHHHHHHcc---CCCCeeEEeE
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK---NDKDDIKREIQIMQHLS---GQPNIVEFKG 147 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~---~h~niv~~~~ 147 (393)
.+.+..+|++++.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+++++. +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 34566789999999999999999999999999999999976543211 12334567999999983 3999999999
Q ss_pred EEEeCCeEEEEEec-cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEee
Q 016233 148 AYEDKQSVHVVMEL-CAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (393)
Q Consensus 148 ~~~~~~~~~lv~e~-~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~D 226 (393)
++.+.+..++|||+ +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++. .++.+||+|
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~kl~d 183 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL--RRGCAKLID 183 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET--TTTEEEECC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC--CCCeEEEEE
Confidence 99999999999999 789999999998888999999999999999999999999999999999999952 456799999
Q ss_pred cCCcccccCCcceecccCcccccchHHHhhc-C-CCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 016233 227 FGLSVFIEEGKVYRDIVGSAYYVAPEVLRRR-Y-GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP 304 (393)
Q Consensus 227 Fg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (393)
||++...... ......||+.|+|||++.+. + +.++||||||+++|+|++|..||.... .+......++
T Consensus 184 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~--- 253 (312)
T 2iwi_A 184 FGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP--- 253 (312)
T ss_dssp CSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC---
T ss_pred cchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc---
Confidence 9999877543 34566799999999998653 3 458999999999999999999996532 2333333332
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
..++..+.+||.+||..||++|||++|+++||||+...
T Consensus 254 -~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 254 -AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp -TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred -ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 46889999999999999999999999999999998643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=368.62 Aligned_cols=254 Identities=22% Similarity=0.347 Sum_probs=218.3
Q ss_pred ccccccceeecceecccCCeEEEEEEEC-----CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEE
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 148 (393)
++....+|++++.||+|+||.||+|.+. .+++.||||++.... .....+.+.+|+.+++.++ ||||++++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~ 118 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGV 118 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEE
Confidence 3455678999999999999999999987 455899999987542 3344678899999999996 9999999999
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEec
Q 016233 149 YEDKQSVHVVMELCAGGELFDRIIAK------------------------GHYSERAAASICRSIVNVVHICHFMGVMHR 204 (393)
Q Consensus 149 ~~~~~~~~lv~e~~~gg~L~~~l~~~------------------------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~ 204 (393)
+.+.+.+++||||+++|+|.+++... ..+++.+++.++.||+.||.|||++||+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 99999999999999999999999763 568999999999999999999999999999
Q ss_pred CCCCCcEEeccCCCCCcEEEeecCCcccccCCc---ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCC
Q 016233 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGK---VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVP 279 (393)
Q Consensus 205 Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~ 279 (393)
||||+|||+ +.++.+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++ |..
T Consensus 199 Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 199 DLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCcceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 999999999 456679999999998764332 2234568899999998875 58999999999999999999 999
Q ss_pred CCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 280 PFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 280 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
||.+....+....+..+..... ...+++++.+||.+||..||++|||+.+++++
T Consensus 276 p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCChHHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 9999998888888877654322 24688999999999999999999999999863
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=361.68 Aligned_cols=245 Identities=24% Similarity=0.411 Sum_probs=206.9
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
..+|.+++.||+|+||.||+|.+..+++.||+|.+... .....+.+.+|+.++++++ ||||+++++++.+++..++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCeeEE
Confidence 35899999999999999999999999999999988542 3455778999999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 158 VMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
||||++|++|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC--
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceecccc
Confidence 9999999999999987 5679999999999999999999999999999999999999 56677999999999876433
Q ss_pred cce---------------ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHH-----HHHHHHc
Q 016233 237 KVY---------------RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKG-----IFDAILQ 295 (393)
Q Consensus 237 ~~~---------------~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-----~~~~i~~ 295 (393)
... ...+||+.|+|||++.+ .++.++||||||+++|+|++|..||....... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 211 14679999999999876 48999999999999999999999986532210 0111111
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 296 GDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 296 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.. ..+.+++.+.+||.+||..||++|||++++++
T Consensus 242 ~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 242 RY------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HT------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cc------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 10 12457889999999999999999999999987
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=367.92 Aligned_cols=258 Identities=22% Similarity=0.369 Sum_probs=213.9
Q ss_pred cccccccceeecceecccCCeEEEEEEE-----CCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeE
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLCTE-----NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 147 (393)
.++....+|++++.||+|+||.||+|.+ ..++..||||++.... .....+.+.+|+.+++++.+||||+++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3455567999999999999999999997 3456789999997543 23456789999999999955999999999
Q ss_pred EEEeCCeEEEEEeccCCCChHHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEec
Q 016233 148 AYEDKQSVHVVMELCAGGELFDRIIAKG-----------------------HYSERAAASICRSIVNVVHICHFMGVMHR 204 (393)
Q Consensus 148 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-----------------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~ 204 (393)
++...+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 9999999999999999999999997643 27899999999999999999999999999
Q ss_pred CCCCCcEEeccCCCCCcEEEeecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCC
Q 016233 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVP 279 (393)
Q Consensus 205 Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~ 279 (393)
||||+|||+ +.++.+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|+| |..
T Consensus 197 Dikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 197 DLAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp TCSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred CCChhhEEE---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence 999999999 4566899999999987654332 233567889999998865 58999999999999999998 999
Q ss_pred CCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 016233 280 PFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHP 337 (393)
Q Consensus 280 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~ 337 (393)
||.+......+..+......... ...+++++.+||.+||..||.+|||+.++++|-
T Consensus 274 p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 274 PYPGIPVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp SSTTCCCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CcccCCcHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 99887765555555444333322 245789999999999999999999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=362.72 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=217.6
Q ss_pred ccccccceeecceecccCCeEEEEEEE-----CCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEE
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTE-----NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 148 (393)
++....+|.+.+.||+|+||.||+|.+ ..+++.||+|++.... .....+.+.+|+.+++.++ ||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~ 94 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVN-HPHVIKLYGA 94 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEE
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCceeeEEEE
Confidence 344567899999999999999999998 3456899999986432 3445678899999999996 9999999999
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHHcCC------------------------CCHHHHHHHHHHHHHHHHHHHHcCcEec
Q 016233 149 YEDKQSVHVVMELCAGGELFDRIIAKGH------------------------YSERAAASICRSIVNVVHICHFMGVMHR 204 (393)
Q Consensus 149 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~------------------------~~~~~~~~i~~qll~~l~~lH~~~ivH~ 204 (393)
+.+.+..++||||++|++|.+++..... +++.+++.++.||+.||.|||++||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 9999999999999999999999987543 8899999999999999999999999999
Q ss_pred CCCCCcEEeccCCCCCcEEEeecCCcccccCCcce---ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCC
Q 016233 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVP 279 (393)
Q Consensus 205 Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~ 279 (393)
||||+||+++ .++.+||+|||++......... ....||+.|+|||++.+ .++.++|||||||++|+|++ |..
T Consensus 175 dikp~NIli~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 175 DLAARNILVA---EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCSGGGEEEE---TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccchheEEEc---CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999994 5667999999999876543322 23467889999998875 48999999999999999999 999
Q ss_pred CCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 280 PFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 280 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
||.+.........+..+... .....+++++.+||.+||..||++|||+.+++++
T Consensus 252 p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 252 PYPGIPPERLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp SSTTCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99998887777777765432 2235689999999999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=361.11 Aligned_cols=265 Identities=28% Similarity=0.387 Sum_probs=200.2
Q ss_pred cccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 71 GKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 71 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
+..+.....+|++++.||+|+||.||+|.+..+|+.||||++..... .......+.++..+++.+. ||||+++++++.
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~ 94 (318)
T 2dyl_A 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHD-CPYIVQCFGTFI 94 (318)
T ss_dssp SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTT-CTTBCCEEEEEE
T ss_pred chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcC-CCceeeEEEEEe
Confidence 34455556789999999999999999999999999999999975432 1122233444455677775 999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCCCCCcEEeccCCCCCcEEEeecC
Q 016233 151 DKQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSKDENALLKATDFG 228 (393)
Q Consensus 151 ~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~-~ivH~Dikp~Nill~~~~~~~~~kl~DFg 228 (393)
+.+.+++||||+ ++.+..+... ...+++..++.++.||+.||.|||++ ||+||||||+||++ +.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg 170 (318)
T 2dyl_A 95 TNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFG 170 (318)
T ss_dssp CSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCT
T ss_pred cCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECC
Confidence 999999999999 5555544443 46799999999999999999999995 99999999999999 556679999999
Q ss_pred CcccccCCcceecccCcccccchHHHh------hcCCCcchHHHHHHHHHHHhhCCCCCCCC-ChHHHHHHHHcCCCCCC
Q 016233 229 LSVFIEEGKVYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAE-TEKGIFDAILQGDIDFE 301 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~ 301 (393)
++.............||+.|+|||++. ..++.++|||||||++|+|++|..||... ...+.+..+........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (318)
T 2dyl_A 171 ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL 250 (318)
T ss_dssp TC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC
T ss_pred CchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC
Confidence 998776655555678999999999984 34889999999999999999999999873 45556666665543322
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 302 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.....+++++.+||.+||..||.+|||++++|+||||+..
T Consensus 251 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 251 -PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp -CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred -CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 2234689999999999999999999999999999999754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=362.21 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=207.1
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
-.+|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++++++ ||||+++++++.+++.+|+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeCCeEEE
Confidence 357999999999999999999999999999999997654333444578899999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||||++|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC--------
T ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCccccccc
Confidence 99999999999999988889999999999999999999999999999999999999 456679999999998765432
Q ss_pred --ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 238 --VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 238 --~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+.. .........+.+++++.+
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~ 267 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ-AIPRPSTVRPGIPVAFDA 267 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS-CCCCGGGTSTTCCTHHHH
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc-CCCCccccCCCCCHHHHH
Confidence 2335679999999999865 588999999999999999999999988776544444433 333333445678999999
Q ss_pred HHHHhcccCCCCCC-CHHHHhc
Q 016233 315 LVRRMLTQDPKKRI-TSAQVLE 335 (393)
Q Consensus 315 li~~~L~~dp~~Rp-t~~e~l~ 335 (393)
||.+||..||++|| |++++++
T Consensus 268 li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 268 VIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHhccCCHHHHHHhHHHHHH
Confidence 99999999999999 7777765
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=353.04 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=203.6
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCC-cccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT-KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
..+|++.+.||+|+||.||+|.+. ++.||||++....... ....+.+.+|+.+++.++ ||||+++++++.+.+..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC--CE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCCceE
Confidence 458999999999999999999976 8899999987543222 234578899999999997 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---cEecCCCCCcEEeccCC-----CCCcEEEeecC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG---VMHRDLKPENFLLSSKD-----ENALLKATDFG 228 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~---ivH~Dikp~Nill~~~~-----~~~~~kl~DFg 228 (393)
+||||++|++|.+++. ...+++..++.++.|++.||.|||++| |+||||||+|||++... ..+.+||+|||
T Consensus 83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999988774 567999999999999999999999999 89999999999996432 25679999999
Q ss_pred CcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 016233 229 LSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (393)
++........ ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+......... ...
T Consensus 162 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 238 (271)
T 3dtc_A 162 LAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI--PST 238 (271)
T ss_dssp C--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC--CTT
T ss_pred cccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC--Ccc
Confidence 9987654332 35679999999999876 4899999999999999999999999998887777777666544332 256
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
+++.+.+||.+||..||++|||+.|++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 88999999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=373.74 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=216.1
Q ss_pred cccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
.+.....+|.+++.||+|+||.||+|.+..+++.||||++.... .......+.+|++++++++ ||||+++++++.+.
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 184 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQK 184 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecC
Confidence 34455678999999999999999999999999999999986432 2334456889999999996 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 153 QSVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
+.+++||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSR 261 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCE
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCce
Confidence 99999999999999999997654 59999999999999999999999999999999999999 556679999999998
Q ss_pred cccCCccee---cccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 016233 232 FIEEGKVYR---DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWP 306 (393)
Q Consensus 232 ~~~~~~~~~---~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 306 (393)
......... ...+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+..+....+..+.... ...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~ 338 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP---CPE 338 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCC---CCT
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCC
Confidence 654432211 1235678999999874 58999999999999999998 999999988887777776654321 224
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 307 TISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+++++.+||.+||..||++|||++++++
T Consensus 339 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 339 LCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 57899999999999999999999999976
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=356.87 Aligned_cols=254 Identities=23% Similarity=0.363 Sum_probs=204.9
Q ss_pred cccccccceeecceecccCCeEEEEEEECCC---CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEE
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENST---GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 149 (393)
.++....+|++++.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.++++++ ||||+++++++
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~ 85 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVI 85 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCccceEEEEE
Confidence 3556677999999999999999999998754 4569999876432 3345677899999999996 99999999998
Q ss_pred EeCCeEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecC
Q 016233 150 EDKQSVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (393)
Q Consensus 150 ~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg 228 (393)
. ++..++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 86 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg 161 (281)
T 1mp8_A 86 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFG 161 (281)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC--
T ss_pred c-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC---CCCCEEECccc
Confidence 5 456899999999999999997654 699999999999999999999999999999999999995 45679999999
Q ss_pred CcccccCCcc--eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 016233 229 LSVFIEEGKV--YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAP 304 (393)
Q Consensus 229 ~a~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (393)
++........ .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+..+.... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~---~ 238 (281)
T 1mp8_A 162 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---M 238 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---C
T ss_pred cccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC---C
Confidence 9987654332 223457789999999875 58999999999999999996 999999988888888887664322 2
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
.+.+++.+.+||.+||..||++|||+.+++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 239 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 35689999999999999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=361.32 Aligned_cols=257 Identities=24% Similarity=0.361 Sum_probs=215.4
Q ss_pred cccccccceeecceecccCCeEEEEEEE-----CCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeE
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLCTE-----NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 147 (393)
.++....+|++++.||+|+||.||+|.+ ..+++.||||++.... .....+.+.+|+.+++++.+||||+++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 3455667999999999999999999985 4577899999997543 23346788999999999955999999999
Q ss_pred EEEeCCeEEEEEeccCCCChHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCC
Q 016233 148 AYEDKQSVHVVMELCAGGELFDRIIAKG------------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPE 209 (393)
Q Consensus 148 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~------------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~ 209 (393)
++.+.+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 9999999999999999999999998754 3899999999999999999999999999999999
Q ss_pred cEEeccCCCCCcEEEeecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCC
Q 016233 210 NFLLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAE 284 (393)
Q Consensus 210 Nill~~~~~~~~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~ 284 (393)
||++ +.++.+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.
T Consensus 175 Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 175 NILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp GEEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred eEEE---cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 9999 4566799999999987655432 223457889999998865 58999999999999999999 99999887
Q ss_pred ChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 285 TEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 285 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
.....+........... ....++..+.+||.+||..||.+|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 252 PVDSKFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp CSSHHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchhHHHHHhccCCCCC--CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 65544444333322222 224688999999999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=359.44 Aligned_cols=255 Identities=20% Similarity=0.291 Sum_probs=212.7
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
..+..+|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.+|+||+++++++.+...
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 345678999999999999999999999999999999986432 234578899999999779999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCC--CCCcEEEeecCCcc
Q 016233 155 VHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD--ENALLKATDFGLSV 231 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~--~~~~~kl~DFg~a~ 231 (393)
.++||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++.
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999999 999999998754 599999999999999999999999999999999999996432 23459999999998
Q ss_pred cccCCcc--------eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCC---hHHHHHHHHcCCCC
Q 016233 232 FIEEGKV--------YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET---EKGIFDAILQGDID 299 (393)
Q Consensus 232 ~~~~~~~--------~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~---~~~~~~~i~~~~~~ 299 (393)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+..+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 7654322 345679999999999876 48999999999999999999999998743 33444444332221
Q ss_pred CC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 300 FE-SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 300 ~~-~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+ ......+++++.+||.+||..||++|||++++++
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 11 1122468899999999999999999999999876
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=365.62 Aligned_cols=262 Identities=25% Similarity=0.371 Sum_probs=192.9
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHH-HHHHccCCCCeeEEeEEEEeC
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQ-IMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~~~~~~~~~ 152 (393)
+.....+|++++.||+|+||.||+|.+..+|+.||||++.... .......+..|+. +++.+ +||||+++++++.+.
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~~ 93 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFRE 93 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEECS
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEeC
Confidence 3344568999999999999999999999999999999997542 2234455666666 55556 599999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCCCCCcEEeccCCCCCcEEEee
Q 016233 153 QSVHVVMELCAGGELFDRIIA-----KGHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSKDENALLKATD 226 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qll~~l~~lH~~-~ivH~Dikp~Nill~~~~~~~~~kl~D 226 (393)
+..++||||+++ +|.+++.. ...+++..++.++.|++.||.|||++ ||+||||||+|||+ +.++.+||+|
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll---~~~~~~kl~D 169 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCD 169 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE---ETTTEEEECC
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE---cCCCCEEEcc
Confidence 999999999975 78777753 56799999999999999999999999 99999999999999 4566799999
Q ss_pred cCCcccccCCcceecccCcccccchHHHh-----hcCCCcchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHcCC-CC
Q 016233 227 FGLSVFIEEGKVYRDIVGSAYYVAPEVLR-----RRYGKEIDIWSAGVILYILLSGVPPFWAETEK-GIFDAILQGD-ID 299 (393)
Q Consensus 227 Fg~a~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~-~~ 299 (393)
||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.... +.+..+..+. ..
T Consensus 170 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (327)
T 3aln_A 170 FGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ 249 (327)
T ss_dssp CSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCC
T ss_pred CCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCC
Confidence 99998776554445568999999999983 34899999999999999999999999765421 2222222221 12
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 300 FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 300 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+....+..+++.+.+||.+||..||++|||+.++++||||...
T Consensus 250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 2223345689999999999999999999999999999999754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=364.67 Aligned_cols=259 Identities=21% Similarity=0.300 Sum_probs=217.7
Q ss_pred ccccceeecceecccCCeEEEEEE-----ECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
....+|++++.||+|+||.||+|. +..+++.||||++.... .......+.+|+.++++++ ||||+++++++.
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 103 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFN-HQNIVRCIGVSL 103 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCC-CCCCCeEEEEEc
Confidence 345689999999999999999999 56678899999986432 3445667889999999996 999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEE
Q 016233 151 DKQSVHVVMELCAGGELFDRIIAKG-------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLK 223 (393)
Q Consensus 151 ~~~~~~lv~e~~~gg~L~~~l~~~~-------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~k 223 (393)
+.+..|+||||++|++|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++.++....+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999999998753 489999999999999999999999999999999999997655667899
Q ss_pred EeecCCcccccCCc---ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCC
Q 016233 224 ATDFGLSVFIEEGK---VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDI 298 (393)
Q Consensus 224 l~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~ 298 (393)
|+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++ |..||......+....+..+..
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 99999998654332 2234568999999998865 58999999999999999998 9999998888888887777643
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 016233 299 DFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (393)
Q Consensus 299 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 340 (393)
.. ....++..+.+||.+||..||.+|||+.++++|.|+.
T Consensus 264 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 264 MD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 22 2246889999999999999999999999999998864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=357.69 Aligned_cols=252 Identities=27% Similarity=0.487 Sum_probs=202.7
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
..+|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++ ||||+++++++...+..++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCcEEE
Confidence 357999999999999999999999999999999997654444556778899999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 158 VMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEeccceeee
Confidence 9999999999998864 4569999999999999999999999999999999999999 55667999999999876
Q ss_pred cCCc-ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCC--hHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 234 EEGK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET--EKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 234 ~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.. .......+...... ......++
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 264 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP--PLPSDHYS 264 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC--CCCTTTSC
T ss_pred cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC--CCcccccC
Confidence 5432 2345679999999999875 58899999999999999999999997653 33455555554432 23335689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+++.+||.+||..||++|||+.++++
T Consensus 265 ~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 265 EELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=364.28 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=211.2
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEE--EEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQF--ACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
.+|++.+.||+|+||.||+|.+..++..+ |+|.+.... .....+.+.+|+.+++++.+||||+++++++.+.+.++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 57999999999999999999999888865 999886432 33456678999999999955999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCC
Q 016233 157 VVMELCAGGELFDRIIAKG----------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA 220 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~ 220 (393)
+||||+++++|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCC
Confidence 9999999999999997654 69999999999999999999999999999999999999 4556
Q ss_pred cEEEeecCCcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCC
Q 016233 221 LLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDI 298 (393)
Q Consensus 221 ~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~ 298 (393)
.+||+|||++.............+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+..+....+..+..
T Consensus 180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~ 259 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 259 (327)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence 799999999975443333344567889999999875 48999999999999999998 9999999988888777766532
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 299 DFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 299 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
. .....+++.+.+||.+||..||++|||+++++++
T Consensus 260 ~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 260 L---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp C---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1 2224688999999999999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=361.13 Aligned_cols=255 Identities=23% Similarity=0.357 Sum_probs=216.8
Q ss_pred ccccccceeecceecccCCeEEEEEEEC-------CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEe
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTEN-------STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~ 146 (393)
++...++|++++.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++++.+||||++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 3445679999999999999999999976 457789999986542 3345677899999999995599999999
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCc
Q 016233 147 GAYEDKQSVHVVMELCAGGELFDRIIAKG----------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210 (393)
Q Consensus 147 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~N 210 (393)
+++.+.+.+++||||+++|+|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 99999999999999999999999997643 38999999999999999999999999999999999
Q ss_pred EEeccCCCCCcEEEeecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCC
Q 016233 211 FLLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAET 285 (393)
Q Consensus 211 ill~~~~~~~~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 285 (393)
||+ +.++.+||+|||++........ .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+..
T Consensus 188 Ill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 188 VLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp EEE---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEE---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 999 5566799999999987655432 223457889999998865 58999999999999999999 999999988
Q ss_pred hHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 286 EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 286 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
..+....+..+.... ....++.++.+||.+||..||++|||+.+++++
T Consensus 265 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 265 VEELFKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 888887777664322 224688999999999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=388.90 Aligned_cols=248 Identities=24% Similarity=0.303 Sum_probs=208.5
Q ss_pred cceeec-ceecccCCeEEEEEEE--CCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 79 LHYSFG-KELGRGQFGVTYLCTE--NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 79 ~~y~~~-~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
..+.+. +.||+|+||.||+|.+ ..+++.||||+++... ......+.+.+|+.+|++++ |||||++++++..+ .+
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~-~~ 444 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEAE-SW 444 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-SE
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC-CE
Confidence 344443 4799999999999954 5667899999997543 23445688999999999996 99999999999754 58
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
++||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+..
T Consensus 445 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~---~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCTTHHHHTTC
T ss_pred EEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe---CCCCEEEEEcCCcccccc
Confidence 89999999999999999888899999999999999999999999999999999999994 456799999999987654
Q ss_pred Ccc----eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 236 GKV----YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 236 ~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
... .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+..+....+..+.... ....++
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~ 598 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGCP 598 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCC
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCC
Confidence 322 223456789999999876 59999999999999999998 999999999988888888765332 224689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+++.+||.+||..||++|||++++++
T Consensus 599 ~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 599 REMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=353.78 Aligned_cols=252 Identities=21% Similarity=0.349 Sum_probs=219.2
Q ss_pred cccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
.++....+|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTRE 81 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccC
Confidence 4556677999999999999999999999999999999998643 335678999999999997 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 153 QSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
+.+++||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLS 158 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGG
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccc
Confidence 9999999999999999999874 349999999999999999999999999999999999999 45567999999999
Q ss_pred ccccCCcc--eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 016233 231 VFIEEGKV--YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWP 306 (393)
Q Consensus 231 ~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 306 (393)
........ .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+.......+...... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~ 235 (288)
T 3kfa_A 159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE 235 (288)
T ss_dssp GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCT
T ss_pred eeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC---CCCC
Confidence 87654432 233457889999999875 58999999999999999999 99999988877777776665322 2235
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 307 TISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+++.+.+||.+||..||.+|||++++++
T Consensus 236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 68999999999999999999999999976
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=371.39 Aligned_cols=259 Identities=24% Similarity=0.408 Sum_probs=207.8
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccC----------CCCeeEEeE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG----------QPNIVEFKG 147 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~----------h~niv~~~~ 147 (393)
..+|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++++.+ ||||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 45899999999999999999999999999999998643 2345678899999998852 789999999
Q ss_pred EEEeCC----eEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHc-CcEecCCCCCcEEeccC---C
Q 016233 148 AYEDKQ----SVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFM-GVMHRDLKPENFLLSSK---D 217 (393)
Q Consensus 148 ~~~~~~----~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~-~ivH~Dikp~Nill~~~---~ 217 (393)
++...+ .+++||||+ +++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+ +
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence 998654 789999999 89999999873 4599999999999999999999998 99999999999999643 2
Q ss_pred CCCcEEEeecCCcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh------HHHH
Q 016233 218 ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE------KGIF 290 (393)
Q Consensus 218 ~~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~------~~~~ 290 (393)
....+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+. .+.+
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp TEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred CcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 3457999999999876543 345689999999999876 489999999999999999999999976542 2222
Q ss_pred HHHHcCCCCCCC--------------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 016233 291 DAILQGDIDFES--------------------------------------APWPTISSSAKDLVRRMLTQDPKKRITSAQ 332 (393)
Q Consensus 291 ~~i~~~~~~~~~--------------------------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e 332 (393)
..+.......+. .....++.++.+||.+||..||++|||++|
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 222210000000 000134578899999999999999999999
Q ss_pred HhcCccccCCC
Q 016233 333 VLEHPWIKEGG 343 (393)
Q Consensus 333 ~l~h~~~~~~~ 343 (393)
+|+||||+...
T Consensus 331 ll~hp~f~~~~ 341 (373)
T 1q8y_A 331 LVNHPWLKDTL 341 (373)
T ss_dssp HHTCGGGTTCT
T ss_pred HhhChhhhccc
Confidence 99999998753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=375.11 Aligned_cols=257 Identities=23% Similarity=0.402 Sum_probs=213.1
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC--
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-- 153 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-- 153 (393)
....+|++.+.||+|+||.||+|.+..+|+.||||++..... ....+.+.+|++++++++ ||||+++++++.+.+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTR 82 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCCCeEEEeeccCCCC
Confidence 456789999999999999999999999999999999975432 334677889999999996 999999999998765
Q ss_pred eEEEEEeccCCCChHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEecc-CCCCCcEEEeecCC
Q 016233 154 SVHVVMELCAGGELFDRIIAKGH---YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSS-KDENALLKATDFGL 229 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~-~~~~~~~kl~DFg~ 229 (393)
..++||||++||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+.. ++....+||+|||+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 78999999999999998875432 999999999999999999999999999999999999832 34556799999999
Q ss_pred cccccCCcceecccCcccccchHHHh---------hcCCCcchHHHHHHHHHHHhhCCCCCCC----CChHHHHHHHHcC
Q 016233 230 SVFIEEGKVYRDIVGSAYYVAPEVLR---------RRYGKEIDIWSAGVILYILLSGVPPFWA----ETEKGIFDAILQG 296 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~~~DiwSlG~il~~lltg~~pf~~----~~~~~~~~~i~~~ 296 (393)
+.............||+.|+|||++. ..++.++|||||||++|+|++|..||.. ....+.+..+..+
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 99877666666778999999999985 3478899999999999999999999964 2334555566554
Q ss_pred CCCCC---------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 297 DIDFE---------------------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 297 ~~~~~---------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
..... ......++..+.++|.+||..||++|||+.++++
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 32110 0001224567899999999999999999999854
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=359.83 Aligned_cols=256 Identities=20% Similarity=0.347 Sum_probs=219.3
Q ss_pred ccccccccceeecceecccCCeEEEEEEEC-----CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEe
Q 016233 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146 (393)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~ 146 (393)
..++....+|++.+.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+++.++ ||||++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~ 94 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLL 94 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcC-CCCEeeeE
Confidence 455666789999999999999999999876 467899999986432 2334567889999999996 99999999
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccC
Q 016233 147 GAYEDKQSVHVVMELCAGGELFDRIIAK----------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK 216 (393)
Q Consensus 147 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~----------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~ 216 (393)
+++.+.+..++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli--- 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--- 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---
Confidence 9999999999999999999999998753 357899999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCCcccccCCcce---ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHH
Q 016233 217 DENALLKATDFGLSVFIEEGKVY---RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFD 291 (393)
Q Consensus 217 ~~~~~~kl~DFg~a~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~ 291 (393)
+.++.+||+|||++......... ....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 251 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence 55667999999999876543322 23457889999999875 58999999999999999999 899999988888888
Q ss_pred HHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 292 AILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 292 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
.+..+..... ...++..+.+||.+||..||++|||+.+++++
T Consensus 252 ~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 252 FVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8777654322 24688999999999999999999999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=360.67 Aligned_cols=249 Identities=20% Similarity=0.300 Sum_probs=204.6
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEE----EEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQF----ACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
..+|++.+.||+|+||.||+|.+..+++.+ |+|.+.... .......+.+|+.++++++ ||||+++++++.+.+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCC-BTTBCCEEEEEESSS
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC
Confidence 458999999999999999999998887765 667664322 3345678999999999996 999999999998765
Q ss_pred eEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 154 SVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
.++|+||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTHHHH
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC---CCCCEEEccCcceeE
Confidence 7899999999999999987 45699999999999999999999999999999999999994 456799999999987
Q ss_pred ccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 016233 233 IEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (393)
Q Consensus 233 ~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (393)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+.... ....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 243 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPI 243 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTT
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC---CCcc
Confidence 654332 223457889999998875 58999999999999999999 999999888877777776654322 2245
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
++.++.+|+.+||..||++|||+.+++++
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 244 CTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp BCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 78999999999999999999999999875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=354.63 Aligned_cols=247 Identities=35% Similarity=0.645 Sum_probs=199.8
Q ss_pred ccccceeec-ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe---
Q 016233 76 DVKLHYSFG-KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--- 151 (393)
Q Consensus 76 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 151 (393)
.+..+|.+. +.||+|+||.||+|.+..+++.||+|++.. ...+.+|+.++.++.+||||+++++++..
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 345568777 789999999999999999999999999853 24677899998666569999999999987
Q ss_pred -CCeEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecC
Q 016233 152 -KQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (393)
Q Consensus 152 -~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg 228 (393)
...+++||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 678999999999999999998754 69999999999999999999999999999999999999765557789999999
Q ss_pred CcccccCCcceecccCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHH----HcCCCCCCCCC
Q 016233 229 LSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI----LQGDIDFESAP 304 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i----~~~~~~~~~~~ 304 (393)
++..... ..++.++|||||||++|+|++|..||.+.........+ ......++...
T Consensus 166 ~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 166 FAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp TCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred ccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence 9875432 23667899999999999999999999876554322111 11222222222
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCCCCcC
Q 016233 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350 (393)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~~~~ 350 (393)
+..+++++.+||.+||..||++|||++|+|+||||.........+.
T Consensus 226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~ 271 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 271 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCBC
T ss_pred cccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCCC
Confidence 3568999999999999999999999999999999987655444443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=353.65 Aligned_cols=251 Identities=25% Similarity=0.379 Sum_probs=208.1
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcc----cHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN----DKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
..+|++.+.||+|+||.||+|.+..+++.||+|++......... ..+.+.+|+.++++++ ||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMHNPP 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEETTTT
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheeecCCC
Confidence 45899999999999999999999999999999998754432221 1267899999999996 999999999997766
Q ss_pred eEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcC--cEecCCCCCcEEeccCCC--CCcEEEeecC
Q 016233 154 SVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKDE--NALLKATDFG 228 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~--ivH~Dikp~Nill~~~~~--~~~~kl~DFg 228 (393)
++||||+++|+|.+++... ..+++..++.++.|++.||.|||++| |+||||||+|||++.++. ...+||+|||
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 6999999999999888654 46999999999999999999999999 999999999999964321 2349999999
Q ss_pred CcccccCCcceecccCcccccchHHHh---hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHH--HHHHHcCCCCCCCC
Q 016233 229 LSVFIEEGKVYRDIVGSAYYVAPEVLR---RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGI--FDAILQGDIDFESA 303 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~--~~~i~~~~~~~~~~ 303 (393)
++..... ......||+.|+|||++. ..++.++|||||||++|+|++|..||........ ...+....... .
T Consensus 175 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~ 250 (287)
T 4f0f_A 175 LSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP--T 250 (287)
T ss_dssp TCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC--C
T ss_pred ccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC--C
Confidence 9985443 345678999999999984 2478899999999999999999999987654332 44444433322 2
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
....+++++.+||.+||..||++|||++++++
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 23568999999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=362.48 Aligned_cols=249 Identities=19% Similarity=0.293 Sum_probs=208.4
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcE----EEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQ----FACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
..+|++.+.||+|+||.||+|.+..+++. ||+|.+.... .......+.+|+.+++.++ ||||+++++++.+ +
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCPG-S 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCC-CTTBCCEEEEECB-S
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC-C
Confidence 45899999999999999999999988876 6777664332 2233456778999999996 9999999999874 5
Q ss_pred eEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 154 SVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
..++||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADL 164 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCcccc
Confidence 689999999999999998764 579999999999999999999999999999999999999 5566799999999987
Q ss_pred ccCCc---ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 016233 233 IEEGK---VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (393)
Q Consensus 233 ~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (393)
..... ......||..|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+...... ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 241 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP---QI 241 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC---TT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC---Cc
Confidence 65432 2345568889999999874 58999999999999999999 99999988887777777766433222 34
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
++.++.+||.+||..||.+|||+.+++++
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 67889999999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=355.06 Aligned_cols=250 Identities=22% Similarity=0.360 Sum_probs=202.4
Q ss_pred ccccceeecceecccCCeEEEEEE----ECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 151 (393)
....+|++++.||+|+||.||+|. +..+++.||||++... .....+.+.+|+.++++++ ||||+++++++..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYS 82 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec
Confidence 346789999999999999999998 6678999999998643 3345678899999999997 9999999999854
Q ss_pred --CCeEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecC
Q 016233 152 --KQSVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (393)
Q Consensus 152 --~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg 228 (393)
...+++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg 159 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFG 159 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc---CCCeEEEccCc
Confidence 356899999999999999997754 499999999999999999999999999999999999994 45679999999
Q ss_pred CcccccCCcc----eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChH----------------
Q 016233 229 LSVFIEEGKV----YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEK---------------- 287 (393)
Q Consensus 229 ~a~~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---------------- 287 (393)
++........ .....|+..|+|||++.+ .++.++||||||+++|+|++|..||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 9987654321 223457888999999875 5899999999999999999999998643211
Q ss_pred HHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 288 GIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 288 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.....+..+.. ......+++++.+||.+||..||++|||+.++++
T Consensus 240 ~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 240 HLIELLKNNGR---LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHTTCC---CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccCc---CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 12222332221 1223468999999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=355.03 Aligned_cols=249 Identities=16% Similarity=0.243 Sum_probs=206.2
Q ss_pred cccceeecceecccCCeEEEEEEECCCC-------cEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTG-------RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY 149 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 149 (393)
..++|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+.+|+.+++.++ ||||+++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 81 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLS-HKHLVLNYGVC 81 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSC-CTTBCCEEEEE
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCC-CCCEeEEEEEE
Confidence 3568999999999999999999998877 479999986532 345678999999999997 99999999999
Q ss_pred EeCCeEEEEEeccCCCChHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCC-----CcEE
Q 016233 150 EDKQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDEN-----ALLK 223 (393)
Q Consensus 150 ~~~~~~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~-----~~~k 223 (393)
.+.+..++||||++|++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.. ..+|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999987654 9999999999999999999999999999999999999654321 2399
Q ss_pred EeecCCcccccCCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC
Q 016233 224 ATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE 301 (393)
Q Consensus 224 l~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 301 (393)
|+|||++...... ....||+.|+|||++.+ .++.++|||||||++|+|++|..|+..................++
T Consensus 162 l~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (289)
T 4fvq_A 162 LSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLP 238 (289)
T ss_dssp ECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred eccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCC
Confidence 9999999765432 33468899999999874 489999999999999999996555444433333333333333222
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 302 SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 302 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
...++++.+||.+||..||++|||+.++++|
T Consensus 239 ----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 239 ----APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp ----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3457889999999999999999999999985
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=350.07 Aligned_cols=250 Identities=23% Similarity=0.309 Sum_probs=211.5
Q ss_pred cccceeecc-eecccCCeEEEEEE--ECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 77 VKLHYSFGK-ELGRGQFGVTYLCT--ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 77 ~~~~y~~~~-~lg~G~~g~V~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
...+|++.+ .||+|+||.||+|. +..+++.||||++..... .....+.+.+|+.+++.++ ||||+++++++ ..+
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGIC-EAE 90 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE-ESS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE-CCC
Confidence 356899998 99999999999995 466788999999975432 2334678999999999996 99999999999 556
Q ss_pred eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
..++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++...
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKAL 167 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe---CCCcEEEccCCcceee
Confidence 7899999999999999999888899999999999999999999999999999999999995 4567999999999876
Q ss_pred cCCcce----ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 016233 234 EEGKVY----RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (393)
Q Consensus 234 ~~~~~~----~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (393)
...... ....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+..+....+..+.... ....
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 244 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAG 244 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTT
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCCC
Confidence 544322 22356789999999875 58899999999999999999 999999988888877777654321 2246
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 308 ISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+++.+.++|.+||..||++|||+.++++
T Consensus 245 ~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 245 CPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8999999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=359.35 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=211.8
Q ss_pred ccccccceeecceecccCCeEEEEEEE-----CCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEE
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTE-----NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 148 (393)
+.....+|++++.||+|+||.||+|.+ ..+++.||||++.... .......+.+|+.+++++.+||||++++++
T Consensus 22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 445567999999999999999999985 4567899999997542 233456789999999999769999999999
Q ss_pred EEeCC-eEEEEEeccCCCChHHHHHHcCC----------------CCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcE
Q 016233 149 YEDKQ-SVHVVMELCAGGELFDRIIAKGH----------------YSERAAASICRSIVNVVHICHFMGVMHRDLKPENF 211 (393)
Q Consensus 149 ~~~~~-~~~lv~e~~~gg~L~~~l~~~~~----------------~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Ni 211 (393)
+...+ .+++||||++|++|.+++..... +++..++.++.||+.||.|||++||+||||||+||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 87754 58999999999999999987543 88999999999999999999999999999999999
Q ss_pred EeccCCCCCcEEEeecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCCh
Q 016233 212 LLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETE 286 (393)
Q Consensus 212 ll~~~~~~~~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~ 286 (393)
++ +.++.+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+...
T Consensus 180 l~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 180 LL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp EE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred EE---CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 99 4556799999999987644322 234567899999999865 58999999999999999998 9999987664
Q ss_pred HH-HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 287 KG-IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 287 ~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
.+ ....+..+... . ....+++.+.++|.+||..||.+|||+.++++|
T Consensus 257 ~~~~~~~~~~~~~~-~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 257 DEEFCRRLKEGTRM-R--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp SHHHHHHHHHTCCC-C--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHhccCccC-C--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33 34444444321 1 124578999999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=359.53 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=213.7
Q ss_pred cccccccceeecceecccCCeEEEEEEECCCCc-----EEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeE
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGR-----QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 147 (393)
.++....+|++.+.||+|+||.||+|.+..+++ .||+|.+.... .....+.+.+|+.+++.+.+||||+++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 344556789999999999999999999987665 79999986542 23456778999999999955999999999
Q ss_pred EEEeCCeEEEEEeccCCCChHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEe
Q 016233 148 AYEDKQSVHVVMELCAGGELFDRIIAK--------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLL 213 (393)
Q Consensus 148 ~~~~~~~~~lv~e~~~gg~L~~~l~~~--------------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill 213 (393)
++.+.+.+++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 999999999999999999999998753 357999999999999999999999999999999999999
Q ss_pred ccCCCCCcEEEeecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHH
Q 016233 214 SSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKG 288 (393)
Q Consensus 214 ~~~~~~~~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~ 288 (393)
+ .++.+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.....
T Consensus 198 ~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 198 T---NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp E---GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred C---CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 4 456799999999987644322 223457889999998865 58999999999999999998 999998876655
Q ss_pred HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 289 IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 289 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+..+........ ....+++.+.+||.+||..||.+|||+.++++
T Consensus 275 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 275 KFYKLVKDGYQMA--QPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 5544444333222 22457899999999999999999999999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=354.02 Aligned_cols=253 Identities=20% Similarity=0.302 Sum_probs=206.8
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
+..+|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.+++++..+..++...+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-----chhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 4568999999999999999999999999999999986543 23468899999999984444555555667888899
Q ss_pred EEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 157 VVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
+||||+ +++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.++.+||+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999999 9999999874 45799999999999999999999999999999999999996444567899999999987654
Q ss_pred Ccc--------eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCC---hHHHHHHHHcCCCCCC-C
Q 016233 236 GKV--------YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAET---EKGIFDAILQGDIDFE-S 302 (393)
Q Consensus 236 ~~~--------~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~---~~~~~~~i~~~~~~~~-~ 302 (393)
... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+..+.......+ .
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 432 245679999999999876 58999999999999999999999997643 2223333333222221 1
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.....+++++.+||.+||+.||++|||++++++
T Consensus 241 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 112467899999999999999999999999876
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=366.87 Aligned_cols=250 Identities=23% Similarity=0.385 Sum_probs=203.0
Q ss_pred cccceeecceecccCCeEEEEEEEC---CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTEN---STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
...+|++.+.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.++++++ ||||+++++++.+.+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSK 119 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCC
Confidence 3458999999999999999999987 567789999986532 3445678999999999996 999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 154 SVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
.+++||||+++|+|.+++...+ .+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-----
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCccccc
Confidence 9999999999999999997654 69999999999999999999999999999999999999 5667899999999987
Q ss_pred ccCCcc----eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 016233 233 IEEGKV----YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWP 306 (393)
Q Consensus 233 ~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 306 (393)
...... .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||...+..+....+..+.... ...
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~---~~~ 273 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP---PPM 273 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC---CCT
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCc
Confidence 654321 122345778999999875 58999999999999999998 999999998888887777653221 224
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 307 TISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.++..+.+||.+||..||++|||+.++++
T Consensus 274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp TCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 67899999999999999999999999876
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=344.96 Aligned_cols=248 Identities=24% Similarity=0.420 Sum_probs=214.8
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
-..+|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.+++.++ ||||+++++++.+.+..+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT----BCHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSCE
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC----CCHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCeE
Confidence 3468999999999999999999987 57889999997543 24578899999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 157 VVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
+||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCC
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEccccccccccc
Confidence 999999999999999775 468999999999999999999999999999999999999 4556799999999987643
Q ss_pred Cc--ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 016233 236 GK--VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (393)
Q Consensus 236 ~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (393)
.. ......||+.|+|||++.+ .++.++||||||+++|+|++ |..||...+..+....+..+..... ...++..
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~ 233 (267)
T 3t9t_A 157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTH 233 (267)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHH
T ss_pred ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC---CccCcHH
Confidence 22 1233467889999999875 58999999999999999999 9999999888888888877643222 2357899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 312 AKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 312 ~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
+.+||.+||..||++|||+.+++++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 234 VYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=351.52 Aligned_cols=247 Identities=23% Similarity=0.451 Sum_probs=212.0
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe----
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED---- 151 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~---- 151 (393)
.+..+|++.+.||+|+||.||+|.+..+++.||+|++.... +.+.+|+.+++.++ ||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 79 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD-HVNIVHYNGCWDGFDYD 79 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCC-CTTBCCEEEEEEEEEEC
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCC-CCCEEEEeeeEeccccC
Confidence 35568999999999999999999999999999999986432 35678999999996 9999999998864
Q ss_pred ------------CCeEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCC
Q 016233 152 ------------KQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217 (393)
Q Consensus 152 ------------~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~ 217 (393)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--- 156 (284)
T 2a19_B 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV--- 156 (284)
T ss_dssp ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---
T ss_pred cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc---
Confidence 45589999999999999999764 5799999999999999999999999999999999999994
Q ss_pred CCCcEEEeecCCcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC
Q 016233 218 ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG 296 (393)
Q Consensus 218 ~~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 296 (393)
.++.+||+|||++.............||+.|+|||++.+ .++.++||||||+++|+|++|..||... ......+..+
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~ 234 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG 234 (284)
T ss_dssp ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT
T ss_pred CCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc
Confidence 456799999999988776555566789999999999875 4899999999999999999999988532 2334444443
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 297 DIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 297 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
.. ...++..+.+||.+||..||++|||+.|+++|.+.-.
T Consensus 235 ~~------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 235 II------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp CC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred cc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 32 1357899999999999999999999999999987654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=371.89 Aligned_cols=255 Identities=29% Similarity=0.449 Sum_probs=200.3
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
+...|.+.+.||+|+||+||.+ ...+|+.||||++... ..+.+.+|+.+++.+.+||||+++++++.+.+.+|
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 85 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY 85 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred hhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence 4456888899999999999875 4457999999998643 24567899999998756999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCC-------CHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccC----------CCC
Q 016233 157 VVMELCAGGELFDRIIAKGHY-------SERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSK----------DEN 219 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~-------~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~----------~~~ 219 (393)
+|||||. |+|.+++...... ++..++.++.||+.||.|||++||+||||||+|||++.+ +..
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence 9999995 6999998765432 223457899999999999999999999999999999643 245
Q ss_pred CcEEEeecCCcccccCCcc-----eecccCcccccchHHHhh--------cCCCcchHHHHHHHHHHHhh-CCCCCCCCC
Q 016233 220 ALLKATDFGLSVFIEEGKV-----YRDIVGSAYYVAPEVLRR--------RYGKEIDIWSAGVILYILLS-GVPPFWAET 285 (393)
Q Consensus 220 ~~~kl~DFg~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~--------~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 285 (393)
..+||+|||++........ ....+||+.|+|||++.+ .++.++|||||||++|+|++ |..||....
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 6899999999987754321 234679999999999853 48899999999999999999 999997665
Q ss_pred hHHHHHHHHcCCCCCCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 286 EKGIFDAILQGDIDFESAP---WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 286 ~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
..+ ..+..+........ ...+++++.+||.+||..||.+|||+.++|+||||..
T Consensus 245 ~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 245 SRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp THH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 433 34444444433221 1234678999999999999999999999999999964
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=374.84 Aligned_cols=252 Identities=20% Similarity=0.348 Sum_probs=218.3
Q ss_pred cccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
.++....+|++.+.||+|+||.||+|.+..++..||||++.... ...+.+.+|+.+|++++ ||||+++++++.+.
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~ 288 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTRE 288 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcC-CCCEeeEEEEEecC
Confidence 35556678999999999999999999999999999999986532 34678999999999996 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 153 QSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
+.++|||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a 365 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLS 365 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCE
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccc
Confidence 9999999999999999999864 458999999999999999999999999999999999999 45667999999999
Q ss_pred ccccCCcc--eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 016233 231 VFIEEGKV--YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWP 306 (393)
Q Consensus 231 ~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 306 (393)
+....... .....++..|+|||++.. .++.++|||||||++|+|++ |..||.+.+..+....+..+.. .....
T Consensus 366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~ 442 (495)
T 1opk_A 366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---MERPE 442 (495)
T ss_dssp ECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---CCCCT
T ss_pred eeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCC
Confidence 87654322 123456788999999875 58999999999999999999 9999999888777777665432 22235
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 307 TISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+++++.+||.+||..||++|||+.++++
T Consensus 443 ~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 443 GCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 68999999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=355.42 Aligned_cols=253 Identities=23% Similarity=0.361 Sum_probs=208.9
Q ss_pred cccccceeecceecccCCeEEEEEEECCCC----cEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTG----RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
+....+|++.+.||+|+||.||+|.+..++ ..||||++.... .......+.+|+.+++.++ ||||+++++++.
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 116 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVIS 116 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEe
Confidence 445568999999999999999999987553 359999986532 3344567889999999996 999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 151 DKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 151 ~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
+.+..++||||+++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGL 193 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCc
Confidence 999999999999999999999764 579999999999999999999999999999999999999 5567799999999
Q ss_pred cccccCCcc----eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCC
Q 016233 230 SVFIEEGKV----YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESA 303 (393)
Q Consensus 230 a~~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 303 (393)
+........ .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+... .
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~---~ 270 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL---P 270 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---C
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC---C
Confidence 987654321 123356789999999875 58999999999999999999 99999998888888887765322 1
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
....+++.+.+||.+||..||++|||+.+++++
T Consensus 271 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 271 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 224688999999999999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=368.92 Aligned_cols=247 Identities=22% Similarity=0.342 Sum_probs=211.1
Q ss_pred cccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
.++....+|++.+.||+|+||.||+|.+. ++.||||+++.. ...+.+.+|+.+|++++ ||||+++++++...
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEE 258 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSC-----TTSHHHHHHHHHHHTCC-CTTBCCEEEEEECT
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCc-----hHHHHHHHHHHHHHhcc-CCCEEEEEEEEEcC
Confidence 34455678999999999999999999986 779999998643 24678999999999996 99999999998765
Q ss_pred C-eEEEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 153 Q-SVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 153 ~-~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
. .+|+||||+++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~ 335 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGL 335 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTT
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCC
Confidence 5 79999999999999999987654 7999999999999999999999999999999999999 5567899999999
Q ss_pred cccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 016233 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (393)
++..... .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+..+....+..+... .....
T Consensus 336 a~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~p~~ 410 (450)
T 1k9a_A 336 TKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDG 410 (450)
T ss_dssp CEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC---CCCTT
T ss_pred ccccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCc
Confidence 9865432 223467889999999875 58999999999999999998 99999988877777777766322 22356
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 308 ISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+++++.+||.+||..||++|||+.++++
T Consensus 411 ~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 411 CPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8999999999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=348.24 Aligned_cols=254 Identities=24% Similarity=0.314 Sum_probs=214.3
Q ss_pred cccccceeecc-eecccCCeEEEEEEEC--CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe
Q 016233 75 EDVKLHYSFGK-ELGRGQFGVTYLCTEN--STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (393)
Q Consensus 75 ~~~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 151 (393)
....++|.+.+ .||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+++.++ ||||+++++++.
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~- 80 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQ- 80 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE-
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCC-CCCEeEEEEEec-
Confidence 33456788877 9999999999999864 467889999997542 3445678999999999996 999999999994
Q ss_pred CCeEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 152 KQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLS 157 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc---CCCCEEECcccce
Confidence 55689999999999999988654 4599999999999999999999999999999999999995 4567999999999
Q ss_pred ccccCCcce----ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 016233 231 VFIEEGKVY----RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAP 304 (393)
Q Consensus 231 ~~~~~~~~~----~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (393)
......... ....||+.|+|||++.+ .++.++||||||+++|+|++ |..||......+....+..+.... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~---~ 234 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---C 234 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC---C
T ss_pred eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCC---C
Confidence 877543322 23456889999999874 58999999999999999998 999999988888888777764322 2
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 016233 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338 (393)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~ 338 (393)
...+++++.+||.+||..||++|||+.+++++.+
T Consensus 235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 2468999999999999999999999999998643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=348.13 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=209.5
Q ss_pred cccccceeecceecccCCeEEEEEEECC---CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENS---TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 151 (393)
.....+|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+.+|+.+++.++ ||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIEE 84 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHC-CTTBCCEEEEECS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCC-CCCcceEEEEEcC
Confidence 3445689999999999999999998654 34569999986542 3345678899999999996 9999999999876
Q ss_pred CCeEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 152 KQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
+ ..++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~ 160 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLS 160 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---ETTEEEECCCCGG
T ss_pred C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC---CCCcEEeCccCCC
Confidence 5 468999999999999999765 4599999999999999999999999999999999999995 4567999999999
Q ss_pred ccccCCcc--eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 016233 231 VFIEEGKV--YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWP 306 (393)
Q Consensus 231 ~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 306 (393)
........ .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||......+....+..+.... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~ 237 (281)
T 3cc6_A 161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP---KPD 237 (281)
T ss_dssp GCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC---CCT
T ss_pred cccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC---CCC
Confidence 87654332 234567889999999875 58999999999999999998 999998887777777766654322 224
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
.+++.+.+||.+||..||++|||+.+++++
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 578999999999999999999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=348.70 Aligned_cols=249 Identities=27% Similarity=0.407 Sum_probs=204.5
Q ss_pred ccceeecceecccCCeEEEEEE----ECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC-
Q 016233 78 KLHYSFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK- 152 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 152 (393)
..+|++++.||+|+||.||+|. +..+++.||+|++.... .......+.+|+.+++.++ ||||+++++++.+.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDG 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC--
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecCC
Confidence 4579999999999999999999 57789999999997543 3445688999999999996 99999999999876
Q ss_pred -CeEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 153 -QSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 153 -~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
+.+++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLT 173 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTC
T ss_pred CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc---CCCCEEECccccc
Confidence 678999999999999999955 45799999999999999999999999999999999999994 4567999999999
Q ss_pred ccccCCcc----eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCC--------------Ch-HHHH
Q 016233 231 VFIEEGKV----YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAE--------------TE-KGIF 290 (393)
Q Consensus 231 ~~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~--------------~~-~~~~ 290 (393)
........ .....||..|+|||++.+ .++.++||||||+++|+|++|..|+... .. ....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 87765432 234568889999998865 5889999999999999999999876321 11 1222
Q ss_pred HHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 291 DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 291 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
..+..+.. ......+++++.+||.+||..||.+|||+.++++
T Consensus 254 ~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 254 NTLKEGKR---LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHTTCC---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHhccCC---CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 33333321 1223568999999999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=346.24 Aligned_cols=246 Identities=17% Similarity=0.263 Sum_probs=210.6
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC--Ce
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QS 154 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~ 154 (393)
...+|++.+.||+|+||.||+|.+. ++.||||++..... .....+.+.+|+.++++++ ||||+++++++.+. +.
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTSSS
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCCCC
Confidence 3468999999999999999999986 88999999976432 3345677999999999996 99999999999887 78
Q ss_pred EEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC--cEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 155 VHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~--ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
.++||||++||+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||++ +.++.++|+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVK 160 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSC
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEeccce
Confidence 899999999999999998765 4899999999999999999999999 9999999999999 55667899988887
Q ss_pred ccccCCcceecccCcccccchHHHhhc-C---CCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 016233 231 VFIEEGKVYRDIVGSAYYVAPEVLRRR-Y---GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP 306 (393)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~---~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 306 (393)
..... ....||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.+..+....+........ ...
T Consensus 161 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 234 (271)
T 3kmu_A 161 FSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT--IPP 234 (271)
T ss_dssp CTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC--CCT
T ss_pred eeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC--CCC
Confidence 65332 345789999999998753 3 3379999999999999999999999888877776665544332 235
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 307 TISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+++++.++|.+||..||++|||++++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 235 GISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 68999999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=355.40 Aligned_cols=248 Identities=21% Similarity=0.309 Sum_probs=204.6
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEE----EEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQF----ACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
..+|++++.||+|+||.||+|.+..+++.+ |+|.+... ........+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEESSS
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEecCC
Confidence 458999999999999999999999888766 55555432 23446788999999999996 999999999998765
Q ss_pred eEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 154 SVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
.++|+||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTC---
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc---CCCCEEEccCcceeE
Confidence 78999999999999999874 5699999999999999999999999999999999999994 456799999999987
Q ss_pred ccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 016233 233 IEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (393)
Q Consensus 233 ~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (393)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+..... ...
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 243 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPI 243 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CTT
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---Ccc
Confidence 654322 233457889999999875 58999999999999999999 9999999888877777766543222 246
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 308 ISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
++.++.+||.+||..||.+|||+.|+++
T Consensus 244 ~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8899999999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=344.35 Aligned_cols=251 Identities=20% Similarity=0.319 Sum_probs=214.8
Q ss_pred ccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe
Q 016233 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (393)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 151 (393)
.+++....+|++++.||+|+||.||+|.+. +++.||+|.+.... ...+.+.+|+++++.++ ||||+++++++.+
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~ 79 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ 79 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhCC-CcCcceEEEEEcC
Confidence 456667789999999999999999999976 46789999986532 34678999999999996 9999999999875
Q ss_pred CCeEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 152 KQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
+..++||||+++++|.+++.... .+++.++..++.|++.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 80 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~ 155 (279)
T 1qpc_A 80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGL 155 (279)
T ss_dssp -SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTT
T ss_pred -CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCcc
Confidence 45899999999999999886532 69999999999999999999999999999999999999 5667799999999
Q ss_pred cccccCCcce--ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 016233 230 SVFIEEGKVY--RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (393)
Q Consensus 230 a~~~~~~~~~--~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (393)
+......... ....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+..+....+..+... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~ 232 (279)
T 1qpc_A 156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM---VRP 232 (279)
T ss_dssp CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCC
T ss_pred cccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC---CCc
Confidence 9877544322 23457789999999874 58899999999999999999 99999998888888877765332 222
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
..+++++.+||.+||..||++|||+.++++
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 468999999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=352.83 Aligned_cols=253 Identities=20% Similarity=0.296 Sum_probs=202.5
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.++++|..+..++...+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 4568999999999999999999999999999999876443 22357889999999984455555666668888999
Q ss_pred EEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 157 VVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999999 9999998875 45799999999999999999999999999999999999996545667799999999987654
Q ss_pred Ccc--------eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChH---HHHHHHHcCCCCCC-C
Q 016233 236 GKV--------YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEK---GIFDAILQGDIDFE-S 302 (393)
Q Consensus 236 ~~~--------~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---~~~~~i~~~~~~~~-~ 302 (393)
... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... ..+..+.......+ .
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 322 235679999999999876 5899999999999999999999999764321 22333322222111 1
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.....+++++.+||.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 112457899999999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=365.06 Aligned_cols=256 Identities=16% Similarity=0.186 Sum_probs=194.9
Q ss_pred cccceeecceecccCCeEEEEEEECCC-----CcEEEEEEeecCccCCc--------ccHHHHHHHHHHHHHccCCCCee
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENST-----GRQFACKSISKRKLVTK--------NDKDDIKREIQIMQHLSGQPNIV 143 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~--------~~~~~~~~E~~~l~~l~~h~niv 143 (393)
...+|++++.||+|+||.||+|.+..+ ++.||||++........ .....+..|+..++.+. ||||+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~~iv 111 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK-YLGVP 111 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS-CCCSC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc-CCCCC
Confidence 445899999999999999999998765 58899999865421000 00111223444455554 99999
Q ss_pred EEeEEEEeC----CeEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCC
Q 016233 144 EFKGAYEDK----QSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE 218 (393)
Q Consensus 144 ~~~~~~~~~----~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~ 218 (393)
++++++... ...||||||+ |++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.+ .
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~-~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK-N 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS-C
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC-C
Confidence 999998764 5589999999 99999999875 679999999999999999999999999999999999999631 4
Q ss_pred CCcEEEeecCCcccccCCcc--------eecccCcccccchHHHhhc-CCCcchHHHHHHHHHHHhhCCCCCCCCChHHH
Q 016233 219 NALLKATDFGLSVFIEEGKV--------YRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGI 289 (393)
Q Consensus 219 ~~~~kl~DFg~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~ 289 (393)
.+.+||+|||+++.+..... .....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 56799999999987643221 1345699999999998764 89999999999999999999999986432221
Q ss_pred -HHHHHcC---CC-CCC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 290 -FDAILQG---DI-DFE--SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 290 -~~~i~~~---~~-~~~--~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
....... .. .+. ......+++++.+|+..||..||++|||+.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1111100 00 000 0011467899999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=368.41 Aligned_cols=251 Identities=21% Similarity=0.342 Sum_probs=215.4
Q ss_pred ccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe
Q 016233 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (393)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 151 (393)
..++....+|++.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|+.+|+.++ ||||+++++++.
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~- 253 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS----MSVEAFLAEANVMKTLQ-HDKLVKLHAVVT- 253 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS----BCHHHHHHHHHHHTTCC-CTTBCCEEEEEC-
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC----ccHHHHHHHHHHHhhCC-CCCEeeEEEEEe-
Confidence 3456667899999999999999999999864 6789999997532 35788999999999996 999999999987
Q ss_pred CCeEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 152 KQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
.+.+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 254 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGL 330 (454)
T ss_dssp SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTG
T ss_pred CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCC
Confidence 56789999999999999999753 368999999999999999999999999999999999999 5567899999999
Q ss_pred cccccCCcc--eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 016233 230 SVFIEEGKV--YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (393)
Q Consensus 230 a~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (393)
++....... .....+|..|+|||++.. .++.++|||||||++|+|++ |..||.+.+..+....+..+... ...
T Consensus 331 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~ 407 (454)
T 1qcf_A 331 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---PRP 407 (454)
T ss_dssp GGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC---CCC
T ss_pred ceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCC
Confidence 987653221 123456788999999874 59999999999999999999 99999999988888888776332 223
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
..+++++.+||.+||..||++|||++++++
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 468999999999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=358.06 Aligned_cols=257 Identities=29% Similarity=0.472 Sum_probs=193.5
Q ss_pred cccccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEE
Q 016233 69 ILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (393)
Q Consensus 69 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 148 (393)
..+...+....+|++.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+++++.+||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 94 (337)
T 3ll6_A 18 FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94 (337)
T ss_dssp STTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred hhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccc
Confidence 33445555667999999999999999999999999999999998543 234567788999999999779999999999
Q ss_pred EE--------eCCeEEEEEeccCCCChHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC--cEecCCCCCcEEecc
Q 016233 149 YE--------DKQSVHVVMELCAGGELFDRIIA---KGHYSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSS 215 (393)
Q Consensus 149 ~~--------~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qll~~l~~lH~~~--ivH~Dikp~Nill~~ 215 (393)
+. ....+++||||+. |+|.+++.. .+.+++.+++.++.||+.||.|||++| |+||||||+|||+
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~-- 171 (337)
T 3ll6_A 95 ASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL-- 171 (337)
T ss_dssp EEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE--
T ss_pred ccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE--
Confidence 83 4456899999995 689888865 456999999999999999999999999 9999999999999
Q ss_pred CCCCCcEEEeecCCcccccCCcce-------------ecccCcccccchHHHh----hcCCCcchHHHHHHHHHHHhhCC
Q 016233 216 KDENALLKATDFGLSVFIEEGKVY-------------RDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGV 278 (393)
Q Consensus 216 ~~~~~~~kl~DFg~a~~~~~~~~~-------------~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~ 278 (393)
+.++.+||+|||++......... ....||+.|+|||++. ..++.++|||||||++|+|++|.
T Consensus 172 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~ 250 (337)
T 3ll6_A 172 -SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250 (337)
T ss_dssp -CTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSS
T ss_pred -CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCC
Confidence 55667999999999876543221 1456999999999983 24788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 016233 279 PPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338 (393)
Q Consensus 279 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~ 338 (393)
.||......... ...... ......+..+.+||.+||+.||++|||+.|+++|-+
T Consensus 251 ~p~~~~~~~~~~----~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 251 HPFEDGAKLRIV----NGKYSI--PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp CCC----------------CCC--CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CCCcchhHHHhh----cCcccC--CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 999765543322 222222 223457788999999999999999999999998754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=361.04 Aligned_cols=256 Identities=22% Similarity=0.356 Sum_probs=207.1
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
......+|++.+.||+|+||.||+|.+. +++.||||.+... .....+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE---SSQGIEEFETEIETLSFCR-HPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC---CSSHHHHHHHHHHGGGSCC-CTTBCCEEEECCCTT
T ss_pred HHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc---ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCC
Confidence 3445678999999999999999999965 6899999987643 2345678999999999996 999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 154 SVHVVMELCAGGELFDRIIAKG----HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
..++||||+++|+|.+++.... .+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeeccc
Confidence 9999999999999999886543 48999999999999999999999999999999999999 5667899999999
Q ss_pred cccccCCc---ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHH-------HHHHcCCC
Q 016233 230 SVFIEEGK---VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIF-------DAILQGDI 298 (393)
Q Consensus 230 a~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~-------~~i~~~~~ 298 (393)
+....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.. .....+..
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 98654321 2234568999999998864 6999999999999999999999999765432111 11111111
Q ss_pred C------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 016233 299 D------FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHP 337 (393)
Q Consensus 299 ~------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~ 337 (393)
. ......+..+..+.+++.+||..||++|||+.+++++-
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1 00111122456789999999999999999999999763
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=357.59 Aligned_cols=247 Identities=21% Similarity=0.294 Sum_probs=199.0
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC----
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ---- 153 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~---- 153 (393)
..+|++++.||+|+||.||+|.+. ++.||||++... ........+|+.++++++ ||||+++++++.+..
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG----GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC----chHHHHHHHHHHHHhcCC-CCCchhhcceeccCCCCCc
Confidence 468999999999999999999876 789999998643 223455667999999996 999999999998754
Q ss_pred eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc----------CcEecCCCCCcEEeccCCCCCcEE
Q 016233 154 SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM----------GVMHRDLKPENFLLSSKDENALLK 223 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~----------~ivH~Dikp~Nill~~~~~~~~~k 223 (393)
.+++||||+++|+|.+++.. ..+++..++.++.|++.||.|||++ ||+||||||+|||+ +..+.+|
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~k 171 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTAC 171 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEE
T ss_pred eEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEE
Confidence 47999999999999998866 4699999999999999999999999 99999999999999 5567899
Q ss_pred EeecCCcccccCCcc---eecccCcccccchHHHhh------cCCCcchHHHHHHHHHHHhhCCCCCCCCCh--------
Q 016233 224 ATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR------RYGKEIDIWSAGVILYILLSGVPPFWAETE-------- 286 (393)
Q Consensus 224 l~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~~lltg~~pf~~~~~-------- 286 (393)
|+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 999999987654332 234679999999999875 356788999999999999999999975421
Q ss_pred --------HHHHHHHHcCCCCCCCC-CCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 287 --------KGIFDAILQGDIDFESA-PWP--TISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 287 --------~~~~~~i~~~~~~~~~~-~~~--~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
......+.......... .+. ..++++.+||.+||+.||++|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22223333222221111 111 12355999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=350.30 Aligned_cols=253 Identities=23% Similarity=0.440 Sum_probs=199.0
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ 153 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 153 (393)
++....+|++.+.||+|+||.||+|.+.. .||+|++..... .....+.+.+|+.+++.++ ||||++++++. ...
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-HVNILLFMGYS-TAP 92 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE-CSS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCC-CCcEEEEEeec-cCC
Confidence 44556789999999999999999998653 599999865432 3445678899999999997 99999999965 455
Q ss_pred eEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 154 SVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
..++||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATE 169 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTTEEEECCCC----
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC---CCCCEEEccceeccc
Confidence 68999999999999998854 35699999999999999999999999999999999999994 556799999999986
Q ss_pred ccC---CcceecccCcccccchHHHh----hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHH-HHHHHHcCCCCCCC-C
Q 016233 233 IEE---GKVYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKG-IFDAILQGDIDFES-A 303 (393)
Q Consensus 233 ~~~---~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~-~ 303 (393)
... ........||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+ ....+..+...... .
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence 543 22334567999999999985 347889999999999999999999998765544 44445554443322 2
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
....+++.+.+||.+||..||++|||+.++++
T Consensus 250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 33568899999999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=378.79 Aligned_cols=252 Identities=24% Similarity=0.318 Sum_probs=208.6
Q ss_pred ccccccceeecc-eecccCCeEEEEEEEC--CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 74 YEDVKLHYSFGK-ELGRGQFGVTYLCTEN--STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 74 ~~~~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
+.....++.+.+ .||+|+||.||+|.+. .++..||||+++... .....+.+.+|+++|+.++ |||||++++++.
T Consensus 330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~ 406 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQ 406 (613)
T ss_dssp SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEec
Confidence 334455666666 8999999999999875 356679999997542 3346788999999999996 999999999997
Q ss_pred eCCeEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 151 DKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 151 ~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
. +.+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 407 ~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~---~~~~vkL~DFGl 482 (613)
T 2ozo_A 407 A-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGL 482 (613)
T ss_dssp S-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCST
T ss_pred c-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc---CCCcEEEeeccC
Confidence 6 5689999999999999998654 4599999999999999999999999999999999999994 556799999999
Q ss_pred cccccCCcce----ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCC
Q 016233 230 SVFIEEGKVY----RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESA 303 (393)
Q Consensus 230 a~~~~~~~~~----~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 303 (393)
++........ ....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+..+....+..+....
T Consensus 483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~--- 559 (613)
T 2ozo_A 483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME--- 559 (613)
T ss_dssp TTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC---
T ss_pred cccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---
Confidence 9876543221 12345689999999874 59999999999999999998 999999998888888888765321
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
....+++++.+||.+||..||++|||+.++++
T Consensus 560 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 22468999999999999999999999999854
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=373.50 Aligned_cols=255 Identities=25% Similarity=0.403 Sum_probs=198.8
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
..+|.+.+.||+|+||+||. ....+++.||||++.... ...+.+|+.+|+.+.+|||||++++++.+.+..||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC------FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT------EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 34799999999999999764 344678999999986432 12356799999999569999999999999999999
Q ss_pred EEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCC--CCCcEEEeecCCccccc
Q 016233 158 VMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD--ENALLKATDFGLSVFIE 234 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~--~~~~~kl~DFg~a~~~~ 234 (393)
|||||. |+|.+++.... .+.+..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++....
T Consensus 96 v~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred EEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 999996 59999887653 356667789999999999999999999999999999996433 33468899999998765
Q ss_pred CCc----ceecccCcccccchHHHh----hcCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 016233 235 EGK----VYRDIVGSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (393)
Q Consensus 235 ~~~----~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (393)
... .....+||+.|+|||++. ..++.++|||||||++|+|++ |..||...........+....... ....
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~ 253 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC-LHPE 253 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTT-SCTT
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccc-cCcc
Confidence 432 234567999999999986 347789999999999999999 999996655443322222211111 1112
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
...+..+.+||.+||..||++|||++++|+||||..
T Consensus 254 ~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 254 KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp CHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 234566899999999999999999999999999964
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=349.07 Aligned_cols=251 Identities=22% Similarity=0.352 Sum_probs=204.2
Q ss_pred ccceeecceecccCCeEEEEEEECC-CCc--EEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENS-TGR--QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
..+|++.+.||+|+||.||+|.+.. +++ .||||++...........+.+.+|+.++++++ ||||+++++++.+.+
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS-
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC-
Confidence 4589999999999999999998643 333 68999987654434456778999999999996 999999999998765
Q ss_pred EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
.++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++...
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRAL 171 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc---CCCCEEEccccccccc
Confidence 78999999999999998764 5699999999999999999999999999999999999994 4567999999999876
Q ss_pred cCCcc----eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 016233 234 EEGKV----YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (393)
Q Consensus 234 ~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (393)
..... .....+|..|+|||++.+ .++.++||||||+++|+|++ |..||.+.+..+....+......++. ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 249 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PED 249 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTT
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--CcC
Confidence 54332 223467889999999875 48899999999999999999 99999999888888888766544332 356
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 308 ISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
++.++.++|.+||..||++|||+.++++
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 8999999999999999999999999987
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=351.63 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=203.8
Q ss_pred ccccceeecceecccCCeEEEEEEECC---CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENS---TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
....+|.+++.||+|+||.||+|.+.. +++.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEM 108 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEC-
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCC-CCCeeeeeEEEeec
Confidence 345689999999999999999998765 556899999875432 3344577899999999996 99999999998765
Q ss_pred C-----eEEEEEeccCCCChHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCc
Q 016233 153 Q-----SVHVVMELCAGGELFDRIIA------KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENAL 221 (393)
Q Consensus 153 ~-----~~~lv~e~~~gg~L~~~l~~------~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~ 221 (393)
+ ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---CTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCc
Confidence 4 35999999999999999853 3469999999999999999999999999999999999999 55667
Q ss_pred EEEeecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcC
Q 016233 222 LKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296 (393)
Q Consensus 222 ~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~ 296 (393)
+||+|||++........ .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+..+
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 265 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC
Confidence 99999999987654321 233467889999999875 48999999999999999999 99999988888888777766
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 297 DIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 297 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
... .....+++++.+||.+||..||++|||+.+++++
T Consensus 266 ~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 266 HRL---KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCC---CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCC---CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 432 2224688999999999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=365.81 Aligned_cols=257 Identities=23% Similarity=0.359 Sum_probs=212.9
Q ss_pred ccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe
Q 016233 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (393)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 151 (393)
..++....+|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+|++++ ||||+++++++.+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 250 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE 250 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC----CCHHHHHHHHHHHHhCC-CCCEeeEEEEEcC
Confidence 3456667899999999999999999999875 4679999987543 24578999999999996 9999999999876
Q ss_pred CCeEEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 152 KQSVHVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
+.+++||||+++|+|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 251 -~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~ 326 (452)
T 1fmk_A 251 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGL 326 (452)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCT
T ss_pred -CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCcc
Confidence 668999999999999999964 3569999999999999999999999999999999999999 4566799999999
Q ss_pred cccccCCcc--eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 016233 230 SVFIEEGKV--YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (393)
Q Consensus 230 a~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (393)
++....... .....++..|+|||++.. .++.++|||||||++|+|++ |..||.+....+....+..+... ...
T Consensus 327 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~ 403 (452)
T 1fmk_A 327 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCP 403 (452)
T ss_dssp TC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCC
T ss_pred ceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCC
Confidence 987654321 223457789999998864 58999999999999999999 99999999888888888766332 222
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CccccC
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLE--HPWIKE 341 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~--h~~~~~ 341 (393)
..+++.+.+||.+||..||++|||++++++ ..++..
T Consensus 404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 468999999999999999999999999986 345543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=353.18 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=207.0
Q ss_pred ccceeecceecccCCeEEEEEE----ECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE--e
Q 016233 78 KLHYSFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE--D 151 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~--~ 151 (393)
..+|++.+.||+|+||.||+|. +..+++.||||++... .....+.+.+|+.++++++ ||||+++++++. +
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALH-SDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCC
Confidence 4589999999999999999999 5678999999998653 2345667899999999996 999999999886 5
Q ss_pred CCeEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 152 KQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
.+.+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLA 174 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCGGGC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC---CCCCEEEcccccc
Confidence 5679999999999999999976 45699999999999999999999999999999999999994 4567999999999
Q ss_pred ccccCCcc----eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh---------------HHHH
Q 016233 231 VFIEEGKV----YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE---------------KGIF 290 (393)
Q Consensus 231 ~~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~---------------~~~~ 290 (393)
........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 87654332 223468889999999875 488999999999999999999999865432 1223
Q ss_pred HHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 291 DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 291 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
..+..+.. ......+++.+.+||.+||..||++|||+.+++++
T Consensus 255 ~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 255 ELLEEGQR---LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhcccC---CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33333321 12235689999999999999999999999999654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=362.67 Aligned_cols=256 Identities=17% Similarity=0.185 Sum_probs=197.7
Q ss_pred cccceeecceecccCCeEEEEEEECC---CCcEEEEEEeecCccCC--------cccHHHHHHHHHHHHHccCCCCeeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENS---TGRQFACKSISKRKLVT--------KNDKDDIKREIQIMQHLSGQPNIVEF 145 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~--------~~~~~~~~~E~~~l~~l~~h~niv~~ 145 (393)
...+|++++.||+|+||.||+|.+.. ++..+|||++....... ......+.+|+.+++.+. ||||+++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~~ 113 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPLF 113 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCCE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCccee
Confidence 34689999999999999999999987 78899999987542100 011234567888888886 9999999
Q ss_pred eEEEEe----CCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCc
Q 016233 146 KGAYED----KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENAL 221 (393)
Q Consensus 146 ~~~~~~----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~ 221 (393)
++++.. ....|+||||+ |++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ ...
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~~ 191 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-PDQ 191 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS-TTS
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC-CCc
Confidence 999987 77899999999 999999998777899999999999999999999999999999999999996432 237
Q ss_pred EEEeecCCcccccCCc--------ceecccCcccccchHHHhhc-CCCcchHHHHHHHHHHHhhCCCCCCCC--ChHHHH
Q 016233 222 LKATDFGLSVFIEEGK--------VYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAE--TEKGIF 290 (393)
Q Consensus 222 ~kl~DFg~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~~lltg~~pf~~~--~~~~~~ 290 (393)
+||+|||+++.+.... ......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+. ......
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 9999999998764321 12445799999999998764 899999999999999999999999653 222221
Q ss_pred HHHHcCCCCCCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 291 DAILQGDIDFES-----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 291 ~~i~~~~~~~~~-----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
..........+. .....+++++.+||.+||..||++|||++++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 111110001110 011268899999999999999999999999976
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=367.91 Aligned_cols=253 Identities=21% Similarity=0.286 Sum_probs=210.1
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
+.++|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.|.++++|+.+..++...+..+
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-----SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 4568999999999999999999999999999999886543 22357889999999986688888888888899999
Q ss_pred EEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 157 VVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
|||||+ +++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||+++....
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 9999999875 56799999999999999999999999999999999999996545667899999999987654
Q ss_pred Ccc--------eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh---HHHHHHHHcCCCCCC-C
Q 016233 236 GKV--------YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE---KGIFDAILQGDIDFE-S 302 (393)
Q Consensus 236 ~~~--------~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~~-~ 302 (393)
... .....||+.|+|||++.+ .++.++|||||||+||+|++|..||.+... .+.+..+........ .
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 332 125689999999999876 589999999999999999999999987443 333433333221111 1
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.....++.++.+||.+||..||++||+++++++
T Consensus 239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111357899999999999999999999998764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=359.94 Aligned_cols=251 Identities=19% Similarity=0.251 Sum_probs=201.2
Q ss_pred cccccccceeecceecccCCeEEEEE-----EECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccC--CCCeeEE
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLC-----TENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG--QPNIVEF 145 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~--h~niv~~ 145 (393)
.......+|.+.+.||+|+||.||+| .+..+++.||||++... ....+.+|+++++.+.. |+||+++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 34445678999999999999999999 46778999999998532 45678888988888852 8999999
Q ss_pred eEEEEeCCeEEEEEeccCCCChHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEecc-----
Q 016233 146 KGAYEDKQSVHVVMELCAGGELFDRIIA-----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSS----- 215 (393)
Q Consensus 146 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~----- 215 (393)
++++...+..|+|||||+||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCc
Confidence 9999999999999999999999999974 456999999999999999999999999999999999999954
Q ss_pred ---CCCCCcEEEeecCCccccc---CCcceecccCcccccchHHHhhc-CCCcchHHHHHHHHHHHhhCCCCCCCCChHH
Q 016233 216 ---KDENALLKATDFGLSVFIE---EGKVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKG 288 (393)
Q Consensus 216 ---~~~~~~~kl~DFg~a~~~~---~~~~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 288 (393)
++..+.+||+|||+++.+. ........+||+.|+|||++.+. ++.++|||||||++|+|+||..||.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 2226789999999997543 33445667899999999998764 8999999999999999999999996543210
Q ss_pred HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 016233 289 IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHP 337 (393)
Q Consensus 289 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~ 337 (393)
......+.. ...++.+.+++.+||..+|.+|++..+.|.+.
T Consensus 293 -----~~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 293 -----CKPEGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp -----EEECSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred -----eeechhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 000011111 12467899999999999999997766655543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=352.25 Aligned_cols=253 Identities=24% Similarity=0.341 Sum_probs=204.9
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE---
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE--- 150 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~--- 150 (393)
......+|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++ ||||+++++++.
T Consensus 24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 99 (317)
T 2buj_A 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFN-HPNILRLVAYCLRER 99 (317)
T ss_dssp EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEE
T ss_pred EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEecc
Confidence 334456899999999999999999999999999999998653 3345678899999999996 999999999986
Q ss_pred -eCCeEEEEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEe
Q 016233 151 -DKQSVHVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225 (393)
Q Consensus 151 -~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~ 225 (393)
.....++||||+.+|+|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~ 176 (317)
T 2buj_A 100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLM 176 (317)
T ss_dssp TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEEC
T ss_pred CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEE
Confidence 33478999999999999998876 3669999999999999999999999999999999999999 556679999
Q ss_pred ecCCcccccCCc----------ceecccCcccccchHHHhh----cCCCcchHHHHHHHHHHHhhCCCCCCCCC--hHHH
Q 016233 226 DFGLSVFIEEGK----------VYRDIVGSAYYVAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAET--EKGI 289 (393)
Q Consensus 226 DFg~a~~~~~~~----------~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~~lltg~~pf~~~~--~~~~ 289 (393)
|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ....
T Consensus 177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 256 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256 (317)
T ss_dssp CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH
T ss_pred ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh
Confidence 999987653211 1123468999999999863 26899999999999999999999995311 1112
Q ss_pred HHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 290 FDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 290 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
...+.. ...+ ...+.++.++.+||.+||..||.+|||+.+++++
T Consensus 257 ~~~~~~-~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 257 ALAVQN-QLSI--PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHHHHC-C--C--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHhhc-cCCC--CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 222222 2222 2235689999999999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=345.94 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=206.7
Q ss_pred cccceeecceecccCCeEEEEEEECCCC---cEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEE-EeC
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTG---RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAY-EDK 152 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~-~~~ 152 (393)
...+|++.+.||+|+||.||+|.+..++ ..+|+|.+.... .....+.+.+|+.++++++ ||||+++++++ ..+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSE 99 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcCC
Confidence 3457999999999999999999976443 358999886432 3345677899999999996 99999999985 556
Q ss_pred CeEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 153 QSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
+..++||||+++|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLAR 176 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGC
T ss_pred CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECcccccc
Confidence 788999999999999999976 3458999999999999999999999999999999999999 566789999999998
Q ss_pred cccCCc-----ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 016233 232 FIEEGK-----VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAP 304 (393)
Q Consensus 232 ~~~~~~-----~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (393)
...... ......||+.|+|||++.+ .++.++||||||+++|+|++ |.+||......+....+..+......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 254 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP-- 254 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC--
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC--
Confidence 764432 2234567889999999875 58999999999999999999 67777777776777777766543332
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
..+++.+.++|.+||..||++|||+.++++
T Consensus 255 -~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 255 -EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 457899999999999999999999999987
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=347.39 Aligned_cols=247 Identities=24% Similarity=0.372 Sum_probs=196.7
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHH--ccCCCCeeEEeEEEEe--
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH--LSGQPNIVEFKGAYED-- 151 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~~h~niv~~~~~~~~-- 151 (393)
.+..+|++.+.||+|+||.||+|.+ +++.||||++... ....+.+|.+++.. ++ ||||+++++++..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~-h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLR-HENILGFIASDMTSR 75 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCC-CTTBCCEEEEEEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhcc-CcCeeeEEEeecccc
Confidence 3567899999999999999999987 5899999998532 35566778888777 64 9999999998654
Q ss_pred --CCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------HcCcEecCCCCCcEEeccCCCCCc
Q 016233 152 --KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH--------FMGVMHRDLKPENFLLSSKDENAL 221 (393)
Q Consensus 152 --~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH--------~~~ivH~Dikp~Nill~~~~~~~~ 221 (393)
...+++||||+++|+|.+++. ...+++..++.++.||+.||.||| ++||+||||||+|||+ +.++.
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~ 151 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQ 151 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSC
T ss_pred CCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCC
Confidence 356899999999999999884 457999999999999999999999 9999999999999999 55667
Q ss_pred EEEeecCCcccccCCcce-----ecccCcccccchHHHhhc-------CCCcchHHHHHHHHHHHhhC----------CC
Q 016233 222 LKATDFGLSVFIEEGKVY-----RDIVGSAYYVAPEVLRRR-------YGKEIDIWSAGVILYILLSG----------VP 279 (393)
Q Consensus 222 ~kl~DFg~a~~~~~~~~~-----~~~~gt~~y~aPE~l~~~-------~~~~~DiwSlG~il~~lltg----------~~ 279 (393)
+||+|||++......... ....||+.|+|||++.+. ++.++|||||||++|+|++| ..
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 999999999876544322 234799999999998753 34689999999999999999 88
Q ss_pred CCCCCC----hHHHHHHHHcCCCCCCCCC----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 280 PFWAET----EKGIFDAILQGDIDFESAP----WPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 280 pf~~~~----~~~~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
||.... ....+..........+... ...+++++.+||.+||..||++|||++++++
T Consensus 232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 986532 2233333332221111111 0124577999999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=342.66 Aligned_cols=245 Identities=22% Similarity=0.339 Sum_probs=202.0
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC-C
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK-Q 153 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~ 153 (393)
.....+|++.+.||+|+||.||+|.+. |+.||||++... ...+.+.+|+.++++++ ||||+++++++... +
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG 88 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCC-CTTBCCEEEEECCC--
T ss_pred cCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch-----hHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCC
Confidence 334568999999999999999999875 889999998643 34678899999999996 99999999987544 5
Q ss_pred eEEEEEeccCCCChHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 154 SVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
.+++||||+++++|.+++...+. +++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~ 165 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK 165 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeeccccc
Confidence 78999999999999999976543 8999999999999999999999999999999999999 556679999999998
Q ss_pred cccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 232 FIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
...... ....+++.|+|||++.+ .++.++||||||+++|+|++ |..||......+....+..+.. ......++
T Consensus 166 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 240 (278)
T 1byg_A 166 EASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCP 240 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCC
T ss_pred cccccc--cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCcccCC
Confidence 654432 34467899999999875 58999999999999999998 9999998887777777765532 22235689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+.+.++|.+||..||++|||+.++++
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 241 PAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=354.23 Aligned_cols=261 Identities=19% Similarity=0.238 Sum_probs=206.5
Q ss_pred cccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 71 GKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 71 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
..+......+|++.+.||+|+||.||+|.+. +++.||||++..... ......+.+|+.+++.++ ||||+++++++.
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 97 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERT--QGGELQFQTEVEMISMAV-HRNLLRLRGFCM 97 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCC-CTTBCCCCEEEC
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccC--chHHHHHHHHHHHHHhcc-CCCccceEEEEe
Confidence 3445566789999999999999999999854 689999999875432 223346889999999997 999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CcEecCCCCCcEEeccCCCCCcEE
Q 016233 151 DKQSVHVVMELCAGGELFDRIIAKG----HYSERAAASICRSIVNVVHICHFM---GVMHRDLKPENFLLSSKDENALLK 223 (393)
Q Consensus 151 ~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qll~~l~~lH~~---~ivH~Dikp~Nill~~~~~~~~~k 223 (393)
+.+..++||||+++|+|.+++.... .+++..++.++.|++.||.|||++ ||+||||||+|||+ +.++.+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~k 174 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV 174 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEE
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEE
Confidence 9999999999999999999997643 399999999999999999999999 99999999999999 5566799
Q ss_pred EeecCCcccccCC--cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCC-----CChHHHHHHHHc
Q 016233 224 ATDFGLSVFIEEG--KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWA-----ETEKGIFDAILQ 295 (393)
Q Consensus 224 l~DFg~a~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~-----~~~~~~~~~i~~ 295 (393)
|+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .........+..
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 9999999876533 23344569999999999864 589999999999999999999999952 111111111111
Q ss_pred CCCCC----------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 016233 296 GDIDF----------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPW 338 (393)
Q Consensus 296 ~~~~~----------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~ 338 (393)
..... ........+..+.+++.+||..||.+|||+.++++|-.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 10000 00001123467999999999999999999999998754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=343.12 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=206.8
Q ss_pred ccceeecceecccCCeEEEEEEECCCCc---EEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGR---QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
...|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 96 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEG 96 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSS
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecCCC
Confidence 3468888999999999999999765554 79999986432 3345678899999999996 9999999999987665
Q ss_pred E-EEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 155 V-HVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 155 ~-~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
. ++||||+.+|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARD 173 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCT
T ss_pred CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCccc
Confidence 5 999999999999999976 4568999999999999999999999999999999999999 5566799999999986
Q ss_pred ccCCc-----ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 016233 233 IEEGK-----VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (393)
Q Consensus 233 ~~~~~-----~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (393)
..... ......||+.|+|||.+.+ .++.++||||||+++|+|++ |.+||...+..+....+..+.... ..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~ 250 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP---QP 250 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC---CC
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC---CC
Confidence 54322 2234568899999999876 58999999999999999999 555555666666666666654322 22
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
..+++.+.+||.+||..||.+|||+.++++
T Consensus 251 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 251 EYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 457899999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=356.60 Aligned_cols=245 Identities=15% Similarity=0.199 Sum_probs=201.0
Q ss_pred ccceeecceecccCCeEEEEEEECCC--------CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeE-----
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENST--------GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE----- 144 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~----- 144 (393)
..+|++.+.||+|+||.||+|.+..+ ++.||||++... ..+.+|+.++++++ ||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~-h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAA-KPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHC-CHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhc-ccchhhhhhhh
Confidence 46899999999999999999999874 889999998643 35788999999996 998887
Q ss_pred ----------EeEEEEe-CCeEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcE
Q 016233 145 ----------FKGAYED-KQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENF 211 (393)
Q Consensus 145 ----------~~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Ni 211 (393)
+++++.. ++..|+||||+ +++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 6777776 78899999999 99999999875 6899999999999999999999999999999999999
Q ss_pred EeccCCCCC--cEEEeecCCcccccCCc--------ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCC
Q 016233 212 LLSSKDENA--LLKATDFGLSVFIEEGK--------VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPP 280 (393)
Q Consensus 212 ll~~~~~~~--~~kl~DFg~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~p 280 (393)
|++ .++ .+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..|
T Consensus 191 l~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 191 FVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp EEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred EEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 995 344 79999999998764322 1134579999999999876 589999999999999999999999
Q ss_pred CCCCC--hHHHHHHH---HcCCCCC--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 281 FWAET--EKGIFDAI---LQGDIDF--ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 281 f~~~~--~~~~~~~i---~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
|.... ........ ......+ ....+..+++++.+||.+||..||++|||++++++
T Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 98753 22222222 2222111 12223467999999999999999999999999976
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=349.19 Aligned_cols=249 Identities=26% Similarity=0.401 Sum_probs=203.2
Q ss_pred cccce-eecceecccCCeEEEEEE----ECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe
Q 016233 77 VKLHY-SFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (393)
Q Consensus 77 ~~~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 151 (393)
+..+| ++++.||+|+||.||+|. +..+++.||||++.... .......+.+|+.++++++ ||||+++++++.+
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 104 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLY-HEHIIKYKGCCED 104 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CcchhhEEEEEec
Confidence 34455 999999999999998875 34578999999997542 3345677899999999997 9999999999987
Q ss_pred C--CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 152 K--QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 152 ~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
. ..+++||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 105 AGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFGL 180 (318)
T ss_dssp TTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGG
T ss_pred CCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCccc
Confidence 4 6789999999999999988654 59999999999999999999999999999999999999 5567799999999
Q ss_pred cccccCCcc----eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChH---------------HH
Q 016233 230 SVFIEEGKV----YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEK---------------GI 289 (393)
Q Consensus 230 a~~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---------------~~ 289 (393)
+........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...... ..
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 260 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence 988765432 234568889999999876 5889999999999999999999999653221 12
Q ss_pred HHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 290 FDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 290 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
...+..+.. ......+++++.+||.+||..||++|||+.++++
T Consensus 261 ~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 261 TELLERGER---LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcccC---CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 222223221 2223568999999999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=387.03 Aligned_cols=260 Identities=25% Similarity=0.422 Sum_probs=212.3
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe------C
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED------K 152 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~------~ 152 (393)
.+|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.++++++ ||||+++++++.. .
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCCCTT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCC-CCCCCceeeeecccccccCC
Confidence 58999999999999999999999999999999886532 3445677899999999996 9999999998765 6
Q ss_pred CeEEEEEeccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 153 QSVHVVMELCAGGELFDRIIAKG---HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
+..++||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++....+||+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 77899999999999999997644 589999999999999999999999999999999999998766666799999999
Q ss_pred cccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHH---------H-----HH
Q 016233 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFD---------A-----IL 294 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~---------~-----i~ 294 (393)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|..||........+. . ..
T Consensus 171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l 250 (676)
T 3qa8_A 171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250 (676)
T ss_dssp CCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred ccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence 998877666667789999999999864 58999999999999999999999997653322110 0 01
Q ss_pred cCCCCCCC------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 295 QGDIDFES------APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 295 ~~~~~~~~------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
.+...+.. .....+++.+.+||.+||..||++|||++++|+||||..
T Consensus 251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 11111111 112236788999999999999999999999999999974
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=358.62 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=199.9
Q ss_pred ccceeecceecccCCeEEEEEEECCCC---cEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE-eCC
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTG---RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE-DKQ 153 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~-~~~ 153 (393)
...|++.+.||+|+||.||+|.+..++ ..||+|.+... ......+.+.+|+.++++++ ||||+++++++. .++
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~ 164 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEG 164 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCCSS
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCC
Confidence 346899999999999999999975433 46899988643 23445678999999999996 999999999864 456
Q ss_pred eEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 154 SVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
..++||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARD 241 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-----
T ss_pred CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeecccccc
Confidence 789999999999999999764 458899999999999999999999999999999999999 5567899999999986
Q ss_pred ccCCc-----ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 016233 233 IEEGK-----VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (393)
Q Consensus 233 ~~~~~-----~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (393)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++ |.+||.+.+..+....+..+..... .
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~---p 318 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---P 318 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC---C
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence 64332 1233467889999999875 58999999999999999999 7888887776666667766654322 2
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
..++..+.++|.+||..||++|||+.+++++
T Consensus 319 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 319 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4678999999999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=369.67 Aligned_cols=256 Identities=23% Similarity=0.361 Sum_probs=217.2
Q ss_pred ccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe
Q 016233 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (393)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 151 (393)
..++....+|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+++|++|+ ||||+++++++.+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 333 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE 333 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC----CCHHHHHHHHHHHHhCC-CCCEeeEEEEEee
Confidence 3456667889999999999999999999875 4679999997543 24578999999999996 9999999999876
Q ss_pred CCeEEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 152 KQSVHVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
+.+||||||+++|+|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 334 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~ 409 (535)
T 2h8h_A 334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGL 409 (535)
T ss_dssp -SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTS
T ss_pred -ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEccccc
Confidence 678999999999999999964 3569999999999999999999999999999999999999 4566799999999
Q ss_pred cccccCCc--ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 016233 230 SVFIEEGK--VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (393)
Q Consensus 230 a~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (393)
++...... ......++..|+|||++.. .++.++|||||||+||+|++ |..||.+....+.+..+..+... ...
T Consensus 410 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~ 486 (535)
T 2h8h_A 410 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCP 486 (535)
T ss_dssp TTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC---CCC
T ss_pred ceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCC
Confidence 98765322 1123456789999998864 58999999999999999999 99999999888888888766322 122
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC--cccc
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEH--PWIK 340 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h--~~~~ 340 (393)
..++.++.+||.+||..||++|||++++++. .+|.
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 4689999999999999999999999999863 4554
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=346.76 Aligned_cols=250 Identities=27% Similarity=0.366 Sum_probs=203.6
Q ss_pred eeecceecccCCeEEEEEEECCCCcEEEEEEeecCcc-CCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEE
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL-VTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVM 159 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 159 (393)
|..++.||+|+||.||+|.+ +++.||||++..... ......+.+.+|+.+++.++ ||||+++++++.+.+..++||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceEEEE
Confidence 45568999999999999986 588999999875432 22344678999999999996 999999999999999999999
Q ss_pred eccCCCChHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 160 ELCAGGELFDRIIA---KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 160 e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeecccccccccc
Confidence 99999999998874 3459999999999999999999999999999999999999 56678999999999876543
Q ss_pred c---ceecccCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCCCCCCChHH----HHHHHHcCCCCC-------CC
Q 016233 237 K---VYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKG----IFDAILQGDIDF-------ES 302 (393)
Q Consensus 237 ~---~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~----~~~~i~~~~~~~-------~~ 302 (393)
. ......||+.|+|||++.+.++.++||||||+++|+|++|..||....... ....+......+ ..
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN 266 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred cccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence 2 123457999999999998889999999999999999999999997654322 222222221110 00
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
......+..+.+++.+||..||.+|||+.+++++
T Consensus 267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1112345678999999999999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=349.74 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=211.2
Q ss_pred ccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe
Q 016233 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (393)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 151 (393)
..++....+|++.+.||+|+||.||+|.+.. .+|+|++..... .....+.+.+|+.++++++ ||||+++++++.+
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTR-HENVVLFMGACMS 100 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCC-CTTBCCCCEEEEC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCC-CCCEeEEEEEEec
Confidence 4455556789999999999999999999864 499999875432 2334556778999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 152 KQSVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
.+.+++||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLF 176 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCC
T ss_pred CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCc
Confidence 999999999999999999987654 699999999999999999999999999999999999994 357999999998
Q ss_pred ccccC------CcceecccCcccccchHHHhh----------cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH
Q 016233 231 VFIEE------GKVYRDIVGSAYYVAPEVLRR----------RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL 294 (393)
Q Consensus 231 ~~~~~------~~~~~~~~gt~~y~aPE~l~~----------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 294 (393)
..... ........||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 256 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence 76532 122334569999999999863 36889999999999999999999999988888877777
Q ss_pred cCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 295 QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 295 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+..... ....++.++.+||.+||..||++|||+.++++
T Consensus 257 ~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 257 TGMKPNL--SQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp TTCCCCC--CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred cCCCCCC--CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 6644322 22357899999999999999999999999987
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=342.46 Aligned_cols=241 Identities=28% Similarity=0.456 Sum_probs=195.0
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
..+|++.+.||+|+||.||+|.+. ++.||||.+.. ....+.+.+|+.++++++ ||||+++++++.+ ..++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~l 76 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-----ESERKAFIVELRQLSRVN-HPNIVKLYGACLN--PVCL 76 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS-----TTHHHHHHHHHHHHHHCC-CTTBCCEEEBCTT--TTEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC-----hhHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC--CcEE
Confidence 357999999999999999999976 78999998853 335678899999999996 9999999998874 4789
Q ss_pred EEeccCCCChHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---cCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 158 VMELCAGGELFDRIIAKG---HYSERAAASICRSIVNVVHICHF---MGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qll~~l~~lH~---~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
||||++||+|.+++.... .+++..+..++.|++.||.|||+ +||+||||||+|||++. +...+||+|||++.
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~--~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA--GGTVLKICDFGTAC 154 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEET--TTTEEEECCCCC--
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeC--CCCEEEEccccccc
Confidence 999999999999997654 37899999999999999999999 89999999999999953 22348999999998
Q ss_pred cccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh--HHHHHHHHcCCCCCCCCCCCCC
Q 016233 232 FIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE--KGIFDAILQGDIDFESAPWPTI 308 (393)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~ 308 (393)
..... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||..... ......+..+.. ......+
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 229 (307)
T 2eva_A 155 DIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR---PPLIKNL 229 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC---CCCBTTC
T ss_pred ccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC---CCccccc
Confidence 65432 234579999999999876 589999999999999999999999975432 233334444322 2223568
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 309 SSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
++.+.+||.+||..||++|||++++++
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=356.28 Aligned_cols=251 Identities=18% Similarity=0.216 Sum_probs=200.0
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccC-----CcccHHHHHHHHHHHHHcc--------CCCCeeE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV-----TKNDKDDIKREIQIMQHLS--------GQPNIVE 144 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~--------~h~niv~ 144 (393)
..+|++++.||+|+||.||+|++ +|+.||||++...... .....+.+.+|+.+++.++ +||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46899999999999999999998 5899999999865431 2334588999999999986 4888888
Q ss_pred EeEEEE------------------------------eCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHH
Q 016233 145 FKGAYE------------------------------DKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194 (393)
Q Consensus 145 ~~~~~~------------------------------~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~ 194 (393)
+.+++. +.+.+|||||||++|++.+.+.+ +.+++.+++.++.||+.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 877653 26789999999999987776644 57899999999999999999
Q ss_pred HHH-HcCcEecCCCCCcEEeccCC-----------------CCCcEEEeecCCcccccCCcceecccCcccccchHHHhh
Q 016233 195 ICH-FMGVMHRDLKPENFLLSSKD-----------------ENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR 256 (393)
Q Consensus 195 ~lH-~~~ivH~Dikp~Nill~~~~-----------------~~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~ 256 (393)
||| ++||+||||||+|||++.++ ....+||+|||+|+..... ..+||+.|+|||++.+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence 999 99999999999999997543 1237999999999977643 3479999999999987
Q ss_pred cCCCcchHHHHHHH-HHHHhhCCCCCCCCCh-HHHHHHHHcC-CCC--CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 016233 257 RYGKEIDIWSAGVI-LYILLSGVPPFWAETE-KGIFDAILQG-DID--FESAPWPTISSSAKDLVRRMLTQDPKKRITSA 331 (393)
Q Consensus 257 ~~~~~~DiwSlG~i-l~~lltg~~pf~~~~~-~~~~~~i~~~-~~~--~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~ 331 (393)
..+.++||||||++ .+++++|..||.+... ......+... ... .....++.+++++.+||.+||..| |++
T Consensus 252 ~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~ 326 (336)
T 2vuw_A 252 DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT 326 (336)
T ss_dssp CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence 77889999998777 7789999999943211 1223333322 111 111123357889999999999977 999
Q ss_pred HHh-cCcccc
Q 016233 332 QVL-EHPWIK 340 (393)
Q Consensus 332 e~l-~h~~~~ 340 (393)
|+| +||||+
T Consensus 327 e~l~~Hp~f~ 336 (336)
T 2vuw_A 327 DLLCQHSLFK 336 (336)
T ss_dssp HHHHHCGGGC
T ss_pred HHHhcCCCcC
Confidence 999 999995
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=342.76 Aligned_cols=250 Identities=20% Similarity=0.305 Sum_probs=195.3
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHcc-CCCCeeEEeEEEEeC-
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS-GQPNIVEFKGAYEDK- 152 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~~~~~~~~~- 152 (393)
..+.++|++.+.||+|+||.||+|.+. ++.||||++... ......+|.+++..+. +||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 345678999999999999999999986 899999998532 2344555666665541 499999999999887
Q ss_pred ---CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc--------CcEecCCCCCcEEeccCCCCCc
Q 016233 153 ---QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM--------GVMHRDLKPENFLLSSKDENAL 221 (393)
Q Consensus 153 ---~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~--------~ivH~Dikp~Nill~~~~~~~~ 221 (393)
..+++||||+++|+|.+++.. ..+++..++.++.|++.||.|||++ ||+||||||+|||+ +.++.
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~ 180 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGT 180 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSC
T ss_pred CCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCC
Confidence 789999999999999999865 4799999999999999999999998 99999999999999 55667
Q ss_pred EEEeecCCcccccCCcce-----ecccCcccccchHHHhhc-CCCc------chHHHHHHHHHHHhhC----------CC
Q 016233 222 LKATDFGLSVFIEEGKVY-----RDIVGSAYYVAPEVLRRR-YGKE------IDIWSAGVILYILLSG----------VP 279 (393)
Q Consensus 222 ~kl~DFg~a~~~~~~~~~-----~~~~gt~~y~aPE~l~~~-~~~~------~DiwSlG~il~~lltg----------~~ 279 (393)
+||+|||++......... ....||+.|+|||++.+. +... +|||||||++|+|++| ..
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 999999999776443221 245799999999998764 4443 8999999999999999 77
Q ss_pred CCCCCC----hHHHHHH-HHcCCCCCCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 280 PFWAET----EKGIFDA-ILQGDIDFESAP---WPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 280 pf~~~~----~~~~~~~-i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
||.... ....... +........... ...+++++.+||.+||..||++|||+.++++|
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 775432 1222222 222222111110 11356779999999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=341.84 Aligned_cols=249 Identities=22% Similarity=0.382 Sum_probs=204.1
Q ss_pred cccceeecceecccCCeEEEEEE----ECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCT----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
...+|++++.||+|+||.||+|. +..+++.||||++... .....+.+.+|+.++++++ ||||+++++++...
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA 114 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC-
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEec
Confidence 35689999999999999999998 4678999999998653 3345678999999999996 99999999998654
Q ss_pred C--eEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 153 Q--SVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 153 ~--~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
+ .+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL 191 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTT
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc---CCCcEEEecCcc
Confidence 4 789999999999999999875 4599999999999999999999999999999999999994 456799999999
Q ss_pred cccccCCcce----ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh------------H----H
Q 016233 230 SVFIEEGKVY----RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETE------------K----G 288 (393)
Q Consensus 230 a~~~~~~~~~----~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~------------~----~ 288 (393)
+......... ....++..|+|||++.+ .++.++||||||+++|+|++|..||..... . .
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 9877554321 23457788999999875 488999999999999999999999854311 0 1
Q ss_pred HHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 289 IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 289 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
+...+..+. .. .....+++++.+||.+||..||++|||+.++++
T Consensus 272 ~~~~~~~~~-~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIELLKNNG-RL--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHTTC-CC--CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhcCC-CC--CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 122222222 11 223568999999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=344.30 Aligned_cols=249 Identities=22% Similarity=0.333 Sum_probs=202.9
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHH--ccCCCCeeEEeEEEEeC
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH--LSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~~h~niv~~~~~~~~~ 152 (393)
..+..+|++.+.||+|+||.||+|.+. ++.||||++... ....+.+|+++++. + +||||+++++++...
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR------EERSWFREAEIYQTVML-RHENILGFIAADNKD 108 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG------GHHHHHHHHHHHHHSCC-CCTTBCCEEEEEECC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch------hHHHHHHHHHHHHHhhc-CCCcEEEEEeeeccc
Confidence 345678999999999999999999984 899999998532 35677889999988 5 499999999999887
Q ss_pred C----eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------HcCcEecCCCCCcEEeccCCCCC
Q 016233 153 Q----SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH--------FMGVMHRDLKPENFLLSSKDENA 220 (393)
Q Consensus 153 ~----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH--------~~~ivH~Dikp~Nill~~~~~~~ 220 (393)
. .+++||||+++|+|.+++.. ..+++.+++.++.|++.||.||| ++||+||||||+|||+ +.++
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~ 184 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNG 184 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTS
T ss_pred CCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCC
Confidence 6 89999999999999999865 47999999999999999999999 8999999999999999 5566
Q ss_pred cEEEeecCCcccccCCcc-----eecccCcccccchHHHhhc-------CCCcchHHHHHHHHHHHhhC----------C
Q 016233 221 LLKATDFGLSVFIEEGKV-----YRDIVGSAYYVAPEVLRRR-------YGKEIDIWSAGVILYILLSG----------V 278 (393)
Q Consensus 221 ~~kl~DFg~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~-------~~~~~DiwSlG~il~~lltg----------~ 278 (393)
.+||+|||++........ .....||+.|+|||++.+. ++.++|||||||++|+|++| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 799999999987665432 2445799999999998753 23689999999999999999 7
Q ss_pred CCCCCCC-----hHHHHHHHHcCCCCCCCCC-C--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 279 PPFWAET-----EKGIFDAILQGDIDFESAP-W--PTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 279 ~pf~~~~-----~~~~~~~i~~~~~~~~~~~-~--~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
.||.... .......+........... + ...+..+.+||.+||..||++|||++++++|
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 8987642 2334444443332221110 1 1234579999999999999999999999875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=359.50 Aligned_cols=250 Identities=18% Similarity=0.197 Sum_probs=194.3
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCe--------------
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNI-------------- 142 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni-------------- 142 (393)
....|++++.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+.++.|+
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 344688999999999999999999999999999998755444445578899999999998622321
Q ss_pred -------eEEeEEEEe-----CCeEEEEEeccCCCChHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHcCcEe
Q 016233 143 -------VEFKGAYED-----KQSVHVVMELCAGGELFDRIIA-------KGHYSERAAASICRSIVNVVHICHFMGVMH 203 (393)
Q Consensus 143 -------v~~~~~~~~-----~~~~~lv~e~~~gg~L~~~l~~-------~~~~~~~~~~~i~~qll~~l~~lH~~~ivH 203 (393)
..+..++.. ...++++|+++ +++|.+++.. ...+++..+..++.||+.||.|||++||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 111121222 22467888876 6799888742 223677888999999999999999999999
Q ss_pred cCCCCCcEEeccCCCCCcEEEeecCCcccccCCcceecccCcccccchHHHh----------h-cCCCcchHHHHHHHHH
Q 016233 204 RDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR----------R-RYGKEIDIWSAGVILY 272 (393)
Q Consensus 204 ~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~----------~-~~~~~~DiwSlG~il~ 272 (393)
|||||+|||+ +.++.+||+|||+++..... ....+| +.|+|||++. + .++.++|||||||++|
T Consensus 235 rDiKp~NILl---~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 235 TYLRPVDIVL---DQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp SCCCGGGEEE---CTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred CCcccceEEE---ecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999 55666999999998865433 456678 9999999983 2 3778999999999999
Q ss_pred HHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 273 ILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 273 ~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
+|++|+.||...+..+....+.. .+..+++++.+||.+||..||++|||+.++|+||||+.
T Consensus 309 elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHCCCCCCCcchhhhHHHHHh--------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 99999999987665433332222 23468899999999999999999999999999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=367.13 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=212.2
Q ss_pred ccccccccceeecceecccCCeEEEEEEECCC---CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEE
Q 016233 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENST---GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (393)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 148 (393)
..++....+|++++.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.++++++ ||||++++++
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~ 459 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGV 459 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEE
Confidence 34555677899999999999999999998654 4579999875432 3344578899999999996 9999999999
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeec
Q 016233 149 YEDKQSVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (393)
Q Consensus 149 ~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DF 227 (393)
+.+ +..|+||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 460 ~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~---~~~~vkL~DF 535 (656)
T 2j0j_A 460 ITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDF 535 (656)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCC
T ss_pred Eec-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe---CCCCEEEEec
Confidence 854 56899999999999999997654 689999999999999999999999999999999999995 4567999999
Q ss_pred CCcccccCCcce--ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCC
Q 016233 228 GLSVFIEEGKVY--RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESA 303 (393)
Q Consensus 228 g~a~~~~~~~~~--~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 303 (393)
|++......... ....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+.+..+..+....
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~--- 612 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP--- 612 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC---
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---
Confidence 999876544322 23457789999999875 58999999999999999997 999999998888888887764322
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 304 PWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 304 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
..+.+++.+.+||.+||..||++|||+.++++
T Consensus 613 ~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 613 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 22468999999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=346.55 Aligned_cols=252 Identities=21% Similarity=0.340 Sum_probs=190.3
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHH--HHccCCCCeeEEeEEEEe----
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIM--QHLSGQPNIVEFKGAYED---- 151 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l--~~l~~h~niv~~~~~~~~---- 151 (393)
.++|++++.||+|+||.||+|.+ +++.||||++... ....+..|.+++ ..+. ||||+++++.+..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~-h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA------NRQNFINEKNIYRVPLME-HDNIARFIVGDERVTAD 82 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG------GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECTT
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc------chhhHHHHHHHHHHHhcc-CcchhhheecccccccC
Confidence 35899999999999999999986 5899999998643 234444455554 4465 9999999986542
Q ss_pred -CCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---------CcEecCCCCCcEEeccCCCCCc
Q 016233 152 -KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM---------GVMHRDLKPENFLLSSKDENAL 221 (393)
Q Consensus 152 -~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~---------~ivH~Dikp~Nill~~~~~~~~ 221 (393)
...+++||||+++|+|.+++... ..++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~ 158 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGT 158 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSC
T ss_pred CCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCCCc
Confidence 33678999999999999988664 568999999999999999999999 99999999999999 55667
Q ss_pred EEEeecCCcccccCCc---------ceecccCcccccchHHHhh--------cCCCcchHHHHHHHHHHHhhCCCCCCCC
Q 016233 222 LKATDFGLSVFIEEGK---------VYRDIVGSAYYVAPEVLRR--------RYGKEIDIWSAGVILYILLSGVPPFWAE 284 (393)
Q Consensus 222 ~kl~DFg~a~~~~~~~---------~~~~~~gt~~y~aPE~l~~--------~~~~~~DiwSlG~il~~lltg~~pf~~~ 284 (393)
+||+|||++..+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 9999999998764321 2234579999999999864 3667899999999999999997776432
Q ss_pred Ch-----------------HHHHHHHH-cCCCCCC-CCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHhc------C
Q 016233 285 TE-----------------KGIFDAIL-QGDIDFE-SAPW---PTISSSAKDLVRRMLTQDPKKRITSAQVLE------H 336 (393)
Q Consensus 285 ~~-----------------~~~~~~i~-~~~~~~~-~~~~---~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~------h 336 (393)
.. .+...... ....... ...| ..+++++.+||.+||..||++|||+.|+++ +
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 11 11111111 1111111 1111 124567999999999999999999999954 6
Q ss_pred ccccCC
Q 016233 337 PWIKEG 342 (393)
Q Consensus 337 ~~~~~~ 342 (393)
+|-++.
T Consensus 319 ~~~~~~ 324 (336)
T 3g2f_A 319 IWERNK 324 (336)
T ss_dssp CCCC--
T ss_pred HHHhcc
Confidence 666554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=336.22 Aligned_cols=228 Identities=15% Similarity=0.086 Sum_probs=187.8
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
+..+|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.+. ||||+++++++.+++..|
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEEECCcEE
Confidence 4568999999999999999999999999999999997655433445678899999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+||||++|++|.+++.. .....++..++.||+.||.|||++||+||||||+|||++ .++.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~--~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~---~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPA-------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---TTSCEEECSCC--------
T ss_pred EEEEecCCCCHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc---CCCCEEEEecc--------
Confidence 99999999999998843 346678899999999999999999999999999999994 45668887543
Q ss_pred cceecccCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHH---HHHcCCCCCCCCCCCCCCHHHH
Q 016233 237 KVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFD---AILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
|++ .++.++|||||||++|+|++|..||.+.+..+.+. ....+.........+.+++++.
T Consensus 175 -----------~~~------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (286)
T 3uqc_A 175 -----------TMP------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS 237 (286)
T ss_dssp -----------CCT------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred -----------ccC------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence 333 36789999999999999999999998765432110 1111111111122356899999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
+||.+||..||++| |+.|+++.
T Consensus 238 ~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 238 AVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHcccCCccC-CHHHHHHH
Confidence 99999999999999 99999873
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=374.96 Aligned_cols=245 Identities=24% Similarity=0.312 Sum_probs=202.8
Q ss_pred ccccccceeecceecccCCeEEEEEEECC-CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENS-TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
.+.+..+|++.+.||+|+||.||+|.+.. +++.||||++.... .......+.+|+.++++++ ||||+++++++...
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHT 151 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEE
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeec
Confidence 34566899999999999999999999976 78999999886432 2344567889999999996 99999999999876
Q ss_pred Ce-----EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeec
Q 016233 153 QS-----VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDF 227 (393)
Q Consensus 153 ~~-----~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DF 227 (393)
+. .||||||++|++|.+++.. .+++.+++.++.||+.||.|||++||+||||||+|||++. ..+||+||
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~----~~~kl~DF 225 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE----EQLKLIDL 225 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS----SCEEECCC
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC----CcEEEEec
Confidence 65 7999999999999887654 7999999999999999999999999999999999999953 26999999
Q ss_pred CCcccccCCcceecccCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 016233 228 GLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (393)
|++...... ....||+.|+|||++.+.++.++|||||||++|+|++|..||.+.... ... .......
T Consensus 226 G~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~-~~~~~~~ 292 (681)
T 2pzi_A 226 GAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLP-EDDPVLK 292 (681)
T ss_dssp TTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCC-TTCHHHH
T ss_pred ccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccc---------ccc-ccccccc
Confidence 999876543 456799999999999888889999999999999999999998653211 000 0111112
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 016233 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (393)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 340 (393)
.++.+.+||.+||..||++||+..+++.|+|+.
T Consensus 293 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 293 TYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 467899999999999999999999999888864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=318.40 Aligned_cols=189 Identities=19% Similarity=0.152 Sum_probs=139.0
Q ss_pred eecccCCeEEEEEEECCCCcEEEEEEeecCccCC-------cccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT-------KNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
..+.|+.|.+..++....|+.||||++.+..... ....+++.+|+++|+++.+|+||+++++++++++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4678888888888888889999999998653221 233567999999999998799999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-c
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-K 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~-~ 237 (393)
|||++|++|.++|...+.+++. .|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+..... .
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC---C
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCCCCc
Confidence 9999999999999988888765 488999999999999999999999999999 55677999999999876543 3
Q ss_pred ceecccCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCC
Q 016233 238 VYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPP 280 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~p 280 (393)
...+.+||+.|||||++.+.+...+|+||+|++++++.++..+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CSHHHHHHHHHHHHHHC-----------------CCCCTTHHH
T ss_pred cccCceechhhccHHHhCCCCCCcccccccccchhhhccccch
Confidence 3456789999999999999888999999999998887766444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-31 Score=260.48 Aligned_cols=184 Identities=18% Similarity=0.151 Sum_probs=143.3
Q ss_pred eecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcc-----cHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 82 SFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN-----DKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
...+.||+|+||.||+|. ..++.+++|........... ..+.+.+|++++++++ ||||+++..++...+..|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETTTTE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCCccE
Confidence 346689999999999995 34789999987654332211 1345799999999997 999996665666777789
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
|||||++|++|.+++.. +..++.|++.+|.|||++||+||||||+|||++ . .+||+|||+++.....
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCTTCEECCCH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECccCEECCCc
Confidence 99999999999998764 678999999999999999999999999999994 3 7999999999987653
Q ss_pred cc--------eecccCcccccchHHHhh---cCCCcchHHHHHHHHHHHhhCCCCC
Q 016233 237 KV--------YRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPF 281 (393)
Q Consensus 237 ~~--------~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf 281 (393)
.. ....+||+.|||||++.. .|+..+|+||..+-..+-..++-+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 22 235689999999999874 4888899999998888877776665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-27 Score=217.02 Aligned_cols=159 Identities=25% Similarity=0.258 Sum_probs=124.0
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCc---------------ccHHHHHHHHHHHHHccCCCCeeE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK---------------NDKDDIKREIQIMQHLSGQPNIVE 144 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~~h~niv~ 144 (393)
.|.+++.||+|+||.||+|.+ .+|+.||||+++....... .....+.+|+.+++++. | ++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~---~~ 165 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-G---LA 165 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-T---SS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-C---CC
Confidence 466779999999999999999 7899999999864321110 13566889999999996 4 55
Q ss_pred EeEEEEeCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEE
Q 016233 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKA 224 (393)
Q Consensus 145 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl 224 (393)
+.+++.. +..|+||||++|++|.+ + .......++.|++.||.|||++||+||||||+|||++ ++.+||
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~----~~~vkl 233 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWI 233 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEEE
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE----CCcEEE
Confidence 5555544 44699999999999987 3 2234567999999999999999999999999999995 567999
Q ss_pred eecCCcccccCCcceecccCcccccchHHHh-----------hcCCCcchHHHH
Q 016233 225 TDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-----------RRYGKEIDIWSA 267 (393)
Q Consensus 225 ~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~-----------~~~~~~~DiwSl 267 (393)
+|||+|.. +..|+|||.+. ..|+..+|+|.+
T Consensus 234 ~DFG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 234 IDFPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp CCCTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred EECCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 99999974 34578999874 235667777654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.7e-23 Score=186.82 Aligned_cols=142 Identities=14% Similarity=0.114 Sum_probs=108.1
Q ss_pred ceeecceecccCCeEEEEEEECCCCcE--EEEEEeecCccCCc---------------------ccHHHHHHHHHHHHHc
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQ--FACKSISKRKLVTK---------------------NDKDDIKREIQIMQHL 136 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~---------------------~~~~~~~~E~~~l~~l 136 (393)
-|.+.+.||+|+||.||+|.+..+|+. ||||+++....... .....+.+|+.+|+++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999999778999 99998754321100 0123678999999999
Q ss_pred cCCCCe--eEEeEEEEeCCeEEEEEeccCC-C----ChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-HcCcEecCCCC
Q 016233 137 SGQPNI--VEFKGAYEDKQSVHVVMELCAG-G----ELFDRIIAKGHYSERAAASICRSIVNVVHICH-FMGVMHRDLKP 208 (393)
Q Consensus 137 ~~h~ni--v~~~~~~~~~~~~~lv~e~~~g-g----~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH-~~~ivH~Dikp 208 (393)
. |++| +.++++ +..+|||||+.+ | +|.+.... .++..+..++.|++.+|.||| ++||+||||||
T Consensus 128 ~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 K-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp H-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred H-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 7 6653 344432 245899999942 3 56554322 335578899999999999999 99999999999
Q ss_pred CcEEeccCCCCCcEEEeecCCccccc
Q 016233 209 ENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 209 ~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+|||++ . .++|+|||+|....
T Consensus 200 ~NILl~---~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 200 YNIMYI---D--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TSEEES---S--SEEECCCTTCEETT
T ss_pred HHEEEc---C--cEEEEECcccccCC
Confidence 999994 3 69999999997653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=170.39 Aligned_cols=145 Identities=17% Similarity=0.208 Sum_probs=103.0
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccC-----------CcccH--------HHHHHHHHHHHHccCCC
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV-----------TKNDK--------DDIKREIQIMQHLSGQP 140 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~--------~~~~~E~~~l~~l~~h~ 140 (393)
-|.+++.||+|+||.||+|.+. +|+.||||+++..... ..... -...+|...|.++. +.
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~ 173 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EE 173 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hc
Confidence 3899999999999999999975 6999999998643211 00011 11245777888874 44
Q ss_pred CeeEEeEEEEeCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCC-
Q 016233 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDEN- 219 (393)
Q Consensus 141 niv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~- 219 (393)
++....-+.... .+|||||++|++|.++. ..+.+..++.||+.+|.+||++|||||||||.|||++.+++.
T Consensus 174 gv~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 174 GFPVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp TCSCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 433222122222 27999999998886432 233567889999999999999999999999999999754321
Q ss_pred ------CcEEEeecCCccccc
Q 016233 220 ------ALLKATDFGLSVFIE 234 (393)
Q Consensus 220 ------~~~kl~DFg~a~~~~ 234 (393)
..+.|+||+-+....
T Consensus 246 d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CTTSEEEEEEECCCTTCEETT
T ss_pred cccccccceEEEEeCCcccCC
Confidence 137899999877543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=3.8e-14 Score=127.74 Aligned_cols=141 Identities=16% Similarity=0.153 Sum_probs=113.0
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
..|++...+|.|+.+.||++... ++.+++|+...... .....+.+|+.+++.|..+..++++++++.+.+..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 35888888999999999998754 68999998864321 12346889999999997677888999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF---------------------------------------- 198 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~---------------------------------------- 198 (393)
|||++|.+|.+.+ .+......++.++..+|..||+
T Consensus 89 ~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 9999999987642 1223345788999999999998
Q ss_pred -------------------cCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 199 -------------------MGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 199 -------------------~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
..++|+|++|.|||++ +...+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhccc
Confidence 4589999999999994 344567999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.38 E-value=1.4e-12 Score=116.87 Aligned_cols=135 Identities=11% Similarity=0.122 Sum_probs=97.7
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCC-CeeEEeEEEEeCCeEEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP-NIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~~~~~~~~~~~lv 158 (393)
.|.+....+.|..+.||++.. .+|..+++|+.... ....+.+|+.+++.+..+. .+++++++....+..++|
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 355544445666799999864 45778999987532 2245788999999997442 266788888888889999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--------------------------------------
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG-------------------------------------- 200 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~-------------------------------------- 200 (393)
|||++|.+|. . .... ...++.++...|..||+..
T Consensus 94 ~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 94 LGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp EECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9999998883 1 1122 2356667777777777643
Q ss_pred --------------------cEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 201 --------------------VMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 201 --------------------ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
++|+|++|.||+++ ++..+.|+|||.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhccc
Confidence 99999999999994 345567999998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.30 E-value=7.4e-12 Score=118.06 Aligned_cols=142 Identities=22% Similarity=0.375 Sum_probs=105.1
Q ss_pred cceecccCCeEEEEEEECCCCcEEEEEEee--cCccCCcccHHHHHHHHHHHHHccC-CCCeeEEeEEEEeC---CeEEE
Q 016233 84 GKELGRGQFGVTYLCTENSTGRQFACKSIS--KRKLVTKNDKDDIKREIQIMQHLSG-QPNIVEFKGAYEDK---QSVHV 157 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~~~~~~~~~---~~~~l 157 (393)
.+.|+.|.++.||++... +..+++|+.. .... ......+.+|+.+++.|.. +..+++++.++.+. +..|+
T Consensus 43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 567899999999998865 5688999765 3221 1224578889999999973 34578888888776 45899
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF--------------------------------------- 198 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~--------------------------------------- 198 (393)
||||++|..+.+.. ...++..+...++.++...|..||+
T Consensus 119 vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99999998774311 1246788888999999999999997
Q ss_pred -------------------cCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 199 -------------------MGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 199 -------------------~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
..++|+|+++.|||++.++. ..+.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-RVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-CEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-cEEEEECcccccc
Confidence 35899999999999964322 3568999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.29 E-value=7.2e-12 Score=115.37 Aligned_cols=186 Identities=15% Similarity=0.228 Sum_probs=124.9
Q ss_pred cceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCC--eeEEeEEEEeCC---eEEEE
Q 016233 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPN--IVEFKGAYEDKQ---SVHVV 158 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n--iv~~~~~~~~~~---~~~lv 158 (393)
.+.++.|....||++. ..+++|+... ......+.+|+.+|+.+..+.. +.+++......+ ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3458999999999863 5688997532 2345778999999999853433 445555443333 34889
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF---------------------------------------- 198 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~---------------------------------------- 198 (393)
||+++|.+|.+... ..++..+...++.++...|..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999998875433 257788888888999888888886
Q ss_pred ------------------cCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcceecccCcccccchHHHh---hc
Q 016233 199 ------------------MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR---RR 257 (393)
Q Consensus 199 ------------------~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~---~~ 257 (393)
..++|+|++|.||+++.+ ....+.|+||+.+.................-..|+... ..
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 136999999999999632 14568899999987643221111111000002333221 12
Q ss_pred CCC------------cchHHHHHHHHHHHhhCCCCCC
Q 016233 258 YGK------------EIDIWSAGVILYILLSGVPPFW 282 (393)
Q Consensus 258 ~~~------------~~DiwSlG~il~~lltg~~pf~ 282 (393)
|+. ..+.|++|.++|.+.+|..+|.
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 222 2589999999999999988763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.88 E-value=2.3e-08 Score=89.97 Aligned_cols=133 Identities=16% Similarity=0.200 Sum_probs=95.9
Q ss_pred ecccCCe-EEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccCCC
Q 016233 87 LGRGQFG-VTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGG 165 (393)
Q Consensus 87 lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~gg 165 (393)
+..|..| .||+......+..+++|+-.. .....+.+|..+|+.|..+--+.+++.++.+.+..|+|||+++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 4445444 699988777788899997643 235678899999999976556788999999999999999999998
Q ss_pred ChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc----------------------------------------------
Q 016233 166 ELFDRIIAKGHYSERAAASICRSIVNVVHICHFM---------------------------------------------- 199 (393)
Q Consensus 166 ~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~---------------------------------------------- 199 (393)
++.+..... ......+..++...|..||+.
T Consensus 106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 876654321 122233445555555555421
Q ss_pred ------------CcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 200 ------------GVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 200 ------------~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
.++|+|+.+.|||+. +...+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECccccc
Confidence 278999999999994 445667999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.86 E-value=3.8e-08 Score=90.44 Aligned_cols=138 Identities=19% Similarity=0.289 Sum_probs=95.2
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCC--CeeEEeEEEE-eCCeEEEEEec
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP--NIVEFKGAYE-DKQSVHVVMEL 161 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~--niv~~~~~~~-~~~~~~lv~e~ 161 (393)
+.++.|....||+. +..+++|+.. .......+.+|+.+|+.|..+- .+.+++.+.. ..+..|+|||+
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eecCCCcceeEEEE-----CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 45788888999987 5678999742 1234578899999999997432 3566666664 45567899999
Q ss_pred cCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc------------------------------------------
Q 016233 162 CAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM------------------------------------------ 199 (393)
Q Consensus 162 ~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~------------------------------------------ 199 (393)
++|.++.+... ..++..+...++.++...|..||+.
T Consensus 95 i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 95 VQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred cCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 99988865321 2345555555555555555555532
Q ss_pred ------------------CcEecCCCCCcEEeccCCC-CCcEEEeecCCccccc
Q 016233 200 ------------------GVMHRDLKPENFLLSSKDE-NALLKATDFGLSVFIE 234 (393)
Q Consensus 200 ------------------~ivH~Dikp~Nill~~~~~-~~~~kl~DFg~a~~~~ 234 (393)
.++|+|++|.||+++.++. ...+.|+||+.+..-.
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 3599999999999964222 3345899999887543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=1.7e-07 Score=89.32 Aligned_cols=81 Identities=16% Similarity=0.141 Sum_probs=52.0
Q ss_pred cceecccCCeEEEEEEECCCCcEEEEEEeecCcc-CC---cccHHHHHHHHHHHHHccCC-C-CeeEEeEEEEeCCeEEE
Q 016233 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKL-VT---KNDKDDIKREIQIMQHLSGQ-P-NIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~---~~~~~~~~~E~~~l~~l~~h-~-niv~~~~~~~~~~~~~l 157 (393)
.+.||.|.++.||++....+++.++||....... .. ......+..|.++++.+... + .+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 4579999999999997666678999998653211 00 12345677899999988533 3 34456544 3444689
Q ss_pred EEeccCCCC
Q 016233 158 VMELCAGGE 166 (393)
Q Consensus 158 v~e~~~gg~ 166 (393)
|||+++|..
T Consensus 113 vmE~l~g~~ 121 (397)
T 2olc_A 113 VMEDLSHLK 121 (397)
T ss_dssp EECCCTTSE
T ss_pred EEEeCCCcc
Confidence 999998743
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=1.7e-07 Score=87.85 Aligned_cols=85 Identities=7% Similarity=0.071 Sum_probs=56.8
Q ss_pred eccee-cccCCeEEEEEEEC--C----CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCC--CCeeEEeEEEEeC-
Q 016233 83 FGKEL-GRGQFGVTYLCTEN--S----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ--PNIVEFKGAYEDK- 152 (393)
Q Consensus 83 ~~~~l-g~G~~g~V~~~~~~--~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~- 152 (393)
..+.| +.|....+|+.... . ++..+++|+..............+.+|+.+++.|..+ -.+.+++.+..+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34567 88888999987643 1 1568899976432200000124578899999988744 3577788877665
Q ss_pred --CeEEEEEeccCCCCh
Q 016233 153 --QSVHVVMELCAGGEL 167 (393)
Q Consensus 153 --~~~~lv~e~~~gg~L 167 (393)
+..|+||||++|.++
T Consensus 104 ~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTSSCEEEEECCCCBCC
T ss_pred ccCCceEEEEecCCCCh
Confidence 356899999988654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.30 E-value=8e-06 Score=75.66 Aligned_cols=74 Identities=12% Similarity=0.122 Sum_probs=44.6
Q ss_pred ceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCC-CCeeEEeE------EEEeCCeEEE
Q 016233 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ-PNIVEFKG------AYEDKQSVHV 157 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~------~~~~~~~~~l 157 (393)
+.|+.|..+.||++... +..+++|+... ....+..|..+++.|..+ -.+++++. +....+..++
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~-------~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHR-------PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECS-------CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCC-------CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 45666778999998764 34699998853 124455667777666421 13444443 2235677899
Q ss_pred EEeccCCCCh
Q 016233 158 VMELCAGGEL 167 (393)
Q Consensus 158 v~e~~~gg~L 167 (393)
||||++|.++
T Consensus 109 l~~~i~G~~~ 118 (346)
T 2q83_A 109 VYDWIEGRPF 118 (346)
T ss_dssp EEECCCCBCC
T ss_pred EEEeecCccC
Confidence 9999998653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.16 E-value=1.2e-05 Score=76.93 Aligned_cols=77 Identities=9% Similarity=0.074 Sum_probs=46.0
Q ss_pred cceecccCCeEEEEEEECCCCcEEEEEEeecCc--cCCc----ccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRK--LVTK----NDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
.+.||.|..+.||++.. +++.++||...... .... .....++.|+..+..-.....+++++.+. .+..++
T Consensus 39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 45689999999999864 46789999532211 0011 12334444443333211234567777665 456789
Q ss_pred EEecc-CC
Q 016233 158 VMELC-AG 164 (393)
Q Consensus 158 v~e~~-~g 164 (393)
||||+ +|
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 77
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.10 E-value=2e-05 Score=72.21 Aligned_cols=76 Identities=12% Similarity=0.125 Sum_probs=61.1
Q ss_pred cceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCC--CCeeEEeEEEEeCCeEEEEEec
Q 016233 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ--PNIVEFKGAYEDKQSVHVVMEL 161 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~~~~~lv~e~ 161 (393)
.+.|+.|....+|+... ++..+++|+.... ....+..|+..|+.|..+ ..+++++.+....+..++||||
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 45689999999999874 4678999986532 367789999999998633 5688899888888889999999
Q ss_pred cCCCCh
Q 016233 162 CAGGEL 167 (393)
Q Consensus 162 ~~gg~L 167 (393)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.82 E-value=3.7e-05 Score=70.63 Aligned_cols=139 Identities=18% Similarity=0.148 Sum_probs=78.7
Q ss_pred cceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCC-CeeEEeEE------EEeCCeEE
Q 016233 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP-NIVEFKGA------YEDKQSVH 156 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~~~------~~~~~~~~ 156 (393)
.+.|+.|....+|++... +..+++|+.... .....+..|+.+++.|..+. .+.+++.. ....+..+
T Consensus 27 ~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~-----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT--KDPLILTLYEKR-----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eeccCCCcccceEEEEeC--CccEEEEEeCCC-----CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 456778888999998754 337889987642 12345667888888886331 13344321 23346679
Q ss_pred EEEeccCCCChH--------------HHHHHc-CCC--------CHHHHHHH---------------HHHHHHHHHHHHH
Q 016233 157 VVMELCAGGELF--------------DRIIAK-GHY--------SERAAASI---------------CRSIVNVVHICHF 198 (393)
Q Consensus 157 lv~e~~~gg~L~--------------~~l~~~-~~~--------~~~~~~~i---------------~~qll~~l~~lH~ 198 (393)
+|++|++|..+. ..+... ..+ ........ ...+...++.+.+
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 999999886431 111111 011 11110110 0113344555553
Q ss_pred -------cCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 199 -------MGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 199 -------~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
.+++|+|+++.|||+. ++..+.|+||+.+..
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFACN 217 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred hCcccCCcccCCCCCCccCEEEe---CCceEEEecchhccC
Confidence 4699999999999995 334457999997754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.80 E-value=3.1e-05 Score=70.58 Aligned_cols=72 Identities=8% Similarity=-0.050 Sum_probs=45.9
Q ss_pred cceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEecc-
Q 016233 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELC- 162 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~- 162 (393)
.+.|+.|....+|++ ..+++|+...... ......+|+.+++.+..+.-..+++.+. ...-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 567889999999998 5688998754211 1112356888888876332224565543 33347899999
Q ss_pred CCCCh
Q 016233 163 AGGEL 167 (393)
Q Consensus 163 ~gg~L 167 (393)
+|.++
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 66554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.74 E-value=5.9e-05 Score=70.98 Aligned_cols=141 Identities=13% Similarity=0.138 Sum_probs=83.9
Q ss_pred cceecccCCeEEEEEEECC-------CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 84 GKELGRGQFGVTYLCTENS-------TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
.+.|..|....+|++.... +++.+++|+.... ......+.+|..+++.|..+.-..++++++.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 3567778888999988642 3578999975321 12356677999999998755444667766543 2
Q ss_pred EEEeccCCCChH--------------HHHH---HcC-----CC--CHHHHHHHHHHHHH-------------------HH
Q 016233 157 VVMELCAGGELF--------------DRII---AKG-----HY--SERAAASICRSIVN-------------------VV 193 (393)
Q Consensus 157 lv~e~~~gg~L~--------------~~l~---~~~-----~~--~~~~~~~i~~qll~-------------------~l 193 (393)
+||||++|.+|. +.|. ... .. -..++..+..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 899999985542 1111 110 11 13455555554422 23
Q ss_pred HHHHH--------cCcEecCCCCCcEEeccC-CCCCcEEEeecCCccc
Q 016233 194 HICHF--------MGVMHRDLKPENFLLSSK-DENALLKATDFGLSVF 232 (393)
Q Consensus 194 ~~lH~--------~~ivH~Dikp~Nill~~~-~~~~~~kl~DFg~a~~ 232 (393)
..|.+ ..++|+|+.+.||++..+ +....+.++||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 33332 258999999999999653 1235689999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00021 Score=60.89 Aligned_cols=122 Identities=15% Similarity=0.077 Sum_probs=75.3
Q ss_pred CChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcceecc
Q 016233 165 GELFDRIIA-KGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDI 242 (393)
Q Consensus 165 g~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~-~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~~~~ 242 (393)
.+|.+.|.. ..+++|+++|.++.|.+.+|.-+-. +.-..+=+.|..|++. .++.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~---~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW---RDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE---TTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe---cCCceeccc-cccc-----------
Confidence 378888876 4579999999999999999877621 1211233456888884 444454332 1110
Q ss_pred cCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhccc
Q 016233 243 VGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQ 322 (393)
Q Consensus 243 ~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 322 (393)
.....+.|||......+.+.=|||||+++|.-+--..| ...-..+|+.+..||..|...
T Consensus 98 ~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~---------------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 98 AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK---------------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ---------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC---------------------TTEEECCCHHHHHHHHHHTTC
T ss_pred ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC---------------------cccchhhCHHHHHHHHHHHhc
Confidence 11234667876544456678899999999988853222 111246899999999999866
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.69 E-value=9.4e-05 Score=70.98 Aligned_cols=74 Identities=12% Similarity=0.127 Sum_probs=51.3
Q ss_pred cceecccCCeEEEEEEECC-------CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 84 GKELGRGQFGVTYLCTENS-------TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
.+.|+.|....||++.... .++.+++|+.... .....+.+|..+++.|..+.-.+++++.+. + .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--C
Confidence 4568889899999998653 3578999987321 112556689999999874433466776654 2 3
Q ss_pred EEEeccCCCC
Q 016233 157 VVMELCAGGE 166 (393)
Q Consensus 157 lv~e~~~gg~ 166 (393)
+|+||++|.+
T Consensus 149 ~v~e~l~G~~ 158 (429)
T 1nw1_A 149 RLEEYIPSRP 158 (429)
T ss_dssp EEECCCCEEE
T ss_pred EEEEEeCCcc
Confidence 8999998743
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.0001 Score=68.10 Aligned_cols=140 Identities=15% Similarity=0.091 Sum_probs=72.1
Q ss_pred ceecccCCeE-EEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCC-CeeEEeEEEEeCCeEEEEEecc
Q 016233 85 KELGRGQFGV-TYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP-NIVEFKGAYEDKQSVHVVMELC 162 (393)
Q Consensus 85 ~~lg~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~~~~~~~~~~~lv~e~~ 162 (393)
+.|+.|+... +|+... .+++.+++|...... ...+..|+.+++.|..+. .+.+++.+..+.+ ++|||++
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l 94 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL 94 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTT------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCC------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence 3465554444 667653 236677777543221 133456788888776332 3556666533333 7899999
Q ss_pred CCCChHHHHHHc--------------------------CCCCHHHHH-------H-HH------------HHHHHHHHHH
Q 016233 163 AGGELFDRIIAK--------------------------GHYSERAAA-------S-IC------------RSIVNVVHIC 196 (393)
Q Consensus 163 ~gg~L~~~l~~~--------------------------~~~~~~~~~-------~-i~------------~qll~~l~~l 196 (393)
.+..+.+.+... ..+...... . +. ..+...+..+
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 776665433211 012221110 0 00 0111122222
Q ss_pred H------HcCcEecCCCCCcEEeccCCC-CCcEEEeecCCcccc
Q 016233 197 H------FMGVMHRDLKPENFLLSSKDE-NALLKATDFGLSVFI 233 (393)
Q Consensus 197 H------~~~ivH~Dikp~Nill~~~~~-~~~~kl~DFg~a~~~ 233 (393)
. ...++|+|+.+.|||+..+.. ...+.|+||+.+..-
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1 246999999999999953211 256899999988754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.55 E-value=0.0003 Score=64.67 Aligned_cols=75 Identities=16% Similarity=0.158 Sum_probs=49.8
Q ss_pred eecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCC-CeeEEeEE-----EEeCCeEEEEE
Q 016233 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP-NIVEFKGA-----YEDKQSVHVVM 159 (393)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~~~-----~~~~~~~~lv~ 159 (393)
.|+ |....||++... +|+.+++|+..... .....+..|..+++.|..+. .+++++.. ....+..++||
T Consensus 33 ~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~----~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDE-DRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEC-CSSSEEEEECCT-TCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred eec-CcccceEEEEcC-CCCEEEEEEcCCCC----CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 466 778899987643 46689999885321 23567788999988886331 24444442 23356678999
Q ss_pred eccCCCC
Q 016233 160 ELCAGGE 166 (393)
Q Consensus 160 e~~~gg~ 166 (393)
++++|.+
T Consensus 107 ~~i~G~~ 113 (328)
T 1zyl_A 107 PSVGGRQ 113 (328)
T ss_dssp ECCCCEE
T ss_pred EecCCCC
Confidence 9998854
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.0016 Score=58.56 Aligned_cols=79 Identities=14% Similarity=0.079 Sum_probs=55.4
Q ss_pred ceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCC--CeeEEeEEEEeCCeEEE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP--NIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~--niv~~~~~~~~~~~~~l 157 (393)
...-.+.+|.|..+.||+.... +|+.|.+|+..... ......+..|+..|+.|.... -+++++.+ +. -++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDA---PALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTC---CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCC---cchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceE
Confidence 3445677999999999998754 68899999765332 223456889999999986332 34555554 22 378
Q ss_pred EEeccCCCC
Q 016233 158 VMELCAGGE 166 (393)
Q Consensus 158 v~e~~~gg~ 166 (393)
||||++++.
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00023 Score=66.71 Aligned_cols=75 Identities=9% Similarity=0.076 Sum_probs=45.6
Q ss_pred cceecccCCeEEEEEEECC--------CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 84 GKELGRGQFGVTYLCTENS--------TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
.+.|+.|....+|++.... .+..+++|+..... ........|..+++.|..+.-++++++.. .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV----DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc----cceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 4567888888999988653 13688999764321 11112467888888886443244666544 23
Q ss_pred EEEEeccCCCC
Q 016233 156 HVVMELCAGGE 166 (393)
Q Consensus 156 ~lv~e~~~gg~ 166 (393)
++||||++|.+
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 68999998854
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.0017 Score=62.70 Aligned_cols=76 Identities=12% Similarity=0.075 Sum_probs=49.6
Q ss_pred cceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEeccC
Q 016233 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCA 163 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 163 (393)
.+.|+.|-...+|++.....+..+++|+..... . ..-...+|..+++.|..+.-.+++++++. + .+||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---D-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C---C-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---h-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 456888888999999876545789999874321 1 11112589999999974433456777663 3 25999998
Q ss_pred CCCh
Q 016233 164 GGEL 167 (393)
Q Consensus 164 gg~L 167 (393)
|.+|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0022 Score=59.29 Aligned_cols=69 Identities=10% Similarity=0.035 Sum_probs=44.3
Q ss_pred cccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCC--CCeeEEeEE------EEeCCeEEEEE
Q 016233 88 GRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ--PNIVEFKGA------YEDKQSVHVVM 159 (393)
Q Consensus 88 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~niv~~~~~------~~~~~~~~lv~ 159 (393)
|.|....||++... +| .+++|+..... ...|+.+++.|..+ |++++.+.. ....+..++||
T Consensus 32 G~g~~N~vy~v~~~-~g-~~vLK~~~~~~---------~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~ 100 (339)
T 3i1a_A 32 GADTNAFAYQADSE-SK-SYFIKLKYGYH---------DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAY 100 (339)
T ss_dssp TSCSSCEEEEEECS-SC-EEEEEEEECSS---------CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEE
T ss_pred cCccccceEEEEeC-CC-CEEEEEecCcc---------chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEE
Confidence 34446789998754 34 89999876432 13567777776522 334555432 23457789999
Q ss_pred eccCCCCh
Q 016233 160 ELCAGGEL 167 (393)
Q Consensus 160 e~~~gg~L 167 (393)
+|++|..+
T Consensus 101 ~~i~G~~~ 108 (339)
T 3i1a_A 101 PFIHAPNG 108 (339)
T ss_dssp ECCCCCBT
T ss_pred eccCCCcC
Confidence 99998755
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0028 Score=60.36 Aligned_cols=75 Identities=13% Similarity=0.114 Sum_probs=49.7
Q ss_pred cceecccCCeEEEEEEECCC-------CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 84 GKELGRGQFGVTYLCTENST-------GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
++.|..|....+|++..... ++.+++|+..... . ..-...+|..+++.|..+.-..++++.+ .+ +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---G-KFYDSKVELDVFRYLSNINIAPNIIADF--PE--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---c-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence 45677788889999987521 5789999864321 1 1223467899998887444445666543 23 6
Q ss_pred EEEeccCCCC
Q 016233 157 VVMELCAGGE 166 (393)
Q Consensus 157 lv~e~~~gg~ 166 (393)
+||||++|.+
T Consensus 147 ~I~efI~G~~ 156 (424)
T 3mes_A 147 RIEEFIDGEP 156 (424)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEeCCcc
Confidence 8999999865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.18 E-value=0.021 Score=53.98 Aligned_cols=32 Identities=31% Similarity=0.410 Sum_probs=25.8
Q ss_pred cEecCCCCCcEEeccC---CCCCcEEEeecCCccc
Q 016233 201 VMHRDLKPENFLLSSK---DENALLKATDFGLSVF 232 (393)
Q Consensus 201 ivH~Dikp~Nill~~~---~~~~~~kl~DFg~a~~ 232 (393)
++|+|+.+.|||+..+ ++...+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999542 3456799999998864
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=91.26 E-value=1.1 Score=40.53 Aligned_cols=137 Identities=14% Similarity=0.142 Sum_probs=72.0
Q ss_pred eeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEE------------
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA------------ 148 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~------------ 148 (393)
...++..-.|..|. |.+.. ++..++||.. .....+.+-.++...-.+. .|+..-+.-.
T Consensus 71 v~~I~~s~~Gstgv-ff~~t--d~~~~VVK~s------~~l~~E~l~s~LA~~LGlp-iP~~Riv~~~~~E~~e~~~~L~ 140 (342)
T 1cja_A 71 FKGIERSEKGTEGL-FFVET--ESGVFIVKRS------TNIESETFCSLLCMRLGLH-APKVRVVSSNSEEGTNMLECLA 140 (342)
T ss_dssp EEEEEECCSTTSCE-EEEEE--SSCEEEEECC------TTHHHHHHHHHHHHHHTCC-CCCEEEEESSSHHHHHHHHHHH
T ss_pred eeEEEeccCCCCCe-EEEEe--CCCEEEEeCc------HHHHHHHHHHHHHHHhCCC-CCCeeEEeeCcHHHHHHHHHHH
Confidence 55666666776654 44444 3778899943 1112333333444333443 5553322211
Q ss_pred ----------EEeCCeEEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHH--HHHHHHHHHcC-----cEecCCCCC
Q 016233 149 ----------YEDKQSVHVVMELCAGGELFDRIIA--KGHYSERAAASICRSI--VNVVHICHFMG-----VMHRDLKPE 209 (393)
Q Consensus 149 ----------~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~ql--l~~l~~lH~~~-----ivH~Dikp~ 209 (393)
....+..+++|||.+|..|.+.-.. ...+.+ ...+++ +-+++.+..++ +.+.--.++
T Consensus 141 ~~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~----~~~k~LG~Ii~FDi~InN~DR~Pl~W~n~GN~~ 216 (342)
T 1cja_A 141 AIDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTK----STMQQLGSLMALDVIVNNSDRLPIAWTNEGNLD 216 (342)
T ss_dssp HHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCH----HHHHHHHHHHHHHHHHTCCSSSCSSSCSCCCGG
T ss_pred HhhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCH----HHHHhhchhheehhhhcCCccCcccccCCCChh
Confidence 0012357799999988766431100 011222 333443 34456666543 222235899
Q ss_pred cEEeccCCCCCcEEEeecCCcccc
Q 016233 210 NFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 210 Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
|||+..++ ..+.++|-+++...
T Consensus 217 NIL~~~~n--~~~~~IDhn~af~~ 238 (342)
T 1cja_A 217 NIMLSERG--ATVVPIDSKIIPLD 238 (342)
T ss_dssp GEEEESBT--TCEEECSCCCCCCC
T ss_pred heEEeCCC--CeEEEEcCCccccC
Confidence 99997533 36888999988653
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=87.60 E-value=0.053 Score=52.23 Aligned_cols=63 Identities=6% Similarity=0.048 Sum_probs=17.6
Q ss_pred ecceecccCCeEEEEEEECCCCcEEEE------EEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 83 FGKELGRGQFGVTYLCTENSTGRQFAC------KSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~~~~vav------K~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
+.+.|| ||.||+|.......+||+ |....... .......+.+|..+++.+. |||+++.+.+..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~-H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQ-IPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-------------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccc-ccccccccccccccccccc-ccccCCCcceEE
Confidence 345666 999999998765568888 65543221 2233456778999999886 999999888754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 393 | ||||
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-98 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-89 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-88 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-87 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-87 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-84 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-83 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-81 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-80 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-79 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-79 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-79 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-79 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-76 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-75 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-74 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-73 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-72 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-72 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-71 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-71 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-69 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-66 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-65 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-65 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-65 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-64 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-63 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-62 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-62 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-61 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-61 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-61 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-61 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-59 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-59 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-57 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-45 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-43 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-21 | |
| d2pula1 | 392 | d.144.1.6 (A:5-396) Methylthioribose kinase MtnK { | 4e-04 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 293 bits (751), Expect = 2e-98
Identities = 122/310 (39%), Positives = 185/310 (59%), Gaps = 5/310 (1%)
Query: 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQ 131
K ED++ Y F LG G F L + T + A K I+K+ L + + ++ EI
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIA 59
Query: 132 IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN 191
++ + PNIV YE ++++M+L +GGELFDRI+ KG Y+ER A+ + +++
Sbjct: 60 VLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 118
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAP 251
V H +G++HRDLKPEN L S DE++ + +DFGLS + G V G+ YVAP
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 178
Query: 252 EVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310
EVL ++ Y K +D WS GVI YILL G PPF+ E + +F+ IL+ + +F+S W IS
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238
Query: 311 SAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKL 370
SAKD +R ++ +DP+KR T Q L+HPWI G A DK I +V ++K+ A +K K+
Sbjct: 239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIA-GDTALDKNIHQSVSEQIKKNFAKSKWKQA 297
Query: 371 ALKVSLIKYM 380
+++++M
Sbjct: 298 FNATAVVRHM 307
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 269 bits (688), Expect = 8e-89
Identities = 82/299 (27%), Positives = 154/299 (51%), Gaps = 12/299 (4%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y ++LGRG+FG+ + C E S+ + + K + + D+ +K+EI I+
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-H 60
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHF 198
NI+ ++E + + ++ E +G ++F+RI +ER S + + H
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RR 257
+ H D++PEN + + ++ +K +FG + ++ G +R + + Y APEV +
Sbjct: 121 HNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
D+WS G ++Y+LLSG+ PF AET + I + I+ + F+ + IS A D V
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 318 RMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVSL 376
R+L ++ K R+T+++ L+HPW+K+ E + + V+ +K R + L K L + +
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIE----RVSTKVIRTLKHRRYYHTLIKKDLNMVV 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 268 bits (687), Expect = 3e-88
Identities = 99/306 (32%), Positives = 163/306 (53%), Gaps = 12/306 (3%)
Query: 58 KQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKL 117
K+ VP+P G Y+ +Y +ELG G FGV + C E +TGR F K I+
Sbjct: 13 KKYVPQP-VEVKQGSVYD----YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP 67
Query: 118 VTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH- 176
+ DK +K EI IM L P ++ A+EDK + +++E +GGELFDRI A+ +
Sbjct: 68 L---DKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK 123
Query: 177 YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236
SE + R + H ++H D+KPEN + +K + +K DFGL+ +
Sbjct: 124 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK-ASSVKIIDFGLATKLNPD 182
Query: 237 KVYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQ 295
++ + +A + APE++ R G D+W+ GV+ Y+LLSG+ PF E + + +
Sbjct: 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 242
Query: 296 GDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVL 355
D +F+ + ++S AKD ++ +L ++P+KR+T LEHPW+K I S+
Sbjct: 243 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRY 302
Query: 356 SRMKQF 361
++++Q
Sbjct: 303 NKIRQK 308
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 267 bits (683), Expect = 1e-87
Identities = 103/322 (31%), Positives = 156/322 (48%), Gaps = 14/322 (4%)
Query: 57 LKQAVPRPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRK 116
KQ P+P ++ V HY +ELG G FGV + TE +TG FA K +
Sbjct: 9 WKQYYPQPVE-----IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH 63
Query: 117 LVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK-G 175
++DK+ +++EIQ M L P +V A+ED + ++ E +GGELF+++ +
Sbjct: 64 ---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN 119
Query: 176 HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235
SE A R + + H +H DLKPEN + ++ + LK DFGL+ ++
Sbjct: 120 KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDP 178
Query: 236 GKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAIL 294
+ + G+A + APEV + G D+WS GV+ YILLSG+ PF E + +
Sbjct: 179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 238
Query: 295 QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAV 354
D + + + + IS KD +R++L DP R+T Q LEHPW+ G
Sbjct: 239 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS--QIP 296
Query: 355 LSRMKQFRAMNKLKKLALKVSL 376
SR + R K K A L
Sbjct: 297 SSRYTKIRDSIKTKYDAWPEPL 318
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 263 bits (674), Expect = 3e-87
Identities = 96/275 (34%), Positives = 150/275 (54%), Gaps = 16/275 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVT------KNDKDDIKREIQIM 133
+Y + LGRG V C T +++A K I + + ++ +E+ I+
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 134 QHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVV 193
+ +SG PNI++ K YE +V +L GELFD + K SE+ I R+++ V+
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV 253
H + ++HRDLKPEN LL D++ +K TDFG S ++ G+ R++ G+ Y+APE+
Sbjct: 124 CALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 254 L-------RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP 306
+ YGKE+D+WS GVI+Y LL+G PPFW + + I+ G+ F S W
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
S + KDLV R L P+KR T+ + L HP+ ++
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 255 bits (653), Expect = 7e-84
Identities = 108/272 (39%), Positives = 161/272 (59%), Gaps = 6/272 (2%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND---KDDIKREIQ 131
E+V +Y G+ELG GQF V C E STG Q+A K I KR+ + ++DI+RE+
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 132 IMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVN 191
I++ + PN++ YE+K V +++EL AGGELFD + K +E A + I+N
Sbjct: 66 ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124
Query: 192 VVHICHFMGVMHRDLKPENFLLSSKDE-NALLKATDFGLSVFIEEGKVYRDIVGSAYYVA 250
V+ H + + H DLKPEN +L ++ +K DFGL+ I+ G +++I G+ +VA
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 184
Query: 251 PEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309
PE++ G E D+WS GVI YILLSG PF +T++ + + +FE + S
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
+ AKD +RR+L +DPKKR+T L+HPWIK
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 253 bits (647), Expect = 2e-83
Identities = 84/263 (31%), Positives = 136/263 (51%), Gaps = 10/263 (3%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ G+ LG+G+FG YL E + A K + K +L + ++RE++I HL
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-H 65
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
PNI+ G + D V++++E G ++ + + E+ A+ + N + CH
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRY 258
V+HRD+KPEN LL S E LK DFG SV + + G+ Y+ PE++ R +
Sbjct: 126 RVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMH 181
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
+++D+WS GV+ Y L G PPF A T + + I + + F ++ A+DL+ R
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGARDLISR 237
Query: 319 MLTQDPKKRITSAQVLEHPWIKE 341
+L +P +R +VLEHPWI
Sbjct: 238 LLKHNPSQRPMLREVLEHPWITA 260
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 250 bits (639), Expect = 1e-81
Identities = 76/315 (24%), Positives = 134/315 (42%), Gaps = 19/315 (6%)
Query: 64 PDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK 123
PD + K +D + +S +E+G G FG Y + A K +S +
Sbjct: 2 PDVAELFFK--DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 124 DDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAA 183
DI +E++ +Q L PN ++++G Y + + +VME C G + K E A
Sbjct: 60 QDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA 118
Query: 184 SICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243
++ + + H ++HRD+K N LL E L+K DFG + + + V
Sbjct: 119 AVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPANSF---V 172
Query: 244 GSAYYVAPEVLR----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID 299
G+ Y++APEV+ +Y ++D+WS G+ L PP + I Q +
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232
Query: 300 FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMK 359
S ++ V L + P+ R TS +L+H ++ + ++ R K
Sbjct: 233 AL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL---RERPPTVIMDLIQRTK 287
Query: 360 QF-RAMNKLKKLALK 373
R ++ L+ +K
Sbjct: 288 DAVRELDNLQYRKMK 302
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (631), Expect = 5e-80
Identities = 95/306 (31%), Positives = 153/306 (50%), Gaps = 19/306 (6%)
Query: 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIV 143
+ LG G G T +FA K + +RE+++ S P+IV
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIV 68
Query: 144 EFKGAYED----KQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHICH 197
YE+ ++ + +VME GGELF RI +G ++ER A+ I +SI + H
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-R 256
+ + HRD+KPEN L +SK NA+LK TDFG + + YYVAPEVL
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188
Query: 257 RYGKEIDIWSAGVILYILLSGVPPFWAETE----KGIFDAILQGDIDFESAPWPTISSSA 312
+Y K D+WS GVI+YILL G PPF++ G+ I G +F + W +S
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKKLAL 372
K L+R +L +P +R+T + + HPWI + + P+ ++ + + + R + +++
Sbjct: 249 KMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTS 308
Query: 373 KVSLIK 378
++ ++
Sbjct: 309 ALATMR 314
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (625), Expect = 1e-79
Identities = 83/266 (31%), Positives = 133/266 (50%), Gaps = 12/266 (4%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ FGK LG G F L E +T R++A K + KR ++ +N + RE +M L
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-H 67
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P V+ ++D + ++ + GEL I G + E IV+ + H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFI---EEGKVYRDIVGSAYYVAPEVLR- 255
G++HRDLKPEN LL +E+ ++ TDFG + + + VG+A YV+PE+L
Sbjct: 128 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315
+ K D+W+ G I+Y L++G+PPF A E IF I++ + DF A+DL
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PEKFFPKARDL 240
Query: 316 VRRMLTQDPKKRITSAQVLEHPWIKE 341
V ++L D KR+ ++ + +K
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (619), Expect = 5e-79
Identities = 78/268 (29%), Positives = 135/268 (50%), Gaps = 12/268 (4%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ + LG G +G L T A K + ++ V + ++IK+EI I + L+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-H 62
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
N+V+F G + ++ +E C+GGELFDRI E A ++ V H +
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFI---EEGKVYRDIVGSAYYVAPEVLRR 256
G+ HRD+KPEN LL +D LK +DFGL+ ++ + G+ YVAPE+L+R
Sbjct: 123 GITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 257 R--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314
R + + +D+WS G++L +L+G P+ ++ + + + + PW I S+
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-PWKKIDSAPLA 238
Query: 315 LVRRMLTQDPKKRITSAQVLEHPWIKEG 342
L+ ++L ++P RIT + + W +
Sbjct: 239 LLHKILVENPSARITIPDIKKDRWYNKP 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (620), Expect = 6e-79
Identities = 81/277 (29%), Positives = 138/277 (49%), Gaps = 11/277 (3%)
Query: 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
D K Y+ +++G+G G Y + +TG++ A + ++ ++ + K+ I EI +M+
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMR 72
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVH 194
PNIV + +Y + VVME AGG L D ++ + E A++CR + +
Sbjct: 73 ENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALE 130
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE-EGKVYRDIVGSAYYVAPEV 253
H V+HRD+K +N LL +K TDFG I E +VG+ Y++APEV
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 254 LRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312
+ R+ YG ++DIWS G++ ++ G PP+ E I E +S+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIF 246
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKP 349
+D + R L D +KR ++ ++L+H ++K S
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (619), Expect = 7e-79
Identities = 77/292 (26%), Positives = 133/292 (45%), Gaps = 25/292 (8%)
Query: 74 YEDVKL------HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK 127
YE V + ELG G FG Y T A K I + + + +D
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYM 57
Query: 128 REIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRII-AKGHYSERAAASIC 186
EI I+ PNIV+ A+ + ++ +++E CAGG + ++ + +E +C
Sbjct: 58 VEIDILASCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 116
Query: 187 RSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-IVGS 245
+ ++ ++ H ++HRDLK N L + +K DFG+S RD +G+
Sbjct: 117 KQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGT 173
Query: 246 AYYVAPEVL------RRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDID 299
Y++APEV+ R Y + D+WS G+ L + PP + I + +
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP 233
Query: 300 FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPID 351
+ P SS+ KD +++ L ++ R T++Q+L+HP++ S+KPI
Sbjct: 234 TLAQP-SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT---VDSNKPIR 281
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 2e-76
Identities = 59/267 (22%), Positives = 118/267 (44%), Gaps = 14/267 (5%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
F E+GRG F Y + T + A + RKL TK+++ K E ++++ L P
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HP 68
Query: 141 NIVEFKGAYED----KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHIC 196
NIV F ++E K+ + +V EL G L + + S CR I+ +
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 128
Query: 197 HFMG--VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL 254
H ++HRDLK +N ++ +K D GL+ + + ++G+ ++APE+
Sbjct: 129 HTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEMY 185
Query: 255 RRRYGKEIDIWSAGVILYILLSGVPPFW-AETEKGIFDAILQGDIDFESAPWPTISSSAK 313
+Y + +D+++ G+ + + + P+ + I+ + G K
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDKVAIPEVK 243
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWIK 340
+++ + Q+ +R + +L H + +
Sbjct: 244 EIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (597), Expect = 4e-75
Identities = 70/264 (26%), Positives = 127/264 (48%), Gaps = 10/264 (3%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ K LG+G FG +L T + FA K++ K ++ +D + E +++ P
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
+ ++ K+++ VME GG+L I + + A I+ + H G
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-KVYRDIVGSAYYVAPEVLR-RRY 258
+++RDLK +N L D++ +K DFG+ G G+ Y+APE+L ++Y
Sbjct: 124 IVYRDLKLDNIL---LDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
+D WS GV+LY +L G PF + E+ +F +I + + + AKDL+ +
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEAKDLLVK 236
Query: 319 MLTQDPKKRITSA-QVLEHPWIKE 341
+ ++P+KR+ + +HP +E
Sbjct: 237 LFVREPEKRLGVRGDIRQHPLFRE 260
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 6e-74
Identities = 74/272 (27%), Positives = 124/272 (45%), Gaps = 21/272 (7%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y +G G +G S G+ K + + T+ +K + E+ +++ L P
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HP 63
Query: 141 NIVEFKGAYEDK--QSVHVVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVH 194
NIV + D+ ++++VME C GG+L I + + E + + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 195 ICHFMG-----VMHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDIVGSAYY 248
CH V+HRDLKP N L D +K DFGL+ + + + VG+ YY
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 180
Query: 249 VAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPT 307
++PE + R Y ++ DIWS G +LY L + +PPF A ++K + I +G
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYR 237
Query: 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339
S +++ RML R + ++LE+P I
Sbjct: 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 3e-73
Identities = 72/304 (23%), Positives = 119/304 (39%), Gaps = 49/304 (16%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ ELG G GV + + +G A K I ++ I RE+Q++ +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-S 63
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P IV F GA+ + + ME GG L + G E+ + +++ +
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 200 -GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RR 257
+MHRD+KP N L++S+ E +K DFG+S + + VG+ Y++PE L+
Sbjct: 124 HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQGTH 179
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEK---GIFDAILQGDIDFESA----------- 303
Y + DIWS G+ L + G P K +F ++GD
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 304 --------------------------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHP 337
P S +D V + L ++P +R Q++ H
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 338 WIKE 341
+IK
Sbjct: 300 FIKR 303
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 227 bits (579), Expect = 2e-72
Identities = 78/268 (29%), Positives = 132/268 (49%), Gaps = 16/268 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ + LG G FG +L GR +A K + K +V + E ++ ++
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-H 63
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P I+ G ++D Q + ++M+ GGELF + + A + + H
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRY 258
+++RDLKPEN LL D+N +K TDFG + ++ + V + G+ Y+APEV+ + Y
Sbjct: 124 DIIYRDLKPENILL---DKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPY 178
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
K ID WS G+++Y +L+G PF+ ++ IL ++ F P + KDL+ R
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDLLSR 234
Query: 319 MLTQDPKKRI-----TSAQVLEHPWIKE 341
++T+D +R+ + V HPW KE
Sbjct: 235 LITRDLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 225 bits (573), Expect = 3e-72
Identities = 59/267 (22%), Positives = 113/267 (42%), Gaps = 7/267 (2%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y G+ LG G +L + R A K + + +RE Q L+
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-H 66
Query: 140 PNIVEFKGAYEDKQS----VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI 195
P IV E + ++VME G L D + +G + + A + ++
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFG-LSVFIEEGKVYRDIVGSAYYVAPEVL 254
H G++HRD+KP N ++S+ + ++ ++ ++G+A Y++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 255 R-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313
R D++S G +LY +L+G PPF ++ + ++ D SA +S+
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246
Query: 314 DLVRRMLTQDPKKRITSAQVLEHPWIK 340
+V + L ++P+ R +A + ++
Sbjct: 247 AVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 225 bits (574), Expect = 4e-71
Identities = 72/271 (26%), Positives = 124/271 (45%), Gaps = 14/271 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS-- 137
+S + +GRG FG Y C + TG+ +A K + K+++ K + E ++ +S
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 138 GQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICH 197
P IV A+ + +++L GG+L + G +SE I+ + H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR- 256
V++RDLKP N LL DE+ ++ +D GL+ + K + VG+ Y+APEVL++
Sbjct: 125 NRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQKG 180
Query: 257 -RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315
Y D +S G +L+ LL G PF K I + + + S + L
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELRSL 239
Query: 316 VRRMLTQDPKKRITS-----AQVLEHPWIKE 341
+ +L +D +R+ +V E P+ +
Sbjct: 240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 5e-71
Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 20/269 (7%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD---IKREIQIMQHL 136
Y G LG G FG Y S A K + K ++ + + + E+ +++ +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 137 SGQ-PNIVEFKGAYEDKQSVHVVMELCAGG-ELFDRIIAKGHYSERAAASICRSIVNVVH 194
S ++ +E S +++E +LFD I +G E A S ++ V
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVL 254
CH GV+HRD+K EN L+ LK DFG +++ Y D G+ Y PE +
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWI 181
Query: 255 R--RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312
R R +G+ +WS G++LY ++ G PF + E I++G + F +SS
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR----QRVSSEC 231
Query: 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
+ L+R L P R T ++ HPW+++
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQD 260
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 4e-69
Identities = 83/269 (30%), Positives = 139/269 (51%), Gaps = 15/269 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ + K LG+G FG L E +TGR +A K + K ++ K++ E +++Q+
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-H 64
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P + K A++ + VME GGELF + + ++E A IV+ + H
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDIVGSAYYVAPEVLRR-R 257
V++RD+K EN +L D++ +K TDFGL +G + G+ Y+APEVL
Sbjct: 125 DVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
YG+ +D W GV++Y ++ G PF+ + + +F+ IL +I F T+S AK L+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAKSLLA 237
Query: 318 RMLTQDPKKRITSA-----QVLEHPWIKE 341
+L +DPK+R+ +V+EH +
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 2e-66
Identities = 88/338 (26%), Positives = 132/338 (39%), Gaps = 48/338 (14%)
Query: 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQH 135
DV Y+ +G G +G+ +N + A K IS + + REI+I+
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLR 62
Query: 136 LSGQPNIVEFKGA-----YEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIV 190
NI+ E + V++V L G +++ H S I+
Sbjct: 63 FR-HENIIGINDIIRAPTIEQMKDVYLVTHLM--GADLYKLLKTQHLSNDHICYFLYQIL 119
Query: 191 NVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD----IVGSA 246
+ H V+HRDLKP N LL + LK DFGL+ + + V +
Sbjct: 120 RGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176
Query: 247 YYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP 304
+Y APE++ Y K IDIWS G IL +LS P F + + IL
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236
Query: 305 W---------------------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHP 337
P S A DL+ +MLT +P KRI Q L HP
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 296
Query: 338 WIKEGGEASDKPIDSAVLSRMKQFRAMNK--LKKLALK 373
++++ + SD+PI A + + K LK+L +
Sbjct: 297 YLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFE 334
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 1e-65
Identities = 58/267 (21%), Positives = 103/267 (38%), Gaps = 19/267 (7%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ G+ +G G FG Y A K ++ T K E+ +++
Sbjct: 9 QITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-H 63
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRI-IAKGHYSERAAASICRSIVNVVHICHF 198
NI+ F G Y + +V + C G L+ + I + + I R + H
Sbjct: 64 VNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK---VYRDIVGSAYYVAPEVLR 255
++HRDLK N L E+ +K DFGL+ + + GS ++APEV+R
Sbjct: 123 KSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 256 ----RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP--WPTIS 309
Y + D+++ G++LY L++G P+ + ++
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEH 336
+ K L+ L + +R Q+L
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 2e-65
Identities = 82/276 (29%), Positives = 144/276 (52%), Gaps = 17/276 (6%)
Query: 80 HYSFGKELGRGQFGVTYLC---TENSTGRQFACKSISKRKLVTK-NDKDDIKREIQIMQH 135
++ K LG G +G +L + + TG+ +A K + K +V K + + E Q+++H
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 136 LSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHI 195
+ P +V A++ + +H++++ GGELF + + ++E IV +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE--EGKVYRDIVGSAYYVAPEV 253
H +G+++RD+K EN LL D N + TDFGLS E + D G+ Y+AP++
Sbjct: 145 LHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 254 LR---RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISS 310
+R + K +D WS GV++Y LL+G PF + EK I + + E +S+
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 261
Query: 311 SAKDLVRRMLTQDPKKRITSA-----QVLEHPWIKE 341
AKDL++R+L +DPKKR+ ++ EH + ++
Sbjct: 262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 2e-65
Identities = 72/286 (25%), Positives = 110/286 (38%), Gaps = 33/286 (11%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDK--DDIKREIQIMQHLSGQPNI 142
LG GQF Y + +T + A K I D REI+++Q LS PNI
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNI 62
Query: 143 VEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVM 202
+ A+ K ++ +V + + + + + H ++
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 203 HRDLKPENFLLSSKDENALLKATDFGLSVFIEEG-KVYRDIVGSAYYVAPEVLR--RRYG 259
HRDLKP N LL DEN +LK DFGL+ + Y V + +Y APE+L R YG
Sbjct: 123 HRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 260 KEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP------------- 306
+D+W+ G IL LL VP +++ I + WP
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 307 -----------TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
DL++ + +P RIT+ Q L+ +
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 3e-64
Identities = 73/318 (22%), Positives = 119/318 (37%), Gaps = 48/318 (15%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P+ D Y ++G+G FG + TG++ A K + + REI+I
Sbjct: 4 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKI 62
Query: 133 MQHLSGQPNIVEFKGAYEDKQS--------VHVVMELCAGGELFDRIIAKGHYSERAAAS 184
+Q L N+V K S +++V + C ++
Sbjct: 63 LQLLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-----VY 239
+ + ++N ++ H ++HRD+K N L+ + +LK DFGL+ K Y
Sbjct: 122 VMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 240 RDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD 297
+ V + +Y PE+L R YG ID+W AG I+ + + P TE+ I Q
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 298 IDFESAPWPTI----------------------------SSSAKDLVRRMLTQDPKKRIT 329
WP + A DL+ ++L DP +RI
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 330 SAQVLEHPWIKEGGEASD 347
S L H + SD
Sbjct: 299 SDDALNHDFFWSDPMPSD 316
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 204 bits (519), Expect = 2e-63
Identities = 75/324 (23%), Positives = 134/324 (41%), Gaps = 58/324 (17%)
Query: 65 DTNTILGKPYEDVKLH---------YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKR 115
D NT + Y D + H Y ++LGRG++ + + + K +
Sbjct: 12 DVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV 71
Query: 116 KLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--KQSVHVVMELCAGGELFDRIIA 173
K K IKREI+I+++L G PNI+ +D ++ +V E +
Sbjct: 72 K------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-- 123
Query: 174 KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233
++ I+ + CH MG+MHRD+KP N ++ + L+ D+GL+ F
Sbjct: 124 -QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFY 180
Query: 234 EEGKVYRDIVGSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAETE----- 286
G+ Y V S Y+ PE+L + Y +D+WS G +L ++ PF+ +
Sbjct: 181 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 240
Query: 287 ---------KGIFDAILQGDID--------------------FESAPWPTISSSAKDLVR 317
+ ++D I + +I+ S +S A D +
Sbjct: 241 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD 300
Query: 318 RMLTQDPKKRITSAQVLEHPWIKE 341
++L D + R+T+ + +EHP+
Sbjct: 301 KLLRYDHQSRLTAREAMEHPYFYT 324
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 2e-62
Identities = 65/290 (22%), Positives = 111/290 (38%), Gaps = 34/290 (11%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y +++G G +G + T A K + + REI +++ L
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKH-K 61
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
NIV + + +V E C G S ++ + CH
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLRRR-- 257
V+HRDLKP+N L++ E K +FGL+ F + Y V + +Y P+VL
Sbjct: 122 VLHRDLKPQNLLINRNGEL---KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 258 YGKEIDIWSAGVILYILLSG-VPPFWAETEKGIFDAILQGDIDFESAPWPT--------- 307
Y ID+WSAG I L + P F I + WP+
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 308 ----------------ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
++++ +DL++ +L +P +RI++ + L+HP+ +
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 199 bits (507), Expect = 4e-62
Identities = 84/289 (29%), Positives = 126/289 (43%), Gaps = 34/289 (11%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
Y +++G G +GV Y +N+ G FA K I K + REI I++ L
Sbjct: 4 YHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HS 60
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
NIV+ K+ + +V E + +G A S ++N + CH
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 201 VMHRDLKPENFLLSSKDENALLKATDFGLSVFI-EEGKVYRDIVGSAYYVAPEVLR--RR 257
V+HRDLKP+N L++ + E LK DFGL+ + Y + + +Y AP+VL ++
Sbjct: 121 VLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 258 YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTI--------- 308
Y IDIWS G I +++G P F +E I + S WP +
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 309 ----------------SSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
S DL+ +ML DP +RIT+ Q LEH + KE
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 1e-61
Identities = 67/337 (19%), Positives = 134/337 (39%), Gaps = 45/337 (13%)
Query: 70 LGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKRE 129
+ K +V+ Y + +G G +G + TG + A K + R ++ RE
Sbjct: 9 VTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRE 67
Query: 130 IQIMQHLSGQPNIVEFKGAYEDKQS------VHVVMELCAGGELFDRIIAKGHYSERAAA 183
+++++H+ N++ + ++ ++VM G +++ E
Sbjct: 68 LRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQ 124
Query: 184 SICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243
+ ++ + H G++HRDLKP N + +E+ LK DFGL+ + V
Sbjct: 125 FLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADS--EMTGYV 179
Query: 244 GSAYYVAPEVLR--RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE 301
+ +Y APEV+ RY + +DIWS G I+ +++G F I++
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239
Query: 302 SAPW---------------------------PTISSSAKDLVRRMLTQDPKKRITSAQVL 334
+ S A +L+ +ML D ++R+T+ + L
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299
Query: 335 EHPWIKEGGEASDKPIDSAVLSRMKQF-RAMNKLKKL 370
HP+ + + D+P R +++ K++
Sbjct: 300 AHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRV 336
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 1e-61
Identities = 74/325 (22%), Positives = 118/325 (36%), Gaps = 46/325 (14%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQI 132
P ++ Y+ K +G G FGV Y +G A K + + DK RE+QI
Sbjct: 14 PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------DKRFKNRELQI 66
Query: 133 MQHLSGQPNIVEFKGAY------EDKQSVHVVMELCAGG---ELFDRIIAKGHYSERAAA 183
M+ L NIV + + +D+ +++V++ AK
Sbjct: 67 MRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 184 SICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIV 243
+ + H G+ HRD+KP+N LL K DFG + + G+ +
Sbjct: 126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL--KLCDFGSAKQLVRGEPNVSYI 183
Query: 244 GSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG----- 296
S YY APE++ Y ID+WSAG +L LL G P F ++ I++
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 297 --------------------DIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
+ P A L R+L P R+T + H
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 337 PWIKEGGEASDKPIDSAVLSRMKQF 361
+ E + + K + + F
Sbjct: 304 SFFDELRDPNVKLPNGRDTPALFNF 328
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 2e-61
Identities = 66/295 (22%), Positives = 113/295 (38%), Gaps = 37/295 (12%)
Query: 80 HYSFGKELGRGQFGVTYLCTE-NSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSG 138
Y E+G G +G + + + GR A K + + + RE+ +++HL
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLET 66
Query: 139 Q--PNIVEFKGAYEDKQS-----VHVVMELCAGGEL-FDRIIAKGHYSERAAASICRSIV 190
PN+V ++ + +V E + + + + ++
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 191 NVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVA 250
+ H V+HRDLKP+N L++S + K DFGL+ +V + +Y A
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQI---KLADFGLARIYSFQMALTSVVVTLWYRA 183
Query: 251 PEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP--- 306
PEVL + Y +D+WS G I + P F ++ IL WP
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 307 --------------------TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
I KDL+ + LT +P KRI++ L HP+ ++
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (505), Expect = 5e-61
Identities = 79/268 (29%), Positives = 136/268 (50%), Gaps = 16/268 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ K LG G FG L +G +A K + K+K+V + E +I+Q ++
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-F 100
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
P +V+ + +++D ++++VME AGGE+F + G +SE A IV H +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR-RRY 258
+++RDLKPEN L+ D+ ++ TDFG + ++ + G+ +APE++ + Y
Sbjct: 161 DLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGY 215
Query: 259 GKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRR 318
K +D W+ GV++Y + +G PPF+A+ I++ I+ G + F SS KDL+R
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLLRN 271
Query: 319 MLTQDPKKRITSA-----QVLEHPWIKE 341
+L D KR + + H W
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 196 bits (498), Expect = 1e-60
Identities = 52/288 (18%), Positives = 101/288 (35%), Gaps = 22/288 (7%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y G+++G G FG YL T+ + G + A K K + E +I + + G
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQGG 62
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
I + + +VMEL +S + + +++ + H
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 200 GVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY--------RDIVGSAYYVAP 251
+HRD+KP+NFL+ + L+ DFGL+ + + + +++ G+A Y +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 252 EVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP----WP 306
+ D+ S G +L G P+ + S P
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 307 TISSSAKDLVRRMLTQDPKKRITSA---QVLEHPWIKEGGEASDKPID 351
S + + + + Q+ + + ++G D D
Sbjct: 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS-YDYVFD 289
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-59
Identities = 57/262 (21%), Positives = 110/262 (41%), Gaps = 17/262 (6%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+F KELG GQFGV A K I + + +D+ E ++M +LS
Sbjct: 5 DLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-H 58
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRII-AKGHYSERAAASICRSIVNVVHICHF 198
+V+ G ++ + ++ E A G L + + + + + +C+ + +
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR--DIVGSAYYVAPEVLR- 255
+HRDL N L+ ++ ++K +DFGLS ++ + + + PEVL
Sbjct: 119 KQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 256 RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314
++ + DIW+ GV+++ + S G P+ T + I QG + S
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---RPHLASEKVYT 232
Query: 315 LVRRMLTQDPKKRITSAQVLEH 336
++ + +R T +L +
Sbjct: 233 IMYSCWHEKADERPTFKILLSN 254
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-59
Identities = 71/291 (24%), Positives = 119/291 (40%), Gaps = 34/291 (11%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
++ +++G G +GV Y TG A K I T+ REI +++ L+
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-H 60
Query: 140 PNIVEFKGAYEDKQSVHVVMELCA-GGELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198
PNIV+ + +++V E + F A S ++ + CH
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLS-VFIEEGKVYRDIVGSAYYVAPEVLR-- 255
V+HRDLKP+N L+ + +K DFGL+ F + Y V + +Y APE+L
Sbjct: 121 HRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 256 RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW---------- 305
+ Y +DIWS G I +++ F ++E I + + W
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 306 ---------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341
P + + L+ +ML DP KRI++ L HP+ ++
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 6e-59
Identities = 61/274 (22%), Positives = 103/274 (37%), Gaps = 24/274 (8%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
F +G G FG G + ++ +K+D D E++++ L P
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRI----------------IAKGHYSERAAAS 184
NI+ GA E + +++ +E G L D + S +
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVG 244
+ + +HRDL N L+ EN + K DFGLS E
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRL 188
Query: 245 SAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFES 302
++A E L Y D+WS GV+L+ ++S G P+ T +++ + QG +
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRL 245
Query: 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
DL+R+ + P +R + AQ+L
Sbjct: 246 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-58
Identities = 70/314 (22%), Positives = 122/314 (38%), Gaps = 40/314 (12%)
Query: 70 LGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKRE 129
L K +V Y +G G +G + TG + A K +S+ + RE
Sbjct: 9 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 67
Query: 130 IQIMQHLSGQPNIVEFKGAYEDKQSV----HVVMELCAGGELFDRIIAKGHYSERAAASI 185
+++++H+ N++ + +S+ V + G + I+ ++ +
Sbjct: 68 LRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 186 CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGS 245
I+ + H ++HRDLKP N +E+ LK DFGL+ V +
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNLA---VNEDCELKILDFGLARHT--DDEMTGYVAT 181
Query: 246 AYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE-- 301
+Y APE++ Y + +DIWS G I+ LL+G F IL+
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 302 -------------------------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
+ + + A DL+ +ML D KRIT+AQ L H
Sbjct: 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301
Query: 337 PWIKEGGEASDKPI 350
+ + + D+P+
Sbjct: 302 AYFAQYHDPDDEPV 315
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-58
Identities = 55/262 (20%), Positives = 102/262 (38%), Gaps = 21/262 (8%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ +G+G+FG L G + A K I E +M L
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-H 59
Query: 140 PNIVEFKGA-YEDKQSVHVVMELCAGGELFDRIIAKGH--YSERAAASICRSIVNVVHIC 196
N+V+ G E+K +++V E A G L D + ++G + +
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 197 HFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLR- 255
+HRDL N L+ E+ + K +DFGL+ + + APE LR
Sbjct: 120 EGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE 174
Query: 256 RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314
+++ + D+WS G++L+ + S G P+ K + + +G ++ + +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPAVYE 231
Query: 315 LVRRMLTQDPKKRITSAQVLEH 336
+++ D R + Q+ E
Sbjct: 232 VMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-58
Identities = 64/272 (23%), Positives = 104/272 (38%), Gaps = 23/272 (8%)
Query: 85 KELGRGQFGVTYLCT--ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNI 142
KELG G FG + A K + K + KD++ E +MQ L P I
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLD-NPYI 70
Query: 143 VEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVM 202
V G E +S +VME+ G L + H ++ + + + +
Sbjct: 71 VRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 129
Query: 203 HRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD----IVGSAYYVAPEVLR-RR 257
HRDL N LL ++ K +DFGLS + + Y + APE + +
Sbjct: 130 HRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 258 YGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316
+ + D+WS GV+++ S G P+ + + +G+ DL+
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYDLM 243
Query: 317 RRMLTQDPKKRITSAQV---LEHPW---IKEG 342
T D + R A V L + + + EG
Sbjct: 244 NLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 3e-58
Identities = 59/262 (22%), Positives = 115/262 (43%), Gaps = 17/262 (6%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+F +E+G GQFG+ +L + A K+I + + ++D E ++M LS
Sbjct: 6 ELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-H 59
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICRSIVNVVHICHF 198
P +V+ G ++ + +V E G L D + + ++ +C + +
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD--IVGSAYYVAPEVLR- 255
V+HRDL N L+ EN ++K +DFG++ F+ + + + +PEV
Sbjct: 120 ACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 256 RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314
RY + D+WS GV+++ + S G P+ + + + I G F S+
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKPRLASTHVYQ 233
Query: 315 LVRRMLTQDPKKRITSAQVLEH 336
++ + P+ R +++L
Sbjct: 234 IMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-57
Identities = 58/288 (20%), Positives = 104/288 (36%), Gaps = 36/288 (12%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD---IKREIQIMQHL 136
+ FGK LG G FG T + ++ + L K D + + E+++M L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH-------------------- 176
NIV GA ++++ E C G+L + + +K
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 177 ---YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233
+ + + F +HRDL N L+ ++K DFGL+ I
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDI 214
Query: 234 EEGK---VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKG 288
V + ++APE L Y + D+WS G++L+ + S GV P+
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 289 IFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
F ++Q + + +++ D +KR + +
Sbjct: 275 NFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 3e-57
Identities = 62/287 (21%), Positives = 119/287 (41%), Gaps = 21/287 (7%)
Query: 63 RPDTNTILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKND 122
+P T + +E + +LG+G FG ++ T N T R A K++ +
Sbjct: 1 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----S 55
Query: 123 KDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKG--HYSER 180
+ +E Q+M+ L +V+ ++ +++V E + G L D + + +
Sbjct: 56 PEAFLQEAQVMKKLR-HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLP 113
Query: 181 AAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR 240
+ I + + M +HRDL+ N L+ EN + K DFGL+ IE+ +
Sbjct: 114 QLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTA 170
Query: 241 D--IVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQG 296
+ APE R+ + D+WS G++L L + G P+ + + D + +G
Sbjct: 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 230
Query: 297 DIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE--HPWIKE 341
+ P S DL+ + ++P++R T + +
Sbjct: 231 ---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 7e-57
Identities = 56/267 (20%), Positives = 90/267 (33%), Gaps = 17/267 (6%)
Query: 80 HYSFGKELGRGQFGVTYLCT---ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHL 136
++LG G FGV + A K + L DD RE+ M L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 137 SGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHI 195
N++ G + +V EL G L DR+ GH+ + + +
Sbjct: 69 D-HRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 196 CHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY----RDIVGSAYYVAP 251
+HRDL N LL L+K DFGL + + + + AP
Sbjct: 127 LESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 252 EVLRRR-YGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309
E L+ R + D W GV L+ + + G P+ I I +
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDCP 241
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEH 336
+++ + P+ R T + +
Sbjct: 242 QDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (472), Expect = 9e-57
Identities = 60/267 (22%), Positives = 108/267 (40%), Gaps = 17/267 (6%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISK-RKLVTKNDKDDIKREIQIMQHLSG 138
+ +G G+FG G++ +I + T+ + D E IM
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD- 85
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICH 197
PN++ +G V ++ E G L + G ++ + R I +
Sbjct: 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY------RDIVGSAYYVAP 251
M +HRDL N L+ + N + K +DFGLS F+E+ + AP
Sbjct: 146 DMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202
Query: 252 EVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309
E ++ R++ D+WS G++++ ++S G P+W T + + +AI Q D+ P
Sbjct: 203 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---DYRLPPPMDCP 259
Query: 310 SSAKDLVRRMLTQDPKKRITSAQVLEH 336
S+ L+ +D R Q++
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 3e-56
Identities = 67/316 (21%), Positives = 118/316 (37%), Gaps = 53/316 (16%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
Y K +G G G+ + R A K +S+ + RE+ +M+ ++
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN-H 75
Query: 140 PNIVEFKGAY------EDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVV 193
NI+ + E+ Q V++VMEL + + + ++ +
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGI 132
Query: 194 HICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEV 253
H G++HRDLKP N ++ S K DFGL+ + V + YY APEV
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTL---KILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 254 LRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGD--------------- 297
+ Y + +DIWS G I+ ++ F ++ +++
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 298 -----------------------IDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVL 334
+S +S A+DL+ +ML DP KRI+ L
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 335 EHPWIKEGGEASDKPI 350
+HP+I + ++
Sbjct: 310 QHPYINVWYDPAEVEA 325
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-55
Identities = 60/266 (22%), Positives = 96/266 (36%), Gaps = 18/266 (6%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVE 144
ELG G FG +Q ++ K D +++ RE QIM L P IV
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVR 73
Query: 145 FKGAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMH 203
G + +++ +VME+ GG L ++ K A + + + +H
Sbjct: 74 LIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 132
Query: 204 RDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD----IVGSAYYVAPEVLR-RRY 258
RDL N LL ++ + +DFGLS + Y + APE + R++
Sbjct: 133 RDLAARNVLLVNRHYAKI---SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 259 GKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317
D+WS GV ++ LS G P+ + I QG P L+
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPPECPPELYALMS 246
Query: 318 RMLTQDPKKRITSAQV---LEHPWIK 340
+ R V + +
Sbjct: 247 DCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-55
Identities = 60/263 (22%), Positives = 106/263 (40%), Gaps = 14/263 (5%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSI-SKRKLVTKNDKDDIKREIQIMQHLSG 138
G+ +G GQFG + S +I + + + + ++ +E M+
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD- 66
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICH 197
P+IV+ G + V ++MELC GEL + + + + +
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR--DIVGSAYYVAPEVLR 255
+HRD+ N L+SS D +K DFGLS ++E+ Y+ ++APE +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 256 -RRYGKEIDIWSAGVILY-ILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313
RR+ D+W GV ++ IL+ GV PF + I G+ P +
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPNCPPTLY 239
Query: 314 DLVRRMLTQDPKKRITSAQVLEH 336
L+ + DP +R ++
Sbjct: 240 SLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-54
Identities = 51/262 (19%), Positives = 95/262 (36%), Gaps = 19/262 (7%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ LG GQFG ++ N + A KS+ + + D E +M+ L
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-H 67
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICH 197
+V + ++++ E G L D + + + I +
Sbjct: 68 QRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD--IVGSAYYVAPEVLR 255
+HRDL+ N L+S K DFGL+ IE+ + + APE +
Sbjct: 127 ERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 256 -RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313
+ + D+WS G++L +++ G P+ T + + +G +
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRPDNCPEELY 240
Query: 314 DLVRRMLTQDPKKRITSAQVLE 335
L+R + P+ R T +
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRS 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 179 bits (454), Expect = 3e-54
Identities = 53/269 (19%), Positives = 103/269 (38%), Gaps = 17/269 (6%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
+ +LG GQ+G Y A K++ + + + ++ +E +M+ +
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-H 72
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY--SERAAASICRSIVNVVHICH 197
PN+V+ G + +++ E G L D + S + I + +
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 198 FMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD--IVGSAYYVAPEVLR 255
+HRDL N L+ EN L+K DFGLS + + APE L
Sbjct: 133 KKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189
Query: 256 R-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314
++ + D+W+ GV+L+ + + + + +L+ D E +
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME--RPEGCPEKVYE 247
Query: 315 LVRRMLTQDPKKRITSAQVLE--HPWIKE 341
L+R +P R + A++ + +E
Sbjct: 248 LMRACWQWNPSDRPSFAEIHQAFETMFQE 276
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 5e-53
Identities = 49/263 (18%), Positives = 92/263 (34%), Gaps = 14/263 (5%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISK--RKLVTKNDKDDIKREIQIMQHLSG 138
+ K LG G FG Y G + K R+ + +I E +M +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD- 69
Query: 139 QPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF 198
P++ G + + G L K + + + C I ++
Sbjct: 70 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 199 MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD---IVGSAYYVAPEVLR 255
++HRDL N L+ +K TDFGL+ + + ++A E +
Sbjct: 130 RRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 256 -RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313
R Y + D+WS GV ++ L++ G P+ I + +G+ P +
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---RLPQPPICTIDVY 243
Query: 314 DLVRRMLTQDPKKRITSAQVLEH 336
++ + D R +++
Sbjct: 244 MIMVKCWMIDADSRPKFRELIIE 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 7e-53
Identities = 62/284 (21%), Positives = 102/284 (35%), Gaps = 35/284 (12%)
Query: 80 HYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
SFGK LG G FG T ++ A K + +++ + E++++
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLS 81
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH------------------ 176
+L NIV GA V+ E C G+L + + K
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 177 YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236
S + + +HRDL N LL+ K DFGL+ I+
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDIKND 198
Query: 237 KVYR---DIVGSAYYVAPEVLRRRY-GKEIDIWSAGVILYILLS-GVPPFWAETEKGIFD 291
Y + ++APE + E D+WS G+ L+ L S G P+ F
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 292 AILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335
+++ S + D+++ DP KR T Q+++
Sbjct: 259 KMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 174 bits (442), Expect = 2e-52
Identities = 48/289 (16%), Positives = 100/289 (34%), Gaps = 22/289 (7%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ 139
HY G+ +G G FGV + T +Q A K +R +D ++ E + + L+G
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAGC 60
Query: 140 PNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFM 199
I ++ +V++L + +S + A + ++ V H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 200 GVMHRDLKPENFLLSSKD--ENALLKATDFGLSVFIEEG--------KVYRDIVGSAYYV 249
+++RD+KP+NFL+ + ++ DFG+ F + + +++ G+A Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 250 APEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP---- 304
+ R + D+ + G + L G P+ + +S P
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLE--HPWIKEGGEASDKPID 351
+ + ++ D+ D
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD 289
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (442), Expect = 2e-52
Identities = 58/290 (20%), Positives = 110/290 (37%), Gaps = 43/290 (14%)
Query: 80 HYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
+ + +++G G FG + A K + + + + + D +RE +M
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHY----------------- 177
PNIV+ G + + ++ E A G+L + + + +
Sbjct: 72 EFD-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 178 -------SERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230
S I R + + +HRDL N L+ EN ++K DFGLS
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLS 187
Query: 231 VFIEEGKVYR---DIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAET 285
I Y+ + ++ PE + RY E D+W+ GV+L+ + S G+ P++
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 286 EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335
+ + + G+I A +L+R ++ P R + +
Sbjct: 248 HEEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-51
Identities = 55/282 (19%), Positives = 104/282 (36%), Gaps = 30/282 (10%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTGR-------QFACKSISKRKLVTKNDKDDIKREIQI 132
GK LG G FG L + + A K + T+ D D+ E+++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEM 71
Query: 133 MQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRI----------------IAKGH 176
M+ + NI+ GA ++V++E + G L + + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 177 YSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236
S + S + + +HRDL N L++ + + I+
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 237 KVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAIL 294
K + ++APE L R Y + D+WS GV+L+ + + G P+ + +F +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251
Query: 295 QGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
+G ++ ++R P +R T Q++E
Sbjct: 252 EG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 3e-50
Identities = 60/267 (22%), Positives = 108/267 (40%), Gaps = 20/267 (7%)
Query: 80 HYSFGKELGRGQFGVTYLCTENSTG----RQFACKSISKRKLVTKNDKDDIKREIQIMQH 135
+ K +G G+FG Y ++ A K++ T+ + D E IM
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQ 65
Query: 136 LSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVH 194
S NI+ +G + + ++ E G L + K G +S + R I +
Sbjct: 66 FS-HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 195 ICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR----DIVGSAYYVA 250
M +HRDL N L+ + N + K +DFGLS +E+ + A
Sbjct: 125 YLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 251 PEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308
PE + R++ D+WS G++++ +++ G P+W + + AI G F
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---FRLPTPMDC 238
Query: 309 SSSAKDLVRRMLTQDPKKRITSAQVLE 335
S+ L+ + Q+ +R A ++
Sbjct: 239 PSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 7e-49
Identities = 57/276 (20%), Positives = 109/276 (39%), Gaps = 23/276 (8%)
Query: 73 PYEDVKLHYSFGKELGRGQFGVTYLCT---ENSTGRQFACKSISKRKLVTKNDKDDIKRE 129
+ +H F + +GRG FG Y T + A KS+++ + E
Sbjct: 23 GPSSLIVH--FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTE 78
Query: 130 IQIMQHLSGQPNIVEFKGA-YEDKQSVHVVMELCAGGELFDRIIAKGH-YSERAAASICR 187
IM+ S PN++ G + S VV+ G+L + I + H + +
Sbjct: 79 GIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 137
Query: 188 SIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-----I 242
+ + +HRDL N +L DE +K DFGL+ + + +
Sbjct: 138 QVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194
Query: 243 VGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDF 300
++A E L+ +++ + D+WS GV+L+ L++ G PP+ I +LQG
Sbjct: 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--- 251
Query: 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
+++ + + R + ++++
Sbjct: 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-48
Identities = 54/288 (18%), Positives = 116/288 (40%), Gaps = 35/288 (12%)
Query: 80 HYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
+ +ELG+G FG+ Y ++ + A K++++ + ++ + E +M+
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMK 78
Query: 135 HLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGH----------YSERAAAS 184
+ ++V G Q V+MEL G+L + + S
Sbjct: 79 EFNC-HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 185 ICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYR---D 241
+ I + + + +HRDL N ++ E+ +K DFG++ I E YR
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 242 IVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGV-PPFWAETEKGIFDAILQGDID 299
+ +++PE L+ + D+WS GV+L+ + + P+ + + + +++G +
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254
Query: 300 FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE------HPWIKE 341
+L+R +PK R + +++ P +E
Sbjct: 255 D---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 4e-45
Identities = 62/284 (21%), Positives = 108/284 (38%), Gaps = 34/284 (11%)
Query: 80 HYSFGKELGRGQFGVTYLCT-----ENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ 134
GK LGRG FG + +T R A K + + T ++ + E++I+
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILI 71
Query: 135 HLSGQPNIVEFKGA-YEDKQSVHVVMELCAGGELFDRI----------------IAKGHY 177
H+ N+V GA + + V++E C G L + + K
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 178 SERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237
+ + + +HRDL N LL E ++K DFGL+ I +
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDP 188
Query: 238 VY---RDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGV-PPFWAETEKGIFDA 292
Y D ++APE + R Y + D+WS GV+L+ + S P+ F
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248
Query: 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336
L+ + + + + +P +R T ++++EH
Sbjct: 249 RLKEGTRMRAPDY--TTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 153 bits (387), Expect = 1e-43
Identities = 58/343 (16%), Positives = 118/343 (34%), Gaps = 68/343 (19%)
Query: 70 LGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKRE 129
G+PY+D + Y ++LG G F +L + A K + K+ + + E
Sbjct: 6 KGEPYKDAR--YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDE 59
Query: 130 IQIMQHLS----------GQPNIVEFKGAYEDKQSVHVVMEL-----CAGGELFDRIIAK 174
I+++Q ++ G +I++ + K V + + +
Sbjct: 60 IKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH 119
Query: 175 GHYSERAAASICRSIVN-VVHICHFMGVMHRDLKPENFLLSSKDENA-LLKATDFGLSVF 232
I + ++ + ++ G++H D+KPEN L+ D L++ L
Sbjct: 120 RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 179
Query: 233 IEEGKVYRDIVGSAYYVAPEVLR-RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFD 291
+ Y + + + Y +PEVL +G DIWS +++ L++G F +
Sbjct: 180 CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239
Query: 292 AI--------------------------------------------LQGDIDFESAPWPT 307
L+ + +
Sbjct: 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 299
Query: 308 ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350
+ D + ML DP+KR + ++ HPW+K+ + +
Sbjct: 300 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 342
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 7e-43
Identities = 52/296 (17%), Positives = 96/296 (32%), Gaps = 51/296 (17%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP 140
+ +G+G+FG + G + A K S R+ + EI L
Sbjct: 5 IVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLR-HE 57
Query: 141 NIVEFKGAYEDKQS----VHVVMELCAGGELFDRIIAKGHYSERA-------AASICRSI 189
NI+ F A + +V + G LFD + E A+ +
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 117
Query: 190 VNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRD-----IVG 244
+ +V + HRDLK +N L+ +N D GL+V + D VG
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 245 SAYYVAPEVLRR-------RYGKEIDIWSAGVILYILLSGVPPFWAETEKG--------- 288
+ Y+APEVL K DI++ G++ + + +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 289 ------IFDAILQGDIDF---ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335
+ + + + ++R + R+T+ ++ +
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.5 bits (221), Expect = 1e-21
Identities = 43/209 (20%), Positives = 70/209 (33%), Gaps = 35/209 (16%)
Query: 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDD--------------- 125
+ GK +G G+ + C + + K K K+
Sbjct: 2 DAIGKLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 126 IKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASI 185
+ E + +Q L G + + + V+MEL EL+ +
Sbjct: 61 ARNEFRALQKLQG-LAVPKVYAWEGN----AVLMELIDAKELY-------RVRVENPDEV 108
Query: 186 CRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVYRDIVGS 245
I+ V + G++H DL N L+S + + DF SV + E +R+I+
Sbjct: 109 LDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG----IWIIDFPQSVEVGEEG-WREILER 163
Query: 246 AYYVAPEVLRRRYGKEIDIWSAGVILYIL 274
R Y E DI S I IL
Sbjct: 164 DVRNIITYFSRTYRTEKDINS--AIDRIL 190
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Score = 39.8 bits (92), Expect = 4e-04
Identities = 17/147 (11%), Positives = 42/147 (28%), Gaps = 4/147 (2%)
Query: 85 KELGRGQFGVTYLCTENSTGRQFACKSISKRKLV----TKNDKDDIKREIQIMQHLSGQP 140
+E+G G + + R K V D + E +
Sbjct: 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV 91
Query: 141 NIVEFKGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG 200
+ + Y D + VME + ++ + + +G + I + +
Sbjct: 92 PHLVPRVFYSDTEMAVTVMEDLSHLKIARKGLIEGENYPHLSQHIGEFLGKTLFYSSDYA 151
Query: 201 VMHRDLKPENFLLSSKDENALLKATDF 227
+ + K ++ + + + F
Sbjct: 152 LEPKVKKQLVKQFTNPELCDITERLVF 178
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 393 | |||
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.75 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.41 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.2 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.69 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.24 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.72 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-68 Score=492.43 Aligned_cols=293 Identities=41% Similarity=0.727 Sum_probs=240.0
Q ss_pred cccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
+.+++.++|++++.||+|+||+||+|.++.+|+.||||++.+.... .....+.+|+.+|++++ |||||++++++.++
T Consensus 3 ~~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 79 (307)
T d1a06a_ 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIK-HPNIVALDDIYESG 79 (307)
T ss_dssp ECSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred CCCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC
Confidence 3456788999999999999999999999999999999999865432 23466889999999996 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccc
Q 016233 153 QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVF 232 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~ 232 (393)
+.+|||||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+...++++.+||+|||+|+.
T Consensus 80 ~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 80 GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred CEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 99999999999999999999888999999999999999999999999999999999999998766778899999999998
Q ss_pred ccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHH
Q 016233 233 IEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSS 311 (393)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 311 (393)
........+.+||+.|||||++.+ .|+.++|||||||++|+|++|..||.+.+..+....+..+...++...++.+|++
T Consensus 160 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 239 (307)
T d1a06a_ 160 EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 239 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred ccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHH
Confidence 776666677899999999999976 4999999999999999999999999999999999999999988888888899999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCCCCcCCHHHHHHHHHHHHhhHHHH
Q 016233 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPIDSAVLSRMKQFRAMNKLKK 369 (393)
Q Consensus 312 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (393)
+.+||.+||..||++|||++|+|+||||+... .............+++....+++++
T Consensus 240 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (307)
T d1a06a_ 240 AKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT-ALDKNIHQSVSEQIKKNFAKSKWKQ 296 (307)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC-CCCCCCHHHHHHHHHHHSCCCTTTS
T ss_pred HHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC-ccccccchhHHHHHHHHHHHhhhhh
Confidence 99999999999999999999999999998643 2333444555556666655555544
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-66 Score=467.04 Aligned_cols=254 Identities=32% Similarity=0.630 Sum_probs=232.4
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|++++++++ |||||++++++.+++.+|+|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCEEEEE
Confidence 47999999999999999999999999999999998655444456778999999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~ 238 (393)
||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|.......
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCCC-
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCCCc-
Confidence 9999999999999998899999999999999999999999999999999999999 556679999999998765443
Q ss_pred eecccCcccccchHHHhhc-CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 016233 239 YRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (393)
Q Consensus 239 ~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (393)
....+||+.|||||++.+. |+.++|||||||++|+|++|..||.+.+..+.+..+.+....++ ..+|+++++||.
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~ 236 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 236 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHH
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHHHH
Confidence 4567899999999999864 89999999999999999999999999999999999988876654 358999999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccC
Q 016233 318 RMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 318 ~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
+||..||++|||++|+|+||||+.
T Consensus 237 ~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHccCCHhHCcCHHHHHcCcCcCC
Confidence 999999999999999999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-65 Score=467.36 Aligned_cols=267 Identities=40% Similarity=0.710 Sum_probs=243.0
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCc---ccHHHHHHHHHHHHHccCCCCeeEEeEEEEe
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK---NDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 151 (393)
+++.++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|++|+ |||||++++++++
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYEN 84 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEE
Confidence 3467899999999999999999999999999999999987654322 24678999999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCC-CCcEEEeecCCc
Q 016233 152 KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDE-NALLKATDFGLS 230 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~-~~~~kl~DFg~a 230 (393)
++.+|||||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++. ...+||+|||+|
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999999999999998889999999999999999999999999999999999999965432 346999999999
Q ss_pred ccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 231 VFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......++...++.+|
T Consensus 165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (293)
T d1jksa_ 165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244 (293)
T ss_dssp EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence 98877777777899999999999976 48999999999999999999999999999999999999988877766667899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+++++||++||..||++|||++|+|+||||+..
T Consensus 245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-65 Score=465.23 Aligned_cols=257 Identities=30% Similarity=0.552 Sum_probs=219.3
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
.++|++++.||+|+||+||+|+++.+|+.||||++..... ....+.+.+|+++|++++ |||||++++++.+++.+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCceeEE
Confidence 4579999999999999999999999999999999976542 234567899999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
|||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+......
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEETT
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccCC
Confidence 99999999999999888889999999999999999999999999999999999999 455679999999999765432
Q ss_pred ---ceecccCcccccchHHHhhc--CCCcchHHHHHHHHHHHhhCCCCCCCCChHH-HHHHHHcCCCCCCCCCCCCCCHH
Q 016233 238 ---VYRDIVGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKG-IFDAILQGDIDFESAPWPTISSS 311 (393)
Q Consensus 238 ---~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~ 311 (393)
.....+||+.|||||++.+. ++.++|||||||++|+|++|+.||....... .+..+..... ....+..+|++
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~ 235 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDSA 235 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT--TSTTGGGSCHH
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCccccCCHH
Confidence 23567899999999998753 4678999999999999999999997765433 3333333322 23345678999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 312 AKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 312 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+.+||.+||..||++|||++|+|+||||++.
T Consensus 236 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 236 PLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 9999999999999999999999999999853
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-64 Score=459.96 Aligned_cols=257 Identities=30% Similarity=0.523 Sum_probs=225.9
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
...+|++.+.||+|+||+||+|.+..+|+.||||++.... ....+.+.+|+.+|++++ |||||++++++.+++.+|
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENK-NPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc---ChHHHHHHHHHHHHHhCC-CCCEeeEeEEEEECCEEE
Confidence 4568999999999999999999999999999999997654 234678999999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
||||||+||+|.+++.+ +.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.+...
T Consensus 94 ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp EEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCST
T ss_pred EEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeeccc
Confidence 99999999999987654 579999999999999999999999999999999999999 45567999999999987543
Q ss_pred -cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 237 -KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 237 -~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+.+..+...... ....++.+|+++++
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~ 248 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRD 248 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSSGGGSCHHHHH
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCCCcccCCHHHHH
Confidence 34456789999999999976 4899999999999999999999999998877776666544321 22234578999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
||.+||..||++|||++|+|+||||+..
T Consensus 249 li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 249 FLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-64 Score=462.65 Aligned_cols=256 Identities=33% Similarity=0.579 Sum_probs=229.4
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++++.||+|+||+||+|.++.+|+.||||++.+.........+.+.+|+++|++++ |||||++++++.+++.+|+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEEEEE
Confidence 47999999999999999999999999999999998655444456788999999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc-
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~- 237 (393)
||||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+|+.+....
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecccCCc
Confidence 9999999999999999999999999999999999999999999999999999999 566779999999998775332
Q ss_pred --ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 238 --VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 238 --~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
.....+||+.|||||++.+ .|+.++|||||||++|+|++|..||.+.+..+++.++.++...++ ..+++++++
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~ 239 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 239 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC----TTCCHHHHH
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC----ccCCHHHHH
Confidence 3345789999999999976 589999999999999999999999999999999999998877654 368999999
Q ss_pred HHHHhcccCCCCCCCHHH------HhcCccccCC
Q 016233 315 LVRRMLTQDPKKRITSAQ------VLEHPWIKEG 342 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e------~l~h~~~~~~ 342 (393)
||.+||..||++|||++| +++||||+.-
T Consensus 240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 999999999999999988 5789999764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.5e-64 Score=473.36 Aligned_cols=262 Identities=35% Similarity=0.640 Sum_probs=239.7
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
+-++|++++.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+|++|+ |||||++++++.+++.+|
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~ 99 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMV 99 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETTEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence 3468999999999999999999999999999999996543 335678899999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 157 VVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
||||||+||+|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||++.+ .++.+||+|||+|+.+..
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~-~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC-CCCeEEEeecchheeccc
Confidence 99999999999998854 4579999999999999999999999999999999999999643 346799999999998887
Q ss_pred CcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 236 GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
........||+.|||||++.+ .|+.++|||||||++|+|++|..||.+.+..+.+..+......++...++.+|+++++
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 258 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 777778899999999999876 4899999999999999999999999999999999999999888887777889999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
||.+||..||++|||++|+|+||||+...
T Consensus 259 li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 259 FIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999999998754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.5e-64 Score=471.95 Aligned_cols=263 Identities=35% Similarity=0.631 Sum_probs=240.2
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
+.++|++++.||+|+||.||+|++..+|+.||||++.... ......+.+|+.+|++|+ |||||+++++|++++.+|
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence 4468999999999999999999999999999999997643 234567889999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 157 VVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
||||||+||+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+|..+..
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~-~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEECCT
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc-CCCeEEEeecccceecCC
Confidence 9999999999998876544 69999999999999999999999999999999999999532 356799999999999887
Q ss_pred CcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHH
Q 016233 236 GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKD 314 (393)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 314 (393)
........||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+.+..+.+..+..+...++...++.+|+++.+
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 777778899999999999876 4999999999999999999999999999999999999999988888888899999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 315 LVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 315 li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
||.+||+.||++|||++|+|+||||+....
T Consensus 262 li~~~L~~dp~~R~s~~eil~Hp~~~~~~~ 291 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence 999999999999999999999999986543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-63 Score=453.54 Aligned_cols=261 Identities=37% Similarity=0.694 Sum_probs=239.5
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcc------cHHHHHHHHHHHHHccCCCCeeEEeEEEEe
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN------DKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 151 (393)
.++|++++.||+|+||+||+|++..+|+.||||++.+....... ..+.+.+|+.++++|+.|||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 46899999999999999999999999999999999876543221 234688999999999779999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 152 KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
++.+|||||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchhee
Confidence 99999999999999999999999999999999999999999999999999999999999999 566779999999999
Q ss_pred cccCCcceecccCcccccchHHHhh-------cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 016233 232 FIEEGKVYRDIVGSAYYVAPEVLRR-------RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAP 304 (393)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 304 (393)
.+.........+||+.|+|||.+.+ .++.++||||+||++|+|++|..||.+.+..+....+..+...++...
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 8877666677899999999999863 267899999999999999999999999999999999999988888878
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
++++|+++++||.+||..||++|||++|+|+||||++
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 8899999999999999999999999999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-63 Score=456.13 Aligned_cols=256 Identities=27% Similarity=0.461 Sum_probs=226.2
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 157 (393)
.+.|++++.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+++|++++ |||||++++++.+++.+||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCeEEE
Confidence 457999999999999999999999999999999997642 345678899999999996 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 158 VMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
|||||+||+|.+++.+. +.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|......
T Consensus 87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHH
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccCCC
Confidence 99999999999987654 569999999999999999999999999999999999999 55667999999999865433
Q ss_pred -cceecccCcccccchHHHh------hcCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 237 -KVYRDIVGSAYYVAPEVLR------RRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 237 -~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
......+||+.|||||++. ..|+.++|||||||++|+|+||..||.+.+..+.+..+..+..... .....+|
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s 242 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRWS 242 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-SSGGGSC
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-CccccCC
Confidence 2234578999999999984 2488999999999999999999999999988888888887754322 2235689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
+++++||.+||+.||++|||++|+|+||||+.
T Consensus 243 ~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-63 Score=460.93 Aligned_cols=257 Identities=26% Similarity=0.441 Sum_probs=229.1
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
....|++++.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+|++|+ |||||++++++.+++.+|
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEE
T ss_pred cHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECCEEE
Confidence 4557999999999999999999999999999999998765444455677899999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
+|||||.||+|..++...+.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|......
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSSB
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---CCCCCEEEeecccccccCCC
Confidence 999999999998777778889999999999999999999999999999999999999 45678999999999876543
Q ss_pred cceecccCcccccchHHHhh----cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHH
Q 016233 237 KVYRDIVGSAYYVAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSA 312 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 312 (393)
...+||+.|||||++.+ .|+.++|||||||++|+|++|..||.+.+..+.+..+..+...... ...+|+++
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~ 243 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSEYF 243 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--CTTSCHHH
T ss_pred ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCCCHHH
Confidence 45689999999999853 4899999999999999999999999998888888887776543322 34689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 313 KDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 313 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
++||.+||..||++|||++|+|+||||...
T Consensus 244 ~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 999999999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-63 Score=463.04 Aligned_cols=255 Identities=33% Similarity=0.589 Sum_probs=233.8
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++++.||+|+||.||+|+++.+|+.||||++++...........+.+|+.+|++++ ||||+++++++++++.+|+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeeccccccccc
Confidence 46999999999999999999999999999999998765444456788899999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC-Cc
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE-GK 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~-~~ 237 (393)
||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.... ..
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccCCc
Confidence 9999999999999999999999999999999999999999999999999999999 5667899999999987644 34
Q ss_pred ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 238 VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..+..+...++ ..+|+++++||
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dli 236 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLL 236 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHHH
Confidence 4566899999999999875 599999999999999999999999999999999999999877665 46899999999
Q ss_pred HHhcccCCCCCCC-----HHHHhcCccccC
Q 016233 317 RRMLTQDPKKRIT-----SAQVLEHPWIKE 341 (393)
Q Consensus 317 ~~~L~~dp~~Rpt-----~~e~l~h~~~~~ 341 (393)
.+||+.||.+|++ ++|+++||||+.
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HhhccCCchhhcccccccHHHHHcCccccc
Confidence 9999999999994 899999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-63 Score=449.81 Aligned_cols=253 Identities=23% Similarity=0.446 Sum_probs=219.7
Q ss_pred eeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe----CCeEE
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED----KQSVH 156 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----~~~~~ 156 (393)
|++.++||+|+||+||+|.+..+++.||+|.+..... .....+.+.+|+++|++++ |||||++++++++ ++.+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCCEEE
Confidence 4788899999999999999999999999999976543 3445678999999999997 9999999999875 45689
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--cEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMG--VMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~--ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+|||||+||+|.+++.+...+++.+++.++.||+.||+|||+++ |+||||||+|||++. .++.+||+|||+|+...
T Consensus 89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~--~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS--TTSCEEECCTTGGGGCC
T ss_pred EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC--CCCCEEEeecCcceecc
Confidence 99999999999999999889999999999999999999999999 999999999999952 35679999999998654
Q ss_pred CCcceecccCcccccchHHHhhcCCCcchHHHHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 235 EGKVYRDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETE-KGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
.. .....+||+.|||||++.+.|+.++|||||||++|+|++|..||.+... .++...+..+... ......++++++
T Consensus 167 ~~-~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~ 243 (270)
T d1t4ha_ 167 AS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIPEVK 243 (270)
T ss_dssp TT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGCCCHHHH
T ss_pred CC-ccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC--cccCccCCHHHH
Confidence 33 3456789999999999998999999999999999999999999986554 4455566554332 122345789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccc
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEHPWIK 340 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h~~~~ 340 (393)
+||.+||..||++|||++|+|+||||+
T Consensus 244 ~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 244 EIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999999999999999999995
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-63 Score=462.94 Aligned_cols=261 Identities=29% Similarity=0.601 Sum_probs=239.1
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
++.++|++++.||+|+||+||+|.++.+|+.||||+++... .....+.+|+++|+.++ |||||+++++|++++.+
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-HRNILHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEE
Confidence 35678999999999999999999999999999999997542 23456889999999997 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIAKG-HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
|||||||+||+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.+ ....+||+|||++....
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~-~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC-CceEEEEcccchhhccc
Confidence 99999999999999997665 69999999999999999999999999999999999999642 34579999999999887
Q ss_pred CCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 235 EGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
.........||+.|+|||.+.+ .|+.++|||||||++|+|++|..||.+.+..+.+..|.++...++...|+.+|++++
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence 7777777889999999999875 589999999999999999999999999999999999999988888777788999999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+||.+||..||++|||++|+|+||||++.
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 99999999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-63 Score=448.34 Aligned_cols=253 Identities=29% Similarity=0.523 Sum_probs=213.2
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe--CCeEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED--KQSVH 156 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~~ 156 (393)
++|++++.||+|+||.||+|+++.+|+.||||++..... .....+.+.+|+++|++++ |||||++++++.+ ++.+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----CEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCCEEE
Confidence 579999999999999999999999999999999976643 3445677899999999996 9999999999864 46789
Q ss_pred EEEeccCCCChHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC-----cEecCCCCCcEEeccCCCCCcEEEeec
Q 016233 157 VVMELCAGGELFDRIIA----KGHYSERAAASICRSIVNVVHICHFMG-----VMHRDLKPENFLLSSKDENALLKATDF 227 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qll~~l~~lH~~~-----ivH~Dikp~Nill~~~~~~~~~kl~DF 227 (393)
||||||+||+|.+++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+||
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DF 158 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDF 158 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECCH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeec
Confidence 99999999999998864 357999999999999999999999976 9999999999999 55677999999
Q ss_pred CCcccccCCc-ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 016233 228 GLSVFIEEGK-VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPW 305 (393)
Q Consensus 228 g~a~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (393)
|+|+.+.... .....+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+.+..++...+..+..... .
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~---~ 235 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---P 235 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---C
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence 9999876543 3456789999999999976 599999999999999999999999999999999999888765432 2
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWI 339 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 339 (393)
..+|+++.+||.+||..||++|||++|+|+|||+
T Consensus 236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 4689999999999999999999999999999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-62 Score=454.24 Aligned_cols=254 Identities=30% Similarity=0.609 Sum_probs=232.1
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|++++ |||||++++++.+++.+|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCeeeeE
Confidence 36999999999999999999999999999999998655434456788999999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~ 238 (393)
||||+||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC--
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEeccc--
Confidence 9999999999999999999999999999999999999999999999999999999 56678999999999887543
Q ss_pred eecccCcccccchHHHhhc-CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 016233 239 YRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (393)
Q Consensus 239 ~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (393)
....+||+.|||||++.+. |+.++|||||||++|+|++|..||.+.+..+.+..+..+...++ +.+++++.++|.
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~ 233 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS 233 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence 3467899999999999864 89999999999999999999999999999999999998876554 468999999999
Q ss_pred HhcccCCCCCC-----CHHHHhcCccccCC
Q 016233 318 RMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (393)
Q Consensus 318 ~~L~~dp~~Rp-----t~~e~l~h~~~~~~ 342 (393)
+||..||.+|+ |++++|+||||+..
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 99999999996 99999999999763
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-63 Score=458.72 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=218.0
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
..++|++++.||+|+||+||+|+++.+|+.||+|+++... .......+.+|+.+|++++ |||||+++++|.+++.+|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence 4568999999999999999999999999999999997643 3345678999999999996 999999999999999999
Q ss_pred EEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 157 VVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~-~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
||||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||+ +.++.+||+|||+|+...+
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHH
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccCC
Confidence 999999999999999988899999999999999999999997 599999999999999 5566799999999997654
Q ss_pred CcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHH-----------------------
Q 016233 236 GKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFD----------------------- 291 (393)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~----------------------- 291 (393)
. ...+.+||+.|||||++.+ .|+.++||||+||++|+|++|+.||.+.+..+...
T Consensus 158 ~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 158 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp H-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred C-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 3 2346799999999999876 59999999999999999999999998765432110
Q ss_pred -------------------HHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 292 -------------------AILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 292 -------------------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.+... ..+......+|.+++|||.+||..||++|||++|+|+||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNE--PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ---------CCCCHHHHHHHHHTS--CCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccchhHHHHHhhhhcc--CCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 00000 00111112468899999999999999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.2e-62 Score=456.46 Aligned_cols=254 Identities=31% Similarity=0.581 Sum_probs=231.9
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+++|+.++ |||||++++++.+.+.+++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeecccccccccccccc
Confidence 58999999999999999999999999999999998655444456778999999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcc
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKV 238 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~ 238 (393)
|||+.||+|.+++...+.+++.+++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.+...
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC--
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeecccc--
Confidence 9999999999999998999999999999999999999999999999999999999 55678999999999987643
Q ss_pred eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHH
Q 016233 239 YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVR 317 (393)
Q Consensus 239 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 317 (393)
....+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+.+....+..+..+...++ ..+++++.+||+
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~ 270 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHHHH
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHHHH
Confidence 346789999999999976 489999999999999999999999999999999999988876554 468999999999
Q ss_pred HhcccCCCCCC-----CHHHHhcCccccCC
Q 016233 318 RMLTQDPKKRI-----TSAQVLEHPWIKEG 342 (393)
Q Consensus 318 ~~L~~dp~~Rp-----t~~e~l~h~~~~~~ 342 (393)
+||..||.+|+ |++++|+||||+..
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHhhhCHHhccccccccHHHHHcCccccCC
Confidence 99999999995 99999999999753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-62 Score=458.80 Aligned_cols=266 Identities=35% Similarity=0.629 Sum_probs=227.4
Q ss_pred cccceeecc-eecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe----
Q 016233 77 VKLHYSFGK-ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED---- 151 (393)
Q Consensus 77 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~---- 151 (393)
+-++|.+.+ .||+|+||+||+|++..+++.||||+++. ...+.+|+.++.++.+|||||+++++|++
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 456798875 59999999999999999999999999853 24677899998776569999999999976
Q ss_pred CCeEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 152 KQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
++.+|||||||+||+|.+++.+. ..+++.+++.++.||+.||+|||++||+||||||+|||++..+..+.+||+|||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence 46789999999999999999864 3699999999999999999999999999999999999998766778899999999
Q ss_pred cccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHH----HHHcCCCCCCCCC
Q 016233 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFD----AILQGDIDFESAP 304 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~----~i~~~~~~~~~~~ 304 (393)
|+...........+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+.+...... .+..+...++...
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (335)
T d2ozaa1 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240 (335)
T ss_dssp CEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred eeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence 998877776778899999999999876 59999999999999999999999998776544433 3344555566555
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCCCCcC
Q 016233 305 WPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEASDKPI 350 (393)
Q Consensus 305 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~~~~ 350 (393)
+..+|+++.+||.+||+.||++|||+.|+|+||||.+.......+.
T Consensus 241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~ 286 (335)
T d2ozaa1 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 286 (335)
T ss_dssp HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCCEE
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCCCc
Confidence 6678999999999999999999999999999999987654444333
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-61 Score=448.41 Aligned_cols=256 Identities=28% Similarity=0.496 Sum_probs=229.0
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHH-HccCCCCeeEEeEEEEeCCeEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQ-HLSGQPNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~~h~niv~~~~~~~~~~~~~l 157 (393)
++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|..++. .+ +|||||++++++.+++.+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~-~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT-TCTTBCCEEEEEECSSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhC-CCCcEEEEEEEEccCCceeE
Confidence 47999999999999999999999999999999998654433445667777888776 46 59999999999999999999
Q ss_pred EEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC-
Q 016233 158 VMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG- 236 (393)
Q Consensus 158 v~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~- 236 (393)
|||||+||+|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+++.....
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhccccc
Confidence 99999999999999999999999999999999999999999999999999999999 56678999999999876543
Q ss_pred cceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHH
Q 016233 237 KVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDL 315 (393)
Q Consensus 237 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 315 (393)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..+++.++..+...++ ..+|+++.+|
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dl 233 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDL 233 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHH
Confidence 33455789999999999976 599999999999999999999999999999999999988766554 3689999999
Q ss_pred HHHhcccCCCCCCCHH-HHhcCccccCC
Q 016233 316 VRRMLTQDPKKRITSA-QVLEHPWIKEG 342 (393)
Q Consensus 316 i~~~L~~dp~~Rpt~~-e~l~h~~~~~~ 342 (393)
|.+||..||++|||+. ++++||||+..
T Consensus 234 i~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 234 LVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 9999999999999995 89999999763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.6e-61 Score=453.08 Aligned_cols=257 Identities=28% Similarity=0.460 Sum_probs=218.0
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHH---HHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKRE---IQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E---~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
++|++++.||+|+||.||+|++..+|+.||||++.+...........+.+| +++++.+. |||||++++++.+.+.+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~-hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEECSSEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC-CCcEEEEEEEEEECCEE
Confidence 479999999999999999999999999999999976544333334445555 55666664 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
|+|||||+||+|.+++.+...+++.+++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+|+.+..
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecCC
Confidence 9999999999999999999999999999999999999999999999999999999999 5667799999999997765
Q ss_pred CcceecccCcccccchHHHh-h-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 236 GKVYRDIVGSAYYVAPEVLR-R-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~l~-~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
.. ....+||+.|+|||++. + .|+.++|||||||++|+|+||..||.+.+..+... +...........+..+|++++
T Consensus 160 ~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp SC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCCCCCCSSSCHHHH
T ss_pred Cc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCCCCCCCCCCHHHH
Confidence 43 35668999999999985 3 48999999999999999999999998765433322 222222333334457999999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHhcCccccC
Q 016233 314 DLVRRMLTQDPKKRIT-----SAQVLEHPWIKE 341 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt-----~~e~l~h~~~~~ 341 (393)
+||.+||..||++||| ++|+++||||+.
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 9999999999999999 799999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-60 Score=440.05 Aligned_cols=258 Identities=26% Similarity=0.366 Sum_probs=215.2
Q ss_pred ecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCc--ccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEe
Q 016233 83 FGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTK--NDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVME 160 (393)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 160 (393)
.+++||+|+||+||+|+++.+|+.||||+++....... .....+.+|+.+|++++ |||||++++++.+++.+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceeehhh
Confidence 35789999999999999999999999999976533211 12456889999999996 9999999999999999999999
Q ss_pred ccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc-ce
Q 016233 161 LCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK-VY 239 (393)
Q Consensus 161 ~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~-~~ 239 (393)
||.|+++..+......+++.+++.+++||+.||+|||++||+||||||+|||+ +..+.+||+|||+|+...... ..
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCcccc
Confidence 99988877666656779999999999999999999999999999999999999 566779999999998765543 34
Q ss_pred ecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC--------------
Q 016233 240 RDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA-------------- 303 (393)
Q Consensus 240 ~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~-------------- 303 (393)
...+||+.|+|||++.. .|+.++|||||||++|+|++|.+||.+.+..+.+..+.+........
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 55789999999999864 47999999999999999999999999999888877765421111110
Q ss_pred ----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 304 ----------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 304 ----------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
.++.+++++.+||.+||..||++|||++|+|+||||++...
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 02357899999999999999999999999999999987543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-60 Score=429.14 Aligned_cols=253 Identities=29% Similarity=0.555 Sum_probs=217.3
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcc---cHHHHHHHHHHHHHcc-CCCCeeEEeEEEEeC
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKN---DKDDIKREIQIMQHLS-GQPNIVEFKGAYEDK 152 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~-~h~niv~~~~~~~~~ 152 (393)
+..+|++++.||+|+||.||+|++..+|+.||||++.+....... ....+.+|+.+|++++ .|||||++++++.++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 356899999999999999999999999999999999875543222 1234678999999996 489999999999999
Q ss_pred CeEEEEEeccCC-CChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 153 QSVHVVMELCAG-GELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 153 ~~~~lv~e~~~g-g~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
+.+|+||||+.+ +++.+++.....+++.+++.++.||+.||+|||++||+||||||+|||++. +.+.+||+|||+|.
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~--~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLIDFGSGA 159 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCTTCE
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec--CCCeEEECccccce
Confidence 999999999976 678888888889999999999999999999999999999999999999953 34579999999998
Q ss_pred cccCCcceecccCcccccchHHHhhc--CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 232 FIEEGKVYRDIVGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
..... ...+.+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+. ..+..+...++ +.+|
T Consensus 160 ~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~----~~~s 228 (273)
T d1xwsa_ 160 LLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR----QRVS 228 (273)
T ss_dssp ECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCS----SCCC
T ss_pred ecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCC----CCCC
Confidence 75443 34567899999999998753 567899999999999999999999753 23445544433 4689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+++++||.+||..||++|||++|+|+||||++.
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999999763
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.7e-60 Score=429.97 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=222.7
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC--
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-- 153 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-- 153 (393)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++++...........+.+|+++++.++ |||||++++++..++
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPA 82 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeeccCC
Confidence 35678999999999999999999999999999999998765545555678999999999996 999999999987654
Q ss_pred --eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 154 --SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 154 --~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
.+|||||||+|++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++ .++.++|+|||.+.
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~---~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIAR 159 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTSCEEECCCTTCE
T ss_pred CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC---ccccceeehhhhhh
Confidence 4899999999999999999989999999999999999999999999999999999999994 55669999999987
Q ss_pred cccCCc----ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 016233 232 FIEEGK----VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWP 306 (393)
Q Consensus 232 ~~~~~~----~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 306 (393)
...... .....+||+.|+|||++.+ .++.++|||||||++|+|+||.+||.+.+..+.+..+......++...++
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSS
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhcc
Confidence 654322 3345689999999999976 48999999999999999999999999999888888888877776666778
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 016233 307 TISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIK 340 (393)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 340 (393)
.+|+++.+||.+||..||++||+..+.|.|+|.+
T Consensus 240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 8999999999999999999999666666677654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-59 Score=427.77 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=216.0
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|++++.||+|+||+||+|.+..+|+.||||+++.... .....+.+.+|+++|++++ |||||++++++.+++.+|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEEeccccccccceeEE
Confidence 479999999999999999999999999999999975432 3345678899999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCC
Q 016233 159 MELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEG 236 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~ 236 (393)
|||+.++ +.+++.. ...+++.+++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.....
T Consensus 80 ~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 80 FEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp EECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCC
T ss_pred EeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCC
Confidence 9999764 4444433 3569999999999999999999999999999999999999 55667999999999877543
Q ss_pred -cceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC----------
Q 016233 237 -KVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESA---------- 303 (393)
Q Consensus 237 -~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~---------- 303 (393)
.......||+.|+|||++.. .++.++|||||||++|+|++|+.||.+.+..+.+..+......+...
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 33445689999999998764 36889999999999999999999999988777766654321111111
Q ss_pred ---------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 304 ---------------PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 304 ---------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
.++.+|+++++||.+||..||++|||++|+|+||||++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 12356899999999999999999999999999999987544
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-58 Score=425.33 Aligned_cols=261 Identities=24% Similarity=0.362 Sum_probs=216.6
Q ss_pred ccceeecceecccCCeEEEEEEECCC-CcEEEEEEeecCccCCcccHHHHHHHHHHHHHcc--CCCCeeEEeEEEEe---
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENST-GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS--GQPNIVEFKGAYED--- 151 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~--- 151 (393)
.++|++++.||+|+||+||+|++..+ ++.||||+++.... .......+.+|+.+|+.|. +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhc-cchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 46899999999999999999999766 56799999976543 2233445667888887763 49999999999853
Q ss_pred --CCeEEEEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecC
Q 016233 152 --KQSVHVVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFG 228 (393)
Q Consensus 152 --~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg 228 (393)
...++++|||+.++.+...... ...+++..++.++.|++.||+|||++||+||||||+|||+ +..+.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecchh
Confidence 3578999999988776544333 3569999999999999999999999999999999999999 556679999999
Q ss_pred CcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC-------
Q 016233 229 LSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDF------- 300 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~------- 300 (393)
++.............||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+.......
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence 9988776666678899999999999865 59999999999999999999999999998888777765311100
Q ss_pred ----------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 301 ----------------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 301 ----------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
....+..+++++++||.+||..||++|||++|+|+||||++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 011234678999999999999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.4e-58 Score=419.37 Aligned_cols=252 Identities=20% Similarity=0.320 Sum_probs=215.6
Q ss_pred cccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
.|+...++|++.+.||+|+||+||+|.++.+++.||||+++.. ....+++.+|+++|++++ |||||++++++.+.
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~----~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTRE 85 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT----CSCHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc----cchHHHHHHHHHHHHhCC-CCCEecCCccEeeC
Confidence 4566667899999999999999999999999999999998653 235678999999999996 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 153 QSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
+.++||||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLS 162 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCT
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccce
Confidence 9999999999999999998764 568999999999999999999999999999999999999 55677999999999
Q ss_pred ccccCCcc--eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCC-CCChHHHHHHHHcCCCCCCCCCCC
Q 016233 231 VFIEEGKV--YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFW-AETEKGIFDAILQGDIDFESAPWP 306 (393)
Q Consensus 231 ~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~ 306 (393)
+....... .....||+.|+|||++.+ .|+.++|||||||++|||++|..||. +.+..++.+.+..+. . .....
T Consensus 163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~-~--~~~~~ 239 (287)
T d1opja_ 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-R--MERPE 239 (287)
T ss_dssp TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-C--CCCCT
T ss_pred eecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC-C--CCCCc
Confidence 98755432 233468899999998875 69999999999999999999766654 455555555555442 2 22335
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 307 TISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 307 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.+++++.+||.+||..||++|||++|+++
T Consensus 240 ~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 78999999999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.4e-58 Score=420.74 Aligned_cols=257 Identities=31% Similarity=0.454 Sum_probs=216.5
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|+++++||+|+||+||+|+++ +|+.||||++..... .......+.+|+.+|++++ |||||++++++.+++..+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCceeEE
Confidence 48999999999999999999986 789999999976543 3445678999999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc-
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~- 237 (393)
||++.++.+..+....+.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||++.......
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCcc
Confidence 9999887777666667889999999999999999999999999999999999999 556779999999998865433
Q ss_pred ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC--------------
Q 016233 238 VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE-------------- 301 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~-------------- 301 (393)
......|++.|+|||.+.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+........
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 2345579999999999864 479999999999999999999999999888777766543111111
Q ss_pred -----------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 016233 302 -----------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKE 341 (393)
Q Consensus 302 -----------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 341 (393)
....+.+++++.|||++||..||++|||++|+|+||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0112457899999999999999999999999999999974
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-58 Score=426.38 Aligned_cols=256 Identities=23% Similarity=0.379 Sum_probs=215.7
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCCc-----EEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEE
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTGR-----QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 148 (393)
|+...++|++++.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+|+++.+|||||+++++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 45556789999999999999999999876554 69999886543 334567889999999999669999999999
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecC
Q 016233 149 YEDKQSVHVVMELCAGGELFDRIIAKG-----------------------HYSERAAASICRSIVNVVHICHFMGVMHRD 205 (393)
Q Consensus 149 ~~~~~~~~lv~e~~~gg~L~~~l~~~~-----------------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~D 205 (393)
+.+.+.+|+|||||+||+|.++|.... .+++.+++.++.||+.||+|||++||||||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 999999999999999999999997542 488999999999999999999999999999
Q ss_pred CCCCcEEeccCCCCCcEEEeecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCC
Q 016233 206 LKPENFLLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPP 280 (393)
Q Consensus 206 ikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~p 280 (393)
|||+|||+ +.++.+||+|||+|+....... ..+..||+.|||||++.+ .|+.++|||||||++|||+| |..|
T Consensus 190 lKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 190 LAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp CSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred Cchhcccc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence 99999999 5667899999999987654432 234568999999998865 59999999999999999998 8999
Q ss_pred CCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 281 FWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 281 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
|.+.+..+.+..+......++. ...+|+++++||.+||+.||++|||++|+++|
T Consensus 267 f~~~~~~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp STTCCCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9987766666666655544333 35689999999999999999999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-58 Score=417.30 Aligned_cols=255 Identities=23% Similarity=0.400 Sum_probs=209.6
Q ss_pred cccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK 152 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 152 (393)
+|+...++|++++.||+|+||.||+|+.+ ..||||+++.... .....+.+.+|+.+|++++ |||||++++++.+
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~- 75 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-HVNILLFMGYSTA- 75 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEec-
Confidence 35556678999999999999999999854 3699999975543 3456788999999999996 9999999998754
Q ss_pred CeEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 153 QSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
+.++||||||+||+|.+++... ..+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+
T Consensus 76 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 76 PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLAT 152 (276)
T ss_dssp SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSC
T ss_pred cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEcccccee
Confidence 5689999999999999999764 569999999999999999999999999999999999999 556789999999998
Q ss_pred cccCC---cceecccCcccccchHHHhh----cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHH-HHHcCCCCCC-C
Q 016233 232 FIEEG---KVYRDIVGSAYYVAPEVLRR----RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFD-AILQGDIDFE-S 302 (393)
Q Consensus 232 ~~~~~---~~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~-~i~~~~~~~~-~ 302 (393)
..... .......||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.+....+. .+.++..... .
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 232 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS 232 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGG
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcch
Confidence 76532 23356789999999999863 37889999999999999999999998876655444 4444433222 2
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
.....+++++.+||.+||..||++|||++|++++
T Consensus 233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 2345789999999999999999999999999976
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-57 Score=419.59 Aligned_cols=262 Identities=26% Similarity=0.392 Sum_probs=216.1
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe------
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED------ 151 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~------ 151 (393)
-++|+++++||+|+||+||+|++..+|+.||||++..... .......+.+|+.+|++++ ||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhc-CCCccceEeeeeccccccc
Confidence 4689999999999999999999999999999999876543 3445678889999999996 9999999998754
Q ss_pred --CCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 152 --KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 152 --~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
++.+|+|||||.++.+.........+++..++.+++||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~ 163 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGL 163 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTT
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecce
Confidence 45689999999887766555556789999999999999999999999999999999999999 5567799999999
Q ss_pred cccccCCc-----ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC
Q 016233 230 SVFIEEGK-----VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFES 302 (393)
Q Consensus 230 a~~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 302 (393)
+..+.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..+....+......+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 98665322 2344679999999999864 4899999999999999999999999998887777666553333322
Q ss_pred CCCCC----------------------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 303 APWPT----------------------------ISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 303 ~~~~~----------------------------~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
..+.. .++++.|||.+||..||++|||++|+|+||||+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~ 313 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 313 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCC
Confidence 22111 2678899999999999999999999999999986543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-57 Score=410.93 Aligned_cols=257 Identities=19% Similarity=0.302 Sum_probs=218.2
Q ss_pred ccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe
Q 016233 72 KPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED 151 (393)
Q Consensus 72 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 151 (393)
.+|+...++|++++.||+|+||.||+|.++ +++.||||+++.. ....+.+.+|+.+|++++ |||||++++++.+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~ 79 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG----SMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ 79 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT----SSCHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccC----cCCHHHHHHHHHHHHhCC-CCCEeEEEeeecc
Confidence 456666789999999999999999999986 5788999998653 234678999999999996 9999999998765
Q ss_pred CCeEEEEEeccCCCChHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 152 KQSVHVVMELCAGGELFDRIIAK--GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 152 ~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
+.+++|||||++|+|.+++... ..+++.++..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+
T Consensus 80 -~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGl 155 (272)
T d1qpca_ 80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGL 155 (272)
T ss_dssp -SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTT
T ss_pred -CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccc
Confidence 4579999999999999876433 359999999999999999999999999999999999999 5677899999999
Q ss_pred cccccCCcc--eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhC-CCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 016233 230 SVFIEEGKV--YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSG-VPPFWAETEKGIFDAILQGDIDFESAPW 305 (393)
Q Consensus 230 a~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (393)
|+....... .....||+.|||||++.+ .++.++|||||||++|||+|| .+||...+..+.+..+..+..... .
T Consensus 156 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~---p 232 (272)
T d1qpca_ 156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---P 232 (272)
T ss_dssp CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---C
T ss_pred eEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---c
Confidence 998765432 234578999999999875 599999999999999999995 556667777777888877643322 2
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CccccC
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLE--HPWIKE 341 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~--h~~~~~ 341 (393)
..+++++.+||.+||+.||++|||++++++ |+||+.
T Consensus 233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 468999999999999999999999999998 788863
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=422.22 Aligned_cols=254 Identities=28% Similarity=0.427 Sum_probs=211.9
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe------C
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED------K 152 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~------~ 152 (393)
.+|+.+++||+|+||+||+|+++.+|+.||||++..... ...+|+++|++|+ ||||++++++|.. .
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSC
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcC-CCCCCcEEEEEEecCccCCc
Confidence 379999999999999999999999999999999975432 2247999999996 9999999999853 3
Q ss_pred CeEEEEEeccCCCChHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 153 QSVHVVMELCAGGELFDR---IIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 153 ~~~~lv~e~~~gg~L~~~---l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
.++|||||||+++.+... ......+++.+++.+++||+.||+|||++||+||||||+|||++. +...+||+|||+
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~--~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGS 169 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TTCCEEECCCTT
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec--CCCceeEecccc
Confidence 458999999977643322 233557999999999999999999999999999999999999953 234699999999
Q ss_pred cccccCCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC-----------
Q 016233 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG----------- 296 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~----------- 296 (393)
+..........+.+||+.|+|||++.+ .|+.++||||+||++|+|++|..||...+..+.+..+...
T Consensus 170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 998877777777899999999998754 5899999999999999999999999988877776665421
Q ss_pred ------CCCCC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 297 ------DIDFE--------SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 297 ------~~~~~--------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
...++ ....+.+++++.+||.+||..||++|||+.|+|+||||++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 01111 11234578999999999999999999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-57 Score=411.01 Aligned_cols=246 Identities=25% Similarity=0.332 Sum_probs=207.7
Q ss_pred ceecccCCeEEEEEEEC--CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEEEecc
Q 016233 85 KELGRGQFGVTYLCTEN--STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVVMELC 162 (393)
Q Consensus 85 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 162 (393)
++||+|+||.||+|.+. .+++.||||+++.... .....+.+.+|+++|++++ |||||+++++++++ ..+||||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~~-~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGICEAE-SWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEESS-SEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCC-CCCCceEEEEeccC-CEEEEEEcC
Confidence 46999999999999864 4567899999965432 3345678999999999996 99999999998755 578999999
Q ss_pred CCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCcce---
Q 016233 163 AGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGKVY--- 239 (393)
Q Consensus 163 ~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~~~--- 239 (393)
++|+|.+++.....+++.++..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++........
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc---cccCcccccchhhhhhcccccccccc
Confidence 999999999988899999999999999999999999999999999999999 45667999999999876544322
Q ss_pred -ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHH
Q 016233 240 -RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLV 316 (393)
Q Consensus 240 -~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 316 (393)
....||+.|||||++.+ .++.++|||||||++|||+| |..||.+.+..++...+.++.... ....+|+++.+||
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~~~~li 243 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGCPREMYDLM 243 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHHHH
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCC---CCcccCHHHHHHH
Confidence 23579999999999865 58999999999999999998 899999999888888888764322 2246899999999
Q ss_pred HHhcccCCCCCCCHHHH---hcCccc
Q 016233 317 RRMLTQDPKKRITSAQV---LEHPWI 339 (393)
Q Consensus 317 ~~~L~~dp~~Rpt~~e~---l~h~~~ 339 (393)
.+||+.||++|||++++ |+|+|+
T Consensus 244 ~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 244 NLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 99999999999999998 456554
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.7e-57 Score=414.07 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=205.0
Q ss_pred ccceeecceecccCCeEEEEEEECCCCc---EEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGR---QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
..+|++.+.||+|+||+||+|.++.+++ .||||.+.... .....+.+.+|+++|++|+ |||||++++++.+.+.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCE
Confidence 4679999999999999999999987765 58888875432 3445678999999999996 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
+++|||||+||+|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.+
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEc
Confidence 99999999999999988764 469999999999999999999999999999999999999 56778999999999876
Q ss_pred cCCcce------ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 016233 234 EEGKVY------RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (393)
Q Consensus 234 ~~~~~~------~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (393)
...... ....||+.|||||++.+ .++.++|||||||++|||+| |..||.+.+..+++..+..+... +..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~---~~~ 255 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL---PPP 255 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCC
Confidence 543221 22457899999999875 59999999999999999998 89999999998888888776432 223
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
..+++++.+||.+||+.||++|||+.|++++
T Consensus 256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 5689999999999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-57 Score=410.19 Aligned_cols=253 Identities=24% Similarity=0.326 Sum_probs=215.1
Q ss_pred ccceeecce-ecccCCeEEEEEEECCC--CcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 78 KLHYSFGKE-LGRGQFGVTYLCTENST--GRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 78 ~~~y~~~~~-lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
+++|.+.+. ||+|+||.||+|.++.+ +..||||+++... .....+.+.+|+++|++++ |||||++++++.++ .
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~-~ 82 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQAE-A 82 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-S
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCC-CCCEeeEeeeeccC-e
Confidence 457888884 99999999999987644 4579999997542 3445678999999999996 99999999998764 5
Q ss_pred EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
+|||||||+||+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.+
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec---cCCceeeccchhhhcc
Confidence 89999999999999987654 5799999999999999999999999999999999999994 5667999999999987
Q ss_pred cCCcce----ecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 016233 234 EEGKVY----RDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (393)
Q Consensus 234 ~~~~~~----~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (393)
...... ....||+.|+|||++.+ .++.++|||||||++|||+| |..||.+.+..++...+..+.... ..+.
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~ 236 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPPE 236 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC---CCTT
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCc
Confidence 654322 24568999999999874 59999999999999999998 999999988888888888765422 2256
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHH---hcCcccc
Q 016233 308 ISSSAKDLVRRMLTQDPKKRITSAQV---LEHPWIK 340 (393)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rpt~~e~---l~h~~~~ 340 (393)
+++++.+||.+||..||++|||+.++ |+|+|+.
T Consensus 237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 89999999999999999999999888 5677775
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-56 Score=420.28 Aligned_cols=259 Identities=24% Similarity=0.438 Sum_probs=212.9
Q ss_pred ccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC--
Q 016233 76 DVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ-- 153 (393)
Q Consensus 76 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-- 153 (393)
.+..+|++++.||+|+||+||+|.++.+|+.||||++++.. ......+.+.+|+.+|+.++ |||||+++++|...+
T Consensus 15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETL 92 (346)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSST
T ss_pred ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCccc
Confidence 46789999999999999999999999999999999997543 23445678899999999996 999999999997654
Q ss_pred ----eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 154 ----SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 154 ----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
.+|+||||| |.+|...+ ..+.+++..++.+++||+.||.|||++||+||||||+|||+ +.++.+|++|||+
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGL 167 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred cccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---ccccccccccccc
Confidence 579999999 65666544 55689999999999999999999999999999999999999 5677799999999
Q ss_pred cccccCCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC---------
Q 016233 230 SVFIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI--------- 298 (393)
Q Consensus 230 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~--------- 298 (393)
|+..... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+....+..+.....
T Consensus 168 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 168 ARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp CEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred eeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 9876543 456789999999999864 478999999999999999999999998877665544432111
Q ss_pred --------------CCC----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCC
Q 016233 299 --------------DFE----SAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGG 343 (393)
Q Consensus 299 --------------~~~----~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 343 (393)
... ......+++++.+||.+||..||++|||++|+|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 111 112356799999999999999999999999999999998643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-57 Score=421.21 Aligned_cols=260 Identities=31% Similarity=0.554 Sum_probs=220.3
Q ss_pred cceeecceecccCCeEEEEEEE---CCCCcEEEEEEeecCccC-CcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 79 LHYSFGKELGRGQFGVTYLCTE---NSTGRQFACKSISKRKLV-TKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
++|++++.||+|+||+||+|.+ +.+|+.||||++++.... .....+.+.+|+++|+++++||||+++++++++.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5799999999999999999997 447899999999765432 223456788999999999856999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 155 VHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
+++||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhhhc
Confidence 99999999999999999999999999999999999999999999999999999999999 556779999999998764
Q ss_pred CC--cceecccCcccccchHHHhh---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 235 EG--KVYRDIVGSAYYVAPEVLRR---RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 235 ~~--~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
.. .......||+.|+|||.+.+ .++.++|||||||+||+|++|..||.+.+..+....+.+............+|
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s 260 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence 33 23456789999999999864 37889999999999999999999998776554444444333333333335689
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHhcCccccC
Q 016233 310 SSAKDLVRRMLTQDPKKRI-----TSAQVLEHPWIKE 341 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rp-----t~~e~l~h~~~~~ 341 (393)
+++.+||.+||..||++|| |++|+|+||||+.
T Consensus 261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999999999999999 5899999999975
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=405.24 Aligned_cols=246 Identities=24% Similarity=0.431 Sum_probs=204.3
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.+|++++.||+|+||.||+|.+. +++.||||+++.. ....+++.+|++++++++ |||||++++++.+++.+++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~----~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG----AMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS----SSCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC----cCcHHHHHHHHHHHHhcC-CCCcccccceeccCCceEEE
Confidence 46999999999999999999986 4678999998653 234578999999999997 99999999999999999999
Q ss_pred EeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 159 MELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
||||++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+++......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC---------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCCC
Confidence 9999999999988764 568899999999999999999999999999999999999 566789999999998765443
Q ss_pred c--eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 238 V--YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 238 ~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
. .....||+.|+|||++.+ .|+.++|||||||++|||+| |.+||...+..+++..+..+..... ...+++++.
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~ 232 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVY 232 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC---CTTSCHHHH
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCHHHH
Confidence 2 234679999999999875 59999999999999999999 5777777777788888877644322 245789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
+||.+||+.||++|||++|+++|
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999885
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-56 Score=416.84 Aligned_cols=254 Identities=27% Similarity=0.503 Sum_probs=213.3
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC--CeE
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK--QSV 155 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~ 155 (393)
.++|+++++||+|+||+||+|+++.+|+.||||+++.. ..+.+.+|+.+|+.+.+||||++++++|... ..+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 46899999999999999999999999999999998642 3577899999999997799999999999744 569
Q ss_pred EEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 156 HVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
++|||||.+++|.... +.+++.+++.+++||+.||+|||++||+||||||+|||++. ++..+||+|||+|.....
T Consensus 108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~--~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCGGGCEECCT
T ss_pred eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC--CCCeeeecccccceeccC
Confidence 9999999999997653 47999999999999999999999999999999999999963 344699999999998877
Q ss_pred CcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHc-------------CCCC
Q 016233 236 GKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEK-GIFDAILQ-------------GDID 299 (393)
Q Consensus 236 ~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~-------------~~~~ 299 (393)
.......+||+.|+|||++.+ .++.++||||+||++|+|++|..||...... +....+.. ....
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 767778899999999999865 4899999999999999999999999765432 22211110 0000
Q ss_pred --------------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 300 --------------------FESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 300 --------------------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
+....+..+++++.|||++||..||++|||++|+|+||||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 1111223478999999999999999999999999999999863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-56 Score=401.19 Aligned_cols=246 Identities=23% Similarity=0.386 Sum_probs=217.1
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
.+|+++++||+|+||+||+|+++ +++.||||++++.. ...+.+.+|+.++++++ ||||+++++++.+++.+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~----~~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS----MSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS----SCHHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc----CCHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEE
Confidence 36889999999999999999985 67899999997643 34678999999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc
Q 016233 159 MELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~ 237 (393)
|||+++|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSS
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCC
Confidence 999999999988765 4579999999999999999999999999999999999999 566789999999998765433
Q ss_pred c--eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHH
Q 016233 238 V--YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTISSSAK 313 (393)
Q Consensus 238 ~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 313 (393)
. .....||+.|+|||++.+ .++.++|||||||++|||+| |+.||.+.+..++...+..+.... ....+++++.
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~ 231 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---RPHLASEKVY 231 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCHHHH
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC---CcccccHHHH
Confidence 2 234679999999999875 58999999999999999998 899999999998888888764332 2246889999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 016233 314 DLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 314 ~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
+||.+||+.||++|||++++|+|
T Consensus 232 ~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 232 TIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=403.92 Aligned_cols=259 Identities=24% Similarity=0.412 Sum_probs=220.3
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
++|+++++||+|+||+||+|++..+|+.||||+++.... .......+.+|+.+|+.++ ||||+++++++.+....++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccceeEE
Confidence 489999999999999999999999999999999976542 3455788999999999996 99999999999999999999
Q ss_pred EeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccCCc-
Q 016233 159 MELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEEGK- 237 (393)
Q Consensus 159 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~- 237 (393)
+|++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||+ +....+||+|||.+.......
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCS
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCCc
Confidence 9999999998888888899999999999999999999999999999999999999 455679999999998876543
Q ss_pred ceecccCcccccchHHHhhc--CCCcchHHHHHHHHHHHhhCCCCCC-CCChHHHHHHHHcCCCCC--------------
Q 016233 238 VYRDIVGSAYYVAPEVLRRR--YGKEIDIWSAGVILYILLSGVPPFW-AETEKGIFDAILQGDIDF-------------- 300 (393)
Q Consensus 238 ~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~~lltg~~pf~-~~~~~~~~~~i~~~~~~~-------------- 300 (393)
......+++.|+|||++... ++.++|||||||++|+|++|..||. +.+..+.+..+.......
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 33445678899999988653 7899999999999999999999865 445555555543211110
Q ss_pred -----------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 301 -----------ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 301 -----------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
.......+++.+.+||.+||..||.+|||++|+|+||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 111224578999999999999999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-56 Score=418.22 Aligned_cols=262 Identities=30% Similarity=0.435 Sum_probs=212.3
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCC---
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQ--- 153 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--- 153 (393)
+..+|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+.+|+.+|++|+ ||||+++++++....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTT
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeeccccc
Confidence 4568999999999999999999999999999999997533 3344667889999999996 999999999997653
Q ss_pred --eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 154 --SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 154 --~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
.+|++ +++.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 83 ~~~~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 83 MKDVYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLAR 157 (345)
T ss_dssp CCCEEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred cceEEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCcee
Confidence 34555 55669999998865 479999999999999999999999999999999999999 556789999999998
Q ss_pred cccCCc----ceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC-------
Q 016233 232 FIEEGK----VYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDI------- 298 (393)
Q Consensus 232 ~~~~~~----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~------- 298 (393)
...... .....+||+.|+|||++.. .++.++||||+||++|+|++|..||.+.+..+..........
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 764432 2345679999999999854 478999999999999999999999988876555444322100
Q ss_pred ----------------CCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCCCC
Q 016233 299 ----------------DFES----APWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGEAS 346 (393)
Q Consensus 299 ----------------~~~~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~ 346 (393)
.... ..++.+++++++||.+||..||++|||++|+|+||||++.....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~ 305 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCc
Confidence 0000 12456889999999999999999999999999999998654433
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-56 Score=402.82 Aligned_cols=253 Identities=23% Similarity=0.366 Sum_probs=206.0
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCC---cEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEE
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTG---RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYE 150 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 150 (393)
|+..+++|++++.||+|+||.||+|++..++ ..||||.++... .....+.+.+|+.+|++++ |||||++++++.
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 78 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT 78 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence 4556789999999999999999999987554 468888875432 3445678999999999996 999999999996
Q ss_pred eCCeEEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCC
Q 016233 151 DKQSVHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGL 229 (393)
Q Consensus 151 ~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~ 229 (393)
+ +.+|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus 79 ~-~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~---~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 79 E-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGL 154 (273)
T ss_dssp S-SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC---
T ss_pred c-CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec---CCCcEEEccchh
Confidence 4 5789999999999999987654 4699999999999999999999999999999999999994 556799999999
Q ss_pred cccccCCc--ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 016233 230 SVFIEEGK--VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPW 305 (393)
Q Consensus 230 a~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 305 (393)
|+...... ......||+.|+|||++.+ .++.++|||||||++|||+| |.+||.+.+..+++..+..+... ..+
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~ 231 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMP 231 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCC
T ss_pred heeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCC
Confidence 98765433 2334578999999999875 69999999999999999998 89999999988888888877543 234
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 306 PTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 306 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
+.+|+++.+||.+||..||++|||+.|+++|
T Consensus 232 ~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 6789999999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-55 Score=399.50 Aligned_cols=261 Identities=22% Similarity=0.349 Sum_probs=213.8
Q ss_pred cccccccccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEE
Q 016233 69 ILGKPYEDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (393)
Q Consensus 69 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 148 (393)
....+|+...++|++++.||+|+||.||+|.++.+ +.||||+++... ...+.+.+|+.++++++ |||||+++++
T Consensus 7 ~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~----~~~~~~~~E~~~l~~l~-h~nIv~~~g~ 80 (285)
T d1fmka3 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAV 80 (285)
T ss_dssp SSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred CCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc----CCHHHHHHHHHHHHhcc-cCCEeEEEEE
Confidence 33445566677899999999999999999998765 579999986432 34678999999999996 9999999999
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEee
Q 016233 149 YEDKQSVHVVMELCAGGELFDRIIA--KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATD 226 (393)
Q Consensus 149 ~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~D 226 (393)
+.+ +.+++|||||++|+|..++.. ...+++.++..++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 81 ~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~D 156 (285)
T d1fmka3 81 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVAD 156 (285)
T ss_dssp ECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECC
T ss_pred Eec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcc
Confidence 865 457899999999999888754 4579999999999999999999999999999999999999 5567799999
Q ss_pred cCCcccccCCc--ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhC-CCCCCCCChHHHHHHHHcCCCCCCC
Q 016233 227 FGLSVFIEEGK--VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSG-VPPFWAETEKGIFDAILQGDIDFES 302 (393)
Q Consensus 227 Fg~a~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~ 302 (393)
||+++...... ......||+.|+|||++.. .++.++|||||||++|||++| .+||.+....+++..+..+...
T Consensus 157 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~--- 233 (285)
T d1fmka3 157 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--- 233 (285)
T ss_dssp CCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---
T ss_pred cchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC---
Confidence 99998765433 2334679999999999875 699999999999999999995 5555666777778777765432
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CccccCC
Q 016233 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQVLE--HPWIKEG 342 (393)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~--h~~~~~~ 342 (393)
+....+++++++||.+||+.||++|||++++++ ++||...
T Consensus 234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 233578999999999999999999999999988 8898764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=415.25 Aligned_cols=260 Identities=25% Similarity=0.390 Sum_probs=214.3
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeC----
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDK---- 152 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---- 152 (393)
+.++|++++.||+|+||+||+|++..+|+.||||++.+.. ......+.+.+|+++|++|+ |||||++++++...
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~~~~ 93 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLE 93 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSTT
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeccccc
Confidence 4578999999999999999999999999999999997543 23345567889999999996 99999999998633
Q ss_pred -CeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 153 -QSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 153 -~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
...++|++|+.||+|.+++. .+.+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+|++|||++.
T Consensus 94 ~~~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 94 EFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLAR 169 (348)
T ss_dssp TCCCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC----
T ss_pred cCceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccchhc
Confidence 33456677778999998774 4579999999999999999999999999999999999999 556779999999997
Q ss_pred cccCCcceecccCcccccchHHHhh--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC--------
Q 016233 232 FIEEGKVYRDIVGSAYYVAPEVLRR--RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGDIDFE-------- 301 (393)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~-------- 301 (393)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+........
T Consensus 170 ~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 170 HTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred ccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence 6543 3456789999999998765 368999999999999999999999999887776666644221111
Q ss_pred ---------------CC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCCC
Q 016233 302 ---------------SA----PWPTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEGGE 344 (393)
Q Consensus 302 ---------------~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 344 (393)
.. .+..++++++|||.+||..||.+|||++|+|+||||++...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 11 13468999999999999999999999999999999987543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-55 Score=413.00 Aligned_cols=258 Identities=26% Similarity=0.417 Sum_probs=202.9
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe-----
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED----- 151 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----- 151 (393)
+..+|+++++||+|+||+||+|++..+|+.||||++.+... .......+.+|+.+|++++ |||||+++++|..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEecccccc
Confidence 34689999999999999999999999999999999976543 3445667899999999996 9999999999953
Q ss_pred -CCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCc
Q 016233 152 -KQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLS 230 (393)
Q Consensus 152 -~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a 230 (393)
...+|+|||||.++ +.+.+ ...+++..++.+++||+.||.|||++||+||||||+|||+ +.++.+|++|||++
T Consensus 93 ~~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 93 EFQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA 166 (355)
T ss_dssp TCCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC-
T ss_pred cCceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeechhhh
Confidence 46899999999665 44444 3579999999999999999999999999999999999999 55667999999999
Q ss_pred ccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC-------------
Q 016233 231 VFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQG------------- 296 (393)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~------------- 296 (393)
+...........+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred hccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 98877666677889999999999876 5899999999999999999999999988876665554321
Q ss_pred ---------CCCCCCCCC----------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 016233 297 ---------DIDFESAPW----------------PTISSSAKDLVRRMLTQDPKKRITSAQVLEHPWIKEG 342 (393)
Q Consensus 297 ---------~~~~~~~~~----------------~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 342 (393)
........+ ...++++.+||++||..||++|||++|+|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 111111100 1136778999999999999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=395.50 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=203.7
Q ss_pred cceeecceecccCCeEEEEEEECCCC----cEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCe
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTG----RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQS 154 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 154 (393)
..|++.+.||+|+||.||+|.++.++ ..||||++.... .......+.+|+++|++++ |||||++++++.+.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecCCc
Confidence 46999999999999999999987655 479999986543 3445567899999999996 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccc
Q 016233 155 VHVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFI 233 (393)
Q Consensus 155 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~ 233 (393)
.++|||||.++++.+.+... ..+++.++..++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC----
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhhcc
Confidence 99999999999999887765 579999999999999999999999999999999999999 56778999999999876
Q ss_pred cCCc----ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhC-CCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 016233 234 EEGK----VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSG-VPPFWAETEKGIFDAILQGDIDFESAPWPT 307 (393)
Q Consensus 234 ~~~~----~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 307 (393)
.... ......||+.|||||++.+ .++.++|||||||++|||++| .+||...+..+++..+..+... .....
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~---~~~~~ 237 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL---PTPMD 237 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCCTT
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC---CCchh
Confidence 5432 2234568999999999875 599999999999999999995 5556666777777777766432 22246
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 308 ISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 308 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
++.++.+||.+||..||++|||+.|+++
T Consensus 238 ~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 238 CPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 8899999999999999999999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-55 Score=402.36 Aligned_cols=256 Identities=24% Similarity=0.351 Sum_probs=202.9
Q ss_pred cccccccceeecceecccCCeEEEEEEECC-----CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeE
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENS-----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 147 (393)
+|+...++|++++.||+|+||.||+|.+.. +++.||||+++... .....+.+.+|..++.++.+|+||+.+++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 455567899999999999999999999754 45689999986433 33456678889999988877999999999
Q ss_pred EEEeC-CeEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCc
Q 016233 148 AYEDK-QSVHVVMELCAGGELFDRIIAK----------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210 (393)
Q Consensus 148 ~~~~~-~~~~lv~e~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~N 210 (393)
++... +.+++|||||++|+|.+++... ..+++.++..++.||+.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N 164 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccc
Confidence 87654 5689999999999999999753 248899999999999999999999999999999999
Q ss_pred EEeccCCCCCcEEEeecCCcccccCCc---ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhC-CCCCCCCC
Q 016233 211 FLLSSKDENALLKATDFGLSVFIEEGK---VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSG-VPPFWAET 285 (393)
Q Consensus 211 ill~~~~~~~~~kl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg-~~pf~~~~ 285 (393)
||+ +.++.+||+|||+|+...... ......||+.|||||++.+ .++.++|||||||++|||+|| .+||.+..
T Consensus 165 ILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 165 ILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp EEE---CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eeE---CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 999 556779999999998765432 2234679999999999875 589999999999999999986 56787765
Q ss_pred hHHHH-HHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 286 EKGIF-DAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 286 ~~~~~-~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
..+.+ ..+..+.. +. ....+++++.+||.+||..||++|||++|+++|
T Consensus 242 ~~~~~~~~~~~~~~-~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 242 IDEEFCRRLKEGTR-MR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CSHHHHHHHHHTCC-CC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhcCCC-CC--CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44444 44444432 22 224689999999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-55 Score=403.33 Aligned_cols=250 Identities=25% Similarity=0.341 Sum_probs=211.2
Q ss_pred cceeecceecccCCeEEEEEEECCCCcE--EEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQ--FACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
++|++.+.||+|+||.||+|+++.+|.. ||||.+.... .....+.+.+|+++|+++.+|||||++++++.+.+.++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 5799999999999999999999988875 6677665332 34456779999999999955999999999999999999
Q ss_pred EEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCC
Q 016233 157 VVMELCAGGELFDRIIAK----------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENA 220 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~ 220 (393)
+||||++||+|.++|... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +..+
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCCC
Confidence 999999999999998653 468999999999999999999999999999999999999 5566
Q ss_pred cEEEeecCCcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCC-CCCCCCChHHHHHHHHcCCC
Q 016233 221 LLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGV-PPFWAETEKGIFDAILQGDI 298 (393)
Q Consensus 221 ~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~-~pf~~~~~~~~~~~i~~~~~ 298 (393)
.+||+|||+++............||..|+|||.+.+ .++.++|||||||++|||++|. +||.+.+..+++..+..+..
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~ 244 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence 799999999987665444456679999999999875 5999999999999999999965 67888888888888877532
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 299 DFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 299 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
...+..+++++.+||.+||..||++|||+.|+++|
T Consensus 245 ---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 245 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22335789999999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=393.85 Aligned_cols=250 Identities=22% Similarity=0.343 Sum_probs=203.4
Q ss_pred cceeecceecccCCeEEEEEEECCC-C--cEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENST-G--RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
.+|++.+.||+|+||.||+|.+..+ + ..||||++.+.........+.+.+|+.+|++++ |||||++++++.++ .+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~~-~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTP-PM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSS-SC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeec-ch
Confidence 4699999999999999999986533 3 368999998766555555678999999999996 99999999999764 67
Q ss_pred EEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
++|||||++|++.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~---~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccc---cccceeeccchhhhhcc
Confidence 8999999999999877654 5699999999999999999999999999999999999995 45679999999999875
Q ss_pred CCcc----eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCC
Q 016233 235 EGKV----YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTI 308 (393)
Q Consensus 235 ~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 308 (393)
.... .....|+..|+|||++.+ .++.++|||||||++|||+| |..||.+.+..+.+..+.+....++ ..+.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~ 240 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPEDC 240 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CCTTC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC--Ccccc
Confidence 4332 223467889999999876 58999999999999999998 8999999999999888887755443 33578
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 309 SSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
|+++.+||.+||..||++|||++++++
T Consensus 241 ~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 241 PQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-54 Score=396.69 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=217.1
Q ss_pred ccccccceeecceecccCCeEEEEEEEC-----CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEE
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGA 148 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 148 (393)
++..+++|++++.||+|+||+||+|+++ .+++.||||+++... .....+++.+|+.+|++++ ||||++++++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~-h~niv~~~~~ 84 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGV 84 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEE
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcC-CCCcccceee
Confidence 4455778999999999999999999975 356789999986543 3345678999999999996 9999999999
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHHcC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEec
Q 016233 149 YEDKQSVHVVMELCAGGELFDRIIAKG------------------------HYSERAAASICRSIVNVVHICHFMGVMHR 204 (393)
Q Consensus 149 ~~~~~~~~lv~e~~~gg~L~~~l~~~~------------------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~ 204 (393)
+.+.+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+++||||
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr 164 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence 999999999999999999999986532 37889999999999999999999999999
Q ss_pred CCCCCcEEeccCCCCCcEEEeecCCcccccCCc---ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCC-C
Q 016233 205 DLKPENFLLSSKDENALLKATDFGLSVFIEEGK---VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGV-P 279 (393)
Q Consensus 205 Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~-~ 279 (393)
||||+|||+ +.++.+||+|||+|+...... ...+..||+.|+|||.+.+ .|+.++|||||||++|||++|. +
T Consensus 165 DlKp~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 165 DLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EEcccceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999 556779999999998764432 2335678999999999876 5999999999999999999985 7
Q ss_pred CCCCCChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 280 PFWAETEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 280 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
||.+.+..+++..+..+.... ....+++++.+||.+||+.||++|||+.|+++
T Consensus 242 p~~~~~~~e~~~~v~~~~~~~---~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 242 PYYGMAHEEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTTTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHcCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 899999999999988876432 23478999999999999999999999999965
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-54 Score=399.37 Aligned_cols=248 Identities=20% Similarity=0.293 Sum_probs=206.7
Q ss_pred ceeecceecccCCeEEEEEEECCCCc----EEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeE
Q 016233 80 HYSFGKELGRGQFGVTYLCTENSTGR----QFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSV 155 (393)
Q Consensus 80 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 155 (393)
+|++++.||+|+||+||+|.+..+|+ .||+|.+.... .....+.+.+|+.++++++ |||||++++++.++ ..
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-SE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC-Ce
Confidence 59999999999999999999988876 57788775432 3445778999999999996 99999999999875 46
Q ss_pred EEEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCccccc
Q 016233 156 HVVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIE 234 (393)
Q Consensus 156 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~ 234 (393)
++++||+.+|+|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+...
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCCSHHHHTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee---CCCCCeEeeccccceecc
Confidence 7888999999999888764 579999999999999999999999999999999999999 456679999999998775
Q ss_pred CCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 235 EGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 235 ~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
.... .....||+.|+|||++.+ .|+.++|||||||++|||+| |.+||.+.+..++...+..+.... ..+.++
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~---~p~~~~ 239 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPICT 239 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC---CCTTBC
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCcccC
Confidence 4332 234568999999998865 59999999999999999998 899999888888887777764322 224689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLEHP 337 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~ 337 (393)
+++.+||.+||..||++|||+.|+++|.
T Consensus 240 ~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 240 IDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 9999999999999999999999999873
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-54 Score=394.76 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=214.0
Q ss_pred ccccccceeecceecccCCeEEEEEEECCCC-------cEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEe
Q 016233 74 YEDVKLHYSFGKELGRGQFGVTYLCTENSTG-------RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFK 146 (393)
Q Consensus 74 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~ 146 (393)
|+...++|++++.||+|+||.||+|++..++ ..||||+++... .......+.+|..++.++.+|||||+++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 5566789999999999999999999976554 379999986543 3445678889999999996699999999
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCc
Q 016233 147 GAYEDKQSVHVVMELCAGGELFDRIIAK----------------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPEN 210 (393)
Q Consensus 147 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~N 210 (393)
+++.+++.+++|||||++|+|.+++... ..+++.++..++.||+.||+|||+++||||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 9999999999999999999999999654 248999999999999999999999999999999999
Q ss_pred EEeccCCCCCcEEEeecCCcccccCCc---ceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCC
Q 016233 211 FLLSSKDENALLKATDFGLSVFIEEGK---VYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAET 285 (393)
Q Consensus 211 ill~~~~~~~~~kl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 285 (393)
||+ +.++.+||+|||+++...... ......||+.|+|||.+.+ .|+.++|||||||++|+|++ |.+||.+.+
T Consensus 166 iLl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 166 VLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp EEE---CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eee---cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 999 566779999999999775543 2344679999999998865 69999999999999999998 799999888
Q ss_pred hHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 286 EKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 286 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
..+++..+..+... . ....+++++.+||.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~i~~~~~~-~--~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLKEGHRM-D--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHTTCCC-C--CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCC-C--CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 88888887776432 2 23468999999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-54 Score=387.02 Aligned_cols=246 Identities=22% Similarity=0.326 Sum_probs=203.3
Q ss_pred cccccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe-CC
Q 016233 75 EDVKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED-KQ 153 (393)
Q Consensus 75 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~ 153 (393)
+.-.++|++++.||+|+||.||+|.++ |..||||+++.. ...+.+.+|++++++++ ||||+++++++.+ ++
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG 74 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCC-CTTBCCEEEEECCC--
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-----HHHHHHHHHHHHHHhCC-CCCEeeEEEEEEecCC
Confidence 334567999999999999999999985 779999998643 34578999999999996 9999999998854 56
Q ss_pred eEEEEEeccCCCChHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 154 SVHVVMELCAGGELFDRIIAKG--HYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 154 ~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK 151 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccce
Confidence 7899999999999999986543 48999999999999999999999999999999999999 566789999999998
Q ss_pred cccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCCC
Q 016233 232 FIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAETEKGIFDAILQGDIDFESAPWPTIS 309 (393)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 309 (393)
..... .....+|+.|+|||++.+ .++.++|||||||++|||+| |.+||...+..++...+.++.... ....++
T Consensus 152 ~~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~ 226 (262)
T d1byga_ 152 EASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---APDGCP 226 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC---CCTTCC
T ss_pred ecCCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCccCC
Confidence 76543 344578999999998864 69999999999999999998 799999888888888887654322 224688
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 310 SSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 310 ~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
+++.+||.+||..||++|||+.+++++
T Consensus 227 ~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 227 PAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 999999999999999999999999773
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=392.27 Aligned_cols=256 Identities=25% Similarity=0.364 Sum_probs=215.2
Q ss_pred cccccccceeecceecccCCeEEEEEEEC-----CCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeE
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLCTEN-----STGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 147 (393)
.|+...++|++++.||+|+||.||+|++. .+++.||||+++... .......+.+|+.+++.+.+|||||++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 45556789999999999999999999863 466799999997543 34456678999999999967999999999
Q ss_pred EEEeCCeEEEEEeccCCCChHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCC
Q 016233 148 AYEDKQSVHVVMELCAGGELFDRIIAKG------------------HYSERAAASICRSIVNVVHICHFMGVMHRDLKPE 209 (393)
Q Consensus 148 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~------------------~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~ 209 (393)
++.+.+.+++|||||++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 9999999999999999999999987643 4889999999999999999999999999999999
Q ss_pred cEEeccCCCCCcEEEeecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhh-CCCCCCCC
Q 016233 210 NFLLSSKDENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLS-GVPPFWAE 284 (393)
Q Consensus 210 Nill~~~~~~~~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~llt-g~~pf~~~ 284 (393)
||++ +..+.+||+|||+++....... .....||+.|+|||++.+ .++.++|||||||++|+|+| |.+||...
T Consensus 175 NIl~---~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 175 NILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp GEEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccc---cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 9999 5567899999999997764332 234578999999999875 58999999999999999998 66667666
Q ss_pred ChHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 285 TEKGIFDAILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 285 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
...+.+..+......... ...+++++.+||.+||+.||++|||++++++
T Consensus 252 ~~~~~~~~~i~~~~~~~~--~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 252 PVDSKFYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CSSHHHHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 665555554443332222 2467899999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-53 Score=388.56 Aligned_cols=260 Identities=20% Similarity=0.335 Sum_probs=221.8
Q ss_pred cccccccceeecceecccCCeEEEEEEECC-----CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeE
Q 016233 73 PYEDVKLHYSFGKELGRGQFGVTYLCTENS-----TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKG 147 (393)
Q Consensus 73 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 147 (393)
.|+...++|++++.||+|+||.||+|.+.. ++..||||+++... .......+.+|+.++++++ |||||++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~-h~nIv~~~~ 90 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLG 90 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcC-CCCEeeeee
Confidence 456667899999999999999999999753 35789999986432 3445567899999999996 999999999
Q ss_pred EEEeCCeEEEEEeccCCCChHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCC
Q 016233 148 AYEDKQSVHVVMELCAGGELFDRIIAK----------GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD 217 (393)
Q Consensus 148 ~~~~~~~~~lv~e~~~gg~L~~~l~~~----------~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~ 217 (393)
++..++..++|||||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||+ +
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d 167 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---A 167 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---C
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---c
Confidence 999999999999999999999988643 236889999999999999999999999999999999999 6
Q ss_pred CCCcEEEeecCCcccccCCcc---eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhC-CCCCCCCChHHHHHH
Q 016233 218 ENALLKATDFGLSVFIEEGKV---YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSG-VPPFWAETEKGIFDA 292 (393)
Q Consensus 218 ~~~~~kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~ 292 (393)
.+..+||+|||+|+....... .....||+.|+|||.+.+ .++.++|||||||++|||+|| .+||.+.+..+.+..
T Consensus 168 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~ 247 (308)
T d1p4oa_ 168 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247 (308)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 677899999999987654332 233468999999999875 588899999999999999998 588888888888888
Q ss_pred HHcCCCCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc------CccccC
Q 016233 293 ILQGDIDFESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE------HPWIKE 341 (393)
Q Consensus 293 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~------h~~~~~ 341 (393)
+..+..... ...+++.+.+||.+||+.||++|||++++++ +|+|++
T Consensus 248 i~~~~~~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 248 VMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp HHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred HHhCCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 887654322 2468899999999999999999999999997 666653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-53 Score=389.94 Aligned_cols=260 Identities=19% Similarity=0.279 Sum_probs=208.5
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
+.++|++++.||+|+||.||+|++..+|+.||||++.... ....+.+|+++++.+++|++|+.+.+++.+.+..+
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 3468999999999999999999999999999999987543 22357889999999985666777888888999999
Q ss_pred EEEeccCCCChHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 157 VVMELCAGGELFDRIIA-KGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
+||||+ +++|.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+|||+...+.+..+||+|||+|+.+..
T Consensus 80 ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 80 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 999999 5566665544 56799999999999999999999999999999999999997666777899999999998754
Q ss_pred Cc--------ceecccCcccccchHHHhhc-CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHH---HcCCCCC-CC
Q 016233 236 GK--------VYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAI---LQGDIDF-ES 302 (393)
Q Consensus 236 ~~--------~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i---~~~~~~~-~~ 302 (393)
.. ......||+.|||||++.+. ++.++|||||||++|+|++|..||...........+ ....... ..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 32 22356899999999998764 999999999999999999999999876544332222 1111111 11
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHH---HhcCccccCC
Q 016233 303 APWPTISSSAKDLVRRMLTQDPKKRITSAQ---VLEHPWIKEG 342 (393)
Q Consensus 303 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e---~l~h~~~~~~ 342 (393)
.....+|+++.+||.+||..||++||++.+ +|+|+|.+.+
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 123568999999999999999999999874 5778776543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-51 Score=376.79 Aligned_cols=247 Identities=21% Similarity=0.307 Sum_probs=202.1
Q ss_pred eeecceecccCCeEEEEEEECCCC---cEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEe-CCeEE
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTG---RQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYED-KQSVH 156 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~~~~ 156 (393)
+.+.++||+|+||+||+|.+..++ ..||||.+++. ......+++.+|+++|++|+ |||||++++++.+ ++.++
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceE
Confidence 344688999999999999987654 36899998643 24456688999999999997 9999999998765 56899
Q ss_pred EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEeecCCcccccC
Q 016233 157 VVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKATDFGLSVFIEE 235 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~~~~~ 235 (393)
+|||||++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||+ +++..+||+|||+++....
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTT
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhccc
Confidence 999999999999988754 357788899999999999999999999999999999999 5677899999999987654
Q ss_pred Ccc-----eecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCC-ChHHHHHHHHcCCCCCCCCCCCCC
Q 016233 236 GKV-----YRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAE-TEKGIFDAILQGDIDFESAPWPTI 308 (393)
Q Consensus 236 ~~~-----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 308 (393)
... .....||+.|+|||.+.. .++.++||||||+++|||+||..||... +..+....+..+..... ...+
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~---p~~~ 259 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PEYC 259 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCC---CTTC
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---cccC
Confidence 322 223568999999998864 6999999999999999999977777654 34455566666643322 2467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 016233 309 SSSAKDLVRRMLTQDPKKRITSAQVLEH 336 (393)
Q Consensus 309 s~~~~~li~~~L~~dp~~Rpt~~e~l~h 336 (393)
++++.+||.+||..||++|||+.|+++|
T Consensus 260 ~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 260 PDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 8999999999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.7e-51 Score=375.38 Aligned_cols=253 Identities=20% Similarity=0.283 Sum_probs=208.5
Q ss_pred cccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 77 VKLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 77 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
+..+|++++.||+|+||+||+|++..+|+.||||++.... ....+.+|+++++.|.+|+||+.+++++......+
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 4568999999999999999999999999999999986543 23457789999999987799999999999999999
Q ss_pred EEEeccCCCChHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCC--CCCcEEEeecCCcccc
Q 016233 157 VVMELCAGGELFDRIIAK-GHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKD--ENALLKATDFGLSVFI 233 (393)
Q Consensus 157 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~--~~~~~kl~DFg~a~~~ 233 (393)
+||||+ |++|.+++... ..+++.++..++.|++.||+|||++||+||||||+|||++... ..+.+||+|||+|+..
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 999999 78999888765 4699999999999999999999999999999999999996432 3567999999999876
Q ss_pred cCCc--------ceecccCcccccchHHHhhc-CCCcchHHHHHHHHHHHhhCCCCCCCCCh---HHHHHHHHcCCCC-C
Q 016233 234 EEGK--------VYRDIVGSAYYVAPEVLRRR-YGKEIDIWSAGVILYILLSGVPPFWAETE---KGIFDAILQGDID-F 300 (393)
Q Consensus 234 ~~~~--------~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~-~ 300 (393)
.... .....+||+.|||||++.+. ++.++|||||||++|+|++|..||.+... ...+..+...... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 5321 23356899999999998764 99999999999999999999999976433 2333333322111 1
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 301 ESAPWPTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 301 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
.....+.+|+++.+++..|+..+|++||+++.+.+
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11123468899999999999999999999877644
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-50 Score=367.82 Aligned_cols=245 Identities=21% Similarity=0.300 Sum_probs=190.0
Q ss_pred ccceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHH--HHHHHHHHccCCCCeeEEeEEEEeCC--
Q 016233 78 KLHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIK--REIQIMQHLSGQPNIVEFKGAYEDKQ-- 153 (393)
Q Consensus 78 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~--~E~~~l~~l~~h~niv~~~~~~~~~~-- 153 (393)
..+|.+.+.||+|+||.||+|++ +|+.||||+++.+ ...... .|+..+..++ |||||++++++.+++
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~------~~~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~~ 72 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLR-HENILGFIAADNKDNGT 72 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc------chhHHHHHHHHHHHhhCC-CCcCcceEEEEEeCCCc
Confidence 35799999999999999999996 4899999998543 223333 4555556675 999999999987654
Q ss_pred --eEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH--------cCcEecCCCCCcEEeccCCCCCcEE
Q 016233 154 --SVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHF--------MGVMHRDLKPENFLLSSKDENALLK 223 (393)
Q Consensus 154 --~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~--------~~ivH~Dikp~Nill~~~~~~~~~k 223 (393)
.+|+|||||++|+|.+++.+. .+++.....++.|++.||.|||+ +||+||||||+|||+ +.++.+|
T Consensus 73 ~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~K 148 (303)
T d1vjya_ 73 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCC 148 (303)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEE
T ss_pred ceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeE
Confidence 689999999999999999764 69999999999999999999996 599999999999999 5667899
Q ss_pred EeecCCcccccCCc-----ceecccCcccccchHHHhhc-------CCCcchHHHHHHHHHHHhhCCCCCCCC-------
Q 016233 224 ATDFGLSVFIEEGK-----VYRDIVGSAYYVAPEVLRRR-------YGKEIDIWSAGVILYILLSGVPPFWAE------- 284 (393)
Q Consensus 224 l~DFg~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~-------~~~~~DiwSlG~il~~lltg~~pf~~~------- 284 (393)
|+|||+++...... ......||+.|+|||++.+. ++.++|||||||+||||+||..||...
T Consensus 149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~ 228 (303)
T d1vjya_ 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence 99999998775433 22356899999999998643 567899999999999999998877321
Q ss_pred --------ChHHHHHHHHcCCCCCCCC-CC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 016233 285 --------TEKGIFDAILQGDIDFESA-PW--PTISSSAKDLVRRMLTQDPKKRITSAQVLE 335 (393)
Q Consensus 285 --------~~~~~~~~i~~~~~~~~~~-~~--~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 335 (393)
........+.........+ .+ ......+.+|+.+||..||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 1122333333322221111 11 112345899999999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.4e-48 Score=365.23 Aligned_cols=258 Identities=25% Similarity=0.454 Sum_probs=197.2
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHcc----------CCCCeeEEeEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLS----------GQPNIVEFKGA 148 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------~h~niv~~~~~ 148 (393)
.+|+++++||+|+||+||+|++..+|+.||||++++.. ...+.+.+|+.+++.+. +|+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 46999999999999999999999999999999997532 23467788999998885 25789999998
Q ss_pred EEe--CCeEEEEEeccCCCChHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH-cCcEecCCCCCcEEeccCCCC---
Q 016233 149 YED--KQSVHVVMELCAGGELFDRII---AKGHYSERAAASICRSIVNVVHICHF-MGVMHRDLKPENFLLSSKDEN--- 219 (393)
Q Consensus 149 ~~~--~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~i~~qll~~l~~lH~-~~ivH~Dikp~Nill~~~~~~--- 219 (393)
+.. ....+++++++..+....... ....+++..++.+++||+.||.|||+ +||+||||||+|||++.++..
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 754 456777777776654433322 23568999999999999999999998 899999999999999654322
Q ss_pred CcEEEeecCCcccccCCcceecccCcccccchHHHhh-cCCCcchHHHHHHHHHHHhhCCCCCCCCChH------HHHHH
Q 016233 220 ALLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRR-RYGKEIDIWSAGVILYILLSGVPPFWAETEK------GIFDA 292 (393)
Q Consensus 220 ~~~kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~------~~~~~ 292 (393)
..++++|||.+...... ....+||+.|+|||++.. .++.++||||+||++++|++|+.||...... +.+..
T Consensus 169 ~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred ceeeEeecccccccccc--cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 35899999999865433 356789999999998875 5899999999999999999999999754321 11111
Q ss_pred HHc--CC------------------C----CCCC--------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 016233 293 ILQ--GD------------------I----DFES--------------APWPTISSSAKDLVRRMLTQDPKKRITSAQVL 334 (393)
Q Consensus 293 i~~--~~------------------~----~~~~--------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l 334 (393)
... +. . .... ..+...++++.|||.+||..||.+|||++|+|
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 100 00 0 0000 01122467899999999999999999999999
Q ss_pred cCccccCC
Q 016233 335 EHPWIKEG 342 (393)
Q Consensus 335 ~h~~~~~~ 342 (393)
+||||++.
T Consensus 327 ~Hp~f~~~ 334 (362)
T d1q8ya_ 327 NHPWLKDT 334 (362)
T ss_dssp TCGGGTTC
T ss_pred cCcccCCC
Confidence 99999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=7.5e-28 Score=205.59 Aligned_cols=165 Identities=22% Similarity=0.197 Sum_probs=123.0
Q ss_pred eeecceecccCCeEEEEEEECCCCcEEEEEEeecCccC-----C----------cccHHHHHHHHHHHHHccCCCCeeEE
Q 016233 81 YSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLV-----T----------KNDKDDIKREIQIMQHLSGQPNIVEF 145 (393)
Q Consensus 81 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~----------~~~~~~~~~E~~~l~~l~~h~niv~~ 145 (393)
|.++++||+|+||+||+|.+. +|+.||||+++..... . ........+|...+.++. |.+++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCCE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCcceE
Confidence 568899999999999999985 6899999987532210 0 001233456889999996 8999988
Q ss_pred eEEEEeCCeEEEEEeccCCCChHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCcEecCCCCCcEEeccCCCCCcEEEe
Q 016233 146 KGAYEDKQSVHVVMELCAGGELFDRIIAKGHYSERAAASICRSIVNVVHICHFMGVMHRDLKPENFLLSSKDENALLKAT 225 (393)
Q Consensus 146 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qll~~l~~lH~~~ivH~Dikp~Nill~~~~~~~~~kl~ 225 (393)
+++.. .+++|||+++..+. .+++..+..++.|++.+|.|||++||+||||||+|||++. ..++|+
T Consensus 80 ~~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~----~~~~li 144 (191)
T d1zara2 80 YAWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE----EGIWII 144 (191)
T ss_dssp EEEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET----TEEEEC
T ss_pred EEecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC----CCEEEE
Confidence 76532 27999999887653 3556667889999999999999999999999999999952 238999
Q ss_pred ecCCcccccCCcceecccCcccccc------hHHHhhcCCCcchHHHHHH
Q 016233 226 DFGLSVFIEEGKVYRDIVGSAYYVA------PEVLRRRYGKEIDIWSAGV 269 (393)
Q Consensus 226 DFg~a~~~~~~~~~~~~~gt~~y~a------PE~l~~~~~~~~DiwSlG~ 269 (393)
|||+|........ ..|.. .+.+...|+.++|+||+.-
T Consensus 145 DFG~a~~~~~~~~-------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 145 DFPQSVEVGEEGW-------REILERDVRNIITYFSRTYRTEKDINSAID 187 (191)
T ss_dssp CCTTCEETTSTTH-------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred ECCCcccCCCCCc-------HHHHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence 9999987653321 11211 1334466899999999854
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.75 E-value=2.9e-08 Score=86.69 Aligned_cols=86 Identities=15% Similarity=0.101 Sum_probs=63.7
Q ss_pred cceeecceecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEEEE
Q 016233 79 LHYSFGKELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVHVV 158 (393)
Q Consensus 79 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 158 (393)
..|++.+..+-++.+.||+.. ..++.+.+|+...... .....+.+|..+++.|..+--+.+++.+.++++..++|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc---cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 356666665555567899876 3467788998764432 23445788999999887665578888888899999999
Q ss_pred EeccCCCChHH
Q 016233 159 MELCAGGELFD 169 (393)
Q Consensus 159 ~e~~~gg~L~~ 169 (393)
|++++|.++.+
T Consensus 89 ~~~l~G~~~~~ 99 (263)
T d1j7la_ 89 MSEADGVLCSE 99 (263)
T ss_dssp EECCSSEEHHH
T ss_pred EEecccccccc
Confidence 99999877654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.41 E-value=4.8e-07 Score=83.71 Aligned_cols=82 Identities=13% Similarity=0.104 Sum_probs=52.4
Q ss_pred cceecccCCeEEEEEEECCCCcEEEEEEeecCc-c---CCcccHHHHHHHHHHHHHccCC--CCeeEEeEEEEeCCeEEE
Q 016233 84 GKELGRGQFGVTYLCTENSTGRQFACKSISKRK-L---VTKNDKDDIKREIQIMQHLSGQ--PNIVEFKGAYEDKQSVHV 157 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~~~~~l 157 (393)
.+.||.|....||++.+..+++.++||.-.... . .......+...|.+.|+.+..+ ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 346899999999999988778899999754211 0 0122345567788888887543 245666654 3444578
Q ss_pred EEeccCCCCh
Q 016233 158 VMELCAGGEL 167 (393)
Q Consensus 158 v~e~~~gg~L 167 (393)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.20 E-value=3.5e-06 Score=72.60 Aligned_cols=74 Identities=8% Similarity=0.052 Sum_probs=52.5
Q ss_pred ecccC-CeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCC-CeeEEeEEEEeCCeEEEEEeccCC
Q 016233 87 LGRGQ-FGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQP-NIVEFKGAYEDKQSVHVVMELCAG 164 (393)
Q Consensus 87 lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~~~~~~~~~~~lv~e~~~g 164 (393)
+..|. .+.||+.... ++..+.+|..... ....+..|+..++.|..+. .+.+++.+..+++..++||++++|
T Consensus 18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~------~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEECT-TSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEeC-CCCEEEEEeCCcc------CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 44444 3679988754 4667888976432 2345778888888886432 366788888888899999999988
Q ss_pred CCh
Q 016233 165 GEL 167 (393)
Q Consensus 165 g~L 167 (393)
.++
T Consensus 91 ~~~ 93 (255)
T d1nd4a_ 91 QDL 93 (255)
T ss_dssp EET
T ss_pred ccc
Confidence 654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.69 E-value=6e-05 Score=69.24 Aligned_cols=75 Identities=13% Similarity=0.150 Sum_probs=53.0
Q ss_pred cceecccCCeEEEEEEECC-------CCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCeeEEeEEEEeCCeEE
Q 016233 84 GKELGRGQFGVTYLCTENS-------TGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNIVEFKGAYEDKQSVH 156 (393)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 156 (393)
++.|+.|-.-.+|++.... ..+.|.+++.-. ........+|..+++.+..+.-.+++++++.+ +
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-----~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-----PETESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-----CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-----cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 4678889999999988653 345688887642 12334567899999999755445578777653 6
Q ss_pred EEEeccCCCCh
Q 016233 157 VVMELCAGGEL 167 (393)
Q Consensus 157 lv~e~~~gg~L 167 (393)
+|+||++|.+|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 89999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.24 E-value=0.00068 Score=60.13 Aligned_cols=68 Identities=16% Similarity=0.159 Sum_probs=46.5
Q ss_pred CeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCCCCe--eEEe-----EEEEeCCeEEEEEeccCC
Q 016233 92 FGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQPNI--VEFK-----GAYEDKQSVHVVMELCAG 164 (393)
Q Consensus 92 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni--v~~~-----~~~~~~~~~~lv~e~~~g 164 (393)
--.||++.. .+|..|++|+.+.. ....+++..|...+..|..+ +| +..+ ..+...+..+.+++++.|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~----~~s~~~i~~E~~~l~~L~~~-gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPE----RWTADQILEEHQFALQLVND-EVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTT----TSCHHHHHHHHHHHHHHHHT-TCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCC----CCCHHHHHHHHHHHHHHHhc-CCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 458999875 46889999987543 23467788899999888622 22 1111 134556778999999987
Q ss_pred C
Q 016233 165 G 165 (393)
Q Consensus 165 g 165 (393)
.
T Consensus 109 ~ 109 (325)
T d1zyla1 109 R 109 (325)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.72 E-value=0.0022 Score=56.28 Aligned_cols=136 Identities=19% Similarity=0.188 Sum_probs=70.2
Q ss_pred eecccCCeEEEEEEECCCCcEEEEEEeecCccCCcccHHHHHHHHHHHHHccCC----CCeeEEe---EEEEeCCeEEEE
Q 016233 86 ELGRGQFGVTYLCTENSTGRQFACKSISKRKLVTKNDKDDIKREIQIMQHLSGQ----PNIVEFK---GAYEDKQSVHVV 158 (393)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h----~niv~~~---~~~~~~~~~~lv 158 (393)
.|..|.--+.|+.... +..+++|++.... ....+..|++++..|..+ |..+... .+..-......+
T Consensus 25 ~i~~G~~N~ny~v~t~--~g~yVLri~~~~~-----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~ 97 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTT--KDPLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 97 (316)
T ss_dssp EECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred cCCCCcccCeEEEEEC--CCcEEEEEcCCCC-----CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeeccccee
Confidence 3456666788998755 3469999885421 234566778888887622 2222111 122334556677
Q ss_pred EeccCCCChH--------------HHHHHcC---------CCCHH------------------HHHHHHHHHHHHHHHHH
Q 016233 159 MELCAGGELF--------------DRIIAKG---------HYSER------------------AAASICRSIVNVVHICH 197 (393)
Q Consensus 159 ~e~~~gg~L~--------------~~l~~~~---------~~~~~------------------~~~~i~~qll~~l~~lH 197 (393)
+.++.|.... ..+.... ..... .....+..+...+...+
T Consensus 98 ~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 177 (316)
T d2ppqa1 98 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 177 (316)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred eeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccC
Confidence 7777664321 0111000 00111 01111222222222222
Q ss_pred ----HcCcEecCCCCCcEEeccCCCCCcEEEeecCCcc
Q 016233 198 ----FMGVMHRDLKPENFLLSSKDENALLKATDFGLSV 231 (393)
Q Consensus 198 ----~~~ivH~Dikp~Nill~~~~~~~~~kl~DFg~a~ 231 (393)
..|+||+|+.++||+++ ++...-|+||+.+.
T Consensus 178 ~~~L~~giIHgDl~~dNvl~~---~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 178 PKDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFAC 212 (316)
T ss_dssp CCSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred ccccccccccCCcchhhhhcc---cccceeEecccccc
Confidence 24799999999999994 45556899999875
|